Citrus Sinensis ID: 046083
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 790 | 2.2.26 [Sep-21-2011] | |||||||
| A8R7E6 | 617 | Chitin elicitor receptor | yes | no | 0.746 | 0.956 | 0.566 | 0.0 | |
| D7UPN3 | 605 | Chitin elicitor receptor | yes | no | 0.683 | 0.892 | 0.522 | 1e-165 | |
| F4IB81 | 651 | LysM domain receptor-like | no | no | 0.413 | 0.502 | 0.453 | 4e-75 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.355 | 0.430 | 0.458 | 2e-65 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.355 | 0.391 | 0.434 | 2e-62 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.378 | 0.439 | 0.412 | 7e-62 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.355 | 0.547 | 0.444 | 8e-62 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.358 | 0.398 | 0.437 | 1e-60 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.450 | 0.495 | 0.372 | 1e-60 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.358 | 0.393 | 0.431 | 8e-60 |
| >sp|A8R7E6|CERK1_ARATH Chitin elicitor receptor kinase 1 OS=Arabidopsis thaliana GN=CERK1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 673 bits (1737), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/628 (56%), Positives = 448/628 (71%), Gaps = 38/628 (6%)
Query: 190 FELKLAL----LLVLAFFCARRRVEAVAECSKGCDLALASYYLWKGANLTFISKVFDTSI 245
+LK++L LL+ +FF A VE+ +C C LALASYYL G L+ I++ ++SI
Sbjct: 1 MKLKISLIAPILLLFSFFFA---VES--KCRTSCPLALASYYLENGTTLSVINQNLNSSI 55
Query: 246 --------KYILSFNPQITNKDKILAGTRINVPFSCNCIQNKFLGHSFSYKVKSGNTYKR 297
IL +N I +KD+I G+R+ VPF C C FLGH+FSY V+ +TY+R
Sbjct: 56 APYDQINFDPILRYNSNIKDKDRIQMGSRVLVPFPCECQPGDFLGHNFSYSVRQEDTYER 115
Query: 298 IAELIYANLTTLDWLKSSNAYDENHTPDVSSSVNVIVNCSCGSKSVSKDYGLFLTYPLRP 357
+A YANLTT++ L++ N + + P +S+++NV+VNCSCG +SVSKD+GLF+TYPLRP
Sbjct: 116 VAISNYANLTTMESLQARNPFPATNIP-LSATLNVLVNCSCGDESVSKDFGLFVTYPLRP 174
Query: 358 GENLSSIANEFELSSELLQSYNPTLDFISGSGLAFVPVK---------------GISSRA 402
++LSSIA +S+++LQ YNP ++F SG+G+ +VP + G+ +
Sbjct: 175 EDSLSSIARSSGVSADILQRYNPGVNFNSGNGIVYVPGRDPNGAFPPFKSSKQDGVGAGV 234
Query: 403 IAGISIGGVAGALFLAFCVYAGVYRRNKVVEASFLPEASEDHYIQHGPAIALVKNSESAA 462
IAGI IG + L + F VY YR+NK SF H + +L A
Sbjct: 235 IAGIVIGVIVALLLILFIVYYA-YRKNKSKGDSFSSSIPLSTKADHASSTSLQSGGLGGA 293
Query: 463 LVAAPGVTGITVDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMD 522
V+ PG+ I+VDKSVEFS EELAKAT++F++ KIGQGGFGAV+YAELRGEKAAIKKMD
Sbjct: 294 GVS-PGIAAISVDKSVEFSLEELAKATDNFNLSFKIGQGGFGAVYYAELRGEKAAIKKMD 352
Query: 523 MQASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTW 582
M+ASK+FLAELKVLT VHH+NLVRLIGYCVEGSLFLVYEY+ENGNL QHL GSG++ L W
Sbjct: 353 MEASKQFLAELKVLTRVHHVNLVRLIGYCVEGSLFLVYEYVENGNLGQHLHGSGREPLPW 412
Query: 583 SARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642
+ R+QIALDSARGLEYIHEHTVPVY+HRDIK ANILID+ FRAKVADFGL KLTEVG ++
Sbjct: 413 TKRVQIALDSARGLEYIHEHTVPVYVHRDIKSANILIDQKFRAKVADFGLTKLTEVGGSA 472
Query: 643 VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVA 702
+ GTFGYM PE YGEVS K+DVYAFGVVLYELISA AVVK E + E GLV
Sbjct: 473 TRGAM-GTFGYMAPETV-YGEVSAKVDVYAFGVVLYELISAKGAVVKMTEAVGEFRGLVG 530
Query: 703 LFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762
+FEE ++ D E L++++DPRLGD YP DSV KMA L +ACTQEN QLRPSMR IVVAL
Sbjct: 531 VFEESFKETDKEEALRKIIDPRLGDSYPFDSVYKMAELGKACTQENAQLRPSMRYIVVAL 590
Query: 763 MTLSSSSEDWDIGSFYENQGLDSLMSGR 790
TL SS+ +WD+G+F +N+ L SLMSGR
Sbjct: 591 STLFSSTGNWDVGNF-QNEDLVSLMSGR 617
|
Lysin motif (LysM) receptor kinase that functions as a cell surface receptor in chitin elicitor (chitooligosaccharides) signaling leading to innate immunity toward both biotic and abiotic stresses (e.g. tolerance to salinity, heavy-metal stresses, and Botrytis cinerea infection). Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands. Involved in the resistance to pathogenic fungi Alternaria brassicicola and Erysiphe cichoracearum, probably by sensing microbe-associated molecular patterns (MAMP) and pathogen-associated molecular patterns (PAMP). Plays an essential role in detecting peptidoglycans (e.g. PGNs) and restricting bacterial growth. Target of the bacterial type III effector E3-ligase protein hopAB2/avrPtoB of Pseudomonas syringae pv. tomato DC3000 that mediates ubiquitination and subsequent proteolysis, thus blocking all defense responses by suppressing PAMP-triggered immunity (PTI). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|D7UPN3|CERK1_ORYSJ Chitin elicitor receptor kinase 1 OS=Oryza sativa subsp. japonica GN=CERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 583 bits (1504), Expect = e-165, Method: Compositional matrix adjust.
Identities = 311/595 (52%), Positives = 404/595 (67%), Gaps = 55/595 (9%)
Query: 215 CSKGCDLALASYYLWKGANLTFISKVF---DTSIKYILSFNPQITNKDKILAGTRINVPF 271
C GC LA+A+YY +G+NLTFI+ +F + +L +NP ITN D ++ G R+ VPF
Sbjct: 26 CRAGCSLAIAAYYFSEGSNLTFIATIFAIGGGGYQALLPYNPAITNPDYVVTGDRVLVPF 85
Query: 272 SCNCI------QNKFLGHSFSYKVK----SGNTYKRIAELIYANLTTLDWLKSSNAYDEN 321
C+C+ + FL + Y + G+TY +A YA+LTT WL+++NAY
Sbjct: 86 PCSCLGLPAAPASTFLAGAIPYPLPLPRGGGDTYDAVAA-NYADLTTAAWLEATNAYPPG 144
Query: 322 HTPDVSSSVNVIVNCSCGSKSVSKDYGLFLTYPLRPGENLSSIANEFELSS----ELLQS 377
P VNV +NCSCG + VS YGLFLTYPL GE L S+A ++ SS EL++
Sbjct: 145 RIPGGDGRVNVTINCSCGDERVSPRYGLFLTYPLWDGETLESVAAQYGFSSPAEMELIRR 204
Query: 378 YNPTLDFISGSGLAFVPVK----------------GISSRAIAGISIGGVAGALFLAFCV 421
YNP + +SG G+ F+PVK +S AIAGI I +A +A +
Sbjct: 205 YNPGMGGVSGKGIVFIPVKDPNGSYHPLKSGGMGNSLSGGAIAGIVIACIA-IFIVAIWL 263
Query: 422 YAGVYRRNKVVEASFLPEASEDHYIQHGPAIALVKNSESAALVAAPGVTGITVDKSVEFS 481
YR K +A+ P E ++ A GI V++S+EFS
Sbjct: 264 IIMFYRWQKFRKATSRPSPEETSHLDD-----------------ASQAEGIKVERSIEFS 306
Query: 482 YEELAKATNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKVLTHVHH 541
YEE+ AT FSM +KIGQGGFG+V+YAELRGEK AIKKM MQA++EFLAELKVLTHVHH
Sbjct: 307 YEEIFNATQGFSMEHKIGQGGFGSVYYAELRGEKTAIKKMGMQATQEFLAELKVLTHVHH 366
Query: 542 LNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE 601
LNLVRLIGYCVE LFLVYE+I+NGNL+QHL+ +G L+W+ R+QIALDSARGLEY+HE
Sbjct: 367 LNLVRLIGYCVENCLFLVYEFIDNGNLSQHLQRTGYAPLSWATRVQIALDSARGLEYLHE 426
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA--SVHTRLVGTFGYMPPEYA 659
H VPVY+HRDIK ANIL+DK+FRAK+ADFGLAKLTEVGS S+ TR+ GTFGYMPPE A
Sbjct: 427 HVVPVYVHRDIKSANILLDKDFRAKIADFGLAKLTEVGSMSQSLSTRVAGTFGYMPPE-A 485
Query: 660 QYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719
+YGEVSPK+DVYAFGVVLYEL+SA +A+V+++E+++ES GLV LFEE L P+P E L
Sbjct: 486 RYGEVSPKVDVYAFGVVLYELLSAKQAIVRSSESVSESKGLVFLFEEALSAPNPTEALDE 545
Query: 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWDI 774
L+DP L DYP+DS K+A LA++CT E P +RP+MR++VVALM L+++++ D+
Sbjct: 546 LIDPSLQGDYPVDSALKIASLAKSCTHEEPGMRPTMRSVVVALMALTANTDLRDM 600
|
Plays an essential role in detecting peptidoglycans (e.g. PGNs) and restricting bacterial growth. Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands (By similarity). Lysin motif (LysM) receptor kinase required as a cell surface receptor for chitin elicitor (chitooligosaccharides) signaling leading to innate immunity in response to both biotic and abiotic stresses. Involved in the resistance to pathogenic fungi, probably by sensing microbe-associated molecular patterns (MAMP) and pathogen-associated molecular patterns (PAMP). Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|F4IB81|LYK3_ARATH LysM domain receptor-like kinase 3 OS=Arabidopsis thaliana GN=LYK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 283 bits (724), Expect = 4e-75, Method: Compositional matrix adjust.
Identities = 156/344 (45%), Positives = 216/344 (62%), Gaps = 17/344 (4%)
Query: 463 LVAAPGVTG---ITVDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELRGEKAAIK 519
+VA P G ++K + F+YEE+ AT++FS N +G G +G+V++ LR ++ A+K
Sbjct: 309 VVAIPKALGDGMFEIEKPMVFTYEEIRAATDEFSDSNLLGHGNYGSVYFGLLREQEVAVK 368
Query: 520 KMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLNQHL---RGS 575
+M +KEF AE+KVL VHH NLV LIGY LF+VYEY+ G L HL +
Sbjct: 369 RMTATKTKEFAAEMKVLCKVHHSNLVELIGYAATVDELFVVYEYVRKGMLKSHLHDPQSK 428
Query: 576 GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635
G L+W R QIALD+ARGLEYIHEHT Y+HRDIK +NIL+D+ FRAK++DFGLAKL
Sbjct: 429 GNTPLSWIMRNQIALDAARGLEYIHEHTKTHYVHRDIKTSNILLDEAFRAKISDFGLAKL 488
Query: 636 TEV---GSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNE 692
E G SV T++VGT+GY+ PEY G + K D+YAFGVVL+E+IS EAV++T
Sbjct: 489 VEKTGEGEISV-TKVVGTYGYLAPEYLSDGLATSKSDIYAFGVVLFEIISGREAVIRTEA 547
Query: 693 TIT---ESTGLVALFEEVLRQ-PDP--REDLQRLVDPRLGDDYPIDSVRKMARLARACTQ 746
T E L ++ VL+ PD L+ VDP + D YP D + K+A LA+ C
Sbjct: 548 IGTKNPERRPLASIMLAVLKNSPDSMNMSSLKEFVDPNMMDLYPHDCLFKIATLAKQCVD 607
Query: 747 ENPQLRPSMRAIVVALMTLSSSSEDWDIGSFYENQGLDSLMSGR 790
++P LRP+M+ +V++L + SS +W+ +Q L+ GR
Sbjct: 608 DDPILRPNMKQVVISLSQILLSSIEWEATLAGNSQVFSGLVQGR 651
|
Putative Lysin motif (LysM) receptor kinase that may recognize microbe-derived N-acetylglucosamine (NAG)-containing ligands. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 251 bits (640), Expect = 2e-65, Method: Compositional matrix adjust.
Identities = 132/288 (45%), Positives = 184/288 (63%), Gaps = 7/288 (2%)
Query: 480 FSYEELAKATNDFSMGNKIGQGGFGAVFYAEL-RGEKAAIKKMDM---QASKEFLAELKV 535
F+YEEL++ATN FS N +GQGGFG V L G++ A+K++ Q +EF AE+++
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327
Query: 536 LTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSAR 594
++ VHH +LV LIGYC+ G LVYE++ N NL HL G G+ T+ WS R++IAL SA+
Sbjct: 328 ISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIALGSAK 387
Query: 595 GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYM 654
GL Y+HE P IHRDIK +NILID F AKVADFGLAK+ + V TR++GTFGY+
Sbjct: 388 GLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFGYL 447
Query: 655 PPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714
PEYA G+++ K DV++FGVVL ELI+ V N + +S LV +L +
Sbjct: 448 APEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDS--LVDWARPLLNRASEE 505
Query: 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762
D + L D ++G++Y + + +M A AC + + + RP M IV AL
Sbjct: 506 GDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRAL 553
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 241 bits (614), Expect = 2e-62, Method: Compositional matrix adjust.
Identities = 125/288 (43%), Positives = 180/288 (62%), Gaps = 7/288 (2%)
Query: 480 FSYEELAKATNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKM---DMQASKEFLAELKV 535
F+YEEL++ATN FS N +GQGGFG VF LR G++ A+K++ Q +EF AE+ +
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVGI 401
Query: 536 LTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSAR 594
++ VHH +LV L+GYC+ + LVYE++ N L HL G G+ T+ WS+R++IA+ SA+
Sbjct: 402 ISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSSRLKIAVGSAK 461
Query: 595 GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYM 654
GL Y+HE+ P IHRDIK +NILID F AKVADFGLAK+ + V TR++GTFGY+
Sbjct: 462 GLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFGYL 521
Query: 655 PPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714
PEYA G+++ K DV++FGVVL ELI+ + N + LV +L Q
Sbjct: 522 APEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNN--VHADNSLVDWARPLLNQVSEL 579
Query: 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762
+ + +VD +L ++Y + + +M A AC + RP M + L
Sbjct: 580 GNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVL 627
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 239 bits (610), Expect = 7e-62, Method: Compositional matrix adjust.
Identities = 127/308 (41%), Positives = 191/308 (62%), Gaps = 9/308 (2%)
Query: 470 TGITVDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDM---QA 525
+G+ ++ FSY+EL++ T+ FS N +G+GGFG V+ L G + A+K++ + Q
Sbjct: 317 SGMVSNQRSWFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQG 376
Query: 526 SKEFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSA 584
+EF AE+++++ VHH +LV L+GYC+ E LVY+Y+ N L+ HL G+ +TW
Sbjct: 377 EREFKAEVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWET 436
Query: 585 RMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH 644
R+++A +ARG+ Y+HE P IHRDIK +NIL+D +F A VADFGLAK+ + + H
Sbjct: 437 RVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTH 496
Query: 645 --TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVA 702
TR++GTFGYM PEYA G++S K DVY++GV+L ELI+ + V + ES LV
Sbjct: 497 VSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDES--LVE 554
Query: 703 LFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762
+L Q E+ LVDPRLG ++ + +M A AC + + RP M +V AL
Sbjct: 555 WARPLLGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRAL 614
Query: 763 MTLSSSSE 770
TL +++
Sbjct: 615 DTLEEATD 622
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 239 bits (609), Expect = 8e-62, Method: Compositional matrix adjust.
Identities = 128/288 (44%), Positives = 180/288 (62%), Gaps = 7/288 (2%)
Query: 480 FSYEELAKATNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDM---QASKEFLAELKV 535
F+Y ELA+ATN FS N +G+GGFG V+ L G + A+K++ + Q KEF AE+ +
Sbjct: 171 FTYGELARATNKFSEANLLGEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEVNI 230
Query: 536 LTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSAR 594
++ +HH NLV L+GYC+ G+ LVYE++ N L HL G G+ T+ WS R++IA+ S++
Sbjct: 231 ISQIHHRNLVSLVGYCIAGAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSLRLKIAVSSSK 290
Query: 595 GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYM 654
GL Y+HE+ P IHRDIK ANILID F AKVADFGLAK+ + V TR++GTFGY+
Sbjct: 291 GLSYLHENCNPKIIHRDIKAANILIDFKFEAKVADFGLAKIALDTNTHVSTRVMGTFGYL 350
Query: 655 PPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714
PEYA G+++ K DVY+FGVVL ELI+ V N +S LV +L Q
Sbjct: 351 APEYAASGKLTEKSDVYSFGVVLLELITGRRPVDANNVYADDS--LVDWARPLLVQALEE 408
Query: 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762
+ + L D +L ++Y + + +M A AC + + RP M +V L
Sbjct: 409 SNFEGLADIKLNNEYDREEMARMVACAAACVRYTARRRPRMDQVVRVL 456
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 235 bits (599), Expect = 1e-60, Method: Compositional matrix adjust.
Identities = 127/290 (43%), Positives = 177/290 (61%), Gaps = 7/290 (2%)
Query: 478 VEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDM---QASKEFLAEL 533
F+YEEL T FS N +G+GGFG V+ +L G+ A+K++ + Q +EF AE+
Sbjct: 339 THFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEV 398
Query: 534 KVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDS 592
++++ VHH +LV L+GYC+ S L+YEY+ N L HL G G+ L W+ R++IA+ S
Sbjct: 399 EIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIGS 458
Query: 593 ARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFG 652
A+GL Y+HE P IHRDIK ANIL+D F A+VADFGLAKL + V TR++GTFG
Sbjct: 459 AKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTFG 518
Query: 653 YMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD 712
Y+ PEYAQ G+++ + DV++FGVVL ELI+ + V + ES LV +L +
Sbjct: 519 YLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEES--LVEWARPLLHKAI 576
Query: 713 PREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762
D LVD RL Y + V +M A AC + + RP M +V AL
Sbjct: 577 ETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRAL 626
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 235 bits (599), Expect = 1e-60, Method: Compositional matrix adjust.
Identities = 148/397 (37%), Positives = 222/397 (55%), Gaps = 41/397 (10%)
Query: 399 SSRAIAGISIGGVAGALFLAFCVYAGVYRRNKVVEAS-----FLPEASED-------HYI 446
+ + + GI I GV LF+A + V R+ K +S +LP A+ HY
Sbjct: 259 TEKTVIGIGIAGVLVILFIAGVFF--VRRKQKKGSSSPRSNQYLPPANVSVNTEGFIHYR 316
Query: 447 QHGPAIALVKNSESAALVAAPGVTGI--------TVDKSV------EFSYEELAKATNDF 492
Q P N S+A ++P + T D +V F+YEEL++ T F
Sbjct: 317 QK-PG-----NGNSSAQNSSPDTNSLGNPKHGRGTPDSAVIGTSKIHFTYEELSQITEGF 370
Query: 493 SMGNKIGQGGFGAVFYAEL-RGEKAAIKKM---DMQASKEFLAELKVLTHVHHLNLVRLI 548
+G+GGFG V+ L G+ AIK++ + +EF AE+++++ VHH +LV L+
Sbjct: 371 CKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEIISRVHHRHLVSLV 430
Query: 549 GYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVY 607
GYC+ E FL+YE++ N L+ HL G L WS R++IA+ +A+GL Y+HE P
Sbjct: 431 GYCISEQHRFLIYEFVPNNTLDYHLHGKNLPVLEWSRRVRIAIGAAKGLAYLHEDCHPKI 490
Query: 608 IHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPK 667
IHRDIK +NIL+D F A+VADFGLA+L + + + TR++GTFGY+ PEYA G+++ +
Sbjct: 491 IHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHISTRVMGTFGYLAPEYASSGKLTDR 550
Query: 668 IDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGD 727
DV++FGVVL ELI+ + V T++ + E + LV L + + D+ +VDPRL +
Sbjct: 551 SDVFSFGVVLLELITGRKP-VDTSQPLGEES-LVEWARPRLIEAIEKGDISEVVDPRLEN 608
Query: 728 DYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764
DY V KM A +C + + RP M +V AL T
Sbjct: 609 DYVESEVYKMIETAASCVRHSALKRPRMVQVVRALDT 645
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 232 bits (592), Expect = 8e-60, Method: Compositional matrix adjust.
Identities = 125/290 (43%), Positives = 177/290 (61%), Gaps = 7/290 (2%)
Query: 478 VEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDM---QASKEFLAEL 533
FSYEELA+ T F+ N +G+GGFG V+ L+ G+ A+K++ Q +EF AE+
Sbjct: 357 THFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEV 416
Query: 534 KVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDS 592
++++ VHH +LV L+GYC+ + L+YEY+ N L HL G G L WS R++IA+ S
Sbjct: 417 EIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVRIAIGS 476
Query: 593 ARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFG 652
A+GL Y+HE P IHRDIK ANIL+D + A+VADFGLA+L + V TR++GTFG
Sbjct: 477 AKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRVMGTFG 536
Query: 653 YMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD 712
Y+ PEYA G+++ + DV++FGVVL EL++ + V +T ES LV +L +
Sbjct: 537 YLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEES--LVEWARPLLLKAI 594
Query: 713 PREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762
DL L+D RL Y V +M A AC + + RP M +V AL
Sbjct: 595 ETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRAL 644
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 790 | ||||||
| 302144092 | 650 | unnamed protein product [Vitis vinifera] | 0.794 | 0.966 | 0.671 | 0.0 | |
| 359485632 | 619 | PREDICTED: proline-rich receptor-like pr | 0.729 | 0.930 | 0.706 | 0.0 | |
| 224115870 | 628 | predicted protein [Populus trichocarpa] | 0.729 | 0.917 | 0.704 | 0.0 | |
| 297739193 | 625 | unnamed protein product [Vitis vinifera] | 0.750 | 0.948 | 0.662 | 0.0 | |
| 147833187 | 2252 | hypothetical protein VITISV_030803 [Viti | 0.859 | 0.301 | 0.568 | 0.0 | |
| 255554785 | 607 | receptor protein kinase, putative [Ricin | 0.731 | 0.952 | 0.703 | 0.0 | |
| 359483329 | 619 | PREDICTED: proline-rich receptor-like pr | 0.741 | 0.946 | 0.682 | 0.0 | |
| 345843162 | 623 | Bti9 [Nicotiana benthamiana] | 0.748 | 0.948 | 0.644 | 0.0 | |
| 356557941 | 625 | PREDICTED: proline-rich receptor-like pr | 0.726 | 0.918 | 0.677 | 0.0 | |
| 255568675 | 603 | receptor protein kinase, putative [Ricin | 0.730 | 0.956 | 0.678 | 0.0 |
| >gi|302144092|emb|CBI23197.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 902 bits (2330), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 451/672 (67%), Positives = 520/672 (77%), Gaps = 44/672 (6%)
Query: 139 YGLFTTYPLRPAQNLSSVAAEAGVAPQSLQRYNPGTNFSAGTGLVFVPARVFELKLALLL 198
YGLF TYPLR +NLS+VAA AG+ ++RYNP +FSAGTGLVFVPA+
Sbjct: 3 YGLFATYPLRDGENLSTVAAAAGITDDLVRRYNPAADFSAGTGLVFVPAKE--------- 53
Query: 199 VLAFFCARRRVEAVAECSKGCDLALASYYLWKGANLTFISKVFDTSIKYILSFNPQITNK 258
++CS+ CDLALASY LWKG +L FI+ F + I SFNPQITN
Sbjct: 54 --------------SKCSRTCDLALASYNLWKGVDLNFIATTFSRDVSEIQSFNPQITNI 99
Query: 259 DKILAGTRINVPFSCNCIQNKFLGHSFSYKVKSGNTYKRIAELIYANLTTLDWLKSSNAY 318
D I+AG R+NVPFSC CI +FLG +F Y K +TY IAE +ANLTT++WL+ N Y
Sbjct: 100 DLIIAGERVNVPFSCGCIDREFLGTTFVYSAKQNDTYSIIAEKYFANLTTVEWLQRFNTY 159
Query: 319 DENHTPDVSSSVNVIVNCSCGSKSVSKDYGLFLTYPLRPGENLSSIANEFELSSELLQSY 378
+ P + + +NV VNCSCG+ SVSKDYGLF+TYPL PGENLS+IAN+ L +LLQ Y
Sbjct: 160 APTNIP-IDAPINVTVNCSCGNSSVSKDYGLFVTYPLEPGENLSTIANQSGLPPQLLQDY 218
Query: 379 NPTLDFISGSGLAFVPVK---------------GISSRAIAGISIGGVAGALFLAFCVYA 423
NP DF GSGL F+P K GISS IAGIS+ G+ G+L AF ++A
Sbjct: 219 NPDSDFSRGSGLVFIPGKDQNETYPPLKLSNSAGISSGVIAGISVAGIVGSLLFAFFLFA 278
Query: 424 GVYRRNKVVEASFLPEASEDHYIQHGPA--IALVKNSESAALVAAP--GVTGITVDKSVE 479
+ +R KV + F P ASE Y+QH A A + S+SAALV A G+ GITVDKSVE
Sbjct: 279 RICKRKKVKKVLFFPAASEQQYMQHRQAHGSASEETSDSAALVGAASLGLVGITVDKSVE 338
Query: 480 FSYEELAKATNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKVLTHV 539
FSYEELA AT++FS+ NKIGQGGFG+V+YAELRGEKAAIKKMDMQASKEFLAELKVLTHV
Sbjct: 339 FSYEELATATDNFSLANKIGQGGFGSVYYAELRGEKAAIKKMDMQASKEFLAELKVLTHV 398
Query: 540 HHLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYI 599
HHLNLVRLIGYCVEGSLFLVYE+I+NGNL+ HLRGSGKD L WS+R+QIALDSARGLEYI
Sbjct: 399 HHLNLVRLIGYCVEGSLFLVYEFIDNGNLSHHLRGSGKDPLPWSSRVQIALDSARGLEYI 458
Query: 600 HEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYA 659
HEHTVPVYIHRDIKPANILIDK FRAKVADFGL KLTEVGSAS+ TRLVGTFGYMPPEYA
Sbjct: 459 HEHTVPVYIHRDIKPANILIDKKFRAKVADFGLTKLTEVGSASIPTRLVGTFGYMPPEYA 518
Query: 660 QYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETIT-ESTGLVALFEEVLRQPDPREDLQ 718
QYG+VSPKIDV+AFGVVLYELISA EA+VKTNE I ES GLVALFE+VL QPDPRED
Sbjct: 519 QYGDVSPKIDVFAFGVVLYELISAKEAIVKTNEPIMPESKGLVALFEDVLSQPDPREDFV 578
Query: 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWDIGSFY 778
+L+D RLGDDYP+DS+ KMA LA+ACTQENPQLRPSMR+IVVALMTLSSS+EDWD+GSFY
Sbjct: 579 KLIDQRLGDDYPLDSIWKMAHLAKACTQENPQLRPSMRSIVVALMTLSSSTEDWDVGSFY 638
Query: 779 ENQGLDSLMSGR 790
EN+ L +LMSGR
Sbjct: 639 ENEALMNLMSGR 650
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485632|ref|XP_002270987.2| PREDICTED: proline-rich receptor-like protein kinase PERK13-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 862 bits (2227), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/583 (70%), Positives = 491/583 (84%), Gaps = 7/583 (1%)
Query: 213 AECSKGCDLALASYYLWKGANLTFISKVFDTSIKYILSFNPQITNKDKILAGTRINVPFS 272
++CS+GCDLAL SYY+W+G+NLTFIS++F T+I ILS+N QI N+D + A TRI VP+S
Sbjct: 39 SQCSRGCDLALGSYYVWQGSNLTFISQLFQTTISEILSYNSQIANQDSVEADTRIRVPYS 98
Query: 273 -CNCIQNKFLGHSFSYKVKSGNTYKRIAELIYANLTTLDWLKSSNAYDENHTPDVSSSVN 331
C+CI +FLG F+Y V+SG+TY +AE Y+NLTT WL++ N+Y N PD + +N
Sbjct: 99 SCDCINGEFLGKVFNYTVQSGDTYDLVAETYYSNLTTSAWLQNFNSYAANQIPDTDAYLN 158
Query: 332 VIVNCSCGSKSVSKDYGLFLTYPLRPGENLSSIANEFELSSELLQSYNPTLDFISGSGLA 391
V +NCSCG+ +VSKDYGLFL+YPLRP +NL+S+A L++ LLQSYNP +F +GSGL
Sbjct: 159 VTLNCSCGNSTVSKDYGLFLSYPLRPEDNLTSVAESEGLNASLLQSYNPDSNFSAGSGLV 218
Query: 392 FVPVKGISSRAIAGISIGGVAGALFLAFCVYAGVYRRNKVVEASFLPEASEDHYIQ--HG 449
++P KG++ IAGISI V G L L C+Y G YR+ KV EA+ LP +E+H +Q HG
Sbjct: 219 YIPTKGLAGGVIAGISIAAVVGVLLLTVCIYIGFYRKRKVKEAALLP--TEEHSLQPGHG 276
Query: 450 PAIALVKNSESA--ALVAAPGVTGITVDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVF 507
P IA K ES A ++ G+TGITVDKSVEFSYEELAKA+++F++ NKIGQGGFG+V+
Sbjct: 277 PGIASDKAVESTGPAFGSSAGLTGITVDKSVEFSYEELAKASDNFNLANKIGQGGFGSVY 336
Query: 508 YAELRGEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN 567
YAELRGEKAAIKKMDMQAS+EFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN
Sbjct: 337 YAELRGEKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN 396
Query: 568 LNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKV 627
L+QHLRGSG+D L WS+R+QIALDSARGLEYIHEHTVPVYIHRDIK ANILIDKNF KV
Sbjct: 397 LSQHLRGSGRDPLQWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHGKV 456
Query: 628 ADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAV 687
ADFGL KLTEVGS+S+ TRLVGTFGYMPPEYAQYG+VSPK+DVYAFGVVLYELISA EAV
Sbjct: 457 ADFGLTKLTEVGSSSLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAV 516
Query: 688 VKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQE 747
VK N ++ ES GLVALFE+VL +PDPREDL++LVDPRL D+YP+DSVRKMA+LA+ACTQE
Sbjct: 517 VKDNGSVAESKGLVALFEDVLNKPDPREDLRKLVDPRLEDNYPLDSVRKMAQLAKACTQE 576
Query: 748 NPQLRPSMRAIVVALMTLSSSSEDWDIGSFYENQGLDSLMSGR 790
NPQLRPSMR IVVALMTLSSS+EDWD+GSFY+NQ L +LMSGR
Sbjct: 577 NPQLRPSMRTIVVALMTLSSSTEDWDVGSFYDNQALVNLMSGR 619
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115870|ref|XP_002317145.1| predicted protein [Populus trichocarpa] gi|222860210|gb|EEE97757.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 859 bits (2219), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/602 (70%), Positives = 485/602 (80%), Gaps = 26/602 (4%)
Query: 213 AECSKGCDLALASYYLWKGANLTFISKVFDTSIKYILSFNPQITNKDKILAGTRINVPFS 272
A+C GCDLALASYY+W+G+NLT+IS +F+ SI IL +NP++ N+D I + TR+NVPFS
Sbjct: 29 AKCRTGCDLALASYYVWQGSNLTYISTIFNQSITEILRYNPKVPNQDSIRSDTRLNVPFS 88
Query: 273 CNCIQNKFLGHSFSYKVKSGNTYKRIAELIYANLTTLDWLKSSNAYDENHTPDVSSSVNV 332
C+C+ FLGH+FSY +SG+TY +IA ++NLTT DW+ N YD P+ +NV
Sbjct: 89 CDCLNGDFLGHTFSYITQSGDTYHKIARNAFSNLTTEDWVHRVNIYDITEIPNYVP-INV 147
Query: 333 IVNCSCGSKSVSKDYGLFLTYPLRPGENLSSIANEFELSSELLQSYNPTLDFISGSGLAF 392
VNC+CG K VS+DYGLF TYPLRP EN SS+ E + ++LL+ YN DF +G G+ +
Sbjct: 148 TVNCTCGDKQVSRDYGLFATYPLRPDENFSSLEAESGVPADLLEKYNLGTDFNAGGGIVY 207
Query: 393 VPVK---------------------GISSRAIAGISIGGVAGALFLAFCVYAGVYRRNKV 431
+P K GISSRAIAGIS+ G+AGA FLA C Y G YRR +V
Sbjct: 208 MPAKDPTGNYPPLKILCCYAWPFQAGISSRAIAGISVAGIAGAFFLASCFYFGFYRRREV 267
Query: 432 VEASFLPEASEDHYI--QHGPAIALVKNSESAALVAAPGVTGITVDKSVEFSYEELAKAT 489
EAS PEA+E YI +HG L + SE+AALV +PG+TG TVDKSVEFSYEELAKAT
Sbjct: 268 -EASLFPEAAESPYIHHRHGSGNILEQTSETAALVGSPGLTGFTVDKSVEFSYEELAKAT 326
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIG 549
NDFSM NKIGQGGFGAV+YAELRGEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIG
Sbjct: 327 NDFSMDNKIGQGGFGAVYYAELRGEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIG 386
Query: 550 YCVEGSLFLVYEYIENGNLNQHLRG-SGKDTLTWSARMQIALDSARGLEYIHEHTVPVYI 608
YCVEGSLFLVYE+IENGNL QHLRG SGKD L WS R+Q+ALDSARGLEYIHEHTVPVYI
Sbjct: 387 YCVEGSLFLVYEFIENGNLGQHLRGNSGKDPLPWSTRVQVALDSARGLEYIHEHTVPVYI 446
Query: 609 HRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKI 668
HRD+K ANILIDKNFR KVADFGL +LTEVGSAS+HTRLVGTFGYMPPEYAQYG+VS KI
Sbjct: 447 HRDVKSANILIDKNFRGKVADFGLTRLTEVGSASLHTRLVGTFGYMPPEYAQYGDVSSKI 506
Query: 669 DVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDD 728
DVYAFGVVLYELISA EAVVKTNE ITES GLVALFEEVL QPDPRE+L +LVD RLGDD
Sbjct: 507 DVYAFGVVLYELISAKEAVVKTNEFITESMGLVALFEEVLGQPDPRENLPKLVDARLGDD 566
Query: 729 YPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWDIGSFYENQGLDSLMS 788
YP+DSV KMA+LARACTQENP +RPSMR+IVVALMTLSSS+EDWD+GS YENQ + LMS
Sbjct: 567 YPLDSVCKMAQLARACTQENPHVRPSMRSIVVALMTLSSSTEDWDVGSLYENQAIVDLMS 626
Query: 789 GR 790
GR
Sbjct: 627 GR 628
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297739193|emb|CBI28844.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 854 bits (2206), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/629 (66%), Positives = 501/629 (79%), Gaps = 36/629 (5%)
Query: 191 ELKLALLLVLAFFCARRRVEAVAECSKGCDLALASYYLWKGANLTFISKVFDTSIKYILS 250
++ L ++L+ FCA ++CS+GCDLAL SYY+W+G+NLTFIS++F T+I ILS
Sbjct: 4 KVGLGFFVLLSVFCA-----VDSQCSRGCDLALGSYYVWQGSNLTFISQLFQTTISEILS 58
Query: 251 FNPQITNKDKILAGTRINVPFS-CNCIQNKFLGHSFSYKVKSGNTYKRIAELIYANLTTL 309
+N QI N+D + A TRI VP+S C+CI +FLG F+Y V+SG+TY +AE Y+NLTT
Sbjct: 59 YNSQIANQDSVEADTRIRVPYSSCDCINGEFLGKVFNYTVQSGDTYDLVAETYYSNLTTS 118
Query: 310 DWLKSSNAYDENHTPDVSSSVNVIVNCSCGSKSVSKDYGLFLTYPLRPGENLSSIANEFE 369
WL++ N+Y N PD + +NV +NCSCG+ +VSKDYGLFL+YPLRP +NL+S+A
Sbjct: 119 AWLQNFNSYAANQIPDTDAYLNVTLNCSCGNSTVSKDYGLFLSYPLRPEDNLTSVAESEG 178
Query: 370 LSSELLQSYNPTLDFISGSGLAFVPVK------------------------GISSRAIAG 405
L++ LLQSYNP +F +GSGL ++P K G++ IAG
Sbjct: 179 LNASLLQSYNPDSNFSAGSGLVYIPTKDTSGSYRALKSSTGDFLFSAYWFAGLAGGVIAG 238
Query: 406 ISIGGVAGALFLAFCVYAGVYRRNKVVEASFLPEASEDHYIQ--HGPAIALVKNSESA-- 461
ISI V G L L C+Y G YR+ KV EA+ LP +E+H +Q HGP IA K ES
Sbjct: 239 ISIAAVVGVLLLTVCIYIGFYRKRKVKEAALLP--TEEHSLQPGHGPGIASDKAVESTGP 296
Query: 462 ALVAAPGVTGITVDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKM 521
A ++ G+TGITVDKSVEFSYEELAKA+++F++ NKIGQGGFG+V+YAELRGEKAAIKKM
Sbjct: 297 AFGSSAGLTGITVDKSVEFSYEELAKASDNFNLANKIGQGGFGSVYYAELRGEKAAIKKM 356
Query: 522 DMQASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLT 581
DMQAS+EFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNL+QHLRGSG+D L
Sbjct: 357 DMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSQHLRGSGRDPLQ 416
Query: 582 WSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641
WS+R+QIALDSARGLEYIHEHTVPVYIHRDIK ANILIDKNF KVADFGL KLTEVGS+
Sbjct: 417 WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHGKVADFGLTKLTEVGSS 476
Query: 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLV 701
S+ TRLVGTFGYMPPEYAQYG+VSPK+DVYAFGVVLYELISA EAVVK N ++ ES GLV
Sbjct: 477 SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAVVKDNGSVAESKGLV 536
Query: 702 ALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761
ALFE+VL +PDPREDL++LVDPRL D+YP+DSVRKMA+LA+ACTQENPQLRPSMR IVVA
Sbjct: 537 ALFEDVLNKPDPREDLRKLVDPRLEDNYPLDSVRKMAQLAKACTQENPQLRPSMRTIVVA 596
Query: 762 LMTLSSSSEDWDIGSFYENQGLDSLMSGR 790
LMTLSSS+EDWD+GSFY+NQ L +LMSGR
Sbjct: 597 LMTLSSSTEDWDVGSFYDNQALVNLMSGR 625
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147833187|emb|CAN68636.1| hypothetical protein VITISV_030803 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 853 bits (2205), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 465/818 (56%), Positives = 544/818 (66%), Gaps = 139/818 (16%)
Query: 3 QAQGKCNTGCQLALASYYVWEGSNPTYISNIFGEDIAQILLYNPNIPNQNTIPSDTRISI 62
+A KC+ GC LALASYYVW+GSN TYI IFG +I++IL YNP I NQ++I + +RI++
Sbjct: 950 KANAKCSRGCDLALASYYVWDGSNLTYIRKIFGREISEILXYNPQIXNQDSIDTGSRINV 1009
Query: 63 PFSCDCLNGDFLGHTFTYETQFGDTYEKVASFAFANLTTEDWVRRVNIYEPTRIPDYAFI 122
PF CDCLN DFLGHTF Y TQFGDTY+ RI + AF
Sbjct: 1010 PFRCDCLNXDFLGHTFEYTTQFGDTYD-------------------------RIAERAFS 1044
Query: 123 NVTVNCSCGDRHISRDYGLFTTYPLRPAQNLSSVAAEAGVAPQSLQRYNPGTNFSAGTGL 182
N+T + + R YP P + P +Q N N S G
Sbjct: 1045 NLTT-----EDWVHR----VNEYP--PTR-----------IPDDVQ-INVTVNCSCGN-- 1079
Query: 183 VFVPARVFELKLALLLVLAFFCARRRVEAVAECSKGCDLALASYYLWKGANLTFISKVFD 242
R +K L A + ++CS+ CDLALASY LWKG +L FI+ F
Sbjct: 1080 -----RRVSMKYGLF-------ATYPLRDESKCSRTCDLALASYNLWKGVDLNFIATTFS 1127
Query: 243 TSIKYILSFNPQITNKDKILAGTRINVPFSCNCIQNKFLGHSFSYKVKSGNTYKRIAELI 302
+ I SFNPQITN B I+AG R+N +F
Sbjct: 1128 RDVSEIQSFNPQITNIBLIIAGERVN----------RF---------------------- 1155
Query: 303 YANLTTLDWLKSSNAYDENHTPDVSSSVNVIVNCSCGSKSVSKDYGLFLTYPLRPGENLS 362
N Y + P + + +NV VNCSCG+ SVSKDYGLF+TYPL PGENLS
Sbjct: 1156 -------------NTYAPTNIP-IDAPINVTVNCSCGNSSVSKDYGLFVTYPLEPGENLS 1201
Query: 363 SIANEFELSSELLQSYNPTLDFISGSGLAFVPVKGISSRAIAGISIGGVAGALFLAFCVY 422
+IAN+ L +LLQ YNP DF GSGL F+P KGISS IAGIS+ G+ G+L AF ++
Sbjct: 1202 TIANQSGLPXQLLQDYNPDSDFSRGSGLVFIPGKGISSGVIAGISVAGIVGSLLFAFFLF 1261
Query: 423 AGVYRRNKVVEASFLPEASEDHYIQHGPA--IALVKNSESAALVAAP--GVTGITVDKSV 478
A + +R KV + F P ASE Y+QH A A + S+SAALV A G+ GITVDKSV
Sbjct: 1262 ARICKRKKVKKVLFFPAASEQQYMQHXQAHGSASEETSDSAALVGAASLGLVGITVDKSV 1321
Query: 479 EFSYEELAKATNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKVLTH 538
EFSYEELA AT++FS+ NKIGQGGFG+V+YAELRGEKAAIKKMDMQASKEFLAELKVLTH
Sbjct: 1322 EFSYEELATATDNFSLANKIGQGGFGSVYYAELRGEKAAIKKMDMQASKEFLAELKVLTH 1381
Query: 539 VHHLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTW---------------S 583
VHHLNLVRLIGYCVEGSLFLVYE+I+NGNL+ HLRGSG+ S
Sbjct: 1382 VHHLNLVRLIGYCVEGSLFLVYEFIDNGNLSHHLRGSGEHYYAHVELKPYLLGRIHCHGS 1441
Query: 584 ARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRA-----------KVADFGL 632
+R+QIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK FRA KVADFGL
Sbjct: 1442 SRVQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKKFRAKVVKTSVQVWQKVADFGL 1501
Query: 633 AKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNE 692
KLTEVGSAS+ TRLVGTFGYMPPEYAQYG+VSPKIDV+AFGVVLYELISA EA+VKTNE
Sbjct: 1502 TKLTEVGSASIPTRLVGTFGYMPPEYAQYGDVSPKIDVFAFGVVLYELISAKEAIVKTNE 1561
Query: 693 TIT-ESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQL 751
I ES GLVALFE+VL QPDPRED +L+D RLGDDYP+DS+ KMA LA+ACTQENPQL
Sbjct: 1562 PIMPESKGLVALFEDVLSQPDPREDFVKLIDQRLGDDYPLDSIWKMAXLAKACTQENPQL 1621
Query: 752 RPSMRAIVVALMTLSSSSEDWDIGSFYENQGLDSLMSG 789
RPSMR+IVVALMTLSSS+EDWD+GSFYEN+ L +LMSG
Sbjct: 1622 RPSMRSIVVALMTLSSSTEDWDVGSFYENEALMNLMSG 1659
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255554785|ref|XP_002518430.1| receptor protein kinase, putative [Ricinus communis] gi|223542275|gb|EEF43817.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 849 bits (2193), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/590 (70%), Positives = 476/590 (80%), Gaps = 12/590 (2%)
Query: 211 AVAECSKGCDLALASYYLWKGANLTFISKVFDTSIKYILSFNPQITNKDKILAGTRINVP 270
A A+C GCDLA ASY NLTFIS +F S+ IL +NP ++N+D ILAGTRINVP
Sbjct: 20 AQAKCKTGCDLAFASYNTSPRVNLTFISTLFSKSLPEILRYNPHVSNQDSILAGTRINVP 79
Query: 271 FSCNCIQNKFLGHSFSYKVKSGNTYKRIAELIYANLTTLDWLKSSNAYDENHTPDVSSSV 330
FSC+C+ FLGH+F Y ++G+TY +IA + +ANLTT DW+ N YD PD + +
Sbjct: 80 FSCDCLNGDFLGHTFIYTTQTGDTYDKIANIAFANLTTEDWVHRVNIYDTTRIPD-DAPI 138
Query: 331 NVIVNCSCGSKSVSKDYGLFLTYPLRPGENLSSIANEFELSSELLQSYNPTLDFISGSGL 390
NV +NCSCG K VSK+YGLF T+PL+PGEN SS+A +S++LLQSYNP ++F +GSG+
Sbjct: 139 NVTLNCSCGDKRVSKNYGLFATFPLQPGENSSSLATASGVSADLLQSYNPGVNFSAGSGI 198
Query: 391 AFVPVKGISS--------RAIAGISIGGVAGALFLAFCVYAGVYRRNKVVEASFLPEASE 442
+VP K + + IAGISI GVAGAL L C+Y G YRR K+ E +PE +E
Sbjct: 199 VYVPAKDATGNYPPLKIRKVIAGISIAGVAGALLLISCIYFGCYRRQKI-ETVLIPETTE 257
Query: 443 DHYIQHGPAI--ALVKNSESAALVAAPGVTGITVDKSVEFSYEELAKATNDFSMGNKIGQ 500
D YIQHG +L K SE VA G+TG TVDKSVEFSYEELA ATNDFSM NKIGQ
Sbjct: 258 DPYIQHGHGFGSSLDKTSEETTFVATLGLTGFTVDKSVEFSYEELANATNDFSMVNKIGQ 317
Query: 501 GGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVY 560
GGFG+V+YAELRGEKAAIKKMDMQASKEFLAELKVLTHV+HLNLVRLIGYCVEGSLFLVY
Sbjct: 318 GGFGSVYYAELRGEKAAIKKMDMQASKEFLAELKVLTHVYHLNLVRLIGYCVEGSLFLVY 377
Query: 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILID 620
E+IENGNL+QHLRGS +D L W R+QIALDSARGLEYIHEHTVPVYIHRDIK ANILID
Sbjct: 378 EFIENGNLSQHLRGSERDPLPWLTRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID 437
Query: 621 KNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYEL 680
KNFR KVADFGL KLTE GSAS+HTRLVGTFGYMPPEYA+YG+VSPKIDVYAFGVVLYEL
Sbjct: 438 KNFRGKVADFGLTKLTEYGSASLHTRLVGTFGYMPPEYARYGDVSPKIDVYAFGVVLYEL 497
Query: 681 ISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARL 740
ISA EAVVK NE ITES GLVALFE+VL QPD EDL +LVDPRLGD+YP+DSV KMA+L
Sbjct: 498 ISAKEAVVKANEIITESKGLVALFEDVLSQPDSNEDLCKLVDPRLGDNYPLDSVHKMAQL 557
Query: 741 ARACTQENPQLRPSMRAIVVALMTLSSSSEDWDIGSFYENQGLDSLMSGR 790
A+ACTQENPQLRPSMR+IVVALMTLSSS+EDWD+G+ YENQ L +LMSGR
Sbjct: 558 AKACTQENPQLRPSMRSIVVALMTLSSSTEDWDVGTLYENQALLNLMSGR 607
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483329|ref|XP_002264327.2| PREDICTED: proline-rich receptor-like protein kinase PERK13-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 840 bits (2169), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/604 (68%), Positives = 481/604 (79%), Gaps = 18/604 (2%)
Query: 200 LAFFCARRRVEAVAECSKGCDLALASYYLWKGANLTFISKVFDTSIKYILSFNPQITNKD 259
L C++ A A+CS+GCDLALASYY+W G+NLT+I K+F I IL +NPQI N+D
Sbjct: 21 LVLLCSK----ANAKCSRGCDLALASYYVWDGSNLTYIRKIFGREISEILKYNPQIENQD 76
Query: 260 KILAGTRINVPFSCNCIQNKFLGHSFSYKVKSGNTYKRIAELIYANLTTLDWLKSSNAYD 319
I G+RINVPF C+C+ FLGH+F Y + G+TY RIAE ++NLTT DW+ N Y
Sbjct: 77 SIDTGSRINVPFRCDCLNGDFLGHTFEYTTQFGDTYDRIAERAFSNLTTEDWVHRVNEYP 136
Query: 320 ENHTPDVSSSVNVIVNCSCGSKSVSKDYGLFLTYPLRPGENLSSIANEFELSSELLQSYN 379
PD +NV VNCSCG++ VS YGLF TYPLR GENLS++A ++ +L++ YN
Sbjct: 137 PTRIPD-DVQINVTVNCSCGNRRVSMKYGLFATYPLRDGENLSTVAAAAGITDDLVRRYN 195
Query: 380 PTLDFISGSGLAFVPVKGIS--------SRAIAGISIGGVAGALFLAFCVYAGVYRRNKV 431
P DF +G+GL FVP K + S IAGIS+ G+ G+L AF ++A + +R KV
Sbjct: 196 PAADFSAGTGLVFVPAKDQNETYPPLKLSGVIAGISVAGIVGSLLFAFFLFARICKRKKV 255
Query: 432 VEASFLPEASEDHYIQHGPA--IALVKNSESAALVAAP--GVTGITVDKSVEFSYEELAK 487
+ F P ASE Y+QH A A + S+SAALV A G+ GITVDKSVEFSYEELA
Sbjct: 256 KKVLFFPAASEQQYMQHRQAHGSASEETSDSAALVGAASLGLVGITVDKSVEFSYEELAT 315
Query: 488 ATNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRL 547
AT++FS+ NKIGQGGFG+V+YAELRGEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRL
Sbjct: 316 ATDNFSLANKIGQGGFGSVYYAELRGEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRL 375
Query: 548 IGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVY 607
IGYCVEGSLFLVYE+I+NGNL+ HLRGSGKD L WS+R+QIALDSARGLEYIHEHTVPVY
Sbjct: 376 IGYCVEGSLFLVYEFIDNGNLSHHLRGSGKDPLPWSSRVQIALDSARGLEYIHEHTVPVY 435
Query: 608 IHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPK 667
IHRDIKPANILIDK FRAKVADFGL KLTEVGSAS+ TRLVGTFGYMPPEYAQYG+VSPK
Sbjct: 436 IHRDIKPANILIDKKFRAKVADFGLTKLTEVGSASIPTRLVGTFGYMPPEYAQYGDVSPK 495
Query: 668 IDVYAFGVVLYELISAMEAVVKTNETIT-ESTGLVALFEEVLRQPDPREDLQRLVDPRLG 726
IDV+AFGVVLYELISA EA+VKTNE I ES GLVALFE+VL QPDPRED +L+D RLG
Sbjct: 496 IDVFAFGVVLYELISAKEAIVKTNEPIMPESKGLVALFEDVLSQPDPREDFVKLIDQRLG 555
Query: 727 DDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWDIGSFYENQGLDSL 786
DDYP+DS+ KMA LA+ACTQENPQLRPSMR+IVVALMTLSSS+EDWD+GSFYEN+ L +L
Sbjct: 556 DDYPLDSIWKMAHLAKACTQENPQLRPSMRSIVVALMTLSSSTEDWDVGSFYENEALMNL 615
Query: 787 MSGR 790
MSGR
Sbjct: 616 MSGR 619
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|345843162|gb|AEO18237.1| Bti9 [Nicotiana benthamiana] | Back alignment and taxonomy information |
|---|
Score = 812 bits (2098), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/613 (64%), Positives = 489/613 (79%), Gaps = 22/613 (3%)
Query: 197 LLVLAFFCARRRVEAVAECSKGCDLALASYYLWKGANLTFISKVFDTSIKY-ILSFNPQ- 254
+++ + + + + C+KGCDLAL S+++W+G NL IS++F S + I+ +N +
Sbjct: 14 FILITVYLSSNSLPVESRCNKGCDLALGSFFVWRGTNLIHISQLFSVSTRQEIIDYNNKE 73
Query: 255 -ITNKDKILAGTRINVPFSCNCIQNKFLGHSFSYKVKSGNTYKRIAELIYANLTTLDWLK 313
I N+D ++AGTRIN+PFSC+C+ +FLGH F YKV SG+TY R+A Y++LTT+D LK
Sbjct: 74 NIPNQDSVIAGTRINIPFSCDCLDGEFLGHVFPYKVISGDTYARVAS-NYSDLTTVDLLK 132
Query: 314 SSNAYDENHTPDVSSSVNVIVNCSCGSKSVSKDYGLFLTYPLRPGENLSSIANEFELSSE 373
N++ EN PD ++ V+VNCSCG+K +SKD+GLF TYPLRP +NL+++A+ +S+E
Sbjct: 133 RFNSHSENKIPD-DVTLKVVVNCSCGNKDISKDFGLFATYPLRPEDNLTAVASTANVSAE 191
Query: 374 LLQSYNPTLDFISGSGLAFVPVK-------------GISSRAIAGISIGGVAGALFLAFC 420
L++SYNP +F +G G+ F+P + GIS AIAGISIG +A L LA
Sbjct: 192 LIRSYNPGANFSAGKGIVFIPGRDKSGNFPPLPTSTGISGGAIAGISIGAIAVVLLLAGL 251
Query: 421 VYAGVYRRNKVVEASFLPEASEDHYIQHGP-AIALVKNSESAALVA--APGVTGITVDKS 477
VY G YR+ K + S L H HGP + +VK ++S L +P ++GITVDKS
Sbjct: 252 VYVGYYRK-KAQKVSLLSSEDRLHQSSHGPESSTIVKAADSGRLANGNSPELSGITVDKS 310
Query: 478 VEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKVLT 537
VEF+YEELA ATNDFS+ NKIGQGGFGAV+YAELRGEKAAIKKMDM+A++EFLAELKVLT
Sbjct: 311 VEFTYEELATATNDFSIANKIGQGGFGAVYYAELRGEKAAIKKMDMEATREFLAELKVLT 370
Query: 538 HVHHLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLE 597
HVHHLNLVRLIGYCVEGSLFLVYEY+ENGN+ QHLRG+G+D L WS+R+QIALDSARGLE
Sbjct: 371 HVHHLNLVRLIGYCVEGSLFLVYEYVENGNIGQHLRGTGRDPLPWSSRVQIALDSARGLE 430
Query: 598 YIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE 657
YIHEHTVPVYIHRDIK ANILIDKNF AKVADFGL KLTEVGS+S+ TRLVGTFGYMPPE
Sbjct: 431 YIHEHTVPVYIHRDIKTANILIDKNFHAKVADFGLTKLTEVGSSSLQTRLVGTFGYMPPE 490
Query: 658 YAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717
YAQYG+VSPK+DVYAFGVVLYELISA EA+VK NE++TES GLV LFEEVL QP+P EDL
Sbjct: 491 YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKPNESVTESKGLVGLFEEVLNQPEPDEDL 550
Query: 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWDIGSF 777
+++VDPRLG+DYP+DSVRKMA+LA+ACT ENP +RPSMR+IVVALMTLSSS+EDWD+GSF
Sbjct: 551 RKVVDPRLGNDYPLDSVRKMAQLAKACTHENPLIRPSMRSIVVALMTLSSSTEDWDVGSF 610
Query: 778 YENQGLDSLMSGR 790
Y NQGL +LMSGR
Sbjct: 611 YGNQGLINLMSGR 623
|
Source: Nicotiana benthamiana Species: Nicotiana benthamiana Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356557941|ref|XP_003547268.1| PREDICTED: proline-rich receptor-like protein kinase PERK8-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 811 bits (2094), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/595 (67%), Positives = 472/595 (79%), Gaps = 21/595 (3%)
Query: 215 CSKGCDLALASYYLWKGANLTFISKVFDTSIKYILSFNPQITNKDKILAGTRINVPFSCN 274
C GC+LALASYYL G NLT+IS +F IL +NP + N + IL+ TRINVPFSC+
Sbjct: 33 CVTGCNLALASYYLGNGTNLTYISNLFGRPTSEILKYNPSVKNPNVILSQTRINVPFSCD 92
Query: 275 CIQNKFLGHSFSYKVKSGNTYKRIAELIYANLTTLDWLKSSNAYDENHTPDVSSSVNVIV 334
C+ FLGH+FSY ++ GNTYK +AE+ ++NLTT DW+ N+Y N PD + ++NV V
Sbjct: 93 CLNGAFLGHTFSYAIQHGNTYKIVAEVDFSNLTTEDWVGRVNSYPPNQIPD-NVNINVTV 151
Query: 335 NCSCGSKSVSKDYGLFLTYPLRPGENLSSIANEFELSSELLQSYNPTLDFISGSGLAFVP 394
NCSCG++ VSKDYGLF+TYPLR G++L +A E + +ELL YNPT DF +G+GL FVP
Sbjct: 152 NCSCGNRHVSKDYGLFMTYPLRVGDSLQRVAAEAGVPAELLLRYNPTADFGAGNGLVFVP 211
Query: 395 VK-------------GISSRAIAGISIGGVAGALFLAFCVYAGVYRRNKVVEASFLP--E 439
K GISS AIAGI++GG G L LA +Y G+ RR KV E S LP
Sbjct: 212 AKDENGNFPPMQLRSGISSGAIAGIAVGGAVGVLILALLLYVGLRRRRKVAEVSLLPVPG 271
Query: 440 ASEDH----YIQHGPAIALVKNSESAALVAAPGVTGITVDKSVEFSYEELAKATNDFSMG 495
ASED + HG +L K SES+ +VA+P +TGITVDKSVEF YEEL KAT+ FS
Sbjct: 272 ASEDQCSPLQLHHGCGSSLDKASESS-VVASPRLTGITVDKSVEFPYEELDKATDGFSAA 330
Query: 496 NKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVEGS 555
N IG+GGFG+V+YAELR EKAAIKKMDMQAS EFLAEL VLTHVHHLNLVRLIGYCVEGS
Sbjct: 331 NIIGRGGFGSVYYAELRNEKAAIKKMDMQASNEFLAELNVLTHVHHLNLVRLIGYCVEGS 390
Query: 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPA 615
LFLVYEYIENGNL+QHLRGSG+D LTW+AR+QIALD+ARGLEYIHEHTVPVYIHRDIK A
Sbjct: 391 LFLVYEYIENGNLSQHLRGSGRDPLTWAARVQIALDAARGLEYIHEHTVPVYIHRDIKSA 450
Query: 616 NILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGV 675
NILIDKNFRAKVADFGL KLTE GS+S+HTRLVGTFGYMPPEYAQYG+VS KIDVYAFGV
Sbjct: 451 NILIDKNFRAKVADFGLTKLTEYGSSSLHTRLVGTFGYMPPEYAQYGDVSSKIDVYAFGV 510
Query: 676 VLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVR 735
VLYELIS EA+V+TNE ES GLVALFEEVL DP+ DL++L+DP LGD+YP+DSV
Sbjct: 511 VLYELISGKEAIVRTNEPENESKGLVALFEEVLGLSDPKVDLRQLIDPTLGDNYPLDSVF 570
Query: 736 KMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWDIGSFYENQGLDSLMSGR 790
K+++LA+ACT ENPQLRPSMR+IVVALMTLSS++EDWD+GSFYENQ L LMSGR
Sbjct: 571 KVSQLAKACTHENPQLRPSMRSIVVALMTLSSATEDWDVGSFYENQALVHLMSGR 625
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255568675|ref|XP_002525309.1| receptor protein kinase, putative [Ricinus communis] gi|223535368|gb|EEF37042.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 802 bits (2071), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/585 (67%), Positives = 479/585 (81%), Gaps = 8/585 (1%)
Query: 211 AVAECSKGCDLALASYYLWKGANLTFISKVFDTSI----KYILSFNP-QITNKDKILAGT 265
A ++C++GCDLA ASYY+W+ AN +FI++V +SI I+++N Q++NKD + +
Sbjct: 22 AHSKCTRGCDLAFASYYVWQEANTSFIAEVMKSSILDSPDTIVTYNSDQVSNKDSLPSFI 81
Query: 266 RINVPFSCNCIQNKFLGHSFSYKVKSGNTYKRIAELIYANLTTLDWLKSSNAYDENHTPD 325
RIN+PF C CI +FLGH F+Y V+SG+TY +AE Y+NLTT+ WL N+Y + PD
Sbjct: 82 RINLPFPCGCIDGEFLGHVFNYDVRSGDTYLVVAEKYYSNLTTVSWLSQLNSYPPTNIPD 141
Query: 326 VSSSVNVIVNCSCGSKSVSKDYGLFLTYPLRPGENLSSIANEFELSSELLQSYNPTLDFI 385
+ +NV VNCSCG+ +SKDYGLF+TYPLRP ++L SIAN+ + ++LLQSYNP ++F
Sbjct: 142 -TGILNVTVNCSCGNSQISKDYGLFITYPLRPEDSLESIANQTSIRADLLQSYNPGVNFS 200
Query: 386 SGSGLAFVPVKGISSRAIAGISIGGVAGALFLAFCVYAGVYRRNKVVEASFLPEASEDHY 445
GSGL ++P +GIS AIAGI I A + +A C+Y G+YR+ KV + + L + H
Sbjct: 201 RGSGLVYIPGQGISGGAIAGICIAAAAVVVLVAVCMYFGLYRKKKV-KGALLSQDISAHA 259
Query: 446 IQHGPAIALVKNSESAALVAAPGVTGITVDKSVEFSYEELAKATNDFSMGNKIGQGGFGA 505
+Q GP K ES L +PG+TGITVDKSVEFSYEELA AT++FS+ NKIGQGGFG+
Sbjct: 260 LQ-GPGSNSDKPVESTGLAPSPGLTGITVDKSVEFSYEELALATDNFSLANKIGQGGFGS 318
Query: 506 VFYAELRGEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIEN 565
V+YAELRGEKAAI+KMDMQASKEF AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIEN
Sbjct: 319 VYYAELRGEKAAIRKMDMQASKEFFAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIEN 378
Query: 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRA 625
GNL+QHL GSG+D L WS R+QIALDSARGLEYIHEHTVPVYIHRDIK ANILIDKNFR
Sbjct: 379 GNLSQHLHGSGRDPLPWSTRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFRG 438
Query: 626 KVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAME 685
KVADFGL KLTEVGSAS+ TRLVGTFGYMPPEYAQYG+VSPK+DVYA GVVLYELISA E
Sbjct: 439 KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYALGVVLYELISAKE 498
Query: 686 AVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACT 745
A++K N + ES GLVALFE+VL QPDP+ED+++LVDPRLGD+YP+DSVRKMA+LA+ACT
Sbjct: 499 AIIKGNSSSAESRGLVALFEDVLNQPDPKEDVRKLVDPRLGDNYPLDSVRKMAQLAKACT 558
Query: 746 QENPQLRPSMRAIVVALMTLSSSSEDWDIGSFYENQGLDSLMSGR 790
QENPQLRPSMR+IVVALMTLSSS+EDWD+GSFYENQ L +LMSGR
Sbjct: 559 QENPQLRPSMRSIVVALMTLSSSTEDWDVGSFYENQALVNLMSGR 603
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 790 | ||||||
| TAIR|locus:2089860 | 617 | CERK1 "chitin elicitor recepto | 0.679 | 0.870 | 0.569 | 1.3e-155 | |
| UNIPROTKB|D7UPN3 | 605 | CERK1 "Chitin elicitor recepto | 0.402 | 0.525 | 0.665 | 4.6e-150 | |
| TAIR|locus:2195814 | 651 | LYK3 "LysM-containing receptor | 0.421 | 0.511 | 0.446 | 2.2e-76 | |
| TAIR|locus:2050987 | 664 | LYK5 "LysM-containing receptor | 0.439 | 0.522 | 0.360 | 7.7e-66 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.396 | 0.483 | 0.431 | 8.8e-63 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.396 | 0.480 | 0.434 | 1.1e-62 | |
| TAIR|locus:2019938 | 718 | PERK11 "proline-rich extensin- | 0.368 | 0.405 | 0.412 | 7.8e-60 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.378 | 0.439 | 0.409 | 1e-59 | |
| TAIR|locus:2095188 | 928 | AT3G23750 [Arabidopsis thalian | 0.384 | 0.327 | 0.446 | 6.6e-58 | |
| TAIR|locus:2026846 | 710 | PERK13 "proline-rich extensin- | 0.355 | 0.395 | 0.440 | 1.4e-57 |
| TAIR|locus:2089860 CERK1 "chitin elicitor receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1517 (539.1 bits), Expect = 1.3e-155, P = 1.3e-155
Identities = 318/558 (56%), Positives = 389/558 (69%)
Query: 248 ILSFNPQITNKDKILAGTRINVPFSCNCIQNKFLGHSFSYKVKSGNTYKRIAELIYANLT 307
IL +N I +KD+I G+R+ VPF C C FLGH+FSY V+ +TY+R+A YANLT
Sbjct: 66 ILRYNSNIKDKDRIQMGSRVLVPFPCECQPGDFLGHNFSYSVRQEDTYERVAISNYANLT 125
Query: 308 TLDWLKSSNAYDENHTPDXXXXXXXXXXXXXGSKSVSKDYGLFLTYPLRPGENLSSIANE 367
T++ L++ N + + P G +SVSKD+GLF+TYPLRP ++LSSIA
Sbjct: 126 TMESLQARNPFPATNIP-LSATLNVLVNCSCGDESVSKDFGLFVTYPLRPEDSLSSIARS 184
Query: 368 FELSSELLQSYNPTLDFISGSGL----------AFVPVKXXXXXXXXXXXXXXXXXXLFL 417
+S+++LQ YNP ++F SG+G+ AF P K + +
Sbjct: 185 SGVSADILQRYNPGVNFNSGNGIVYVPGRDPNGAFPPFKSSKQDGVGAGVIAGIVIGVIV 244
Query: 418 A-----FCVYAGVYRRNKVVEASFLPEASEDHYIQHGPAIALVKNSESAALVAAPGVTGI 472
A F VY YR+NK SF H + +L A V+ PG+ I
Sbjct: 245 ALLLILFIVYYA-YRKNKSKGDSFSSSIPLSTKADHASSTSLQSGGLGGAGVS-PGIAAI 302
Query: 473 TVDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAE 532
+VDKSVEFS EELAKAT++F++ KIGQGGFGAV+YAELRGEKAAIKKMDM+ASK+FLAE
Sbjct: 303 SVDKSVEFSLEELAKATDNFNLSFKIGQGGFGAVYYAELRGEKAAIKKMDMEASKQFLAE 362
Query: 533 LKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDS 592
LKVLT VHH+NLVRLIGYCVEGSLFLVYEY+ENGNL QHL GSG++ L W+ R+QIALDS
Sbjct: 363 LKVLTRVHHVNLVRLIGYCVEGSLFLVYEYVENGNLGQHLHGSGREPLPWTKRVQIALDS 422
Query: 593 ARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFG 652
ARGLEYIHEHTVPVY+HRDIK ANILID+ FRAKVADFGL KLTEVG ++ + GTFG
Sbjct: 423 ARGLEYIHEHTVPVYVHRDIKSANILIDQKFRAKVADFGLTKLTEVGGSATRGAM-GTFG 481
Query: 653 YMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD 712
YM PE YGEVS K+DVYAFGVVLYELISA AVVK E + E GLV +FEE ++ D
Sbjct: 482 YMAPETV-YGEVSAKVDVYAFGVVLYELISAKGAVVKMTEAVGEFRGLVGVFEESFKETD 540
Query: 713 PREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDW 772
E L++++DPRLGD YP DSV KMA L +ACTQEN QLRPSMR IVVAL TL SS+ +W
Sbjct: 541 KEEALRKIIDPRLGDSYPFDSVYKMAELGKACTQENAQLRPSMRYIVVALSTLFSSTGNW 600
Query: 773 DIGSFYENQGLDSLMSGR 790
D+G+F +N+ L SLMSGR
Sbjct: 601 DVGNF-QNEDLVSLMSGR 617
|
|
| UNIPROTKB|D7UPN3 CERK1 "Chitin elicitor receptor kinase 1" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1113 (396.9 bits), Expect = 4.6e-150, Sum P(2) = 4.6e-150
Identities = 215/323 (66%), Positives = 267/323 (82%)
Query: 459 ESAALVAAPGVTGITVDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELRGEKAAI 518
E++ L A GI V++S+EFSYEE+ AT FSM +KIGQGGFG+V+YAELRGEK AI
Sbjct: 284 ETSHLDDASQAEGIKVERSIEFSYEEIFNATQGFSMEHKIGQGGFGSVYYAELRGEKTAI 343
Query: 519 KKMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKD 578
KKM MQA++EFLAELKVLTHVHHLNLVRLIGYCVE LFLVYE+I+NGNL+QHL+ +G
Sbjct: 344 KKMGMQATQEFLAELKVLTHVHHLNLVRLIGYCVENCLFLVYEFIDNGNLSQHLQRTGYA 403
Query: 579 TLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638
L+W+ R+QIALDSARGLEY+HEH VPVY+HRDIK ANIL+DK+FRAK+ADFGLAKLTEV
Sbjct: 404 PLSWATRVQIALDSARGLEYLHEHVVPVYVHRDIKSANILLDKDFRAKIADFGLAKLTEV 463
Query: 639 GSAS--VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITE 696
GS S + TR+ GTFGYMPPE A+YGEVSPK+DVYAFGVVLYEL+SA +A+V+++E+++E
Sbjct: 464 GSMSQSLSTRVAGTFGYMPPE-ARYGEVSPKVDVYAFGVVLYELLSAKQAIVRSSESVSE 522
Query: 697 STGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMR 756
S GLV LFEE L P+P E L L+DP L DYP+DS K+A LA++CT E P +RP+MR
Sbjct: 523 SKGLVFLFEEALSAPNPTEALDELIDPSLQGDYPVDSALKIASLAKSCTHEEPGMRPTMR 582
Query: 757 AIVVALMTLSSSSE--DWDIGSF 777
++VVALM L+++++ D D F
Sbjct: 583 SVVVALMALTANTDLRDMDYHPF 605
|
|
| TAIR|locus:2195814 LYK3 "LysM-containing receptor-like kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 724 (259.9 bits), Expect = 2.2e-76, Sum P(2) = 2.2e-76
Identities = 156/349 (44%), Positives = 218/349 (62%)
Query: 457 NSESAALVAAPGVTG---ITVDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELRG 513
N E+ +VA P G ++K + F+YEE+ AT++FS N +G G +G+V++ LR
Sbjct: 304 NGETQ-VVAIPKALGDGMFEIEKPMVFTYEEIRAATDEFSDSNLLGHGNYGSVYFGLLRE 362
Query: 514 EKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLNQHL 572
++ A+K+M +KEF AE+KVL VHH NLV LIGY LF+VYEY+ G L HL
Sbjct: 363 QEVAVKRMTATKTKEFAAEMKVLCKVHHSNLVELIGYAATVDELFVVYEYVRKGMLKSHL 422
Query: 573 ---RGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVAD 629
+ G L+W R QIALD+ARGLEYIHEHT Y+HRDIK +NIL+D+ FRAK++D
Sbjct: 423 HDPQSKGNTPLSWIMRNQIALDAARGLEYIHEHTKTHYVHRDIKTSNILLDEAFRAKISD 482
Query: 630 FGLAKLTE-VGSASVH-TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAV 687
FGLAKL E G + T++VGT+GY+ PEY G + K D+YAFGVVL+E+IS EAV
Sbjct: 483 FGLAKLVEKTGEGEISVTKVVGTYGYLAPEYLSDGLATSKSDIYAFGVVLFEIISGREAV 542
Query: 688 VKTNETIT---ESTGLVALFEEVLRQ-PDPRE--DLQRLVDPRLGDDYPIDSVRKMARLA 741
++T T E L ++ VL+ PD L+ VDP + D YP D + K+A LA
Sbjct: 543 IRTEAIGTKNPERRPLASIMLAVLKNSPDSMNMSSLKEFVDPNMMDLYPHDCLFKIATLA 602
Query: 742 RACTQENPQLRPSMRAIVVALMTLSSSSEDWDIGSFYENQGLDSLMSGR 790
+ C ++P LRP+M+ +V++L + SS +W+ +Q L+ GR
Sbjct: 603 KQCVDDDPILRPNMKQVVISLSQILLSSIEWEATLAGNSQVFSGLVQGR 651
|
|
| TAIR|locus:2050987 LYK5 "LysM-containing receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 574 (207.1 bits), Expect = 7.7e-66, Sum P(2) = 7.7e-66
Identities = 132/366 (36%), Positives = 213/366 (58%)
Query: 417 LAFCVYAGVYRRNKVVEA-SFLPEASEDHYIQHGPAIALVKNSE-SAALVAAPGVTGI-- 472
LA C Y RR+K S LPE ++ +I ++ S L + G+
Sbjct: 296 LALCFYK---RRSKKKSLPSSLPEENKLFDSSTKQSIPTTTTTQWSIDLSNSSEAFGLKS 352
Query: 473 TVDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAE 532
++ + + +L AT++FS N+I G+V+ A + G+ AA+K + S +E
Sbjct: 353 AIESLTLYRFNDLQSATSNFSDENRIK----GSVYRATINGDDAAVKVIKGDVSS---SE 405
Query: 533 LKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALD 591
+ +L ++H N++RL G+C+ EG+ +LV+EY ENG+++ L SGK +LTW R++IA D
Sbjct: 406 INLLKKLNHSNIIRLSGFCIREGTSYLVFEYSENGSISDWLHSSGKKSLTWKQRVEIARD 465
Query: 592 SARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH-TRLV-G 649
A L+Y+H + P +IH++++ NIL+D NFRAK+A+FG+A++ + G + TR V G
Sbjct: 466 VAEALDYLHNYITPPHIHKNLESTNILLDSNFRAKIANFGVARILDEGDLDLQLTRHVEG 525
Query: 650 TFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVV--KTNETITESTGLVALFEEV 707
T GY+ PEY + G ++ K+DV+AFGV + EL+S EAV K E E L + V
Sbjct: 526 TQGYLAPEYVENGVITSKLDVFAFGVAVLELLSGREAVTIHKKKEGEEEVEMLCKVINSV 585
Query: 708 LRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767
L + RE L+ +DP LG++YP++ MA+LA++C + RPS+ ++ L + S
Sbjct: 586 LGGENVREKLKEFMDPSLGNEYPLELAYTMAQLAKSCVATDLNSRPSVTQVLTTLSMIVS 645
Query: 768 SSEDWD 773
SS DW+
Sbjct: 646 SSIDWE 651
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 641 (230.7 bits), Expect = 8.8e-63, P = 8.8e-63
Identities = 141/327 (43%), Positives = 203/327 (62%)
Query: 466 APGVTGITVDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAEL-RGEKAAIKKMDM- 523
+PG+ + KS F+YEELA+ATN FS N +GQGGFG V L G++ A+K++ +
Sbjct: 251 SPGLV-LGFSKST-FTYEELARATNGFSEANLLGQGGFGYVHKGVLPSGKEVAVKQLKVG 308
Query: 524 --QASKEFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLNQHLRGSGKDTL 580
Q +EF AE+++++ VHH +LV L+GYC+ G+ LVYE++ N NL HL G G+ T+
Sbjct: 309 SGQGEREFQAEVEIISRVHHRHLVSLVGYCIAGAKRLLVYEFVPNNNLELHLHGEGRPTM 368
Query: 581 TWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640
WS R++IAL SA+GL Y+HE P IHRDIK +NILID F AKVADFGLAK+ +
Sbjct: 369 EWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTN 428
Query: 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGL 700
V TR++GTFGY+ PEYA G+++ K DV++FGVVL ELI+ V N + +S L
Sbjct: 429 THVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDS--L 486
Query: 701 VALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVV 760
V +L + + D + L D ++ + Y + + +M A AC + + + RP M IV
Sbjct: 487 VDWARPLLNRASEQGDFEGLADAKMNNGYDREEMARMVACAAACVRHSARRRPRMSQIVR 546
Query: 761 AL---MTLSSSSEDWDIG--SFYENQG 782
AL ++LS +E G + Y + G
Sbjct: 547 ALEGNVSLSDLNEGMRPGQSNVYSSYG 573
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 640 (230.4 bits), Expect = 1.1e-62, P = 1.1e-62
Identities = 142/327 (43%), Positives = 202/327 (61%)
Query: 466 APGVTGITVDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAEL-RGEKAAIKKMDM- 523
+PG+ + KS F+YEEL++ATN FS N +GQGGFG V L G++ A+K++
Sbjct: 256 SPGLV-LGFSKST-FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAG 313
Query: 524 --QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLNQHLRGSGKDTL 580
Q +EF AE+++++ VHH +LV LIGYC+ G LVYE++ N NL HL G G+ T+
Sbjct: 314 SGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTM 373
Query: 581 TWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640
WS R++IAL SA+GL Y+HE P IHRDIK +NILID F AKVADFGLAK+ +
Sbjct: 374 EWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTN 433
Query: 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGL 700
V TR++GTFGY+ PEYA G+++ K DV++FGVVL ELI+ V N + +S L
Sbjct: 434 THVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDS--L 491
Query: 701 VALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVV 760
V +L + D + L D ++G++Y + + +M A AC + + + RP M IV
Sbjct: 492 VDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVR 551
Query: 761 AL---MTLSSSSEDWDIG--SFYENQG 782
AL ++LS +E G + Y + G
Sbjct: 552 ALEGNVSLSDLNEGMRPGHSNVYSSYG 578
|
|
| TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 592 (213.5 bits), Expect = 7.8e-60, Sum P(2) = 7.8e-60
Identities = 123/298 (41%), Positives = 185/298 (62%)
Query: 478 VEFSYEELAKATNDFSMGNKIGQGGFGAVFYAEL-RGEKAAIKKM---DMQASKEFLAEL 533
+ F+YEEL++ T F +G+GGFG V+ L G+ AIK++ + +EF AE+
Sbjct: 356 IHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEV 415
Query: 534 KVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDS 592
++++ VHH +LV L+GYC+ E FL+YE++ N L+ HL G L WS R++IA+ +
Sbjct: 416 EIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKNLPVLEWSRRVRIAIGA 475
Query: 593 ARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFG 652
A+GL Y+HE P IHRDIK +NIL+D F A+VADFGLA+L + + + TR++GTFG
Sbjct: 476 AKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHISTRVMGTFG 535
Query: 653 YMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD 712
Y+ PEYA G+++ + DV++FGVVL ELI+ + V T++ + E + LV L +
Sbjct: 536 YLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPV-DTSQPLGEES-LVEWARPRLIEAI 593
Query: 713 PREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770
+ D+ +VDPRL +DY V KM A +C + + RP M +V AL T S+
Sbjct: 594 EKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRALDTRDDLSD 651
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 612 (220.5 bits), Expect = 1.0e-59, P = 1.0e-59
Identities = 126/308 (40%), Positives = 194/308 (62%)
Query: 470 TGITVDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDM---QA 525
+G+ ++ FSY+EL++ T+ FS N +G+GGFG V+ L G + A+K++ + Q
Sbjct: 317 SGMVSNQRSWFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQG 376
Query: 526 SKEFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSA 584
+EF AE+++++ VHH +LV L+GYC+ E LVY+Y+ N L+ HL G+ +TW
Sbjct: 377 EREFKAEVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWET 436
Query: 585 RMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH 644
R+++A +ARG+ Y+HE P IHRDIK +NIL+D +F A VADFGLAK+ + + H
Sbjct: 437 RVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTH 496
Query: 645 --TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVA 702
TR++GTFGYM PEYA G++S K DVY++GV+L ELI+ + V T++ + + + LV
Sbjct: 497 VSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPV-DTSQPLGDES-LVE 554
Query: 703 LFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762
+L Q E+ LVDPRLG ++ + +M A AC + + RP M +V AL
Sbjct: 555 WARPLLGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRAL 614
Query: 763 MTLSSSSE 770
TL +++
Sbjct: 615 DTLEEATD 622
|
|
| TAIR|locus:2095188 AT3G23750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 600 (216.3 bits), Expect = 6.6e-58, P = 6.6e-58
Identities = 145/325 (44%), Positives = 190/325 (58%)
Query: 477 SVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQAS-----KEFL 530
SV E L + TN+FS N +G+GGFG V+ EL G K A+K+M+ A EF
Sbjct: 563 SVTIPMEVLRQVTNNFSEDNILGRGGFGVVYAGELHDGTKTAVKRMECAAMGNKGMSEFQ 622
Query: 531 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHL-RGS--GKDTLTWSARM 586
AE+ VLT V H +LV L+GYCV G+ LVYEY+ GNL QHL S G LTW R+
Sbjct: 623 AEIAVLTKVRHRHLVALLGYCVNGNERLLVYEYMPQGNLGQHLFEWSELGYSPLTWKQRV 682
Query: 587 QIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR 646
IALD ARG+EY+H +IHRD+KP+NIL+ + RAKVADFGL K G SV TR
Sbjct: 683 SIALDVARGVEYLHSLAQQSFIHRDLKPSNILLGDDMRAKVADFGLVKNAPDGKYSVETR 742
Query: 647 LVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEE 706
L GTFGY+ PEYA G V+ K+DVYAFGVVL E+++ +A+ + E + LV F
Sbjct: 743 LAGTFGYLAPEYAATGRVTTKVDVYAFGVVLMEILTGRKAL--DDSLPDERSHLVTWFRR 800
Query: 707 VLRQPDPREDLQRLVDPRL-GDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765
+L +E++ + +D L D+ ++S+ ++A LA CT PQ RP M V L L
Sbjct: 801 ILIN---KENIPKALDQTLEADEETMESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 857
Query: 766 SSSSEDWDIGSFYENQ--GLDSLMS 788
E W E + G+D MS
Sbjct: 858 V---EKWKPSCQEEEESFGIDVNMS 879
|
|
| TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 592 (213.5 bits), Expect = 1.4e-57, P = 1.4e-57
Identities = 127/288 (44%), Positives = 177/288 (61%)
Query: 480 FSYEELAKATNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDM---QASKEFLAELKV 535
F+YEEL T FS N +G+GGFG V+ +L G+ A+K++ + Q +EF AE+++
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEI 400
Query: 536 LTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSAR 594
++ VHH +LV L+GYC+ S L+YEY+ N L HL G G+ L W+ R++IA+ SA+
Sbjct: 401 ISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIGSAK 460
Query: 595 GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYM 654
GL Y+HE P IHRDIK ANIL+D F A+VADFGLAKL + V TR++GTFGY+
Sbjct: 461 GLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTFGYL 520
Query: 655 PPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714
PEYAQ G+++ + DV++FGVVL ELI+ + V + ES LV +L +
Sbjct: 521 APEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEES--LVEWARPLLHKAIET 578
Query: 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762
D LVD RL Y + V +M A AC + + RP M +V AL
Sbjct: 579 GDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRAL 626
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| D7UPN3 | CERK1_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.5226 | 0.6835 | 0.8925 | yes | no |
| A8R7E6 | CERK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5668 | 0.7468 | 0.9562 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00006888001 | SubName- Full=Chromosome chr10 scaffold_179, whole genome shotgun sequence; (857 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 790 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-57 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-57 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-52 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-52 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-51 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-50 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-39 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-37 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-35 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-35 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-35 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-34 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-33 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-33 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-32 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-31 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-31 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-30 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-29 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-29 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-28 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-28 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-28 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-27 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-27 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-27 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-26 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-26 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-26 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-25 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-25 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-25 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-25 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-24 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-24 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-24 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-24 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-23 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-23 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-23 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-23 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-22 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-22 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-22 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-22 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-21 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-21 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-21 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-21 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-21 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-21 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-21 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-20 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-20 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-20 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-19 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-19 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-19 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-19 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-18 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-18 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-18 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-18 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-18 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-17 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-17 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-17 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-16 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-15 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-15 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-15 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-15 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-15 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-14 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-13 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-13 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-13 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-12 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.002 | |
| TIGR02899 | 44 | TIGR02899, spore_safA, spore coat assembly protein | 0.002 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 5e-57
Identities = 81/287 (28%), Positives = 140/287 (48%), Gaps = 48/287 (16%)
Query: 493 SMGNKIGQGGFGAVFYAELRG------EKAAIKKM----DMQASKEFLAELKVLTHVHHL 542
++G K+G+G FG V+ +L+G + A+K + Q +EFL E +++ + H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 543 NLVRLIGYCVE-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE 601
N+V+L+G C E L++V EY+E G+L +LR + + L+ S + AL ARG+EY+
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN-RPKLSLSDLLSFALQIARGMEYLES 120
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS--ASVHTRLVGTFGYMPPEYA 659
+IHRD+ N L+ +N K++DFGL++ +L +M PE
Sbjct: 121 KN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESL 175
Query: 660 QYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719
+ G+ + K DV++FGV+L+E+ + E QP P +
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFT---------------------LGE---QPYPGMSNEE 211
Query: 720 LVDPRLGDDY----PIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762
++ L + Y P + ++ L C E+P+ RP+ +V L
Sbjct: 212 VL-EYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 7e-57
Identities = 79/287 (27%), Positives = 135/287 (47%), Gaps = 47/287 (16%)
Query: 493 SMGNKIGQGGFGAVFYAELRG------EKAAIKKM----DMQASKEFLAELKVLTHVHHL 542
++G K+G+G FG V+ L+G + A+K + Q +EFL E +++ + H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 543 NLVRLIGYCVE-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE 601
N+V+L+G C E L +V EY+ G+L +LR + L+ S + AL ARG+EY+
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS--ASVHTRLVGTFGYMPPEYA 659
+IHRD+ N L+ +N K++DFGL++ +L +M PE
Sbjct: 122 KN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESL 176
Query: 660 QYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719
+ G+ + K DV++FGV+L+E+ + E +P P
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFT---------------------LGE---EPYPGMSNAE 212
Query: 720 LVDPRLGDDY----PIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762
++ L Y P + ++ +L C E+P+ RP+ +V L
Sbjct: 213 VL-EYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 2e-52
Identities = 78/275 (28%), Positives = 125/275 (45%), Gaps = 35/275 (12%)
Query: 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE----FLAELKVLTHVHHLNLV 545
+ + K+G+G FG V+ A + G+ AIK + + K+ L E+K+L + H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 546 RLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTV 604
RL E L+LV EY E G+L L+ G+ + + LEY+H +
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF--YLRQILSALEYLHSKGI 118
Query: 605 PVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEV 664
+HRD+KP NIL+D++ K+ADFGLA+ ++ T VGT YM PE
Sbjct: 119 ---VHRDLKPENILLDEDGHVKLADFGLAR--QLDPGEKLTTFVGTPEYMAPEVLLGKGY 173
Query: 665 SPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724
+D+++ GV+LYEL+ TG F E +++ P+
Sbjct: 174 GKAVDIWSLGVILYELL----------------TGK-PPFPG---DDQLLELFKKIGKPK 213
Query: 725 LGDDYPIDSVRKMAR-LARACTQENPQLRPSMRAI 758
P + A+ L R ++P+ R +
Sbjct: 214 PPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 2e-52
Identities = 82/289 (28%), Positives = 140/289 (48%), Gaps = 49/289 (16%)
Query: 492 FSMGNKIGQGGFGAVFYAELRGE------KAAIKKMDMQAS----KEFLAELKVLTHVHH 541
+G K+G+G FG V+ L+G+ K A+K + AS +EFL E ++ + H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 542 LNLVRLIGYCVEG-SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH 600
N+VRL+G C +G L++V EY+ G+L LR + LT +Q+AL A+G+EY+
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLR-KHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFG---YMPPE 657
++HRD+ N L+ +N K++DFGL++ + + + G +M PE
Sbjct: 120 SKN---FVHRDLAARNCLVTENLVVKISDFGLSRD--IYEDDYYRKRGGGKLPIKWMAPE 174
Query: 658 YAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717
+ G+ + K DV++FGV+L+E+ + G QP P
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIF---------------TLG---------EQPYPGMSN 210
Query: 718 QRLVDPRLGDDY----PIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762
+ +++ L D Y P + ++ L C +P+ RP+ +V L
Sbjct: 211 EEVLE-LLEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 7e-52
Identities = 76/192 (39%), Positives = 111/192 (57%), Gaps = 14/192 (7%)
Query: 498 IGQGGFGAVFYAELR--GEKAAIKKMD----MQASKEFLAELKVLTHVHHLNLVRLIGYC 551
+G+GGFG V+ A + G+K AIK + +E L E+++L ++H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 552 V-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHR 610
E L+LV EY E G+L L+ + L+ ++I L GLEY+H + + IHR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHSNGI---IHR 116
Query: 611 DIKPANILIDK-NFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE-YAQYGEVSPKI 668
D+KP NIL+D N + K+ADFGL+KL + + T VGT YM PE G S K
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI-VGTPAYMAPEVLLGKGYYSEKS 175
Query: 669 DVYAFGVVLYEL 680
D+++ GV+LYEL
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 4e-51
Identities = 85/301 (28%), Positives = 137/301 (45%), Gaps = 74/301 (24%)
Query: 496 NKIGQGGFGAVFYAELRGEKA-----AIKKMDMQAS----KEFLAELKVLTHVHHLNLVR 546
K+G+G FG V+ +L+G+ A+K + AS K+FL E +V+ + H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 547 LIGYCVE-GSLFLVYEYIENGNLNQHLRGS-------GKDTLTWSARMQIALDSARGLEY 598
L+G C E L+LV EY+E G+L +LR S K TL+ + A+ A+G+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 599 IHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV-------GSASVHTRLVGTF 651
+ +HRD+ N L+ ++ K++DFGL++ + R
Sbjct: 121 LASKKF---VHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----- 172
Query: 652 GYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-------AMEAVVKTNETITESTGLVALF 704
+M PE + G + K DV++FGV+L+E+ + +
Sbjct: 173 -WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN------------------ 213
Query: 705 EEVLRQPDPREDLQ---RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761
EEVL E L+ RL P D ++ L +C Q +P+ RP+ +V
Sbjct: 214 EEVL------EYLRKGYRLPKPEYCPD-------ELYELMLSCWQLDPEDRPTFSELVER 260
Query: 762 L 762
L
Sbjct: 261 L 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 3e-50
Identities = 95/274 (34%), Positives = 141/274 (51%), Gaps = 35/274 (12%)
Query: 497 KIGQGGFGAVFYAELR--GEKAAIKKM-----DMQASKEFLAELKVLTHVHHLNLVRLIG 549
K+G G FG V+ A+ + G+ A+K + + + E+++L + H N+VRLI
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 550 YCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYI 608
+ L+LV EY E G+L +L G L+ +IAL RGLEY+H + + I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSNGI---I 120
Query: 609 HRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYG-EVSPK 667
HRD+KP NIL+D+N K+ADFGLAK S+S+ T VGT YM PE G PK
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTF-VGTPWYMAPEVLLGGNGYGPK 179
Query: 668 IDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGD 727
+DV++ GV+LYEL+ TG F D + ++R++ P L
Sbjct: 180 VDVWSLGVILYELL----------------TG-KPPFSG-ENILDQLQLIRRILGPPLEF 221
Query: 728 DYP-IDSVRKMAR-LARACTQENPQLRPSMRAIV 759
D P S + A+ L + C ++P RP+ I+
Sbjct: 222 DEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 6e-42
Identities = 87/288 (30%), Positives = 147/288 (51%), Gaps = 49/288 (17%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKAAIKKM--DMQASKEFLAELKVLTHVHHLNLVRL 547
+ +G IG+G FG V + RG+K A+K + D A++ FLAE V+T + H NLV+L
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQL 65
Query: 548 IGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPV 606
+G ++G+ L++V EY+ G+L +LR G+ +T + ++ ALD G+EY+ E
Sbjct: 66 LGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF-- 123
Query: 607 YIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMP-----PEYAQY 661
+HRD+ N+L+ ++ AKV+DFGLAK G S G +P PE +
Sbjct: 124 -VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDS---------GKLPVKWTAPEALRE 173
Query: 662 GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721
+ S K DV++FG++L+E+ S F R P PR L+ +V
Sbjct: 174 KKFSTKSDVWSFGILLWEIYS---------------------FG---RVPYPRIPLKDVV 209
Query: 722 DPRLGDDYPIDSVRK----MARLARACTQENPQLRPSMRAIVVALMTL 765
P + Y +++ + ++ + C + +P RP+ + + L +
Sbjct: 210 -PHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 22/207 (10%)
Query: 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLN 543
+++ G +G+G FG+V+ A + GE A+K +++ + E+++L+ + H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 544 LVRLIGYCVE---GSLFLVYEYIENGNLNQHLRGSGK--DTLTWS-ARMQIALDSARGLE 597
+VR G + +L + EY+ G+L+ L+ GK + + R QI GL
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTR-QIL----EGLA 115
Query: 598 YIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR-LVGTFGYMPP 656
Y+H + + +HRDIK ANIL+D + K+ADFG AK T + GT +M P
Sbjct: 116 YLHSNGI---VHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
Query: 657 EYAQYGEVSPKIDVYAFGVVLYELISA 683
E + E D+++ G + E+ +
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATG 199
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 77/288 (26%), Positives = 127/288 (44%), Gaps = 66/288 (22%)
Query: 496 NKIGQGGFGAVFYAE--LRGEKAAIKKMDM----QASKEF-LAELKVLTHVHHLNLVRLI 548
+IG+G FG V+ G+ +K++D+ + +E L E+K+L ++H N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 549 GYCVE-GSLFLVYEYIENGNLNQHL--RGSGKDTLT------WSARMQIALDSARGLEYI 599
E G L +V EY + G+L+Q + + W Q+ L L+Y+
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV--QLCL----ALKYL 119
Query: 600 HEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYA 659
H + +HRDIKP NI + N K+ DFG++K+ T +VGT Y+ PE
Sbjct: 120 HSRKI---LHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-VVGTPYYLSPELC 175
Query: 660 Q---YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQ---PDP 713
Q Y K D+++ G VLYEL + N L+ L ++L+ P P
Sbjct: 176 QNKPYNY---KSDIWSLGCVLYELCTLKHPFEGEN--------LLELALKILKGQYPPIP 224
Query: 714 R---EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
+L+ LV + Q++P+ RPS+ I
Sbjct: 225 SQYSSELRNLVS--------------------SLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 86/278 (30%), Positives = 136/278 (48%), Gaps = 49/278 (17%)
Query: 492 FSMGNKIGQGGFGAVFYAELRGEKAAIK--KMDMQASKEFLAELKVLTHVHHLNLVRLIG 549
++G IG+G FGAV E G+K A+K K D+ A + FL E V+T +HH NLVRL+G
Sbjct: 8 LTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTA-QAFLEETAVMTKLHHKNLVRLLG 66
Query: 550 YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIH 609
+ L++V E + GNL LR G+ ++ +Q +LD A G+EY+ + +H
Sbjct: 67 VILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKL---VH 123
Query: 610 RDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKID 669
RD+ NIL+ ++ AKV+DFGLA+ VGS V + + PE ++ + S K D
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLAR---VGSMGVDNSKL-PVKWTAPEALKHKKFSSKSD 179
Query: 670 VYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL--------- 720
V+++GV+L+E+ S R P P+ L+ +
Sbjct: 180 VWSYGVLLWEVFSYG------------------------RAPYPKMSLKEVKECVEKGYR 215
Query: 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
++P G + L +C + P+ RPS +
Sbjct: 216 MEPPEGCPADVYV------LMTSCWETEPKKRPSFHKL 247
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 60/198 (30%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMD---MQASKEFLAELKVLTHVHHLNLV 545
F + KIG+GGFG V+ A + G++ AIK + + ++ + E+++L H N+V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 546 RLIG-YCVEGSLFLVYEYIENGNLNQHLRGS-GKDTLTWSARMQIALDSARGLEYIHEHT 603
+ G Y + L++V E+ G+L L+ + T + A + + +GLEY+H +
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIA--YVCKELLKGLEYLHSNG 118
Query: 604 VPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGE 663
+ IHRDIK ANIL+ + K+ DFGL+ ++ +VGT +M PE
Sbjct: 119 I---IHRDIKAANILLTSDGEVKLIDFGLS--AQLSDTKARNTMVGTPYWMAPEVINGKP 173
Query: 664 VSPKIDVYAFGVVLYELI 681
K D+++ G+ EL
Sbjct: 174 YDYKADIWSLGITAIELA 191
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 83/284 (29%), Positives = 132/284 (46%), Gaps = 37/284 (13%)
Query: 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIK--KMDMQASKEFLAELKVLTHVHHLNLVR 546
D +M +K+G G +G V+ + A+K K D +EFL E V+ + H NLV+
Sbjct: 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 66
Query: 547 LIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVP 605
L+G C E +++ E++ GNL +LR + + + +A + +EY+ +
Sbjct: 67 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 606 VYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVS 665
+IHRD+ N L+ +N KVADFGL++L + + H + PE Y + S
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 183
Query: 666 PKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725
K DV+AFGV+L+E+ + G+ P P DL ++ + L
Sbjct: 184 IKSDVWAFGVLLWEI---------------ATYGM---------SPYPGIDLSQVYE-LL 218
Query: 726 GDDYPIDSVR----KMARLARACTQENPQLRPSMRAIVVALMTL 765
Y ++ K+ L RAC Q NP RPS I A T+
Sbjct: 219 EKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 7e-35
Identities = 85/315 (26%), Positives = 136/315 (43%), Gaps = 34/315 (10%)
Query: 491 DFSMGNKIGQGGFGAVFYAELRGEKAAIKKM------DMQASKEFLAELKVLTHV-HHLN 543
+ + K+G+G FG V+ A R + A+K + + + FL E+++L + H N
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 544 LVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSG-KDTLTWSARMQIALDSARGLEYIHE 601
+V+L + EGSL+LV EY++ G+L L+ G K L+ S + I LEY+H
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 602 HTVPVYIHRDIKPANILIDKN-FRAKVADFGLAKLTEVGSASVHTR-----LVGTFGYMP 655
+ IHRDIKP NIL+D++ K+ DFGLAKL ++ VGT GYM
Sbjct: 120 KGI---IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 656 PEYAQ---YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD 712
PE S D+++ G+ LYEL+ T E + + L+
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELL--------TGLPPFEGEKNSSATSQTLKI-- 226
Query: 713 PREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA--LMTLSSSSE 770
E + L P + + L + ++P+ R S + + L L
Sbjct: 227 ILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES 286
Query: 771 DWDIGSFYENQGLDS 785
D ++
Sbjct: 287 DLSDLLKPDDSAPLR 301
|
Length = 384 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 67/201 (33%), Positives = 110/201 (54%), Gaps = 22/201 (10%)
Query: 496 NKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE-----FLAELKVLTHVHHLNLVRLI 548
+IG+G +G V+ A + GE A+KK+ M+ KE + E+K+L + H N+VRL
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 549 GYCVE---GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVP 605
GS+++V+EY+++ +L L S + T S GL+Y+H + +
Sbjct: 65 EIVTSKGKGSIYMVFEYMDH-DLTGLLD-SPEVKFTESQIKCYMKQLLEGLQYLHSNGI- 121
Query: 606 VYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEY----AQY 661
+HRDIK +NILI+ + K+ADFGLA+ +++ +T V T Y PPE +Y
Sbjct: 122 --LHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRY 179
Query: 662 GEVSPKIDVYAFGVVLYELIS 682
G P++D+++ G +L EL
Sbjct: 180 G---PEVDMWSVGCILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 70/203 (34%), Positives = 108/203 (53%), Gaps = 26/203 (12%)
Query: 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLA--ELKVLTHVHHLNLVRL 547
+ KIG+G G V+ A R G++ AIKKM ++ + L E+ ++ H N+V
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 548 IG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWS-ARM---QIA---LDSARGLEYI 599
Y V L++V EY++ G+L D +T + RM QIA + +GLEY+
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSLT--------DIITQNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 600 HEHTVPVYIHRDIKPANILIDKNFRAKVADFGL-AKLTEVGSASVHTRLVGTFGYMPPEY 658
H V IHRDIK NIL+ K+ K+ADFG A+LT+ S +VGT +M PE
Sbjct: 133 HSQNV---IHRDIKSDNILLSKDGSVKLADFGFAAQLTK--EKSKRNSVVGTPYWMAPEV 187
Query: 659 AQYGEVSPKIDVYAFGVVLYELI 681
+ + PK+D+++ G++ E+
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 7e-33
Identities = 82/273 (30%), Positives = 133/273 (48%), Gaps = 39/273 (14%)
Query: 491 DFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKE-FLAELKVLTHVHHLNLVRLIG 549
+ + IG+G FG V + RG K A+K + A+ + FLAE V+T + H NLV+L+G
Sbjct: 7 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 550 YCVE--GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVY 607
VE G L++V EY+ G+L +LR G+ L ++ +LD +EY+ + +
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---F 123
Query: 608 IHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPK 667
+HRD+ N+L+ ++ AKV+DFGL K E S +L + PE + + S K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKKFSTK 179
Query: 668 IDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGD 727
DV++FG++L+E+ S R P PR L+ +V PR+
Sbjct: 180 SDVWSFGILLWEIYS------------------------FGRVPYPRIPLKDVV-PRVEK 214
Query: 728 DYPIDSVRK----MARLARACTQENPQLRPSMR 756
Y +D+ + + + C + RPS
Sbjct: 215 GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFL 247
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 62/202 (30%), Positives = 94/202 (46%), Gaps = 31/202 (15%)
Query: 498 IGQGGFGAVF----------YA--ELRGEKAAIKKMDMQASKEFLAELKVLTHVHHLNLV 545
+G+G FG V YA L+ K I K L E +L+ ++H +V
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLK--KKKIIKRKEVEH--TLTERNILSRINHPFIV 56
Query: 546 RLIGYCV---EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM--QIALDSARGLEYIH 600
+L + E L+LV EY G L HL G+ + + +I L LEY+H
Sbjct: 57 KL--HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVL----ALEYLH 110
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQ 660
+ I+RD+KP NIL+D + K+ DFGLAK + +T GT Y+ PE
Sbjct: 111 SLGI---IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLL 166
Query: 661 YGEVSPKIDVYAFGVVLYELIS 682
+D ++ GV+LYE+++
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 65/201 (32%), Positives = 100/201 (49%), Gaps = 15/201 (7%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGE-KAAIK-----KMDMQASKEFLAELKVLTHVHHLN 543
+ K+G G FG V+ G K A+K M +A FL E +++ + H
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA---FLQEAQIMKKLRHDK 62
Query: 544 LVRLIGYCVEGS-LFLVYEYIENGNLNQHLR-GSGKDTLTWSARMQIALDSARGLEYIHE 601
LV+L C E +++V EY+ G+L L+ G GK L + +A A G+ Y+
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKK-LRLPQLVDMAAQIAEGMAYLES 121
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQY 661
YIHRD+ NIL+ +N K+ADFGLA+L E + + PE A Y
Sbjct: 122 RN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY 178
Query: 662 GEVSPKIDVYAFGVVLYELIS 682
G + K DV++FG++L E+++
Sbjct: 179 GRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 79/296 (26%), Positives = 127/296 (42%), Gaps = 69/296 (23%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA--AIKKMD------MQASKEFLAELKVLTHV-H 540
+DF G IG+G F V A+ + AIK +D + K E +VLT +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 541 HLNLVRLIGYCV---EGSLFLVYEYIENGNLNQHLRGSG----KDTLTWSARMQIALDSA 593
H +++L Y E +L+ V EY NG L Q++R G K T ++A +I L
Sbjct: 61 HPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAA--EILL--- 113
Query: 594 RGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL-------TEVGSASVHTR 646
LEY+H + IHRD+KP NIL+DK+ K+ DFG AK+ + +
Sbjct: 114 -ALEYLHSKGI---IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 647 ------------LVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISA----------- 683
VGT Y+ PE D++A G ++Y++++
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229
Query: 684 -MEAVVKTNETITESTGLVA--LFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRK 736
+ ++K + + A L E++L DP++ RLG + D ++
Sbjct: 230 TFQKILKLEYSFPPNFPPDAKDLIEKLLVL-DPQD--------RLGVNEGYDELKA 276
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 6e-31
Identities = 69/202 (34%), Positives = 108/202 (53%), Gaps = 20/202 (9%)
Query: 491 DFSMGNKIGQGGFGAVFYA--ELRGEKAAIKKM-----DMQASKEFLAELKVLTHVHHLN 543
++ +G+ IG+G FG V+ G+ AIK++ +A K + E+ +L ++ H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 544 LVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSAR--MQIALDSARGLEYIH 600
+V+ IG SL+++ EY ENG+L Q ++ G + A Q+ +GL Y+H
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL----QGLAYLH 116
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLA-KLTEVGSASVHTRLVGTFGYMPPEYA 659
E V IHRDIK ANIL K+ K+ADFG+A KL +V +VGT +M PE
Sbjct: 117 EQGV---IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD--ASVVGTPYWMAPEVI 171
Query: 660 QYGEVSPKIDVYAFGVVLYELI 681
+ S D+++ G + EL+
Sbjct: 172 EMSGASTASDIWSLGCTVIELL 193
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 83/283 (29%), Positives = 133/283 (46%), Gaps = 43/283 (15%)
Query: 491 DFSMGNKIGQGGFGAVFYAELRGE-KAAIKKMDMQASKE--FLAELKVLTHVHHLNLVRL 547
+ + ++G G FG V + RG+ AIK + A E F+ E KV+ + H NLV+L
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL 64
Query: 548 IGYCVE-GSLFLVYEYIENGNLNQHLRG-SGKDTLTWSARMQIALDSARGLEYIHEHTVP 605
G C + +F+V EY+ NG L +LR GK W M D +EY+ +
Sbjct: 65 YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDM--CSDVCEAMEYLESNG-- 120
Query: 606 VYIHRDIKPANILIDKNFRAKVADFGLAK--LTEVGSASVHTRLVGTFGYMPPEYAQYGE 663
+IHRD+ N L+ ++ KV+DFGLA+ L + ++S T+ + PPE Y
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF--PVKWAPPEVFDYSR 177
Query: 664 VSPKIDVYAFGVVLYELIS--AMEAVVKTNETITE--STGLVALFEEVLRQPDPREDLQR 719
S K DV++FGV+++E+ S M +N + E S G R
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY------------------R 219
Query: 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762
L P+L + ++ + +C E P+ RP+ + ++ L
Sbjct: 220 LYRPKL-------APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 68/205 (33%), Positives = 94/205 (45%), Gaps = 34/205 (16%)
Query: 497 KIGQGGFGAVFYAELR--GEKAAIKKM-----DMQASKEFLAELKVLTHVHHLNLVRLIG 549
+G+G +G V + GE AIKK D K L E+KVL + H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 550 YC-VEGSLFLVYEYIENGNLNQHL----RGSGKDT---LTWSARMQIALDSARGLEYIHE 601
+G L+LV+EY+E L + L G D W Q+ + + Y H
Sbjct: 68 AFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIW----QLL----QAIAYCHS 118
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE---- 657
H + IHRDIKP NIL+ ++ K+ DFG A+ AS T V T Y PE
Sbjct: 119 HNI---IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVG 175
Query: 658 YAQYGEVSPKIDVYAFGVVLYELIS 682
YG +DV+A G ++ EL+
Sbjct: 176 DTNYG---KPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 71/218 (32%), Positives = 111/218 (50%), Gaps = 44/218 (20%)
Query: 498 IGQGGFGAVFYAELR-----GEKA--AIKKM----DMQASKEFLAELKVLTHVHHLNLVR 546
+G+G FG VF E +K A+K + A K+F E ++LT+ H N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 547 LIGYCVEG-SLFLVYEYIENGNLNQHLRGSGKDT------------LTWSARMQIALDSA 593
G C EG +V+EY+E+G+LN+ LR G D LT S +QIA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 594 RGLEYI-HEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT----RLV 648
G+ Y+ +H ++HRD+ N L+ + K+ DFG+ S V+T R+
Sbjct: 133 SGMVYLASQH----FVHRDLATRNCLVGYDLVVKIGDFGM-------SRDVYTTDYYRVG 181
Query: 649 GT----FGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
G +MPPE Y + + + DV++FGVVL+E+ +
Sbjct: 182 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKK----MDMQASKEFLAELKVLTHVHHLN 543
+D +GQG G V+ + G+ A+KK D + K+ L ELK L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 544 LVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM--QIALDSARGLEYIH 600
+V+ G + EG + +V EY++ G+L L+ GK + IA +GL+Y+H
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGK----IPEPVLAYIARQILKGLDYLH 116
Query: 601 -EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYA 659
+ + IHRDIKP+N+LI+ K+ADFG++K+ E +T VGT YM PE
Sbjct: 117 TKRHI---IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT-FVGTVTYMSPERI 172
Query: 660 QYGEVSPKIDVYAFGVVLYEL 680
Q S D+++ G+ L E
Sbjct: 173 QGESYSYAADIWSLGLTLLEC 193
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 26/206 (12%)
Query: 492 FSMGNKIGQGGFGAVFYAE--LRGEKAAIKKMDMQASKEF--------LAELKVLTHVHH 541
+ G K+G+G + V+ A G AIKK+ + KE L E+K+L + H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 542 LNLVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH 600
N++ L+ + + ++ LV+E++E +L + + LT + L + RGLEY+H
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFME-TDL-EKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH-TRLVGTFGYMPPEY- 658
+ + +HRD+KP N+LI + K+ADFGLA+ GS + T V T Y PE
Sbjct: 120 SNWI---LHRDLKPNNLLIASDGVLKLADFGLAR--SFGSPNRKMTHQVVTRWYRAPELL 174
Query: 659 ---AQYGEVSPKIDVYAFGVVLYELI 681
YG +D+++ G + EL+
Sbjct: 175 FGARHYG---VGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 65/197 (32%), Positives = 109/197 (55%), Gaps = 19/197 (9%)
Query: 497 KIGQGGFGAVFYAELRGE-KAAIK--KMDMQAS--KEFLAELKVLTHVHHLNLVRLIGYC 551
KIG+G FG V+ L+G + A+K + + ++FL E ++L H N+V+LIG C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 552 VEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHR 610
V+ +++V E + G+L LR K+ LT +Q++LD+A G+EY+ IHR
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNC---IHR 117
Query: 611 DIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMP-----PEYAQYGEVS 665
D+ N L+ +N K++DFG+++ E G +V L +P PE YG +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL----KQIPIKWTAPEALNYGRYT 173
Query: 666 PKIDVYAFGVVLYELIS 682
+ DV+++G++L+E S
Sbjct: 174 SESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 17/201 (8%)
Query: 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEF-----LAELKVLTHV-HHLN 543
+ + ++G G FG+V+ A + GE AIKKM + + L E+K L + H N
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 544 LVRLIGYCVE-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH 602
+V+L E L+ V+EY+E GNL Q ++ + S I +GL +IH+H
Sbjct: 60 IVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE-YAQY 661
+ HRD+KP N+L+ K+ADFGLA+ E+ S +T V T Y PE +
Sbjct: 119 G---FFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 662 GEVSPKIDVYAFGVVLYELIS 682
S +D++A G ++ EL +
Sbjct: 174 TSYSSPVDIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 79/275 (28%), Positives = 126/275 (45%), Gaps = 42/275 (15%)
Query: 491 DFSMGNKIGQGGFGAVFYAELRGEKAA-------IKKMDMQASKEFLAELKVLTHVHHLN 543
DF + NKIG+G FG VF + +K + KM+ + +E + E +VL +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 544 LVRLIGYCVE-GSLFLVYEYIENGNLNQHLRGSGKDTLT----WSARMQIALDSARGLEY 598
++R ++ G L +V EY ENG+L++ L+ L W +QI L GL +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL----GLAH 116
Query: 599 IHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEY 658
+H + +HRDIK N+ +D K+ D G+AKL + +T +VGT Y+ PE
Sbjct: 117 LHSKKI---LHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPEL 172
Query: 659 AQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718
+ + K DV+A GVVLYE + N+ AL +++R
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--------GALILKIIRG-------- 216
Query: 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRP 753
V P + Y +A+L C ++ + RP
Sbjct: 217 --VFPPVSQMYSQQ----LAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 3e-28
Identities = 98/314 (31%), Positives = 149/314 (47%), Gaps = 50/314 (15%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGE----KAAIKKMDMQASKE----FLAELKVLTHV-H 540
ND + IG+G FG V A ++ + AAIK+M ASK+ F EL+VL + H
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 541 HLNLVRLIGYCVE-GSLFLVYEYIENGNLNQHLRGS--------------GKDTLTWSAR 585
H N++ L+G C G L+L EY +GNL LR S TL+
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 586 MQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645
+ A D ARG++Y+ + +IHRD+ NIL+ +N+ AK+ADFGL++ EV
Sbjct: 127 LHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 183
Query: 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFE 705
RL +M E Y + DV+++GV+L+E++S + T E L+E
Sbjct: 184 RL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS-LGGTPYCGMTCAE------LYE 234
Query: 706 EVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765
++ + RL P DD ++ L R C +E P RPS I+V+L +
Sbjct: 235 KLPQG-------YRLEKPLNCDD-------EVYDLMRQCWREKPYERPSFAQILVSLNRM 280
Query: 766 SSSSEDWDIGSFYE 779
+ + + YE
Sbjct: 281 LEERKTYVNTTLYE 294
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 82/279 (29%), Positives = 130/279 (46%), Gaps = 41/279 (14%)
Query: 491 DFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQAS---KEFLAELKVLTHVHHLNLVRL 547
D + ++G G FG V Y + RG+ KM + S EF+ E KV+ + H LV+L
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL 64
Query: 548 IGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPV 606
G C + +++V EY+ NG L +LR GK S +++ D G+ Y+
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKR-FQPSQLLEMCKDVCEGMAYLESKQ--- 120
Query: 607 YIHRDIKPANILIDKNFRAKVADFGLAK--LTEVGSASVHTRLVGTFGYMPPEYAQYGEV 664
+IHRD+ N L+D KV+DFGL++ L + ++SV ++ + PPE Y +
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLLYSKF 178
Query: 665 SPKIDVYAFGVVLYELIS--AMEAVVKTNETITE--STGLVALFEEVLRQPDPREDLQRL 720
S K DV+AFGV+++E+ S M N E S GL RL
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL------------------RL 220
Query: 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIV 759
P L + K+ + +C E + RP+ + ++
Sbjct: 221 YRPHLASE-------KVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 60/197 (30%), Positives = 105/197 (53%), Gaps = 9/197 (4%)
Query: 491 DFSMGNKIGQGGFGAVFYAELRGE-KAAIKKM---DMQASKEFLAELKVLTHVHHLNLVR 546
+F++ K+G G FG V+ + + AIK + D+ ++F E++ L + H +L+
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66
Query: 547 LIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVP 605
L C G ++++ E +E G+L LR L ++ + +A A G+ Y+ E
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN-- 124
Query: 606 VYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVS 665
IHRD+ NIL+ ++ KVADFGLA+L + + + + + PE A +G S
Sbjct: 125 -SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI-PYKWTAPEAASHGTFS 182
Query: 666 PKIDVYAFGVVLYELIS 682
K DV++FG++LYE+ +
Sbjct: 183 TKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 35/212 (16%)
Query: 492 FSMGNKIGQGGFGAVFYAELR--GEKA----AIK----KMDMQASKEFLAELKVLTHVHH 541
+G G FG V+ GEK AIK + +A+KE L E V+ V H
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 542 LNLVRLIGYCVEGSLFLVYEYIENGNLNQHLR------GSGKDTLTWSARMQIALDSARG 595
++VRL+G C+ + L+ + + G L ++R GS + L W +QI A+G
Sbjct: 69 PHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGS-QYLLNWC--VQI----AKG 121
Query: 596 LEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMP 655
+ Y+ E + +HRD+ N+L+ K+ DFGLAKL +V H G +P
Sbjct: 122 MSYLEEKRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHA----EGGKVP 174
Query: 656 -----PEYAQYGEVSPKIDVYAFGVVLYELIS 682
E + + K DV+++GV ++EL++
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 6e-27
Identities = 88/308 (28%), Positives = 144/308 (46%), Gaps = 57/308 (18%)
Query: 490 NDFSMGNKIGQGGFGAVFYAE---LRGEKAAI-------KKMDMQASKEFLAELKVLTHV 539
++ + ++G+G FG VF AE L E+ I K A K+F E ++LT++
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 540 HHLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDT-----------LTWSARMQ 587
H ++V+ G CVEG L +V+EY+++G+LN+ LR G D LT S +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 588 IALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK---LTEVGSASVH 644
IA A G+ Y+ ++HRD+ N L+ +N K+ DFG+++ T+ H
Sbjct: 125 IAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181
Query: 645 TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEA---VVKTNETITESTGLV 701
T L +MPPE Y + + + DV++ GVVL+E+ + + + NE I
Sbjct: 182 TML--PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI------- 232
Query: 702 ALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761
E + Q LQR P +++ L C Q P +R +++ I
Sbjct: 233 ----ECITQG---RVLQR----------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSL 275
Query: 762 LMTLSSSS 769
L L+ +S
Sbjct: 276 LQNLAKAS 283
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 78/260 (30%), Positives = 121/260 (46%), Gaps = 44/260 (16%)
Query: 498 IGQGGFGAVFYAE--LRGEKAAIKKM---DMQAS---KEFLAELKVLTHVHHLNLVRLIG 549
I +G +G VF A+ G+ AIK + DM + L E +L+ +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 550 YCVEG--SLFLVYEYIENGNLNQHLR--GSGKDTLTWSARM---QIALDSARGLEYIHEH 602
Y +G +L+LV EY+ G+L L GS + AR+ +I L LEY+H +
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDED---VARIYIAEIVL----ALEYLHSN 112
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKL------TEVGSASVHT-RLVGTFGYMP 655
+ IHRD+KP NILID N K+ DFGL+K+ + R+VGT Y+
Sbjct: 113 GI---IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 656 PEYAQYGEVSPKIDVYAFGVVLYELISAM-----EAVVKTNETITESTGLVALFEEVLRQ 710
PE S +D ++ G +LYE + + E + + I G + E+V
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL--NGKIEWPEDVEVS 227
Query: 711 PDPREDLQRLVDP----RLG 726
+ + + +L+ P RLG
Sbjct: 228 DEAIDLISKLLVPDPEKRLG 247
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 71/282 (25%), Positives = 122/282 (43%), Gaps = 32/282 (11%)
Query: 496 NKIGQGGFGAVFYAEL------RGEKAAIKK----MDMQASKEFLAELKVLTHVHHLNLV 545
++G+G FG V GE+ A+K + Q +F E+++L + H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 546 RLIGYC---VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH 602
+ G C SL L+ EY+ +G+L +L+ +D + + + +G++Y+
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVG---TFGYMPPEYA 659
YIHRD+ NIL++ K++DFGLAK+ + + G F Y P
Sbjct: 129 R---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 660 QYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719
+ S DV++FGV LYEL + + + E ++ + + + E L+
Sbjct: 186 TS-KFSSASDVWSFGVTLYELFTYGD---PSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241
Query: 720 LVDPRLG--DDYPIDSVRKMARLARACTQENPQLRPSMRAIV 759
RL P + M C + PQ RPS ++
Sbjct: 242 --GERLPRPPSCPDEVYDLMKL----CWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 64/208 (30%), Positives = 108/208 (51%), Gaps = 23/208 (11%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEK---AAIKKMDMQASK----EFLAELKVLTHVH 540
+ ++ IG G FG V L+ G+K AIK + +S +FL E ++
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63
Query: 541 HLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYI 599
H N++RL G + + ++ EY+ENG+L++ LR T + + A G++Y+
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR-ENDGKFTVGQLVGMLRGIASGMKYL 122
Query: 600 HEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMP---- 655
E Y+HRD+ NIL++ N KV+DFGL++ E A+ T+ G G +P
Sbjct: 123 SEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK--G--GKIPIRWT 175
Query: 656 -PEYAQYGEVSPKIDVYAFGVVLYELIS 682
PE Y + + DV++FG+V++E++S
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 94/314 (29%), Positives = 146/314 (46%), Gaps = 50/314 (15%)
Query: 491 DFSMGNKIGQGGFGAVFYAELRGE----KAAIKKMDMQAS----KEFLAELKVLTHV-HH 541
D + IG+G FG V A ++ + AAIK + AS ++F EL+VL + HH
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62
Query: 542 LNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGS--------------GKDTLTWSARM 586
N++ L+G C G L++ EY GNL LR S TLT +
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 587 QIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR 646
Q A D A G++Y+ E +IHRD+ N+L+ +N +K+ADFGL++ EV R
Sbjct: 123 QFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGR 179
Query: 647 LVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEE 706
L +M E Y + K DV++FGV+L+E++S + T E L+E+
Sbjct: 180 L--PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS-LGGTPYCGMTCAE------LYEK 230
Query: 707 VLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLS 766
+ + R+ PR DD ++ L R C ++ P RP I V L +
Sbjct: 231 LPQG-------YRMEKPRNCDD-------EVYELMRQCWRDRPYERPPFAQISVQLSRML 276
Query: 767 SSSEDWDIGSFYEN 780
+ + + + +EN
Sbjct: 277 EARKAYVNMALFEN 290
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 41/212 (19%)
Query: 492 FSMGNKIGQGGFGAVFYA--ELRGEKAAIKKMDMQASKE-----FLAELKVLTHVHHLNL 544
+ K+G+G +G V+ A + GE A+KK+ + +E L E+ +L + H N+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 545 VRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSA---------- 593
V+L+ E L+LV+EY + +L ++L + L
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDM-DLKKYLD-----------KRPGPLSPNLIKSIMYQLL 108
Query: 594 RGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGY 653
RGL Y H H + +HRD+KP NILI+++ K+ADFGLA+ + + +T V T Y
Sbjct: 109 RGLAYCHSHRI---LHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVVTLWY 164
Query: 654 MPPE----YAQYGEVSPKIDVYAFGVVLYELI 681
PE Y S +D+++ G + E+I
Sbjct: 165 RAPEILLGSKHY---STAVDIWSVGCIFAEMI 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 482 YEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMD---M-QASKEFL-AELK 534
YE L IG+G FG V + G+ K++D M + K+ L +E+
Sbjct: 2 YEVL----------ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVN 51
Query: 535 VLTHVHHLNLVRLIGYCVEGS---LFLVYEYIENGNLNQHLRGSGKDT--LTWSARMQIA 589
+L + H N+VR ++ S L++V EY E G+L Q ++ K+ + +I
Sbjct: 52 ILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRIL 111
Query: 590 LDSARGLEYIH--EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRL 647
L H +HRD+KPANI +D N K+ DFGLAK+ S+ T
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-Y 170
Query: 648 VGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYEL 680
VGT YM PE + K D+++ G ++YEL
Sbjct: 171 VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 76/211 (36%), Positives = 111/211 (52%), Gaps = 37/211 (17%)
Query: 496 NKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE-F----LAELKVLTHVHHLNLVRLI 548
KIGQG FG VF A + + A+KK+ M+ KE F L E+K+L + H N+V LI
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 549 GYC---------VEGSLFLVYEYIEN---GNLNQHLRGSGKDTLTWSARMQIALDSARGL 596
C +GS +LV+E+ E+ G L+ K TL+ ++ L + GL
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV---KFTLSEIKKVMKMLLN--GL 132
Query: 597 EYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK---LTEVGSASVHTRLVGTFGY 653
YIH + + +HRD+K ANILI K+ K+ADFGLA+ L++ + +T V T Y
Sbjct: 133 YYIHRNKI---LHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWY 189
Query: 654 MPPEY----AQYGEVSPKIDVYAFGVVLYEL 680
PPE YG P ID++ G ++ E+
Sbjct: 190 RPPELLLGERDYG---PPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 59/192 (30%), Positives = 100/192 (52%), Gaps = 11/192 (5%)
Query: 497 KIGQGGFGAVFYAELRGEKA-AIK--KMDMQASKEFLAELKVLTHVHHLNLVRLIGYC-V 552
K+G G FG V+ A+K K K+FLAE +++ + H L++L C +
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 553 EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDI 612
E +++V E ++ G+L ++L+G L + +A A G+ Y+ YIHRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDL 129
Query: 613 KPANILIDKNFRAKVADFGLAKL--TEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDV 670
N+L+ +N KVADFGLA++ ++ A + + PE A Y S K DV
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAALYNRFSIKSDV 187
Query: 671 YAFGVVLYELIS 682
++FG++L E+++
Sbjct: 188 WSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 64/197 (32%), Positives = 100/197 (50%), Gaps = 8/197 (4%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRG-EKAAIKKMDMQASKE---FLAELKVLTHVHHLNLV 545
+ K+G G FG V+ G K AIK + Q S FLAE ++ + H LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 546 RLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVP 605
RL + ++++ EY+ENG+L L+ LT + + +A A G+ +I
Sbjct: 65 RLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN-- 122
Query: 606 VYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVS 665
YIHRD++ ANIL+ + K+ADFGLA+L E + + PE YG +
Sbjct: 123 -YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 181
Query: 666 PKIDVYAFGVVLYELIS 682
K DV++FG++L E+++
Sbjct: 182 IKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 6e-26
Identities = 66/220 (30%), Positives = 109/220 (49%), Gaps = 33/220 (15%)
Query: 491 DFSMGNKIGQGGFGAVFYAELRGEKAAIKKM----------DMQASKEFLAELKVLTHVH 540
D + ++G+G FG VF AE KM + A K+F E ++LT++
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ 65
Query: 541 HLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDT--------------LTWSAR 585
H ++V+ G C +G L +V+EY+++G+LN+ LR G D L S
Sbjct: 66 HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 586 MQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK---LTEVGSAS 642
+ IA A G+ Y+ ++HRD+ N L+ N K+ DFG+++ T+
Sbjct: 126 LHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 182
Query: 643 VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
HT L +MPPE Y + + + DV++FGV+L+E+ +
Sbjct: 183 GHTML--PIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 75/287 (26%), Positives = 119/287 (41%), Gaps = 48/287 (16%)
Query: 498 IGQGGFGAVFYAELRGE-----------KAAIKKMDMQASKEFLAELKVLTHVHHLNLVR 546
+G+G FG VF A+ +G KA K D EF EL + + H N+VR
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 547 LIGYCVEGSLF-LVYEYIENGNLNQHLRGS-GKDT------LTWSARMQIALDSARGLEY 598
L+G C E ++ EY + G+L Q LR + KD L+ ++ + A G+++
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 599 IHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEY 658
+ ++HRD+ N L+ KV+ L+K + ++ PE
Sbjct: 133 LSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189
Query: 659 AQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR---E 715
Q + S K DV++FGV+++E+ + E +++ L L L P P
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFTQGE---LPFYGLSDEEVLNRLQAGKLELPVPEGCPS 246
Query: 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762
L +L M R C NP+ RPS +V AL
Sbjct: 247 RLYKL----------------MTR----CWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 67/202 (33%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 495 GNKIGQGGFGAVFYA-ELR-GEKAAIKKMDMQAS-----KEFLAELKVLTHVHHLNLVRL 547
GNKIG G FG V+ A L GE A+K++ +Q + KE E+KVL + H NLV+
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 548 IGYCVEGSLFLVY-EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPV 606
G V ++ EY G L + L + L GL Y+H H +
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLHSHGI-- 120
Query: 607 YIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR---LVGTFGYMPPEYAQYGE 663
+HRDIKPANI +D N K+ DFG A + + ++ L GT YM PE G+
Sbjct: 121 -VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 664 VSPK---IDVYAFGVVLYELIS 682
D+++ G V+ E+ +
Sbjct: 180 GKGHGRAADIWSLGCVVLEMAT 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 65/189 (34%), Positives = 98/189 (51%), Gaps = 6/189 (3%)
Query: 497 KIGQGGFGAVFYAELRGE-KAAIK--KMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVE 553
K+GQG FG V+ G + AIK K + + FL E +V+ + H LV+L E
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 554 GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIK 613
+++V EY+ G+L L+G L + +A A G+ Y+ Y+HRD++
Sbjct: 73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLR 129
Query: 614 PANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAF 673
ANIL+ +N KVADFGLA+L E + + PE A YG + K DV++F
Sbjct: 130 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189
Query: 674 GVVLYELIS 682
G++L EL +
Sbjct: 190 GILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 30/207 (14%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA--AIKKMD------MQASKEFLAELKVLTHVHH 541
+DF +G G FG V +G A+K + ++ + L E ++L + H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 542 LNLVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM---QIALDSARGLE 597
LV L G + + +L+LV EY+ G L HLR SG+ AR Q+ L LE
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPV-ARFYAAQVVL----ALE 115
Query: 598 YIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE 657
Y+H ++RD+KP N+L+D + K+ DFG AK + + +T L GT Y+ PE
Sbjct: 116 YLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT---YT-LCGTPEYLAPE 168
Query: 658 YAQ---YGEVSPKIDVYAFGVVLYELI 681
YG+ +D +A G+++YE++
Sbjct: 169 IILSKGYGK---AVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 93/289 (32%), Positives = 140/289 (48%), Gaps = 50/289 (17%)
Query: 498 IGQGGFGAVFYAELRGE----KAAIKKMDMQAS----KEFLAELKVLTHV-HHLNLVRLI 548
IG+G FG V A ++ + AAIK+M AS ++F EL+VL + HH N++ L+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 549 GYCV-EGSLFLVYEYIENGNLNQHLRGS--------------GKDTLTWSARMQIALDSA 593
G C G L+L EY +GNL LR S TL+ + A D A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 594 RGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGY 653
RG++Y+ + +IHRD+ NIL+ +N+ AK+ADFGL++ EV RL +
Sbjct: 123 RGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL--PVRW 177
Query: 654 MPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713
M E Y + DV+++GV+L+E++S + T E L+E++ +
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVS-LGGTPYCGMTCAE------LYEKLPQG--- 227
Query: 714 REDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762
RL P DD ++ L R C +E P RPS I+V+L
Sbjct: 228 ----YRLEKPLNCDD-------EVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 67/220 (30%), Positives = 106/220 (48%), Gaps = 40/220 (18%)
Query: 498 IGQGGFGAVFYAELRG-------EKAAIKKMDMQAS----KEFLAELKVLTHVHHLNLVR 546
IGQG FG VF A G A+K + +AS +F E ++ H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 547 LIGYCVEGS-LFLVYEYIENGNLNQHLR--------------------GSGKDTLTWSAR 585
L+G C G + L++EY+ G+LN+ LR G L+ + +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 586 MQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK---LTEVGSAS 642
+ IA A G+ Y+ E ++HRD+ N L+ +N K+ADFGL++ + AS
Sbjct: 133 LCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 643 VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
+ + +MPPE Y + + DV+A+GVVL+E+ S
Sbjct: 190 ENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 67/218 (30%), Positives = 111/218 (50%), Gaps = 30/218 (13%)
Query: 491 DFSMGNKIGQGGFGAVFYAE---LRGEK-------AAIKKMDMQASKEFLAELKVLTHVH 540
D + ++G+G FG VF AE L E+ A+K+ A ++F E ++LT +
Sbjct: 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQ 65
Query: 541 HLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDT-------------LTWSARM 586
H ++VR G C EG L +V+EY+ +G+LN+ LR G D LT +
Sbjct: 66 HQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 587 QIALDSARGLEYIHE-HTVPVYIHRDIKPANILIDKNFRAKVADFGLAK-LTEVGSASVH 644
IA A G+ Y+ H ++HRD+ N L+ + K+ DFG+++ + V
Sbjct: 126 AIASQIASGMVYLASLH----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 181
Query: 645 TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
R + +MPPE Y + + + D+++FGVVL+E+ +
Sbjct: 182 GRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 60/199 (30%), Positives = 93/199 (46%), Gaps = 16/199 (8%)
Query: 492 FSMGNKIGQGGFGAVFYAELRGEKA--AIKKMD------MQASKEFLAELKVLTHVHHLN 543
F + IG+G FG V + R K A+K M+ + + L E ++L ++H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 544 LVRL-IGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH 602
LV L + E +++LV + + G+L HL K + + I + LEY+H
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE-QVKFWIC-EIVLALEYLHSK 119
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYG 662
+ IHRDIKP NIL+D+ + DF +A + + T GT GYM PE
Sbjct: 120 GI---IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST--SGTPGYMAPEVLCRQ 174
Query: 663 EVSPKIDVYAFGVVLYELI 681
S +D ++ GV YE +
Sbjct: 175 GYSVAVDWWSLGVTAYECL 193
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 76/268 (28%), Positives = 129/268 (48%), Gaps = 41/268 (15%)
Query: 497 KIGQGGFGAVFYAE-LRGEKAAIKKM--DMQASKEFLAELKVLTHVHHLNLVRLIGYCVE 553
+IG G FG V+ L K AIK + + ++F+ E +V+ + H LV+L G C E
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 554 GS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDI 612
S + LV+E++E+G L+ +LR + + + + + LD G+ Y+ V IHRD+
Sbjct: 71 RSPICLVFEFMEHGCLSDYLR-AQRGKFSQETLLGMCLDVCEGMAYLESSNV---IHRDL 126
Query: 613 KPANILIDKNFRAKVADFGLAK--LTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDV 670
N L+ +N KV+DFG+ + L + ++S T+ + PE + + S K DV
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF--PVKWSSPEVFSFSKYSSKSDV 184
Query: 671 YAFGVVLYELISA--MEAVVKTNETITE--STGLVALFEEVLRQPDPREDLQRLVDPRLG 726
++FGV+++E+ S ++N + E + G RL PRL
Sbjct: 185 WSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF------------------RLYKPRLA 226
Query: 727 DDYPIDSVRKMARLARACTQENPQLRPS 754
+ + L + C +E P+ RPS
Sbjct: 227 S-------QSVYELMQHCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 23/199 (11%)
Query: 497 KIGQGGFGAVF--YAELRGEKAAIKKM-----DMQASKEFLAELKVLTHVHHLNLVRLIG 549
KIG+G +G V+ +L GE AIKK+ K L E+K+L ++H N+++L+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 550 -YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYI 608
+ +G L+LV+E+++ +L + ++ + L S +GL + H H + +
Sbjct: 66 VFRHKGDLYLVFEFMDT-DLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHSHGI---L 120
Query: 609 HRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS-VHTRLVGTFGYMPPEY----AQYGE 663
HRD+KP N+LI+ K+ADFGLA+ GS +T V T Y PE Y
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLAR--SFGSPVRPYTHYVVTRWYRAPELLLGDKGYS- 177
Query: 664 VSPKIDVYAFGVVLYELIS 682
+D+++ G + EL+S
Sbjct: 178 --TPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 24/205 (11%)
Query: 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE-----FLAELKVLTHVHHLN 543
+ + +IG+G G VF A+ R GE A+KK+ ++ + L E+K L H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 544 LVRLIGYCVEGSLF-LVYEYIENGNLNQHLRGSGKDTLTWSAR--MQIALDSARGLEYIH 600
+V+L+ GS F LV EY+ + L++ LR + + M++ L G+ Y+H
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLK---GVAYMH 116
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE--Y 658
+ + +HRD+KPAN+LI + K+ADFGLA+L +++ V T Y PE Y
Sbjct: 117 ANGI---MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173
Query: 659 AQ--YGEVSPKIDVYAFGVVLYELI 681
Y P +D++A G + EL+
Sbjct: 174 GARKYD---PGVDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 78/304 (25%), Positives = 135/304 (44%), Gaps = 60/304 (19%)
Query: 491 DFSMGNKIGQGGFGAVFYAELRG-------EKAAIKKMDMQAS----KEFLAELKVLTHV 539
++G +G+G FG V AE G A+K + A+ + ++E++++ +
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMI 72
Query: 540 -HHLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRG--------------SGKDTLTWS 583
H N++ L+G C EG L++V EY +GNL LR ++TLT
Sbjct: 73 GKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132
Query: 584 ARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK-LTEVGSAS 642
+ A ARG+E++ IHRD+ N+L+ ++ K+ADFGLA+ + +
Sbjct: 133 DLVSFAYQVARGMEFLASKKC---IHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYR 189
Query: 643 VHTRLVGTFGYMPPEYAQYGEV-SPKIDVYAFGVVLYELIS---AMEAVVKTNETITEST 698
T +M PE A + V + + DV++FGV+L+E+ + + + E
Sbjct: 190 KTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------ 242
Query: 699 GLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
L L +E R + P + +++ L R C E P RP+ + +
Sbjct: 243 -LFKLLKEGYRM-----------------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQL 284
Query: 759 VVAL 762
V L
Sbjct: 285 VEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 62/189 (32%), Positives = 95/189 (50%), Gaps = 6/189 (3%)
Query: 497 KIGQGGFGAVFYAELRGE-KAAIK--KMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVE 553
K+G G FG V+ G K A+K K + + FL E +++ + H LV+L E
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 554 GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIK 613
+++V EY+ G+L L+ L + +A A G+ YI YIHRD++
Sbjct: 73 EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLR 129
Query: 614 PANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAF 673
ANIL+ K+ADFGLA+L E + + PE A YG + K DV++F
Sbjct: 130 SANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189
Query: 674 GVVLYELIS 682
G++L EL++
Sbjct: 190 GILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 69/201 (34%), Positives = 101/201 (50%), Gaps = 27/201 (13%)
Query: 497 KIGQGGFGAVFYAELR--GEKAAIKKM-----DMQASKEFLAELKVLTHVHHLNLVRLIG 549
KIG+G +G VF R G+ AIKK D K L E+++L + H NLV LI
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 550 -YCVEGSLFLVYEYIENGNLN---QHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVP 605
+ + L LV+EY ++ LN ++ RG + + +I + + + + H+H
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLI-----KKIIWQTLQAVNFCHKHNC- 121
Query: 606 VYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEY----AQY 661
IHRD+KP NILI K + K+ DFG A++ +T V T Y PE QY
Sbjct: 122 --IHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-YTDYVATRWYRAPELLVGDTQY 178
Query: 662 GEVSPKIDVYAFGVVLYELIS 682
G P +DV+A G V EL++
Sbjct: 179 G---PPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 72/285 (25%), Positives = 127/285 (44%), Gaps = 52/285 (18%)
Query: 491 DFSMGNKIGQGGFGAVFYAELRGEKA--AIKKMDM----QASKE-FLAELKVLTHVHHLN 543
DF + K+G+G +G+V+ + + A+K++D+ Q +E + E+++L V+H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 544 LVRLIGYCVEG-SLFLVYEYIENGNLNQHLRGSGK------DTLTWSARMQIALDSARGL 596
++ ++G L +V EY G+L++ + K + W +Q+ RGL
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGL 116
Query: 597 EYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPP 656
+ +HE + +HRD+K ANIL+ N K+ D G++K+ + A GT YM P
Sbjct: 117 QALHEQKI---LHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAP 170
Query: 657 EYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716
E + S K D+++ G +LYE+ + P
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMAT-------------------------FAPPFEARS 205
Query: 717 LQRLVDPRLGDDYP-IDSV--RKMARLARACTQENPQLRPSMRAI 758
+Q L YP I + + + R+ Q P+LRP+ I
Sbjct: 206 MQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 64/214 (29%), Positives = 113/214 (52%), Gaps = 34/214 (15%)
Query: 498 IGQGGFGAVFYAELRG-------EKAAIKKMDMQAS----KEFLAELKVLTHVHHLNLVR 546
+G+G FG V+ EL G AIK + A +EF E ++++ + H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 547 LIGYCV-EGSLFLVYEYIENGNLNQHL--------------RGSGKDTLTWSARMQIALD 591
L+G C E +++EY+ +G+L++ L + K +L S + IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 592 SARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS---VHTRLV 648
A G+EY+ H ++HRD+ N L+ + K++DFGL++ ++ SA V ++ +
Sbjct: 133 IAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSR--DIYSADYYRVQSKSL 187
Query: 649 GTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
+MPPE YG+ + + D+++FGVVL+E+ S
Sbjct: 188 LPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 69/214 (32%), Positives = 111/214 (51%), Gaps = 36/214 (16%)
Query: 492 FSMGNKIGQGGFGAVFYA--ELRGEKAAIKKMDMQASKE-----FLAELKVLTHVHHLNL 544
F + +IG+G +G V+ A + GE A+KK+ + KE + E+K+L ++H N+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 545 VRLIGYCVE-----------GSLFLVYEYIEN---GNLNQHLRGSGKDTLTWSARMQIAL 590
V L + G+ +LV+EY+++ G L L +D + + M+ L
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI--KSFMKQLL 126
Query: 591 DSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGT 650
+ GL Y H+ ++HRDIK +NIL++ + K+ADFGLA+L + +T V T
Sbjct: 127 E---GLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVIT 180
Query: 651 FGYMPPEY----AQYGEVSPKIDVYAFGVVLYEL 680
Y PPE +YG P IDV++ G +L EL
Sbjct: 181 LWYRPPELLLGEERYG---PAIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 64/189 (33%), Positives = 95/189 (50%), Gaps = 6/189 (3%)
Query: 497 KIGQGGFGAVFYAELRGE-KAAIK--KMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVE 553
K+GQG FG V+ G K AIK K + FL E +++ + H LV L E
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 554 GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIK 613
+++V E++ G+L L+ L + +A A G+ YI YIHRD++
Sbjct: 73 EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLR 129
Query: 614 PANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAF 673
ANIL+ N K+ADFGLA+L E + + PE A YG + K DV++F
Sbjct: 130 AANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189
Query: 674 GVVLYELIS 682
G++L EL++
Sbjct: 190 GILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 23/207 (11%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAE--LRGEKAAIKK------MDMQASKEFLAELKVLTHVH 540
+F + KIG+G F V+ A L G A+KK MD +A ++ L E+ +L +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 541 HLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLT------WSARMQIALDSA 593
H N+++ + +E + L +V E + G+L++ ++ K W +Q+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC---- 116
Query: 594 RGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGY 653
LE++H + +HRDIKPAN+ I K+ D GL + + + H+ LVGT Y
Sbjct: 117 SALEHMHSKRI---MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYY 172
Query: 654 MPPEYAQYGEVSPKIDVYAFGVVLYEL 680
M PE + K D+++ G +LYE+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 70/226 (30%), Positives = 110/226 (48%), Gaps = 54/226 (23%)
Query: 482 YEELAKATNDFSMGNKIGQGGFGAVFYA--ELRGEKAAIKKMDMQASKEFL--------A 531
YEEL +IG+G +G V+ A G A+KK+ + S+E + A
Sbjct: 1 YEEL----------AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIA 50
Query: 532 ELKVLTHVHHLNLVRLIGYCV------EGSLFLVYEYIENGNLNQHLR-----GSGKDTL 580
LK L H N+VRL+ C E L LV+E+++ +L +L G +T+
Sbjct: 51 LLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETI 109
Query: 581 TWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640
R Q+ RG++++H H + +HRD+KP NIL+ + + K+ADFGLA++
Sbjct: 110 KDLMR-QLL----RGVDFLHSHRI---VHRDLKPQNILVTSDGQVKIADFGLARIYSFEM 161
Query: 641 ASVHTRLVGTFGYMPPE------YAQYGEVSPKIDVYAFGVVLYEL 680
A T +V T Y PE YA +P +D+++ G + EL
Sbjct: 162 AL--TSVVVTLWYRAPEVLLQSSYA-----TP-VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 4e-23
Identities = 80/292 (27%), Positives = 127/292 (43%), Gaps = 53/292 (18%)
Query: 493 SMGNKIGQGGFGAVFYAELRGEKAAIKKMDM-----------QASKEFLAELKVLTHVHH 541
++ +G G FG V+ RG ++ + Q +FL E +++ +H
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68
Query: 542 LNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDT-----LTWSARMQIALDSARG 595
N+VRLIG E F++ E + G+L LR + LT + A D A+G
Sbjct: 69 QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 596 LEYIHEHTVPVYIHRDIKPANILID---KNFRAKVADFGLAKLTEVGSASVHT---RLVG 649
+Y+ E+ +IHRDI N L+ AK+ADFG+A+ ++ AS + R +
Sbjct: 129 CKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMAR--DIYRASYYRKGGRAML 183
Query: 650 TFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS--AMEAVVKTNETITESTGLVALFEEV 707
+MPPE G + K DV++FGV+L+E+ S M +TN+ + E V
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME---FVTG---- 236
Query: 708 LRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIV 759
RL D P + R+ C Q P+ RP+ I+
Sbjct: 237 --------------GGRL--DPPKGCPGPVYRIMTDCWQHTPEDRPNFATIL 272
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 82/298 (27%), Positives = 137/298 (45%), Gaps = 55/298 (18%)
Query: 497 KIGQGGFGAVFYAELRG-----EKA-------------AIKKM----DMQASKEFLAELK 534
K+G+G FG V E G EKA A+K + A ++FL E+K
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 535 VLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLNQHLRGS---------GKDTLTWSA 584
+L+ + N+ RL+G C V+ L ++ EY+ENG+LNQ L+ +L++S
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 585 RMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK-LTEVGSASV 643
+ +A A G+ Y+ ++HRD+ N L+ KN+ K+ADFG+++ L V
Sbjct: 132 LLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 644 HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVK--TNETITESTGL 700
R +M E G+ + K DV+AFGV L+E+++ E + T++ + E+ G
Sbjct: 189 QGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAG- 247
Query: 701 VALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
R + L R P + + + L C + + + RP+ R I
Sbjct: 248 -----HFFRDDGRQIYLPR----------PPNCPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 6e-23
Identities = 78/281 (27%), Positives = 132/281 (46%), Gaps = 43/281 (15%)
Query: 497 KIGQGGFGAVFYAELRGEKA--AIKKM------DMQASKEFLAELKVLTHVHHLNLVRLI 548
+IG+G FG VF LR + A+K D++A +FL E ++L H N+VRLI
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA--KFLQEARILKQYSHPNIVRLI 59
Query: 549 GYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVY 607
G C + +++V E ++ G+ LR G L +Q+ ++A G+EY+
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGP-RLKVKELIQMVENAAAGMEYLESKHC--- 115
Query: 608 IHRDIKPANILIDKNFRAKVADFGLAKLTEVG--SASVHTRLVGTFGYMPPEYAQYGEVS 665
IHRD+ N L+ + K++DFG+++ E G +++ + + + PE YG S
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI-PVKWTAPEALNYGRYS 174
Query: 666 PKIDVYAFGVVLYELIS--AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723
+ DV++FG++L+E S A+ +N+ E+ E+ +R P P
Sbjct: 175 SESDVWSFGILLWEAFSLGAVPYANLSNQQTREA------IEQGVRLPCP---------- 218
Query: 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764
+ P R M R C + +P RPS + L +
Sbjct: 219 ---ELCPDAVYRLMER----CWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 7e-23
Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 30/205 (14%)
Query: 496 NKIGQGGFGAV---FYAELRGE--KAAIKKM---DMQASK-EFLAELKVLTHVHHLNLVR 546
++G G FG+V Y G+ + A+K + + A K EFL E V+ + H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 547 LIGYCVEGSLFLVYEYIENGNLNQHLRGSG----KDTLTWSARMQIALDSARGLEYIHEH 602
LIG C L LV E G L ++L+ D A A G+ Y+
Sbjct: 61 LIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLESK 114
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMP-----PE 657
++HRD+ N+L+ +AK++DFG+++ GS T G P PE
Sbjct: 115 H---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT---TAGRWPLKWYAPE 168
Query: 658 YAQYGEVSPKIDVYAFGVVLYELIS 682
YG+ S K DV+++GV L+E S
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 62/199 (31%), Positives = 107/199 (53%), Gaps = 18/199 (9%)
Query: 498 IGQGGFGAVFYAEL-----RGEKAAIKKM----DMQASKEFLAELKVLTHVHHLNLVRLI 548
IG+G FG V++ L + A+K + D++ ++FL E ++ H N++ L+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 549 GYCV--EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPV 606
G C+ EGS +V Y+++G+L +R S T + L A+G+EY+
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIR-SETHNPTVKDLIGFGLQVAKGMEYLASKK--- 118
Query: 607 YIHRDIKPANILIDKNFRAKVADFGLAK-LTEVGSASVHTRLVGTF--GYMPPEYAQYGE 663
++HRD+ N ++D++F KVADFGLA+ + + SVH +M E Q +
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK 178
Query: 664 VSPKIDVYAFGVVLYELIS 682
+ K DV++FGV+L+EL++
Sbjct: 179 FTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 67/206 (32%), Positives = 103/206 (50%), Gaps = 28/206 (13%)
Query: 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEF---LAELKVLTHVHHLNLV 545
D+ + +IG G +G V+ A GE AIK + ++ +F E+ +L H N+V
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV 63
Query: 546 RLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIAL---DSARGLEYIHE 601
G Y L++V EY G+L Q + + L+ +QIA ++ +GL Y+HE
Sbjct: 64 AYFGSYLRRDKLWIVMEYCGGGSL-QDIYQVTRGPLS---ELQIAYVCRETLKGLAYLHE 119
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGL-AKLTEVGSASVHTRLVGTFGYMPPEYAQ 660
IHRDIK ANIL+ ++ K+ADFG+ A+LT + + +GT +M PE A
Sbjct: 120 TGK---IHRDIKGANILLTEDGDVKLADFGVSAQLTA--TIAKRKSFIGTPYWMAPEVAA 174
Query: 661 ------YGEVSPKIDVYAFGVVLYEL 680
Y K D++A G+ EL
Sbjct: 175 VERKGGYDG---KCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 76/282 (26%), Positives = 128/282 (45%), Gaps = 53/282 (18%)
Query: 497 KIGQGGFGAVFYAELRGE-KAAIKKMDMQASKE--FLAELKVLTHVHHLNLVRLIGYCVE 553
++G G FG V + R + K AIK ++ A E F+ E KV+ + H LV+L G C +
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 554 GS-LFLVYEYIENGNLNQHLRGS----GKDTLTWSARMQIALDSARGLEYIHEHTVPVYI 608
L++V E++ENG L +LR KD L + + D G+EY+ ++ +I
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDML-----LSMCQDVCEGMEYLERNS---FI 122
Query: 609 HRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFG------YMPPEYAQYG 662
HRD+ N L+ KV+DFG+ + + + G + PPE +
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYV------LDDEYTSSSGAKFPVKWSPPEVFNFS 176
Query: 663 EVSPKIDVYAFGVVLYELIS--AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720
+ S K DV++FGV+++E+ + M K+N + E + R RL
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---------YEVVEMISRG-------FRL 220
Query: 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762
P+L + + +C E P+ RP+ ++ A+
Sbjct: 221 YRPKLASMT-------VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 2e-22
Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 30/204 (14%)
Query: 498 IGQGGFGAVFYA--ELRGEKAAIKKM-----DMQASKEFLAELKVLTHVHHLNLVRLI-- 548
IG G +G V A + G K AIKK+ D+ +K L E+K+L H+ H N++ L+
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67
Query: 549 ----GYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQ-IALDSARGLEYIHEHT 603
+++V E +E +L++ ++ S + LT +Q RGL+Y+H
Sbjct: 68 LRPPSPEDFNDVYIVTELMET-DLHKVIK-SPQP-LT-DDHIQYFLYQILRGLKYLHSAN 123
Query: 604 VPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH--TRLVGTFGYMPPE---- 657
V IHRD+KP+NIL++ N K+ DFGLA+ + T V T Y PE
Sbjct: 124 V---IHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180
Query: 658 YAQYGEVSPKIDVYAFGVVLYELI 681
++Y + ID+++ G + EL+
Sbjct: 181 SSRY---TKAIDIWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 73/228 (32%), Positives = 106/228 (46%), Gaps = 46/228 (20%)
Query: 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE-F----LAELKVLTHVH 540
D+ + K+G+G FG V+ A G A+KK+ M K+ F L E+K+L +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 541 HLNLVRLIGYCVE---------GSLFLVYEYIE---NGNL-NQHLRGSGKDTLTWSARMQ 587
H N+V LI VE GS+++V Y++ +G L N ++ LT S
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK------LTESQIKC 119
Query: 588 IALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE---------- 637
L G+ Y+HE+ +HRDIK ANILID K+ADFGLA+ +
Sbjct: 120 YMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 638 VGSASVHTRLVGTFGYMPPEY----AQYGEVSPKIDVYAFGVVLYELI 681
G +T LV T Y PPE +Y +D++ G V E+
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYT---TAVDIWGIGCVFAEMF 221
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-22
Identities = 79/299 (26%), Positives = 131/299 (43%), Gaps = 63/299 (21%)
Query: 497 KIGQGGFGAVFYAEL------RGEKAAIKKM----DMQASKEFLAELKVLTHVHHLNLVR 546
++G+ FG ++ L + AIK + + Q EF E ++ +HH N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 547 LIGYCV-EGSLFLVYEYIENGNLNQHL---------------RGSGKDTLTWSARMQIAL 590
L+G E + +++EY+ G+L++ L G+ K +L + IA+
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 591 DSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS---VHTRL 647
A G+EY+ H ++H+D+ NILI + K++D GL++ E+ SA V +
Sbjct: 132 QIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSR--EIYSADYYRVQPKS 186
Query: 648 VGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALF--- 704
+ +MPPE YG+ S D+++FGVVL+E+ S GL +
Sbjct: 187 LLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF---------------SFGLQPYYGFS 231
Query: 705 -EEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762
+EV+ R+ L D +M L C QE P RP + I L
Sbjct: 232 NQEVIEMVRKRQLLP----------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 4e-22
Identities = 67/227 (29%), Positives = 102/227 (44%), Gaps = 37/227 (16%)
Query: 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMD------MQASKEFLAELKVLTHVHHL 542
DF MG +G G FG V A+ + GE AIK + M+ + E +L + H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 543 NLVRLI-GYCVEGSLFLVYEYIENGNLNQHLRGSGK---DTLT-WSARMQIALDSARGLE 597
+V ++ + E ++ + E++ G L HLR +G+ D + A + +A E
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAF------E 132
Query: 598 YIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR---LVGTFGYM 654
Y+H + I+RD+KP N+L+D KV DFG AK V R L GT Y+
Sbjct: 133 YLHSKDI---IYRDLKPENLLLDNKGHVKVTDFGFAK-------KVPDRTFTLCGTPEYL 182
Query: 655 PPEYAQYGEVSPKIDVYAFGVVLYELISAM-----EAVVKTNETITE 696
PE Q +D + GV+LYE I+ + + E I
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA 229
|
Length = 329 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 80/300 (26%), Positives = 131/300 (43%), Gaps = 57/300 (19%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRG-------EKAAIKKMDMQAS----KEFLAELKVLTH 538
++ ++GQG FG V+ +G + AIK ++ AS EFL E V+
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65
Query: 539 VHHLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRG--------SGKDTLTWSARMQIA 589
+ ++VRL+G G +V E + G+L +LR G T +Q+A
Sbjct: 66 FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125
Query: 590 LDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT-------EVGSAS 642
+ A G+ Y+ ++HRD+ N ++ ++ K+ DFG+ + + G
Sbjct: 126 AEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 643 VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVA 702
+ R +M PE + G + K DV++FGVVL+E+ + E + GL
Sbjct: 183 LPVR------WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ---------GLSN 227
Query: 703 LFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762
EEVL + V D P + K+ L R C Q NP++RP+ IV +L
Sbjct: 228 --EEVL----------KFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 5e-22
Identities = 77/284 (27%), Positives = 126/284 (44%), Gaps = 30/284 (10%)
Query: 498 IGQGGFGAV-FYA-----ELRGEKAAIKKMDMQASKE----FLAELKVLTHVHHLNLVRL 547
+G+G FG V Y + GE A+K + + ++ + E+ +L ++H N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 548 IGYCVEG---SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTV 604
G C E L L+ EY+ G+L +L K L + + A G+ Y+H
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLP---KHKLNLAQLLLFAQQICEGMAYLHSQH- 127
Query: 605 PVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVG---TFGYMPPEYAQY 661
YIHRD+ N+L+D + K+ DFGLAK G R G F Y +
Sbjct: 128 --YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN 185
Query: 662 GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721
+ S DV++FGV LYEL++ ++ + E G V+R + E RL
Sbjct: 186 -KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLP 244
Query: 722 DPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765
P + P + V L + C + + RP+ R+++ L +
Sbjct: 245 CP---KNCPQE-VYI---LMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 5e-22
Identities = 54/189 (28%), Positives = 95/189 (50%), Gaps = 6/189 (3%)
Query: 497 KIGQGGFGAVFYAEL-RGEKAAIKKMD--MQASKEFLAELKVLTHVHHLNLVRLIGYCVE 553
K+G G FG V+ A + K A+K M + + FLAE V+ + H LV+L +
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 554 GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIK 613
++++ E++ G+L L+ + + A G+ +I + YIHRD++
Sbjct: 73 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLR 129
Query: 614 PANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAF 673
ANIL+ + K+ADFGLA++ E + + PE +G + K DV++F
Sbjct: 130 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 189
Query: 674 GVVLYELIS 682
G++L E+++
Sbjct: 190 GILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 60/198 (30%), Positives = 107/198 (54%), Gaps = 15/198 (7%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA-SKEFLAELKVLTHVHHLNLVR 546
F + K+G+G +G+V+ A + G+ AIK + ++ +E + E+ +L +V+
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVK 62
Query: 547 LIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIAL---DSARGLEYIHEH 602
G Y L++V EY G+++ ++ + K TLT +IA + +GLEY+H +
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEE---EIAAILYQTLKGLEYLHSN 118
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYG 662
IHRDIK NIL+++ +AK+ADFG++ A +T ++GT +M PE Q
Sbjct: 119 KK---IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEI 174
Query: 663 EVSPKIDVYAFGVVLYEL 680
+ K D+++ G+ E+
Sbjct: 175 GYNNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 74/281 (26%), Positives = 126/281 (44%), Gaps = 47/281 (16%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKM----DMQASKEFLAELKVLTHVHHLN 543
+D ++G G G V R G+ A+K + + K+ L EL +L +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 544 LVRLIGYC-VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE- 601
+V G G + + EY++ G+L++ L+ + + +IA+ +GL Y+HE
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILK-EVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLA-KLTEVGSASVHTRLVGTFGYMPPEYAQ 660
H + IHRD+KP+NIL++ + K+ DFG++ +L S+ VGT YM PE Q
Sbjct: 120 HKI---IHRDVKPSNILVNSRGQIKLCDFGVSGQLV----NSLAKTFVGTSSYMAPERIQ 172
Query: 661 YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR------ 714
+ S K D+++ G+ L EL + N+ G+ L + ++ +P PR
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFPYPPENDP---PDGIFELLQYIVNEPPPRLPSGKF 229
Query: 715 -EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPS 754
D Q V+ C ++P+ RPS
Sbjct: 230 SPDFQDFVN--------------------LCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 78/296 (26%), Positives = 123/296 (41%), Gaps = 66/296 (22%)
Query: 498 IGQGGFGAV---FYAELR---GEKAAIKKMDMQASKE-----FLAELKVLTHVHHLNLVR 546
+G+G FG+V Y L+ GE A+KK+ Q S F E+++L + H N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKL--QHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 547 LIGYCVEG---SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT 603
G C +L LV EY+ G+L +L+ ++ L + A +G+EY+
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYLGSKR 128
Query: 604 VPVYIHRDIKPANILIDKNFRAKVADFGLAKL----------TEVGSASVHTRLVGTFGY 653
Y+HRD+ NIL++ R K+ DFGL K+ E G + + F Y
Sbjct: 129 ---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI-------FWY 178
Query: 654 MPPEYAQYGEVSPKIDVYAFGVVLYELISA-----------MEAVVKTNETITESTGLVA 702
PE + S DV++FGVVLYEL + M + + L+
Sbjct: 179 -APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237
Query: 703 LFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
L + R P P P ++ + + C +P RPS +
Sbjct: 238 LLKNNGRLPAP-------------PGCPA----EIYAIMKECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 21/207 (10%)
Query: 490 NDFSMGNKIGQGGFGAVFYAEL--RGEKAAIKKMDMQAS----KEFLAELKVLTHVHHLN 543
+D+ + IG G V+ A EK AIK++D++ E E++ ++ +H N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 544 LVRLIGYCVEG-SLFLVYEYIENGNLNQHLRGS-GKDTLTWSARMQIALDSARGLEYIHE 601
+V+ V G L+LV Y+ G+L ++ S + L + + + +GLEY+H
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGL-AKLTEVGSASVHTR--LVGTFGYMPPEY 658
+ IHRDIK NIL+ ++ K+ADFG+ A L + G + R VGT +M PE
Sbjct: 121 NG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 659 AQ----YGEVSPKIDVYAFGVVLYELI 681
+ Y K D+++FG+ EL
Sbjct: 178 MEQVHGYDF---KADIWSFGITAIELA 201
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-21
Identities = 74/258 (28%), Positives = 124/258 (48%), Gaps = 49/258 (18%)
Query: 497 KIGQGGFGAVFYAEL------------------RGEKAAIKKMDMQASK----EFLAELK 534
K+G+G FG V E+ R A+K + A+K +FL E+K
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 535 VLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLR--------GSGKD------- 578
+L+ + N++RL+G CV E L ++ EY+ENG+LNQ L +G D
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 579 --TLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636
+++S+ + +AL A G++Y+ ++HRD+ N L+ +N K+ADFG+++
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 637 EVGS-ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVK---TNE 692
G + R V +M E G+ + DV+AFGV L+E++ + T+E
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE 248
Query: 693 TITESTGLVALFEEVLRQ 710
+ E+ G F + RQ
Sbjct: 249 QVIENAG--EFFRDQGRQ 264
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 75/280 (26%), Positives = 112/280 (40%), Gaps = 46/280 (16%)
Query: 497 KIGQGGFGAVFYAELRGE---------KAAIK--KMD--MQASKEFLAELKVLTHVHHLN 543
K+G G FG V RGE A+K K D +FL E ++ + H N
Sbjct: 2 KLGDGSFGVVR----RGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHEN 57
Query: 544 LVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT 603
L+RL G + L +V E G+L LR S A+ A G+ Y+
Sbjct: 58 LIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 604 VPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS----ASVHTRLVGTFGYMPPEYA 659
+IHRD+ NIL+ + + K+ DFGL + H ++ F + PE
Sbjct: 118 ---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESL 172
Query: 660 QYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719
+ S DV+ FGV L+E+ + E GL ++L++ D +R
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEPWA---------GLSG--SQILKKIDKE--GER 219
Query: 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIV 759
L P + P D M + C NP RP+ A+
Sbjct: 220 LERP---EACPQDIYNVMLQ----CWAHNPADRPTFAALR 252
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 65/201 (32%), Positives = 104/201 (51%), Gaps = 31/201 (15%)
Query: 496 NKIGQGGFGAVFYAELR--GEKAAIKKMDM--QASKEFL-AELKVLTHVHHLNLVRLIG- 549
KIG+G G V A + G + A+KKMD+ Q +E L E+ ++ H N+V +
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 550 YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM---QIA---LDSARGLEYIHEHT 603
Y V L++V E++E G L D +T RM QIA L + L ++H
Sbjct: 85 YLVGDELWVVMEFLEGGALT--------DIVT-HTRMNEEQIATVCLAVLKALSFLHAQG 135
Query: 604 VPVYIHRDIKPANILIDKNFRAKVADFGL-AKLTEVGSASVHTR--LVGTFGYMPPEYAQ 660
V IHRDIK +IL+ + R K++DFG A++++ V R LVGT +M PE
Sbjct: 136 V---IHRDIKSDSILLTSDGRVKLSDFGFCAQVSK----EVPRRKSLVGTPYWMAPEVIS 188
Query: 661 YGEVSPKIDVYAFGVVLYELI 681
++D+++ G+++ E++
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 66/199 (33%), Positives = 104/199 (52%), Gaps = 21/199 (10%)
Query: 496 NKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE-----FLAELKVLTHVHHLNLVRLI 548
N+IG+G +G V+ A GE A+KK+ M ++ L E+ +L ++ H N+V L
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 549 GYCVEG----SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTV 604
V G S+FLV EY E +L L + + S + L RGL+Y+HE+ +
Sbjct: 73 -EVVVGKHLDSIFLVMEYCEQ-DLAS-LLDNMPTPFSESQVKCLMLQLLRGLQYLHENFI 129
Query: 605 PVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYG-- 662
IHRD+K +N+L+ K+ADFGLA+ + + + ++V T Y PE G
Sbjct: 130 ---IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELL-LGCT 184
Query: 663 EVSPKIDVYAFGVVLYELI 681
+ ID++A G +L EL+
Sbjct: 185 TYTTAIDMWAVGCILAELL 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 4e-21
Identities = 80/306 (26%), Positives = 139/306 (45%), Gaps = 61/306 (19%)
Query: 497 KIGQGGFGAVFYAELRGEK------------------AAIKKMDMQASK----EFLAELK 534
K+G+G FG V E G + A+K + A+K +FL E+K
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 535 VLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHL---------RGSGKDTLTWSA 584
+++ + N++RL+ C+ L ++ EY+ENG+LNQ L + T+++S
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 585 RMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS-ASV 643
+ +A A G++Y+ ++HRD+ N L+ KN+ K+ADFG+++ G +
Sbjct: 132 LIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 644 HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEA---VVKTNETITESTGL 700
R V +M E G+ + DV+AFGV L+E+++ + ++E + E+TG
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTG- 247
Query: 701 VALFEEVLRQ---PDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRA 757
F + RQ P P D +L +C + N + RPS +
Sbjct: 248 -EFFRDQGRQVYLPKP---------ALCPDSL--------YKLMLSCWRRNAKERPSFQE 289
Query: 758 IVVALM 763
I L+
Sbjct: 290 IHATLL 295
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 5e-21
Identities = 75/298 (25%), Positives = 135/298 (45%), Gaps = 49/298 (16%)
Query: 488 ATNDFSMGNKIGQGGFGAVFYAELRG-------EKAAIKKMDMQASK----EFLAELKVL 536
A +M ++GQG FG V+ +G + AIK ++ AS EFL E V+
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 537 THVHHLNLVRLIGYCVEGSLFLV-YEYIENGNLNQHLRG--------SGKDTLTWSARMQ 587
+ ++VRL+G +G LV E + G+L +LR + + +Q
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 588 IALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK-LTEVGSASVHTR 646
+A + A G+ Y++ + ++HRD+ N ++ ++F K+ DFG+ + + E +
Sbjct: 124 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 647 LVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVK--TNETITESTGLVALF 704
+ +M PE + G + DV++FGVVL+E+ + E + +NE + +
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR----FVME 236
Query: 705 EEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762
+L +PD D+ + L R C Q NP++RPS I+ ++
Sbjct: 237 GGLLDKPDNCPDM-------------------LFELMRMCWQYNPKMRPSFLEIISSI 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 5e-21
Identities = 63/245 (25%), Positives = 118/245 (48%), Gaps = 38/245 (15%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEK----------------AAIKKMDMQASK----EF 529
+ K+G+G FG V E G A+K + +K +F
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 530 LAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHL----------RGSGKD 578
L E+K+++ + + N++RL+G CV L ++ EY+ENG+LNQ L +
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124
Query: 579 TLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK-LTE 637
+++ + + +A+ A G++Y+ ++HRD+ N L+ ++ K+ADFG+++ L
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181
Query: 638 VGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEA---VVKTNETI 694
+ R V +M E G+ + DV+AFGV L+E+ + + + ++E +
Sbjct: 182 GDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241
Query: 695 TESTG 699
E+TG
Sbjct: 242 IENTG 246
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-21
Identities = 62/201 (30%), Positives = 95/201 (47%), Gaps = 26/201 (12%)
Query: 498 IGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHVHHLNLVRLIG 549
+G+GGFG V +++ G+ A KK+D + + L E K+L V +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 550 YCVE--GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM-----QIALDSARGLEYIHEH 602
Y E L LV + G+L H+ G+ AR QI GLE++H+
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP-EARAIFYAAQIIC----GLEHLHQR 114
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYG 662
+ ++RD+KP N+L+D + +++D GLA E+ GT GYM PE Q
Sbjct: 115 RI---VYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGE 169
Query: 663 EVSPKIDVYAFGVVLYELISA 683
+D +A G LYE+I+
Sbjct: 170 VYDFSVDWFALGCTLYEMIAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 6e-21
Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 17/198 (8%)
Query: 494 MGNKIGQGGFGAVFYAELRGE-KAAIK-----KMDMQASKEFLAELKVLTHVHHLNLVRL 547
+ K+G G FG V+ K A+K M +QA FL E ++ + H LVRL
Sbjct: 10 LVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRL 66
Query: 548 IGYCV---EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTV 604
Y V E ++++ EY+ G+L L+ + + + A G+ YI
Sbjct: 67 --YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN- 123
Query: 605 PVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEV 664
YIHRD++ AN+L+ ++ K+ADFGLA++ E + + PE +G
Sbjct: 124 --YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 181
Query: 665 SPKIDVYAFGVVLYELIS 682
+ K DV++FG++LYE+++
Sbjct: 182 TIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 6e-21
Identities = 60/191 (31%), Positives = 101/191 (52%), Gaps = 10/191 (5%)
Query: 498 IGQGGFGAVFYAELRGEKA-AIK--KMDM--QASKEFLAELKVLTHVHHLNLVRLIGYCV 552
+G+G FG VF L+ + A+K K D+ + +FL+E ++L H N+V+LIG C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 553 EGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRD 611
+ +++V E + G+ LR KD L ++ ALD+A G+ Y+ IHRD
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLR-KKKDELKTKQLVKFALDAAAGMAYLESKNC---IHRD 118
Query: 612 IKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVY 671
+ N L+ +N K++DFG+++ + G S + PE YG S + DV+
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVW 178
Query: 672 AFGVVLYELIS 682
++G++L+E S
Sbjct: 179 SYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 8e-21
Identities = 70/225 (31%), Positives = 106/225 (47%), Gaps = 43/225 (19%)
Query: 485 LAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS--KEFLAELKVLT-HV 539
L T F + IG+G +G V+ A + G+ AIK MD+ +E E +L +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60
Query: 540 HHLNLVRLIG-------YCVEGSLFLVYEYIENG---NLNQHLRGSGKDTLTWSARM--- 586
+H N+ G + L+LV E G +L + LR GK R+
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK-------RLKEE 113
Query: 587 QIAL---DSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGL-AKLTEVGSAS 642
IA ++ RGL Y+HE+ V IHRDIK NIL+ KN K+ DFG+ A+L ++
Sbjct: 114 WIAYILRETLRGLAYLHENKV---IHRDIKGQNILLTKNAEVKLVDFGVSAQLD----ST 166
Query: 643 VHTR--LVGTFGYMPPEY---AQYGEVS--PKIDVYAFGVVLYEL 680
+ R +GT +M PE + + S + DV++ G+ EL
Sbjct: 167 LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIEL 211
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 70/207 (33%), Positives = 110/207 (53%), Gaps = 31/207 (14%)
Query: 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM--------QASKEFLAELKVLTHVHH 541
+ + KIG+G FG ++ A+ + E IK++D+ +ASK+ E+ +L + H
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKH 58
Query: 542 LNLVRLIG-YCVEGSLFLVYEYIENGNLNQHL---RG---SGKDTLTWSARMQIALDSAR 594
N+V + G LF+V EY + G+L + + RG S L+W +QI+L
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF--VQISL---- 112
Query: 595 GLEYIHEHTVPVYIHRDIKPANILIDKNFR-AKVADFGLAKLTEVGSASVHTRLVGTFGY 653
GL++IH+ + +HRDIK NI + KN AK+ DFG+A+ +T VGT Y
Sbjct: 113 GLKHIHDRKI---LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYY 168
Query: 654 MPPEYAQYGEVSPKIDVYAFGVVLYEL 680
+ PE Q + K D+++ G VLYEL
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 76/283 (26%), Positives = 131/283 (46%), Gaps = 39/283 (13%)
Query: 497 KIGQGGFGAVFYAELR--GEKAAIKKM-----DMQASKEFLAELKVLTHVHHLNLVRLIG 549
+G+G +G V + + G+ AIKK D K + E+++L + H NLV LI
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 550 YCVEGS-LFLVYEYIENGNLN--QHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPV 606
L+LV+E++++ L+ + ++ QI RG+E+ H H +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQIL----RGIEFCHSHNI-- 121
Query: 607 YIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEY----AQYG 662
IHRDIKP NIL+ ++ K+ DFG A+ T V+T V T Y PE +YG
Sbjct: 122 -IHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179
Query: 663 EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR--- 719
+D++A G ++ E+++ E + + I + ++ ++ P +E Q+
Sbjct: 180 R---AVDIWAVGCLVTEMLTG-EPLFPGDSDIDQLYHIIKCLGNLI--PRHQEIFQKNPL 233
Query: 720 LVDPRLGDDYPIDSVRK--------MARLARACTQENPQLRPS 754
RL + I+ + K + LA+ C + +P RPS
Sbjct: 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 3e-20
Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 28/207 (13%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMD------MQASKEFLAELKVLTHVHH 541
DF + ++GQGG+G VF A+ + GE A+K+M + + L E +LT
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 542 LNLVRLIGYCVE--GSLFLVYEYIENGNLNQHLRGSG----KDTLTWSARMQIALDSARG 595
LV+L+ Y + L+L EY+ G+ L G + A M A+D+
Sbjct: 61 EWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDA--- 116
Query: 596 LEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMP 655
+HE YIHRD+KP N LID + K+ DFGL+K G + +VG+ YM
Sbjct: 117 ---LHELG---YIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMA 166
Query: 656 PEYAQYGEVSPKIDVYAFGVVLYELIS 682
PE + +D ++ G +LYE +
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLA----ELKVLTHVHHLN 543
F++ IG+G FG V+ A + + AIK +D++ +++ + E++ L+
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 544 LVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH 602
+ + G ++GS L+++ EY G+ L+ GK T+ A I + GLEY+HE
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK-PGKLDETYIA--FILREVLLGLEYLHEE 117
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV--HTRLVGTFGYMPPEYAQ 660
IHRDIK ANIL+ + K+ADFG++ ++ S +T VGT +M PE +
Sbjct: 118 GK---IHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMSKRNT-FVGTPFWMAPEVIK 171
Query: 661 YGEVSPKIDVYAFGVVLYELI 681
K D+++ G+ EL
Sbjct: 172 QSGYDEKADIWSLGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 6e-20
Identities = 77/278 (27%), Positives = 127/278 (45%), Gaps = 50/278 (17%)
Query: 494 MGNKIGQGGFGAVF--YAELRGEKAAIKKMDM--------QASKEFLAELKVLTHVHHLN 543
G +G G FG+V+ G+ A+K++ + +A K+ E+ +L+ + H N
Sbjct: 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63
Query: 544 LVRLIGYCVEG-SLFLVYEYIENGNLNQHLR--GSGKDTLTWSARMQIALDSARGLEYIH 600
+V+ +G E +L++ E + G+L + L+ GS + + QI L GLEY+H
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL----GLEYLH 119
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK-LTEVGSASVHTRLVGTFGYMPPEY- 658
+ +HRDIK ANIL+D N K+ADFG+AK + E A G+ +M PE
Sbjct: 120 DRNT---VHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK---SFKGSPYWMAPEVI 173
Query: 659 AQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718
AQ G D+++ G + E+ ++ G+ A+F+
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEM-------ATGKPPWSQLEGVAAVFKIG----------- 215
Query: 719 RLVDPRLGDDYPI-DSVRKMARL-ARACTQENPQLRPS 754
R + PI D + A+ C Q +P LRP+
Sbjct: 216 -----RSKELPPIPDHLSDEAKDFILKCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 9e-20
Identities = 60/201 (29%), Positives = 106/201 (52%), Gaps = 18/201 (8%)
Query: 498 IGQGGFGAVFYAELR--GEK---AAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLI 548
IG G FG V L+ G++ AIK + + ++FL+E ++ H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 549 GYCVEGS-LFLVYEYIENGNLNQHLR-GSGKDTLTWSARMQIALDSARGLEYIHEHTVPV 606
G + + +V EY+ENG+L+ LR G+ T+ M + A G++Y+ +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGI--ASGMKYLSDMG--- 126
Query: 607 YIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFG--YMPPEYAQYGEV 664
Y+HRD+ NIL++ N KV+DFGL+++ E + +T G + PE Y +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186
Query: 665 SPKIDVYAFGVVLYELISAME 685
+ DV+++G+V++E++S E
Sbjct: 187 TSASDVWSYGIVMWEVMSYGE 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 68/226 (30%), Positives = 115/226 (50%), Gaps = 44/226 (19%)
Query: 476 KSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYA--ELRGEKAAIKKMDMQASKE-F--- 529
+SV+ YE+L N+I +G +G V+ A + GE A+KK+ M+ KE F
Sbjct: 2 RSVD-EYEKL----------NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPIT 50
Query: 530 -LAELKVLTHVHHLNLVRLIGYCVEGS----LFLVYEYIENGNLNQHLRG---SGKDTLT 581
L E+ +L + H N+V + V GS +++V EY+E+ L+ + K
Sbjct: 51 SLREINILLKLQHPNIVT-VKEVVVGSNLDKIYMVMEYVEH-----DLKSLMETMKQPFL 104
Query: 582 WSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS- 640
S + L G+ ++H++ + +HRD+K +N+L++ K+ DFGLA+ E GS
Sbjct: 105 QSEVKCLMLQLLSGVAHLHDNWI---LHRDLKTSNLLLNNRGILKICDFGLAR--EYGSP 159
Query: 641 ASVHTRLVGTFGYMPPEY----AQYGEVSPKIDVYAFGVVLYELIS 682
+T+LV T Y PE +Y S ID+++ G + EL++
Sbjct: 160 LKPYTQLVVTLWYRAPELLLGAKEY---STAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 1e-19
Identities = 72/233 (30%), Positives = 105/233 (45%), Gaps = 47/233 (20%)
Query: 497 KIGQGGFGAVFYAE--LRGEKAAIKKMDMQASK------EFLAELKVLTHVHHLNLVRLI 548
+IG G FGAV++A E AIKKM + + + E++ L + H N +
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 549 G-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSAR-MQ------IALDSARGLEYIH 600
G Y E + +LV EY GS D L + +Q I + +GL Y+H
Sbjct: 82 GCYLREHTAWLVMEYC---------LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEY-- 658
H IHRDIK NIL+ + K+ADFG A L S VGT +M PE
Sbjct: 133 SHER---IHRDIKAGNILLTEPGTVKLADFGSASL-----VSPANSFVGTPYWMAPEVIL 184
Query: 659 -AQYGEVSPKIDVYAFGVVLYEL---------ISAMEAV--VKTNETITESTG 699
G+ K+DV++ G+ EL ++AM A+ + N++ T S+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSN 237
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 23/205 (11%)
Query: 491 DFSMGNKIGQGGFGAVFYAE--LRGEKAAIKK------MDMQASKEFLAELKVLTHVHHL 542
+F + KIG+G F V+ A L + A+KK MD +A ++ + E+ +L ++H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 543 NLVR-LIGYCVEGSLFLVYEYIENGNLNQHLRGSGK------DTLTWSARMQIALDSARG 595
N+++ L + + L +V E + G+L+Q ++ K + W +Q+
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SA 118
Query: 596 LEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMP 655
+E++H V +HRDIKPAN+ I K+ D GL + + + H+ LVGT YM
Sbjct: 119 VEHMHSRRV---MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMS 174
Query: 656 PEYAQYGEVSPKIDVYAFGVVLYEL 680
PE + K D+++ G +LYE+
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 28/200 (14%)
Query: 498 IGQGGFGAVFYAELRGEK-----AAIKKMDMQASKEF---LAELKVLTHV-HHLNLVRLI 548
+G+G FG V AEL+G +KK + + + E +VL H L +L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL- 61
Query: 549 GYC---VEGSLFLVYEYIENGNLNQHLRGSGK----DTLTWSARMQIALDSARGLEYIHE 601
+ + LF V EY+ G+L H++ SG+ ++A +I L GL+++HE
Sbjct: 62 -HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAA--EIVL----GLQFLHE 114
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQY 661
+ I+RD+K N+L+D K+ADFG+ K +G + T GT Y+ PE Y
Sbjct: 115 RGI---IYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST-FCGTPDYIAPEILSY 170
Query: 662 GEVSPKIDVYAFGVVLYELI 681
P +D +A GV+LYE++
Sbjct: 171 QPYGPAVDWWALGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 25/206 (12%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKAAI-KKMDMQAS-----KEFLAELKVLTHVHHLN 543
+++G+G G+V L+ K K+ L EL++
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 544 LVRLIGYCV---EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM------QIALDSAR 594
+V+ G + S+ + EY E G+L+ K R+ +IA +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDS----IYKKVKKRGGRIGEKVLGKIAESVLK 116
Query: 595 GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYM 654
GL Y+H + IHRDIKP+NIL+ + + K+ DFG++ E+ + S+ GT YM
Sbjct: 117 GLSYLHSRKI---IHRDIKPSNILLTRKGQVKLCDFGVSG--ELVN-SLAGTFTGTSFYM 170
Query: 655 PPEYAQYGEVSPKIDVYAFGVVLYEL 680
PE Q S DV++ G+ L E+
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 64/233 (27%), Positives = 111/233 (47%), Gaps = 42/233 (18%)
Query: 495 GNKIGQGGFGAVFYA--ELRGEKAAIKKMDMQASKE------------FLAELKVLTHVH 540
G IG G FG+V+ GE A+K++++ + E+ +L +
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 541 HLNLVRLIGYCVEGS-LFLVYEYIENGN----LNQHLRGSGKDTLTWSARMQIALDSARG 595
H N+V+ +G ++ L + EY+ G+ LN + G+ ++TL + QI +G
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQIL----KG 118
Query: 596 LEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR-----LVGT 650
L Y+H + IHRDIK ANIL+D K++DFG++K E S S T L G+
Sbjct: 119 LNYLHNRGI---IHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 651 FGYMPPEYAQYGEVSPKIDVYAFGVVLYELISA---------MEAVVKTNETI 694
+M PE + + K D+++ G ++ E+++ ++A+ K E
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 64/270 (23%), Positives = 121/270 (44%), Gaps = 44/270 (16%)
Query: 498 IGQGGFG-AVFYAELR-GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGY 550
+G+G FG A Y K++++ + ++ L E+ +L+ + H N++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 551 CVE-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIAL--DSARGLEYIHEHTVPVY 607
++ +L + EY G L + + + M + + YIH+ +
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKI--VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGI--- 122
Query: 608 IHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR-LVGTFGYMPPEYAQYGEVSP 666
+HRDIK NI + K K+ DFG++K+ +GS +VGT YM PE Q + +
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSPELCQGVKYNF 180
Query: 667 KIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLG 726
K D++A G VLYEL++ ++T + L ++++ G
Sbjct: 181 KSDIWALGCVLYELLTLKRTF--------DATNPLNLVVKIVQ----------------G 216
Query: 727 DDYPIDSV--RKMARLARACTQENPQLRPS 754
+ P+ SV ++ L + Q++P+ RP+
Sbjct: 217 NYTPVVSVYSSELISLVHSLLQQDPEKRPT 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 62/205 (30%), Positives = 108/205 (52%), Gaps = 24/205 (11%)
Query: 498 IGQGGFGAVFYAELR--GEK---AAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLI 548
IG G FG V L+ G++ AIK + + ++FL+E ++ H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 549 GYCVEGS-LFLVYEYIENGNLNQHLR-GSGKDTLTWSARMQIALDSARGLEYIHEHTVPV 606
G + + ++ E++ENG L+ LR G+ T+ M + A G++Y+ E
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGI--AAGMKYLSEMN--- 126
Query: 607 YIHRDIKPANILIDKNFRAKVADFGLAK-LTEVGSASVHTRLVGTFGYMP-----PEYAQ 660
Y+HRD+ NIL++ N KV+DFGL++ L + S +T +G G +P PE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG--GKIPIRWTAPEAIA 184
Query: 661 YGEVSPKIDVYAFGVVLYELISAME 685
Y + + DV+++G+V++E++S E
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGE 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 74/280 (26%), Positives = 134/280 (47%), Gaps = 42/280 (15%)
Query: 491 DFSMGNKIGQGGFGAVFYAE--LRGEKAAIKK------MDMQASKEFLAELKVLTHVHHL 542
+F + KIG+G F V+ A L G A+KK MD +A + + E+ +L ++H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 543 NLVRLIGYCVE-GSLFLVYEYIENGNLNQHLRGSGK------DTLTWSARMQIALDSARG 595
N+++ +E L +V E + G+L++ ++ K + W +Q+
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SA 118
Query: 596 LEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMP 655
LE++H V +HRDIKPAN+ I K+ D GL + + + H+ LVGT YM
Sbjct: 119 LEHMHSRRV---MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMS 174
Query: 656 PEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715
PE + K D+++ G +LYE+ +A+++ ++ L +L +++ Q D
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM-AALQSPFYGDK-----MNLYSLCKKI-EQCDY-- 225
Query: 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSM 755
P L D+ + +R++ + C +P+ RP +
Sbjct: 226 -------PPLPSDHYSEELRQLVNM---CINPDPEKRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 4e-19
Identities = 64/196 (32%), Positives = 100/196 (51%), Gaps = 20/196 (10%)
Query: 498 IGQGGFGAVFYAELRGEKA--AIKKMDMQASKE------FLAELKVLTHV-HHLNLVRLI 548
+G+G FG V AEL+G AIK + E + E +VL H L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL- 61
Query: 549 GYC---VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVP 605
+C + LF V EY+ G+L H++ SG+ AR A + GL+++H+ +
Sbjct: 62 -FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA-RARF-YAAEIICGLQFLHKKGI- 117
Query: 606 VYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVS 665
I+RD+K N+L+DK+ K+ADFG+ K G T GT Y+ PE + + +
Sbjct: 118 --IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEILKGQKYN 174
Query: 666 PKIDVYAFGVVLYELI 681
+D ++FGV+LYE++
Sbjct: 175 ESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 6e-19
Identities = 66/195 (33%), Positives = 102/195 (52%), Gaps = 21/195 (10%)
Query: 497 KIGQGGFGAVFYA--ELRGEKAAIKKMDM--QASKEFLA-ELKVLTHVHHLNLVR-LIGY 550
KIGQG G V+ A G++ AIK+M++ Q KE + E+ V+ H N+V L Y
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 551 CVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIAL---DSARGLEYIHEHTVPVY 607
V L++V EY+ G+L + T T QIA + + LE++H + V
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHSNQV--- 136
Query: 608 IHRDIKPANILIDKNFRAKVADFGL-AKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSP 666
IHRDIK NIL+ + K+ DFG A++T S + +VGT +M PE P
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 667 KIDVYAFGVVLYELI 681
K+D+++ G++ E++
Sbjct: 195 KVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 7e-19
Identities = 61/202 (30%), Positives = 106/202 (52%), Gaps = 20/202 (9%)
Query: 498 IGQGGFGAVFYAELR--GEK---AAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLI 548
IG G FG VF L+ G K AIK + + ++FL+E ++ H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 549 GYCVE-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIAL--DSARGLEYIHEHTVP 605
G + ++ EY+ENG L+++LR + +S+ + + A G++Y+ +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGE---FSSYQLVGMLRGIAAGMKYLSDMN-- 127
Query: 606 VYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFG--YMPPEYAQYGE 663
Y+HRD+ NIL++ N KV+DFGL+++ E +T G + PE Y +
Sbjct: 128 -YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 664 VSPKIDVYAFGVVLYELISAME 685
+ DV++FG+V++E++S E
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGE 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 8e-19
Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 50/221 (22%)
Query: 491 DFSMGNKIGQGGFGAVFYA--ELRGEKAAIKKMDMQASKEF----LAELKVLTHVHH--- 541
+ + IG+G +G V A + G K AIKK+ + F L E+K+L H
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65
Query: 542 ---LNLVRLIGYCVEGSLFLVYEYIENG--------NL-NQHLRGSGKDTLTWSARMQIA 589
L+++R + +++V E +E +L N H++ L
Sbjct: 66 IGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQIL--------- 116
Query: 590 LDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRL-- 647
RGL+YIH V +HRD+KP+N+L++ N K+ DFGLA++ + HT
Sbjct: 117 ----RGLKYIHSANV---LHRDLKPSNLLLNTNCDLKICDFGLARIAD--PEHDHTGFLT 167
Query: 648 --VGTFGYMPPE----YAQYGEVSPKIDVYAFGVVLYELIS 682
V T Y PE Y + ID+++ G +L E++S
Sbjct: 168 EYVATRWYRAPEIMLNSKGY---TKAIDIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 9e-19
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 28/206 (13%)
Query: 491 DFSMGNKIGQGGFGAVFYAELRGEKA--AIKKM------DMQASKEFLAELKVLTHVHHL 542
D +G G FG V R + A+K M ++ + E +VL V H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 543 NLVRLIGYCV---EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYI 599
++RL + + L+++ EY+ G L +LR SG+ + + + A LEY+
Sbjct: 62 FIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCA--LEYL 117
Query: 600 HEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR---LVGTFGYMPP 656
H + ++RD+KP NIL+DK K+ DFG AK + R L GT Y+ P
Sbjct: 118 HSKEI---VYRDLKPENILLDKEGHIKLTDFGFAK-------KLRDRTWTLCGTPEYLAP 167
Query: 657 EYAQYGEVSPKIDVYAFGVVLYELIS 682
E Q + +D +A G+++YE++
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLV 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 1e-18
Identities = 69/237 (29%), Positives = 98/237 (41%), Gaps = 58/237 (24%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA--AIKKM---DMQASKE---FLAELKVLTHVHH 541
+DF + IG+G FG V+ + A+K + DM + AE +L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 542 LNLVRLIGYCV---EGSLFLVYEYIENGNLNQHLRGSGKDTLT------WSARMQIALDS 592
+V+L Y E L+LV EY+ G+L L KD + A + +ALDS
Sbjct: 61 PWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLL--IRKDVFPEETARFYIAELVLALDS 116
Query: 593 ARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK-----------------L 635
L +IH RDIKP NILID + K+ADFGL K L
Sbjct: 117 VHKLGFIH---------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167
Query: 636 TEVGSASVHTRL-----------VGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELI 681
+ V R VGT Y+ PE + + D ++ GV+LYE++
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 30/205 (14%)
Query: 497 KIGQGGFGAVFYA--ELRGEKAAIKKM----DM-QASKEFLAELKVLTHVHHLNLV--RL 547
IG G +G V A G+K AIKK+ D+ +K L ELK+L H H N++ R
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRD 71
Query: 548 IGYCVEGSLF----LVYEYIENGNLNQHLRGSGKDTLTWSARMQIAL-DSARGLEYIHEH 602
I G+ F +V + +E+ +L+ + T ++ L RGL+YIH
Sbjct: 72 I-LRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTE---EHIRYFLYQLLRGLKYIHSA 126
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH-----TRLVGTFGYMPPE 657
V IHRD+KP+N+L++++ ++ DFG+A+ + S+ T V T Y PE
Sbjct: 127 NV---IHRDLKPSNLLVNEDCELRIGDFGMAR--GLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 658 YA-QYGEVSPKIDVYAFGVVLYELI 681
E + ID+++ G + E++
Sbjct: 182 LLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 83/332 (25%), Positives = 153/332 (46%), Gaps = 70/332 (21%)
Query: 475 DKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELRG---EK------AAIKKMDMQA 525
D EFS ++L ++G +G+G FG V AE G +K A+K + A
Sbjct: 7 DPRWEFSRDKL-------TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA 59
Query: 526 SKEFLA----ELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLNQHLRGS---- 575
+++ L+ E++++ + H N++ L+G C + G L+++ EY GNL ++LR
Sbjct: 60 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 119
Query: 576 ----------GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRA 625
+ +T+ + ARG+EY+ IHRD+ N+L+ +N
Sbjct: 120 MEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC---IHRDLAARNVLVTENNVM 176
Query: 626 KVADFGLAKLTEVGSASVHTRLVG---TFGYMPPEYAQYGEV-SPKIDVYAFGVVLYELI 681
K+ADFGLA+ +V + + + +M PE A + V + + DV++FGV+++E+
Sbjct: 177 KIADFGLAR--DVNNIDYYKKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIF 233
Query: 682 SAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLA 741
+ + G+ P E+L +L+ D P + ++ +
Sbjct: 234 TLGG---------SPYPGI------------PVEELFKLLKEGHRMDKPANCTNELYMMM 272
Query: 742 RACTQENPQLRPSMRAIVVAL---MTLSSSSE 770
R C P RP+ + +V L +TL+++ E
Sbjct: 273 RDCWHAIPSHRPTFKQLVEDLDRILTLTTNEE 304
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 67/269 (24%), Positives = 121/269 (44%), Gaps = 34/269 (12%)
Query: 498 IGQGGFGAVFYAELRGEKAAIKK------MDMQASKEFLAELKVLTHVHHLNLVRLIG-Y 550
+G G G+V + + K K+ L EL+++ +V G +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 551 CVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH-EHTVPVYIH 609
E ++ + E+++ G+L++ + G + +IA+ GL Y++ H + +H
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGP--IPVEILGKIAVAVVEGLTYLYNVHRI---MH 127
Query: 610 RDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKID 669
RDIKP+NIL++ + K+ DFG++ E+ + S+ VGT YM PE Q G+ + K D
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVSG--ELIN-SIADTFVGTSTYMSPERIQGGKYTVKSD 184
Query: 670 VYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD---PRL- 725
V++ G+ + EL +N + + + LQ++V PRL
Sbjct: 185 VWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL----------LQQIVQEPPPRLP 234
Query: 726 GDDYPIDSVRKMARLARACTQENPQLRPS 754
D+P D + AC ++P RP+
Sbjct: 235 SSDFPED----LRDFVDACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 64/201 (31%), Positives = 104/201 (51%), Gaps = 28/201 (13%)
Query: 497 KIGQGGFGAVFYAE--LRGEKAAIKKMDMQASKE-----FLAELKVLTHVHHLNLVRL-- 547
KIG+G +G V+ A L GE A+KK+ ++ E + E+ +L ++H N+VRL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 548 IGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIA---LDSARGLEYIHEHTV 604
+ + E L+LV+E++ + +L +++ S L I +G+ Y H H V
Sbjct: 66 VVHS-ENKLYLVFEFL-DLDLKKYMDSSPLTGLD---PPLIKSYLYQLLQGIAYCHSHRV 120
Query: 605 PVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEY----AQ 660
+HRD+KP N+LID+ K+ADFGLA+ V +T V T Y PE Q
Sbjct: 121 ---LHRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGSRQ 176
Query: 661 YGEVSPKIDVYAFGVVLYELI 681
Y S +D+++ G + E++
Sbjct: 177 Y---STPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 58/197 (29%), Positives = 101/197 (51%), Gaps = 18/197 (9%)
Query: 497 KIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE-----FLAELKVLTHVHHLNLVRLIG 549
KIG+G +G V+ A + GE A+KK+ + E + E+ +L ++H N+V+L+
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 550 YC-VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYI 608
E L+LV+E++ + +L + + S + +GL + H H V +
Sbjct: 67 VIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV---L 122
Query: 609 HRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEY---AQYGEVS 665
HRD+KP N+LI+ K+ADFGLA+ V + +T V T Y PE +Y S
Sbjct: 123 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKY--YS 179
Query: 666 PKIDVYAFGVVLYELIS 682
+D+++ G + E+++
Sbjct: 180 TAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 60/216 (27%), Positives = 107/216 (49%), Gaps = 41/216 (18%)
Query: 498 IGQGGFGAVFYAELRGE--------KAAIKKM----DMQASKEFLAELKVLTHVHHLNLV 545
+G G FG V+ + A+K + Q KEFL E ++++ +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 546 RLIGYCVEG-SLFLVYEYIENGNLNQHLRGSGKDT-----LTWSARMQIALDSARGLEYI 599
+L+G C+ +++ E +E G+L +LR + + LT + I LD A+G Y+
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 600 HE-HTVPVYIHRDIKPANILI-DKNFRA----KVADFGLAK-------LTEVGSASVHTR 646
+ H +IHRD+ N L+ +K + A K+ DFGLA+ + G + R
Sbjct: 123 EQMH----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 647 LVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
+M PE G+ + + DV++FGV+++E+++
Sbjct: 179 ------WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRG---EKAAIK---KM-----DMQASKEFLAELKVLTH 538
N+ S G +G G FG V A G A +K KM + ++ELK+++H
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 539 V-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGL 596
+ +H N+V L+G C G + ++ EY G+L LR + LT + + A+G+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 597 EYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV---HTRLVGTFGY 653
++ IHRD+ N+L+ K+ DFGLA+ S V + RL +
Sbjct: 155 AFLASKNC---IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKW 209
Query: 654 MPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
M PE + + DV+++G++L+E+ S
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 84/324 (25%), Positives = 151/324 (46%), Gaps = 63/324 (19%)
Query: 492 FSMGNKIGQGGFGAVFYAELRG-EK--------AAIKKMDMQAS----KEFLAELKVLTH 538
++G +G+G FG V AE G +K A+K + A+ + ++E++++
Sbjct: 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKM 73
Query: 539 V-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLNQHLRGS---GKD-----------TLTW 582
+ H N++ L+G C + G L+++ EY GNL ++LR G D LT+
Sbjct: 74 IGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133
Query: 583 SARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT---EVG 639
+ A ARG+EY+ IHRD+ N+L+ ++ K+ADFGLA+ +
Sbjct: 134 KDLVSCAYQVARGMEYLASQKC---IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY 190
Query: 640 SASVHTRLVGTFGYMPPEYAQYGEV-SPKIDVYAFGVVLYELISAMEAVVKTNETITEST 698
+ + RL +M PE A + V + + DV++FGV+L+E+ + +
Sbjct: 191 KKTTNGRL--PVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFTLGG---------SPYP 238
Query: 699 GLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
G+ P E+L +L+ D P + ++ + R C P RP+ + +
Sbjct: 239 GI------------PVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQL 286
Query: 759 VVAL---MTLSSSSEDWDIGSFYE 779
V L +T++S+ E D+ +E
Sbjct: 287 VEDLDRVLTVTSTDEYLDLSVPFE 310
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 491 DFSMGNKIGQGGFGAVF---YAELRGEKAAI-----KKMDMQASKE-FLAELKVLTHVHH 541
D ++G IG+G FG V+ Y EK A+ K + +E FL E ++ H
Sbjct: 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH 66
Query: 542 LNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE 601
++V+LIG E +++V E G L +L+ K +L ++ + + + L Y+
Sbjct: 67 PHIVKLIGVITENPVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALAYLES 125
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS---ASVHTRLVGTFGYMPPEY 658
++HRDI N+L+ K+ DFGL++ E S AS +L +M PE
Sbjct: 126 KR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASK-GKL--PIKWMAPES 179
Query: 659 AQYGEVSPKIDVYAFGVVLYELIS 682
+ + DV+ FGV ++E++
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 3e-18
Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 497 KIGQGGFGAVFYAE--LRGEKAAIKKMDMQAS--KEFLA-ELKVLTHVHHLNLVRLI-GY 550
KIGQG G VF A G++ AIK++++Q KE + E+ V+ + + N+V + +
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 551 CVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHR 610
V LF+V EY+ G+L + + D +A + + + LE++H + V IHR
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA---VCRECLQALEFLHANQV---IHR 139
Query: 611 DIKPANILIDKNFRAKVADFGL-AKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKID 669
DIK N+L+ + K+ DFG A++T S + +VGT +M PE PK+D
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 670 VYAFGVVLYELISAMEAVVKTN 691
+++ G++ E++ + N
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 38/217 (17%)
Query: 490 NDFSMGNKIGQGGFGAVF--YAELRGEKAAIKKM-----DMQASKEFLA---ELKVLTHV 539
++ G +GQG FG V+ Y G + A+K++ + KE A E+++L ++
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 540 HHLNLVRLIGYCVE--GSLFLVYEYIENGNLNQHLRGSG--KDTLTWSARMQIALDSARG 595
H +V+ G C+ +L + EY+ G++ L+ G +T+T QI G
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EG 116
Query: 596 LEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK------LTEVGSASVHTRLVG 649
+EY+H + + +HRDIK ANIL D K+ DFG +K + G SV G
Sbjct: 117 VEYLHSNMI---VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT----G 169
Query: 650 TFGYMPPEYAQ---YGEVSPKIDVYAFGVVLYELISA 683
T +M PE YG K DV++ G + E+++
Sbjct: 170 TPYWMSPEVISGEGYGR---KADVWSVGCTVVEMLTE 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 33/217 (15%)
Query: 492 FSMGNKIGQGGFGAVFYAELRGE-----KAAIK--KMDMQASKE---FLAELKVLTHVHH 541
+G +G+G FG+V +L + K A+K K+D+ E FL+E + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 542 LNLVRLIGYCVEGSL-------FLVYEYIENGNLNQHL----RGSGKDTLTWSARMQIAL 590
N+++LIG C E S ++ ++++G+L+ L G + L ++ +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 591 DSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGT 650
D A G+EY+ +IHRD+ N ++ ++ VADFGL+K G R+
Sbjct: 121 DIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRI--- 174
Query: 651 FGYMPPEYAQYGEV-----SPKIDVYAFGVVLYELIS 682
MP ++ + + K DV+AFGV ++E+ +
Sbjct: 175 -AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 4e-18
Identities = 80/278 (28%), Positives = 116/278 (41%), Gaps = 57/278 (20%)
Query: 496 NKIGQGGFGAVFYA--ELRGEKAAIKKMDMQASK------EFLAELKVLTHVHHLNLVRL 547
++IG G FGAV++A E A+KKM + + + E+K L + H N +
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 548 IG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSAR-------MQIALDSARGLEYI 599
G Y E + +LV EY GS D L + I + +GL Y+
Sbjct: 87 KGCYLKEHTAWLVMEYC---------LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYL 137
Query: 600 HEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEY- 658
H H + IHRDIK NIL+ + + K+ADFG A +S VGT +M PE
Sbjct: 138 HSHNM---IHRDIKAGNILLTEPGQVKLADFGSASK-----SSPANSFVGTPYWMAPEVI 189
Query: 659 --AQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716
G+ K+DV++ G+ EL + N + AL+ + Q D
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYH--IAQND---- 236
Query: 717 LQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPS 754
P L + DS R C Q+ PQ RP+
Sbjct: 237 -----SPTLQSNEWTDSFR---GFVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 4e-18
Identities = 54/199 (27%), Positives = 96/199 (48%), Gaps = 20/199 (10%)
Query: 497 KIGQGGFGAVFYAELRGEK----AAIKKMDMQASK----EFLAELKVLTHVHHLNLVRLI 548
++G G FG V + K AIK + + K E + E +++ + + +VR+I
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 549 GYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYI 608
G C +L LV E G LN+ L KD +T S +++ + G++Y+ ++
Sbjct: 62 GVCEAEALMLVMEMASGGPLNKFL-SGKKDEITVSNVVELMHQVSMGMKYLEGKN---FV 117
Query: 609 HRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMP-----PEYAQYGE 663
HRD+ N+L+ AK++DFGL+K + R + G P PE + +
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR---SAGKWPLKWYAPECINFRK 174
Query: 664 VSPKIDVYAFGVVLYELIS 682
S + DV+++G+ ++E S
Sbjct: 175 FSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 498 IGQGGFGAVFYAELRGEKA-------AIKKMDMQASKEFLAELKVLTHVHHLNLVRLI-G 549
+G+G FG V + ++ +++M E +VL + H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 550 YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIH 609
+ + +L +V EY G L ++++ L + + L ++H + +H
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLI---LH 124
Query: 610 RDIKPANILIDKN-FRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKI 668
RD+K NIL+DK+ K+ DFG++K + S S +VGT Y+ PE + + K
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISK--ILSSKSKAYTVVGTPCYISPELCEGKPYNQKS 182
Query: 669 DVYAFGVVLYELISAMEAVVKTN 691
D++A G VLYEL S A N
Sbjct: 183 DIWALGCVLYELASLKRAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 75/297 (25%), Positives = 136/297 (45%), Gaps = 54/297 (18%)
Query: 498 IGQGGFGAVFYAEL---------RGEKAAIKKMDMQASKEFLAELK----VLTHVHHLNL 544
+G+G FG V EL GE+ A+K + ++ +A+LK +L +++H N+
Sbjct: 12 LGEGHFGKV---ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 545 VRLIGYCVEG---SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE 601
V+ G C E + L+ E++ +G+L ++L K+ + +++ A+ +G++Y+
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-RNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL--TEVGSASVHTRLVGTFGYMPPEYA 659
Y+HRD+ N+L++ + K+ DFGL K T+ +V L + PE
Sbjct: 128 RQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 660 QYGEVSPKIDVYAFGVVLYELI-------SAMEAVVK----TNETITESTGLVALFEEVL 708
+ DV++FGV LYEL+ S M +K T+ +T T LV + EE
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMT-VTRLVRVLEEGK 243
Query: 709 RQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765
R P P + P ++ +L R C + P R + + ++ +
Sbjct: 244 RLPRP-------------PNCP----EEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 5e-18
Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 29/209 (13%)
Query: 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE-----FLAELKVLTHVHHLN 543
D++ KIG+G +G V+ + G+ A+KK+ +++ +E + E+ +L + H N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 544 LVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKD-----TLTWSARMQIALDSARGLE 597
+V L ++ S L+L++E++ +L ++L K L S QI G+
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQ----GIL 115
Query: 598 YIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE 657
+ H V +HRD+KP N+LID K+ADFGLA+ + V+T V T Y PE
Sbjct: 116 FCHSRRV---LHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVVTLWYRAPE 171
Query: 658 Y----AQYGEVSPKIDVYAFGVVLYELIS 682
+Y S +D+++ G + E+ +
Sbjct: 172 VLLGSPRY---STPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 83/281 (29%), Positives = 128/281 (45%), Gaps = 53/281 (18%)
Query: 497 KIGQGGFGAVFYAELR--GEKAAIKKMDM--QASKEFL-AELKVLTHVHHLNLVRLI-GY 550
KIG+G G V A + G++ A+KKMD+ Q +E L E+ ++ HH N+V + Y
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 551 CVEGSLFLVYEYIENGNLNQ---HLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVY 607
V L++V E++E G L H R + + T + L R L Y+H V
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT------VCLSVLRALSYLHNQGV--- 139
Query: 608 IHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR--LVGTFGYMPPEYAQYGEVS 665
IHRDIK +IL+ + R K++DFG S V R LVGT +M PE
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQV---SKEVPKRKSLVGTPYWMAPEVISRLPYG 196
Query: 666 PKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD--- 722
++D+++ G+++ E+I G F E P + ++R+ D
Sbjct: 197 TEVDIWSLGIMVIEMID----------------GEPPYFNE-----PPLQAMRRIRDNLP 235
Query: 723 PRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763
PR+ D + + SV + L +E PS RA L+
Sbjct: 236 PRVKDSHKVSSVLR-GFLDLMLVRE-----PSQRATAQELL 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 75/287 (26%), Positives = 133/287 (46%), Gaps = 37/287 (12%)
Query: 497 KIGQGGFGAVFYA-ELR--GEKAAIKKMDMQASKEFLA-----ELKVLTHVH---HLNLV 545
+IG+G +G VF A +L+ G A+K++ +Q +E + E+ VL H+ H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 546 RLIGYCV------EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYI 599
RL C E L LV+E+++ +L +L + + + RGL+++
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 126
Query: 600 HEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYA 659
H H V +HRD+KP NIL+ + + K+ADFGLA++ A T +V T Y PE
Sbjct: 127 HSHRV---VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEVL 181
Query: 660 QYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719
+ +D+++ G + E+ + + + + + + L + +V+ P + +
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ---LGKIL-DVIGLPGEEDWPRD 236
Query: 720 LVDPRLG----DDYPIDS-VRKMARLAR----ACTQENPQLRPSMRA 757
+ PR PI+ V + L + C NP R S +
Sbjct: 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 9e-18
Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 27/202 (13%)
Query: 497 KIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE-----FLAELKVLTHVHHLNLVRLIG 549
KIG+G +G VF A+ R E A+K++ + E L E+ +L + H N+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL-- 64
Query: 550 YCV---EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIA----LDSARGLEYIHEH 602
Y V + L LV+EY + +L ++ D+ +I +GL + H H
Sbjct: 65 YDVLHSDKKLTLVFEYCDQ-DLKKYF-----DSCNGDIDPEIVKSFMFQLLKGLAFCHSH 118
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYG 662
V +HRD+KP N+LI+KN K+ADFGLA+ + +V T Y PP+
Sbjct: 119 NV---LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGA 174
Query: 663 EV-SPKIDVYAFGVVLYELISA 683
++ S ID+++ G + EL +A
Sbjct: 175 KLYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 9e-18
Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 31/203 (15%)
Query: 498 IGQGGFGAVF-------------YAELRGEKAAIKKMDMQASKEFLAELKVLTHVHHLNL 544
+GQG FG VF YA +KA +K D +K E +L V+H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTK---MERDILAEVNHPFI 60
Query: 545 VRL-IGYCVEGSLFLVYEYIENGNLNQHLRG----SGKDTLTWSARMQIALDSARGLEYI 599
V+L + EG L+L+ +++ G+L L + +D + A + +ALD
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD-------- 112
Query: 600 HEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYA 659
H H++ + I+RD+KP NIL+D+ K+ DFGL+K + ++ GT YM PE
Sbjct: 113 HLHSLGI-IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVV 170
Query: 660 QYGEVSPKIDVYAFGVVLYELIS 682
+ D ++FGV+++E+++
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 23/196 (11%)
Query: 497 KIGQGGFGAVFYAELR--GEKAAIKKMDM--QASKEFL-AELKVLTHVHHLNLVRLI-GY 550
KIG+G G V A ++ G+ A+KKMD+ Q +E L E+ ++ H N+V + Y
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 551 CVEGSLFLVYEYIENGNLNQ---HLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVY 607
V L++V E++E G L H R + + + L + L +H V
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA------VCLAVLKALSVLHAQGV--- 137
Query: 608 IHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR--LVGTFGYMPPEYAQYGEVS 665
IHRDIK +IL+ + R K++DFG S V R LVGT +M PE
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPELISRLPYG 194
Query: 666 PKIDVYAFGVVLYELI 681
P++D+++ G+++ E++
Sbjct: 195 PEVDIWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 71/271 (26%), Positives = 126/271 (46%), Gaps = 35/271 (12%)
Query: 498 IGQGGFGAVFYAELR--GEKAAIKKMDMQ--ASKEFLA---ELKVLTHVHHLNLV--RLI 548
+G+G +G V R G++ IKK++++ + +E A E ++L+ + H N+V R
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 549 GYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYI 608
+G L++V + E G+L L+ L + ++ + A L+Y+HE + +
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHI---L 124
Query: 609 HRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKI 668
HRD+K N+ + + KV D G+A++ E + + L+GT YM PE + K
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPELFSNKPYNYKS 183
Query: 669 DVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDD 728
DV+A G +YE+ A +K + LV E P P++ P LG+
Sbjct: 184 DVWALGCCVYEM-----ATLKHAFNAKDMNSLVYRIIEGKLPPMPKD-----YSPELGE- 232
Query: 729 YPIDSVRKMARLARACTQENPQLRPSMRAIV 759
L + P+ RPS+++I+
Sbjct: 233 -----------LIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 29/204 (14%)
Query: 498 IGQGGFGAVFYAELR--GEKAAIKKMDMQASKE------FLAELKVLTHVHHLNLVRL-I 548
+G+GGFG V ++R G+ A KK++ + K+ + E ++L VH +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 549 GYCVEGSLFLVYEYIENGNLNQHLRGSGKDT--------LTWSARMQIALDSARGLEYIH 600
+ + L LV + G+L H+ ++ ++A QI GLE++H
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTA--QIIS----GLEHLH 114
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR-LVGTFGYMPPEYA 659
+ + I+RD+KP N+L+D + +++D GLA E+ T+ GT G+M PE
Sbjct: 115 QRRI---IYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELL 169
Query: 660 QYGEVSPKIDVYAFGVVLYELISA 683
Q E +D +A GV LYE+I+A
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAA 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 64/207 (30%), Positives = 107/207 (51%), Gaps = 27/207 (13%)
Query: 497 KIGQGGFGAVFYAELR--GEKAAIK-----KMDMQASKEFLAELKVLTHVHHLNLVRLIG 549
KIG+G FG + + G++ IK KM + +E E+ VL+++ H N+V+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 550 YCVE-GSLFLVYEYIENGNLNQHL---RG---SGKDTLTWSARMQIALDSARGLEYIHEH 602
E G+L++V +Y E G+L + + RG L W +QI L L+++H+
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF--VQICL----ALKHVHDR 120
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYG 662
+ +HRDIK NI + K+ K+ DFG+A++ + + +GT Y+ PE +
Sbjct: 121 KI---LHRDIKSQNIFLTKDGTIKLGDFGIARVLN-STVELARTCIGTPYYLSPEICENR 176
Query: 663 EVSPKIDVYAFGVVLYELIS---AMEA 686
+ K D++A G VLYE+ + A EA
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFEA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 79/313 (25%), Positives = 143/313 (45%), Gaps = 63/313 (20%)
Query: 494 MGNKIGQGGFGAVFYAELRG---------EKAAIKKMDMQASK----EFLAELKVLTHV- 539
+G +G+G FG V AE G K A+K + A++ + ++E++++ +
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 81
Query: 540 HHLNLVRLIGYCVE-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSAR------------- 585
H N++ L+G C + G L+++ EY GNL ++LR + +
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 586 -MQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK---LTEVGSA 641
+ A ARG+EY+ IHRD+ N+L+ ++ K+ADFGLA+ +
Sbjct: 142 LVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198
Query: 642 SVHTRLVGTFGYMPPEYAQYGEV-SPKIDVYAFGVVLYELISAMEAVVKTNETITESTGL 700
+ + RL +M PE A + + + + DV++FGV+L+E+ T+ S
Sbjct: 199 TTNGRL--PVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIF-----------TLGGSP-- 242
Query: 701 VALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVV 760
+ V P E+L +L+ D P + ++ + R C P RP+ + +V
Sbjct: 243 ---YPGV-----PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294
Query: 761 AL---MTLSSSSE 770
L + L+S+ E
Sbjct: 295 DLDRILALTSNQE 307
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 71/289 (24%), Positives = 127/289 (43%), Gaps = 57/289 (19%)
Query: 495 GNKIGQGGFGAVFYA--ELRGEKAAIKKMDMQAS-------------KEFLAELKVLTHV 539
G IG+G +G V+ A GE A+K++++ A+ K +E++ L +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 540 HHLNLVRLIGY-CVEGSLFLVYEYIENGNLNQHLRGSGK--DTLTWSARMQIALDSARGL 596
HLN+V+ +G+ E L + EY+ G++ LR G+ + L Q+ GL
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL----EGL 121
Query: 597 EYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE-VGSASVHTRLVGTFGYMP 655
Y+H + +HRD+K N+L+D + K++DFG++K ++ + + + G+ +M
Sbjct: 122 AYLHSKGI---LHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178
Query: 656 PE--YAQYGEVSPKIDVYAFGVVLYELI------SAMEAVVKTNETITESTGLVALFEEV 707
PE ++ S K+D+++ G V+ E+ S EA+ + L +
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI----------AAMFKLGNKR 228
Query: 708 LRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMR 756
P P D+ + P AC NP RP+ R
Sbjct: 229 SAPPIP-PDVSMNLSP------------VALDFLNACFTINPDNRPTAR 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 24/197 (12%)
Query: 498 IGQGGFGAVFYAELR--GEKAAIKKM------DMQASKEFLAELKVLTHVHHLNLVRLIG 549
+G GGFG V +++ A+K + + + +E ++L +H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 550 YCV-EGSLFLVYEYIENGNLNQHLRGSGK-DTLTWSARMQIALDSARGLEYIHEHTVPVY 607
+ ++++ EY G L LR G D ++AR IA EY+H +
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE--YTARFYIAC-VVLAFEYLHNRGI--- 114
Query: 608 IHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQ---YGEV 664
I+RD+KP N+L+D N K+ DFG AK + G + T GT Y+ PE Y
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT-WT-FCGTPEYVAPEIILNKGYDFS 172
Query: 665 SPKIDVYAFGVVLYELI 681
D ++ G++LYEL+
Sbjct: 173 V---DYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 31/204 (15%)
Query: 497 KIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE-----FLAELKVLTHVHHLNLVRL-- 547
KIG+G +G V+ A R E A+KK+ ++ E + E+ +L + H N+VRL
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 548 IGYCVEGSLFLVYEYIENGNLNQHLRGS---GKD-TLTWSARMQIALDSARGLEYIHEHT 603
+ + E L+LV+EY++ +L +H+ S K+ L + QI RG+ Y H H
Sbjct: 69 VVHS-EKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQIL----RGIAYCHSHR 122
Query: 604 VPVYIHRDIKPANILIDKNFRA-KVADFGLAKLTEVGSASVHTRLVGTFGYMPPEY---- 658
V +HRD+KP N+LID+ A K+ADFGLA+ + T V T Y PE
Sbjct: 123 V---LHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVVTLWYRAPEILLGS 178
Query: 659 AQYGEVSPKIDVYAFGVVLYELIS 682
Y S +D+++ G + E+++
Sbjct: 179 RHY---STPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-17
Identities = 90/349 (25%), Positives = 147/349 (42%), Gaps = 85/349 (24%)
Query: 474 VDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELRG---------EKAAIKKMDMQ 524
+D EF + L +G +G+G FG V AE G A+K +
Sbjct: 3 LDPKWEFPRDRLV-------LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN 55
Query: 525 ASKEFLAEL-------KVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRG-- 574
A+ + LA+L K++ H N++ L+G C EG L+++ EY GNL + LR
Sbjct: 56 ATDKDLADLISEMELMKLIGK--HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARR 113
Query: 575 ------------SGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN 622
++ L++ + A ARG+EY+ IHRD+ N+L+ ++
Sbjct: 114 PPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRC---IHRDLAARNVLVTED 170
Query: 623 FRAKVADFGLA---------KLTEVGSASVHTRLVGTFGYMPPEYAQYGEV-SPKIDVYA 672
K+ADFGLA K T G V +M PE A + V + + DV++
Sbjct: 171 NVMKIADFGLARGVHDIDYYKKTSNGRLPVK--------WMAPE-ALFDRVYTHQSDVWS 221
Query: 673 FGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPID 732
FG++++E+ T+ S P E+L +L+ D P +
Sbjct: 222 FGILMWEIF-----------TLGGSPYPGI----------PVEELFKLLREGHRMDKPSN 260
Query: 733 SVRKMARLARACTQENPQLRPSMRAIVVAL--MTLSSSSEDWDIGSFYE 779
++ L R C P RP+ + +V AL + + S E D+ +E
Sbjct: 261 CTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLDLSMPFE 309
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 64/199 (32%), Positives = 103/199 (51%), Gaps = 26/199 (13%)
Query: 498 IGQGGFGAVFYAELRGEKA--AIKKM---------DMQASKEFLAELKVLTHV-HHLNLV 545
+G+G FG VF AEL+G AIK + D++ + + E +VL+ H L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECT---MVEKRVLSLAWEHPFLT 59
Query: 546 RLIGYCV---EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH 602
L YC + +LF V EY+ G+L H++ K L + A + GL+++H
Sbjct: 60 HL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY--AAEIICGLQFLHSK 115
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYG 662
+ ++RD+K NIL+D + K+ADFG+ K +G A T GT Y+ PE
Sbjct: 116 GI---VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQ 171
Query: 663 EVSPKIDVYAFGVVLYELI 681
+ + +D ++FGV+LYE++
Sbjct: 172 KYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 2e-17
Identities = 74/234 (31%), Positives = 109/234 (46%), Gaps = 47/234 (20%)
Query: 492 FSMGNKIGQGGFGAVFYA-ELR-GEKAAIKKMDMQASK------EFLAELKVLTHVHHLN 543
F+ +IG G FGAV++A ++R E AIKKM + + + E+K L + H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 544 LVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSAR-------MQIALDSARG 595
+ G Y E + +LV EY GS D L + I + +G
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC---------LGSASDLLEVHKKPLQEVEIAAITHGALQG 137
Query: 596 LEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMP 655
L Y+H H + IHRDIK NIL+ + + K+ADFG A + AS VGT +M
Sbjct: 138 LAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSASI-----ASPANSFVGTPYWMA 189
Query: 656 PEY---AQYGEVSPKIDVYAFGVVLYEL---------ISAMEAV--VKTNETIT 695
PE G+ K+DV++ G+ EL ++AM A+ + NE+ T
Sbjct: 190 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT 243
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 59/195 (30%), Positives = 103/195 (52%), Gaps = 14/195 (7%)
Query: 496 NKIGQGGFGAVF--YAELRGEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIG 549
+K+G+G + VF ++L A+K++ ++ A + E+ +L ++ H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 550 YC-VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYI 608
E L LV+EY+++ +L Q+L G + ++ RGL Y H+ + +
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKI-FMFQLLRGLSYCHKRKI---L 125
Query: 609 HRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE-YAQYGEVSPK 667
HRD+KP N+LI++ K+ADFGLA+ V + + +V T Y PP+ E S
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTP 184
Query: 668 IDVYAFGVVLYELIS 682
ID++ G +LYE+ +
Sbjct: 185 IDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 16/197 (8%)
Query: 497 KIGQGGFGAV---FYAELRGEKAAIKKM------DMQASKEFLAELKVLTHVHHLNLVRL 547
++G G FG V Y + EK K+ D E L E V+ + + +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 548 IGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVY 607
IG C S LV E E G LN+ L+ + +T ++ + G++Y+ E +
Sbjct: 62 IGICEAESWMLVMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETN---F 116
Query: 608 IHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTF--GYMPPEYAQYGEVS 665
+HRD+ N+L+ AK++DFGL+K + G + + PE Y + S
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 666 PKIDVYAFGVVLYELIS 682
K DV++FGV+++E S
Sbjct: 177 SKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 58/194 (29%), Positives = 94/194 (48%), Gaps = 20/194 (10%)
Query: 498 IGQGGFGAVFYAELR--GEKAAIK---KMDMQASKE---FLAELKVL-THVHHLNLVRLI 548
I +G FG+V+ A+ R G+ AIK K DM A + AE ++ + +L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 549 -GYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVY 607
+ + L+LV EY+ G+ ++ G W A+ IA + G+E +H+ +
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDW-AKQYIA-EVVLGVEDLHQRGI--- 118
Query: 608 IHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPK 667
IHRDIKP N+LID+ K+ DFGL++ + + VGT Y+ PE
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGL-----ENKKFVGTPDYLAPETILGVGDDKM 173
Query: 668 IDVYAFGVVLYELI 681
D ++ G V++E +
Sbjct: 174 SDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 60/210 (28%), Positives = 109/210 (51%), Gaps = 31/210 (14%)
Query: 495 GNKIGQGGFGAVFYAE--LRGEKAAIKKMDMQAS---------KEFLAELKVLTHVHHLN 543
G ++G G F + + A G A+K++ + + E++++ ++H +
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 544 LVRLIGYCVEGSLFLVY-EYIENGNLNQHLR--GSGKDTLTWSARMQIALDSARGLEYIH 600
++R++G E S F ++ E++ G+++ L G+ K+ + + Q+ RGL Y+H
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGLSYLH 120
Query: 601 EHTVPVYIHRDIKPANILIDKN-FRAKVADFGLA-KLTE--VGSASVHTRLVGTFGYMPP 656
E+ + IHRD+K AN+LID R ++ADFG A +L G+ +L+GT +M P
Sbjct: 121 ENQI---IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 657 EY---AQYGEVSPKIDVYAFGVVLYELISA 683
E QYG DV++ G V+ E+ +A
Sbjct: 178 EVLRGEQYGRSC---DVWSVGCVIIEMATA 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 24/198 (12%)
Query: 498 IGQGGFGAVFYAELR--GEKAAIKKMDMQASKE---FLAELKVLTHVHHLNLVRLI-GYC 551
+G G FG V+ A+ + G AA K + +++ +E F+ E+ +L+ H N+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 552 VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRD 611
E L+++ E+ + G L+ + + LT + L ++H H V IHRD
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLHSHKV---IHRD 128
Query: 612 IKPANILIDKNFRAKVADFGL-AKLTEVGSASVHTRLVGTFGYMPPEY--------AQYG 662
+K NIL+ + K+ADFG+ AK + +GT +M PE Y
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKS--TLQKRDTFIGTPYWMAPEVVACETFKDNPY- 185
Query: 663 EVSPKIDVYAFGVVLYEL 680
K D+++ G+ L EL
Sbjct: 186 --DYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 82.5 bits (203), Expect = 4e-17
Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 497 KIGQGGFGAVFYAE--LRGEKAAIKKMDMQAS--KEFLA-ELKVLTHVHHLNLVR-LIGY 550
KIGQG G V+ A G++ AI++M++Q KE + E+ V+ + N+V L Y
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 551 CVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHR 610
V L++V EY+ G+L + + D +A + + + LE++H + V IHR
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---VCRECLQALEFLHSNQV---IHR 140
Query: 611 DIKPANILIDKNFRAKVADFGL-AKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKID 669
DIK NIL+ + K+ DFG A++T S + +VGT +M PE PK+D
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 670 VYAFGVVLYELISAMEAVVKTN 691
+++ G++ E+I + N
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNEN 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-17
Identities = 79/289 (27%), Positives = 133/289 (46%), Gaps = 49/289 (16%)
Query: 497 KIGQGGFGAVFYAE----LRGE---KAAIKKMDMQASK----EFLAELKVLT--HVHHLN 543
++GQG FG V+ ++GE + A+K ++ AS EFL E V+ HH+
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV- 71
Query: 544 LVRLIGYCVEGS-LFLVYEYIENGNLNQHLRG--------SGKDTLTWSARMQIALDSAR 594
VRL+G +G +V E + +G+L +LR G+ T +Q+A + A
Sbjct: 72 -VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 595 GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK-LTEVGSASVHTRLVGTFGY 653
G+ Y++ ++HRD+ N ++ +F K+ DFG+ + + E + + +
Sbjct: 131 GMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 654 MPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713
M PE + G + D+++FGVVL+E+ S E + GL E+VL
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ---------GLSN--EQVL----- 231
Query: 714 REDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762
+ V D P + ++ L R C Q NP++RP+ IV L
Sbjct: 232 -----KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 4e-17
Identities = 65/224 (29%), Positives = 111/224 (49%), Gaps = 28/224 (12%)
Query: 498 IGQGGFGAVFYA--ELRGEKAAIKKMD-----MQASKEFLAELKVLTHVHHLNLVRLIGY 550
IG+G +G V A GEK AIKK++ + + L E+K+L + H ++V +
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 551 CVEGS------LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTV 604
+ S +++V+E +E+ +L+Q ++ + D LT R L+YIH V
Sbjct: 68 MLPPSRREFKDIYVVFELMES-DLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANV 124
Query: 605 PVYIHRDIKPANILIDKNFRAKVADFGLAK--LTEVGSASVHTRLVGTFGYMPPEYAQ-- 660
HRD+KP NIL + + + K+ DFGLA+ + +A T V T Y PE
Sbjct: 125 ---FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 181
Query: 661 YGEVSPKIDVYAFGVVLYELISAM-----EAVVKTNETITESTG 699
+ + +P ID+++ G + E+++ + VV + IT+ G
Sbjct: 182 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLG 225
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 5e-17
Identities = 70/259 (27%), Positives = 115/259 (44%), Gaps = 26/259 (10%)
Query: 498 IGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIG 549
+G+GGFG V +++ G+ A KK+D + K L E ++L V+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 550 YCVEGS--LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVY 607
Y E L LV + G+L H+ G+ L + + G+ ++H +
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI--- 116
Query: 608 IHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPK 667
++RD+KP N+L+D +++D GLA E+ T+ GT GYM PE + S
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEPYSYP 174
Query: 668 IDVYAFGVVLYELISAMEAVVKTNETIT-ESTGLVALFEEVLRQPD----PREDLQRL-- 720
+D +A G +YE+++ E + E L +EV + +D+ RL
Sbjct: 175 VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFL 234
Query: 721 ---VDPRLGDDYPIDSVRK 736
+ RLG D RK
Sbjct: 235 AKKPEDRLGSREKNDDPRK 253
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 6e-17
Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 30/201 (14%)
Query: 498 IGQGGFGAVFYAEL--RGEKAAIKKM---------DMQAS---KEFLA---ELKVLTHVH 540
+G+G FG V AEL +GE A+K + D++ + K LA E LTH++
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 541 HLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH 600
+ + LF V E++ G+L H++ G+ L + A A + GL+++H
Sbjct: 63 -------CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL-YRATF-YAAEIVCGLQFLH 113
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQ 660
+ I+RD+K N+++D++ K+ADFG+ K G T GT Y+ PE Q
Sbjct: 114 SKGI---IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQ 169
Query: 661 YGEVSPKIDVYAFGVVLYELI 681
+ + +D ++FGV+LYE++
Sbjct: 170 GLKYTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 7e-17
Identities = 82/286 (28%), Positives = 136/286 (47%), Gaps = 46/286 (16%)
Query: 497 KIGQGGFGAVFYAELR--GEKAAIKKMDMQASK----EFLAELKVLTHVHHLNLVRLIGY 550
K+G+G + V+ R GE A+K++ + A + + E+ ++ + H N+VRL
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 551 C-VEGSLFLVYEYIENGNLNQHL-----RGSGKDTLTWSARMQIALDSARGLEYIHEHTV 604
E L LV+EY++ +L +++ RG+ S Q+ +G+ + HE+ V
Sbjct: 67 IHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLL----KGIAFCHENRV 121
Query: 605 PVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEV 664
+HRD+KP N+LI+K K+ADFGLA+ + + +V T Y P+
Sbjct: 122 ---LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRT 177
Query: 665 -SPKIDVYAFGVVLYELISAMEAVVKTNE------------TITEST--GLVALFE-EVL 708
S ID+++ G ++ E+I+ TN T TEST G+ L E +
Sbjct: 178 YSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237
Query: 709 RQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPS 754
P +DLQ+L P D ID + ++ +L NP+LR S
Sbjct: 238 FPRYPPQDLQQLF-PHA-DPLGIDLLHRLLQL-------NPELRIS 274
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 57/224 (25%)
Query: 497 KIGQGGFGAVFYAEL----RGEKAAIKKMDMQASKEFLA--------ELKVLTHVHHLNL 544
IG+G +G V+ A+ G++ AIKK KE E+ +L + H N+
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFK--GDKEQYTGISQSACREIALLRELKHENV 64
Query: 545 VRLIGYCVE---GSLFLVYEYIEN--GNLNQHLRGSGKD--------TLTWSARMQIALD 591
V L+ +E S++L+++Y E+ + + R + + +L W QI L+
Sbjct: 65 VSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW----QI-LN 119
Query: 592 SARGLEYIHEHTVPVYIHRDIKPANILI----DKNFRAKVADFGLAKLTEVGSASVHT-- 645
G+ Y+H + V +HRD+KPANIL+ + K+ D GLA+L +
Sbjct: 120 ---GVHYLHSNWV---LHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173
Query: 646 RLVGTFGYMPPE-------YAQYGEVSPKIDVYAFGVVLYELIS 682
+V T Y PE Y + ID++A G + EL++
Sbjct: 174 PVVVTIWYRAPELLLGARHY------TKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 61/235 (25%), Positives = 95/235 (40%), Gaps = 46/235 (19%)
Query: 495 GNKIGQGGFGAVFYAE--LRGEKAAIKKMDMQASKEF-----------------LAELKV 535
G +G+G +G V A L G+ AIKK+ + L ELK+
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 536 LTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSAR 594
+ + H N++ L+ Y + LV + + +L + + K LT S I L
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVV--DRKIRLTESQVKCILLQILN 130
Query: 595 GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLA-------------KLTEVGSA 641
GL +H+ ++HRD+ PANI I+ K+ADFGLA K +
Sbjct: 131 GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 642 SVHTRLVGTFGYMPPEY----AQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNE 692
T V T Y PE +Y +D+++ G + EL++ NE
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFA---VDMWSVGCIFAELLTGKPLFPGENE 239
|
Length = 335 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-16
Identities = 69/248 (27%), Positives = 113/248 (45%), Gaps = 32/248 (12%)
Query: 529 FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQ 587
+A++ L H N+V+LIG C E +L++EYIE NL++ LR L+W R +
Sbjct: 733 EIADMGKL---QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRK 784
Query: 588 IALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRL 647
IA+ A+ L ++H P + ++ P I+ID D +L+ G T+
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID------GKDEPHLRLSLPGLLCTDTKC 838
Query: 648 VGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELI---SAMEAVVKTNETITESTGLVALF 704
+ Y+ PE + +++ K D+Y FG++L EL+ S +A + +I E
Sbjct: 839 FISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWA------ 892
Query: 705 EEVLRQPDPREDLQRLVDPRLGDDYPIDS---VRKMARLARACTQENPQLRPSMRAIVVA 761
R L +DP + D ++ V M LA CT +P RP ++
Sbjct: 893 ----RYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVM-NLALHCTATDPTARPCANDVLKT 947
Query: 762 LMTLSSSS 769
L + S SS
Sbjct: 948 LESASRSS 955
|
Length = 968 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 497 KIGQGGFGAVFYAE--LRGEKAAIKKMDMQAS--KEFLA-ELKVLTHVHHLNLVR-LIGY 550
KIGQG G V+ A G++ AIK+M++Q KE + E+ V+ + N+V L Y
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 551 CVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHR 610
V L++V EY+ G+L + + D +A + + + L+++H + V IHR
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---VCRECLQALDFLHSNQV---IHR 139
Query: 611 DIKPANILIDKNFRAKVADFGL-AKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKID 669
DIK NIL+ + K+ DFG A++T S + +VGT +M PE PK+D
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 670 VYAFGVVLYELISAMEAVVKTN 691
+++ G++ E++ + N
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 39/212 (18%)
Query: 489 TNDFSMGNKIGQGGFGAVFYA--ELRGEKAAIKKMDMQASKEFLA-----ELKVLTHVHH 541
TN + +G G FG V A +L G+ AIKK+ S LA ELK+L H+ H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 542 LNLVRLIGYCVEGS--LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQ------IALDSA 593
N++ L + ++ V E L G+ L S ++
Sbjct: 69 ENIISLSDIFISPLEDIYFVTE----------LLGTDLHRLLTSRPLEKQFIQYFLYQIL 118
Query: 594 RGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGY 653
RGL+Y+H V +HRD+KP+NILI++N K+ DFGLA++ + T V T Y
Sbjct: 119 RGLKYVHSAGV---VHRDLKPSNILINENCDLKICDFGLARIQD----PQMTGYVSTRYY 171
Query: 654 MPPE----YAQYGEVSPKIDVYAFGVVLYELI 681
PE + +Y ++D+++ G + E++
Sbjct: 172 RAPEIMLTWQKYDV---EVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 63/199 (31%), Positives = 102/199 (51%), Gaps = 29/199 (14%)
Query: 498 IGQGGFGAVFYA--ELRGEKAAIKKM-------DMQASKEFLAELKVLTHVHHLNLVRLI 548
+G+G FG +K A+K++ ++ S++ E +L + H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVAFK 64
Query: 549 -GYCVEGSLFLVYEYIENGNLNQHLRGS-GK----DT-LTWSARMQIALDSARGLEYIHE 601
+ +G L++V EY + G+L Q ++ GK DT L W +M + G+++IHE
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHE 118
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQY 661
V +HRDIK NI + +N + K+ DFG A+L A T VGT Y+PPE +
Sbjct: 119 KRV---LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT-YVGTPYYVPPEIWEN 174
Query: 662 GEVSPKIDVYAFGVVLYEL 680
+ K D+++ G +LYEL
Sbjct: 175 MPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 71/287 (24%), Positives = 129/287 (44%), Gaps = 53/287 (18%)
Query: 493 SMGNKIGQGGFGAVFYAELRGE----KAAIKKMDM-----QASKEFLAELKVLTHVHHLN 543
++G +G+G FG+V +L + K A+K M + ++FL+E + H N
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 544 LVRLIGYCVEG-------SLFLVYEYIENGNLNQHLRGS--GKDTLTWSARMQIAL--DS 592
++RLIG C++ S ++ ++++G+L+ L S G +M + D
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 593 ARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFG 652
A G+EY+ + +IHRD+ N ++++N VADFGL+K G R+
Sbjct: 122 ASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRI----A 174
Query: 653 YMPPEYAQYGEVSPKI-----DVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEV 707
MP ++ ++ ++ DV++FGV ++E+ + + E + +
Sbjct: 175 KMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--------SEIYDY 226
Query: 708 LRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPS 754
LRQ + RL P D + + L +C NP+ RPS
Sbjct: 227 LRQGN-----------RLKQ--PPDCLDGLYSLMSSCWLLNPKDRPS 260
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 24/199 (12%)
Query: 498 IGQGGFGAVF--YAELRGEKAAIKKM----------DMQASKEFLAELKVLTHVHHLNLV 545
IG+G +GAV+ G A+K + D+Q L++L+ N+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLR---QSQPPNIT 65
Query: 546 RLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTV 604
+ G Y L+++ EY E G++ ++ S ++ L L+YIH+ V
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVL---VALKYIHKVGV 122
Query: 605 PVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYG-E 663
IHRDIK ANIL+ K+ DFG+A L S S + VGT +M PE G
Sbjct: 123 ---IHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-SKRSTFVGTPYWMAPEVITEGKY 178
Query: 664 VSPKIDVYAFGVVLYELIS 682
K D+++ G+ +YE+ +
Sbjct: 179 YDTKADIWSLGITIYEMAT 197
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 69/276 (25%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 492 FSMGNKIGQGGFGAVFYA-ELRGEKA-AIKKMDMQASKEFL----AELKVLTHVHHLNLV 545
F+ +IG+G FG VF + R ++ AIK +D++ +++ + E+ VL+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 546 RLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTV 604
+ G ++G+ L+++ EY+ G+ LR D + ++ L +GL+Y+H
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSEK- 121
Query: 605 PVYIHRDIKPANILIDKNFRAKVADFGLA-KLTEVGSASVHTRLVGTFGYMPPEYAQYGE 663
IHRDIK AN+L+ + K+ADFG+A +LT+ + VGT +M PE Q
Sbjct: 122 --KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIQQSA 177
Query: 664 VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723
K D+++ G+ EL K ++ + LF + + P
Sbjct: 178 YDSKADIWSLGITAIEL-------AKGEPPNSDMHPMRVLFL-----------IPKNNPP 219
Query: 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIV 759
L ++ + AC ++P RP+ + ++
Sbjct: 220 TLTGEF----SKPFKEFIDACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 60/217 (27%), Positives = 117/217 (53%), Gaps = 33/217 (15%)
Query: 492 FSMGNKIGQGGFGAVFYAELR-----GEKAAIK--KMDMQAS---KEFLAELKVLTHVHH 541
F++G +G+G FG+V A+L+ +K A+K K D+ +S +EFL E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 542 LNLVRLIGYCV----EGSL---FLVYEYIENGNLNQHLRGS--GKDTLTWSAR--MQIAL 590
N+++LIG + +G L ++ ++++G+L+ L S G++ T + ++ +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 591 DSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGT 650
D A G+EY+ +IHRD+ N ++++N VADFGL+K ++ S + + G
Sbjct: 121 DIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSK--KIYSGDYYRQ--GC 173
Query: 651 FGYMPPEYAQYGEVSPKI-----DVYAFGVVLYELIS 682
+P ++ ++ + DV+AFGV ++E+++
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 65/201 (32%), Positives = 98/201 (48%), Gaps = 25/201 (12%)
Query: 496 NKIGQGGFGAVFYAELR--GEKAAIKKMD------MQA--SKEFLAELKVLTHVHHLNLV 545
KIG+G F V A+ R G+ AIK M Q +E A L+ L+ H N++
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQA-LRRLSP--HPNIL 61
Query: 546 RLIGYCVE---GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH 602
RLI + G L LV+E ++ NL + ++G K L + L+++H +
Sbjct: 62 RLIEVLFDRKTGRLALVFELMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE-YAQY 661
+ HRDIKP NILI + K+ADFG + + S +T + T Y PE
Sbjct: 120 GI---FHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYISTRWYRAPECLLTD 173
Query: 662 GEVSPKIDVYAFGVVLYELIS 682
G PK+D++A G V +E++S
Sbjct: 174 GYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 18/200 (9%)
Query: 498 IGQGGFGAVFYAEL-----RGEKAAIKKMDMQASKE----FLAELKVLTHVHHLNLVRLI 548
+G G FG + L R AI + S + FLAE L H N+VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 549 GYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVY 607
G G+ + +V EY+ NG L+ LR + L M + A G++Y+ E Y
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLR-KHEGQLVAGQLMGMLPGLASGMKYLSEMG---Y 128
Query: 608 IHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVG--TFGYMPPEYAQYGEVS 665
+H+ + +L++ + K++ F +L E S +++T + G + PE QY S
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186
Query: 666 PKIDVYAFGVVLYELISAME 685
DV++FG+V++E++S E
Sbjct: 187 SASDVWSFGIVMWEVMSYGE 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-16
Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 36/203 (17%)
Query: 497 KIGQGGFGAVFYA-ELRG-EKAAIKKMDMQASK------EFLAELKVLTHVHHLNLVRLI 548
+IG G FGAV++A ++R E AIKKM + + + E++ L + H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 549 G-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSAR----MQIAL---DSARGLEYIH 600
G Y E + +LV EY GS D L + ++IA + +GL Y+H
Sbjct: 82 GCYLREHTAWLVMEYC---------LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEY-- 658
H + IHRD+K NIL+ + K+ DFG A + + VGT +M PE
Sbjct: 133 SHNM---IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FVGTPYWMAPEVIL 184
Query: 659 -AQYGEVSPKIDVYAFGVVLYEL 680
G+ K+DV++ G+ EL
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 62/238 (26%), Positives = 113/238 (47%), Gaps = 40/238 (16%)
Query: 498 IGQGGFGAVF---YAELRGEKAAIKKMDM----------QASKEF---LAELKVLT-HVH 540
+G G FG V+ A+K++++ + K ++E+ ++ +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 541 HLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHL------RGSGKDTLTWSARMQIALDSA 593
H N+VR +E L++V + IE L +H + + W+ +Q+ L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL--- 124
Query: 594 RGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGY 653
L Y+H+ V HRD+ P NI++ ++ + + DFGLAK + S T +VGT Y
Sbjct: 125 -ALRYLHKEKRIV--HRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILY 179
Query: 654 MPPEYAQ---YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLV-ALFEEV 707
PE + YGE K DV+AFG +LY++ ++ + ++ +T +V A++E +
Sbjct: 180 SCPEIVKNEPYGE---KADVWAFGCILYQM-CTLQPPFYSTNMLSLATKIVEAVYEPL 233
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 9e-16
Identities = 60/201 (29%), Positives = 93/201 (46%), Gaps = 25/201 (12%)
Query: 498 IGQGGFGAVFYAELRGEKAAIKKMDMQASKEFL------------AELKVLTHVHHLNLV 545
+G+GG+G VF K M+ K+ AE +L V H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 546 RLI-GYCVEGSLFLVYEYIENGNLNQHLRGSG---KDTLTWSARMQIALDSARGLEYIHE 601
LI + G L+L+ EY+ G L HL G +DT + +I+L LE++H+
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-EISL----ALEHLHQ 118
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQY 661
+ I+RD+KP NIL+D K+ DFGL K + HT GT YM PE
Sbjct: 119 QGI---IYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FCGTIEYMAPEILMR 174
Query: 662 GEVSPKIDVYAFGVVLYELIS 682
+D ++ G ++Y++++
Sbjct: 175 SGHGKAVDWWSLGALMYDMLT 195
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 32/233 (13%)
Query: 498 IGQGGFGAVFYAELR--GEKAAIKKMDMQASKE------FLAELKVLTHVHHLNLVRLI- 548
+G+GGFG V ++R G+ A KK++ + K+ L E ++L V+ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 549 GYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYI 608
Y + +L LV + G+L H+ G+ + A + GLE +H+ + +
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERI---V 124
Query: 609 HRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKI 668
+RD+KP NIL+D + +++D GLA G ++ R VGT GYM PE + +
Sbjct: 125 YRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGR-VGTVGYMAPEVVKNERYTFSP 182
Query: 669 DVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721
D +A G +LYE+I+ + + I RE+++RLV
Sbjct: 183 DWWALGCLLYEMIAGQSPFQQRKKKIK------------------REEVERLV 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 64/202 (31%), Positives = 101/202 (50%), Gaps = 29/202 (14%)
Query: 498 IGQGGFGAVFYAELR--GEKAAIKKM-----DMQASKEFLAELKVLTHVHHLNLVRLIGY 550
IG+G +G V A+ EK AIKK+ + +K L E+K+L H+ H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKD- 71
Query: 551 CVE-------GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT 603
+ +++VYE ++ +L+Q +R S TL+ RGL+YIH
Sbjct: 72 IMPPPHREAFNDVYIVYELMDT-DLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSAN 128
Query: 604 VPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEY----A 659
V +HRD+KP+N+L++ N K+ DFGLA+ T T V T Y PE +
Sbjct: 129 V---LHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRWYRAPELLLNCS 184
Query: 660 QYGEVSPKIDVYAFGVVLYELI 681
+Y IDV++ G + EL+
Sbjct: 185 EYTTA---IDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-15
Identities = 71/223 (31%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 498 IGQGGFGAVFYAELRG--EKAAIK--KMDMQASKE----FLAELKVLT-HVHHLNLVRLI 548
+G+G FG V AEL+G E AIK K D+ + + E ++L H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL- 61
Query: 549 GYC---VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVP 605
+C + LF V EY+ G+L ++ S K S + A L ++H H V
Sbjct: 62 -HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLA--LMFLHRHGV- 117
Query: 606 VYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVS 665
I+RD+K NIL+D K+ADFG+ K + + T GT Y+ PE Q E
Sbjct: 118 --IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT-FCGTPDYIAPEILQELEYG 174
Query: 666 PKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVL 708
P +D +A GV++YE+++ NE LFE +L
Sbjct: 175 PSVDWWALGVLMYEMMAGQPPFEADNED--------DLFESIL 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 57/196 (29%), Positives = 101/196 (51%), Gaps = 14/196 (7%)
Query: 496 NKIGQGGFGAVF--YAELRGEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIG 549
+K+G+G + V+ ++L A+K++ ++ A + E+ +L + H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 550 YC-VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYI 608
E SL LV+EY++ +L Q+L G + ++ RGL Y H V +
Sbjct: 72 IIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKL-FLFQLLRGLNYCHRRKV---L 126
Query: 609 HRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE-YAQYGEVSPK 667
HRD+KP N+LI++ K+ADFGLA+ + + + +V T Y PP+ + S +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQ 185
Query: 668 IDVYAFGVVLYELISA 683
ID++ G + YE+ +
Sbjct: 186 IDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-15
Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 38/221 (17%)
Query: 497 KIGQGGFGAVF--YAELRGEKAAIKKMDMQAS------KEFLAELKVLTHVHHLNLVRLI 548
IG+GG G V+ Y + + A+KK+ S K FL E K+ + H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 549 GYCVEG-SLFLVYEYIENGNLNQHLRGS-GKDTL--------TWSARMQIALDSARGLEY 598
C +G ++ YIE L L+ K++L + A + I +EY
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128
Query: 599 IHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV-----------------GSA 641
+H V +HRD+KP NIL+ + D+G A ++ S
Sbjct: 129 VHSKGV---LHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
++ ++VGT YM PE S D+YA GV+LY++++
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 58/196 (29%), Positives = 100/196 (51%), Gaps = 14/196 (7%)
Query: 496 NKIGQGGFGAVF--YAELRGEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIG 549
K+G+G + VF ++L A+K++ ++ A + E+ +L + H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 550 YC-VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYI 608
+ SL LV+EY++ +L Q++ G + ++ RGL Y H V +
Sbjct: 72 IVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKI-FLYQILRGLAYCHRRKV---L 126
Query: 609 HRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE-YAQYGEVSPK 667
HRD+KP N+LI++ K+ADFGLA+ V + + +V T Y PP+ E S +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYSTQ 185
Query: 668 IDVYAFGVVLYELISA 683
ID++ G + +E+ S
Sbjct: 186 IDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 72/302 (23%), Positives = 130/302 (43%), Gaps = 63/302 (20%)
Query: 494 MGNKIGQGGFGAVFYA---ELRGEKA----AIKKMDMQAS----KEFLAELKVLTHVHHL 542
+G +G+G FG V A L+G A+K + AS ++ L+E +L V+H
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHP 63
Query: 543 NLVRLIGYCVE-GSLFLVYEYIENGNLNQHLRGS----------------------GKDT 579
++++L G C + G L L+ EY + G+L LR S +
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 580 LTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK-LTEV 638
LT + A +RG++Y+ E + +HRD+ N+L+ + + K++DFGL++ + E
Sbjct: 124 LTMGDLISFAWQISRGMQYLAEMKL---VHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 639 GSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITES- 697
S ++ +M E + + DV++FGV+L+E++ T+ +
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV-----------TLGGNP 229
Query: 698 -TGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMR 756
G+ E L L+ + P + +M L C ++ P RP+
Sbjct: 230 YPGI------------APERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFA 277
Query: 757 AI 758
I
Sbjct: 278 DI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-15
Identities = 68/264 (25%), Positives = 110/264 (41%), Gaps = 37/264 (14%)
Query: 513 GEKAAIKKM------DMQASKEFLAELKVLTHVHHLNLVRLI--GYCVEGSLFLVYEYIE 564
G + AIK + + F E + ++H N+V L+ G G LF V+EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 565 NGNLNQHLRGSGKDTLTWSAR-MQIALDSARGLEYIHEHTVPVYIHRDIKPANILI---D 620
L + L G + R M LD L H + +HRD+KP NI++
Sbjct: 63 GRTLREVLAADGALPAGETGRLMLQVLD---ALACAHNQGI---VHRDLKPQNIMVSQTG 116
Query: 621 KNFRAKVADFGLAKL------TEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFG 674
AKV DFG+ L +V + + T ++GT Y PE + V+P D+YA+G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 675 VVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSV 734
++ E ++ V ++ E L++++ P + LG ++
Sbjct: 177 LIFLECLTGQRVV--QGASVAE-----ILYQQL--SPVDVSLPPWIAGHPLGQVLR-KAL 226
Query: 735 RKMARLARACTQENPQLRPSMRAI 758
K R RA + P L RA+
Sbjct: 227 NKDPR-QRAASA--PALAERFRAL 247
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 64/205 (31%), Positives = 101/205 (49%), Gaps = 25/205 (12%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKM-DMQASKEF----LAELKVLTHVHHL 542
N F + +G+G +G V + E AIKK D + ++E L ELK+L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 543 NLVRLI-GYCVEGSLFLVYEYIENGNLN---QHLRGSGKDTLTWSARMQIALDSARGLEY 598
N+V L + G L+LV+EY+E L + G + + S Q+ + + +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR-SYIYQLI----KAIHW 115
Query: 599 IHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEY 658
H++ + +HRDIKP N+LI N K+ DFG A+ GS + +T V T Y PE
Sbjct: 116 CHKNDI---VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPEL 172
Query: 659 ---AQYGEVSPKIDVYAFGVVLYEL 680
A YG+ +D+++ G +L EL
Sbjct: 173 LLGAPYGK---AVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-15
Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 498 IGQGGFGAVFYAELRGEK-----AAIKKMDMQASKEF---LAELKVLTHVHHLNLVRL-I 548
IG+G FG V R + I+K + + E LAE VL V+ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 549 GYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLT----WSARMQIALDSARGLEYIHEHTV 604
+ L+LV +I G L HL+ G+ L+ ++A + AL E +H+ V
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCAL------ENLHKFNV 114
Query: 605 PVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEV 664
I+RD+KP NIL+D + DFGL KL +T GT Y+ PE
Sbjct: 115 ---IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHGY 170
Query: 665 SPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD 712
+ +D + GV+LYE+++ + +E + E + +E LR PD
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPPFY--DENVNEM--YRKILQEPLRFPD 214
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 4e-15
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 48/210 (22%)
Query: 498 IGQGGFGAVFYAELR--GEKAAIKKMD------MQASKEFLAELKVLTHVHHLNLVRLIG 549
+G G +G V A G K AIKK+ + A + + EL++L H+ H N++ L+
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY-RELRLLKHMDHENVIGLLD 81
Query: 550 -YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM----------QIALDSARGLEY 598
+ SL E ++ L HL G+ + + ++ QI RGL+Y
Sbjct: 82 VFTPASSL----EDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQIL----RGLKY 133
Query: 599 IHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE- 657
IH + IHRD+KP+NI ++++ K+ DFGLA+ T+ T V T Y PE
Sbjct: 134 IHSAGI---IHRDLKPSNIAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEI 186
Query: 658 ------YAQYGEVSPKIDVYAFGVVLYELI 681
Y Q +D+++ G ++ EL+
Sbjct: 187 MLNWMHYNQ------TVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 4e-15
Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 32/226 (14%)
Query: 498 IGQGGFGAVFYAELR--GEKAAIKKM---------DMQASKEFLAELKVLTHVHHLNLVR 546
+G+G FG V A L+ G A+K + D++ + + E ++L+ + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECT---MTEKRILSLARNHPFLT 59
Query: 547 LIGYCVEGS--LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQI-ALDSARGLEYIHEHT 603
+ C + LF V E++ G+L H++ S + AR + A + L ++H+
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD---EARARFYAAEITSALMFLHDKG 116
Query: 604 VPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGE 663
+ I+RD+K N+L+D K+ADFG+ K + + + GT Y+ PE Q
Sbjct: 117 I---IYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEILQEML 172
Query: 664 VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLR 709
P +D +A GV+LYE++ NE LFE +L
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAENED--------DLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 5e-15
Identities = 54/197 (27%), Positives = 99/197 (50%), Gaps = 17/197 (8%)
Query: 498 IGQGGFGAVFYA------ELRGEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRL 547
+G G FG V+ E AIK ++ +A+ EF+ E ++ + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 548 IGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVY 607
+G C+ ++ LV + + +G L ++ KD + + + A+G+ Y+ E +
Sbjct: 75 LGVCLSPTIQLVTQLMPHGCLLDYVH-EHKDNIGSQLLLNWCVQIAKGMMYLEERRL--- 130
Query: 608 IHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTF--GYMPPEYAQYGEVS 665
+HRD+ N+L+ K+ DFGLA+L E G + G +M E Y + +
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLE-GDEKEYNADGGKMPIKWMALECIHYRKFT 189
Query: 666 PKIDVYAFGVVLYELIS 682
+ DV+++GV ++EL++
Sbjct: 190 HQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 68/275 (24%), Positives = 128/275 (46%), Gaps = 48/275 (17%)
Query: 497 KIGQGGFGAVFYAELRGEKAAIKKMDMQASKEF-LAELK------------VLTHVHHLN 543
++G+G FG V+ L +K A+ + ++ KE + EL +L+ + H
Sbjct: 7 RLGKGSFGTVY---LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 544 LVRLIGYCVEGSLF-LVYEYIENGNLN---QHLRGSGKDTLTWSARMQIALDSARGLEYI 599
+V+ +E F ++ EY E +L+ + L+ +GK TL+ + + + G+ Y+
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGK-TLSENQVCEWFIQLLLGVHYM 122
Query: 600 HEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYA 659
H+ + +HRD+K NI + N K+ DFG+++L +GS + T GT YM PE
Sbjct: 123 HQRRI---LHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPEAL 177
Query: 660 QYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719
++ K D+++ G +LYE+ A N +++ ++ P
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--------FLSVVLRIVEGP-------- 221
Query: 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPS 754
P L + Y R++ + ++ ++P LRPS
Sbjct: 222 --TPSLPETYS----RQLNSIMQSMLNKDPSLRPS 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-15
Identities = 62/203 (30%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 491 DFSMGNKIGQGGFGAVFYAE--LRGEKAAIKKMDMQASKEFLA---ELKVLTHVHHLNLV 545
DF + +IG G +G V+ A GE AAIK + ++ ++F E+ ++ H N+V
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 546 RLIG-YCVEGSLFLVYEYIENGNLNQ--HLRGSGKDTLTWSARMQIALDSARGLEYIHEH 602
G Y L++ E+ G+L H+ G L+ S ++ ++ +GL Y+H
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP----LSESQIAYVSRETLQGLYYLHSK 125
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR--LVGTFGYMPPEYA- 659
+HRDIK ANIL+ N K+ADFG++ +A++ R +GT +M PE A
Sbjct: 126 G---KMHRDIKGANILLTDNGHVKLADFGVSAQI---TATIAKRKSFIGTPYWMAPEVAA 179
Query: 660 --QYGEVSPKIDVYAFGVVLYEL 680
+ G + D++A G+ EL
Sbjct: 180 VERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 491 DFSMGNKIGQGGFGAVFYAELRG--EKAAIK--KMDMQASKE----FLAELKVLTHVHHL 542
DF+ +G+G FG V AE +G E AIK K D+ + + E +VL
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 543 NLVRLIGYCVE--GSLFLVYEYIENGNLNQHLRGSGK----DTLTWSARMQIALDSARGL 596
+ + C + L+ V EY+ G+L H++ GK + ++A + + GL
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV------GL 114
Query: 597 EYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPP 656
++H + I+RD+K N+++D K+ADFG+ K V + T GT Y+ P
Sbjct: 115 FFLHRRGI---IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT-FCGTPDYIAP 170
Query: 657 EYAQYGEVSPKIDVYAFGVVLYELISA 683
E Y +D +A+GV+LYE+++
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 6e-15
Identities = 72/235 (30%), Positives = 112/235 (47%), Gaps = 55/235 (23%)
Query: 474 VDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKM--------DM 523
+DK + YE + K+G+G +G V+ A R E A+KK+ D
Sbjct: 1 IDKHILRKYE----------ILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDA 50
Query: 524 QAS-KE--FLAELKVLTHVHHLNLVRLIG-YCVEGS--LFLVYEYIENGNLNQHLRGSGK 577
Q + +E FL EL H N+V+L+ E ++LV+EY+E +L+ +R
Sbjct: 51 QRTFREIMFLQELG-----DHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIR---A 101
Query: 578 DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK--- 634
+ L + I + L+YIH V IHRD+KP+NIL++ + R K+ADFGLA+
Sbjct: 102 NILEDVHKRYIMYQLLKALKYIHSGNV---IHRDLKPSNILLNSDCRVKLADFGLARSLS 158
Query: 635 -LTEVGSASVHTRLVGTFGYMPPE-------YAQYGEVSPKIDVYAFGVVLYELI 681
L E V T V T Y PE Y + +D+++ G +L E++
Sbjct: 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRY------TKGVDMWSVGCILGEML 207
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 59/194 (30%), Positives = 95/194 (48%), Gaps = 16/194 (8%)
Query: 498 IGQGGFGAVFYAELR--GEKAAIKKMDMQASKE------FLAELKVLTHVHHLNLVRLI- 548
+G+GGFG V ++R G+ A K+++ + K+ L E ++L V+ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 549 GYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYI 608
Y + +L LV + G+L H+ G + A + GLE +H +
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT---V 124
Query: 609 HRDIKPANILIDKNFRAKVADFGLA-KLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPK 667
+RD+KP NIL+D +++D GLA K+ E S+ R VGT GYM PE +
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAVKIPE--GESIRGR-VGTVGYMAPEVLNNQRYTLS 181
Query: 668 IDVYAFGVVLYELI 681
D + G ++YE+I
Sbjct: 182 PDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-15
Identities = 72/276 (26%), Positives = 128/276 (46%), Gaps = 38/276 (13%)
Query: 492 FSMGNKIGQGGFGAVFYA-ELRGEKA-AIKKMDMQASKEFL----AELKVLTHVHHLNLV 545
F+ KIG+G FG VF + R +K AIK +D++ +++ + E+ VL+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 546 RLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTV 604
+ G Y + L+++ EY+ G+ L D + ++ L +GL+Y+H
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSEK- 121
Query: 605 PVYIHRDIKPANILIDKNFRAKVADFGLA-KLTEVGSASVHTRLVGTFGYMPPEYAQYGE 663
IHRDIK AN+L+ ++ K+ADFG+A +LT+ + VGT +M PE +
Sbjct: 122 --KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 664 VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723
K D+++ G+ EL K +E + LF ++ + +P P
Sbjct: 178 YDSKADIWSLGITAIEL-------AKGEPPHSELHPMKVLF--LIPKNNP---------P 219
Query: 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIV 759
L +Y + + AC + P RP+ + ++
Sbjct: 220 TLEGNYS----KPLKEFVEACLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 7e-15
Identities = 67/206 (32%), Positives = 96/206 (46%), Gaps = 29/206 (14%)
Query: 497 KIGQGGFGAV----FYAELRGEKAAIKKMDMQASKEFLA-----ELKVLTHVH-HLNLVR 546
++GQG +G V E AIKK+ SK+ LA ELK+L H H N+
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 547 LIGYCV--EGSLFLVYEYIE--NGNLNQHLRGSGK---DTLTWSARMQIALDSARGLEYI 599
L + G+ +Y Y E +L+Q +R SG+ D S QI GL+YI
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQIIR-SGQPLTDAHFQSFIYQIL----CGLKYI 121
Query: 600 HEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH---TRLVGTFGYMPP 656
H V +HRD+KP N+L++ + K+ DFGLA+ T V T Y P
Sbjct: 122 HSANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178
Query: 657 EYA-QYGEVSPKIDVYAFGVVLYELI 681
E + + IDV++ G +L EL+
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELL 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 7e-15
Identities = 72/276 (26%), Positives = 116/276 (42%), Gaps = 60/276 (21%)
Query: 498 IGQGGFGAVFYAELRGEKA-----AIKKMDMQASKE---FLAELKVL---THVHHLNLVR 546
+G+G FG V AE + A+KK D+ A E + E ++ H LV
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 547 LIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVP 605
L + E + V EY G+L H+ D + + A GL+Y+HE+ +
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHENKI- 122
Query: 606 VYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEY---AQYG 662
++RD+K N+L+D K+ADFGL K +G + GT ++ PE Y
Sbjct: 123 --VYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179
Query: 663 EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD 722
+D + GV++YE++ + ES P P +D + + D
Sbjct: 180 RA---VDWWGLGVLIYEML------------VGES-------------PFPGDDEEEVFD 211
Query: 723 PRLGDD--YPI----DSVRKMARLARACTQENPQLR 752
+ D+ YP +++ M RL R NP+ R
Sbjct: 212 SIVNDEVRYPRFLSREAISIMRRLLR----RNPERR 243
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 21/208 (10%)
Query: 491 DFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEF------------LAELKVLTH 538
+F + +G G +G VF G A K M+ K+ E +VL
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 539 VHHLN-LVRL-IGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGL 596
V LV L + + L L+ +Y+ G L HL T + R+ IA + L
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYIA-EIVLAL 118
Query: 597 EYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPP 656
+++H+ + I+RDIK NIL+D + DFGL+K GT YM P
Sbjct: 119 DHLHQLGI---IYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 657 EYAQYGEV--SPKIDVYAFGVVLYELIS 682
E + G +D ++ GV+ +EL++
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 22/200 (11%)
Query: 497 KIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFL--------AELKVLTHVHHLNLVR 546
+IG G +G V+ A G A+K + +Q +++ L A LK L H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 547 LIGYCV------EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH 600
L+ C E + LV+E+++ +L +L L + RGL+++H
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQ 660
+ + +HRD+KP NIL+ + K+ADFGLA++ A T +V T Y PE
Sbjct: 126 ANCI---VHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL--TPVVVTLWYRAPEVLL 180
Query: 661 YGEVSPKIDVYAFGVVLYEL 680
+ +D+++ G + E+
Sbjct: 181 QSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 9e-15
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 32/207 (15%)
Query: 500 QGGFGAVFYAELRGEK------AAIKKMDMQASKE----FLAELKVLTHVHHLNLVRLIG 549
+G FG +FY L EK +K + AS+ L E +L + H N++ ++
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 550 YCVEGSL--FLVYEYIENGNLNQHLR------GSGKDTLTWSARMQIALDSARGLEYIHE 601
C+E F++Y Y+ GNL L+ + L+ + +A+ A G+ Y+H+
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH------TRLVGTFGYMP 655
V IH+DI N +ID+ + K+ D L++ ++ H R V +M
Sbjct: 136 RGV---IHKDIAARNCVIDEELQVKITDNALSR--DLFPMDYHCLGDNENRPV---KWMA 187
Query: 656 PEYAQYGEVSPKIDVYAFGVVLYELIS 682
E E S DV++FGV+L+EL++
Sbjct: 188 LESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 31/208 (14%)
Query: 490 NDFSMGNKIGQGGFGAVFYAE--LRGEKAAIKKMDMQASKEF---LAELKVLTHVHHLNL 544
+D+ + ++G G +G V+ A GE AA+K + ++ +F E+ ++ H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 545 VRLIG-YCVEGSLFLVYEYIENGNLNQ--HLRGSGKDTLTWSARMQIAL---DSARGLEY 598
V G Y L++ EY G+L H+ G + +QIA ++ +GL Y
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGP-------LSELQIAYVCRETLQGLAY 121
Query: 599 IHEHTVPVYIHRDIKPANILIDKNFRAKVADFGL-AKLTEVGSASVHTR--LVGTFGYMP 655
+H +HRDIK ANIL+ N K+ADFG+ AK+T A++ R +GT +M
Sbjct: 122 LHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKIT----ATIAKRKSFIGTPYWMA 174
Query: 656 PEYA---QYGEVSPKIDVYAFGVVLYEL 680
PE A + G + D++A G+ EL
Sbjct: 175 PEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 14/206 (6%)
Query: 498 IGQGGFGAVFYAELR--GEKAAIKKMDMQASKE------FLAELKVLTHVHHLNLVRL-I 548
+G+GGFG V ++R G+ A KK++ + K+ L E ++L V+ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 549 GYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYI 608
Y + +L LV + G+L H+ G + A + GLE + + +
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERI---V 124
Query: 609 HRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKI 668
+RD+KP NIL+D +++D GLA ++ VGT GYM PE + +
Sbjct: 125 YRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPEVINNEKYTFSP 182
Query: 669 DVYAFGVVLYELISAMEAVVKTNETI 694
D + G ++YE+I K E +
Sbjct: 183 DWWGLGCLIYEMIQGQSPFRKRKERV 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 55/218 (25%), Positives = 105/218 (48%), Gaps = 29/218 (13%)
Query: 478 VEFSYEELAKATNDFSMGNKIGQGGFGAVFYA-ELRGE-KAAIKKM---DMQASKEFLAE 532
+E+ YE + + +G+G +G V+ A +L + + AIK++ D + + E
Sbjct: 1 LEYEYE--YDENGERVV---LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEE 55
Query: 533 LKVLTHVHHLNLVRLIGYCVEGSLFLVY-EYIENGNLNQHLR------GSGKDTLTWSAR 585
+ + +++ H N+V+ +G E F ++ E + G+L+ LR + T+ + +
Sbjct: 56 IALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK 115
Query: 586 MQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK-NFRAKVADFGLAKLTEVGSASVH 644
QI GL+Y+H++ + +HRDIK N+L++ + K++DFG +K G
Sbjct: 116 -QI----LEGLKYLHDNQI---VHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCT 166
Query: 645 TRLVGTFGYMPPEYAQYGE--VSPKIDVYAFGVVLYEL 680
GT YM PE G D+++ G + E+
Sbjct: 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEM 204
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 491 DFSMGNKIGQGGFGAVFYAELRG--EKAAIK--KMDMQASKE----FLAELKVLTHVHHL 542
DF+ +G+G FG V AE +G E AIK K D+ + + E +VL
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 543 NLVRLIGYC--VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH 600
+ + C L+ V EY+ G+L H++ GK + A + A GL ++H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY--AAEIAIGLFFLH 118
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQ 660
+ I+RD+K N+++D K+ADFG+ K G + T GT Y+ PE
Sbjct: 119 SKGI---IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTPDYIAPEIIA 174
Query: 661 YGEVSPKIDVYAFGVVLYELIS 682
Y +D +AFGV+LYE+++
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLA 196
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 42/210 (20%)
Query: 498 IGQGGFGAVF-YAELR-GEKAAIKKM-----DMQASKEFLAELKVLTHVHHLNLVR---- 546
IG G FG V+ + R G++ A+KKM ++ + K ELK+L H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 547 ----LIGYCVEGSLFLVYEYIENGNL------NQHLRGSGKDTLTWSARMQIALDSARGL 596
I E +++V E +++ +L Q L + QI RGL
Sbjct: 68 LQPPHIDPFEE--IYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLY----QIL----RGL 116
Query: 597 EYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPP 656
+Y+H + +HRDIKP N+L++ N K+ DFGLA++ E + T+ V T Y P
Sbjct: 117 KYLHSAGI---LHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173
Query: 657 EY----AQYGEVSPKIDVYAFGVVLYELIS 682
E Y +D+++ G + EL+
Sbjct: 174 EILMGSRHYTS---AVDIWSVGCIFAELLG 200
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 41/143 (28%), Positives = 75/143 (52%), Gaps = 5/143 (3%)
Query: 541 HLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH 600
H +VRL+G C SL LV + G+L H+R +D+L + + A+G+ Y+
Sbjct: 68 HAYIVRLLGICPGASLQLVTQLSPLGSLLDHVR-QHRDSLDPQRLLNWCVQIAKGMYYLE 126
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS-VHTRLVGTFGYMPPEYA 659
EH + +HR++ NIL+ + ++ADFG+A L ++ +M E
Sbjct: 127 EHRM---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 660 QYGEVSPKIDVYAFGVVLYELIS 682
+G + + DV+++GV ++E++S
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 59/195 (30%), Positives = 90/195 (46%), Gaps = 18/195 (9%)
Query: 498 IGQGGFGAV----------FYAELRGEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRL 547
+G+GGFG V YA + EK IKK +A L E ++L V+ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 548 I-GYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPV 606
Y + +L LV + G+L H+ G + A + GLE +H +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERI-- 123
Query: 607 YIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSP 666
++RD+KP NIL+D +++D GLA E+ VGT GYM PE + +
Sbjct: 124 -VYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPEVVKNERYTF 180
Query: 667 KIDVYAFGVVLYELI 681
D + G ++YE+I
Sbjct: 181 SPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 38/214 (17%)
Query: 491 DFSMGNKIGQGGFGAVFYAELRG--EKAAIK--KMDM----------QASKEFLA---EL 533
DF+ +G+G FG V AE +G E AIK K D+ K LA +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 534 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGK----DTLTWSARMQIA 589
LT +H + L+ V EY+ G+L ++ G+ + ++A + I
Sbjct: 61 PFLTQLHSC-------FQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI- 112
Query: 590 LDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVG 649
GL ++H + I+RD+K N+++D K+ADFG+ K + T G
Sbjct: 113 -----GLFFLHSKGI---IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT-FCG 163
Query: 650 TFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISA 683
T Y+ PE Y +D +AFGV+LYE+++
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 54/204 (26%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 495 GNKIGQGGFGAVFYAEL-RGEKAAIKKMDMQASKEFLAE---------LKVLTHVHHLNL 544
G +G+G +G V+ +G+ A+K++++ S AE + +L + H+N+
Sbjct: 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 545 VRLIGYCVEGSLFLVY-EYIENGNLNQHLR--GSGKDTLTWSARMQIALDSARGLEYIHE 601
V+ +G C++ + ++ E++ G+++ L G + + QI LD G+ Y+H
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI-LD---GVAYLHN 120
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLA-KLTEVGSASVHTRLV----GTFGYMPP 656
+ V +HRDIK N+++ N K+ DFG A +L VG H+ ++ GT +M P
Sbjct: 121 NCV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 657 EYAQYGEVSPKIDVYAFGVVLYEL 680
E K D+++ G ++E+
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-14
Identities = 79/288 (27%), Positives = 130/288 (45%), Gaps = 60/288 (20%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEK-----AAIKKMDMQASKE---FLAELKVL----- 536
+DF + IG+G FG V +++ + + K +M E F E VL
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 537 ---THVHHLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLT------WSARMQ 587
T +H+ + E L+LV +Y G+L L +D L + A M
Sbjct: 61 QWITTLHY-------AFQDENYLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFYIAEMV 112
Query: 588 IALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFG-LAKLTEVGSASVHTR 646
+A+ S IH+ Y+HRDIKP N+L+D N ++ADFG K+ + G+ +
Sbjct: 113 LAIHS------IHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ-SSV 162
Query: 647 LVGTFGYMPPEYAQ-----YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLV 701
VGT Y+ PE Q G+ P+ D ++ GV +YE++ E++ E+ G +
Sbjct: 163 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA--ESLVETYGKI 220
Query: 702 ALFEEVLRQP--------DPREDLQRLV---DPRLGDDYPIDSVRKMA 738
EE + P + ++ +QRL+ + RLG + I+ +K A
Sbjct: 221 MNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQN-GIEDFKKHA 267
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 66/220 (30%), Positives = 104/220 (47%), Gaps = 31/220 (14%)
Query: 495 GNKIGQGGFGAVF--YAELRGEKAAIKKMDM-----QASKEFLA---ELKVLTHVHHLNL 544
G +GQG FG V+ Y G + A K++ + SKE A E+++L ++ H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 545 VRLIGYCV----EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH 600
V+ G C+ E +L + EY+ G++ L+ G LT S + G+ Y+H
Sbjct: 67 VQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLH 123
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK-LTEVGSASVHTRLV-GTFGYMPPEY 658
+ + +HRDIK ANIL D K+ DFG +K L + + R V GT +M PE
Sbjct: 124 SNMI---VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 659 AQYGEVSPKIDVYAFGVVLYELIS---------AMEAVVK 689
K DV++ G + E+++ AM A+ K
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK 220
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 68/236 (28%), Positives = 113/236 (47%), Gaps = 21/236 (8%)
Query: 492 FSMGNKIGQGGFGAVFYAE--LRGEKAAIKKMDMQA--SKEFLAELKVLT-HVHHLNLVR 546
F + +G G +G V+ G+ AAIK MD+ +E E+ +L + HH N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 547 LIGYCV-------EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYI 599
G + + L+LV E+ G++ ++ + +TL I + RGL ++
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 600 HEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYA 659
H+H V IHRDIK N+L+ +N K+ DFG++ + +T +GT +M PE
Sbjct: 128 HQHKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVI 183
Query: 660 QYGEVSPKIDVYAFGVVLYEL-ISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714
E +P Y F L+ L I+A+E + + + + + ALF + R P PR
Sbjct: 184 ACDE-NPDA-TYDFKSDLWSLGITAIE-MAEGAPPLCDMHPMRALF-LIPRNPAPR 235
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 70/277 (25%), Positives = 128/277 (46%), Gaps = 40/277 (14%)
Query: 492 FSMGNKIGQGGFGAVFYA--ELRGEKAAIKKMDMQASKEFL----AELKVLTHVHHLNLV 545
F+ +IG+G FG V+ E AIK +D++ +++ + E+ VL+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 546 RLIGYCVEGS-LFLVYEYIENGNLNQHLR-GSGKDTLTWSARMQIALDSARGLEYIHEHT 603
R G ++G+ L+++ EY+ G+ L+ G ++T + +I +GL+Y+H
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL----KGLDYLHSER 121
Query: 604 VPVYIHRDIKPANILIDKNFRAKVADFGLA-KLTEVGSASVHTRLVGTFGYMPPEYAQYG 662
IHRDIK AN+L+ + K+ADFG+A +LT+ + VGT +M PE +
Sbjct: 122 ---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQS 176
Query: 663 EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD 722
K D+++ G+ EL K ++ + LF ++ + P
Sbjct: 177 AYDFKADIWSLGITAIEL-------AKGEPPNSDLHPMRVLF--LIPKNSP--------- 218
Query: 723 PRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIV 759
P L Y + AC ++P+ RP+ + ++
Sbjct: 219 PTLEGQYS----KPFKEFVEACLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 36/216 (16%)
Query: 497 KIGQGGFGAVFYAELRG-------EKAAIK----KMDMQASKEFLAELKVLTHVHHLNLV 545
++G+ FG V+ L G + AIK K + +EF E + + + H N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 546 RLIGYCV-EGSLFLVYEYIENGNLNQHLR--------GSGKDTLTWSARMQ------IAL 590
L+G E L +++ Y + +L++ L GS D T + ++ I
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 591 DSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGT 650
A G+E++ H V +H+D+ N+L+ K++D GL + EV +A + +L+G
Sbjct: 132 QIAAGMEFLSSHHV---VHKDLATRNVLVFDKLNVKISDLGLFR--EVYAADYY-KLMGN 185
Query: 651 ----FGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
+M PE YG+ S D++++GVVL+E+ S
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 65/199 (32%), Positives = 90/199 (45%), Gaps = 20/199 (10%)
Query: 498 IGQGGFGAV----------FYAELRGEKAAIKKMDMQASKEFLAELKVL-THVHHLNLVR 546
IG+G FG V FYA +K AI K Q K +AE VL +V H LV
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQ--KHIMAERNVLLKNVKHPFLVG 60
Query: 547 L-IGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVP 605
L + L+ V +Y+ G L HL+ + AR A + A L Y+H +
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRE-RSFPEPRARFYAA-EIASALGYLHSLNI- 117
Query: 606 VYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVS 665
I+RD+KP NIL+D + DFGL K S + T GT Y+ PE +
Sbjct: 118 --IYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPEVLRKQPYD 174
Query: 666 PKIDVYAFGVVLYELISAM 684
+D + G VLYE++ +
Sbjct: 175 RTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 9e-14
Identities = 57/200 (28%), Positives = 105/200 (52%), Gaps = 18/200 (9%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS----KEFLAELKVLTHVHHLN 543
+DF +++G G G VF + G A K + ++ + + EL+VL +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 544 LVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE- 601
+V G + +G + + E+++ G+L+Q L+ +G+ ++ IA+ +GL Y+ E
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREK 122
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLA-KLTEVGSASVHTRLVGTFGYMPPEYAQ 660
H + +HRD+KP+NIL++ K+ DFG++ +L + S+ VGT YM PE Q
Sbjct: 123 HKI---MHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQ 175
Query: 661 YGEVSPKIDVYAFGVVLYEL 680
S + D+++ G+ L E+
Sbjct: 176 GTHYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 56/193 (29%), Positives = 94/193 (48%), Gaps = 17/193 (8%)
Query: 497 KIGQGGFGAVFYAELR--GEKAAIKKMDM--QASKEFL-AELKVLTHVHHLNLVRLI-GY 550
KIG+G G V A + G + A+K MD+ Q +E L E+ ++ H N+V + Y
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 551 CVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHR 610
V L+++ E+++ G L + + L + + L Y+H V IHR
Sbjct: 88 LVGEELWVLMEFLQGGALTDIV---SQTRLNEEQIATVCESVLQALCYLHSQGV---IHR 141
Query: 611 DIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR--LVGTFGYMPPEYAQYGEVSPKI 668
DIK +IL+ + R K++DFG S V R LVGT +M PE ++
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 669 DVYAFGVVLYELI 681
D+++ G+++ E++
Sbjct: 199 DIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 33/211 (15%)
Query: 491 DFSMGNKIGQGGFGAV----------FYAELRGEK-AAIKKMDMQASKEFLAELKVLTHV 539
DF + IG+G FG V YA K IK+ D S F E ++ H
Sbjct: 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSD---SAFFWEERDIMAHA 100
Query: 540 HHLNLVRL-IGYCVEGSLFLVYEYIENG---NLNQHLRGSGKDTLTWSARMQIALDSARG 595
+ +V+L + + L++V EY+ G NL + K ++A + +ALD+
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDA--- 157
Query: 596 LEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLA-KLTEVGSASVHTRLVGTFGYM 654
IH +IHRD+KP N+L+DK+ K+ADFG K+ G T VGT Y+
Sbjct: 158 ---IHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA-VGTPDYI 210
Query: 655 PPEY----AQYGEVSPKIDVYAFGVVLYELI 681
PE G + D ++ GV LYE++
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 63/230 (27%), Positives = 109/230 (47%), Gaps = 36/230 (15%)
Query: 515 KAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGY----CVEGSLFLVYEYIENGNLNQ 570
K AI+ + + ELKVL H N ++G+ +G + + E+++ G+L+Q
Sbjct: 39 KPAIRN-------QIIRELKVL---HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 88
Query: 571 HLRGSGKDTLTWSARMQIALDSARGLEYIHE-HTVPVYIHRDIKPANILIDKNFRAKVAD 629
L+ +G+ ++ IA+ RGL Y+ E H + +HRD+KP+NIL++ K+ D
Sbjct: 89 VLKKAGRIPENILGKISIAV--LRGLTYLREKHKI---MHRDVKPSNILVNSRGEIKLCD 143
Query: 630 FGLA-KLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVV 688
FG++ +L + S+ VGT YM PE Q + + D+++ G+ L E+ +
Sbjct: 144 FGVSGQLID----SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP 199
Query: 689 KTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMA 738
+ L A+F P + + R +P DS R MA
Sbjct: 200 PPDA-----KELEAMF------GRPVSEGEAKESHRPVSGHPPDSPRPMA 238
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 74/248 (29%), Positives = 112/248 (45%), Gaps = 34/248 (13%)
Query: 491 DFSMGNKIGQGGFGAVFYAELRGEKAA-----IKKMDMQASKE---FLAELKVLTHVHHL 542
DF + IG+G FG V +L+ + K +M E F E VL + +
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 543 NLVRL-IGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLT------WSARMQIALDSARG 595
+ L + E +L+LV +Y G+L L +D L + A M IA+DS
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 596 LEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFG-LAKLTEVGSASVHTRLVGTFGYM 654
L Y+H RDIKP NIL+D N ++ADFG KL E G+ + VGT Y+
Sbjct: 121 LHYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-SSVAVGTPDYI 170
Query: 655 PPEYAQY-----GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLR 709
PE Q G+ P+ D ++ GV +YE++ E++ E+ G + +E +
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA--ESLVETYGKIMNHKERFQ 228
Query: 710 QPDPREDL 717
P D+
Sbjct: 229 FPAQVTDV 236
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 62/201 (30%), Positives = 106/201 (52%), Gaps = 24/201 (11%)
Query: 497 KIGQGGFGAVF--YAELRGEKAAIKKMDMQASK--EFLA--ELKVLTHVHHLNLVRL--I 548
K+G+G + V+ ++L G+ A+K++ ++ + F A E +L + H N+V L I
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 549 GYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM---QIALDSARGLEYIHEHTVP 605
+ + +L LV+EY++ +L Q++ G + R+ Q+ RGL Y H+ V
Sbjct: 72 IH-TKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLL----RGLAYCHQRRV- 124
Query: 606 VYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYG--E 663
+HRD+KP N+LI + K+ADFGLA+ V S + +V T Y PP+ G E
Sbjct: 125 --LHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPD-VLLGSTE 180
Query: 664 VSPKIDVYAFGVVLYELISAM 684
S +D++ G + YE+ +
Sbjct: 181 YSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 32/218 (14%)
Query: 481 SYEELAKATNDFSMGNKIGQGGFGAVFY--AELRGEKAAIKKMDMQASK--EFLA--ELK 534
SYE+L K+G+G + V+ +++ G+ A+K + +Q + F A E
Sbjct: 6 SYEKL----------EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREAS 55
Query: 535 VLTHVHHLNLVRL--IGYCVEGSLFLVYEYIENG---NLNQHLRGSGKDTLTWSARMQIA 589
+L + H N+V L I + E +L LV+EY+ +++H G + +
Sbjct: 56 LLKGLKHANIVLLHDIIHTKE-TLTLVFEYVHTDLCQYMDKHPGGLHPENVKL-----FL 109
Query: 590 LDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVG 649
RGL YIH+ + +HRD+KP N+LI K+ADFGLA+ V S + +V
Sbjct: 110 FQLLRGLSYIHQRYI---LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV- 165
Query: 650 TFGYMPPE-YAQYGEVSPKIDVYAFGVVLYELISAMEA 686
T Y PP+ E S +D++ G + E+I + A
Sbjct: 166 TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 69/243 (28%), Positives = 105/243 (43%), Gaps = 61/243 (25%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKM---DMQASKEFL----AELKVLTHVH 540
+DF IG+G FG V + + G A+KK+ +M KE + AE +L
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM-LEKEQVAHVRAERDILAEAD 59
Query: 541 HLNLVRLIGYCV---EGSLFLVYEYIENGNLNQHLRGSGKDTLTWS-ARMQIALDSARGL 596
+ +V+L Y E L+L+ EY+ G++ L KDT T R IA ++ +
Sbjct: 60 NPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLL--MKKDTFTEEETRFYIA-ETILAI 114
Query: 597 EYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK------LTEVGSASVHTRL--- 647
+ IH+ YIHRDIKP N+L+D K++DFGL TE H
Sbjct: 115 DSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171
Query: 648 ----------------------------VGTFGYMPPE-YAQYGEVSPKIDVYAFGVVLY 678
VGT Y+ PE + Q G + + D ++ GV++Y
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMY 230
Query: 679 ELI 681
E++
Sbjct: 231 EML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 31/202 (15%)
Query: 498 IGQGGFGAVFYAEL--RGEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYC---- 551
IG+GGFG V+ G+ A+K +D + K E L L+LV G C
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS-TGDCPFIV 60
Query: 552 -------VEGSLFLVYEYIENGNLNQHLRGSG----KDTLTWSARMQIALDSARGLEYIH 600
L + + + G+L+ HL G K+ ++ + + GLE++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL------GLEHMH 114
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQ 660
V ++RD+KPANIL+D++ +++D GLA + H VGT GYM PE Q
Sbjct: 115 NRFV---VYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS-VGTHGYMAPEVLQ 168
Query: 661 YGEV-SPKIDVYAFGVVLYELI 681
G D ++ G +L++L+
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 63/227 (27%), Positives = 107/227 (47%), Gaps = 37/227 (16%)
Query: 491 DFSMGNKIGQGGFGAVF--YAELRGEKAAIKKMDM-----QASKEFLA---ELKVLTHVH 540
++ +G +GQG FG V+ Y G + A+K++ + SKE A E+++L ++
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 541 HLNLVRLIGYC---VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLE 597
H +V+ G +E +L + E++ G++ L+ G LT + + G+
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVS 120
Query: 598 YIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK------LTEVGSASVHTRLVGTF 651
Y+H + + +HRDIK ANIL D K+ DFG +K L+ G SV GT
Sbjct: 121 YLHSNMI---VHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV----TGTP 173
Query: 652 GYMPPEYAQYGEVSPKIDVYAFGVVLYELIS---------AMEAVVK 689
+M PE K D+++ G + E+++ AM A+ K
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK 220
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 32/203 (15%)
Query: 498 IGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLA-----ELKVLTHVHHLNLVRLIG- 549
+G G +G V A R G K AIKK+ E A EL++L H+ H N++ L+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 550 YCVEGSL------FLVYEYI--ENGNLNQHLRGSGKDTLTWSARMQ-IALDSARGLEYIH 600
+ + SL +LV ++ + G L +H + S R+Q + +GL+YIH
Sbjct: 83 FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS-------EDRIQFLVYQMLKGLKYIH 135
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYA- 659
+ IHRD+KP N+ ++++ K+ DFGLA+ T+ S T V T Y PE
Sbjct: 136 AAGI---IHRDLKPGNLAVNEDCELKILDFGLARQTD----SEMTGYVVTRWYRAPEVIL 188
Query: 660 QYGEVSPKIDVYAFGVVLYELIS 682
+ + +D+++ G ++ E+++
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 38/220 (17%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRG--EKAAIKKMDMQA------SKEFLAELKVLTHVHH 541
DF I G +GAV+ + ++ A+KK++ Q ++ E +LT +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 542 LNLVRLIGYC---VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEY 598
+V + +C + L +V EY+E G+ L+ G + ARM A ++ LEY
Sbjct: 61 PFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVD-MARMYFA-ETVLALEY 116
Query: 599 IHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL------TEV--GSASVHTR---- 646
+H + + +HRD+KP N+LI K+ DFGL+K+ T + G TR
Sbjct: 117 LHNYGI---VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 647 --LVGTFGYMPPEY---AQYGEVSPKIDVYAFGVVLYELI 681
+ GT Y+ PE YG+ +D +A G++LYE +
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGK---PVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 73/287 (25%), Positives = 117/287 (40%), Gaps = 66/287 (22%)
Query: 498 IGQGGFGAVFYAELR--GEKAAIKKMDMQASKE-----FLAELKVLTHVHHLNLVRLIGY 550
+G G G V A+ GE A+K +DM+ E AE+ L + ++V+
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK---- 95
Query: 551 CVEGSLF-------------LVYEYIENGNLNQHLRGSGKDTLTWSAR------MQIALD 591
C E LV +Y G+L Q ++ K T+ +Q+ L
Sbjct: 96 CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLL- 154
Query: 592 SARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL-TEVGSASVHTRLVGT 650
+ ++H + IHRDIK ANIL+ N K+ DFG +K+ S V GT
Sbjct: 155 ---AVHHVHSKHM---IHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGT 208
Query: 651 FGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQ 710
Y+ PE + S K D+++ GV+LYEL++ L++
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLT-------------------------LKR 243
Query: 711 PDPREDLQRLVDPRLG---DDYPIDSVRKMARLARACTQENPQLRPS 754
P E+++ ++ L D P +M + A +P+ RPS
Sbjct: 244 PFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPS 290
|
Length = 496 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 79/271 (29%), Positives = 124/271 (45%), Gaps = 49/271 (18%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIK---KMDMQASKE---FLAELKVLTHVHH 541
+DF + IG+G FG V +++ G+ A+K K +M E F E VL +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 542 LNLVRL-IGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLT------WSARMQIALDSAR 594
+ L + E +L+LV +Y G+L L D L + A M +A+DS
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVH 119
Query: 595 GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFG-LAKLTEVGS--ASVHTRLVGTF 651
L Y+H RDIKP N+L+DKN ++ADFG +L G+ ++V VGT
Sbjct: 120 QLGYVH---------RDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV---AVGTP 167
Query: 652 GYMPPEYAQ-----YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEE 706
Y+ PE Q G P+ D ++ GV +YE++ E++ E+ G + +E
Sbjct: 168 DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA--ESLVETYGKIMNHKE 225
Query: 707 VLRQPDPRED--------LQRLV---DPRLG 726
+ P D ++RL+ + RLG
Sbjct: 226 HFQFPPDVTDVSEEAKDLIRRLICSPETRLG 256
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 68/266 (25%), Positives = 108/266 (40%), Gaps = 52/266 (19%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA-----AIKKMDMQA--SKE----FLAELKVLTH 538
DF + + +G+G FG V ++ EKA A+K M ++E F E +L+
Sbjct: 1 KDFDVKSLVGRGHFGEV---QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 539 VHHLNLVRLIGYCVEGS--LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGL 596
+ + +L Y + L+LV EY G+L L+ R + D
Sbjct: 58 SNSPWIPQLQ-YAFQDKDNLYLVMEYQPGGDL-----------LSLLNRYEDQFDEDMAQ 105
Query: 597 EYIHEHTVPV-------YIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVG 649
Y+ E + + Y+HRDIKP N+LID+ K+ADFG A VG
Sbjct: 106 FYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVG 165
Query: 650 TFGYMPPEYAQYGEVSPK------IDVYAFGVVLYELISAMEAVVKTNETITESTGLVAL 703
T Y+ PE K D ++ GV+ YE+I + T + +
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNN--IMN 223
Query: 704 FEEVLRQPDPREDLQRLVDPRLGDDY 729
F+ L+ P+ DP++ D+
Sbjct: 224 FQRFLKFPE---------DPKVSSDF 240
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 31/202 (15%)
Query: 498 IGQGGFGAVFYAEL--RGEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYC---- 551
IG+GGFG V+ G+ A+K +D + K E L L+LV G C
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS-TGDCPFIV 60
Query: 552 -------VEGSLFLVYEYIENGNLNQHLRGSG----KDTLTWSARMQIALDSARGLEYIH 600
L + + + G+L+ HL G + ++A + + GLE++H
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIIL------GLEHMH 114
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQ 660
V ++RD+KPANIL+D++ +++D GLA + H VGT GYM PE Q
Sbjct: 115 NRFV---VYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS-VGTHGYMAPEVLQ 168
Query: 661 YG-EVSPKIDVYAFGVVLYELI 681
G D ++ G +L++L+
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 57/195 (29%), Positives = 99/195 (50%), Gaps = 18/195 (9%)
Query: 497 KIGQGGFGAVF--YAELRGEKAAIKKMDMQASK--EFLA--ELKVLTHVHHLNLVRL--I 548
K+G+G + V+ + + G+ A+K + M+ + F A E +L + H N+V L I
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 549 GYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYI 608
+ E +L V+EY+ +L Q++ ++ R+ RGL YIH + +
Sbjct: 72 IHTKE-TLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHGQHI---L 125
Query: 609 HRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYG--EVSP 666
HRD+KP N+LI K+ADFGLA+ + S + + +V T Y PP+ G + S
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPD-VLLGATDYSS 183
Query: 667 KIDVYAFGVVLYELI 681
+D++ G + E++
Sbjct: 184 ALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 74/268 (27%), Positives = 117/268 (43%), Gaps = 49/268 (18%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE----FLAELKVLTHVHHL- 542
ND +IG G G V+ + G A+K+M +KE L +L V+ H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCP 74
Query: 543 NLVRLIGYCV-EGSLFLVYEYIE----------NGNLNQHLRGSGKDTLTWSARMQIALD 591
+V+ GY + + +F+ E + G + + + G +M +A+
Sbjct: 75 YIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG----------KMTVAIV 124
Query: 592 SARGLEYIHE-HTVPVYIHRDIKPANILIDKNFRAKVADFGLA-KLTEVGSASVHTRLVG 649
A L Y+ E H V IHRD+KP+NIL+D + K+ DFG++ +L + + TR G
Sbjct: 125 KA--LHYLKEKHGV---IHRDVKPSNILLDASGNVKLCDFGISGRLVD---SKAKTRSAG 176
Query: 650 TFGYMPPEYAQYGEVSPKI----DVYAFGVVLYELISAMEAVVKTNETITESTGLVALFE 705
YM PE + +PK DV++ G+ L EL + + K + TE L + +
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATG-QFPYKNCK--TEFEVLTKILQ 233
Query: 706 EVLRQPDPRE----DLQRLVDPRLGDDY 729
E P E D VD L D+
Sbjct: 234 EEPPSLPPNEGFSPDFCSFVDLCLTKDH 261
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 492 FSMGNKIGQGGFGAVFYAE--LRGEKAAIKKMDM--QASKEFLAELKVLT-HVHHLNLVR 546
F + +G G +G V+ G+ AAIK MD+ +E E+ +L + HH N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 547 LIGYCVEGS-------LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYI 599
G ++ S L+LV E+ G++ ++ + + L I + RGL ++
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137
Query: 600 HEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYA 659
H H V IHRDIK N+L+ +N K+ DFG++ + +T +GT +M PE
Sbjct: 138 HAHKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVI 193
Query: 660 QYGEVSP------KIDVYAFGVVLYEL 680
E +P + D+++ G+ E+
Sbjct: 194 ACDE-NPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 73/286 (25%), Positives = 124/286 (43%), Gaps = 48/286 (16%)
Query: 498 IGQGGFGAVFYAEL--RGEK----AAIKKM----DMQASKEFLAELKVLTHVHHLNLVRL 547
+G G FG V+ GE AIK + +A+KE L E V+ V + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 548 IGYCVEGSLFLVYEYIENGNLNQHLR------GSGKDTLTWSARMQIALDSARGLEYIHE 601
+G C+ ++ LV + + G L ++R GS +D L W ++ A+G+ Y+ E
Sbjct: 75 LGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGS-QDLLNWCVQI------AKGMSYLEE 127
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGT-FGYMPPEYAQ 660
+ +HRD+ N+L+ K+ DFGLA+L ++ H +M E
Sbjct: 128 VRL---VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 661 YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720
+ + + DV+++GV ++EL M K + I E+ PD E +RL
Sbjct: 185 HRRFTHQSDVWSYGVTVWEL---MTFGAKPYDGIPA--------REI---PDLLEKGERL 230
Query: 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLS 766
P PI ++ + + C + + RP R +V ++
Sbjct: 231 PQP------PICTIDVYMIMVK-CWMIDSECRPRFRELVDEFSRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 5e-13
Identities = 56/200 (28%), Positives = 101/200 (50%), Gaps = 27/200 (13%)
Query: 498 IGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKVLTHVHHLN-LVR--------LI 548
IG+G FG V+ + + I M + + KE +A+ +V + N LVR ++
Sbjct: 1 IGKGTFGQVYQVR-KKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIV 59
Query: 549 G----YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTV 604
G + + L+LV +Y+ G L HL+ G+ + A+ IA + LE++H++ +
Sbjct: 60 GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED-RAKFYIA-ELVLALEHLHKYDI 117
Query: 605 PVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEY----AQ 660
++RD+KP NIL+D + DFGL+K + + +T GT Y+ PE
Sbjct: 118 ---VYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT-FCGTTEYLAPEVLLDEKG 173
Query: 661 YGEVSPKIDVYAFGVVLYEL 680
Y + +D ++ GV+++E+
Sbjct: 174 YTK---HVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 63/224 (28%), Positives = 98/224 (43%), Gaps = 24/224 (10%)
Query: 498 IGQGGFGAVFYAELRGEKA--AIKKMDMQA------SKEFLAELKVL-THVHHLNLVRL- 547
IG+G FG V A + E+ A+K + +A K ++E VL +V H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 548 IGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVY 607
+ L+ V +YI G L HL+ + L AR A + A L Y+H +
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAA-EIASALGYLHSLNI--- 117
Query: 608 IHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPK 667
++RD+KP NIL+D + DFGL K + + GT Y+ PE
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT 176
Query: 668 IDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQP 711
+D + G VLYE++ + N +++ +L +P
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRNTA--------EMYDNILNKP 212
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 67/233 (28%), Positives = 105/233 (45%), Gaps = 42/233 (18%)
Query: 476 KSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMD--MQASKEFLA 531
S E L T+ + + IG+G +G V+ + G AA+K +D +E A
Sbjct: 8 NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA 67
Query: 532 ELKVLTHV-HHLNLVRLIG------YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSA 584
E +L + +H N+V+ G V G L+LV E G++ + ++G L
Sbjct: 68 EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG----LLICGQ 123
Query: 585 RMQ------IALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGL-AKLTE 637
R+ I + GL+++H + + IHRD+K NIL+ K+ DFG+ A+LT
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNNRI---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180
Query: 638 VGSASVHTRL-----VGTFGYMPPEY----AQYG-EVSPKIDVYAFGVVLYEL 680
TRL VGT +M PE QY + DV++ G+ EL
Sbjct: 181 -------TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 9e-13
Identities = 64/246 (26%), Positives = 108/246 (43%), Gaps = 57/246 (23%)
Query: 460 SAALVAAPGVTGITVDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAA 517
S++ ++ + S S EL + N+IG G G V+ R G A
Sbjct: 51 SSSSSSSSSSSASGSAPSAAKSLSELER-------VNRIGSGAGGTVYKVIHRPTGRLYA 103
Query: 518 IKKM----DMQASKEFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNL-NQH 571
+K + + ++ E+++L V+H N+V+ + G + ++ E+++ G+L H
Sbjct: 104 LKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH 163
Query: 572 LRGSGKDTLTWSARMQIALDSAR----GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKV 627
+ A Q D AR G+ Y+H + +HRDIKP+N+LI+ K+
Sbjct: 164 I-----------ADEQFLADVARQILSGIAYLHRRHI---VHRDIKPSNLLINSAKNVKI 209
Query: 628 ADFG----LAKLTEVGSASVHTRLVGTFGYMPPE----------YAQYGEVSPKIDVYAF 673
ADFG LA+ + ++S VGT YM PE Y Y D+++
Sbjct: 210 ADFGVSRILAQTMDPCNSS-----VGTIAYMSPERINTDLNHGAYDGYAG-----DIWSL 259
Query: 674 GVVLYE 679
GV + E
Sbjct: 260 GVSILE 265
|
Length = 353 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 9e-13
Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 21/199 (10%)
Query: 498 IGQGGFGAVFYAEL---RGEK----AAIKKM----DMQASKEFLAELKVLTHVHHLNLVR 546
+G G FG V Y L GEK AIK++ +A+KE L E V+ V + ++ R
Sbjct: 15 LGSGAFGTV-YKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 547 LIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPV 606
L+G C+ ++ L+ + + G L ++R KD + + + A+G+ Y+ E +
Sbjct: 74 LLGICLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEERRL-- 130
Query: 607 YIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVG---TFGYMPPEYAQYGE 663
+HRD+ N+L+ K+ DFGLAKL H G +M E +
Sbjct: 131 -VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE--GGKVPIKWMALESILHRI 187
Query: 664 VSPKIDVYAFGVVLYELIS 682
+ + DV+++GV ++EL++
Sbjct: 188 YTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 34/209 (16%)
Query: 497 KIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE-----FLAELKVLTHVHHLN-LVRLI 548
KIG+G +G V+ A + G+ A+KK ++ +E L E+ +L + +VRL+
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 549 GYCVEG--------SLFLVYEYIENGNLNQHLRGSGKDT---LTWSARMQIALDSARGLE 597
VE SL+LV+EY+++ +L + + +G+ L +G+
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 598 YIHEHTVPVYIHRDIKPANILIDKN-FRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPP 656
+ H+H V +HRD+KP N+L+DK K+AD GL + + S +T + T Y P
Sbjct: 125 HCHKHGV---MHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS-YTHEIVTLWYRAP 180
Query: 657 EY----AQYGEVSPKIDVYAFGVVLYELI 681
E Y S +D+++ G + E+
Sbjct: 181 EVLLGSTHY---STPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 54/200 (27%), Positives = 105/200 (52%), Gaps = 18/200 (9%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKAAIKK----MDMQAS--KEFLAELKVLTHVHHLN 543
+DF +++G G G V + + + + ++++ + + + EL+VL +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 544 LVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE- 601
+V G + +G + + E+++ G+L+Q L+ + + ++ IA+ RGL Y+ E
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV--LRGLAYLREK 122
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLA-KLTEVGSASVHTRLVGTFGYMPPEYAQ 660
H + +HRD+KP+NIL++ K+ DFG++ +L + S+ VGT YM PE Q
Sbjct: 123 HQI---MHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQ 175
Query: 661 YGEVSPKIDVYAFGVVLYEL 680
S + D+++ G+ L EL
Sbjct: 176 GTHYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 68/270 (25%), Positives = 117/270 (43%), Gaps = 48/270 (17%)
Query: 491 DFSMGNKIGQGGFGAVF-------------YAELRGEKAAIKKMDMQASKEFLAELKVLT 537
+F + +G G +G VF YA +KA I + + ++ E +VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQ-KAKTTEHTRTERQVLE 59
Query: 538 HVHHLNLVRLIGYC--VEGSLFLVYEYIENGNLNQHL----RGSGKDTLTWSARMQIALD 591
H+ + + Y + L L+ +YI G L HL R ++ +S + +AL
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL- 118
Query: 592 SARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTF 651
E++H+ + I+RDIK NIL+D N + DFGL+K GT
Sbjct: 119 -----EHLHKLGI---IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170
Query: 652 GYMPPEYAQYGEV--SPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLR 709
YM P+ + G+ +D ++ GV++YEL++ E +++ + +L+
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAE----ISRRILK 226
Query: 710 QPDP---------REDLQRLV--DP--RLG 726
P ++ +QRL+ DP RLG
Sbjct: 227 SEPPYPQEMSALAKDIIQRLLMKDPKKRLG 256
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 59/197 (29%), Positives = 92/197 (46%), Gaps = 16/197 (8%)
Query: 498 IGQGGFGAVFYAE--LRGEKAAIKKM------DMQASKEFLAELKVL-THVHHLNLVRL- 547
IG+G FG V A+ L G+ A+K + + + K +AE VL +V H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 548 IGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVY 607
+ L+ V +++ G L HL+ + AR A + A L Y+H +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRE-RSFPEPRARFYAA-EIASALGYLHSINI--- 117
Query: 608 IHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPK 667
++RD+KP NIL+D + DFGL K + + T GT Y+ PE +
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176
Query: 668 IDVYAFGVVLYELISAM 684
+D + G VLYE++ +
Sbjct: 177 VDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 18/196 (9%)
Query: 497 KIGQGGFGAVFYAELRGEK--AAIKKMDMQASKE---FLAELKVLTHVHHLNLVRLI-GY 550
++G G FG V+ A+ + AA K +D ++ +E ++ E+ +L H N+V+L+ +
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 551 CVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHR 610
E +L+++ E+ G ++ + + LT + + L Y+HE+ + IHR
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELER-PLTEPQIRVVCKQTLEALNYLHENKI---IHR 127
Query: 611 DIKPANILIDKNFRAKVADFGL-AKLTEVGSASVHTRLVGTFGYMPPEYA--QYGEVSP- 666
D+K NIL + K+ADFG+ AK T + +GT +M PE + + P
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185
Query: 667 --KIDVYAFGVVLYEL 680
K DV++ G+ L E+
Sbjct: 186 DYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 33/203 (16%)
Query: 498 IGQGGFGAVFYA--ELRGEKAAIKKMDMQASKEFLA-----ELKVLTHVHHLNLVRLIGY 550
+G G +G+V A + GEK AIKK+ E A EL +L H+ H N++ L+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 551 CVEGS-------LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT 603
+LV Y++ +L Q + G L+ + GL+YIH
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQT-DL-QKIMGH---PLSEDKVQYLVYQMLCGLKYIHSAG 137
Query: 604 VPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE----YA 659
+ IHRD+KP N+ ++++ K+ DFGLA+ + + T V T Y PE +
Sbjct: 138 I---IHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVTRWYRAPEVILNWM 190
Query: 660 QYGEVSPKIDVYAFGVVLYELIS 682
Y + +D+++ G ++ E+++
Sbjct: 191 HYNQT---VDIWSVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 4e-12
Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 29/200 (14%)
Query: 498 IGQGGFGAVFYAELRGEKAAIKKMDMQASKE-----------FLAELKVLTHVHHLNLVR 546
+G+G FG V L EKA+ K M+ K+ L E +VL + H L
Sbjct: 3 LGKGTFGKVI---LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 547 L-IGYCVEGSLFLVYEYIENGNLNQHLRG----SGKDTLTWSARMQIALDSARGLEYIHE 601
L + + L V EY+ G L HL S T + A + ALD Y+H
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALD------YLHS 113
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQY 661
+ ++RD+K N+++DK+ K+ DFGL K +A++ T GT Y+ PE +
Sbjct: 114 GKI---VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLED 169
Query: 662 GEVSPKIDVYAFGVVLYELI 681
+ +D + GVV+YE++
Sbjct: 170 NDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 4e-12
Identities = 49/162 (30%), Positives = 73/162 (45%), Gaps = 37/162 (22%)
Query: 538 HVHHL-----NLVRLIGYCVE--GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIAL 590
VH L N ++L Y V L+ +YI++G+L L+ GK L+ + +I
Sbjct: 60 MVHQLMKDNPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLKKEGK--LSEAEVKKIIR 116
Query: 591 DSARGLEYIHEHTVPVYIHRDIKPANILID-KNFRAKVADFGLAKLTEVGSASVHTRLVG 649
L +H+H IH DIK N+L D R + D+GL K+ +G+ S + G
Sbjct: 117 QLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI--IGTPSCYD---G 168
Query: 650 TFGYMPPEYAQYGEVSPKI---------DVYAFGVVLYELIS 682
T Y PE KI D +A GV+ YEL++
Sbjct: 169 TLDYFSPE---------KIKGHNYDVSFDWWAVGVLTYELLT 201
|
Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-12
Identities = 64/228 (28%), Positives = 98/228 (42%), Gaps = 32/228 (14%)
Query: 498 IGQGGFGAV----------FYAELRGEKAAIKKMDMQASKEFLAELKVL-THVHHLNLVR 546
IG+G FG V FYA +K I K Q +AE VL ++ H LV
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQ--NHIMAERNVLLKNLKHPFLVG 60
Query: 547 L-IGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVP 605
L + L+ V +Y+ G L HL+ + L AR A + A + Y+H +
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRE-RCFLEPRARFYAA-EVASAIGYLHSLNI- 117
Query: 606 VYIHRDIKPANILIDKNFRAKVADFGLAK--LTEVGSASVHTRLVGTFGYMPPEYAQYGE 663
I+RD+KP NIL+D + DFGL K + + S GT Y+ PE +
Sbjct: 118 --IYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST---FCGTPEYLAPEVLRKEP 172
Query: 664 VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQP 711
+D + G VLYE++ + S + +++ +L +P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFY--------SRDVSQMYDNILHKP 212
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 70/268 (26%), Positives = 119/268 (44%), Gaps = 50/268 (18%)
Query: 491 DFSMGNKIGQGGFGAVF--YAELRGEKAAIKKM-----DMQASKEFLA---ELKVLTHVH 540
++ +G +G+G FG V+ Y G + A+K++ + SKE A E+++L ++
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 541 HLNLVRLIGYCV----EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGL 596
H +V+ G C+ E L + EY+ G++ L+ G LT + + +G+
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGV 119
Query: 597 EYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK------LTEVGSASVHTRLVGT 650
Y+H + + +HRDIK ANIL D K+ DFG +K ++ G SV GT
Sbjct: 120 SYLHSNMI---VHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV----TGT 172
Query: 651 FGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS---------AMEAVVK-----TNETITE 696
+M PE K DV++ + E+++ AM A+ K T + +
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPD 232
Query: 697 STG------LVALFEEVLRQPDPREDLQ 718
L +F E R+P L+
Sbjct: 233 GVSDACRDFLKQIFVEEKRRPTAEFLLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 69/303 (22%), Positives = 135/303 (44%), Gaps = 46/303 (15%)
Query: 496 NKIGQGGFGAVFYAELR--GEKAAIK--KMDMQASK--EFLAELKVLTHVHHLNLVRLIG 549
+++G+G +G+V+ R G A+K ++++ SK + + EL +L +V G
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 550 -YCVEGSLFLVYEYIENGNLNQ-HLRGSGKDTLTWSARMQIALDSARGLEYIHE-HTVPV 606
+ +EG++++ EY++ G+L++ + G + + +I +GL+++ E H +
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI-- 124
Query: 607 YIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEY------AQ 660
IHRD+KP N+L++ N + K+ DFG++ AS+ +G YM PE Q
Sbjct: 125 -IHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---ASLAKTNIGCQSYMAPERIKSGGPNQ 180
Query: 661 YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720
+ + DV++ G+ + E+ A+ ET + + Q L +
Sbjct: 181 NPTYTVQSDVWSLGLSILEM--ALGRYPYPPET----------YANIFAQ------LSAI 222
Query: 721 VD---PRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWDIGSF 777
VD P L Y D+ C + P RP+ ++ + + D D+ +
Sbjct: 223 VDGDPPTLPSGYSDDA----QDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEW 278
Query: 778 YEN 780
Sbjct: 279 VTG 281
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 9e-12
Identities = 58/200 (29%), Positives = 90/200 (45%), Gaps = 29/200 (14%)
Query: 498 IGQGGFGAVFYAELRGEKA-----AIK--KMDMQASKEFLA----ELKVLTHVHHLNLVR 546
+G+G FG V L EKA A+K K ++ +K+ +A E +VL + H L
Sbjct: 3 LGKGTFGKVI---LVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 547 L-IGYCVEGSLFLVYEYIENGNLNQHLRG----SGKDTLTWSARMQIALDSARGLEYIHE 601
L + L V EY G L HL S + A + AL Y+H
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALG------YLHS 113
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQY 661
V ++RD+K N+++DK+ K+ DFGL K + + GT Y+ PE +
Sbjct: 114 CDV---VYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLED 169
Query: 662 GEVSPKIDVYAFGVVLYELI 681
+ +D + GVV+YE++
Sbjct: 170 NDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-11
Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 37/237 (15%)
Query: 531 AELKVLTHVHHLNLVR-LIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSAR---- 585
+EL L H +V+ + + L L+ EY G+LN+ ++ K+ L +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 586 --MQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK-LTEVGSAS 642
QI L L+ +H + +HRD+K ANI + K+ DFG +K ++ S
Sbjct: 174 LFYQIVL----ALDEVHSRKM---MHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226
Query: 643 VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVA 702
V + GT Y+ PE + S K D+++ GV+LYEL++
Sbjct: 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT-------------------- 266
Query: 703 LFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIV 759
+ P RE +Q+++ + D +P M L +NP LRP+ + ++
Sbjct: 267 -LHRPFKGPSQREIMQQVLYGKY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 25/204 (12%)
Query: 491 DFSMGNKIGQGGFGAVFYAELRGEK---AAIKKMD------MQASKEFLAELKVLTHVHH 541
DF+ +G G FG V A + E AIK+ + + +E K+L +++H
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 542 LNLVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGK---DTLTWSARMQIALDSARGLE 597
V L G + E L+LV E++ G LR + + D + A QI L E
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYA-AQIVLI----FE 145
Query: 598 YIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE 657
Y+ + ++RD+KP N+L+DK+ K+ DFG AK+ + + + L GT Y+ PE
Sbjct: 146 YLQSLNI---VYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT----LCGTPEYIAPE 198
Query: 658 YAQYGEVSPKIDVYAFGVVLYELI 681
D + G+ +YE++
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 53/199 (26%), Positives = 102/199 (51%), Gaps = 24/199 (12%)
Query: 497 KIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE---FLAELKVLTHVHHLNLVRLIG-Y 550
++G G FG V+ A+ + G AA K ++ ++ +E ++ E+++L +H +V+L+G +
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 551 CVEGSLFLVYEYIENGNLNQHL----RGSGKDTLTWSARMQIALDSARGLEYIHEHTVPV 606
+G L+++ E+ G ++ + RG LT I L+Y+H +
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRG-----LTEPQIQVICRQMLEALQYLHSMKI-- 131
Query: 607 YIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE--YAQYGEV 664
IHRD+K N+L+ + K+ADFG++ V + +GT +M PE + +
Sbjct: 132 -IHRDLKAGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 665 SP---KIDVYAFGVVLYEL 680
+P K D+++ G+ L E+
Sbjct: 190 TPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 63/279 (22%), Positives = 123/279 (44%), Gaps = 44/279 (15%)
Query: 498 IGQGGFGAVF---------YAELRGEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLV 545
+GQG F +F Y EL + +K +D S+ F +++ + H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 546 RLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTV 604
G CV +V EY++ G+L+ +L+ K+ + S ++++A A L ++ + +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLK-KNKNLINISWKLEVAKQLAWALHFLEDKGL 121
Query: 605 PVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG-SASVHTR--LVGTFGYMPPEYAQY 661
H ++ N+L+ + K + KL++ G S +V + L+ ++PPE +
Sbjct: 122 T---HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIEN 178
Query: 662 GE-VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720
+ +S D ++FG L+E+ S + + + +S + +E+ + P P+
Sbjct: 179 PQNLSLAADKWSFGTTLWEIFSGGDKPL----SALDSQKKLQFYEDRHQLPAPKWT---- 230
Query: 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIV 759
++A L C P RPS RAI+
Sbjct: 231 ---------------ELANLINQCMDYEPDFRPSFRAII 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 61/237 (25%), Positives = 114/237 (48%), Gaps = 43/237 (18%)
Query: 498 IGQGGFGAV---FYAELRGEKAAIKKMD-----MQASKEFLAELKVLTHVHHLNLVRLIG 549
+G G +G+V + LR +K A+KK+ + ++ EL++L H+ H N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLR-QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL- 80
Query: 550 YCVEGSLFLVYEYIENGN---LNQHLRGSGKDTLTWSARMQ------IALDSARGLEYIH 600
+F IEN N L +L G+ + + ++ + RGL+YIH
Sbjct: 81 -----DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH 135
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE--- 657
+ IHRD+KP+N+ ++++ ++ DFGLA+ + T V T Y PE
Sbjct: 136 SAGI---IHRDLKPSNVAVNEDCELRILDFGLARQAD----DEMTGYVATRWYRAPEIML 188
Query: 658 -YAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713
+ Y + +D+++ G ++ EL+ +A+ N+ I + ++ EV+ P P
Sbjct: 189 NWMHYNQT---VDIWSVGCIMAELLKG-KALFPGNDYIDQLKRIM----EVVGTPSP 237
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 59/196 (30%), Positives = 88/196 (44%), Gaps = 21/196 (10%)
Query: 498 IGQGGFGAVFYAELRGEKAA--------IKKMDMQASKEF---LAELKVLTHVHHLNLVR 546
+G+G FG V L EKA ++K + A E + E +VL + H L
Sbjct: 3 LGKGTFGKVI---LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 547 L-IGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVP 605
L + L V EY G L HL S + T + LEY+H V
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDV- 116
Query: 606 VYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVS 665
++RDIK N+++DK+ K+ DFGL K A++ T GT Y+ PE + +
Sbjct: 117 --VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYG 173
Query: 666 PKIDVYAFGVVLYELI 681
+D + GVV+YE++
Sbjct: 174 RAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (163), Expect = 2e-11
Identities = 66/266 (24%), Positives = 112/266 (42%), Gaps = 44/266 (16%)
Query: 482 YEELAKATNDFSMGNKIGQGGFGAVFYAELRGEKA-------AIKKMDMQASKEFLAELK 534
Y++ N++ + KIG G FG VF + + + + + + + + + E+
Sbjct: 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN 64
Query: 535 VLTHVHHLNLVRLIGYCVEGS---LFLVYEYIENGNLNQHLRGSGK--DTLTWSARMQIA 589
V+ + H N+VR I + + L+++ E+ + G+L+++++ K + A + I
Sbjct: 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDIT 124
Query: 590 LDSARGLEYIHE----HTVPVYIHRDIKPANILIDKNFR-----------------AKVA 628
L Y H +HRD+KP NI + R AK+
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184
Query: 629 DFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVS--PKIDVYAFGVVLYELISAMEA 686
DFGL+K +G S+ VGT Y PE + S K D++A G ++YEL S
Sbjct: 185 DFGLSK--NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
Query: 687 VVKTNETITESTGLVALFEEVLRQPD 712
K N L E+ R PD
Sbjct: 243 FHKANN-------FSQLISELKRGPD 261
|
Length = 1021 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 24/200 (12%)
Query: 498 IGQGGFGAVFYA--ELRGEKAAIKKMD--MQA---SKEFLAELKVLTHVHHLNLVRLIGY 550
+G G +G+V A G + A+KK+ Q+ +K EL++L H+ H N++ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 551 CVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQ------IALDSARGLEYIHEHTV 604
E + L HL G+ + + ++ + RGL+YIH +
Sbjct: 85 FTPARSL---EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 141
Query: 605 PVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYA-QYGE 663
IHRD+KP+N+ ++++ K+ DFGLA+ T T V T Y PE +
Sbjct: 142 ---IHRDLKPSNLAVNEDCELKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMH 194
Query: 664 VSPKIDVYAFGVVLYELISA 683
+ +D+++ G ++ EL++
Sbjct: 195 YNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 42/151 (27%), Positives = 75/151 (49%), Gaps = 15/151 (9%)
Query: 497 KIGQGGFGAVFYAE----LRGEKAAIKKMDMQAS----KEFLAELKVLTHVHHLNLVRLI 548
+IG G FG V E + +K++ + AS +FL E + + H NL++ +
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 549 GYCVEGSLFL-VYEYIENGNLNQHLRGSGK-DTLTWSARM--QIALDSARGLEYIHEHTV 604
G C E + +L V E+ G+L +LR K + +T ++A + A GL ++H++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 605 PVYIHRDIKPANILIDKNFRAKVADFGLAKL 635
+IH D+ N L+ + K+ D+GL+
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 45/166 (27%), Positives = 81/166 (48%), Gaps = 17/166 (10%)
Query: 553 EGSLFLVYEYIENGNLNQHLRGSGK----DTLTWSARMQIALDSARGLEYIHEHTVPVYI 608
LFLV EY+ G+L H++ K ++A + IAL+ ++HE + I
Sbjct: 68 TSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALN------FLHERGI---I 118
Query: 609 HRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKI 668
+RD+K N+L+D + K+ D+G+ K +G + GT Y+ PE + E +
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSV 177
Query: 669 DVYAFGVVLYELI---SAMEAVVKTNETITESTGLVALFEEVLRQP 711
D +A GV+++E++ S + + + TE + E+ +R P
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP 223
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 6e-11
Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 492 FSMGNKIGQGGFGAVFYAEL--RGEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIG 549
+ +GN IG G FG V+ A EK AIKK+ +Q + EL ++ +++H+N++ L
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV-LQDPQYKNRELLIMKNLNHINIIFLKD 126
Query: 550 Y----CV---EGSLFL--VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDS---ARGLE 597
Y C E ++FL V E+I ++++++ ++ + + L S R L
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFL-VKLYSYQLCRALA 184
Query: 598 YIHEHTVPVYIHRDIKPANILIDKNFRA-KVADFGLAKLTEVGSASVHTRLVGTFGYMPP 656
YIH + HRD+KP N+LID N K+ DFG AK G SV + + F P
Sbjct: 185 YIHSKFI---CHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV-SYICSRFYRAPE 240
Query: 657 EYAQYGEVSPKIDVYAFGVVLYELI 681
+ ID+++ G ++ E+I
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 54/203 (26%), Positives = 99/203 (48%), Gaps = 37/203 (18%)
Query: 498 IGQGGFGAVF--YAELRGEKAAIK----KMDMQASKEFLAELKVLTHVHHLNLVRLIG-Y 550
+G G G V+ Y L A+K + ++ K+ ++EL++L ++ G +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 551 CVEGSLFLVYEYIENGNLN------QHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTV 604
VE + + E+++ G+L+ +H+ G +IA+ +GL Y+ +
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPEHVLG------------RIAVAVVKGLTYLWSLKI 116
Query: 605 PVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEY---AQY 661
+HRD+KP+N+L++ + K+ DFG++ T++ + S+ VGT YM PE QY
Sbjct: 117 ---LHRDVKPSNMLVNTRGQVKLCDFGVS--TQLVN-SIAKTYVGTNAYMAPERISGEQY 170
Query: 662 GEVSPKIDVYAFGVVLYELISAM 684
G S DV++ G+ EL
Sbjct: 171 GIHS---DVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 59/197 (29%), Positives = 89/197 (45%), Gaps = 22/197 (11%)
Query: 498 IGQGGFGAVFYAELRGEKAA--------IKKMDMQASKEF---LAELKVLTHVHHLNLVR 546
+G+G FG V L EKA +KK + A E L E +VL + H L
Sbjct: 3 LGKGTFGKVI---LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 547 L-IGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQI-ALDSARGLEYIHEHTV 604
L + L V EY G L HL ++ + R + + L+Y+H
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLHSEKN 116
Query: 605 PVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEV 664
VY RD+K N+++DK+ K+ DFGL K A++ T GT Y+ PE + +
Sbjct: 117 VVY--RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDY 173
Query: 665 SPKIDVYAFGVVLYELI 681
+D + GVV+YE++
Sbjct: 174 GRAVDWWGLGVVMYEMM 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 25/155 (16%)
Query: 496 NKIGQGGFGAVFYAE----LRGEKAAIKKMDMQASKE----FLAELKVLTHVHHLNLVRL 547
++IG G FG V E + + +K++ A+ + FL E++ ++H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 548 IGYCVEGS-LFLVYEYIENGNLNQHLRG--------SGKDTLTWSARMQIALDSARGLEY 598
+G C+E LV E+ G+L +LR + KD L RM A + A GL +
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ---RM--ACEVASGLLW 115
Query: 599 IHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLA 633
+H+ +IH D+ N + + K+ D+GLA
Sbjct: 116 LHQAD---FIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 33/218 (15%)
Query: 484 ELAKATNDFSMGNKIGQGGFG-----------AVFYAELRGEKAAIKKMDMQASKEFLAE 532
+L D+ + IG+G FG V+ +L + IK+ D S F E
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD---SAFFWEE 93
Query: 533 LKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENG---NLNQHLRGSGKDTLTWSARMQI 588
++ + +V+L + + L++V EY+ G NL + K ++A + +
Sbjct: 94 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL 153
Query: 589 ALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLA-KLTEVGSASVHTRL 647
ALD+ IH +IHRD+KP N+L+DK+ K+ADFG K+ + G T
Sbjct: 154 ALDA------IHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA- 203
Query: 648 VGTFGYMPPEYAQY----GEVSPKIDVYAFGVVLYELI 681
VGT Y+ PE + G + D ++ GV LYE++
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 4e-10
Identities = 63/232 (27%), Positives = 95/232 (40%), Gaps = 48/232 (20%)
Query: 491 DFSMGNKIGQGGFGAVFYAELRGE------KAAIKKMDMQASK--EFLAELKVLTHVHHL 542
F +G+G G VF L+G K KK ++ +K L E ++L + H
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 543 NLVRLIGYCV---EGSLFLVYEYIENGNLNQHL-RGSGKDTLTWSARMQIALDSARGLEY 598
L L Y E L LV +Y G L + L R GK AR A + LEY
Sbjct: 62 FLPTL--YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALEY 118
Query: 599 IHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG------------------- 639
+H ++RD+KP NIL+ ++ ++DF L+K ++V
Sbjct: 119 LHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 640 ------SASVHTR---LVGTFGYMPPEY-AQYGEVSPKIDVYAFGVVLYELI 681
S R VGT Y+ PE + G +D + G++LYE++
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 49/218 (22%)
Query: 498 IGQGGFGAVFYAELR--GEKAAIKKM---DMQASKEFLAELKVLTHVHHLNLVRL----- 547
+G G G VF A ++ A+KK+ D Q+ K L E+K++ + H N+V++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 548 ---------IGYCVE-GSLFLVYEYIENG---NLNQHLRGSGKDTLTWSARMQIALDSAR 594
+G E S+++V EY+E L Q L R
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL-------FMYQLLR 125
Query: 595 GLEYIHEHTVPVYIHRDIKPANILID-KNFRAKVADFGLAKLTEVGSASVH----TRLVG 649
GL+YIH V +HRD+KPAN+ I+ ++ K+ DFGLA++ V H + +
Sbjct: 126 GLKYIHSANV---LHRDLKPANVFINTEDLVLKIGDFGLARI--VDPHYSHKGYLSEGLV 180
Query: 650 TFGYMPPEYAQYGEVSPK-----IDVYAFGVVLYELIS 682
T Y P +SP ID++A G + E+++
Sbjct: 181 TKWYRSPRLL----LSPNNYTKAIDMWAAGCIFAEMLT 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 69/269 (25%), Positives = 104/269 (38%), Gaps = 89/269 (33%)
Query: 494 MGNKIGQGGFGAVFYAELRG-------EKAAIKKMDMQAS----KEFLAELKVLTHV-HH 541
+G +G+G FG V A G A+K + A+ K + ELK+L H+ HH
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHH 70
Query: 542 LNLVRLIG--------------YCVEGSL----------FLVYE---------------- 561
LN+V L+G YC G+L F Y
Sbjct: 71 LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKK 130
Query: 562 ----------------YIENGNLNQHLRGS-----GKDTLTWSARMQIALDSARGLEYIH 600
+IE+ +L+ K+ LT + + ARG+E++
Sbjct: 131 QRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLA 190
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK-------LTEVGSASVHTRLVGTFGY 653
IHRD+ NIL+ +N K+ DFGLA+ G A RL +
Sbjct: 191 SRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA----RL--PLKW 241
Query: 654 MPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
M PE + + DV++FGV+L+E+ S
Sbjct: 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 85/368 (23%), Positives = 138/368 (37%), Gaps = 117/368 (31%)
Query: 479 EFSYEELAKATNDFSMGNKIGQGGFGAVFYAELRG-------EKAAIKKMDMQAS----K 527
EF + L +G +G G FG V A G A+K + A+ K
Sbjct: 3 EFPRDRL-------RLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHK 55
Query: 528 EFLAELKVLTHV-HHLNLVRLIG--------------YCVEGSL----------FLVY-- 560
++ELK+L H+ +HLN+V L+G +C G+L F Y
Sbjct: 56 ALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYRE 115
Query: 561 ----------EYIENGNLNQHLRGSGKDTL--------------------TWSARMQI-- 588
+E +++ + L W + + +
Sbjct: 116 KSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMED 175
Query: 589 ----ALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK-------LTE 637
+ ARG+E++ IHRD+ NIL+ +N K+ DFGLA+
Sbjct: 176 LICYSFQVARGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 232
Query: 638 VGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITES 697
GSA + + +M PE + + DV++FGV+L+E+ S + A I E
Sbjct: 233 KGSARLPLK------WMAPESIFDKVYTTQSDVWSFGVLLWEIFS-LGASPYPGVQINEE 285
Query: 698 TGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRA 757
F + L+ D R+ P + + R+ AC Q +P+ RP+ A
Sbjct: 286 ------FCQRLK------DGTRMRAP----ENATPEIY---RIMLACWQGDPKERPTFSA 326
Query: 758 IVVALMTL 765
+V L L
Sbjct: 327 LVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 78/293 (26%), Positives = 127/293 (43%), Gaps = 68/293 (23%)
Query: 498 IGQGGFGAVF--YAELRGEKAAIKKMD--MQASKEFLAELKVLTHVH-HLNLVRLIGYCV 552
IG+G +G VF + G KAA+K +D +E AE +L + H N+V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 553 E------GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQ------IALDSARGLEYIH 600
+ L+LV E G++ ++G L RM+ I ++ GL+++H
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVKG----FLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGL-AKLTEVGSASVHTRL-----VGTFGYM 654
+ IHRD+K NIL+ K+ DFG+ A+LT TRL VGT +M
Sbjct: 142 VNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTS-------TRLRRNTSVGTPFWM 191
Query: 655 PPEY--------AQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEE 706
PE + Y + DV++ G+ EL + + + + ALF +
Sbjct: 192 APEVIACEQQLDSTYDA---RCDVWSLGITAIELGDG-------DPPLADLHPMRALF-K 240
Query: 707 VLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIV 759
+ R P P L P L + D +RK C ++ + RP++ ++
Sbjct: 241 IPRNPPP-----TLHQPELWSNEFNDFIRK-------CLTKDYEKRPTVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 81/342 (23%), Positives = 143/342 (41%), Gaps = 74/342 (21%)
Query: 491 DFSMGNKIGQGGFGAVF-------------YAELRGEKAAIKKMDMQASKEFLAELKVLT 537
+F + +G G +G VF YA +KAA+ + + + E VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKA-KTVEHTRTERNVLE 59
Query: 538 HVHHLNLVRLIGYC--VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARG 595
HV + + Y E L L+ +Y+ G + HL +D + + +
Sbjct: 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHL--YQRDNFSEDEVRFYSGEIILA 117
Query: 596 LEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK--LTEVGSASVHTRLVGTFGY 653
LE++H+ + ++RDIK NIL+D + DFGL+K L+E + GT Y
Sbjct: 118 LEHLHKLGI---VYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY--SFCGTIEY 172
Query: 654 MPPEYAQ----YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLR 709
M PE + +G+ +D ++ G++++EL++ E T+S + +L+
Sbjct: 173 MAPEIIRGKGGHGKA---VDWWSLGILIFELLTGASPFTLEGERNTQS----EVSRRILK 225
Query: 710 ---------QPDPREDLQRLV--DP--RLG---------DDYPIDSVRKMARLARACTQE 747
P+ ++ L +L+ DP RLG ++P + + A A +
Sbjct: 226 CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF--FKGLDWEALALRKV 283
Query: 748 NPQLRPSMRAIVVALMTLSSSSEDWDIGSFYEN-QGLDSLMS 788
NP RPS+R + D+G+F E L+ + S
Sbjct: 284 NPPFRPSIR-------------NELDVGNFAEEFTNLEPVYS 312
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 37/219 (16%)
Query: 485 LAKATNDFSMGNKIGQGGFG-----------AVFYAELRGEKAAIKKMDMQASKEFLAEL 533
L D+ + IG+G FG V+ +L + IK+ D S F E
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSD---SAFFWEER 94
Query: 534 KVLTHVHHLNLVRLIGYCV---EGSLFLVYEYIENG---NLNQHLRGSGKDTLTWSARMQ 587
++ + +V+L +C + L++V EY+ G NL + K ++A +
Sbjct: 95 DIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVV 152
Query: 588 IALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLA-KLTEVGSASVHTR 646
+ALD+ IH + IHRD+KP N+L+DK+ K+ADFG K+ E G T
Sbjct: 153 LALDA------IHSMGL---IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA 203
Query: 647 LVGTFGYMPPEYAQY----GEVSPKIDVYAFGVVLYELI 681
VGT Y+ PE + G + D ++ GV L+E++
Sbjct: 204 -VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 51/200 (25%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 498 IGQGGFGAVFYAELRGEK----AAIKKMDMQASKEFLAELKVLTHV-----HHLNLVRLI 548
IG+G + V L+ + + K ++ E + ++ HV +H LV L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 549 G-YCVEGSLFLVYEYIENGNLNQHLRGSGK----DTLTWSARMQIALDSARGLEYIHEHT 603
+ E LF V EY+ G+L H++ K +SA + +AL+ Y+HE
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN------YLHERG 116
Query: 604 VPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGE 663
+ I+RD+K N+L+D K+ D+G+ K + + GT Y+ PE + +
Sbjct: 117 I---IYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 664 VSPKIDVYAFGVVLYELISA 683
+D +A GV+++E+++
Sbjct: 173 YGFSVDWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 35/109 (32%), Positives = 53/109 (48%), Gaps = 30/109 (27%)
Query: 587 QIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFG--------LAKLTEV 638
+IA+ + LEY+H + V IHRD+KP+N+LI++N + K+ DFG +AK +
Sbjct: 107 KIAVSIVKALEYLHS-KLSV-IHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA 164
Query: 639 GSASVHTRLVGTFGYMPPE-------YAQYGEVSPKIDVYAFGVVLYEL 680
G YM PE Y K DV++ G+ + EL
Sbjct: 165 GCKP----------YMAPERINPELNQKGY---DVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 59/233 (25%), Positives = 109/233 (46%), Gaps = 29/233 (12%)
Query: 498 IGQGGFGAVFYAELRGEKA--AIK--KMDMQASKEFLAELKVLTHV-----HHLNLVRLI 548
IG+G + V EL+ + A+K K ++ E + ++ HV +H LV L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 549 G-YCVEGSLFLVYEYIENGNLNQHLRGSGK----DTLTWSARMQIALDSARGLEYIHEHT 603
+ E LF V E++ G+L H++ K +SA + +AL+ ++HE
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN------FLHERG 116
Query: 604 VPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGE 663
+ I+RD+K N+L+D K+ D+G+ K + + GT Y+ PE + +
Sbjct: 117 I---IYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 664 VSPKIDVYAFGVVLYELI---SAMEAVVKTN--ETITESTGLVALFEEVLRQP 711
+D +A GV+++E++ S + V ++ + TE + E+ +R P
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP 225
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 34/215 (15%)
Query: 495 GNKIGQGGFGAVFYAELRGEKA----AIKKMD-----MQASKEFLAELKVLTHVHHLNLV 545
G K+G+G +G V+ A+ + K A+K+++ M A +E +A L+ L H + ++L
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACRE-IALLRELKHPNVISLQ 64
Query: 546 RLIGYCVEGSLFLVYEYIENG--NLNQHLRGSGKDT--------LTWSARMQIALDSARG 595
++ + ++L+++Y E+ ++ + R S + + S QI LD G
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI-LD---G 120
Query: 596 LEYIHEHTVPVYIHRDIKPANILI----DKNFRAKVADFGLAKL--TEVGSASVHTRLVG 649
+ Y+H + V +HRD+KPANIL+ + R K+AD G A+L + + + +V
Sbjct: 121 IHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 650 TFGYMPPEYAQYGEVSPK-IDVYAFGVVLYELISA 683
TF Y PE K ID++A G + EL+++
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 61/234 (26%), Positives = 99/234 (42%), Gaps = 48/234 (20%)
Query: 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIK---KMDMQASKE---FLAELKVLTHVHHL 542
DF IG+G FG V + + G A+K K DM ++ AE +L L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 543 NLVRLI-GYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE 601
+V++ + + +L+L+ E++ G++ L KDTLT ++ ++ IH+
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQ 119
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGL------AKLTEVGSASVHT---------- 645
+IHRDIKP N+L+D K++DFGL A TE H+
Sbjct: 120 LG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 646 ------------------RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELI 681
VGT Y+ PE + D ++ GV++YE++
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 49/212 (23%)
Query: 498 IGQGGFGAV---FYAELRGEKAAIKKM----DMQASKEFLAELKVLTHVHHL-NLVRLIG 549
IG+G FG V + G A+K++ D + K L +L V+ +V+ G
Sbjct: 12 IGRGAFGTVNKMLHKPS-GTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 550 ---------YCVE---GSLFLVYEYI---ENGNLNQHLRGSGKDTLTWSARMQIALDSAR 594
C+E SL Y+Y+ + + + G +IA+ + +
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILG------------KIAVATVK 118
Query: 595 GLEYI-HEHTVPVYIHRDIKPANILIDKNFRAKVADFGLA-KLTEVGSASV-HTRLVGTF 651
L Y+ E + IHRD+KP+NIL+D+N K+ DFG++ +L + S+ TR G
Sbjct: 119 ALNYLKEELKI---IHRDVKPSNILLDRNGNIKLCDFGISGQLVD----SIAKTRDAGCR 171
Query: 652 GYMPPEYAQYGEVSP---KIDVYAFGVVLYEL 680
YM PE + DV++ G+ LYE+
Sbjct: 172 PYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 46/209 (22%)
Query: 498 IGQGGFGAVF--YAELRGEKAAIKKMD------MQASKEFLAELKVLTHVHHLNLVRLIG 549
IG G G V Y + G+ AIKK+ A + + EL ++ V+H N++ L+
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY-RELVLMKLVNHKNIIGLLN 82
Query: 550 -YCVEGSL------FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSAR-------- 594
+ + SL +LV E ++ NL Q +Q+ LD R
Sbjct: 83 VFTPQKSLEEFQDVYLVMELMD-ANLCQ--------------VIQMDLDHERMSYLLYQM 127
Query: 595 --GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFG 652
G++++H + IHRD+KP+NI++ + K+ DFGLA+ G++ + T V T
Sbjct: 128 LCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY 182
Query: 653 YMPPEYAQYGEVSPKIDVYAFGVVLYELI 681
Y PE +D+++ G ++ E+I
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 40/212 (18%)
Query: 497 KIGQGGFGAVFYAEL----RGEKAAIKKMDMQAS----KEFLAELKVLTHVHHLNLVRLI 548
+IG G FG V +E+ + +K++ AS EFL + + H N+++ +
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 549 GYCVEG-SLFLVYEYIENGNLNQHLRGS----GKDTLTWSARMQIALDSARGLEYIHEHT 603
G CVE LV+EY E G+L +L L RM A + A G+ ++H+H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIAAGVTHMHKHN 119
Query: 604 VPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT-------------RLVGT 650
++H D+ N + + KV D+G+ + + T LVG
Sbjct: 120 ---FLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPELVGE 175
Query: 651 F--GYMPPEYAQYGEVSPKIDVYAFGVVLYEL 680
F G + E + +V+A GV L+EL
Sbjct: 176 FHGGLITAEQTKPS------NVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 58/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 495 GNKIGQGGFGAVFYAELRGEKA----AIKKMD-----MQASKEFLAELKVLTHVHHLNLV 545
G K+G+G +G V+ A+ + K A+K+++ M A +E +A L+ L H + + L
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACRE-IALLRELKHPNVIALQ 64
Query: 546 RLIGYCVEGSLFLVYEYIENG--NLNQHLRGSGKDT----LTWSARMQIALDSARGLEYI 599
++ + ++L+++Y E+ ++ + R S + L S + G+ Y+
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 600 HEHTVPVYIHRDIKPANILI----DKNFRAKVADFGLAKL--TEVGSASVHTRLVGTFGY 653
H + V +HRD+KPANIL+ + R K+AD G A+L + + + +V TF Y
Sbjct: 125 HANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 654 MPPEYAQYGEVSPK-IDVYAFGVVLYELISA 683
PE K ID++A G + EL+++
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTS 212
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 62/246 (25%), Positives = 106/246 (43%), Gaps = 47/246 (19%)
Query: 526 SKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSAR 585
S F +++ + H +LV+L G CV +V EY++ G L+ L K+ ++ +
Sbjct: 45 SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEEYVKFGPLDVFLH-REKNNVSLHWK 103
Query: 586 MQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGL-------AKLTEV 638
+ +A A L Y+ + + +H ++ NIL VA +GL KL++
Sbjct: 104 LDVAKQLASALHYLEDKKL---VHGNVCGKNIL--------VARYGLNEGYVPFIKLSDP 152
Query: 639 G-SASVHTR--LVGTFGYMPPEYAQYGEVSPKI--DVYAFGVVLYELISAMEAVVKTNET 693
G +V +R V ++ PE + G+ S I D ++FG L E+ S E + T
Sbjct: 153 GIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST--- 209
Query: 694 ITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRP 753
++ E+ +D RL P+ ++A L C +P RP
Sbjct: 210 -------LSSSEKERFY----QDQHRL---------PMPDCAELANLINQCWTYDPTKRP 249
Query: 754 SMRAIV 759
S RAI+
Sbjct: 250 SFRAIL 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 5e-09
Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 32/164 (19%)
Query: 491 DFSMGNKIGQGGFGAVFYAELRGEK-----AAIKKMDM---------QASKEFLAELKVL 536
+F + I +G FG V+ + +KK DM QA ++ LA K
Sbjct: 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSP 64
Query: 537 THVHHLNLVRLIGYCVEGS--LFLVYEYIENGNLNQ--HLRGSGKDTLTWSARMQIALDS 592
VH + Y ++ + ++LV EY+ G++ H+ G + + A I+ +
Sbjct: 65 FIVH-------LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEM---AVKYIS-EV 113
Query: 593 ARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636
A L+Y+H H + IHRD+KP N+LI K+ DFGL+K+T
Sbjct: 114 ALALDYLHRHGI---IHRDLKPDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-09
Identities = 64/239 (26%), Positives = 95/239 (39%), Gaps = 64/239 (26%)
Query: 498 IGQGGFGAV----------FYAELRGEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRL 547
IG G FG V YA KA + + A + AE +L + +V+L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVK--AERDILAEADNEWVVKL 66
Query: 548 I-GYCVEGSLFLVYEYIENGNLNQHL--RGSGKDTLTWSARMQIALDSARGLEYIHEHTV 604
+ + +L+ V +YI G++ L G ++ L AR IA + +E +H+
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL---ARFYIA-ELTCAIESVHKMG- 121
Query: 605 PVYIHRDIKPANILIDKNFRAKVADFGLA------------------------------- 633
+IHRDIKP NILID++ K+ DFGL
Sbjct: 122 --FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 634 ------KLTEVGSASVHTR-----LVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELI 681
K E H R LVGT Y+ PE + D ++ GV+LYE++
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 7e-09
Identities = 51/221 (23%), Positives = 95/221 (42%), Gaps = 31/221 (14%)
Query: 475 DKSVEFSYEELAKATNDFSMGNKIGQ----GGFGAVFYAELRGE-KAAIKKMDMQASKEF 529
D + + ++ + G + + G G VF A G+ + K+ + +
Sbjct: 49 DDGLIPTKQKAREVVASL--GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTT-- 104
Query: 530 LAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIA 589
L E +L +V+H +++R+ V G++ + + H LT +R +
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCM--------VLPHYSSDLYTYLTKRSR-PLP 155
Query: 590 LDSA--------RGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641
+D A GL Y+H + IHRD+K NI I+ + + D G A+ V A
Sbjct: 156 IDQALIIEKQILEGLRYLHAQRI---IHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA 212
Query: 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
+ L GT PE + + K D+++ G+VL+E+++
Sbjct: 213 FLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 14/106 (13%)
Query: 494 MGNKIGQGGFGAVFYAELRG-------EKAAIKKMDMQAS----KEFLAELKVLTHV-HH 541
+G +G+G FG V A+ G A+K + A+ + ++ELK+L H+ HH
Sbjct: 11 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 70
Query: 542 LNLVRLIGYCVE--GSLFLVYEYIENGNLNQHLRGSGKDTLTWSAR 585
LN+V L+G C + G L ++ E+ + GNL+ +LR + + + +
Sbjct: 71 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTK 116
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 37/161 (22%), Positives = 78/161 (48%), Gaps = 21/161 (13%)
Query: 532 ELKVLTHVHHLNLVRLIGYCVEGS-----LFLVYEYIENGNLNQHLRGSGKDTLTWSARM 586
E+K L + N++++ G+ ++ L L+ EY G L + L KD L++ ++
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-KD-LSFKTKL 125
Query: 587 QIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR 646
+A+D +GL ++++T Y + + + L+ +N++ K+ GL K+ +
Sbjct: 126 DMAIDCCKGLYNLYKYTNKPYKN--LTSVSFLVTENYKLKIICHGLEKILSSPP----FK 179
Query: 647 LVGTFGYMPPE-----YAQYGEVSPKIDVYAFGVVLYELIS 682
V Y + +++Y D+Y+ GVVL+E+ +
Sbjct: 180 NVNFMVYFSYKMLNDIFSEYTIKD---DIYSLGVVLWEIFT 217
|
Length = 283 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 60/235 (25%), Positives = 99/235 (42%), Gaps = 48/235 (20%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIK---KMDMQASKEFL---AELKVLTHVHH 541
+DF IG+G FG V + + G A+K K DM ++ AE +L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 542 LNLVRLI-GYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH 600
+V++ + + +L+L+ E++ G++ L KDTL+ A ++ ++ IH
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIH 118
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGL------AKLTEVGSASVHT--------- 645
+ +IHRDIKP N+L+D K++DFGL A TE H
Sbjct: 119 QLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 646 -------------------RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELI 681
VGT Y+ PE + D ++ GV++YE++
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 43/147 (29%), Positives = 67/147 (45%), Gaps = 18/147 (12%)
Query: 543 NLVRLIGYCV-EGSLFLVYEYIENGNLNQH----LRGSGKDTLTWSARMQIALDSARGLE 597
N+V L Y V E S+FLV ++ E G L H L + W+A M +ALD+
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 598 YIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE 657
+H + + RD+ P NIL+D ++ F + +EV S V Y PE
Sbjct: 101 -LHREGI---VCRDLNPNNILLDDRGHIQLTYFS--RWSEV-EDSCDGEAVENM-YCAPE 152
Query: 658 YAQYGEVSPKIDVYAFGVVLYELISAM 684
E + D ++ G +L+EL++
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 60/241 (24%), Positives = 104/241 (43%), Gaps = 43/241 (17%)
Query: 529 FLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLNQHLRGS-GKDTLTWSARM 586
F +++ V H++L + G CV GS +V E++E+G L+ LR G+ + W ++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 587 QIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRA-------KVADFGLAKLTEVG 639
+A A L Y+ + + +H ++ NIL+ + A K++D G++
Sbjct: 121 TVAQQLASALSYLEDKNL---VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS----FT 173
Query: 640 SASVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITEST 698
+ S R V ++ PE G +S D ++FG L E+ E +K T +E
Sbjct: 174 ALSREER-VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK-ERTPSEKE 231
Query: 699 GLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
+E+ R P+P S +++A L C P RPS R I
Sbjct: 232 ---RFYEKKHRLPEP-------------------SCKELATLISQCLTYEPTQRPSFRTI 269
Query: 759 V 759
+
Sbjct: 270 L 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 44/167 (26%), Positives = 73/167 (43%), Gaps = 26/167 (15%)
Query: 594 RGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGY 653
R ++Y+HE+ + IHRDIK NI I+ + DFG A +A+ + GT
Sbjct: 193 RAIQYLHENRI---IHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249
Query: 654 MPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713
PE P +D+++ G+VL+E+ +T +LFE+ D
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEM----------------ATCHDSLFEKDGLDGDC 293
Query: 714 REDLQ-RLVDPRLG---DDYPIDSVRKMARL-ARAC--TQENPQLRP 753
D Q +L+ R G +++PID+ + + + P RP
Sbjct: 294 DSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRP 340
|
Length = 391 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 44/208 (21%)
Query: 498 IGQGGFGAV--FYAELRGEKAAIKKM-----DMQASKEFLAELKVLTHVHHLNLVRLIG- 549
IG G G V Y + AIKK+ + +K EL ++ V+H N++ L+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 550 YCVEGSL------FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSAR--------- 594
+ + SL +LV E ++ NL Q +Q+ LD R
Sbjct: 85 FTPQKSLEEFQDVYLVMELMD-ANLCQ--------------VIQMELDHERMSYLLYQML 129
Query: 595 -GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGY 653
G++++H + IHRD+KP+NI++ + K+ DFGLA+ G++ + T V T Y
Sbjct: 130 CGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 184
Query: 654 MPPEYAQYGEVSPKIDVYAFGVVLYELI 681
PE +D+++ G ++ E++
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 44/208 (21%)
Query: 498 IGQGGFGAVFYA--ELRGEKAAIKKM-----DMQASKEFLAELKVLTHVHHLNLVRLIG- 549
IG G G V A + G A+KK+ + +K EL +L V+H N++ L+
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 550 YCVEGSL------FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSAR--------- 594
+ + SL +LV E ++ NL Q + + LD R
Sbjct: 89 FTPQKSLEEFQDVYLVMELMD-ANLCQ--------------VIHMELDHERMSYLLYQML 133
Query: 595 -GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGY 653
G++++H + IHRD+KP+NI++ + K+ DFGLA+ + + T V T Y
Sbjct: 134 CGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYY 188
Query: 654 MPPEYAQYGEVSPKIDVYAFGVVLYELI 681
PE +D+++ G ++ EL+
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 65/247 (26%), Positives = 93/247 (37%), Gaps = 76/247 (30%)
Query: 498 IGQGGFGAVFYAELRGEKAAIKKMDMQASKEFL---------AELKVLTHVHHLNLVRLI 548
+G G FG V A + + A+ M K+ L AE +L + +VRL
Sbjct: 9 LGIGAFGEVCLAR-KVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLY 67
Query: 549 -GYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPV- 606
+ + +L+ V +YI G D ++ RM I + YI E T V
Sbjct: 68 YSFQDKDNLYFVMDYIPGG-----------DMMSLLIRMGIFPEDLARF-YIAELTCAVE 115
Query: 607 ------YIHRDIKPANILIDKNFRAKVADFGLA--------------------------- 633
+IHRDIKP NILID++ K+ DFGL
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175
Query: 634 --------------KLTEVGSASVHTR-----LVGTFGYMPPEYAQYGEVSPKIDVYAFG 674
K E +A H R LVGT Y+ PE + D ++ G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235
Query: 675 VVLYELI 681
V+LYE++
Sbjct: 236 VILYEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-07
Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 44/208 (21%)
Query: 498 IGQGGFGAV--FYAELRGEKAAIKKM-----DMQASKEFLAELKVLTHVHHLNLVRLIG- 549
IG G G V Y + AIKK+ + +K EL ++ V+H N++ L+
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 550 YCVEGSL------FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSAR--------- 594
+ + SL ++V E ++ NL Q +Q+ LD R
Sbjct: 92 FTPQKSLEEFQDVYIVMELMD-ANLCQ--------------VIQMELDHERMSYLLYQML 136
Query: 595 -GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGY 653
G++++H + IHRD+KP+NI++ + K+ DFGLA+ G++ + T V T Y
Sbjct: 137 CGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 654 MPPEYAQYGEVSPKIDVYAFGVVLYELI 681
PE +D+++ G ++ E+I
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 50/157 (31%), Positives = 73/157 (46%), Gaps = 22/157 (14%)
Query: 490 NDFSMGNKIGQGGFGAV----------FYAELRGEKAAIKKMDMQASKEFLAELKVLTHV 539
DF IG+G FG V YA K+ + K D A + AE VL
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVK--AERDVLAES 58
Query: 540 HHLNLVRLIGYCVEGS--LFLVYEYIENGNLNQHLRGSGKDTLTWS-ARMQIALDSARGL 596
+V L Y + + L+L+ E++ G+L L DT + R +A + +
Sbjct: 59 DSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTML--IKYDTFSEDVTRFYMA-ECVLAI 114
Query: 597 EYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLA 633
E +H+ +IHRDIKP NILID+ K++DFGL+
Sbjct: 115 EAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 29/143 (20%), Positives = 55/143 (38%), Gaps = 13/143 (9%)
Query: 497 KIGQGGFGAVFYAELRGEKAAIKKMD-MQASKEFLAELKVLTHVHHLNLV--RLIGYC-V 552
+ G V+ + E +K + + E+ +L + L +++
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGES 64
Query: 553 EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDI 612
+G +L+ E+IE G D ++ + IA A L +H+ + V H D+
Sbjct: 65 DGWSYLLMEWIE---------GETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDL 115
Query: 613 KPANILIDKNFRAKVADFGLAKL 635
P NIL+D + D+ A
Sbjct: 116 HPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 28/86 (32%), Positives = 40/86 (46%), Gaps = 4/86 (4%)
Query: 596 LEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLA-KLTEVGSASVHTRLVGTFGYM 654
L Y+H + IHRD+K NI +D+ A + DFG A KL GT
Sbjct: 198 LAYLHGRGI---IHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETN 254
Query: 655 PPEYAQYGEVSPKIDVYAFGVVLYEL 680
PE K D+++ G+VL+E+
Sbjct: 255 SPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 38/135 (28%), Positives = 58/135 (42%), Gaps = 15/135 (11%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRG-------EKAAIKKMDMQASKE----FLAELKVLTH 538
++ G +G G FG V A G + A+K + A + ++ELK+L+H
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 539 V-HHLNLVRLIGYCVEGSLFLVY-EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGL 596
+ H N+V L+G C G LV EY G+L LR + L + M + S
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFV--MALPEISETSS 155
Query: 597 EYIHEHTVPVYIHRD 611
+Y + YI D
Sbjct: 156 DYKNITLEKKYIRSD 170
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 8e-06
Identities = 60/289 (20%), Positives = 101/289 (34%), Gaps = 44/289 (15%)
Query: 499 GQGGFGAVFYAELRGEKAAIKKMDMQ-ASKEFL----AELKVLTHVHHLN-LVRLIGYCV 552
+ + A+KK+++ SKE L E+ + H N L + + V
Sbjct: 11 EDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV 70
Query: 553 EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDI 612
+ L++V + G+ L+ + L A I D L+YIH +IHR +
Sbjct: 71 DSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSV 127
Query: 613 KPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFG--------YMPPEYAQ---- 660
K ++IL+ + + ++ GL + R+V F ++ PE Q
Sbjct: 128 KASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQ 185
Query: 661 -YGEVSPKIDVYAFGVVLYELISAMEAVVKTNET--ITES-TGLV-------ALFEEVLR 709
Y E K D+Y+ G+ EL + T + E G V
Sbjct: 186 GYNE---KSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS 242
Query: 710 QPDPREDLQRLVDPRLGDDYPIDSVRKMA----RLARACTQENPQLRPS 754
R + P D R + + C Q +P+ RPS
Sbjct: 243 MSQSRSSNE---HPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS 288
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 22/46 (47%), Positives = 28/46 (60%), Gaps = 3/46 (6%)
Query: 588 IALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLA 633
I D LEYIHEH + H DIKP NI++D N R + D+G+A
Sbjct: 131 IMKDMLTTLEYIHEHGIS---HGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 13/92 (14%)
Query: 494 MGNKIGQGGFGAVFYAELRG-------EKAAIKKMDMQA----SKEFLAELKVLTHVH-H 541
+G +G G FG V A G K A+K + A + ++ELK+++H+ H
Sbjct: 41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPH 100
Query: 542 LNLVRLIGYCVE-GSLFLVYEYIENGNLNQHL 572
LN+V L+G C + G ++++ EY G+L +L
Sbjct: 101 LNIVNLLGACTKGGPIYIITEYCRYGDLVDYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 32/126 (25%), Positives = 59/126 (46%), Gaps = 8/126 (6%)
Query: 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI 619
Y+ + + L G + LT + ARG+E++ +HRD+ N+L+
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNC---VHRDLAARNVLL 270
Query: 620 DKNFRAKVADFGLAKLTEVGSASVHTRLVGTF---GYMPPEYAQYGEVSPKIDVYAFGVV 676
+ K+ DFGLA+ ++ S + TF +M PE + DV+++G++
Sbjct: 271 AQGKIVKICDFGLAR--DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGIL 328
Query: 677 LYELIS 682
L+E+ S
Sbjct: 329 LWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 68/272 (25%), Positives = 104/272 (38%), Gaps = 68/272 (25%)
Query: 498 IGQGGFGAVFYAELRGEKAAIKKMDMQASKEFL---------AELKVLTHVHHLNLVRLI 548
+G G FG V A + + A+ M K+ L AE +L + +V+L
Sbjct: 9 LGIGAFGEVCLA-CKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLY 67
Query: 549 -GYCVEGSLFLVYEYIENGNLNQHL--RGSGKDTLTWSARMQIALDSARGLEYIHEHTVP 605
+ + +L+ V +YI G++ L + L AR IA + +E +H+
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL---ARFYIA-ELTLAIESVHKMG-- 121
Query: 606 VYIHRDIKPANILIDKNFRAKVADFGLA-------------------------------- 633
+IHRDIKP NILID + K+ DFGL
Sbjct: 122 -FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 634 ---------KLTEVGSASVHTR-----LVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYE 679
K E + H R LVGT Y+ PE + D ++ GV+L+E
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240
Query: 680 LISAMEAVVKTNETITESTGLVALFEEVLRQP 711
++ + T TE+ V +E L P
Sbjct: 241 MLVGQPPFLAP--TPTETQLKVINWENTLHIP 270
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 28/86 (32%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 596 LEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS--VHTRLVGTFGY 653
++YIH + IHRDIK N+L++ + DFG A GS S H + GT
Sbjct: 273 IDYIHGEGI---IHRDIKTENVLVNGPEDICLGDFGAACFAR-GSWSTPFHYGIAGTVDT 328
Query: 654 MPPEYAQYGEVSPKIDVYAFGVVLYE 679
PE +P +D+++ G+V++E
Sbjct: 329 NAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 13/92 (14%)
Query: 494 MGNKIGQGGFGAVF----YAELRGE---KAAIKKMDMQA----SKEFLAELKVLTHV-HH 541
+G +G G FG V Y R + K A+K + A + ++ELK++TH+ H
Sbjct: 41 LGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPH 100
Query: 542 LNLVRLIGYCVE-GSLFLVYEYIENGNLNQHL 572
LN+V L+G C + G ++++ EY G+L +L
Sbjct: 101 LNIVNLLGACTKSGPIYIITEYCFYGDLVNYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 28/100 (28%), Positives = 52/100 (52%), Gaps = 8/100 (8%)
Query: 586 MQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV-- 643
++ + A+G++++ IHRD+ N+L+ AK+ DFGLA+ S V
Sbjct: 215 LRFSSQVAQGMDFLASKNC---IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271
Query: 644 -HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
+ RL +M PE + + DV+++G++L+E+ S
Sbjct: 272 GNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 34/97 (35%), Positives = 49/97 (50%), Gaps = 13/97 (13%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRG-------EKAAIKKMDMQA---SKEFL-AELKVLTH 538
N S G +G G FG V A G A+K + A +E L +ELKVL++
Sbjct: 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 94
Query: 539 V-HHLNLVRLIGYC-VEGSLFLVYEYIENGNLNQHLR 573
+ +H+N+V L+G C V G ++ EY G+L LR
Sbjct: 95 LGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLR 131
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 9e-04
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 593 ARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV---HTRLVG 649
A+G+ ++ IHRD+ NIL+ K+ DFGLA+ S V + RL
Sbjct: 224 AKGMSFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL-- 278
Query: 650 TFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
+M PE + + DV+++G++L+E+ S
Sbjct: 279 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 28/106 (26%), Positives = 53/106 (50%), Gaps = 8/106 (7%)
Query: 580 LTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639
L++ + + A G+E++ +HRD+ N+LI + K+ DFGLA+ ++
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNC---VHRDLAARNVLICEGKLVKICDFGLAR--DIM 290
Query: 640 SASVHTRLVGTF---GYMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
S + TF +M PE + DV++FG++L+E+ +
Sbjct: 291 RDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|131945 TIGR02899, spore_safA, spore coat assembly protein SafA | Back alignment and domain information |
|---|
Score = 36.3 bits (84), Expect = 0.002
Identities = 13/42 (30%), Positives = 22/42 (52%)
Query: 230 KGANLTFISKVFDTSIKYILSFNPQITNKDKILAGTRINVPF 271
KG L I+K + ++ NPQ++N + I G +I +P
Sbjct: 3 KGDTLWKIAKKYGVDFDELIQANPQLSNPNLIYPGMKIKIPS 44
|
SafA (YrbB) (SafA) of Bacillus subtilis is a protein found at the interface of the spore cortex and spore coat, and is dependent on SpoVID for its localization. This model is based on the N-terminal LysM (lysin motif) domain (see pfam01476) of SafA and, from several other spore-forming species, the protein with the most similar N-terminal region. However, this set of proteins differs greatly in C-terminal of the LysM domaim; blocks of 12-residue and 13-residue repeats are found in the Bacillus cereus group, tandem LysM domains in Thermoanaerobacter tengcongensis MB4, etc. in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins [Cellular processes, Sporulation and germination]. Length = 44 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.004
Identities = 35/130 (26%), Positives = 59/130 (45%), Gaps = 17/130 (13%)
Query: 557 FLVYEYIENGNLNQHLRGSGKDT-LTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPA 615
F +Y ++ + + KD L R I +EYIH+ + IHRDIK
Sbjct: 247 FDLYSFMYDEAFDW------KDRPLLKQTR-AIMKQLLCAVEYIHDKKL---IHRDIKLE 296
Query: 616 NILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQ---YGEVSPKIDVYA 672
NI ++ + + + DFG A E + VGT PE Y E++ D+++
Sbjct: 297 NIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEIT---DIWS 353
Query: 673 FGVVLYELIS 682
G++L +++S
Sbjct: 354 CGLILLDMLS 363
|
Length = 501 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 790 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| PRK06347 | 592 | autolysin; Reviewed | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| PRK06347 | 592 | autolysin; Reviewed | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK10783 | 456 | mltD membrane-bound lytic murein transglycosylase | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| PRK10783 | 456 | mltD membrane-bound lytic murein transglycosylase | 99.78 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.72 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.71 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.67 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.65 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.64 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.63 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.63 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.62 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.58 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.51 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.48 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.46 | |
| PRK13914 | 481 | invasion associated secreted endopeptidase; Provis | 99.42 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.38 | |
| PRK13914 | 481 | invasion associated secreted endopeptidase; Provis | 99.33 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.27 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.0 | |
| PF01476 | 44 | LysM: LysM domain; InterPro: IPR018392 This domain | 99.0 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.98 | |
| PF01476 | 44 | LysM: LysM domain; InterPro: IPR018392 This domain | 98.98 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.96 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.95 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.94 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.91 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.9 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.84 | |
| COG1388 | 124 | LytE FOG: LysM repeat [Cell envelope biogenesis, o | 98.83 | |
| COG1388 | 124 | LytE FOG: LysM repeat [Cell envelope biogenesis, o | 98.79 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.78 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.76 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.7 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.64 | |
| PRK14125 | 103 | cell division suppressor protein YneA; Provisional | 98.59 | |
| TIGR02899 | 44 | spore_safA spore coat assembly protein SafA. in wh | 98.59 | |
| PRK14125 | 103 | cell division suppressor protein YneA; Provisional | 98.54 | |
| TIGR02899 | 44 | spore_safA spore coat assembly protein SafA. in wh | 98.5 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.48 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.4 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.37 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.35 | |
| TIGR02907 | 338 | spore_VI_D stage VI sporulation protein D. SpoVID, | 98.25 | |
| COG3858 | 423 | Predicted glycosyl hydrolase [General function pre | 98.25 | |
| cd00118 | 46 | LysM Lysin domain, found in a variety of enzymes i | 98.24 | |
| cd00118 | 46 | LysM Lysin domain, found in a variety of enzymes i | 98.24 | |
| PRK10871 | 319 | nlpD lipoprotein NlpD; Provisional | 98.18 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.12 | |
| PRK10871 | 319 | nlpD lipoprotein NlpD; Provisional | 98.11 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.1 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.1 | |
| COG3858 | 423 | Predicted glycosyl hydrolase [General function pre | 98.09 | |
| TIGR02907 | 338 | spore_VI_D stage VI sporulation protein D. SpoVID, | 98.04 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.0 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.92 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.89 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.87 | |
| PRK11198 | 147 | LysM domain/BON superfamily protein; Provisional | 97.86 | |
| PRK11198 | 147 | LysM domain/BON superfamily protein; Provisional | 97.84 | |
| smart00257 | 44 | LysM Lysin motif. | 97.79 | |
| smart00257 | 44 | LysM Lysin motif. | 97.78 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.73 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.73 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.72 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.71 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.58 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.58 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.47 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.43 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.35 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.33 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.23 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.23 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.0 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-51 Score=445.24 Aligned_cols=286 Identities=46% Similarity=0.809 Sum_probs=245.7
Q ss_pred cccccCHHHHHHHhcCcccceeeeecCceEEEEEEECC-ceEEEEEeChhh---HHHHHHHHHHHHhcCCCCCcceEEEE
Q 046083 476 KSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELRG-EKAAIKKMDMQA---SKEFLAELKVLTHVHHLNLVRLIGYC 551 (790)
Q Consensus 476 ~~~~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~g-~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~ 551 (790)
....|++.++..+|++|...+.||+|+||.||+|.+.+ ..+|||++.... .++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 34579999999999999999999999999999999985 899999987543 56799999999999999999999999
Q ss_pred ecCe--EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEE
Q 046083 552 VEGS--LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVAD 629 (790)
Q Consensus 552 ~~~~--~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~D 629 (790)
.+.+ .+||||||++|+|.++|+.....+++|..|++|+.++|+||+|||+...|+||||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 8653 89999999999999999986533789999999999999999999999988999999999999999999999999
Q ss_pred eCCCcccccCCccccccc-ccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHH
Q 046083 630 FGLAKLTEVGSASVHTRL-VGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVL 708 (790)
Q Consensus 630 fGla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 708 (790)
||+|+..... ....... .||.+|+|||+...+..+.|+|||||||+|+||+||+++...... .....+..|....+
T Consensus 221 FGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~--~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 221 FGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP--RGELSLVEWAKPLL 297 (361)
T ss_pred ccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC--cccccHHHHHHHHH
Confidence 9999765431 1111112 799999999999999999999999999999999999988865432 12233566665555
Q ss_pred cCCCChhhhhhhcCCcCC-CCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 709 RQPDPREDLQRLVDPRLG-DDYPI-DSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 709 ~~~~~~~~l~~~~d~~l~-~~~~~-~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
... .+.+++|+.+. ..++. ++..++..++.+|++.+|.+||+|.||++.|..+...
T Consensus 298 ~~~----~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 298 EEG----KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HCc----chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 443 78899999987 66664 6888999999999999999999999999999665543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=395.45 Aligned_cols=251 Identities=33% Similarity=0.553 Sum_probs=213.4
Q ss_pred ccceeeeecCceEEEEEEECCce-EEEEEeChhh-----HHHHHHHHHHHHhcCCCCCcceEEEEecCe--EEEEEEEec
Q 046083 493 SMGNKIGQGGFGAVFYAELRGEK-AAIKKMDMQA-----SKEFLAELKVLTHVHHLNLVRLIGYCVEGS--LFLVYEYIE 564 (790)
Q Consensus 493 ~~~~~lG~G~fg~Vy~a~~~g~~-vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~lv~e~~~ 564 (790)
.+.+.||+|+||+||+|.+.|.. +|||++.... .++|.+|+.+|.+++|||||+++|+|.+.. +++|||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 34566999999999999999988 9999997533 568999999999999999999999999764 899999999
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC-cEEEEEeCCCcccccCCccc
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF-RAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~-~~kl~DfGla~~~~~~~~~~ 643 (790)
+|+|.++++...+..+++..+++++.+||+||.|||+++. ||||||||+|||++.++ ++||+|||+++...... ..
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~ 200 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TS 200 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-cc
Confidence 9999999988545679999999999999999999999992 39999999999999998 99999999998765332 22
Q ss_pred ccccccCCCccchhccc--CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhc
Q 046083 644 HTRLVGTFGYMPPEYAQ--YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~--~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 721 (790)
.+...||+.|||||++. ...++.|+||||||++||||+||+.||..... ... ...++
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--------~~~-------------~~~v~ 259 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--------VQV-------------ASAVV 259 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--------HHH-------------HHHHH
Confidence 33468999999999999 56899999999999999999999999976432 111 11222
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 722 DPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 722 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
....+...+..++..+..++.+||+.||..||++.|++..|..+..
T Consensus 260 ~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 260 VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 2334445565677889999999999999999999999999998755
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=388.98 Aligned_cols=259 Identities=29% Similarity=0.512 Sum_probs=220.7
Q ss_pred cccCHHHHHHHhcCcccceeeeecCceEEEEEEECCc-eEEEEEeCh--hhHHHHHHHHHHHHhcCCCCCcceEEEEecC
Q 046083 478 VEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELRGE-KAAIKKMDM--QASKEFLAELKVLTHVHHLNLVRLIGYCVEG 554 (790)
Q Consensus 478 ~~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~g~-~vavK~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 554 (790)
..+..+++ .+.+.||+|.||.||.|.+++. .+|+|.++. ...++|.+|+++|++++|+|||+++|+|.++
T Consensus 201 wei~r~~l-------~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~ 273 (468)
T KOG0197|consen 201 WEIPREEL-------KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ 273 (468)
T ss_pred eeecHHHH-------HHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence 45555555 4578999999999999999966 999999975 3447899999999999999999999999975
Q ss_pred e-EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCC
Q 046083 555 S-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLA 633 (790)
Q Consensus 555 ~-~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla 633 (790)
+ +|||||||+.|+|.++|+...+..+...+.+.++.|||+|++||+++++ |||||.++||||+++..+||+|||||
T Consensus 274 ~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~---IHRDLAARNiLV~~~~~vKIsDFGLA 350 (468)
T KOG0197|consen 274 EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNY---IHRDLAARNILVDEDLVVKISDFGLA 350 (468)
T ss_pred CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCc---cchhhhhhheeeccCceEEEcccccc
Confidence 5 9999999999999999998666789999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCC
Q 046083 634 KLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPD 712 (790)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (790)
+..............-+..|.|||.+..+.++.|||||||||+||||+| |+.|+.....
T Consensus 351 r~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-------------------- 410 (468)
T KOG0197|consen 351 RLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-------------------- 410 (468)
T ss_pred cccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH--------------------
Confidence 9654433333334455789999999999999999999999999999998 6666543221
Q ss_pred ChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 713 PREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 713 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
..+-+.++...+-..|..++..+.+||..||+.+|++|||++.+...|..+...
T Consensus 411 --~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 411 --EEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred --HHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 233345555556667888999999999999999999999999999998877554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=367.18 Aligned_cols=255 Identities=26% Similarity=0.448 Sum_probs=214.1
Q ss_pred ccceeeeecCceEEEEEEEC--CceEEEEEe----ChhhHHHHHHHHHHHHhcCCCCCcceEEEEe-cC-eEEEEEEEec
Q 046083 493 SMGNKIGQGGFGAVFYAELR--GEKAAIKKM----DMQASKEFLAELKVLTHVHHLNLVRLIGYCV-EG-SLFLVYEYIE 564 (790)
Q Consensus 493 ~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~-~~~lv~e~~~ 564 (790)
+..+.||+|..|+||++.++ +..+|+|.+ +....+++.+|++++++.+||+||.+||.|. ++ +..++||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 44789999999999999987 788999999 3455678999999999999999999999776 55 4999999999
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE-HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
+|+|++++...+ .+++....+++.+|++||.|||+ +++ |||||||+|||++..|++||||||.+..+... .
T Consensus 162 gGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~~I---IHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~ 233 (364)
T KOG0581|consen 162 GGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEERKI---IHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---I 233 (364)
T ss_pred CCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhccCe---eeccCCHHHeeeccCCCEEeccccccHHhhhh---h
Confidence 999999998764 48999999999999999999996 776 99999999999999999999999999876533 4
Q ss_pred ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 644 HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
...++||..|||||.+++..|+.++||||||+.++|+.+|+.|+....+ ...+...+...+...+.+
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~---~~~~~~~Ll~~Iv~~ppP---------- 300 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP---PYLDIFELLCAIVDEPPP---------- 300 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC---CCCCHHHHHHHHhcCCCC----------
Confidence 4568899999999999999999999999999999999999999865421 123444555555543322
Q ss_pred cCCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccC
Q 046083 724 RLGDDYPID-SVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDW 772 (790)
Q Consensus 724 ~l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~ 772 (790)
..|.+ ...++..++..||++||.+||+++|++++-.-......+-
T Consensus 301 ----~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~v 346 (364)
T KOG0581|consen 301 ----RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNV 346 (364)
T ss_pred ----CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccccc
Confidence 22332 5678999999999999999999999999776554444433
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=391.61 Aligned_cols=257 Identities=32% Similarity=0.564 Sum_probs=214.6
Q ss_pred hcCcccceeeeecCceEEEEEEEC-------CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecCe-E
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEGS-L 556 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~ 556 (790)
+.+....+.||+|.||.||+|+.. ...||||.++.. ...+|++|++++..++|||||+|+|+|.+++ +
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 445667889999999999999864 346999999742 4578999999999999999999999999776 8
Q ss_pred EEEEEEecCCChhhhhhcCC--------CC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCc
Q 046083 557 FLVYEYIENGNLNQHLRGSG--------KD----TLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFR 624 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~--------~~----~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~ 624 (790)
++|+|||..|||.+||+... .+ +|+..+.+.|+.|||.|++||.++.. |||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~F---VHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHF---VHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcc---cccchhhhhceeccceE
Confidence 99999999999999998532 12 38999999999999999999999997 99999999999999999
Q ss_pred EEEEEeCCCcccccCCccccc-ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHH
Q 046083 625 AKVADFGLAKLTEVGSASVHT-RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVA 702 (790)
Q Consensus 625 ~kl~DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 702 (790)
+||+||||++.....+..... ...-..+||+||.++.++||++||||||||+|||++| |+.|+.....
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---------- 711 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---------- 711 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch----------
Confidence 999999999965433322222 3344779999999999999999999999999999998 7777654332
Q ss_pred HHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCc
Q 046083 703 LFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770 (790)
Q Consensus 703 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~ 770 (790)
.+.++.+-+..+ -..|++++.++.+||..||+.+|.+||+++||-..|+.....++
T Consensus 712 -----------~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 712 -----------QEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred -----------HHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 122333333344 56788999999999999999999999999999999998766554
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=355.52 Aligned_cols=196 Identities=30% Similarity=0.562 Sum_probs=176.0
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVY 560 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~ 560 (790)
..+|...+.||+|.||+||+|+.+ +..||||.+... ..+-+..|+.+|++++|||||.+++++..+ .+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 356888899999999999999986 889999998654 456688999999999999999999999854 589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC------CcEEEEEeCCCc
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN------FRAKVADFGLAK 634 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~------~~~kl~DfGla~ 634 (790)
|||.+|+|.+|++..+ .+++.....++.|++.||++||++++ |||||||+||||+.. -.+||+|||+|+
T Consensus 89 EyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~I---iHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNI---IHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999999875 59999999999999999999999998 999999999999765 468999999999
Q ss_pred ccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccc
Q 046083 635 LTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTN 691 (790)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~ 691 (790)
.+.. .......+|++-|||||+++..+|+.|+|+||+|+++|||++|+.||....
T Consensus 164 ~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 164 FLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 8763 334456899999999999999999999999999999999999999997543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=368.35 Aligned_cols=246 Identities=24% Similarity=0.448 Sum_probs=210.0
Q ss_pred cCcccceeeeecCceEEEEEEE-C-CceEEEEEeCh------hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAEL-R-GEKAAIKKMDM------QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~-~-g~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~ 560 (790)
.+|...+.||+|||+.||.++. . |+.+|+|++.. ...+...+|++|.++++|||||++++|+++. ..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688999999999999999998 3 99999999864 4557789999999999999999999999976 489999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
|+|.+++|..++.. +.++++.+++.+..||+.||.|||+++| +|||||..|+||+++.++||+|||||..+....
T Consensus 98 ELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~I---iHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLGI---IHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcCc---eecccchhheeecCcCcEEecccceeeeecCcc
Confidence 99999999999984 3479999999999999999999999998 999999999999999999999999999876432
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
+.....+|||.|.|||++.....+..+||||+||+||-||.|++||.... +......+...
T Consensus 173 -Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~--------vkety~~Ik~~---------- 233 (592)
T KOG0575|consen 173 -ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT--------VKETYNKIKLN---------- 233 (592)
T ss_pred -cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch--------HHHHHHHHHhc----------
Confidence 34556899999999999999999999999999999999999999996532 21222222111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
. -.+|.....+..+||.++|+.||.+|||+++|+.+=..
T Consensus 234 ---~--Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 234 ---E--YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred ---C--cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 1 12244566678899999999999999999999986543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=350.13 Aligned_cols=263 Identities=25% Similarity=0.431 Sum_probs=214.6
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEe-cCeEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLV 559 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~lv 559 (790)
.++|++.+.||+|+||.||.++.+ ++.+|+|++++. ..+...+|..+|.+++||+||+++--+. .+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 467999999999999999999876 889999998743 3456889999999999999999975554 5679999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
+||+.||.|..+|.+.+ .+++..+.-++.+|+.||.|||+++| |||||||+|||||++|+++|+|||+++.....
T Consensus 104 ld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~gI---iyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKGI---IYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCCe---eeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 99999999999999866 48999999999999999999999998 99999999999999999999999999954332
Q ss_pred CcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
. ......+||+.|||||++.+..++..+|+||+|+++|||++|.+||...+. ..+.+.+....
T Consensus 179 ~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~--------~~~~~~I~~~k-------- 241 (357)
T KOG0598|consen 179 G-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV--------KKMYDKILKGK-------- 241 (357)
T ss_pred C-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH--------HHHHHHHhcCc--------
Confidence 2 233447999999999999999999999999999999999999999965432 22333333321
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccCCcCCccccccccccccC
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWDIGSFYENQGLDSLMSG 789 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~~~~~~~~~~~~~~~~~~ 789 (790)
+ ...+.-...+..+++...++.||++|-- ......+...+.|+.+-+|+++..+
T Consensus 242 -----~-~~~p~~ls~~ardll~~LL~rdp~~RLg----------~~~d~~~ik~HpfF~~inW~~l~~k 295 (357)
T KOG0598|consen 242 -----L-PLPPGYLSEEARDLLKKLLKRDPRQRLG----------GPGDAEEIKRHPFFKGINWEKLLAK 295 (357)
T ss_pred -----C-CCCCccCCHHHHHHHHHHhccCHHHhcC----------CCCChHHhhcCcccccCCHHHHHhc
Confidence 1 1122224567889999999999999964 2223334677788888888887654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=339.48 Aligned_cols=250 Identities=27% Similarity=0.454 Sum_probs=203.9
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEe--cCe-EEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCV--EGS-LFLV 559 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~-~~lv 559 (790)
.+|.+.++||+|.||.||++... |..+|.|.++. ....++..|+.+|++++|||||+.+++.. +.+ +++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 45788999999999999999764 88999998863 34567899999999999999999998443 444 8999
Q ss_pred EEEecCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc--eeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 560 YEYIENGNLNQHLRG--SGKDTLTWSARMQIALDSARGLEYIHEHTVPV--YIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
|||++.|+|...+.. ..+..++++.+|+++.|+++||.++|+. +++ ++||||||.||+|+.+|.+||+|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999875 3456799999999999999999999992 233 79999999999999999999999999998
Q ss_pred cccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChh
Q 046083 636 TEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715 (790)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (790)
+... .......+|||.||+||.+....|+.||||||+||++|||..=++||... .+..+...+-..
T Consensus 178 l~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--------n~~~L~~KI~qg----- 243 (375)
T KOG0591|consen 178 LSSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--------NLLSLCKKIEQG----- 243 (375)
T ss_pred hcch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--------cHHHHHHHHHcC-----
Confidence 7543 33445689999999999999999999999999999999999999998653 222222222211
Q ss_pred hhhhhcCCcCCCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 716 DLQRLVDPRLGDDYP-IDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 716 ~l~~~~d~~l~~~~~-~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
--...| .-.+..+.+|+..|+..||+.||+.-.+++.+.
T Consensus 244 ---------d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 244 ---------DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ---------CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 111223 456778999999999999999999655555444
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=351.53 Aligned_cols=251 Identities=25% Similarity=0.403 Sum_probs=203.2
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh----------HHHHHHHHHHHHhcCCCCCcceEEEEecCe-
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA----------SKEFLAELKVLTHVHHLNLVRLIGYCVEGS- 555 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~----------~~~~~~E~~~l~~l~h~niv~l~g~~~~~~- 555 (790)
.+.|.+.+.||+|+||.|-+|..+ |+.||||.++... .....+|+++|++++|||||++++++.+.+
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 356888999999999999999876 8999999986421 123569999999999999999999998654
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC---CcEEEEEeCC
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN---FRAKVADFGL 632 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~---~~~kl~DfGl 632 (790)
.|+||||++||+|.+.+-.++ .+.+.....++.|++.|+.|||++|+ +||||||+|||+..+ ..+||+|||+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~GI---~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQGI---IHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred eEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcCc---ccccCCcceEEeccCCcceEEEecccch
Confidence 799999999999999998765 37777788899999999999999999 999999999999765 7899999999
Q ss_pred CcccccCCcccccccccCCCccchhcccCCC--C-CchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHc
Q 046083 633 AKLTEVGSASVHTRLVGTFGYMPPEYAQYGE--V-SPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLR 709 (790)
Q Consensus 633 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~-s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 709 (790)
|+... ........+||+.|.|||++.... + ..+.|+||+||+||-+++|.+||....... .+.+.+..
T Consensus 326 AK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-------sl~eQI~~ 396 (475)
T KOG0615|consen 326 AKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-------SLKEQILK 396 (475)
T ss_pred hhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-------cHHHHHhc
Confidence 99765 445567789999999999997654 2 348899999999999999999997543321 12222222
Q ss_pred CCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 710 QPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 710 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
..... ....-.+..++..+|+.+||..||++|||++|++++-|.
T Consensus 397 G~y~f-----------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~ 440 (475)
T KOG0615|consen 397 GRYAF-----------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWF 440 (475)
T ss_pred Ccccc-----------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhh
Confidence 11110 011123566788999999999999999999999987774
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=373.86 Aligned_cols=257 Identities=27% Similarity=0.499 Sum_probs=219.5
Q ss_pred CcccceeeeecCceEEEEEEEC--C---ceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecCe-EEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--G---EKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVY 560 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g---~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~lv~ 560 (790)
...+.+.||.|.||.||+|+++ + ..||||.++. +...+|..|..||.++.||||++|.|+..... .++|.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 4578899999999999999986 3 4699999984 45578999999999999999999999998765 78999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
|||++|+|+.||+.+.. .+++.+..-+.++|+.|+.||.+.+. |||||.++|||++.+..+|++|||+++.++...
T Consensus 710 EyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~Y---VHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcCc---hhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 99999999999998765 49999999999999999999999998 999999999999999999999999999876554
Q ss_pred ccccccccc--CCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 641 ASVHTRLVG--TFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 641 ~~~~~~~~g--t~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
....+...| ..+|.|||.+...+++.+|||||||++|||.++ |.+|+..... .+.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN----------------------QdV 843 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----------------------QDV 843 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch----------------------HHH
Confidence 322222222 568999999999999999999999999999886 8888755432 122
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccCC
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWD 773 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~~ 773 (790)
-+.++...+-.-|++++..|.+||..||++|-.+||++.+|+..|.++...+...+
T Consensus 844 IkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk 899 (996)
T KOG0196|consen 844 IKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLK 899 (996)
T ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhc
Confidence 23344455556688999999999999999999999999999999999877666543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=342.87 Aligned_cols=254 Identities=26% Similarity=0.443 Sum_probs=206.8
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh---HHHHHHHHHHHHhcCCCCCcceEEEEe--cC-eEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA---SKEFLAELKVLTHVHHLNLVRLIGYCV--EG-SLFLVYE 561 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~--~~-~~~lv~e 561 (790)
.++...+.||+|.||+||++... |+..|||.+.... .+.+.+|+.+|++++|||||+.+|... ++ .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45667899999999999999986 6999999987654 556899999999999999999999743 33 5899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC-CCcEEEEEeCCCccccc--
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK-NFRAKVADFGLAKLTEV-- 638 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~-~~~~kl~DfGla~~~~~-- 638 (790)
|+++|+|.+++...+. .+++..+.++..++++||.|||++++ +||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~---vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGI---VHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCE---eccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999998776 79999999999999999999999998 99999999999999 79999999999987653
Q ss_pred CCcccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 639 GSASVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
..........||+.|||||++..+ ....++|||||||++.||+||..||.... ........+
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-------~~~~~~~~i---------- 235 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-------EEAEALLLI---------- 235 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-------chHHHHHHH----------
Confidence 111223347899999999999953 34459999999999999999999986520 011111111
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
.... ..+.+|...+.+..+++..|++.+|++|||+++++++......
T Consensus 236 --g~~~-~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 236 --GRED-SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred --hccC-CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 1111 1124566677789999999999999999999999998775443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=349.12 Aligned_cols=249 Identities=29% Similarity=0.474 Sum_probs=209.6
Q ss_pred cccCHHHHHHHhcCcccceeeeecCceEEEEEEECCceEEEEEeChhhHHHHHHHHHHHHhcCCCCCcceEEEEecCe-E
Q 046083 478 VEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVEGS-L 556 (790)
Q Consensus 478 ~~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~ 556 (790)
+++.|+++. .++.||.|..|.||+|++.++.||||+++... ..+++-|++++|+||+.|.|+|.+.. +
T Consensus 119 WeiPFe~Is-------ELeWlGSGaQGAVF~Grl~netVAVKKV~elk----ETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 119 WEIPFEEIS-------ELEWLGSGAQGAVFLGRLHNETVAVKKVRELK----ETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred ccCCHHHhh-------hhhhhccCcccceeeeeccCceehhHHHhhhh----hhhHHHHHhccCcceeeEeeeecCCcee
Confidence 566677764 36899999999999999999999999986432 24688999999999999999999765 7
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
|+|||||..|.|...|+... .+.-.....+..+||.|+.|||.+.+ ||||||+-||||..+..+||+|||-++..
T Consensus 188 CIiMEfCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hKI---IHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHKI---IHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred EEeeeccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhhH---hhhccCCCceEeeccceEEeccccchHhh
Confidence 89999999999999998754 57788889999999999999999998 99999999999999999999999999866
Q ss_pred ccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhh
Q 046083 637 EVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716 (790)
Q Consensus 637 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (790)
... .....+.||..|||||++.+...++|.|||||||||||||||.-|+...+... -+|...
T Consensus 263 ~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----------IIwGVG----- 324 (904)
T KOG4721|consen 263 SDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----------IIWGVG----- 324 (904)
T ss_pred hhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-----------eEEecc-----
Confidence 433 22345789999999999999999999999999999999999999986644311 011111
Q ss_pred hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 717 LQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 717 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
...|.-..|..++.-|.-|+++||+..|.+||++++++.+|...
T Consensus 325 -----sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 325 -----SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred -----CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 11233345667778899999999999999999999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=331.43 Aligned_cols=257 Identities=24% Similarity=0.366 Sum_probs=206.6
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEe-cCeEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYE 561 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~lv~e 561 (790)
.++|++.+.||.|..++||+|+.. ++.||||+++.+ ..+.+.+|+..|+.++||||++.+..|. +.++|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 467899999999999999999875 899999999853 3467899999999999999999998766 667999999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
||.+|++.+.+...-+..+++..+.-|.+++++||.|||.+|. ||||||+.||||+.+|.+||+|||.+..+.....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~---IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGH---IHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCc---eecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 9999999999987666679999999999999999999999998 9999999999999999999999998876654432
Q ss_pred ccc---cccccCCCccchhcccC--CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhh
Q 046083 642 SVH---TRLVGTFGYMPPEYAQY--GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716 (790)
Q Consensus 642 ~~~---~~~~gt~~y~aPE~~~~--~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (790)
... ....|+++|||||+++. ..|+.|+||||||+..+||.+|+.||....+. ..+...+-..++...
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-------kvLl~tLqn~pp~~~- 253 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-------KVLLLTLQNDPPTLL- 253 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-------HHHHHHhcCCCCCcc-
Confidence 221 34689999999999643 46999999999999999999999999765442 111222222221111
Q ss_pred hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 717 LQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 717 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
-...+. +-.......+.+++..||+.||++|||+++++.+
T Consensus 254 -t~~~~~----d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 -TSGLDK----DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred -cccCCh----HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 111111 1112233478999999999999999999998753
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=342.53 Aligned_cols=249 Identities=29% Similarity=0.482 Sum_probs=209.9
Q ss_pred HHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhhH------HHHHHHHHHHHhc-CCCCCcceEEEEec-Ce
Q 046083 486 AKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS------KEFLAELKVLTHV-HHLNLVRLIGYCVE-GS 555 (790)
Q Consensus 486 ~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~------~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~ 555 (790)
.+..++|.+++.||+|+|++|++|+.. +..+|||++.++.. +-...|-+.|.+| .||.|++||-.+.+ ..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 556789999999999999999999886 88999999875432 3367788999999 89999999987765 46
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
+|+|+||+++|+|.++|.+.+ .|++.....++.+|+.||+|||++|| |||||||+|||||+|+++||+|||.|+.
T Consensus 149 LYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~GI---IHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNGI---IHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcCc---eeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999999999876 59999999999999999999999998 9999999999999999999999999997
Q ss_pred cccCCcc------------cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHH
Q 046083 636 TEVGSAS------------VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVAL 703 (790)
Q Consensus 636 ~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 703 (790)
+...... ....++||..|.+||++.....+..+|+|+|||+||+|+.|++||...++ ...
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne--------yli 295 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE--------YLI 295 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH--------HHH
Confidence 7543211 11347999999999999999999999999999999999999999977543 223
Q ss_pred HHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 704 FEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 704 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
++.++.- .-++|...++.+.+|+.+.|..||.+|+|..+|-++.
T Consensus 296 FqkI~~l---------------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 296 FQKIQAL---------------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHHHHh---------------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 3333321 1234555557788999999999999999998887653
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=317.85 Aligned_cols=259 Identities=28% Similarity=0.457 Sum_probs=217.3
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~ 560 (790)
++|+..+.||.|+||+|..++.+ |..+|+|.++.+ ..+...+|.++|+.+.||+++++++.+.+. .+|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 56888999999999999999886 889999999753 345678999999999999999999877754 599999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||++||.|..+|++.+ .++.+.+..++.+|+.||+|||+.++ ++|||||+|||+|.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~i---iYRDLKPENiLlD~~G~iKitDFGFAK~v~~-- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLDI---IYRDLKPENLLLDQNGHIKITDFGFAKRVSG-- 196 (355)
T ss_pred eccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcCe---eeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence 9999999999999876 49999999999999999999999998 9999999999999999999999999997642
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
.....+|||.|+|||.++...+..++|+|+|||++|||+.|.+||....+ ... .+++
T Consensus 197 --rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~i-------------Y~KI 253 (355)
T KOG0616|consen 197 --RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQI-------------YEKI 253 (355)
T ss_pred --cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHH-------------HHHH
Confidence 23458999999999999999999999999999999999999999976443 122 2333
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccCCcCCccccccccccccC
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWDIGSFYENQGLDSLMSG 789 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~~~~~~~~~~~~~~~~~~ 789 (790)
+...+ .+|.-...++.+|+...++.|-.+| +-.+..-..+...+.||.+-+|..+.+.
T Consensus 254 ~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R---------~gnlknG~~dIk~H~wF~~v~W~~i~~r 311 (355)
T KOG0616|consen 254 LEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR---------FGNLKNGVEDIKNHPWFKGVDWEAILQR 311 (355)
T ss_pred HhCcc--cCCcccCHHHHHHHHHHHhhhhHhh---------hcCcCCCccccccCcccccccHHHHhhc
Confidence 33333 3455566778899999999998888 3344445566677777777777776654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=322.02 Aligned_cols=259 Identities=26% Similarity=0.385 Sum_probs=200.3
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEe-cCeEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYE 561 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~lv~e 561 (790)
+.|+...++|+|+||+||+++.+ |+.||||++... ..+-..+|+++|++++|+|+|.++.+|. ...++||||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45777899999999999999886 899999999632 2345789999999999999999999887 556999999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|++. ++.+-|.... ..++.....+++.|++.|+.|+|++++ |||||||+|||++.++.+||||||+|+.+.. ..
T Consensus 82 ~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~---IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg 155 (396)
T KOG0593|consen 82 YCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNC---IHRDIKPENILITQNGVVKLCDFGFARTLSA-PG 155 (396)
T ss_pred ecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCe---ecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence 9998 4445554432 358889999999999999999999998 9999999999999999999999999998764 44
Q ss_pred ccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh------
Q 046083 642 SVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR------ 714 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 714 (790)
...+..+.|.+|+|||.+-+ .+|....|||++||++.||++|.+.|...++. +..-.....+....++
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi-----DQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI-----DQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH-----HHHHHHHHHHcccCHHHHHHhc
Confidence 55667888999999999987 68999999999999999999999888654431 1111111112111110
Q ss_pred --hhhhhhcCCcCC------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046083 715 --EDLQRLVDPRLG------DDYPIDSVRKMARLARACTQENPQLRPSMRAIVV 760 (790)
Q Consensus 715 --~~l~~~~d~~l~------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 760 (790)
..+..+.-|... ..+ +....-+.+++..|++.||.+|++.++++.
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cCCceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 011111111111 111 234457889999999999999999999875
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=348.88 Aligned_cols=256 Identities=30% Similarity=0.493 Sum_probs=202.2
Q ss_pred HhcCcccceeeeecCceEEEEEEEC-------CceEEEEEeCh----hhHHHHHHHHHHHHhc-CCCCCcceEEEEec--
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDM----QASKEFLAELKVLTHV-HHLNLVRLIGYCVE-- 553 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-- 553 (790)
..++|++.+.||+|+||.||+|... +..||+|.++. ...+.+.+|++++.++ +||||++++++|.+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3567999999999999999999742 45799999864 2345688999999999 89999999998874
Q ss_pred CeEEEEEEEecCCChhhhhhcCC---------------------------------------------------------
Q 046083 554 GSLFLVYEYIENGNLNQHLRGSG--------------------------------------------------------- 576 (790)
Q Consensus 554 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 576 (790)
+..+++|||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 34899999999999999987531
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc-cccccccCCC
Q 046083 577 ---KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS-VHTRLVGTFG 652 (790)
Q Consensus 577 ---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~ 652 (790)
...+++..+.+++.|+++||+|||++++ +||||||+|||++.++.+||+|||+++........ ......++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~i---vHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCE---ECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 1348889999999999999999999997 99999999999999999999999999865322211 1122345678
Q ss_pred ccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCH
Q 046083 653 YMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPI 731 (790)
Q Consensus 653 y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 731 (790)
|+|||++.+..++.++|||||||++|||++ |..||...... ..+...+... . ....+.
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--------~~~~~~~~~~------------~-~~~~~~ 300 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--------EEFCQRLKDG------------T-RMRAPE 300 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--------HHHHHHHhcC------------C-CCCCCC
Confidence 999999998899999999999999999997 99998643211 0011111110 0 011123
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 732 DSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 732 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
..+..+.+++.+||+.||.+|||+.|+++.|+.+..
T Consensus 301 ~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 301 NATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 345678999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=340.66 Aligned_cols=261 Identities=31% Similarity=0.451 Sum_probs=208.3
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh--hHHH--HHHHHHHHHhcC-CCCCcceEEEEecC--eEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ--ASKE--FLAELKVLTHVH-HLNLVRLIGYCVEG--SLFLV 559 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~--~~~~--~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~lv 559 (790)
-++|...++||.|.||.||+|+.. ++.||||+++.. ..++ -.+|+..|++++ ||||+++.+++.+. .+|+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 357888999999999999999875 889999999753 3344 367999999998 99999999988754 58999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
||||+. +|++++..+ ...+++..+..|+.||++||+|+|.+|. .|||+||+|||+..+..+||+|||+||.....
T Consensus 89 fE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~Gf---FHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGF---FHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred HHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCc---ccccCChhheEecccceeEecccccccccccC
Confidence 999987 999999987 5689999999999999999999999998 99999999999999999999999999976543
Q ss_pred CcccccccccCCCccchhccc-CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChh---
Q 046083 640 SASVHTRLVGTFGYMPPEYAQ-YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE--- 715 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 715 (790)
...+..+.|.+|+|||++. .+.|+.+.|+|++|||++|+.+=++.|...++. +..--..+++..+....
T Consensus 164 --pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~-----Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 164 --PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI-----DQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred --CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH-----HHHHHHHHHhCCCccccchh
Confidence 3346678899999999874 567999999999999999999988888665442 11122233444333221
Q ss_pred --hhhhhcCCcC--------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 716 --DLQRLVDPRL--------GDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 716 --~l~~~~d~~l--------~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
.+...+.-.+ ..-.+ ....+..+|+.+|+++||.+|||+.|.+++-
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 1112221111 11112 3667899999999999999999999998754
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=372.14 Aligned_cols=257 Identities=30% Similarity=0.516 Sum_probs=210.0
Q ss_pred hcCcccceeeeecCceEEEEEEEC---Cc----eEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR---GE----KAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SL 556 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~---g~----~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~ 556 (790)
..+.++.+.||+|.||.||+|... +. .||||.++. +...+|.+|..+|++++|||||+++|+|.+. ..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 345667899999999999999875 33 489998864 4567899999999999999999999999864 48
Q ss_pred EEEEEEecCCChhhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeC
Q 046083 557 FLVYEYIENGNLNQHLRGSG-----KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFG 631 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfG 631 (790)
++++|||++|+|..||++.. ...++....+.++.+||+|+.||++++. |||||..+|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~f---vHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHF---VHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCC---cCcchhhhheeecccCcEEEcccc
Confidence 99999999999999999762 3468999999999999999999999997 999999999999999999999999
Q ss_pred CCcccccCCc-ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHc
Q 046083 632 LAKLTEVGSA-SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLR 709 (790)
Q Consensus 632 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 709 (790)
||+....... .......-...|||||.+..+.++.|+|||||||+|||++| |..||..... .+....+.+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n--------~~v~~~~~~ 919 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN--------FEVLLDVLE 919 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch--------HHHHHHHHh
Confidence 9994432222 22222344679999999999999999999999999999998 7777754332 112222222
Q ss_pred CCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCc
Q 046083 710 QPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770 (790)
Q Consensus 710 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~ 770 (790)
. . +-+.|..++..+.+||..||+.+|++||++..+++.+..+.+...
T Consensus 920 g-------------g-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 920 G-------------G-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred C-------------C-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 1 1 234466788899999999999999999999999998887755443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=335.68 Aligned_cols=254 Identities=18% Similarity=0.336 Sum_probs=204.4
Q ss_pred ccCHHHHHHHhcCcccceeeeecCceEEEEEEECCceEEEEEeChhh------HHHHHHHHHHHHhcCCCCCcceEEEEe
Q 046083 479 EFSYEELAKATNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQA------SKEFLAELKVLTHVHHLNLVRLIGYCV 552 (790)
Q Consensus 479 ~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~------~~~~~~E~~~l~~l~h~niv~l~g~~~ 552 (790)
.++.+++. ......||+|++|.||+|.+.|+.+|||.++... .+.|.+|+++|++++||||++++|++.
T Consensus 14 ~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~ 88 (283)
T PHA02988 14 CIESDDID-----KYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFII 88 (283)
T ss_pred ecCHHHcC-----CCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEE
Confidence 44555552 2224689999999999999999999999986421 356789999999999999999999886
Q ss_pred c-----CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCEEecCCCcEE
Q 046083 553 E-----GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH-TVPVYIHRDIKPANILIDKNFRAK 626 (790)
Q Consensus 553 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~~vH~dlkp~NILl~~~~~~k 626 (790)
+ ...++||||+++|+|.+++.... .++|....+++.+++.||.|||+. ++ +||||||+|||+++++.+|
T Consensus 89 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~---~Hrdlkp~nill~~~~~~k 163 (283)
T PHA02988 89 DIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNK---PYKNLTSVSFLVTENYKLK 163 (283)
T ss_pred ecccCCCceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCC---CCCcCChhhEEECCCCcEE
Confidence 5 24789999999999999998643 589999999999999999999985 66 7999999999999999999
Q ss_pred EEEeCCCcccccCCcccccccccCCCccchhcccC--CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHH
Q 046083 627 VADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQY--GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALF 704 (790)
Q Consensus 627 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 704 (790)
|+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... ....
T Consensus 164 l~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~--------~~~~ 231 (283)
T PHA02988 164 IICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--------KEIY 231 (283)
T ss_pred EcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH--------HHHH
Confidence 99999998653221 23467899999999976 6899999999999999999999999965321 1122
Q ss_pred HHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 705 EEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 705 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
..+... ......+...+..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 232 ~~i~~~-------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 232 DLIINK-------------NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHHhc-------------CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 222211 11112233456679999999999999999999999999998653
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=339.67 Aligned_cols=259 Identities=29% Similarity=0.443 Sum_probs=205.0
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh-----HHHHHHHHHHHHhcCCCCCcceEEEEec---CeEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA-----SKEFLAELKVLTHVHHLNLVRLIGYCVE---GSLFLV 559 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~g~~~~---~~~~lv 559 (790)
+.|+..++||+|.||.||+|+.. |+.||+|++..+. .....+||.+|+++.||||++|.+...+ +.+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 45777889999999999999875 8899999987543 3446799999999999999999998764 469999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
+|||++ +|.-++...+ -.|+..++..++.|++.||.|+|++++ +|||||.+|||||.+|.+||+|||||+++...
T Consensus 197 FeYMdh-DL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~gv---lHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRGV---LHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred Eecccc-hhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcCe---eeccccccceEEcCCCCEEeccccceeeccCC
Confidence 999998 9998887643 359999999999999999999999998 99999999999999999999999999988776
Q ss_pred CcccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
.....+..+-|.+|+|||++.+. .|+.+.|+||.||||.||+.|++.|....+. ..+...+ .+...+.. ..+.
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv----eQl~kIf-klcGSP~e-~~W~ 345 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV----EQLHKIF-KLCGSPTE-DYWP 345 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH----HHHHHHH-HHhCCCCh-hccc
Confidence 66666777889999999999875 7999999999999999999999988665432 1121111 12221111 1111
Q ss_pred -------hhcCCcCCCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 719 -------RLVDPRLGDDYP-------IDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 719 -------~~~d~~l~~~~~-------~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
..+.+. ..+. ...+....+|+..+|..||.+|.|+.++++.
T Consensus 346 ~~kLP~~~~~kp~--~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 346 VSKLPHATIFKPQ--QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cccCCcccccCCC--CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 111111 0111 1234567789999999999999999998863
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=344.97 Aligned_cols=265 Identities=27% Similarity=0.487 Sum_probs=211.2
Q ss_pred CHHHHHHHhcCcccceeeeecCceEEEEEEECCceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEecCe
Q 046083 481 SYEELAKATNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVEGS 555 (790)
Q Consensus 481 ~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 555 (790)
+.+++....+.+.+...||+|.||+||+|+|.| .||||.++. +..+.|++|+..|++-+|.||+-+.|||.+..
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 335555556667789999999999999999987 479999874 45678999999999999999999999999888
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
+.+|.-||+|.+|+.+|+-.. ..|+..+.+.|+.|+++|+.|||.++| ||||||..||+|.+++.+||+|||++..
T Consensus 462 ~AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~I---IHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 462 LAIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNI---IHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred eeeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhh---hhhhccccceEEccCCcEEEecccceee
Confidence 899999999999999999764 468999999999999999999999998 9999999999999999999999999864
Q ss_pred ccc-CCcccccccccCCCccchhcccC---CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCC
Q 046083 636 TEV-GSASVHTRLVGTFGYMPPEYAQY---GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQP 711 (790)
Q Consensus 636 ~~~-~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (790)
-.. ..........|...|||||+++. ..|+..+||||||+++|||++|..||...... ..-..+...
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d---------qIifmVGrG 608 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD---------QIIFMVGRG 608 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh---------heEEEeccc
Confidence 321 11111222457789999999964 46899999999999999999999999732211 000011111
Q ss_pred CChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 712 DPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 712 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
....++ .....+++.++.+|+..||..++++||.+.+|+..|..+..+
T Consensus 609 ~l~pd~---------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 609 YLMPDL---------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ccCccc---------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 000000 011235677899999999999999999999999988876653
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=339.49 Aligned_cols=242 Identities=28% Similarity=0.455 Sum_probs=208.6
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEe-cCeEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYE 561 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~lv~e 561 (790)
++|.+.+.||+|.||+||||+.+ .+.||+|.+.+. +.+.+.+|++|+++++||||+.+++++. ..++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999887 678999998643 3345889999999999999999999887 567999999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|+.| +|..+|...+. +++..+..++.+++.||.|||++++ +|||+||.|||++.++.+|+||||+|+.+.. ..
T Consensus 82 ~a~g-~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs~ri---lhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHSNRI---LHRDMKPQNILLEKGGTLKLCDFGLARAMST-NT 154 (808)
T ss_pred hhhh-hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHhcCc---ccccCCcceeeecCCCceeechhhhhhhccc-Cc
Confidence 9988 99999987654 8999999999999999999999998 9999999999999999999999999998754 34
Q ss_pred ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhc
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 721 (790)
...+...|||-|||||+..+..|+..+|.||+||++|||++|++||... .+..+.+.+..++
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~--------si~~Lv~~I~~d~---------- 216 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR--------SITQLVKSILKDP---------- 216 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH--------HHHHHHHHHhcCC----------
Confidence 4566788999999999999999999999999999999999999999652 2334444443321
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 722 DPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 722 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
...|......+.+++...|.+||..|.|..+++.+
T Consensus 217 -----v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 217 -----VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -----CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 12344667789999999999999999999998764
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=340.95 Aligned_cols=262 Identities=31% Similarity=0.489 Sum_probs=225.5
Q ss_pred HHHHHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh--hHHHHHHHHHHHHhcCCCCCcceEEEEe-cCeEE
Q 046083 483 EELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ--ASKEFLAELKVLTHVHHLNLVRLIGYCV-EGSLF 557 (790)
Q Consensus 483 ~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~ 557 (790)
++++....+..+.++||-|.||.||.|.|+ .-.||||.++.+ ..++|..|..+|+.++|||+|+|+|+|. +..+|
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 555566677888999999999999999998 567999999864 4578999999999999999999999998 45699
Q ss_pred EEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccc
Q 046083 558 LVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~ 637 (790)
||.|||..|+|.+||+...+..++-...+.++.||+.|++||..++. |||||..+|+|+.++..+|++||||++++.
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknF---IHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNF---IHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhccccccceEEeeccchhhhhc
Confidence 99999999999999999888889999999999999999999999997 999999999999999999999999999986
Q ss_pred cCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhh
Q 046083 638 VGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716 (790)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (790)
.....-+...-..+.|.|||.+....++.|+|||+|||+|||+.| |..|+... ++. .
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi--------dlS--------------q 474 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI--------DLS--------------Q 474 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc--------cHH--------------H
Confidence 544444444555789999999999999999999999999999987 66666432 111 2
Q ss_pred hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCC
Q 046083 717 LQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSS 769 (790)
Q Consensus 717 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~ 769 (790)
+..++++..+-+.|..|+..+.+||+.||+++|.+||+++|+-+.++.+.++.
T Consensus 475 VY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 475 VYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred HHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 23444555556667889999999999999999999999999999999875544
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=346.16 Aligned_cols=257 Identities=30% Similarity=0.514 Sum_probs=208.1
Q ss_pred hcCcccceeeeecCceEEEEEEEC---C--ce-EEEEEeCh------hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-e
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR---G--EK-AAIKKMDM------QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-S 555 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~---g--~~-vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~ 555 (790)
.++..+.++||+|.||.||+|++. + .. ||||..+. ...++|.+|.++|+.++|||||++||++... .
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 344556799999999999999886 2 23 89998873 4557899999999999999999999999865 4
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
+++|||+|.||+|.++|+..+. .++..++++++.+.|.||+|||++++ +||||.++|+|++.++.+||+||||++.
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~---IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNC---IHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCC---cchhHhHHHheecCCCeEEeCccccccC
Confidence 8999999999999999998754 69999999999999999999999998 9999999999999999999999999886
Q ss_pred cccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 636 TEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
....... .....-...|+|||.+..+.|+.++|||||||++||+++ |..|+..... ......+.
T Consensus 312 ~~~~~~~-~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~--------~~v~~kI~------ 376 (474)
T KOG0194|consen 312 GSQYVMK-KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN--------YEVKAKIV------ 376 (474)
T ss_pred Ccceeec-cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH--------HHHHHHHH------
Confidence 4311111 111124679999999999999999999999999999998 7778755332 11222221
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCcc
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSED 771 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~ 771 (790)
....+...+...+..+..++.+||..+|++||+|.++.+.|..+......
T Consensus 377 -------~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 377 -------KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred -------hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 22222334446677888999999999999999999999999988665553
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=339.24 Aligned_cols=246 Identities=26% Similarity=0.462 Sum_probs=205.1
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChh---hHHHHHHHHHHHHhcCCCCCcceEEEEe-cCeEEEEEEEec
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ---ASKEFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIE 564 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~lv~e~~~ 564 (790)
.|..-.+||+|..|.||.|... ++.||||++... ..+-+.+|+.+|+..+|+|||.+++-+. .+++|+|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 4666789999999999999875 788999998642 3455889999999999999999998554 667999999999
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccc
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH 644 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 644 (790)
+|+|.+.+... .+++.++..|++++++||+|||.+++ +|||||.+|||++.+|.+||+|||++..+..... ..
T Consensus 354 ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gI---iHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR 426 (550)
T KOG0578|consen 354 GGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGI---IHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KR 426 (550)
T ss_pred CCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcce---eeeccccceeEeccCCcEEEeeeeeeeccccccC-cc
Confidence 99999999864 48999999999999999999999998 9999999999999999999999999987654433 34
Q ss_pred cccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCc
Q 046083 645 TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724 (790)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 724 (790)
...+||+.|||||+.....|++|.||||||++++||+-|++||....+ +..++.-... . .+.
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-------lrAlyLIa~n-g----------~P~ 488 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALYLIATN-G----------TPK 488 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-------HHHHHHHhhc-C----------CCC
Confidence 557899999999999999999999999999999999999999976332 1111111111 0 111
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 725 LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 725 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
-..+......|.+++.+||+.|+++||++.|+|++--
T Consensus 489 --lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpF 525 (550)
T KOG0578|consen 489 --LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPF 525 (550)
T ss_pred --cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChh
Confidence 1234566788999999999999999999999998533
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=342.04 Aligned_cols=264 Identities=27% Similarity=0.467 Sum_probs=218.2
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh------hhHHHHHHHHHHHHhc-CCCCCcceEEEEe-cCeEE
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHV-HHLNLVRLIGYCV-EGSLF 557 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~------~~~~~~~~E~~~l~~l-~h~niv~l~g~~~-~~~~~ 557 (790)
..++|.+.+.||+|.||.|+.+..+ ++.+|||.+++ ++.+..+.|.+++... +||.++.++.++. +.++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4578999999999999999999987 77899999875 4457788899998888 5999999999876 56799
Q ss_pred EEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccc
Q 046083 558 LVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~ 637 (790)
+||||+.||++..+.+ ...+++..+..++..|+.||+|||+++| |+||||.+|||||.+|.+||+||||++..-
T Consensus 446 fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~I---IYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGI---IYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCc---eeeecchhheEEcccCcEEecccccccccC
Confidence 9999999999555444 2469999999999999999999999998 999999999999999999999999998643
Q ss_pred cCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 638 VGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
. .......++||+.|||||++.+..|+...|+|||||+|||||.|+.||...++. ..+..++..
T Consensus 520 ~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe--------e~FdsI~~d------- 583 (694)
T KOG0694|consen 520 G-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE--------EVFDSIVND------- 583 (694)
T ss_pred C-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHhcC-------
Confidence 2 233456789999999999999999999999999999999999999999765432 233333321
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccCCcCCccccccccccccCC
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWDIGSFYENQGLDSLMSGR 790 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 790 (790)
...+|...+.+...++++++..+|++|--+. ....++...+.||...+|+.|+..+
T Consensus 584 --------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~---------e~d~~~i~~hpFFr~i~w~~L~~r~ 639 (694)
T KOG0694|consen 584 --------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSG---------ERDAEDIKKHPFFRSIDWDDLLNRR 639 (694)
T ss_pred --------CCCCCCcccHHHHHHHHHHhccCcccccCCC---------CCCchhhhhCCccccCCHHHHhhcc
Confidence 1235667778899999999999999996542 2234455677888888888887653
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=320.48 Aligned_cols=263 Identities=30% Similarity=0.473 Sum_probs=210.2
Q ss_pred hcCcccceeeeecCceEEEEEEECCceEEEEEeChhhHHHHHHHHHHHHhc--CCCCCcceEEEEec--C---eEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKVLTHV--HHLNLVRLIGYCVE--G---SLFLVYE 561 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~~~~~~~E~~~l~~l--~h~niv~l~g~~~~--~---~~~lv~e 561 (790)
..+..+.+.||+|.||.||+|.|+|+.||||++...+.+.+++|.++++.+ +|+||+.+++.-.. + ++|||.+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd 289 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD 289 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence 456788999999999999999999999999999999899999999999876 99999999986542 2 3899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE-----HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-----~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
|.+.|+|+|||.. ..++....++++..+|.||+|||. +|.|.|.|||||+.|||+..++...|+|+|||...
T Consensus 290 YHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h 366 (513)
T KOG2052|consen 290 YHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 366 (513)
T ss_pred cccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence 9999999999986 469999999999999999999994 67788999999999999999999999999999876
Q ss_pred ccCCccc---ccccccCCCccchhcccCCC----C--CchhhHHHHHHHHHHHHhC----------Cccccccccccccc
Q 046083 637 EVGSASV---HTRLVGTFGYMPPEYAQYGE----V--SPKIDVYAFGVVLYELISA----------MEAVVKTNETITES 697 (790)
Q Consensus 637 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~----~--s~~sDvwS~Gvvl~elltG----------~~p~~~~~~~~~~~ 697 (790)
....... ....+||-+|||||++...- + -..+||||||.|+||+.-. +.||...
T Consensus 367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~------- 439 (513)
T KOG2052|consen 367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV------- 439 (513)
T ss_pred cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC-------
Confidence 5443221 23468999999999996431 2 2369999999999999642 2333221
Q ss_pred cchHHHHHHHHcCCCChhhhhhh-cCCcCCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCcc
Q 046083 698 TGLVALFEEVLRQPDPREDLQRL-VDPRLGDDY-----PIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSED 771 (790)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~l~~~-~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~ 771 (790)
....+..+++.++ ...++++.. ..+....+.+||+.||..+|.-|-|+-.+-..|.++..+++.
T Consensus 440 ----------Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~ek 509 (513)
T KOG2052|consen 440 ----------VPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDEK 509 (513)
T ss_pred ----------CCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChhh
Confidence 1112222222222 233343333 356788899999999999999999999999999988765443
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=332.41 Aligned_cols=261 Identities=29% Similarity=0.483 Sum_probs=210.1
Q ss_pred HhcCcccceeeeecCceEEEEEEECC-ceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEE
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELRG-EKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYE 561 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~g-~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e 561 (790)
......+.++||+|.||.|..+...+ ..||||.++.. ...+|.+|+++|.+++||||+.++|+|.. +.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 44567889999999999999999985 89999999853 34789999999999999999999999984 55899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
||++|+|.+|+.++....+.-....+|+.||+.|++||.+.+. |||||.++|+|+|.++++||+|||+++.+..+..
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nf---VHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNF---VHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhch---hhccccccceeecCcccEEecCcccccccccCCc
Confidence 9999999999998765555667778899999999999999998 9999999999999999999999999996654443
Q ss_pred cc-ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh--CCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 642 SV-HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS--AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 642 ~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
.. ..+.+-...|||+|.+..++++.++|||+||+++||+++ ...||...... +..+-...+++....
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e-----~vven~~~~~~~~~~----- 762 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE-----QVVENAGEFFRDQGR----- 762 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH-----HHHHhhhhhcCCCCc-----
Confidence 32 234556789999999999999999999999999999864 56676543321 111111111111110
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLS 766 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~ 766 (790)
.....-|.-++..+.+++.+||..+-++||+++++...|....
T Consensus 763 -----~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 763 -----QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred -----ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 1111235567788999999999999999999999998887643
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=324.20 Aligned_cols=251 Identities=23% Similarity=0.371 Sum_probs=200.5
Q ss_pred hcCcccceeeeecCceEEEEEEEC-----CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-----GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFL 558 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-----g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~l 558 (790)
.++|++.+.||+|+||.||+|.+. +..+|+|.++.. ..+.|.+|+..+.+++||||+++++++.. ...++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356889999999999999999764 458999988743 23568899999999999999999998875 45899
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
||||+++|+|.+++.... ..+++..+++++.+++.||+|||++++ +||||||+|||++.++.+|++|||.+.....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~i---iH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGY---VHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCE---eeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999998643 368999999999999999999999997 9999999999999999999999998765322
Q ss_pred CCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 639 GSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
..........++..|+|||.+.+..++.++|||||||++|||++ |..||...... .......+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--------~~~~~~~~~------- 224 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--------DVIKAVEDG------- 224 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHCC-------
Confidence 21111112335678999999999999999999999999999875 99998643221 111111110
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
.....+...+..+.+++.+||+.+|++||++++|.+.|.++
T Consensus 225 -------~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 -------FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11122334556789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=302.61 Aligned_cols=262 Identities=25% Similarity=0.402 Sum_probs=204.1
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChhhH-----HHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS-----KEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYE 561 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~-----~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e 561 (790)
++|...++||+|.||.||+|+.. |+.||||+++.... ....+|++.|+.++|+||+.+++++.. +.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46777899999999999999986 89999999975433 357899999999999999999998874 56899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
||+. +|...++... ..++-..+..++.++++|++|||++.+ +||||||.|+|++++|.+||+|||+|+.+.....
T Consensus 82 fm~t-dLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~I---lHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKWI---LHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred eccc-cHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhhh---hcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9987 9999998764 468889999999999999999999998 9999999999999999999999999998765443
Q ss_pred ccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChh--h--
Q 046083 642 SVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE--D-- 716 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-- 716 (790)
.. +..+.|..|+|||.+.+. .|+...||||.||++.||+-|.+-|....+- +........+..+.+.. .
T Consensus 157 ~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi-----dQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 157 IQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI-----DQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred cc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH-----HHHHHHHHHcCCCCcccCcccc
Confidence 32 223678999999999875 6999999999999999999887766543321 11122222333222110 1
Q ss_pred -------hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 717 -------LQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 717 -------l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
++..-.+.+.. .-........+++..|+..||.+|+|+.|++++=.
T Consensus 231 ~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred ccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence 11111112221 22334556689999999999999999999988644
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=321.77 Aligned_cols=272 Identities=28% Similarity=0.424 Sum_probs=216.5
Q ss_pred cccceeeeecCceEEEEEEECCceEEEEEeChhhHHHHHHHHHHHHhc--CCCCCcceEEEEec-----CeEEEEEEEec
Q 046083 492 FSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKVLTHV--HHLNLVRLIGYCVE-----GSLFLVYEYIE 564 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~~~~~~~E~~~l~~l--~h~niv~l~g~~~~-----~~~~lv~e~~~ 564 (790)
..+.+.||+|+||.||+|.++++.||||++..+..+.|.+|-+|++.. +|+||+++++.... .+++||+||.+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~ 291 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP 291 (534)
T ss_pred hhhHHHhhcCccceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence 445678999999999999999999999999999999999999998875 79999999987652 25899999999
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH------TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
.|+|.+||... .++|....+|+..+++||+|||+. ..|+|+|||||++||||.+|++..|+|||+|..+..
T Consensus 292 kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p 368 (534)
T KOG3653|consen 292 KGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEP 368 (534)
T ss_pred CCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecC
Confidence 99999999864 699999999999999999999963 346799999999999999999999999999998865
Q ss_pred CCccc-ccccccCCCccchhcccCCC-CC-----chhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCC
Q 046083 639 GSASV-HTRLVGTFGYMPPEYAQYGE-VS-----PKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQP 711 (790)
Q Consensus 639 ~~~~~-~~~~~gt~~y~aPE~~~~~~-~s-----~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (790)
+.... ....+||.+|||||++.+.- +. .+.||||+|.|||||++....+.. ++ .......++.-+...
T Consensus 369 ~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~----vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 369 GKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GP----VPEYQLPFEAEVGNH 443 (534)
T ss_pred CCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CC----CCcccCchhHHhcCC
Confidence 43322 22368999999999997642 22 369999999999999997665532 11 112223344444444
Q ss_pred CChhhhhhhcC-CcCCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCcc
Q 046083 712 DPREDLQRLVD-PRLGDDYPI-----DSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSED 771 (790)
Q Consensus 712 ~~~~~l~~~~d-~~l~~~~~~-----~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~ 771 (790)
+..+.+++++- ++.++.++. ..+.-+.+.+..||+.||+.|-|+.=|.+.++.+...+..
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 44455554443 233333332 3456788999999999999999999999999998877765
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=334.61 Aligned_cols=250 Identities=26% Similarity=0.439 Sum_probs=207.5
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh--------hHHHHHHHHHHHHhcC-CCCCcceEEEEe-cCe
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ--------ASKEFLAELKVLTHVH-HLNLVRLIGYCV-EGS 555 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~--------~~~~~~~E~~~l~~l~-h~niv~l~g~~~-~~~ 555 (790)
...+|.+.+.||+|.||.|+.|... ++.+|+|.++.+ ..+.+.+|+.++++++ ||||++++.++. ...
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3567899999999999999999875 899999977653 2345678999999998 999999999987 456
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC-CcEEEEEeCCCc
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN-FRAKVADFGLAK 634 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~-~~~kl~DfGla~ 634 (790)
.|+||||+.+|+|.+++...+ .+.+....++++|++.|++|||++++ +||||||+|||+|.+ +++||+|||++.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~gi---~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSRGI---VHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCE---eeCCCCHHHEEecCCCCCEEEecccccc
Confidence 999999999999999999844 58889999999999999999999998 999999999999999 999999999999
Q ss_pred ccccCCcccccccccCCCccchhcccCCC-CC-chhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC
Q 046083 635 LTEVGSASVHTRLVGTFGYMPPEYAQYGE-VS-PKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD 712 (790)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (790)
... .........+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||.... ...++..+....
T Consensus 170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~--------~~~l~~ki~~~~- 239 (370)
T KOG0583|consen 170 ISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN--------VPNLYRKIRKGE- 239 (370)
T ss_pred ccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc--------HHHHHHHHhcCC-
Confidence 774 3334556689999999999999877 76 78999999999999999999997622 222222222211
Q ss_pred ChhhhhhhcCCcCCCCCCHHH-HHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 046083 713 PREDLQRLVDPRLGDDYPIDS-VRKMARLARACTQENPQLRPSMRAIVVALMTLS 766 (790)
Q Consensus 713 ~~~~l~~~~d~~l~~~~~~~~-~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~ 766 (790)
-.+|... ..++..++.+|+..||.+|+|+.+|+.+=+...
T Consensus 240 --------------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 240 --------------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred --------------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 1222223 567899999999999999999999997666443
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=331.37 Aligned_cols=257 Identities=23% Similarity=0.401 Sum_probs=206.4
Q ss_pred cCcccceeeeecCceEEEEEEEC--Cc----eEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GE----KAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLV 559 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~----~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv 559 (790)
.+|+..+.||+|+||.||+|.+. +. .+|+|.++. ...+++.+|+.+++.++||||++++|+|.....+++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v 86 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 86 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence 46899999999999999999864 33 389999863 334678899999999999999999999988888999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
+||+++|+|.+++.... ..+++..+++++.|++.||+|||+.++ +||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i---iH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 87 TQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCe---eccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999999998653 358899999999999999999999997 99999999999999999999999999876533
Q ss_pred Ccccc-cccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 640 SASVH-TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 640 ~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
..... ....++..|+|||++.+..++.++||||||+++|||++ |..||..... .. .......
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--------~~-~~~~~~~------- 226 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SE-ISSILEK------- 226 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------HH-HHHHHhC-------
Confidence 22211 12234678999999999999999999999999999998 9888854221 01 1111111
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccC
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDW 772 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~ 772 (790)
......+..+...+.+++.+||+.+|.+||++.+++..|..+......|
T Consensus 227 ------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~~ 275 (316)
T cd05108 227 ------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 275 (316)
T ss_pred ------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCchh
Confidence 1111112233456889999999999999999999999999887766543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=321.24 Aligned_cols=251 Identities=30% Similarity=0.508 Sum_probs=204.4
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh--hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEec
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ--ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIE 564 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~ 564 (790)
.+|++.+.||+|+||.||+|.+. +..+++|.++.. ..+++.+|++++++++|+|++++++++.. +..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 45788899999999999999875 788999998743 34578999999999999999999998874 45899999999
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccc
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH 644 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 644 (790)
+++|.+++.......+++..++.++.|+++||+|||++++ +||||||+|||+++++.+||+|||++...........
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i---~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE---eecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence 9999999987655678999999999999999999999997 9999999999999999999999999986643322222
Q ss_pred cccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 645 TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
....++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ...+.....
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~~~~~~~-------------- 220 (263)
T cd05052 163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYELLEK-------------- 220 (263)
T ss_pred CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHC--------------
Confidence 22334668999999998999999999999999999998 8888753221 111111111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
......+...+..+.+++.+||+.+|++||++.++++.|..+
T Consensus 221 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 221 GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111222334456799999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=325.74 Aligned_cols=244 Identities=32% Similarity=0.606 Sum_probs=192.2
Q ss_pred cceeeeecCceEEEEEEEC------CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 494 MGNKIGQGGFGAVFYAELR------GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 494 ~~~~lG~G~fg~Vy~a~~~------g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
+.+.||.|.||.||+|.+. +..|+||.++. +..++|.+|++.+++++||||++++|++.+ +..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 5689999999999999987 56899999964 235789999999999999999999999984 458999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc-
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA- 641 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~- 641 (790)
+++|+|.++|.......+++..+++++.|+++||.|||++++ +|+||+++|||++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~i---iH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNI---IHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTE---EEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 999999999998755679999999999999999999999987 9999999999999999999999999987632211
Q ss_pred ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
...........|+|||.+....++.++||||||+++|||++ |+.|+..... ......+..
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--------~~~~~~~~~----------- 220 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--------EEIIEKLKQ----------- 220 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--------HHHHHHHHT-----------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccc-----------
Confidence 12223456779999999998889999999999999999999 6777644321 111122211
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
. .....+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 221 --~-~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 221 --G-QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --T-EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --c-ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1 11122334566789999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=323.85 Aligned_cols=259 Identities=27% Similarity=0.422 Sum_probs=207.7
Q ss_pred HHHHHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----------------hHHHHHHHHHHHHhcCCCC
Q 046083 483 EELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----------------ASKEFLAELKVLTHVHHLN 543 (790)
Q Consensus 483 ~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----------------~~~~~~~E~~~l~~l~h~n 543 (790)
.+-.+..++|++.+.||+|.||.|-+|+.. ++.+|||++... ..+...+|+.+|++++|||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 334455688999999999999999999876 889999998532 1256889999999999999
Q ss_pred CcceEEEEec---CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEec
Q 046083 544 LVRLIGYCVE---GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILID 620 (790)
Q Consensus 544 iv~l~g~~~~---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~ 620 (790)
||+|+.+-.+ ..+|||+|||..|.+.+.-.. +..++..+++++++++..||+|||.+++ |||||||+|+||+
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d--~~els~~~Ar~ylrDvv~GLEYLH~Qgi---iHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPD--KPELSEQQARKYLRDVVLGLEYLHYQGI---IHRDIKPSNLLLS 244 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccCCCC--cccccHHHHHHHHHHHHHHHHHHHhcCe---eccccchhheEEc
Confidence 9999999874 358999999998887544332 2239999999999999999999999998 9999999999999
Q ss_pred CCCcEEEEEeCCCcccccCC----cccccccccCCCccchhcccCCC----CCchhhHHHHHHHHHHHHhCCcccccccc
Q 046083 621 KNFRAKVADFGLAKLTEVGS----ASVHTRLVGTFGYMPPEYAQYGE----VSPKIDVYAFGVVLYELISAMEAVVKTNE 692 (790)
Q Consensus 621 ~~~~~kl~DfGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDvwS~Gvvl~elltG~~p~~~~~~ 692 (790)
++|++||+|||.+.....+. ........|||.|+|||.+.++. .+.+.||||+||+||.|+.|+.||....
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~- 323 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF- 323 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch-
Confidence 99999999999998653321 12233578999999999997743 3568999999999999999999996532
Q ss_pred ccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 693 TITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
...++..+.. ..+.-....++.+.+.+|+.++|++||+.|.+..+|..+.+....
T Consensus 324 -------~~~l~~KIvn-------------~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 324 -------ELELFDKIVN-------------DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred -------HHHHHHHHhc-------------CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 2233333333 333222223566789999999999999999999999988886543
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=321.01 Aligned_cols=252 Identities=23% Similarity=0.449 Sum_probs=203.5
Q ss_pred hcCcccceeeeecCceEEEEEEEC-CceEEEEEeChh--hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEEec
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ--ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIE 564 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~~~ 564 (790)
.++|++.++||+|+||.||+|... +..+++|.+... ..+.+.+|+.++++++|+||+++++++.+. ..+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 357899999999999999999876 677999988643 346789999999999999999999987654 5899999999
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccc
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH 644 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 644 (790)
+++|.+++.......+++..++.++.+++.||+|||+.++ +|+||||+||+++.++.++|+|||++...........
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i---~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY---IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe---eccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 9999999976545568999999999999999999999997 9999999999999999999999999987643322222
Q ss_pred cccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 645 TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
....++..|+|||++....++.++||||||+++|||++ |..||...... .....+....
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~~------------ 221 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--------DVMSALQRGY------------ 221 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--------HHHHHHHcCC------------
Confidence 23345678999999998899999999999999999998 88888543211 1111111110
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
........+..+.+++.+||+.+|++||+++++.+.|+.+
T Consensus 222 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 222 --RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred --CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0011122345788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=312.01 Aligned_cols=263 Identities=25% Similarity=0.369 Sum_probs=205.8
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChhhHH-----HHHHHHHHHHhcCCCCCcceEEEEec---CeEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASK-----EFLAELKVLTHVHHLNLVRLIGYCVE---GSLFLV 559 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~~-----~~~~E~~~l~~l~h~niv~l~g~~~~---~~~~lv 559 (790)
++|+.++.|++|+||.||+|+++ ++.||+|+++.+..+ .-.+|+.+|.+++|||||.+-.+... ++.|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45778999999999999999987 889999999875543 36789999999999999999988763 358999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
||||+. +|..+++... +++...+..-+..|+++|++|||.+.+ +|||||++|+|++..|.+||+|||+|+.+...
T Consensus 156 Me~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wi---lHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWI---LHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhcee---EecccchhheeeccCCcEEecccchhhhhcCC
Confidence 999999 9999998765 579999999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC----Ch
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD----PR 714 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~ 714 (790)
. ...+..+-|.+|+|||.+.+. .|++..|+||+|||+.||+++++.|....+. ..+...+ ..+..+. +.
T Consensus 231 ~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~----dQl~~If-~llGtPte~iwpg 304 (419)
T KOG0663|consen 231 L-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI----DQLDKIF-KLLGTPSEAIWPG 304 (419)
T ss_pred c-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH----HHHHHHH-HHhCCCccccCCC
Confidence 2 234556779999999999875 6999999999999999999999888665432 1122222 2222111 00
Q ss_pred -hhhh--------hhcCCcCCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 715 -EDLQ--------RLVDPRLGDDYPID-SVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 715 -~~l~--------~~~d~~l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
..+. ......++..|+.. ..+.-++|+..++..||.+|-|++|.+.+=.
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~ 363 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEY 363 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccc
Confidence 0000 00011122223322 4467789999999999999999999887544
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=339.08 Aligned_cols=252 Identities=25% Similarity=0.429 Sum_probs=198.3
Q ss_pred hcCcccceeeeecCceEEEEEEEC-------CceEEEEEeChh----hHHHHHHHHHHHHhc-CCCCCcceEEEEecC-e
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDMQ----ASKEFLAELKVLTHV-HHLNLVRLIGYCVEG-S 555 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~ 555 (790)
.++|++.+.||+|+||.||+|.+. +..+|||.++.. ..+.+.+|++++..+ +||||++++++|.++ .
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 457889999999999999999742 457999998642 335688999999999 899999999998754 5
Q ss_pred EEEEEEEecCCChhhhhhcCC-----------------------------------------------------------
Q 046083 556 LFLVYEYIENGNLNQHLRGSG----------------------------------------------------------- 576 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------- 576 (790)
.++||||+++|+|.++++...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 899999999999999986422
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 577 --------------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 577 --------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
...++|..+++++.++++||+|||++++ +||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i---vH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCe---eccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1247899999999999999999999997 99999999999999999999999999865432221
Q ss_pred c-ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 643 V-HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 643 ~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
. .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... ... ...+..
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-------~~~-~~~~~~---------- 332 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-------SKF-YKMIKE---------- 332 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-------HHH-HHHHHh----------
Confidence 1 112334668999999999999999999999999999998 88887543211 011 111111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
......+...+.++.+++.+||+.||++||++.||++.|++
T Consensus 333 ---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 333 ---GYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ---CccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 11111122234578999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.84 Aligned_cols=250 Identities=28% Similarity=0.545 Sum_probs=201.9
Q ss_pred cCcccceeeeecCceEEEEEEECC-------ceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELRG-------EKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLF 557 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~g-------~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~ 557 (790)
++|++.+.||+|+||.||+|...+ ..+++|.++.. ...+|.+|++++.+++||||+++++++.+. ..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999998752 46899988642 235688999999999999999999998754 589
Q ss_pred EEEEEecCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC
Q 046083 558 LVYEYIENGNLNQHLRGSGK--------------DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF 623 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~ 623 (790)
++|||+++++|.+++..... ..+++..++.++.+++.||.|||++++ +|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i---~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHF---VHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCe---eccccccceEEEcCCC
Confidence 99999999999999975321 458899999999999999999999997 9999999999999999
Q ss_pred cEEEEEeCCCcccccCCc-ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchH
Q 046083 624 RAKVADFGLAKLTEVGSA-SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLV 701 (790)
Q Consensus 624 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~ 701 (790)
.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-------- 233 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-------- 233 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence 999999999986533221 12223456788999999998899999999999999999998 99888543211
Q ss_pred HHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 702 ALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 702 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
.....+. .......+...+.++.+|+.+||+.||.+||++.||++.|..
T Consensus 234 ~~~~~i~--------------~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 EVIEMIR--------------SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHH--------------cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111111 111122344566789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=337.51 Aligned_cols=246 Identities=26% Similarity=0.396 Sum_probs=207.9
Q ss_pred cccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
|.+++.||.|+.|.|-.|+.. |+.+|||.+... ....+.+|+-+|+-+.|||++++|+++.+ .++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 677899999999999999885 999999998653 22457899999999999999999998875 569999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+++|.|+++|..++ ++.+.+..++++||+.|+.|+|..++ +||||||+|+|||..+++||+|||||.+... ..
T Consensus 94 v~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~i---cHRDLKpENlLLd~~~nIKIADFGMAsLe~~--gk 166 (786)
T KOG0588|consen 94 VPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFNI---CHRDLKPENLLLDVKNNIKIADFGMASLEVP--GK 166 (786)
T ss_pred cCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhcc---eeccCCchhhhhhcccCEeeeccceeecccC--Cc
Confidence 99999999998876 58999999999999999999999998 9999999999999999999999999986543 33
Q ss_pred cccccccCCCccchhcccCCCCC-chhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhc
Q 046083 643 VHTRLVGTFGYMPPEYAQYGEVS-PKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s-~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 721 (790)
....-+|+++|.+||++++..|+ .++||||.|||||.||||+.||... ++..+...+-...
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd--------Nir~LLlKV~~G~---------- 228 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD--------NIRVLLLKVQRGV---------- 228 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc--------cHHHHHHHHHcCc----------
Confidence 44567899999999999999885 6899999999999999999999632 2222222222111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 722 DPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 722 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
-+.|...+.+..+|+++|+..||++|.|++||+.+-+-..-
T Consensus 229 -----f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 229 -----FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred -----ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 12355677789999999999999999999999998775443
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=317.82 Aligned_cols=252 Identities=28% Similarity=0.479 Sum_probs=204.5
Q ss_pred hcCcccceeeeecCceEEEEEEEC-CceEEEEEeChh--hHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEEEecC
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ--ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIEN 565 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e~~~~ 565 (790)
.++|++.++||+|+||.||+|.+. ...+++|.++.. ..+++.+|++++++++|+||+++++++.+...++||||+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 84 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCC
Confidence 356899999999999999999876 457999998742 34678999999999999999999998877778999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
|+|.+++.......+++..+..++.+++.||+|||+.++ +|+||||+||++++++.+||+|||+++...........
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i---~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~ 161 (262)
T cd05071 85 GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 161 (262)
T ss_pred CcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCc---cccccCcccEEEcCCCcEEeccCCceeecccccccccc
Confidence 999999986544568999999999999999999999998 99999999999999999999999999866433322222
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCc
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 724 (790)
...++..|+|||+..+..++.++||||||+++|||++ |..||...... .........
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--------~~~~~~~~~-------------- 219 (262)
T cd05071 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVERG-------------- 219 (262)
T ss_pred CCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--------HHHHHHhcC--------------
Confidence 3446678999999988899999999999999999999 77787543211 111111110
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 725 LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 725 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
.....+.+.+..+.+++.+|++.+|++||++.++++.|+..
T Consensus 220 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 220 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 00112234556789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.93 Aligned_cols=252 Identities=25% Similarity=0.447 Sum_probs=203.4
Q ss_pred hcCcccceeeeecCceEEEEEEEC-CceEEEEEeChh--hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEec
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ--ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIE 564 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~ 564 (790)
.++|++.+.||+|++|.||+|.+. +..+|+|.++.. ..+++.+|++++++++|+|++++++++.. +..+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 467899999999999999999876 668999998753 34678999999999999999999998875 45899999999
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccc
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH 644 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 644 (790)
+++|.+++.......+++..+..++.+++.||.|||+.++ +|+||||+||++++++.+||+|||+++..........
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05068 85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY---IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR 161 (261)
T ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCe---eeccCCcceEEEcCCCCEEECCcceEEEccCCccccc
Confidence 9999999987554568999999999999999999999998 9999999999999999999999999987642221111
Q ss_pred cccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 645 TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
.....+..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+..
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~-------------- 219 (261)
T cd05068 162 EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--------AEVLQQVDQ-------------- 219 (261)
T ss_pred CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHc--------------
Confidence 11223457999999998899999999999999999999 8888854321 111111111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
......+...+..+.+++.+|++.+|.+||++.++++.|+.+
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 220 GYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 111112233456789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=327.79 Aligned_cols=243 Identities=28% Similarity=0.434 Sum_probs=203.0
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEEe
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYI 563 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~~ 563 (790)
.|+..+.||+|.||.||+|.+. ++.||+|.+..+ ..+++..|+.+|.+++++||.+.||.+..+ .++++|||+
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 4666789999999999999986 889999999854 446789999999999999999999987765 589999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
.+|++.+.|.... .+++....-++++++.||.|||.++. +|||||+.|||+..+|.+||+|||.+-.+.......
T Consensus 94 ~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~k---iHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEKK---IHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred cCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcce---ecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 9999999998654 35777788889999999999999998 999999999999999999999999998765433332
Q ss_pred ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 644 HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
..++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+... ...+.+-..|
T Consensus 169 -~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv------------------lflIpk~~PP 229 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV------------------LFLIPKSAPP 229 (467)
T ss_pred -ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE------------------EEeccCCCCC
Confidence 568999999999999988999999999999999999999999876544100 0112222334
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.+.+ .....+.+++..||+.||+.||++.+++.+
T Consensus 230 ~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 230 RLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 4444 344568999999999999999999998763
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=337.93 Aligned_cols=255 Identities=24% Similarity=0.418 Sum_probs=200.3
Q ss_pred HhcCcccceeeeecCceEEEEEEEC-------CceEEEEEeChh----hHHHHHHHHHHHHhc-CCCCCcceEEEEec-C
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDMQ----ASKEFLAELKVLTHV-HHLNLVRLIGYCVE-G 554 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~ 554 (790)
..++|.+.+.||+|+||.||+|... +..||+|.++.. ..+.+.+|+++++.+ +|+||++++++|.+ +
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3457889999999999999999753 247999998642 235688999999999 89999999998875 4
Q ss_pred eEEEEEEEecCCChhhhhhcCC----------------------------------------------------------
Q 046083 555 SLFLVYEYIENGNLNQHLRGSG---------------------------------------------------------- 576 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 576 (790)
..++||||+++|+|.++++...
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 5899999999999999986421
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc-ccc
Q 046083 577 ----------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS-VHT 645 (790)
Q Consensus 577 ----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~ 645 (790)
...+++..+++++.|++.||+|||++++ +||||||+|||+++++.+||+|||+++........ ...
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gi---iHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNC---IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCE---EeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 1247889999999999999999999997 99999999999999999999999999865432211 111
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCc
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 724 (790)
...++..|+|||++.+..++.++|||||||++|||++ |+.||...... . ........ .
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~----~----~~~~~~~~-------------~ 331 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN----S----KFYKMVKR-------------G 331 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc----H----HHHHHHHc-------------c
Confidence 2335678999999998899999999999999999997 99998643211 0 01111111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 046083 725 LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLS 766 (790)
Q Consensus 725 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~ 766 (790)
.....+...+.++.+++.+||+.||.+|||+.+|++.|.++.
T Consensus 332 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 332 YQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 111112223467899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=323.89 Aligned_cols=248 Identities=25% Similarity=0.386 Sum_probs=198.8
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChhh------HHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA------SKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYE 561 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~------~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e 561 (790)
.|+..+.||+|+||.||++... ++.+|+|.+.... ...+.+|++++.+++|+|++++++++.+ +..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3778899999999999999875 8899999886422 2357789999999999999999998764 45899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|+++|+|.+++.......+++..+..++.|++.||+|||+.++ +||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i---iH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERI---VYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCE---EeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 9999999988875544568999999999999999999999997 999999999999999999999999998653221
Q ss_pred ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhc
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 721 (790)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....... ..........
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~~~~~~~~------------ 218 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-----KREEVDRRVK------------ 218 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-----hHHHHHHHhh------------
Confidence 2234568999999999999999999999999999999999999997543210 0000000000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 046083 722 DPRLGDDYPIDSVRKMARLARACTQENPQLRPS-----MRAIVVAL 762 (790)
Q Consensus 722 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~L 762 (790)
. ....++......+.+|+.+||+.||.+||+ +++++++-
T Consensus 219 ~--~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~ 262 (285)
T cd05631 219 E--DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHP 262 (285)
T ss_pred c--ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence 0 011223344567889999999999999997 78887753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=316.96 Aligned_cols=248 Identities=27% Similarity=0.472 Sum_probs=199.1
Q ss_pred cCcccceeeeecCceEEEEEEEC-CceEEEEEeChh--hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEEecC
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ--ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIEN 565 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~~~~ 565 (790)
++|++.+.||+|+||.||++.++ +..+|+|.+... ..+++.+|++++++++||||+++++++.+. ..+++|||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 45888999999999999999887 558999987643 346789999999999999999999988754 58999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
|+|.++++... ..+++..+..++.+++.||.|||++++ +|+||||+||+++.++.+||+|||+++...........
T Consensus 84 ~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 84 GCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSF---IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred CcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCc---cccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 99999997543 258999999999999999999999998 99999999999999999999999998865322222222
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCc
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 724 (790)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+.....
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--------~~~~~~i~~~~~------------ 219 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--------YEVVEMISRGFR------------ 219 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCC------------
Confidence 2345668999999998899999999999999999999 8888854321 112222221110
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 725 LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 725 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
...+......+.+++.+||+.+|.+||+++|+++.|+
T Consensus 220 --~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 220 --LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred --CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111223457899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.06 Aligned_cols=250 Identities=28% Similarity=0.489 Sum_probs=203.8
Q ss_pred cCcccceeeeecCceEEEEEEEC-CceEEEEEeChh--hHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEEEecCC
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ--ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENG 566 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e~~~~g 566 (790)
++|++.++||+|+||.||+|... +..+|+|.++.. ..+.+.+|+.++++++|+|++++++++.+...+++|||++++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~ 85 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSKG 85 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCCC
Confidence 46888999999999999999876 678999988742 346789999999999999999999998777789999999999
Q ss_pred ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccccc
Q 046083 567 NLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR 646 (790)
Q Consensus 567 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 646 (790)
+|.+++.......+++..++.++.+++.||.|||++++ +|+||||+||++++++.++|+|||++.............
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i---~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05070 86 SLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY---IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQG 162 (260)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCccceEEEeCCceEEeCCceeeeeccCcccccccC
Confidence 99999986554568999999999999999999999998 999999999999999999999999998654322222222
Q ss_pred cccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 647 LVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 647 ~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
..++..|+|||.+.+..++.++|+||||+++|||++ |..||..... ......+.. ..
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~--------------~~ 220 (260)
T cd05070 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--------REVLEQVER--------------GY 220 (260)
T ss_pred CCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHc--------------CC
Confidence 345678999999988899999999999999999999 8888854221 111111111 11
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
....+...+..+.+++.+|++.+|++|||++++.+.|..
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 112233445679999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=320.08 Aligned_cols=257 Identities=22% Similarity=0.391 Sum_probs=203.9
Q ss_pred cCcccceeeeecCceEEEEEEEC--Cc----eEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GE----KAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLV 559 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~----~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv 559 (790)
++|++.+.||+|+||.||+|.+. ++ .+++|.+... ...++..|+..+.+++||||+++++++.....+++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i 86 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV 86 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence 46778899999999999999874 43 4788887532 23567788889999999999999999887778999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
+||+++|+|.+++.... ..+++..+..++.|++.||+|||+.++ +||||||+|||+++++.+||+|||+++.....
T Consensus 87 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i---iH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 87 TQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRM---VHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCE---eccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999999997643 368999999999999999999999997 99999999999999999999999999865432
Q ss_pred Ccc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 640 SAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 640 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
... ......++..|+|||.+.++.++.++||||||+++|||++ |..||...... .....+....
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---------~~~~~~~~~~----- 228 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---------EVPDLLEKGE----- 228 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---------HHHHHHHCCC-----
Confidence 221 1223456778999999998899999999999999999998 98888543211 0111111110
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccC
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDW 772 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~ 772 (790)
....+......+.+++.+||..+|++|||+.|+++.|..+...+..|
T Consensus 229 --------~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~~ 275 (279)
T cd05111 229 --------RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPRY 275 (279)
T ss_pred --------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCcce
Confidence 00111123346788999999999999999999999999887765544
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=317.48 Aligned_cols=251 Identities=28% Similarity=0.491 Sum_probs=205.5
Q ss_pred hcCcccceeeeecCceEEEEEEEC-CceEEEEEeChh--hHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEEEecC
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ--ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIEN 565 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e~~~~ 565 (790)
.++|++.++||+|+||.||+|... ++.+|+|.+... ..+++.+|+.++++++|+|++++++++.++..+++|||+.+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMEN 84 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCCC
Confidence 457889999999999999999876 788999998743 34678999999999999999999999877779999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
++|.+++.......+++.+++.++.+++.||+|||+.++ +|+||||+||+++.++.++|+|||++............
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i---~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05067 85 GSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE 161 (260)
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCe---ecccccHHhEEEcCCCCEEEccCcceeecCCCCccccc
Confidence 999999976555578999999999999999999999997 99999999999999999999999999865432222222
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCc
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 724 (790)
...++..|+|||++....++.++||||||+++|||++ |+.||...... ........ .
T Consensus 162 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~--------------~ 219 (260)
T cd05067 162 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--------EVIQNLER--------------G 219 (260)
T ss_pred CCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--------HHHHHHHc--------------C
Confidence 3345678999999998899999999999999999999 99998543211 11111111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 725 LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 725 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
.....+...+.++.+++.+||+.+|++||++++++..|+.
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 220 YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1111222344679999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=330.17 Aligned_cols=255 Identities=30% Similarity=0.493 Sum_probs=201.4
Q ss_pred hcCcccceeeeecCceEEEEEEEC-------CceEEEEEeCh----hhHHHHHHHHHHHHhc-CCCCCcceEEEEec--C
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDM----QASKEFLAELKVLTHV-HHLNLVRLIGYCVE--G 554 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~--~ 554 (790)
.++|++.+.||+|+||.||+|... ++.+|+|+++. ...+.+..|++++.++ +|+||++++++|.. .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357899999999999999999643 36799999863 2335678899999999 89999999998863 3
Q ss_pred eEEEEEEEecCCChhhhhhcCC----------------------------------------------------------
Q 046083 555 SLFLVYEYIENGNLNQHLRGSG---------------------------------------------------------- 576 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 576 (790)
..+++|||+++++|.+++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 4889999999999999886421
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc-ccccccCCCcc
Q 046083 577 -KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV-HTRLVGTFGYM 654 (790)
Q Consensus 577 -~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~ 654 (790)
...++|..+.+++.+++.||+|||++++ +||||||+|||++.++.+||+|||+++.+....... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~i---vHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 1268999999999999999999999997 999999999999999999999999998654322211 22345567899
Q ss_pred chhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHH
Q 046083 655 PPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDS 733 (790)
Q Consensus 655 aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 733 (790)
|||++.+..++.++|||||||++|||++ |..||...... ......+.. ......+...
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--------~~~~~~~~~-------------~~~~~~~~~~ 301 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--------EEFCRRLKE-------------GTRMRAPEYA 301 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--------HHHHHHHhc-------------cCCCCCCccC
Confidence 9999999999999999999999999998 99988543211 001111111 0111112234
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 734 VRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 734 ~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
..++.+++.+||+.+|++||++.|++++|.++..
T Consensus 302 ~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 302 TPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 4678999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=325.01 Aligned_cols=262 Identities=25% Similarity=0.357 Sum_probs=205.0
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEE
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFL 558 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~l 558 (790)
..++|+++..||+|+||.||.|+.+ |+.+|+|+++.. ..+....|-++|....+|+||+||-.+.+. .+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 5678999999999999999999876 899999999753 445688999999999999999998777654 5999
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
||||++||++..+|...+ .|++.....++.+++-|+..||++|+ |||||||+|+|||..|++||+||||+.-+..
T Consensus 219 iMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~gy---IHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLGY---IHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcCc---ccccCChhheeecCCCCEeeccccccchhhh
Confidence 999999999999998754 69999999999999999999999998 9999999999999999999999999852210
Q ss_pred --------------------CC---c----cc-------------------ccccccCCCccchhcccCCCCCchhhHHH
Q 046083 639 --------------------GS---A----SV-------------------HTRLVGTFGYMPPEYAQYGEVSPKIDVYA 672 (790)
Q Consensus 639 --------------------~~---~----~~-------------------~~~~~gt~~y~aPE~~~~~~~s~~sDvwS 672 (790)
.. . .. ....+|||-|||||++.+..|+..+|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 00 0 00 01247999999999999999999999999
Q ss_pred HHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCC
Q 046083 673 FGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLR 752 (790)
Q Consensus 673 ~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R 752 (790)
+|||+||||.|-+||....+. ..+..++.+. . .+.......+..+..+||.+|+. ||++|
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~--------~T~rkI~nwr-------~----~l~fP~~~~~s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQ--------ETYRKIVNWR-------E----TLKFPEEVDLSDEAKDLITRLLC-DPENR 433 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHh-------h----hccCCCcCcccHHHHHHHHHHhc-CHHHh
Confidence 999999999999999765432 2222222210 0 01111112334678899999999 99999
Q ss_pred CC---HHHHHHHHHhhccCCccCCcCCcccccccccccc
Q 046083 753 PS---MRAIVVALMTLSSSSEDWDIGSFYENQGLDSLMS 788 (790)
Q Consensus 753 Pt---~~evl~~L~~l~~~~~~~~~~~~~~~~~~~~~~~ 788 (790)
-- ++|| ..+.||..-.|++|.+
T Consensus 434 LG~~G~~EI--------------K~HPfF~~v~W~~l~~ 458 (550)
T KOG0605|consen 434 LGSKGAEEI--------------KKHPFFKGVDWDHLRE 458 (550)
T ss_pred cCcccHHHH--------------hcCCccccCCcchhhc
Confidence 64 3333 3445566666665544
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=318.13 Aligned_cols=252 Identities=27% Similarity=0.512 Sum_probs=206.0
Q ss_pred HhcCcccceeeeecCceEEEEEEEC-CceEEEEEeChh---hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEE
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ---ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEY 562 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~ 562 (790)
...+|++.++||+|+||.||+|... +..+++|.+... ...++.+|+++++.++|+|++++++++.+. ..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 3457889999999999999999987 678999998743 346789999999999999999999988754 48999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+++++|.+++.......+++..+++++.+++.||.|||++++ +|+||+|+||++++++.+||+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i---~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNS---IHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe---eccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 999999999987655678999999999999999999999997 99999999999999999999999999865432211
Q ss_pred cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhc
Q 046083 643 VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 721 (790)
.....++..|+|||.+....++.++||||||+++++|++ |+.||..... ...+....
T Consensus 161 -~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~------------- 218 (261)
T cd05148 161 -SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--------HEVYDQIT------------- 218 (261)
T ss_pred -ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHH-------------
Confidence 123345678999999998899999999999999999998 8888854321 11111111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 722 DPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 722 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
.......+..++..+.+++.+||+.+|.+|||++++++.|+.+
T Consensus 219 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 219 -AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 1111222344556789999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=314.65 Aligned_cols=250 Identities=29% Similarity=0.477 Sum_probs=203.2
Q ss_pred cCcccceeeeecCceEEEEEEEC-CceEEEEEeChh--hHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEEEecCC
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ--ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENG 566 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e~~~~g 566 (790)
++|.+.+.||+|+||.||+|.+. +..+++|.+... ..+.+.+|++++++++|+|++++++++.+...+++|||+.++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~ 85 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKG 85 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCCC
Confidence 45888999999999999999886 457999987643 335688999999999999999999998777789999999999
Q ss_pred ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccccc
Q 046083 567 NLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR 646 (790)
Q Consensus 567 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 646 (790)
+|.++++......+++..+..++.+++.||.|||+.++ +|+||||+||++++++.++|+|||++.............
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i---~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05069 86 SLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY---IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG 162 (260)
T ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE---eecccCcceEEEcCCCeEEECCCccceEccCCcccccCC
Confidence 99999986554568999999999999999999999997 999999999999999999999999998654332222222
Q ss_pred cccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 647 LVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 647 ~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
..++..|+|||...+..++.++||||||+++|||++ |..||..... .......... .
T Consensus 163 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~--------------~ 220 (260)
T cd05069 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--------REVLEQVERG--------------Y 220 (260)
T ss_pred CccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcC--------------C
Confidence 345678999999998899999999999999999999 8888854321 1111111111 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
....+...+..+.+++.+||+.+|++||++++|++.|+.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 221 RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111223445678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=323.28 Aligned_cols=256 Identities=28% Similarity=0.484 Sum_probs=196.8
Q ss_pred cCcccceeeeecCceEEEEEEEC------------------CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcce
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR------------------GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRL 547 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~------------------g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l 547 (790)
++|++.++||+|+||.||++.+. +..+|+|.+... ...+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 56888999999999999999753 236999988642 34578999999999999999999
Q ss_pred EEEEec-CeEEEEEEEecCCChhhhhhcCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceee
Q 046083 548 IGYCVE-GSLFLVYEYIENGNLNQHLRGSG-----------------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIH 609 (790)
Q Consensus 548 ~g~~~~-~~~~lv~e~~~~g~L~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH 609 (790)
++++.+ ...++||||+++|+|.+++.... ...++|..+++++.|++.||.|||++++ +|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i---vH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF---VH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc---cc
Confidence 999875 45899999999999999886431 1247889999999999999999999998 99
Q ss_pred cCCCCCCEEecCCCcEEEEEeCCCcccccCCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhC--Ccc
Q 046083 610 RDIKPANILIDKNFRAKVADFGLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISA--MEA 686 (790)
Q Consensus 610 ~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG--~~p 686 (790)
|||||+|||++.++.+||+|||+++........ ......++..|+|||++..+.++.++||||||+++|||+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999865432221 12234557889999999988999999999999999999874 455
Q ss_pred ccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 687 VVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
|...... .............. .......+..++..+.+++.+||+.+|++|||+.+|.+.|.
T Consensus 242 ~~~~~~~-----~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDE-----QVIENAGEFFRDQG----------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHH-----HHHHHHHHHhhhcc----------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 5432211 11111111111000 00001112344567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=315.38 Aligned_cols=251 Identities=27% Similarity=0.460 Sum_probs=201.5
Q ss_pred hcCcccceeeeecCceEEEEEEEC-----CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-----GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFL 558 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-----g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~l 558 (790)
.++|++.+.||+|+||.||+|.+. ...+++|.++.. ...+|.+|+.++++++||||+++++++.++ ..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 357899999999999999999875 247899988642 345688999999999999999999988754 5899
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
+|||+++++|.+++..... .+++..+++++.+++.||+|||++++ +|+||||+|||+++++.++|+|||+++....
T Consensus 83 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~i---~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999999976432 68999999999999999999999998 9999999999999999999999999987642
Q ss_pred CCccc-ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhh
Q 046083 639 GSASV-HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716 (790)
Q Consensus 639 ~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (790)
..... .....++..|+|||.+.+..++.++||||||+++|||++ |..||..... ..........
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~------ 224 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--------QDVIKAVEDG------ 224 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH--------HHHHHHHHcC------
Confidence 22211 112334678999999998999999999999999999998 9888754321 1111111110
Q ss_pred hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 717 LQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 717 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
.....+...+..+.+++.+||+.+|++||+++||++.|.++
T Consensus 225 --------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 --------YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=320.58 Aligned_cols=261 Identities=27% Similarity=0.359 Sum_probs=198.1
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYE 561 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e 561 (790)
++|++.+.||+|+||.||+++.. ++.+|+|+++.. ..+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47899999999999999999986 678999988632 23567889999999999999999998764 56899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|++++.|..+.... ..+++..+..++.|++.||.|||+.++ +||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i---~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKNDI---VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99997776554432 358999999999999999999999998 9999999999999999999999999987643333
Q ss_pred ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh---
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ--- 718 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--- 718 (790)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||....... .. ........ +.+...+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~----~~-~~~~~~~~-~~~~~~~~~~~ 229 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID----QL-FTIQKVLG-PLPAEQMKLFY 229 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH----HH-HHHHHhhC-CCCHHHHHhhh
Confidence 23334568999999999998899999999999999999999999986533210 00 00111110 00000000
Q ss_pred ------hhcCCcCCC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 719 ------RLVDPRLGD------DYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 719 ------~~~d~~l~~------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
....+.... ......+..+.+++.+||+.||++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 0011234578999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=324.56 Aligned_cols=242 Identities=27% Similarity=0.405 Sum_probs=199.4
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
++|++.+.||+|+||.||+|... ++.+|+|.+... ..+.+.+|++++++++||||+++++++.+ ...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47889999999999999999986 889999998642 23568899999999999999999998775 4589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++|+|.+++...+ .+++.....++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKEI---VYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 9999999999998654 58899999999999999999999998 99999999999999999999999999865322
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+....
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~--------- 214 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--------FGIYEKILAGK--------- 214 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC---------
Confidence 1235689999999999988999999999999999999999999864321 11222222111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPS-----MRAIVVALM 763 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~L~ 763 (790)
..++......+.+++.+||+.||.+||+ ++|++++-+
T Consensus 215 ------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 215 ------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred ------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence 1122233457889999999999999995 888887654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=369.62 Aligned_cols=271 Identities=25% Similarity=0.431 Sum_probs=211.4
Q ss_pred cCHHHHHHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eE
Q 046083 480 FSYEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SL 556 (790)
Q Consensus 480 ~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~ 556 (790)
++++++. ..|...+.||+|+||.||+|... +..||+|+++.... ....|++.+++++||||++++|+|.+. ..
T Consensus 683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~ 758 (968)
T PLN00113 683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEIADMGKLQHPNIVKLIGLCRSEKGA 758 (968)
T ss_pred hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence 3444543 35677889999999999999974 78999999864322 223568899999999999999999754 58
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
++||||+++|+|.++++. ++|..+.+++.++++||+|||+...+.++||||||+||+++.++..++. ||.+...
T Consensus 759 ~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred EEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 999999999999999963 8999999999999999999996654556999999999999999988876 6665533
Q ss_pred ccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhh
Q 046083 637 EVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716 (790)
Q Consensus 637 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (790)
... ....+++.|+|||++.+..++.++|||||||++|||+||+.|+..... .......+....... ..
T Consensus 833 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~----~~ 900 (968)
T PLN00113 833 CTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG---VHGSIVEWARYCYSD----CH 900 (968)
T ss_pred ccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC---CCCcHHHHHHHhcCc----cc
Confidence 211 223678999999999999999999999999999999999999843221 122233333332221 23
Q ss_pred hhhhcCCcCCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccC
Q 046083 717 LQRLVDPRLGD--DYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDW 772 (790)
Q Consensus 717 l~~~~d~~l~~--~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~ 772 (790)
...++|+.+.. ..+.++..++.+++.+||+.+|++||||+||++.|+.+...+.+.
T Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~~ 958 (968)
T PLN00113 901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSC 958 (968)
T ss_pred hhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccccc
Confidence 44566666543 234567778999999999999999999999999999986655543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=329.10 Aligned_cols=241 Identities=27% Similarity=0.456 Sum_probs=198.0
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
++|++.+.||+|+||.||+|... ++.+|+|.++.. ..+.+.+|+.++++++||||+++++++.+ +..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56889999999999999999986 788999998643 23568899999999999999999998875 4589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~i---vH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKDI---IYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred cCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 9999999999998654 58889999999999999999999998 999999999999999999999999998653221
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
....|++.|+|||++.+..++.++|||||||++|||++|..||..... ......+...
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~---------- 230 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------FRIYEKILAG---------- 230 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--------HHHHHHHhcC----------
Confidence 235689999999999999999999999999999999999999864321 1111222111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPS-----MRAIVVAL 762 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~L 762 (790)
.+ .++......+.+++.+||+.||.+||+ +++++.+-
T Consensus 231 ---~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 231 ---RL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred ---Cc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 11 112223456889999999999999997 68877653
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=312.81 Aligned_cols=247 Identities=30% Similarity=0.501 Sum_probs=202.6
Q ss_pred cCcccceeeeecCceEEEEEEECCceEEEEEeChh-hHHHHHHHHHHHHhcCCCCCcceEEEEec--CeEEEEEEEecCC
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQ-ASKEFLAELKVLTHVHHLNLVRLIGYCVE--GSLFLVYEYIENG 566 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~lv~e~~~~g 566 (790)
++|.+.+.||+|+||.||++...+..+++|.++.. ..+.+.+|+.++++++|+|++++++++.. +..+++|||++++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 85 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCC
Confidence 46888999999999999999999999999998754 34568999999999999999999997653 4589999999999
Q ss_pred ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccccc
Q 046083 567 NLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR 646 (790)
Q Consensus 567 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 646 (790)
+|.+++.......+++..+++++.+++.||+|||++++ +||||||+||++++++.+||+|||+++...... ..
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~~ 158 (256)
T cd05082 86 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNF---VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DT 158 (256)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCE---eccccchheEEEcCCCcEEecCCccceeccccC----CC
Confidence 99999987655568999999999999999999999997 999999999999999999999999987543221 22
Q ss_pred cccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 647 LVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 647 ~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
..++..|+|||++....++.++||||||+++|||++ |+.||.... .......... ..
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~--------~~~~~~~~~~--------------~~ 216 (256)
T cd05082 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPRVEK--------------GY 216 (256)
T ss_pred CccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHhc--------------CC
Confidence 334668999999998899999999999999999998 888875321 1111111111 11
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
....+...+..+.+++.+||+.+|++|||+.++++.|..+
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 217 KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1122234456789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.87 Aligned_cols=253 Identities=25% Similarity=0.433 Sum_probs=214.6
Q ss_pred hcCcccceeeeecCceEEEEEEEC----Cc--eEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR----GE--KAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFL 558 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~----g~--~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~l 558 (790)
.+..++.++||.|.||.||+|.+. |+ .||||.-+. +..+.|..|.-+|+.++||||++++|+|.+...|+
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~Wi 467 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWI 467 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeE
Confidence 344567889999999999999874 33 478887653 55678999999999999999999999999999999
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
|||.++-|.|..||+.. +..++......++.|++.||+|||+... |||||..+|||+.....+||+|||+++.++.
T Consensus 468 vmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSkrf---VHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESKRF---VHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhhch---hhhhhhhhheeecCcceeeecccchhhhccc
Confidence 99999999999999875 3578999999999999999999999987 9999999999999999999999999998876
Q ss_pred CCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 639 GSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
......+...-...|||||.+....++.++|||.|||.+||+++ |..||....... .
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------------V 601 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------------V 601 (974)
T ss_pred cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------------e
Confidence 55444444445778999999999999999999999999999876 999997654321 1
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
-..++..-+...|+.++..+..|+.+||+.+|.+||++.|+...|+.+.+
T Consensus 602 I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 602 IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 11122233346678899999999999999999999999999999887754
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=314.22 Aligned_cols=248 Identities=29% Similarity=0.490 Sum_probs=198.8
Q ss_pred cCcccceeeeecCceEEEEEEECC-ceEEEEEeChhh--HHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEEecC
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELRG-EKAAIKKMDMQA--SKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIEN 565 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~g-~~vavK~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~~~~ 565 (790)
++|++.+.||+|+||.||+|.+.+ ..+|+|.+.... .+++.+|+.++++++||||+++++++.+. ..+++|||+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 457889999999999999998874 469999887432 46789999999999999999999998754 47999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
|+|.+++..... .+++..+++++.+++.||+|||+.++ +|+||||+||+++.++.+||+|||+++...........
T Consensus 84 ~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 84 GCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQF---IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred CcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCe---eccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 999999976433 68999999999999999999999997 99999999999999999999999998865432221112
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCc
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 724 (790)
...++..|++||.+.+..++.++||||||+++|||++ |..||...... ..........
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~------------- 218 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--------ETVEKVSQGL------------- 218 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHhcCC-------------
Confidence 2345678999999998889999999999999999998 88887543221 1111111110
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 725 LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 725 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
....+......+.+++.+||+.+|.+||++.++++.|+
T Consensus 219 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 219 -RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 01111223467899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=316.48 Aligned_cols=258 Identities=22% Similarity=0.382 Sum_probs=206.2
Q ss_pred hcCcccceeeeecCceEEEEEEEC--Cc----eEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GE----KAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFL 558 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~----~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~l 558 (790)
.++|++.+.||+|+||.||+|.+. +. .||+|.++. ...+++.+|+.++..++|+|++++++++.....++
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l 85 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQL 85 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEE
Confidence 457888999999999999999864 43 489998863 23456889999999999999999999998777899
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
+|||+++|+|.++++... ..+++..++.++.|++.||+|||++++ +||||||+|||+++++.+||+|||+++....
T Consensus 86 ~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i---iH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRL---VHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCe---eccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999997643 358999999999999999999999997 9999999999999999999999999987643
Q ss_pred CCccc-ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhh
Q 046083 639 GSASV-HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716 (790)
Q Consensus 639 ~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (790)
..... .....++..|+|||.+.+..++.++||||||+++|||++ |..||..... ... ...+...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~----~~~~~~~----- 227 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-----REI----PDLLEKG----- 227 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHH----HHHHHCC-----
Confidence 32211 112234678999999998899999999999999999998 8888754221 001 1111110
Q ss_pred hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccC
Q 046083 717 LQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDW 772 (790)
Q Consensus 717 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~ 772 (790)
.....+......+.+++.+||+.||++||++.++++.|..+...+..|
T Consensus 228 --------~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~~ 275 (279)
T cd05109 228 --------ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRF 275 (279)
T ss_pred --------CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcCe
Confidence 011112234457889999999999999999999999999887776554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=295.09 Aligned_cols=248 Identities=25% Similarity=0.442 Sum_probs=210.0
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh------HHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA------SKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLV 559 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~------~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv 559 (790)
.++|++++.||+|.||.||.|+.+ +-.+|+|++..+. ..++.+|+++-+.++||||+++|+++.+. ..||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 467899999999999999999987 5689999986543 35689999999999999999999999865 58999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
+||..+|.|...|+......++......++.|+|.||.|+|..++ +||||||+|+|++..+..||+|||-+...+
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~V---IhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCc---ccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 999999999999997666679999999999999999999999998 999999999999999999999999987543
Q ss_pred CcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
.......+||.-|++||...+...+...|+|++|++.||++.|.+||..... ...+..+..
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~--------~etYkrI~k---------- 236 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH--------SETYKRIRK---------- 236 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh--------HHHHHHHHH----------
Confidence 2233457899999999999999999999999999999999999999965431 112222211
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
-. -.+|........++|.+|+..+|.+|.+..|++.+-+..
T Consensus 237 ---~~--~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 237 ---VD--LKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred ---cc--ccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 11 123445667789999999999999999999999887643
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=322.85 Aligned_cols=264 Identities=23% Similarity=0.371 Sum_probs=201.7
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYE 561 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e 561 (790)
.++|++.+.||+|+||.||++... +..+|+|.+... ..+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367999999999999999999986 778999988643 34568999999999999999999998764 56899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|+++++|.+++.... .+++..+..++.+++.||.|||+.+. ++||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 999999999997643 58899999999999999999998641 399999999999999999999999998755321
Q ss_pred ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHH-HHcCC---------
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEE-VLRQP--------- 711 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~-~~~~~--------- 711 (790)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...... .+...... .....
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-----ELEAIFGRPVVDGEEGEPHSISP 231 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHhcccccccccCCccccCc
Confidence 223456899999999999999999999999999999999999998543221 00000000 00000
Q ss_pred ----------------CCh---hhhhhhcCCcCCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 712 ----------------DPR---EDLQRLVDPRLGDDY-PIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 712 ----------------~~~---~~l~~~~d~~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
... ..+.+.+........ ......++.+|+.+||+.||++|||++|++++.+-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 000 000011100000111 11345678999999999999999999999987664
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=328.26 Aligned_cols=250 Identities=26% Similarity=0.393 Sum_probs=201.0
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~ 560 (790)
++|++.+.||+|+||.||+|... ++.+|+|+++.. ..+.+.+|++++..++||||+++++++.++ ..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46899999999999999999986 789999998743 235678899999999999999999988754 589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++|+|.+++...+ .+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i---vH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGY---IHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999999997643 58899999999999999999999998 9999999999999999999999999986532
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
......|++.|+|||++.+..++.++|||||||++|||++|..||..... ...+..+.... ..
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~-------~~ 216 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP--------NETWENLKYWK-------ET 216 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH--------HHHHHHHHhcc-------cc
Confidence 22345789999999999999999999999999999999999999865322 11111111110 00
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
+..............++.+++.+||+.+|.+||++++++++-.
T Consensus 217 ~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~ 259 (333)
T cd05600 217 LQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF 259 (333)
T ss_pred ccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence 0000000000134567889999999999999999999997643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=332.00 Aligned_cols=255 Identities=24% Similarity=0.421 Sum_probs=201.4
Q ss_pred hcCcccceeeeecCceEEEEEEEC-------CceEEEEEeChh----hHHHHHHHHHHHHhcC-CCCCcceEEEEec-Ce
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDMQ----ASKEFLAELKVLTHVH-HLNLVRLIGYCVE-GS 555 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~g~~~~-~~ 555 (790)
.++|.+.+.||+|+||.||+|... +..||||+++.. ..+.+.+|+++++++. ||||+++++++.+ +.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 567899999999999999999863 236999998642 2356889999999996 9999999999875 45
Q ss_pred EEEEEEEecCCChhhhhhcCC-----------------------------------------------------------
Q 046083 556 LFLVYEYIENGNLNQHLRGSG----------------------------------------------------------- 576 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------- 576 (790)
.|+||||+++|+|.++++...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 899999999999999886421
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC
Q 046083 577 -----------------------------------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK 621 (790)
Q Consensus 577 -----------------------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~ 621 (790)
...+++..+.+++.|+++||.|||+.++ +||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~i---vH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNC---VHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCe---eCCCCChHhEEEeC
Confidence 1247888999999999999999999997 99999999999999
Q ss_pred CCcEEEEEeCCCcccccCCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccc
Q 046083 622 NFRAKVADFGLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTG 699 (790)
Q Consensus 622 ~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~ 699 (790)
++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~------ 346 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD------ 346 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh------
Confidence 999999999999865332221 1122456788999999998899999999999999999997 88887543210
Q ss_pred hHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 700 LVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 700 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
......... ......+...+..+.+++.+||+.+|++|||+.+|.+.|.++..
T Consensus 347 --~~~~~~~~~-------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 347 --STFYNKIKS-------------GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred --HHHHHHHhc-------------CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 000111111 01111223445678999999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.96 Aligned_cols=248 Identities=30% Similarity=0.555 Sum_probs=204.8
Q ss_pred hcCcccceeeeecCceEEEEEEECCceEEEEEeChhh--HHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecC
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQA--SKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIEN 565 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~ 565 (790)
.++|++.+.||+|+||.||+|...++.+++|.++... .+++.+|+.++++++|+|++++++++.+ ...++||||+++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 3568889999999999999999999999999997543 4678999999999999999999999874 558999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
++|.+++.......+++..+..++.+++.||.|||++++ +|+||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i---~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---- 157 (256)
T cd05039 85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF---VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---- 157 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc---cchhcccceEEEeCCCCEEEcccccccccccccc----
Confidence 999999987655579999999999999999999999998 9999999999999999999999999986532211
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCc
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 724 (790)
....+..|+|||.+....++.++||||||+++|||++ |..||..... ......... .
T Consensus 158 ~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~--------------~ 215 (256)
T cd05039 158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPHVEK--------------G 215 (256)
T ss_pred cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHhc--------------C
Confidence 2334668999999998899999999999999999997 9888754321 111111111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 725 LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 725 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
.....+...+..+.+++.+||+.+|++|||++|++..|..+
T Consensus 216 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 216 YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11112233456789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=312.12 Aligned_cols=241 Identities=25% Similarity=0.411 Sum_probs=195.5
Q ss_pred eeeecCceEEEEEEEC----CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEEEecCCC
Q 046083 497 KIGQGGFGAVFYAELR----GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN 567 (790)
Q Consensus 497 ~lG~G~fg~Vy~a~~~----g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e~~~~g~ 567 (790)
+||+|+||.||+|.+. +..+|+|.++.. ..+++.+|+.+++.++|+||+++++++.+...++||||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 6899999999999753 678999988632 3457889999999999999999999998777899999999999
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc--cc
Q 046083 568 LNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV--HT 645 (790)
Q Consensus 568 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~--~~ 645 (790)
|.+++.... .+++..+.+++.|++.||+|||++++ +||||||+||+++.++.+||+|||+++......... ..
T Consensus 82 L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i---~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 82 LNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETNF---VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCE---eecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999997543 58999999999999999999999997 999999999999999999999999998664332211 11
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCc
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 724 (790)
...++..|+|||.+....++.++|+||||+++|||++ |..||...... ..... +. ..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~-i~-------------~~ 214 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--------EVTQM-IE-------------SG 214 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHH-HH-------------CC
Confidence 2234578999999988889999999999999999998 99998643221 11111 11 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 725 LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 725 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
.....+...+..+.+++.+||+.||++||++.+|.+.|..
T Consensus 215 ~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 215 ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1122233455678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=339.03 Aligned_cols=256 Identities=23% Similarity=0.364 Sum_probs=210.4
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeC---hhhHHHHHHHHHHHHhcC-CCCCcceEE-EEe----cC---
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMD---MQASKEFLAELKVLTHVH-HLNLVRLIG-YCV----EG--- 554 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~g-~~~----~~--- 554 (790)
..+.++.+.|.+|||+.||.|.+. +..+|+|++- ....+.+.+|+++|++|+ |+|||.+++ ... ++
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 456788999999999999999986 4899999874 455677899999999996 999999999 332 12
Q ss_pred eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCc
Q 046083 555 SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK 634 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~ 634 (790)
+.+|+||||.+|.|-++|..+....|++.++++|+.++++|+++||... |||||||||-+||||+.++..||||||.+.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 4789999999999999999766666999999999999999999999998 788999999999999999999999999997
Q ss_pred ccccCCcccc--------cccccCCCccchhcc---cCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHH
Q 046083 635 LTEVGSASVH--------TRLVGTFGYMPPEYA---QYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVAL 703 (790)
Q Consensus 635 ~~~~~~~~~~--------~~~~gt~~y~aPE~~---~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 703 (790)
.......... -....|+-|+|||++ .+...++|+|||+|||+||-|+....||+..+..
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---------- 264 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---------- 264 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----------
Confidence 4432221110 012468999999987 5678999999999999999999999999765332
Q ss_pred HHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCc
Q 046083 704 FEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770 (790)
Q Consensus 704 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~ 770 (790)
.++.....-.-.......|.+||+.||+.||.+||++-+|+..+.+++...-
T Consensus 265 ---------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 265 ---------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred ---------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 2233232222224678899999999999999999999999999998876544
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=312.75 Aligned_cols=247 Identities=28% Similarity=0.465 Sum_probs=197.5
Q ss_pred cCcccceeeeecCceEEEEEEEC-CceEEEEEeChh--hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEEecC
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ--ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIEN 565 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~~~~ 565 (790)
.+|++.+.||+|+||.||++.+. +..+++|.+... ...++.+|++++++++|+||+++++++.+. ..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 35778899999999999999886 558999988643 345688999999999999999999988754 58999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
++|.+++..... .+++..++.++.+++.||+|||+.++ +||||||+||++++++.+||+|||+++...........
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i---~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 84 GCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNGF---IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCc---ccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 999999976433 68999999999999999999999998 99999999999999999999999999865322211111
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCc
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 724 (790)
...++..|+|||.+.+..++.++||||||+++|||++ |..||...... ........ .
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~--------------~ 217 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--------EVVESVSA--------------G 217 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--------HHHHHHHc--------------C
Confidence 2233457999999998999999999999999999999 78887542211 11111111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 725 LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 725 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
.....+...+.++.+++.+||+.+|++|||+.|+++.|
T Consensus 218 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 218 YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11122233456799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=331.62 Aligned_cols=265 Identities=20% Similarity=0.269 Sum_probs=198.5
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecC
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIEN 565 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~ 565 (790)
.++|++.+.||+|+||.||++... ++.+|+|.... ..+.+|++++++++||||+++++++.. ...++++|++.
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~- 166 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK- 166 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-
Confidence 357999999999999999999885 78999997543 356789999999999999999998764 45899999985
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
++|..++.... .+++..++.++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++...........
T Consensus 167 ~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~I---vHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 167 TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENRI---IHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence 68988887543 58899999999999999999999998 99999999999999999999999999754322222233
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHc---CCC------Chhh
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLR---QPD------PRED 716 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~------~~~~ 716 (790)
...||+.|+|||++.+..++.++|||||||++|||++|+.|+.......... +.......++. ... ....
T Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~-~~~~~l~~i~~~~g~~p~~~~~~~~~~ 320 (391)
T PHA03212 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDC-DSDRQIKLIIRRSGTHPNEFPIDAQAN 320 (391)
T ss_pred cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccC-chhHHHHHHHHHhcCChhhcCcchhHH
Confidence 4679999999999999899999999999999999999998875433211110 00111111111 000 0000
Q ss_pred hhhhc----C-----CcCCCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 717 LQRLV----D-----PRLGDDY--PIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 717 l~~~~----d-----~~l~~~~--~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
+.... . +...... ....+.++.+|+.+||+.||++|||++|++++-+
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~ 378 (391)
T PHA03212 321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378 (391)
T ss_pred HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence 11100 0 0000000 0134567889999999999999999999997554
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.12 Aligned_cols=259 Identities=29% Similarity=0.523 Sum_probs=206.2
Q ss_pred hcCcccceeeeecCceEEEEEEEC-------CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLF 557 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~ 557 (790)
.++|.+.+.||+|+||.||++... +..+++|.+.. ...+.+.+|++++++++|||++++++++.++ ..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357889999999999999999752 34688998864 2345689999999999999999999998754 589
Q ss_pred EEEEEecCCChhhhhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEE
Q 046083 558 LVYEYIENGNLNQHLRGSG-----------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAK 626 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~k 626 (790)
++|||+++++|.+++...+ ...+++..+++++.|++.||+|||++++ +||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i---~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHF---VHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCe---eecccCcceEEEccCCcEE
Confidence 9999999999999997532 1358999999999999999999999998 9999999999999999999
Q ss_pred EEEeCCCcccccCCc-ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHH
Q 046083 627 VADFGLAKLTEVGSA-SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALF 704 (790)
Q Consensus 627 l~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 704 (790)
|+|||+++....... .......++..|+|||.+.+..++.++||||||++++||++ |..||..... ....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--------~~~~ 232 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEVI 232 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHH
Confidence 999999986532221 11223345778999999998899999999999999999998 8888754322 1111
Q ss_pred HHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccC
Q 046083 705 EEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDW 772 (790)
Q Consensus 705 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~ 772 (790)
..+..... ...+...+..+.+++.+||+.+|.+|||+.|+++.|..+...+..|
T Consensus 233 ~~i~~~~~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~~~ 286 (288)
T cd05093 233 ECITQGRV--------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPVY 286 (288)
T ss_pred HHHHcCCc--------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcccc
Confidence 22211110 0111223457899999999999999999999999999988776654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=293.41 Aligned_cols=257 Identities=23% Similarity=0.355 Sum_probs=204.8
Q ss_pred hcCcccceeeeecCceEEEEEEE--CCceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec------CeEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAEL--RGEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE------GSLF 557 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~--~g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~ 557 (790)
.++|++.++||+|||+-||.++. .++.+|+|++.. ++.+..++|++..++++|||++++++++.. .+.|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 46899999999999999999984 388899999853 556678999999999999999999987642 2389
Q ss_pred EEEEEecCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 558 LVYEYIENGNLNQHLRGS--GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
++++|...|+|.+.++.. ++..+++.++++|+.++++||++||+.. |++.||||||.|||+.+++.++|.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999999998753 3457999999999999999999999988 6789999999999999999999999999976
Q ss_pred cccCCccc--------ccccccCCCccchhccc---CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHH
Q 046083 636 TEVGSASV--------HTRLVGTFGYMPPEYAQ---YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALF 704 (790)
Q Consensus 636 ~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 704 (790)
....-... ......|..|+|||.+. +...++++|||||||+||+|+.|..||....+.. .++.
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G---gSla--- 252 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG---GSLA--- 252 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC---CeEE---
Confidence 54221111 11235789999999985 4567899999999999999999999996543311 0000
Q ss_pred HHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 705 EEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 705 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
-.+..+.+...-....++.+.+++.+|++.||.+||+..+++..+..+
T Consensus 253 -------------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 253 -------------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -------------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 011111111111223667899999999999999999999999998865
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=316.28 Aligned_cols=251 Identities=27% Similarity=0.465 Sum_probs=198.5
Q ss_pred HhcCcccceeeeecCceEEEEEEEC-------CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-e
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-S 555 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~ 555 (790)
.+++|++.+.||+|+||.||+|... +..+|+|.+.. ....++.+|+.+++.++|+||+++++++.++ .
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999999764 35699998853 2345688999999999999999999988754 5
Q ss_pred EEEEEEEecCCChhhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEE
Q 046083 556 LFLVYEYIENGNLNQHLRGSG--------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKV 627 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl 627 (790)
.++||||+++++|.+++.... ...+++..+..++.+++.||.|||+.++ +|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCcchheEEEcCCCCEEE
Confidence 899999999999999987532 1246889999999999999999999997 99999999999999999999
Q ss_pred EEeCCCcccccCCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHH
Q 046083 628 ADFGLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFE 705 (790)
Q Consensus 628 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 705 (790)
+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||..... .....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--------~~~~~ 232 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--------EQVLR 232 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHH
Confidence 999998754322211 1112345778999999998899999999999999999999 6777754321 11111
Q ss_pred HHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 706 EVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 706 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
..... .. ...+...+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 233 ~~~~~-------------~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 233 FVMEG-------------GL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHcC-------------Cc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11111 00 1112234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.59 Aligned_cols=259 Identities=27% Similarity=0.437 Sum_probs=194.5
Q ss_pred cCcccceeeeecCceEEEEEEEC---CceEEEEEeChh-----hHHHHHHHHHHHHhc---CCCCCcceEEEEe------
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR---GEKAAIKKMDMQ-----ASKEFLAELKVLTHV---HHLNLVRLIGYCV------ 552 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~---g~~vavK~~~~~-----~~~~~~~E~~~l~~l---~h~niv~l~g~~~------ 552 (790)
++|++.+.||+|+||.||+|+.. +..+|+|.++.. ....+.+|+++++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 46889999999999999999873 567999988632 224566777777766 6999999999875
Q ss_pred cCeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCC
Q 046083 553 EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGL 632 (790)
Q Consensus 553 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGl 632 (790)
+...++||||+. ++|.+++.......+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i---iH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe---eeCCCCHHHEEEcCCCCEEEccccc
Confidence 234899999996 599999986555568999999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC
Q 046083 633 AKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD 712 (790)
Q Consensus 633 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (790)
++..... .......|++.|+|||.+.+..++.++|||||||++|||++|++||...... +...........+.
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-----~~~~~i~~~~~~~~ 229 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-----DQLGKILDVIGLPG 229 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-----HHHHHHHHHhCCCC
Confidence 9865432 2223456899999999999889999999999999999999999998654321 11111111111111
Q ss_pred Chhhhhh-------hcCCcCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046083 713 PREDLQR-------LVDPRLGD---DYPIDSVRKMARLARACTQENPQLRPSMRAIVV 760 (790)
Q Consensus 713 ~~~~l~~-------~~d~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 760 (790)
. +.+.. ...+.... ....+....+.+++.+||+.||++|||+.|+++
T Consensus 230 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 E-EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred h-hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 1 11100 00000000 001123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=325.38 Aligned_cols=237 Identities=25% Similarity=0.386 Sum_probs=193.3
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecCC
Q 046083 496 NKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENG 566 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~g 566 (790)
+.||+|+||.||++... ++.+|+|.++.. ....+.+|++++++++||||+++++++.+ ...++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 789999998743 23457789999999999999999998775 4589999999999
Q ss_pred ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccccc
Q 046083 567 NLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR 646 (790)
Q Consensus 567 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 646 (790)
+|.+++...+ .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~i---vHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~ 154 (323)
T cd05571 81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCDV---VYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT 154 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---EeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccc
Confidence 9999997643 58999999999999999999999998 999999999999999999999999987532211 12234
Q ss_pred cccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCC
Q 046083 647 LVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLG 726 (790)
Q Consensus 647 ~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 726 (790)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ...........
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~~~~~~~--------------- 211 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILMEE--------------- 211 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--------HHHHHHHHcCC---------------
Confidence 5789999999999999999999999999999999999999854321 11112221110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 046083 727 DDYPIDSVRKMARLARACTQENPQLRP-----SMRAIVVA 761 (790)
Q Consensus 727 ~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 761 (790)
..++......+.+++.+||+.||++|| ++.+++++
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 212 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 122334456788999999999999999 79998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=309.99 Aligned_cols=243 Identities=24% Similarity=0.431 Sum_probs=195.1
Q ss_pred eeeecCceEEEEEEEC----CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEEEecCCCh
Q 046083 497 KIGQGGFGAVFYAELR----GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNL 568 (790)
Q Consensus 497 ~lG~G~fg~Vy~a~~~----g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e~~~~g~L 568 (790)
.||+|+||.||+|.+. +..+|+|.+... ..+++.+|++++++++|+||+++++++.....++||||+++++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 4899999999999764 446899988643 23568899999999999999999999887778999999999999
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccc--cc
Q 046083 569 NQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH--TR 646 (790)
Q Consensus 569 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~--~~ 646 (790)
.+++.... ..+++..+++++.+++.||.|||++++ +||||||+|||++.++.+||+|||++........... ..
T Consensus 82 ~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 82 NKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNF---VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCe---eecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99997542 468999999999999999999999997 9999999999999999999999999986543222111 11
Q ss_pred cccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 647 LVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 647 ~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
..++..|+|||.+....++.++||||||+++|||++ |..||...... .... .+. ...
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~-~~~-------------~~~ 215 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--------EVMS-FIE-------------QGK 215 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHH-HHH-------------CCC
Confidence 223578999999988889999999999999999996 99998643221 1111 111 111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
....+...+.++.+++.+||..+|++||++.+|.+.|...
T Consensus 216 ~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 216 RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1223334567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.27 Aligned_cols=262 Identities=25% Similarity=0.418 Sum_probs=202.8
Q ss_pred cccceeeeecCceEEEEEEE------CCceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEec---CeEEE
Q 046083 492 FSMGNKIGQGGFGAVFYAEL------RGEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVE---GSLFL 558 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~------~g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~---~~~~l 558 (790)
|...+.||+|+||.||++.. .+..+|+|.++.. ..+.+.+|++++++++||||+++++++.. ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988753 2668999988642 34668899999999999999999998763 24789
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
+|||+++++|.+++... .+++..+..++.+++.||.|||++++ +||||||+|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i---~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCe---eccccChheEEEcCCCcEEEeecccccccCC
Confidence 99999999999999753 48999999999999999999999998 9999999999999999999999999986643
Q ss_pred CCccc--ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhh
Q 046083 639 GSASV--HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716 (790)
Q Consensus 639 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (790)
..... .....++..|+|||.+....++.++||||||+++|||++|..|+........+ ..... ........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~------~~~~~-~~~~~~~~ 232 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE------MIGPK-QGQMTVVR 232 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh------hhccc-ccccchhh
Confidence 22211 11234566799999999889999999999999999999999997543321100 00000 00011112
Q ss_pred hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 046083 717 LQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLS 766 (790)
Q Consensus 717 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~ 766 (790)
+.+.++.......+...+..+.+++.+||+.+|++|||++++++.|..+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 22233333333334455678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.75 Aligned_cols=250 Identities=28% Similarity=0.514 Sum_probs=197.6
Q ss_pred cCcccceeeeecCceEEEEEEE------CCceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAEL------RGEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFL 558 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~------~g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~l 558 (790)
++|++.+.||+|+||.||+|.. .+..+++|.+.. ....++.+|++++++++||||+++++++..+ ..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678899999999999999985 246899999863 2335688999999999999999999988754 5899
Q ss_pred EEEEecCCChhhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC
Q 046083 559 VYEYIENGNLNQHLRGSG---------------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF 623 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~ 623 (790)
+|||+++++|.+++.... ...+++...+.++.+++.||.|||++++ +||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i---~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFF---VHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCe---ehhccccceEEEcCCC
Confidence 999999999999985321 2357899999999999999999999997 9999999999999999
Q ss_pred cEEEEEeCCCcccccCCc-ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchH
Q 046083 624 RAKVADFGLAKLTEVGSA-SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLV 701 (790)
Q Consensus 624 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~ 701 (790)
.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||..... .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--------~ 233 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--------Q 233 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------H
Confidence 999999999986532221 11222345678999999988889999999999999999998 8888754221 0
Q ss_pred HHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 702 ALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 702 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
........ ......+...+..+.+++.+||+.+|++||++.+|.+.|..
T Consensus 234 ~~~~~~~~--------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 EVIEMVRK--------------RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHc--------------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111 10011223345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=309.11 Aligned_cols=251 Identities=24% Similarity=0.452 Sum_probs=203.3
Q ss_pred hcCcccceeeeecCceEEEEEEEC-CceEEEEEeChh--hHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEEEecC
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ--ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIEN 565 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e~~~~ 565 (790)
.++|.+.++||+|+||.||++.+. +..+++|.+... ..+.+.+|++++++++|+|++++++++.+...+++|||+++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAK 84 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCCC
Confidence 467889999999999999999875 667999988643 34578899999999999999999999887778999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
++|.+++.......+++..++.++.+++.||.|||+.++ +|+||+|+||+++.++.+||+|||++............
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i---~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 161 (260)
T cd05073 85 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 161 (260)
T ss_pred CcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCc---cccccCcceEEEcCCCcEEECCCcceeeccCCCccccc
Confidence 999999987555568999999999999999999999998 99999999999999999999999999765432222222
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCc
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 724 (790)
...++..|+|||++....++.++|+||||++++||++ |..||..... ....... ...
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~-~~~------------- 219 (260)
T cd05073 162 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PEVIRAL-ERG------------- 219 (260)
T ss_pred CCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHH-hCC-------------
Confidence 2345678999999998889999999999999999999 8888854321 1111111 110
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 725 LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 725 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
.....+...+..+.+++.+|++.+|++||++.++.+.|..
T Consensus 220 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 220 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011122344678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=310.13 Aligned_cols=246 Identities=32% Similarity=0.542 Sum_probs=202.6
Q ss_pred cCcccceeeeecCceEEEEEEECCceEEEEEeChh-hHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEEEecCCCh
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQ-ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNL 568 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e~~~~g~L 568 (790)
++|++.+.||+|+||.||++...++.+++|..+.. ..+.+.+|+.++++++|||++++++++.....+++|||+++++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~~L 85 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGNL 85 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCCCH
Confidence 45888999999999999999988999999998754 34578899999999999999999999887778999999999999
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccccccc
Q 046083 569 NQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLV 648 (790)
Q Consensus 569 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 648 (790)
.+++.......+++..++.++.+++.||.|||+.++ +||||||+||+++.++.+||+|||++....... ....
T Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----~~~~ 158 (254)
T cd05083 86 VNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKL---VHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----DNSK 158 (254)
T ss_pred HHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCe---eccccCcceEEEcCCCcEEECCCccceeccccC----CCCC
Confidence 999987655568999999999999999999999998 999999999999999999999999987543211 1223
Q ss_pred cCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCC
Q 046083 649 GTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGD 727 (790)
Q Consensus 649 gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 727 (790)
.+..|+|||.+.+..++.++|+||||+++|||++ |+.||..... ......... ....
T Consensus 159 ~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~--------------~~~~ 216 (254)
T cd05083 159 LPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--------KEVKECVEK--------------GYRM 216 (254)
T ss_pred CCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH--------HHHHHHHhC--------------CCCC
Confidence 4568999999998899999999999999999998 8888854321 111111111 1111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 728 DYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 728 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
..+...+..+.+++.+||+.+|++||+++++++.|..
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1122345678899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=315.04 Aligned_cols=252 Identities=26% Similarity=0.466 Sum_probs=199.6
Q ss_pred CcccceeeeecCceEEEEEEEC-------CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFL 558 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~l 558 (790)
+|++.+.||+|+||.||+|... ...+++|.+... ..+++.+|+.+++.++||||+++++.+.+ +..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999864 246888887532 34568899999999999999999998874 45899
Q ss_pred EEEEecCCChhhhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCC
Q 046083 559 VYEYIENGNLNQHLRGSG----------------------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPAN 616 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~N 616 (790)
+|||+.+++|.+++.... ...+++..++.++.+++.||.|||++++ +||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i---vH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKL---VHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCe---ehhhhhhhe
Confidence 999999999999986421 1358899999999999999999999998 999999999
Q ss_pred EEecCCCcEEEEEeCCCcccccCCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCcccccccccc
Q 046083 617 ILIDKNFRAKVADFGLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETI 694 (790)
Q Consensus 617 ILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~ 694 (790)
||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 99999999999999999865332221 1122345678999999988899999999999999999998 8888843221
Q ss_pred ccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 695 TESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
...+. .+........+......+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 236 ------~~~~~--------------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 ------ERLFN--------------LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ------HHHHH--------------HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11111 111111122233445678999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=315.65 Aligned_cols=255 Identities=29% Similarity=0.526 Sum_probs=203.6
Q ss_pred cCcccceeeeecCceEEEEEEEC-------CceEEEEEeChhh---HHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDMQA---SKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFL 558 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~l 558 (790)
.+|.+.+.||+|+||.||++... +..+++|.+.... .+.+.+|++++++++|+||+++++++.++ ..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45788899999999999999753 3458889886432 35688999999999999999999998754 4899
Q ss_pred EEEEecCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCc
Q 046083 559 VYEYIENGNLNQHLRGSG--------------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFR 624 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~ 624 (790)
||||+++++|.+++...+ ...+++..+++++.+++.||+|||++++ +||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i---~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHF---VHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCe---eecccCcceEEEccCCc
Confidence 999999999999997532 1348999999999999999999999998 99999999999999999
Q ss_pred EEEEEeCCCcccccCCc-ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHH
Q 046083 625 AKVADFGLAKLTEVGSA-SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVA 702 (790)
Q Consensus 625 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 702 (790)
++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||...... .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--------~ 233 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--------E 233 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------H
Confidence 99999999976543221 11223456788999999998999999999999999999999 99988543221 1
Q ss_pred HHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCC
Q 046083 703 LFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSS 769 (790)
Q Consensus 703 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~ 769 (790)
....+.... ....+...+..+.+++.+||+.+|.+|||+++|++.|..+....
T Consensus 234 ~~~~~~~~~--------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 234 VIECITQGR--------------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred HHHHHhCCC--------------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 111111110 01112234567899999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=315.47 Aligned_cols=261 Identities=25% Similarity=0.398 Sum_probs=197.1
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEY 562 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~ 562 (790)
++|++.+.||+|+||.||+|... +..+|+|.++.. ....+.+|++++++++||||+++++++... ..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57899999999999999999876 789999988632 234678999999999999999999988754 58999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+++ +|.+++...+ ..+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~i---vH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 85 LDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKI---LHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 985 9999887543 357899999999999999999999998 9999999999999999999999999976432221
Q ss_pred cccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC--------
Q 046083 643 VHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP-------- 713 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 713 (790)
......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ............+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK-----EELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCChHHhhcccc
Confidence 1233467899999998865 56899999999999999999999998654321 111111111111110
Q ss_pred hhhhhhhcCCcCCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 714 REDLQRLVDPRLGDD----YPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 714 ~~~l~~~~d~~l~~~----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.+.+.....+..... .......++.+++.+||+.||.+|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 011111111111000 011234567899999999999999999999854
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.09 Aligned_cols=249 Identities=29% Similarity=0.521 Sum_probs=200.3
Q ss_pred cCcccceeeeecCceEEEEEEEC-------CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLF 557 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~ 557 (790)
++|.+.+.||+|+||.||+|... +..+|+|.++.. ..+.+.+|++++++++|+|++++++++..+ ..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 46888899999999999999763 367999998642 346789999999999999999999988754 589
Q ss_pred EEEEEecCCChhhhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcE
Q 046083 558 LVYEYIENGNLNQHLRGSG------------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRA 625 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~ 625 (790)
++|||+++++|.++++..+ ...+++..+..++.+++.||+|||++++ +||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i---~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHF---VHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCe---eccccccceEEEcCCCeE
Confidence 9999999999999997542 2357899999999999999999999997 999999999999999999
Q ss_pred EEEEeCCCcccccCCc-ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHH
Q 046083 626 KVADFGLAKLTEVGSA-SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVAL 703 (790)
Q Consensus 626 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 703 (790)
||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |..||...... ..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--------~~ 233 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--------EV 233 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--------HH
Confidence 9999999975432211 11223445788999999999999999999999999999998 99998543221 11
Q ss_pred HHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 704 FEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 704 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
....... .....+...+..+.+++.+||+.||++||++.||++.|.
T Consensus 234 ~~~~~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 234 IECITQG--------------RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHcC--------------CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111110 011122234567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=307.62 Aligned_cols=245 Identities=29% Similarity=0.458 Sum_probs=201.3
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
+|++.+.||+|++|.||++... ++.+++|.+.. ...+++.+|++++++++|||++++++++.+ +..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999885 78899998753 345678899999999999999999998875 458999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+++++|.++++......+++..+++++.+++.||.|||+.++ +|+||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i---~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKI---LHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 999999999987645579999999999999999999999998 9999999999999999999999999886543222
Q ss_pred cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcC
Q 046083 643 VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD 722 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d 722 (790)
......|++.|+|||++.+..++.++|+||||+++|||++|+.||..... ..........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~------------ 216 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--------GALILKIIRG------------ 216 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcC------------
Confidence 12234678899999999999999999999999999999999999864331 1111111111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 723 PRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 723 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.....+......+.+++.+||+.+|++||++.++++.
T Consensus 217 --~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 217 --VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1112222445678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=325.45 Aligned_cols=241 Identities=23% Similarity=0.365 Sum_probs=197.5
Q ss_pred cCcccceeeeecCceEEEEEEEC---CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR---GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLV 559 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~---g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv 559 (790)
++|.+.+.||+|+||.||+|.+. +..+|+|.+... ..+.+.+|++++..++||||+++++++.++ ..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 46889999999999999999865 257999988532 335688899999999999999999988754 58999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+.++ +||||||+|||++.++.+||+|||+++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~i---vHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLNI---VYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999998654 58999999999999999999999998 99999999999999999999999999865322
Q ss_pred CcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+...
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--------~~~~~i~~~--------- 243 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--------LIYQKILEG--------- 243 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--------HHHHHHhcC---------
Confidence 22357899999999999888999999999999999999999999653221 111122211
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRP-----SMRAIVVAL 762 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~L 762 (790)
. ..++......+.+++.+|++.||++|+ ++++++++-
T Consensus 244 ----~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 244 ----I--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred ----C--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence 0 012223345678999999999999995 899887753
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=307.33 Aligned_cols=242 Identities=28% Similarity=0.503 Sum_probs=192.4
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEEecCCCh
Q 046083 496 NKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNL 568 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~~~~g~L 568 (790)
+.||+|+||.||+|... ++.+|+|.... +....+.+|++++++++||||+++++++... ..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999874 78899998753 3346689999999999999999999998754 58999999999999
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccc-ccc
Q 046083 569 NQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH-TRL 647 (790)
Q Consensus 569 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~-~~~ 647 (790)
.+++...+ ..+++..++.++.|++.||.|||++++ +|+||||+||+++.++.+||+|||++........... ...
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i---~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHC---IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCc---cccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99997543 358999999999999999999999998 9999999999999999999999999875432211110 111
Q ss_pred ccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCC
Q 046083 648 VGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLG 726 (790)
Q Consensus 648 ~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 726 (790)
..+..|+|||.+.++.++.++||||||+++|||++ |..||...... . ....+.....
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--------~--------------~~~~~~~~~~ 214 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--------Q--------------TREAIEQGVR 214 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--------H--------------HHHHHHcCCC
Confidence 23457999999998899999999999999999998 87877542210 0 0111111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 727 DDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 727 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
...+...+..+.+++.+|++.+|++|||+.++++.|.
T Consensus 215 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2223344567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=321.67 Aligned_cols=261 Identities=26% Similarity=0.438 Sum_probs=196.0
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec------CeEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE------GSLF 557 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~ 557 (790)
+|++.+.||+|+||.||+|... +..+|||+++. .....+.+|++++++++||||+++++++.. ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999875 78999998863 233468899999999999999999998752 2379
Q ss_pred EEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccc
Q 046083 558 LVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~ 637 (790)
+||||+. ++|.+++.... .+++..+..++.|+++||.|||++++ +||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTANV---FHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 68999887643 58999999999999999999999998 999999999999999999999999998543
Q ss_pred cCCc--ccccccccCCCccchhcccC--CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC
Q 046083 638 VGSA--SVHTRLVGTFGYMPPEYAQY--GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 638 ~~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
.... .......|++.|+|||++.+ ..++.++|||||||++|||++|+.||...... ............+.
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~-----~~~~~~~~~~~~~~- 228 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-----HQLDLITDLLGTPS- 228 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH-----HHHHHHHHHhCCCC-
Confidence 2211 11234578999999999865 67899999999999999999999998643221 01111111111111
Q ss_pred hhhhhh--------h---cCCcCCCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 714 REDLQR--------L---VDPRLGDDYP---IDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 714 ~~~l~~--------~---~d~~l~~~~~---~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
...+.. . +.+....... ......+.+++.+||+.||++|||++|++++-.
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~ 292 (338)
T cd07859 229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292 (338)
T ss_pred HHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCch
Confidence 000000 0 0010000000 123356789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=329.98 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=200.0
Q ss_pred HHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEE
Q 046083 487 KATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLF 557 (790)
Q Consensus 487 ~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~ 557 (790)
...++|++.+.||+|+||.||++... ++.+|+|.++.. ..+.+.+|+.+++.++||||+++++++.++ ..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34568999999999999999999886 789999998642 224477899999999999999999988754 589
Q ss_pred EEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccc
Q 046083 558 LVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~ 637 (790)
+||||+++|+|.+++... .++...+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||++....
T Consensus 120 lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~i---vHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCe---eccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 999999999999998753 47888889999999999999999998 999999999999999999999999998654
Q ss_pred cCCcccccccccCCCccchhcccCC----CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC
Q 046083 638 VGSASVHTRLVGTFGYMPPEYAQYG----EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
...........||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+..+.....
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~~- 264 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMDHKN- 264 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--------HHHHHHHHcCCC-
Confidence 3322222346799999999998653 478999999999999999999999965321 122222222110
Q ss_pred hhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHH
Q 046083 714 REDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQL--RPSMRAIVVALM 763 (790)
Q Consensus 714 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~L~ 763 (790)
.+........+..+.+++.+||+.+|.+ ||+++|++.+-.
T Consensus 265 ----------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 265 ----------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306 (370)
T ss_pred ----------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence 0100111134567889999999999988 999999987643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=328.88 Aligned_cols=249 Identities=25% Similarity=0.343 Sum_probs=201.2
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
++|.+.+.||+|+||.||+|... ++.+|+|+++.. ....+..|++++..++|+||+++++++.+ ...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999987 889999998643 33568899999999999999999988775 4589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++++|.+++... ..+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~gi---iH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGF---IHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCe---eccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999865 358999999999999999999999998 999999999999999999999999998654332
Q ss_pred ----------------------------cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCcccccccc
Q 046083 641 ----------------------------ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNE 692 (790)
Q Consensus 641 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~ 692 (790)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 0112235689999999999999999999999999999999999999965432
Q ss_pred ccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHH
Q 046083 693 TITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPS-MRAIVVALM 763 (790)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~evl~~L~ 763 (790)
......+.... ..+........+..+.+++.+|++ +|.+||+ ++|++++..
T Consensus 236 --------~~~~~~i~~~~-----------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~ 287 (350)
T cd05573 236 --------QETYNKIINWK-----------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287 (350)
T ss_pred --------HHHHHHHhccC-----------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence 11112222110 000000011135678899999998 9999999 999988643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=328.17 Aligned_cols=255 Identities=24% Similarity=0.452 Sum_probs=200.8
Q ss_pred HhcCcccceeeeecCceEEEEEEEC-------CceEEEEEeChh----hHHHHHHHHHHHHhcC-CCCCcceEEEEec-C
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDMQ----ASKEFLAELKVLTHVH-HLNLVRLIGYCVE-G 554 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~g~~~~-~ 554 (790)
..++|.+.++||+|+||.||+|.+. +..||+|+++.. ..+.+.+|+++|.++. ||||+++++++.. +
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3456778999999999999999864 357999999742 2346889999999997 9999999999875 4
Q ss_pred eEEEEEEEecCCChhhhhhcCC----------------------------------------------------------
Q 046083 555 SLFLVYEYIENGNLNQHLRGSG---------------------------------------------------------- 576 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 576 (790)
..++||||+++|+|.++++...
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 5899999999999999996532
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEE
Q 046083 577 --------------------------------------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANIL 618 (790)
Q Consensus 577 --------------------------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NIL 618 (790)
...+++..+++++.+++.||+|||+.++ +||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~i---vHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNC---VHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCc---CcccCCcceEE
Confidence 1246788899999999999999999987 99999999999
Q ss_pred ecCCCcEEEEEeCCCcccccCCc-ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCcccccccccccc
Q 046083 619 IDKNFRAKVADFGLAKLTEVGSA-SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITE 696 (790)
Q Consensus 619 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~ 696 (790)
+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~--- 348 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN--- 348 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch---
Confidence 99999999999999986432221 11122456788999999998889999999999999999998 88887543211
Q ss_pred ccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 046083 697 STGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLS 766 (790)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~ 766 (790)
......+ ........+......+.+++.+||+.+|.+||+++||++.|+.+.
T Consensus 349 -----~~~~~~~-------------~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 -----EQFYNAI-------------KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -----HHHHHHH-------------HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111111 111111223334567999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=315.45 Aligned_cols=253 Identities=25% Similarity=0.447 Sum_probs=201.1
Q ss_pred hcCcccceeeeecCceEEEEEEEC-------CceEEEEEeCh----hhHHHHHHHHHHHHhc-CCCCCcceEEEEec-Ce
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDM----QASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GS 555 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~ 555 (790)
.++|.+.+.||+|+||.||++... +..+|+|.++. ...+.+.+|+++++++ +|+||+++++++.. +.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357899999999999999999752 34799998864 2345688999999999 79999999998874 45
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
.+++|||+.+|+|.++++......+++.++..++.+++.||+|||++++ +|+||||+|||++.++.++|+|||+++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i---vH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe---ehhhhccceEEEcCCCeEEECCCccccc
Confidence 8999999999999999986544458999999999999999999999997 9999999999999999999999999986
Q ss_pred cccCCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCC
Q 046083 636 TEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 636 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..+.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--------~~~~~~~~---- 258 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--------SKFYKLIK---- 258 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--------HHHHHHHH----
Confidence 5432211 1122345678999999998999999999999999999998 88887543211 11111111
Q ss_pred hhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 714 REDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 714 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
.......+.....++.+++.+||+.+|++|||+.|+++.|.++
T Consensus 259 ---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 259 ---------EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---------cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111111222345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=308.32 Aligned_cols=254 Identities=24% Similarity=0.408 Sum_probs=203.2
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh------hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
++|++.+.||+|+||.||+|... ++.+|||.++. .....+.+|++++++++|||++++++++.+ +..+++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999875 78999997642 233568899999999999999999998764 5689999
Q ss_pred EEecCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 561 EYIENGNLNQHLRGS--GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 561 e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
||+++++|.+++... ....+++..+..++.+++.||.|||++++ +|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i---~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRV---MHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCe---eCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988642 23458899999999999999999999998 9999999999999999999999999886543
Q ss_pred CCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 639 GSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||...... .......+...
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~------~~~~~~~~~~~-------- 223 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LFSLCQKIEQC-------- 223 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc------HHHHHHHHhcC--------
Confidence 221 112346788999999999888999999999999999999999998543211 11111111110
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLS 766 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~ 766 (790)
......+......+.+++.+||+.+|++||++.+|++.|.++.
T Consensus 224 -----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 224 -----DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -----CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0011112234567899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=317.84 Aligned_cols=265 Identities=27% Similarity=0.389 Sum_probs=196.5
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYE 561 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e 561 (790)
.++|++.+.||+|+||.||+|... ++.+|+|.++.. ....+.+|+++++.++||||+++++++.+. ..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999985 789999998642 234577899999999999999999988754 5899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|+. ++|.+++.... ..+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i---vH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYI---LHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 996 58888886543 358889999999999999999999998 999999999999999999999999987543221
Q ss_pred ccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 642 SVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
.......+++.|+|||.+.+ ..++.++|||||||++|||++|..||...... .............+. ...+...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~-~~~~~~~ 232 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI----QDQLERIFLVLGTPN-EDTWPGV 232 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH----HHHHHHHHHHhCCCC-hhhccch
Confidence 12233567899999999865 45889999999999999999999999653221 001111111111110 0000000
Q ss_pred -----cCC-cCCCCCC---------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 721 -----VDP-RLGDDYP---------IDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 721 -----~d~-~l~~~~~---------~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
.++ ......+ ......+.+++.+||+.||++|||++|++++-.-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f 291 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccc
Confidence 000 0000000 0122467899999999999999999999875554
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=314.49 Aligned_cols=253 Identities=33% Similarity=0.542 Sum_probs=199.2
Q ss_pred cCcccceeeeecCceEEEEEEEC--Cc--eEEEEEeCh----hhHHHHHHHHHHHHhc-CCCCCcceEEEEec-CeEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GE--KAAIKKMDM----QASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSLFLV 559 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~--~vavK~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~~lv 559 (790)
++|++.+.||+|+||.||+|... +. .+++|.++. ...+.+.+|++++.++ +||||+++++++.+ +..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57889999999999999999875 32 468887763 2345688999999999 79999999998875 458999
Q ss_pred EEEecCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcE
Q 046083 560 YEYIENGNLNQHLRGSG--------------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRA 625 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~ 625 (790)
|||+++++|.+++.... ...+++..+..++.|++.||+|||++++ +||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~i---vH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQF---IHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCcCCcceEEECCCCeE
Confidence 99999999999997532 1258899999999999999999999998 999999999999999999
Q ss_pred EEEEeCCCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHH
Q 046083 626 KVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALF 704 (790)
Q Consensus 626 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 704 (790)
||+|||++........ ......+..|+|||++....++.++|||||||++|||++ |..||..... ....
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~--------~~~~ 228 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC--------AELY 228 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHH
Confidence 9999999874321111 111223557999999988889999999999999999998 9999854321 1111
Q ss_pred HHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCC
Q 046083 705 EEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSS 769 (790)
Q Consensus 705 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~ 769 (790)
.... .......+...+..+.+++.+||+.+|.+|||++++++.|..+...-
T Consensus 229 ~~~~--------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 229 EKLP--------------QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHh--------------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111 11111222334567899999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=321.82 Aligned_cols=237 Identities=25% Similarity=0.391 Sum_probs=192.4
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecCC
Q 046083 496 NKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENG 566 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~g 566 (790)
+.||+|+||.||++... +..+|+|.++.. ....+.+|+++++.++||||+++++++.. +..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999875 789999998643 23457789999999999999999998764 4589999999999
Q ss_pred ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccccc
Q 046083 567 NLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR 646 (790)
Q Consensus 567 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 646 (790)
+|..++.... .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~i---vH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 154 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT 154 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccc
Confidence 9999887643 58999999999999999999999998 999999999999999999999999987532211 12233
Q ss_pred cccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCC
Q 046083 647 LVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLG 726 (790)
Q Consensus 647 ~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 726 (790)
..|++.|+|||++.+..++.++|||||||++|||++|+.||..... .......... .
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~~~~~-------------~-- 211 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILME-------------E-- 211 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcC-------------C--
Confidence 5689999999999999999999999999999999999999864321 1111111111 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 046083 727 DDYPIDSVRKMARLARACTQENPQLRP-----SMRAIVVA 761 (790)
Q Consensus 727 ~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 761 (790)
..++......+.+++.+||+.||++|| ++.+++++
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 212 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 012233456788999999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=309.62 Aligned_cols=253 Identities=22% Similarity=0.394 Sum_probs=203.7
Q ss_pred cCcccceeeeecCceEEEEEEECC-----ceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELRG-----EKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~g-----~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~ 560 (790)
++|.+.+.||+|+||.||+|.+.. ..+++|.... ...+.+.+|+.++++++|||++++++++.+...++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~ 85 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM 85 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence 458889999999999999998642 3688998763 3345789999999999999999999999888889999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++++|.+++.... ..+++..++.++.+++.||.|||+.++ +|+||||+||+++.++.+||+|||+++......
T Consensus 86 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 86 ELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRF---VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCe---eccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999999997643 358999999999999999999999997 999999999999999999999999998654332
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
........++..|+|||.+....++.++||||||+++|||++ |..||...... ..........
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--------~~~~~~~~~~-------- 225 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--------DVIGRIENGE-------- 225 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHcCC--------
Confidence 222222334568999999988889999999999999999996 99998543221 1111111110
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
....+...+..+.+++.+|+..+|++|||+.+++..|..+...
T Consensus 226 ------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 226 ------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0112234456789999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=311.86 Aligned_cols=262 Identities=25% Similarity=0.435 Sum_probs=200.7
Q ss_pred cCcccceeeeecCceEEEEEEEC------CceEEEEEeChh---hHHHHHHHHHHHHhcCCCCCcceEEEEec---CeEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR------GEKAAIKKMDMQ---ASKEFLAELKVLTHVHHLNLVRLIGYCVE---GSLF 557 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~------g~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~---~~~~ 557 (790)
++|++.+.||+|+||.||++... +..+++|.+... ..+.+.+|++++++++||||+++++++.. ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46888999999999999999742 678999998643 34578899999999999999999998752 3479
Q ss_pred EEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccc
Q 046083 558 LVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~ 637 (790)
+||||+++++|.+++.... ..+++..++.++.+++.||+|||++++ +||||||+||++++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i---~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRY---VHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCc---eeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999997543 358999999999999999999999998 999999999999999999999999998664
Q ss_pred cCCccc--ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC---
Q 046083 638 VGSASV--HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD--- 712 (790)
Q Consensus 638 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 712 (790)
...... .....++..|+|||++.+..++.++||||||+++|||++|..++...... +...+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----------~~~~~~~~~~~~ 229 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----------FMRMMGNDKQGQ 229 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----------hhhhcccccccc
Confidence 322211 11122345699999999889999999999999999999987765332211 000000000
Q ss_pred -ChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 713 -PREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 713 -~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
....+.+.+........+...+..+.+++.+||+.+|++|||+.||++.|..+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 230 MIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00111122222111122334556799999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=312.18 Aligned_cols=250 Identities=30% Similarity=0.461 Sum_probs=197.3
Q ss_pred hcCcccceeeeecCceEEEEEEECC-------ceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELRG-------EKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSL 556 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~g-------~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~ 556 (790)
+++|.+.+.||+|+||.||+|.+.+ ..+++|.+.. .....|..|+.++++++|+||+++++++.+ ...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678999999999999999998853 5788998753 223568899999999999999999998764 458
Q ss_pred EEEEEEecCCChhhhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC---cEEEE
Q 046083 557 FLVYEYIENGNLNQHLRGSGK-----DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF---RAKVA 628 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~---~~kl~ 628 (790)
+++|||+++++|.+++..... ..++|..+++++.+++.||+|||++++ +|+||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i---vH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHF---IHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCE---eecccchheEEEeccCCCcceEec
Confidence 999999999999999976431 358999999999999999999999997 9999999999998754 59999
Q ss_pred EeCCCcccccCCccc-ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHH
Q 046083 629 DFGLAKLTEVGSASV-HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEE 706 (790)
Q Consensus 629 DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 706 (790)
|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||...... .....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--------~~~~~ 233 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--------EVMEF 233 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHH
Confidence 999998653221111 112233568999999998999999999999999999997 88888543211 11111
Q ss_pred HHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 707 VLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 707 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.... .....+...+..+.+++.+||+.+|++||++.+|+++|.
T Consensus 234 ~~~~--------------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGG--------------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcC--------------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111 111223344567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=325.78 Aligned_cols=248 Identities=24% Similarity=0.400 Sum_probs=207.1
Q ss_pred cccceeeeecCceEEEEEEEC---Cc--eEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEEE
Q 046083 492 FSMGNKIGQGGFGAVFYAELR---GE--KAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEY 562 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~---g~--~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e~ 562 (790)
..+.++||+|.||.|++|.|+ |+ .||||+++.. ...+|.+|+.+|.+++|+|+++|||+..+....+|||.
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~EL 191 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFEL 191 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhh
Confidence 346789999999999999997 43 5899999743 45789999999999999999999999998888999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
++.|+|.+.|++..+..|-......++.|||.|+.||.+++. |||||..+|+||-....+||+||||.+.+......
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrl---vHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRL---VHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhh---hhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 999999999998556678888899999999999999999998 99999999999999999999999999977544332
Q ss_pred cc-c-ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 643 VH-T-RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 643 ~~-~-~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
.. . ..--...|+|||.+....|+.++|||+|||++|||+| |..||..... -.+-+
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----------------------~qIL~ 326 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----------------------IQILK 326 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH----------------------HHHHH
Confidence 21 1 1223568999999999999999999999999999998 5677754322 12223
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
.+|..-+-.-|..++++++++++.||..+|++|||+..|.+.+-.
T Consensus 327 ~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 327 NIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred hccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 344333345577899999999999999999999999999854443
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=308.43 Aligned_cols=249 Identities=26% Similarity=0.444 Sum_probs=195.1
Q ss_pred cccceeeeecCceEEEEEEEC--Cc--eEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-------Ce
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GE--KAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-------GS 555 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~--~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------~~ 555 (790)
|.+.+.||+|+||.||+|.+. +. .+|+|.++. ...+.+.+|+++++.++|+||+++++++.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 356789999999999999876 22 589998753 335678899999999999999999998742 13
Q ss_pred EEEEEEEecCCChhhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeC
Q 046083 556 LFLVYEYIENGNLNQHLRGS----GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFG 631 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfG 631 (790)
.+++|||+++|+|.+++... ....+++.....++.|++.||+|||++++ +||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSF---IHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCe---eccccchhheEEcCCCCEEECCCC
Confidence 68999999999999987432 12358999999999999999999999997 999999999999999999999999
Q ss_pred CCcccccCCccc-ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHc
Q 046083 632 LAKLTEVGSASV-HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLR 709 (790)
Q Consensus 632 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 709 (790)
+++......... .....+++.|++||++.+..++.++||||||+++|||++ |+.||..... .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~~ 229 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--------SEIYDYLRQ 229 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHc
Confidence 998764322111 122345678999999999999999999999999999999 7888754221 111111111
Q ss_pred CCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 710 QPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 710 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
... ...+...+..+.+++.+||+.+|++|||+.++++.|..+
T Consensus 230 ~~~--------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 GNR--------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC--------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 100 011223445689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=306.98 Aligned_cols=252 Identities=27% Similarity=0.491 Sum_probs=204.0
Q ss_pred HhcCcccceeeeecCceEEEEEEEC-CceEEEEEeCh--hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEe
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDM--QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
..++|++.+.||+|+||.||+|..+ +..+++|.+.. ...+++.+|++++++++|+|++++++++.+ ...+++|||+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 3467999999999999999999876 56799998874 334679999999999999999999998875 5689999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
++++|.+++.......+++..+..++.+++.||.|||++++ +|+||||+||++++++.+||+|||++..........
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i---~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNY---IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 99999999987655579999999999999999999999998 999999999999999999999999988654321111
Q ss_pred ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcC
Q 046083 644 HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD 722 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d 722 (790)
.....++..|+|||.+.+..++.++|+||||++++||++ |+.||..... ..........
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------~~~~~~~~~~------------ 220 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--------REVLEQVERG------------ 220 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcC------------
Confidence 122334568999999998899999999999999999998 8988853221 1111111111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 723 PRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 723 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
.....+...+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 221 --~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 221 --YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0111122335678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=315.42 Aligned_cols=254 Identities=28% Similarity=0.486 Sum_probs=201.8
Q ss_pred HhcCcccceeeeecCceEEEEEEEC-------CceEEEEEeChh----hHHHHHHHHHHHHhc-CCCCCcceEEEEec-C
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDMQ----ASKEFLAELKVLTHV-HHLNLVRLIGYCVE-G 554 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~ 554 (790)
..++|++.+.||+|+||.||++... ...+|+|.+... ...++.+|++++.++ +|+||+++++++.+ +
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 4467888999999999999999864 257899988642 234688999999999 89999999998875 4
Q ss_pred eEEEEEEEecCCChhhhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEec
Q 046083 555 SLFLVYEYIENGNLNQHLRGS--------------GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILID 620 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~ 620 (790)
..+++|||+++|+|.++++.. ....+++..+++++.|++.||.|||++++ +||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~i---vH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKC---IHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCc---cccccceeeEEEc
Confidence 589999999999999999642 12468999999999999999999999998 9999999999999
Q ss_pred CCCcEEEEEeCCCcccccCCccc-ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCcccccccccccccc
Q 046083 621 KNFRAKVADFGLAKLTEVGSASV-HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITEST 698 (790)
Q Consensus 621 ~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~ 698 (790)
.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------ 240 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------ 240 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH------
Confidence 99999999999998654322111 122335678999999998899999999999999999998 8888753221
Q ss_pred chHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 046083 699 GLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLS 766 (790)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~ 766 (790)
......... ......+......+.+++.+||+.+|.+|||+.|+++.|..+.
T Consensus 241 --~~~~~~~~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 --EELFKLLKE--------------GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --HHHHHHHHc--------------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111111111 1111223344567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.49 Aligned_cols=235 Identities=28% Similarity=0.421 Sum_probs=190.7
Q ss_pred eeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecCCCh
Q 046083 498 IGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNL 568 (790)
Q Consensus 498 lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~g~L 568 (790)
||+|+||.||++... ++.+|+|.++.. ....+.+|++++.+++||||+++++++.+ ...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999986 778999998642 23557889999999999999999998875 468999999999999
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccccccc
Q 046083 569 NQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLV 648 (790)
Q Consensus 569 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 648 (790)
.+++...+ .+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 154 (312)
T cd05585 81 FHHLQREG--RFDLSRARFYTAELLCALENLHKFNV---IYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFC 154 (312)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---EeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccccc
Confidence 99997643 58999999999999999999999998 999999999999999999999999998542221 2223457
Q ss_pred cCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCC
Q 046083 649 GTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDD 728 (790)
Q Consensus 649 gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 728 (790)
|++.|+|||.+.+..++.++|||||||++|||++|+.||.... ....+....... ..
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~--------~~~~~~~~~~~~---------------~~ 211 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--------VNEMYRKILQEP---------------LR 211 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC--------HHHHHHHHHcCC---------------CC
Confidence 8999999999999999999999999999999999999986432 112222222211 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 046083 729 YPIDSVRKMARLARACTQENPQLRPS---MRAIVVA 761 (790)
Q Consensus 729 ~~~~~~~~l~~li~~Cl~~dP~~RPt---~~evl~~ 761 (790)
++......+.+++.+||+.||.+||+ +.|++.+
T Consensus 212 ~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 212 FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 23334567889999999999999985 5666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=313.80 Aligned_cols=249 Identities=25% Similarity=0.419 Sum_probs=198.0
Q ss_pred CcccceeeeecCceEEEEEEEC-------CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFL 558 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~l 558 (790)
+|++.+.||+|+||.||+|... +..+|+|+++.. ..+.+..|+.++..++||||+++++++.+ ...++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4677899999999999999864 367999998743 23568899999999999999999999875 45899
Q ss_pred EEEEecCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCc
Q 046083 559 VYEYIENGNLNQHLRGSG--------------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFR 624 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~ 624 (790)
++||+.+++|.+++.... ...+++..+.+++.|++.||+|||++++ +||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi---~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHV---VHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCc---cccccchhheEecCCCc
Confidence 999999999999985321 2358899999999999999999999998 99999999999999999
Q ss_pred EEEEEeCCCcccccCCc-ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHH
Q 046083 625 AKVADFGLAKLTEVGSA-SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVA 702 (790)
Q Consensus 625 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 702 (790)
+||+|||+++....... .......+++.|+|||.+.++.++.++||||||+++|||++ |..||..... ..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~ 234 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--------QD 234 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--------HH
Confidence 99999999886532221 11123345779999999988899999999999999999998 7777754221 11
Q ss_pred HHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 703 LFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 703 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
....+... . ....+.+.+..+.+++.+||+.+|++||++++|++.|..
T Consensus 235 ~~~~i~~~-------------~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIRNR-------------Q-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHcC-------------C-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 12222111 1 112234456678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=313.54 Aligned_cols=247 Identities=26% Similarity=0.381 Sum_probs=198.6
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChhh------HHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA------SKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYE 561 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~------~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e 561 (790)
+|+..+.||+|+||.||++... ++.+|+|.+.... ...+.+|++++++++||||+++++.+.+ ...++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788999999999999999875 7899999986432 2346789999999999999999998875 45899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|+++|+|.+++.......+++..+..++.|++.||.|||+.++ +||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i---vH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERI---VYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCc---EecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 9999999998876544569999999999999999999999998 9999999999999999999999999986532221
Q ss_pred ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhc
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 721 (790)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ......... +
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-----~~~~~~~~~-------------~ 217 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-----VKREEVERR-------------V 217 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-----hHHHHHHHH-------------h
Confidence 22346899999999999889999999999999999999999999653221 000011111 1
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 046083 722 DPRLGDDYPIDSVRKMARLARACTQENPQLRP-----SMRAIVVA 761 (790)
Q Consensus 722 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 761 (790)
.. ....++...+..+.+++.+||+.||.+|| ++++++++
T Consensus 218 ~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 218 KE-DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred hh-cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 10 01122334556788999999999999999 78888665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=306.34 Aligned_cols=243 Identities=26% Similarity=0.442 Sum_probs=196.5
Q ss_pred eeeeecCceEEEEEEEC--C---ceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEEEecCC
Q 046083 496 NKIGQGGFGAVFYAELR--G---EKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENG 566 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~--g---~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e~~~~g 566 (790)
++||+|+||.||+|.+. + ..+++|.+... ..+++.+|+++++.+.|+|++++++++.....+++|||++++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 47999999999999864 2 57999998643 345688999999999999999999998877789999999999
Q ss_pred ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc-
Q 046083 567 NLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT- 645 (790)
Q Consensus 567 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~- 645 (790)
+|.+++.... .+++..++.++.|++.||+|||+.++ +|+||||+|||++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i---~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 81 PLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHF---VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCe---eccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 9999998654 58999999999999999999999997 99999999999999999999999999866433322111
Q ss_pred -ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 646 -RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 646 -~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
...++..|+|||.+.+..++.++||||||+++|||++ |..||..... ......+... .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--------~~~~~~~~~~-~----------- 215 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--------AEVIAMLESG-E----------- 215 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHcC-C-----------
Confidence 1223567999999998899999999999999999998 9999854321 1111111111 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
....+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 216 --~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 216 --RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred --cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 0112233446789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=315.14 Aligned_cols=256 Identities=34% Similarity=0.576 Sum_probs=200.7
Q ss_pred cCcccceeeeecCceEEEEEEEC--Cc--eEEEEEeCh----hhHHHHHHHHHHHHhc-CCCCCcceEEEEec-CeEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GE--KAAIKKMDM----QASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSLFLV 559 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~--~vavK~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~~lv 559 (790)
++|++.+.||+|+||.||+|.+. +. .+++|.++. ...+.+.+|++++.++ +|+||+++++++.+ +..+++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57888999999999999999875 33 457777653 2345688899999999 89999999999875 458999
Q ss_pred EEEecCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcE
Q 046083 560 YEYIENGNLNQHLRGSG--------------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRA 625 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~ 625 (790)
|||+++++|.++++..+ ...+++.+++.++.|++.||+|||++++ +||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi---~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCc---cccccchheEEecCCCcE
Confidence 99999999999997542 1358899999999999999999999998 999999999999999999
Q ss_pred EEEEeCCCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHH
Q 046083 626 KVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALF 704 (790)
Q Consensus 626 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 704 (790)
||+|||+++....... .....++..|+|||.+....++.++|||||||++|||+| |..||..... ....
T Consensus 164 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~ 233 (303)
T cd05088 164 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELY 233 (303)
T ss_pred EeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh--------HHHH
Confidence 9999999874321111 111234567999999988889999999999999999998 9999854321 1111
Q ss_pred HHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccC
Q 046083 705 EEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDW 772 (790)
Q Consensus 705 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~ 772 (790)
.... .......+......+.+++.+||+.+|++||+++++++.|..+......|
T Consensus 234 ~~~~--------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~ 287 (303)
T cd05088 234 EKLP--------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287 (303)
T ss_pred HHHh--------------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence 1111 11111122233456889999999999999999999999999876555544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=319.65 Aligned_cols=248 Identities=23% Similarity=0.340 Sum_probs=196.0
Q ss_pred CcccceeeeecCceEEEEEEE-----CCceEEEEEeChh-------hHHHHHHHHHHHHhc-CCCCCcceEEEEec-CeE
Q 046083 491 DFSMGNKIGQGGFGAVFYAEL-----RGEKAAIKKMDMQ-------ASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSL 556 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~-----~g~~vavK~~~~~-------~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~ 556 (790)
+|++.+.||+|+||.||+++. .+..+|+|.+... ..+.+..|++++.++ +|+||+++++++.+ +..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588899999999999999876 2678999998642 234578899999999 59999999988764 458
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---vHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLGI---VYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---EecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999999999997643 58999999999999999999999998 99999999999999999999999999865
Q ss_pred ccCCcccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChh
Q 046083 637 EVGSASVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715 (790)
Q Consensus 637 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (790)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ............
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----~~~~~~~~~~~~----- 226 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN----TQSEVSRRILKC----- 226 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC----CHHHHHHHHhcC-----
Confidence 43333333346789999999999865 47889999999999999999999996432210 111111111111
Q ss_pred hhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 046083 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRP-----SMRAIVVAL 762 (790)
Q Consensus 716 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~L 762 (790)
++ ..+......+.+++.+||+.||++|| ++++++++-
T Consensus 227 ------~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 227 ------DP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred ------CC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 11 12233456788999999999999999 777887653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=310.42 Aligned_cols=254 Identities=24% Similarity=0.404 Sum_probs=203.1
Q ss_pred hcCcccceeeeecCceEEEEEEECC------ceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEec--CeE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELRG------EKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVE--GSL 556 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~g------~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~ 556 (790)
.++|.+.+.||+|+||.||+|.... ..+++|.+.. ...+.+.+|+.++++++|+|++++++++.+ ...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 5678999999999999999998753 6788998763 334568899999999999999999998875 458
Q ss_pred EEEEEEecCCChhhhhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEe
Q 046083 557 FLVYEYIENGNLNQHLRGSGK------DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADF 630 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~Df 630 (790)
++++||+++++|.+++..... ..+++..++.++.+++.||+|||++++ +|+||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i---~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGV---IHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCE---eecccCHhhEEEcCCCcEEECCC
Confidence 999999999999999875321 468999999999999999999999997 99999999999999999999999
Q ss_pred CCCcccccCCccc-ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHH
Q 046083 631 GLAKLTEVGSASV-HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVL 708 (790)
Q Consensus 631 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 708 (790)
|+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||..... ........
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~ 233 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--------FEMAAYLK 233 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--------HHHHHHHH
Confidence 9998654322211 122345678999999998889999999999999999999 9999854321 11111111
Q ss_pred cCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 709 RQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 709 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
.. .....+..++..+.+++.+||+.+|++|||+.++++.|..+..
T Consensus 234 ~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 DG--------------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred cC--------------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11 0011122344678999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=336.20 Aligned_cols=253 Identities=26% Similarity=0.383 Sum_probs=202.5
Q ss_pred HHHHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC--
Q 046083 484 ELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-- 554 (790)
Q Consensus 484 ~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-- 554 (790)
+.....++|.+.+.||+|+||.||+|... ++.+|||.++. .....+.+|+..+..++|+|+++++..+...
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 34445679999999999999999999874 88999999853 2345688899999999999999988765321
Q ss_pred -------eEEEEEEEecCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcE
Q 046083 555 -------SLFLVYEYIENGNLNQHLRGSG--KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRA 625 (790)
Q Consensus 555 -------~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~ 625 (790)
..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.++ +||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~I---iHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHM---IHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCE---ecCCCCHHHEEEeCCCCE
Confidence 2579999999999999987532 3468999999999999999999999997 999999999999999999
Q ss_pred EEEEeCCCcccccCC-cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHH
Q 046083 626 KVADFGLAKLTEVGS-ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALF 704 (790)
Q Consensus 626 kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 704 (790)
||+|||+++.+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~--------~~~~ 254 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM--------EEVM 254 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--------HHHH
Confidence 999999998654321 1222346789999999999999999999999999999999999999854321 1122
Q ss_pred HHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 705 EEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 705 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
...... . ....+...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 255 ~~~~~~-------------~-~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 255 HKTLAG-------------R-YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHhcC-------------C-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 222111 0 011233445678999999999999999999999864
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=333.93 Aligned_cols=245 Identities=24% Similarity=0.375 Sum_probs=197.0
Q ss_pred CcccceeeeecCceEEEEEEEC---CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEe
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR---GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~---g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
.|.+.+.||+|+||.||+|... ++.+++|.+.. .....+.+|+++++.++||||+++++++.. +..|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888999999999999999764 56788887643 223457889999999999999999998874 5689999999
Q ss_pred cCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 564 ENGNLNQHLRGS--GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 564 ~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
++|+|.+++... ...++++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~i---vHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKM---MHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCE---EECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988642 23468999999999999999999999997 9999999999999999999999999986543221
Q ss_pred -ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 642 -SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 642 -~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..........
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--------~~~~~~~~~~---------- 286 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--------REIMQQVLYG---------- 286 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhC----------
Confidence 123345789999999999999999999999999999999999999854321 1112222111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVV 760 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 760 (790)
.. ...+......+.+++.+||+.+|++||++++++.
T Consensus 287 ---~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 287 ---KY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---CC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 00 1122234467899999999999999999999875
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=317.79 Aligned_cols=262 Identities=24% Similarity=0.399 Sum_probs=198.9
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYE 561 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e 561 (790)
.++|++.++||+|+||.||++... +..+|+|.+... ..+.+.+|++++++++|+||+++++++.+ +..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367999999999999999999986 778899987642 33568899999999999999999998874 56899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH-TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
|+++++|.+++...+ .+++..+..++.+++.||.|||+. ++ +|+||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~i---vH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKI---MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCE---EecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 999999999997643 488999999999999999999985 55 99999999999999999999999998754321
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcC----------
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQ---------- 710 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---------- 710 (790)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....... ...........
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE-----LELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH-----HHHHhcCcccCCccccccCcc
Confidence 1223568999999999998899999999999999999999999986432210 00000000000
Q ss_pred --------------CCChh---hhhhhcCCcCCCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 711 --------------PDPRE---DLQRLVDPRLGDDYP-IDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 711 --------------~~~~~---~l~~~~d~~l~~~~~-~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
..+.. .+...+........+ .....++.+++.+||+.||++|||++|++.+-.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 00000 000000000000111 113456889999999999999999999987655
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=314.54 Aligned_cols=257 Identities=26% Similarity=0.473 Sum_probs=202.9
Q ss_pred hcCcccceeeeecCceEEEEEEEC---------CceEEEEEeCh----hhHHHHHHHHHHHHhc-CCCCCcceEEEEec-
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR---------GEKAAIKKMDM----QASKEFLAELKVLTHV-HHLNLVRLIGYCVE- 553 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~---------g~~vavK~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~- 553 (790)
.++|.+.+.||+|+||.||++... +..+++|.+.. ...+++.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456788999999999999999742 34689998863 2345688999999999 89999999998875
Q ss_pred CeEEEEEEEecCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe
Q 046083 554 GSLFLVYEYIENGNLNQHLRGSG--------------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI 619 (790)
Q Consensus 554 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl 619 (790)
...+++|||+.+|+|.+++.... ...+++..+++++.|++.||.|||++++ +||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~gi---vH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC---IHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCe---eecccccceEEE
Confidence 45899999999999999997532 1357899999999999999999999998 999999999999
Q ss_pred cCCCcEEEEEeCCCcccccCCccc-ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccc
Q 046083 620 DKNFRAKVADFGLAKLTEVGSASV-HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITES 697 (790)
Q Consensus 620 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~ 697 (790)
++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------ 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------ 244 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------
Confidence 999999999999998664322211 122345678999999998889999999999999999998 777764321
Q ss_pred cchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCc
Q 046083 698 TGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770 (790)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~ 770 (790)
........... .....+...+..+.+++.+||+.+|.+|||+.|+++.|.++...+.
T Consensus 245 --~~~~~~~~~~~--------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 245 --VEELFKLLKEG--------------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred --HHHHHHHHHcC--------------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 11112111111 1111223455678999999999999999999999999998766544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=320.41 Aligned_cols=237 Identities=25% Similarity=0.401 Sum_probs=192.9
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecCC
Q 046083 496 NKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENG 566 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~g 566 (790)
+.||+|+||.||++... +..+|+|.+... ....+.+|+++++.++||||+++++++.+ +..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 789999998642 33567889999999999999999988774 4589999999999
Q ss_pred ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccccc
Q 046083 567 NLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR 646 (790)
Q Consensus 567 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 646 (790)
+|.+++.... .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~i---vHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGKI---VYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKT 154 (328)
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---EecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccc
Confidence 9999887643 58999999999999999999999998 999999999999999999999999987532211 12234
Q ss_pred cccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCC
Q 046083 647 LVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLG 726 (790)
Q Consensus 647 ~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 726 (790)
..|++.|+|||++.+..++.++|||||||++|||++|+.||..... .......... +
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~--------~~~~~~~~~~-----------~---- 211 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILME-----------D---- 211 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH--------HHHHHHhccC-----------C----
Confidence 5789999999999988999999999999999999999999864321 1111111111 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 046083 727 DDYPIDSVRKMARLARACTQENPQLRP-----SMRAIVVA 761 (790)
Q Consensus 727 ~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 761 (790)
..++......+.+++.+||+.||++|| +++|++++
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 212 IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 112333456788999999999999997 89998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=316.07 Aligned_cols=254 Identities=27% Similarity=0.474 Sum_probs=200.9
Q ss_pred cCcccceeeeecCceEEEEEEEC---------CceEEEEEeChh----hHHHHHHHHHHHHhc-CCCCCcceEEEEec-C
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR---------GEKAAIKKMDMQ----ASKEFLAELKVLTHV-HHLNLVRLIGYCVE-G 554 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~---------g~~vavK~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~ 554 (790)
++|.+.+.||+|+||.||++... ...+|+|.++.. ...++.+|++++..+ +|+||+++++++.+ +
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56899999999999999999753 246999998742 335688899999999 79999999998875 4
Q ss_pred eEEEEEEEecCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEec
Q 046083 555 SLFLVYEYIENGNLNQHLRGSGK--------------DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILID 620 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~ 620 (790)
..++||||+.+|+|.+++..... ..+++.++++++.|++.||+|||++++ +||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi---~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCc---ccccccHHheEEc
Confidence 58999999999999999975421 358999999999999999999999998 9999999999999
Q ss_pred CCCcEEEEEeCCCcccccCCccc-ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCcccccccccccccc
Q 046083 621 KNFRAKVADFGLAKLTEVGSASV-HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITEST 698 (790)
Q Consensus 621 ~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~ 698 (790)
.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~------ 248 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------ 248 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH------
Confidence 99999999999987553221111 111234568999999998889999999999999999998 7788743211
Q ss_pred chHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 699 GLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
....... . .......+.....++.+++.+||+.+|.+|||+.+|++.|..+...
T Consensus 249 --~~~~~~~-~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 249 --EELFKLL-K-------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred --HHHHHHH-H-------------cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1111111 1 1111122334556888999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=307.05 Aligned_cols=244 Identities=23% Similarity=0.408 Sum_probs=205.9
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh------HHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA------SKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLV 559 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~------~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv 559 (790)
..+|++.+.||+|.||.|-+|... |+.||||.++... .-.+.+|++||+.++||||+.+|.+|.+. .+.+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 457888999999999999999874 9999999886533 23478999999999999999999999864 58999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||..+|.|++|+...+ .|++.+..++++||..|+.|+|.+++ +|||||.+|||||+++++||+|||++.++..
T Consensus 132 MEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrV---vHRDLKLENILLD~N~NiKIADFGLSNly~~- 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRV---VHRDLKLENILLDQNNNIKIADFGLSNLYAD- 205 (668)
T ss_pred EEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccc---eecccchhheeecCCCCeeeeccchhhhhcc-
Confidence 99999999999998765 59999999999999999999999998 9999999999999999999999999988753
Q ss_pred CcccccccccCCCccchhcccCCCC-CchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGEV-SPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
....+.++|++-|.+||...+..| .+..|-|||||+||-|+.|.-||... +...++.++-+...
T Consensus 206 -~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~--------Dhk~lvrQIs~GaY------ 270 (668)
T KOG0611|consen 206 -KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR--------DHKRLVRQISRGAY------ 270 (668)
T ss_pred -ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc--------hHHHHHHHhhcccc------
Confidence 334567899999999999999887 57899999999999999999998643 33334444333211
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.+| ..+....-||++||..+|++|-|+++|..+-|
T Consensus 271 --rEP--------~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 271 --REP--------ETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred --cCC--------CCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 111 22234667999999999999999999998876
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=326.86 Aligned_cols=255 Identities=22% Similarity=0.321 Sum_probs=199.8
Q ss_pred HHHHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEecC-
Q 046083 484 ELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG- 554 (790)
Q Consensus 484 ~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~- 554 (790)
.+....++|++.+.||+|+||.||++... ++.+|+|.+... ..+.+.+|+.+++.++||||+++++++.++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34445678999999999999999999986 778999998632 234578899999999999999999988754
Q ss_pred eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCc
Q 046083 555 SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK 634 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~ 634 (790)
..|+||||+++|+|.+++... .+++..+..++.|++.||+|||++++ +||||||+|||+++++.+||+|||++.
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~I---vHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGL---IHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCe---EecCCCHHHEEECCCCCEEEEecccce
Confidence 589999999999999999753 47889999999999999999999998 999999999999999999999999998
Q ss_pred ccccCCcccccccccCCCccchhcccCC----CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcC
Q 046083 635 LTEVGSASVHTRLVGTFGYMPPEYAQYG----EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQ 710 (790)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 710 (790)
..............||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+...
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--------~~~~~~i~~~ 262 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--------VGTYSKIMDH 262 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH--------HHHHHHHHhC
Confidence 7643332223346799999999998754 378899999999999999999999964321 1122222221
Q ss_pred CCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHH
Q 046083 711 PDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQL--RPSMRAIVVALM 763 (790)
Q Consensus 711 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~L~ 763 (790)
.. .+...........+.+++..|++.++.+ ||++.|++++-+
T Consensus 263 ~~-----------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 263 KN-----------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred Cc-----------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 10 0000111123556788999999865544 899999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=324.09 Aligned_cols=248 Identities=23% Similarity=0.308 Sum_probs=198.5
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
++|.+.+.||+|+||.||++... ++.+|+|.++.. ..+.+.+|+.+++.++|+||+++++++.+ ...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47899999999999999999875 789999998743 23458889999999999999999988775 4589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+.++ +||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i---~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGY---VHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCe---EcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999998652 368999999999999999999999998 999999999999999999999999998664433
Q ss_pred cccccccccCCCccchhccc------CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQ------YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
........|++.|+|||++. ...++.++|||||||++|||++|+.||..... ...+..+.....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~~~~~-- 226 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS--------AKTYNNIMNFQR-- 226 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH--------HHHHHHHHcCCC--
Confidence 32233457899999999986 45678999999999999999999999864321 112222221100
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.+...........+.+++..|++ +|.+|||+++++.+
T Consensus 227 ---------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 227 ---------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ---------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00001111344678899999998 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=307.96 Aligned_cols=249 Identities=25% Similarity=0.451 Sum_probs=197.5
Q ss_pred cccceeeeecCceEEEEEEEC-----CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEecCe------
Q 046083 492 FSMGNKIGQGGFGAVFYAELR-----GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVEGS------ 555 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~-----g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 555 (790)
|.+.+.||+|+||.||+|... +..+|+|.++.. ..+.+.+|++.++.++|+|++++++++.+..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567899999999999999874 257999988632 2356889999999999999999999875322
Q ss_pred -EEEEEEEecCCChhhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEe
Q 046083 556 -LFLVYEYIENGNLNQHLRGS----GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADF 630 (790)
Q Consensus 556 -~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~Df 630 (790)
.+++|||+++|+|..++... ....+++..+..++.|++.||.|||++++ +||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i---~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNF---IHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCe---eccccchheEEECCCCeEEECCc
Confidence 68999999999999988542 22468999999999999999999999997 99999999999999999999999
Q ss_pred CCCcccccCCccc-ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHH
Q 046083 631 GLAKLTEVGSASV-HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVL 708 (790)
Q Consensus 631 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 708 (790)
|+++......... .....++..|+|||.+....++.++||||||+++|||++ |..||..... ........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--------~~~~~~~~ 229 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--------HEIYDYLR 229 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHH
Confidence 9998664332211 111234678999999988899999999999999999999 8888744221 11122221
Q ss_pred cCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 709 RQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 709 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
... ....+......+.+++.+||+.||.+|||+.|+++.|.++
T Consensus 230 ~~~--------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 HGN--------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCC--------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 110 1112334556789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=305.82 Aligned_cols=247 Identities=25% Similarity=0.404 Sum_probs=198.9
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh--------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ--------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFL 558 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~l 558 (790)
++|.+.+.||+|++|.||++... +..+++|.+... ..+.+.+|++++++++||||+++++++.+ ...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999864 789999987531 23468889999999999999999999875 45899
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
+|||+++++|.+++.... .+++..+.+++.+++.||.|||+.++ +|+||+|+||++++++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i---~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNMI---VHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999999997643 58899999999999999999999998 9999999999999999999999999976533
Q ss_pred CCcccc--cccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhh
Q 046083 639 GSASVH--TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716 (790)
Q Consensus 639 ~~~~~~--~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (790)
...... ....++..|+|||.+.+..++.++||||||+++|||++|+.||...... .......
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~~~-------- 220 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM--------AAIFKIA-------- 220 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH--------HHHHHHh--------
Confidence 221111 2345788999999999988999999999999999999999998543210 1111111
Q ss_pred hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 717 LQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 717 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
........+......+.+++.+||+.+|.+|||+.+++++.
T Consensus 221 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 221 -----TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred -----ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 11111223334456788999999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=320.46 Aligned_cols=256 Identities=28% Similarity=0.466 Sum_probs=198.8
Q ss_pred hcCcccceeeeecCceEEEEEEEC-------CceEEEEEeChh----hHHHHHHHHHHHHhc-CCCCCcceEEEEec--C
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDMQ----ASKEFLAELKVLTHV-HHLNLVRLIGYCVE--G 554 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~g~~~~--~ 554 (790)
.++|++.+.||+|+||.||+|.+. ++.+|||.++.. ....+.+|+.++.++ +|+||+++++++.. .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 457899999999999999999742 568999998642 235688899999999 68999999998764 3
Q ss_pred eEEEEEEEecCCChhhhhhcCC----------------------------------------------------------
Q 046083 555 SLFLVYEYIENGNLNQHLRGSG---------------------------------------------------------- 576 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 576 (790)
..+++|||+++|+|.++++...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 4789999999999999986421
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc-cccccc
Q 046083 577 -------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS-VHTRLV 648 (790)
Q Consensus 577 -------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~ 648 (790)
...+++..+.+++.|+++||+|||++++ +||||||+|||+++++.+||+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i---~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 1236888999999999999999999998 99999999999999999999999999865322111 112234
Q ss_pred cCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCC
Q 046083 649 GTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGD 727 (790)
Q Consensus 649 gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 727 (790)
++..|+|||.+.+..++.++||||||+++|||++ |..||...... .......... ...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~-------------~~~ 301 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------EEFCRRLKEG-------------TRM 301 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--------HHHHHHHhcc-------------CCC
Confidence 5678999999998899999999999999999997 88887542211 0011111110 001
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 728 DYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 728 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
..+......+.+++..||+.+|++|||+.||+++|..+.+.
T Consensus 302 ~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 302 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 11112234688999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=322.57 Aligned_cols=196 Identities=27% Similarity=0.416 Sum_probs=169.9
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~ 560 (790)
++|++.+.||+|+||.||++... ++.+|+|.++.. ....+.+|++++.+++|+||+++++.+.+. ..|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999875 789999998642 224578899999999999999999988754 589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~gi---vHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLGF---IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---EecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999998643 58999999999999999999999998 999999999999999999999999987543211
Q ss_pred c----------------------------------ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCcc
Q 046083 641 A----------------------------------SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEA 686 (790)
Q Consensus 641 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p 686 (790)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 001234799999999999999999999999999999999999999
Q ss_pred cccc
Q 046083 687 VVKT 690 (790)
Q Consensus 687 ~~~~ 690 (790)
|...
T Consensus 236 f~~~ 239 (363)
T cd05628 236 FCSE 239 (363)
T ss_pred CCCC
Confidence 9643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=325.80 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=196.5
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~ 560 (790)
++|++.+.||+|+||.||+++.. ++.+|||++... ..+.+.+|++++..++||||+++++++.++ ..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999985 789999998743 234578899999999999999999988754 589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~i---vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLGY---IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999997644 58999999999999999999999998 999999999999999999999999987543211
Q ss_pred cc-------------------------------------cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhC
Q 046083 641 AS-------------------------------------VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISA 683 (790)
Q Consensus 641 ~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG 683 (790)
.. ......||+.|+|||++....++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 00124689999999999999999999999999999999999
Q ss_pred CccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 046083 684 MEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPS---MRAIVV 760 (790)
Q Consensus 684 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~evl~ 760 (790)
..||..... ......+..... .+...........+.+++.+|+. +|.+|++ ++|+++
T Consensus 236 ~~Pf~~~~~--------~~~~~~i~~~~~-----------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 236 YPPFCSDNP--------QETYRKIINWKE-----------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCH--------HHHHHHHHcCCC-----------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999965322 111122221100 00000011234567889999997 9999998 998877
Q ss_pred HH
Q 046083 761 AL 762 (790)
Q Consensus 761 ~L 762 (790)
+-
T Consensus 296 h~ 297 (364)
T cd05599 296 HP 297 (364)
T ss_pred CC
Confidence 53
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=323.70 Aligned_cols=245 Identities=23% Similarity=0.374 Sum_probs=190.5
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEe
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
+|+..++||+|+||.||+|... ++.+|||.+.. ...+.+.+|+++++.++|+||+++++++.+ +..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3556789999999999999886 78999999853 234568899999999999999999998874 5689999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
++++|.+.. ...+..+..++.|++.||+|||++++ +||||||+|||+++++.+||+|||+++....... .
T Consensus 155 ~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~i---vHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 224 (353)
T PLN00034 155 DGGSLEGTH------IADEQFLADVARQILSGIAYLHRRHI---VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-P 224 (353)
T ss_pred CCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCCE---eecCCCHHHEEEcCCCCEEEcccccceecccccc-c
Confidence 999986532 35677788999999999999999998 9999999999999999999999999986543211 1
Q ss_pred ccccccCCCccchhcccC-----CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 644 HTRLVGTFGYMPPEYAQY-----GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
.....|+..|+|||++.. ...+.++|||||||++|||++|+.||...... +...........
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-----~~~~~~~~~~~~-------- 291 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-----DWASLMCAICMS-------- 291 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-----cHHHHHHHHhcc--------
Confidence 233578999999998743 23456899999999999999999999632211 111111111100
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
.....+.....++.+++.+||+.||++|||+.|++++-+-
T Consensus 292 ------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~ 331 (353)
T PLN00034 292 ------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFI 331 (353)
T ss_pred ------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 0111223345678999999999999999999999986543
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=310.08 Aligned_cols=249 Identities=29% Similarity=0.522 Sum_probs=197.8
Q ss_pred cCcccceeeeecCceEEEEEEEC-------CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFL 558 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~l 558 (790)
++|...++||+|+||.||++... +..+++|.+.. ...+.+.+|+++++.++|+||+++++++.++ ..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46788999999999999999642 45788888764 3346799999999999999999999988754 4899
Q ss_pred EEEEecCCChhhhhhcCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcE
Q 046083 559 VYEYIENGNLNQHLRGSGK-------------DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRA 625 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~-------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~ 625 (790)
+|||+++++|.+++..... ..+++..++.++.|++.||+|||++++ +|+||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i---~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHF---VHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCe---ecccccHhhEEEcCCCCE
Confidence 9999999999999975431 358999999999999999999999998 999999999999999999
Q ss_pred EEEEeCCCcccccCCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHH
Q 046083 626 KVADFGLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVAL 703 (790)
Q Consensus 626 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 703 (790)
||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... ..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~ 233 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT--------EA 233 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--------HH
Confidence 99999999765332211 1122345678999999999999999999999999999998 88887543221 11
Q ss_pred HHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 704 FEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 704 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
....... .....+...+..+.+++.+||+.||.+||+++||.+.|+
T Consensus 234 ~~~~~~~--------------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 234 IECITQG--------------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHcC--------------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1111110 001112234467889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=324.32 Aligned_cols=257 Identities=23% Similarity=0.318 Sum_probs=201.8
Q ss_pred HHHHHHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec
Q 046083 482 YEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE 553 (790)
Q Consensus 482 ~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 553 (790)
+.++....++|++.+.||+|+||.||++... ++.+|+|.+... ..+.+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455556789999999999999999999986 778999998632 23457789999999999999999998875
Q ss_pred C-eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCC
Q 046083 554 G-SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGL 632 (790)
Q Consensus 554 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGl 632 (790)
+ ..++||||+++|+|.+++... .++...+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~i---vHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCE---EeCCCCHHHEEECCCCCEEEEeCCc
Confidence 4 589999999999999999753 47888899999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCcccccccccCCCccchhcccCC----CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHH
Q 046083 633 AKLTEVGSASVHTRLVGTFGYMPPEYAQYG----EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVL 708 (790)
Q Consensus 633 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 708 (790)
++..............||+.|+|||++... .++.++|||||||++|||++|+.||..... ...+..+.
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~ 260 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIM 260 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--------HHHHHHHH
Confidence 986643332233346799999999998754 378999999999999999999999965321 12223332
Q ss_pred cCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHH
Q 046083 709 RQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQL--RPSMRAIVVALM 763 (790)
Q Consensus 709 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~L~ 763 (790)
..... +...........+.+++..|+..++.+ ||+++|++++..
T Consensus 261 ~~~~~-----------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 261 NHKNS-----------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred cCCCc-----------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 21110 000111234567889999999844443 789999988764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.54 Aligned_cols=242 Identities=27% Similarity=0.487 Sum_probs=193.3
Q ss_pred eeeeecCceEEEEEEEC-CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEEecCCChh
Q 046083 496 NKIGQGGFGAVFYAELR-GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLN 569 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~~~~g~L~ 569 (790)
+.||+|+||.||+|... +..+|+|.++.. ....+.+|++++++++||||+++++++... ..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999875 678999987642 234688999999999999999999998754 589999999999999
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccccccc
Q 046083 570 QHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVG 649 (790)
Q Consensus 570 ~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 649 (790)
+++.... ..+++..++.++.+++.+|.|||++++ +|+||+|+||+++.++.+||+|||++...............+
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~---~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNC---IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCe---eecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9987643 358999999999999999999999998 999999999999999999999999987543322211122334
Q ss_pred CCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCC
Q 046083 650 TFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDD 728 (790)
Q Consensus 650 t~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 728 (790)
+..|+|||++....++.++||||||+++|||++ |..||...... ........ .....
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--------~~~~~~~~--------------~~~~~ 214 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--------QAREQVEK--------------GYRMS 214 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHHc--------------CCCCC
Confidence 668999999998899999999999999999998 88888543211 11111111 11112
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 729 YPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 729 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.+...+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 215 CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 23344567999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=306.46 Aligned_cols=251 Identities=27% Similarity=0.468 Sum_probs=200.3
Q ss_pred hcCcccceeeeecCceEEEEEEEC--Cc---eEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GE---KAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFL 558 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~---~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~l 558 (790)
.++|+..+.||+|+||.||+|... +. .+++|.++.. ..+++..|++++++++|+|++++++++.+ +..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 357888999999999999999875 32 6899988642 34568899999999999999999998875 45899
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
||||+++++|.+++.... ..+++..+..++.+++.||+|||+.++ +|+||||+||++++++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i---~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNY---VHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCe---eccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999997643 358999999999999999999999997 9999999999999999999999999986543
Q ss_pred CCccccc--ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChh
Q 046083 639 GSASVHT--RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715 (790)
Q Consensus 639 ~~~~~~~--~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (790)
....... ....+..|+|||++....++.++||||||+++|||++ |+.||..... ......+..
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--------~~~~~~i~~------ 225 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--------HEVMKAIND------ 225 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHHhc------
Confidence 2221111 1223457999999998899999999999999999997 9999854321 111111111
Q ss_pred hhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 716 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
......+.+.+..+.+++.+||+.+|++||++.+|++.|.++
T Consensus 226 --------~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 --------GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011112233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=309.53 Aligned_cols=250 Identities=27% Similarity=0.448 Sum_probs=198.2
Q ss_pred HHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh--hhHHHHHHHHHHHHhc-CCCCCcceEEEEec-------C
Q 046083 487 KATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM--QASKEFLAELKVLTHV-HHLNLVRLIGYCVE-------G 554 (790)
Q Consensus 487 ~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-------~ 554 (790)
.+++.|++.+.||+|+||.||+|... ++.+|+|.+.. ....++..|+.++.++ +|+|++++++++.. .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 35667888999999999999999875 77899999864 3345688999999998 79999999998763 2
Q ss_pred eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCc
Q 046083 555 SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK 634 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~ 634 (790)
..+++|||+.+++|.+++.......+++..+..++.|++.||+|||++++ +|+||||+||++++++.++|+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i---vh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC---ccCCCCHHHEEECCCCCEEEccCCCce
Confidence 47899999999999999987555578999999999999999999999998 999999999999999999999999998
Q ss_pred ccccCCcccccccccCCCccchhccc-----CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHc
Q 046083 635 LTEVGSASVHTRLVGTFGYMPPEYAQ-----YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLR 709 (790)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 709 (790)
....... ......|+..|+|||++. ...++.++|||||||++|||++|..||...... ... .....
T Consensus 160 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-------~~~-~~~~~ 230 (272)
T cd06637 160 QLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------RAL-FLIPR 230 (272)
T ss_pred ecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-------HHH-HHHhc
Confidence 6543221 223456889999999986 345788999999999999999999998543211 000 01111
Q ss_pred CCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 710 QPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 710 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.. .+.+ .+...+..+.+++.+||+.+|.+|||+.|++.+
T Consensus 231 ~~----------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 231 NP----------APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CC----------CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00 0011 111234578899999999999999999999763
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=325.31 Aligned_cols=248 Identities=24% Similarity=0.289 Sum_probs=193.1
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYE 561 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e 561 (790)
.|+..+.||+|+||.||+|... ++.+|+|++... ..+.+.+|++++++++|+||+++++++.+. ..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999885 779999998642 234688999999999999999999988754 5899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|+++|+|.+++.... .+++..+..++.|++.||+|||+.++ +||||||+|||++.++++||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~gi---vHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMGF---IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---eecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999997643 58899999999999999999999998 9999999999999999999999999753311000
Q ss_pred ----------------------------------------------ccccccccCCCccchhcccCCCCCchhhHHHHHH
Q 046083 642 ----------------------------------------------SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGV 675 (790)
Q Consensus 642 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gv 675 (790)
.......||+.|+|||.+.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0012346999999999999889999999999999
Q ss_pred HHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHH--ccccCCCCCC
Q 046083 676 VLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARA--CTQENPQLRP 753 (790)
Q Consensus 676 vl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~--Cl~~dP~~RP 753 (790)
++|||++|..||...... .......... ..+..........++.+++.+ |+..+|..||
T Consensus 237 il~elltG~~Pf~~~~~~--------~~~~~i~~~~-----------~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~ 297 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPT--------ETQLKVINWE-----------NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRN 297 (381)
T ss_pred HHHHHHhCCCCCcCCCHH--------HHHHHHHccc-----------cccCCCCCCCCCHHHHHHHHHHccCcccccCCC
Confidence 999999999999653321 1111111100 000000011234567778877 5566777799
Q ss_pred CHHHHHHHH
Q 046083 754 SMRAIVVAL 762 (790)
Q Consensus 754 t~~evl~~L 762 (790)
+++|++.+-
T Consensus 298 ~~~~~l~hp 306 (381)
T cd05626 298 GADDIKAHP 306 (381)
T ss_pred CHHHHhcCc
Confidence 999998764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=307.53 Aligned_cols=257 Identities=28% Similarity=0.399 Sum_probs=197.9
Q ss_pred cccceeeeecCceEEEEEEEC--CceEEEEEeChhhHHHHHHHHHHHHhcCCCCCcceEEEEe---cC-e--EEEEEEEe
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYCV---EG-S--LFLVYEYI 563 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~---~~-~--~~lv~e~~ 563 (790)
|...+++|.|+||.||+|... ++.+|||+.-.+.. .-.+|+++|+.+.|||||+|.-++. +. + ..+|||||
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 556789999999999999986 78999999854322 2346899999999999999988765 22 2 46899999
Q ss_pred cCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC-CcEEEEEeCCCcccccCC
Q 046083 564 ENGNLNQHLRGS--GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN-FRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 564 ~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~-~~~kl~DfGla~~~~~~~ 640 (790)
+. +|.++++.. .+..++...+.-+..|+.+||.|||+.++ +||||||+|+|+|.+ |.+||||||.|+.+..+.
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~I---cHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGI---CHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCc---ccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 88 999998852 23457777788899999999999999998 999999999999987 899999999999876554
Q ss_pred cccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
.. .....|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|...+. .+.....-.++..+. .+++..
T Consensus 181 pn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-----~dQL~eIik~lG~Pt-~e~I~~ 252 (364)
T KOG0658|consen 181 PN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-----VDQLVEIIKVLGTPT-REDIKS 252 (364)
T ss_pred Cc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH-----HHHHHHHHHHhCCCC-HHHHhh
Confidence 43 446678999999999864 799999999999999999999998866332 222222333333322 233332
Q ss_pred hcCC-------cC-----CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 720 LVDP-------RL-----GDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 720 ~~d~-------~l-----~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
+... .+ ..-+......+..+++.++++.+|.+|.++.|++.+
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 2211 11 111234556788999999999999999999998763
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=305.94 Aligned_cols=254 Identities=25% Similarity=0.431 Sum_probs=202.9
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh------hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
++|++.+.||+|+||.||++... +..++||.+.. ....++.+|+++++.++|+||+++++++.+ +..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46888899999999999999864 88999997753 233578899999999999999999998764 5689999
Q ss_pred EEecCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 561 EYIENGNLNQHLRGS--GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 561 e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
||+++++|.+++... ....+++..++.++.+++.||.|||++++ +|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i---~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV---MHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999998742 23468999999999999999999999998 9999999999999999999999999876543
Q ss_pred CCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 639 GSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
... ......++..|+|||++.+..++.++|+||||+++|||++|..||...... .........
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~---------- 221 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIE---------- 221 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch------HHHHhhhhh----------
Confidence 221 122346788999999999888999999999999999999999998543211 111111111
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLS 766 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~ 766 (790)
....+.+ .+......+.+++.+||+.+|.+||||.+|++.+.++.
T Consensus 222 ~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 222 QCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred cCCCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1111111 11234567899999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=309.46 Aligned_cols=250 Identities=27% Similarity=0.452 Sum_probs=199.6
Q ss_pred hcCcccceeeeecCceEEEEEEEC-------CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SL 556 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~ 556 (790)
.++|++.+.||+|+||.||+|... +..+++|.+... ....+.+|+.++..++|+|++++++++.++ ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 357889999999999999999875 257999998632 235688999999999999999999998754 58
Q ss_pred EEEEEEecCCChhhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEE
Q 046083 557 FLVYEYIENGNLNQHLRGSG--------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVA 628 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~ 628 (790)
++||||+++++|.+++.... ...++|..++.++.|++.||.|||+.++ +|+||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKF---VHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCc---cccccChheEEEcCCCCEEEC
Confidence 99999999999999997532 1247899999999999999999999998 999999999999999999999
Q ss_pred EeCCCcccccCCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHH
Q 046083 629 DFGLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEE 706 (790)
Q Consensus 629 DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 706 (790)
|||+++........ ......++..|+|||.+....++.++||||||+++|||++ |..||..... ......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------~~~~~~ 233 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--------EEVLKF 233 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--------HHHHHH
Confidence 99999865432211 1223456788999999998899999999999999999998 8888753221 111111
Q ss_pred HHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 707 VLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 707 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
... . .....+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 234 ~~~-------------~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 234 VID-------------G-GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred Hhc-------------C-CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111 0 011223334567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=318.08 Aligned_cols=237 Identities=26% Similarity=0.433 Sum_probs=191.3
Q ss_pred eeeeecCceEEEEEEE-----CCceEEEEEeChh-------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 496 NKIGQGGFGAVFYAEL-----RGEKAAIKKMDMQ-------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~-----~g~~vavK~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
+.||+|+||.||+++. .++.+|+|.++.. ....+.+|+++++.++||||+++++++.. +..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999975 2678999998642 22356789999999999999999988764 568999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+++++|.+++...+ .+.+..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 155 (323)
T cd05584 82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQGI---IYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-T 155 (323)
T ss_pred CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-C
Confidence 99999999997654 47888889999999999999999998 999999999999999999999999987532222 1
Q ss_pred cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcC
Q 046083 643 VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD 722 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d 722 (790)
......|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~--------~~~~~~~~~~------------ 215 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--------KKTIDKILKG------------ 215 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcC------------
Confidence 22335689999999999988899999999999999999999999864321 1111222211
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 046083 723 PRLGDDYPIDSVRKMARLARACTQENPQLRP-----SMRAIVVA 761 (790)
Q Consensus 723 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 761 (790)
. ...+......+.+++.+||+.+|++|| ++++++++
T Consensus 216 -~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 216 -K--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred -C--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1 112233446788999999999999999 78888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=338.92 Aligned_cols=264 Identities=25% Similarity=0.416 Sum_probs=207.4
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~ 560 (790)
++|++.++||+|+||.||+|... ++.+|+|++... ..+++.+|++++++++||||+++++++.++ ..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999875 789999998632 235689999999999999999999998754 589999
Q ss_pred EEecCCChhhhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeC
Q 046083 561 EYIENGNLNQHLRGSG---------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFG 631 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfG 631 (790)
||+++|+|.+++.... ...+++..+++++.++++||+|||++++ +||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GI---IHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGV---LHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCc---cccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886421 1346778889999999999999999998 999999999999999999999999
Q ss_pred CCcccccCCc-----------------ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCcccccccccc
Q 046083 632 LAKLTEVGSA-----------------SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETI 694 (790)
Q Consensus 632 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~ 694 (790)
+++....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~- 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR- 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence 9986521110 0112356899999999999999999999999999999999999998642211
Q ss_pred ccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHhhccCCccCC
Q 046083 695 TESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRP-SMRAIVVALMTLSSSSEDWD 773 (790)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~L~~l~~~~~~~~ 773 (790)
.. ...... .++... .-..+.+..+.+++.+|++.||++|| +++++.+.|........+|.
T Consensus 238 ----ki--~~~~~i------------~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~w~ 298 (932)
T PRK13184 238 ----KI--SYRDVI------------LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPEWT 298 (932)
T ss_pred ----hh--hhhhhc------------cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcccc
Confidence 00 000000 000000 00113445688999999999999995 68888899998877777776
Q ss_pred cCC
Q 046083 774 IGS 776 (790)
Q Consensus 774 ~~~ 776 (790)
+..
T Consensus 299 ~~~ 301 (932)
T PRK13184 299 VKA 301 (932)
T ss_pred ccc
Confidence 543
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=301.49 Aligned_cols=261 Identities=26% Similarity=0.394 Sum_probs=199.9
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChhhH-----HHHHHHHHHHHhcCCCC-CcceEEEEec-C------
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS-----KEFLAELKVLTHVHHLN-LVRLIGYCVE-G------ 554 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~-----~~~~~E~~~l~~l~h~n-iv~l~g~~~~-~------ 554 (790)
..|...++||+|.||+||+|+.. |+.||+|+++.+.. ....+|+.+|++++|+| |+.+++++.. .
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 44666788999999999999886 88999999875433 34689999999999999 9999998863 2
Q ss_pred eEEEEEEEecCCChhhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCC
Q 046083 555 SLFLVYEYIENGNLNQHLRGSGK--DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGL 632 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGl 632 (790)
.+++||||++. +|..++..... ..++...+..++.|+++||+|||++++ +||||||+|||++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~I---lHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGI---LHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCe---ecccCCcceEEECCCCcEeeeccch
Confidence 57899999977 99999987653 357778899999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCcccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCC
Q 046083 633 AKLTEVGSASVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQP 711 (790)
Q Consensus 633 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (790)
|+...... ...+..++|..|+|||++.+. .|+...||||+||++.||+++++.|....+. ..+. .....+..+
T Consensus 167 Ara~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~----~ql~-~If~~lGtP 240 (323)
T KOG0594|consen 167 ARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI----DQLF-RIFRLLGTP 240 (323)
T ss_pred HHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH----HHHH-HHHHHcCCC
Confidence 99654222 224456789999999999877 7999999999999999999998888665431 1111 122222222
Q ss_pred CChhhhhhhc---CCc--CCCCC-CH-------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 712 DPREDLQRLV---DPR--LGDDY-PI-------DSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 712 ~~~~~l~~~~---d~~--l~~~~-~~-------~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.. +.+.... +-. ..... +. .......+++.+|++.+|.+|.|++.++++
T Consensus 241 ~e-~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NE-KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred Cc-cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11 1111111 111 00000 11 111367899999999999999999999986
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.96 Aligned_cols=250 Identities=26% Similarity=0.457 Sum_probs=199.8
Q ss_pred cCcccceeeeecCceEEEEEEEC-----CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR-----GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLV 559 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~-----g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv 559 (790)
.+|++.+.||+|+||.||+|... +..+|+|.++. ...+.+.+|+.++.+++||||+++++++.+ +..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56888999999999999999864 23689998864 234578999999999999999999998874 458999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+++++|.+++.... ..+++.++++++.+++.||+|||+.++ +||||||+|||++.++.++|+|||++......
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i---~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCE---eehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999998654 358999999999999999999999997 99999999999999999999999999866433
Q ss_pred Ccccc--cccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhh
Q 046083 640 SASVH--TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716 (790)
Q Consensus 640 ~~~~~--~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (790)
..... ....++..|+|||++.+..++.++|+||||+++||+++ |..||...... .....+...
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--------~~~~~~~~~------ 225 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--------DVIKAIEEG------ 225 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--------HHHHHHhCC------
Confidence 22111 11223568999999998899999999999999999887 99998643221 111111111
Q ss_pred hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 717 LQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 717 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
.....+...+..+.+++.+|++.+|.+||+|.++++.|..+
T Consensus 226 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 --------YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --------CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00111223456788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=309.48 Aligned_cols=241 Identities=27% Similarity=0.411 Sum_probs=191.4
Q ss_pred eeecCceEEEEEEEC--CceEEEEEeChhh------HHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecCCCh
Q 046083 498 IGQGGFGAVFYAELR--GEKAAIKKMDMQA------SKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNL 568 (790)
Q Consensus 498 lG~G~fg~Vy~a~~~--g~~vavK~~~~~~------~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~g~L 568 (790)
||+|+||+||++... ++.+|+|.+.... .+.+..|+++++.++|+||+++.+++.. ...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999875 7899999986432 2456789999999999999999988764 568999999999999
Q ss_pred hhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccccc
Q 046083 569 NQHLRGS--GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR 646 (790)
Q Consensus 569 ~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 646 (790)
..++... ....+++..+..++.|++.||.|||++++ +||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i---~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRI---IYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 9887542 23468999999999999999999999998 9999999999999999999999999976543222 2233
Q ss_pred cccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCC
Q 046083 647 LVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLG 726 (790)
Q Consensus 647 ~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 726 (790)
..|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ....... ......
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~----~~~~~~~-------------~~~~~~-- 217 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV----ENKELKQ-------------RILNDS-- 217 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch----hHHHHHH-------------hhcccC--
Confidence 578999999999999999999999999999999999999996533210 0000011 111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 046083 727 DDYPIDSVRKMARLARACTQENPQLRP-----SMRAIVVA 761 (790)
Q Consensus 727 ~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 761 (790)
..++...+..+.+++.+||+.||++|| ++++++.+
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 218 VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 122334556789999999999999999 67777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=317.09 Aligned_cols=240 Identities=26% Similarity=0.419 Sum_probs=191.3
Q ss_pred cccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHH---HhcCCCCCcceEEEEec-CeEEEE
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVL---THVHHLNLVRLIGYCVE-GSLFLV 559 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l---~~l~h~niv~l~g~~~~-~~~~lv 559 (790)
|++.+.||+|+||.||+|... ++.+|||.++.. ..+.+.+|++++ +.++||||+++++++.+ +..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999886 789999998643 234466666655 56689999999998875 458999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+++++|..+++. ..+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~i---vHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKI---VYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCe---EecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999988864 358999999999999999999999998 99999999999999999999999998753221
Q ss_pred CcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
. .......|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+...
T Consensus 155 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~--------~~~~~~i~~~--------- 216 (324)
T cd05589 155 G-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE--------EEVFDSIVND--------- 216 (324)
T ss_pred C-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhC---------
Confidence 1 222346789999999999999999999999999999999999999864321 1111121111
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRP-----SMRAIVVA 761 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 761 (790)
. ...+...+..+.+++.+||+.||.+|| ++.+++++
T Consensus 217 ----~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 217 ----E--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ----C--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 0 112233456788999999999999999 56666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=309.16 Aligned_cols=244 Identities=25% Similarity=0.372 Sum_probs=192.2
Q ss_pred eeecCceEEEEEEEC--CceEEEEEeChhh------HHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecCCCh
Q 046083 498 IGQGGFGAVFYAELR--GEKAAIKKMDMQA------SKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNL 568 (790)
Q Consensus 498 lG~G~fg~Vy~a~~~--g~~vavK~~~~~~------~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~g~L 568 (790)
||+|+||.||++... |+.+|+|.+.... ...+..|++++++++||||+++++++.+ ...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999875 8899999986422 2345679999999999999999988764 458999999999999
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccccccc
Q 046083 569 NQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLV 648 (790)
Q Consensus 569 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 648 (790)
.+++.......+++..+..++.|++.||+|||+.++ +||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i---vH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI---VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCE---EEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 998876655669999999999999999999999997 999999999999999999999999987654322 223356
Q ss_pred cCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCC
Q 046083 649 GTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDD 728 (790)
Q Consensus 649 gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 728 (790)
|+..|+|||++.+..++.++|||||||++|||++|+.||....... ......... ........
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~----~~~~~~~~~-------------~~~~~~~~ 218 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV----AKEELKRRT-------------LEDEVKFE 218 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh----hHHHHHHHh-------------hccccccc
Confidence 8999999999998889999999999999999999999986432210 001111111 11111000
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 729 YPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 729 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
......++.+++..||+.||++||+++|+++.+..
T Consensus 219 -~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 219 -HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRK 253 (277)
T ss_pred -cccCCHHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence 11234568999999999999999999877654443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=319.16 Aligned_cols=248 Identities=27% Similarity=0.449 Sum_probs=209.6
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEec-Ce-EEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GS-LFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~-~~lv~ 560 (790)
++|...+.+|+|+||.++..+.+ +..+++|.+... ..+...+|+.++++++|||||.+.+.+.+ +. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56888999999999999988765 678999998642 23457889999999999999999997764 45 79999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
+|++||+|.+.+.......+++..+.+++.|++.|+.|||++.+ +|||||+.|||++.+..+||+|||+|+.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~i---LHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRV---LHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhh---hcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 99999999999988766789999999999999999999999988 999999999999999999999999999886543
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
.......||+.||.||.+.+.+|..|+|||||||++|||++=+++|...+ ...+...+...
T Consensus 161 -~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~--------m~~Li~ki~~~---------- 221 (426)
T KOG0589|consen 161 -SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN--------MSELILKINRG---------- 221 (426)
T ss_pred -hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc--------hHHHHHHHhhc----------
Confidence 23456889999999999999999999999999999999999999886543 22233333221
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.....|.....++..++..|++.+|+.||++.+++....
T Consensus 222 ----~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~ 260 (426)
T KOG0589|consen 222 ----LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPH 260 (426)
T ss_pred ----cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChh
Confidence 123345567788999999999999999999999987533
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=302.16 Aligned_cols=253 Identities=25% Similarity=0.440 Sum_probs=204.3
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh------hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
++|++.+.||+|+||.||+|... ++.+++|.++. ...+.+.+|++++++++|+|++++++++.+ +..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999986 88999998752 234678899999999999999999998875 4589999
Q ss_pred EEecCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 561 EYIENGNLNQHLRGS--GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 561 e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
||+++++|.+++... ....+++.++++++.+++.||.|||+.++ +|+||+|+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i---~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRI---MHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCE---ecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998642 23458999999999999999999999998 9999999999999999999999999876543
Q ss_pred CCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 639 GSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
... ......++..|+|||.+.+..++.++|+||||+++|||++|+.||..... ...........
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~--------- 222 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEK--------- 222 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc------cHHHHHhhhhc---------
Confidence 221 12234578899999999988999999999999999999999999854321 11111111111
Q ss_pred hhcCCcCCCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 046083 719 RLVDPRLGDDYPI-DSVRKMARLARACTQENPQLRPSMRAIVVALMTLS 766 (790)
Q Consensus 719 ~~~d~~l~~~~~~-~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~ 766 (790)
......+. .....+.+++.+||+.+|++|||+.+|++.|..+.
T Consensus 223 -----~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 223 -----CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -----CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00111122 44567889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.34 Aligned_cols=254 Identities=26% Similarity=0.447 Sum_probs=199.5
Q ss_pred HhcCcccceeeeecCceEEEEEEEC-------CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-e
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-S 555 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~ 555 (790)
..++|++.+.||+|+||.||+|..+ +..+|+|.++.. ....+.+|+.+++.++|+||+++++++.++ .
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999653 347999987632 234578899999999999999999987754 5
Q ss_pred EEEEEEEecCCChhhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEE
Q 046083 556 LFLVYEYIENGNLNQHLRGSG--------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKV 627 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl 627 (790)
.++||||+++|+|.+++.... ...+++..+.+++.+++.||.|||++++ +||||||+|||+++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i---~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKF---VHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC---cCCCCChheEEEcCCCcEEE
Confidence 899999999999999997532 2346788899999999999999999998 99999999999999999999
Q ss_pred EEeCCCcccccCCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHH
Q 046083 628 ADFGLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFE 705 (790)
Q Consensus 628 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 705 (790)
+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--------~~~~~ 232 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------EQVLK 232 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH
Confidence 999999855332211 1122345678999999998899999999999999999998 6777754221 11111
Q ss_pred HHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 046083 706 EVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLS 766 (790)
Q Consensus 706 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~ 766 (790)
..... .. ...+...+..+.+++.+||+.+|++|||+.++++.|....
T Consensus 233 ~~~~~-------------~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 233 FVMDG-------------GY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHcC-------------CC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11111 00 1112233467999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=316.49 Aligned_cols=246 Identities=22% Similarity=0.340 Sum_probs=191.3
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhc-CCCCCcceEEEEec-CeEEEEEEEecC
Q 046083 496 NKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIEN 565 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~~lv~e~~~~ 565 (790)
+.||+|+||.||++... ++.+|+|.++.. ..+.+..|+.++.++ +||||+++++++.. ...++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999886 678999998643 234577888888877 89999999998764 568999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
|+|..++.... .+++..+..++.+++.||+|||++++ +||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i---vH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTS 154 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cccc
Confidence 99999887643 58999999999999999999999998 999999999999999999999999987532211 1223
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
...|++.|+|||++.+..++.++|||||||++|||++|+.||....................+ ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i------------~~~~- 221 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI------------LEKQ- 221 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH------------hcCC-
Confidence 457899999999999999999999999999999999999999643221111111111111111 1111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRPS------MRAIVVA 761 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt------~~evl~~ 761 (790)
..+|......+.+++.+||+.||++||+ +.+++++
T Consensus 222 -~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 222 -IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1233344567889999999999999998 5676654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=302.69 Aligned_cols=248 Identities=27% Similarity=0.483 Sum_probs=198.5
Q ss_pred cCcccceeeeecCceEEEEEEEC-CceEEEEEeChh--hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecC
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ--ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIEN 565 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~ 565 (790)
.+|++.+.||+|+||.||++.+. +..+++|.+... ...++.+|++++++++|||++++++++.. ...+++|||+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 46788899999999999999886 788999988743 24678999999999999999999998874 458999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
++|.+++.... ..+++..++.++.+++.||+|||+.++ +|+||||+||+++.++.+||+|||+++...........
T Consensus 84 ~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i---~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 84 GCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNV---IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred CcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCc---cccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 99999997643 358899999999999999999999998 99999999999999999999999998755322211122
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCc
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 724 (790)
...++.+|+|||.+.+..++.++||||||+++|||++ |..||..... ..........
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~-------------- 217 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--------SEVVETINAG-------------- 217 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHhCC--------------
Confidence 2335678999999998899999999999999999998 8888854321 1111111110
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 725 LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 725 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.....+...+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 218 ~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 218 FRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 000111123467899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=316.18 Aligned_cols=246 Identities=22% Similarity=0.348 Sum_probs=192.3
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhc-CCCCCcceEEEEec-CeEEEEEEEecC
Q 046083 496 NKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIEN 565 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~~lv~e~~~~ 565 (790)
+.||+|+||.||++... +..+|+|.++.. ..+.+..|..++..+ +||||+++++++.+ ...|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999886 788999998743 234577899999988 79999999998875 458999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
|+|.+++...+ .+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i---vH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERGI---IYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTS 154 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EecCCCHHHeEECCCCCEEECcCccccccccC-CCccc
Confidence 99999887643 58999999999999999999999998 99999999999999999999999998743211 11223
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
...|++.|+|||++.+..++.++|+|||||++|||++|+.||.................... +.....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~------------~~~~~~ 222 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV------------ILEKQI 222 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH------------HHcCCC
Confidence 45789999999999999999999999999999999999999964332111011111111111 111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRPS------MRAIVVA 761 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt------~~evl~~ 761 (790)
..|......+.+++.+||+.||.+||+ +++++++
T Consensus 223 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 223 --RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred --CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 123334567889999999999999997 6777654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=315.98 Aligned_cols=242 Identities=28% Similarity=0.458 Sum_probs=192.8
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCC-CCcceEEEEec-CeEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHL-NLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~-niv~l~g~~~~-~~~~lv~ 560 (790)
+|++.+.||+|+||.||+|... ++.+|+|.+... ..+.+..|.+++..++|+ +|+++++++.+ +..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5888999999999999999886 678999998642 335578899999999765 57778877764 5689999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++|+|.+++.... .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~i---vH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKGI---IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999999997654 48899999999999999999999998 999999999999999999999999987432211
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~---------- 216 (324)
T cd05587 156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQSIMEH---------- 216 (324)
T ss_pred -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcC----------
Confidence 122345689999999999999999999999999999999999999864321 1112222211
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSM-----RAIVVA 761 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~~ 761 (790)
. ..++......+.+++.+||+.||.+||+. +++.++
T Consensus 217 ---~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 217 ---N--VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred ---C--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0 12233345678899999999999999976 566543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=324.35 Aligned_cols=249 Identities=24% Similarity=0.318 Sum_probs=194.2
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~ 560 (790)
++|++.+.||+|+||.||++... ++.+|||.+... ..+.+.+|++++++++||||+++++++.+. ..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47889999999999999999875 789999988542 235678899999999999999999988754 589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.++ +||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi---vHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLGF---IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---eccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999997643 58899999999999999999999998 999999999999999999999999996321100
Q ss_pred cc----------------------------------------------cccccccCCCccchhcccCCCCCchhhHHHHH
Q 046083 641 AS----------------------------------------------VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFG 674 (790)
Q Consensus 641 ~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~G 674 (790)
.. ......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 00124689999999999999999999999999
Q ss_pred HHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCC--
Q 046083 675 VVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLR-- 752 (790)
Q Consensus 675 vvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R-- 752 (790)
|++|||++|..||..... ...+..+..... .+.-.........+.+++.+|++ +|.+|
T Consensus 236 vil~elltG~~Pf~~~~~--------~~~~~~i~~~~~-----------~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~ 295 (377)
T cd05629 236 AIMFECLIGWPPFCSENS--------HETYRKIINWRE-----------TLYFPDDIHLSVEAEDLIRRLIT-NAENRLG 295 (377)
T ss_pred hhhhhhhcCCCCCCCCCH--------HHHHHHHHccCC-----------ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCC
Confidence 999999999999964322 111222221100 00000011234568899999997 66665
Q ss_pred -CCHHHHHHHHH
Q 046083 753 -PSMRAIVVALM 763 (790)
Q Consensus 753 -Pt~~evl~~L~ 763 (790)
+++.|++.+-+
T Consensus 296 r~~~~~~l~hp~ 307 (377)
T cd05629 296 RGGAHEIKSHPF 307 (377)
T ss_pred CCCHHHHhcCCC
Confidence 69999988654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=301.70 Aligned_cols=245 Identities=27% Similarity=0.419 Sum_probs=198.6
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEe
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
+|++.+.||+|+||.||++... +..+++|.++. ...+.+..|+.+++.++|+|++++++.+.+ +..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5788999999999999999875 78899998753 234568889999999999999999998764 5689999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
++++|.+++.......+++...+.++.+++.||.|||++++ +|+||||+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i---~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRV---LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AY 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCc---ccCCCCcceEEECCCCcEEEcccCcceeecccc-cc
Confidence 99999999876544568999999999999999999999998 999999999999999999999999997654322 12
Q ss_pred ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 644 HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
.....|++.|+|||++.+..++.++|+||||+++|+|++|..||..... ...........
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--------~~~~~~~~~~~------------ 216 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW--------KNLILKVCQGS------------ 216 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH--------HHHHHHHhcCC------------
Confidence 2335688899999999988999999999999999999999999854321 11111111110
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
....+......+.+++.+||+.||++||++.|++..
T Consensus 217 --~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 217 --YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 011122344568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=301.44 Aligned_cols=274 Identities=28% Similarity=0.427 Sum_probs=209.2
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeC-----hhhHHHHHHHHHHHHhcCCCCCcceEEEEec------Ce
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMD-----MQASKEFLAELKVLTHVHHLNLVRLIGYCVE------GS 555 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~ 555 (790)
...|...+.||+|.||.|+.+..+ |+.||||++. .-..++..+|+++|++++|+||+.+++.+.. .+
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 345666789999999999999886 8999999986 2345678899999999999999999998753 24
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
.|+|+|+|+. +|...++.. +.++...+..++.|+++||.|+|+.++ +||||||+|+|++.+..+||+|||+|+.
T Consensus 101 vYiV~elMet-DL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnV---iHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 101 VYLVFELMET-DLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANV---IHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eEEehhHHhh-HHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccc---cccccchhheeeccCCCEEeccccceee
Confidence 8999999955 999999864 348899999999999999999999998 9999999999999999999999999998
Q ss_pred cccC-CcccccccccCCCccchhccc-CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC
Q 046083 636 TEVG-SASVHTRLVGTFGYMPPEYAQ-YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 636 ~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
.... .....+..+.|.+|+|||.+. ...|+...||||.||||.||++|++.|...+. .+........+..+.
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~-----v~Ql~lI~~~lGtP~- 248 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY-----VHQLQLILELLGTPS- 248 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch-----HHHHHHHHHhcCCCC-
Confidence 7543 122345677899999999875 56899999999999999999999998866432 122233333333332
Q ss_pred hhhhhhhc--------C--CcC-CCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccCCc
Q 046083 714 REDLQRLV--------D--PRL-GDDY---PIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWDI 774 (790)
Q Consensus 714 ~~~l~~~~--------d--~~l-~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~~~ 774 (790)
.+.+..+- . +.. +..+ -........+|+.+||..||.+|+|++|.+++---..-...+.|+
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 22222211 1 000 0010 013445678999999999999999999999865544333344344
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.02 Aligned_cols=256 Identities=25% Similarity=0.459 Sum_probs=200.8
Q ss_pred hcCcccceeeeecCceEEEEEEEC---------CceEEEEEeCh----hhHHHHHHHHHHHHhc-CCCCCcceEEEEecC
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR---------GEKAAIKKMDM----QASKEFLAELKVLTHV-HHLNLVRLIGYCVEG 554 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~---------g~~vavK~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 554 (790)
.++|.+.+.||+|+||.||++... ...+|+|.++. ....++.+|+++++++ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 356888999999999999999752 34689998763 2345688999999999 699999999988754
Q ss_pred -eEEEEEEEecCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe
Q 046083 555 -SLFLVYEYIENGNLNQHLRGSG--------------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI 619 (790)
Q Consensus 555 -~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl 619 (790)
..+++|||+++|+|.+++.... ...+++.++.+++.|++.||.|||++++ +||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi---~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRC---IHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCe---eeccccceeEEE
Confidence 5899999999999999996532 1358999999999999999999999998 999999999999
Q ss_pred cCCCcEEEEEeCCCcccccCCccc-ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccc
Q 046083 620 DKNFRAKVADFGLAKLTEVGSASV-HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITES 697 (790)
Q Consensus 620 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~ 697 (790)
++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----- 242 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV----- 242 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH-----
Confidence 999999999999998654322111 112234567999999998899999999999999999999 8888743221
Q ss_pred cchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCC
Q 046083 698 TGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSS 769 (790)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~ 769 (790)
...+...... .....+...+..+.+++.+||+.+|++|||+.|+++.|..+....
T Consensus 243 ---~~~~~~~~~~--------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 243 ---EELFKLLREG--------------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred ---HHHHHHHHcC--------------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 1111111110 011223344567889999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=304.46 Aligned_cols=250 Identities=26% Similarity=0.478 Sum_probs=198.1
Q ss_pred cCcccceeeeecCceEEEEEEEC--C---ceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--G---EKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLV 559 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g---~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv 559 (790)
.+|++.+.||+|+||.||+|... + ..+++|.++. ...++|..|+.++++++||||+++++++.++ ..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 35778999999999999999875 3 2599999864 2346799999999999999999999988754 58999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+++++|.+++.... ..+++..++.++.|++.||.|||++++ +|+||||+||+++.++.+||+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~---~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 84 TEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCE---eecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999997643 358999999999999999999999997 99999999999999999999999998765432
Q ss_pred Cccc--ccccc--cCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 640 SASV--HTRLV--GTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 640 ~~~~--~~~~~--gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
.... ..... .+..|+|||.+.+..++.++||||||+++|||++ |..||..... ......+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--------~~~~~~i~~~---- 227 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--------QDVINAIEQD---- 227 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--------HHHHHHHHcC----
Confidence 2111 11111 2457999999999999999999999999999886 9998854321 1111111110
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
.....+.+.+..+.+++.+||+.+|.+||++++|+..|..+
T Consensus 228 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 ----------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01111233456788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.62 Aligned_cols=248 Identities=21% Similarity=0.360 Sum_probs=195.0
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
++|++.+.||+|+||.||+|... +..+|+|.+.. ...+++.+|++++.+++|||++++++++.. ...++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 46788899999999999999874 78899998753 234568899999999999999999998774 568999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+++++|..+. .+++..+..++.+++.||.|||+.++ +|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKI---LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCE---eeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence 9999997653 36788899999999999999999998 99999999999999999999999999765322
Q ss_pred cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcC
Q 046083 643 VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD 722 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d 722 (790)
......|+..|+|||++.+..++.++|+||||+++|||++|+.||......... .............. .
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~----------~ 217 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS-LMPLQLLQCIVDED----------P 217 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc-cchHHHHHHHhccC----------C
Confidence 223356889999999999889999999999999999999999998653321100 00011111111110 0
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 723 PRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 723 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
+.+ .......++.+++.+|++.+|++||+++|++++.+
T Consensus 218 ~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 218 PVL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred CCC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 111 01123456889999999999999999999988654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=327.95 Aligned_cols=263 Identities=25% Similarity=0.381 Sum_probs=194.6
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhhHHHHHHHHHHHHhcCCCCCcceEEEEec-------C--eE
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVE-------G--SL 556 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------~--~~ 556 (790)
..++|++.+.||+|+||.||+|... ++.+|||++.... ....+|+.+++.++||||+++++++.. . .+
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 3467999999999999999999875 7899999885432 234579999999999999999887531 1 25
Q ss_pred EEEEEEecCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC-cEEEEEeCCC
Q 046083 557 FLVYEYIENGNLNQHLRGS--GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF-RAKVADFGLA 633 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~-~~kl~DfGla 633 (790)
++||||+++ +|.+++... ....+++..+..++.|++.||+|||++++ +||||||+|||++.++ .+||+|||++
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~I---iHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFI---CHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCE---ecCCcCHHHEEEcCCCCceeeeccccc
Confidence 789999985 777776532 23468999999999999999999999998 9999999999999665 7999999999
Q ss_pred cccccCCcccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC
Q 046083 634 KLTEVGSASVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD 712 (790)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (790)
+...... ......|++.|+|||++.+. .++.++|||||||++|||++|.+||...... ..+.. ....+..+.
T Consensus 219 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~----~~~~~-i~~~~~~p~ 291 (440)
T PTZ00036 219 KNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV----DQLVR-IIQVLGTPT 291 (440)
T ss_pred hhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHH-HHHHhCCCC
Confidence 8654322 22335689999999998754 6899999999999999999999999653321 01111 111111111
Q ss_pred Chhhhhhh------------cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 713 PREDLQRL------------VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 713 ~~~~l~~~------------~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.+.+..+ ....+...++...+.++.+|+.+||+.||.+|||+.|++++-.
T Consensus 292 -~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 292 -EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred -HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 1111110 0001111123334567899999999999999999999987644
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=310.33 Aligned_cols=254 Identities=22% Similarity=0.401 Sum_probs=201.4
Q ss_pred cCcccceeeeecCceEEEEEEEC--Cc----eEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GE----KAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLV 559 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~----~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv 559 (790)
++|+..+.||+|+||.||+|.+. +. .+|+|.+... ...++.+|+.++++++||||+++++++.....+++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v 86 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV 86 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence 46778899999999999999874 43 4788887642 23468899999999999999999999987778899
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
+||+++|+|.+++.... ..+++..++.++.|++.||.|||++++ +|+||||+|||++.++.+||+|||+++.....
T Consensus 87 ~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i---vH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 87 TQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRL---VHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCe---eccccccceeeecCCCceEEccccccccccCc
Confidence 99999999999987643 358999999999999999999999998 99999999999999999999999999865432
Q ss_pred Cccc-ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 640 SASV-HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 640 ~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
.... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... . ...++...
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--------~-~~~~~~~~------ 227 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--------E-IPDLLEKG------ 227 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------H-HHHHHHCC------
Confidence 2211 122345678999999998899999999999999999997 88888543210 0 11111111
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCC
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSS 769 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~ 769 (790)
.....+......+.+++..||..+|++||+++++++.|..+....
T Consensus 228 -------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 228 -------ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred -------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 001111223457889999999999999999999999999875543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=318.40 Aligned_cols=238 Identities=25% Similarity=0.388 Sum_probs=191.7
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecCC
Q 046083 496 NKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENG 566 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~g 566 (790)
+.||+|+||.||++... +..+|+|.++.. ....+..|++++..++||||+++++++.+ +..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 789999998643 23457789999999999999999988764 5589999999999
Q ss_pred ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 567 NLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE-HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 567 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
+|..++.... .+++..+..++.|++.||+|||+ .++ +||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~i---vHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNV---VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMK 154 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCE---EecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cccc
Confidence 9999887643 58999999999999999999997 676 999999999999999999999999987532211 1223
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... .......... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~--------~~~~~~i~~~-------------~- 212 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILME-------------E- 212 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH--------HHHHHHHhcC-------------C-
Confidence 35689999999999999999999999999999999999999854321 1111111111 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRP-----SMRAIVVAL 762 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~L 762 (790)
..++.....++.+++.+||+.||++|+ ++.+++++-
T Consensus 213 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 213 -IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 112233445788999999999999996 899998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=308.71 Aligned_cols=257 Identities=28% Similarity=0.475 Sum_probs=199.2
Q ss_pred hcCcccceeeeecCceEEEEEEECC------------------ceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcc
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELRG------------------EKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVR 546 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~g------------------~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~ 546 (790)
..+|++.+.||+|+||.||++...+ ..+|+|.+... ..+++.+|++++++++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578999999999999999987642 35899998643 3467889999999999999999
Q ss_pred eEEEEec-CeEEEEEEEecCCChhhhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCC
Q 046083 547 LIGYCVE-GSLFLVYEYIENGNLNQHLRGSG---------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPAN 616 (790)
Q Consensus 547 l~g~~~~-~~~~lv~e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~N 616 (790)
+++++.. +..+++|||+++++|.+++.... ...+++..++.++.+++.||+|||++++ +|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i---~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNF---VHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCc---cccccchhc
Confidence 9998875 56899999999999999997643 1268999999999999999999999998 999999999
Q ss_pred EEecCCCcEEEEEeCCCcccccCCc-ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh--CCccccccccc
Q 046083 617 ILIDKNFRAKVADFGLAKLTEVGSA-SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS--AMEAVVKTNET 693 (790)
Q Consensus 617 ILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt--G~~p~~~~~~~ 693 (790)
|+++.++.++|+|||+++....... .......++..|+|||.+....++.++||||||+++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999876532221 11223456788999999998899999999999999999998 5566643221
Q ss_pred cccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 694 ITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
...+......... .........+...+.++.+++.+||+.+|.+|||+.||++.|.
T Consensus 240 -------~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 -------QQVIENAGHFFRD-------DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred -------HHHHHHHHhcccc-------ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1111111110000 0000111112234467999999999999999999999998885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=324.16 Aligned_cols=248 Identities=24% Similarity=0.294 Sum_probs=193.7
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
++|++.+.||+|+||.||+++.. ++.+|+|.+... ..+.+.+|++++++++|+||+++++.+.+ +..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999876 789999998642 23557889999999999999999998875 4589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~i---vHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGF---IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999997654 58888999999999999999999998 999999999999999999999999975321000
Q ss_pred ------------------------------------------cccccccccCCCccchhcccCCCCCchhhHHHHHHHHH
Q 046083 641 ------------------------------------------ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLY 678 (790)
Q Consensus 641 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ 678 (790)
........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00011246899999999999999999999999999999
Q ss_pred HHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC---CH
Q 046083 679 ELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRP---SM 755 (790)
Q Consensus 679 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP---t~ 755 (790)
||++|+.||...... .......... ..+...........+.+++.+|+ .+|.+|+ ++
T Consensus 236 ell~G~~Pf~~~~~~--------~~~~~i~~~~-----------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~ 295 (376)
T cd05598 236 EMLVGQPPFLADTPA--------ETQLKVINWE-----------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGA 295 (376)
T ss_pred ehhhCCCCCCCCCHH--------HHHHHHhccC-----------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCH
Confidence 999999999654321 1111111110 00000111123455677888876 4999999 89
Q ss_pred HHHHHHH
Q 046083 756 RAIVVAL 762 (790)
Q Consensus 756 ~evl~~L 762 (790)
.|++++-
T Consensus 296 ~ell~h~ 302 (376)
T cd05598 296 DEIKAHP 302 (376)
T ss_pred HHHhCCC
Confidence 9998763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=304.22 Aligned_cols=255 Identities=24% Similarity=0.398 Sum_probs=204.0
Q ss_pred cCcccceeeeecCceEEEEEEEC--Cc----eEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GE----KAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLV 559 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~----~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv 559 (790)
.+|++.+.||+|+||.||+|.+. ++ .+++|.+... ...++.+|+.++++++|+|++++++++.....+++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 86 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI 86 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence 46788899999999999999874 32 5899987643 34678899999999999999999999988889999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+++|+|.+++.... ..+++..+++++.|++.||+|||++++ +|+||||+||+++.++.+||+|||+++.....
T Consensus 87 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i---~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 87 TQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCE---EecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999998643 358999999999999999999999987 99999999999999999999999999866433
Q ss_pred Ccccc-cccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 640 SASVH-TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 640 ~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
..... ....++..|+|||.+....++.++|+||||+++|||++ |+.||..... ......+...
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~------- 227 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--------VEIPDLLEKG------- 227 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhCC-------
Confidence 22111 11223568999999988899999999999999999998 9999854321 1111111110
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCc
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~ 770 (790)
.....+..+...+.+++.+||..+|.+||++.++++.|..+.....
T Consensus 228 -------~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05057 228 -------ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ 273 (279)
T ss_pred -------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence 0111122334568899999999999999999999999999866443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=325.84 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=212.9
Q ss_pred cceeeeecCceEEEEEEEC------CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEEEe
Q 046083 494 MGNKIGQGGFGAVFYAELR------GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYI 563 (790)
Q Consensus 494 ~~~~lG~G~fg~Vy~a~~~------g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e~~ 563 (790)
..++||+|.||+||+|.+- +-+||+|++.. +...++.+|+-+|.+++|||+++|+|+|....+.||.+||
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~m 779 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQLM 779 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHhc
Confidence 4689999999999999874 34789998853 4567899999999999999999999999988899999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
+.|+|.+|++.. +..+.-...+.+..|||+||.|||.++. |||||..+|||+.....+||.|||+++.+.....+.
T Consensus 780 P~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~qrl---VHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 780 PLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQRL---VHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred ccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhcch---hhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 999999999875 3568889999999999999999999998 999999999999999999999999999887665544
Q ss_pred ccc-cccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhc
Q 046083 644 HTR-LVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721 (790)
Q Consensus 644 ~~~-~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 721 (790)
... ..-.+.|||-|.+....++.++|||||||.+|||+| |..|+..... +.+.+++
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~----------------------~eI~dll 913 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA----------------------EEIPDLL 913 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH----------------------HHhhHHH
Confidence 332 234678999999999999999999999999999998 8888755322 2333444
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCc
Q 046083 722 DPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770 (790)
Q Consensus 722 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~ 770 (790)
....+-.-|+-+..++..++.+||..|+..||+++++...+.+.+....
T Consensus 914 e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 914 EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 4333344566788899999999999999999999999999998776555
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.07 Aligned_cols=236 Identities=28% Similarity=0.455 Sum_probs=187.4
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhc-CCCCCcceEEEEec-CeEEEEEEEecC
Q 046083 496 NKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIEN 565 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~~lv~e~~~~ 565 (790)
+.||+|+||.||+|... ++.+|+|.++.. ..+.+..|..++... +||||+++++++.. +..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999886 678999998643 223456677777654 89999999998764 468999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
|+|.+++.... .+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~i---vH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGI---IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCE---EeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 99999997644 58999999999999999999999997 999999999999999999999999997543222 2223
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~--------------- 211 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--------DELFDSILND--------------- 211 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcC---------------
Confidence 45789999999999988999999999999999999999999864321 1111221111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRPSMR-AIVV 760 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl~ 760 (790)
...++......+.+++.+||+.+|.+||++. ++++
T Consensus 212 ~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 212 RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 0112233445678999999999999999975 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.52 Aligned_cols=237 Identities=28% Similarity=0.453 Sum_probs=190.4
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhc-CCCCCcceEEEEec-CeEEEEEEEecC
Q 046083 496 NKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIEN 565 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~~lv~e~~~~ 565 (790)
+.||+|+||.||+|+.. ++.+|+|.++.. ..+.+..|.+++..+ +||||+++++++.+ +..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999986 778999998643 234577888888877 69999999998875 458999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
|+|.+++.... .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~i---vH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKGI---IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTS 154 (320)
T ss_pred chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccc
Confidence 99999987653 58999999999999999999999998 999999999999999999999999987532221 1223
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~~~~-------------- 212 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAILNDE-------------- 212 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHhcCC--------------
Confidence 45789999999999988999999999999999999999999964322 11222222111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRPSM------RAIVVA 761 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~------~evl~~ 761 (790)
...+......+.+++.+||+.||++||++ ++++.+
T Consensus 213 -~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 213 -VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 01122344578899999999999999998 666553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=303.31 Aligned_cols=244 Identities=34% Similarity=0.574 Sum_probs=191.2
Q ss_pred eeeeecCceEEEEEEEC--Cc--eEEEEEeCh----hhHHHHHHHHHHHHhc-CCCCCcceEEEEecC-eEEEEEEEecC
Q 046083 496 NKIGQGGFGAVFYAELR--GE--KAAIKKMDM----QASKEFLAELKVLTHV-HHLNLVRLIGYCVEG-SLFLVYEYIEN 565 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~--g~--~vavK~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~~~lv~e~~~~ 565 (790)
+.||+|+||.||+|.+. +. .+++|.++. ...+.+.+|++++.++ +||||+++++++... ..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999885 32 468888763 2345788999999999 899999999998754 58999999999
Q ss_pred CChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeC
Q 046083 566 GNLNQHLRGSG--------------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFG 631 (790)
Q Consensus 566 g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfG 631 (790)
|+|.+++.... ...+++..+..++.+++.||+|||++++ +|+||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i---~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCE---eecccccceEEEcCCCeEEECCCC
Confidence 99999997532 1347899999999999999999999987 999999999999999999999999
Q ss_pred CCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcC
Q 046083 632 LAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQ 710 (790)
Q Consensus 632 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 710 (790)
++........ ......+..|+|||++....++.++||||||+++|||++ |..||..... .........
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~~~~~~~- 226 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELYEKLPQ- 226 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--------HHHHHHHhC-
Confidence 9864321111 111233567999999988899999999999999999997 9999854321 111111111
Q ss_pred CCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 046083 711 PDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLS 766 (790)
Q Consensus 711 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~ 766 (790)
......+......+.+++.+||+.+|.+|||+.++++.|..+.
T Consensus 227 -------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 -------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -------------CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1111112234457889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=314.98 Aligned_cols=238 Identities=31% Similarity=0.454 Sum_probs=191.5
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhc-CCCCCcceEEEEec-CeEEEEEEEecC
Q 046083 496 NKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIEN 565 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~~lv~e~~~~ 565 (790)
+.||+|+||.||+|+.. ++.+|+|.++.. ..+.+..|.+++..+ +||||+++++++.+ +..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999886 678999998643 234567888888876 79999999998875 458999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
|+|..++.... .+++..+..++.+++.||.|||++++ +||||||+|||++.++.+||+|||++....... ....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~i---vHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHGV---IYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTT 154 (321)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eccCCCHHHeEECCCCCEEEeecccceecccCC-cccc
Confidence 99999987643 58899999999999999999999998 999999999999999999999999987543222 1223
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--------~~~~~~i~~~~-------------~ 213 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE--------DDLFESILHDD-------------V 213 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCC-------------C
Confidence 45689999999999988999999999999999999999999965332 11222222111 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCC-------CHHHHHHHH
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRP-------SMRAIVVAL 762 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-------t~~evl~~L 762 (790)
..+.....++.+++.+||+.||++|| ++++++++-
T Consensus 214 --~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 214 --LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred --CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 11222345788999999999999999 788887653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=307.21 Aligned_cols=251 Identities=29% Similarity=0.486 Sum_probs=198.5
Q ss_pred hcCcccceeeeecCceEEEEEEEC-------CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SL 556 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~ 556 (790)
.++|++.+.||+|+||.||+|... +..+|+|.+... ..+++.+|+.++.+++|||++++++++.++ ..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999863 468999988643 245688999999999999999999988754 58
Q ss_pred EEEEEEecCCChhhhhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCC
Q 046083 557 FLVYEYIENGNLNQHLRGSG--------------------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPAN 616 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~N 616 (790)
+++|||+++|+|.+++.... ...+++..++.++.+++.||.|||+.++ +||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i---~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKF---VHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCe---ecccccHhh
Confidence 99999999999999997421 1347899999999999999999999997 999999999
Q ss_pred EEecCCCcEEEEEeCCCcccccCCc-ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCcccccccccc
Q 046083 617 ILIDKNFRAKVADFGLAKLTEVGSA-SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETI 694 (790)
Q Consensus 617 ILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~ 694 (790)
||+++++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999875432211 11112234667999999998899999999999999999997 7778753321
Q ss_pred ccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 695 TESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
......+.. ... ...+...+.++.+++.+||+.+|++|||+.|+++.|++
T Consensus 239 ------~~~~~~~~~-------------~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 ------EEVIYYVRD-------------GNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------HHHHHHHhc-------------CCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111111111 111 11122345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=319.44 Aligned_cols=261 Identities=24% Similarity=0.362 Sum_probs=197.4
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC------eEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG------SLF 557 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 557 (790)
+|++.+.||+|+||.||++... ++.+|+|++.. ...+.+.+|+++++.++|+||+++++++... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999874 88999998853 2345688999999999999999999988643 579
Q ss_pred EEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccc
Q 046083 558 LVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~ 637 (790)
+||||+. ++|.+++... ..+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~i---vH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGI---LHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCe---eCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999997 4888887653 358999999999999999999999998 999999999999999999999999998654
Q ss_pred cCCcccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhh
Q 046083 638 VGSASVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716 (790)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (790)
...........++..|+|||.+.+. .++.++|||||||++|||++|+.||...... ............+.. +.
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~~g~~~~-~~ 228 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-----QQLDLITDLLGTPSL-EA 228 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHHHcCCCCH-HH
Confidence 3333333345678999999998764 4799999999999999999999999654321 011111111111110 00
Q ss_pred h-------hhhcCCc-CC-C------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 717 L-------QRLVDPR-LG-D------DYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 717 l-------~~~~d~~-l~-~------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
+ ...+... .. . ........++.+++.+||+.||++|||++|++++-+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 0 0000000 00 0 011223457889999999999999999999998654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=303.77 Aligned_cols=249 Identities=25% Similarity=0.420 Sum_probs=195.9
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh---hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEe
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ---ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
++|++.+.||+|+||.||+|... ++.+|+|.+... ....+.+|+.++++++||||+++++++.. +..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 56889999999999999999974 778999988642 34567889999999999999999998864 5689999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
++++|.++++..+ .+++..+..++.|++.||.|||+.++ +||||+|+||+++.++.+||+|||++........ .
T Consensus 89 ~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06646 89 GGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K 162 (267)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence 9999999987543 58999999999999999999999998 9999999999999999999999999986532221 1
Q ss_pred ccccccCCCccchhccc---CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 644 HTRLVGTFGYMPPEYAQ---YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~---~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
.....++..|+|||.+. ...++.++|||||||++|||++|+.|+....... ....... ...
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~-----------~~~~~~~-----~~~ 226 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-----------ALFLMSK-----SNF 226 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh-----------hheeeec-----CCC
Confidence 22346788999999884 3457889999999999999999999985432110 0000000 000
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
..+... .....+..+.+++.+||+.+|++|||++++++.|
T Consensus 227 ~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 QPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 001110 0112346788999999999999999999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=306.70 Aligned_cols=265 Identities=22% Similarity=0.424 Sum_probs=200.7
Q ss_pred cCcccceeeeecCceEEEEEEEC------CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC---eE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR------GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG---SL 556 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~------g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~---~~ 556 (790)
+.|.+.+.||+|+||.||++.+. +..+|+|.++. ...+.+.+|+++++.++|||++++++++.+. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 45788999999999999999742 67899999863 2345789999999999999999999988753 47
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
++||||+++++|.+++.... ..+++..++.++.+++.||+|||++++ +||||||+||+++.++.++|+|||+++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi---~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCe---eecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999999997543 358999999999999999999999998 99999999999999999999999999865
Q ss_pred ccCCcc--cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 637 EVGSAS--VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 637 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
...... ......++..|+|||++.+..++.++||||||+++|||++++.|............. .. ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~------~~-~~~~~~ 232 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIG------PT-HGQMTV 232 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcc------cc-cccccH
Confidence 432221 112345677899999999889999999999999999999987764332111000000 00 000000
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
......+........+...+..+.+++.+||+.+|.+|||++++++.|..+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 233 TRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 001111111111122234557899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=322.35 Aligned_cols=246 Identities=24% Similarity=0.304 Sum_probs=190.9
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYE 561 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e 561 (790)
+|+..+.||+|+||.||+|+.. ++.+|+|.+... ..+.+.+|++++++++|+||+++++.+.+ ...++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5889999999999999999875 788999998743 23568899999999999999999998875 45899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC-
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS- 640 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~- 640 (790)
|+++|+|.+++...+ .+++.....++.|++.||+|||++++ +||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~i---vHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGF---IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999997643 58888999999999999999999998 999999999999999999999999975321000
Q ss_pred ---------------------------------------------cccccccccCCCccchhcccCCCCCchhhHHHHHH
Q 046083 641 ---------------------------------------------ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGV 675 (790)
Q Consensus 641 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gv 675 (790)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00011246899999999999999999999999999
Q ss_pred HHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC-
Q 046083 676 VLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPS- 754 (790)
Q Consensus 676 vl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt- 754 (790)
++|||++|+.||...... .....+.... ..+..........++.+++.+|+ .+|++|++
T Consensus 237 il~elltG~~Pf~~~~~~--------~~~~~i~~~~-----------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~ 296 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPL--------ETQMKVINWQ-----------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK 296 (382)
T ss_pred HHHHHHhCCCCCCCCCHH--------HHHHHHHccC-----------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCC
Confidence 999999999999653221 1111111100 00100111123345667777766 49999987
Q ss_pred --HHHHHHH
Q 046083 755 --MRAIVVA 761 (790)
Q Consensus 755 --~~evl~~ 761 (790)
++|++++
T Consensus 297 ~~~~ei~~h 305 (382)
T cd05625 297 NGADEIKAH 305 (382)
T ss_pred CCHHHHhcC
Confidence 8887764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=308.71 Aligned_cols=270 Identities=25% Similarity=0.399 Sum_probs=203.0
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEe-cCeEEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEY 562 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~lv~e~ 562 (790)
++|++.+.||+|+||.||++... +..+++|.++.. ...++.+|++++++++||||+++++++. ++..+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46899999999999999999876 678899887642 2356889999999999999999999887 4568999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE-HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
+++++|.+++... ..+++..+..++.++++||.|||+ .++ +|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i---~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKI---MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCE---EECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 9999999999865 358899999999999999999998 466 999999999999999999999999987543221
Q ss_pred ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC--------
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP-------- 713 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 713 (790)
.....++..|+|||.+.+..++.++|+||||+++|||++|+.||...... .....+.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
T cd06615 155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-----ELEAMFGRPVSEGEAKESHRPVS 227 (308)
T ss_pred --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh-----hHHHhhcCccccccccCCccccc
Confidence 22356889999999998888999999999999999999999998543211 000000000000000
Q ss_pred ------------hhhhhhhcCCcCCCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccCC
Q 046083 714 ------------REDLQRLVDPRLGDDYP-IDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWD 773 (790)
Q Consensus 714 ------------~~~l~~~~d~~l~~~~~-~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~~ 773 (790)
.+.....+.. .....+ ......+.+++.+||+.+|++|||+++++++.+-.....++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~ 299 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIVNE-PPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELEEVD 299 (308)
T ss_pred CCCCCccchhhHHHHHHHHhcC-CCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccccch
Confidence 0000011100 001111 1234568999999999999999999999998776444334443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.24 Aligned_cols=241 Identities=27% Similarity=0.445 Sum_probs=192.9
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhc-CCCCCcceEEEEec-CeEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~~lv~ 560 (790)
+|.+.+.||+|+||.||+|... +..+|+|.++.. ..+.+..|.+++..+ +|++|+++++++.+ +..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5888999999999999999886 678999998643 223466788888777 58899999988775 4589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~i---vHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKGI---IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCE---EecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999999987653 48899999999999999999999997 999999999999999999999999987532211
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--------~~~~~~i~~~---------- 216 (323)
T cd05616 156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEH---------- 216 (323)
T ss_pred -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--------HHHHHHHHhC----------
Confidence 122345789999999999999999999999999999999999999964322 1122222211
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSM-----RAIVV 760 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~ 760 (790)
. ..++.....++.+++.+|++.+|.+|++. +++.+
T Consensus 217 ---~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 217 ---N--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred ---C--CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 1 12233445678899999999999999984 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=308.23 Aligned_cols=256 Identities=26% Similarity=0.470 Sum_probs=195.6
Q ss_pred cCcccceeeeecCceEEEEEEECC----------------ceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELRG----------------EKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIG 549 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~g----------------~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g 549 (790)
++|++.+.||+|+||.||++...+ ..+|+|.++.. ..+.|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578999999999999999987532 24899988642 3356889999999999999999999
Q ss_pred EEec-CeEEEEEEEecCCChhhhhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEE
Q 046083 550 YCVE-GSLFLVYEYIENGNLNQHLRGSG----------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANIL 618 (790)
Q Consensus 550 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NIL 618 (790)
++.. ...++||||+++++|.+++.... ...+++..+++++.+++.||+|||++++ +|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i---~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNF---VHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCe---eccccChhhEE
Confidence 9874 45899999999999999986532 1247899999999999999999999998 99999999999
Q ss_pred ecCCCcEEEEEeCCCcccccCCc-ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh--CCccccccccccc
Q 046083 619 IDKNFRAKVADFGLAKLTEVGSA-SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS--AMEAVVKTNETIT 695 (790)
Q Consensus 619 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt--G~~p~~~~~~~~~ 695 (790)
+++++.+||+|||++........ .......++..|+|||.+....++.++||||||++++||++ |..||......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-- 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-- 239 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--
Confidence 99999999999999976533221 11222345678999999998899999999999999999998 45565432211
Q ss_pred cccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 696 ESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
............. ........+...+..+.+++.+||+.+|++||++++|++.|.
T Consensus 240 ---~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 ---QVIENTGEFFRNQ----------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ---HHHHHHHHhhhhc----------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 0110001111000 000001112224467999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=300.12 Aligned_cols=244 Identities=26% Similarity=0.438 Sum_probs=196.4
Q ss_pred eeeeecCceEEEEEEEC---Cc--eEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEEEecCC
Q 046083 496 NKIGQGGFGAVFYAELR---GE--KAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENG 566 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~---g~--~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e~~~~g 566 (790)
+.||+|++|.||+|.+. +. .+|+|.+... ..+.+.+|++.+++++||||+++++++.+...+++|||++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG 80 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence 46899999999999874 22 5899998753 345789999999999999999999988877789999999999
Q ss_pred ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc--cc
Q 046083 567 NLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS--VH 644 (790)
Q Consensus 567 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~--~~ 644 (790)
+|.+++.......++|...+.++.|++.||+|||++++ +|+||+|+||+++.++.+||+|||+++........ ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i---~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF---IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCc---cccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 99999987543468999999999999999999999998 99999999999999999999999999876432221 11
Q ss_pred cccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 645 TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
....++..|+|||++....++.++||||||+++|||++ |+.||..... ............
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~----------- 218 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--------SQILKKIDKEGE----------- 218 (257)
T ss_pred cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHhcCC-----------
Confidence 12456789999999998899999999999999999999 9999854321 111111111100
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 219 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 --RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 01112234567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=324.69 Aligned_cols=264 Identities=20% Similarity=0.273 Sum_probs=195.5
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecC
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIEN 565 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~ 565 (790)
...|.+.+.||+|+||.||++... ++.||||.... ..+.+|+++|++++|+||+++++++.. +..++|||++.
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~- 243 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR- 243 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence 346999999999999999999986 67899996433 346689999999999999999998764 56899999995
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc-cc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS-VH 644 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~ 644 (790)
++|.+++.... ..++|..++.++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++........ ..
T Consensus 244 ~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gI---vHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 244 SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGI---IHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCE---EECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 68998887543 369999999999999999999999997 99999999999999999999999999865432211 22
Q ss_pred cccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC------C---hh
Q 046083 645 TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD------P---RE 715 (790)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~---~~ 715 (790)
....||..|+|||++.+..++.++|||||||+||||++|..++........... .......++.... . ..
T Consensus 320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~-~~~~l~~~i~~~~~~~~~~~~~~~~ 398 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRP-YDAQILRIIRQAQVHVDEFPQHAGS 398 (461)
T ss_pred cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCC-cHHHHHHHHHhhccccccCCCCcch
Confidence 245689999999999999999999999999999999998877654332111111 1111111111100 0 00
Q ss_pred hh-hhhc---CCcCCCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 716 DL-QRLV---DPRLGDDYP-------IDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 716 ~l-~~~~---d~~l~~~~~-------~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.+ ..+. ......... ......+.+|+.+||+.||.+|||+.|++++
T Consensus 399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 0000 000000000 0122367899999999999999999999975
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=299.12 Aligned_cols=245 Identities=26% Similarity=0.452 Sum_probs=198.8
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec--CeEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE--GSLFLVYE 561 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~lv~e 561 (790)
+|++.+.||+|++|.||++... ++.+++|++.. ...+.+.+|++++++++|+|++++++.+.. ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999875 67899999853 233568889999999999999999987653 34789999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|+++++|.+++.......+++.++..++.+++.|++|||+.++ +|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i---~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHI---LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCe---eccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 9999999999987544568999999999999999999999998 999999999999999999999999998654322
Q ss_pred ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhc
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 721 (790)
.......+++.|+|||.+.+..++.++||||||++++||++|+.||..... ...........
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--------~~~~~~~~~~~---------- 218 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM--------NSLVYRIIEGK---------- 218 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhcC----------
Confidence 122335678999999999999999999999999999999999999853221 11111111110
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 722 DPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 722 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
+ ...+......+.+++.+|++.+|++|||+.+++++
T Consensus 219 ---~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 219 ---L-PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---C-CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 11223445678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=317.85 Aligned_cols=233 Identities=26% Similarity=0.376 Sum_probs=188.4
Q ss_pred eeeeecCceEEEEEEE-----CCceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEec
Q 046083 496 NKIGQGGFGAVFYAEL-----RGEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIE 564 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~-----~g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~ 564 (790)
+.||+|+||.||++.. .++.+|+|.++.. ....+..|++++++++||||+++++++.+ +..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999875 2688999998743 23456789999999999999999998874 46899999999
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccc
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH 644 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 644 (790)
+|+|.+++.... .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++...... ...
T Consensus 82 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i---~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~ 155 (318)
T cd05582 82 GGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKA 155 (318)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCE---ecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cce
Confidence 999999997643 58999999999999999999999998 999999999999999999999999998653321 122
Q ss_pred cccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCc
Q 046083 645 TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724 (790)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 724 (790)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+... .
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--------~~~~~~i~~~-------------~ 214 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--------KETMTMILKA-------------K 214 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--------HHHHHHHHcC-------------C
Confidence 345789999999999988899999999999999999999999864321 1111122111 0
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 046083 725 LGDDYPIDSVRKMARLARACTQENPQLRPSMRA 757 (790)
Q Consensus 725 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 757 (790)
...+......+.+++.+||+.||++||++.+
T Consensus 215 --~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 --LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1122234457889999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=303.73 Aligned_cols=250 Identities=25% Similarity=0.433 Sum_probs=198.7
Q ss_pred cCcccceeeeecCceEEEEEEEC-------CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLF 557 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~ 557 (790)
++|+....||+|+||.||+|+.+ ...+++|.+... ..+++.+|++++++++|+|++++++++.+. ..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888999999999999999864 356899988642 245789999999999999999999998754 589
Q ss_pred EEEEEecCCChhhhhhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEe
Q 046083 558 LVYEYIENGNLNQHLRGSGK-------DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADF 630 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~-------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~Df 630 (790)
+||||+++|+|.+++..... ..+++..+..++.+++.||+|||++++ +||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i---~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARF---VHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCc---ccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999976441 258999999999999999999999998 99999999999999999999999
Q ss_pred CCCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHc
Q 046083 631 GLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLR 709 (790)
Q Consensus 631 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 709 (790)
|++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...... ........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--------~~~~~~~~ 233 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--------EVLNRLQA 233 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--------HHHHHHHc
Confidence 9987543222222223456778999999988889999999999999999998 77777432210 11111111
Q ss_pred CCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 710 QPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 710 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
..+....+...+..+.+++.+||+.+|.+|||+.|++..|+
T Consensus 234 -------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 -------------GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -------------CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11111112234567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=306.80 Aligned_cols=249 Identities=26% Similarity=0.411 Sum_probs=198.3
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYE 561 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e 561 (790)
.|+..+.||+|+||.||++... ++.+|+|.+... ..+.+..|+.++++++|+|++++++.+.+ ...++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677899999999999999886 789999988642 12456789999999999999999998764 45899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|+++++|.+++...+...+++..+..++.|++.||.|||+.++ +||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i---iH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERI---VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCE---EeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 9999999999976555569999999999999999999999997 999999999999999999999999987543222
Q ss_pred ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhc
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 721 (790)
......|+..|+|||++.+..++.++||||||+++|||++|+.||....... ...........
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-----~~~~~~~~~~~----------- 219 (285)
T cd05630 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-----KREEVERLVKE----------- 219 (285)
T ss_pred -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-----hHHHHHhhhhh-----------
Confidence 1223468999999999999999999999999999999999999996533210 00000111100
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 046083 722 DPRLGDDYPIDSVRKMARLARACTQENPQLRPS-----MRAIVVALM 763 (790)
Q Consensus 722 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~L~ 763 (790)
....++......+.+++.+||+.||++||| ++|++++-+
T Consensus 220 ---~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 220 ---VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred ---hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence 001112233456889999999999999999 888887544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=299.85 Aligned_cols=245 Identities=27% Similarity=0.459 Sum_probs=190.3
Q ss_pred eeeeecCceEEEEEEEC-----CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEe--cCeEEEEEEEec
Q 046083 496 NKIGQGGFGAVFYAELR-----GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCV--EGSLFLVYEYIE 564 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~-----g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~lv~e~~~ 564 (790)
+.||+|+||.||+|.+. +..+|+|.+.. ...+.+.+|+.+++.++|||++++++++. ++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999863 34689998753 23467889999999999999999999875 344799999999
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc---
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA--- 641 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~--- 641 (790)
+|+|.+++.... ..+++..+..++.+++.||.|||+.++ +||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKF---VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCc---cccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999997643 246788889999999999999999998 9999999999999999999999999975432111
Q ss_pred ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCC-ccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAM-EAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
.......++..|+|||.+.+..++.++||||||+++|||++|. +|+.... ............
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--------~~~~~~~~~~~~--------- 219 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--------SFDITVYLLQGR--------- 219 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHhcCC---------
Confidence 1112234567899999998889999999999999999999964 4443211 111111111110
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLS 766 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~ 766 (790)
....+...+..+.+++.+||+.+|++||++.||+..|+.+.
T Consensus 220 -----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 220 -----RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -----CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 00111223457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=312.14 Aligned_cols=237 Identities=30% Similarity=0.490 Sum_probs=191.4
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhc-CCCCCcceEEEEec-CeEEEEEEEecC
Q 046083 496 NKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIEN 565 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~~lv~e~~~~ 565 (790)
+.||+|+||.||++... +..+|+|.++.. ....+..|.+++..+ +||||+++++++.+ +..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999886 678999998743 234567888899888 79999999998774 468999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
|+|.+++...+ .+++..+..++.|++.||.|||+.++ +||||||+|||+++++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i---vH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERGI---IYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTS 154 (318)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---EccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccc
Confidence 99999987653 58999999999999999999999998 999999999999999999999999987532211 1123
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+....
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--------~~~~~~i~~~~-------------- 212 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--------DELFQSILEDE-------------- 212 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--------HHHHHHHHcCC--------------
Confidence 35689999999999999999999999999999999999999864321 11122221110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRPSM-----RAIVVA 761 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~~ 761 (790)
..++......+.+++.+||+.||.+||++ .+++++
T Consensus 213 -~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 213 -VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred -CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 11222345678899999999999999999 887764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.72 Aligned_cols=232 Identities=27% Similarity=0.442 Sum_probs=185.0
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEeChhh------HHHHHHHHH-HHHhcCCCCCcceEEEEec-CeEEEEEEEecC
Q 046083 496 NKIGQGGFGAVFYAELR--GEKAAIKKMDMQA------SKEFLAELK-VLTHVHHLNLVRLIGYCVE-GSLFLVYEYIEN 565 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~------~~~~~~E~~-~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~ 565 (790)
+.||+|+||.||+|... ++.+|+|.+.... .+++..|.. +++.++||||+++++++.+ ...++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999985 7899999986432 234455544 5678899999999998764 458999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
|+|.+++.... .+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~gi---vH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (323)
T cd05575 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLNI---IYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTS 154 (323)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCccc
Confidence 99999997643 58899999999999999999999998 99999999999999999999999998753221 12223
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
...|++.|+|||++.+..++.++|||||||++|||++|..||..... ......+.... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~-------------~ 213 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--------AEMYDNILNKP-------------L 213 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH--------HHHHHHHHcCC-------------C
Confidence 45789999999999999999999999999999999999999864321 12222222211 1
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRPSMR 756 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 756 (790)
..+......+.+++.+||+.||.+||+++
T Consensus 214 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 214 --RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11223356788999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=312.19 Aligned_cols=255 Identities=26% Similarity=0.466 Sum_probs=201.0
Q ss_pred cCcccceeeeecCceEEEEEEEC---------CceEEEEEeCh----hhHHHHHHHHHHHHhc-CCCCCcceEEEEecC-
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR---------GEKAAIKKMDM----QASKEFLAELKVLTHV-HHLNLVRLIGYCVEG- 554 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~---------g~~vavK~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~- 554 (790)
.+|++.+.||+|+||.||++... +..+|+|.++. ...+++.+|++++.++ +|+||+++++++.++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46889999999999999999752 12689998763 2346788999999999 799999999998754
Q ss_pred eEEEEEEEecCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEec
Q 046083 555 SLFLVYEYIENGNLNQHLRGSG--------------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILID 620 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~ 620 (790)
..+++|||+++|+|.+++.... ...++|..+++++.|++.||.|||++++ +||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi---vH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKC---IHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCe---eccccccceEEEc
Confidence 5899999999999999987532 2358899999999999999999999998 9999999999999
Q ss_pred CCCcEEEEEeCCCcccccCCccc-ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCcccccccccccccc
Q 046083 621 KNFRAKVADFGLAKLTEVGSASV-HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITEST 698 (790)
Q Consensus 621 ~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~ 698 (790)
+++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------- 241 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------- 241 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-------
Confidence 99999999999998654322111 112234567999999999999999999999999999998 778774322
Q ss_pred chHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCC
Q 046083 699 GLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSS 769 (790)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~ 769 (790)
.......+... .....+......+.+++.+||+.+|.+||++.|+++.|..+....
T Consensus 242 -~~~~~~~~~~~--------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 242 -VEELFKLLKEG--------------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred -HHHHHHHHHcC--------------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11111111111 111223344567889999999999999999999999999876444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=304.72 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=196.1
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYE 561 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e 561 (790)
.|+..+.||+|+||+||++... ++.+|+|.+... ..+.+.+|++++++++|+|++++++++.. +..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677899999999999999886 789999998642 22447789999999999999999987764 45899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|+++++|.+++...+...+++..+..++.|++.||.|||+.++ +||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i---iH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT---VYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCe---eecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 9999999999876555579999999999999999999999998 999999999999999999999999997653221
Q ss_pred ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhc
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 721 (790)
......|+..|+|||++.+..++.++|+||||+++|||++|..||....... ...........
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~----~~~~~~~~~~~------------ 219 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV----KREEVDRRVLE------------ 219 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhhhc------------
Confidence 1233568999999999998899999999999999999999999986432210 00000000000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 046083 722 DPRLGDDYPIDSVRKMARLARACTQENPQLRPS-----MRAIVVA 761 (790)
Q Consensus 722 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 761 (790)
. ...++......+.+|+..||+.||++||+ +++++.+
T Consensus 220 -~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 220 -T--EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -c--ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0 01122234456889999999999999999 5666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=311.22 Aligned_cols=236 Identities=28% Similarity=0.454 Sum_probs=188.2
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhc-CCCCCcceEEEEec-CeEEEEEEEecC
Q 046083 496 NKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIEN 565 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~~lv~e~~~~ 565 (790)
+.||+|+||.||+|... ++.+|+|.++.. ..+.+..|..++... +||||+++++++.+ +..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999986 789999998753 234466788888765 89999999998875 458999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
|+|.+++.... .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---vHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKGI---IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS 154 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EecCCCHHHeEECCCCCEEeCccCCCeecccCC-Ccee
Confidence 99999987643 58899999999999999999999998 999999999999999999999999987432211 2223
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... .+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--------~~~~~~~~~~-----------~~-- 213 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--------DELFESIRVD-----------TP-- 213 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhC-----------CC--
Confidence 46789999999999999999999999999999999999999964321 1112221111 01
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRPSMR-AIVV 760 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl~ 760 (790)
..+.....++.+++.+||+.||++||++. ++.+
T Consensus 214 --~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 214 --HYPRWITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred --CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 11222345688999999999999999984 5653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=299.81 Aligned_cols=245 Identities=24% Similarity=0.392 Sum_probs=193.5
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh--------hhHHHHHHHHHHHHhcCCCCCcceEEEEec---CeE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM--------QASKEFLAELKVLTHVHHLNLVRLIGYCVE---GSL 556 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---~~~ 556 (790)
.+|+..+.||+|+||.||+|... +..+++|.+.. ...+.+.+|+.++++++||||+++++++.+ ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47889999999999999999875 78999998752 223468889999999999999999998764 347
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
+++|||+++++|.+++.... .+++...+.++.|++.||.|||+.++ +|+||+|+||+++.++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i---~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMI---VHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---eeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 89999999999999997643 48899999999999999999999997 99999999999999999999999999865
Q ss_pred ccCCc--ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 637 EVGSA--SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 637 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
..... .......++..|+|||.+.+..++.++|||||||++|||++|+.||...... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~--------~~~~~~~~----- 223 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM--------AAIFKIAT----- 223 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH--------HHHHHHhc-----
Confidence 32111 1112345788999999999889999999999999999999999998643210 00111111
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.......+......+.+++ +||..+|++||+++||+.+
T Consensus 224 --------~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 224 --------QPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred --------CCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 0111222333445566777 6888999999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=311.28 Aligned_cols=252 Identities=24% Similarity=0.355 Sum_probs=194.0
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
++|++.+.||+|+||.||++... ++.+|+|.++.. ..+.+.+|..++..++|+||+++++++.+ +..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999876 789999998642 23457889999999999999999998875 4589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++|+|.+++.... ..+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i---vH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGY---VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCe---EECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999999999997532 358899999999999999999999998 999999999999999999999999987654332
Q ss_pred cccccccccCCCccchhcccC-----CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQY-----GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (790)
........|++.|+|||++.. ..++.++|||||||++|||++|+.||..... ......+......
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~--------~~~~~~i~~~~~~-- 226 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHKEH-- 226 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH--------HHHHHHHHcCCCc--
Confidence 222233568999999999863 4578899999999999999999999854321 1222222221100
Q ss_pred hhhhhcCCcCCCCCCHHHHHHHHHHHHHcccc--CCCCCCCHHHHHHHHH
Q 046083 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQE--NPQLRPSMRAIVVALM 763 (790)
Q Consensus 716 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~--dP~~RPt~~evl~~L~ 763 (790)
. .+... ....+..+.+++.+|+.. ++..||++++++++-+
T Consensus 227 -----~--~~~~~-~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 227 -----F--QFPPD-VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268 (331)
T ss_pred -----c--cCCCc-cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence 0 00000 112345677888887754 3344889999988743
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=305.51 Aligned_cols=258 Identities=28% Similarity=0.499 Sum_probs=197.2
Q ss_pred hcCcccceeeeecCceEEEEEEEC------------------CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcc
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR------------------GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVR 546 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~------------------g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~ 546 (790)
.++|++.+.||+|+||.||++... +..+|+|.+... ...++.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357899999999999999998532 235899988642 3457899999999999999999
Q ss_pred eEEEEec-CeEEEEEEEecCCChhhhhhcCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCC
Q 046083 547 LIGYCVE-GSLFLVYEYIENGNLNQHLRGSGK---------DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPAN 616 (790)
Q Consensus 547 l~g~~~~-~~~~lv~e~~~~g~L~~~l~~~~~---------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~N 616 (790)
+++++.. +..+++|||+++++|.+++..... ..+++.++++++.+++.||+|||++++ +|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i---~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNF---VHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCe---ecccCChhe
Confidence 9998875 458999999999999999876421 247888999999999999999999997 999999999
Q ss_pred EEecCCCcEEEEEeCCCcccccCCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh--CCccccccccc
Q 046083 617 ILIDKNFRAKVADFGLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS--AMEAVVKTNET 693 (790)
Q Consensus 617 ILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt--G~~p~~~~~~~ 693 (790)
||++.++.++|+|||+++.+...... ......++..|++||....+.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999999865332211 1122344678999999888899999999999999999998 66777543221
Q ss_pred cccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 694 ITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
............. ........+..++..+.+++.+||+.||.+||++.||++.|++
T Consensus 241 -----~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 -----QVIENTGEFFRDQ----------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred -----HHHHHHHHHHhhc----------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0110001111000 0000011122344678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=297.50 Aligned_cols=247 Identities=26% Similarity=0.418 Sum_probs=200.8
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh-HHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEEecC
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA-SKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIEN 565 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~~~~ 565 (790)
++|++.+.||+|+||.||+|... +..+++|.++... .+++.+|++++++++|+|++++++++.+. ..++++||+.+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 57889999999999999999986 6889999987543 67899999999999999999999988754 58999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
++|.+++.... ..+++..+..++.+++.||.|||+.++ +|+||+|+||+++.++.+||+|||++........ ...
T Consensus 83 ~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i---~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (256)
T cd06612 83 GSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKK---IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRN 157 (256)
T ss_pred CcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCcceEEECCCCcEEEcccccchhcccCcc-ccc
Confidence 99999997543 468999999999999999999999998 9999999999999999999999999986543321 222
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
...++..|+|||.+.+..++.++||||||+++|||++|+.||....... ....... ...+.
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~--------~~~~~~~----------~~~~~- 218 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR--------AIFMIPN----------KPPPT- 218 (256)
T ss_pred cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh--------hhhhhcc----------CCCCC-
Confidence 3457889999999998899999999999999999999999986432210 0000000 00000
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
...+......+.+++.+||+.+|.+|||++|++++
T Consensus 219 -~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 219 -LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred -CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 11122344678999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=302.07 Aligned_cols=246 Identities=26% Similarity=0.418 Sum_probs=199.4
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEY 562 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~ 562 (790)
++|++.+.||.|+||.||+|... ++.+++|.+... ....+.+|+++++.++|+|++++++++.++ ..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999875 789999988643 335688999999999999999999987754 58999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+++++|.+++... .+++..+..++.|++.||.|||+.++ +|+||+|+||++++++.++|+|||+++...... .
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i---~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-S 153 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCHHHEEECCCCCEEEcccccceeecccc-c
Confidence 9999999999854 68999999999999999999999998 999999999999999999999999998765332 1
Q ss_pred cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcC
Q 046083 643 VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD 722 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d 722 (790)
......++..|+|||++.+..++.++||||||+++|||++|+.||...... ........ ...
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--------~~~~~~~~----------~~~ 215 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--------RVLFLIPK----------NNP 215 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--------HHHHHhhh----------cCC
Confidence 223356788999999999888999999999999999999999998543211 00111110 011
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 723 PRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 723 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
+.+... ..+..+.+++.+||..+|++|||+++++++-.
T Consensus 216 ~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~ 253 (274)
T cd06609 216 PSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKHKF 253 (274)
T ss_pred CCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhChh
Confidence 111111 14456889999999999999999999988544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=309.66 Aligned_cols=236 Identities=28% Similarity=0.459 Sum_probs=187.8
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhc-CCCCCcceEEEEec-CeEEEEEEEecC
Q 046083 496 NKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIEN 565 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~~lv~e~~~~ 565 (790)
+.||+|+||.||+|... ++.+|+|.++.. ..+.+..|..++... +||||+++++++.+ +..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999986 678999998753 234466788888764 89999999998875 458999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
|+|.+++.... .+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~i---vHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05619 81 GDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKGI---VYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTC 154 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---EeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Ccee
Confidence 99999997643 58899999999999999999999998 999999999999999999999999987532211 1223
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... .+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~i~~~-----------~~-- 213 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--------EELFQSIRMD-----------NP-- 213 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhC-----------CC--
Confidence 45689999999999988999999999999999999999999864321 1111111110 01
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRPSMR-AIVV 760 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl~ 760 (790)
.++......+.+++.+||+.||.+||++. ++.+
T Consensus 214 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 214 --CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred --CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11222345678999999999999999997 6644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=296.10 Aligned_cols=247 Identities=27% Similarity=0.369 Sum_probs=203.7
Q ss_pred cCcccceeeeecCceEEEEEEECC--ceEEEEEeChhhH------HHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELRG--EKAAIKKMDMQAS------KEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~g--~~vavK~~~~~~~------~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~ 560 (790)
++|++.+.||.|.-|+||.+++++ ..+|+|++..+.. .+...|-+||+.+.||.++.||+.+... ..|++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 457788999999999999999985 6899999986433 3467799999999999999999988754 589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC-
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG- 639 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~- 639 (790)
|||+||+|..+++.+....+++..+..++.+++-||+|||-.|+ |.|||||+||||-++|++-|+||.|+......
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGi---vYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGI---VYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhce---eeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 99999999999999888889999999999999999999999998 99999999999999999999999987533110
Q ss_pred --------------------------------Cc----------------------ccccccccCCCccchhcccCCCCC
Q 046083 640 --------------------------------SA----------------------SVHTRLVGTFGYMPPEYAQYGEVS 665 (790)
Q Consensus 640 --------------------------------~~----------------------~~~~~~~gt~~y~aPE~~~~~~~s 665 (790)
.. .....++||-.|+|||++.+..-+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 00 001135789999999999999999
Q ss_pred chhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHcc
Q 046083 666 PKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACT 745 (790)
Q Consensus 666 ~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl 745 (790)
.+.|+|.|||++|||+.|..||...+.. +.+..++.+.+.-.........+.+||++.|
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~---------------------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNK---------------------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLL 372 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCch---------------------hhHHHHhcCCCcCCCCCcchhHHHHHHHHHh
Confidence 9999999999999999999999765432 3344444443322222355678899999999
Q ss_pred ccCCCCCCC----HHHHHH
Q 046083 746 QENPQLRPS----MRAIVV 760 (790)
Q Consensus 746 ~~dP~~RPt----~~evl~ 760 (790)
.+||.+|-. +.||-+
T Consensus 373 vKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ccChhhhhccccchHHhhc
Confidence 999999987 555543
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=300.04 Aligned_cols=253 Identities=22% Similarity=0.369 Sum_probs=198.0
Q ss_pred HHHHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh---hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEE
Q 046083 484 ELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ---ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLF 557 (790)
Q Consensus 484 ~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~ 557 (790)
|++.+++++.....||+|+||.||+|.+. +..+++|.+... ..+.+.+|++++++++|+||+++++++..+ ..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34556778888899999999999999875 668999987643 445789999999999999999999998754 589
Q ss_pred EEEEEecCCChhhhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC-CCcEEEEEeCCCc
Q 046083 558 LVYEYIENGNLNQHLRGSGKDTL--TWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK-NFRAKVADFGLAK 634 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~-~~~~kl~DfGla~ 634 (790)
++|||+++++|.+++.... ..+ ++..+..++.|++.||+|||+.++ +||||||+||+++. ++.++|+|||++.
T Consensus 82 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i---~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQI---VHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCE---eecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 9999999999999998642 234 788899999999999999999997 99999999999986 6799999999987
Q ss_pred ccccCCcccccccccCCCccchhcccCCC--CCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC
Q 046083 635 LTEVGSASVHTRLVGTFGYMPPEYAQYGE--VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD 712 (790)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (790)
....... ......++..|+|||++.... ++.++||||||+++|||++|+.||....... ...+....
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~------~~~~~~~~---- 226 (268)
T cd06624 158 RLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ------AAMFKVGM---- 226 (268)
T ss_pred ecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh------hhHhhhhh----
Confidence 6532221 122345788999999986643 7899999999999999999999985432110 00000000
Q ss_pred ChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 713 PREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 713 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.......+.....++.+++.+||+.+|.+|||+.|++++
T Consensus 227 ----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 227 ----------FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ----------hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 001112233445678899999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=304.23 Aligned_cols=247 Identities=24% Similarity=0.421 Sum_probs=198.7
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEe
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
.+|+..+.||+|+||.||+|... +..+++|.+.. ...+.+.+|+.+++.++|+|++++++++.. ...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 47888999999999999999874 78999998864 234568899999999999999999998764 5689999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
++++|.+++... .+++.++..++.|++.||+|||+.++ +|+||||+||+++.++.+||+|||++........ .
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi---~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~ 172 (296)
T cd06654 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (296)
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEEcCCCCEEECccccchhcccccc-c
Confidence 999999998643 48899999999999999999999998 9999999999999999999999999876532221 1
Q ss_pred ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 644 HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
.....+++.|+|||.+.+..++.++|||||||++|||++|+.||...... ..+.. ...... +
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-------~~~~~-~~~~~~----------~ 234 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYL-IATNGT----------P 234 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-------HhHHH-HhcCCC----------C
Confidence 22346788999999999888999999999999999999999998543221 01111 111000 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
. ...+......+.+++.+||..+|++|||++|++..-.
T Consensus 235 ~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~ 272 (296)
T cd06654 235 E--LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (296)
T ss_pred C--CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChh
Confidence 0 1112334467889999999999999999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=310.10 Aligned_cols=236 Identities=27% Similarity=0.458 Sum_probs=189.3
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcC-CCCCcceEEEEec-CeEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVH-HLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~-h~niv~l~g~~~~-~~~~lv~ 560 (790)
+|+..+.||+|+||.||+|... ++.+|+|.++.. ..+.+..|.+++..+. |++|+++++++.+ +..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788899999999999999875 789999998642 2345778888888885 5677788887764 4589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~i---vHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRGI---IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999999997644 58999999999999999999999998 999999999999999999999999987532221
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~---------- 216 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DELFQSIMEH---------- 216 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhC----------
Confidence 122335689999999999988999999999999999999999999865322 1122222211
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSM 755 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 755 (790)
. ..++......+.+++.+||+.+|.+|++.
T Consensus 217 ---~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 217 ---N--VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---C--CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1 11223344578899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=304.26 Aligned_cols=259 Identities=25% Similarity=0.383 Sum_probs=193.5
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhc---CCCCCcceEEEEec------C
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHV---HHLNLVRLIGYCVE------G 554 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l---~h~niv~l~g~~~~------~ 554 (790)
+|++.+.||+|+||.||+|... ++.+|+|.++.. ....+.+|+++++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788999999999999999886 788999988642 123456677777665 79999999998753 2
Q ss_pred eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCc
Q 046083 555 SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK 634 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~ 634 (790)
..+++|||+.+ +|.+++.......+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i---vH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCI---VHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEECCCCCEEECccCccc
Confidence 37999999985 89998876555568999999999999999999999997 999999999999999999999999998
Q ss_pred ccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 635 LTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
...... ......++..|+|||++.+..++.++|||||||++|||++|++||...... ..... .......+..
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~----~~~~~-~~~~~~~~~~- 228 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA----DQLGK-IFDLIGLPPE- 228 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH----HHHHH-HHHHhCCCCh-
Confidence 654221 123356789999999999889999999999999999999999998543221 01111 1111111100
Q ss_pred hhhhh-------hcCCcCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 715 EDLQR-------LVDPRLG---DDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 715 ~~l~~-------~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
..+.. ...+... ..........+.+++.+||+.||++|||+.|++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 0000000 00112344568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=296.94 Aligned_cols=243 Identities=31% Similarity=0.531 Sum_probs=197.9
Q ss_pred eeeeecCceEEEEEEEC-----CceEEEEEeChhh----HHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecC
Q 046083 496 NKIGQGGFGAVFYAELR-----GEKAAIKKMDMQA----SKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIEN 565 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~-----g~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~ 565 (790)
+.||+|+||.||+|... +..+++|.++... .+.+.+|++.++.++|+|++++++++.+ ...+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 46999999999999886 6689999987432 4678899999999999999999998875 458999999999
Q ss_pred CChhhhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 566 GNLNQHLRGSG-------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 566 g~L~~~l~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
++|.+++.... ...+++..+++++.+++.||.|||++++ +|+||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i---~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKF---VHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCc---ccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999998752 2468999999999999999999999998 9999999999999999999999999987654
Q ss_pred CCc-ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhh
Q 046083 639 GSA-SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716 (790)
Q Consensus 639 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (790)
... .......++..|+|||.+....++.++||||||++++||++ |..||..... .........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~------- 222 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------EEVLEYLRK------- 222 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHc-------
Confidence 321 11223457889999999988899999999999999999999 5888865421 111111111
Q ss_pred hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 717 LQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 717 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
......+...+.++.+++.+||+.+|++|||+.|++..|.
T Consensus 223 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 -------GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -------CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111223344568999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=303.08 Aligned_cols=265 Identities=25% Similarity=0.433 Sum_probs=204.1
Q ss_pred cCcccceeeeecCceEEEEEEEC------CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEec--C-eE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR------GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVE--G-SL 556 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~------g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~-~~ 556 (790)
++|++.+.||+|+||.||++.+. +..+|||.++.. ..++|.+|+++++.++|+||+++++++.. + ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777899999999999999864 568999998743 24679999999999999999999998864 2 47
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
+++|||+++++|.+++.... ..+++..++.++.+++.||+|||+.++ +|+||||+||+++.++.++|+|||++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i---~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRY---IHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999998653 258999999999999999999999997 99999999999999999999999999876
Q ss_pred ccCCccc--ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 637 EVGSASV--HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 637 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
....... .....++..|++||.+....++.++||||||+++|||++|..|+............. .......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-------~~~~~~~ 232 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-------AQGQMIV 232 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-------ccccccH
Confidence 4222111 112234567999999998899999999999999999999998875432211000000 0000011
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
..+.+.+........+..++.++.+++.+||+.+|++|||+.||++.|..+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 233 TRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 112222222222222334457799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=314.72 Aligned_cols=265 Identities=22% Similarity=0.284 Sum_probs=195.9
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-------
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG------- 554 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------- 554 (790)
.++|++.+.||+|+||.||++... +..+|+|.+.. .....+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 478999999999999999999875 78999999853 2345688999999999999999999987532
Q ss_pred eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCc
Q 046083 555 SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK 634 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~ 634 (790)
..|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~i---vHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 36999999976 67666643 37888999999999999999999998 999999999999999999999999997
Q ss_pred ccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCcccccccccccc----------ccch----
Q 046083 635 LTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITE----------STGL---- 700 (790)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~----------~~~~---- 700 (790)
..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...+....- ....
T Consensus 172 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 172 TACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 54321 1223456899999999999999999999999999999999999999754321000 0000
Q ss_pred HHHHHHHHcCC-C-ChhhhhhhcCCcCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 701 VALFEEVLRQP-D-PREDLQRLVDPRLG---DDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 701 ~~~~~~~~~~~-~-~~~~l~~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
........... . ....+.+....... ...+......+.+++.+||+.||++|||+.|++++-+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 00000000000 0 00001111000000 0011122456889999999999999999999998765
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=310.41 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=193.8
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
++|++.+.||+|+||.||++..+ ++.+|+|.+... ....+.+|+.++..++|+||+++++++.+ ...++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999986 678999998642 22347889999999999999999998875 4589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++|+|.+++.... ..+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i---iHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHY---VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCe---EecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999997643 358999999999999999999999998 999999999999999999999999987543322
Q ss_pred cccccccccCCCccchhccc-----CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQ-----YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (790)
........||+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+......
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~-- 226 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHKER-- 226 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH--------HHHHHHHhCCCcc--
Confidence 22223457899999999986 34688999999999999999999999964321 1222222221100
Q ss_pred hhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 046083 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQ--LRPSMRAIVVA 761 (790)
Q Consensus 716 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~--~RPt~~evl~~ 761 (790)
. .. ..........+.+++.+|+..++. .|++++|++++
T Consensus 227 ----~---~~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 ----F---QF-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ----c---cC-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 00 001123455678889988855444 47899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=303.49 Aligned_cols=255 Identities=26% Similarity=0.430 Sum_probs=201.0
Q ss_pred CHHHHHHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh--hHHHHHHHHHHHHhc-CCCCCcceEEEEe---
Q 046083 481 SYEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ--ASKEFLAELKVLTHV-HHLNLVRLIGYCV--- 552 (790)
Q Consensus 481 ~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~--- 552 (790)
+..++......|++.+.||+|+||.||+|... ++.+|+|.+... ...++..|+.++.++ +|+|++++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 45566666788999999999999999999985 788999988643 345688899999998 7999999999874
Q ss_pred ----cCeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEE
Q 046083 553 ----EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVA 628 (790)
Q Consensus 553 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~ 628 (790)
....+++|||+.+|+|.+++.......+++..+..++.|++.||.|||++++ +|+||+|+||++++++.++|+
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i---vH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKV---IHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEECCCCCEEEe
Confidence 2347999999999999999986555568899999999999999999999998 999999999999999999999
Q ss_pred EeCCCcccccCCcccccccccCCCccchhccc-----CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHH
Q 046083 629 DFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQ-----YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVAL 703 (790)
Q Consensus 629 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 703 (790)
|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|..||...... ...
T Consensus 164 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-------~~~ 235 (282)
T cd06636 164 DFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-------RAL 235 (282)
T ss_pred eCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-------hhh
Confidence 9999875532211 123356889999999875 346788999999999999999999998543211 000
Q ss_pred HHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046083 704 FEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVV 760 (790)
Q Consensus 704 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 760 (790)
. ... ....+.. .....+..+.+++.+||+.||.+|||+.|++.
T Consensus 236 ~-~~~----------~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 F-LIP----------RNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred h-hHh----------hCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 000 0001111 11234467899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=323.62 Aligned_cols=267 Identities=21% Similarity=0.299 Sum_probs=195.1
Q ss_pred HHHHHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh--hhHHHHHHHHHHHHhcCCC------CCcceEEEEe
Q 046083 483 EELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM--QASKEFLAELKVLTHVHHL------NLVRLIGYCV 552 (790)
Q Consensus 483 ~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~--~~~~~~~~E~~~l~~l~h~------niv~l~g~~~ 552 (790)
+++...+++|++.++||+|+||+||+|... ++.||||+++. ....++..|++++.+++|. +++++++++.
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 344456788999999999999999999875 77899999863 3344567788888877654 5788888876
Q ss_pred c--CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCEEecCCC------
Q 046083 553 E--GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE-HTVPVYIHRDIKPANILIDKNF------ 623 (790)
Q Consensus 553 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~vH~dlkp~NILl~~~~------ 623 (790)
. +..++|||++ +++|.+++...+ .+++..+..++.|++.||.|||+ .++ +||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~gI---iHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELHL---MHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCe---ecCCCCHHHEEEecCCcccccc
Confidence 4 3578999988 678999887643 58999999999999999999998 487 9999999999998765
Q ss_pred ----------cEEEEEeCCCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccc
Q 046083 624 ----------RAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNET 693 (790)
Q Consensus 624 ----------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~ 693 (790)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 499999998764321 223467899999999999999999999999999999999999999653321
Q ss_pred cccccchHHHHHHHHcCCCC-------hhhhhhhcCC--cCCCCC---------------CHHHHHHHHHHHHHccccCC
Q 046083 694 ITESTGLVALFEEVLRQPDP-------REDLQRLVDP--RLGDDY---------------PIDSVRKMARLARACTQENP 749 (790)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~-------~~~l~~~~d~--~l~~~~---------------~~~~~~~l~~li~~Cl~~dP 749 (790)
.........+..... ......+.+. .+.... .......+.+|+.+||+.||
T Consensus 352 -----~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 426 (467)
T PTZ00284 352 -----EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR 426 (467)
T ss_pred -----HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence 111111111111000 0000000000 000000 00113467899999999999
Q ss_pred CCCCCHHHHHHHHHh
Q 046083 750 QLRPSMRAIVVALMT 764 (790)
Q Consensus 750 ~~RPt~~evl~~L~~ 764 (790)
++|||++|++++-+.
T Consensus 427 ~~R~ta~e~L~Hp~~ 441 (467)
T PTZ00284 427 QKRLNARQMTTHPYV 441 (467)
T ss_pred hhCCCHHHHhcCccc
Confidence 999999999986654
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=296.42 Aligned_cols=246 Identities=23% Similarity=0.379 Sum_probs=199.9
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEY 562 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~ 562 (790)
+|+..+.||+|+||.||.++.. ++.+++|.+.. ....++.+|++++++++|+||+++++++.+. ..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999998888764 78899998653 3345688999999999999999999988754 58999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+++++|.+++.......+++..+..++.+++.||.|||+.++ +|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i---~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGI---LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCc---cccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 999999999986544568999999999999999999999998 9999999999999999999999999986543321
Q ss_pred cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcC
Q 046083 643 VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD 722 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d 722 (790)
......+++.|+|||.+.+..++.++||||||+++|||++|..||..... ..........
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~~------------ 216 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--------LNLVVKIVQG------------ 216 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcC------------
Confidence 22345689999999999988899999999999999999999999854221 1111121111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 723 PRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 723 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
.. ...+......+.+++.+||+.+|++||+++++++++
T Consensus 217 -~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 217 -NY-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -CC-CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11 111123446788999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=303.73 Aligned_cols=259 Identities=24% Similarity=0.396 Sum_probs=201.5
Q ss_pred cCHHHHHHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh--hhHHHHHHHHHHHHhc-CCCCCcceEEEEe--
Q 046083 480 FSYEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM--QASKEFLAELKVLTHV-HHLNLVRLIGYCV-- 552 (790)
Q Consensus 480 ~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~-- 552 (790)
+.++.+....++|++.+.||+|+||.||++... ++.+++|.++. ....++.+|+.+++++ +|+|++++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 344566667899999999999999999999885 78899998864 2335688899999999 6999999999874
Q ss_pred ----cCeEEEEEEEecCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEE
Q 046083 553 ----EGSLFLVYEYIENGNLNQHLRGS--GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAK 626 (790)
Q Consensus 553 ----~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~k 626 (790)
+...++||||+++++|.+++... ....+++..+..++.++++||.|||++++ +||||||+||+++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKT---IHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCc---cccCCCHHhEEECCCCCEE
Confidence 23479999999999999988642 23468899999999999999999999998 9999999999999999999
Q ss_pred EEEeCCCcccccCCcccccccccCCCccchhcccC-----CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchH
Q 046083 627 VADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQY-----GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLV 701 (790)
Q Consensus 627 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~ 701 (790)
|+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.|+......
T Consensus 165 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-------- 235 (286)
T cd06638 165 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-------- 235 (286)
T ss_pred EccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh--------
Confidence 999999886543221 1223468899999998853 45788999999999999999999998643211
Q ss_pred HHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 702 ALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 702 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
......... ..+.+ ..+......+.+++.+||+.+|++|||+.|+++++
T Consensus 236 ~~~~~~~~~----------~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 236 RALFKIPRN----------PPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred HHHhhcccc----------CCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000000000 00000 01112234688999999999999999999999865
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=312.14 Aligned_cols=235 Identities=26% Similarity=0.422 Sum_probs=185.0
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEeChhh------HHHHHHHHH-HHHhcCCCCCcceEEEEec-CeEEEEEEEecC
Q 046083 496 NKIGQGGFGAVFYAELR--GEKAAIKKMDMQA------SKEFLAELK-VLTHVHHLNLVRLIGYCVE-GSLFLVYEYIEN 565 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~------~~~~~~E~~-~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~ 565 (790)
+.||+|+||.||++... ++.+|+|.+.... ...+..|.. +++.++|+||+++++++.+ +..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999886 6789999986422 223444443 5678899999999998764 458999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
|+|.+++.... .+.+.....++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~gi---iHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~ 154 (325)
T cd05602 81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNI---VYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTS 154 (325)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcc
Confidence 99999997643 47788888999999999999999998 999999999999999999999999997532211 1223
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
...|++.|+|||++.+..++.++|||||||++|||++|..||..... ........... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~-------------~ 213 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILNKP-------------L 213 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH--------HHHHHHHHhCC-------------c
Confidence 45789999999999999999999999999999999999999964322 11222222111 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRPSMRAIV 759 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 759 (790)
..+......+.+++.+|++.+|.+||++.+.+
T Consensus 214 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 214 --QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred --CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 11223445788999999999999999977543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=302.55 Aligned_cols=244 Identities=24% Similarity=0.395 Sum_probs=196.5
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEe
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
.|+..+.||+|+||.||+|.+. +..+|+|.++. ...+.+.+|++++++++||||+++++++.. ...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3666788999999999999875 77899998763 234568899999999999999999998875 4589999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
++++|.+++.. ..+++..+..++.++++|+.|||++++ +|+||+|+||++++++.++|+|||++........ .
T Consensus 85 ~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i---vH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06642 85 GGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCe---eccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence 99999999864 358999999999999999999999997 9999999999999999999999999976543221 1
Q ss_pred ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 644 HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
.....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ..... .. .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~~~-~~-------------~ 215 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM--------RVLFL-IP-------------K 215 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh--------hHHhh-hh-------------c
Confidence 22345788999999999889999999999999999999999997543211 00000 00 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
......+...+..+.+++.+||+.+|++||++.+++++-.
T Consensus 216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 216 NSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 0011122234567889999999999999999999998644
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=311.31 Aligned_cols=232 Identities=25% Similarity=0.413 Sum_probs=184.0
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEeChhh------HHHHHHHHH-HHHhcCCCCCcceEEEEec-CeEEEEEEEecC
Q 046083 496 NKIGQGGFGAVFYAELR--GEKAAIKKMDMQA------SKEFLAELK-VLTHVHHLNLVRLIGYCVE-GSLFLVYEYIEN 565 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~------~~~~~~E~~-~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~ 565 (790)
+.||+|+||.||+|+.. ++.+|+|.+.... ...+..|.. +++.++||||+++++++.+ +..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999985 7889999986422 233555554 5788899999999998764 458999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
++|..++... ..+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i---vH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNI---IYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTS 154 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCe---EeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCccc
Confidence 9999988754 358888899999999999999999998 99999999999999999999999998753221 11223
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
...|++.|+|||.+.+..++.++|||||||++|||++|..||.... .......+... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~-------------~- 212 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------VSQMYDNILHK-------------P- 212 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC--------HHHHHHHHhcC-------------C-
Confidence 4578999999999998899999999999999999999999986432 11222222211 1
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRPSMR 756 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 756 (790)
...+......+.+++.+||+.+|.+||+..
T Consensus 213 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 213 -LQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 112333456788999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=312.34 Aligned_cols=261 Identities=23% Similarity=0.315 Sum_probs=196.0
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-------
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE------- 553 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------- 553 (790)
..++|++.+.||+|+||.||++... ++.+|+|++.. ...+.+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3468999999999999999999875 78999999863 234567889999999999999999998752
Q ss_pred CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCC
Q 046083 554 GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLA 633 (790)
Q Consensus 554 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla 633 (790)
...++||||+++ +|.+.+.. .+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~gi---vHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCChHHEEECCCCCEEEeeCccc
Confidence 236999999976 67776653 47889999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC
Q 046083 634 KLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
+..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||....... ........ +..+..
T Consensus 167 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~~~~~-~~~~~~ 239 (355)
T cd07874 167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID----QWNKVIEQ-LGTPCP 239 (355)
T ss_pred ccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHH-hCCCCH
Confidence 865322 12234568999999999999899999999999999999999999986533110 00000000 000000
Q ss_pred ------hhhhhhhcC----------C-----cC---CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 714 ------REDLQRLVD----------P-----RL---GDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 714 ------~~~l~~~~d----------~-----~l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
......+++ + .+ ....+......+.+++.+||+.||++|||+.|++++-+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~ 313 (355)
T cd07874 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313 (355)
T ss_pred HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcc
Confidence 000000000 0 00 00111223457889999999999999999999998744
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=288.76 Aligned_cols=249 Identities=22% Similarity=0.363 Sum_probs=201.0
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeC-----hhhHHHHHHHHHHHHhcCCCCCcceEEEEe-cCeEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMD-----MQASKEFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVY 560 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~lv~ 560 (790)
++.|++-+.||+|.|+.||+.... |+.+|+|.++ ....+++.+|++|.+.++||||+++..... ++..|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 456788899999999999998765 7888877664 456688999999999999999999998665 55689999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC---CCcEEEEEeCCCcccc
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK---NFRAKVADFGLAKLTE 637 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~---~~~~kl~DfGla~~~~ 637 (790)
|+|+|++|..-+-.. ...++..+-+.++||+++|.|+|.++| ||||+||+|+||.. .--+||+|||+|..+.
T Consensus 90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~I---vHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGI---VHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCc---eeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999998766543 347788889999999999999999998 99999999999943 3458999999999876
Q ss_pred cCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 638 VGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
.........|||+|||||++....++..+|||+.||+||-|+.|.+||.... ...+++.++.....
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~--------~~rlye~I~~g~yd---- 230 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYEQIKAGAYD---- 230 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc--------HHHHHHHHhccccC----
Confidence 3333455789999999999999999999999999999999999999997532 23445555443211
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
+++ ..=....++..+|+++||..||.+|.|+.|.+.+-|
T Consensus 231 ---~~~----~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 231 ---YPS----PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred ---CCC----cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 011 001134456789999999999999999999876554
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=316.99 Aligned_cols=247 Identities=23% Similarity=0.362 Sum_probs=192.6
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
++|+..+.||+|+||.||++... ++.+|+|.++.. ....+.+|+.++.+++|+||+++++.+.+ +..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999885 789999998642 23457889999999999999999998875 4589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~gi---vHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLGF---IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999999997643 58999999999999999999999998 999999999999999999999999987542110
Q ss_pred c----------------------------------ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCcc
Q 046083 641 A----------------------------------SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEA 686 (790)
Q Consensus 641 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p 686 (790)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 001134689999999999999999999999999999999999999
Q ss_pred ccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 046083 687 VVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPS---MRAIVVA 761 (790)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~evl~~ 761 (790)
|..... ......+..... ... .... .....++.+++.+|+. +|.+|++ ++|++++
T Consensus 236 f~~~~~--------~~~~~~i~~~~~------~~~---~p~~--~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 236 FCSETP--------QETYRKVMNWKE------TLV---FPPE--VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCH--------HHHHHHHHcCCC------cee---cCCC--CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 965332 111222221100 000 0000 1133467778888764 9999985 6777665
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=296.33 Aligned_cols=245 Identities=26% Similarity=0.438 Sum_probs=199.9
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
+|++.+.||+|+||.+|++... ++.+++|.+.. ...+++.+|++++++++|+||+++++++.+ +..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999875 78899998753 234578999999999999999999998875 468999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+++++|.+++.......+++..+++++.+++.||.|||++++ +|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i---~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKI---LHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCE---ecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 999999999986544568999999999999999999999997 9999999999999999999999999986543221
Q ss_pred cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcC
Q 046083 643 VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD 722 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d 722 (790)
......|++.|+|||++.+..++.++|+||||++++||++|..||..... ...........
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~~~----------- 217 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--------KNLVLKIIRGS----------- 217 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--------HHHHHHHhcCC-----------
Confidence 12234578899999999988999999999999999999999999854221 11122221110
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 723 PRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 723 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
....+......+.+++.+||+.+|.+||++++|+++
T Consensus 218 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 218 ---YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ---CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 011233445678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=300.68 Aligned_cols=243 Identities=28% Similarity=0.470 Sum_probs=191.9
Q ss_pred eeeeecCceEEEEEEECC--------ceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 496 NKIGQGGFGAVFYAELRG--------EKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~g--------~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
+.||+|+||.||+|.... ..+++|.+.. ....++.+|+++++.++||||+++++++.. ...+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998752 5689988753 235678899999999999999999998875 458999999
Q ss_pred ecCCChhhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC-----cEEEEEeCC
Q 046083 563 IENGNLNQHLRGSG-----KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF-----RAKVADFGL 632 (790)
Q Consensus 563 ~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~-----~~kl~DfGl 632 (790)
+++++|.+++.... ...+++..++.++.+++.||.|||+.++ +|+||||+||+++.+. .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i---~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHF---IHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCc---ccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 2348899999999999999999999997 9999999999999877 899999999
Q ss_pred CcccccCCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcC
Q 046083 633 AKLTEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQ 710 (790)
Q Consensus 633 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 710 (790)
++........ ......++..|+|||++.++.++.++||||||+++|||++ |+.||..... .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--------~~~~~~~~~- 228 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--------QEVLQHVTA- 228 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--------HHHHHHHhc-
Confidence 9755322111 1122345678999999999999999999999999999998 9988853221 011111100
Q ss_pred CCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 711 PDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 711 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
......+...+..+.+++.+||+.+|.+||++++|++.|.
T Consensus 229 -------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 229 -------------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -------------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0011122345567899999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=285.51 Aligned_cols=248 Identities=25% Similarity=0.413 Sum_probs=201.8
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----------hhHHHHHHHHHHHHhc-CCCCCcceEEEEecC
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----------QASKEFLAELKVLTHV-HHLNLVRLIGYCVEG 554 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----------~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 554 (790)
-+.|...+.||+|..++|-+...+ +..+|+|++.. +-.+.-.+|+.||+++ .||+|+++.+++...
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 356777889999999999988776 78899998742 1224567899999999 699999999998755
Q ss_pred e-EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCC
Q 046083 555 S-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLA 633 (790)
Q Consensus 555 ~-~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla 633 (790)
. .++|+|.|+.|.|.++|...- .++++...+|++|+.+|+.|||.+++ |||||||+|||+|++.++||+|||++
T Consensus 96 sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~I---VHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARNI---VHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred chhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhhh---hhcccChhheeeccccceEEecccee
Confidence 4 799999999999999998743 69999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCcccccccccCCCccchhcccC------CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHH
Q 046083 634 KLTEVGSASVHTRLVGTFGYMPPEYAQY------GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEV 707 (790)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 707 (790)
..+..+ ......+|||+|+|||.+.. ..|+...|+|+.||+||-|+.|.+||..... ......+
T Consensus 171 ~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ--------mlMLR~I 240 (411)
T KOG0599|consen 171 CQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ--------MLMLRMI 240 (411)
T ss_pred eccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH--------HHHHHHH
Confidence 977644 34556899999999998853 3688899999999999999999999965422 1122223
Q ss_pred HcCCCChhhhhhhcCCcCCCCCC--HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 708 LRQPDPREDLQRLVDPRLGDDYP--IDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 708 ~~~~~~~~~l~~~~d~~l~~~~~--~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
+... .+-..| .+......+|+.+||+.||.+|.|.+|++++-..
T Consensus 241 meGk-------------yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 241 MEGK-------------YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred Hhcc-------------cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 2221 111111 2445678899999999999999999999986554
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.82 Aligned_cols=245 Identities=21% Similarity=0.418 Sum_probs=195.2
Q ss_pred CcccceeeeecCceEEEEEEEC-CceEEEEEeChh---------hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ---------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLV 559 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv 559 (790)
+|+..+.||+|+||.||+|... ++.+|+|.++.. ..+.+.+|++++++++|+||+++++++.+. ..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778899999999999999875 788999987531 224588899999999999999999998754 58999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+++++|.+++.... .+++..+..++.+++.||+|||+.++ +|+||+|+||++++++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNCV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999997643 58899999999999999999999997 99999999999999999999999998754221
Q ss_pred C-----cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 640 S-----ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 640 ~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
. ........++..|+|||++.+..++.++||||||+++|||++|..||...... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~--- 224 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL--------AAMFYIGAHR--- 224 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH--------HHHHHhhhcc---
Confidence 1 11112346889999999999888999999999999999999999998643211 0000000000
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVV 760 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 760 (790)
...+ ..+......+.+++.+||+.+|.+||++.|+++
T Consensus 225 -----~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 -----GLMP----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -----CCCC----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0011 122234567889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=297.70 Aligned_cols=244 Identities=24% Similarity=0.432 Sum_probs=195.9
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChh------------hHHHHHHHHHHHHhcCCCCCcceEEEEec-Ce
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GS 555 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~ 555 (790)
+|.+...||+|+||.||+|... +..+++|.+... ..+.+.+|+.++++++||||+++++++.+ ..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677899999999999999875 788999987521 12468899999999999999999998875 45
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
.+++|||+++++|.+++...+ .+++..+..++.+++.||+|||+.++ +||||+|+||++++++.++|+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~i---vH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRGI---IHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcCc---ccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 899999999999999997643 58899999999999999999999998 9999999999999999999999999986
Q ss_pred cccCCcc-----cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcC
Q 046083 636 TEVGSAS-----VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQ 710 (790)
Q Consensus 636 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 710 (790)
....... ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||...... .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~-- 225 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--------QAIFKIG-- 225 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--------HHHHHHh--
Confidence 6421111 112245788999999999889999999999999999999999998643210 0011110
Q ss_pred CCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 711 PDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 711 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.... ...+...+..+.+++.+||+.+|.+||++.|++++
T Consensus 226 --------~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 226 --------ENAS----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred --------ccCC----CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 1111 12233445678899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=311.09 Aligned_cols=250 Identities=23% Similarity=0.334 Sum_probs=194.1
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
++|.+.+.||+|+||.||+++.. ++.+|+|.+... ....+.+|..++..++|+||+++++++.+ +..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57899999999999999999886 678999998642 22447889999999999999999998875 4589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++|+|.+++.... ..+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~i---iHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHY---VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCe---eeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999998643 358899999999999999999999998 999999999999999999999999998654332
Q ss_pred cccccccccCCCccchhcccC-----CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQY-----GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (790)
........|++.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+......
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~-- 226 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHEER-- 226 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH--------HHHHHHHHcCCCc--
Confidence 222233568999999999875 4678899999999999999999999864321 1122222211100
Q ss_pred hhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 046083 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQL--RPSMRAIVVA 761 (790)
Q Consensus 716 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~ 761 (790)
+ .+. ....+.+.++.+++.+|+..++++ |+++++++.+
T Consensus 227 -~------~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 227 -F------QFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -c------cCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 000 001123467888999998866544 5688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=305.26 Aligned_cols=264 Identities=25% Similarity=0.384 Sum_probs=197.5
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
++|.+.++||+|+||.||+|... ++.+|+|.++.. ....+.+|++++++++||||+++++++.. +..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56889999999999999999875 778999988632 23457789999999999999999998874 568999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+++ +|.+++...+ ..+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i---vH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 86 LDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKV---LHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 986 8888887643 358899999999999999999999998 9999999999999999999999999975432221
Q ss_pred cccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh-------
Q 046083 643 VHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR------- 714 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 714 (790)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... +........+..+...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-----DELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCCHHHHhhhcc
Confidence 1223457899999998865 46899999999999999999999999654321 1111111111111100
Q ss_pred -hhhhhhcCCcCCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 715 -EDLQRLVDPRLGD----DYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 715 -~~l~~~~d~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
......-.+.... .........+.+++.+||+.||.+|||++|++++-+-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 289 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhh
Confidence 0000000011000 0011234567899999999999999999999885543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=311.30 Aligned_cols=257 Identities=23% Similarity=0.311 Sum_probs=195.9
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-------C
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-------G 554 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------~ 554 (790)
.++|.+.+.||+|+||.||++... ++.+|||++.. ...+.+.+|+.+++.++||||+++++++.. .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 468999999999999999999875 78899999863 234568889999999999999999987642 2
Q ss_pred eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCc
Q 046083 555 SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK 634 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~ 634 (790)
..|+||||+++ +|.+++.. .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~i---vH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCe---ecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 36999999975 77777753 47889999999999999999999998 999999999999999999999999998
Q ss_pred ccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcC---C
Q 046083 635 LTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQ---P 711 (790)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~ 711 (790)
..... .......++..|+|||++.+..++.++|||||||++|||++|+.||...... ..+..++.. +
T Consensus 175 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--------~~~~~~~~~~~~~ 244 (364)
T cd07875 175 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI--------DQWNKVIEQLGTP 244 (364)
T ss_pred ccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHhcCCC
Confidence 65322 1223456899999999999999999999999999999999999999654321 111111110 0
Q ss_pred CC---------------------hhhhhhhcCCcC---CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 712 DP---------------------REDLQRLVDPRL---GDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 712 ~~---------------------~~~l~~~~d~~l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.+ ......+....+ ...........+.+++.+|++.||.+|||++|++++-+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~ 320 (364)
T cd07875 245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320 (364)
T ss_pred CHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 00 000000000000 00011112356789999999999999999999998644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=295.62 Aligned_cols=243 Identities=24% Similarity=0.428 Sum_probs=203.2
Q ss_pred cccceeeeecCceEEEEEEEC--CceEEEEEeCh-hhHHHHHHHHHHHHhcCCCCCcceEEEEe-cCeEEEEEEEecCCC
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-QASKEFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGN 567 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~lv~e~~~~g~ 567 (790)
|.++++||+|+||.||+|..+ |..+|||.+.. .+.+++..|+.+|++.+.|++|+.||.+. ..++|+|||||.-|+
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 677899999999999999876 89999999975 45688999999999999999999999555 667999999999999
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccccc
Q 046083 568 LNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRL 647 (790)
Q Consensus 568 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 647 (790)
..+.++.+. .++++.++..+++..++||+|||.... +|||||+.||||+-+|.+||+|||.|-.+...- .....+
T Consensus 115 iSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~K---IHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRNTV 189 (502)
T KOG0574|consen 115 ISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKK---IHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRNTV 189 (502)
T ss_pred HHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHH---HHhhcccccEEEcccchhhhhhccccchhhhhH-HhhCcc
Confidence 999998765 479999999999999999999999988 999999999999999999999999997553211 123457
Q ss_pred ccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCC
Q 046083 648 VGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGD 727 (790)
Q Consensus 648 ~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 727 (790)
.||+.|||||+++.-.|..++||||+|+...||.-|++|+....+. +.++ ++...-..
T Consensus 190 IGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM-----------RAIF-----------MIPT~PPP 247 (502)
T KOG0574|consen 190 IGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM-----------RAIF-----------MIPTKPPP 247 (502)
T ss_pred ccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc-----------ceeE-----------eccCCCCC
Confidence 8999999999999999999999999999999999999998764431 0000 01111111
Q ss_pred --CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 728 --DYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 728 --~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
..|+.-..++-+++++||-..|++|-|+.+++++
T Consensus 248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1244456789999999999999999998887664
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=304.81 Aligned_cols=193 Identities=27% Similarity=0.443 Sum_probs=159.3
Q ss_pred ceeeeecCceEEEEEEEC----CceEEEEEeChhh-HHHHHHHHHHHHhcCCCCCcceEEEEec---CeEEEEEEEecCC
Q 046083 495 GNKIGQGGFGAVFYAELR----GEKAAIKKMDMQA-SKEFLAELKVLTHVHHLNLVRLIGYCVE---GSLFLVYEYIENG 566 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~----g~~vavK~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~---~~~~lv~e~~~~g 566 (790)
.++||+|+||.||+|... +..+|+|.+.... ...+.+|++++++++||||+++++++.. ...+++|||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-
Confidence 568999999999999864 4679999987533 4567889999999999999999998753 347899999865
Q ss_pred ChhhhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe----cCCCcEEEEEeCCCcc
Q 046083 567 NLNQHLRGS-------GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI----DKNFRAKVADFGLAKL 635 (790)
Q Consensus 567 ~L~~~l~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl----~~~~~~kl~DfGla~~ 635 (790)
+|.+++... ....+++..+..++.|++.||.|||++++ +||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~i---vHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCE---EcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 888877532 12358899999999999999999999997 999999999999 4567899999999987
Q ss_pred cccCCcc--cccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccc
Q 046083 636 TEVGSAS--VHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTN 691 (790)
Q Consensus 636 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~ 691 (790)
....... ......||+.|+|||++.+ ..++.++|||||||++|||++|++||....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 6432221 1234578999999999876 458999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=294.43 Aligned_cols=242 Identities=30% Similarity=0.509 Sum_probs=193.2
Q ss_pred eeeeecCceEEEEEEEC-CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEEecCCChh
Q 046083 496 NKIGQGGFGAVFYAELR-GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLN 569 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~~~~g~L~ 569 (790)
++||+|+||.||++... ++.+++|.+... ..+.+.+|++++++++|+||+++++++.+. ..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 47999999999999886 889999987642 345789999999999999999999988754 589999999999999
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccc-cccc
Q 046083 570 QHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH-TRLV 648 (790)
Q Consensus 570 ~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~-~~~~ 648 (790)
+++.... ..+++..++.++.+++.||.|||++++ +||||+|+|||++.++.+||+|||++........... ....
T Consensus 81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i---~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNC---IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCE---ehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 9997643 358899999999999999999999997 9999999999999999999999999986542211111 1123
Q ss_pred cCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCC
Q 046083 649 GTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGD 727 (790)
Q Consensus 649 gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 727 (790)
++..|+|||.+.++.++.++|+||||+++|||++ |..||...... ..... .. .....
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--------~~~~~-~~-------------~~~~~ 214 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--------QTRER-IE-------------SGYRM 214 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--------HHHHH-Hh-------------cCCCC
Confidence 3567999999998899999999999999999999 77777443211 11111 11 11111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 728 DYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 728 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
..+...+..+.+++.+||+.+|.+|||+.|+++.|.
T Consensus 215 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 215 PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 123344567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=299.29 Aligned_cols=248 Identities=29% Similarity=0.546 Sum_probs=195.5
Q ss_pred cccceeeeecCceEEEEEEEC--CceEEEEEeChhhH-----HHHHHHHHHHHhcCCCCCcceEEEEe-cCeEEEEEEEe
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS-----KEFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYI 563 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~-----~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~lv~e~~ 563 (790)
|++.+.||+|+||+||++... ++.+|+|.+..... ....+|+.++++++||||+++++++. +...+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 577899999999999999997 56799999975432 22355999999999999999999987 45689999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
++++|.+++... ..+++..+..++.++++||.+||++++ +|+||||+||++++++.++|+|||.+.... .....
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i---~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGI---VHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNEN 154 (260)
T ss_dssp TTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTE---EESSBSGGGEEESTTSEEEESSGTTTEEST-STTSE
T ss_pred cccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc-ccccc
Confidence 999999999832 358999999999999999999999997 999999999999999999999999997541 12223
Q ss_pred ccccccCCCccchhccc-CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcC
Q 046083 644 HTRLVGTFGYMPPEYAQ-YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD 722 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~-~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d 722 (790)
.....++..|+|||.+. +..++.++||||+|+++|+|++|..||..... .+............ .....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~-----~~~~~~~~~~~~~~-----~~~~~- 223 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS-----DDQLEIIEKILKRP-----LPSSS- 223 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH-----HHHHHHHHHHHHTH-----HHHHT-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc-----hhhhhhhhhccccc-----ccccc-
Confidence 34467899999999998 88899999999999999999999999875411 11111111111100 00000
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 723 PRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 723 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.........+.+++.+||+.||++||++.+++++
T Consensus 224 -----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 -----QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp -----TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred -----cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000112689999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=311.99 Aligned_cols=233 Identities=26% Similarity=0.421 Sum_probs=185.0
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHH-HHHhcCCCCCcceEEEEec-CeEEEEEEEecC
Q 046083 496 NKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELK-VLTHVHHLNLVRLIGYCVE-GSLFLVYEYIEN 565 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~-~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~ 565 (790)
+.||+|+||.||+|... ++.+|+|.+... ...++..|.. +++.++||||+++++++.. +..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999875 789999998643 2234555554 4677899999999988764 568999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
|+|..++.... .+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~gi---vH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~ 154 (325)
T cd05604 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSINI---VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTT 154 (325)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCcc
Confidence 99999887643 58999999999999999999999998 99999999999999999999999998753221 11223
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
...|++.|+|||++.+..++.++|||||||++|||++|..||..... ...+....... +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~~~~~~-------------~ 213 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV--------AEMYDNILHKP-------------L 213 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH--------HHHHHHHHcCC-------------c
Confidence 45789999999999999999999999999999999999999864321 12222222211 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRPSMRA 757 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 757 (790)
..+......+.+++.+|++.+|.+||++++
T Consensus 214 --~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 214 --VLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred --cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 111223456789999999999999998864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=295.99 Aligned_cols=234 Identities=24% Similarity=0.443 Sum_probs=187.0
Q ss_pred eeeeecCceEEEEEEECCc------------eEEEEEeChhh--HHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEE
Q 046083 496 NKIGQGGFGAVFYAELRGE------------KAAIKKMDMQA--SKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYE 561 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~g~------------~vavK~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e 561 (790)
+.||+|+||.||+|.+... .+++|.+.... ...+.+|+.++++++|||++++++++.....++|||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e 80 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEE 80 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEEE
Confidence 4689999999999998632 47888776433 567899999999999999999999887766899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC-------cEEEEEeCCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF-------RAKVADFGLAK 634 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~-------~~kl~DfGla~ 634 (790)
|+++|+|.+++..... .+++..+..++.|++.||+|||++++ +||||||+|||++.++ .+||+|||++.
T Consensus 81 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i---~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 81 YVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKL---VHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred cCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCe---ecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 9999999999986542 68999999999999999999999998 9999999999999887 79999999998
Q ss_pred ccccCCcccccccccCCCccchhcccCC--CCCchhhHHHHHHHHHHHHhC-CccccccccccccccchHHHHHHHHcCC
Q 046083 635 LTEVGSASVHTRLVGTFGYMPPEYAQYG--EVSPKIDVYAFGVVLYELISA-MEAVVKTNETITESTGLVALFEEVLRQP 711 (790)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDvwS~Gvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (790)
.... .....++..|+|||++... .++.++||||||+++|||++| ..|+...... .. .......
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-----~~----~~~~~~~ 222 (259)
T cd05037 157 TVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-----EK----ERFYQDQ 222 (259)
T ss_pred cccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-----hH----HHHHhcC
Confidence 6532 1223467789999999876 789999999999999999994 6666443211 00 0011000
Q ss_pred CChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 712 DPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 712 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
. ..+......+.+++.+||+.+|.+|||+.+|++.|
T Consensus 223 ------------~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 223 ------------H---RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred ------------C---CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 00111126788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=315.10 Aligned_cols=264 Identities=20% Similarity=0.275 Sum_probs=197.6
Q ss_pred hcCcccceeeeecCceEEEEEEEC----CceEEEEEeChhhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEe
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR----GEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~----g~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
..+|.+.+.||+|+||.||++... +..+++|.+... +.+.+|++++++++||||+++++++.. ...+++||++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 168 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY 168 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc
Confidence 357999999999999999999764 467899988643 345689999999999999999998764 5689999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc-
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS- 642 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~- 642 (790)
. ++|.+++... ..+++..++.++.|++.||.|||++++ +||||||+|||++.++.++|+|||+++........
T Consensus 169 ~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~gi---vHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 169 K-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGI---IHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred C-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 6 5888888543 469999999999999999999999998 99999999999999999999999999765433221
Q ss_pred cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC------Chh-
Q 046083 643 VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD------PRE- 715 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~- 715 (790)
......||+.|+|||++....++.++|||||||++|||++|+.||....... ....+..... .+.... ...
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~i~~-~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRSIIR-CMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHHHHH-HhccCccccCCccchh
Confidence 2234578999999999999999999999999999999999999986543221 0011111111 111000 000
Q ss_pred ---hhhhhcCCcCCCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 716 ---DLQRLVDPRLGDDYP-------IDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 716 ---~l~~~~d~~l~~~~~-------~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.+.... ......+. .....++.+++.+||+.||++|||+.|++.+-.
T Consensus 321 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~ 377 (392)
T PHA03207 321 LCKHFKQYA-IVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377 (392)
T ss_pred HHHHHHhhc-ccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence 000000 00111110 112356788999999999999999999998654
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=299.70 Aligned_cols=247 Identities=24% Similarity=0.412 Sum_probs=186.6
Q ss_pred eeeeecCceEEEEEEEC----CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEEecCC
Q 046083 496 NKIGQGGFGAVFYAELR----GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENG 566 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~----g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~~~~g 566 (790)
+.||+|+||.||+|... +..+++|.++.. ....+.+|+.++++++||||+++++++.+. ..++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36899999999999864 346899988642 234688899999999999999999988754 489999999999
Q ss_pred ChhhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 567 NLNQHLRGSG---KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 567 ~L~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
+|.++++... ...+++..+.+++.|++.||+|||+.++ +|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i---~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNF---IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCE---eccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997532 2346788888999999999999999997 999999999999999999999999997543222111
Q ss_pred -ccccccCCCccchhcccCC-------CCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 644 -HTRLVGTFGYMPPEYAQYG-------EVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 644 -~~~~~gt~~y~aPE~~~~~-------~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
.....++..|+|||++... .++.++|+||||+++|||++ |..||...... .........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~---- 225 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE--------QVLTYTVRE---- 225 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH--------HHHHHHhhc----
Confidence 1234567889999998642 35789999999999999996 99998543221 000111110
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
......++.+. ......+.+++..|+ .+|++|||++||+..|+
T Consensus 226 -~~~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 226 -QQLKLPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred -ccCCCCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00111122221 123346788999999 58999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=295.36 Aligned_cols=246 Identities=30% Similarity=0.544 Sum_probs=197.5
Q ss_pred cccceeeeecCceEEEEEEECC------ceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 492 FSMGNKIGQGGFGAVFYAELRG------EKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~g------~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
|++.+.||.|+||.||++.... ..+|+|.+... ..+.+..|++++.+++|+|++++++++.+ +..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999999863 77999998743 35678999999999999999999998875 5689999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++++|.+++.......+++..+..++.|++.||+|||+.++ +|+||+|+||++++++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~---~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNF---IHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCe---eecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999999999986543338999999999999999999999998 999999999999999999999999998664332
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
........++..|+|||.+....++.++||||||++++||++ |..||..... ...........
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~~~~-------- 221 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------EEVLEYLKKGY-------- 221 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcCC--------
Confidence 221112336789999999988889999999999999999998 7777654211 11112211111
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
....+...+.++.+++.+|+..+|++|||+.|+++.|
T Consensus 222 ------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 ------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1111223456789999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=295.99 Aligned_cols=245 Identities=22% Similarity=0.369 Sum_probs=195.6
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh--------hhHHHHHHHHHHHHhcCCCCCcceEEEEecC---eE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM--------QASKEFLAELKVLTHVHHLNLVRLIGYCVEG---SL 556 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~---~~ 556 (790)
++|++.+.||+|+||.||+|... +..+++|.+.. ...+.+.+|++++++++||||+++++++.+. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57889999999999999999875 78899998742 2235688899999999999999999987642 47
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
+++|||+++++|.+++.... .+++...++++.+++.||+|||+.++ +|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i---~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNMI---VHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCE---ecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 89999999999999987643 47888999999999999999999997 99999999999999999999999999855
Q ss_pred ccCCc--ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 637 EVGSA--SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 637 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
..... .......++..|+|||.+.+..++.++||||||+++|||++|+.||...... . .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~-~~~~~~~----- 223 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-------A-AIFKIAT----- 223 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-------H-HHHHHhc-----
Confidence 32111 1122345788999999999888999999999999999999999998543210 0 1111111
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.......+......+.+++.+|+. +|++||+++||+++
T Consensus 224 --------~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 224 --------QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred --------CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 111122344555678889999995 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=297.76 Aligned_cols=244 Identities=25% Similarity=0.416 Sum_probs=198.6
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEEe
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYI 563 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~~ 563 (790)
.|+..+.||.|+||.||+|... +..+|+|.++. ...+.+.+|+.++++++|+|++++++++.++ ..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667889999999999999875 78899998763 2345688999999999999999999988754 589999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
++++|.+++... .+++.....++.+++.||+|||+.++ +|+||+|+||+++.++.++|+|||++........ .
T Consensus 85 ~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~i---vH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06640 85 GGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCc---cCcCCChhhEEEcCCCCEEEcccccceeccCCcc-c
Confidence 999999998753 48899999999999999999999998 9999999999999999999999999976543221 1
Q ss_pred ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 644 HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
.....++..|+|||++.+..++.++|+||||+++|||++|..||...... .... .+..
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~~--------------~~~~ 215 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM--------RVLF--------------LIPK 215 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH--------hHhh--------------hhhc
Confidence 22345788999999999889999999999999999999999998543211 0000 0011
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
......+...+..+.+++.+||+.+|++||++++++.+-.
T Consensus 216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 216 NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 1112233456678899999999999999999999987644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=304.43 Aligned_cols=248 Identities=25% Similarity=0.367 Sum_probs=198.2
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~ 560 (790)
++|+..+.||+|+||.||++... ++.+|+|.+... ..+.+..|++++..++|+||+++++++.++ ..+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46889999999999999999885 789999988642 335688999999999999999999988754 589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+.+++|.+++.......+++..+..++.|++.||+|||+.++ +|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i---~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGI---VYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCe---eccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 99999999999986544578999999999999999999999997 999999999999999999999999987543221
Q ss_pred cc----------------------------cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCcccccccc
Q 046083 641 AS----------------------------VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNE 692 (790)
Q Consensus 641 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~ 692 (790)
.. ......|+..|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 01124678899999999988999999999999999999999999864332
Q ss_pred ccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC----HHHHHHH
Q 046083 693 TITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPS----MRAIVVA 761 (790)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt----~~evl~~ 761 (790)
. ..+..... ...........+..+.+++.+||+.+|++||| ++|++.+
T Consensus 238 ~--------~~~~~~~~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 D--------ETFSNILK-------------KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred H--------HHHHHHhc-------------CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 1 11111111 11111111124578999999999999999999 6666553
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=301.72 Aligned_cols=258 Identities=26% Similarity=0.419 Sum_probs=202.5
Q ss_pred cCHHHHHHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh--hHHHHHHHHHHHHhc-CCCCCcceEEEEec-
Q 046083 480 FSYEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ--ASKEFLAELKVLTHV-HHLNLVRLIGYCVE- 553 (790)
Q Consensus 480 ~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~~- 553 (790)
+..+++..++++|++.+.||+|+||.||++... ++.+|+|.+... ..+++.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 455666677899999999999999999999885 788999998642 345678899999999 89999999998763
Q ss_pred -----CeEEEEEEEecCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEE
Q 046083 554 -----GSLFLVYEYIENGNLNQHLRGS--GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAK 626 (790)
Q Consensus 554 -----~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~k 626 (790)
+..++||||+++++|.++++.. ....+++..++.++.+++.||+|||+.++ +|+||||+||+++.++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i---vH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRI---IHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCe---eccCCCHHHEEEcCCCCEE
Confidence 2479999999999999988642 23468999999999999999999999997 9999999999999999999
Q ss_pred EEEeCCCcccccCCcccccccccCCCccchhcccCC-----CCCchhhHHHHHHHHHHHHhCCccccccccccccccchH
Q 046083 627 VADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYG-----EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLV 701 (790)
Q Consensus 627 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~ 701 (790)
|+|||++........ ......|+..|+|||.+... .++.++|||||||++|||++|+.||...... .
T Consensus 169 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-------~ 240 (291)
T cd06639 169 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-------K 240 (291)
T ss_pred Eeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-------H
Confidence 999999886542221 11234678899999998643 3688999999999999999999998643211 0
Q ss_pred HHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 702 ALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 702 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
. ...+..... +.+ ..+......+.+++.+||+.+|++||++.|++++
T Consensus 241 ~-~~~~~~~~~----------~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 241 T-LFKIPRNPP----------PTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred H-HHHHhcCCC----------CCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 111111100 011 1122334568999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.75 Aligned_cols=262 Identities=23% Similarity=0.332 Sum_probs=195.0
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
+|++.+.||+|++|.||+|... +..+|+|.++.. ..+.+.+|+.++++++|||++++++++.+ ...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5788999999999999999875 789999988632 23568899999999999999999998875 568999999
Q ss_pred ecCCChhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 563 IENGNLNQHLRGSG-KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 563 ~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
++ ++|.+++.... ...+++..+..++.|++.||+|||++++ +|+||+|+|||++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i---~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRV---LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCe---eecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 58988887543 2568999999999999999999999998 999999999999999999999999997553222
Q ss_pred ccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHH-------cCCCC
Q 046083 642 SVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVL-------RQPDP 713 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~ 713 (790)
.......+++.|+|||.+.+. .++.++||||||+++|||++|+.||....... ........+. .....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID----QLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHHHhCCCChhhhhcchh
Confidence 112234568899999988654 57899999999999999999999986533210 0111111000 00000
Q ss_pred hhhhhhhcCCcCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 714 REDLQRLVDPRLGD---DYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 714 ~~~l~~~~d~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
........+..... ........++.+++.+||+.||++|||+++|+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00111111100000 0011234677899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.94 Aligned_cols=255 Identities=25% Similarity=0.441 Sum_probs=200.7
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
++|++.+.||+|+||.||++... +..+|+|.+.. ...+.+.+|+++++.++||||+++++++.. ...++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56888999999999999999886 78899998753 234678899999999999999999998875 568999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE-HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
+++++|.+++...+ .+++..+..++.+++.||.|||+ +++ +|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~i---~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHRI---MHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcCe---eccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 99999999987643 58999999999999999999997 466 999999999999999999999999987542211
Q ss_pred ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCcccccccccccc---ccchHHHHHHHHcCCCChhhhh
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITE---STGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
.....|+..|+|||++.+..++.++|+|||||++|||++|..||......... ...............
T Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 229 (284)
T cd06620 159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------- 229 (284)
T ss_pred --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-------
Confidence 12356899999999998889999999999999999999999999754322110 011111111111110
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
.+.+ .....+..+.+++.+||+.||++|||++|++.+..-+
T Consensus 230 ---~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 230 ---PPRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred ---CCCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 0111 0112445788999999999999999999999875443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=302.03 Aligned_cols=278 Identities=27% Similarity=0.423 Sum_probs=222.8
Q ss_pred cCHHHHHHH-hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhhH------HHHHHHHHHHHhcCCCCCcce-EE
Q 046083 480 FSYEELAKA-TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS------KEFLAELKVLTHVHHLNLVRL-IG 549 (790)
Q Consensus 480 ~~~~~l~~~-~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~------~~~~~E~~~l~~l~h~niv~l-~g 549 (790)
+.+-|+... .+.|+.-+.||+|+||.||-+... |+.+|.|++..... ....+|-.||.+++.+.||.+ |.
T Consensus 174 WK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA 253 (591)
T KOG0986|consen 174 WKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA 253 (591)
T ss_pred HHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee
Confidence 334444333 356899999999999999987664 88999998865433 236789999999999999998 45
Q ss_pred EEecCeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEE
Q 046083 550 YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVAD 629 (790)
Q Consensus 550 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~D 629 (790)
|...+.+++|+..|.||+|.-+|...+...+++..+..++.+|+.||++||..++ |.|||||+|||||+.|+++|+|
T Consensus 254 feTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~i---VYRDLKPeNILLDd~GhvRISD 330 (591)
T KOG0986|consen 254 FETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRI---VYRDLKPENILLDDHGHVRISD 330 (591)
T ss_pred ecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcce---eeccCChhheeeccCCCeEeec
Confidence 5556779999999999999999998887889999999999999999999999998 9999999999999999999999
Q ss_pred eCCCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHc
Q 046083 630 FGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLR 709 (790)
Q Consensus 630 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 709 (790)
+|||..+..+. .....+||.+|||||+++++.|+...|+|||||++|||+.|+.||....+..
T Consensus 331 LGLAvei~~g~--~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv--------------- 393 (591)
T KOG0986|consen 331 LGLAVEIPEGK--PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV--------------- 393 (591)
T ss_pred cceEEecCCCC--ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh---------------
Confidence 99998775433 3344589999999999999999999999999999999999999997654321
Q ss_pred CCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccCCcCCccccccccccccC
Q 046083 710 QPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWDIGSFYENQGLDSLMSG 789 (790)
Q Consensus 710 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~~~~~~~~~~~~~~~~~~ 789 (790)
..+.+++.+.. ...+++....++..+|.+..|+.||++|--.+. ....+...+.||++-+|..+..|
T Consensus 394 ---k~eEvdrr~~~-~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg---------~ga~evk~HpfFk~lnw~rleag 460 (591)
T KOG0986|consen 394 ---KREEVDRRTLE-DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRG---------EGAQEVKEHPFFKDLNWRRLEAG 460 (591)
T ss_pred ---hHHHHHHHHhc-chhhcccccCHHHHHHHHHHHccCHHHhccCCC---------cCcchhhhCcccccCCHhHHhcc
Confidence 01112111111 112445566678888999999999999976542 24456678899999999888776
Q ss_pred C
Q 046083 790 R 790 (790)
Q Consensus 790 ~ 790 (790)
+
T Consensus 461 m 461 (591)
T KOG0986|consen 461 M 461 (591)
T ss_pred C
Confidence 4
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=294.56 Aligned_cols=244 Identities=25% Similarity=0.391 Sum_probs=197.6
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEe-cCeEEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEY 562 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~lv~e~ 562 (790)
+|+..+.||+|+||.||++... ++.+++|.+.. ...+.+.+|++++++++|||++++++.+. ++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5788999999999999999875 78899998753 23467889999999999999999999776 4568999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC-CcEEEEEeCCCcccccCCc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN-FRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~-~~~kl~DfGla~~~~~~~~ 641 (790)
+++++|.+++.......+++..+.+++.+++.||.|||++++ +|+||+|+||+++++ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i---~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLI---LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 999999999987655568999999999999999999999998 999999999999865 468999999998654322
Q ss_pred ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhc
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 721 (790)
......++..|+|||.+.+..++.++||||||+++|+|++|..||..... ...........
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--------~~~~~~~~~~~---------- 217 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL--------PALVLKIMSGT---------- 217 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch--------HHHHHHHHhcC----------
Confidence 12235678899999999988899999999999999999999999854321 11111111110
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 722 DPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 722 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
....+......+.+++.+||+.+|++|||++|++++
T Consensus 218 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 218 ----FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ----CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 011222345578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=299.74 Aligned_cols=234 Identities=24% Similarity=0.411 Sum_probs=182.2
Q ss_pred eeeecCceEEEEEEEC--------------------------CceEEEEEeChhh---HHHHHHHHHHHHhcCCCCCcce
Q 046083 497 KIGQGGFGAVFYAELR--------------------------GEKAAIKKMDMQA---SKEFLAELKVLTHVHHLNLVRL 547 (790)
Q Consensus 497 ~lG~G~fg~Vy~a~~~--------------------------g~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l 547 (790)
+||+|+||.||+|.+. ...+++|.++... ..+|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999999742 1258889887532 3568889999999999999999
Q ss_pred EEEEecC-eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC---
Q 046083 548 IGYCVEG-SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF--- 623 (790)
Q Consensus 548 ~g~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~--- 623 (790)
++++.++ ..++||||+++|+|..++.... ..+++..+.+++.|+++||+|||+.++ +||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i---iH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNL---VHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCc---cCCCCCcccEEEeccCccc
Confidence 9998754 5899999999999999987542 358899999999999999999999998 9999999999997643
Q ss_pred ----cEEEEEeCCCcccccCCcccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHH-hCCccccccccccccc
Q 046083 624 ----RAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELI-SAMEAVVKTNETITES 697 (790)
Q Consensus 624 ----~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~ell-tG~~p~~~~~~~~~~~ 697 (790)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.......
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--- 229 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--- 229 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH---
Confidence 4899999988643211 12346788999998865 56899999999999999995 7888875432210
Q ss_pred cchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 698 TGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
. ...... .. ..+......+.+++.+||+.+|++|||+++|++.|+
T Consensus 230 --~----~~~~~~-------------~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 --K----ERFYEK-------------KH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --H----HHHHHh-------------cc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0 011110 00 011112346889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=307.35 Aligned_cols=244 Identities=22% Similarity=0.331 Sum_probs=190.7
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhc-CCCCCcceEEEEec-CeEEEEEEEecC
Q 046083 496 NKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIEN 565 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~~lv~e~~~~ 565 (790)
+.||+|+||.||++... +..+|+|.++.. ..+.+..|+.++.++ +||||+++++++.+ ...++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999876 678999998743 234577899999888 69999999998764 458999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
|+|..++.... .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~i---vHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERGI---IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTS 154 (327)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eccCCCHHHEEEeCCCCEEEeccccceeccCCC-Ccee
Confidence 99999887543 58999999999999999999999998 999999999999999999999999987532211 1223
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
...|++.|+|||++.+..++.++|||||||++|||++|..||........ ..........+ ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~--~~~~~~~~~~~------------~~~~- 219 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD--MNTEDYLFQVI------------LEKP- 219 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc--cccHHHHHHHH------------HhCC-
Confidence 45789999999999999999999999999999999999999964332110 01111111111 1111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRPS------MRAIVVA 761 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt------~~evl~~ 761 (790)
...|......+.+++.+||+.||++||+ +++++.+
T Consensus 220 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 220 -IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred -CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 1123334456889999999999999998 4566554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=312.53 Aligned_cols=261 Identities=25% Similarity=0.370 Sum_probs=202.7
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeCh--hhHHHHHHHHHHHHhcC-C-----CCCcceEEEEe-cCeEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM--QASKEFLAELKVLTHVH-H-----LNLVRLIGYCV-EGSLFLV 559 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~--~~~~~~~~E~~~l~~l~-h-----~niv~l~g~~~-~~~~~lv 559 (790)
+|.+.+.||+|.||.|-+|.+. ++.||||+++. ....+-..|+.+|..++ | -|+|++++++. .+++|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 7899999999999999999886 88999999974 34466778999999996 4 38999999886 6779999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC--CcEEEEEeCCCcccc
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN--FRAKVADFGLAKLTE 637 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~--~~~kl~DfGla~~~~ 637 (790)
+|.++. +|+++|.......++...+..++.||+.||.+||+.++ ||+||||+||||.+- ..+||+|||.+....
T Consensus 267 fELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~I---IHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGI---IHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred ehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe---eeccCChhheeeccCCcCceeEEecccccccC
Confidence 999976 99999998887889999999999999999999999998 999999999999654 379999999998653
Q ss_pred cCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh---
Q 046083 638 VGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR--- 714 (790)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 714 (790)
... ....-+..|+|||++.+..|+.+.||||||||+.||++|.+.|...++. +......+++..+...
T Consensus 343 q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~-----DQl~~I~e~lG~Pp~~mL~ 413 (586)
T KOG0667|consen 343 QRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY-----DQLARIIEVLGLPPPKMLD 413 (586)
T ss_pred Ccc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH-----HHHHHHHHHhCCCCHHHHH
Confidence 221 2456688999999999999999999999999999999998777654431 1222222222211100
Q ss_pred ---------hh-------------------------hhhhcCCcCCC--------CCCHHHHHHHHHHHHHccccCCCCC
Q 046083 715 ---------ED-------------------------LQRLVDPRLGD--------DYPIDSVRKMARLARACTQENPQLR 752 (790)
Q Consensus 715 ---------~~-------------------------l~~~~d~~l~~--------~~~~~~~~~l~~li~~Cl~~dP~~R 752 (790)
+. +....+..... ..+......+.+++.+|+++||.+|
T Consensus 414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R 493 (586)
T KOG0667|consen 414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER 493 (586)
T ss_pred hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence 00 00000110001 0112345678999999999999999
Q ss_pred CCHHHHHHHHHh
Q 046083 753 PSMRAIVVALMT 764 (790)
Q Consensus 753 Pt~~evl~~L~~ 764 (790)
+|..|.+.+-..
T Consensus 494 ~tp~qal~Hpfl 505 (586)
T KOG0667|consen 494 ITPAQALNHPFL 505 (586)
T ss_pred CCHHHHhcCccc
Confidence 999999886553
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=307.29 Aligned_cols=248 Identities=25% Similarity=0.413 Sum_probs=206.9
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcC-CCCCcceEEEEec-CeEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVH-HLNLVRLIGYCVE-GSLFL 558 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~-h~niv~l~g~~~~-~~~~l 558 (790)
...|++.+.||+|.||.||+++.+ |+.+|+|.+... ..+.+.+|+.+|+++. |||||.+++.+.. ...++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 456888899999999999999886 889999998643 2357999999999998 9999999998875 46899
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC----CcEEEEEeCCCc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN----FRAKVADFGLAK 634 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~----~~~kl~DfGla~ 634 (790)
|||++.||.|.+.+... .+++.....++.+++.++.|||+.++ +||||||+|+|+... +.+|++|||++.
T Consensus 114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gv---vHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGV---VHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCc---eeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999999876 29999999999999999999999998 999999999999543 579999999999
Q ss_pred ccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 635 LTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
.... .......+||+.|+|||++....++...||||+||++|.|++|.+||...... ..+..+.....
T Consensus 188 ~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~--------~~~~~i~~~~~-- 255 (382)
T KOG0032|consen 188 FIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF--------EIFLAILRGDF-- 255 (382)
T ss_pred EccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh--------HHHHHHHcCCC--
Confidence 8765 44556689999999999999999999999999999999999999999765432 11112222111
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
......-......+.++++.|+..||.+|+|+.+++++-|
T Consensus 256 ---------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 256 ---------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred ---------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 1111112344667889999999999999999999999755
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=308.83 Aligned_cols=259 Identities=20% Similarity=0.294 Sum_probs=191.3
Q ss_pred cceeeeec--CceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEe
Q 046083 494 MGNKIGQG--GFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 494 ~~~~lG~G--~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
+.++||+| +|++||++... ++.+|+|+++.. ..+.+.+|+++++.++||||+++++++.. +..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 78999999876 789999998743 23457789999999999999999998874 5689999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc-
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS- 642 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~- 642 (790)
++|+|.+++.......+++..+++++.|++.||+|||++++ +||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i---iH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCE---ecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 99999999976444468999999999999999999999997 99999999999999999999999865433211110
Q ss_pred -----cccccccCCCccchhcccC--CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC---
Q 046083 643 -----VHTRLVGTFGYMPPEYAQY--GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD--- 712 (790)
Q Consensus 643 -----~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 712 (790)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ..........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~~~~~~~~~~ 230 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--------MLLEKLNGTVPCL 230 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--------HHHHHhcCCcccc
Confidence 1112346778999999976 468999999999999999999999996432210 0000000000
Q ss_pred ------Chhh-------------hhhhc---------CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 713 ------PRED-------------LQRLV---------DPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 713 ------~~~~-------------l~~~~---------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
..+. +.... ...............+.+++.+||+.||++|||++|++++-.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence 0000 00000 000000111233457889999999999999999999987543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=332.42 Aligned_cols=250 Identities=27% Similarity=0.421 Sum_probs=195.2
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec---CeEE
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE---GSLF 557 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---~~~~ 557 (790)
..++|.+.+.||+|+||.||++... +..+|+|.+.. .....|..|+.++.+++||||+++++++.+ ..+|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 4568999999999999999999986 67889998753 334568899999999999999999998753 3489
Q ss_pred EEEEEecCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCC----CceeecCCCCCCEEecC----------
Q 046083 558 LVYEYIENGNLNQHLRGSG--KDTLTWSARMQIALDSARGLEYIHEHTV----PVYIHRDIKPANILIDK---------- 621 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~----~~~vH~dlkp~NILl~~---------- 621 (790)
|||||+++|+|.++|.... ...+++..++.|+.||+.||.|||+.+. ..||||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999997531 2469999999999999999999998651 23599999999999964
Q ss_pred -------CCcEEEEEeCCCcccccCCcccccccccCCCccchhcccC--CCCCchhhHHHHHHHHHHHHhCCcccccccc
Q 046083 622 -------NFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQY--GEVSPKIDVYAFGVVLYELISAMEAVVKTNE 692 (790)
Q Consensus 622 -------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~ 692 (790)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||.....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 2358999999998653221 2234578999999999854 4588999999999999999999999964321
Q ss_pred ccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 693 TITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
...+...+...+ .+. ....+..+.+|+..||+.+|.+||++.|++..
T Consensus 249 -------~~qli~~lk~~p------------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 249 -------FSQLISELKRGP------------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred -------HHHHHHHHhcCC------------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 111111111110 010 01234578899999999999999999999854
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=298.39 Aligned_cols=247 Identities=23% Similarity=0.404 Sum_probs=194.5
Q ss_pred cccceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecC
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIEN 565 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~ 565 (790)
|++.+.||+|+||.||+|... +..+++|.+.. ...+.+.+|+++++.++|+|++++++++.. ...++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567789999999999999986 66788998864 334568899999999999999999998774 458999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
++|..++.... ..+++..+..++.|++.||.|||+.++ +||||||+|||++.++.+||+|||++....... ....
T Consensus 87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i---~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 161 (282)
T cd06643 87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKI---IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD 161 (282)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCe---eecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence 99999886532 368999999999999999999999998 999999999999999999999999987543221 1223
Q ss_pred ccccCCCccchhccc-----CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 646 RLVGTFGYMPPEYAQ-----YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~-----~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
...++..|+|||++. +..++.++|||||||++|||++|+.||..... ............
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~~~~-------- 225 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSEP-------- 225 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--------HHHHHHHhhcCC--------
Confidence 356889999999984 44578899999999999999999999854321 111111111100
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
+.+ ..+...+..+.+++.+||+.+|.+||++.+++++-.
T Consensus 226 --~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 226 --PTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred --CCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 000 112233467899999999999999999999986544
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=293.90 Aligned_cols=245 Identities=27% Similarity=0.451 Sum_probs=198.2
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec---CeEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE---GSLFLVY 560 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---~~~~lv~ 560 (790)
+|++.+.||.|+||.||++... +..+++|.++. ...+.+..|++++++++|+|++++++++.. ...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999875 78899998753 234568889999999999999999997752 3479999
Q ss_pred EEecCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCceeecCCCCCCEEecCCCcEEEEEeCCC
Q 046083 561 EYIENGNLNQHLRGS--GKDTLTWSARMQIALDSARGLEYIH-----EHTVPVYIHRDIKPANILIDKNFRAKVADFGLA 633 (790)
Q Consensus 561 e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH-----~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla 633 (790)
||+++++|.+++... ....+++..++.++.+++.||.||| +.++ +|+||+|+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i---~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTV---LHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcc---eecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999998753 2346899999999999999999999 7776 99999999999999999999999999
Q ss_pred cccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC
Q 046083 634 KLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
........ ......+++.|+|||.+....++.++|+||||+++|+|++|+.||..... ........
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~----- 223 (265)
T cd08217 158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--------LQLASKIK----- 223 (265)
T ss_pred ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--------HHHHHHHh-----
Confidence 87643322 12334688999999999988899999999999999999999999864321 11111111
Q ss_pred hhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 714 REDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 714 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.......+......+.+++.+|++.+|++||++++|+++
T Consensus 224 ---------~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 224 ---------EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---------cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111122333455678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=301.35 Aligned_cols=246 Identities=23% Similarity=0.399 Sum_probs=198.3
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEe
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
.+|++.+.||+|+||.||++... ++.+|+|.+.. ...+.+.+|+.+++.++|+|++++++++.. ...++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 57889999999999999999864 88999998863 234568889999999999999999998875 4689999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
++++|.+++... .+++..+..++.+++.||.|||+.++ +||||||+|||++.++.++|+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i---~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~ 171 (297)
T cd06656 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (297)
T ss_pred CCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEECCCCCEEECcCccceEccCCcc-C
Confidence 999999998743 47899999999999999999999998 9999999999999999999999999876533221 1
Q ss_pred ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 644 HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
.....+++.|+|||.+.+..++.++|+|||||++|+|++|..||....... ... ..... .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~-------~~~-~~~~~------------~ 231 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALY-LIATN------------G 231 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch-------hee-eeccC------------C
Confidence 223467889999999998899999999999999999999999996432210 000 00000 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
......+......+.+++.+||+.+|++||++++++++=
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 270 (297)
T cd06656 232 TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHP 270 (297)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 000111233456688999999999999999999998843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=299.32 Aligned_cols=247 Identities=23% Similarity=0.419 Sum_probs=195.4
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh---hHHHHHHHHHHHHhcCCCCCcceEEEEe-cCeEEEEEEEe
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ---ASKEFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYI 563 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~lv~e~~ 563 (790)
+.|++.++||+|+||.||+|... +..+++|.+... ..+.+.+|+++++.++|+|++++++++. ++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999885 788999998643 3456888999999999999999999876 55689999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
++++|..++.... ..+++..+..++.|++.+|+|||++++ +||||||+||+++.++.+||+|||++....... ..
T Consensus 92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i---~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 166 (292)
T cd06644 92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKI---IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QR 166 (292)
T ss_pred CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCe---eecCCCcceEEEcCCCCEEEccCccceeccccc-cc
Confidence 9999998876543 358999999999999999999999998 999999999999999999999999987542211 11
Q ss_pred ccccccCCCccchhccc-----CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 644 HTRLVGTFGYMPPEYAQ-----YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
.....++..|+|||++. ...++.++|||||||++|||++|..||..... ............
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~~------ 232 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSEP------ 232 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--------HHHHHHHhcCCC------
Confidence 23356788999999984 34578899999999999999999999854321 111111111110
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
+.. ..+......+.+++.+||+.+|++||++++++++
T Consensus 233 ----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 233 ----PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ----ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 1122344568899999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=294.31 Aligned_cols=234 Identities=23% Similarity=0.379 Sum_probs=182.6
Q ss_pred eeeeecCceEEEEEEEC--------------CceEEEEEeChh---hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEE
Q 046083 496 NKIGQGGFGAVFYAELR--------------GEKAAIKKMDMQ---ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLF 557 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~--------------g~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~ 557 (790)
+.||+|+||.||+|.+. ...+++|.+... ....|.+|+.+++.++||||+++++++.+ ...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 46899999999999853 125888987643 23468889999999999999999999875 4589
Q ss_pred EEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCc-------EEEEEe
Q 046083 558 LVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFR-------AKVADF 630 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~-------~kl~Df 630 (790)
++|||+++++|..++.... ..+++..+++++.|++.||+|||+.++ +||||||+|||++.++. ++++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i---vH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDL---VHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCe---ECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999887543 358999999999999999999999998 99999999999987664 899999
Q ss_pred CCCcccccCCcccccccccCCCccchhccc-CCCCCchhhHHHHHHHHHHHH-hCCccccccccccccccchHHHHHHHH
Q 046083 631 GLAKLTEVGSASVHTRLVGTFGYMPPEYAQ-YGEVSPKIDVYAFGVVLYELI-SAMEAVVKTNETITESTGLVALFEEVL 708 (790)
Q Consensus 631 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwS~Gvvl~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~~ 708 (790)
|++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..|+...... . .....
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--------~-~~~~~ 222 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA--------E-KERFY 222 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh--------H-HHHHH
Confidence 998754321 2245788899999886 467899999999999999998 577776432110 0 00111
Q ss_pred cCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 709 RQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 709 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
.. ... ........+.+++.+||+.||.+||++.+|++.|
T Consensus 223 ~~-------------~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 223 EG-------------QCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred hc-------------Ccc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 10 000 0111235688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=309.46 Aligned_cols=264 Identities=21% Similarity=0.313 Sum_probs=192.6
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEEec
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIE 564 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~~~ 564 (790)
...+|++.+.||+|+||.||+|... ++.+|+|..... ....|+.++++++|+||+++++++.++ ..++||||+.
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 3467999999999999999999986 568999976533 235689999999999999999988754 5889999995
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccc
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH 644 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 644 (790)
++|.+++.... ..+++..+++++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++..... ...
T Consensus 141 -~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i---vHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~ 213 (357)
T PHA03209 141 -SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRI---IHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAF 213 (357)
T ss_pred -CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHEEECCCCCEEEecCccccccccC--ccc
Confidence 58888887543 368999999999999999999999998 99999999999999999999999999753221 122
Q ss_pred cccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCcccccccccccc--ccchHHHHHHHHcC----C------C
Q 046083 645 TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITE--STGLVALFEEVLRQ----P------D 712 (790)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~----~------~ 712 (790)
....||..|+|||++.+..++.++|||||||++|||+++..++......... ...........+.. + .
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 293 (357)
T PHA03209 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDP 293 (357)
T ss_pred ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCC
Confidence 3356899999999999999999999999999999999876665432221100 00000111111110 0 0
Q ss_pred ChhhhhhhcCCcC--CCCC-------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 713 PREDLQRLVDPRL--GDDY-------PIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 713 ~~~~l~~~~d~~l--~~~~-------~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.......+++... ...+ .......+.+++.+||+.||++|||++|++++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 294 GSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred ccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0001111111000 0000 01223456679999999999999999999875
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=300.42 Aligned_cols=247 Identities=23% Similarity=0.427 Sum_probs=199.0
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEe
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
.+|+..+.||.|+||.||+|... ++.+++|.+.. ...+.+.+|+++++.++|+|++++++++.+ ...++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46889999999999999999864 78999998853 234568899999999999999999998875 4589999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
++++|.+++... .+++.++..++.+++.||+|||++++ +|+||||+||+++.++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i---~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 171 (296)
T cd06655 99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQV---IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-K 171 (296)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEECCCCCEEEccCccchhcccccc-c
Confidence 999999998743 48999999999999999999999998 9999999999999999999999999876543221 1
Q ss_pred ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 644 HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
.....++..|+|||.+.+..++.++|||||||++|+|++|..||...... ........... +
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~--------~~~~~~~~~~~----------~ 233 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RALYLIATNGT----------P 233 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhcCC----------c
Confidence 22346788999999999888999999999999999999999998653321 00111111000 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.+ ..+......+.+++.+||..+|.+||++.+++.+=+
T Consensus 234 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~ 271 (296)
T cd06655 234 EL--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPF 271 (296)
T ss_pred cc--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 00 112234457889999999999999999999987544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=310.09 Aligned_cols=242 Identities=30% Similarity=0.467 Sum_probs=196.4
Q ss_pred cccceeeeecCceEEEEEEEC--CceEEEEEeCh------hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
|.-++.||.|+||.||.|+.. .+.||||++.- +...++..|+++|++++|||.+..-|++.. ...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 556789999999999999875 78899999963 233578999999999999999999999875 458999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
|-| +-.|++.-.. .++.+..+..|+.+.+.||+|||+++. ||||||+.||||.+.|.+||+|||.|....+
T Consensus 108 ClG-SAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~---IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---- 178 (948)
T KOG0577|consen 108 CLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNR---IHRDIKAGNILLSEPGLVKLADFGSASIMAP---- 178 (948)
T ss_pred Hhc-cHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhH---HhhhccccceEecCCCeeeeccccchhhcCc----
Confidence 965 7777776443 468899999999999999999999998 9999999999999999999999999987653
Q ss_pred cccccccCCCccchhccc---CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 643 VHTRLVGTFGYMPPEYAQ---YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
...++|||.|||||++. .+.|+-|.||||||++..||.-.++|+++.+.. ..++. +.....
T Consensus 179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-------SALYH-IAQNes------- 242 (948)
T KOG0577|consen 179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYH-IAQNES------- 242 (948)
T ss_pred -hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-------HHHHH-HHhcCC-------
Confidence 23578999999999884 568999999999999999999999998765431 11111 111111
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
|.|+ ..+-...|.+++..||+.-|.+|||.++++.+---
T Consensus 243 ---PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv 281 (948)
T KOG0577|consen 243 ---PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFV 281 (948)
T ss_pred ---CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchh
Confidence 2221 12345678999999999999999999998765443
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=296.93 Aligned_cols=247 Identities=23% Similarity=0.437 Sum_probs=184.4
Q ss_pred eeeeecCceEEEEEEEC----CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEEecCC
Q 046083 496 NKIGQGGFGAVFYAELR----GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENG 566 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~----g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~~~~g 566 (790)
+.||+|+||.||+|... ...+++|.+... ....+.+|++.++.++|+||+++++.+.+. ..++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 36899999999999753 346888877532 235688999999999999999999988754 589999999999
Q ss_pred ChhhhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc-
Q 046083 567 NLNQHLRGSGK---DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS- 642 (790)
Q Consensus 567 ~L~~~l~~~~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~- 642 (790)
+|.+++..... ...++...++++.|++.||+|||++++ +||||||+|||+++++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i---vH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADF---IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCE---ecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976432 335788889999999999999999997 99999999999999999999999998754322111
Q ss_pred cccccccCCCccchhcccC-------CCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 643 VHTRLVGTFGYMPPEYAQY-------GEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~-------~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
......++..|+|||++.. ..++.++|||||||++|||++ |..||...... ...........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--------~~~~~~~~~~~-- 227 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--------QVLKQVVREQD-- 227 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--------HHHHHHhhccC--
Confidence 1122345678999998743 356889999999999999999 67777543211 11111111110
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
..+.++.+ +......+.+++..|| .||++|||++||++.|+
T Consensus 228 ---~~~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 228 ---IKLPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ---ccCCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 01111211 2234456778888898 59999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=301.43 Aligned_cols=263 Identities=23% Similarity=0.362 Sum_probs=187.6
Q ss_pred ceeeeecCceEEEEEEEC----CceEEEEEeChhh-HHHHHHHHHHHHhcCCCCCcceEEEEec---CeEEEEEEEecCC
Q 046083 495 GNKIGQGGFGAVFYAELR----GEKAAIKKMDMQA-SKEFLAELKVLTHVHHLNLVRLIGYCVE---GSLFLVYEYIENG 566 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~----g~~vavK~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~---~~~~lv~e~~~~g 566 (790)
..+||+|+||.||+|... +..+|+|.++... ...+.+|++++++++||||+++++++.. ...+++|||+.+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 468999999999999864 4679999887543 3567889999999999999999998752 357999999875
Q ss_pred ChhhhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe----cCCCcEEEEEeCCCcc
Q 046083 567 NLNQHLRGS-------GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI----DKNFRAKVADFGLAKL 635 (790)
Q Consensus 567 ~L~~~l~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl----~~~~~~kl~DfGla~~ 635 (790)
+|.+++... ....+++..+..++.|++.||.|||+.++ +||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~i---vH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCE---EcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 787776421 12358899999999999999999999997 999999999999 5667999999999986
Q ss_pred cccCCcc--cccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccc-hHHHHHHHHcC-
Q 046083 636 TEVGSAS--VHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTG-LVALFEEVLRQ- 710 (790)
Q Consensus 636 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~-~~~~~~~~~~~- 710 (790)
....... ......+++.|+|||.+.+ ..++.++|||||||++|||+||++||............ ...........
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 5432221 1223568999999999876 45899999999999999999999999654322111000 00111111110
Q ss_pred -CCChhhhhhh------------cC-CcCC--------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 711 -PDPREDLQRL------------VD-PRLG--------DDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 711 -~~~~~~l~~~------------~d-~~l~--------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
......+..+ .. .... ..........+.+|+.+|++.||.+|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000000000 00 0000 00011123457889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=297.19 Aligned_cols=251 Identities=28% Similarity=0.466 Sum_probs=198.6
Q ss_pred HHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh--hHHHHHHHHHHHHhc-CCCCCcceEEEEecC-------
Q 046083 487 KATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ--ASKEFLAELKVLTHV-HHLNLVRLIGYCVEG------- 554 (790)
Q Consensus 487 ~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~------- 554 (790)
..+++|++.+.||+|+||.||+|... ++.+++|.+... ..+++.+|+++++++ +|+|++++++++.+.
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 35688999999999999999999985 678999988643 346789999999999 799999999988642
Q ss_pred eEEEEEEEecCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCC
Q 046083 555 SLFLVYEYIENGNLNQHLRGSG--KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGL 632 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGl 632 (790)
..++||||+++++|.+++.... ...+++..+..++.|++.||.|||++++ +|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i---~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKV---IHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCc---ccCCCCHHHEEEccCCeEEECCCcc
Confidence 2799999999999999987543 3568999999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCcccccccccCCCccchhcccC-----CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHH
Q 046083 633 AKLTEVGSASVHTRLVGTFGYMPPEYAQY-----GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEV 707 (790)
Q Consensus 633 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 707 (790)
+....... .......++..|+|||.+.. ..++.++||||||++++||++|+.||...... ......
T Consensus 160 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~ 230 (275)
T cd06608 160 SAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--------RALFKI 230 (275)
T ss_pred ceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--------HHHHHh
Confidence 87653222 12233568889999998753 34678999999999999999999998542211 111111
Q ss_pred HcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 708 LRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 708 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.... .+.+ ..+......+.+++.+||..||++|||+.+++++
T Consensus 231 ~~~~----------~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 231 PRNP----------PPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hccC----------CCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1110 0011 1122345678899999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=296.67 Aligned_cols=248 Identities=27% Similarity=0.453 Sum_probs=194.8
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh---hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEe
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ---ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
++|.+.+.||+|+||.||+|... ++.+++|.++.. ....+.+|+.+++.++||||+++++++.+ +..+++|||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46788899999999999999875 788999988643 33457889999999999999999998764 5689999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
++++|.+++...+ .+++.+++.++.+++.||.|||++++ +|+||||+||+++.++.++|+|||++....... ..
T Consensus 89 ~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06645 89 GGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATI-AK 162 (267)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cc
Confidence 9999999987654 58999999999999999999999998 999999999999999999999999987553221 11
Q ss_pred ccccccCCCccchhccc---CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 644 HTRLVGTFGYMPPEYAQ---YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~---~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
.....|+..|+|||++. ...++.++|+|||||++|||++|..||...... ..... .... ..
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~-------~~~~~-~~~~--------~~ 226 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-------RALFL-MTKS--------NF 226 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch-------hhHHh-hhcc--------CC
Confidence 23356889999999874 456889999999999999999999998543321 00000 0000 00
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
..+.... ....+..+.+++.+||+.+|++||++++|+++
T Consensus 227 ~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 227 QPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0011100 01233468899999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=292.14 Aligned_cols=249 Identities=26% Similarity=0.425 Sum_probs=199.0
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh---hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ---ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
.++|++.+.||+|+||.||+|... ++.+++|.+... ..+.+.+|++++++++|||++++++++.+ ...+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367899999999999999999875 678999988643 45678999999999999999999998764 458999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+++++|.+++.... ..+++..+..++.|++.||.|||++++ +|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i---~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 82 CGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGK---IHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCc---eecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 99999999987642 358999999999999999999999998 9999999999999999999999999876543221
Q ss_pred cccccccCCCccchhcccCC---CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 643 VHTRLVGTFGYMPPEYAQYG---EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~---~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
......++..|+|||.+... .++.++|+||||+++|||++|+.||....... . ....... .
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-------~-~~~~~~~--------~ 220 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-------A-LFLISKS--------N 220 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-------H-HHHHHhc--------c
Confidence 12235678899999999776 88999999999999999999999986533210 0 0000000 0
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVV 760 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 760 (790)
...+.+ ..+...+..+.+++.+||+.+|.+|||+.+|+.
T Consensus 221 ~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 221 FPPPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CCCccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000011 112344567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=292.04 Aligned_cols=243 Identities=26% Similarity=0.416 Sum_probs=196.2
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeCh--------hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM--------QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLV 559 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv 559 (790)
+|+..+.||+|+||.||+|... ++.+++|.+.. +..+.+.+|++++++++|+|++++++++.+ ...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677899999999999999885 78999998753 234678999999999999999999998875 458999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+++++|.+++.... .+++..+..++.+++.||+|||+.++ +|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRNT---VHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999997653 58899999999999999999999998 99999999999999999999999998865432
Q ss_pred CcccccccccCCCccchhcccCCC-CCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGE-VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
. ......++..|++||.+.... ++.++|+||||+++|+|++|+.||..... . ..........
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-------~-~~~~~~~~~~------- 218 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-------V-AAVFKIGRSK------- 218 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-------H-HHHHHHHhcc-------
Confidence 2 223456788999999987776 89999999999999999999999854321 0 0011111000
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.....+......+.+++.+||+.+|.+||++++++.+
T Consensus 219 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 219 ------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 0011223345678899999999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=294.52 Aligned_cols=247 Identities=24% Similarity=0.451 Sum_probs=194.9
Q ss_pred CcccceeeeecCceEEEEEEEC---CceEEEEEeCh-------------hhHHHHHHHHHHHHh-cCCCCCcceEEEEec
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR---GEKAAIKKMDM-------------QASKEFLAELKVLTH-VHHLNLVRLIGYCVE 553 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~---g~~vavK~~~~-------------~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~ 553 (790)
+|++.+.||+|+||.||+|... ++.+|+|.+.. ....++..|+.++.+ ++|||++++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4778899999999999999985 47899997642 123457778888865 799999999998874
Q ss_pred -CeEEEEEEEecCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCEEecCCCcEEEEE
Q 046083 554 -GSLFLVYEYIENGNLNQHLRGS--GKDTLTWSARMQIALDSARGLEYIHE-HTVPVYIHRDIKPANILIDKNFRAKVAD 629 (790)
Q Consensus 554 -~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~vH~dlkp~NILl~~~~~~kl~D 629 (790)
+..+++|||+++++|.+++... ....+++..+++++.+++.||.|||+ .++ +|+||+|+|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i---~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRI---VHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCce---eecCCCHHHEEECCCCcEEEec
Confidence 5689999999999999988542 23468999999999999999999996 566 9999999999999999999999
Q ss_pred eCCCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHc
Q 046083 630 FGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLR 709 (790)
Q Consensus 630 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 709 (790)
||++....... ......++..|++||.+.+..++.++|+||||+++|||++|+.||..... .........
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~--------~~~~~~~~~ 227 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM--------LSLATKIVE 227 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH--------HHHHHHHhh
Confidence 99998654332 23345688999999999988899999999999999999999999854321 111111111
Q ss_pred CCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 710 QPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 710 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
. .............+.+++.+||+.||++||++.|+.+++.
T Consensus 228 ~-------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 A-------------VYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred c-------------cCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1 1000001123457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=297.10 Aligned_cols=234 Identities=24% Similarity=0.426 Sum_probs=184.2
Q ss_pred eeeeecCceEEEEEEEC---------CceEEEEEeChh---hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 496 NKIGQGGFGAVFYAELR---------GEKAAIKKMDMQ---ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~---------g~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
+.||+|+||.||+|... ...+++|.+... ..+++.+|+.+++.++|||++++++++.. ...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 46899999999999764 224788877643 33568899999999999999999998875 568999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCc--------EEEEEeCCCc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFR--------AKVADFGLAK 634 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~--------~kl~DfGla~ 634 (790)
+++|+|.++++..+. .+++..+++++.|++.||+|||++++ +||||||+||+++.++. ++++|||++.
T Consensus 81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i---iH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKGL---THGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999986543 68999999999999999999999998 99999999999987765 6999999987
Q ss_pred ccccCCcccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCC-ccccccccccccccchHHHHHHHHcCCC
Q 046083 635 LTEVGSASVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAM-EAVVKTNETITESTGLVALFEEVLRQPD 712 (790)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (790)
.... .....++..|+|||++.+. .++.++||||||+++|||++|. .|+...... .. ......
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--------~~-~~~~~~-- 220 (258)
T cd05078 157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--------KK-LQFYED-- 220 (258)
T ss_pred ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--------HH-HHHHHc--
Confidence 5432 1224578899999999864 5799999999999999999995 444322110 00 001110
Q ss_pred ChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 713 PREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 713 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
....+.....++.+++.+||+.+|++|||++++++.|
T Consensus 221 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 221 -------------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -------------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0112223345789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=310.57 Aligned_cols=241 Identities=22% Similarity=0.398 Sum_probs=195.9
Q ss_pred ccceeeeecCceEEEEEEEC--CceEEEEEeC-------hhhHHHHHHHHHHHHhcCCCCCcceEEEEecC---eEEEEE
Q 046083 493 SMGNKIGQGGFGAVFYAELR--GEKAAIKKMD-------MQASKEFLAELKVLTHVHHLNLVRLIGYCVEG---SLFLVY 560 (790)
Q Consensus 493 ~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~---~~~lv~ 560 (790)
+....||+|.|-+||||.+. |-.||--.++ ....+.|..|+.+|+.|+|+||+++|.++.+. ...+|.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 44578999999999999886 5555532221 34457899999999999999999999988743 378999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC-CCcEEEEEeCCCcccccC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK-NFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~-~~~~kl~DfGla~~~~~~ 639 (790)
|.|..|+|+.|+.+.+ .++.+....+++||++||.|||++. |||+|||||.+||+|+. .|.+||+|+|||..+...
T Consensus 123 EL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999999865 4888999999999999999999988 89999999999999976 489999999999987543
Q ss_pred CcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
. ...+.|||.|||||+.. ..|++..||||||+.|+||+|+..|+..-. +-...+..+..... ...+.+
T Consensus 200 ~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-------n~AQIYKKV~SGiK-P~sl~k 267 (632)
T KOG0584|consen 200 H---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-------NPAQIYKKVTSGIK-PAALSK 267 (632)
T ss_pred c---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-------CHHHHHHHHHcCCC-HHHhhc
Confidence 3 23478999999999988 899999999999999999999999985432 23344444444322 233444
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
+-| .++.++|.+|+.. .++|||+.|++..
T Consensus 268 V~d------------Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 268 VKD------------PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred cCC------------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 333 3578999999999 9999999999873
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=299.47 Aligned_cols=262 Identities=25% Similarity=0.400 Sum_probs=196.9
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
++|++.+.||+|+||.||+|... ++.+|+|.++.. ....+.+|+.++++++||||+++++++.+ ...++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56889999999999999999875 788999988632 23467789999999999999999998874 458999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
++ ++|.+++.... ..+++..+..++.|++.||+|||++++ +|+||||+|||+++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i---~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 86 LD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKV---LHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCe---eCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 97 58999887643 358899999999999999999999998 9999999999999999999999999975432221
Q ss_pred cccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhc
Q 046083 643 VHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 721 (790)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... .........+..+. ...+..++
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~-----~~~~~~~~~~~~~~-~~~~~~~~ 233 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE-----EQLHFIFRILGTPT-EETWPGIL 233 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHcCCCC-hhhchhhh
Confidence 12234568899999988654 5788999999999999999999998654321 11111111111110 01111111
Q ss_pred C---------CcCCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 722 D---------PRLGDD----YPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 722 d---------~~l~~~----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
. +..... ........+.+|+.+|++.||.+|||++|++++-+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~ 288 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0 111000 01123456889999999999999999999987544
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=294.19 Aligned_cols=249 Identities=25% Similarity=0.470 Sum_probs=194.5
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChh-------------hHHHHHHHHHHHHhcCCCCCcceEEEEecC-
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-------------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG- 554 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-------------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~- 554 (790)
+|...+.||+|+||.||+|... ++.+|+|.++.. ..+.+.+|+.++++++|+|++++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677899999999999999864 789999987521 124578899999999999999999998754
Q ss_pred eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCc
Q 046083 555 SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK 634 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~ 634 (790)
..++||||+++++|.++++..+ .+++..+..++.+++.||.|||++++ +|+||+|+||+++.++.++|+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i---~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKGI---LHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCe---eecCCChhhEEEcCCCeEEEeeccccc
Confidence 5899999999999999998753 58999999999999999999999997 999999999999999999999999997
Q ss_pred ccccCCcc-cccccccCCCccchhcccCCC--CCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCC
Q 046083 635 LTEVGSAS-VHTRLVGTFGYMPPEYAQYGE--VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQP 711 (790)
Q Consensus 635 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (790)
........ ......++..|+|||.+.... ++.++|+||||+++|||++|..||..... ..... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~~~-~~~~~~ 228 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-------IAAMF-KLGNKR 228 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-------HHHHH-Hhhccc
Confidence 65322111 122346788999999987654 88999999999999999999999853221 11111 111000
Q ss_pred CChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 712 DPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 712 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
................+.+++.+||+.+|.+||++++|+++
T Consensus 229 ---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 ---------SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ---------cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00011111112345678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=292.71 Aligned_cols=245 Identities=28% Similarity=0.463 Sum_probs=197.9
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
+|++.+.||+|+||.||++... +..+|+|.+... ..+.+.+|++++++++|+|++++++.+.+ +..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788999999999999999986 788999998643 34568899999999999999999998875 458999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC-cEEEEEeCCCcccccCCc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF-RAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~-~~kl~DfGla~~~~~~~~ 641 (790)
+++++|.+++.......+++..+..++.+++.||.|||+.++ +|+||+|+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i---~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKI---LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM- 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCc---ccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence 999999999986555568999999999999999999999998 9999999999999885 46999999998654322
Q ss_pred ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhc
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 721 (790)
.......|++.|+|||.+....++.++|+||||+++|||++|..||.... ...........
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~----------- 217 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--------LHQLVLKICQG----------- 217 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHhcc-----------
Confidence 12223468889999999988889999999999999999999999985322 11122221111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 722 DPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 722 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.. ...+......+.+++.+||+.+|++|||+.|++.+
T Consensus 218 --~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 218 --YF-APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --cC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00 01112334578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=298.01 Aligned_cols=243 Identities=26% Similarity=0.454 Sum_probs=206.5
Q ss_pred cccceeeeecCceEEEEEEE--CCceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEe-cCeEEEEEEEe
Q 046083 492 FSMGNKIGQGGFGAVFYAEL--RGEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYI 563 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~--~g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~lv~e~~ 563 (790)
|.+.+.||+|.|..|-.|+. .|+.||||++... ....++.|++.|+-++|||||+||.+.. +..+|||+|.-
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 66678999999999999975 4999999998753 2346889999999999999999999876 45699999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe-cCCCcEEEEEeCCCcccccCCcc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI-DKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl-~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
++|+|++|+-+.. ..+.+....+++.||+.|+.|+|+..+ |||||||+||.+ ..-|-+||.|||++..+.++.
T Consensus 100 D~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHV---VHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~-- 173 (864)
T KOG4717|consen 100 DGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHV---VHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK-- 173 (864)
T ss_pred CCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhh---hcccCCcceeEEeeecCceEeeeccccccCCCcc--
Confidence 9999999997654 358999999999999999999999998 999999999755 667899999999998765443
Q ss_pred cccccccCCCccchhcccCCCCC-chhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhc
Q 046083 643 VHTRLVGTFGYMPPEYAQYGEVS-PKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s-~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 721 (790)
..+..+|+..|-|||.+.+..|+ ++.||||||||||-|++|++||...+.. +.+..++
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS---------------------ETLTmIm 232 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS---------------------ETLTMIM 232 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch---------------------hhhhhhh
Confidence 34567899999999999999886 5799999999999999999999765542 3344455
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 722 DPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 722 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
|-+. ..|.....+..+||..||..||.+|-+.+||+..-|
T Consensus 233 DCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 233 DCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred cccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 5443 446677888999999999999999999999987555
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=297.44 Aligned_cols=261 Identities=28% Similarity=0.435 Sum_probs=198.1
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYE 561 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e 561 (790)
++|++.+.||+|+||.||+|... ++.+++|.++.. ..+.+.+|++++++++|+||+++++++.+ +..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999886 778999987642 23568899999999999999999998875 45899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|++++.|..+.... ..+++..+..++.+++.||.|||+.++ +|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i---~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNI---IHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99987777666543 348999999999999999999999997 9999999999999999999999999987654433
Q ss_pred ccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh------
Q 046083 642 SVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR------ 714 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 714 (790)
.......++..|+|||++... .++.++||||||+++|||++|+.||...... +...............
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI-----DQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCCHHHhhhcc
Confidence 233345678899999999887 8899999999999999999999988643221 0000111111100000
Q ss_pred --hhhh--hhcCCc----CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046083 715 --EDLQ--RLVDPR----LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVV 760 (790)
Q Consensus 715 --~~l~--~~~d~~----l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 760 (790)
.... +..+.. ....++...+.++.+++.+||+.+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000 000000 000112223677999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=304.28 Aligned_cols=246 Identities=26% Similarity=0.433 Sum_probs=198.7
Q ss_pred cCcccceeeeecCceEEEEEEEC-CceEEEEEeCh-----hhHHHHHHHHHHHHhc-CCCCCcceEEEEe-cCeEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDM-----QASKEFLAELKVLTHV-HHLNLVRLIGYCV-EGSLFLVYE 561 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~-~~~~~lv~e 561 (790)
..|++.++||+||.+.||++... .+.+|+|++.. ....-|.+|+.+|.++ .|.+|++|++|.. ++.+|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 45888999999999999999886 56778877653 3445699999999999 5999999999986 667999999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|-+. +|..+|.........| .+..+..|++.++.++|.+++ ||.||||.|+|+-. |.+||+|||+|..+.....
T Consensus 441 ~Gd~-DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~gI---VHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 441 CGDI-DLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHGI---VHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred cccc-cHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhce---eecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 9765 9999999877666667 778899999999999999998 99999999998865 5899999999998766554
Q ss_pred ccc-cccccCCCccchhcccCC-----------CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHc
Q 046083 642 SVH-TRLVGTFGYMPPEYAQYG-----------EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLR 709 (790)
Q Consensus 642 ~~~-~~~~gt~~y~aPE~~~~~-----------~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 709 (790)
... ..-+||+.||+||.+... ..++++||||+|||||+|+.|+.||..... .
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n----------~------ 578 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN----------Q------ 578 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH----------H------
Confidence 433 346899999999988543 256899999999999999999999854211 1
Q ss_pred CCCChhhhhhhcCCcCCCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 710 QPDPREDLQRLVDPRLGDDYPI-DSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 710 ~~~~~~~l~~~~d~~l~~~~~~-~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
...+..+.+|...-+||. ....++.++|+.||+.||.+|||..|++++
T Consensus 579 ----~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 579 ----IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 124556666654444442 122338999999999999999999999874
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=294.27 Aligned_cols=249 Identities=25% Similarity=0.443 Sum_probs=194.4
Q ss_pred cccceeeeecCceEEEEEEEC-----CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-------
Q 046083 492 FSMGNKIGQGGFGAVFYAELR-----GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG------- 554 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~-----g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------- 554 (790)
|.+.+.||+|+||.||+|.+. +..+|||.+.. ...+++.+|++++++++|||++++++++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999863 57899998864 2345688999999999999999999987532
Q ss_pred eEEEEEEEecCCChhhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEe
Q 046083 555 SLFLVYEYIENGNLNQHLRGSG----KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADF 630 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~Df 630 (790)
..++++||+.+|+|.+++.... ...+++...++++.+++.||+|||+.++ +||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i---~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNF---IHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE---eecccchhhEEEcCCCCEEECcc
Confidence 1478999999999998875321 2357899999999999999999999997 99999999999999999999999
Q ss_pred CCCcccccCCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHH
Q 046083 631 GLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVL 708 (790)
Q Consensus 631 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 708 (790)
|+++........ ......+++.|++||.+....++.++||||||+++|||++ |+.||..... ........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~ 229 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--------SEIYNYLI 229 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--------HHHHHHHH
Confidence 999865432211 1112334678999999998889999999999999999999 7888754321 11111111
Q ss_pred cCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 709 RQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 709 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
.... ...+......+.+++.+||+.+|++||++.|+++.|..+
T Consensus 230 ~~~~--------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 KGNR--------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCCc--------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1100 011123446799999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=292.92 Aligned_cols=251 Identities=27% Similarity=0.436 Sum_probs=200.6
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
++|++.+.||.|+||.||+|... +..+++|++.. .....+.+|++.++.++|+|++++++.+.+ ...+++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999874 77899998863 234678999999999999999999997764 458999999
Q ss_pred ecCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 563 IENGNLNQHLRGSGK-DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
+++++|.++++.... ..+++.....++.|++.||+|||+.++ +|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i---~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976432 468999999999999999999999998 9999999999999999999999999876644322
Q ss_pred c---cccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 642 S---VHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 642 ~---~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
. ......|+..|+|||.+... .++.++|+||||+++|||++|+.||...... ...........
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~----- 224 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--------KVLMLTLQNDP----- 224 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--------hhHHHHhcCCC-----
Confidence 2 12334688999999998877 7899999999999999999999998643221 11111111110
Q ss_pred hhhcCCcCCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 718 QRLVDPRLGDDY-PIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 718 ~~~~d~~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
+.+.... ....+..+.+++.+||+.||++||++++++++
T Consensus 225 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 225 -----PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred -----CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1111111 12345678999999999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=297.15 Aligned_cols=250 Identities=24% Similarity=0.433 Sum_probs=198.7
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
.++|++.+.||.|+||.||++... +..+++|.... ...+.+..|++++++++|+|++++++++.+ ...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356889999999999999999885 78899998864 334578899999999999999999998874 458999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+++++|.+++...+ ..+++..+.+++.|++.||.|||+.++ +|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i---~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 84 CDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKV---IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred cCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 99999999987643 358999999999999999999999998 9999999999999999999999999875432221
Q ss_pred cccccccCCCccchhccc-----CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 643 VHTRLVGTFGYMPPEYAQ-----YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
......+++.|++||.+. ...++.++|+||||+++|||++|+.||..... ......+.....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~----- 225 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP--------MRVLLKILKSEP----- 225 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH--------HHHHHHHhcCCC-----
Confidence 122356889999999875 34578899999999999999999999864321 111111111100
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
+.+ ..+......+.+++.+||+.+|.+||++++++++-+
T Consensus 226 -----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (280)
T cd06611 226 -----PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF 264 (280)
T ss_pred -----CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChh
Confidence 011 112234457889999999999999999999988644
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=298.82 Aligned_cols=259 Identities=24% Similarity=0.379 Sum_probs=199.4
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
++|++.+.||+|+||.||++... ++.+++|.++.. ..+.+.+|+++++.++||||+++++.+.. +..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47889999999999999999886 678999988643 23467889999999999999999998764 4589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++++|.+++...+ .+++..+..++.+++.||.|||++++ +||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYGI---VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999997653 58999999999999999999999998 999999999999999999999999987421110
Q ss_pred c--------------ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHH
Q 046083 641 A--------------SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEE 706 (790)
Q Consensus 641 ~--------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 706 (790)
. .......++..|+|||.+.+..++.++|+||||+++|||++|..||..... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~--------~~~~~~ 227 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--------EELFGQ 227 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH
Confidence 0 001123578899999999888999999999999999999999999853221 111111
Q ss_pred HHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccCC
Q 046083 707 VLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWD 773 (790)
Q Consensus 707 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~~ 773 (790)
..... ...+.. +...+..+.+++.+||+.+|++||++.++.+.|...-....+|+
T Consensus 228 ~~~~~--------~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~ 282 (305)
T cd05609 228 VISDD--------IEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWN 282 (305)
T ss_pred HHhcc--------cCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHH
Confidence 11110 000111 11234568899999999999999997666665555333334443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=291.16 Aligned_cols=246 Identities=30% Similarity=0.490 Sum_probs=195.8
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
+|...+.||+|+||.||+|... +..+++|.++.. ..+.+.+|++++++++|+||+++++++.+ ...++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999874 788999988632 45678999999999999999999998765 458999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+++++|.+++.... .+++..+..++.+++.||.|||+.++ +|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i---~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHGI---VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999998643 47899999999999999999999998 99999999999999999999999999876433322
Q ss_pred ccc---ccccCCCccchhcccCCC---CCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhh
Q 046083 643 VHT---RLVGTFGYMPPEYAQYGE---VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716 (790)
Q Consensus 643 ~~~---~~~gt~~y~aPE~~~~~~---~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (790)
... ...++..|++||++.... .+.++||||||+++|||++|+.||...... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~------ 222 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-------FQIMFHVGAG------ 222 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-------HHHHHHHhcC------
Confidence 211 346788999999998766 889999999999999999999998643211 0000000000
Q ss_pred hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046083 717 LQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVV 760 (790)
Q Consensus 717 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 760 (790)
..+.+.. .......+.+++.+||+.+|.+|||+++++.
T Consensus 223 ----~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 ----HKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ----CCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0011100 1122556789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=285.71 Aligned_cols=260 Identities=24% Similarity=0.359 Sum_probs=211.0
Q ss_pred CHHHHHHHhcCcccceeeeecCceEEEEEEECC-------ceEEEEEeChhh----HHHHHHHHHHHHhcCCCCCcceEE
Q 046083 481 SYEELAKATNDFSMGNKIGQGGFGAVFYAELRG-------EKAAIKKMDMQA----SKEFLAELKVLTHVHHLNLVRLIG 549 (790)
Q Consensus 481 ~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~g-------~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~g 549 (790)
...++.....+++....+-+|.||.||+|.|.. +.+.+|.++... ...+..|..++..+.|||+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 456777777889999999999999999997752 345666665432 245788888999999999999999
Q ss_pred EEecC--eEEEEEEEecCCChhhhhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC
Q 046083 550 YCVEG--SLFLVYEYIENGNLNQHLRG------SGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK 621 (790)
Q Consensus 550 ~~~~~--~~~lv~e~~~~g~L~~~l~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~ 621 (790)
++.+. ..+++|.++.-|+|..||.. ...+.++-.+...++.|++.|++|||++++ ||.||..+|+++|+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~V---iHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGV---IHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCc---ccchhhhhcceehh
Confidence 98754 37999999999999999982 234568888899999999999999999998 99999999999999
Q ss_pred CCcEEEEEeCCCcccccCCcccc-cccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccc
Q 046083 622 NFRAKVADFGLAKLTEVGSASVH-TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTG 699 (790)
Q Consensus 622 ~~~~kl~DfGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~ 699 (790)
..++||+|-.+++.+.+.+.... .....+..||+||.+.+..|+..+|||||||+||||+| |+.|+...++.
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf------ 505 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF------ 505 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH------
Confidence 99999999999997765544322 22345678999999999999999999999999999997 88887654331
Q ss_pred hHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 700 LVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 700 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
.....+....+-.-|.+++.++..+|..||..+|++||++++++.-|++.
T Consensus 506 ----------------Em~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 506 ----------------EMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred ----------------HHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 11222222222333667889999999999999999999999999988865
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=293.03 Aligned_cols=248 Identities=24% Similarity=0.453 Sum_probs=197.6
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChh---------hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ---------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFL 558 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~l 558 (790)
+|+..+.||+|+||.||++... ++.+|+|.+... ..+.+.+|++++++++|+|++++++++.++ ..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4778899999999999999874 789999988632 246789999999999999999999998754 5899
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC-cEEEEEeCCCcccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF-RAKVADFGLAKLTE 637 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~-~~kl~DfGla~~~~ 637 (790)
||||+++++|.+++.... .+++..+..++.|++.||.|||++++ +|+||+|+||+++.++ .+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~i---~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQI---IHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999997643 58899999999999999999999998 9999999999998776 59999999997664
Q ss_pred cCCcc---cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 638 VGSAS---VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 638 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
..... ......++..|+|||.+.+..++.++|+||||++++||++|..||...... .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~--------- 221 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS-----NHLALIF--------- 221 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc-----chHHHHH---------
Confidence 32111 112346788999999998888999999999999999999999998543211 1111111
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
+..........+......+.+++.+|++.+|++||++.|++.+
T Consensus 222 ----~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 222 ----KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ----HHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 1111111123344556778999999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=296.12 Aligned_cols=261 Identities=27% Similarity=0.426 Sum_probs=197.4
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEY 562 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~ 562 (790)
+|++.+.||+|+||.||+|... ++.+++|.+... ..+.+.+|+.++++++|||++++++++.++ ..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788999999999999999975 789999998643 246789999999999999999999988754 58999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+ +++|.+++.... ..+++..++.++.+++.||+|||++++ +|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGI---MHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9 999999987654 469999999999999999999999997 99999999999999999999999999866543322
Q ss_pred cccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh-------
Q 046083 643 VHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR------- 714 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 714 (790)
......++..|+|||.+.+. .++.++||||||++++||++|.++|...... ............+...
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-----EQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-----HHHHHHHHHcCCCChHHHhhccC
Confidence 22335688899999998654 4689999999999999999997777543211 0111111111111000
Q ss_pred -hhhhhhcCCcCC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 715 -EDLQRLVDPRLG----DDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 715 -~~l~~~~d~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
........+... .....+....+.+++.+|++.+|++|||+++++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000000 00011334788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=293.66 Aligned_cols=256 Identities=25% Similarity=0.396 Sum_probs=200.4
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEec---CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVE---GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~---~~~~lv~ 560 (790)
++|+..+.||.|++|.||++... ++.+|+|.+... ...++.+|++++++++||||+++++++.+ +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999985 788999988642 34668999999999999999999998863 2489999
Q ss_pred EEecCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 561 EYIENGNLNQHLRGS--GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 561 e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
||+++++|.+++... ....+++.....++.+++.||.|||+.++ +|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i---~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKI---IHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999987642 23458899999999999999999999998 9999999999999999999999999875432
Q ss_pred CCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 639 GSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
.. .....++..|+|||.+.+..++.++||||||+++|||++|..||....... ...............
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~------ 225 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP---LGPIELLSYIVNMPN------ 225 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC---CChHHHHHHHhcCCc------
Confidence 21 123457889999999998999999999999999999999999987543210 111112222221110
Q ss_pred hhcCCcCCCCCC--HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 719 RLVDPRLGDDYP--IDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 719 ~~~d~~l~~~~~--~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
+.+....+ ......+.+++.+||+.+|++|||+.|++.+-+-
T Consensus 226 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~ 269 (287)
T cd06621 226 ----PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269 (287)
T ss_pred ----hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence 01100101 1234678999999999999999999999985543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=300.51 Aligned_cols=260 Identities=26% Similarity=0.376 Sum_probs=195.4
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChhh--------HHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA--------SKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLV 559 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv 559 (790)
+|++.+.||+|+||.||+|... ++.+++|.+.... ...+..|++++++++|+||+++++++.+ ...++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999875 7899999986432 2356789999999999999999998875 458999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+ +++|.+++.... ..+++..++.++.|+++||.|||++++ +|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i---~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWI---LHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCe---eecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 889999998654 369999999999999999999999998 99999999999999999999999999865432
Q ss_pred CcccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh----
Q 046083 640 SASVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR---- 714 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 714 (790)
.. ......++..|+|||.+.+ ..++.++|||||||++|||++|.++|...... ..+..... ....+...
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~ 229 (298)
T cd07841 156 NR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI----DQLGKIFE-ALGTPTEENWPG 229 (298)
T ss_pred Cc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH----HHHHHHHH-HcCCCchhhhhh
Confidence 21 1223356788999998864 46789999999999999999997776543221 00111111 11110000
Q ss_pred -hhhhhhcCCcCCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 715 -EDLQRLVDPRLGDDY-----PIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 715 -~~l~~~~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
..+............ .......+.+++.+||+.+|++|||++|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000011110000111 12335678899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=292.62 Aligned_cols=241 Identities=24% Similarity=0.420 Sum_probs=195.3
Q ss_pred cccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEEec
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIE 564 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~~~ 564 (790)
|+..+.||+|+||.||+|... +..+|+|..... ..+.+.+|++++.+++|||++++++++.++ ..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 667889999999999999874 789999987632 335688999999999999999999988754 5899999999
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccc
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH 644 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 644 (790)
+++|.+++... .+++..+..++.+++.++.|||+.++ +|+||+|+||+++.++.++|+|||++........ ..
T Consensus 86 ~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i---~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06641 86 GGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred CCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCe---ecCCCCHHhEEECCCCCEEEeecccceecccchh-hh
Confidence 99999998743 58999999999999999999999998 9999999999999999999999999876543221 12
Q ss_pred cccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCc
Q 046083 645 TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724 (790)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 724 (790)
....++..|+|||.+.+..++.++|+|||||++|||++|..|+...... ..........
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~------------- 217 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--------KVLFLIPKNN------------- 217 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--------HHHHHHhcCC-------------
Confidence 2346788999999999888999999999999999999999998542210 1111111100
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 725 LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 725 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
....+...+..+.+++.+||+.+|.+||++.+++++
T Consensus 218 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 218 -PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 011222345678899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=294.02 Aligned_cols=261 Identities=29% Similarity=0.411 Sum_probs=195.9
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYE 561 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e 561 (790)
++|+..+.||+|+||.||+|... ++.+|+|++... ..+.+.+|++++++++|+|++++++++..+ ..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999986 789999987532 235678999999999999999999988754 5899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|++++.|..++.... .+++..++.++.|++.||.|||+.++ +|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~i---~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHNC---IHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCc---eecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999998888776533 58999999999999999999999998 9999999999999999999999999986643321
Q ss_pred ccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC-------
Q 046083 642 SVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP------- 713 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 713 (790)
......++..|+|||.+.+ ..++.++||||||+++|||++|..||....... ... ...........
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD----QLY-LIRKTLGDLIPRHQQIFS 229 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH----HHH-HHHHHhCCCChHHhhhcc
Confidence 1223457789999999876 457899999999999999999999986433210 000 01111100000
Q ss_pred -hhhhhhhcCCcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 714 -REDLQRLVDPRLGDDYP-----IDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 714 -~~~l~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.........+......+ ......+.+++.+||+.+|++||++.|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000000111000001 1234678899999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=292.97 Aligned_cols=248 Identities=28% Similarity=0.487 Sum_probs=199.3
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEe-cCeEEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEY 562 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~lv~e~ 562 (790)
++|+..+.||+|+||.||++... ++.+++|.+... ..+++.+|++++++++||||+++++++. +...++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999986 788999987642 3456889999999999999999999876 4568999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE-HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
+++++|.+++.... ..+++....+++.+++.||+|||+ .++ +|+||||+||++++++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i---~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKI---IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCe---ecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99999999998653 468999999999999999999999 887 9999999999999999999999999875532211
Q ss_pred ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhc
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 721 (790)
....++..|+|||.+.+..++.++||||||+++|+|++|..||....... ...............
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~--------- 221 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP---DGIFELLQYIVNEPP--------- 221 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc---ccHHHHHHHHhcCCC---------
Confidence 12567889999999999999999999999999999999999986543211 111112222221110
Q ss_pred CCcCCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 722 DPRLGDDYPID-SVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 722 d~~l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
...+.. ....+.+++.+||..+|++|||+.+++.+
T Consensus 222 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 222 -----PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -----CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 111111 45678899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=300.12 Aligned_cols=261 Identities=26% Similarity=0.394 Sum_probs=195.9
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYE 561 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e 561 (790)
++|+..+.||+|+||.||+|.+. ++.+|+|.+... ..+.+.+|+++++.++||||+++++++.+ +..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999985 789999987532 23568899999999999999999998875 45899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|+++++|.++..... .+++..++.++.+++.||+|||+.++ +|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i---~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHNI---IHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 999999988776533 48999999999999999999999998 999999999999999999999999988654332
Q ss_pred ccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh------
Q 046083 642 SVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR------ 714 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 714 (790)
.......++..|+|||++.+ ..++.++||||||+++|||++|.+||...... ..... ...........
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI----DQLYH-IIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH----HHHHH-HHHHhCCCchhhHHHhc
Confidence 22233567889999999875 35788999999999999999999888543210 00000 01111100000
Q ss_pred --hhhhhhcCCcCCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 715 --EDLQRLVDPRLGDD-----YPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 715 --~~l~~~~d~~l~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.....+..+..... .....+..+.+++.+||+.+|++||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000001111000 011345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=295.76 Aligned_cols=240 Identities=28% Similarity=0.471 Sum_probs=197.1
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~ 560 (790)
++|++.+.||+|+||.||++... ++.+|+|.+... ..+.+.+|++++++++||||+++++++.++ ..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47889999999999999999885 789999988642 345688999999999999999999988754 589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++++|.+++.... .+++..+..++.|++.||.|||+.++ +|+||+|+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~i---~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLDI---VYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCE---ecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999999997653 58999999999999999999999997 99999999999999999999999999865432
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
.....+++.|+|||.+.+...+.++|+||||+++|||++|+.||..... ..........
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~---------- 213 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKILEG---------- 213 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcC----------
Confidence 2334688999999999888899999999999999999999999854321 1111111111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRP-----SMRAIVVA 761 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 761 (790)
. ...+......+.+++.+||+.+|.+|| +++|++.+
T Consensus 214 ---~--~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 214 ---K--VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ---C--ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 0 112223346788999999999999999 77777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=288.36 Aligned_cols=247 Identities=29% Similarity=0.485 Sum_probs=202.8
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
++|++.+.||+|++|.||+|... ++.+++|++... ..+.+.+|++.+.+++|+|++++++++.. ...+++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888999999999999999886 789999998754 35679999999999999999999998875 468999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE-HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
+++++|.+++... ..+++..+++++.++++||+|||+ .++ +|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~---~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHI---IHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCC---ccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999865 458999999999999999999999 998 9999999999999999999999999986643222
Q ss_pred ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhc
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 721 (790)
. .....++..|+|||.+....++.++|+||||+++|||++|+.||..... .........+....
T Consensus 156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~~---------- 219 (264)
T cd06623 156 Q-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAICDGP---------- 219 (264)
T ss_pred c-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHhcCC----------
Confidence 1 1234678899999999988999999999999999999999999865432 01122222222111
Q ss_pred CCcCCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 722 DPRLGDDYPID-SVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 722 d~~l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
....+.. .+..+.+++.+||+.+|++||++.|++++
T Consensus 220 ----~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 220 ----PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ----CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0111222 45679999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=290.55 Aligned_cols=247 Identities=22% Similarity=0.421 Sum_probs=183.9
Q ss_pred eeeeecCceEEEEEEEC-C---ceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEEecCC
Q 046083 496 NKIGQGGFGAVFYAELR-G---EKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENG 566 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~-g---~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~~~~g 566 (790)
+.||+|+||.||++... + ..+++|.++. ...+.+.+|+.+++.++||||+++++++.+. ..++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999754 2 3466776653 2346789999999999999999999998754 489999999999
Q ss_pred ChhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC-ccc
Q 046083 567 NLNQHLRGSG--KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS-ASV 643 (790)
Q Consensus 567 ~L~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~-~~~ 643 (790)
+|.++++... ...+++..+..++.|+++||+|||+.++ +||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i---~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNF---LHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCe---eccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999997642 2346777888999999999999999997 999999999999999999999999986432111 111
Q ss_pred ccccccCCCccchhcccC-------CCCCchhhHHHHHHHHHHHHhC-CccccccccccccccchHHHHHHHHcCCCChh
Q 046083 644 HTRLVGTFGYMPPEYAQY-------GEVSPKIDVYAFGVVLYELISA-MEAVVKTNETITESTGLVALFEEVLRQPDPRE 715 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~-------~~~s~~sDvwS~Gvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (790)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..||..... ......++....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~~~~~~~~--- 226 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--------REVLNHVIKDQQ--- 226 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHhhcc---
Confidence 223567889999998753 2457899999999999999974 556643211 112222222111
Q ss_pred hhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 716 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
..+.++.+.. .....+.+++..|| .+|++||++++|++.|.
T Consensus 227 --~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 227 --VKLFKPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred --cccCCCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1122233222 23356788999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=293.42 Aligned_cols=247 Identities=24% Similarity=0.409 Sum_probs=189.5
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHH-HHhcCCCCCcceEEEEec-CeEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKV-LTHVHHLNLVRLIGYCVE-GSLFLVYE 561 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~-l~~l~h~niv~l~g~~~~-~~~~lv~e 561 (790)
++|++.+.||+|+||.||++... ++.+|+|+++.. ...++..|+.. ++..+|||++++++++.. +..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47899999999999999999986 889999988642 23345566665 566689999999998874 56899999
Q ss_pred EecCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 562 YIENGNLNQHLRGS--GKDTLTWSARMQIALDSARGLEYIHEH-TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 562 ~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
|++ |+|.+++... ....+++..++.++.|++.||+|||++ ++ +||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i---~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSV---IHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCe---ecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 5888887642 234689999999999999999999997 76 9999999999999999999999999986532
Q ss_pred CCcccccccccCCCccchhcccC----CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 639 GSASVHTRLVGTFGYMPPEYAQY----GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
.. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||...... . ..........
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~~--- 224 (283)
T cd06617 157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP------F-QQLKQVVEEP--- 224 (283)
T ss_pred cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC------H-HHHHHHHhcC---
Confidence 11 1223457889999998864 45688999999999999999999998542211 0 0111111110
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
.+.+. ....+..+.+++.+||+.+|.+||++++++++-
T Consensus 225 -------~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 262 (283)
T cd06617 225 -------SPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHP 262 (283)
T ss_pred -------CCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 01110 112346789999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=304.09 Aligned_cols=257 Identities=23% Similarity=0.371 Sum_probs=194.1
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEec-------
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVE------- 553 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~------- 553 (790)
..++|.+.+.||+|+||.||+|... ++.+|||++... ..+.+.+|++++++++||||+++++++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999875 778999998642 23557789999999999999999987642
Q ss_pred CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCC
Q 046083 554 GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLA 633 (790)
Q Consensus 554 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla 633 (790)
...++++|++ +++|.+++.. ..+++..+..++.|++.||.|||++++ +||||||+|||+++++.+||+|||++
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~i---vHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGI---IHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCe---ecccCChhhEEECCCCCEEEcCCccc
Confidence 2368999988 6799888764 358999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCcccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC
Q 046083 634 KLTEVGSASVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD 712 (790)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (790)
+..... .....|++.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..............
T Consensus 166 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~ 236 (343)
T cd07878 166 RQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-----DQLKRIMEVVGTPS 236 (343)
T ss_pred eecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHHHhCCCC
Confidence 865422 233568999999999876 56899999999999999999999998543211 00011111111110
Q ss_pred Chhhh--------hhhcCCcCCCCCC--------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 713 PREDL--------QRLVDPRLGDDYP--------IDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 713 ~~~~l--------~~~~d~~l~~~~~--------~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.+.+ ...+. .+. ..+ ......+.+++.+|++.||.+|||+.|++++-+
T Consensus 237 -~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~ 300 (343)
T cd07878 237 -PEVLKKISSEHARKYIQ-SLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300 (343)
T ss_pred -HHHHHhcchhhHHHHhh-ccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 0000 00000 000 000 012235789999999999999999999998644
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=291.81 Aligned_cols=245 Identities=26% Similarity=0.458 Sum_probs=195.3
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHHHHHhcC---CCCCcceEEEEecC-eEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHVH---HLNLVRLIGYCVEG-SLFLVY 560 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~-~~~lv~ 560 (790)
.|+..+.||+|+||.||+|... +..+++|.++. ...+++.+|++++++++ |||++++++++.++ ..+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4777899999999999999975 78999998753 33466888999999996 99999999988754 589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++++|.++++.. .+++...+.++.+++.||.|||+.++ +|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i---~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGV---IHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999998753 58999999999999999999999998 999999999999999999999999998664433
Q ss_pred cccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
. ......|+..|+|||.+..+ .++.++|+||||+++|+|++|..||...... ...... ..
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--------~~~~~~----------~~ 216 (277)
T cd06917 156 S-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF--------RAMMLI----------PK 216 (277)
T ss_pred c-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh--------hhhhcc----------cc
Confidence 2 12334688899999998754 4689999999999999999999998543211 000000 00
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
...+.+... .....+.+++.+||+.||++||++.|++.+-+
T Consensus 217 ~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~ 257 (277)
T cd06917 217 SKPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKSKW 257 (277)
T ss_pred CCCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhChH
Confidence 011111111 13457889999999999999999999987543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=293.90 Aligned_cols=249 Identities=22% Similarity=0.446 Sum_probs=196.7
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEe-cCeEEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEY 562 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~lv~e~ 562 (790)
++|++.+.||+|+||.||++... +..+|+|.+.. .....+.+|++++++++|+||+++++++. ++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999986 88999998753 22457889999999999999999999776 4568999999
Q ss_pred ecCCChhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 563 IENGNLNQHLRGSG-KDTLTWSARMQIALDSARGLEYIHEH-TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 563 ~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
+++++|.+++.... ...+++..+..++.+++.||.|||+. ++ +|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i---~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI---IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCE---eeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999987632 23689999999999999999999974 66 99999999999999999999999998755322
Q ss_pred cccccccccCCCccchhcccCCC------CCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGE------VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~------~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
......++..|+|||.+.+.. ++.++|+|||||++|||++|+.||...... .......
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~--------- 220 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-----NIFAQLS--------- 220 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-----hHHHHHH---------
Confidence 122345788999999985543 588999999999999999999998542210 1111111
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
...+.. ....+......+.+++.+||+.+|++||++++++.+-+
T Consensus 221 ----~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 221 ----AIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred ----HHhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 111111 11223345667889999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=305.91 Aligned_cols=236 Identities=22% Similarity=0.345 Sum_probs=183.0
Q ss_pred eeecCceEEEEEEEC--CceEEEEEeChhh------HHHHHHHHHHHHhc---CCCCCcceEEEEec-CeEEEEEEEecC
Q 046083 498 IGQGGFGAVFYAELR--GEKAAIKKMDMQA------SKEFLAELKVLTHV---HHLNLVRLIGYCVE-GSLFLVYEYIEN 565 (790)
Q Consensus 498 lG~G~fg~Vy~a~~~--g~~vavK~~~~~~------~~~~~~E~~~l~~l---~h~niv~l~g~~~~-~~~~lv~e~~~~ 565 (790)
||+|+||.||+|+.. ++.+|+|++.... ...+..|..++... +||||+++++++.+ ...|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999876 7899999986422 22345566777665 69999999998774 458999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
|+|.+++...+ .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~i---vHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~ 154 (330)
T cd05586 81 GELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYDI---VYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTN 154 (330)
T ss_pred ChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCcc
Confidence 99999987643 58999999999999999999999998 999999999999999999999999987532221 1223
Q ss_pred ccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCc
Q 046083 646 RLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 724 (790)
...||+.|+|||.+.+. .++.++|||||||++|||++|+.||..... ......+.... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~-----------~~ 215 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--------QQMYRNIAFGK-----------VR 215 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH--------HHHHHHHHcCC-----------CC
Confidence 45789999999998754 479999999999999999999999854321 11112211110 00
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCC----CHHHHHHH
Q 046083 725 LGDDYPIDSVRKMARLARACTQENPQLRP----SMRAIVVA 761 (790)
Q Consensus 725 l~~~~~~~~~~~l~~li~~Cl~~dP~~RP----t~~evl~~ 761 (790)
+.. ......+.+++.+||+.||.+|| ++.+++++
T Consensus 216 ~~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 216 FPK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CCC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 100 11345678999999999999998 56666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=295.14 Aligned_cols=244 Identities=30% Similarity=0.456 Sum_probs=193.5
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh------hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
+.|...+.||+|+||.||+|... ++.+++|.+.. +..+++.+|+++++.++|||++++++++.+ ...++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45788899999999999999875 78999998752 223568899999999999999999999875 4589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+. |+|.+++.... ..+++..+..++.|++.||.|||+.++ +|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i---~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCc---eecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 9997 57777776433 358999999999999999999999998 99999999999999999999999998765322
Q ss_pred cccccccccCCCccchhccc---CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQ---YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
....++..|+|||.+. ...++.++||||||+++|||++|..||...... ...........
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~--------~~~~~~~~~~~----- 231 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNDS----- 231 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH--------HHHHHHhcCCC-----
Confidence 2345788999999874 456889999999999999999999998543221 00111111000
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
+.+ .+......+.+++.+||+.+|++||++.+|+.+.+.
T Consensus 232 -----~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 270 (307)
T cd06607 232 -----PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFV 270 (307)
T ss_pred -----CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 011 112345678999999999999999999999986553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=296.65 Aligned_cols=261 Identities=27% Similarity=0.378 Sum_probs=193.0
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
+|++.+.||+|+||.||+|... |+.+++|.++.. ....+.+|++++++++|+|++++++++.+ ...++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999985 889999988642 22457889999999999999999998764 458999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+++ +|.+++.... ..+++..++.++.|+++||.|||+.++ +|+||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i---~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 81 CDQ-DLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNV---LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCE---ecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 975 8888876543 358999999999999999999999997 99999999999999999999999999865432221
Q ss_pred cccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh--hhhhh
Q 046083 643 VHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR--EDLQR 719 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~ 719 (790)
.....++..|+|||.+.+. .++.++|||||||++|||++|..|+....... ................ ..+..
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 156 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD----DQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred -cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH----HHHHHHHHHhCCCChHHhHHhhh
Confidence 2234568899999998764 47899999999999999999998865432210 0000011111110000 00001
Q ss_pred hcCCc----CCC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 720 LVDPR----LGD-----DYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 720 ~~d~~----l~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
..+.. ... ........++.+++.+||+.||.+|||++|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 11100 000 0111244678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=297.74 Aligned_cols=245 Identities=24% Similarity=0.416 Sum_probs=194.1
Q ss_pred cccceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecC
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIEN 565 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~ 565 (790)
|.....||+|+||.||++... +..+|||.+.. ...+.+.+|+.+++.++|+|++++++.+.. +..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 334567999999999999875 78999998864 334568899999999999999999988764 458999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
++|.+++... .+++..+..++.+++.||+|||++++ +||||||+||++++++.++|+|||++........ ...
T Consensus 104 ~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~i---vH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 176 (292)
T cd06658 104 GALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGV---IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRK 176 (292)
T ss_pred CcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCE---eecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCc
Confidence 9999988642 48899999999999999999999997 9999999999999999999999999875432221 122
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
...|+..|+|||.+.+..++.++||||||+++|||++|..||...... .....+ ...+.+.+
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~~----------~~~~~~~~ 238 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--------QAMRRI----------RDNLPPRV 238 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHH----------HhcCCCcc
Confidence 356889999999998888999999999999999999999998643210 111111 11111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.. .......+.+++.+||+.||.+|||++|++++-.
T Consensus 239 ~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~ 274 (292)
T cd06658 239 KD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQHPF 274 (292)
T ss_pred cc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 11 1123456889999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=293.01 Aligned_cols=260 Identities=26% Similarity=0.428 Sum_probs=194.5
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEY 562 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~ 562 (790)
+|+..+.||.|+||.||+|... +..++||.++.. ....+.+|++++++++||||+++++++.++ ..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5788999999999999999875 789999988642 224688999999999999999999988754 58999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+. ++|.+++.......+++..+..++.+++.||+|||+.++ +|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i---~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 96 589999877655678999999999999999999999997 9999999999999999999999999876543221
Q ss_pred cccccccCCCccchhcccCCC-CCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC--------
Q 046083 643 VHTRLVGTFGYMPPEYAQYGE-VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP-------- 713 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 713 (790)
......++..|+|||.+.+.. ++.++||||||+++|||+||+.||...... ........ ....+..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~~ 230 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI----DQLFRIFR-TLGTPDEVVWPGVTS 230 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHH-HhCCCChhhhhhhhH
Confidence 122235678999999887644 588999999999999999999998643221 11111111 1100000
Q ss_pred ----hhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 714 ----REDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 714 ----~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
...+.......+. .........+.+++.+||+.||++|||++|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 231 LPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000000 0011233567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=294.60 Aligned_cols=246 Identities=23% Similarity=0.394 Sum_probs=197.5
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEe
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
++|.+.+.||+|+||.||++... +..+++|.+.. ...+.+.+|+.++++++|||++++++++.. ...++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888999999999999999864 77899998863 234568899999999999999999998875 4589999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
++++|.+++... .+++..+..++.+++.||.|||++++ +|+||+|+||+++.++.++|+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi---~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~ 171 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCE---eeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence 999999999753 47899999999999999999999997 9999999999999999999999999875543222 1
Q ss_pred ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 644 HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
.....+++.|++||.+....++.++|+||||+++|||++|+.||....... . ....... +
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~----~----~~~~~~~------------~ 231 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR----A----LYLIATN------------G 231 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh----h----eeehhcC------------C
Confidence 223467889999999988889999999999999999999999996432210 0 0000000 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
......+......+.+++.+||+.+|.+||++++++.+-
T Consensus 232 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 232 TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 000111223445788999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=294.82 Aligned_cols=261 Identities=26% Similarity=0.410 Sum_probs=193.7
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh----HHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA----SKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEY 562 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~ 562 (790)
++|+..+.||+|++|.||+|... ++.+|+|.+.... ...+.+|++++++++|+||+++++++.+. ..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67899999999999999999875 7899999986422 24567899999999999999999988754 58999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+.+ +|.+++..... .+++.....++.|++.||.|||+.++ +|+||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~i---~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 85 LDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRRV---LHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred CCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCe---ecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 985 99998876543 68999999999999999999999998 9999999999999999999999999875432211
Q ss_pred cccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhc
Q 046083 643 VHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 721 (790)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..........+..+.. +.+....
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~-~~~~~~~ 233 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV----EDQLHKIFRVLGTPTE-ETWPGVS 233 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH----HHHHHHHHHhcCCCCh-hhhhhhh
Confidence 1122346789999999875 45889999999999999999999998543311 0011111111111100 0000000
Q ss_pred --------------CCcCCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 722 --------------DPRLGDDY-PIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 722 --------------d~~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
...+.... .......+.+++.+||+.+|++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000000 01112567899999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=292.83 Aligned_cols=251 Identities=25% Similarity=0.427 Sum_probs=202.4
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh--HHHHHHHHHHHHhcCCCCCcceEEEEe-cCeEEEEEEE
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA--SKEFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEY 562 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~lv~e~ 562 (790)
.++.|+..+.||+|+||.||++... +..+++|.+.... .+.+.+|++++++++|+|++++++++. +...++++||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 4567888899999999999999987 7899999987544 567889999999999999999999876 4568999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+++++|.+++.... ..+++..+..++.+++.||.|||+.++ +|+||+|+||+++.++.++|+|||++........
T Consensus 97 ~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi---~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 97 MDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNV---IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred cCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCe---eeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 99999999998754 369999999999999999999999998 9999999999999999999999999875432221
Q ss_pred cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcC
Q 046083 643 VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD 722 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d 722 (790)
......++..|++||.+.+..++.++|+||||+++|+|++|+.|+...... ...........
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--------~~~~~~~~~~~---------- 233 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--------RALFLITTKGI---------- 233 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhcCC----------
Confidence 122345788999999998888999999999999999999999998542211 11111111100
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 723 PRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 723 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
+. ...+...+..+.+++.+||+.+|.+||++.+++++..
T Consensus 234 ~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 234 PP--LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred CC--CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence 00 0111224567889999999999999999999987544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=287.33 Aligned_cols=245 Identities=22% Similarity=0.363 Sum_probs=196.6
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh--------hhHHHHHHHHHHHHhcCCCCCcceEEEEec---CeE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM--------QASKEFLAELKVLTHVHHLNLVRLIGYCVE---GSL 556 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---~~~ 556 (790)
.+|++.+.||+|+||.||+|... +..+++|.+.. ...+.+.+|++++++++|+||+++++++.+ ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57899999999999999999875 78999998642 233568899999999999999999998864 347
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
++++||+++++|.+++...+ .+++....+++.+++.||.|||+.++ +|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~i---~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNMI---VHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCE---ecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 89999999999999997643 47899999999999999999999997 99999999999999999999999999865
Q ss_pred ccCCc--ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 637 EVGSA--SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 637 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
..... .......++..|+|||++.+..++.++|+|||||+++||++|+.||..... .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~------- 221 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA--------MAAIFKI------- 221 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH--------HHHHHHH-------
Confidence 32111 111235688999999999988899999999999999999999999854321 0111111
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.........+......+.+++.+||+ +|..||+..+++.+
T Consensus 222 ------~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 222 ------ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ------HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 11111223344556779999999999 57999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=291.96 Aligned_cols=263 Identities=25% Similarity=0.361 Sum_probs=192.6
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEE
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVY 560 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~ 560 (790)
++++|.+.+.||+|+||.||+|... ++.+++|.+... ....+.+|+++++.++|+||+++++++.++ ..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999875 889999998632 224578899999999999999999988754 589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+. ++|.+++.... ..+.+..+..++.|++.||.|||++++ +|+||||+|||++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i---~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHI---LHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9996 67777765432 357888899999999999999999998 999999999999999999999999997543222
Q ss_pred cccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChh----
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE---- 715 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 715 (790)
.. .....+++.|+|||.+.+. .++.++||||||+++|||++|..||....... ..+.. ....+..+....
T Consensus 158 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~---~~~~~-~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 158 QT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF---EQLEK-IWTVLGVPTEDTWPGV 232 (291)
T ss_pred CC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH---HHHHH-HHHHcCCCChhhhhhh
Confidence 11 1234568899999998754 57899999999999999999999986543210 00100 001111000000
Q ss_pred -hh----hhhcCCcCCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046083 716 -DL----QRLVDPRLGDDY-----PIDSVRKMARLARACTQENPQLRPSMRAIVV 760 (790)
Q Consensus 716 -~l----~~~~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 760 (790)
.+ ..+......... .......+.+++.+|++.||++|||++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00 000000000000 0012356789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=293.35 Aligned_cols=259 Identities=27% Similarity=0.427 Sum_probs=194.4
Q ss_pred cccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEEe
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYI 563 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~~ 563 (790)
|+..+.||.|++|.||+|... |..+++|++... ..+.+.+|++++++++|+|++++++++.++ ..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567899999999999999875 889999988642 235688999999999999999999988754 589999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
+ ++|.+++.......+++..++.++.++++||+|||++++ +|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~---~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRV---LHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe---eCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 5 699999876554568999999999999999999999987 99999999999999999999999999765432211
Q ss_pred ccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh--------
Q 046083 644 HTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR-------- 714 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 714 (790)
.....++..|+|||++.+. .++.++|+||||+++|||++|+.||...... ......... ...+...
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~~ 230 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI----DQLFRIFRT-LGTPDEDVWPGVTSL 230 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHH-hCCCChHHhhhhhhc
Confidence 1223468899999988654 5789999999999999999999998653321 001111111 0000000
Q ss_pred hhhh----hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 715 EDLQ----RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 715 ~~l~----~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.... ....... ..........+.+++.+||+.+|++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 231 PDYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 0000000 01112334678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=293.87 Aligned_cols=250 Identities=28% Similarity=0.441 Sum_probs=197.4
Q ss_pred cccceeeeecCceEEEEEEEC--CceEEEEEeCh------hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEE
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEY 562 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~ 562 (790)
|...+.||+|+||.||++... +..+++|.+.. +..+.+.+|++++++++|+|++++++++.++ ..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 666789999999999999875 78899998852 2235688899999999999999999988754 58999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+.+ +|.+++... ...+++..+..++.+++.||.|||++++ +|+||+|+||+++.++.+||+|||++......
T Consensus 107 ~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i---~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 107 CLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred CCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 975 788777543 2358999999999999999999999998 99999999999999999999999998754321
Q ss_pred cccccccCCCccchhccc---CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 643 VHTRLVGTFGYMPPEYAQ---YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
....++..|+|||++. .+.++.++|||||||++|||++|..||...... .....+...
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~~~--------- 239 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQN--------- 239 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHhc---------
Confidence 2345788999999973 457899999999999999999999998543211 111111111
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccC
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDW 772 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~ 772 (790)
.............+.+++.+||+.+|.+||++.++++++..+......+
T Consensus 240 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~ 288 (317)
T cd06635 240 ----ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETV 288 (317)
T ss_pred ----cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcccc
Confidence 0001111234456889999999999999999999999887766655554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=295.71 Aligned_cols=243 Identities=23% Similarity=0.388 Sum_probs=193.3
Q ss_pred cceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecCCC
Q 046083 494 MGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGN 567 (790)
Q Consensus 494 ~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~g~ 567 (790)
....||+|+||.||++... +..+++|.++. ...+.+.+|+.++..++|||++++++++.. ...+++|||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999875 78999999853 234568899999999999999999998764 56899999999999
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccccc
Q 046083 568 LNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRL 647 (790)
Q Consensus 568 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 647 (790)
|.+++.. ..+++..++.++.|++.||+|||+.++ +|+||+|+||+++.++.+||+|||++........ .....
T Consensus 105 L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~i---vH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~ 177 (297)
T cd06659 105 LTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGV---IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSL 177 (297)
T ss_pred HHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccce
Confidence 9998864 348999999999999999999999997 9999999999999999999999999875432221 12235
Q ss_pred ccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCC
Q 046083 648 VGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGD 727 (790)
Q Consensus 648 ~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 727 (790)
.++..|+|||++.+..++.++||||||+++|||++|..||...... .....+..... +..
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~~----------~~~-- 237 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--------QAMKRLRDSPP----------PKL-- 237 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhccCC----------CCc--
Confidence 6889999999999889999999999999999999999998643221 11111111000 000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 728 DYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 728 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.........+.+++.+||+.+|.+||++++++++-.
T Consensus 238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~ 273 (297)
T cd06659 238 KNAHKISPVLRDFLERMLTREPQERATAQELLDHPF 273 (297)
T ss_pred cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChh
Confidence 011123456889999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=285.47 Aligned_cols=243 Identities=26% Similarity=0.438 Sum_probs=198.4
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
+|++.+.||+|+||.||++... ++.+++|.+.. ....++.+|++++++++|+||+++++++.+ ...++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5788999999999999999875 77899998864 234567889999999999999999987764 568999999
Q ss_pred ecCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 563 IENGNLNQHLRGS--GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 563 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
+++++|.+++... ....+++..++.++.+++.||+|||+.++ +|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i---~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKI---LHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCc---ccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998762 22468999999999999999999999998 99999999999999999999999999876543
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
......++..|++||.+.+..++.++|+||||+++|||++|+.||..... .........
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~----------- 215 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM--------QDLRYKVQR----------- 215 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhc-----------
Confidence 12234578899999999998999999999999999999999999854321 111111111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
......+.....++.+++.+|++.+|++||++.+++++
T Consensus 216 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 216 ---GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ---CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11112233456779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=282.92 Aligned_cols=246 Identities=26% Similarity=0.437 Sum_probs=202.1
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChhh-----HHHHHHHHHHHHhcCCCCCcceEEEEecC---eEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA-----SKEFLAELKVLTHVHHLNLVRLIGYCVEG---SLFLVY 560 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~g~~~~~---~~~lv~ 560 (790)
+|+..+.||+|++|.||+|... +..+++|.+.... .+.+.+|++++++++|+|++++++++.+. ..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999986 8899999886543 56789999999999999999999988754 589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++++|.+++.... .+++..++.++.+++.||+|||+.++ +|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~---~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGI---VHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999998654 69999999999999999999999998 999999999999999999999999998665432
Q ss_pred cc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 641 AS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 641 ~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
.. ......++..|++||.+.....+.++||||||+++++|++|..||...... .... ..
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~-------------~~ 215 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-------MAAL-------------YK 215 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-------HHHH-------------Hh
Confidence 21 122356788999999999888999999999999999999999998654310 0101 11
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
..........+......+.+++.+|++.+|.+||++.+++.+
T Consensus 216 ~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 216 IGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 111111122344446789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=292.74 Aligned_cols=261 Identities=25% Similarity=0.385 Sum_probs=195.6
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh-----HHHHHHHHHHHHhcCCCCCcceEEEEec---CeEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA-----SKEFLAELKVLTHVHHLNLVRLIGYCVE---GSLFLV 559 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~g~~~~---~~~~lv 559 (790)
++|+..+.||+|+||.||+|... +..+++|.++... ...+.+|++++++++||||+++++++.. ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999986 7789999886322 2346789999999999999999998764 458999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+.+ +|.+++.... ..+++..++.++.|++.||+|||+.++ +|+||||+||+++.++.+||+|||++......
T Consensus 85 ~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i---~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWI---LHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCe---eeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 999975 9999887643 368999999999999999999999997 99999999999999999999999999865433
Q ss_pred CcccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC-----
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP----- 713 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 713 (790)
.. ......+++.|+|||.+.+. .++.++|+||||+++|||++|..||....... ...... .....+..
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~----~~~~~~-~~~~~~~~~~~~~ 233 (293)
T cd07843 160 LK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID----QLNKIF-KLLGTPTEKIWPG 233 (293)
T ss_pred cc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHH-HHhCCCchHHHHH
Confidence 21 12234578899999998754 46899999999999999999999986433210 011111 00000000
Q ss_pred -------h-hhhhhhcCCcCCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 714 -------R-EDLQRLVDPRLGDDYPID-SVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 714 -------~-~~l~~~~d~~l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
. ..+.......+...++.. ....+.+++.+||+.+|++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 000000111111122222 35678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=302.63 Aligned_cols=239 Identities=25% Similarity=0.419 Sum_probs=198.0
Q ss_pred eeeecCceEEEEEEEC--CceEEEEEeChhhH---HHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEEecCCChhh
Q 046083 497 KIGQGGFGAVFYAELR--GEKAAIKKMDMQAS---KEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLNQ 570 (790)
Q Consensus 497 ~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~---~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~~~~g~L~~ 570 (790)
.||+|.||+||-|++. ...+|||.+..... +-+..|+.+.++++|.|||+.+|.+.++ .+-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 7899999999999987 45679998875433 4488999999999999999999998765 4678899999999999
Q ss_pred hhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEec-CCCcEEEEEeCCCcccccCCccccccc
Q 046083 571 HLRGSGKDTL--TWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILID-KNFRAKVADFGLAKLTEVGSASVHTRL 647 (790)
Q Consensus 571 ~l~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~ 647 (790)
+|+..= .++ .+.+.-.+.+||++||.|||++.| ||||||-+|+|++ -.|.+||+|||-++.+.. -......+
T Consensus 662 LLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~I---VHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETF 736 (1226)
T KOG4279|consen 662 LLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKI---VHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETF 736 (1226)
T ss_pred HHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcce---eeccccCCcEEEeeccceEEecccccchhhcc-CCcccccc
Confidence 998642 234 778888999999999999999998 9999999999996 478999999999987642 33345567
Q ss_pred ccCCCccchhcccCC--CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 648 VGTFGYMPPEYAQYG--EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 648 ~gt~~y~aPE~~~~~--~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
.||.-|||||++..+ .|..++|||||||.+.||.||++||...+.. ....|..-+ -+.
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp------qAAMFkVGm--------------yKv 796 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP------QAAMFKVGM--------------YKV 796 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh------hHhhhhhcc--------------eec
Confidence 899999999999876 5889999999999999999999999765542 111111111 123
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRPSMRAIVV 760 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 760 (790)
++.+|.+...+...++.+|+.+||.+||++.++++
T Consensus 797 HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 797 HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 45678888999999999999999999999999986
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=286.63 Aligned_cols=239 Identities=24% Similarity=0.394 Sum_probs=193.7
Q ss_pred eeecCceEEEEEEEC--CceEEEEEeCh------hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEEecCCCh
Q 046083 498 IGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNL 568 (790)
Q Consensus 498 lG~G~fg~Vy~a~~~--g~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~~~~g~L 568 (790)
||.|+||.||++... +..+++|.+.. ...+.+.+|+.+++.++||||+++++++.++ ..+++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999987 88999998853 2335688999999999999999999987754 58999999999999
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccccccc
Q 046083 569 NQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLV 648 (790)
Q Consensus 569 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 648 (790)
.+++.... .+++..+..++.+++.||+|||++++ +|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~~---~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 81 WTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGI---IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCCc---ccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 99998643 48999999999999999999999998 999999999999999999999999998664332 222346
Q ss_pred cCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCC
Q 046083 649 GTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDD 728 (790)
Q Consensus 649 gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 728 (790)
++..|++||.+....++.++|+||||+++|||++|..||...... ...... ...+......
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~-------------~~~~~~~~~~ 214 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED------PMEIYN-------------DILKGNGKLE 214 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC------HHHHHH-------------HHhccCCCCC
Confidence 788999999998888999999999999999999999998654321 111111 1121111223
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 046083 729 YPIDSVRKMARLARACTQENPQLRPS-----MRAIVVAL 762 (790)
Q Consensus 729 ~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~L 762 (790)
++......+.+++.+||+.+|++||+ ++|++++-
T Consensus 215 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~ 253 (262)
T cd05572 215 FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHK 253 (262)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcCh
Confidence 33344568999999999999999999 67776643
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=299.73 Aligned_cols=260 Identities=27% Similarity=0.417 Sum_probs=196.2
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC------eE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG------SL 556 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~ 556 (790)
+++|++.+.||+|+||.||+|... ++.||+|.++. .....+.+|+.++++++|+||+++++++... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 478999999999999999999875 78999999863 2335678899999999999999999886532 37
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
++++||+.+ +|.+++.. ..+++..+..++.|++.||+|||+.++ +||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~i---vH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANV---LHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCe---eccCCCHHHEEECCCCCEEECcccceeec
Confidence 999999975 88887764 358999999999999999999999998 99999999999999999999999999865
Q ss_pred ccCCcc--cccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC
Q 046083 637 EVGSAS--VHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 637 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
...... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ..........+..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-----~~~~~~~~~~~~~~~- 230 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-----LHQLNLILGVLGTPS- 230 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCCC-
Confidence 432211 1123567899999998754 5689999999999999999999999854321 111111111222111
Q ss_pred hhhhhhhcCCcC---------CCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 714 REDLQRLVDPRL---------GDDYP-----IDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 714 ~~~l~~~~d~~l---------~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.+.+..+.+... ....+ .....++.+++.+||+.+|++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 122221111100 00000 1234568899999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=289.79 Aligned_cols=243 Identities=23% Similarity=0.395 Sum_probs=194.1
Q ss_pred cccceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecC
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIEN 565 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~ 565 (790)
|...+.||+|++|.||++... +..+++|+++. ...+.+.+|+.+++.++|+|++++++++.. ...++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 445679999999999999875 78899998853 234568899999999999999999998764 568999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
++|.+++.. ..+++..+..++.+++.||+|||++++ +||||+|+||+++.++.++|+|||++........ ...
T Consensus 101 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i---~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~ 173 (285)
T cd06648 101 GALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGV---IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRK 173 (285)
T ss_pred CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccc
Confidence 999999986 258999999999999999999999998 9999999999999999999999998875432221 122
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
...|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ........... .+..
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--------~~~~~~~~~~~----------~~~~ 235 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--------LQAMKRIRDNL----------PPKL 235 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHHhcC----------CCCC
Confidence 34688999999999888899999999999999999999999854321 11111111110 0111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
. .+......+.+++.+||+.+|++||++.+++++
T Consensus 236 ~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 236 K--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred c--ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 0 111244578999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=282.11 Aligned_cols=245 Identities=29% Similarity=0.502 Sum_probs=198.8
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChh---hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEec
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ---ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIE 564 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~ 564 (790)
+|+..+.||+|++|.||++... +..+++|++... ..+.+.+|++++++++|+|++++++++.. ...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999986 788999998754 44678999999999999999999998874 46899999999
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccc
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH 644 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 644 (790)
+++|.+++.... ..+++..+..++.+++.||.|||+.++ +|+||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i---~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGI---IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCE---ecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999999998653 468999999999999999999999987 9999999999999999999999999986654322 2
Q ss_pred cccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCc
Q 046083 645 TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724 (790)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 724 (790)
....++..|++||.+....++.++|+||||+++++|++|+.||...... .......... .+.
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~----------~~~ 216 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--------KALFKIATNG----------PPG 216 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--------HHHHHHHhcC----------CCC
Confidence 3456788999999999888999999999999999999999998643210 0011111000 000
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 725 LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 725 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
+. .+......+.+++.+||+.||++|||+.|++++
T Consensus 217 ~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 217 LR--NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cC--cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 10 011124678999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=292.73 Aligned_cols=250 Identities=24% Similarity=0.408 Sum_probs=191.3
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHHHHHhcC-CCCCcceEEEEec-CeEEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHVH-HLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
+|...+.||+|+||.||++... +..+|+|.+.. .....+.+|+.++.++. |+||+++++++.. +..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4566789999999999999885 78999998864 23456889999999996 9999999998764 458999999
Q ss_pred ecCCChhhh---hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 563 IENGNLNQH---LRGSGKDTLTWSARMQIALDSARGLEYIHEH-TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 563 ~~~g~L~~~---l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
+.. +|.++ +.......+++..+.+++.+++.||+|||+. ++ +||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i---~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKI---IHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe---eccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 865 55443 3333335689999999999999999999975 76 9999999999999999999999999975432
Q ss_pred CCcccccccccCCCccchhcccCC---CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChh
Q 046083 639 GSASVHTRLVGTFGYMPPEYAQYG---EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715 (790)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (790)
.. ......|+..|+|||.+... .++.++|||||||++|||++|+.||..... ............
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~---- 227 (288)
T cd06616 161 SI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-------VFDQLTQVVKGD---- 227 (288)
T ss_pred CC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-------HHHHHhhhcCCC----
Confidence 21 11234578899999999766 689999999999999999999999854321 111111111110
Q ss_pred hhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 716 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.+.+....+...+..+.+++.+||+.+|++|||+++|+.+-.
T Consensus 228 ------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~ 269 (288)
T cd06616 228 ------PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPF 269 (288)
T ss_pred ------CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 112222222345567899999999999999999999988643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=288.49 Aligned_cols=242 Identities=26% Similarity=0.369 Sum_probs=197.5
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeCh------hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYE 561 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e 561 (790)
+|++.+.||.|+||.||++... +..+++|.+.. ...+.+.+|++++++++||||+++++++.+ ...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999986 88999998864 234678999999999999999999988765 45899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|+.+++|.+++... ..+++..+..++.++++||.|||++++ +|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i---~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGI---IHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCe---eccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999765 368999999999999999999999997 999999999999999999999999988654322
Q ss_pred ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhc
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 721 (790)
......|+..|+|||.+....++.++|+||||+++|+|++|..||...... ....+......
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~----------- 216 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT------IRDQIRAKQET----------- 216 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc------HHHHHHHHhcc-----------
Confidence 223356788999999999888999999999999999999999998654321 01111111110
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 046083 722 DPRLGDDYPIDSVRKMARLARACTQENPQLRPSM--RAIV 759 (790)
Q Consensus 722 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~--~evl 759 (790)
.....+...+..+.+++.+||+.||.+||++ +|++
T Consensus 217 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 ---ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ---ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1112233445788999999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=297.75 Aligned_cols=266 Identities=22% Similarity=0.296 Sum_probs=197.4
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-------
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE------- 553 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------- 553 (790)
..++|+..+.||+|+||.||+|... ++.+|+|.+.. ...+++.+|+.++++++|+||+++++++..
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3478999999999999999999875 78999999853 234567789999999999999999998752
Q ss_pred CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCC
Q 046083 554 GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLA 633 (790)
Q Consensus 554 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla 633 (790)
...++||||+.+ +|.+.+... +++..+..++.|++.||+|||++++ +||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi---~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCe---eeCCCCHHHEEECCCCCEEEccCccc
Confidence 236999999965 888887642 8889999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccc----------cccchHHH
Q 046083 634 KLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETIT----------ESTGLVAL 703 (790)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~----------~~~~~~~~ 703 (790)
+...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.... ....+...
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 166 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 8654321 12234578899999999999999999999999999999999999864432100 00000000
Q ss_pred ----HHHHHcCCC--ChhhhhhhcCCcC----CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 704 ----FEEVLRQPD--PREDLQRLVDPRL----GDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 704 ----~~~~~~~~~--~~~~l~~~~d~~l----~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
......... ....+.+.+...+ ....+......+.+++.+||+.||++|||+.|++.+-+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~ 313 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChh
Confidence 000000000 0000111111111 01112234567889999999999999999999998644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=287.07 Aligned_cols=260 Identities=25% Similarity=0.419 Sum_probs=195.5
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEe
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
+|+..+.||.|++|.||+|+.. +..+|+|.++.. ..+.+.+|++++++++|+|++++++++.+ +..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999985 788999988643 23567789999999999999999998875 4589999999
Q ss_pred cCCChhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 564 ENGNLNQHLRGSG-KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 564 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
++ +|.+++.... ...+++..+.+++.|++.||.|||+.++ +|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i---~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV---LHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCe---eeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 8988887543 2468999999999999999999999997 9999999999999999999999999975533221
Q ss_pred cccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhc
Q 046083 643 VHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 721 (790)
......++..|++||++.+. .++.++||||||+++|||++|+.||...... ............+. ...+..+.
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~~-~~~~~~~~ 229 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-----DQLLKIFRIMGTPT-ESTWPGIS 229 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-----HHHHHHHHHhCCCC-hhhHHHHh
Confidence 11234568899999988654 5789999999999999999999998654321 01111111111111 01111111
Q ss_pred C-CcCCCCC-----------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 722 D-PRLGDDY-----------PIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 722 d-~~l~~~~-----------~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
+ +.+...+ .......+.+++.+|++.||.+||++.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 0000111 11234578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=283.27 Aligned_cols=245 Identities=27% Similarity=0.499 Sum_probs=200.9
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
+|.+.+.||+|+||.||++... +..+++|++.. ...+++.+|++++++++|+|++++++.+.+ ...++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999987 88999999864 344678899999999999999999998764 458999999
Q ss_pred ecCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 563 IENGNLNQHLRGSG--KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 563 ~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
+++++|.+++.... ...+++..+..++.+++.||.|||++++ +|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKI---LHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCE---ecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999998643 3579999999999999999999999987 999999999999999999999999998654432
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
.......|++.|+|||.+....++.++|+||||+++++|++|..||..... ...........
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~~--------- 219 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL--------LELALKILKGQ--------- 219 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH--------HHHHHHHhcCC---------
Confidence 122335688899999999888899999999999999999999999854321 11111211111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
....+......+.+++.+||+.+|++|||+.|++++
T Consensus 220 -----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 -----YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111222345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=311.19 Aligned_cols=271 Identities=20% Similarity=0.313 Sum_probs=187.6
Q ss_pred HhcCcccceeeeecCceEEEEEEEC---CceEEEE------------------EeC--hhhHHHHHHHHHHHHhcCCCCC
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR---GEKAAIK------------------KMD--MQASKEFLAELKVLTHVHHLNL 544 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~---g~~vavK------------------~~~--~~~~~~~~~E~~~l~~l~h~ni 544 (790)
..++|++.+.||+|+||.||++..+ +...+.| .+. ......+.+|+++|++++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3578999999999999999998754 1122222 111 1223468899999999999999
Q ss_pred cceEEEEecC-eEEEEEEEecCCChhhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEec
Q 046083 545 VRLIGYCVEG-SLFLVYEYIENGNLNQHLRGSG---KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILID 620 (790)
Q Consensus 545 v~l~g~~~~~-~~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~ 620 (790)
+++++++.+. ..|+++|++. ++|.+++.... ..........+++.|++.||.|||++++ +||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gI---iHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKL---IHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEEC
Confidence 9999998754 5899999985 47777765432 1223456677899999999999999998 9999999999999
Q ss_pred CCCcEEEEEeCCCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccch
Q 046083 621 KNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGL 700 (790)
Q Consensus 621 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~ 700 (790)
.++.+||+|||+++.+............|+..|+|||++.+..++.++|||||||++|||++|..++....... ....+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~-~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK-PGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC-HHHHH
Confidence 99999999999998765433333334679999999999999999999999999999999999875443222110 00111
Q ss_pred HHHHHHHH--c--CCCChhhhhhhcCCc-C---CCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 701 VALFEEVL--R--QPDPREDLQRLVDPR-L---GDDYP-----IDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 701 ~~~~~~~~--~--~~~~~~~l~~~~d~~-l---~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
......+. . .+.....+.+.++.. + ....+ ......+.+++.+||+.||.+|||+.|++++-.
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 11111000 0 000001111111110 0 00000 012345778899999999999999999987544
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=290.55 Aligned_cols=261 Identities=28% Similarity=0.432 Sum_probs=193.4
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYE 561 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e 561 (790)
++|++.+.||+|++|.||+|... ++.+++|.+... ..+.+.+|++++++++|+|++++++++.+ ...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999875 788999988542 23568899999999999999999998875 45899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC-CCcEEEEEeCCCcccccCC
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK-NFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~-~~~~kl~DfGla~~~~~~~ 640 (790)
|++ ++|.+++.......+++..+..++.+++.||+|||++++ +|+||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i---~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRV---LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCe---eCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 588888866544457888999999999999999999997 99999999999985 5679999999997653321
Q ss_pred cccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhh---
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRED--- 716 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 716 (790)
. ......+++.|+|||++.+. .++.++||||||+++|+|+||+.||...... ......+ .....+. ...
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~----~~~~~~~-~~~~~~~-~~~~~~ 230 (294)
T PLN00009 158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI----DELFKIF-RILGTPN-EETWPG 230 (294)
T ss_pred c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH-HHhCCCC-hhhccc
Confidence 1 12234568899999988764 5789999999999999999999998653321 0111111 1111110 000
Q ss_pred ---hhhhcC--CcCCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 717 ---LQRLVD--PRLGD----DYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 717 ---l~~~~d--~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
+..... +.... .........+.+++.+|++.+|++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 00000 0112234568899999999999999999999874
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=289.08 Aligned_cols=259 Identities=27% Similarity=0.390 Sum_probs=195.2
Q ss_pred cccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEecC---eEEEEEE
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG---SLFLVYE 561 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~---~~~lv~e 561 (790)
|++.+.||+|+||.||+|... ++.+++|.+... ..+.+.+|++++++++|+|++++++++.+. ..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567899999999999999886 688999998754 235688999999999999999999988754 5899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|+++ +|.+++.... ..+++..++.++.+++.||+|||+.++ +|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~---~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGI---LHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCc---eeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9975 8998887653 368999999999999999999999998 9999999999999999999999999986654332
Q ss_pred ccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 642 SVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ............... ..+..+
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-----~~~~~~~~~~~~~~~-~~~~~~ 229 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-----EQLEKIFELCGSPTD-ENWPGV 229 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCch-hhcccc
Confidence 22233456788999998764 46789999999999999999999998643321 001111111111000 000000
Q ss_pred --------cC------CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 721 --------VD------PRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 721 --------~d------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.. ..+...+...+...+.+++.+||+.+|++||+++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 000000011125678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=299.92 Aligned_cols=247 Identities=23% Similarity=0.433 Sum_probs=196.3
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeC---hhhHHHHHHHHHHHHhcCCCCCcceEE-EEecCeEEEEEEEec
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMD---MQASKEFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIE 564 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g-~~~~~~~~lv~e~~~ 564 (790)
.+.+...||.|.||.||+|..+ +-..|-|.+. .+..++|.-|++||....||+||+|++ |+.++.++++.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 3566789999999999999877 3345667765 345677999999999999999999998 566889999999999
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccc
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH 644 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 644 (790)
||..+..+-.-+ ..|+..++.-++.+++.||.|||++++ ||||||+.|||++-+|.++|+|||.+..... .....
T Consensus 113 GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~i---IHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkR 187 (1187)
T KOG0579|consen 113 GGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQNI---IHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKR 187 (1187)
T ss_pred CchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcch---hhhhccccceEEEecCcEeeecccccccchh-HHhhh
Confidence 999999887654 479999999999999999999999998 9999999999999999999999998864321 11223
Q ss_pred cccccCCCccchhccc-----CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 645 TRLVGTFGYMPPEYAQ-----YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 645 ~~~~gt~~y~aPE~~~-----~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
..+.|||+|||||+.+ ...|+.++||||||+.|.||..+.+|-...+. +...-.+....+
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp--------MRVllKiaKSeP------- 252 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSEP------- 252 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--------HHHHHHHhhcCC-------
Confidence 4578999999999875 45799999999999999999999888654332 111111111111
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
|.| .-|..-...+.+++..||..||+.||++.+++++-
T Consensus 253 ---PTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 253 ---PTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred ---Ccc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 111 11334456789999999999999999999987653
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=284.36 Aligned_cols=255 Identities=28% Similarity=0.413 Sum_probs=190.5
Q ss_pred cccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcC-CCCCcceEEEEec---CeEEEEEE
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVH-HLNLVRLIGYCVE---GSLFLVYE 561 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~g~~~~---~~~~lv~e 561 (790)
|++.+.||+|+||.||+|... +..+|+|.++.. ......+|+.++.++. |+|++++++++.+ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567899999999999999875 788999988642 1233457888999885 9999999998874 45899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|++ ++|.+++.... ..++|..++.++.|++.||+|||+.++ +||||+|+||+++. +.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i---~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGI---FHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCc---eecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 997 48888887543 368999999999999999999999998 99999999999999 9999999999986543221
Q ss_pred ccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 642 SVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
.....++..|+|||.+.. ..++.++|||||||++|||++|..||...... +............. ..+...
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~-----~~~~~~~~~~~~~~--~~~~~~ 225 (282)
T cd07831 155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL-----DQIAKIHDVLGTPD--AEVLKK 225 (282)
T ss_pred --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH-----HHHHHHHHHcCCCC--HHHHHh
Confidence 223457889999997654 55788999999999999999999998553321 11111111111111 111111
Q ss_pred cCCcCC--CCC-----------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 721 VDPRLG--DDY-----------PIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 721 ~d~~l~--~~~-----------~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
....-. ..+ ....+..+.+++.+||+.+|++||++++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 110000 000 11345789999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=285.68 Aligned_cols=238 Identities=29% Similarity=0.476 Sum_probs=191.3
Q ss_pred eeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecCCCh
Q 046083 498 IGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNL 568 (790)
Q Consensus 498 lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~g~L 568 (790)
||+|+||.||++... ++.+++|.+... ..+.+.+|++++++++|+|++++++.+.. ...+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 889999998643 33568899999999999999999987764 458999999999999
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc-------
Q 046083 569 NQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA------- 641 (790)
Q Consensus 569 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~------- 641 (790)
.+++...+ .+++..+..++.|++.||+|||+.++ +|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i---~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGI---IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCe---ecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99998654 58999999999999999999999997 9999999999999999999999999875433211
Q ss_pred ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhc
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 721 (790)
.......++..|++||.......+.++||||||++++||++|..||..... ...+......
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~----------- 216 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP--------EEIFQNILNG----------- 216 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcC-----------
Confidence 122235678899999999888899999999999999999999999854321 1111121111
Q ss_pred CCcCCCCCCHH--HHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 722 DPRLGDDYPID--SVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 722 d~~l~~~~~~~--~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.. ..+.. ....+.+++.+||+.+|++|||+.++.+.|.
T Consensus 217 --~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 217 --KI--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred --Cc--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00 01111 2567899999999999999999966666555
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=288.82 Aligned_cols=259 Identities=24% Similarity=0.345 Sum_probs=200.6
Q ss_pred CcccceeeeecCceEEEEEEEC-----CceEEEEEeChh-------hHHHHHHHHHHHHhc-CCCCCcceEEEEec-CeE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR-----GEKAAIKKMDMQ-------ASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSL 556 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~-----g~~vavK~~~~~-------~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~ 556 (790)
+|++.+.||+|+||.||++... ++.+|||.++.. ..+.+.+|++++.++ +|+|++++++.+.. ...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4778899999999999998753 568999988632 234578899999999 59999999987764 458
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
++||||+++++|.+++... ..+++..+..++.|+++||.|||+.++ +|+||+|+||+++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~---~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGI---IYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCe---eccCCCHHHeEECCCCCEEEEECcccccc
Confidence 8999999999999998754 358899999999999999999999997 99999999999999999999999998865
Q ss_pred ccCCcccccccccCCCccchhcccCCC--CCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 637 EVGSASVHTRLVGTFGYMPPEYAQYGE--VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 637 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
............|+..|+|||.+.+.. .+.++||||||+++|||++|..||...... .............
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~~~~~~~~~~---- 227 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ----NSQSEISRRILKS---- 227 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc----chHHHHHHHHHcc----
Confidence 433222222346789999999987665 788999999999999999999998543211 0011111111111
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccCC
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWD 773 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~~ 773 (790)
. ...+......+.+++.+||+.+|++|||+.++.+.|...--...+|+
T Consensus 228 -------~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~ 275 (288)
T cd05583 228 -------K----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD 275 (288)
T ss_pred -------C----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence 0 11222334568899999999999999999988887776544555553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=294.35 Aligned_cols=261 Identities=27% Similarity=0.404 Sum_probs=195.7
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhc-CCCCCcceEEEEecC---eEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHV-HHLNLVRLIGYCVEG---SLF 557 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~---~~~ 557 (790)
.++|++.+.||+|+||.||+|.+. ++.+++|++.. .....+.+|+.+++++ +|+||+++++++... ..+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 467889999999999999999875 78899998742 2345677899999999 999999999987532 479
Q ss_pred EEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccc
Q 046083 558 LVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~ 637 (790)
+||||+. ++|.+++... .++|..+..++.+++.||+|||+.++ +|+||||+||+++.++.+||+|||++....
T Consensus 86 lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i---~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNV---IHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 9999997 4999988754 58899999999999999999999998 999999999999999999999999998654
Q ss_pred cCCc----ccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC
Q 046083 638 VGSA----SVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD 712 (790)
Q Consensus 638 ~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (790)
.... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-----~~~~~~~~~~~~- 232 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-----QLEKIIEVIGPP- 232 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHHhCCC-
Confidence 3321 12233568899999998764 457899999999999999999999985433210 000000110000
Q ss_pred Chhhhh--------hhcCC----cCC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 713 PREDLQ--------RLVDP----RLG--DDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 713 ~~~~l~--------~~~d~----~l~--~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
..+.+. .+++. ... .......+..+.+++.+||+.+|++|||+.+++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~ 296 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHP 296 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhCh
Confidence 000000 01110 000 000112456789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=292.12 Aligned_cols=266 Identities=26% Similarity=0.404 Sum_probs=194.1
Q ss_pred CcccceeeeecCceEEEEEEEC----CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEecC---eEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR----GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG---SLF 557 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~----g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~---~~~ 557 (790)
+|++.++||+|+||.||+|... +..+|+|.+... ..+.+.+|+.++.+++||||+++++++.+. ..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999984 579999998752 235678899999999999999999998744 489
Q ss_pred EEEEEecCCChhhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC----CCcEEEEEe
Q 046083 558 LVYEYIENGNLNQHLRGSG---KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK----NFRAKVADF 630 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~----~~~~kl~Df 630 (790)
+||||+++ +|.+++.... ...+++..+..++.|++.||.|||+.++ +||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i---~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWV---LHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCE---eeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 6777664321 2368999999999999999999999997 99999999999999 999999999
Q ss_pred CCCcccccCCcc--cccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCcccccccccccc-----ccchHH
Q 046083 631 GLAKLTEVGSAS--VHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITE-----STGLVA 702 (790)
Q Consensus 631 Gla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~-----~~~~~~ 702 (790)
|++......... ......++..|+|||.+.+. .++.++||||||++++||++|+.||......... ...+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 999865433221 12234678899999988764 5789999999999999999999999754432200 001111
Q ss_pred HHHHHHcCCCCh--------hhhhhhcCCcCCCCCC---------H--HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 703 LFEEVLRQPDPR--------EDLQRLVDPRLGDDYP---------I--DSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 703 ~~~~~~~~~~~~--------~~l~~~~d~~l~~~~~---------~--~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.+ ..+..+... .......+......++ . ....++.+++.+||+.||++|||+.|++++
T Consensus 237 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IF-EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HH-HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11 111111000 0000000000000111 0 234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-32 Score=285.87 Aligned_cols=240 Identities=28% Similarity=0.418 Sum_probs=189.9
Q ss_pred eeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecCCCh
Q 046083 498 IGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNL 568 (790)
Q Consensus 498 lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~g~L 568 (790)
||+|+||+||++... ++.+++|.+... ..+.+.+|++++++++|||++++++.+.. +..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999875 789999988642 23346789999999999999999988764 568999999999999
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccccccc
Q 046083 569 NQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLV 648 (790)
Q Consensus 569 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 648 (790)
.+++.......+++..+..++.+++.||.|||+.++ +|+||+|+||++++++.++|+|||++...... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i---~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI---VYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccccc
Confidence 999987655579999999999999999999999998 99999999999999999999999998765331 1122345
Q ss_pred cCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCC
Q 046083 649 GTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDD 728 (790)
Q Consensus 649 gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 728 (790)
++..|+|||.+.+..++.++||||||+++++|++|+.||....... ........... ....
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~---------------~~~~ 216 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV----EKEELKRRTLE---------------MAVE 216 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc----cHHHHHhcccc---------------cccc
Confidence 7889999999988889999999999999999999999986543210 00000000000 0111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 046083 729 YPIDSVRKMARLARACTQENPQLRP-----SMRAIVVA 761 (790)
Q Consensus 729 ~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 761 (790)
.+......+.+++.+||+.+|++|| +..+++.+
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 217 YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 2233456788999999999999999 66666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=287.24 Aligned_cols=261 Identities=25% Similarity=0.389 Sum_probs=192.2
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcC-CCCCcceEEEEec-Ce-----
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVH-HLNLVRLIGYCVE-GS----- 555 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~-h~niv~l~g~~~~-~~----- 555 (790)
++|++.+.||+|+||.||+|... ++.+|+|.++.. ..+.+.+|+.+++.++ |+|++++++++.. ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999975 789999987643 2356888999999995 6999999998763 22
Q ss_pred EEEEEEEecCCChhhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC-CCcEEEEEeC
Q 046083 556 LFLVYEYIENGNLNQHLRGSG---KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK-NFRAKVADFG 631 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~-~~~~kl~DfG 631 (790)
.|++|||+++ +|.+++.... ...+++..++.++.|++.||.|||++++ +||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i---~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGV---MHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCe---eecCCChHHEEEecCCCeEEEeecc
Confidence 6999999986 8988886532 2468999999999999999999999998 99999999999998 8899999999
Q ss_pred CCcccccCCcccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcC
Q 046083 632 LAKLTEVGSASVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQ 710 (790)
Q Consensus 632 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 710 (790)
+++....... ......+++.|+|||.+.+ ..++.++|+||||+++|||++|..||...... ......+. .+..
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~-~~~~ 230 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL----QQLLHIFK-LLGT 230 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHH-HhCC
Confidence 9885532211 1122356788999998865 45789999999999999999999998653221 00111111 1110
Q ss_pred CCChhhhhhhc-------CCcCC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 711 PDPREDLQRLV-------DPRLG----DDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 711 ~~~~~~l~~~~-------d~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
+. ...+.... .+... ..........+.+++.+||+.+|.+||+++|++.+
T Consensus 231 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 231 PT-EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CC-hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 00000000 00000 00011345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=279.41 Aligned_cols=242 Identities=31% Similarity=0.532 Sum_probs=197.8
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
+|++.+.||+|++|.||++... ++.+++|.+... ..+.+.+|++++++++|+|++++++++.+ +..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788999999999999999875 678999988643 34678999999999999999999998775 458999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+++++|.+++... ..+++..+..++.+++.||.|||+.++ +|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i---~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGV---IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCc---ccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999999865 358999999999999999999999998 99999999999999999999999999876543321
Q ss_pred cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcC
Q 046083 643 VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD 722 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d 722 (790)
.....++..|+|||......++.++||||||+++|+|++|+.||..... ...... ....
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-------~~~~~~-~~~~------------ 214 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-------MAALFR-IVQD------------ 214 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHH-Hhcc------------
Confidence 2335678899999999888899999999999999999999999854321 111111 1100
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046083 723 PRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVV 760 (790)
Q Consensus 723 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 760 (790)
.....+......+.+++.+||+.+|++|||+.+++.
T Consensus 215 --~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 215 --DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 011222334567889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=285.56 Aligned_cols=239 Identities=24% Similarity=0.338 Sum_probs=183.6
Q ss_pred eeeecCceEEEEEEEC--CceEEEEEeChhh------HHHHHHHHHHHH---hcCCCCCcceEEEEe-cCeEEEEEEEec
Q 046083 497 KIGQGGFGAVFYAELR--GEKAAIKKMDMQA------SKEFLAELKVLT---HVHHLNLVRLIGYCV-EGSLFLVYEYIE 564 (790)
Q Consensus 497 ~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~------~~~~~~E~~~l~---~l~h~niv~l~g~~~-~~~~~lv~e~~~ 564 (790)
.||+|+||.||++... ++.+|+|.+.... ...+.+|..+++ ..+|||++.+++++. ++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 7899999875321 122344444333 347999999998876 456899999999
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccc
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH 644 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 644 (790)
+++|.+++...+ .+++..+..++.|++.||+|||+.++ +|+||||+|||+++++.++|+|||++....... .
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~i---vH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~ 152 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---CCCCCCHHHEEECCCCCEEEccCCcceeccccC---c
Confidence 999999987643 59999999999999999999999998 999999999999999999999999987543221 1
Q ss_pred cccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 645 TRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 645 ~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
....|+..|+|||.+.. ..++.++|+|||||+++||++|..||....... ... ..... .
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~-~~~~~--------------~ 212 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHE-IDRMT--------------L 212 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC-----HHH-HHHHh--------------h
Confidence 23468999999999864 568999999999999999999999986533210 000 00000 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRP-----SMRAIVVALM 763 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~L~ 763 (790)
......+...+.++.+++.+||+.||++|| +++|++++..
T Consensus 213 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~ 257 (279)
T cd05633 213 TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVF 257 (279)
T ss_pred cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcc
Confidence 011122334456788999999999999999 5999887644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=286.03 Aligned_cols=252 Identities=20% Similarity=0.281 Sum_probs=181.3
Q ss_pred cCcccceeeeecCceEEEEEEECC-----ceEEEEEeChhhH--------------HHHHHHHHHHHhcCCCCCcceEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELRG-----EKAAIKKMDMQAS--------------KEFLAELKVLTHVHHLNLVRLIGY 550 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~g-----~~vavK~~~~~~~--------------~~~~~E~~~l~~l~h~niv~l~g~ 550 (790)
++|.+.+.||+|+||.||+|...+ ..+++|....... .....+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 578999999999999999998763 3556665432110 112233344566789999999987
Q ss_pred EecCe-----EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcE
Q 046083 551 CVEGS-----LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRA 625 (790)
Q Consensus 551 ~~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~ 625 (790)
+.... .++++|++.. ++.+.+.... ..++..+..++.|++.||+|||+.++ +||||||+|||++.++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i---iHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHGI---SHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEEcCCCcE
Confidence 65332 3667776644 6666665432 35788889999999999999999997 999999999999999999
Q ss_pred EEEEeCCCcccccCCcc------cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccc
Q 046083 626 KVADFGLAKLTEVGSAS------VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTG 699 (790)
Q Consensus 626 kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~ 699 (790)
+|+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~---~~ 242 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG---NL 242 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch---HH
Confidence 99999999865322111 1123468999999999999999999999999999999999999997653211 00
Q ss_pred hHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 700 LVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 700 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
.......++ .++..+.+. ....+..+.+++..|++.+|++||++.++.+.|
T Consensus 243 ~~~~~~~~~---------~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 IHAAKCDFI---------KRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhHHHHH---------HHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 000001111 111111110 112346789999999999999999999999876
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=292.87 Aligned_cols=261 Identities=18% Similarity=0.250 Sum_probs=194.1
Q ss_pred ccceeeeecCceEEEEEEECCceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecCC
Q 046083 493 SMGNKIGQGGFGAVFYAELRGEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENG 566 (790)
Q Consensus 493 ~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~g 566 (790)
.+.+.+|.|+++.||++...++.+|+|+++. ...+.+.+|++++++++|+||+++++++.+ ...+++|||++++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 3456667777777888777799999999753 234578999999999999999999998774 4589999999999
Q ss_pred ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc-----
Q 046083 567 NLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA----- 641 (790)
Q Consensus 567 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~----- 641 (790)
+|.+++.......+++.....++.|++.||+|||++++ +||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i---vH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGF---IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 99999986544568899999999999999999999998 9999999999999999999999998875432211
Q ss_pred -ccccccccCCCccchhcccC--CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC------
Q 046083 642 -SVHTRLVGTFGYMPPEYAQY--GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD------ 712 (790)
Q Consensus 642 -~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 712 (790)
.......++..|+|||++.. ..++.++|+|||||++|||++|..||....... ...+.......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~-------~~~~~~~~~~~~~~~~~ 234 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-------MLLEKVRGTVPCLLDKS 234 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhccCccccccC
Confidence 11122456778999999875 358899999999999999999999996543211 01111100000
Q ss_pred -Chh---hhh----hhcCCc----CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 713 -PRE---DLQ----RLVDPR----LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 713 -~~~---~l~----~~~d~~----l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
... ... ...++. ...........++.+++.+||+.||++|||+++++++-.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred chhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 000 000 000000 011122334567889999999999999999999998655
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=282.53 Aligned_cols=247 Identities=22% Similarity=0.331 Sum_probs=189.7
Q ss_pred HHHHHHhcCcccceee--eecCceEEEEEEEC--CceEEEEEeChhhHHHHHHHHHHHHhc-CCCCCcceEEEEe-cCeE
Q 046083 483 EELAKATNDFSMGNKI--GQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHV-HHLNLVRLIGYCV-EGSL 556 (790)
Q Consensus 483 ~~l~~~~~~f~~~~~l--G~G~fg~Vy~a~~~--g~~vavK~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~-~~~~ 556 (790)
.+.....++|++.+.+ |+|+||.||++... +..+++|.......... |+.....+ +|+|++++++.+. ++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3444445677777776 99999999999875 77899999875433222 22222222 7999999999876 4568
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC-cEEEEEeCCCcc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF-RAKVADFGLAKL 635 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~-~~kl~DfGla~~ 635 (790)
++||||+++++|.+++.... .+++..+..++.|+++||.|||+.++ +||||||+||+++.++ .++|+|||++..
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i---~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNI---IHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---eeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 99999999999999998653 69999999999999999999999997 9999999999999998 999999999876
Q ss_pred cccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChh
Q 046083 636 TEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715 (790)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (790)
.... ....++..|+|||++.+..++.++||||||+++|||++|..||....... .....+...
T Consensus 160 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~--------- 222 (267)
T PHA03390 160 IGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE---LDLESLLKR--------- 222 (267)
T ss_pred cCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch---hhHHHHHHh---------
Confidence 5322 22457889999999998899999999999999999999999997432211 111111110
Q ss_pred hhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 046083 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPS-MRAIVV 760 (790)
Q Consensus 716 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~evl~ 760 (790)
.... ...+......+.+++.+||+.+|.+||+ ++|+++
T Consensus 223 -----~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 223 -----QQKK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -----hccc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1100 0112235567899999999999999996 688875
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=287.80 Aligned_cols=262 Identities=27% Similarity=0.412 Sum_probs=195.9
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEecC------
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG------ 554 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------ 554 (790)
..++|++.+.||+|+||.||+|... ++.+++|.++.. ....+.+|++++++++|||++++++++.+.
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4578999999999999999999985 788999998642 224577899999999999999999987632
Q ss_pred -----eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEE
Q 046083 555 -----SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVAD 629 (790)
Q Consensus 555 -----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~D 629 (790)
..++++||+++ +|..++... ...+++..+..++.|++.||+|||+.++ +|+||+|+||++++++.+||+|
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i---~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNF---LHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEECCCCcEEeCc
Confidence 47999999986 777777654 3468999999999999999999999998 9999999999999999999999
Q ss_pred eCCCcccccCCcccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHH
Q 046083 630 FGLAKLTEVGSASVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVL 708 (790)
Q Consensus 630 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 708 (790)
||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..........
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-----~~~~~~~~~~ 234 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-----AQLELISRLC 234 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHh
Confidence 99998664433222222345778999998864 35789999999999999999999998643211 1111111111
Q ss_pred cCCCChhhhhhhc--------CC------cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 709 RQPDPREDLQRLV--------DP------RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 709 ~~~~~~~~l~~~~--------d~------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
..+.. ..+..+. ++ ..... ....+..+.+++.+||+.+|.+||+++++++.
T Consensus 235 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 235 GSPCP-AVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCCCh-hhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11110 0110000 00 00000 11234678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=286.55 Aligned_cols=259 Identities=28% Similarity=0.412 Sum_probs=193.1
Q ss_pred cccceeeeecCceEEEEEEEC--CceEEEEEeChhh----HHHHHHHHHHHHhcC-CCCCcceEEEEec-CeEEEEEEEe
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA----SKEFLAELKVLTHVH-HLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~----~~~~~~E~~~l~~l~-h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
|++.+.||+|+||.||+|... ++.++||++.... .....+|+..+.+++ |+|++++++++.+ +..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567899999999999999985 6789999886432 223567899999998 9999999998765 4589999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
+|+|.+++.......+++..+..++.+++.+|.|||++++ +|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i---~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~ 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF---FHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--P 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCChhhEEEcCCCCEEEeecccceeccCCC--C
Confidence 8899999887654568999999999999999999999998 999999999999999999999999998654322 1
Q ss_pred ccccccCCCccchhccc-CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChh-----hh
Q 046083 644 HTRLVGTFGYMPPEYAQ-YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE-----DL 717 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~-~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~l 717 (790)
.....++..|+|||.+. ...++.++|+||||+++|||++|+.||....... ........+..+.... .+
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-----QLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-----HHHHHHHhcCCCChhhhhhHhhh
Confidence 23356788999999875 4467999999999999999999999885443210 0001111111110000 00
Q ss_pred hhhcCCcCC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 718 QRLVDPRLG-------DDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 718 ~~~~d~~l~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
....+..+. ..........+.+++++||+.+|++|||++|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000 00001124678999999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=288.87 Aligned_cols=263 Identities=29% Similarity=0.378 Sum_probs=195.8
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh-----HHHHHHHHHHHHhcCCCCCcceEEEEecC---eEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA-----SKEFLAELKVLTHVHHLNLVRLIGYCVEG---SLFL 558 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~g~~~~~---~~~l 558 (790)
.++|++.+.||+|+||.||+|... ++.+|+|.++... ...+.+|++++++++|+|++++++++.+. ..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999985 8899999886332 23466899999999999999999988643 4799
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
||||+.+ +|.+++.... ..+++..+..++.|++.||+|||+.++ +||||||+||++++++.+||+|||++.....
T Consensus 86 v~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i---~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFI---IHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 9999975 8888887543 468999999999999999999999998 9999999999999999999999999986643
Q ss_pred CCcccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 639 GSASVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ............+.. ..+
T Consensus 161 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-----~~~~~~~~~~~~~~~-~~~ 233 (309)
T cd07845 161 PAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-----EQLDLIIQLLGTPNE-SIW 233 (309)
T ss_pred ccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhcCCCCh-hhc
Confidence 221 1222345788999999865 45789999999999999999999998643321 111111111111100 000
Q ss_pred hhhcC------CcCC--C--CC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 718 QRLVD------PRLG--D--DY---PIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 718 ~~~~d------~~l~--~--~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
..+.+ -.+. . .. .......+.+++.+|++.||++|||++|++.+-+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~ 292 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 00000 0000 0 00 0112456789999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=284.13 Aligned_cols=259 Identities=26% Similarity=0.399 Sum_probs=192.6
Q ss_pred cccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhc---CCCCCcceEEEEecC-e-----
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHV---HHLNLVRLIGYCVEG-S----- 555 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~-~----- 555 (790)
|++.+.||+|+||.||+|..+ +..+|+|.++.. ....+.+|+.++.++ +|+|++++++++.+. .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567899999999999999986 789999998632 223566788777666 599999999988643 2
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
.+++|||+.+ +|.+++.......+++..++.++.+++.||.|||+.++ +|+||+|+||+++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i---~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRI---VHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCe---eeccCChhhEEEccCCCEEEeccCccee
Confidence 7999999975 89998876544468999999999999999999999997 9999999999999999999999999987
Q ss_pred cccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChh
Q 046083 636 TEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715 (790)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (790)
...... .....++..|+|||.+.+..++.++|+||||+++|||++|++||...... ......... ........
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~----~~~~~~~~~-~~~~~~~~ 229 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA----DQLDKIFDV-IGLPSEEE 229 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH----HHHHHHHHH-cCCCChHh
Confidence 643321 12335788999999999999999999999999999999998888643221 111111111 00000000
Q ss_pred h------hhhhcCCcCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 716 D------LQRLVDPRLG---DDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 716 ~------l~~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
. .......... .....+....+.+++.+||+.||.+||+++|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 0000000000 01112345677899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=290.27 Aligned_cols=257 Identities=20% Similarity=0.314 Sum_probs=190.7
Q ss_pred eeeeec--CceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEEecC
Q 046083 496 NKIGQG--GFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIEN 565 (790)
Q Consensus 496 ~~lG~G--~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~~~~ 565 (790)
..||+| +||+||++... ++.||+|.+... ..+.+.+|+.+++.++||||+++++++..+ ..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 89999999884 899999998632 236688999999999999999999998754 58999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc--
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV-- 643 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~-- 643 (790)
++|.+++.......+++..+..++.|++.||+|||+.++ +||||||+|||++.++.++++||+............
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i---vHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY---IHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 999999987655568999999999999999999999998 999999999999999999999998654322111100
Q ss_pred ----ccccccCCCccchhcccCC--CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC----
Q 046083 644 ----HTRLVGTFGYMPPEYAQYG--EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP---- 713 (790)
Q Consensus 644 ----~~~~~gt~~y~aPE~~~~~--~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 713 (790)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||....... ...........
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~ 232 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--------MLLQKLKGPPYSPLD 232 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--------HHHHHhcCCCCCCcc
Confidence 0112345679999999763 47899999999999999999999986532210 00000000000
Q ss_pred -----------------------hhhh-----hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 714 -----------------------REDL-----QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 714 -----------------------~~~l-----~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.... ..+.+..+....+......+.+|+.+||+.||++|||++|++++-+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred ccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 0000 0111111222223346678899999999999999999999987655
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=275.46 Aligned_cols=256 Identities=25% Similarity=0.397 Sum_probs=204.4
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh------HHHHHHHHHHHHhcCCCCCcce-EEEEecCeEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA------SKEFLAELKVLTHVHHLNLVRL-IGYCVEGSLFLV 559 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~------~~~~~~E~~~l~~l~h~niv~l-~g~~~~~~~~lv 559 (790)
-++|..++.||+|.||.|-.++.+ ++.+|+|+++.+. ...-..|-+.|+..+||.+..+ |.|.....+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467889999999999999999876 8899999987542 3345678899999999999888 456667789999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+.||.|.-+|.+. ..+++.....+..+|+.||.|||++++ |.||||.+|.|||.+|++||.|||+.+..-.
T Consensus 247 MeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~i---vYRDlKLENLlLDkDGHIKitDFGLCKE~I~- 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNI---VYRDLKLENLLLDKDGHIKITDFGLCKEEIK- 320 (516)
T ss_pred EEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCe---eeeechhhhheeccCCceEeeecccchhccc-
Confidence 9999999999998764 358888888999999999999999998 9999999999999999999999999985432
Q ss_pred CcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
.......++|||.|+|||++....|....|+|.+||++|||++|+.||...+. ..+++-++..
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh--------~kLFeLIl~e--------- 383 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH--------EKLFELILME--------- 383 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch--------hHHHHHHHhh---------
Confidence 23344568999999999999999999999999999999999999999965432 2333333221
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC--HHHHHHHHHhhccCCccCC
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPS--MRAIVVALMTLSSSSEDWD 773 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt--~~evl~~L~~l~~~~~~~~ 773 (790)
. -.+|.....+...|+...|..||.+|.. .+++.+...----.+.+|+
T Consensus 384 ----d--~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~ 433 (516)
T KOG0690|consen 384 ----D--LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE 433 (516)
T ss_pred ----h--ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence 1 1345556667888999999999999953 3333333333333445664
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-32 Score=293.96 Aligned_cols=267 Identities=28% Similarity=0.408 Sum_probs=199.3
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC------e
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG------S 555 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~ 555 (790)
.++|.+.+.||+|+||.||++... +..+|||.+.. .....+.+|+.+++.++|+||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457899999999999999999875 78999998753 2335677899999999999999999977532 3
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
.+++|||+. ++|.+++...+ .+++..+..++.|++.||.|||++++ +|+||||+||+++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i---~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSANV---LHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCE---ecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999996 68998887643 58999999999999999999999997 9999999999999999999999999986
Q ss_pred cccCCcccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 636 TEVGSASVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
..... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...... ................
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 158 TSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-----HQLKLITELLGSPSEE 231 (337)
T ss_pred cCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-----HHHHHHHHHhCCCChH
Confidence 54322 22233467889999998865 46899999999999999999999998543211 1111111111111100
Q ss_pred -------hhhhhhcCC---cCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhhcc
Q 046083 715 -------EDLQRLVDP---RLGD---DYPIDSVRKMARLARACTQENPQLRPSMRAIVVA--LMTLSS 767 (790)
Q Consensus 715 -------~~l~~~~d~---~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~l~~ 767 (790)
....+.+.. .... .........+.+++.+||+.+|++|||++|++++ +..+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 001111100 0000 0112345678899999999999999999999987 544433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=313.76 Aligned_cols=254 Identities=28% Similarity=0.465 Sum_probs=204.5
Q ss_pred HhcCcccceeeeecCceEEEEEEEC---------CceEEEEEeCh----hhHHHHHHHHHHHHhc-CCCCCcceEEEEec
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR---------GEKAAIKKMDM----QASKEFLAELKVLTHV-HHLNLVRLIGYCVE 553 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~---------g~~vavK~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 553 (790)
..+++.+.+.||+|.||.|++|... ...||||.++. ...+.+..|+++|+.+ +|+|++.++|+|.+
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3444556679999999999999754 23689999874 3456799999999999 69999999999986
Q ss_pred -CeEEEEEEEecCCChhhhhhcCC------------C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEE
Q 046083 554 -GSLFLVYEYIENGNLNQHLRGSG------------K--DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANIL 618 (790)
Q Consensus 554 -~~~~lv~e~~~~g~L~~~l~~~~------------~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NIL 618 (790)
+..++|+||+..|+|.++|+... . ..++....+.++.|||.|++||++..+ |||||..+|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~---vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPC---VHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCc---cchhhhhhhEE
Confidence 56899999999999999998765 0 238899999999999999999999997 99999999999
Q ss_pred ecCCCcEEEEEeCCCcccccCCcccccccc--cCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccc
Q 046083 619 IDKNFRAKVADFGLAKLTEVGSASVHTRLV--GTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETIT 695 (790)
Q Consensus 619 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~ 695 (790)
+.++..+||+|||+++............-. -...|||||.+....|+.++|||||||+||||+| |..|+.....
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--- 527 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--- 527 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc---
Confidence 999999999999999965443332222222 2456999999999999999999999999999998 6666633110
Q ss_pred cccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 696 ESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
. ..+-+.+.+..+.+.|..+..++.++|+.||+.+|++||++.++++.+...
T Consensus 528 ----~--------------~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 528 ----T--------------EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred ----H--------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 0 111223333333455667788999999999999999999999999999985
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=288.83 Aligned_cols=253 Identities=27% Similarity=0.418 Sum_probs=197.2
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeCh------hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYE 561 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e 561 (790)
.|...+.||+|+||.||+|... +..+++|.+.. ...+++.+|+++++.++|+|++++++++.+. ..++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666789999999999999975 77899998752 2234678899999999999999999988754 5899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|+. |+|.+++.... ..+++..+..++.+++.||.|||+.++ +||||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i---~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 96 YCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred ccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 996 58888776443 358999999999999999999999998 99999999999999999999999998765322
Q ss_pred ccccccccCCCccchhccc---CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 642 SVHTRLVGTFGYMPPEYAQ---YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
....++..|+|||.+. ...++.++|||||||++|||++|..|+...... ..........
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~------- 230 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNE------- 230 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--------HHHHHHhhcC-------
Confidence 2345788999999974 356888999999999999999999997543211 0011111100
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccCCc
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWDI 774 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~~~ 774 (790)
.+. ..+......+.+++.+||+.+|++||++.+++.+.+........+.+
T Consensus 231 ---~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~~~~~ 280 (308)
T cd06634 231 ---SPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIM 280 (308)
T ss_pred ---CCC---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCChhHHH
Confidence 011 11123445688999999999999999999999987766655554443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=286.97 Aligned_cols=259 Identities=30% Similarity=0.410 Sum_probs=191.5
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEecC--------
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-------- 554 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-------- 554 (790)
++|++.+.||+|+||.||+|... ++.+|+|.+... ....+.+|++++++++||||+++++++...
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 57899999999999999999885 789999988532 123467899999999999999999987532
Q ss_pred -eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCC
Q 046083 555 -SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLA 633 (790)
Q Consensus 555 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla 633 (790)
..++||||+.+ +|.+++.... ..+++.+++.++.|++.||.|||++++ +|+||||+||+++.++.+||+|||++
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i---~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKI---LHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCe---eccCCCHHHEEECCCCcEEECcCCCc
Confidence 35999999975 8888886543 358999999999999999999999997 99999999999999999999999999
Q ss_pred cccccCCcc---cccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHc
Q 046083 634 KLTEVGSAS---VHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLR 709 (790)
Q Consensus 634 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 709 (790)
......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...... ........+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-----~~~~~~~~~~~ 241 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-----HQLTLISQLCG 241 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhC
Confidence 865432211 11234567889999988764 4788999999999999999999988543321 11111111111
Q ss_pred CCCCh--------hhhhh---------hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 710 QPDPR--------EDLQR---------LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 710 ~~~~~--------~~l~~---------~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
..... ..... .+...+.. ......+.+++.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~---~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKP---YVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhccc---ccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 10000 00000 00000000 0112456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=285.26 Aligned_cols=247 Identities=25% Similarity=0.378 Sum_probs=193.1
Q ss_pred CcccceeeeecCceEEEEEEE-----CCceEEEEEeChh-------hHHHHHHHHHHHHhc-CCCCCcceEEEEec-CeE
Q 046083 491 DFSMGNKIGQGGFGAVFYAEL-----RGEKAAIKKMDMQ-------ASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSL 556 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~-----~g~~vavK~~~~~-------~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~ 556 (790)
+|++.+.||+|+||.||++.. .|..+|+|.++.. ..+.+.+|++++.++ +|+||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999986 3788999998642 235678899999999 59999999988764 457
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
++||||+++++|.+++.... .+++..+..++.+++.||.|||+.++ +||||+|+|||+++++.+||+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~i---~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLGI---IYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---eccCCCHHHeEECCCCCEEEeeCccceec
Confidence 89999999999999997643 58899999999999999999999997 99999999999999999999999999865
Q ss_pred ccCCcccccccccCCCccchhcccCC--CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 637 EVGSASVHTRLVGTFGYMPPEYAQYG--EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 637 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
............|+..|+|||.+... .++.++||||||+++|+|++|..||...... .............
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~---- 227 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK----NSQAEISRRILKS---- 227 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc----ccHHHHHHHhhcc----
Confidence 43322222345688999999998753 4678999999999999999999998542211 1111111111111
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRP-----SMRAIVVA 761 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 761 (790)
...++......+.+++.+||+.+|++|| +.++++.+
T Consensus 228 -----------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 -----------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -----------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0112333456788999999999999997 66776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=291.93 Aligned_cols=266 Identities=24% Similarity=0.370 Sum_probs=199.4
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEec-----CeE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-----GSL 556 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~ 556 (790)
.++|++.+.||+|+||.||+|... +..+++|++... ..+.+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999875 889999988642 33567889999999999999999987642 347
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
++||||+. ++|.+++.... .+++..+..++.|++.||+|||++++ +||||||+||++++++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999996 58999987643 48999999999999999999999997 99999999999999999999999999765
Q ss_pred ccCCcc---cccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC
Q 046083 637 EVGSAS---VHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD 712 (790)
Q Consensus 637 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (790)
...... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||...... ............+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-----~~~~~~~~~~g~~~ 232 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-----HQLKLILSVLGSPS 232 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-----HHHHHHHHHhCCCh
Confidence 432211 1123468889999998865 46889999999999999999999999543221 00111111111110
Q ss_pred C-------hhhhhhhcCCc-CCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 713 P-------REDLQRLVDPR-LGDDY-----PIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 713 ~-------~~~l~~~~d~~-l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
. ...+.+..+.. ..... ....+..+.+++.+||+.+|++||++++++.+.+.-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~ 298 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298 (334)
T ss_pred hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence 0 00111111100 00011 122456799999999999999999999999876653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=286.24 Aligned_cols=243 Identities=30% Similarity=0.501 Sum_probs=198.0
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh------hhHHHHHHHHHHHHhcC-CCCCcceEEEEec-CeEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHVH-HLNLVRLIGYCVE-GSLFLV 559 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~------~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~-~~~~lv 559 (790)
++|.+.+.||+|+||.||++... +..+++|.+.. ...+.+.+|.+++++++ |+||+++++++.+ ...+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47889999999999999999885 88999998864 22356888999999998 9999999998764 468999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+++++|.+++...+ .+++..++.++.+++.||.|||++++ +|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~---~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGI---IHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999998754 59999999999999999999999998 99999999999999999999999999865432
Q ss_pred Cc-------------------ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccch
Q 046083 640 SA-------------------SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGL 700 (790)
Q Consensus 640 ~~-------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~ 700 (790)
.. .......++..|+|||.+....++.++|+||||+++++|++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------- 227 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-------- 227 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH--------
Confidence 21 111234578899999999888899999999999999999999999865431
Q ss_pred HHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 046083 701 VALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSM----RAIVV 760 (790)
Q Consensus 701 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~----~evl~ 760 (790)
...+..... .....+...+..+.+++.+||+.+|.+||++ ++++.
T Consensus 228 ~~~~~~~~~---------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 228 YLTFQKILK---------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHHHh---------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111111111 1112233345678999999999999999999 77765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-31 Score=285.29 Aligned_cols=239 Identities=29% Similarity=0.467 Sum_probs=188.7
Q ss_pred cccceeeeecCceEEEEEEEC--CceEEEEEeCh------hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEE
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEY 562 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~ 562 (790)
|...+.||+|+||.||+|... +..+++|.+.. ...+.+.+|+++++.++|||++++++++.++ ..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 566788999999999999875 78999998853 2235688899999999999999999988754 58999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+. ++|.+++.... ..+++..++.++.+++.||.|||+.++ +|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi---~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 96 57888776543 368999999999999999999999998 9999999999999999999999999864321
Q ss_pred cccccccCCCccchhccc---CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 643 VHTRLVGTFGYMPPEYAQ---YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
.....|+..|+|||++. ...++.++||||||+++|||++|..|+...... ...........
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~~~~~------- 237 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNDS------- 237 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHhcCC-------
Confidence 22356788999999984 456889999999999999999999998553221 11111111100
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
+.. ........+.+++.+||+.+|.+||++.+++.+
T Consensus 238 ---~~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 ---PTL---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011 111233468899999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=294.51 Aligned_cols=251 Identities=26% Similarity=0.407 Sum_probs=207.5
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEe-cCeEEEE
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLV 559 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~lv 559 (790)
....|.+...||+|.|+.|..|+.. +..||||.+++. ....+.+|+++|..++|||||+++.+.. +..+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 4567899999999999999999875 899999998643 3345889999999999999999999887 6679999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+.+|.+++++.+.++ +.......++.|+.+|++|||++++ ||||||++||||+.+..+||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~i---vHrdLk~eNilL~~~mnikIaDfgfS~~~~~- 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKNI---VHRDLKAENILLDENMNIKIADFGFSTFFDY- 207 (596)
T ss_pred EEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcce---eccccchhhcccccccceeeeccccceeecc-
Confidence 999999999999998764 5558888999999999999999998 9999999999999999999999999998763
Q ss_pred CcccccccccCCCccchhcccCCCC-CchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGEV-SPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
.......+|++.|.|||++.+..+ .+++|+||+|+++|-|+.|..||.... +..+..
T Consensus 208 -~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~--------lk~Lr~------------- 265 (596)
T KOG0586|consen 208 -GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN--------LKELRP------------- 265 (596)
T ss_pred -cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc--------cccccc-------------
Confidence 334566899999999999998876 578999999999999999999996422 111111
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
+.+-.+++- +.-...+..+++++++-.+|.+|++++++.+.-+.....
T Consensus 266 rvl~gk~rI--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 266 RVLRGKYRI--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred hheeeeecc--cceeechhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence 111122221 223345677999999999999999999999887764333
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=285.23 Aligned_cols=250 Identities=25% Similarity=0.437 Sum_probs=191.6
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcC-CCCCcceEEEEec-CeEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVH-HLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~g~~~~-~~~~lv~ 560 (790)
.++|++.+.||+|+||.||+|.+. +..+|||.++.. ...++..|+.++.+.. |+||+++++++.+ ...+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 356788999999999999999987 889999998642 3345667777777774 9999999999875 4589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE-HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
||+.+ +|.+++.... ..+++..+.+++.+++.||+|||+ .++ +||||+|+||++++++.+||+|||++......
T Consensus 94 e~~~~-~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i---~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 94 ELMST-CLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGV---IHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eccCc-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCE---ecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 99854 7777766533 368999999999999999999997 466 99999999999999999999999998765322
Q ss_pred CcccccccccCCCccchhcccCCC----CCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGE----VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (790)
.. .....++..|+|||.+.... ++.++||||||+++|||++|+.||...... ............
T Consensus 169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~--- 236 (296)
T cd06618 169 KA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------FEVLTKILQEEP--- 236 (296)
T ss_pred Cc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------HHHHHHHhcCCC---
Confidence 21 12335778999999987554 788999999999999999999998542111 111111221110
Q ss_pred hhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 716 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
+.. ........++.+++.+||+.||.+||++++++++.+.
T Consensus 237 -------~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~ 276 (296)
T cd06618 237 -------PSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFI 276 (296)
T ss_pred -------CCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence 000 0011234678999999999999999999999886653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=279.28 Aligned_cols=239 Identities=24% Similarity=0.342 Sum_probs=184.2
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEeChhh------HHHHHHHHHHH-HhcCCCCCcceEEEEecC-eEEEEEEEecC
Q 046083 496 NKIGQGGFGAVFYAELR--GEKAAIKKMDMQA------SKEFLAELKVL-THVHHLNLVRLIGYCVEG-SLFLVYEYIEN 565 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~------~~~~~~E~~~l-~~l~h~niv~l~g~~~~~-~~~lv~e~~~~ 565 (790)
+.||+|+||.||+|... ++.+|+|.+.... ...+..|..++ ...+|+|++++++++.++ ..+++|||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57899999999999885 7899999986422 12344454444 445899999999988754 58999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
++|.+++.... .+++..+.+++.|++.||.|||+.++ +|+||+|+||++++++.+||+|||+++.... ..
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~i---~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~ 151 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRGI---IHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK 151 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence 99999997643 58899999999999999999999998 9999999999999999999999999875432 22
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
...++..|++||.+.+..++.++||||||+++|||++|..||..... ...+........ ..
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~-----------~~ 212 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--------DAVFDNILSRRI-----------NW 212 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhccc-----------CC
Confidence 34578899999999888899999999999999999999999854321 111111111100 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.......++..+.+++.+||+.+|++||++.++.+.|.
T Consensus 213 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 213 PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 01111234567899999999999999997765554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=289.57 Aligned_cols=258 Identities=22% Similarity=0.406 Sum_probs=192.7
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-------e
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-------S 555 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-------~ 555 (790)
++|...+.||+|+||.||+|... ++.+|+|++... ....+.+|++++++++|+||+++++++... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 78999999999999999999874 789999988632 234578899999999999999999987532 3
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
.++|+||+.. +|.+++. ..+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++.
T Consensus 95 ~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i---~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 95 FYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGI---IHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred EEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 6899999965 7776653 258899999999999999999999998 9999999999999999999999999886
Q ss_pred cccCCcccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcC-CCC
Q 046083 636 TEVGSASVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQ-PDP 713 (790)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 713 (790)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... .......+.. ...
T Consensus 167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~--------~~~~~~~~~~~~~~ 234 (342)
T cd07879 167 ADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--------LDQLTQILKVTGVP 234 (342)
T ss_pred CCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHhcCCC
Confidence 4321 123457889999999876 4689999999999999999999999964321 1111111110 000
Q ss_pred hhhhh---------hhcC--CcC-CCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhhcc
Q 046083 714 REDLQ---------RLVD--PRL-GDDY---PIDSVRKMARLARACTQENPQLRPSMRAIVVA--LMTLSS 767 (790)
Q Consensus 714 ~~~l~---------~~~d--~~l-~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~l~~ 767 (790)
...+. ..+. +.. .... .......+.+++.+||+.||++||+++|++.+ +.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00000 0000 000 0000 01234568899999999999999999999965 554433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=284.30 Aligned_cols=240 Identities=24% Similarity=0.410 Sum_probs=190.7
Q ss_pred ceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecCCCh
Q 046083 495 GNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNL 568 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~g~L 568 (790)
..+||+|+||.||++... ++.+++|++.. ...+.+.+|+.+++.++|+|++++++++.. ...+++|||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 368999999999999885 78999998753 234568899999999999999999998875 458999999999999
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccccccc
Q 046083 569 NQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLV 648 (790)
Q Consensus 569 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 648 (790)
.+++... .+++.....++.+++.||+|||+.++ +|+||+|+||++++++.++|+|||++........ ......
T Consensus 105 ~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~gi---vH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 177 (292)
T cd06657 105 TDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLV 177 (292)
T ss_pred HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccc
Confidence 9988643 48999999999999999999999997 9999999999999999999999999875532221 122346
Q ss_pred cCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCC
Q 046083 649 GTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDD 728 (790)
Q Consensus 649 gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 728 (790)
++..|++||.+....++.++|+||||+++|||++|..||...... ...... . ....+.+..
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--------~~~~~~-~---------~~~~~~~~~- 238 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------KAMKMI-R---------DNLPPKLKN- 238 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHH-H---------hhCCcccCC-
Confidence 788999999998888999999999999999999999998542211 111111 0 011111100
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 729 YPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 729 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.......+.+++.+||+.+|.+||++.+++.+
T Consensus 239 -~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 239 -LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred -cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 11234567899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=279.59 Aligned_cols=244 Identities=23% Similarity=0.441 Sum_probs=190.5
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeCh--------hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM--------QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLV 559 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv 559 (790)
+|.+.+.||+|+||.||++... +...++|.++. ....++..|+.++++++|||++++++++.+ ...+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999876 34455554432 223456778999999999999999998764 458999
Q ss_pred EEEecCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccc
Q 046083 560 YEYIENGNLNQHLRGS--GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~ 637 (790)
|||+++++|.+++... ....+++..++.++.+++.||.|||+.++ +|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i---~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI---LHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCc---cccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988742 23469999999999999999999999998 99999999999976 569999999987653
Q ss_pred cCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 638 VGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ............
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--------~~~~~~~~~~~~------ 221 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--------FLSVVLRIVEGP------ 221 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHcCC------
Confidence 322 12223567889999999988889999999999999999999999984321 111111111110
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
....+......+.+++.+||+.+|++||++.|++++
T Consensus 222 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 222 --------TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --------CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 111233455678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=281.90 Aligned_cols=258 Identities=27% Similarity=0.414 Sum_probs=195.2
Q ss_pred cccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEe
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
|+..+.||+|++|.||++... ++.+++|.++.. ....+.+|++++++++|+|++++++++.. ...+++|||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999875 788999988643 23568889999999999999999998765 4589999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
++ +|.+++.... ..+++..+..++.+++.||.|||++++ +|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i---~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGI---LHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCe---eecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 76 8888887643 468999999999999999999999998 999999999999999999999999998664432 11
Q ss_pred ccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcC
Q 046083 644 HTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD 722 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d 722 (790)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...... +........+..+. ...+..+.+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-----~~~~~~~~~~~~~~-~~~~~~~~~ 228 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-----DQLFKIFRTLGTPD-PEVWPKFTS 228 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHcCCCc-hHhcccchh
Confidence 2234577889999998876 7899999999999999999999988543321 00000001111100 000101000
Q ss_pred ---------CcCC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 723 ---------PRLG----DDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 723 ---------~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
+... ..........+.+++.+||+.||.+||++++++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 01112346788999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-33 Score=321.13 Aligned_cols=249 Identities=28% Similarity=0.420 Sum_probs=201.3
Q ss_pred HHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEE
Q 046083 487 KATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFL 558 (790)
Q Consensus 487 ~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~l 558 (790)
.-+-++.-..+||.|.||.||.|... |+..|+|-++.. ..+...+|+.++..++|||+|+.||+-.+. ..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 34456778899999999999999864 888999977642 234578899999999999999999998754 5889
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
.||||++|+|.+.++..+ -.++.....+..|++.|++|||++|+ |||||||.||||+.+|.+|++|||.|.....
T Consensus 1312 FMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~gI---VHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHGI---VHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcCc---eecCCCccceeeecCCcEEeecccceeEecC
Confidence 999999999999998653 36666677788999999999999999 9999999999999999999999999997754
Q ss_pred CCccc---ccccccCCCccchhcccCCC---CCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC
Q 046083 639 GSASV---HTRLVGTFGYMPPEYAQYGE---VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD 712 (790)
Q Consensus 639 ~~~~~---~~~~~gt~~y~aPE~~~~~~---~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (790)
..... ....+||+-|||||++.+.. -..+.||||+|||++||+||+.||...+.. ....+...+..
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne------~aIMy~V~~gh-- 1458 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE------WAIMYHVAAGH-- 1458 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch------hHHHhHHhccC--
Confidence 43222 23568999999999997643 456899999999999999999999765432 11222222211
Q ss_pred ChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 713 PREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 713 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.+.+|.....+-.+++..||+.||++|.++.|++++
T Consensus 1459 -------------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 -------------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -------------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 134566677788999999999999999999887764
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=289.25 Aligned_cols=261 Identities=26% Similarity=0.398 Sum_probs=199.1
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEecC------eEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG------SLF 557 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 557 (790)
+|.+.+.||+|+||.||+|... ++.+++|++... ..+.+.+|+++++.++|+||+++++++... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788999999999999999975 789999988642 345788999999999999999999987643 479
Q ss_pred EEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccc
Q 046083 558 LVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~ 637 (790)
++|||+.+ +|.+++.... .+++..++.++.+++.||+|||++++ +|+||||+|||++.++.++|+|||++....
T Consensus 81 lv~e~~~~-~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi---~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANV---IHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchhh-hHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 99999985 8999887643 69999999999999999999999997 999999999999999999999999998765
Q ss_pred cCCc--ccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 638 VGSA--SVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 638 ~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
.... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...... ............+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~~~~~~~ 229 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI-----DQLNLIVEVLGTPSEE 229 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH-----HHHHHHHHhcCCCChh
Confidence 4321 112334678899999999887 7899999999999999999999998654321 0011111111111000
Q ss_pred -------hhhhhhcCC-cCCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 715 -------EDLQRLVDP-RLGDD-----YPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 715 -------~~l~~~~d~-~l~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
....+.+.. ..... ........+.+++.+||+.+|++||++++++.+-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 290 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence 000011100 00000 0112456789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=287.23 Aligned_cols=258 Identities=22% Similarity=0.392 Sum_probs=194.4
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEecC------
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG------ 554 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------ 554 (790)
..++|++.+.||+|+||.||++... +..+|+|++... ..+.+.+|++++++++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 3578999999999999999999875 789999988531 234678999999999999999999987532
Q ss_pred -eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCC
Q 046083 555 -SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLA 633 (790)
Q Consensus 555 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla 633 (790)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+.++ +||||||+||+++.++.++|+|||++
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi---~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEEcCCCCEEEeecccc
Confidence 358999998 6799888864 358999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCcccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcC-C
Q 046083 634 KLTEVGSASVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQ-P 711 (790)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-~ 711 (790)
...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...... ......... .
T Consensus 166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--------~~~~~~~~~~~ 233 (343)
T cd07880 166 RQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL--------DQLMEIMKVTG 233 (343)
T ss_pred cccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHhcC
Confidence 865322 123456889999999876 45889999999999999999999998643221 011111110 0
Q ss_pred CChhhh---------hhhcC--CcCCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 712 DPREDL---------QRLVD--PRLGD----DYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 712 ~~~~~l---------~~~~d--~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
.....+ ..... +.... .........+.+++.+|++.||++|||+.+++.+-..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~ 301 (343)
T cd07880 234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF 301 (343)
T ss_pred CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccH
Confidence 000000 00000 00000 0111234568899999999999999999999965443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=270.73 Aligned_cols=271 Identities=25% Similarity=0.359 Sum_probs=197.8
Q ss_pred cCcccceeeeecCceEEEEEEEC------CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEe--cCeE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR------GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCV--EGSL 556 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~------g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~ 556 (790)
..|+....||+|.||.||+|... ...+|||+++.+ ......+|+.++++++|||++.+..++. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46888999999999999999653 236899999754 2356788999999999999999988765 4568
Q ss_pred EEEEEEecCCChhhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC----CcEEEEE
Q 046083 557 FLVYEYIENGNLNQHLRGSG---KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN----FRAKVAD 629 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~----~~~kl~D 629 (790)
++++||.+. +|...++... ...++...+..|++||+.|+.|||++.+ +||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWv---lHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWV---LHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhhe---eeccCCcceEEEeccCCccCeeEeec
Confidence 999999998 9998886432 2468888899999999999999999998 999999999999877 8999999
Q ss_pred eCCCcccccCCccc--ccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccc----cchHH
Q 046083 630 FGLAKLTEVGSASV--HTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITES----TGLVA 702 (790)
Q Consensus 630 fGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~----~~~~~ 702 (790)
||+++.+...-... ...++-|..|+|||.+.+. .|+.+.|||+.|||+.||+|-.+.|.......... .+...
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999876443222 2346779999999999875 69999999999999999999887776554322111 01111
Q ss_pred HHHHHHcCCCCh--hhhhhhcCC---------cCCCCCCH--------HHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 703 LFEEVLRQPDPR--EDLQRLVDP---------RLGDDYPI--------DSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 703 ~~~~~~~~~~~~--~~l~~~~d~---------~l~~~~~~--------~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
....++..+... ..+..+-+- ........ .-.....+|+..+|+.||.+|.|+++.+++.-
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 111222221110 011111110 00000000 00112678999999999999999999988654
Q ss_pred h
Q 046083 764 T 764 (790)
Q Consensus 764 ~ 764 (790)
-
T Consensus 340 F 340 (438)
T KOG0666|consen 340 F 340 (438)
T ss_pred c
Confidence 4
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=287.33 Aligned_cols=263 Identities=29% Similarity=0.401 Sum_probs=191.9
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEec--------
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-------- 553 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------- 553 (790)
.++|++.+.||+|+||.||+|... ++.+++|.+... ....+.+|++++++++|+||+++++++.+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999985 788999987532 22457789999999999999999987642
Q ss_pred -CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCC
Q 046083 554 -GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGL 632 (790)
Q Consensus 554 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGl 632 (790)
...++||||+.+ +|...+.... ..+++..+..++.|+++||+|||+.++ +|+||||+||++++++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i---~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHI---LHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEECCCCCEEECcCcc
Confidence 136999999976 7777776532 369999999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCcc----------cccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchH
Q 046083 633 AKLTEVGSAS----------VHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLV 701 (790)
Q Consensus 633 a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~ 701 (790)
++........ ......+++.|+|||.+.+. .++.++||||||+++|||++|++||...... ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-----~~~ 236 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-----DQL 236 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-----HHH
Confidence 9865432211 11224567889999988654 5789999999999999999999998643321 111
Q ss_pred HHHHHHHcCCCCh-----hhhhhhcCCcCCCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 702 ALFEEVLRQPDPR-----EDLQRLVDPRLGDDYP-------IDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 702 ~~~~~~~~~~~~~-----~~l~~~~d~~l~~~~~-------~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
............. ..+....+.......+ ......+.+++.+||+.+|++|||+.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 1111111111000 0000000000000001 1122568899999999999999999998763
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=285.80 Aligned_cols=266 Identities=23% Similarity=0.355 Sum_probs=198.2
Q ss_pred CHHHHHHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEec
Q 046083 481 SYEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVE 553 (790)
Q Consensus 481 ~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 553 (790)
..+++...+++|.+.+.||+|+||.||++... ++.+|+|+++.. ..+.+.+|++++++++|+||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 34566778899999999999999999999864 789999998632 23567889999999999999999998752
Q ss_pred -------CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEE
Q 046083 554 -------GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAK 626 (790)
Q Consensus 554 -------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~k 626 (790)
...+++++++ +++|.+++... .+++..+..++.|+++||+|||+.++ +||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~i---vH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCe---eecCCChHHEEEcCCCCEE
Confidence 2267788876 77998888643 48999999999999999999999998 9999999999999999999
Q ss_pred EEEeCCCcccccCCcccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHH
Q 046083 627 VADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFE 705 (790)
Q Consensus 627 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 705 (790)
|+|||+++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..+ ....
T Consensus 161 l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~----~~~-~~~~ 231 (345)
T cd07877 161 ILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI----DQL-KLIL 231 (345)
T ss_pred Eeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHH-HHHH
Confidence 9999998754321 223467889999998866 56889999999999999999999998543221 000 0000
Q ss_pred HHHcCCCChhhh--------hhh---cCCcCCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 706 EVLRQPDPREDL--------QRL---VDPRLGDDY---PIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 706 ~~~~~~~~~~~l--------~~~---~d~~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
...... ..... ... +.......+ .......+.+++.+|++.||.+||++.+++.+-.
T Consensus 232 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 232 RLVGTP-GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred HHhCCC-CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 000000 00000 000 000000000 0113456889999999999999999999988654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=265.14 Aligned_cols=247 Identities=24% Similarity=0.423 Sum_probs=189.9
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHHHHHhcC-CCCCcceEEEEe-cCeEEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHVH-HLNLVRLIGYCV-EGSLFLVYEY 562 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~g~~~-~~~~~lv~e~ 562 (790)
+.+....||.|..|.|++++.. |...|||.+.. +..+.+...++++..-+ +|+||+.+||+. +.+.++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 3455789999999999999987 68999999964 34455667777766654 899999999987 5568889998
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
|.. .+..++... +.++++.-+-++...++.||.||.++.. ++|||+||+|||+|+.|.+||||||++-.+-...
T Consensus 173 Ms~-C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-- 246 (391)
T KOG0983|consen 173 MST-CAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-- 246 (391)
T ss_pred HHH-HHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeeccc--
Confidence 854 555555543 3468888889999999999999997653 4999999999999999999999999997664332
Q ss_pred cccccccCCCccchhcccC---CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 643 VHTRLVGTFGYMPPEYAQY---GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
-+++-.|-+.|||||.+.- ..|+-++||||||+.|+||.||+.||...... + .....++...
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td------F-e~ltkvln~e-------- 311 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD------F-EVLTKVLNEE-------- 311 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc------H-HHHHHHHhcC--------
Confidence 2345568889999999853 46889999999999999999999999764322 1 1111222211
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
.|.|... ......+.+++..||+.|+.+||...+++++-
T Consensus 312 --PP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 312 --PPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred --CCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 1222211 22456799999999999999999999998753
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=286.23 Aligned_cols=263 Identities=25% Similarity=0.389 Sum_probs=197.3
Q ss_pred HHHHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec--C
Q 046083 484 ELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE--G 554 (790)
Q Consensus 484 ~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~ 554 (790)
++...+++|++.+.||+|+||.||++... ++.+|+|++.. ...+.+.+|++++++++|||++++++++.. .
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34456789999999999999999999875 78899998753 234668899999999999999999998763 3
Q ss_pred eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCc
Q 046083 555 SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK 634 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~ 634 (790)
..++++||+ +++|.+++... .+++.....++.|++.||.|||+.++ +|+||+|+||++++++.++|+|||++.
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~i---iH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGV---VHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCHHHEeECCCCCEEeCcccccc
Confidence 589999998 55898888643 47888889999999999999999998 999999999999999999999999987
Q ss_pred ccccCCcccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC-
Q 046083 635 LTEVGSASVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD- 712 (790)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 712 (790)
..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ............+.
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~-----~~~~~~~~~~~~~~~ 227 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV-----NQFSIITDLLGTPPD 227 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCCH
Confidence 54321 123456889999998765 56899999999999999999999998543221 01111111111110
Q ss_pred -------ChhhhhhhcCCcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 713 -------PREDLQRLVDPRLGDDYP-----IDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 713 -------~~~~l~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
......-+..-......+ ......+.+++.+||+.+|++|||+++++.+-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~ 289 (328)
T cd07856 228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289 (328)
T ss_pred HHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 000000000000111111 12346789999999999999999999998863
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=286.44 Aligned_cols=261 Identities=26% Similarity=0.330 Sum_probs=192.6
Q ss_pred cCcc-cceeeeecCceEEEEEEEC--CceEEEEEeChhhH-----------------HHHHHHHHHHHhcCCCCCcceEE
Q 046083 490 NDFS-MGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS-----------------KEFLAELKVLTHVHHLNLVRLIG 549 (790)
Q Consensus 490 ~~f~-~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~-----------------~~~~~E~~~l~~l~h~niv~l~g 549 (790)
++|. +.+.||+|+||.||+|... ++.+|||.++.... ..+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 4577999999999999875 78999998864221 14678999999999999999999
Q ss_pred EEec-CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEE
Q 046083 550 YCVE-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVA 628 (790)
Q Consensus 550 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~ 628 (790)
++.. ...+++|||+. |+|.+++.... .+++.....++.|++.||+|||+.++ +|+||+|+||+++.++.++|+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~i---~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWYF---MHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---ecccccHHHeEECCCCCEEEC
Confidence 8874 45899999997 59999987543 58999999999999999999999998 999999999999999999999
Q ss_pred EeCCCcccccCC-------------cccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCcccccccccc
Q 046083 629 DFGLAKLTEVGS-------------ASVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETI 694 (790)
Q Consensus 629 DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~ 694 (790)
|||++....... ........++..|+|||.+.+. .++.++|+||||+++|||++|..||......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~- 240 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI- 240 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 999997654110 0111123467889999998764 4689999999999999999999998654321
Q ss_pred ccccchHHHHHHHHcCCCChhhhhhhc------------CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 695 TESTGLVALFEEVLRQPDPREDLQRLV------------DPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~l~~~~------------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
+...........+.. ..+.... .+... .........+.+++.+||+.+|++|||++|++.+-
T Consensus 241 ----~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 241 ----DQLGRIFELLGTPNE-DNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred ----HHHHHHHHHhCCCch-hhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 111111111111111 0000000 00000 00112345688999999999999999999999755
Q ss_pred H
Q 046083 763 M 763 (790)
Q Consensus 763 ~ 763 (790)
+
T Consensus 315 ~ 315 (335)
T PTZ00024 315 Y 315 (335)
T ss_pred c
Confidence 4
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=277.84 Aligned_cols=238 Identities=24% Similarity=0.323 Sum_probs=182.6
Q ss_pred eeeecCceEEEEEEEC--CceEEEEEeChhh------HHHHHHHHH---HHHhcCCCCCcceEEEEec-CeEEEEEEEec
Q 046083 497 KIGQGGFGAVFYAELR--GEKAAIKKMDMQA------SKEFLAELK---VLTHVHHLNLVRLIGYCVE-GSLFLVYEYIE 564 (790)
Q Consensus 497 ~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~------~~~~~~E~~---~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~ 564 (790)
.||+|+||.||++... ++.+|+|.+.... ...+..|.. .++...|||++++++++.+ ...++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999874 7899999875321 122334433 4444579999999988774 55899999999
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccc
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH 644 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 644 (790)
+++|.+++... ..+++..+..++.|++.||.|||+.++ +||||||+||+++.++.+||+|||++....... .
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i---~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~ 152 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCE---EcCCCCHHHEEECCCCCEEEccCcCccccCccC---C
Confidence 99999988754 359999999999999999999999997 999999999999999999999999987543221 1
Q ss_pred cccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 645 TRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
....|+..|+|||.+.++ .++.++||||||+++|||++|+.||....... ......... ...
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~-----------~~~- 215 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTL-----------TMA- 215 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc-----hHHHHHHhh-----------ccC-
Confidence 234689999999998754 68999999999999999999999986542211 000000000 001
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRP-----SMRAIVVAL 762 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~L 762 (790)
...+......+.+++.+|+..+|.+|| ++.+++++-
T Consensus 216 ---~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 216 ---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred ---CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence 112223356789999999999999999 999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=292.50 Aligned_cols=263 Identities=22% Similarity=0.402 Sum_probs=198.9
Q ss_pred cccceeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-------eEEE
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-------SLFL 558 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-------~~~l 558 (790)
+...+.||+|+||.||+|+.+ |+.+|||.++. ...+...+|+++|++++|+|||++++.-.+. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 344678999999999999975 99999999875 4456788999999999999999999876532 3689
Q ss_pred EEEEecCCChhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe--cCCC--cEEEEEeCCC
Q 046083 559 VYEYIENGNLNQHLRGSG-KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI--DKNF--RAKVADFGLA 633 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl--~~~~--~~kl~DfGla 633 (790)
+||||.+|+|+..|+... ...|++.+.+.+..+++.||.|||+++| +||||||.||++ .++| ..||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~I---vHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGI---VHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCc---eeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 999999999999998753 3579999999999999999999999998 999999999988 3334 4699999999
Q ss_pred cccccCCcccccccccCCCccchhccc-CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHH-HHHHHHcCC
Q 046083 634 KLTEVGSASVHTRLVGTFGYMPPEYAQ-YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVA-LFEEVLRQP 711 (790)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 711 (790)
+.++.+. ....+.||..|++||+.. ...|+.-.|.|||||++||..||..||....... .... .+....+.+
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk----~~~~~~~~~~tkkp 245 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK----NNKEIMWHIITKKP 245 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc----ccchhhhhhhccCC
Confidence 9876443 567789999999999998 4889999999999999999999999997644321 1111 122222222
Q ss_pred CChh-----------hhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC--CHHHHHHHHHhh
Q 046083 712 DPRE-----------DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRP--SMRAIVVALMTL 765 (790)
Q Consensus 712 ~~~~-----------~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP--t~~evl~~L~~l 765 (790)
..-. .+...+.. .-.........+-..+..++..+|++|. ...+....+..+
T Consensus 246 ~~v~i~~~~~eNgpv~~s~~lP~--p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 246 SGVAIGAQEEENGPVEWSSTLPQ--PNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred CceeEeeecccCCceeeeccCCC--cccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 1100 00000000 0011234455677788888999999998 555555555444
|
|
| >PRK06347 autolysin; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=295.49 Aligned_cols=241 Identities=17% Similarity=0.143 Sum_probs=172.9
Q ss_pred cceeEEeccCCchHHHHhhhcCCCChHHHHHHccCCCCCCCCCCcEEEEEeeccCCCC----c--------c-cCCceeE
Q 046083 76 HTFTYETQFGDTYEKVASFAFANLTTEDWVRRVNIYEPTRIPDYAFINVTVNCSCGDR----H--------I-SRDYGLF 142 (790)
Q Consensus 76 ~~~~Y~V~~GDTl~~IA~~~~~~~~t~~~l~~~N~~~~~~l~~Gq~l~iP~~~~~~~~----~--------~-~~~~~~~ 142 (790)
....|+|++||||+.|| ++|+. ++++|+++|.+..+.|.+||+|.||........ . . .......
T Consensus 329 ~~~~Y~V~sGDTL~~IA-~rygv--Sv~eL~~~N~l~~d~L~~Gq~L~VP~~~~~~~~~t~~~~~~~~~~~~~~~~~~~~ 405 (592)
T PRK06347 329 NAKIYTVVKGDSLWRIA-NNHKV--TVANLKAWNNLKSDFIYPGQKLKVSAGSTTSDTNTSKPSTGTSTSKPSTGTSTNA 405 (592)
T ss_pred CceEEEeCCCCCHHHHH-HHhCC--CHHHHHHHhCCCccccccCcEEEEeccccccccccccccccccccccccccccCc
Confidence 45689999999999999 78976 999999999888899999999999974211000 0 0 0001123
Q ss_pred EEeecCCCCCHHHHHHHhCCChHHHhhhCCC-CcccCCcceEEeechhhHHHHHHHHHHHHhhhhhccccccccchhhhh
Q 046083 143 TTYPLRPAQNLSSVAAEAGVAPQSLQRYNPG-TNFSAGTGLVFVPARVFELKLALLLVLAFFCARRRVEAVAECSKGCDL 221 (790)
Q Consensus 143 ~~y~v~~gd~l~~ia~~~~~~~~~l~~~N~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (790)
..|+|++||+|+.||++||+++++|+++|+. .+.+..++.+.||....... ... ................ .
T Consensus 406 ~~ytVk~GDTL~sIA~kygVSv~~L~~~N~l~s~~L~~Gq~L~IP~~~~~~~-----~t~-~~s~~~~~~k~~s~~~--~ 477 (592)
T PRK06347 406 KVYTVVKGDSLWRIANNNKVTIANLKSWNNLKSDFIYPGQKLKVSAGSTSNT-----NTS-KPSTNTNTSKPSTNTN--T 477 (592)
T ss_pred eeEEecCCCCHHHHHHHhCCCHHHHHHHhCCCcceeccCcEEEEecCCcccc-----ccc-cccccccccccccccc--c
Confidence 5799999999999999999999999999983 34566777777885321000 000 0000000000000000 1
Q ss_pred hheeeecCCCCCHHHHHHHcCCChhhHhhcCCCCCCcccccCCceEEeccccccCCC---------ceeeeeEEEEeccC
Q 046083 222 ALASYYLWKGANLTFISKVFDTSIKYILSFNPQITNKDKILAGTRINVPFSCNCIQN---------KFLGHSFSYKVKSG 292 (790)
Q Consensus 222 ~~~~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~ip~~~~~~~~---------~~~~~~~~y~V~~g 292 (790)
....|+|++||||+.||++||+++++|+++| ++. .+.|++||.|.||........ ........|+|++|
T Consensus 478 ~~~~YtVk~GDTL~sIAkkygVSv~~L~~~N-~l~-s~~L~~GQ~L~Ip~~~~~s~~~t~~~s~~~~~~~~~~~Y~Vk~G 555 (592)
T PRK06347 478 NAKVYTVAKGDSLWRIANNNKVTIANLKSWN-NLK-SDFIYPGQKLKVSAGSTTNNTNTAKPSTNKPSNSTVKTYTVKKG 555 (592)
T ss_pred cceeeeecCCCCHHHHHHHHCCCHHHHHHhc-CCC-cccccCCcEEEEecCcccccccccCCccCCccCccceeeecCCC
Confidence 2347999999999999999999999999999 674 468999999999985432110 00112357999999
Q ss_pred chHHHHHHHhhcccccHHHHHhcCCCCCCCCCCCCcEEEEe
Q 046083 293 NTYKRIAELIYANLTTLDWLKSSNAYDENHTPDVSSSVNVI 333 (790)
Q Consensus 293 Dtl~~IA~~~~~~l~~~~~l~~~N~~~~~~~~~~Gq~l~ip 333 (790)
||||.|| ++|. +++++|++||++.++.|.+ ||+|.|+
T Consensus 556 DTL~sIA-~Kyg--vSv~~L~~~N~L~~~~L~~-GQ~L~I~ 592 (592)
T PRK06347 556 DSLWAIS-RQYK--TTVDNIKAWNKLTSNMIHV-GQKLTIK 592 (592)
T ss_pred CcHHHHH-HHhC--CCHHHHHHhcCCCcccCCC-CCEEecC
Confidence 9999999 5565 7889999999998887777 9999985
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=288.25 Aligned_cols=257 Identities=25% Similarity=0.353 Sum_probs=189.6
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec-----------
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE----------- 553 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----------- 553 (790)
.+|.+.+.||.|+||.||+|... +..+++|.+.. ...+.+.+|++++++++||||+++++++..
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 67999999999999999999885 78999998854 334568899999999999999999876542
Q ss_pred ----CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC-CCcEEEE
Q 046083 554 ----GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK-NFRAKVA 628 (790)
Q Consensus 554 ----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~-~~~~kl~ 628 (790)
...++||||++ ++|.+++... .+++..+..++.|++.||.|||+.++ +||||||+||+++. ++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~gi---vH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANV---LHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCHHHEEEcCCCceEEEC
Confidence 23689999997 4898888642 48899999999999999999999998 99999999999974 5678999
Q ss_pred EeCCCcccccCCcc--cccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHH
Q 046083 629 DFGLAKLTEVGSAS--VHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFE 705 (790)
Q Consensus 629 DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 705 (790)
|||+++........ ......++..|+|||.+.. ..++.++|||||||++|||++|+.||....... ...
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--------~~~ 229 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE--------QMQ 229 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHH
Confidence 99999765322111 1122357889999998754 568889999999999999999999996443210 001
Q ss_pred HHHcC-CCChh-hhh-------hhcC-CcCCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 706 EVLRQ-PDPRE-DLQ-------RLVD-PRLGDDY-----PIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 706 ~~~~~-~~~~~-~l~-------~~~d-~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
..... +.... ... .... ....... ......++.+++.+||+.||++|||++|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 11100 00000 000 0000 0000000 11234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=277.18 Aligned_cols=258 Identities=27% Similarity=0.402 Sum_probs=194.2
Q ss_pred cccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEe
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
|+..+.||+|+||.||+|... ++.+++|.+... ..+.+..|++++++++|+|++++++++.+ +..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566789999999999999886 789999988753 23567889999999999999999998775 4589999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
. ++|.+++.... ..+++..+.+++.+++.||+|||++++ +|+||+|+||++++++.++|+|||++........ .
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i---~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRI---LHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 8 49999998653 358999999999999999999999998 9999999999999999999999999986543221 1
Q ss_pred ccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC---------
Q 046083 644 HTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP--------- 713 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 713 (790)
.....++..|+|||.+... .++.++||||||+++|||++|+.||...... ...............
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-----DQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHHHHhCCCcHHHHHhhccc
Confidence 2223457789999998766 7899999999999999999999888553321 000001111111000
Q ss_pred ---hhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 714 ---REDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 714 ---~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
...+............ ......+.+++.+||+.+|++||++++++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000000000000001 1225678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=270.33 Aligned_cols=231 Identities=28% Similarity=0.437 Sum_probs=188.2
Q ss_pred eeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecCCCh
Q 046083 498 IGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNL 568 (790)
Q Consensus 498 lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~g~L 568 (790)
||+|+||.||++... ++.+++|.+... ....+..|++++++++|+|++++++.+.. ...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999886 789999988643 33478899999999999999999987764 458999999999999
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccccccc
Q 046083 569 NQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLV 648 (790)
Q Consensus 569 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 648 (790)
.+++.... .+++.....++.+++.||.|||+.++ +|+||+|+||+++.++.++|+|||++....... .......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~---~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGI---IYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC 154 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---eecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence 99998653 58999999999999999999999998 999999999999999999999999998654322 1223456
Q ss_pred cCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCC
Q 046083 649 GTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDD 728 (790)
Q Consensus 649 gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 728 (790)
++..|++||...+...+.++|+||||+++|||++|+.||..... ......... . ...
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~-------------~--~~~ 211 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILK-------------D--PLR 211 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhc-------------C--CCC
Confidence 78899999999988899999999999999999999999854321 111111111 0 112
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 046083 729 YPIDSVRKMARLARACTQENPQLRPSMRA 757 (790)
Q Consensus 729 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 757 (790)
.+...+..+.+++.+||..||++||++.+
T Consensus 212 ~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 212 FPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 23333567889999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PRK06347 autolysin; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=291.31 Aligned_cols=235 Identities=17% Similarity=0.184 Sum_probs=174.5
Q ss_pred HhhhcccCCCCCHHHHHHHhCCCHHHHHhhCCCCCCCCCcCCCCeEEeeeecccCC--------C--------CCcccce
Q 046083 15 ALASYYVWEGSNPTYISNIFGEDIAQILLYNPNIPNQNTIPSDTRISIPFSCDCLN--------G--------DFLGHTF 78 (790)
Q Consensus 15 ~~~~y~v~~gdtl~~Ia~~~~~~~~~l~~~Np~~~~~~~~~~g~~l~ip~~~~~~~--------~--------~~~~~~~ 78 (790)
....|+|++||||+.||++||+++++|+++| ++.. +.|.+||.|+||....... . .......
T Consensus 329 ~~~~Y~V~sGDTL~~IA~rygvSv~eL~~~N-~l~~-d~L~~Gq~L~VP~~~~~~~~~t~~~~~~~~~~~~~~~~~~~~~ 406 (592)
T PRK06347 329 NAKIYTVVKGDSLWRIANNHKVTVANLKAWN-NLKS-DFIYPGQKLKVSAGSTTSDTNTSKPSTGTSTSKPSTGTSTNAK 406 (592)
T ss_pred CceEEEeCCCCCHHHHHHHhCCCHHHHHHHh-CCCc-cccccCcEEEEeccccccccccccccccccccccccccccCce
Confidence 3457999999999999999999999999999 5754 7899999999997421100 0 0012235
Q ss_pred eEEeccCCchHHHHhhhcCCCChHHHHHHccCCCCCCCCCCcEEEEEeeccCCCC---c---------ccCCceeEEEee
Q 046083 79 TYETQFGDTYEKVASFAFANLTTEDWVRRVNIYEPTRIPDYAFINVTVNCSCGDR---H---------ISRDYGLFTTYP 146 (790)
Q Consensus 79 ~Y~V~~GDTl~~IA~~~~~~~~t~~~l~~~N~~~~~~l~~Gq~l~iP~~~~~~~~---~---------~~~~~~~~~~y~ 146 (790)
.|+|++||||+.|| ++|+. ++..|+++|.+..+.|.+||+|.||........ . ..........|+
T Consensus 407 ~ytVk~GDTL~sIA-~kygV--Sv~~L~~~N~l~s~~L~~Gq~L~IP~~~~~~~~t~~~s~~~~~~k~~s~~~~~~~~Yt 483 (592)
T PRK06347 407 VYTVVKGDSLWRIA-NNNKV--TIANLKSWNNLKSDFIYPGQKLKVSAGSTSNTNTSKPSTNTNTSKPSTNTNTNAKVYT 483 (592)
T ss_pred eEEecCCCCHHHHH-HHhCC--CHHHHHHHhCCCcceeccCcEEEEecCCcccccccccccccccccccccccccceeee
Confidence 79999999999999 78976 889999999777789999999999974211000 0 000111235799
Q ss_pred cCCCCCHHHHHHHhCCChHHHhhhCCC-CcccCCcceEEeechhhHHHHHHHHHHHHhhhhhccccccccchhhhhhhee
Q 046083 147 LRPAQNLSSVAAEAGVAPQSLQRYNPG-TNFSAGTGLVFVPARVFELKLALLLVLAFFCARRRVEAVAECSKGCDLALAS 225 (790)
Q Consensus 147 v~~gd~l~~ia~~~~~~~~~l~~~N~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (790)
|++||||+.||++||+++++|+++|+. .+.+..++.+.||...... ....... ...+. .......
T Consensus 484 Vk~GDTL~sIAkkygVSv~~L~~~N~l~s~~L~~GQ~L~Ip~~~~~s-----------~~~t~~~-s~~~~--~~~~~~~ 549 (592)
T PRK06347 484 VAKGDSLWRIANNNKVTIANLKSWNNLKSDFIYPGQKLKVSAGSTTN-----------NTNTAKP-STNKP--SNSTVKT 549 (592)
T ss_pred ecCCCCHHHHHHHHCCCHHHHHHhcCCCcccccCCcEEEEecCcccc-----------cccccCC-ccCCc--cCcccee
Confidence 999999999999999999999999983 3456778888888542100 0000000 00000 0112457
Q ss_pred eecCCCCCHHHHHHHcCCChhhHhhcCCCCCCcccccCCceEEec
Q 046083 226 YYLWKGANLTFISKVFDTSIKYILSFNPQITNKDKILAGTRINVP 270 (790)
Q Consensus 226 y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~ip 270 (790)
|+|++|||||.||++|||++++|+++| ++. .+.|++||.|.|+
T Consensus 550 Y~Vk~GDTL~sIA~KygvSv~~L~~~N-~L~-~~~L~~GQ~L~I~ 592 (592)
T PRK06347 550 YTVKKGDSLWAISRQYKTTVDNIKAWN-KLT-SNMIHVGQKLTIK 592 (592)
T ss_pred eecCCCCcHHHHHHHhCCCHHHHHHhc-CCC-cccCCCCCEEecC
Confidence 999999999999999999999999999 784 4679999999985
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=303.00 Aligned_cols=140 Identities=29% Similarity=0.472 Sum_probs=126.4
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
++|.+.++||+|+||.||+|... ++.||||+++.. ....+..|+.++..++|+||+++++++.. ...|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67899999999999999999987 889999998642 23568899999999999999999987764 5689999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCc
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK 634 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~ 634 (790)
||+.+++|.+++...+ .+++..+++++.|++.||.|||.+++ +||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~gI---iHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHGI---IHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCE---EeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997643 48899999999999999999999987 999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=279.51 Aligned_cols=261 Identities=28% Similarity=0.374 Sum_probs=191.3
Q ss_pred CcccceeeeecCceEEEEEEEC----CceEEEEEeChh-----hHHHHHHHHHHHHhc-CCCCCcceEEEEec-----Ce
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR----GEKAAIKKMDMQ-----ASKEFLAELKVLTHV-HHLNLVRLIGYCVE-----GS 555 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~----g~~vavK~~~~~-----~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-----~~ 555 (790)
+|++.+.||+|+||.||++... +..+|+|++... ..+.+.+|+++++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788999999999999999986 458999987632 235678899999999 59999999987532 23
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
.++++||+. ++|.+++... ..+++..+..++.|++.||+|||+.++ +||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gi---vH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANV---LHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 688889886 5899988754 358999999999999999999999998 9999999999999999999999999986
Q ss_pred cccCCcc---cccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCC
Q 046083 636 TEVGSAS---VHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQP 711 (790)
Q Consensus 636 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (790)
....... ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...... ............+
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~ 229 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-----DQLNQILQVLGTP 229 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-----HHHHHHHHHhCCC
Confidence 5432211 1223568899999998765 46899999999999999999999998653311 0011011111100
Q ss_pred CChhhhhhhcCC-----------cCCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 712 DPREDLQRLVDP-----------RLGDD---YPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 712 ~~~~~l~~~~d~-----------~l~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
..+.+..+..+ .-... ........+.+++.+|++.+|++|||+.+++..=+
T Consensus 230 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~ 294 (332)
T cd07857 230 -DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294 (332)
T ss_pred -CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 00011110000 00000 01123457889999999999999999999986543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=303.19 Aligned_cols=247 Identities=31% Similarity=0.494 Sum_probs=182.6
Q ss_pred HHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEec-------
Q 046083 487 KATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVE------- 553 (790)
Q Consensus 487 ~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~------- 553 (790)
+-.++|+..+.||+||||.||+++.+ |..+|||++... ......+|+..|.+++|||||++|..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 44567888899999999999999876 999999998744 23457889999999999999975421100
Q ss_pred --------------------------------------------------------------------------------
Q 046083 554 -------------------------------------------------------------------------------- 553 (790)
Q Consensus 554 -------------------------------------------------------------------------------- 553 (790)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 046083 554 ---------------------------------GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH 600 (790)
Q Consensus 554 ---------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH 600 (790)
.-+|+=||||+...|.++++.+.... .....++++++|++||.|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH
Confidence 00355678888877777776543211 46677999999999999999
Q ss_pred hCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccc----------------cCCcc-cccccccCCCccchhcccCC-
Q 046083 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE----------------VGSAS-VHTRLVGTFGYMPPEYAQYG- 662 (790)
Q Consensus 601 ~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~----------------~~~~~-~~~~~~gt~~y~aPE~~~~~- 662 (790)
+.++ |||||||.||+||++..+||+|||+|.... .+... ..+..+||.-|+|||++.+.
T Consensus 715 ~~gi---IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQGI---IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCce---eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 9997 999999999999999999999999998621 00111 23457899999999999765
Q ss_pred --CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCC--CCCHHHHHHHH
Q 046083 663 --EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGD--DYPIDSVRKMA 738 (790)
Q Consensus 663 --~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~--~~~~~~~~~l~ 738 (790)
.|+.|+|+||+||||+||+. ||....+. .. + +..+-++.+.. .+..+....=.
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER-------a~----i---------L~~LR~g~iP~~~~f~~~~~~~e~ 848 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMER-------AS----I---------LTNLRKGSIPEPADFFDPEHPEEA 848 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHH-------HH----H---------HHhcccCCCCCCcccccccchHHH
Confidence 49999999999999999994 45332221 11 1 11111222211 12233344557
Q ss_pred HHHHHccccCCCCCCCHHHHHH
Q 046083 739 RLARACTQENPQLRPSMRAIVV 760 (790)
Q Consensus 739 ~li~~Cl~~dP~~RPt~~evl~ 760 (790)
.+|++|++.||.+|||+.|++.
T Consensus 849 slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 849 SLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHhcCCCccCCCHHHHhh
Confidence 8999999999999999999875
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=290.50 Aligned_cols=257 Identities=25% Similarity=0.418 Sum_probs=208.9
Q ss_pred CHHHHHHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh--hhHHHHHHHHHHHHhc-CCCCCcceEEEEe---
Q 046083 481 SYEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM--QASKEFLAELKVLTHV-HHLNLVRLIGYCV--- 552 (790)
Q Consensus 481 ~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--- 552 (790)
.++.+..-++.|++.+.||.|.+|.||+++.. ++..|+|++.. +..++...|.++|+.. .|||++.+||++.
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 34455556778999999999999999999764 78888888875 4457788899999988 6999999999875
Q ss_pred ---cCeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEE
Q 046083 553 ---EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVAD 629 (790)
Q Consensus 553 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~D 629 (790)
++.+|||||||.+|+..|++.......+.|..+..|++++++||++||.+.+ +|||||-.|||++.++.+||+|
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkv---iHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKV---IHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcce---eeecccCceEEEeccCcEEEee
Confidence 3469999999999999999987666789999999999999999999999998 9999999999999999999999
Q ss_pred eCCCcccccCCcccccccccCCCccchhcccCC-----CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHH
Q 046083 630 FGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYG-----EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALF 704 (790)
Q Consensus 630 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 704 (790)
||.+..++..-. ......||+.|||||++... .|+.++|+||||++..||--|.+|+....+.
T Consensus 167 FGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm----------- 234 (953)
T KOG0587|consen 167 FGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM----------- 234 (953)
T ss_pred eeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-----------
Confidence 999987654332 23346899999999999643 4788999999999999999999998765542
Q ss_pred HHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 705 EEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 705 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
..++.-+.. -.|.+ .-+..-..++.++|..||..|-++||++.+++++
T Consensus 235 raLF~IpRN-------PPPkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 235 RALFLIPRN-------PPPKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hhhccCCCC-------CCccc--cchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 111111110 01111 2244556789999999999999999999998764
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=283.39 Aligned_cols=259 Identities=24% Similarity=0.380 Sum_probs=194.2
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-C-----
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-G----- 554 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~----- 554 (790)
..++|++.+.||+|+||.||+|... +..+|+|++.. ...+.+.+|+.++++++|+|++++++++.. .
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3578999999999999999999986 78899998763 233557789999999999999999886642 2
Q ss_pred -eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCC
Q 046083 555 -SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLA 633 (790)
Q Consensus 555 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla 633 (790)
..++|+||+ +++|.+++.. ..+++..+..++.++++||+|||+.++ +|+||+|+||++++++.++|+|||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi---~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGI---IHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHeEECCCCCEEEcccccc
Confidence 279999998 5699998875 358999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCcccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC
Q 046083 634 KLTEVGSASVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD 712 (790)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (790)
...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ............+.
T Consensus 166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-----~~~~~i~~~~~~~~ 236 (343)
T cd07851 166 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-----DQLKRIMNLVGTPD 236 (343)
T ss_pred cccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHhcCCCC
Confidence 865322 223457889999999865 36789999999999999999999998643221 00000001111000
Q ss_pred -------ChhhhhhhcCC---cCCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 713 -------PREDLQRLVDP---RLGDDY---PIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 713 -------~~~~l~~~~d~---~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
.......++.. .....+ .......+.+++.+||+.+|++|||+.||+++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~ 299 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHP 299 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCC
Confidence 00011111110 000000 012356789999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=272.01 Aligned_cols=268 Identities=21% Similarity=0.301 Sum_probs=204.7
Q ss_pred ccCHHHHHHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh--hhHHHHHHHHHHHHhcCC--C----CCcceE
Q 046083 479 EFSYEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM--QASKEFLAELKVLTHVHH--L----NLVRLI 548 (790)
Q Consensus 479 ~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~--~~~~~~~~E~~~l~~l~h--~----niv~l~ 548 (790)
.+...|.. +++|.+..++|+|.||.|-...+. +..+|||+++. ...+.-.-|+++|+++.+ | -+|.+.
T Consensus 80 v~~~gD~l--~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 80 VYQVGDIL--TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EEEecccc--ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 34434443 788999999999999999998776 67899999874 334556779999999932 2 256666
Q ss_pred EEEe-cCeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC------
Q 046083 549 GYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK------ 621 (790)
Q Consensus 549 g~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~------ 621 (790)
+|+. .++.++|+|.+ |.+++++|..++..+++...+..++.|++++++|||+.++ +|.||||+|||+.+
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl---~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKL---THTDLKPENILFVSSEYFKT 233 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcce---eecCCChheEEEeccceEEE
Confidence 7665 67899999998 5599999999888899999999999999999999999998 99999999999932
Q ss_pred --------------CCcEEEEEeCCCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccc
Q 046083 622 --------------NFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAV 687 (790)
Q Consensus 622 --------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~ 687 (790)
+..+|++|||.|....... ...+.|..|+|||++.+..++.++||||+||||.||.+|...|
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence 3468999999998754332 4467799999999999999999999999999999999999888
Q ss_pred cccccccccccchHHHHHHHHcCCCChhhhhhh-------------------------cCCcC----CCCCCHHHHHHHH
Q 046083 688 VKTNETITESTGLVALFEEVLRQPDPREDLQRL-------------------------VDPRL----GDDYPIDSVRKMA 738 (790)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-------------------------~d~~l----~~~~~~~~~~~l~ 738 (790)
...+.. ....+.+.++. +.+...+.+. .++.. .......+..+|.
T Consensus 310 qtHen~-----EHLaMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf 383 (415)
T KOG0671|consen 310 QTHENL-----EHLAMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF 383 (415)
T ss_pred ccCCcH-----HHHHHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence 654421 22233333333 2211111111 11000 0011235667899
Q ss_pred HHHHHccccCCCCCCCHHHHHHHH
Q 046083 739 RLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 739 ~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
+|+++||..||.+|+|+.|++++-
T Consensus 384 DLl~~mL~fDP~~RiTl~EAL~Hp 407 (415)
T KOG0671|consen 384 DLLRRMLEFDPARRITLREALSHP 407 (415)
T ss_pred HHHHHHHccCccccccHHHHhcCH
Confidence 999999999999999999998753
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=271.66 Aligned_cols=262 Identities=26% Similarity=0.439 Sum_probs=206.8
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh------HHHHHHHHHHHHhc-CCCCCcceEEEEe-cCeEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA------SKEFLAELKVLTHV-HHLNLVRLIGYCV-EGSLFL 558 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~------~~~~~~E~~~l~~l-~h~niv~l~g~~~-~~~~~l 558 (790)
..+|.++..||+|+||.|..|..+ .+.+|||+++... .+--+.|-++|.-. +-|.+++++.++. -+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 347889999999999999999987 4679999987532 23345566676665 5788999988776 456999
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
||||+.||+|--+++.-++ +.++.+..++.+||-||-+||+++| +.||||.+||+||.+|++||+|||+.+.--.
T Consensus 428 VMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~kgI---iYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSKGI---IYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcCCe---eeeeccccceEeccCCceEeeeccccccccc
Confidence 9999999999999988764 7788889999999999999999998 9999999999999999999999999985432
Q ss_pred CCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 639 GSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
.. ......+||+.|+|||.+....|+.+.|+|||||+||||+.|++||...++ ..++..+++
T Consensus 503 ~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE--------~elF~aI~e--------- 564 (683)
T KOG0696|consen 503 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQAIME--------- 564 (683)
T ss_pred CC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHH---------
Confidence 22 223458999999999999999999999999999999999999999976443 233444433
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccCCcCCcccccccccccc
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWDIGSFYENQGLDSLMS 788 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~~~~~~~~~~~~~~~~~ 788 (790)
... .+|...+.+...+....+...|.+|.... .....+...+.|+..-+|.+++.
T Consensus 565 ----hnv--syPKslSkEAv~ickg~ltK~P~kRLGcg---------~~ge~di~~H~FFR~iDWek~E~ 619 (683)
T KOG0696|consen 565 ----HNV--SYPKSLSKEAVAICKGLLTKHPGKRLGCG---------PEGERDIREHPFFRRIDWEKLER 619 (683)
T ss_pred ----ccC--cCcccccHHHHHHHHHHhhcCCccccCCC---------CccccchhhCcchhhccHHHHhh
Confidence 222 45666677788899999999999994321 11123445666777777766653
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=301.99 Aligned_cols=256 Identities=25% Similarity=0.357 Sum_probs=207.7
Q ss_pred ccCHHHHHHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh------hhHHHHHHHHHHHHhcCCCCCcceEE-
Q 046083 479 EFSYEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHVHHLNLVRLIG- 549 (790)
Q Consensus 479 ~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g- 549 (790)
.-...++.-..++|.+.+.||+|+||.|..++.+ ++.+|.|+++. ....-|..|-++|..-+.+-|+.++-
T Consensus 64 v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA 143 (1317)
T KOG0612|consen 64 VKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA 143 (1317)
T ss_pred HHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH
Confidence 3455677777889999999999999999999986 78899999875 23345888999999889999999964
Q ss_pred EEecCeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEE
Q 046083 550 YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVAD 629 (790)
Q Consensus 550 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~D 629 (790)
|..+..+|+|||||+||+|-.+|...+ .+++..+..++..++.||.-||+.|+ |||||||+|||||..|++||+|
T Consensus 144 FQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgy---VHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 144 FQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGY---VHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred hcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccc---eeccCCcceeEecccCcEeecc
Confidence 445667999999999999999999876 58889999999999999999999998 9999999999999999999999
Q ss_pred eCCCcccccCCcccccccccCCCccchhccc----C-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHH
Q 046083 630 FGLAKLTEVGSASVHTRLVGTFGYMPPEYAQ----Y-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALF 704 (790)
Q Consensus 630 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 704 (790)
||.+..+...+.-.....+|||-|.+||+++ + +.|+..+|+||+||++|||+.|..||... .++..+
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad--------slveTY 290 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD--------SLVETY 290 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH--------HHHHHH
Confidence 9999888766665666789999999999985 2 57899999999999999999999999542 234444
Q ss_pred HHHHcCCCChhhhhhhcCCcCCCCCC--HHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 046083 705 EEVLRQPDPREDLQRLVDPRLGDDYP--IDSVRKMARLARACTQENPQLRPS---MRAIVVA 761 (790)
Q Consensus 705 ~~~~~~~~~~~~l~~~~d~~l~~~~~--~~~~~~l~~li~~Cl~~dP~~RPt---~~evl~~ 761 (790)
..++... -.-.|| .+.+.+..+||++.+. +|+.|-. ++++-.+
T Consensus 291 ~KIm~hk-------------~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 291 GKIMNHK-------------ESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred HHHhchh-------------hhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 4444331 112233 3456777888888775 5777766 6666543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=259.48 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=197.5
Q ss_pred HhcCcccc-eeeeecCceEEEEEEEC--CceEEEEEeChhhHHHHHHHHHHHHhc-CCCCCcceEEEEec---C--eEEE
Q 046083 488 ATNDFSMG-NKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHV-HHLNLVRLIGYCVE---G--SLFL 558 (790)
Q Consensus 488 ~~~~f~~~-~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~---~--~~~l 558 (790)
.+++|++. ++||-|-.|.|-.+..+ ++++|+|.+... ....+|+++.-.. .|||||.+++++.+ + -+.+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi 136 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI 136 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence 35666554 57899999999988776 889999988643 2345677765555 69999999998763 2 2689
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC---CCcEEEEEeCCCcc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK---NFRAKVADFGLAKL 635 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~---~~~~kl~DfGla~~ 635 (790)
|||.|+||.|+..+..++...+++.++..|+.+|+.|+.|||+.+| .||||||+|+|... |-.+||+|||+|+.
T Consensus 137 VmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nI---AHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 137 VMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNI---AHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcch---hhccCChhheeeecCCCCcceEecccccccc
Confidence 9999999999999999988899999999999999999999999998 99999999999954 45789999999996
Q ss_pred cccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChh
Q 046083 636 TEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715 (790)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (790)
.... ......+.|+.|.|||++-..+|+..+|+||+||++|-|++|-+||....... -..+.
T Consensus 214 t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-ispgM--------------- 275 (400)
T KOG0604|consen 214 TQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPGM--------------- 275 (400)
T ss_pred cCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-CChhH---------------
Confidence 5432 22345678999999999999999999999999999999999999996543311 00000
Q ss_pred hhhhhcCCcCCCCCCHH----HHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 716 DLQRLVDPRLGDDYPID----SVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 716 ~l~~~~d~~l~~~~~~~----~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
-.++.... -+||.. .++...++++.+|..+|.+|-|+++++.+-+.
T Consensus 276 -k~rI~~gq--y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi 325 (400)
T KOG0604|consen 276 -KRRIRTGQ--YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWI 325 (400)
T ss_pred -HhHhhccC--ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchh
Confidence 01111111 133433 44566789999999999999999999987664
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=293.83 Aligned_cols=263 Identities=20% Similarity=0.280 Sum_probs=172.4
Q ss_pred HhcCcccceeeeecCceEEEEEEEC------CceEEEEEeChhhHHHHHHHHHHHHhcCCCCCcceEE-E------EecC
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR------GEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIG-Y------CVEG 554 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~------g~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~g-~------~~~~ 554 (790)
..++|++.+.||+|+||.||+|.+. +..+|+|++......+...+. .+....+.++..++. + ..+.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e-~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE-RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH-HHHhhchhhHHHHHHhhhcccccccCC
Confidence 4578999999999999999999875 568999998653322211111 122222222222221 1 1234
Q ss_pred eEEEEEEEecCCChhhhhhcCCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCC
Q 046083 555 SLFLVYEYIENGNLNQHLRGSGKD------------------TLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPAN 616 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~~~------------------~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~N 616 (790)
..++||||+.+++|.+++...... ......+..++.|++.||.|||++++ +||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gI---iHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI---VHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCE---EeCcCCHHH
Confidence 589999999999999998753210 11233456799999999999999997 999999999
Q ss_pred EEecC-CCcEEEEEeCCCcccccCCcccccccccCCCccchhcccCC----------------------CCCchhhHHHH
Q 046083 617 ILIDK-NFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYG----------------------EVSPKIDVYAF 673 (790)
Q Consensus 617 ILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~sDvwS~ 673 (790)
||+++ ++.+||+|||+++.+............+++.|+|||.+... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99986 57999999999986654444444556789999999965322 23456799999
Q ss_pred HHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCC----C--CHHHHHHHHHHHHHcccc
Q 046083 674 GVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDD----Y--PIDSVRKMARLARACTQE 747 (790)
Q Consensus 674 Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~----~--~~~~~~~l~~li~~Cl~~ 747 (790)
||+||||+++..++... .......+.........+...+.+....+ + .........+|+.+||+.
T Consensus 366 GviL~el~~~~~~~~~~---------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSN---------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHhCcCCCchH---------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 99999999876553211 11111111111111112222222211000 0 001123456899999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 046083 748 NPQLRPSMRAIVVALM 763 (790)
Q Consensus 748 dP~~RPt~~evl~~L~ 763 (790)
||++|||++|++++-.
T Consensus 437 dP~kR~ta~e~L~Hpf 452 (566)
T PLN03225 437 KGRQRISAKAALAHPY 452 (566)
T ss_pred CcccCCCHHHHhCCcC
Confidence 9999999999998644
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=280.55 Aligned_cols=237 Identities=23% Similarity=0.377 Sum_probs=198.0
Q ss_pred cCcccceeeeecCceEEEEEEECCce--EEEEEeCh------hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELRGEK--AAIKKMDM------QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~g~~--vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~ 560 (790)
.++.....||-|+||.|=.+..+++. +|+|.+++ ...+....|-++|...+.|.||++|..+.+. ..|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34556778999999999999988665 78887764 3345688999999999999999999877765 489999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
|-|-||.|+..|+..+ .++..+...++-.+++|++|||++++ |.|||||+|++||.+|-+||.|||+|+....+.
T Consensus 500 EaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~i---IYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKGI---IYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred HhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcCc---eeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 9999999999999876 48888899999999999999999998 999999999999999999999999999876443
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
....++||+.|.|||.+.+...+.+.|.||||++++||++|.+||...++. ..+..++...
T Consensus 575 --KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm--------ktYn~ILkGi--------- 635 (732)
T KOG0614|consen 575 --KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM--------KTYNLILKGI--------- 635 (732)
T ss_pred --ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH--------HHHHHHHhhh---------
Confidence 344689999999999999999999999999999999999999999876542 2222222211
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPS 754 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt 754 (790)
-...+|........+|+++.+..+|.+|--
T Consensus 636 ----d~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 636 ----DKIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ----hhhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 112456666777889999999999999965
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=282.98 Aligned_cols=242 Identities=24% Similarity=0.386 Sum_probs=195.0
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhhHHHHHHHHHHHHhc-CCCCCcceEEEEecC-eEEEEEEEe
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHV-HHLNLVRLIGYCVEG-SLFLVYEYI 563 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~~~lv~e~~ 563 (790)
.++.|.+...+|.|+|+.|-++... +...++|++... ..+..+|+.++... +|||++++.+.+.++ +.|+|||.+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l 398 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL 398 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence 3567888889999999999999876 778899998765 33445677666665 799999999998865 689999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe-cCCCcEEEEEeCCCcccccCCcc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI-DKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl-~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
.++-|.+.+..... +. ..+..|+.+++.|+.|||++++ |||||||+|||+ ++.++++|+|||.++.....
T Consensus 399 ~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~gv---vhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 399 DGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQGV---VHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred cccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcCe---eecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 99988888775432 33 6777899999999999999998 999999999999 58899999999999876543
Q ss_pred cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcC
Q 046083 643 VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD 722 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d 722 (790)
....+-|..|.|||++....+++++|+||||++||+|++|+.||...... . +....+-
T Consensus 470 -~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~-------------ei~~~i~- 527 (612)
T KOG0603|consen 470 -CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------I-------------EIHTRIQ- 527 (612)
T ss_pred -hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------H-------------HHHHhhc-
Confidence 22334578999999999999999999999999999999999999764321 0 1111111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 723 PRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 723 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
.+.+....+....+|+.+||+.||.+||+|.++..+-+.
T Consensus 528 ---~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 528 ---MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ---CCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 122234556678899999999999999999999876655
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-30 Score=263.47 Aligned_cols=218 Identities=22% Similarity=0.229 Sum_probs=173.5
Q ss_pred cCceEEEEEEEC--CceEEEEEeChhhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecCCChhhhhhcCCC
Q 046083 501 GGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLNQHLRGSGK 577 (790)
Q Consensus 501 G~fg~Vy~a~~~--g~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~g~L~~~l~~~~~ 577 (790)
|.||.||++... ++.+|+|.+.... .+..|...+....|||++++++++.+ ...+++|||+++|+|.+++....
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~- 80 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL- 80 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc-
Confidence 889999999885 7899999987643 33445555666679999999998775 45899999999999999987643
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccccccccCCCccchh
Q 046083 578 DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE 657 (790)
Q Consensus 578 ~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE 657 (790)
.+++..+..++.+++.||.|||+.++ +||||||+||+++.++.++++|||.+...... .....++..|+|||
T Consensus 81 -~l~~~~~~~~~~ql~~~l~~lH~~~i---~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~aPE 152 (237)
T cd05576 81 -NIPEECVKRWAAEMVVALDALHREGI---VCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAPE 152 (237)
T ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCe---eccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccCCc
Confidence 48999999999999999999999997 99999999999999999999999987654322 12234567899999
Q ss_pred cccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHH
Q 046083 658 YAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKM 737 (790)
Q Consensus 658 ~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l 737 (790)
.+....++.++|+||+|+++|||++|..|+....... . .. .....+......+
T Consensus 153 ~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--------------~---------~~----~~~~~~~~~~~~~ 205 (237)
T cd05576 153 VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI--------------N---------TH----TTLNIPEWVSEEA 205 (237)
T ss_pred ccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--------------c---------cc----cccCCcccCCHHH
Confidence 9988889999999999999999999988764321100 0 00 0001222334578
Q ss_pred HHHHHHccccCCCCCCCHH
Q 046083 738 ARLARACTQENPQLRPSMR 756 (790)
Q Consensus 738 ~~li~~Cl~~dP~~RPt~~ 756 (790)
.+++.+|++.||++||++.
T Consensus 206 ~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHccCCHHHhcCCC
Confidence 8999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=281.71 Aligned_cols=263 Identities=21% Similarity=0.284 Sum_probs=180.2
Q ss_pred HhcCcccceeeeecCceEEEEEEE------------------CCceEEEEEeChhh---HHH--------------HHHH
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAEL------------------RGEKAAIKKMDMQA---SKE--------------FLAE 532 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~------------------~g~~vavK~~~~~~---~~~--------------~~~E 532 (790)
..++|++.++||+|+||.||+|.+ .+..||||+++... .++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 367899999999999999999964 24579999986321 122 3447
Q ss_pred HHHHHhcCCCCC-----cceEEEEe---------cCeEEEEEEEecCCChhhhhhcCC----------------------
Q 046083 533 LKVLTHVHHLNL-----VRLIGYCV---------EGSLFLVYEYIENGNLNQHLRGSG---------------------- 576 (790)
Q Consensus 533 ~~~l~~l~h~ni-----v~l~g~~~---------~~~~~lv~e~~~~g~L~~~l~~~~---------------------- 576 (790)
+.++.+++|.++ ++++++|. ++..+|||||+++++|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777788876654 56777664 245799999999999999987421
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccccccccCCCccch
Q 046083 577 KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPP 656 (790)
Q Consensus 577 ~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aP 656 (790)
...++|..+..++.+++.+|.|||+.++ +||||||+|||++.++.+||+|||+++..............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~i---vHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGI---VHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 1235678889999999999999999997 9999999999999999999999999976543222111223457899999
Q ss_pred hcccCCCC----------------------CchhhHHHHHHHHHHHHhCCc-cccccccccccccchHHHHHHHHcCCCC
Q 046083 657 EYAQYGEV----------------------SPKIDVYAFGVVLYELISAME-AVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 657 E~~~~~~~----------------------s~~sDvwS~Gvvl~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
|.+..... ..+.||||+||+++||++|.. |+........+ .......
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~----------~~~~~~~ 449 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE----------LRQYDND 449 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH----------Hhhccch
Confidence 98754321 134799999999999999875 55321110000 0000000
Q ss_pred hhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCC---CCCCCHHHHHHHHH
Q 046083 714 REDLQRLVDPRLGDDYPIDSVRKMARLARACTQENP---QLRPSMRAIVVALM 763 (790)
Q Consensus 714 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP---~~RPt~~evl~~L~ 763 (790)
...+.........-...........+++.+|+..+| .+|+|++|++++-+
T Consensus 450 ~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 450 LNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred HHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 001111111111111112334677899999999766 78999999987643
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=238.32 Aligned_cols=261 Identities=29% Similarity=0.421 Sum_probs=192.4
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChhh-----HHHHHHHHHHHHhcCCCCCcceEEEEe-cCeEEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA-----SKEFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEY 562 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~lv~e~ 562 (790)
+|.-.++||+|.+|+||+|+.. ++.||+|+++..+ .....+|+.+++.++|.|||++++... +..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 3555689999999999999876 7889999986432 345789999999999999999999876 5568999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
|+. +|..+...... .++...+..++.|+++||.|+|++++ .|||+||+|.|++.+|+.|++|||+++.+......
T Consensus 83 cdq-dlkkyfdslng-~~d~~~~rsfmlqllrgl~fchshnv---lhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSHNV---LHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred hhH-HHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhhhh---hhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 976 88888876543 58888999999999999999999998 99999999999999999999999999976543222
Q ss_pred cccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC--Chhhhhh
Q 046083 643 VHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD--PREDLQR 719 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~ 719 (790)
....+-|..|++|.++.+. -|++..|+||-||++.||.....|....... ...+...+ ..+..+. ....+..
T Consensus 158 -ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv---ddqlkrif-~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV---DDQLKRIF-RLLGTPTEDQWPSMTK 232 (292)
T ss_pred -eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH---HHHHHHHH-HHhCCCccccCCcccc
Confidence 2234568999999999875 5899999999999999998754444322211 11122222 2222111 1112223
Q ss_pred hcCCcCCCCCCH---------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 720 LVDPRLGDDYPI---------DSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 720 ~~d~~l~~~~~~---------~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
+-|-...+.+|. .....=.+++...+.-+|..|.++++.+++
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 333332222321 122233578888888899999999988764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=254.34 Aligned_cols=232 Identities=31% Similarity=0.516 Sum_probs=187.7
Q ss_pred CceEEEEEEEC--CceEEEEEeChhh----HHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecCCChhhhhhc
Q 046083 502 GFGAVFYAELR--GEKAAIKKMDMQA----SKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLNQHLRG 574 (790)
Q Consensus 502 ~fg~Vy~a~~~--g~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~g~L~~~l~~ 574 (790)
+||.||+|... ++.+++|.+.... .+.+.+|++.+++++|+|++++++++.. ...+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 5899999987432 5789999999999999999999998875 568999999999999999976
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccccccccCCCcc
Q 046083 575 SGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYM 654 (790)
Q Consensus 575 ~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~ 654 (790)
... +++..++.++.++++++.|||+.++ +|+||+|+||++++++.++|+|||.+....... ......++..|+
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~~i---~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSNGI---IHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM 153 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHcCe---ecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence 543 8999999999999999999999998 999999999999999999999999998765332 223456788999
Q ss_pred chhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCH-HH
Q 046083 655 PPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPI-DS 733 (790)
Q Consensus 655 aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~-~~ 733 (790)
+||.+....++.++||||||+++++|++|..||..... ........... ........ ..
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-------~~~~~~~~~~~-------------~~~~~~~~~~~ 213 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ-------LLELFKKIGKP-------------KPPFPPPEWKI 213 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------HHHHHHHHhcc-------------CCCCccccccC
Confidence 99999988899999999999999999999999854211 11111111111 00000000 14
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 046083 734 VRKMARLARACTQENPQLRPSMRAIVV 760 (790)
Q Consensus 734 ~~~l~~li~~Cl~~dP~~RPt~~evl~ 760 (790)
...+.+++.+|+..+|++||++.++++
T Consensus 214 ~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 214 SPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CHHHHHHHHHHccCCchhccCHHHHhh
Confidence 467899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-30 Score=253.89 Aligned_cols=259 Identities=22% Similarity=0.378 Sum_probs=200.2
Q ss_pred cCHHHHHHHhcCcccceeeeecCceEEEEEEE--CCceEEEEEeCh---hhHHHHHHHHHHHHhc-CCCCCcceEEEEec
Q 046083 480 FSYEELAKATNDFSMGNKIGQGGFGAVFYAEL--RGEKAAIKKMDM---QASKEFLAELKVLTHV-HHLNLVRLIGYCVE 553 (790)
Q Consensus 480 ~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~--~g~~vavK~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 553 (790)
-+|+|+.+-| .+.||+|.++.|--+.. .|..+|||++.+ .......+|++++.+. .|+||+.|++|+.+
T Consensus 73 g~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 73 GKFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred chHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 3578887777 68999999999998765 388999999874 3456789999999998 59999999999986
Q ss_pred C-eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCc---EEEEE
Q 046083 554 G-SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFR---AKVAD 629 (790)
Q Consensus 554 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~---~kl~D 629 (790)
+ ..|||||-|.||+|..+++... .+++.++.++.++|+.||.|||.++| .||||||+|||-..... +||+|
T Consensus 148 d~~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kgI---AHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKGI---AHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred cceEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcCc---ccccCCccceeecCCCCcCceeeec
Confidence 5 5899999999999999998754 59999999999999999999999998 99999999999966543 79999
Q ss_pred eCCCcccccC------CcccccccccCCCccchhccc-----CCCCCchhhHHHHHHHHHHHHhCCcccccccccc--cc
Q 046083 630 FGLAKLTEVG------SASVHTRLVGTFGYMPPEYAQ-----YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETI--TE 696 (790)
Q Consensus 630 fGla~~~~~~------~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~--~~ 696 (790)
|.+..-.... ........+|+..|||||+.. ..-|+.++|.||||||||-|++|-+||....... ++
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd 302 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD 302 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence 9887643211 112223467899999999763 3458899999999999999999999997655321 11
Q ss_pred ccc-----hHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHH----HHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 697 STG-----LVALFEEVLRQPDPREDLQRLVDPRLGDDYPID----SVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 697 ~~~-----~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~----~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
... ...+|+.+-+ .. -+||.. +..+..+++...+-.|+.+|-++.+++.+-+
T Consensus 303 rGe~Cr~CQ~~LFesIQE-------------Gk--YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw 363 (463)
T KOG0607|consen 303 RGEVCRVCQNKLFESIQE-------------GK--YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW 363 (463)
T ss_pred CCCccHHHHHHHHHHHhc-------------cC--CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence 111 1122222221 11 134443 3455678888899999999999998887443
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-31 Score=255.67 Aligned_cols=247 Identities=25% Similarity=0.370 Sum_probs=186.7
Q ss_pred cccceeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHHHHHhc-CCCCCcceEEEEe-cCeEEEEEEEe
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHV-HHLNLVRLIGYCV-EGSLFLVYEYI 563 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~-~~~~~lv~e~~ 563 (790)
.+-+..||.|.||+|+|-..+ |+..|||+++. .+.+++..|.+...+- +.||||++||.+. +++.|+.||.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 344679999999999998876 88999999974 3445678888765554 7999999999765 78899999999
Q ss_pred cCCChhhhh---hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 564 ENGNLNQHL---RGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 564 ~~g~L~~~l---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
+- +|..+- ..-.+..+++.-..+|..-.+.||.||...-. |||||+||+|||||..|.+||||||++-.+....
T Consensus 146 d~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 146 DI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI 222 (361)
T ss_pred hh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence 65 665433 22234568888888999999999999997643 4999999999999999999999999987553222
Q ss_pred cccccccccCCCccchhcccCC--CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYG--EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
. .+.-.|-..|||||.+... .|+-+|||||||++|+|+.||..|+..-+. .......+.....+
T Consensus 223 A--kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-------vfeql~~Vv~gdpp----- 288 (361)
T KOG1006|consen 223 A--KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-------VFEQLCQVVIGDPP----- 288 (361)
T ss_pred H--hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-------HHHHHHHHHcCCCC-----
Confidence 1 1234566789999998543 589999999999999999999999854322 22233333332221
Q ss_pred hhcCCcCC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046083 719 RLVDPRLG-DDYPIDSVRKMARLARACTQENPQLRPSMRAIVV 760 (790)
Q Consensus 719 ~~~d~~l~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 760 (790)
.+. +....+....+..++..|+.+|-..||...++..
T Consensus 289 -----~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 289 -----ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred -----eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 111 1111335567899999999999999999999865
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=265.12 Aligned_cols=251 Identities=24% Similarity=0.406 Sum_probs=193.5
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh----------hhHHHHHHHHHHHHhcCCCCCcceEEEEe-c-C
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----------QASKEFLAELKVLTHVHHLNLVRLIGYCV-E-G 554 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~-~ 554 (790)
.++|-++++||+|||+.||+|.+- .+.||||+-.. ...+...+|.+|.+.+.||.||++|+++. + .
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 356888999999999999999864 67899997642 11234678999999999999999999986 4 4
Q ss_pred eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC---CCcEEEEEeC
Q 046083 555 SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK---NFRAKVADFG 631 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~---~~~~kl~DfG 631 (790)
.+|-|+|||+|.+|+-+|.... .++++++..|+.||+.||.||.+.. |||||-||||.||||.+ .|.+||.|||
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 5899999999999999998653 6899999999999999999999987 78999999999999944 5789999999
Q ss_pred CCcccccCCcc------cccccccCCCccchhcccCC----CCCchhhHHHHHHHHHHHHhCCccccccccccccccchH
Q 046083 632 LAKLTEVGSAS------VHTRLVGTFGYMPPEYAQYG----EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLV 701 (790)
Q Consensus 632 la~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~ 701 (790)
+++.++..... ......||.+|++||++--+ ..+.|.||||+||++|..+.|+.||......
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-------- 690 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-------- 690 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--------
Confidence 99988654332 22346799999999988533 5788999999999999999999999654321
Q ss_pred HHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 046083 702 ALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIV 759 (790)
Q Consensus 702 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 759 (790)
..++...- +.. ...+.-...+....+...+|++||+.--++|....++.
T Consensus 691 ---QdILqeNT----Ilk--AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 691 ---QDILQENT----ILK--ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ---HHHHhhhc----hhc--ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 11111100 000 00111111123345677899999999999998777664
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=250.98 Aligned_cols=262 Identities=29% Similarity=0.394 Sum_probs=190.7
Q ss_pred cccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEec---------Ce
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVE---------GS 555 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~---------~~ 555 (790)
|.-..+||+|.||.||+|+.+ |+.||+|+.-.+ -.....+|+++|..++|+|++.++..|.. ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 444678999999999999876 677888876432 23456889999999999999999887741 23
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
+|+||.+|+. +|.-+|... ...++...+.+++.++..||.|+|...+ +|||+|+.|+|++.++.+||+|||+++.
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~ki---lHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKI---LHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhH---HhhcccHhhEEEcCCceEEeeccccccc
Confidence 8999999998 888888754 2468999999999999999999999998 9999999999999999999999999986
Q ss_pred cccCCcc---cccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHc--
Q 046083 636 TEVGSAS---VHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLR-- 709 (790)
Q Consensus 636 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-- 709 (790)
+...... ..+..+-|..|++||.+.+ ..++++.|||+-||++.||+|+.+-+....+. . ...+...+..
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq----q-ql~~Is~LcGs~ 248 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ----Q-QLHLISQLCGSI 248 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH----H-HHHHHHHHhccC
Confidence 6433222 2334566999999998876 47999999999999999999998777554321 1 1111111111
Q ss_pred --CCCC----hhhhhhhcCCcCC-CCCC--HHH------HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 710 --QPDP----REDLQRLVDPRLG-DDYP--IDS------VRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 710 --~~~~----~~~l~~~~d~~l~-~~~~--~~~------~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
+-++ .+.++.+-.+.+. +.+. .+. ..+..+|+..++..||.+|++.++++.+-.
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 0010 0111111001010 0000 011 125678999999999999999999876543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=267.52 Aligned_cols=242 Identities=22% Similarity=0.356 Sum_probs=190.9
Q ss_pred ceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecCC
Q 046083 495 GNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENG 566 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~g 566 (790)
.+.||+|.||+||-|+.+ |+.||||.+.+ .....+.+|+.||+.++||.||.+.-.|.. +..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 579999999999999875 99999998863 344678999999999999999999887774 568999999955
Q ss_pred ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC---CcEEEEEeCCCcccccCCccc
Q 046083 567 NLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN---FRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 567 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~---~~~kl~DfGla~~~~~~~~~~ 643 (790)
+..+.+-...+..+++.....++.||+.||.|||.++| +|+||||+||||... ..+||||||+|+..... ..
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knI---vHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--sF 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNI---VHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--SF 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcce---eeccCCchheeeccCCCCCceeeccccceeecchh--hh
Confidence 66666655556678888888899999999999999998 999999999999543 47999999999987533 33
Q ss_pred ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 644 HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
...++||+.|+|||+++...|...-|+||.||++|--++|..||....+ +....+.. .++.|
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-------IndQIQNA-----------aFMyP 784 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-------INDQIQNA-----------AFMYP 784 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-------hhHHhhcc-----------ccccC
Confidence 4568999999999999999999999999999999999999999964322 11111110 11111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.-.. .+......+||...|+..-++|-+.+.-+.+.|
T Consensus 785 p~PW---~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 785 PNPW---SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred CCch---hhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 1000 133455678999999999999999877655433
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=247.04 Aligned_cols=245 Identities=23% Similarity=0.383 Sum_probs=193.4
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhhH------HHHHHHHHHHHhc-CCCCCcceEEEEe-cCeEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS------KEFLAELKVLTHV-HHLNLVRLIGYCV-EGSLFL 558 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~------~~~~~E~~~l~~l-~h~niv~l~g~~~-~~~~~l 558 (790)
.++|.+++.||+|+|..|..++++ .+.+|+|+++++-. .=.+.|-....+. +||.+|.+..++. +..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 468999999999999999999886 67899998875322 2245566666655 7999999998776 667999
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
|.||+.||+|--+++... .+++..+..+..+|+.||.|||++|+ +.||||..|+|+|..|++||.|+|+.+.- .
T Consensus 329 vieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rgi---iyrdlkldnvlldaeghikltdygmcke~-l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERGI---IYRDLKLDNVLLDAEGHIKLTDYGMCKEG-L 402 (593)
T ss_pred EEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcCe---eeeeccccceEEccCCceeecccchhhcC-C
Confidence 999999999988887654 48899999999999999999999998 99999999999999999999999999853 2
Q ss_pred CCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 639 GSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
........++||+.|.|||.+.+..|....|+|++||+++||+.|+.||.-.+....+...-.-++..
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv------------ 470 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV------------ 470 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH------------
Confidence 33444566899999999999999999999999999999999999999997655322111111112222
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPS 754 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt 754 (790)
++++.+ .+|.........+++..|++||.+|..
T Consensus 471 -ilekqi--riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 471 -ILEKQI--RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred -Hhhhcc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 222222 234445556778999999999999853
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=279.93 Aligned_cols=243 Identities=26% Similarity=0.406 Sum_probs=188.8
Q ss_pred cccceeeeecCceE-EEEEEECCceEEEEEeChhhHHHHHHHHHHHHhc-CCCCCcceEEEEecCe-EEEEEEEecCCCh
Q 046083 492 FSMGNKIGQGGFGA-VFYAELRGEKAAIKKMDMQASKEFLAELKVLTHV-HHLNLVRLIGYCVEGS-LFLVYEYIENGNL 568 (790)
Q Consensus 492 f~~~~~lG~G~fg~-Vy~a~~~g~~vavK~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~-~~lv~e~~~~g~L 568 (790)
|...+.+|.|+.|+ ||+|.+.|+.||||++-.+......+|+..|+.- .|||||++|+...+.+ .|+..|.|.- +|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL 589 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SL 589 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hH
Confidence 45566789999875 8999999999999999888887888999999988 6999999998776544 8999999976 99
Q ss_pred hhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC---C--CcEEEEEeCCCcccccCCc
Q 046083 569 NQHLRGSGK--DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK---N--FRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 569 ~~~l~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~---~--~~~kl~DfGla~~~~~~~~ 641 (790)
.+++...+. ....-...+.+..|++.||++||+.++ |||||||+||||+. + .+++|+|||+++.+..+..
T Consensus 590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~i---VHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKI---VHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred HHHHhccccchhhcccccHHHHHHHHHHHHHHHHhccc---ccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 999987421 111113446788899999999999998 99999999999965 2 5789999999998876544
Q ss_pred cc--ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhC-CccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 642 SV--HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISA-MEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 642 ~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
.. .....||.+|+|||.+....-+.+.||||+||++|+.++| ..||...... ...++.... .+.
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R----------~~NIl~~~~---~L~ 733 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER----------QANILTGNY---TLV 733 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh----------hhhhhcCcc---cee
Confidence 33 3357799999999999998889999999999999999987 7888543221 111111111 010
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVV 760 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 760 (790)
. +.. ..++ +..+||.+|++.+|..||++.+|+.
T Consensus 734 ~-----L~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 734 H-----LEP--LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred e-----ecc--CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0 100 0111 6789999999999999999999974
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-28 Score=229.70 Aligned_cols=256 Identities=22% Similarity=0.369 Sum_probs=196.9
Q ss_pred hcCcccceeeeecCceEEEEEEE--CCceEEEEEeChhhHHHHHHHHHHHHhcC-CCCCcceEEEEecC---eEEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAEL--RGEKAAIKKMDMQASKEFLAELKVLTHVH-HLNLVRLIGYCVEG---SLFLVYEY 562 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~--~g~~vavK~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~---~~~lv~e~ 562 (790)
.++|++.+++|+|.++.||.|.. ++++++||.+++-..+.+.+|+.+|..++ ||||+++++...+. ...||+||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 46799999999999999999984 58899999999988899999999999996 99999999988754 36899999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC-CcEEEEEeCCCcccccCCc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN-FRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~-~~~kl~DfGla~~~~~~~~ 641 (790)
+.+.+...+.. .++...+..++.+++.||.|+|+.|+ .|||+||.|+++|.. -.++|+|+|+|.++.++..
T Consensus 117 v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GI---mHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e 188 (338)
T KOG0668|consen 117 VNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGI---MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
T ss_pred hccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCc---ccccCCcceeeechhhceeeeeecchHhhcCCCce
Confidence 99977766543 47778889999999999999999998 999999999999875 4689999999998865433
Q ss_pred ccccccccCCCccchhccc-CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHH--------HHHcC--
Q 046083 642 SVHTRLVGTFGYMPPEYAQ-YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFE--------EVLRQ-- 710 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~--------~~~~~-- 710 (790)
. .-.+.+..|.-||.+- ...|+-.-|+|||||+|.+|+..+.||........ .+..... ..+.+
T Consensus 189 Y--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D---QLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 189 Y--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD---QLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred e--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH---HHHHHHHHhChHHHHHHHHHHc
Confidence 2 2234567889999885 45688899999999999999999999976554321 1111110 00100
Q ss_pred ------------CCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 711 ------------PDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 711 ------------~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
...+..+..++.+.-+.. ...+..+++...|..|-.+|||++|.+.+
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl----~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHL----VSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCcccccc----CChHHHHHHHHHHhhccccccchHHHhcC
Confidence 001112223332221111 12567899999999999999999998764
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=241.02 Aligned_cols=260 Identities=25% Similarity=0.401 Sum_probs=194.1
Q ss_pred cccceeeeecCceEEEEEEEC--CceEEEEEeC-----hhhHHHHHHHHHHHHhcCCCCCcceEEEEec------CeEEE
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMD-----MQASKEFLAELKVLTHVHHLNLVRLIGYCVE------GSLFL 558 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~l 558 (790)
.+..+.||.|.||.||.+.+. |+.|++|++. ....+.+.+|+++|..++|.|++..++.-.. .++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 344689999999999999875 8899999985 2455789999999999999999999886543 24688
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
+.|.|.. +|...+-. .+.++-..+.-+..||++||.|||+.++ .||||||.|.|++.|..+||||||+++..+.
T Consensus 135 ~TELmQS-DLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~I---LHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANI---LHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHh-hhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcch---hhccCCCccEEeccCceEEecccccccccch
Confidence 8898866 78777764 3467777777788999999999999998 9999999999999999999999999998766
Q ss_pred CCcccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 639 GSASVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
......+..+-|..|+|||.+++. .|+.+.||||.||++.||+..+-.|...++. ....+..+++..+.. +.+
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi-----qQL~lItdLLGTPs~-EaM 282 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI-----EQLQMIIDLLGTPSQ-EAM 282 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH-----HHHHHHHHHhCCCcH-HHH
Confidence 655555556678999999999875 6999999999999999999776666544331 122233333332221 111
Q ss_pred h--------hhcC-----CcCCCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 718 Q--------RLVD-----PRLGDDY----PIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 718 ~--------~~~d-----~~l~~~~----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
+ .++. |.+...+ +..-..+-..+...++..||+.|.+.++.+..+.
T Consensus 283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 1 0111 1111111 1122234567888899999999999998877654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=252.79 Aligned_cols=210 Identities=28% Similarity=0.390 Sum_probs=172.5
Q ss_pred ccCHHHHHHHhc---CcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcce
Q 046083 479 EFSYEELAKATN---DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRL 547 (790)
Q Consensus 479 ~~~~~~l~~~~~---~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l 547 (790)
+..|-.|.++.- -|...+.||-|.||.|.+++.. ...+|.|.+++. .....+.|-+||.....+-||+|
T Consensus 615 ESnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrL 694 (1034)
T KOG0608|consen 615 ESNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRL 694 (1034)
T ss_pred hhhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEE
Confidence 334445555443 4888999999999999999754 557888887643 33457889999999999999999
Q ss_pred EEEEe-cCeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEE
Q 046083 548 IGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAK 626 (790)
Q Consensus 548 ~g~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~k 626 (790)
|-.|. ++.+|+||+|++||++-.+|-..+ -|.+..+..++.++..|+++.|..|. |||||||+|||||.+|++|
T Consensus 695 yySFQDkdnLYFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmGF---IHRDiKPDNILIDrdGHIK 769 (1034)
T KOG0608|consen 695 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMGF---IHRDIKPDNILIDRDGHIK 769 (1034)
T ss_pred EEEeccCCceEEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhccc---eecccCccceEEccCCcee
Confidence 86665 456999999999999999888765 58888888999999999999999997 9999999999999999999
Q ss_pred EEEeCCCccccc---------CCcc--------------------------------cccccccCCCccchhcccCCCCC
Q 046083 627 VADFGLAKLTEV---------GSAS--------------------------------VHTRLVGTFGYMPPEYAQYGEVS 665 (790)
Q Consensus 627 l~DfGla~~~~~---------~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~s 665 (790)
|.||||+.-+.. ++.. .....+||+.|+|||++....++
T Consensus 770 LTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~ 849 (1034)
T KOG0608|consen 770 LTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT 849 (1034)
T ss_pred eeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc
Confidence 999999853211 0000 00124799999999999999999
Q ss_pred chhhHHHHHHHHHHHHhCCccccccccc
Q 046083 666 PKIDVYAFGVVLYELISAMEAVVKTNET 693 (790)
Q Consensus 666 ~~sDvwS~Gvvl~elltG~~p~~~~~~~ 693 (790)
..+|+||.|||||||+-|+.||......
T Consensus 850 q~cdwws~gvil~em~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 850 QLCDWWSVGVILYEMLVGQPPFLADTPG 877 (1034)
T ss_pred ccchhhHhhHHHHHHhhCCCCccCCCCC
Confidence 9999999999999999999999765543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=242.58 Aligned_cols=269 Identities=22% Similarity=0.288 Sum_probs=195.2
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh--hhHHHHHHHHHHHHhcC-----C---CCCcceEEEEe----
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM--QASKEFLAELKVLTHVH-----H---LNLVRLIGYCV---- 552 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~--~~~~~~~~E~~~l~~l~-----h---~niv~l~g~~~---- 552 (790)
..+|.+.++||+|.|++||++.+. .+.||+|+.+. ...+....|+++|++++ | .+||+|+++|.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 367999999999999999999886 67899999985 34466789999999993 3 36999999885
Q ss_pred c-CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC---------
Q 046083 553 E-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN--------- 622 (790)
Q Consensus 553 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~--------- 622 (790)
. .+.+||+|++ |-+|..+|.....+.++...+.+|+.||+.||.|||..+. |||.||||+|||+..+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeeeeccccchhhhhh
Confidence 2 2589999999 4499999988877789999999999999999999998864 5999999999999311
Q ss_pred --C-----------------------------------------------------------------------------
Q 046083 623 --F----------------------------------------------------------------------------- 623 (790)
Q Consensus 623 --~----------------------------------------------------------------------------- 623 (790)
+
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence 0
Q ss_pred ------------------------------------------------------------------------------cE
Q 046083 624 ------------------------------------------------------------------------------RA 625 (790)
Q Consensus 624 ------------------------------------------------------------------------------~~ 625 (790)
++
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 01
Q ss_pred EEEEeCCCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccc-cccchHHHH
Q 046083 626 KVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETIT-ESTGLVALF 704 (790)
Q Consensus 626 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~-~~~~~~~~~ 704 (790)
||+|||-|....... +.-..|..|+|||++.+..|++.+|||||+|++|||.||...|........ .+.+.....
T Consensus 394 KIaDlGNACW~~khF----T~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i 469 (590)
T KOG1290|consen 394 KIADLGNACWVHKHF----TEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI 469 (590)
T ss_pred EEeeccchhhhhhhh----chhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence 111111111110000 001235579999999999999999999999999999999999876554322 233333444
Q ss_pred HHHHcCCCC-----hhhhhhhcCCc--------CC-----------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046083 705 EEVLRQPDP-----REDLQRLVDPR--------LG-----------DDYPIDSVRKMARLARACTQENPQLRPSMRAIVV 760 (790)
Q Consensus 705 ~~~~~~~~~-----~~~l~~~~d~~--------l~-----------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 760 (790)
.+++...+. ....+++++.. |. -.++.+...++.+++.-||+.+|++|||+.+.++
T Consensus 470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 443332110 00111222211 00 1356788999999999999999999999999998
Q ss_pred HHHh
Q 046083 761 ALMT 764 (790)
Q Consensus 761 ~L~~ 764 (790)
+-+.
T Consensus 550 hPwL 553 (590)
T KOG1290|consen 550 HPWL 553 (590)
T ss_pred Cccc
Confidence 7664
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=223.81 Aligned_cols=195 Identities=26% Similarity=0.393 Sum_probs=156.1
Q ss_pred cccceeeeecCceEEEEEEE--CCceEEEEEeCh----hhHHHHHHHHHHHHhc-CCCCCcceEEEE-ecCeEEEEEEEe
Q 046083 492 FSMGNKIGQGGFGAVFYAEL--RGEKAAIKKMDM----QASKEFLAELKVLTHV-HHLNLVRLIGYC-VEGSLFLVYEYI 563 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~--~g~~vavK~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~-~~~~~~lv~e~~ 563 (790)
..-...||+|++|.|-+-++ .|...|+|++.. +..+...+|+++..+- .+|.+|.+||.. .+++.++.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 34467899999998876665 489999998863 4456677888876554 799999999954 578899999999
Q ss_pred cCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 564 ENGNLNQHLRG--SGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 564 ~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
+- +|+.+-+. .....+++...-+|+..+.+||.|||++-. ++|||+||+|||++.+|++|+||||++-.+...-.
T Consensus 128 ~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 128 DT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred hh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence 76 78766543 123468899999999999999999999753 59999999999999999999999999986643222
Q ss_pred ccccccccCCCccchhcccC----CCCCchhhHHHHHHHHHHHHhCCccccccc
Q 046083 642 SVHTRLVGTFGYMPPEYAQY----GEVSPKIDVYAFGVVLYELISAMEAVVKTN 691 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~----~~~s~~sDvwS~Gvvl~elltG~~p~~~~~ 691 (790)
. +.-.|--.|||||.+.. ..|+-|+||||||+.+.||.+++.|+....
T Consensus 205 k--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 205 K--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred H--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 1 11345568999998853 368999999999999999999999986644
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-26 Score=227.96 Aligned_cols=205 Identities=40% Similarity=0.686 Sum_probs=179.9
Q ss_pred eeecCceEEEEEEEC--CceEEEEEeChhhH----HHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecCCChhh
Q 046083 498 IGQGGFGAVFYAELR--GEKAAIKKMDMQAS----KEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLNQ 570 (790)
Q Consensus 498 lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~----~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~g~L~~ 570 (790)
||+|.+|.||++... ++.+++|.+..... +.+.+|++.++.++|++++++++++.. ...+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999997 88999999986543 679999999999999999999998875 56899999999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC-CCcEEEEEeCCCcccccCCccccccccc
Q 046083 571 HLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK-NFRAKVADFGLAKLTEVGSASVHTRLVG 649 (790)
Q Consensus 571 ~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~g 649 (790)
++.... ..+++..+..++.++++++.+||+.++ +|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~---~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSNGI---IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCe---eccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 998642 358999999999999999999999997 99999999999999 89999999999986643321 1233457
Q ss_pred CCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCC
Q 046083 650 TFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDD 728 (790)
Q Consensus 650 t~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 728 (790)
...|++||.+... ..+.+.|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8899999999877 888999999999999998
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 729 YPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 729 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
..+.+++..|++.+|.+||++.+++..
T Consensus 188 ------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 357789999999999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-26 Score=228.24 Aligned_cols=254 Identities=24% Similarity=0.334 Sum_probs=189.9
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-------Ce
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-------GS 555 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------~~ 555 (790)
.+|.-...+|.|.- .|-.+.+. +++|++|++.. ...+...+|...+..++|+|+++++.++.. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 34555678888887 56666554 88999998753 345677889999999999999999998852 24
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
.|+|||+|+. +|...+.. .++-.....+..|++.|++|||+.++ +||||||+||++..+..+||.|||+|+.
T Consensus 96 ~y~v~e~m~~-nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~I---ihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILM----ELDHETISYILYQMLCGIKHLHSAGI---IHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhhhh-HHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcce---eecccCcccceecchhheeeccchhhcc
Confidence 7999999966 99998873 36777888999999999999999998 9999999999999999999999999986
Q ss_pred cccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHH---cCCC
Q 046083 636 TEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVL---RQPD 712 (790)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~ 712 (790)
.... -..+..+.+..|+|||++.+..+.+..||||+||++.||++|.-.|..... ...+..+. +.++
T Consensus 168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~--------idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH--------IDQWNKIIEQLGTPD 237 (369)
T ss_pred cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH--------HHHHHHHHHHhcCCC
Confidence 5432 245567788999999999988899999999999999999999887753221 11111111 1111
Q ss_pred C------------------h---hhhhhhcCCc-CCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 713 P------------------R---EDLQRLVDPR-LGD--DYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 713 ~------------------~---~~l~~~~d~~-l~~--~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
+ . -.+.+.+... ... +.+.-......+++.+||-.+|++|-+.++++.+-
T Consensus 238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 0 0 0111111110 000 11122344578899999999999999999998754
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=222.57 Aligned_cols=194 Identities=35% Similarity=0.591 Sum_probs=167.9
Q ss_pred cccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEec
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIE 564 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~ 564 (790)
|.+.+.||+|++|.||++... ++.+++|.+... ..+.+.+|++.+++++|+|++++++++.. ...++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 567889999999999999986 588999999754 45678999999999999999999998875 45899999999
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccc
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH 644 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 644 (790)
+++|.+++..... .+++.....++.+++.++.+||++++ +|+||+|+||+++.++.++|+|||.+...........
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i---~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGI---VHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 9999999986532 28899999999999999999999987 9999999999999999999999999987654321122
Q ss_pred cccccCCCccchhcc-cCCCCCchhhHHHHHHHHHHHHhCCccccc
Q 046083 645 TRLVGTFGYMPPEYA-QYGEVSPKIDVYAFGVVLYELISAMEAVVK 689 (790)
Q Consensus 645 ~~~~gt~~y~aPE~~-~~~~~s~~sDvwS~Gvvl~elltG~~p~~~ 689 (790)
....++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 335677889999998 666788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-26 Score=248.01 Aligned_cols=247 Identities=26% Similarity=0.431 Sum_probs=194.6
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh---HHHHHHHHHHHHhcCCCCCcceEEEEe-cCeEEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA---SKEFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEY 562 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~lv~e~ 562 (790)
.++|.+...+|.|.+|.|||+++. ++..|+|.++.+. ..-...|+-+++..+||||+.++|-+. ...+++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 467889999999999999999986 8899999988643 344678999999999999999999776 5568999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+.+|+|.+.-+..+ ++++.++..++++.++||+|||+.+. +|||||-.|||+++.+.+|++|||.+-.+...-.
T Consensus 94 cgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~gk---~hRdiKGanilltd~gDvklaDfgvsaqitati~- 167 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQGK---IHRDIKGANILLTDEGDVKLADFGVSAQITATIA- 167 (829)
T ss_pred cCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcCCc---ccccccccceeecccCceeecccCchhhhhhhhh-
Confidence 99999999877654 69999999999999999999999998 9999999999999999999999999876543222
Q ss_pred cccccccCCCccchhcc---cCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 643 VHTRLVGTFGYMPPEYA---QYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~---~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
....+.||+.|||||+. ..+.|.+.+|||+.|+...||--=++|.....+ .....+... .
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp----------mr~l~LmTk-------S 230 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP----------MRALFLMTK-------S 230 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch----------HHHHHHhhc-------c
Confidence 22347899999999976 456789999999999999998655566543322 111111110 1
Q ss_pred hcCC-cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046083 720 LVDP-RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVV 760 (790)
Q Consensus 720 ~~d~-~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 760 (790)
..++ .+.+ +..-.+.|.++++.|+..+|.+||+++.+++
T Consensus 231 ~~qpp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 231 GFQPPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCCCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1111 1111 2233457899999999999999999887654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=238.62 Aligned_cols=191 Identities=24% Similarity=0.407 Sum_probs=163.9
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChhhH-----------HHHHHHHHHHHhcC---CCCCcceEEEEec
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS-----------KEFLAELKVLTHVH---HLNLVRLIGYCVE 553 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~-----------~~~~~E~~~l~~l~---h~niv~l~g~~~~ 553 (790)
.+|+..+.+|+|+||.|+.+.++ ...|+||.+.++.. -..-.|+.||..++ |+||+++++|+++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46899999999999999999987 55788998765432 12567999999997 9999999999987
Q ss_pred Ce-EEEEEEEe-cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeC
Q 046083 554 GS-LFLVYEYI-ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFG 631 (790)
Q Consensus 554 ~~-~~lv~e~~-~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfG 631 (790)
++ +||+||-- ++.+|++++..+. .+++.+..-|++|++.|+++||+.++ ||||||-+|+.++.+|-+||+|||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~i---vhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGI---VHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCc---eecccccccEEEecCCeEEEeecc
Confidence 65 78888866 4669999998754 59999999999999999999999998 999999999999999999999999
Q ss_pred CCcccccCCcccccccccCCCccchhcccCCCC-CchhhHHHHHHHHHHHHhCCcccc
Q 046083 632 LAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEV-SPKIDVYAFGVVLYELISAMEAVV 688 (790)
Q Consensus 632 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwS~Gvvl~elltG~~p~~ 688 (790)
.+.+...++. ..++||..|.|||++.+..| ...-|||++|++||-++....||.
T Consensus 716 saa~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9987655443 34689999999999998887 456899999999999987777763
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=235.68 Aligned_cols=271 Identities=25% Similarity=0.326 Sum_probs=201.9
Q ss_pred cccccCHHHHHHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh--HHHHHHHHHHHHhcC------CCCCc
Q 046083 476 KSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA--SKEFLAELKVLTHVH------HLNLV 545 (790)
Q Consensus 476 ~~~~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~--~~~~~~E~~~l~~l~------h~niv 545 (790)
.+..+.+.|++ -.+|.+....|+|-|++|-+|.+. |..||||++.... .+.=..|+++|.+|+ .-|++
T Consensus 420 GYYrv~igE~L--D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 420 GYYRVRIGELL--DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred ceEEEehhhhh--cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHH
Confidence 34455666665 367999999999999999999886 8899999997543 345577999999995 24677
Q ss_pred ceEEEE-ecCeEEEEEEEecCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC-
Q 046083 546 RLIGYC-VEGSLFLVYEYIENGNLNQHLRGSGK-DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN- 622 (790)
Q Consensus 546 ~l~g~~-~~~~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~- 622 (790)
+++..| ...++|||||-+.. +|.++|...+. -.|....+..++.|+.-||..|...++ +|.||||.|||+++.
T Consensus 498 rl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~v---lHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGV---LHADIKPDNILVNESK 573 (752)
T ss_pred HHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCe---eecccCccceEeccCc
Confidence 877644 57789999998855 99999998764 458889999999999999999999998 999999999999875
Q ss_pred CcEEEEEeCCCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHH
Q 046083 623 FRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVA 702 (790)
Q Consensus 623 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 702 (790)
..+||||||.|....... .+.+.-+..|.|||++.+..|+...|+||.||.||||.||+-.|...... +...
T Consensus 574 ~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN-----~MLr 645 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN-----QMLR 645 (752)
T ss_pred ceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH-----HHHH
Confidence 467999999997654221 22344566899999999999999999999999999999999888654321 1112
Q ss_pred HHHHHHcCCC-----------------------------------------Chhhhhh-hcC-CcCCCCCCHHHHHHHHH
Q 046083 703 LFEEVLRQPD-----------------------------------------PREDLQR-LVD-PRLGDDYPIDSVRKMAR 739 (790)
Q Consensus 703 ~~~~~~~~~~-----------------------------------------~~~~l~~-~~d-~~l~~~~~~~~~~~l~~ 739 (790)
++.++-...+ +..++.. ++. +.+ ..-.......|.+
T Consensus 646 l~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~-~deq~~~~~~~rd 724 (752)
T KOG0670|consen 646 LFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRL-PDEQPKIVQQLRD 724 (752)
T ss_pred HHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCC-CchhHHHHHHHHH
Confidence 2222111100 0000111 110 001 1112346678999
Q ss_pred HHHHccccCCCCCCCHHHHHHH
Q 046083 740 LARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 740 li~~Cl~~dP~~RPt~~evl~~ 761 (790)
|+..|+..||++|.|..+.+.+
T Consensus 725 LLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 725 LLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHHHHhccChhhcCCHHHHhcC
Confidence 9999999999999999998764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-25 Score=216.31 Aligned_cols=238 Identities=21% Similarity=0.395 Sum_probs=177.7
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh--hhHHHHHHHHHHHHhc-CCCCCcceEEEEe--cCeEEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM--QASKEFLAELKVLTHV-HHLNLVRLIGYCV--EGSLFLVYEY 562 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~~~~lv~e~ 562 (790)
+.|.+.+.||+|.||.+..++.+ ...+++|.+.. ...++|.+|...--.+ .|.||+.-|+... .+-.++++||
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 45888999999999999999987 56899998864 3457899998766666 5899999887544 3457789999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe-cC-CCcEEEEEeCCCcccccCC
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI-DK-NFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl-~~-~~~~kl~DfGla~~~~~~~ 640 (790)
++.|+|.+-+...+ +.+....+++.|++.|+.|||++++ ||||||.+|||+ +. ..++||||||+.+.....
T Consensus 104 aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHsknl---VHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t- 176 (378)
T KOG1345|consen 104 APRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHSKNL---VHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT- 176 (378)
T ss_pred CccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhccch---hhcccccceEEEecCCccEEEeeecccccccCce-
Confidence 99999999988754 7888899999999999999999998 999999999999 33 348999999998854321
Q ss_pred cccccccccCCCccchhcccCC-----CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYG-----EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (790)
.....-+..|.+||..... ...+.+|+|.||++++.++||..||...... ......+. .+....
T Consensus 177 ---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~---d~~Y~~~~-~w~~rk---- 245 (378)
T KOG1345|consen 177 ---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM---DKPYWEWE-QWLKRK---- 245 (378)
T ss_pred ---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc---CchHHHHH-HHhccc----
Confidence 1223345679999977432 3567899999999999999999999743321 11222222 222111
Q ss_pred hhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCC
Q 046083 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLR 752 (790)
Q Consensus 716 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R 752 (790)
.+.+...+. ...+.+.++.++-+..+|++|
T Consensus 246 ------~~~~P~~F~-~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 246 ------NPALPKKFN-PFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred ------CccCchhhc-ccCHHHHHHHHHhcCCccccc
Confidence 112222221 233467788888899999999
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.6e-25 Score=228.26 Aligned_cols=269 Identities=23% Similarity=0.331 Sum_probs=195.0
Q ss_pred HHHHhcCcccceeeeecCceEEEEEEEC-----CceEEEEEeCh-hhHHHHHHHHHHHHhc-CCCCCcceEEEEec-CeE
Q 046083 485 LAKATNDFSMGNKIGQGGFGAVFYAELR-----GEKAAIKKMDM-QASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSL 556 (790)
Q Consensus 485 l~~~~~~f~~~~~lG~G~fg~Vy~a~~~-----g~~vavK~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~ 556 (790)
+....+.|...++||+|.|++||++.+. .+.||+|.+.. .......+|+++|..+ .+.||+++.+++.. +..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 3345567899999999999999999753 56899999875 4456789999999999 59999999998874 568
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC-CcEEEEEeCCCcc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN-FRAKVADFGLAKL 635 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~-~~~kl~DfGla~~ 635 (790)
.+|+||+++-...++... ++...+..+++.+..||.++|.+|+ |||||||+|+|.+.. +.-.|.|||+|..
T Consensus 111 ~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GI---vHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGI---VHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred EEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCc---cccCCCccccccccccCCceEEechhHHH
Confidence 999999999998888874 6788899999999999999999998 999999999999764 5679999999972
Q ss_pred cccCC--------------c-----------------------------ccccccccCCCccchhcccC-CCCCchhhHH
Q 046083 636 TEVGS--------------A-----------------------------SVHTRLVGTFGYMPPEYAQY-GEVSPKIDVY 671 (790)
Q Consensus 636 ~~~~~--------------~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvw 671 (790)
.+... . .......||+||+|||++.. ...+++.|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 21000 0 00012469999999998864 5689999999
Q ss_pred HHHHHHHHHHhCCccccccccccccccchHHHHH------HHH--cC-----CCC----h------hhhh-hhcCCc---
Q 046083 672 AFGVVLYELISAMEAVVKTNETITESTGLVALFE------EVL--RQ-----PDP----R------EDLQ-RLVDPR--- 724 (790)
Q Consensus 672 S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~------~~~--~~-----~~~----~------~~l~-~~~d~~--- 724 (790)
|.|||++.+++++.||.........-..+...+. ... +. ... . +.+. +.+.+.
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 9999999999999999876543221111111110 000 00 000 0 0010 111110
Q ss_pred -C-CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 725 -L-GDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 725 -l-~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
+ ........+..+.+++.+|+..||.+|.|++|.+.+
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0 001111223467899999999999999999998753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=207.24 Aligned_cols=168 Identities=23% Similarity=0.269 Sum_probs=127.7
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
|+|.++++..+ ..++|..++.++.|++.||.|||+++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-----
Confidence 68999998643 36999999999999999999999986 999999999999999 99988654321
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
..|++.|+|||++.+..++.++|||||||++|||++|+.||...... ......+....... ++.
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-------~~~~~~~~~~~~~~-------~~~- 127 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-------SAILEILLNGMPAD-------DPR- 127 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-------cHHHHHHHHHhccC-------Ccc-
Confidence 25789999999999999999999999999999999999998543221 11111111110000 000
Q ss_pred CCCCCHHHHH--HHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 046083 726 GDDYPIDSVR--KMARLARACTQENPQLRPSMRAIVVALMTLS 766 (790)
Q Consensus 726 ~~~~~~~~~~--~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~ 766 (790)
....+..... .+.+++.+||+.+|.+||++.|+++++..+.
T Consensus 128 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 128 DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 0011122222 6899999999999999999999999988764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-24 Score=259.55 Aligned_cols=197 Identities=17% Similarity=0.251 Sum_probs=138.7
Q ss_pred hcCC-CCCcceEEEEe-------c-CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcee
Q 046083 538 HVHH-LNLVRLIGYCV-------E-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYI 608 (790)
Q Consensus 538 ~l~h-~niv~l~g~~~-------~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~v 608 (790)
.++| .||+.+++++. + ..++++|||+ +++|.++|... ...+++..++.++.||++||.|||++++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gI---v 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGI---V 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCe---e
Confidence 4455 57888888662 1 2357788887 55999999754 2469999999999999999999999998 9
Q ss_pred ecCCCCCCEEecCCC-------------------cEEEEEeCCCcccccCCc---------------ccccccccCCCcc
Q 046083 609 HRDIKPANILIDKNF-------------------RAKVADFGLAKLTEVGSA---------------SVHTRLVGTFGYM 654 (790)
Q Consensus 609 H~dlkp~NILl~~~~-------------------~~kl~DfGla~~~~~~~~---------------~~~~~~~gt~~y~ 654 (790)
||||||+||||+..+ .+|++|||+++....... .......||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 999999999996544 455666666553211000 0011245788999
Q ss_pred chhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHH
Q 046083 655 PPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSV 734 (790)
Q Consensus 655 aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~ 734 (790)
|||++.+..++.++|||||||+||||++|.+|+..... ....... ..+.+.. ....
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----------~~~~~~~---------~~~~~~~-----~~~~ 238 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----------TMSSLRH---------RVLPPQI-----LLNW 238 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----------HHHHHHH---------hhcChhh-----hhcC
Confidence 99999999999999999999999999998877542111 0111100 0011110 1112
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 735 RKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 735 ~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.....++.+||+.+|.+||+|.|++++-.
T Consensus 239 ~~~~~~~~~~L~~~P~~Rps~~eil~h~~ 267 (793)
T PLN00181 239 PKEASFCLWLLHPEPSCRPSMSELLQSEF 267 (793)
T ss_pred HHHHHHHHHhCCCChhhCcChHHHhhchh
Confidence 34568889999999999999999987554
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.9e-24 Score=206.96 Aligned_cols=243 Identities=22% Similarity=0.375 Sum_probs=192.8
Q ss_pred ceeeeecCceEEEEEEECCceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecCCCh
Q 046083 495 GNKIGQGGFGAVFYAELRGEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNL 568 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~g~L 568 (790)
..+|.+...|..|+|+++|..++.|+++.. ..++|..|.-.|+-+.||||++++|.|.. ..+.++..||+.|+|
T Consensus 195 ~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 457888899999999999999888888643 34679999999999999999999999975 468999999999999
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccccccc
Q 046083 569 NQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLV 648 (790)
Q Consensus 569 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 648 (790)
+..|+....-..+-.+..+++.++++|++|||+.. |.|.---|.+..+++|++.+++|+ .+-+++.. ......
T Consensus 275 ynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris-mad~kfsf-----qe~gr~ 347 (448)
T KOG0195|consen 275 YNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS-MADTKFSF-----QEVGRA 347 (448)
T ss_pred HHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee-cccceeee-----eccccc
Confidence 99999876656788899999999999999999976 333444688999999999988875 11111110 011123
Q ss_pred cCCCccchhcccCCCCC---chhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 649 GTFGYMPPEYAQYGEVS---PKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 649 gt~~y~aPE~~~~~~~s---~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
-.+.||+||.++..+-+ .++|+|||.+++|||.|...||....+. +.--++.-..+
T Consensus 348 y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm---------------------ecgmkialegl 406 (448)
T KOG0195|consen 348 YSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM---------------------ECGMKIALEGL 406 (448)
T ss_pred cCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch---------------------hhhhhhhhccc
Confidence 46899999999876543 5799999999999999999999765432 11112223345
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
+..+|+.....+.+|+.-|+..||.+||.++.|+-.|++.
T Consensus 407 rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 5667778888999999999999999999999999998875
|
|
| >PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-23 Score=229.45 Aligned_cols=252 Identities=17% Similarity=0.241 Sum_probs=156.9
Q ss_pred CCCcccceeEEeccCCchHHHHhhhcCCCChHHHH----HHccCCCCCCCCCCcEEEEEeeccCCCCcccCCceeEEEee
Q 046083 71 GDFLGHTFTYETQFGDTYEKVASFAFANLTTEDWV----RRVNIYEPTRIPDYAFINVTVNCSCGDRHISRDYGLFTTYP 146 (790)
Q Consensus 71 ~~~~~~~~~Y~V~~GDTl~~IA~~~~~~~~t~~~l----~~~N~~~~~~l~~Gq~l~iP~~~~~~~~~~~~~~~~~~~y~ 146 (790)
++|..+.+.|+..+|-....|.+.+..+..+..|. .+...+.+..|..-..+.-|.......+.. .+...+....
T Consensus 189 g~~~lalAAYNaG~g~v~~~~~~~~~~~~~~d~w~~~lp~ETr~YV~~~la~~~i~~~~~~~~~~~~~~-~~~~~~~~V~ 267 (456)
T PRK10783 189 GDWLLTVAAYNSGEGRVMKAIKANKAKGKPTDFWSLSLPRETKIYVPKMLALSDILKNSKRYGVRLPTT-DESRALARVD 267 (456)
T ss_pred CCHHHHHHHHcCCHhHHHHHHHHhhhcCCCccchhcCccHHHHHHHHHHHHHHHHHhhHHhcCCCCCCc-CCCCceEEEe
Confidence 34445555566666666666653333333333332 222223333333333332232222211111 1234456677
Q ss_pred cCCCCCHHHHHHHhCCChHHHhhhCCCCcc----cCCcceEEeechhhH-HHHHHHHHHHHhhhhhccccccccchhhhh
Q 046083 147 LRPAQNLSSVAAEAGVAPQSLQRYNPGTNF----SAGTGLVFVPARVFE-LKLALLLVLAFFCARRRVEAVAECSKGCDL 221 (790)
Q Consensus 147 v~~gd~l~~ia~~~~~~~~~l~~~N~~~~~----~~~~~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (790)
+..+.+|..||+++|+++++|..+||+... +.+...+++|..... +...+...............+.. .
T Consensus 268 v~~~i~L~~iA~~~gvs~~eL~~LNP~~kr~~t~p~g~~~llvP~~~~~~f~~~l~~~~~~~~~p~~~~~~~~------~ 341 (456)
T PRK10783 268 LGQQIELAQAAEMAGMSLTKLKTFNAGYKRSTTAPSGPHYIMVPKKHADQLRESLASGEIAAVQSTLVADNTP------L 341 (456)
T ss_pred cCCCcCHHHHHHHcCCCHHHHHHhCccccCCCcCCCCCeEEEecCchhhHHHHhhhhhhhhhcccccccccCc------C
Confidence 878889999999999999999999996442 234567778864322 21111100000000000000000 1
Q ss_pred hheeeecCCCCCHHHHHHHcCCChhhHhhcCCCCCCcccccCCceEEeccccccCCCceeeeeEEEEeccCchHHHHHHH
Q 046083 222 ALASYYLWKGANLTFISKVFDTSIKYILSFNPQITNKDKILAGTRINVPFSCNCIQNKFLGHSFSYKVKSGNTYKRIAEL 301 (790)
Q Consensus 222 ~~~~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~ip~~~~~~~~~~~~~~~~y~V~~gDtl~~IA~~ 301 (790)
.+..|+|++||||++||++||+++.+|+++| ++.. +.|.+||.|.||.++.+..........+|+|++|||||+|| +
T Consensus 342 ~~~~y~Vk~GDTL~sIA~r~gvs~~~L~~~N-~l~~-~~L~~Gq~L~Ip~~~~~~~~~~~~~~~~Y~Vr~GDTL~sIA-~ 418 (456)
T PRK10783 342 NSRSYKVRSGDTLSGIASRLNVSTKDLQQWN-NLRG-SKLKVGQTLTIGAGSSAQRLANNSDSITYRVRKGDSLSSIA-K 418 (456)
T ss_pred CceEEEECCCCcHHHHHHHHCcCHHHHHHHc-CCCc-ccCCCCCEEEecCCcccccccccccceeEEeCCCCCHHHHH-H
Confidence 3457999999999999999999999999999 6644 78999999999988765422222334679999999999999 5
Q ss_pred hhcccccHHHHHhcCCCCCCCCCCCCcEEEEeEe
Q 046083 302 IYANLTTLDWLKSSNAYDENHTPDVSSSVNVIVN 335 (790)
Q Consensus 302 ~~~~l~~~~~l~~~N~~~~~~~~~~Gq~l~ip~~ 335 (790)
+|. +++++|++||++..+.|.+ ||+|.|++.
T Consensus 419 kyg--Vtv~~L~~~N~l~~~~L~p-Gq~L~l~v~ 449 (456)
T PRK10783 419 RHG--VNIKDVMRWNSDTAKNLQP-GDKLTLFVK 449 (456)
T ss_pred HhC--CCHHHHHHhcCCCCCcCCC-CCEEEEecC
Confidence 565 7889999999976666666 999999875
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=210.02 Aligned_cols=160 Identities=21% Similarity=0.207 Sum_probs=125.9
Q ss_pred HhcCcccceeeeecCceEEEEEEEC---CceEEEEEeChh--------hHHHHHHHHHHHHhcCCCCCcceEEEEecCeE
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR---GEKAAIKKMDMQ--------ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSL 556 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~---g~~vavK~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 556 (790)
..++|.+.+.||+|+||+||+|.+. +..+|||++... ..+.|.+|+++|++++|+|+++.+.. .+..
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--~~~~ 93 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--TGKD 93 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--cCCc
Confidence 3467999999999999999999864 567899986422 24568999999999999999864322 2457
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCC-CCCCEEecCCCcEEEEEeCCCcc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDI-KPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dl-kp~NILl~~~~~~kl~DfGla~~ 635 (790)
|+||||+++++|... ... . ...++.+++++|.|||++++ +|||| ||+|||++.++.+||+|||+++.
T Consensus 94 ~LVmE~~~G~~L~~~-~~~-----~---~~~~~~~i~~aL~~lH~~gI---iHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 94 GLVRGWTEGVPLHLA-RPH-----G---DPAWFRSAHRALRDLHRAGI---THNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred EEEEEccCCCCHHHh-Ccc-----c---hHHHHHHHHHHHHHHHHCCC---eeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 999999999999732 211 1 14577899999999999998 99999 99999999999999999999997
Q ss_pred cccCCccc-------ccccccCCCccchhcccC
Q 046083 636 TEVGSASV-------HTRLVGTFGYMPPEYAQY 661 (790)
Q Consensus 636 ~~~~~~~~-------~~~~~gt~~y~aPE~~~~ 661 (790)
........ .....+++.|+|||++..
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 65432111 134567888999999854
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.6e-20 Score=200.59 Aligned_cols=256 Identities=22% Similarity=0.285 Sum_probs=190.4
Q ss_pred CcccceeeeecCceEEEEEEECC---ceEEEEEeChhh---HHHHHHHHHHHHhcCC----CCCcceEEEEe-c-CeEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELRG---EKAAIKKMDMQA---SKEFLAELKVLTHVHH----LNLVRLIGYCV-E-GSLFL 558 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~g---~~vavK~~~~~~---~~~~~~E~~~l~~l~h----~niv~l~g~~~-~-~~~~l 558 (790)
+|.+.++||+|+||.||.+.... ..+|+|...... ...+..|..++..+.+ +++..+++... . ...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 79999999999999999999864 368888765432 1267888999988863 57888887773 3 34789
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC-----CcEEEEEeCCC
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN-----FRAKVADFGLA 633 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~-----~~~kl~DfGla 633 (790)
||+.+ |.+|.++........++..+.++++.|++.+|++||+.|. +||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~---iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGF---IHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCc---ccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99887 6699998866555679999999999999999999999998 999999999999765 46899999999
Q ss_pred c--ccccCCc-----cc--ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHH
Q 046083 634 K--LTEVGSA-----SV--HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALF 704 (790)
Q Consensus 634 ~--~~~~~~~-----~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 704 (790)
+ .+..... .. .....||..|.+++...+...+.+.|+||++.++.|++.|..||........ ...+
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-----~~~~ 249 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-----KSKF 249 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-----HHHH
Confidence 8 3221111 11 1235699999999999999999999999999999999999999865443210 1111
Q ss_pred HHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 705 EEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 705 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
...... ..... .....+..+.++...+-..+...+|....+...|......
T Consensus 250 ~~~~~~--------~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 250 EKDPRK--------LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred HHHhhh--------hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 111100 00000 1112334566666666678999999999999988776443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-18 Score=186.92 Aligned_cols=256 Identities=30% Similarity=0.523 Sum_probs=193.7
Q ss_pred cccceeeeecCceEEEEEEECCceEEEEEeChh------hHHHHHHHHHHHHhcCCC-CCcceEEEEecCe-EEEEEEEe
Q 046083 492 FSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQ------ASKEFLAELKVLTHVHHL-NLVRLIGYCVEGS-LFLVYEYI 563 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~-niv~l~g~~~~~~-~~lv~e~~ 563 (790)
|.....||.|+||.||++... ..+++|.+... ....+.+|+.++..+.|+ +++++++++.... .+++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 667889999999999999988 78888888632 356789999999999988 7999999886544 69999999
Q ss_pred cCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC-cEEEEEeCCCcccccCCc
Q 046083 564 ENGNLNQHLRGSGK-DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF-RAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 564 ~~g~L~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~-~~kl~DfGla~~~~~~~~ 641 (790)
.+++|.+++..... ..+.......+..+++.++.|+|+.++ +|||+||+||+++..+ .++++|||+++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~---~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGI---IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCe---eccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999977765432 258889999999999999999999997 9999999999999988 799999999985543322
Q ss_pred c-----cccccccCCCccchhcccC---CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC
Q 046083 642 S-----VHTRLVGTFGYMPPEYAQY---GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 642 ~-----~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
. ......|+..|++||.+.. ...+...|+||+|++++++++|..|+...... .........+......
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILELPTP 233 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHhcCCc
Confidence 1 2345689999999999987 57899999999999999999999996443221 0011111111111110
Q ss_pred hhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 714 REDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 714 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.................+.+++..|+..+|..|.++.+....
T Consensus 234 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 ------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223567899999999999999999887764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.1e-19 Score=180.32 Aligned_cols=255 Identities=22% Similarity=0.280 Sum_probs=192.9
Q ss_pred cCcccceeeeecCceEEEEEEE--CCceEEEEEeCh-hhHHHHHHHHHHHHhcC-CCCCcceEEEEecCe-EEEEEEEec
Q 046083 490 NDFSMGNKIGQGGFGAVFYAEL--RGEKAAIKKMDM-QASKEFLAELKVLTHVH-HLNLVRLIGYCVEGS-LFLVYEYIE 564 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~--~g~~vavK~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~-~~lv~e~~~ 564 (790)
-+|.++++||+|.||..+.|+. .++.||||.-.. ....++..|.+.++.+. .+.|...|-|-.++- -.||+|.+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 3588999999999999999975 499999997654 45567889999999884 678888776655553 46899988
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC-----cEEEEEeCCCcccccC
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF-----RAKVADFGLAKLTEVG 639 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~-----~~kl~DfGla~~~~~~ 639 (790)
|.+|.|++.-.++ .++.+++..++.|++.-++|+|++.. |.|||||+|+||...+ .+.|+|||+|+.+...
T Consensus 107 GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k~L---IYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 107 GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEKDL---IYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhcce---eecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 6799998887764 69999999999999999999999998 9999999999996543 5899999999987544
Q ss_pred Ccc------cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC
Q 046083 640 SAS------VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 640 ~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
.+. ......||..||+-....+.+.+.+.|+-|+|-++++.|-|..||...... ....-.+.+-+...
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~-----tnK~kYeKIGe~Kr- 256 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD-----TNKEKYEKIGETKR- 256 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc-----chHHHHHHhccccc-
Confidence 332 223467999999999999999999999999999999999999999875432 11112222221111
Q ss_pred hhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 714 REDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 714 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
...+.++. . ..+.++..-++-.-..+-++-|..+-+...+..
T Consensus 257 ~T~i~~Lc-----~----g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~d 298 (449)
T KOG1165|consen 257 STPIEVLC-----E----GFPEEFATYLRYVRRLDFFETPDYDYLRKLFDD 298 (449)
T ss_pred cCCHHHHH-----h----cCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 01122221 1 234566666666667788888997665554443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4e-20 Score=212.86 Aligned_cols=251 Identities=20% Similarity=0.265 Sum_probs=181.7
Q ss_pred ccceeeeecCceEEEEEEEC--CceEEEEEe-----ChhhH----HHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEE
Q 046083 493 SMGNKIGQGGFGAVFYAELR--GEKAAIKKM-----DMQAS----KEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVY 560 (790)
Q Consensus 493 ~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~-----~~~~~----~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~ 560 (790)
...+.+|.|.+|.|+..... .+..+.|.. ..... ..+..|+.+-..++|+|++..+..+.+. ..+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35789999999988777543 333333322 11111 1255677777888999997776654433 233449
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++ +|+.++...+ .+....+..++.|++.|+.|||+.|+ .|||+|++|+++..++.+||+|||.+.......
T Consensus 401 E~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~Gi---ahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMGL---AHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcCc---eeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 9999998753 47788888999999999999999998 999999999999999999999999998665433
Q ss_pred c---ccccccccCCCccchhcccCCCCCc-hhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhh
Q 046083 641 A---SVHTRLVGTFGYMPPEYAQYGEVSP-KIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716 (790)
Q Consensus 641 ~---~~~~~~~gt~~y~aPE~~~~~~~s~-~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (790)
. ......+|+..|+|||.+.+.+|++ ..||||.|+++..|++|+.||.......... ... .... .
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------~~~-~~~~---~ 543 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------KTN-NYSD---Q 543 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-------hhh-cccc---c
Confidence 3 2334578999999999999999986 5899999999999999999997765432111 000 0000 0
Q ss_pred hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 717 LQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 717 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
...... ........+.+...++.+||+.+|.+|-|+++|++.=|
T Consensus 544 -~~~~~~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W 587 (601)
T KOG0590|consen 544 -RNIFEG--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEW 587 (601)
T ss_pred -cccccC--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChH
Confidence 000000 00112345667889999999999999999999987443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=8e-19 Score=170.00 Aligned_cols=257 Identities=22% Similarity=0.264 Sum_probs=189.5
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh-HHHHHHHHHHHHhcCC-CCCcceEEEEecCe-EEEEEEEe
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA-SKEFLAELKVLTHVHH-LNLVRLIGYCVEGS-LFLVYEYI 563 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~-~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~-~~lv~e~~ 563 (790)
...|.+.++||+|+||.+|.|..- |+.||||.-+... ...+.-|.++++.++| ..|..+..|..+.+ -.+||+.+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL 93 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL 93 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence 357999999999999999999864 9999999876433 3457778999999975 45555666665544 58999988
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC---CcEEEEEeCCCcccccCC
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN---FRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~---~~~kl~DfGla~~~~~~~ 640 (790)
|.+|.+++.-..+ .++.++.+-++-|++.-++|+|.++. +||||||+|+|..-+ ..+.|+|||+++.+....
T Consensus 94 -GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r~f---iHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 94 -GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLRNF---IHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred -CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhhcc---ccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 7799998876543 68999999999999999999999997 999999999999643 468999999999764332
Q ss_pred cc------cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 641 AS------VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 641 ~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
.. ......||..|.+-....+.+.+.+.|+-|+|.+|..+.-|..||....... ..+-.+.+.+....
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t-----k~QKyEkI~EkK~s- 242 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT-----KKQKYEKISEKKMS- 242 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh-----HHHHHHHHHHhhcC-
Confidence 22 2234679999999998888889999999999999999999999997654321 11112222221110
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
..+. .+... .+.++...+.-|-..--++-|...-+-+.+..+
T Consensus 243 ~~ie-----~LC~G----~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 243 TPIE-----VLCKG----FPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred CCHH-----HHhCC----CcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 0011 12222 235677778888888888888876655544443
|
|
| >PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.4e-19 Score=194.25 Aligned_cols=168 Identities=17% Similarity=0.171 Sum_probs=127.4
Q ss_pred hHhhhcccCCCCCHHHHHHHhCCCHHHHHhhCCCCCCCCCcCCC-CeEEeeeecccC-----C--------C-----CCc
Q 046083 14 LALASYYVWEGSNPTYISNIFGEDIAQILLYNPNIPNQNTIPSD-TRISIPFSCDCL-----N--------G-----DFL 74 (790)
Q Consensus 14 ~~~~~y~v~~gdtl~~Ia~~~~~~~~~l~~~Np~~~~~~~~~~g-~~l~ip~~~~~~-----~--------~-----~~~ 74 (790)
..+..+.|..+.+|..||+++|+++++|+.+||+++.....+.| +.|.||...... . . ...
T Consensus 261 ~~~~~V~v~~~i~L~~iA~~~gvs~~eL~~LNP~~kr~~t~p~g~~~llvP~~~~~~f~~~l~~~~~~~~~p~~~~~~~~ 340 (456)
T PRK10783 261 RALARVDLGQQIELAQAAEMAGMSLTKLKTFNAGYKRSTTAPSGPHYIMVPKKHADQLRESLASGEIAAVQSTLVADNTP 340 (456)
T ss_pred CceEEEecCCCcCHHHHHHHcCCCHHHHHHhCccccCCCcCCCCCeEEEecCchhhHHHHhhhhhhhhhcccccccccCc
Confidence 34556677777899999999999999999999999765555556 778888853210 0 0 001
Q ss_pred ccceeEEeccCCchHHHHhhhcCCCChHHHHHHccCCCCCCCCCCcEEEEEeeccCCCCcccCCceeEEEeecCCCCCHH
Q 046083 75 GHTFTYETQFGDTYEKVASFAFANLTTEDWVRRVNIYEPTRIPDYAFINVTVNCSCGDRHISRDYGLFTTYPLRPAQNLS 154 (790)
Q Consensus 75 ~~~~~Y~V~~GDTl~~IA~~~~~~~~t~~~l~~~N~~~~~~l~~Gq~l~iP~~~~~~~~~~~~~~~~~~~y~v~~gd~l~ 154 (790)
.....|+|++||||++|| ++|+. +...|+++|.+.++.|.+||+|.||..+.+... .......+|+|++||||+
T Consensus 341 ~~~~~y~Vk~GDTL~sIA-~r~gv--s~~~L~~~N~l~~~~L~~Gq~L~Ip~~~~~~~~---~~~~~~~~Y~Vr~GDTL~ 414 (456)
T PRK10783 341 LNSRSYKVRSGDTLSGIA-SRLNV--STKDLQQWNNLRGSKLKVGQTLTIGAGSSAQRL---ANNSDSITYRVRKGDSLS 414 (456)
T ss_pred CCceEEEECCCCcHHHHH-HHHCc--CHHHHHHHcCCCcccCCCCCEEEecCCcccccc---cccccceeEEeCCCCCHH
Confidence 124579999999999999 78865 778899999776688999999999976544211 112224689999999999
Q ss_pred HHHHHhCCChHHHhhhCCCC-cccCCcceEEeec
Q 046083 155 SVAAEAGVAPQSLQRYNPGT-NFSAGTGLVFVPA 187 (790)
Q Consensus 155 ~ia~~~~~~~~~l~~~N~~~-~~~~~~~~~~~p~ 187 (790)
+||++||+++++|+++|+.. +...+++.+.++.
T Consensus 415 sIA~kygVtv~~L~~~N~l~~~~L~pGq~L~l~v 448 (456)
T PRK10783 415 SIAKRHGVNIKDVMRWNSDTAKNLQPGDKLTLFV 448 (456)
T ss_pred HHHHHhCCCHHHHHHhcCCCCCcCCCCCEEEEec
Confidence 99999999999999999843 2566677666653
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=175.38 Aligned_cols=173 Identities=16% Similarity=0.178 Sum_probs=134.1
Q ss_pred HHHHHH--HhcCcccceeeeecCceEEEEEEECCceEEEEEeChhh--H----HH------HHHHHHHHHhcCCCCCcce
Q 046083 482 YEELAK--ATNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQA--S----KE------FLAELKVLTHVHHLNLVRL 547 (790)
Q Consensus 482 ~~~l~~--~~~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~--~----~~------~~~E~~~l~~l~h~niv~l 547 (790)
|.++.. -.++|+..+.||.|+||.||.+...+..+|||.+..+. . .. +.+|++.+.++.|++|..+
T Consensus 21 ~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~ 100 (232)
T PRK10359 21 YKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASL 100 (232)
T ss_pred HHHHHHHHhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcc
Confidence 444433 35789999999999999999987778899999996421 1 11 5789999999999999999
Q ss_pred EEEEec---------CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEE
Q 046083 548 IGYCVE---------GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANIL 618 (790)
Q Consensus 548 ~g~~~~---------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NIL 618 (790)
..+... +..+++|||++|.+|.++.. ++. ....+++.+|..||..++ +|||++|+||+
T Consensus 101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi---~H~Dikp~Nil 167 (232)
T PRK10359 101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGM---VSGDPHKGNFI 167 (232)
T ss_pred eEeeeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCC---ccCCCChHHEE
Confidence 887542 24789999999999988742 222 245589999999999998 99999999999
Q ss_pred ecCCCcEEEEEeCCCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHH
Q 046083 619 IDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELI 681 (790)
Q Consensus 619 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ell 681 (790)
++.++ ++|+|||........... ..+.....+..++|+||||+.+.-+.
T Consensus 168 i~~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 168 VSKNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EeCCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99988 999999988754211110 11334445667999999999988765
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=5e-18 Score=167.11 Aligned_cols=184 Identities=17% Similarity=0.159 Sum_probs=142.0
Q ss_pred ccceeeeecCceEEEEEEECCceEEEEEeChhhH-------HHHHHHHHHHHhcC-CCCCcceEEEEecCeEEEEEEEec
Q 046083 493 SMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQAS-------KEFLAELKVLTHVH-HLNLVRLIGYCVEGSLFLVYEYIE 564 (790)
Q Consensus 493 ~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~~-------~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~lv~e~~~ 564 (790)
.....|++|+||+||.+...+.+++.+.++.... ..+.+|+++|+++. |+++.+++++ ...+++|||+.
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---~~~~lvmeyI~ 81 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---DGRHLDRSYLA 81 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---cCEEEEEeeec
Confidence 3467899999999998888888998887764322 24789999999995 5889999886 34699999999
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCC-CCCCEEecCCCcEEEEEeCCCcccccCCcc-
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDI-KPANILIDKNFRAKVADFGLAKLTEVGSAS- 642 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dl-kp~NILl~~~~~~kl~DfGla~~~~~~~~~- 642 (790)
|.+|...+... ...++.+++++|.++|++++ +|||| ||+|||++.++.++|+|||++.........
T Consensus 82 G~~L~~~~~~~---------~~~~~~qi~~~L~~lH~~GI---vHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 82 GAAMYQRPPRG---------DLAYFRAARRLLQQLHRCGV---AHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred CccHHhhhhhh---------hHHHHHHHHHHHHHHHHCcC---ccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 99987644211 13467889999999999998 99999 799999999999999999999865433311
Q ss_pred ---c--------ccccccCCCccchhcccCC-CCC-chhhHHHHHHHHHHHHhCCccccccc
Q 046083 643 ---V--------HTRLVGTFGYMPPEYAQYG-EVS-PKIDVYAFGVVLYELISAMEAVVKTN 691 (790)
Q Consensus 643 ---~--------~~~~~gt~~y~aPE~~~~~-~~s-~~sDvwS~Gvvl~elltG~~p~~~~~ 691 (790)
. ......++.|++|+...-. ..+ .+.+.++-|.-+|.++|++.+.....
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0112357788888855432 333 57889999999999999988865543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.9e-18 Score=170.51 Aligned_cols=135 Identities=18% Similarity=0.177 Sum_probs=106.7
Q ss_pred ceeeeecCceEEEEEEEC-CceEEEEEeChhhH------------HH-----------------HHHHHHHHHhcCCCCC
Q 046083 495 GNKIGQGGFGAVFYAELR-GEKAAIKKMDMQAS------------KE-----------------FLAELKVLTHVHHLNL 544 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~~~------------~~-----------------~~~E~~~l~~l~h~ni 544 (790)
.+.||+|+||.||+|... |+.||||+++.... .. ...|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 468999999999999885 89999999864210 11 2349999999988876
Q ss_pred cceEEEEecCeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceeecCCCCCCEEecCCC
Q 046083 545 VRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYI-HEHTVPVYIHRDIKPANILIDKNF 623 (790)
Q Consensus 545 v~l~g~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~~vH~dlkp~NILl~~~~ 623 (790)
.....+... ..++||||+++++|...+... ..+++....+++.|++.+|.+| |+.++ +||||||+|||++ ++
T Consensus 82 ~~p~~~~~~-~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~gi---iHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILLK-SHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRL---VHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEec-CCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCHHHEEEE-CC
Confidence 544333222 248999999998776553322 3588999999999999999999 68888 9999999999998 47
Q ss_pred cEEEEEeCCCccc
Q 046083 624 RAKVADFGLAKLT 636 (790)
Q Consensus 624 ~~kl~DfGla~~~ 636 (790)
.++|+|||++...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.5e-18 Score=189.00 Aligned_cols=218 Identities=25% Similarity=0.421 Sum_probs=162.2
Q ss_pred HHhcCCCCCcceEEEEecC-eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCC
Q 046083 536 LTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKP 614 (790)
Q Consensus 536 l~~l~h~niv~l~g~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp 614 (790)
|+.+.|.|+.+++|.+.++ ..+.|.+|+..|+|.+.+... ...++|.....++++++.||+|||+-.+ ..|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i--~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPI--GYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcc--eeeeeecc
Confidence 3568999999999999865 588999999999999999874 3569999999999999999999999876 39999999
Q ss_pred CCEEecCCCcEEEEEeCCCcccccCC-cccccccccCCCccchhcccCC-------CCCchhhHHHHHHHHHHHHhCCcc
Q 046083 615 ANILIDKNFRAKVADFGLAKLTEVGS-ASVHTRLVGTFGYMPPEYAQYG-------EVSPKIDVYAFGVVLYELISAMEA 686 (790)
Q Consensus 615 ~NILl~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-------~~s~~sDvwS~Gvvl~elltG~~p 686 (790)
+|+++|..+.+||+|||+........ ........-..-|.|||.+... ..+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999999999999999988764210 0111112234579999998753 257789999999999999999999
Q ss_pred ccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 046083 687 VVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLS 766 (790)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~ 766 (790)
|......... ......+.... ...+.|.+... .+...++..++..||..+|++||++++|-..+..+.
T Consensus 158 ~~~~~~~~~~----~eii~~~~~~~------~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 158 FDLRNLVEDP----DEIILRVKKGG------SNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred cccccccCCh----HHHHHHHHhcC------CCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 9765433211 11111111100 01111111111 033347889999999999999999999998888765
Q ss_pred cC
Q 046083 767 SS 768 (790)
Q Consensus 767 ~~ 768 (790)
..
T Consensus 226 ~~ 227 (484)
T KOG1023|consen 226 KG 227 (484)
T ss_pred cc
Confidence 54
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.7e-17 Score=165.45 Aligned_cols=135 Identities=17% Similarity=0.159 Sum_probs=109.2
Q ss_pred ceeeeecCceEEEEEEEC-CceEEEEEeChhh-----------------------------HHHHHHHHHHHHhcCCCCC
Q 046083 495 GNKIGQGGFGAVFYAELR-GEKAAIKKMDMQA-----------------------------SKEFLAELKVLTHVHHLNL 544 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~~-----------------------------~~~~~~E~~~l~~l~h~ni 544 (790)
.+.||+|+||.||+|... |+.||||.++... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 578999999999999986 9999999986421 1123578999999999988
Q ss_pred cceEEEEecCeEEEEEEEecCCChhhh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCEEecCC
Q 046083 545 VRLIGYCVEGSLFLVYEYIENGNLNQH-LRGSGKDTLTWSARMQIALDSARGLEYIHE-HTVPVYIHRDIKPANILIDKN 622 (790)
Q Consensus 545 v~l~g~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~vH~dlkp~NILl~~~ 622 (790)
.....+... ..++||||++++++... +.. ..++.....+++.+++.++.+||+ .++ +||||||+|||++ +
T Consensus 82 ~~p~~~~~~-~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~gi---vHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK-KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGL---VHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec-CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCE---ecCCCChhhEEEE-C
Confidence 655544333 24899999998865443 432 247788899999999999999999 897 9999999999999 7
Q ss_pred CcEEEEEeCCCcccc
Q 046083 623 FRAKVADFGLAKLTE 637 (790)
Q Consensus 623 ~~~kl~DfGla~~~~ 637 (790)
+.++|+|||++....
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.3e-17 Score=170.97 Aligned_cols=227 Identities=22% Similarity=0.317 Sum_probs=146.5
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeCh------hhHHHHHHHHHHHHhcCC----------CCCcceEEE--
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHVHH----------LNLVRLIGY-- 550 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~------~~~~~~~~E~~~l~~l~h----------~niv~l~g~-- 550 (790)
.+...+.||.|+++.||.+++. ++.+|+|.+-. ...+++++|.-....+.+ -.++..++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3456789999999999999997 69999998742 234566666655554332 122221111
Q ss_pred -------Ee---cC------eEEEEEEEecCCChhhhhhc---CC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceee
Q 046083 551 -------CV---EG------SLFLVYEYIENGNLNQHLRG---SG--KDTLTWSARMQIALDSARGLEYIHEHTVPVYIH 609 (790)
Q Consensus 551 -------~~---~~------~~~lv~e~~~~g~L~~~l~~---~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH 609 (790)
.. +. ..+++|+-+. ++|.+++.. .. ...+....++.+..|+++.+++||+.|+ +|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~Gl---VH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGL---VH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE---EE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcce---Ee
Confidence 11 11 1367888774 488887542 21 1235566778888999999999999998 99
Q ss_pred cCCCCCCEEecCCCcEEEEEeCCCcccccCCcccccccccCCCccchhcccC--------CCCCchhhHHHHHHHHHHHH
Q 046083 610 RDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQY--------GEVSPKIDVYAFGVVLYELI 681 (790)
Q Consensus 610 ~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDvwS~Gvvl~ell 681 (790)
+||+|+|++++++|.+.|+||+......... .. ...+..|.+||.... -.++.+.|.|++|+++|.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRY---RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEE---EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCcee---ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 9999999999999999999998776443211 11 234578999997743 24788999999999999999
Q ss_pred hCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCC
Q 046083 682 SAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLR 752 (790)
Q Consensus 682 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R 752 (790)
+|..||........... .. ..+. +.++.+..||..+|+.+|++|
T Consensus 245 C~~lPf~~~~~~~~~~~-------------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW-------------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG-------------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc-------------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999865433211000 01 1233 667789999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.5e-18 Score=194.12 Aligned_cols=242 Identities=23% Similarity=0.254 Sum_probs=171.0
Q ss_pred CcccceeeeecCceEEEEEEECCceEEEEEeChh----hHHHHHHHHHH--HHhcCCCCCcceEEEEec-CeEEEEEEEe
Q 046083 491 DFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQ----ASKEFLAELKV--LTHVHHLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~----~~~~~~~E~~~--l~~l~h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
++...+.||++.|=.|.+|+.+...++||++-.. ..+.|.++++- ...++|||.+++.-+-.. .-.|||=+|+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 5777899999999999999998777999987432 22344433333 455589999988655432 2357888888
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccc--cCCc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE--VGSA 641 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~--~~~~ 641 (790)
.+ +|+|.|..+ +-+...+...|+.|++.||.-+|..++ +|||||.+|||++.-.-+.|+||..-+... ..+.
T Consensus 104 kh-nLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~gV---cHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 104 KH-NLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLGV---CHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred hh-hhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcCc---cccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 77 899888754 347778888999999999999999999 999999999999998889999998665321 1111
Q ss_pred cccc----ccccCCCccchhcccCC-----------CCCchhhHHHHHHHHHHHHhC-CccccccccccccccchHHHHH
Q 046083 642 SVHT----RLVGTFGYMPPEYAQYG-----------EVSPKIDVYAFGVVLYELISA-MEAVVKTNETITESTGLVALFE 705 (790)
Q Consensus 642 ~~~~----~~~gt~~y~aPE~~~~~-----------~~s~~sDvwS~Gvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~ 705 (790)
.... .-..-.+|+|||.+-.. ..+++.||||+||++.||++- +++|.. .+++.
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-----------SQL~a 246 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-----------SQLLA 246 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-----------HHHHh
Confidence 1111 11223589999977431 267899999999999999984 666532 11111
Q ss_pred HHHc-CCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 706 EVLR-QPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 706 ~~~~-~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
---. .......++++-|+ .+++|+..|++.||++|-++++.++.
T Consensus 247 Yr~~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HhccCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHh
Confidence 1111 11111122222222 46789999999999999999999876
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.4e-18 Score=188.71 Aligned_cols=237 Identities=24% Similarity=0.345 Sum_probs=181.8
Q ss_pred eeecCceEEEEEEE-----CCceEEEEEeChh-----hHHHHHHHHHHHHhcC-CCCCcceEEEE-ecCeEEEEEEEecC
Q 046083 498 IGQGGFGAVFYAEL-----RGEKAAIKKMDMQ-----ASKEFLAELKVLTHVH-HLNLVRLIGYC-VEGSLFLVYEYIEN 565 (790)
Q Consensus 498 lG~G~fg~Vy~a~~-----~g~~vavK~~~~~-----~~~~~~~E~~~l~~l~-h~niv~l~g~~-~~~~~~lv~e~~~~ 565 (790)
+|+|.||.|+.++. .+..+|.|.++.. .......|..++..++ ||.++++.-.+ .++..+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 68999999996542 3666777766532 1124556788888886 99999997654 47789999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
|.|...+.... .++......+...++-+++++|+.++ +|||+|++||+++.+|.+++.|||+++..-...
T Consensus 82 g~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~i---iyrd~k~enilld~~Ghi~~tdfglske~v~~~----- 151 (612)
T KOG0603|consen 82 GDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLGI---AYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK----- 151 (612)
T ss_pred chhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhHH---HHhcccccceeecccCccccCCchhhhHhHhhh-----
Confidence 99998887654 46667777788889999999999998 999999999999999999999999998643222
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
..+||..|||||++. ......|.||||++++||+||..||.. +....++..+
T Consensus 152 ~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------------------------~~~~~Il~~~- 203 (612)
T KOG0603|consen 152 IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------------------------DTMKRILKAE- 203 (612)
T ss_pred hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------------------------HHHHHHhhhc-
Confidence 128899999999998 567789999999999999999998854 0111222111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCH--HHHHHHHHhhccCCccCC
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRPSM--RAIVVALMTLSSSSEDWD 773 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~--~evl~~L~~l~~~~~~~~ 773 (790)
...|........+++..++..+|.+|--. ..+.+.++--...+.+|.
T Consensus 204 -~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 204 -LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred -cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 24466677778889999999999999654 455555555555666664
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.3e-16 Score=156.47 Aligned_cols=132 Identities=17% Similarity=0.255 Sum_probs=102.6
Q ss_pred ccceeeeecCceEEEEEEECCceEEEEEeChh---hHHHHHHHHHHHHhc-----CCCCCcceEEEEecC----eEE-EE
Q 046083 493 SMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQ---ASKEFLAELKVLTHV-----HHLNLVRLIGYCVEG----SLF-LV 559 (790)
Q Consensus 493 ~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~---~~~~~~~E~~~l~~l-----~h~niv~l~g~~~~~----~~~-lv 559 (790)
.-.+.||+|+||.||. .-.....+||++... ..+++.+|+++++++ .||||++++|++..+ ..+ +|
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 4467999999999996 222333468887653 456799999999999 579999999998754 333 78
Q ss_pred EEE--ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCceeecCCCCCCEEecC----CCcEEEEEeCC
Q 046083 560 YEY--IENGNLNQHLRGSGKDTLTWSARMQIALDSARGL-EYIHEHTVPVYIHRDIKPANILIDK----NFRAKVADFGL 632 (790)
Q Consensus 560 ~e~--~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~~vH~dlkp~NILl~~----~~~~kl~DfGl 632 (790)
+|| +.+++|.+++... .+++. ..++.+++.++ +|||++++ +||||||+|||++. ++.++|+||+.
T Consensus 84 ~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~I---vhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRI---VTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred ecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCE---eecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 999 5579999999753 25554 35577888777 99999998 99999999999974 34899999544
Q ss_pred C
Q 046083 633 A 633 (790)
Q Consensus 633 a 633 (790)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 4
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.5e-16 Score=181.87 Aligned_cols=196 Identities=20% Similarity=0.265 Sum_probs=155.8
Q ss_pred HHHHHhcCcccceeeeecCceEEEEEEEC-CceEEEEEeChhhHHHHHHHHHHHHhcCCCCCcc----eEE-EEecCeEE
Q 046083 484 ELAKATNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVR----LIG-YCVEGSLF 557 (790)
Q Consensus 484 ~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~----l~g-~~~~~~~~ 557 (790)
+.....+.|.+.+.||+|+||+||+|... |+.+|+|.-++...-+|.-=.+++.+|+ +-+.. +.. +...+..+
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLK-PQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhc-hhhhcchHHHHHHHccCCcce
Confidence 33445567999999999999999999875 8899999988765555443345555665 32222 221 12244568
Q ss_pred EEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEec-------CCCcEEEEEe
Q 046083 558 LVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILID-------KNFRAKVADF 630 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~-------~~~~~kl~Df 630 (790)
||+||.+-|+|.+++... ..++|...+.++.++++.+++||..+| ||+||||+|+||. ++..++|+||
T Consensus 771 lv~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH~~~I---IHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLHAMGI---IHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHHhcce---ecccCCcceeEeecccCCCCcccceEEEec
Confidence 999999999999999843 468999999999999999999999998 9999999999993 2346899999
Q ss_pred CCCcccccCCc-ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCc
Q 046083 631 GLAKLTEVGSA-SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAME 685 (790)
Q Consensus 631 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~ 685 (790)
|.+..+..-.. ......++|-.+-.+|+..+..++...|-|.|.-+++-||.|+.
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99986643322 23455778999999999999999999999999999999998853
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.3e-16 Score=158.59 Aligned_cols=146 Identities=16% Similarity=0.158 Sum_probs=113.3
Q ss_pred HHHHHHHhcCcccceeeeecCceEEEEEE-E--CCceEEEEEeChhh---------------------------HHHHHH
Q 046083 482 YEELAKATNDFSMGNKIGQGGFGAVFYAE-L--RGEKAAIKKMDMQA---------------------------SKEFLA 531 (790)
Q Consensus 482 ~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~-~--~g~~vavK~~~~~~---------------------------~~~~~~ 531 (790)
...+.+...-|.+.+.||+|+||.||+|. . .|..||+|.++... ...+..
T Consensus 20 ~~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (237)
T smart00090 20 LYSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEK 99 (237)
T ss_pred HHHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHH
Confidence 34444445568899999999999999998 3 38999999876321 122568
Q ss_pred HHHHHHhcCCCC--CcceEEEEecCeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCcee
Q 046083 532 ELKVLTHVHHLN--LVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT-VPVYI 608 (790)
Q Consensus 532 E~~~l~~l~h~n--iv~l~g~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-~~~~v 608 (790)
|++.+.++.+.. +.+.+++ ...++||||+++++|...+... ..+.......++.+++.++.+||+++ + +
T Consensus 100 E~~~L~~L~~~~i~~p~~~~~---~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~i---i 171 (237)
T smart00090 100 EFRNLQRLYEAGVPVPKPIAW---RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGEL---V 171 (237)
T ss_pred HHHHHHHHHhcCCCCCeeeEe---cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCE---E
Confidence 999999997533 3344443 3458999999998887765332 23556667889999999999999999 8 9
Q ss_pred ecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 609 HRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 609 H~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
||||||+||+++ ++.++|+|||.+...
T Consensus 172 H~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 172 HGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred eCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 999999999999 889999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.9e-15 Score=153.45 Aligned_cols=130 Identities=22% Similarity=0.379 Sum_probs=110.7
Q ss_pred eeeeecCceEEEEEEECCceEEEEEeChh-----------hHHHHHHHHHHHHhcCCCCCcceEEEEe-cCeEEEEEEEe
Q 046083 496 NKIGQGGFGAVFYAELRGEKAAIKKMDMQ-----------ASKEFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYI 563 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~g~~vavK~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~lv~e~~ 563 (790)
+.||+|++|.||+|.+.+..+++|..... ....+.+|++++..++|+++.....++. ....+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 57999999999999999999999976421 1235778999999999999877766654 45679999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
+|++|.+++.... + .+..++.+++.+|.+||+.++ +|+|++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i---~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGI---IHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCc---ccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999986432 2 788999999999999999998 9999999999999 78899999999874
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.5e-15 Score=157.05 Aligned_cols=181 Identities=25% Similarity=0.303 Sum_probs=128.9
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe--cCCC--cEEEEEeC
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI--DKNF--RAKVADFG 631 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl--~~~~--~~kl~DfG 631 (790)
+|+||.-.+. +|.+++... ..+.....-++.|+++|+.|||.+++ .|||+|++|||+ |+|. ...|+|||
T Consensus 318 lylvMkrY~~-tLr~yl~~~---~~s~r~~~~~laQlLEav~hL~~hgv---AhRDlKSDNiL~ElddD~~P~LVvaDFG 390 (598)
T KOG4158|consen 318 LYLVMKRYRQ-TLREYLWTR---HRSYRTGRVILAQLLEAVTHLHKHGV---AHRDLKSDNILLELDDDEIPQLVVADFG 390 (598)
T ss_pred EEEehhcchh-hHHHHHhcC---CCchHHHHHHHHHHHHHHHHHHHccc---hhhcccccceEEEecCCCCcEEEEcccc
Confidence 6889988866 899999854 35556667788999999999999998 999999999999 3333 57899999
Q ss_pred CCcccccCCc-----ccccccccCCCccchhcccCCC------CCchhhHHHHHHHHHHHHhCCccccccccccccccch
Q 046083 632 LAKLTEVGSA-----SVHTRLVGTFGYMPPEYAQYGE------VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGL 700 (790)
Q Consensus 632 la~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~------~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~ 700 (790)
++-..+...- .......|...-||||+..... --.|+|.|+.|-+.||+++...||...++..-+..
T Consensus 391 CcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r-- 468 (598)
T KOG4158|consen 391 CCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR-- 468 (598)
T ss_pred eeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh--
Confidence 8864433211 1112345777899999885432 23589999999999999999999976443211111
Q ss_pred HHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 701 VALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 701 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
..++---|.+ |..++..+.+++...|+.||++||+..-....|.-
T Consensus 469 ---------------~Yqe~qLPal----p~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~L 513 (598)
T KOG4158|consen 469 ---------------TYQESQLPAL----PSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNL 513 (598)
T ss_pred ---------------hhhhhhCCCC----cccCChHHHHHHHHHhcCCccccCCccHHHhHHHH
Confidence 1122222333 34455678889999999999999997665555544
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.1e-15 Score=150.33 Aligned_cols=141 Identities=22% Similarity=0.217 Sum_probs=111.3
Q ss_pred HHHHHHhcCcccceeeeecCceEEEEEEEC-CceEEEEEeChhh-------------------------HHHHHHHHHHH
Q 046083 483 EELAKATNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQA-------------------------SKEFLAELKVL 536 (790)
Q Consensus 483 ~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~~-------------------------~~~~~~E~~~l 536 (790)
+++......|.+.+.||+|+||.||++... |+.+|||++.... ...+..|..++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 455555555888899999999999999885 8899999764311 11356788899
Q ss_pred HhcCCCC--CcceEEEEecCeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCC
Q 046083 537 THVHHLN--LVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKP 614 (790)
Q Consensus 537 ~~l~h~n--iv~l~g~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp 614 (790)
..+.|++ +...++ .+..+++|||+++++|...... .....++.+++.++.++|+.++ +|+||+|
T Consensus 88 ~~l~~~~i~v~~~~~---~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi---~H~Dl~p 153 (198)
T cd05144 88 KALYEEGFPVPKPID---WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGI---IHGDLSE 153 (198)
T ss_pred HHHHHcCCCCCceee---cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCC---CcCCCCc
Confidence 9998774 444443 2346899999999999775431 2345788899999999999998 9999999
Q ss_pred CCEEecCCCcEEEEEeCCCcccc
Q 046083 615 ANILIDKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 615 ~NILl~~~~~~kl~DfGla~~~~ 637 (790)
+||++++++.++|+|||++....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.7e-15 Score=173.64 Aligned_cols=134 Identities=22% Similarity=0.320 Sum_probs=111.0
Q ss_pred hcCcccceeeeecCceEEEEEEECCceEEEEEeCh-----------hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDM-----------QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSL 556 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~-----------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~ 556 (790)
...|...+.||+|+||.||+|.+.+..+++|+... ...+.+.+|++++..++|++++....++.+ ...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 44556789999999999999998876666654311 112458899999999999999887776654 457
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
++||||+++++|.+++. ....++.+++++|.+||+.++ +||||||+|||+ .++.++|+|||+++..
T Consensus 412 ~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~gi---iHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGI---VHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCC---ccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 89999999999999886 346789999999999999998 999999999999 6779999999999753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.9e-15 Score=149.73 Aligned_cols=126 Identities=22% Similarity=0.370 Sum_probs=104.1
Q ss_pred eeeecCceEEEEEEECCceEEEEEeChh-----------hHHHHHHHHHHHHhcCCCCCcceEEEEe-cCeEEEEEEEec
Q 046083 497 KIGQGGFGAVFYAELRGEKAAIKKMDMQ-----------ASKEFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIE 564 (790)
Q Consensus 497 ~lG~G~fg~Vy~a~~~g~~vavK~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~lv~e~~~ 564 (790)
.||+|+||.||+|.+.+..+++|..... ..+++.+|++++..++|+++.....++. +...+++|||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 4899999999999988999999985421 1245778999999999887554444433 445789999999
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
+++|.+++..... .++.+++.+|.+||+.++ +|+|++|.||+++ ++.+++.|||++..
T Consensus 81 g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~gi---~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGND---------ELLREIGRLVGKLHKAGI---VHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcHH---------HHHHHHHHHHHHHHHCCe---ecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998764321 788999999999999998 9999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=2e-15 Score=173.43 Aligned_cols=206 Identities=26% Similarity=0.421 Sum_probs=142.0
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChhhHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEEEecCCC
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN 567 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e~~~~g~ 567 (790)
++|...+.|-.|.+|.||..+++ .+++|.| ++.+.. +.+ .++.....|.+| |+
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l--ilR--nilt~a~npfvv--------------------gD 137 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL--ILR--NILTFAGNPFVV--------------------GD 137 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccch--hhh--ccccccCCccee--------------------ch
Confidence 57888999999999999999877 6778884 332211 000 022222333333 34
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc-----
Q 046083 568 LNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS----- 642 (790)
Q Consensus 568 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~----- 642 (790)
-...+...+..+. +++.+++|||+.++ +|||+||+|.|+..-|++|+.|||+.+..-.....
T Consensus 138 c~tllk~~g~lPv----------dmvla~Eylh~ygi---vhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg 204 (1205)
T KOG0606|consen 138 CATLLKNIGPLPV----------DMVLAVEYLHSYGI---VHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEG 204 (1205)
T ss_pred hhhhcccCCCCcc----------hhhHHhHhhccCCe---ecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhc
Confidence 4444444333222 22679999999998 99999999999999999999999998743211110
Q ss_pred ---------cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC
Q 046083 643 ---------VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 643 ---------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
....++||+.|+|||++....|....|+|++|+++||.+-|..||...... +++..++...
T Consensus 205 ~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe--------elfg~visd~-- 274 (1205)
T KOG0606|consen 205 HIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--------ELFGQVISDD-- 274 (1205)
T ss_pred chHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH--------HHHhhhhhhh--
Confidence 112368999999999999999999999999999999999999999765432 2233333211
Q ss_pred hhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 046083 714 REDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRP 753 (790)
Q Consensus 714 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP 753 (790)
..+.+ .....+.+.++++.+.|+.+|..|-
T Consensus 275 ----i~wpE------~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 275 ----IEWPE------EDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ----ccccc------cCcCCCHHHHHHHHHHHHhChHhhc
Confidence 01111 1123345688999999999999994
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.58 E-value=6e-16 Score=166.96 Aligned_cols=121 Identities=35% Similarity=0.566 Sum_probs=106.9
Q ss_pred EEEEEEEecCCChhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCc
Q 046083 556 LFLVYEYIENGNLNQHLRGS-GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK 634 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~ 634 (790)
+|+.|++++..+|.+||.+. .....+|...+.++.|++.|+.| ++. +|+|+||.||+...+..+||.|||+..
T Consensus 331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~---ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGL---IHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccc---hhhhccccccccccchhhhhhhhhhee
Confidence 68999999999999999753 34568899999999999999999 666 999999999999999999999999998
Q ss_pred ccccCC-----cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh
Q 046083 635 LTEVGS-----ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682 (790)
Q Consensus 635 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt 682 (790)
...... ...++...||..||+||.+.+..|+.|+||||||++|+||+.
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 765444 224456789999999999999999999999999999999995
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.6e-13 Score=130.52 Aligned_cols=133 Identities=21% Similarity=0.272 Sum_probs=112.6
Q ss_pred cceeeeecCceEEEEEEECCceEEEEEeChhh-HHHHHHHHHHHHhcCC--CCCcceEEEEec-CeEEEEEEEecCCChh
Q 046083 494 MGNKIGQGGFGAVFYAELRGEKAAIKKMDMQA-SKEFLAELKVLTHVHH--LNLVRLIGYCVE-GSLFLVYEYIENGNLN 569 (790)
Q Consensus 494 ~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~-~~~~~~E~~~l~~l~h--~niv~l~g~~~~-~~~~lv~e~~~~g~L~ 569 (790)
+.+.||+|.++.||++...+..+++|...... ...+..|+.++..++| .++.+++++... +..+++|||++++.+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 45789999999999999988899999987543 3578899999999976 588888887764 4589999999987776
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 570 QHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 570 ~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
.+ +......++.++++++++||......++|+|++|+||++++.+.+++.|||.+..
T Consensus 82 ~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 82 EV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 54 5566778899999999999997644569999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.5e-13 Score=138.20 Aligned_cols=131 Identities=22% Similarity=0.306 Sum_probs=104.7
Q ss_pred ceeee-ecCceEEEEEEECCceEEEEEeChh----------------hHHHHHHHHHHHHhcCCCCC--cceEEEEec--
Q 046083 495 GNKIG-QGGFGAVFYAELRGEKAAIKKMDMQ----------------ASKEFLAELKVLTHVHHLNL--VRLIGYCVE-- 553 (790)
Q Consensus 495 ~~~lG-~G~fg~Vy~a~~~g~~vavK~~~~~----------------~~~~~~~E~~~l~~l~h~ni--v~l~g~~~~-- 553 (790)
...|| .|+.|+||.+...+..++||.+... ....+.+|++++.+++|+++ +..+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 45787 8999999999999999999977421 12357789999999998775 667766432
Q ss_pred C---eEEEEEEEecC-CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEE
Q 046083 554 G---SLFLVYEYIEN-GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVAD 629 (790)
Q Consensus 554 ~---~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~D 629 (790)
+ ..++|||++++ .+|.+++... .++.. .+.+++.+|.+||+.++ +|+||||.|||++.++.++|+|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~GI---~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAGV---YHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCCC---CCCCCCchhEEEcCCCCEEEEE
Confidence 1 13599999997 6999888642 34443 35688999999999998 9999999999999999999999
Q ss_pred eCCCcc
Q 046083 630 FGLAKL 635 (790)
Q Consensus 630 fGla~~ 635 (790)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 999875
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.3e-13 Score=133.37 Aligned_cols=132 Identities=21% Similarity=0.258 Sum_probs=96.5
Q ss_pred ceeeeecCceEEEEEEEC-CceEEEEEeChhh-----HHH----------------------HHHHHHHHHhcCCCC--C
Q 046083 495 GNKIGQGGFGAVFYAELR-GEKAAIKKMDMQA-----SKE----------------------FLAELKVLTHVHHLN--L 544 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~~-----~~~----------------------~~~E~~~l~~l~h~n--i 544 (790)
.+.||+|+||.||+|... ++.+|||.++... ... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 568999999999999987 8899999876321 111 134566666664432 4
Q ss_pred cceEEEEecCeEEEEEEEecCCChhh-hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCEEecCC
Q 046083 545 VRLIGYCVEGSLFLVYEYIENGNLNQ-HLRGSGKDTLTWSARMQIALDSARGLEYIHE-HTVPVYIHRDIKPANILIDKN 622 (790)
Q Consensus 545 v~l~g~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~vH~dlkp~NILl~~~ 622 (790)
.+.+++ ...+++|||++++.+.. .+.... .. .....++.+++.++.++|. .++ +|+||||+||+++ +
T Consensus 82 ~~~~~~---~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~i---vH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL---NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGL---VHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec---CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCc---CcCCCChhhEEEE-C
Confidence 444443 24589999999955432 121111 11 5677899999999999999 887 9999999999999 8
Q ss_pred CcEEEEEeCCCcccc
Q 046083 623 FRAKVADFGLAKLTE 637 (790)
Q Consensus 623 ~~~kl~DfGla~~~~ 637 (790)
+.++|+|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK13914 invasion associated secreted endopeptidase; Provisional | Back alignment and domain information |
|---|
Probab=99.42 E-value=5.6e-13 Score=144.93 Aligned_cols=218 Identities=16% Similarity=0.122 Sum_probs=115.5
Q ss_pred hhhcccCCCCCHHHHHHHhCCCHHHHHhhCCCCCCCCCcCCCCeEEeeeecccCCCCCcccceeEEeccCCchHHHHhhh
Q 046083 16 LASYYVWEGSNPTYISNIFGEDIAQILLYNPNIPNQNTIPSDTRISIPFSCDCLNGDFLGHTFTYETQFGDTYEKVASFA 95 (790)
Q Consensus 16 ~~~y~v~~gdtl~~Ia~~~~~~~~~l~~~Np~~~~~~~~~~g~~l~ip~~~~~~~~~~~~~~~~Y~V~~GDTl~~IA~~~ 95 (790)
...|+|++|||||.||++||+++++|+++| ++. ++.|.+||.|.||-..........-....-.|+.|=.. .
T Consensus 27 a~tytVq~GDTLw~IA~~ygvtv~~I~~~N-~l~-~~~I~~Gq~L~Ip~~~~~~~~~~~Vta~~LNVRsgps~------s 98 (481)
T PRK13914 27 ASTVVVEAGDTLWGIAQSKGTTVDAIKKAN-NLT-TDKIVPGQKLQVNEVAAAEKTEKSVSATWLNVRSGAGV------D 98 (481)
T ss_pred CceEEECCCCCHHHHHHHHCCCHHHHHHHh-CCC-cccccCCCEEEeCCCCcccccceeEecceEEEecCCCC------C
Confidence 367999999999999999999999999999 785 57899999999996532110000000111222222110 0
Q ss_pred cCCCChHHHHHHccCCCCCCCCCCcEEEEEeeccCCCCcc---cCCceeEEEeecCCCCCHHHHHHHhCCChHHHhhhCC
Q 046083 96 FANLTTEDWVRRVNIYEPTRIPDYAFINVTVNCSCGDRHI---SRDYGLFTTYPLRPAQNLSSVAAEAGVAPQSLQRYNP 172 (790)
Q Consensus 96 ~~~~~t~~~l~~~N~~~~~~l~~Gq~l~iP~~~~~~~~~~---~~~~~~~~~y~v~~gd~l~~ia~~~~~~~~~l~~~N~ 172 (790)
| -.-..|..|+++.|-...+.+=..+ .+..|+....-+..-.++..+++ .++++. |-
T Consensus 99 ~--------------~IIgsl~~G~~V~Vl~~~~ngW~kI~~~~GktGwV~~~YLs~~~~~~~~~~-----~~~~~~-~~ 158 (481)
T PRK13914 99 N--------------SIITSIKGGTKVTVETTESNGWHKITYNDGKTGFVNGKYLTDKVTSTPVAP-----TQEVKK-ET 158 (481)
T ss_pred c--------------ceeeeecCCCEEEEeecccCCeEEEEcCCCCEEEEecccccCCCccCcccc-----chhhhh-cc
Confidence 0 0112477888888842111000011 12234433333444444444442 122222 10
Q ss_pred CCcccCCcceEEeechhhHHHHHHHHHHHHhhhhhccccccccchhhhhhheeeecCCCCCHHHHHHHcCCChhhHhhcC
Q 046083 173 GTNFSAGTGLVFVPARVFELKLALLLVLAFFCARRRVEAVAECSKGCDLALASYYLWKGANLTFISKVFDTSIKYILSFN 252 (790)
Q Consensus 173 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~v~~gdtl~~Ia~~~~~~~~~l~~~N 252 (790)
-. + .-.|............ .+... .+.... .+..+.-......|+|++|||||.||++||+++++|+++|
T Consensus 159 ~~------~-~~~~~~~~~~~~~~~~-~~~~~-~~~~~~-~~~~~~~~~~a~tytVq~GDTL~sIAkrYgVtv~eI~~~N 228 (481)
T PRK13914 159 TT------Q-QAAPAAETKTEVKQTT-QATTP-APKVAE-TKETPVVDQNATTHAVKSGDTIWALSVKYGVSVQDIMSWN 228 (481)
T ss_pred cc------c-cccchhcccchhccCC-cccCC-cccccc-cccCccccCCCeEEEECCCCCHHHHHHHHCCCHHHHHHhc
Confidence 00 0 0001000000000000 00000 000000 0000111123558999999999999999999999999999
Q ss_pred CCCCCcccccCCceEEecccc
Q 046083 253 PQITNKDKILAGTRINVPFSC 273 (790)
Q Consensus 253 ~~~~~~~~l~~gq~l~ip~~~ 273 (790)
++.. ..|++||.|.||...
T Consensus 229 -~l~s-~~L~pGQ~L~Ip~sa 247 (481)
T PRK13914 229 -NLSS-SSIYVGQKLAIKQTA 247 (481)
T ss_pred -CCCc-cccCCCCEEEecCCC
Confidence 7844 579999999999653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.9e-14 Score=163.53 Aligned_cols=249 Identities=23% Similarity=0.314 Sum_probs=180.8
Q ss_pred CcccceeeeecCceEEEEEEEC---CceEEEEEeChh-----hHHHHHHHHHHHHhcC-CCCCcceEEEEecCe-EEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR---GEKAAIKKMDMQ-----ASKEFLAELKVLTHVH-HLNLVRLIGYCVEGS-LFLVY 560 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~---g~~vavK~~~~~-----~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~-~~lv~ 560 (790)
.|.+.+.||+|.|+.|-..... ...+|+|.+... ..+....|..+-..+. |+|++.+++...+.+ .++..
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4566777999999999887664 345666665432 1233444667767776 999999999887654 78999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceeecCCCCCCEEecCCC-cEEEEEeCCCccccc
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH-EHTVPVYIHRDIKPANILIDKNF-RAKVADFGLAKLTEV 638 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~~vH~dlkp~NILl~~~~-~~kl~DfGla~~~~~ 638 (790)
+|.+++++.+-+........+....-.++.|+..++.|+| ..++ .|+||||+|.+++..+ ..+++|||+|..+..
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~---~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGV---THRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCccccc---ccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999999883222223555666788999999999999 8888 9999999999999999 999999999987765
Q ss_pred --CCccccccccc-CCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 639 --GSASVHTRLVG-TFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 639 --~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
+.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........... .+.....
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~-------~~~~~~~-- 248 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS-------SWKSNKG-- 248 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce-------eeccccc--
Confidence 22333344677 9999999999874 557789999999999999999999876554321110 1111100
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVV 760 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 760 (790)
...............++...++..+|..|.+.+++..
T Consensus 249 ---------~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 ---------RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ---------ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0000011123345678889999999999999988754
|
|
| >PRK13914 invasion associated secreted endopeptidase; Provisional | Back alignment and domain information |
|---|
Probab=99.33 E-value=4.7e-12 Score=137.80 Aligned_cols=107 Identities=19% Similarity=0.207 Sum_probs=85.3
Q ss_pred heeeecCCCCCHHHHHHHcCCChhhHhhcCCCCCCcccccCCceEEeccccccC--------------------------
Q 046083 223 LASYYLWKGANLTFISKVFDTSIKYILSFNPQITNKDKILAGTRINVPFSCNCI-------------------------- 276 (790)
Q Consensus 223 ~~~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~ip~~~~~~-------------------------- 276 (790)
+..|+|++|||||.||++||+++++|+++| ++ +++.|++||.|.||-.....
T Consensus 27 a~tytVq~GDTLw~IA~~ygvtv~~I~~~N-~l-~~~~I~~Gq~L~Ip~~~~~~~~~~~Vta~~LNVRsgps~s~~IIgs 104 (481)
T PRK13914 27 ASTVVVEAGDTLWGIAQSKGTTVDAIKKAN-NL-TTDKIVPGQKLQVNEVAAAEKTEKSVSATWLNVRSGAGVDNSIITS 104 (481)
T ss_pred CceEEECCCCCHHHHHHHHCCCHHHHHHHh-CC-CcccccCCCEEEeCCCCcccccceeEecceEEEecCCCCCcceeee
Confidence 347999999999999999999999999999 88 45789999999999542100
Q ss_pred -------------CCcee--------------------------------------------------------------
Q 046083 277 -------------QNKFL-------------------------------------------------------------- 281 (790)
Q Consensus 277 -------------~~~~~-------------------------------------------------------------- 281 (790)
.+..+
T Consensus 105 l~~G~~V~Vl~~~~ngW~kI~~~~GktGwV~~~YLs~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (481)
T PRK13914 105 IKGGTKVTVETTESNGWHKITYNDGKTGFVNGKYLTDKVTSTPVAPTQEVKKETTTQQAAPAAETKTEVKQTTQATTPAP 184 (481)
T ss_pred ecCCCEEEEeecccCCeEEEEcCCCCEEEEecccccCCCccCccccchhhhhccccccccchhcccchhccCCcccCCcc
Confidence 00000
Q ss_pred ------------eeeEEEEeccCchHHHHHHHhhcccccHHHHHhcCCCCCCCCCCCCcEEEEeEe
Q 046083 282 ------------GHSFSYKVKSGNTYKRIAELIYANLTTLDWLKSSNAYDENHTPDVSSSVNVIVN 335 (790)
Q Consensus 282 ------------~~~~~y~V~~gDtl~~IA~~~~~~l~~~~~l~~~N~~~~~~~~~~Gq~l~ip~~ 335 (790)
.....|+|++|||||.|| +.|. +++++|++||++..+.+.+ ||+|.||..
T Consensus 185 ~~~~~~~~~~~~~~a~tytVq~GDTL~sIA-krYg--Vtv~eI~~~N~l~s~~L~p-GQ~L~Ip~s 246 (481)
T PRK13914 185 KVAETKETPVVDQNATTHAVKSGDTIWALS-VKYG--VSVQDIMSWNNLSSSSIYV-GQKLAIKQT 246 (481)
T ss_pred cccccccCccccCCCeEEEECCCCCHHHHH-HHHC--CCHHHHHHhcCCCccccCC-CCEEEecCC
Confidence 001359999999999999 5565 7889999999998877777 999999964
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.8e-11 Score=119.53 Aligned_cols=129 Identities=18% Similarity=0.155 Sum_probs=99.4
Q ss_pred ceeeeecCceEEEEEEECCceEEEEEeChhh--HHHHHHHHHHHHhcCCCCCcc-eEEEEecCeEEEEEEEecCCChhhh
Q 046083 495 GNKIGQGGFGAVFYAELRGEKAAIKKMDMQA--SKEFLAELKVLTHVHHLNLVR-LIGYCVEGSLFLVYEYIENGNLNQH 571 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~--~~~~~~E~~~l~~l~h~niv~-l~g~~~~~~~~lv~e~~~~g~L~~~ 571 (790)
.+.|+.|.++.||++...+..+++|...... ...+..|++++..+.+.++++ ++.+ .....++||||+++.++.+.
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~-~~~~~~lv~e~i~G~~l~~~ 81 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF-DPETGVLITEFIEGSELLTE 81 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEE-eCCCCeEEEEecCCCccccc
Confidence 4678899999999999999999999976543 345778999999987666554 4444 33345899999999887643
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC--CceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 572 LRGSGKDTLTWSARMQIALDSARGLEYIHEHTV--PVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 572 l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~--~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
. . ....+..+++++|+.||..+. ..++|+|++|.||+++ ++.++++||+.+..
T Consensus 82 ~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 82 D-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred c-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 0 1 112356789999999999873 2369999999999999 66899999999763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.8e-11 Score=135.68 Aligned_cols=136 Identities=21% Similarity=0.219 Sum_probs=96.9
Q ss_pred ceeeeecCceEEEEEEEC-CceEEEEEeChhhHHH-------------------------------------------HH
Q 046083 495 GNKIGQGGFGAVFYAELR-GEKAAIKKMDMQASKE-------------------------------------------FL 530 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~~~~~-------------------------------------------~~ 530 (790)
.+.||.|++|.||+|++. |+.||||+.++...+. |.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 468999999999999986 8999999986532222 33
Q ss_pred HHHHHHHhc----CCCCCcceEEEEe--cCeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 046083 531 AELKVLTHV----HHLNLVRLIGYCV--EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSAR-GLEYIHEHT 603 (790)
Q Consensus 531 ~E~~~l~~l----~h~niv~l~g~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~-~L~~LH~~~ 603 (790)
+|.+.+.++ +|.+-+.+-.++. .+..+|||||++|++|.++...... ..+ +.+++..++. .+..+|..+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhCC
Confidence 344444444 2222233222222 3347999999999999987753211 122 3456666665 478899999
Q ss_pred CCceeecCCCCCCEEecCCCcEEEEEeCCCcccc
Q 046083 604 VPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 604 ~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~ 637 (790)
+ +|+|++|.||+++.+++++++|||++..+.
T Consensus 278 ~---~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 F---FHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred c---eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8 999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.9e-12 Score=128.58 Aligned_cols=203 Identities=20% Similarity=0.308 Sum_probs=139.1
Q ss_pred HHHHHhcCCCCCcceEEEEec------CeEEEEEEEecCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 046083 533 LKVLTHVHHLNLVRLIGYCVE------GSLFLVYEYIENGNLNQHLRGSG--KDTLTWSARMQIALDSARGLEYIHEHTV 604 (790)
Q Consensus 533 ~~~l~~l~h~niv~l~g~~~~------~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~ 604 (790)
+.-|-++-|.|||+++.|+.+ .+..++.|||..|+|..+|++.. ...+......+++-||..||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 344555679999999988763 23688999999999999998643 345777888899999999999999987
Q ss_pred CceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc----ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHH
Q 046083 605 PVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA----SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYEL 680 (790)
Q Consensus 605 ~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~el 680 (790)
|+++|+++..+-|++..++-+|+.--. ......... .......+-++|.+||+-.....+..+|||+||+..+||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 889999999999999999888875321 111111100 011123467899999998888888999999999999999
Q ss_pred HhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046083 681 ISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVV 760 (790)
Q Consensus 681 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 760 (790)
--+.--...... ... ..+.+...+-. +... .=+.++..|++..|..||+|++++.
T Consensus 276 ailEiq~tnseS-----~~~------------~ee~ia~~i~~-len~-------lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 276 AILEIQSTNSES-----KVE------------VEENIANVIIG-LENG-------LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHheeccCCCcc-----eee------------hhhhhhhheee-ccCc-------cccCcCcccccCCCCCCcchhhhhc
Confidence 755322111100 000 00111111100 0000 1135788999999999999999865
Q ss_pred HH
Q 046083 761 AL 762 (790)
Q Consensus 761 ~L 762 (790)
+.
T Consensus 331 Hp 332 (458)
T KOG1266|consen 331 HP 332 (458)
T ss_pred Cc
Confidence 43
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=8.8e-11 Score=129.84 Aligned_cols=242 Identities=23% Similarity=0.298 Sum_probs=171.5
Q ss_pred Ccccceeeee--cCceEEEEEEE--C--CceEEEEEeCh-----hhHHHHHHHHHHHHhc-CCCCCcceEEEEecCe-EE
Q 046083 491 DFSMGNKIGQ--GGFGAVFYAEL--R--GEKAAIKKMDM-----QASKEFLAELKVLTHV-HHLNLVRLIGYCVEGS-LF 557 (790)
Q Consensus 491 ~f~~~~~lG~--G~fg~Vy~a~~--~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~-~~ 557 (790)
.|.+.+.+|. |.+|.||.+.. . +..+|+|+-+. .....-.+|+...+.+ .|+|.++.+..+.++. .+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4667889999 99999999877 3 77888887431 2223344566666666 4999999777776655 56
Q ss_pred EEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCceeecCCCCCCEEecCC-CcEEEEEeCC
Q 046083 558 LVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSAR----GLEYIHEHTVPVYIHRDIKPANILIDKN-FRAKVADFGL 632 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~~vH~dlkp~NILl~~~-~~~kl~DfGl 632 (790)
+=.|++ +.+|..+.+... ..++....+.+..+... ||.++|+..+ +|-|+||.||+...+ ...+++|||+
T Consensus 195 iqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~---~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNNI---VHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCcc---cccccchhheecccccceeecCCcce
Confidence 666666 568888887643 23566666777777777 9999999998 999999999999999 7889999999
Q ss_pred CcccccCCcc----cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHH
Q 046083 633 AKLTEVGSAS----VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVL 708 (790)
Q Consensus 633 a~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 708 (790)
...+...... ...+..|...|++||... +.++..+|+|++|.+++|..+|...........+.
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~------------ 336 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS------------ 336 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCcc------------
Confidence 9877544321 112346788999999887 57888999999999999999887665432111000
Q ss_pred cCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046083 709 RQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVV 760 (790)
Q Consensus 709 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 760 (790)
.++.+. ++.++-.....++...+.+|++.+|..|++.+++..
T Consensus 337 -------~~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 -------QLRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -------cccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 000111 111222222344556899999999999998877643
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.8e-08 Score=114.43 Aligned_cols=139 Identities=16% Similarity=0.274 Sum_probs=90.0
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChhhHH----------------------------------------
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASK---------------------------------------- 527 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~~---------------------------------------- 527 (790)
..|+. +.||+|++|.||+|+++ |+.||||+.++...+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35665 78999999999999985 799999998643111
Q ss_pred ---HHHHHHHHHHhcC----CCCCcceEEEEe--cCeEEEEEEEecCCChhhh--hhcCCCCCCCHHHHHHHHHHHHHHH
Q 046083 528 ---EFLAELKVLTHVH----HLNLVRLIGYCV--EGSLFLVYEYIENGNLNQH--LRGSGKDTLTWSARMQIALDSARGL 596 (790)
Q Consensus 528 ---~~~~E~~~l~~l~----h~niv~l~g~~~--~~~~~lv~e~~~~g~L~~~--l~~~~~~~l~~~~~~~i~~~ia~~L 596 (790)
+|.+|...+.+++ +.+.+.+-.++. ....+|||||++|++|.++ +...+ .+....... .+..-+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g---~d~~~la~~--~v~~~~ 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG---TDMKLLAER--GVEVFF 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC---CCHHHHHHH--HHHHHH
Confidence 1333444444442 333333333333 2456899999999999874 33222 222211111 111113
Q ss_pred HHHHhCCCCceeecCCCCCCEEecCCC----cEEEEEeCCCcccc
Q 046083 597 EYIHEHTVPVYIHRDIKPANILIDKNF----RAKVADFGLAKLTE 637 (790)
Q Consensus 597 ~~LH~~~~~~~vH~dlkp~NILl~~~~----~~kl~DfGla~~~~ 637 (790)
.-++..|+ +|+|++|.||+++.++ ++++.|||+...++
T Consensus 274 ~Qif~~Gf---fHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 274 TQVFRDGF---FHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHHhCCe---eeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 33456776 9999999999999988 99999999987553
|
|
| >PF01476 LysM: LysM domain; InterPro: IPR018392 This domain is about 40 residues long and is found in a variety of enzymes involved in bacterial cell wall degradation [] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.1e-10 Score=84.80 Aligned_cols=44 Identities=27% Similarity=0.536 Sum_probs=37.8
Q ss_pred cccCCCCCHHHHHHHhCCCHHHHHhhCCCCCCCCCcCCCCeEEee
Q 046083 19 YYVWEGSNPTYISNIFGEDIAQILLYNPNIPNQNTIPSDTRISIP 63 (790)
Q Consensus 19 y~v~~gdtl~~Ia~~~~~~~~~l~~~Np~~~~~~~~~~g~~l~ip 63 (790)
|+|++|||++.||++||++.++|+++||++.... |.+||.|.||
T Consensus 1 y~V~~gDtl~~IA~~~~~~~~~l~~~N~~~~~~~-l~~G~~l~iP 44 (44)
T PF01476_consen 1 YTVQPGDTLWSIAKRYGISVDELMELNPNIDSDN-LQPGQKLCIP 44 (44)
T ss_dssp EEE-TT--HHHHHHHTTS-HHHHHHHCCTTHGGC-GGTTEEEEEC
T ss_pred CEECcCCcHHHHHhhhhhhHhHHHHhcCCCCccc-CCCCCEEEeC
Confidence 8999999999999999999999999999997655 9999999998
|
This domain may have a general peptidoglycan binding function.; GO: 0016998 cell wall macromolecule catabolic process; PDB: 2DJP_A 3ZQD_A 1Y7M_B 4A52_A 2L9Y_A 1E0G_A. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.98 E-value=8.8e-09 Score=101.84 Aligned_cols=133 Identities=16% Similarity=0.169 Sum_probs=96.9
Q ss_pred ceeeeecCceEEEEEEEC--------CceEEEEEeChh-------------------------hHHHH----HHHHHHHH
Q 046083 495 GNKIGQGGFGAVFYAELR--------GEKAAIKKMDMQ-------------------------ASKEF----LAELKVLT 537 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~--------g~~vavK~~~~~-------------------------~~~~~----~~E~~~l~ 537 (790)
...||.|.-+.||.|... +..+|||..+.. ..+.+ .+|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 357899999999999754 368999976310 01122 37999999
Q ss_pred hcCC--CCCcceEEEEecCeEEEEEEEecCCChhh-hhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceeecCCC
Q 046083 538 HVHH--LNLVRLIGYCVEGSLFLVYEYIENGNLNQ-HLRGSGKDTLTWSARMQIALDSARGLEYI-HEHTVPVYIHRDIK 613 (790)
Q Consensus 538 ~l~h--~niv~l~g~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~~vH~dlk 613 (790)
++.. -++...+++ .+.+|||||+.+..+.. .+.. ..++......+..+++.+|..| |..++ ||+||+
T Consensus 82 rl~~~Gv~vP~pi~~---~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~gl---VHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVL---KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNL---VHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEe---cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCe---ecCCCC
Confidence 9853 466666655 35689999998754432 2222 1244456677889999999999 88888 999999
Q ss_pred CCCEEecCCCcEEEEEeCCCcccc
Q 046083 614 PANILIDKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 614 p~NILl~~~~~~kl~DfGla~~~~ 637 (790)
+.|||+++ +.+.|+|||.+....
T Consensus 153 ~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEEC-CcEEEEECCCceeCC
Confidence 99999974 679999999887554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF01476 LysM: LysM domain; InterPro: IPR018392 This domain is about 40 residues long and is found in a variety of enzymes involved in bacterial cell wall degradation [] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.3e-10 Score=83.11 Aligned_cols=44 Identities=25% Similarity=0.542 Sum_probs=37.0
Q ss_pred eecCCCCCHHHHHHHcCCChhhHhhcCCCCCCcccccCCceEEec
Q 046083 226 YYLWKGANLTFISKVFDTSIKYILSFNPQITNKDKILAGTRINVP 270 (790)
Q Consensus 226 y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~ip 270 (790)
|+|++|||++.||++||++.++|+++|+++... .|.+||.|.||
T Consensus 1 y~V~~gDtl~~IA~~~~~~~~~l~~~N~~~~~~-~l~~G~~l~iP 44 (44)
T PF01476_consen 1 YTVQPGDTLWSIAKRYGISVDELMELNPNIDSD-NLQPGQKLCIP 44 (44)
T ss_dssp EEE-TT--HHHHHHHTTS-HHHHHHHCCTTHGG-CGGTTEEEEEC
T ss_pred CEECcCCcHHHHHhhhhhhHhHHHHhcCCCCcc-cCCCCCEEEeC
Confidence 899999999999999999999999999888544 49999999998
|
This domain may have a general peptidoglycan binding function.; GO: 0016998 cell wall macromolecule catabolic process; PDB: 2DJP_A 3ZQD_A 1Y7M_B 4A52_A 2L9Y_A 1E0G_A. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.1e-08 Score=114.26 Aligned_cols=159 Identities=18% Similarity=0.232 Sum_probs=115.8
Q ss_pred CceEEEEEeChhh---HHHHHHHHHHHHhcCCCCCcceEEEEe-cCeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHH
Q 046083 513 GEKAAIKKMDMQA---SKEFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQI 588 (790)
Q Consensus 513 g~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i 588 (790)
+.++.|...+... .+...+-++.|+.++||||++++.... ++..|+|.|-+ ..|..++...+ .......
T Consensus 37 ~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-----~~~v~~G 109 (690)
T KOG1243|consen 37 GGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-----KEEVCLG 109 (690)
T ss_pred CCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-----HHHHHHH
Confidence 6677776665432 344677788999999999999998766 56799999987 35777776533 4445557
Q ss_pred HHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccccccccCCCccchhcccCCCCCchh
Q 046083 589 ALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKI 668 (790)
Q Consensus 589 ~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~s 668 (790)
+.||+.||.|||+.+. ++|++|.-..|++++.|+.||++|.+......... ......---.|..|+.+.... -..
T Consensus 110 l~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s~ 184 (690)
T KOG1243|consen 110 LFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WSI 184 (690)
T ss_pred HHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cch
Confidence 7899999999986654 59999999999999999999999998764432221 001111122466666554322 346
Q ss_pred hHHHHHHHHHHHHhC
Q 046083 669 DVYAFGVVLYELISA 683 (790)
Q Consensus 669 DvwS~Gvvl~elltG 683 (790)
|.|.||++++|++.|
T Consensus 185 D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 185 DSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhHHHHHHHHhCc
Confidence 999999999999998
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.95 E-value=9.4e-09 Score=104.86 Aligned_cols=137 Identities=20% Similarity=0.313 Sum_probs=108.7
Q ss_pred eeeeecCceEEEEEEECC-ceEEEEEeChh----hHHHHHHHHHHHHhcCC--CCCcceEEEEecC----eEEEEEEEec
Q 046083 496 NKIGQGGFGAVFYAELRG-EKAAIKKMDMQ----ASKEFLAELKVLTHVHH--LNLVRLIGYCVEG----SLFLVYEYIE 564 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~g-~~vavK~~~~~----~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~----~~~lv~e~~~ 564 (790)
+.|+.|.++.||++...+ +.+++|..... ....+..|.+++..+++ .++.+++.+..+. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 578999999999998875 89999987643 24578899999999976 4467778777642 4689999999
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT----------------------------------------- 603 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----------------------------------------- 603 (790)
+.+|.+.+.. ..++...+..++.+++++|..||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9988876542 24677778888888889998888531
Q ss_pred ------------CCceeecCCCCCCEEecC--CCcEEEEEeCCCcc
Q 046083 604 ------------VPVYIHRDIKPANILIDK--NFRAKVADFGLAKL 635 (790)
Q Consensus 604 ------------~~~~vH~dlkp~NILl~~--~~~~kl~DfGla~~ 635 (790)
...++|+|+.+.||++++ ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999998 56789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.3e-08 Score=96.48 Aligned_cols=139 Identities=20% Similarity=0.242 Sum_probs=104.3
Q ss_pred cceeeeecCceEEEEEEECCceEEEEEeCh-----------hhHHHHHHHHHHHHhcCCCCCcce-EEEEecCeEEEEEE
Q 046083 494 MGNKIGQGGFGAVFYAELRGEKAAIKKMDM-----------QASKEFLAELKVLTHVHHLNLVRL-IGYCVEGSLFLVYE 561 (790)
Q Consensus 494 ~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~-----------~~~~~~~~E~~~l~~l~h~niv~l-~g~~~~~~~~lv~e 561 (790)
....|-+|.-+.|+++.+.|+.+.||.--. -......+|.+.|.+++--.|.-. +-++....-.++||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 467899999999999999999999985321 123457889999998865444333 22333344578999
Q ss_pred EecC-CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC---cEEEEEeCCCcc
Q 046083 562 YIEN-GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF---RAKVADFGLAKL 635 (790)
Q Consensus 562 ~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~---~~kl~DfGla~~ 635 (790)
|+++ .++.+++................+..+-+.+.-||.+++ +|+||..+||+|..++ .+.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndi---iHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDI---IHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCe---ecccccccceEEecCCCcCceEEEeecchhc
Confidence 9987 578888876544333334446788888899999999998 9999999999996554 468999999864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.6e-08 Score=96.53 Aligned_cols=127 Identities=23% Similarity=0.354 Sum_probs=96.8
Q ss_pred eeeeecCceEEEEEEECCceEEEEEeChh-----------hHHHHHHHHHHHHhcCCCCCcceEEEEe-cCeEEEEEEEe
Q 046083 496 NKIGQGGFGAVFYAELRGEKAAIKKMDMQ-----------ASKEFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYI 563 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~g~~vavK~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~lv~e~~ 563 (790)
..+++|+-+.+|.+.+.|..+++|.--++ ..+...+|.+++.+++--.|...+=|.. .....++|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 35789999999999888888777753211 1244678999999986554433333333 34468999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
+|-.|.+++... ...++..+-+-+.-||..++ +|+||.++||++..+. +.++||||+..
T Consensus 82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~gi---vHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA---------RPDLLREVGRLVGKLHKAGI---VHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCe---ecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999988754 24566777777888999998 9999999999998765 99999999874
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=5.7e-08 Score=102.59 Aligned_cols=270 Identities=15% Similarity=0.191 Sum_probs=161.3
Q ss_pred ccceeeeecCceEEEEEEECCceEEEEEeChhhHHHHHHHHHHHHhc-CCCCCcceEEE--------EecCeEEEEEEEe
Q 046083 493 SMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKVLTHV-HHLNLVRLIGY--------CVEGSLFLVYEYI 563 (790)
Q Consensus 493 ~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~--------~~~~~~~lv~e~~ 563 (790)
...+.||+|+.+.+|-.-.-+..|| |+...-....-...+..|... .||-+-.-+.| -.....-++|..+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v 92 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKV 92 (637)
T ss_pred CCCccccCCccceeeecchhhchhh-eeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccC
Confidence 4578899999999996544344444 444321111111223344443 46544331221 1111256777777
Q ss_pred cCC-Chhhhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 564 ENG-NLNQHLRG----SGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 564 ~~g-~L~~~l~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
.+. ...+++.. .......|...++.++.++.+.+.||.+|. +-+|+.++|+|+.+++.+.|.|-..-....
T Consensus 93 ~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh---~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~- 168 (637)
T COG4248 93 SGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGH---VVGDVNQNSFLVSDDSKVVLVDSDSFQINA- 168 (637)
T ss_pred CCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCC---cccccCccceeeecCceEEEEcccceeecc-
Confidence 653 23333321 223568999999999999999999999998 889999999999999999999855433321
Q ss_pred CCcccccccccCCCccchhccc-----CCCCCchhhHHHHHHHHHHHHhC-CccccccccccccccchHHHH-HHHHcCC
Q 046083 639 GSASVHTRLVGTFGYMPPEYAQ-----YGEVSPKIDVYAFGVVLYELISA-MEAVVKTNETITESTGLVALF-EEVLRQP 711 (790)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwS~Gvvl~elltG-~~p~~~~~~~~~~~~~~~~~~-~~~~~~~ 711 (790)
........+|.+.|.+||.-. +-.-+...|-|.+||++++|+.| ++||...........-+...+ ...+..
T Consensus 169 -ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y- 246 (637)
T COG4248 169 -NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY- 246 (637)
T ss_pred -CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee-
Confidence 222333467899999999764 33567789999999999999887 899876432211111111000 000000
Q ss_pred CChhhhhhhcCCcCCCCCCH-HHHHHHHHHHHHccccC--CCCCCCHHHHHHHHHhhccCCccC
Q 046083 712 DPREDLQRLVDPRLGDDYPI-DSVRKMARLARACTQEN--PQLRPSMRAIVVALMTLSSSSEDW 772 (790)
Q Consensus 712 ~~~~~l~~~~d~~l~~~~~~-~~~~~l~~li~~Cl~~d--P~~RPt~~evl~~L~~l~~~~~~~ 772 (790)
....-..... -....|- -.+..+..|..+|+... +.-|||.+..+..|..+.++-..+
T Consensus 247 -a~~~~~g~~p--~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C 307 (637)
T COG4248 247 -ASDQRRGLKP--PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKC 307 (637)
T ss_pred -chhccCCCCC--CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhh
Confidence 0000000000 0111221 23456677778887654 578999999999988876554433
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=9.7e-08 Score=99.76 Aligned_cols=137 Identities=14% Similarity=0.132 Sum_probs=101.1
Q ss_pred eeeeecCceEEEEEEECCceEEEEEeChhh----HH----------HHHHHHHHHHhcCCC--CCcceEEEEec------
Q 046083 496 NKIGQGGFGAVFYAELRGEKAAIKKMDMQA----SK----------EFLAELKVLTHVHHL--NLVRLIGYCVE------ 553 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~----~~----------~~~~E~~~l~~l~h~--niv~l~g~~~~------ 553 (790)
+.+-.-....|.+..+.|+.+.||...... .+ .+.+|.+.+.++... .....+++...
T Consensus 28 e~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 28 EVFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred cEEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344444445577888889999999775322 11 377888888888433 33444555431
Q ss_pred CeEEEEEEEecCC-ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC-------CCcE
Q 046083 554 GSLFLVYEYIENG-NLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK-------NFRA 625 (790)
Q Consensus 554 ~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~-------~~~~ 625 (790)
...+||+|++++. +|.+++........+...+..++.+++..+.-||..|+ +|+|++++|||++. +..+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi---~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGI---NHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcC---ccCCCChhhEEEeccccCCCCCceE
Confidence 2468999999986 89998864322345667778899999999999999998 99999999999975 4689
Q ss_pred EEEEeCCCcc
Q 046083 626 KVADFGLAKL 635 (790)
Q Consensus 626 kl~DfGla~~ 635 (790)
.|+||+.++.
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998863
|
|
| >COG1388 LytE FOG: LysM repeat [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Probab=98.83 E-value=5.9e-09 Score=96.18 Aligned_cols=93 Identities=19% Similarity=0.251 Sum_probs=73.9
Q ss_pred HHHHhCCCHHHHHhhCCCCCC-CCCcCCCCeEEeeee--cccCCCC--Ccc--------------cceeEEeccCCchHH
Q 046083 30 ISNIFGEDIAQILLYNPNIPN-QNTIPSDTRISIPFS--CDCLNGD--FLG--------------HTFTYETQFGDTYEK 90 (790)
Q Consensus 30 Ia~~~~~~~~~l~~~Np~~~~-~~~~~~g~~l~ip~~--~~~~~~~--~~~--------------~~~~Y~V~~GDTl~~ 90 (790)
||.+|++++.+|+.+| .+.. .+.+.+||+|.+|.. .....+. +.. ....|+|++||||+.
T Consensus 1 ia~~~~~~v~~l~~~n-~~~~~s~~i~~gq~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~V~~gdtL~~ 79 (124)
T COG1388 1 IASKYGVSVKALKKAN-ALTGKSDAIKPGQVLKIPGDISSTVNAGQTLSSLSNKVSDSSSASKAPPVVTYTVKKGDTLSK 79 (124)
T ss_pred CcccccccHHHHHHHh-cccCCCCccccCceEEccCCcccccccccccccccceeeccccccccCCCceEEEecCCCHHH
Confidence 6889999999999999 5543 789999999999953 1111110 111 125799999999999
Q ss_pred HHhhhcCCCChHHHHHHccCCCCCCCCCCcEEEEEe
Q 046083 91 VASFAFANLTTEDWVRRVNIYEPTRIPDYAFINVTV 126 (790)
Q Consensus 91 IA~~~~~~~~t~~~l~~~N~~~~~~l~~Gq~l~iP~ 126 (790)
|| ++|+. ++..|+++|.+..+.+++||.|.+|.
T Consensus 80 Ia-~~~~~--tv~~l~~~n~l~~~~i~~gq~l~~~~ 112 (124)
T COG1388 80 IA-RKYGV--TVAELKQLNNLSSDKIKVGQKLKLPV 112 (124)
T ss_pred HH-HHhCC--CHHHHHHHhccCCCceecCcEEEEec
Confidence 99 77877 99999999988777999999999997
|
|
| >COG1388 LytE FOG: LysM repeat [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Probab=98.79 E-value=8.2e-09 Score=95.21 Aligned_cols=94 Identities=24% Similarity=0.366 Sum_probs=72.5
Q ss_pred HHHHcCCChhhHhhcCCCCCC-cccccCCceEEecccccc--CCCce---eee-------------eEEEEeccCchHHH
Q 046083 237 ISKVFDTSIKYILSFNPQITN-KDKILAGTRINVPFSCNC--IQNKF---LGH-------------SFSYKVKSGNTYKR 297 (790)
Q Consensus 237 Ia~~~~~~~~~l~~~N~~~~~-~~~l~~gq~l~ip~~~~~--~~~~~---~~~-------------~~~y~V~~gDtl~~ 297 (790)
||.+|++++.+|+++| .+.. .+.+.+||+|.+|..-.- ..+.. ... ..+|+|++||||+.
T Consensus 1 ia~~~~~~v~~l~~~n-~~~~~s~~i~~gq~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~V~~gdtL~~ 79 (124)
T COG1388 1 IASKYGVSVKALKKAN-ALTGKSDAIKPGQVLKIPGDISSTVNAGQTLSSLSNKVSDSSSASKAPPVVTYTVKKGDTLSK 79 (124)
T ss_pred CcccccccHHHHHHHh-cccCCCCccccCceEEccCCcccccccccccccccceeeccccccccCCCceEEEecCCCHHH
Confidence 6889999999999999 7742 788999999999963111 10000 000 14799999999999
Q ss_pred HHHHhhcccccHHHHHhcCCCCCCCCCCCCcEEEEeEe
Q 046083 298 IAELIYANLTTLDWLKSSNAYDENHTPDVSSSVNVIVN 335 (790)
Q Consensus 298 IA~~~~~~l~~~~~l~~~N~~~~~~~~~~Gq~l~ip~~ 335 (790)
||++ |. +++.+|+++|.+..+.+.. ||.|.+|..
T Consensus 80 Ia~~-~~--~tv~~l~~~n~l~~~~i~~-gq~l~~~~~ 113 (124)
T COG1388 80 IARK-YG--VTVAELKQLNNLSSDKIKV-GQKLKLPVS 113 (124)
T ss_pred HHHH-hC--CCHHHHHHHhccCCCceec-CcEEEEecc
Confidence 9954 44 6779999999998887777 999999873
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=1e-09 Score=127.22 Aligned_cols=243 Identities=22% Similarity=0.317 Sum_probs=161.1
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh------hhHHHHHHHHHHHHhcCCCCCcceEEEEe-cCeEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLV 559 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~lv 559 (790)
.+.|.+.+-+-+|.++.++.+.-. |...+.|.... ...+....+-.++-..+||-++...--+. ....+|+
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 455677778889999999877654 43334333221 11222223333333334455444332222 2347999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
++|+.+++|...|+..+ ..+..........+...++|||...+ .|+|++|.|.|...++..++.|||.......-
T Consensus 883 ~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r---~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLR---KHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchh---hcccccccchhhcccCCcccCccccccccccc
Confidence 99999999999999865 24444445566677889999999876 99999999999999999999999844321100
Q ss_pred --------C----------------------cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccc
Q 046083 640 --------S----------------------ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVK 689 (790)
Q Consensus 640 --------~----------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~ 689 (790)
. ........||+.|.+||.+.+......+|+|++|++++|.++|.+||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 0011235689999999999999999999999999999999999999865
Q ss_pred cccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 046083 690 TNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMR 756 (790)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 756 (790)
.... ..++.+..... + -...+.....+..+++...+..+|.+|-.+.
T Consensus 1038 ~tpq--------~~f~ni~~~~~----------~--~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQ--------QIFENILNRDI----------P--WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchh--------hhhhccccCCC----------C--CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 4331 11111111100 0 0122344555677888888899999997665
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.3e-07 Score=102.53 Aligned_cols=163 Identities=17% Similarity=0.227 Sum_probs=125.2
Q ss_pred eEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEe-----cCeEEEEEEEecC-CChhhhh
Q 046083 504 GAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCV-----EGSLFLVYEYIEN-GNLNQHL 572 (790)
Q Consensus 504 g~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~-----~~~~~lv~e~~~~-g~L~~~l 572 (790)
.+.|++... |..+++|+++. ........-+++++++.|.|+|++..++. +..+++||+|.++ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 578999765 88999999942 22233445688999999999999988654 4458999999986 5777643
Q ss_pred hcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 573 RGS-------------GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 573 ~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
-.. .....++...|.++.|+..||.++|+.|. ..+-|.+++||++.+.+++|+..|........
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGL---Ack~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGL---ACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCc---eeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 221 11246788999999999999999999998 88999999999999999999999987765443
Q ss_pred CcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccc
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAV 687 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~ 687 (790)
... -+ +--.+-|.=-||.+++.|.||...-
T Consensus 447 ~~~---------------~l---e~~Qq~D~~~lG~ll~aLAt~~~ns 476 (655)
T KOG3741|consen 447 PTE---------------PL---ESQQQNDLRDLGLLLLALATGTENS 476 (655)
T ss_pred CCc---------------ch---hHHhhhhHHHHHHHHHHHhhccccc
Confidence 311 11 1123679999999999999996553
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.1e-08 Score=113.39 Aligned_cols=245 Identities=20% Similarity=0.228 Sum_probs=165.7
Q ss_pred HHHhcCcccceeeeecCceEEEEEEEC---CceEEEEEeChhhH----HH-HHHHHHHHHhc-CCCCCcceEE-EEecCe
Q 046083 486 AKATNDFSMGNKIGQGGFGAVFYAELR---GEKAAIKKMDMQAS----KE-FLAELKVLTHV-HHLNLVRLIG-YCVEGS 555 (790)
Q Consensus 486 ~~~~~~f~~~~~lG~G~fg~Vy~a~~~---g~~vavK~~~~~~~----~~-~~~E~~~l~~l-~h~niv~l~g-~~~~~~ 555 (790)
..-+.+|..+..||.|.|+.|+....+ +..+++|.+..... +. -..|+-+...+ .|.++++.+. |.....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 344568999999999999999988754 55778776643211 11 12344444444 5888887765 444556
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC-CcEEEEEeCCCc
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN-FRAKVADFGLAK 634 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~-~~~kl~DfGla~ 634 (790)
.|+=-||++++++...+.- ...++...++++..+++.++.++|+... +|+|+||+||++..+ +..++.|||.+.
T Consensus 341 ~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~---~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLF---VHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred ccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhh---hcccccccceeeccchhhhhcccccccc
Confidence 7788999999988766522 2347777888999999999999999887 999999999999886 788999999986
Q ss_pred ccccCCcccccccccCCCcc--chhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC
Q 046083 635 LTEVGSASVHTRLVGTFGYM--PPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD 712 (790)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (790)
.+..... ......++. +++......+-.+.|+||||.-+.|.++|..--.....
T Consensus 416 ~~~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-------------------- 471 (524)
T KOG0601|consen 416 RLAFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-------------------- 471 (524)
T ss_pred ccceecc----cccccccccccchhhccccccccccccccccccccccccCcccCccccc--------------------
Confidence 4221111 112233344 55566667788899999999999999987433221110
Q ss_pred ChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 713 PREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 713 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
+..+....+ ...+ .....+..+..-+...++..||...++..+....
T Consensus 472 ----~~~i~~~~~-p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 472 ----SLTIRSGDT-PNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ----ceeeecccc-cCCC-chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 000000000 0111 1225667788889999999999998877665543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.9e-07 Score=89.61 Aligned_cols=135 Identities=14% Similarity=0.171 Sum_probs=106.5
Q ss_pred eeeecCceEEEEEEECCceEEEEEeC---------hhhHHHHHHHHHHHHhcCC--CCCcceEEEEe---cC---eEEEE
Q 046083 497 KIGQGGFGAVFYAELRGEKAAIKKMD---------MQASKEFLAELKVLTHVHH--LNLVRLIGYCV---EG---SLFLV 559 (790)
Q Consensus 497 ~lG~G~fg~Vy~a~~~g~~vavK~~~---------~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~---~~---~~~lv 559 (790)
--|+||.+-|++..+.|..+-+|+-. +.....|.+|+..|.++.. -.+.+.. ++. .+ ..+||
T Consensus 25 N~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 25 NYRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CcCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 34678999999999988889999765 3345679999999999853 2344444 332 11 26899
Q ss_pred EEEecC-CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCc--EEEEEeCCCcc
Q 046083 560 YEYIEN-GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFR--AKVADFGLAKL 635 (790)
Q Consensus 560 ~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~--~kl~DfGla~~ 635 (790)
+|-+++ -+|.+++......+.+...+..++.+++..++-||+.++ .|+|+.+.|||++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv---~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNR---QHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCC---cCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998864 489999876554567788888999999999999999999 99999999999986666 99999987763
|
|
| >PRK14125 cell division suppressor protein YneA; Provisional | Back alignment and domain information |
|---|
Probab=98.59 E-value=6.8e-08 Score=84.48 Aligned_cols=50 Identities=24% Similarity=0.250 Sum_probs=41.3
Q ss_pred ceeEEeccCCchHHHHhhhcCC---CCh---HHHHHHccCCCCCCCCCCcEEEEEee
Q 046083 77 TFTYETQFGDTYEKVASFAFAN---LTT---EDWVRRVNIYEPTRIPDYAFINVTVN 127 (790)
Q Consensus 77 ~~~Y~V~~GDTl~~IA~~~~~~---~~t---~~~l~~~N~~~~~~l~~Gq~l~iP~~ 127 (790)
..+|+|++|||||+|| ++|.. ++. .++|++.|.++++.|++||+|.||..
T Consensus 36 ~~~~tV~~GDTLW~IA-~~y~~~~~l~~~~~v~~I~~~N~l~~~~I~~Gq~L~IP~~ 91 (103)
T PRK14125 36 YVEITVQEGDTLWALA-DQYAGKHHMAKNEFIEWVEDVNNLPSGHIKAGDKLVIPVL 91 (103)
T ss_pred cEEEEECCCCCHHHHH-HHhCCCcCCCHHHHHHHHHHhcCCCCCcCCCCCEEEEecC
Confidence 4689999999999999 67753 122 56788999888889999999999974
|
|
| >TIGR02899 spore_safA spore coat assembly protein SafA | Back alignment and domain information |
|---|
Probab=98.59 E-value=6.5e-08 Score=71.24 Aligned_cols=44 Identities=30% Similarity=0.470 Sum_probs=40.2
Q ss_pred cCCCCCHHHHHHHhCCCHHHHHhhCCCCCCCCCcCCCCeEEeee
Q 046083 21 VWEGSNPTYISNIFGEDIAQILLYNPNIPNQNTIPSDTRISIPF 64 (790)
Q Consensus 21 v~~gdtl~~Ia~~~~~~~~~l~~~Np~~~~~~~~~~g~~l~ip~ 64 (790)
|++||||++||++|+++.++|+++||.+.++..+.+||.|.||.
T Consensus 1 v~~gdtl~~IA~~~~~~~~~l~~~N~~~~~~~~~~~g~~l~ip~ 44 (44)
T TIGR02899 1 VQKGDTLWKIAKKYGVDFDELIQANPQLSNPNLIYPGMKIKIPS 44 (44)
T ss_pred CCCCCCHHHHHHHHCcCHHHHHHHhhcCCCCCCcCCCCEEecCC
Confidence 68999999999999999999999998776667899999999983
|
in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins. |
| >PRK14125 cell division suppressor protein YneA; Provisional | Back alignment and domain information |
|---|
Probab=98.54 E-value=1e-07 Score=83.41 Aligned_cols=52 Identities=15% Similarity=0.297 Sum_probs=44.4
Q ss_pred hheeeecCCCCCHHHHHHHcCCC--------hhhHhhcCCCCCCcccccCCceEEecccccc
Q 046083 222 ALASYYLWKGANLTFISKVFDTS--------IKYILSFNPQITNKDKILAGTRINVPFSCNC 275 (790)
Q Consensus 222 ~~~~y~v~~gdtl~~Ia~~~~~~--------~~~l~~~N~~~~~~~~l~~gq~l~ip~~~~~ 275 (790)
.+..|+|++|||||+||++|+++ ++.|++.| ++. ++.|++||.|.||...+.
T Consensus 35 ~~~~~tV~~GDTLW~IA~~y~~~~~l~~~~~v~~I~~~N-~l~-~~~I~~Gq~L~IP~~~~~ 94 (103)
T PRK14125 35 QYVEITVQEGDTLWALADQYAGKHHMAKNEFIEWVEDVN-NLP-SGHIKAGDKLVIPVLKSK 94 (103)
T ss_pred CcEEEEECCCCCHHHHHHHhCCCcCCCHHHHHHHHHHhc-CCC-CCcCCCCCEEEEecCCCC
Confidence 56689999999999999999875 57788889 885 457999999999987654
|
|
| >TIGR02899 spore_safA spore coat assembly protein SafA | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.3e-07 Score=69.64 Aligned_cols=44 Identities=30% Similarity=0.518 Sum_probs=39.0
Q ss_pred cCCCCCHHHHHHHcCCChhhHhhcCCCCCCcccccCCceEEecc
Q 046083 228 LWKGANLTFISKVFDTSIKYILSFNPQITNKDKILAGTRINVPF 271 (790)
Q Consensus 228 v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~ip~ 271 (790)
|++||||++||++|++++.+|.++|+.+.+++.+.+||.|.||.
T Consensus 1 v~~gdtl~~IA~~~~~~~~~l~~~N~~~~~~~~~~~g~~l~ip~ 44 (44)
T TIGR02899 1 VQKGDTLWKIAKKYGVDFDELIQANPQLSNPNLIYPGMKIKIPS 44 (44)
T ss_pred CCCCCCHHHHHHHHCcCHHHHHHHhhcCCCCCCcCCCCEEecCC
Confidence 57899999999999999999999996565556799999999983
|
in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.2e-06 Score=86.45 Aligned_cols=121 Identities=21% Similarity=0.256 Sum_probs=79.3
Q ss_pred EEEEEEEC-CceEEEEEeChh-----------------------------hHHHHHHHHHHHHhcCCC--CCcceEEEEe
Q 046083 505 AVFYAELR-GEKAAIKKMDMQ-----------------------------ASKEFLAELKVLTHVHHL--NLVRLIGYCV 552 (790)
Q Consensus 505 ~Vy~a~~~-g~~vavK~~~~~-----------------------------~~~~~~~E~~~l~~l~h~--niv~l~g~~~ 552 (790)
.||.|... |..+|||..+.. ......+|.+.|.++... ++.+.+.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999875 889999976310 012367899999999765 456666542
Q ss_pred cCeEEEEEEEec--CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCceeecCCCCCCEEecCCCcEEEEE
Q 046083 553 EGSLFLVYEYIE--NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEY-IHEHTVPVYIHRDIKPANILIDKNFRAKVAD 629 (790)
Q Consensus 553 ~~~~~lv~e~~~--~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~~~~~vH~dlkp~NILl~~~~~~kl~D 629 (790)
.-.|||||++ +..+..+.... ++......++.+++..+.. +|..++ +|+||.+.|||++++ .+.|+|
T Consensus 80 --~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~gi---vHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 --RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGI---VHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp --TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTE---EESS-STTSEEEETT-CEEE--
T ss_pred --CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCc---eecCCChhhEEeecc-eEEEEe
Confidence 3479999999 65555443321 1123345667777775555 578887 999999999999988 999999
Q ss_pred eCCCccc
Q 046083 630 FGLAKLT 636 (790)
Q Consensus 630 fGla~~~ 636 (790)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.1e-07 Score=107.06 Aligned_cols=150 Identities=19% Similarity=0.353 Sum_probs=102.4
Q ss_pred HHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc--------cccccccCCCccchhcccCC
Q 046083 591 DSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS--------VHTRLVGTFGYMPPEYAQYG 662 (790)
Q Consensus 591 ~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~ 662 (790)
+++.|+.|+|..-. +||++|.|++|.++.++..||+.|+.+......... ..--..-...|.|||++.+.
T Consensus 107 ~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 44589999998754 699999999999999999999999987644321110 11112345689999999998
Q ss_pred CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHH
Q 046083 663 EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLAR 742 (790)
Q Consensus 663 ~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~ 742 (790)
..+.++|+||+|++++-+..|..+........ +. .......+..-...++.+.+.++.+=+.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-----~~-------------~~~~~~~~~~~~~~~s~~~p~el~~~l~ 246 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-----LS-------------YSFSRNLLNAGAFGYSNNLPSELRESLK 246 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCc-----ch-------------hhhhhcccccccccccccCcHHHHHHHH
Confidence 89999999999999999996655543322110 00 0000111111111223455677888888
Q ss_pred HccccCCCCCCCHHHHHH
Q 046083 743 ACTQENPQLRPSMRAIVV 760 (790)
Q Consensus 743 ~Cl~~dP~~RPt~~evl~ 760 (790)
+++..++.-||++.++..
T Consensus 247 k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 247 KLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHhcCCcccCcchhhhhc
Confidence 899999999998877643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.37 E-value=3.4e-06 Score=85.14 Aligned_cols=105 Identities=21% Similarity=0.293 Sum_probs=83.1
Q ss_pred HHHHHHHHHHHhcC--CCCCcceEEEEec-----CeEEEEEEEecCC-ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 046083 527 KEFLAELKVLTHVH--HLNLVRLIGYCVE-----GSLFLVYEYIENG-NLNQHLRGSGKDTLTWSARMQIALDSARGLEY 598 (790)
Q Consensus 527 ~~~~~E~~~l~~l~--h~niv~l~g~~~~-----~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~ 598 (790)
....+|.+.+..+. .-...+.+++... ...++|+|++++. +|.+++..... ++......++.++++.++-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 35677888887774 3445566666543 1358999999984 89999886332 5566778899999999999
Q ss_pred HHhCCCCceeecCCCCCCEEecCCC---cEEEEEeCCCccc
Q 046083 599 IHEHTVPVYIHRDIKPANILIDKNF---RAKVADFGLAKLT 636 (790)
Q Consensus 599 LH~~~~~~~vH~dlkp~NILl~~~~---~~kl~DfGla~~~ 636 (790)
||..++ +|+|+++.|||++.+. .+.++||+-++..
T Consensus 134 lH~~gi---~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAGI---YHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCcC---CCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999998 9999999999999887 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=3.3e-06 Score=85.63 Aligned_cols=131 Identities=22% Similarity=0.219 Sum_probs=96.0
Q ss_pred cccceeeeecCceEEEEEEEC-CceEEEEEeChh-------------------------hHHHHHHHHHHHHhcCCC--C
Q 046083 492 FSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ-------------------------ASKEFLAELKVLTHVHHL--N 543 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~-------------------------~~~~~~~E~~~l~~l~h~--n 543 (790)
..++.+||-|.-+.||.|... |.++|||.-+.. ......+|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 566789999999999999987 999999954210 112357899999998654 5
Q ss_pred CcceEEEEecCeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC
Q 046083 544 LVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF 623 (790)
Q Consensus 544 iv~l~g~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~ 623 (790)
+.+.+++ +...+||||+++-.|...-- +....-.++..|++-+.-+-..|+ ||+|+++-||+++++|
T Consensus 173 VP~P~~~---nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~~Gi---VHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIAW---NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYRRGI---VHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCcccc---ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHHcCc---cccCCchheEEEecCC
Confidence 6665554 24579999999977765431 122223444555555555557887 9999999999999999
Q ss_pred cEEEEEeCCCcc
Q 046083 624 RAKVADFGLAKL 635 (790)
Q Consensus 624 ~~kl~DfGla~~ 635 (790)
.+.++||--+..
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999987654
|
|
| >TIGR02907 spore_VI_D stage VI sporulation protein D | Back alignment and domain information |
|---|
Probab=98.25 E-value=8.8e-07 Score=91.63 Aligned_cols=48 Identities=17% Similarity=0.349 Sum_probs=44.5
Q ss_pred hhheeeecCCCCCHHHHHHHcCCChhhHhhcCCCCCCcccccCCceEEec
Q 046083 221 LALASYYLWKGANLTFISKVFDTSIKYILSFNPQITNKDKILAGTRINVP 270 (790)
Q Consensus 221 ~~~~~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~ip 270 (790)
..|..|+|++||||+.||++||++++.|+++| ++. ++.|++||.|+||
T Consensus 291 ~~~~~YiVq~GDTL~sIAkRYGVSV~~L~r~N-~L~-~~~L~~GQ~L~IP 338 (338)
T TIGR02907 291 TKLRMCIVQEGDTIETIAERYEISVSQLIRHN-QLE-DFEVNEGQILYIP 338 (338)
T ss_pred cccEEEEECCCCCHHHHHHHHCcCHHHHHHHh-CCC-ccccCCCCEEEeC
Confidence 35789999999999999999999999999999 785 6789999999998
|
SpoVID, the stage VI sporulation protein D, is restricted to endospore-forming members of the bacteria, all of which are found among the Firmicutes. It is widely distributed but not quite universal in this group. Between well-conserved N-terminal and C-terminal domains is a poorly conserved, low-complexity region of variable length, rich enough in glutamic acid to cause spurious BLAST search results unless a filter is used. The seed alignment for this model was trimmed, in effect, by choosing member sequences in which these regions are relatively short. SpoVID is involved in spore coat assembly by the mother cell compartment late in the process of sporulation. |
| >COG3858 Predicted glycosyl hydrolase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.4e-06 Score=92.61 Aligned_cols=94 Identities=19% Similarity=0.170 Sum_probs=81.3
Q ss_pred hcccCCCCCHHHHHHHhCCCHHHHHhhCCCCCCCCCcCCCCeEEeeeecccCCCCCcccceeEEeccCCchHHHHhhhcC
Q 046083 18 SYYVWEGSNPTYISNIFGEDIAQILLYNPNIPNQNTIPSDTRISIPFSCDCLNGDFLGHTFTYETQFGDTYEKVASFAFA 97 (790)
Q Consensus 18 ~y~v~~gdtl~~Ia~~~~~~~~~l~~~Np~~~~~~~~~~g~~l~ip~~~~~~~~~~~~~~~~Y~V~~GDTl~~IA~~~~~ 97 (790)
.|-|++||++..||..|+.+.++|...| .+.+ +.+++||++.||... ..|.|++|||+++|| .+++
T Consensus 3 i~~~~pg~~~~~i~~~~~~~~~~i~~~~-~~~~-d~~~~~q~~~v~~~~-----------~~y~~~~~d~~~Sia-~~~~ 68 (423)
T COG3858 3 IHLVGPGDSRLIIAVYFPYTNNRIVNGN-DYTN-DDLVDGQTFVVPPSG-----------HFYDVGPGDTLTSIA-RTVG 68 (423)
T ss_pred EEEccCCceeeeehhhcccccccccccc-cccc-ccccCceeEEECCcc-----------eEEEecCCcchhhhh-hhhc
Confidence 4789999999999999999999998888 7777 889999999999743 579999999999999 6775
Q ss_pred CCChHHHHHHcc-CCCCCCCCCCcEEEEEee
Q 046083 98 NLTTEDWVRRVN-IYEPTRIPDYAFINVTVN 127 (790)
Q Consensus 98 ~~~t~~~l~~~N-~~~~~~l~~Gq~l~iP~~ 127 (790)
. |.+.+...| ...|.-+.+|-.|.+|..
T Consensus 69 v--t~~~~~~m~~~~~~~~l~~~~~l~~P~~ 97 (423)
T COG3858 69 V--TQDSAAIMNFVICPGYLQYGLNLYIPSA 97 (423)
T ss_pred C--CHHHHHhhcccccccceeeeeEEeccCC
Confidence 4 666666666 778889999999999974
|
|
| >cd00118 LysM Lysin domain, found in a variety of enzymes involved in bacterial cell wall degradation | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.4e-06 Score=63.96 Aligned_cols=45 Identities=20% Similarity=0.438 Sum_probs=40.8
Q ss_pred hcccCCCCCHHHHHHHhCCCHHHHHhhCCCCCCCCCcCCCCeEEee
Q 046083 18 SYYVWEGSNPTYISNIFGEDIAQILLYNPNIPNQNTIPSDTRISIP 63 (790)
Q Consensus 18 ~y~v~~gdtl~~Ia~~~~~~~~~l~~~Np~~~~~~~~~~g~~l~ip 63 (790)
.|+|++|||++.||++|+++..+|+++|+. .....+.+|+.|.||
T Consensus 2 ~~~v~~gdt~~~ia~~~~~~~~~~~~~N~~-~~~~~~~~g~~l~ip 46 (46)
T cd00118 2 TYTVKKGDTLSSIAQRYGISVEELLKLNGL-SDPDNLQVGQKLKIP 46 (46)
T ss_pred EEEECCCCCHHHHHHHHCcCHHHHHHHcCC-CCccccCCCCEEecC
Confidence 689999999999999999999999999965 455789999999987
|
This domain may have a general peptidoglycan binding function. |
| >cd00118 LysM Lysin domain, found in a variety of enzymes involved in bacterial cell wall degradation | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.6e-06 Score=63.69 Aligned_cols=45 Identities=24% Similarity=0.584 Sum_probs=40.5
Q ss_pred eeecCCCCCHHHHHHHcCCChhhHhhcCCCCCCcccccCCceEEec
Q 046083 225 SYYLWKGANLTFISKVFDTSIKYILSFNPQITNKDKILAGTRINVP 270 (790)
Q Consensus 225 ~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~ip 270 (790)
.|++++|||++.||++|+++..+|.++|+ ......+.+|+.|.||
T Consensus 2 ~~~v~~gdt~~~ia~~~~~~~~~~~~~N~-~~~~~~~~~g~~l~ip 46 (46)
T cd00118 2 TYTVKKGDTLSSIAQRYGISVEELLKLNG-LSDPDNLQVGQKLKIP 46 (46)
T ss_pred EEEECCCCCHHHHHHHHCcCHHHHHHHcC-CCCccccCCCCEEecC
Confidence 59999999999999999999999999995 4355689999999987
|
This domain may have a general peptidoglycan binding function. |
| >PRK10871 nlpD lipoprotein NlpD; Provisional | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.3e-06 Score=91.57 Aligned_cols=48 Identities=23% Similarity=0.347 Sum_probs=45.2
Q ss_pred hhcccCCCCCHHHHHHHhCCCHHHHHhhCCCCCCCCCcCCCCeEEeeee
Q 046083 17 ASYYVWEGSNPTYISNIFGEDIAQILLYNPNIPNQNTIPSDTRISIPFS 65 (790)
Q Consensus 17 ~~y~v~~gdtl~~Ia~~~~~~~~~l~~~Np~~~~~~~~~~g~~l~ip~~ 65 (790)
.+|+|++||||+.||.+||+++.+|+++| ++.++..|.+||.|.||.+
T Consensus 61 ~~y~Vk~GDTL~~IA~~~g~~~~~La~~N-~l~~p~~I~~GQ~L~i~~~ 108 (319)
T PRK10871 61 STYTVKKGDTLFYIAWITGNDFRDLAQRN-NIQAPYSLNVGQTLQVGNA 108 (319)
T ss_pred CceEECCCCHHHHHHHHHCcCHHHHHHhc-CCCCCccccCCCEEEeCCC
Confidence 36999999999999999999999999999 8888999999999999864
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.12 E-value=5.9e-05 Score=77.28 Aligned_cols=141 Identities=21% Similarity=0.249 Sum_probs=87.1
Q ss_pred ceeeeecCceEEEEEEECCceEEEEEeChh-hHHHHHHHHHHHHhcCCC--CCcceEEEEec----CeEEEEEEEecCCC
Q 046083 495 GNKIGQGGFGAVFYAELRGEKAAIKKMDMQ-ASKEFLAELKVLTHVHHL--NLVRLIGYCVE----GSLFLVYEYIENGN 567 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~-~~~~~~~E~~~l~~l~h~--niv~l~g~~~~----~~~~lv~e~~~~g~ 567 (790)
.+.|+.|..+.||+....++.+++|..... ....+..|..+++.+... .+.+++.++.. +..+++|+++++..
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~ 81 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRP 81 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecccc
Confidence 468899999999999998889999998765 556788899999888533 35566765542 23689999999988
Q ss_pred hhh----------------hh---hcC--CCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh---
Q 046083 568 LNQ----------------HL---RGS--GKDTLTWSA---------RMQI------------ALDSAR-GLEYIHE--- 601 (790)
Q Consensus 568 L~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~~ia~-~L~~LH~--- 601 (790)
+.. .+ +.. ....+.+.. .... ...+.+ .++.++.
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (239)
T PF01636_consen 82 LDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLP 161 (239)
T ss_dssp HHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhc
Confidence 777 11 111 111111111 0000 111222 3334442
Q ss_pred -CCCCceeecCCCCCCEEec-CCCcEEEEEeCCCcc
Q 046083 602 -HTVPVYIHRDIKPANILID-KNFRAKVADFGLAKL 635 (790)
Q Consensus 602 -~~~~~~vH~dlkp~NILl~-~~~~~kl~DfGla~~ 635 (790)
..-..++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 162 ~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 162 KPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp CCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred cCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1334579999999999999 666678999998763
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK10871 nlpD lipoprotein NlpD; Provisional | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.4e-06 Score=89.66 Aligned_cols=48 Identities=19% Similarity=0.288 Sum_probs=45.0
Q ss_pred eeeecCCCCCHHHHHHHcCCChhhHhhcCCCCCCcccccCCceEEeccc
Q 046083 224 ASYYLWKGANLTFISKVFDTSIKYILSFNPQITNKDKILAGTRINVPFS 272 (790)
Q Consensus 224 ~~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~ip~~ 272 (790)
..|+|++||||+.||.+||+++.+|+++| +|.++..|++||.|.||.+
T Consensus 61 ~~y~Vk~GDTL~~IA~~~g~~~~~La~~N-~l~~p~~I~~GQ~L~i~~~ 108 (319)
T PRK10871 61 STYTVKKGDTLFYIAWITGNDFRDLAQRN-NIQAPYSLNVGQTLQVGNA 108 (319)
T ss_pred CceEECCCCHHHHHHHHHCcCHHHHHHhc-CCCCCccccCCCEEEeCCC
Confidence 36999999999999999999999999999 8988899999999999864
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.10 E-value=8.2e-05 Score=74.23 Aligned_cols=133 Identities=19% Similarity=0.228 Sum_probs=93.2
Q ss_pred HhcCcccceeeeecCceEEEEEEECCceEEEEEeChhhH------------HHHHHHHHHHHhcC---CCCCcceEEEEe
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQAS------------KEFLAELKVLTHVH---HLNLVRLIGYCV 552 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~~------------~~~~~E~~~l~~l~---h~niv~l~g~~~ 552 (790)
...+|...+.+-......|.+...+++.+++|..+.+.. ....+++..+.+++ --....++-...
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 346788888888888888999999999999998864322 11233444444442 233333333322
Q ss_pred ------cCeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEE
Q 046083 553 ------EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAK 626 (790)
Q Consensus 553 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~k 626 (790)
....+++|||++|-.|.++.. ++. .+...+.+++.-||..|. .|+|..|.|+++++++ ++
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~---~HGD~hpgNFlv~~~~-i~ 174 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGF---YHGDPHPGNFLVSNNG-IR 174 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCC---ccCCCCcCcEEEECCc-EE
Confidence 233578999999988876543 222 244567788999999998 9999999999998654 99
Q ss_pred EEEeCCCc
Q 046083 627 VADFGLAK 634 (790)
Q Consensus 627 l~DfGla~ 634 (790)
+.||+..+
T Consensus 175 iID~~~k~ 182 (229)
T PF06176_consen 175 IIDTQGKR 182 (229)
T ss_pred EEECcccc
Confidence 99998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.10 E-value=5.2e-05 Score=77.58 Aligned_cols=137 Identities=20% Similarity=0.271 Sum_probs=84.2
Q ss_pred eeeeecCceEEEEEEECCceEEEEEeChh-hHHHHHHHHHHHHhcCCCC--CcceEEEEec-CeEEEEEEEecCCC-hhh
Q 046083 496 NKIGQGGFGAVFYAELRGEKAAIKKMDMQ-ASKEFLAELKVLTHVHHLN--LVRLIGYCVE-GSLFLVYEYIENGN-LNQ 570 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~g~~vavK~~~~~-~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~-~~~~lv~e~~~~g~-L~~ 570 (790)
..||+|..+.||+. .+..+++|..... ......+|.++++.+..-. +.+.+++..+ +...+|||+++|.+ +..
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~ 84 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSR 84 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhh
Confidence 68899999999984 3667788887653 3456788999999986443 4566777654 34688999999963 211
Q ss_pred h---------------------hhcCCCCCCCHHHHHH-HHH----------HHHH-HHHHHHhC-CCCceeecCCCCCC
Q 046083 571 H---------------------LRGSGKDTLTWSARMQ-IAL----------DSAR-GLEYIHEH-TVPVYIHRDIKPAN 616 (790)
Q Consensus 571 ~---------------------l~~~~~~~l~~~~~~~-i~~----------~ia~-~L~~LH~~-~~~~~vH~dlkp~N 616 (790)
. ||.-............ +.. .+.+ ...+|... ..+.++|+|+.|.|
T Consensus 85 ~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~N 164 (226)
T TIGR02172 85 IISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGN 164 (226)
T ss_pred hhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCc
Confidence 1 1111001111111110 000 0111 12222221 12346999999999
Q ss_pred EEecCCCcEEEEEeCCCcc
Q 046083 617 ILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 617 ILl~~~~~~kl~DfGla~~ 635 (790)
|++++++ +.++||+.+..
T Consensus 165 ii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 165 LITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred EEEcCCC-cEEEechhcCc
Confidence 9999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG3858 Predicted glycosyl hydrolase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.3e-06 Score=89.80 Aligned_cols=94 Identities=22% Similarity=0.171 Sum_probs=77.7
Q ss_pred eeecCCCCCHHHHHHHcCCChhhHhhcCCCCCCcccccCCceEEeccccccCCCceeeeeEEEEeccCchHHHHHHHhhc
Q 046083 225 SYYLWKGANLTFISKVFDTSIKYILSFNPQITNKDKILAGTRINVPFSCNCIQNKFLGHSFSYKVKSGNTYKRIAELIYA 304 (790)
Q Consensus 225 ~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~ip~~~~~~~~~~~~~~~~y~V~~gDtl~~IA~~~~~ 304 (790)
.|-+++||++..|+++|+++...|...| .+++ +.+.+||++.||... ..|.|++|||+++||++ +.
T Consensus 3 i~~~~pg~~~~~i~~~~~~~~~~i~~~~-~~~~-d~~~~~q~~~v~~~~-----------~~y~~~~~d~~~Sia~~-~~ 68 (423)
T COG3858 3 IHLVGPGDSRLIIAVYFPYTNNRIVNGN-DYTN-DDLVDGQTFVVPPSG-----------HFYDVGPGDTLTSIART-VG 68 (423)
T ss_pred EEEccCCceeeeehhhcccccccccccc-cccc-ccccCceeEEECCcc-----------eEEEecCCcchhhhhhh-hc
Confidence 5889999999999999999999998777 7766 889999999999542 25999999999999955 44
Q ss_pred ccccHHHHHhcCC-CCCCCCCCCCcEEEEeEe
Q 046083 305 NLTTLDWLKSSNA-YDENHTPDVSSSVNVIVN 335 (790)
Q Consensus 305 ~l~~~~~l~~~N~-~~~~~~~~~Gq~l~ip~~ 335 (790)
||.+.+...|. ..+.-+.. |-.|.+|..
T Consensus 69 --vt~~~~~~m~~~~~~~~l~~-~~~l~~P~~ 97 (423)
T COG3858 69 --VTQDSAAIMNFVICPGYLQY-GLNLYIPSA 97 (423)
T ss_pred --CCHHHHHhhcccccccceee-eeEEeccCC
Confidence 77799999987 44445555 888888853
|
|
| >TIGR02907 spore_VI_D stage VI sporulation protein D | Back alignment and domain information |
|---|
Probab=98.04 E-value=3.6e-06 Score=87.13 Aligned_cols=46 Identities=20% Similarity=0.284 Sum_probs=42.7
Q ss_pred hhhcccCCCCCHHHHHHHhCCCHHHHHhhCCCCCCCCCcCCCCeEEee
Q 046083 16 LASYYVWEGSNPTYISNIFGEDIAQILLYNPNIPNQNTIPSDTRISIP 63 (790)
Q Consensus 16 ~~~y~v~~gdtl~~Ia~~~~~~~~~l~~~Np~~~~~~~~~~g~~l~ip 63 (790)
...|+|++||||+.||++||+++..|+++| ++. ++.|.+||.|+||
T Consensus 293 ~~~YiVq~GDTL~sIAkRYGVSV~~L~r~N-~L~-~~~L~~GQ~L~IP 338 (338)
T TIGR02907 293 LRMCIVQEGDTIETIAERYEISVSQLIRHN-QLE-DFEVNEGQILYIP 338 (338)
T ss_pred cEEEEECCCCCHHHHHHHHCcCHHHHHHHh-CCC-ccccCCCCEEEeC
Confidence 457999999999999999999999999999 776 6899999999998
|
SpoVID, the stage VI sporulation protein D, is restricted to endospore-forming members of the bacteria, all of which are found among the Firmicutes. It is widely distributed but not quite universal in this group. Between well-conserved N-terminal and C-terminal domains is a poorly conserved, low-complexity region of variable length, rich enough in glutamic acid to cause spurious BLAST search results unless a filter is used. The seed alignment for this model was trimmed, in effect, by choosing member sequences in which these regions are relatively short. SpoVID is involved in spore coat assembly by the mother cell compartment late in the process of sporulation. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.00 E-value=7.6e-05 Score=77.49 Aligned_cols=138 Identities=15% Similarity=0.147 Sum_probs=85.7
Q ss_pred eeeecCc-eEEEEEEECCceEEEEEeChhhHHHHHHHHHHHHhcC-CCCCcceEEEEec-CeEEEEEEEecCCChhhhh-
Q 046083 497 KIGQGGF-GAVFYAELRGEKAAIKKMDMQASKEFLAELKVLTHVH-HLNLVRLIGYCVE-GSLFLVYEYIENGNLNQHL- 572 (790)
Q Consensus 497 ~lG~G~f-g~Vy~a~~~g~~vavK~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~-~~~~lv~e~~~~g~L~~~l- 572 (790)
.|-.|.. ..||+....+..+.+|........++.+|++++..+. +--+.+++++... +..++|||+++|.+|....
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~ 84 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWE 84 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhc
Confidence 4555555 7899998777888899887654456778999998884 4345566766654 3478999999998776432
Q ss_pred ------------------hcCCC--CCCC--HHHHHHHHH--------------------HHHHHHHHHHh----CCCCc
Q 046083 573 ------------------RGSGK--DTLT--WSARMQIAL--------------------DSARGLEYIHE----HTVPV 606 (790)
Q Consensus 573 ------------------~~~~~--~~l~--~~~~~~i~~--------------------~ia~~L~~LH~----~~~~~ 606 (790)
+.... .++. ......... .+...+..|-. ..-+.
T Consensus 85 ~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 164 (244)
T cd05150 85 ELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLV 164 (244)
T ss_pred ccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceE
Confidence 11100 0111 001110000 01111222211 12245
Q ss_pred eeecCCCCCCEEecCCCcEEEEEeCCCc
Q 046083 607 YIHRDIKPANILIDKNFRAKVADFGLAK 634 (790)
Q Consensus 607 ~vH~dlkp~NILl~~~~~~kl~DfGla~ 634 (790)
++|+|+.|.|||++++....|+||+.+.
T Consensus 165 l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 165 VTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred EECCCCCCccEEEeCCcEEEEEEccccc
Confidence 8999999999999998778899999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.92 E-value=5.7e-05 Score=85.66 Aligned_cols=136 Identities=19% Similarity=0.202 Sum_probs=89.5
Q ss_pred eeeeecCceEEEEEEEC-CceEEEEEeChhhHHH-------------------------------------------HHH
Q 046083 496 NKIGQGGFGAVFYAELR-GEKAAIKKMDMQASKE-------------------------------------------FLA 531 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~~~~~-------------------------------------------~~~ 531 (790)
+-|+.++-|.||+|+++ |+.||||+.++.-.+. +..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 78999999999999998 9999999876432221 333
Q ss_pred HHHHHHhcC----CCCCcceEEEEe--cCeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHH-HHHHHhCCC
Q 046083 532 ELKVLTHVH----HLNLVRLIGYCV--EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARG-LEYIHEHTV 604 (790)
Q Consensus 532 E~~~l~~l~----h~niv~l~g~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~-L~~LH~~~~ 604 (790)
|..-+.+++ +..-+.+=.++. .+...|+|||++|-.+.+...... ..++.+. ++..++++ +..+-..+.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q~~~dgf 286 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHHHHhcCc
Confidence 444444442 111122222332 355789999999999998743221 2344333 33333332 333334565
Q ss_pred CceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 605 PVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 605 ~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
.|.|..|.||+++.++++.+.|||+....+.
T Consensus 287 ---fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 287 ---FHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---cccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 9999999999999999999999999876543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.89 E-value=9.8e-05 Score=70.42 Aligned_cols=128 Identities=17% Similarity=0.247 Sum_probs=93.5
Q ss_pred cceeeeecCceEEEEEEECCceEEEEEeChh-hHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEEEecCCChhhhh
Q 046083 494 MGNKIGQGGFGAVFYAELRGEKAAIKKMDMQ-ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLNQHL 572 (790)
Q Consensus 494 ~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e~~~~g~L~~~l 572 (790)
..+.|++|++|.||.+.+.|..+|+|.-..+ ....+..|.++|..+.-.++-+=+-++. ..++.|||++|-+|.++-
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg--~~~i~me~i~G~~L~~~~ 103 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYG--EDFIRMEYIDGRPLGKLE 103 (201)
T ss_pred hhhhhhcccccEEEEeeccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEec--hhhhhhhhhcCcchhhhh
Confidence 4678999999999999999999999987654 4567999999999998777765433332 234559999998887655
Q ss_pred hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCC-CCCEEecCCCcEEEEEeCCCcc
Q 046083 573 RGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIK-PANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 573 ~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlk-p~NILl~~~~~~kl~DfGla~~ 635 (790)
... + .+-...+++.-.-|...|+ -|+.|+ |...+|..+..+.|+||..|..
T Consensus 104 ~~~-----~----rk~l~~vlE~a~~LD~~GI---~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 104 IGG-----D----RKHLLRVLEKAYKLDRLGI---EHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hcc-----c----HHHHHHHHHHHHHHHHhcc---chhhhcCCceeEEecCCcEEEEEccchhh
Confidence 432 1 2334556666666777787 888887 4444444555899999999873
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.87 E-value=7.1e-05 Score=74.10 Aligned_cols=102 Identities=25% Similarity=0.328 Sum_probs=82.6
Q ss_pred HHHHHHHHhcCC-CCCcceEEEEecCeEEEEEEEecCCChhhh---hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 046083 530 LAELKVLTHVHH-LNLVRLIGYCVEGSLFLVYEYIENGNLNQH---LRGSGKDTLTWSARMQIALDSARGLEYIHEHTVP 605 (790)
Q Consensus 530 ~~E~~~l~~l~h-~niv~l~g~~~~~~~~lv~e~~~~g~L~~~---l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ 605 (790)
..|.-+++.+++ +++.+++|+|. .+++.||...+++... +.. -...+|..|.+|+.++++.+.+|++....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG---~~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG---RFYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC---CEEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 357888888876 69999999994 3679999987766432 111 12368999999999999999999997665
Q ss_pred ceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 606 VYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 606 ~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
.+.-.|++++|+-+++++++|+.|.......
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 6788999999999999999999999887644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK11198 LysM domain/BON superfamily protein; Provisional | Back alignment and domain information |
|---|
Probab=97.86 E-value=1.7e-05 Score=75.01 Aligned_cols=49 Identities=18% Similarity=0.285 Sum_probs=39.2
Q ss_pred ceeEEeccCCchHHHHhhhcCCCChHHHHHHcc---CCCCCCCCCCcEEEEE
Q 046083 77 TFTYETQFGDTYEKVASFAFANLTTEDWVRRVN---IYEPTRIPDYAFINVT 125 (790)
Q Consensus 77 ~~~Y~V~~GDTl~~IA~~~~~~~~t~~~l~~~N---~~~~~~l~~Gq~l~iP 125 (790)
...|+|++|||||+||.++|+.-.....|.+.| +.+++.|++||+|.||
T Consensus 95 ~~~y~Vk~GDTL~~IA~~~~g~~~~~~~I~~~N~~~l~~~~~I~pGq~L~IP 146 (147)
T PRK11198 95 SQFYTVKSGDTLSAIAKKVYGNANKYNKIFEANKPMLKSPDKIYPGQVLRIP 146 (147)
T ss_pred CeEEEECCCCCHHHHHHHHcCChhhHHHHHHhhhhcCCCcCCcCcCCEEecC
Confidence 357999999999999955455434566788888 3578899999999998
|
|
| >PRK11198 LysM domain/BON superfamily protein; Provisional | Back alignment and domain information |
|---|
Probab=97.84 E-value=2e-05 Score=74.44 Aligned_cols=48 Identities=23% Similarity=0.319 Sum_probs=38.7
Q ss_pred EEEEeccCchHHHHHHHhhcccccHHHHHhcCC--CC-CCCCCCCCcEEEEe
Q 046083 285 FSYKVKSGNTYKRIAELIYANLTTLDWLKSSNA--YD-ENHTPDVSSSVNVI 333 (790)
Q Consensus 285 ~~y~V~~gDtl~~IA~~~~~~l~~~~~l~~~N~--~~-~~~~~~~Gq~l~ip 333 (790)
..|+|++|||||+||++++..-..++.|.++|+ +. ++.+.+ ||+|.||
T Consensus 96 ~~y~Vk~GDTL~~IA~~~~g~~~~~~~I~~~N~~~l~~~~~I~p-Gq~L~IP 146 (147)
T PRK11198 96 QFYTVKSGDTLSAIAKKVYGNANKYNKIFEANKPMLKSPDKIYP-GQVLRIP 146 (147)
T ss_pred eEEEECCCCCHHHHHHHHcCChhhHHHHHHhhhhcCCCcCCcCc-CCEEecC
Confidence 369999999999999776665456789999997 44 455666 9999998
|
|
| >smart00257 LysM Lysin motif | Back alignment and domain information |
|---|
Probab=97.79 E-value=3.3e-05 Score=55.80 Aligned_cols=44 Identities=23% Similarity=0.520 Sum_probs=38.1
Q ss_pred eeecCCCCCHHHHHHHcCCChhhHhhcCCCCCCcccccCCceEEe
Q 046083 225 SYYLWKGANLTFISKVFDTSIKYILSFNPQITNKDKILAGTRINV 269 (790)
Q Consensus 225 ~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~i 269 (790)
.|++++|||++.||++|+++..+|.++|+.. ....+.+|+.|.|
T Consensus 1 ~~~v~~gdt~~~ia~~~~~~~~~~~~~N~~~-~~~~~~~g~~l~i 44 (44)
T smart00257 1 TYTVKKGDTLSSIARRYGISVSDLLELNNIL-DPDNLQVGQKLKI 44 (44)
T ss_pred CeEeCCCCCHHHHHHHhCCCHHHHHHHcCCC-CccccCCCCEEeC
Confidence 3889999999999999999999999999533 5567999998864
|
|
| >smart00257 LysM Lysin motif | Back alignment and domain information |
|---|
Probab=97.78 E-value=3.8e-05 Score=55.49 Aligned_cols=44 Identities=18% Similarity=0.410 Sum_probs=38.2
Q ss_pred hcccCCCCCHHHHHHHhCCCHHHHHhhCCCCCCCCCcCCCCeEEe
Q 046083 18 SYYVWEGSNPTYISNIFGEDIAQILLYNPNIPNQNTIPSDTRISI 62 (790)
Q Consensus 18 ~y~v~~gdtl~~Ia~~~~~~~~~l~~~Np~~~~~~~~~~g~~l~i 62 (790)
.|+|++|||++.||++|+++..+|+++|+.. ....+.+|+.|.|
T Consensus 1 ~~~v~~gdt~~~ia~~~~~~~~~~~~~N~~~-~~~~~~~g~~l~i 44 (44)
T smart00257 1 TYTVKKGDTLSSIARRYGISVSDLLELNNIL-DPDNLQVGQKLKI 44 (44)
T ss_pred CeEeCCCCCHHHHHHHhCCCHHHHHHHcCCC-CccccCCCCEEeC
Confidence 4899999999999999999999999999744 4467889988864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.73 E-value=4.1e-06 Score=93.36 Aligned_cols=184 Identities=16% Similarity=0.106 Sum_probs=128.2
Q ss_pred CcccceeeeecCceEEEEEEEC-CceEEEEEeChhhHHHHHHHHHHHHhcCCCC-CcceEEEEe-cCeEEEEEEEecCC-
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQASKEFLAELKVLTHVHHLN-LVRLIGYCV-EGSLFLVYEYIENG- 566 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~-~~~~~lv~e~~~~g- 566 (790)
-+..-+..++++++.+||.+-. .+...++.+... ....-++++|.+++||| .+..++-+. +...++.++++..+
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~--l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhheeceeeccc--hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 3444567789999999998765 233335554433 44556899999999999 444444333 34478899999876
Q ss_pred ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccccc
Q 046083 567 NLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR 646 (790)
Q Consensus 567 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 646 (790)
+-....... ...+...+...+.+.-.+++++||+.-. +|+| |||..+ +..|..||+.+..+.... ....
T Consensus 321 s~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~~---~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t 389 (829)
T KOG0576|consen 321 SSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSYK---VHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRT 389 (829)
T ss_pred cccccCChh-hHhhhhhhhhhhhhhhcccccccccccc---cCcc----cccccc-cccccccccCCcccCccc--cccc
Confidence 222211111 1123444455666777889999999865 8999 777665 578999999987665332 2344
Q ss_pred cccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccc
Q 046083 647 LVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAV 687 (790)
Q Consensus 647 ~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~ 687 (790)
..+++.|+|||+.....+..+.|+|+.|+--.+|--|-+|-
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 67899999999999999999999999998777776665554
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00048 Score=84.14 Aligned_cols=74 Identities=20% Similarity=0.427 Sum_probs=56.3
Q ss_pred ceeeeecCceEEEEEEECC----ceEEEEEeChh----hHHHHHHHHHHHHhcC-CCCC--cceEEEEec----CeEEEE
Q 046083 495 GNKIGQGGFGAVFYAELRG----EKAAIKKMDMQ----ASKEFLAELKVLTHVH-HLNL--VRLIGYCVE----GSLFLV 559 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~g----~~vavK~~~~~----~~~~~~~E~~~l~~l~-h~ni--v~l~g~~~~----~~~~lv 559 (790)
.+.++.|.+..+|+....+ ..+++|+.... ....+.+|.++|+.+. |.++ .+++.+|.+ +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 5788999999999987763 46788876432 3356889999999995 6654 777888765 357999
Q ss_pred EEEecCCCh
Q 046083 560 YEYIENGNL 568 (790)
Q Consensus 560 ~e~~~~g~L 568 (790)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998653
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00058 Score=73.04 Aligned_cols=76 Identities=12% Similarity=0.042 Sum_probs=59.4
Q ss_pred ccceeeeecCceEEEEEEECCceEEEEEeChh-hHHHHHHHHHHHHhcCC---CCCcceEEEEec----CeEEEEEEEec
Q 046083 493 SMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQ-ASKEFLAELKVLTHVHH---LNLVRLIGYCVE----GSLFLVYEYIE 564 (790)
Q Consensus 493 ~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~-~~~~~~~E~~~l~~l~h---~niv~l~g~~~~----~~~~lv~e~~~ 564 (790)
.-.+.||.|..+.||+....+..+.+|..+.. ....+..|.+.|+.+.. ..+.+.+++|.. +..++|||+++
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred heeeecCCccceeEEEEEcCCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 34678999999999999877667777876542 45689999999999853 467888888753 44899999999
Q ss_pred CCCh
Q 046083 565 NGNL 568 (790)
Q Consensus 565 ~g~L 568 (790)
++++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8765
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00087 Score=67.75 Aligned_cols=148 Identities=19% Similarity=0.242 Sum_probs=96.4
Q ss_pred cCHHHHHHHhcCcccceee---eecCceEEEEEEEC-CceEEEEEeChhhH----------------------HH-----
Q 046083 480 FSYEELAKATNDFSMGNKI---GQGGFGAVFYAELR-GEKAAIKKMDMQAS----------------------KE----- 528 (790)
Q Consensus 480 ~~~~~l~~~~~~f~~~~~l---G~G~fg~Vy~a~~~-g~~vavK~~~~~~~----------------------~~----- 528 (790)
.+.+.+....++..+.... ..|.-+.||+|... +..+|+|+.+.... ++
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 3455555555555555554 46777789999875 88999998753111 00
Q ss_pred HHHHHHHHHhcC--CCCCcceEEEEecCeEEEEEEEecCCCh-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCC
Q 046083 529 FLAELKVLTHVH--HLNLVRLIGYCVEGSLFLVYEYIENGNL-NQHLRGSGKDTLTWSARMQIALDSARGLEYIHE-HTV 604 (790)
Q Consensus 529 ~~~E~~~l~~l~--h~niv~l~g~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~ 604 (790)
...|..-|.++. +-.+.+.+++. +-.|||||+....+ .-.|..- ++.......+..++++.+.-|-. .+.
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~---~nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~~a~L 188 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR---NNVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYKEAGL 188 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec---CCeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHHhcCc
Confidence 245677777763 44444555443 23789999965311 1111111 12222466677788888888877 676
Q ss_pred CceeecCCCCCCEEecCCCcEEEEEeCCCcccc
Q 046083 605 PVYIHRDIKPANILIDKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 605 ~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~ 637 (790)
||+||+.=|||+. ++.+.|+|||-|....
T Consensus 189 ---VHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 189 ---VHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred ---ccccchhhheEEE-CCeEEEEECccccccC
Confidence 9999999999999 7899999999887544
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00057 Score=70.49 Aligned_cols=71 Identities=15% Similarity=0.236 Sum_probs=46.6
Q ss_pred eeeeecCce-EEEEEEECCceEEEEEeChh-hHHHHHHHHHHHHhcCCC---CCcceEEEEec----CeEEEEEEEecCC
Q 046083 496 NKIGQGGFG-AVFYAELRGEKAAIKKMDMQ-ASKEFLAELKVLTHVHHL---NLVRLIGYCVE----GSLFLVYEYIENG 566 (790)
Q Consensus 496 ~~lG~G~fg-~Vy~a~~~g~~vavK~~~~~-~~~~~~~E~~~l~~l~h~---niv~l~g~~~~----~~~~lv~e~~~~g 566 (790)
+.|+.|+.. .||+. +..+++|..+.. ....+.+|.+++..+... -+...++.... +..+++||+++|.
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G~ 79 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEGE 79 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecCC
Confidence 567777776 58875 346777876543 345788999999888532 33444444332 1248899999997
Q ss_pred Chh
Q 046083 567 NLN 569 (790)
Q Consensus 567 ~L~ 569 (790)
++.
T Consensus 80 ~l~ 82 (235)
T cd05155 80 TAT 82 (235)
T ss_pred CCC
Confidence 764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00066 Score=67.05 Aligned_cols=121 Identities=24% Similarity=0.421 Sum_probs=90.1
Q ss_pred cCcccceeeeecCc-eEEEEEEECCceEEEEEeCh------------------------hhHHHHHHHHHHHHhcC---C
Q 046083 490 NDFSMGNKIGQGGF-GAVFYAELRGEKAAIKKMDM------------------------QASKEFLAELKVLTHVH---H 541 (790)
Q Consensus 490 ~~f~~~~~lG~G~f-g~Vy~a~~~g~~vavK~~~~------------------------~~~~~~~~E~~~l~~l~---h 541 (790)
.+++..+.||.|.. |.||+++..|..+|+|.+.. .....|..|.+.+.+++ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 78899999999999 99999999999999999321 01124788998888884 4
Q ss_pred CCC--cceEEEEe-c--C----------------eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 046083 542 LNL--VRLIGYCV-E--G----------------SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH 600 (790)
Q Consensus 542 ~ni--v~l~g~~~-~--~----------------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH 600 (790)
.++ |+.+||.. . . ..-+|.||++... .+. .+-+.++.+-+..+|
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRDLKILH 181 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHHHHHHH
Confidence 466 89999863 1 0 0356777776532 122 233456777888999
Q ss_pred hCCCCceeecCCCCCCEEecCCCcEEEEEeCCC
Q 046083 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLA 633 (790)
Q Consensus 601 ~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla 633 (790)
..++ +-+|+++.|.. .-||+|||.+
T Consensus 182 k~gI---~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGI---VPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCe---eeccCcccccc-----CCEEEecccC
Confidence 9998 99999999986 3589999964
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0009 Score=69.99 Aligned_cols=134 Identities=18% Similarity=0.174 Sum_probs=79.5
Q ss_pred eeecCceEEEEEEECCceEEEEEeChhhH---HHHHHHHHHHHhcCCCCCc-ceEEEEecCeEEEEEEEecCCChhhh--
Q 046083 498 IGQGGFGAVFYAELRGEKAAIKKMDMQAS---KEFLAELKVLTHVHHLNLV-RLIGYCVEGSLFLVYEYIENGNLNQH-- 571 (790)
Q Consensus 498 lG~G~fg~Vy~a~~~g~~vavK~~~~~~~---~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~lv~e~~~~g~L~~~-- 571 (790)
+..|-...+|+....+..+++|....... -+..+|.++++.+....++ +++.++ + -++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-~--~~~v~e~i~G~~~~~~~~ 80 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-E--HWLLVEWLEGEVITLDQF 80 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-C--CEEEEEeccCcccccccc
Confidence 44577788999987788899987653321 1457899999988654443 334433 2 3689999998765421
Q ss_pred ---------------hhcCC--CCCCCHHHH-HHHHHH---------HHHHHHHHHhCC-----CCceeecCCCCCCEEe
Q 046083 572 ---------------LRGSG--KDTLTWSAR-MQIALD---------SARGLEYIHEHT-----VPVYIHRDIKPANILI 619 (790)
Q Consensus 572 ---------------l~~~~--~~~l~~~~~-~~i~~~---------ia~~L~~LH~~~-----~~~~vH~dlkp~NILl 619 (790)
||... ..+++.... .+...+ +...+..+-... -+.++|+|+.|.||++
T Consensus 81 ~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~ 160 (256)
T TIGR02721 81 VALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVV 160 (256)
T ss_pred cCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEE
Confidence 11111 112222211 111111 111122222211 1247999999999999
Q ss_pred cCCCcEEEEEeCCCcc
Q 046083 620 DKNFRAKVADFGLAKL 635 (790)
Q Consensus 620 ~~~~~~kl~DfGla~~ 635 (790)
++++ +.|+||..+..
T Consensus 161 ~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 161 TPQG-LKLIDWEYASD 175 (256)
T ss_pred eCCC-CEEEeccccCc
Confidence 9877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0042 Score=61.84 Aligned_cols=129 Identities=23% Similarity=0.307 Sum_probs=90.2
Q ss_pred cceeeeecCceEEEEEEECCceEEEEEeChhh-------------------HHHHHHHHHHHHhcC------CCCCcceE
Q 046083 494 MGNKIGQGGFGAVFYAELRGEKAAIKKMDMQA-------------------SKEFLAELKVLTHVH------HLNLVRLI 548 (790)
Q Consensus 494 ~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~-------------------~~~~~~E~~~l~~l~------h~niv~l~ 548 (790)
-...||+|+.=.||.--. +....||+..... .++..+|+..+..+. +.+|.+++
T Consensus 5 ~~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CCcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 356899999998985322 3445677776554 567888888877776 78899999
Q ss_pred EEEec-CeEEEEEEEecCC------ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC
Q 046083 549 GYCVE-GSLFLVYEYIENG------NLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK 621 (790)
Q Consensus 549 g~~~~-~~~~lv~e~~~~g------~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~ 621 (790)
|+... ...-+|+|.+.+. +|.+++... .++. .. ...+-+-..||-++++ +.+|++|+||++..
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~---~~~L~~f~~~l~~~~I---v~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-EL---RQALDEFKRYLLDHHI---VIRDLNPHNIVVQR 153 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HH---HHHHHHHHHHHHHcCC---eecCCCcccEEEEe
Confidence 99874 4578899888642 577788543 2444 32 3334455678888898 99999999999954
Q ss_pred CC----cEEEEE-eCCC
Q 046083 622 NF----RAKVAD-FGLA 633 (790)
Q Consensus 622 ~~----~~kl~D-fGla 633 (790)
+. .+.|+| ||..
T Consensus 154 ~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 154 RDSGEFRLVLIDGLGEK 170 (199)
T ss_pred cCCCceEEEEEeCCCCc
Confidence 32 566776 4543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0032 Score=64.81 Aligned_cols=72 Identities=14% Similarity=0.183 Sum_probs=48.0
Q ss_pred ceeeeecCceEEEEEEEC---CceEEEEEeChhhH--HHHHHHHHHHHhcCCCCCc-ceEEEEecCeEEEEEEEecCCCh
Q 046083 495 GNKIGQGGFGAVFYAELR---GEKAAIKKMDMQAS--KEFLAELKVLTHVHHLNLV-RLIGYCVEGSLFLVYEYIENGNL 568 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~---g~~vavK~~~~~~~--~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~lv~e~~~~g~L 568 (790)
.+.|..|-...+|+.... ++.+++|....... -+..+|+.++..+....++ ++++.+. + .++|||++|.++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~--~~l~e~i~G~~l 79 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ-N--GLIYEFIPGRTL 79 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC-C--cEEEEeeCCCcC
Confidence 356777888899998876 46788887754322 2335788889888544444 4444332 2 479999998776
Q ss_pred h
Q 046083 569 N 569 (790)
Q Consensus 569 ~ 569 (790)
.
T Consensus 80 ~ 80 (235)
T cd05157 80 E 80 (235)
T ss_pred C
Confidence 3
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.00069 Score=81.08 Aligned_cols=198 Identities=18% Similarity=0.171 Sum_probs=138.0
Q ss_pred HHHHHHHHHHhcCCCCCcceEEEEecCe-----EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 046083 528 EFLAELKVLTHVHHLNLVRLIGYCVEGS-----LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH 602 (790)
Q Consensus 528 ~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~ 602 (790)
...-|.+.+.++.|+|++.++.|..+.. ..+..|++..-++...+...+ ..+....+.+..++.+||.|+|+.
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHHh
Confidence 3456778888999999999999876431 345678888888888887654 477788888899999999999998
Q ss_pred CCCceeecCCCCC---CEEecCCCcEEEE--EeCCCcccccCCcccccccccCCCccchhcccCCCCCc--hhhHHHHHH
Q 046083 603 TVPVYIHRDIKPA---NILIDKNFRAKVA--DFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSP--KIDVYAFGV 675 (790)
Q Consensus 603 ~~~~~vH~dlkp~---NILl~~~~~~kl~--DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--~sDvwS~Gv 675 (790)
.. .|.-+..+ +...+..+...++ ||+..+........ ....-+..+-++|.......+. ..|+|.+|.
T Consensus 306 ~l---~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 306 SL---EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred cc---ceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 76 66666655 4455666677777 88888765433222 1223455678888877655544 479999999
Q ss_pred HHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 046083 676 VLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSM 755 (790)
Q Consensus 676 vl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 755 (790)
.+..+..|..+-..... ...+++. .+. ..+.+....|+..++++|++.
T Consensus 381 l~~~~~~~~~i~~~~~~------------------------~~~~l~~----~~~----~~~~d~~~~~~~~~~~~Rl~~ 428 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSAV------------------------PVSLLDV----LST----SELLDALPKCLDEDSEERLSA 428 (1351)
T ss_pred HHhhhhhcCcccccccc------------------------hhhhhcc----ccc----hhhhhhhhhhcchhhhhccch
Confidence 99999987544321110 0011110 001 146678899999999999999
Q ss_pred HHHHHHHHh
Q 046083 756 RAIVVALMT 764 (790)
Q Consensus 756 ~evl~~L~~ 764 (790)
.+++.+...
T Consensus 429 ~~ll~~~f~ 437 (1351)
T KOG1035|consen 429 LELLTHPFL 437 (1351)
T ss_pred hhhhhchhc
Confidence 999887654
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0022 Score=68.66 Aligned_cols=141 Identities=19% Similarity=0.215 Sum_probs=88.5
Q ss_pred ceeeeecCceEEEEEEECCceEEEEEeChhhHHHHHHHHHHHHhcCCCC--CcceEEE-------EecCeEEEEEEEecC
Q 046083 495 GNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKVLTHVHHLN--LVRLIGY-------CVEGSLFLVYEYIEN 565 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~-------~~~~~~~lv~e~~~~ 565 (790)
.+.|..|....+|+....+..+++|.......+....|++++..+.+.. +.+.+.. ..++..++|++|++|
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G 98 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAG 98 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCC
Confidence 5567777778999998887889999887655566778888888885332 4444431 123456899999998
Q ss_pred CChhh----h----------hhcC--C--C-----CCCCHHHHHH----------HHHHHHHHHHHHHhC---CC-Ccee
Q 046083 566 GNLNQ----H----------LRGS--G--K-----DTLTWSARMQ----------IALDSARGLEYIHEH---TV-PVYI 608 (790)
Q Consensus 566 g~L~~----~----------l~~~--~--~-----~~l~~~~~~~----------i~~~ia~~L~~LH~~---~~-~~~v 608 (790)
..+.. . +|.. . . ....|..... ....+..++.++... .. ..++
T Consensus 99 ~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 178 (296)
T cd05153 99 EHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVI 178 (296)
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCC
Confidence 76532 0 1110 0 0 1123322210 111233445555531 11 2369
Q ss_pred ecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 609 HRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 609 H~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
|+|+.|.|+|++++..+.|.||+.+..
T Consensus 179 HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 179 HADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred ccCcCcccEEEeCCceEEEeehhhhcC
Confidence 999999999999987778999998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0022 Score=72.74 Aligned_cols=134 Identities=22% Similarity=0.290 Sum_probs=85.8
Q ss_pred ceeeeecCceEEEEEEEC-CceEEEEEeChhhH----------------------------------H------HHHHHH
Q 046083 495 GNKIGQGGFGAVFYAELR-GEKAAIKKMDMQAS----------------------------------K------EFLAEL 533 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~~~----------------------------------~------~~~~E~ 533 (790)
.+.||.-+.|.||+|+++ |+.||||+-++.-. + +|..|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 468999999999999998 88899998653211 1 134444
Q ss_pred HHHHhc----CCCCCcc---eEEEEe--cCeEEEEEEEecCCChhhh--hhcCCCCCCCHHHHHHHHHHHHHHHHH-HHh
Q 046083 534 KVLTHV----HHLNLVR---LIGYCV--EGSLFLVYEYIENGNLNQH--LRGSGKDTLTWSARMQIALDSARGLEY-IHE 601 (790)
Q Consensus 534 ~~l~~l----~h~niv~---l~g~~~--~~~~~lv~e~~~~g~L~~~--l~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~ 601 (790)
+-..++ +|-++.. +=.++. .....|+||||+|..+.+. |.+.+ ++-. .++..+.++... +=.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~---~i~~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG---ISPH---DILNKLVEAYLEQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC---CCHH---HHHHHHHHHHHHHHHh
Confidence 433333 3444211 212222 3457999999999887764 44433 3333 334444443222 223
Q ss_pred CCCCceeecCCCCCCEEecC----CCcEEEEEeCCCcccc
Q 046083 602 HTVPVYIHRDIKPANILIDK----NFRAKVADFGLAKLTE 637 (790)
Q Consensus 602 ~~~~~~vH~dlkp~NILl~~----~~~~kl~DfGla~~~~ 637 (790)
.|. +|+|=.|.||+++. ++++.+-|||+.....
T Consensus 320 ~Gf---fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGF---FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCC---ccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 444 99999999999983 6789999999987654
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.015 Score=62.92 Aligned_cols=155 Identities=16% Similarity=0.172 Sum_probs=84.7
Q ss_pred CHHHHHHHhcCccc-----ceeeeecCceEEEEEEECCceEEEEEeChhhHHHHHHHHHHHHhcCCC--CCcceEEE---
Q 046083 481 SYEELAKATNDFSM-----GNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKVLTHVHHL--NLVRLIGY--- 550 (790)
Q Consensus 481 ~~~~l~~~~~~f~~-----~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~--- 550 (790)
+.+++......|.+ .+.|+.|....+|+....+..+++|+......+....|+.++..+... .+.+.+..
T Consensus 8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G 87 (319)
T PRK05231 8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQGEYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDG 87 (319)
T ss_pred CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCCcEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCC
Confidence 34444443344433 345666777789999887778999988633344555566666666322 23333321
Q ss_pred ----EecCeEEEEEEEecCCChhh-----------hh---hcCC---------CCCCCH-HHHHHHH------------H
Q 046083 551 ----CVEGSLFLVYEYIENGNLNQ-----------HL---RGSG---------KDTLTW-SARMQIA------------L 590 (790)
Q Consensus 551 ----~~~~~~~lv~e~~~~g~L~~-----------~l---~~~~---------~~~l~~-~~~~~i~------------~ 590 (790)
...+..++++||++|..+.. .| |... ...+.| .....-. .
T Consensus 88 ~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 167 (319)
T PRK05231 88 AALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLE 167 (319)
T ss_pred CEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHH
Confidence 12455789999999875421 11 1100 001112 2211111 1
Q ss_pred H-HHHHHHHHHhC----CCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 591 D-SARGLEYIHEH----TVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 591 ~-ia~~L~~LH~~----~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
+ +...+..+... --..+||+|+.+.|||++.+...-|+||+.+..
T Consensus 168 ~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 168 AELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1 11122333211 112369999999999999776568999998763
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 790 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-46 | ||
| 4eby_A | 212 | Crystal Structure Of The Ectodomain Of A Receptor L | 4e-45 | ||
| 4eby_A | 212 | Crystal Structure Of The Ectodomain Of A Receptor L | 4e-38 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-45 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-44 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-41 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-41 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-37 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-28 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-26 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-26 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-26 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-26 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-26 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-26 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-26 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-26 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-26 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-26 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-26 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-26 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-26 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-26 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-26 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-25 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-25 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-25 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-25 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-25 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-25 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-25 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-25 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-25 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-25 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-25 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-25 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-25 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-24 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-24 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-24 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-24 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-24 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-24 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-24 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-24 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-24 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-24 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-24 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-24 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-24 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-24 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-24 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-24 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-24 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-24 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-24 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-23 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-23 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-23 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-23 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-23 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-23 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-23 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-23 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-23 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-23 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-23 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-23 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-23 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-22 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-22 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-22 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-22 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-22 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-21 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-21 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-21 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-21 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-20 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-20 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-20 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-20 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-20 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-20 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-20 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-20 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-20 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-20 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-20 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-19 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-19 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-19 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-19 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-18 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-18 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-18 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-18 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-18 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-17 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-17 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-17 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-17 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-17 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-17 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-17 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-17 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-17 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-17 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-17 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-17 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-17 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-17 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-17 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-17 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-17 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-17 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-17 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-17 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-17 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-17 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-17 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-16 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-16 | ||
| 1oec_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-16 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-16 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-15 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-15 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-14 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-14 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-13 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-13 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-13 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-13 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-13 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-13 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-12 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-12 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-12 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-12 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-12 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-12 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-12 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-11 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-11 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 9e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-09 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4EBY|A Chain A, Crystal Structure Of The Ectodomain Of A Receptor Like Kinase Length = 212 | Back alignment and structure |
|
| >pdb|4EBY|A Chain A, Crystal Structure Of The Ectodomain Of A Receptor Like Kinase Length = 212 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 367 bits (944), Expect = e-121
Identities = 112/306 (36%), Positives = 167/306 (54%), Gaps = 21/306 (6%)
Query: 480 FSYEELAKATNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQAS----KEFLAELK 534
FS EL A+++FS N +G+GGFG V+ L G A+K++ + + +F E++
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 535 VLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRG--SGKDTLTWSARMQIALD 591
+++ H NL+RL G+C+ + LVY Y+ NG++ LR + L W R +IAL
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 592 SARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTF 651
SARGL Y+H+H P IHRD+K ANIL+D+ F A V DFGLAKL + V T + GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199
Query: 652 GYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVA----LFEEV 707
G++ PEY G+ S K DV+ +GV+L ELI+ A + L+ L +E
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE- 258
Query: 708 LRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767
+ L+ LVD L +Y + V ++ ++A CTQ +P RP M +V L
Sbjct: 259 -------KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML-EGDG 310
Query: 768 SSEDWD 773
+E W+
Sbjct: 311 LAERWE 316
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 359 bits (923), Expect = e-118
Identities = 111/313 (35%), Positives = 171/313 (54%), Gaps = 17/313 (5%)
Query: 458 SESAALVAAPGVTGITVDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELR-GEKA 516
+ ++ A + + +S +L +ATN+F IG G FG V+ LR G K
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 517 AIKKMD---MQASKEFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHL 572
A+K+ Q +EF E++ L+ H +LV LIG+C E + + L+Y+Y+ENGNL +HL
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 573 RGSGKDT--LTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADF 630
GS T ++W R++I + +ARGL Y+H + IHRD+K NIL+D+NF K+ DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI---IHRDVKSINILLDENFVPKITDF 183
Query: 631 GLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVK 689
G++K + + T + GT GY+ PEY G ++ K DVY+FGVVL+E++ A A+V+
Sbjct: 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243
Query: 690 TNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENP 749
+ E L E L+++VDP L D +S+RK A C +
Sbjct: 244 SLP--REMVNLAEWAVESHN----NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSS 297
Query: 750 QLRPSMRAIVVAL 762
+ RPSM ++ L
Sbjct: 298 EDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 350 bits (901), Expect = e-115
Identities = 108/305 (35%), Positives = 170/305 (55%), Gaps = 28/305 (9%)
Query: 480 FSYEELAKATNDFS------MGNKIGQGGFGAVFYAELRGEKAAIKKMD-------MQAS 526
FS+ EL TN+F GNK+G+GGFG V+ + A+KK+ +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 527 KEFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRG-SGKDTLTWSA 584
++F E+KV+ H NLV L+G+ +G L LVY Y+ NG+L L G L+W
Sbjct: 75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 585 RMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS-V 643
R +IA +A G+ ++HE+ IHRDIK ANIL+D+ F AK++DFGLA+ +E + + +
Sbjct: 135 RCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 644 HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVAL 703
+R+VGT YM PE + GE++PK D+Y+FGVVL E+I+ + AV + E L+ +
Sbjct: 192 TSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL----LLDI 246
Query: 704 FEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763
EE+ + + ++ +D ++ D SV M +A C E RP ++ + L
Sbjct: 247 KEEIEDE---EKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 764 TLSSS 768
+++S
Sbjct: 303 EMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 318 bits (817), Expect = e-102
Identities = 88/319 (27%), Positives = 140/319 (43%), Gaps = 35/319 (10%)
Query: 477 SVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKV- 535
V+ E L + + +G FG V+ A+L E A+K +Q + + E +V
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVY 70
Query: 536 -LTHVHHLNLVRLIGYCVEGS-----LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIA 589
L + H N+++ IG G+ L+L+ + E G+L+ L+ + ++W+ IA
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELCHIA 127
Query: 590 LDSARGLEYIHEHTV-------PVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642
ARGL Y+HE P HRDIK N+L+ N A +ADFGLA E G ++
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 643 VHT-RLVGTFGYMPPEYAQYG-----EVSPKIDVYAFGVVLYELISAMEAVVKTNETITE 696
T VGT YM PE + + +ID+YA G+VL+EL S A +
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD---- 243
Query: 697 STGLVALFEEVLRQPDPREDLQRLV-----DPRLGDDYPIDSV-RKMARLARACTQENPQ 750
+ FEE + Q ED+Q +V P L D + + + C + +
Sbjct: 244 --EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301
Query: 751 LRPSMRAIVVALMTLSSSS 769
R S + + + +
Sbjct: 302 ARLSAGCVGERITQMQRLT 320
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 287 bits (736), Expect = 1e-90
Identities = 74/328 (22%), Positives = 130/328 (39%), Gaps = 42/328 (12%)
Query: 478 VEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKV-- 535
+E + E + ++ + IG+G +GAV+ L A+K + F+ E +
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYR 60
Query: 536 LTHVHHLNLVRLIGYCVEGS------LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIA 589
+ + H N+ R I + LV EY NG+L ++L T W + ++A
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCRLA 117
Query: 590 LDSARGLEYIHE------HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643
RGL Y+H H P HRD+ N+L+ + ++DFGL+
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 644 H-------TRLVGTFGYMPPEYAQ-------YGEVSPKIDVYAFGVVLYELISAMEAVVK 689
VGT YM PE + ++D+YA G++ +E+ +
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF- 236
Query: 690 TNETITESTGLVALFEEVLRQPDPREDLQRLVD-----PRLGDDYPIDSV--RKMARLAR 742
E++ E +A EV P ED+Q LV P+ + + +S+ R +
Sbjct: 237 PGESVPEY--QMAFQTEVGNHPTF-EDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 743 ACTQENPQLRPSMRAIVVALMTLSSSSE 770
C ++ + R + + + L E
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWE 321
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 2e-69
Identities = 85/299 (28%), Positives = 133/299 (44%), Gaps = 54/299 (18%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNL 544
D ++ KIG G FG V AE G A+K + Q EFL E+ ++ + H N+
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 545 VRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSG-KDTLTWSARMQIALDSARGLEYIHEH 602
V +G + L +V EY+ G+L + L SG ++ L R+ +A D A+G+ Y+H
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYG 662
P+ +HR++K N+L+DK + KV DFGL++L + + GT +M PE +
Sbjct: 157 NPPI-VHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 663 EVSPKIDVYAFGVVLYELIS------------AMEAVVKTNETITESTGLVALFEEVLRQ 710
+ K DVY+FGV+L+EL + + AV R
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC----------------KRL 258
Query: 711 PDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSS 769
PR ++P ++A + C P RPS I+ L L S+
Sbjct: 259 EIPRN-----LNP------------QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 230 bits (587), Expect = 5e-69
Identities = 78/307 (25%), Positives = 133/307 (43%), Gaps = 37/307 (12%)
Query: 491 DFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKV--LTHVHHLNLVRLI 548
M +IG+G +G V+ + RGEK A+K + E ++ + H N++ I
Sbjct: 38 QIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFI 97
Query: 549 GYCVEGS-----LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT 603
++G+ L+L+ +Y ENG+L +L+ TL + +++A S GL ++H
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 604 V-----PVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH---TRLVGTFGYMP 655
P HRD+K NIL+ KN +AD GLA + V VGT YMP
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 656 PE------YAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLR 709
PE + + D+Y+FG++L+E+ + E + +++
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE-------YQLPYHDLVP 267
Query: 710 QPDPREDLQRLVD-----PRLGDDYPIDSV-RKMARLARACTQENPQLRPSMRAIVVALM 763
ED++ +V P + + D R+M +L C NP R + + L
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
Query: 764 TLSSSSE 770
+S S +
Sbjct: 328 KMSESQD 334
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 2e-68
Identities = 82/297 (27%), Positives = 131/297 (44%), Gaps = 32/297 (10%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQA-SKEFLAELKVLTHVHHLNLVRLI 548
+ + +G+G FG V A+ R + AIK+++ ++ K F+ EL+ L+ V+H N+V+L
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLY 67
Query: 549 GYCVEGSLFLVYEYIENGNLNQHLRGSGK-DTLTWSARMQIALDSARGLEYIHEHTVPVY 607
G C+ + LV EY E G+L L G+ T + M L ++G+ Y+H
Sbjct: 68 GACLN-PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 608 IHRDIKPANILIDKNFR-AKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSP 666
IHRD+KP N+L+ K+ DFG A + T G+ +M PE + S
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 667 KIDVYAFGVVLYELISAMEAVVKTNETITE--STGLVALFEEVLRQPDPREDLQRLVDPR 724
K DV+++G++L+E+I T + + V R P
Sbjct: 183 KCDVFSWGIILWEVI--------TRRKPFDEIGGPAFRIMWAVHNG-------TR---PP 224
Query: 725 LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWDIGSFYENQ 781
L + P + + L C ++P RPSM IV + L D Y Q
Sbjct: 225 LIKNLP----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQ 277
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 6e-66
Identities = 78/302 (25%), Positives = 117/302 (38%), Gaps = 45/302 (14%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKM---DMQASKEFLAELKVLTHVHHLNL 544
+D G +G+G FG R GE +K++ D + + FL E+KV+ + H N+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 545 VRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT 603
++ IG + L + EYI+ G L ++ WS R+ A D A G+ Y+H
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHSMN 128
Query: 604 VPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR-------------LVGT 650
IHRD+ N L+ +N VADFGLA+L +VG
Sbjct: 129 ---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 651 FGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVAL-FEEVLR 709
+M PE K+DV++FG+VL E+I + A T L L
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD----PDYLPRTMDFGLNVRGFLD 241
Query: 710 QPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSS 769
+ P P + C +P+ RPS + L TL
Sbjct: 242 RYCPPN-----CPPSF------------FPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284
Query: 770 ED 771
Sbjct: 285 AG 286
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 1e-64
Identities = 74/302 (24%), Positives = 132/302 (43%), Gaps = 37/302 (12%)
Query: 491 DFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKV--LTHVHHLNLVRLI 548
D ++ +G+G +G V+ +GE A+K + K + E ++ + H N++ I
Sbjct: 9 DITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 549 GYCVEGS-----LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT 603
+ L+L+ Y E G+L +L+ TL + ++I L A GL ++H
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 604 V-----PVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH---TRLVGTFGYMP 655
P HRD+K NIL+ KN + +AD GLA + + + VGT YM
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 656 PE------YAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLR 709
PE + ++D++AFG+VL+E+ M + + F +V+
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED-------YKPPFYDVVP 238
Query: 710 QPDPREDLQRLVD-----PRLGDDYPIDSV-RKMARLARACTQENPQLRPSMRAIVVALM 763
ED++++V P + + + D +A+L + C +NP R + I L
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
Query: 764 TL 765
+
Sbjct: 299 KI 300
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 2e-64
Identities = 74/283 (26%), Positives = 130/283 (45%), Gaps = 33/283 (11%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNL 544
++G +IG G FG V+ + G+ A+K +++ + F E+ VL H+N+
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 545 VRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTV 604
+ +GY L +V ++ E +L HL + + + IA +ARG++Y+H +
Sbjct: 83 LLFMGYSTAPQLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLHAKS- 140
Query: 605 PVYIHRDIKPANILIDKNFRAKVADFGLAKL-TEVGSASVHTRLVGTFGYMPPEYAQYGE 663
IHRD+K NI + ++ K+ DFGLA + + +L G+ +M PE + +
Sbjct: 141 --IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 664 VSP---KIDVYAFGVVLYELISAMEAVVKTNET-ITESTGLVALFEEVLRQPDPREDLQR 719
+P + DVYAFG+VLYEL+ T + + + E V R
Sbjct: 199 SNPYSFQSDVYAFGIVLYELM--------TGQLPYSNINNRDQIIEMVGRG------SLS 244
Query: 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762
++ + P ++M RL C ++ RPS I+ +
Sbjct: 245 PDLSKVRSNCP----KRMKRLMAECLKKKRDERPSFPRILAEI 283
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 3e-64
Identities = 56/293 (19%), Positives = 110/293 (37%), Gaps = 57/293 (19%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNL 544
+ K+ + G ++ +G +K + ++ S++F E L H N+
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 545 VRLIGYCVE---GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE 601
+ ++G C L+ ++ G+L L + S ++ ALD ARG+ ++H
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE---Y 658
+ + +++ID++ A+++ + + + ++ PE
Sbjct: 130 LEPLI-PRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQK 182
Query: 659 AQYGEVSPKIDVYAFGVVLYEL---------ISAMEAVVKTNETITESTGLVALFEEVLR 709
D+++F V+L+EL +S ME +K VAL E LR
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK-----------VAL--EGLR 229
Query: 710 QPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762
P + P +++L + C E+P RP IV L
Sbjct: 230 PTIPPG-----ISP------------HVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 8e-64
Identities = 75/305 (24%), Positives = 134/305 (43%), Gaps = 37/305 (12%)
Query: 491 DFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKV--LTHVHHLNLVRLI 548
+ IG+G FG V+ + RGE+ A+K + + + E ++ + H N++ I
Sbjct: 43 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFI 102
Query: 549 GYCVEGS-----LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT 603
+ + L+LV +Y E+G+L +L + T+T +++AL +A GL ++H
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 604 V-----PVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH---TRLVGTFGYMP 655
V P HRD+K NIL+ KN +AD GLA + + ++ VGT YM
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 656 PE------YAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLR 709
PE ++ E + D+YA G+V +E+ + + +++
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY-------QLPYYDLVP 272
Query: 710 QPDPREDLQRLVD-----PRLGDDYPIDSV-RKMARLARACTQENPQLRPSMRAIVVALM 763
E+++++V P + + + R MA++ R C N R + I L
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
Query: 764 TLSSS 768
LS
Sbjct: 333 QLSQQ 337
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 6e-63
Identities = 77/296 (26%), Positives = 121/296 (40%), Gaps = 51/296 (17%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQAS-------KEFLAELKVLTHVHHL 542
+ ++ IG GGFG V+ A G++ A+K + E K+ + H
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 543 NLVRLIGYCVEG-SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE 601
N++ L G C++ +L LV E+ G LN+ L G + + A+ ARG+ Y+H+
Sbjct: 67 NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHD 123
Query: 602 HTVPVYIHRDIKPANILIDK--------NFRAKVADFGLAKLTEVGSASVHTRLVGTFGY 653
+ IHRD+K +NILI + N K+ DFGLA+ + G + +
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMSAAGAYAW 180
Query: 654 MPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNET----ITESTGLVALFEEVLR 709
M PE + S DV+++GV+L+EL+ T E I + L
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELL--------TGEVPFRGIDGLAVAYGVAMNKLA 232
Query: 710 QPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765
P P A+L C +P RPS I+ L T+
Sbjct: 233 LPIPST-----CPEPF------------AKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 1e-62
Identities = 78/301 (25%), Positives = 133/301 (44%), Gaps = 57/301 (18%)
Query: 490 NDFSMGNKIGQGGFGAVFYAEL--RGEKAAIKKMDMQAS----------KEFLAELKVLT 537
N+ +IG+GGFG V L AIK + + S +EF E+ +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 538 HVHHLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLE 597
+++H N+V+L G +V E++ G+L L + WS ++++ LD A G+E
Sbjct: 79 NLNHPNIVKLYGLMHNP-PRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIE 136
Query: 598 YIHEHTVPVYIHRDIKPANILIDK-----NFRAKVADFGLAKLTEVGSASVHTRLVGTFG 652
Y+ P+ +HRD++ NI + AKVADFGL++ + + L+G F
Sbjct: 137 YMQNQNPPI-VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV----SGLLGNFQ 191
Query: 653 YMPPE--YAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNE------TITESTGLVALF 704
+M PE A+ + K D Y+F ++LY ++ T E + + + +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTIL--------TGEGPFDEYSYGKIKFINMIR 243
Query: 705 EEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764
EE LR P + +D P ++ + C +P+ RP IV L
Sbjct: 244 EEGLR-------------PTIPEDCP----PRLRNVIELCWSGDPKKRPHFSYIVKELSE 286
Query: 765 L 765
L
Sbjct: 287 L 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 5e-60
Identities = 61/310 (19%), Positives = 113/310 (36%), Gaps = 56/310 (18%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNL 544
+G IG+G FG V++ GE AI+ +D++ K F E+ H N+
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENV 91
Query: 545 VRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT 603
V +G C+ L ++ + L +R K L + QIA + +G+ Y+H
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVR-DAKIVLDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 604 VPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS----VHTRLVGTFGYMPPE-- 657
+ +H+D+K N+ D + + DFGL ++ V A G ++ PE
Sbjct: 151 I---LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 658 -------YAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEV--- 707
S DV+A G + YEL E ++ A+ ++
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELH--------AREWPFKTQPAEAIIWQMGTG 258
Query: 708 LRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL-- 765
++ + + ++++ + C + RP+ ++ L L
Sbjct: 259 MKPNLSQIGMG----------------KEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302
Query: 766 --SSSSEDWD 773
S
Sbjct: 303 RNRRLSHPGH 312
|
| >4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* Length = 212 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-56
Identities = 91/189 (48%), Positives = 122/189 (64%), Gaps = 8/189 (4%)
Query: 8 CNTGCQLALASYYVWEGSNPTYISNIFGEDIAQ--------ILLYNPNIPNQNTIPSDTR 59
C T C LALASYY+ G+ + I+ IA IL YN NI +++ I +R
Sbjct: 1 CRTSCPLALASYYLENGTTLSVINQNLNSSIAPYDQINFDPILRYNSNIKDKDRIQMGSR 60
Query: 60 ISIPFSCDCLNGDFLGHTFTYETQFGDTYEKVASFAFANLTTEDWVRRVNIYEPTRIPDY 119
+ +PF C+C GDFLGH F+Y + DTYE+VA +ANLTT + ++ N + T IP
Sbjct: 61 VLVPFPCECQPGDFLGHNFSYSVRQEDTYERVAISNYANLTTMESLQARNPFPATNIPLS 120
Query: 120 AFINVTVNCSCGDRHISRDYGLFTTYPLRPAQNLSSVAAEAGVAPQSLQRYNPGTNFSAG 179
A +NV VNCSCGD +S+D+GLF TYPLRP +LSS+A +GV+ LQRYNPG NF++G
Sbjct: 121 ATLNVLVNCSCGDESVSKDFGLFVTYPLRPEDSLSSIARSSGVSADILQRYNPGVNFNSG 180
Query: 180 TGLVFVPAR 188
G+V+VP R
Sbjct: 181 NGIVYVPGR 189
|
| >4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* Length = 212 | Back alignment and structure |
|---|
Score = 191 bits (485), Expect = 3e-56
Identities = 90/190 (47%), Positives = 131/190 (68%), Gaps = 9/190 (4%)
Query: 215 CSKGCDLALASYYLWKGANLTFISKVFDTSI--------KYILSFNPQITNKDKILAGTR 266
C C LALASYYL G L+ I++ ++SI IL +N I +KD+I G+R
Sbjct: 1 CRTSCPLALASYYLENGTTLSVINQNLNSSIAPYDQINFDPILRYNSNIKDKDRIQMGSR 60
Query: 267 INVPFSCNCIQNKFLGHSFSYKVKSGNTYKRIAELIYANLTTLDWLKSSNAYDENHTPDV 326
+ VPF C C FLGH+FSY V+ +TY+R+A YANLTT++ L++ N + + P +
Sbjct: 61 VLVPFPCECQPGDFLGHNFSYSVRQEDTYERVAISNYANLTTMESLQARNPFPATNIP-L 119
Query: 327 SSSVNVIVNCSCGSKSVSKDYGLFLTYPLRPGENLSSIANEFELSSELLQSYNPTLDFIS 386
S+++NV+VNCSCG +SVSKD+GLF+TYPLRP ++LSSIA +S+++LQ YNP ++F S
Sbjct: 120 SATLNVLVNCSCGDESVSKDFGLFVTYPLRPEDSLSSIARSSGVSADILQRYNPGVNFNS 179
Query: 387 GSGLAFVPVK 396
G+G+ +VP +
Sbjct: 180 GNGIVYVPGR 189
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-47
Identities = 85/293 (29%), Positives = 133/293 (45%), Gaps = 37/293 (12%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGE--KAAIK--KMDMQASKEFLAELKVLTHVHHLNLV 545
D +M +K+G G +G V+ + A+K K D +EFL E V+ + H NLV
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 279
Query: 546 RLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTV 604
+L+G C +++ E++ GNL +LR + ++ + +A + +EY+ +
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN- 338
Query: 605 PVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEV 664
+IHR++ N L+ +N KVADFGL++L + + H + PE Y +
Sbjct: 339 --FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396
Query: 665 SPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724
S K DV+AFGV+L+E+ + G P P DL ++ +
Sbjct: 397 SIKSDVWAFGVLLWEIAT---------------YG---------MSPYPGIDLSQVYE-L 431
Query: 725 LGDDY----PIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWD 773
L DY P K+ L RAC Q NP RPS I A T+ S D
Sbjct: 432 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 484
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-47
Identities = 76/291 (26%), Positives = 118/291 (40%), Gaps = 47/291 (16%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGE--KAAIKKM----DMQASKEFLAELKVLTHVHHLN 543
D +G +IG+G FG VF LR + A+K +FL E ++L H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 544 LVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH 602
+VRLIG C + +++V E ++ G+ LR G L +Q+ D+A G+EY+
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLESK 232
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGY----MPPEY 658
IHRD+ N L+ + K++DFG+++ V+ G PE
Sbjct: 233 C---CIHRDLAARNCLVTEKNVLKISDFGMSREEA---DGVYAASGGLRQVPVKWTAPEA 286
Query: 659 AQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718
YG S + DV++FG++L+E S G P P Q
Sbjct: 287 LNYGRYSSESDVWSFGILLWETF---------------SLG---------ASPYPNLSNQ 322
Query: 719 RLVDPRLGDDY----PIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765
+ + + P + RL C P RPS I L ++
Sbjct: 323 QTRE-FVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 6e-47
Identities = 83/287 (28%), Positives = 135/287 (47%), Gaps = 41/287 (14%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKAAIK--KMDMQASKEFLAELKVLTHVHHLNLVRL 547
+ + IG+G FG V + RG K A+K K D ++ FLAE V+T + H NLV+L
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT-AQAFLAEASVMTQLRHSNLVQL 251
Query: 548 IGYCVE--GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVP 605
+G VE G L++V EY+ G+L +LR G+ L ++ +LD +EY+ +
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-- 309
Query: 606 VYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVS 665
++HRD+ N+L+ ++ AKV+DFGL K E S +L + PE + + S
Sbjct: 310 -FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKKFS 364
Query: 666 PKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725
K DV++FG++L+E+ S G R P PR L+ +V R+
Sbjct: 365 TKSDVWSFGILLWEIYSF---------------G---------RVPYPRIPLKDVVP-RV 399
Query: 726 GDDY----PIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768
Y P + + + C + RP+ + L + +
Sbjct: 400 EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 6e-47
Identities = 84/302 (27%), Positives = 136/302 (45%), Gaps = 45/302 (14%)
Query: 479 EFSYEELAKATNDFSMGNKIGQGGFGAVFYAELRGEKAAIK--KMDMQASKEFLAELKVL 536
EF A + + IG+G FG V + RG K A+K K D ++ FLAE V+
Sbjct: 10 EFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT-AQAFLAEASVM 68
Query: 537 THVHHLNLVRLIGYCV--EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSAR 594
T + H NLV+L+G V +G L++V EY+ G+L +LR G+ L ++ +LD
Sbjct: 69 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 128
Query: 595 GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGY- 653
+EY+ + ++HRD+ N+L+ ++ AKV+DFGL K + G
Sbjct: 129 AMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT------GKLPVK 179
Query: 654 -MPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD 712
PE + + S K DV++FG++L+E+ S G R P
Sbjct: 180 WTAPEALREKKFSTKSDVWSFGILLWEIYSF---------------G---------RVPY 215
Query: 713 PREDLQRLVDPRLGDDY----PIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768
PR L+ +V R+ Y P + + + C + +RPS + L + +
Sbjct: 216 PRIPLKDVVP-RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
Query: 769 SE 770
Sbjct: 275 EL 276
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 7e-47
Identities = 68/299 (22%), Positives = 122/299 (40%), Gaps = 32/299 (10%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA------AIKKM---DMQASKEFLAELKVLTHVH 540
++G+G FG+V + A+KK+ + ++F E+++L +
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 541 HLNLVRLIGYCVEG---SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLE 597
H N+V+ G C +L L+ EY+ G+L +L+ K+ + +Q +G+E
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGME 128
Query: 598 YIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTF--GYMP 655
Y+ YIHRD+ NIL++ R K+ DFGL K+ + G +
Sbjct: 129 YLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 656 PEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715
PE + S DV++FGVVLYEL + +E G +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG---------NDKQGQM 236
Query: 716 DLQRLVDPRLGDDY----PIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770
+ L++ L ++ P ++ + C N RPS R + + + + +
Sbjct: 237 IVFHLIE-LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 9e-47
Identities = 76/345 (22%), Positives = 133/345 (38%), Gaps = 42/345 (12%)
Query: 444 HYIQHGPAIALVKNSESAALVAAPGVTGITVDKSVEFSYEELAKATNDFSMGNKIGQGGF 503
H+ H E+ A G D + +F L ++G+G F
Sbjct: 5 HHHHHHDYDIPTT--ENLYFQGAMGSAFEDRDPT-QFEERHL-------KFLQQLGKGNF 54
Query: 504 GAVFYAELRGEKA------AIKKM---DMQASKEFLAELKVLTHVHHLNLVRLIGYCVEG 554
G+V + A+KK+ + ++F E+++L + H N+V+ G C
Sbjct: 55 GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114
Query: 555 ---SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRD 611
+L L+ EY+ G+L +L+ K+ + +Q +G+EY+ YIHRD
Sbjct: 115 GRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRD 170
Query: 612 IKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTF--GYMPPEYAQYGEVSPKID 669
+ NIL++ R K+ DFGL K+ + G + PE + S D
Sbjct: 171 LATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASD 230
Query: 670 VYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDY 729
V++FGVVLYEL + +E G + + L++ L ++
Sbjct: 231 VWSFGVVLYELFTYIEKSKSPPAEFMRMIG---------NDKQGQMIVFHLIE-LLKNNG 280
Query: 730 ----PIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770
P ++ + C N RPS R + + + +
Sbjct: 281 RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 5e-46
Identities = 86/296 (29%), Positives = 134/296 (45%), Gaps = 43/296 (14%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGE--KAAIK--KMDMQASKEFLAELKVLTHVHHLNLV 545
D +M +K+G G +G V+ + A+K K D +EFL E V+ + H NLV
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 546 RLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTV 604
+L+G C +++ E++ GNL +LR + ++ + +A + +EY+ +
Sbjct: 73 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN- 131
Query: 605 PVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG--SASVHTRL-VGTFGYMPPEYAQY 661
+IHRD+ N L+ +N KVADFGL++L +A + + + PE Y
Sbjct: 132 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK---WTAPESLAY 186
Query: 662 GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721
+ S K DV+AFGV+L+E+ + G P P DL ++
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATY---------------G---------MSPYPGIDLSQVY 222
Query: 722 DPRLGDDY----PIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWD 773
+ L DY P K+ L RAC Q NP RPS I A T+ S D
Sbjct: 223 E-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 277
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 6e-46
Identities = 80/288 (27%), Positives = 128/288 (44%), Gaps = 35/288 (12%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGE-KAAIK--KMDMQASKEFLAELKVLTHVHHLNLVR 546
+ K+GQG FG V+ G + AIK K + + FL E +V+ + H LV+
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 547 LIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPV 606
L E +++V EY+ G+L L+G L + +A A G+ Y+
Sbjct: 244 LYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--- 300
Query: 607 YIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSP 666
Y+HRD++ ANIL+ +N KVADFGLA+L E + + PE A YG +
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 667 KIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLG 726
K DV++FG++L EL + G R P P + ++D ++
Sbjct: 361 KSDVWSFGILLTELT---------------TKG---------RVPYPGMVNREVLD-QVE 395
Query: 727 DDY----PIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770
Y P + + L C ++ P+ RP+ + L +S+E
Sbjct: 396 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 9e-46
Identities = 79/290 (27%), Positives = 130/290 (44%), Gaps = 39/290 (13%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGE-KAAIK--KMDMQASKEFLAELKVLTHVHHLNLVR 546
+ ++G G FG V+ G K A+K K + FLAE ++ + H LVR
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 547 LIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPV 606
L + ++++ EY+ENG+L L+ LT + + +A A G+ +I E
Sbjct: 73 LYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--- 129
Query: 607 YIHRDIKPANILIDKNFRAKVADFGLAKLTEVG--SASVHTRLVGTFGYMPPEYAQYGEV 664
YIHRD++ ANIL+ K+ADFGLA+L E +A + + PE YG
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINYGTF 187
Query: 665 SPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724
+ K DV++FG++L E+++ G R P P ++
Sbjct: 188 TIKSDVWSFGILLTEIVTH---------------G---------RIPYPGMTNPEVIQ-N 222
Query: 725 LGDDY----PIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770
L Y P + ++ +L R C +E P+ RP+ + L +++E
Sbjct: 223 LERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-45
Identities = 80/288 (27%), Positives = 128/288 (44%), Gaps = 35/288 (12%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGE-KAAIK--KMDMQASKEFLAELKVLTHVHHLNLVR 546
+ K+GQG FG V+ G + AIK K + + FL E +V+ + H LV+
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 326
Query: 547 LIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPV 606
L E +++V EY+ G+L L+G L + +A A G+ Y+
Sbjct: 327 LYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--- 383
Query: 607 YIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSP 666
Y+HRD++ ANIL+ +N KVADFGLA+L E + + PE A YG +
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 667 KIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLG 726
K DV++FG++L EL + G R P P + ++D ++
Sbjct: 444 KSDVWSFGILLTELT---------------TKG---------RVPYPGMVNREVLD-QVE 478
Query: 727 DDY----PIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770
Y P + + L C ++ P+ RP+ + L +S+E
Sbjct: 479 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-44
Identities = 70/290 (24%), Positives = 129/290 (44%), Gaps = 43/290 (14%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGE-KAAIK--KMDMQASKEFLAELKVLTHVHHLNLVR 546
++ + +IG G FG V + K AIK + + ++F+ E +V+ + H LV+
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 67
Query: 547 LIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVP 605
L G C+E + + LV E++E+G L+ +LR + + + + LD G+ Y+ E
Sbjct: 68 LYGVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEAC-- 124
Query: 606 VYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGT---FGYMPPEYAQYG 662
IHRD+ N L+ +N KV+DFG+ + +T GT + PE +
Sbjct: 125 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVL---DDQYTSSTGTKFPVKWASPEVFSFS 180
Query: 663 EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD 722
S K DV++FGV+++E+ S G + P +V+
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSE---------------G---------KIPYENRSNSEVVE 216
Query: 723 PRLGDDY----PIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768
+ + P + + ++ C +E P+ RP+ ++ L ++ S
Sbjct: 217 -DISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 8e-44
Identities = 77/321 (23%), Positives = 132/321 (41%), Gaps = 57/321 (17%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA------AIKKM----DMQASKEFLAELKVLTHV 539
+ + IG G FG V+ L+ AIK + + +FL E ++
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 540 HHLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEY 598
H N++RL G + + ++ EY+ENG L++ LR + + + A G++Y
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKY 162
Query: 599 IHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGY--MPP 656
+ Y+HRD+ NIL++ N KV+DFGL+++ E + +T G P
Sbjct: 163 LANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219
Query: 657 EYAQYGEVSPKIDVYAFGVVLYELIS-------AMEAVVKTNETITESTGLVALFEEVLR 709
E Y + + DV++FG+V++E+++ + +N EV++
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-----SN-------------HEVMK 261
Query: 710 QPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSS 769
D RL P P+D + +L C Q+ RP IV L L +
Sbjct: 262 AI---NDGFRL--PT-----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311
Query: 770 EDWDIGSFYENQGLDSLMSGR 790
+ S D +S R
Sbjct: 312 D-----SLKTLADFDPRVSIR 327
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-43
Identities = 70/304 (23%), Positives = 116/304 (38%), Gaps = 66/304 (21%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS----KEFLAELKVLTHVHHLN 543
DF +G+GGFG VF A+ + AIK++ + ++ + E+K L + H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 544 LVRLIGYCVE-------------GSLFLVYEYIENGNLNQHLRGSGKDTLT-----WSAR 585
+VR +E L++ + NL + G
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 586 MQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK----------- 634
+QIA +E++H + +HRD+KP+NI + KV DFGL
Sbjct: 125 LQIAE----AVEFLHSKGL---MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 635 LTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETI 694
LT + + + HT VGT YM PE S K+D+++ G++L+EL+ ++ T+
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTL 237
Query: 695 TESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPS 754
T D++ L P L + + +P RP
Sbjct: 238 T--------------------DVRNLKFPPLFTQKY----PCEYVMVQDMLSPSPMERPE 273
Query: 755 MRAI 758
I
Sbjct: 274 AINI 277
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-43
Identities = 72/292 (24%), Positives = 117/292 (40%), Gaps = 60/292 (20%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRL 547
DF IG GGFG VF A+ R G+ IK++ +++ E+K L + H+N+V
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-NEKAEREVKALAKLDHVNIVHY 69
Query: 548 IGYCVE-----------------GSLFLVYEYIENGNLNQHLRGSGKDTLT----WSARM 586
G LF+ E+ + G L Q + + L
Sbjct: 70 NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFE 129
Query: 587 QIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR 646
QI G++YIH + I+RD+KP+NI + + K+ DFGL + + TR
Sbjct: 130 QITK----GVDYIHSKKL---INRDLKPSNIFLVDTKQVKIGDFGLVTSLK--NDGKRTR 180
Query: 647 LVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEE 706
GT YM PE + ++D+YA G++L EL+ + +T++
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF------------ 228
Query: 707 VLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
L D + D + +K L + + P+ RP+ I
Sbjct: 229 -----------TDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEI 265
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-43
Identities = 70/287 (24%), Positives = 129/287 (44%), Gaps = 43/287 (14%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGE-KAAIK--KMDMQASKEFLAELKVLTHVHHLNLVR 546
+ ++ ++G G FG V + +G+ A+K K + EF E + + + H LV+
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVK 67
Query: 547 LIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVP 605
G C + +++V EYI NG L +LR GK L S +++ D G+ ++ H
Sbjct: 68 FYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFLESHQ-- 124
Query: 606 VYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGT---FGYMPPEYAQYG 662
+IHRD+ N L+D++ KV+DFG+ + + VGT + PE Y
Sbjct: 125 -FIHRDLAARNCLVDRDLCVKVSDFGMTRYVL---DDQYVSSVGTKFPVKWSAPEVFHYF 180
Query: 663 EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD 722
+ S K DV+AFG++++E+ S G + P +V
Sbjct: 181 KYSSKSDVWAFGILMWEVFSL---------------G---------KMPYDLYTNSEVVL 216
Query: 723 PRLGDDY----PIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765
++ + P + + ++ +C E P+ RP+ + ++ ++ L
Sbjct: 217 -KVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-43
Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 14/200 (7%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGE-KAAIK--KMDMQASKEFLAELKVLTHVHHLNLVR 546
D + ++G G FG V Y + RG+ AIK K + EF+ E KV+ ++ H LV+
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 547 LIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVP 605
L G C + +F++ EY+ NG L +LR + +++ D +EY+
Sbjct: 84 LYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESKQ-- 140
Query: 606 VYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGT---FGYMPPEYAQYG 662
++HRD+ N L++ KV+DFGL++ +T VG+ + PPE Y
Sbjct: 141 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL---DDEYTSSVGSKFPVRWSPPEVLMYS 196
Query: 663 EVSPKIDVYAFGVVLYELIS 682
+ S K D++AFGV+++E+ S
Sbjct: 197 KFSSKSDIWAFGVLMWEIYS 216
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-43
Identities = 70/291 (24%), Positives = 124/291 (42%), Gaps = 41/291 (14%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGE-KAAIK--KMDMQASKEFLAELKVLTHVHHLNLVR 546
+ K+G G FG V+ A K A+K K + + FLAE V+ + H LV+
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVK 247
Query: 547 LIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPV 606
L + ++++ E++ G+L L+ + + A G+ +I +
Sbjct: 248 LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--- 304
Query: 607 YIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGT---FGYMPPEYAQYGE 663
YIHRD++ ANIL+ + K+ADFGLA++ E + +T G + PE +G
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGS 361
Query: 664 VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723
+ K DV++FG++L E+++ G R P P ++
Sbjct: 362 FTIKSDVWSFGILLMEIVTY---------------G---------RIPYPGMSNPEVIR- 396
Query: 724 RLGDDY----PIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770
L Y P + ++ + C + P+ RP+ I L +++E
Sbjct: 397 ALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-43
Identities = 63/295 (21%), Positives = 127/295 (43%), Gaps = 34/295 (11%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA------AIKKM----DMQASKEFLAELKVLTHV 539
+G+G FG V E A+K + + E+++L ++
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 540 HHLNLVRLIGYCVEG---SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGL 596
+H N+V+ G C E + L+ E++ +G+L ++L K+ + +++ A+ +G+
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICKGM 139
Query: 597 EYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTF--GYM 654
+Y+ Y+HRD+ N+L++ + K+ DFGL K E + +
Sbjct: 140 DYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY 196
Query: 655 PPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714
PE + DV++FGV L+EL++ + + +ALF +++ +
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCD----------SDSSPMALFLKMIGPTHGQ 246
Query: 715 EDLQRLVDPRLGDDY----PIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765
+ RLV+ L + P + ++ +L R C + P R S + ++ L
Sbjct: 247 MTVTRLVN-TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-43
Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA------AIKKM----DMQASKEFLAELKVLTHV 539
+F +G G FG V+ E AIK++ +A+KE L E V+ V
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 540 HHLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYI 599
+ ++ RL+G C+ ++ L+ + + G L ++R KD + + + A+G+ Y+
Sbjct: 75 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYL 133
Query: 600 HEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGT---FGYMPP 656
+ +HRD+ N+L+ K+ DFGLAKL H G +M
Sbjct: 134 EDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMAL 188
Query: 657 EYAQYGEVSPKIDVYAFGVVLYELIS 682
E + + + DV+++GV ++EL++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-43
Identities = 65/303 (21%), Positives = 113/303 (37%), Gaps = 42/303 (13%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA------AIKKM----DMQASKEFLAELKVLTHV 539
+G+G FG V A+K + Q + E+ +L +
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 540 HHLNLVRLIGYCVEG---SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGL 596
+H ++++ G C + SL LV EY+ G+L +L + ++ + + A G+
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGM 147
Query: 597 EYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS----ASVHTRLVGTFG 652
Y+H YIHRD+ N+L+D + K+ DFGLAK G
Sbjct: 148 AYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS--PVF 202
Query: 653 YMPPEYAQYGEVSPKIDVYAFGVVLYELIS-----AMEAVVKTNETITESTGLVALFEEV 707
+ PE + + DV++FGV LYEL++ + +
Sbjct: 203 WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV--LRL 260
Query: 708 LRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767
E +RL P D P + + L + C + RP+ ++ L T+
Sbjct: 261 TEL---LERGERLPRP---DKCPAE----VYHLMKNCWETEASFRPTFENLIPILKTVHE 310
Query: 768 SSE 770
+
Sbjct: 311 KYQ 313
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 6e-43
Identities = 78/300 (26%), Positives = 125/300 (41%), Gaps = 51/300 (17%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA-----AIKKM----DMQASKEFLAELKVLTHVH 540
+ + IG G G V Y LR AIK + + ++FL+E ++
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 541 HLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYI 599
H N++RL G G +V EY+ENG+L+ LR + T + + G+ Y+
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 600 HEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGY--MPPE 657
+ Y+HRD+ N+L+D N KV+DFGL+++ E + +T G PE
Sbjct: 168 SDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE 224
Query: 658 YAQYGEVSPKIDVYAFGVVLYELIS-------AMEAVVKTNETITESTGLVALFEEVLRQ 710
+ S DV++FGVV++E+++ M TN +V+
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM-----TN-------------RDVISS 266
Query: 711 PDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770
E+ RL P P+ + +L C ++ RP IV L L S E
Sbjct: 267 V---EEGYRL--PA-----PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-42
Identities = 80/317 (25%), Positives = 139/317 (43%), Gaps = 72/317 (22%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA-------AIKKM---DMQASKEFLAELKVLTHV 539
D + ++G+G FG VF AE A+K + + A K+F E ++LT++
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 540 HHLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSG--------------KDTLTWSA 584
H ++V+ G C +G L +V+EY+++G+LN+ LR G K L S
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 585 RMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH 644
+ IA A G+ Y+ ++HRD+ N L+ N K+ DFG+++ +V S +
Sbjct: 135 MLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTDYY 189
Query: 645 TRLVGTFG-----YMPPEYAQYGEVSPKIDVYAFGVVLYELIS-------AMEAVVKTNE 692
VG +MPPE Y + + + DV++FGV+L+E+ + + +N
Sbjct: 190 R--VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL-----SN- 241
Query: 693 TITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLR 752
EV+ L+R P +++ + C Q PQ R
Sbjct: 242 ------------TEVIECITQGRVLER----------PRVCPKEVYDVMLGCWQREPQQR 279
Query: 753 PSMRAIVVALMTLSSSS 769
+++ I L L ++
Sbjct: 280 LNIKEIYKILHALGKAT 296
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-42
Identities = 75/302 (24%), Positives = 120/302 (39%), Gaps = 39/302 (12%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA------AIKKM---DMQASKEFLAELKVLTHVH 540
+++G+G FG+V A+K++ ++F E+++L +H
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 541 HLNLVRLIGYCV---EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLE 597
+V+ G SL LV EY+ +G L L+ + L S + + +G+E
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGME 141
Query: 598 YIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS----ASVHTRLVGTFGY 653
Y+ +HRD+ NIL++ K+ADFGLAKL + + +
Sbjct: 142 YLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS--PIFW 196
Query: 654 MPPEYAQYGEVSPKIDVYAFGVVLYELIS-----AMEAVVKTNETITESTGLVALFEEVL 708
PE S + DV++FGVVLYEL + + E +L
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL--SRLL 254
Query: 709 RQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768
E+ QRL P P + + L + C +PQ RPS A+ L L S
Sbjct: 255 EL---LEEGQRLPAP---PACPAE----VHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304
Query: 769 SE 770
S
Sbjct: 305 SR 306
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 6e-42
Identities = 96/323 (29%), Positives = 145/323 (44%), Gaps = 66/323 (20%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGE----KAAIKKMDMQAS----KEFLAELKVLTHV-H 540
ND + IG+G FG V A ++ + AAIK+M AS ++F EL+VL + H
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 541 HLNLVRLIGYC-VEGSLFLVYEYIENGNLNQHLRGS--------------GKDTLTWSAR 585
H N++ L+G C G L+L EY +GNL LR S TL+
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 586 MQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645
+ A D ARG++Y+ + +IHRD+ NIL+ +N+ AK+ADFGL++ EV
Sbjct: 145 LHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 201
Query: 646 RL-VGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-------AMEAVVKTNETITES 697
RL V +M E Y + DV+++GV+L+E++S M
Sbjct: 202 RLPV---RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----------- 247
Query: 698 TGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRA 757
E+ + RL P DD ++ L R C +E P RPS
Sbjct: 248 -------AELYEK---LPQGYRLEKPLNCDD-------EVYDLMRQCWREKPYERPSFAQ 290
Query: 758 IVVALMTLSSSSEDWDIGSFYEN 780
I+V+L + + + + YE
Sbjct: 291 ILVSLNRMLEERKTYVNTTLYEK 313
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 9e-42
Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 481 SYEELAKAT-----NDFSMGNK-IGQGGFGAVFYAELRGEKA----AIKK-----MDMQA 525
+ EE+ ++ +K +G G FG V + +K A+K D
Sbjct: 2 ALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL 61
Query: 526 SKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSAR 585
E LAE V+ + + +VR+IG C S LV E E G LN++L+ + +
Sbjct: 62 KDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNI 119
Query: 586 MQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645
+++ + G++Y+ E ++HRD+ N+L+ AK++DFGL+K
Sbjct: 120 IELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 176
Query: 646 RLVGTF--GYMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
+ G + + PE Y + S K DV++FGV+++E S
Sbjct: 177 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 9e-42
Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA-----AIKKM----DMQASKEFLAELKVLTHVH 540
+ S+ +G G FG V L+ AIK + + ++FL E ++
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 541 HLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYI 599
H N++RL G + + +V EY+ENG+L+ LR T + + A G++Y+
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 600 HEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGY--MPPE 657
+ Y+HRD+ NILI+ N KV+DFGL ++ E + +T G PE
Sbjct: 164 SDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 658 YAQYGEVSPKIDVYAFGVVLYELIS 682
Y + + DV+++G+VL+E++S
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 66/300 (22%), Positives = 118/300 (39%), Gaps = 52/300 (17%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA-----AIKKM----DMQASKEFLAELKVLTHVH 540
D + +G+G FG V+ K A+K + ++F++E ++ ++
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 541 HLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH 600
H ++V+LIG E +++ E G L +L K++L + +L + + Y+
Sbjct: 72 HPHIVKLIGIIEEEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS--ASVHTRLVGTFGYMPPEY 658
+HRDI NIL+ K+ DFGL++ E + TRL +M PE
Sbjct: 131 SIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPES 185
Query: 659 AQYGEVSPKIDVYAFGVVLYELIS-------AMEAVVKTNETITESTGLVALFEEVLRQP 711
+ + DV+ F V ++E++S + N ++V+
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWL-----EN-------------KDVIGV- 226
Query: 712 DPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSED 771
E RL P D P + L C +P RP +V +L + +D
Sbjct: 227 --LEKGDRLPKP---DLCPPV----LYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 49/206 (23%), Positives = 82/206 (39%), Gaps = 17/206 (8%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA-----AIKKM------DMQASKEFLAELKVLTH 538
D + K+G G FG V E A+K + +A +F+ E+ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 539 VHHLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEY 598
+ H NL+RL G + + +V E G+L LR + + A+ A G+ Y
Sbjct: 78 LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGY 136
Query: 599 IHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGY--MPP 656
+ +IHRD+ N+L+ K+ DFGL + + + P
Sbjct: 137 LESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
Query: 657 EYAQYGEVSPKIDVYAFGVVLYELIS 682
E + S D + FGV L+E+ +
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-41
Identities = 68/281 (24%), Positives = 121/281 (43%), Gaps = 42/281 (14%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHL 542
+ KIG+G FG + G + IK++++ + +E E+ VL ++ H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 543 NLVRLIGYCVE-GSLFLVYEYIENGNLNQHLRGSGKDTLT----WSARMQIALDSARGLE 597
N+V+ E GSL++V +Y E G+L + + +QI L L+
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICL----ALK 139
Query: 598 YIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE 657
++H+ + +HRDIK NI + K+ ++ DFG+A++ +GT Y+ PE
Sbjct: 140 HVHDRKI---LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTPYYLSPE 195
Query: 658 YAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717
+ + K D++A G VLYEL + A + + L +++
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS--------MKNLVLKIISGS------ 241
Query: 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
P + Y D + L + NP+ RPS+ +I
Sbjct: 242 ----FPPVSLHYSYD----LRSLVSQLFKRNPRDRPSVNSI 274
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 50/206 (24%), Positives = 92/206 (44%), Gaps = 19/206 (9%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA------AIKKM----DMQASKEFLAELKVLTHV 539
+ +G G FG V E IK + Q+ + + + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 540 HHLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYI 599
H ++VRL+G C SL LV +Y+ G+L H+R + L + + A+G+ Y+
Sbjct: 73 DHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 600 HEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGT---FGYMPP 656
EH +HR++ N+L+ + +VADFG+A L + +M
Sbjct: 132 EEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS--EAKTPIKWMAL 186
Query: 657 EYAQYGEVSPKIDVYAFGVVLYELIS 682
E +G+ + + DV+++GV ++EL++
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-41
Identities = 81/388 (20%), Positives = 152/388 (39%), Gaps = 95/388 (24%)
Query: 444 HYIQHGPAIALVKNSESAALVAAPGVTGITVDKSVEFSYEELAKATNDFSMGNKIGQGGF 503
H+ H I +N ++A + D E + L +G +G+G F
Sbjct: 30 HHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRL-------VLGKPLGEGAF 82
Query: 504 GAVFYAELRG---------EKAAIKKM----DMQASKEFLAELKVLTHV-HHLNLVRLIG 549
G V AE G K A+K + + + ++E++++ + H N++ L+G
Sbjct: 83 GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 142
Query: 550 YC-VEGSLFLVYEYIENGNLNQHLRGS--------------GKDTLTWSARMQIALDSAR 594
C +G L+++ EY GNL ++L+ ++ L+ + A AR
Sbjct: 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVAR 202
Query: 595 GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGY- 653
G+EY+ IHRD+ N+L+ ++ K+ADFGLA R + Y
Sbjct: 203 GMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLA------------RDIHHIDYY 247
Query: 654 ------------MPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLV 701
M PE + + DV++FGV+L+E+ +
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------------------- 288
Query: 702 ALFEEVL-RQPDPREDLQRLVDPRLGDDY----PIDSVRKMARLARACTQENPQLRPSMR 756
L P P ++ L L + + P + ++ + R C P RP+ +
Sbjct: 289 ------LGGSPYPGVPVEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 341
Query: 757 AIVVALMTLSSSSEDWDIGSFYENQGLD 784
+V L + + + + ++G ++ + D
Sbjct: 342 QLVEDLDRIVALTSNQEMGYYHHHHHHD 369
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-41
Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA------AIKKM----DMQASKEFLAELKVLTHV 539
+F +G G FG V+ E AIK++ +A+KE L E V+ V
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 540 HHLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYI 599
+ ++ RL+G C+ ++ L+ + + G L ++R KD + + + A+G+ Y+
Sbjct: 75 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYL 133
Query: 600 HEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGT---FGYMPP 656
+ +HRD+ N+L+ K+ DFGLAKL H G +M
Sbjct: 134 EDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMAL 188
Query: 657 EYAQYGEVSPKIDVYAFGVVLYELIS 682
E + + + DV+++GV ++EL++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-41
Identities = 71/287 (24%), Positives = 125/287 (43%), Gaps = 48/287 (16%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKK------MDMQASKEFLAELKVLTHVHH 541
+F + KIG+G F V+ A G A+KK MD +A + + E+ +L ++H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 542 LNLVRLIGYCVE-GSLFLVYEYIENGNLNQHLRGSGKDTLT------WSARMQIALDSAR 594
N+++ +E L +V E + G+L++ ++ K W +Q+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS---- 147
Query: 595 GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYM 654
LE++H V +HRDIKPAN+ I K+ D GL + + + H+ LVGT YM
Sbjct: 148 ALEHMHSRRV---MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYM 203
Query: 655 PPEYAQYGEVSPKIDVYAFGVVLYELIS---AMEAVVKTNETITESTGLVALFEEVLRQP 711
PE + K D+++ G +LYE+ + + L +L +++ +
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG---------DKMNLYSLCKKIEQCD 254
Query: 712 DPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
P P D Y + + +L C +P+ RP + +
Sbjct: 255 YP---------PLPSDHYSEE----LRQLVNMCINPDPEKRPDVTYV 288
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 6e-41
Identities = 77/308 (25%), Positives = 114/308 (37%), Gaps = 69/308 (22%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE--FLAELKVLTHVHHLNL 544
+DF +GQG FG V A AIKK+ K L+E+ +L ++H +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 545 VRLIGYCVEGS--------------LFLVYEYIENGNLNQHLRGSGKDTLTWSAR---MQ 587
VR +E LF+ EY ENG L + + Q
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 588 IALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE---------- 637
I L YIH + IHRD+KP NI ID++ K+ DFGLAK
Sbjct: 125 ILE----ALSYIHSQGI---IHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 638 ---VGSASVHTRLVGTFGYMPPE----YAQYGEVSPKIDVYAFGVVLYELISAMEAVVKT 690
GS+ T +GT Y+ E Y E KID+Y+ G++ +E+I ++
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNE---KIDMYSLGIIFFEMIYPFSTGMER 234
Query: 691 NETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQ 750
+ + LR P D+ + ++ R +P
Sbjct: 235 VNIL-----------KKLRSVSIEF------PPDFDDNKM----KVEKKIIRLLIDHDPN 273
Query: 751 LRPSMRAI 758
RP R +
Sbjct: 274 KRPGARTL 281
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 7e-41
Identities = 53/196 (27%), Positives = 98/196 (50%), Gaps = 14/196 (7%)
Query: 497 KIGQGGFGAVFYAELRGEKA----AIKKM----DMQASKEFLAELKVLTHVHHLNLVRLI 548
++G G FG+V R K AIK + + ++E + E +++ + + +VRLI
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 549 GYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYI 608
G C +L LV E G L++ L G + + S ++ + G++Y+ E ++
Sbjct: 77 GVCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN---FV 132
Query: 609 HRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTF--GYMPPEYAQYGEVSP 666
HRD+ N+L+ AK++DFGL+K + R G + + PE + + S
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 667 KIDVYAFGVVLYELIS 682
+ DV+++GV ++E +S
Sbjct: 193 RSDVWSYGVTMWEALS 208
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 7e-41
Identities = 65/299 (21%), Positives = 115/299 (38%), Gaps = 52/299 (17%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA-----AIKKM----DMQASKEFLAELKVLTHVH 540
+G IG+G FG V + AIK ++FL E +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 541 HLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH 600
H ++V+LIG E ++++ E G L L+ K +L ++ + A + L Y+
Sbjct: 75 HPHIVKLIGVITENPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLE 133
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTF--GYMPPEY 658
++HRDI N+L+ N K+ DFGL++ E ++ + G +M PE
Sbjct: 134 SKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME--DSTYYKASKGKLPIKWMAPES 188
Query: 659 AQYGEVSPKIDVYAFGVVLYELIS-------AMEAVVKTNETITESTGLVALFEEVLRQP 711
+ + DV+ FGV ++E++ + N +V+ +
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-----KN-------------NDVIGR- 229
Query: 712 DPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770
E+ +RL P P + + L C +P RP + L T+ +
Sbjct: 230 --IENGERL--PM-----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 8e-41
Identities = 74/344 (21%), Positives = 133/344 (38%), Gaps = 68/344 (19%)
Query: 457 NSESAALVAAPGVTGITVDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELRGEKA 516
+ S+ LV + V L +G +G+G FG+V L+ E
Sbjct: 8 HHHSSGLVPRGSEELQNKLEDVVIDRNLL-------ILGKILGEGEFGSVMEGNLKQEDG 60
Query: 517 -----AIK-----KMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVE------GSLFLVY 560
A+K + +EFL+E + H N++RL+G C+E ++
Sbjct: 61 TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVIL 120
Query: 561 EYIENGNLNQHLRGS----GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPAN 616
+++ G+L+ +L S G + ++ +D A G+EY+ ++HRD+ N
Sbjct: 121 PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARN 177
Query: 617 ILIDKNFRAKVADFGLAKLTEVGS---ASVHTRL-VGTFGYMPPEYAQYGEVSPKIDVYA 672
++ + VADFGL+K G ++ V ++ E + K DV+A
Sbjct: 178 CMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV---KWIAIESLADRVYTSKSDVWA 234
Query: 673 FGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQP----DPREDLQRLVD-PRLGD 727
FGV ++E+ + G P E L+ RL
Sbjct: 235 FGVTMWEIA---------------TRG---------MTPYPGVQNHEMYDYLLHGHRL-- 268
Query: 728 DYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSED 771
P D + ++ + +C + +P RP+ + + L L S D
Sbjct: 269 KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 9e-41
Identities = 75/298 (25%), Positives = 132/298 (44%), Gaps = 53/298 (17%)
Query: 494 MGNKIGQGGFGAVFYAELRGE-----KAAIKKM----DMQASKEFLAELKVLTHVHHLNL 544
IG+G FG V++ E + + AIK + +MQ + FL E ++ ++H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 545 VRLIGYCV--EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH 602
+ LIG + EG ++ Y+ +G+L Q +R ++ T + L ARG+EY+ E
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-PTVKDLISFGLQVARGMEYLAEQ 143
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFG-----YMPPE 657
++HRD+ N ++D++F KVADFGLA+ ++ + E
Sbjct: 144 K---FVHRDLAARNCMLDESFTVKVADFGLARDIL--DREYYSVQQHRHARLPVKWTALE 198
Query: 658 YAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQP----DP 713
Q + K DV++FGV+L+EL++ G P DP
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTR---------------G---------APPYRHIDP 234
Query: 714 REDLQRLVD-PRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770
+ L RL P + ++ + C + +P +RP+ R +V + + S+
Sbjct: 235 FDLTHFLAQGRRL--PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-40
Identities = 75/326 (23%), Positives = 130/326 (39%), Gaps = 87/326 (26%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA-------AIKKM---DMQASKEFLAELKVLTHV 539
D + ++G+G FG VF AE A+K + A ++F E ++LT +
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 540 HHLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSAR------------- 585
H ++VR G C EG L +V+EY+ +G+LN+ LR G D +
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 586 MQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645
+ +A A G+ Y+ ++HRD+ N L+ + K+ DFG++
Sbjct: 161 LAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMS------------ 205
Query: 646 RLVGTFGY-------------MPPEYAQYGEVSPKIDVYAFGVVLYELIS-------AME 685
R + + Y MPPE Y + + + DV++FGVVL+E+ + +
Sbjct: 206 RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL- 264
Query: 686 AVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACT 745
+N E + + L + P ++ + R C
Sbjct: 265 ----SN-------------TEAIDC---ITQGREL-------ERPRACPPEVYAIMRGCW 297
Query: 746 QENPQLRPSMRAIVVALMTLSSSSED 771
Q PQ R S++ + L L+ +
Sbjct: 298 QREPQQRHSIKDVHARLQALAQAPPV 323
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-40
Identities = 69/331 (20%), Positives = 133/331 (40%), Gaps = 92/331 (27%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA---------AIKKMDMQAS----KEFLAELKVL 536
+ ++G +G+G FG V AE G A+K + A+ + ++E++++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 537 THV-HHLNLVRLIGYC-VEGSLFLVYEYIENGNLNQHLRGS--------------GKDTL 580
+ H N++ L+G C +G L+++ EY GNL ++LR ++ +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 581 TWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640
T+ + ARG+EY+ IHRD+ N+L+ +N K+ADFGLA
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLA------- 204
Query: 641 ASVHTRLVGTFGY-------------MPPEYAQYGEVSPKIDVYAFGVVLYELIS----- 682
R + Y M PE + + DV++FGV+++E+ +
Sbjct: 205 -----RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 683 --AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARL 740
+ EE+ + ++ R+ P + ++ +
Sbjct: 260 YPGI-----PV-------------EELFKL---LKEGHRMDKPANCTN-------ELYMM 291
Query: 741 ARACTQENPQLRPSMRAIVVALMTLSSSSED 771
R C P RP+ + +V L + + + +
Sbjct: 292 MRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-40
Identities = 69/331 (20%), Positives = 133/331 (40%), Gaps = 92/331 (27%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGE---------KAAIKKMDMQAS----KEFLAELKVL 536
+ ++G +G+G FG V AE G A+K + A+ + ++E++++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 537 THV-HHLNLVRLIGYC-VEGSLFLVYEYIENGNLNQHLRGS--------------GKDTL 580
+ H N++ L+G C +G L+++ EY GNL ++LR ++ +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 581 TWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640
T+ + ARG+EY+ IHRD+ N+L+ +N K+ADFGLA
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLA------- 250
Query: 641 ASVHTRLVGTFGY-------------MPPEYAQYGEVSPKIDVYAFGVVLYELIS----- 682
R + Y M PE + + DV++FGV+++E+ +
Sbjct: 251 -----RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
Query: 683 --AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARL 740
+ EE+ + ++ R+ P + ++ +
Sbjct: 306 YPGI-----PV-------------EELFKL---LKEGHRMDKPANCTN-------ELYMM 337
Query: 741 ARACTQENPQLRPSMRAIVVALMTLSSSSED 771
R C P RP+ + +V L + + + +
Sbjct: 338 MRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 61/275 (22%), Positives = 107/275 (38%), Gaps = 42/275 (15%)
Query: 494 MGNKIGQGGFGAVFYA--ELRGEKAAIKKMDMQAS-----KEFLAELKVLTHVHHLNLVR 546
+IG+G F V+ + A ++ + + F E ++L + H N+VR
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 547 LIGYCV-----EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE 601
+ + LV E + +G L +L+ + +GL+++H
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHT 147
Query: 602 HTVPVYIHRDIKPANILID-KNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQ 660
T P+ IHRD+K NI I K+ D GLA L AS ++GT +M PE +
Sbjct: 148 RTPPI-IHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYE 203
Query: 661 YGEVSPKIDVYAFGVVLYELISAMEAVVKTNET-ITESTGLVALFEEVLRQPDPREDLQR 719
+ +DVYAFG+ + E+ T+E +E ++ V +
Sbjct: 204 -EKYDESVDVYAFGMCMLEMA--------TSEYPYSECQNAAQIYRRV-TSGVKPASFDK 253
Query: 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPS 754
+ P + + + C ++N R S
Sbjct: 254 VAIPEVKE------------IIEGCIRQNKDERYS 276
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 62/293 (21%), Positives = 108/293 (36%), Gaps = 50/293 (17%)
Query: 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKM---DMQASKEFLAELKVLTHVHHLNLV 545
+ K+G+GGF V E G A+K++ + Q +E E + +H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 546 RLIGYCVEGS-----LFLVYEYIENGNLNQHL--RGSGKDTLTWSARMQIALDSARGLEY 598
RL+ YC+ +L+ + + G L + + LT + + L RGLE
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 599 IHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRL--------VGT 650
IH Y HRD+KP NIL+ + + D G + L T
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 651 FGYMPPE---YAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEV 707
Y PE + + + DV++ G VLY ++ ++ V
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMF-----------------GEGPYDMV 249
Query: 708 LRQPDPREDLQRLVDPRLGDDYPIDSV--RKMARLARACTQENPQLRPSMRAI 758
++ D + V +L P + +L + +P RP + +
Sbjct: 250 FQKGDS---VALAVQNQL--SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLL 297
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 70/330 (21%), Positives = 118/330 (35%), Gaps = 89/330 (26%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRG-------EKAAIKKM----DMQASKEFLAELKVLTH 538
N S G +G G FG V A G A+K + + + ++ELKVL++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 539 V-HHLNLVRLIGYC-VEGSLFLVYEYIENGNLNQHLRGSGKD----------------TL 580
+ +H+N+V L+G C + G ++ EY G+L LR L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 581 TWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640
+ + A+G+ ++ IHRD+ NIL+ K+ DFGLA
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLA------- 192
Query: 641 ASVHTRLVGTFGY-------------MPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAV 687
R + M PE + + DV+++G+ L+EL S
Sbjct: 193 -----RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL---- 243
Query: 688 VKTNETITESTGLVALFEEVLRQP----DPREDLQRLVDP--RLGDDYPIDSVRKMARLA 741
G P +++ R+ P + +M +
Sbjct: 244 -----------G---------SSPYPGMPVDSKFYKMIKEGFRM--LSPEHAPAEMYDIM 281
Query: 742 RACTQENPQLRPSMRAIVVALMTLSSSSED 771
+ C +P RP+ + IV + S S +
Sbjct: 282 KTCWDADPLKRPTFKQIVQLIEKQISESTN 311
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-40
Identities = 74/313 (23%), Positives = 127/313 (40%), Gaps = 67/313 (21%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA-------AIKKMDMQAS----KEFLAELKVLTH 538
+ ++ +G G FG V+ ++ G A+K + S +FL E +++
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 539 VHHLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKD-----TLTWSARMQIALDS 592
+H N+VR IG ++ F++ E + G+L LR + +L + +A D
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 593 ARGLEYIHEHTVPVYIHRDIKPANILIDK---NFRAKVADFGLAKLTEVGSASVHTRLVG 649
A G +Y+ E+ +IHRDI N L+ AK+ DFG+A+ S + R G
Sbjct: 150 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS---YYR-KG 202
Query: 650 TFGY-----MPPEYAQYGEVSPKIDVYAFGVVLYELIS-------AMEAVVKTNETITES 697
MPPE G + K D ++FGV+L+E+ S + +N
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-----SN------ 251
Query: 698 TGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRA 757
+EVL R+ D P + + R+ C Q P+ RP+
Sbjct: 252 -------QEVLEF---VTSGGRM-------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAI 294
Query: 758 IVVALMTLSSSSE 770
I+ + + +
Sbjct: 295 ILERIEYCTQDPD 307
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 6e-40
Identities = 80/330 (24%), Positives = 133/330 (40%), Gaps = 88/330 (26%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRG-------EKAAIKKMDMQAS----KEFLAELKVLTH 538
+ +G +G+G FG V A+ G A+K + A+ + ++ELK+L H
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 539 V-HHLNLVRLIGYC--VEGSLFLVYEYIENGNLNQHLRGS--------------GKDTLT 581
+ HHLN+V L+G C G L ++ E+ + GNL+ +LR KD LT
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 582 WSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641
+ + A+G+E++ IHRD+ NIL+ + K+ DFGLA
Sbjct: 147 LEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLA-------- 195
Query: 642 SVHTRLVGTFGY-------------MPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVV 688
R + M PE + + DV++FGV+L+E+ S
Sbjct: 196 ----RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL----- 246
Query: 689 KTNETITESTGL-----VALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARA 743
G V + EE R+ ++ R+ P + +M +
Sbjct: 247 ----------GASPYPGVKIDEEFCRR---LKEGTRM-------RAPDYTTPEMYQTMLD 286
Query: 744 CTQENPQLRPSMRAIVVALMTL--SSSSED 771
C P RP+ +V L L +++ +D
Sbjct: 287 CWHGEPSQRPTFSELVEHLGNLLQANAQQD 316
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 6e-40
Identities = 72/310 (23%), Positives = 129/310 (41%), Gaps = 52/310 (16%)
Query: 493 SMGNKIGQGGFGAVFYAELRGEKA-----AIKKM----DMQASKEFLAELKVLTHVHHLN 543
IG+G FG V++ L A+K + D+ +FL E ++ H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 544 LVRLIGYCV--EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE 601
++ L+G C+ EGS +V Y+++G+L +R + T + L A+G++++
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKFLAS 210
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLAK-LTEVGSASVHTRLVGTF--GYMPPEY 658
++HRD+ N ++D+ F KVADFGLA+ + + SVH + +M E
Sbjct: 211 KK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 659 AQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQP----DPR 714
Q + + K DV++FGV+L+EL++ G P +
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTR---------------G---------APPYPDVNTF 303
Query: 715 EDLQRLVD-PRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL---SSSSE 770
+ L+ RL P + + C ++RPS +V + +
Sbjct: 304 DITVYLLQGRRL--LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361
Query: 771 DWDIGSFYEN 780
+ + Y N
Sbjct: 362 YVHVNATYVN 371
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 8e-40
Identities = 66/326 (20%), Positives = 129/326 (39%), Gaps = 69/326 (21%)
Query: 475 DKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELRGE-----KAAIK-----KMDMQ 524
+ V ++ ++G +G+G FG+V A+L+ E K A+K +
Sbjct: 15 LEDVLIPEQQF-------TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS 67
Query: 525 ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-------SLFLVYEYIENGNLNQHLRGS-- 575
+EFL E + H ++ +L+G + ++ ++++G+L+ L S
Sbjct: 68 DIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRI 127
Query: 576 --GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLA 633
L ++ +D A G+EY+ +IHRD+ N ++ ++ VADFGL+
Sbjct: 128 GENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLS 184
Query: 634 KLTEVGS---ASVHTRL-VGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVK 689
+ G ++L V ++ E + DV+AFGV ++E+++
Sbjct: 185 RKIYSGDYYRQGCASKLPV---KWLALESLADNLYTVHSDVWAFGVTMWEIMTR------ 235
Query: 690 TNETITESTGLVALFEEVLRQP----DPREDLQRLVD-PRLGDDYPIDSVRKMARLARAC 744
G + P + E L+ RL P + + ++ L C
Sbjct: 236 ---------G---------QTPYAGIENAEIYNYLIGGNRL--KQPPECMEEVYDLMYQC 275
Query: 745 TQENPQLRPSMRAIVVALMTLSSSSE 770
+P+ RPS + + L +
Sbjct: 276 WSADPKQRPSFTCLRMELENILGHLS 301
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 70/299 (23%), Positives = 126/299 (42%), Gaps = 53/299 (17%)
Query: 493 SMGNKIGQGGFGAVFYAELRGEKA-----AIKKM----DMQASKEFLAELKVLTHVHHLN 543
IG+G FG V++ L A+K + D+ +FL E ++ H N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 544 LVRLIGYCV--EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE 601
++ L+G C+ EGS +V Y+++G+L +R + T + L A+G++Y+
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKYLAS 146
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFG-----YMPP 656
++HRD+ N ++D+ F KVADFGLA+ ++ ++ T +M
Sbjct: 147 KK---FVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWMAL 201
Query: 657 EYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQP----D 712
E Q + + K DV++FGV+L+EL++ G P +
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTR---------------G---------APPYPDVN 237
Query: 713 PREDLQRLVD-PRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770
+ L+ RL P + + C ++RPS +V + + S+
Sbjct: 238 TFDITVYLLQGRRL--LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-39
Identities = 73/313 (23%), Positives = 129/313 (41%), Gaps = 67/313 (21%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA-------AIKKMDMQAS----KEFLAELKVLTH 538
+ ++ +G G FG V+ ++ G A+K + S +FL E +++
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 539 VHHLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKD-----TLTWSARMQIALDS 592
+H N+VR IG ++ F++ E + G+L LR + +L + +A D
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 593 ARGLEYIHEHTVPVYIHRDIKPANILIDK---NFRAKVADFGLAKLTEVGSASVHTRLVG 649
A G +Y+ E+ +IHRDI N L+ AK+ DFG+A+ ++ A + + G
Sbjct: 191 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRK--G 243
Query: 650 TFGY-----MPPEYAQYGEVSPKIDVYAFGVVLYELIS-------AMEAVVKTNETITES 697
MPPE G + K D ++FGV+L+E+ S + +N
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-----SN------ 292
Query: 698 TGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRA 757
+EVL R+ D P + + R+ C Q P+ RP+
Sbjct: 293 -------QEVLEF---VTSGGRM-------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAI 335
Query: 758 IVVALMTLSSSSE 770
I+ + + +
Sbjct: 336 ILERIEYCTQDPD 348
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 69/294 (23%), Positives = 120/294 (40%), Gaps = 56/294 (19%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQASKE-----FLAE---LKVLTHVH 540
+S+ +IG GG VF + AIK ++++ + + E L L H
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-H 86
Query: 541 HLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSAR--MQIALDSARGLE 597
++RL Y + + +++V E N +LN L+ + +
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNML----EAVH 141
Query: 598 YIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR-LVGTFGYMPP 656
IH+H + +H D+KPAN LI K+ DFG+A + + SV VGT YMPP
Sbjct: 142 TIHQHGI---VHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 657 E-----------YAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFE 705
E ++SPK DV++ G +LY + G F+
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT----------------YG-KTPFQ 240
Query: 706 EVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMAR-LARACTQENPQLRPSMRAI 758
++ + L ++DP ++P D K + + + C + +P+ R S+ +
Sbjct: 241 QI---INQISKLHAIIDPNHEIEFP-DIPEKDLQDVLKCCLKRDPKQRISIPEL 290
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 77/332 (23%), Positives = 135/332 (40%), Gaps = 85/332 (25%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGE-------KAAIKKMDMQAS----KEFLAELKVLTH 538
+M ++GQG FG V+ +G + AIK ++ AS EFL E V+
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 539 VHHLNLVRLIGYCVEG-SLFLVYEYIENGNLNQHLRGSGKDT--------LTWSARMQIA 589
+ ++VRL+G +G ++ E + G+L +LR + S +Q+A
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 590 LDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVG 649
+ A G+ Y++ + ++HRD+ N ++ ++F K+ DFG+ R +
Sbjct: 145 GEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT------------RDIY 189
Query: 650 TFGY-------------MPPEYAQYGEVSPKIDVYAFGVVLYELIS-------AMEAVVK 689
Y M PE + G + DV++FGVVL+E+ + +
Sbjct: 190 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL----- 244
Query: 690 TNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENP 749
+N E+VLR L + P + + L R C Q NP
Sbjct: 245 SN-------------EQVLRFVMEGGLLDK----------PDNCPDMLFELMRMCWQYNP 281
Query: 750 QLRPSMRAIVVALMTLSSSSEDWDIGSFYENQ 781
++RPS I+ ++ + SFY ++
Sbjct: 282 KMRPSFLEIISSIKEE--MEPGFREVSFYYSE 311
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 33/221 (14%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRG-------EKAAIKKMDMQAS----KEFLAELKVLTH 538
N+ G +G G FG V A G K A+K + A + ++ELK+++H
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 539 V-HHLNLVRLIGYC-VEGSLFLVYEYIENGNLNQHLR------------GSGKDTLTWSA 584
+ H N+V L+G C G + ++ EY G+L LR T +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 585 RMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS---A 641
+ + A+G+ ++ IHRD+ N+L+ AK+ DFGLA+ S
Sbjct: 166 LLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
+ RL +M PE + + DV+++G++L+E+ S
Sbjct: 223 KGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-39
Identities = 67/280 (23%), Positives = 105/280 (37%), Gaps = 47/280 (16%)
Query: 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHV-HHL 542
F +++G G +G VF + G A+K+ + LAE+ V H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 543 NLVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGK---DTLTWSARMQIALDSARGLEY 598
VRL + G L+L E +L QH G + W L L +
Sbjct: 118 CCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLL----ALAH 172
Query: 599 IHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEY 658
+H + +H D+KPANI + R K+ DFGL E+G+A G YM PE
Sbjct: 173 LHSQGL---VHLDVKPANIFLGPRGRCKLGDFGLLV--ELGTAGAGEVQEGDPRYMAPEL 227
Query: 659 AQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718
Q G DV++ G+ + E+ ME P E Q
Sbjct: 228 LQ-GSYGTAADVFSLGLTILEVACNMEL------------------------PHGGEGWQ 262
Query: 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
+L L ++ ++ + + +P+LR + A+
Sbjct: 263 QLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEAL 302
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 63/287 (21%), Positives = 112/287 (39%), Gaps = 45/287 (15%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHL 542
D+ + IG G +G + G+ K++D + ++E+ +L + H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 543 NLVRLIGYCVE---GSLFLVYEYIENGNLNQHLRGSGKDTLT------WSARMQIALDSA 593
N+VR ++ +L++V EY E G+L + K+ Q+ L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL--- 122
Query: 594 RGLEYIHEHTVPVY--IHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTF 651
L+ H + + +HRD+KPAN+ +D K+ DFGLA++ ++ T VGT
Sbjct: 123 -ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTP 180
Query: 652 GYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQP 711
YM PE + K D+++ G +LYEL + M + L ++
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAGKIREGK 232
Query: 712 DPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
R+ Y + + + RPS+ I
Sbjct: 233 ----------FRRIPYRYSDE----LNEIITRMLNLKDYHRPSVEEI 265
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 62/316 (19%), Positives = 118/316 (37%), Gaps = 82/316 (25%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA---------AIKKMD---MQASKEFLAELKVLT 537
D +GQG F +F R +K +D S+ F +++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 538 HVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGL 596
+ H +LV G CV G LV E+++ G+L+ +L+ K+ + ++++A A +
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAM 126
Query: 597 EYIHEHTVPVYIHRDIKPANILIDKNFR--------AKVADFGLAKLTEVGSASVHTRLV 648
++ E+T IH ++ NIL+ + K++D G++ V
Sbjct: 127 HFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS------------ITV 171
Query: 649 GTFGY-------MPPEYAQYGEV-SPKIDVYAFGVVLYELIS-------AMEAVVKTNET 693
+PPE + + + D ++FG L+E+ S A+ +
Sbjct: 172 LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL-----DS-- 224
Query: 694 ITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRP 753
+ L+ + R +L P+ + + + C P RP
Sbjct: 225 -----------QRKLQFYEDRH---QLPAPKAAELANL-----I----NNCMDYEPDHRP 261
Query: 754 SMRAIVVALMTLSSSS 769
S RAI+ L +L +
Sbjct: 262 SFRAIIRDLNSLFTPD 277
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-39
Identities = 71/344 (20%), Positives = 132/344 (38%), Gaps = 98/344 (28%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA-------AIKKM----DMQASKEFLAELKVLTH 538
+ G +G G FG V A G A+K + D + ++ELK++T
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 539 V-HHLNLVRLIGYC-VEGSLFLVYEYIENGNLNQHLRGS--------------------- 575
+ H N+V L+G C + G ++L++EY G+L +LR
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 576 GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635
+ LT+ + A A+G+E++ + +HRD+ N+L+ K+ DFGLA
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLA-- 219
Query: 636 TEVGSASVHTRLVGTFGY-------------MPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
R + + M PE G + K DV+++G++L+E+ S
Sbjct: 220 ----------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
Query: 683 AMEAVVKTNETITESTGLVALFEEVLRQP----DPREDLQRLVDP--RLGDDYPIDSVRK 736
G P + +L+ ++ D P + +
Sbjct: 270 L---------------G---------VNPYPGIPVDANFYKLIQNGFKM--DQPFYATEE 303
Query: 737 MARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWDIGSFYEN 780
+ + ++C + + RPS + L + +E+ + Y+N
Sbjct: 304 IYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE----AMYQN 343
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMD------MQASKEFLAELKVLTHVHH 541
DF +G +G+G FG V+ A + A+K + + E+++ +H+ H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 542 LNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSAR--MQIALDSARGLEY 598
N++RL GY + + ++L+ EY G + + L+ K +A ++A L Y
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN----ALSY 124
Query: 599 IHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEY 658
H V IHRDIKP N+L+ K+ADFG + S+ L GT Y+PPE
Sbjct: 125 CHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTD-LCGTLDYLPPEM 178
Query: 659 AQYGEVSPKIDVYAFGVVLYELI 681
+ K+D+++ GV+ YE +
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFL 201
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-39
Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 52/292 (17%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR-GEKAAIK-----KMDMQASKEFLAE---LKVLTHVH 540
+S+ +IG GG VF + AIK + D Q + E L L H
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-H 67
Query: 541 HLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYI 599
++RL Y + + +++V E N +LN L+ + R + + I
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTI 124
Query: 600 HEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR-LVGTFGYMPPE- 657
H+H + +H D+KPAN LI K+ DFG+A + + SV VGT YMPPE
Sbjct: 125 HQHGI---VHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 658 ----------YAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEV 707
++SPK DV++ G +LY + G F+++
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT----------------YG-KTPFQQI 223
Query: 708 LRQPDPREDLQRLVDPRLGDDYPIDSVRKMAR-LARACTQENPQLRPSMRAI 758
+ L ++DP ++P D K + + + C + +P+ R S+ +
Sbjct: 224 ---INQISKLHAIIDPNHEIEFP-DIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-39
Identities = 67/319 (21%), Positives = 112/319 (35%), Gaps = 89/319 (27%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA-------AIKKM----DMQASKEFLAELKVLTH 538
+ ++G+ FG V+ L G AIK + + +EF E +
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 539 VHHLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSG--------------KDTLTWS 583
+ H N+V L+G + L +++ Y +G+L++ L K L
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 584 ARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643
+ + A G+EY+ H +H+D+ N+L+ K++D GL
Sbjct: 129 DFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLF---------- 175
Query: 644 HTRLVGTFGY-------------MPPEYAQYGEVSPKIDVYAFGVVLYELIS-------A 683
R V Y M PE YG+ S D++++GVVL+E+ S
Sbjct: 176 --REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 233
Query: 684 MEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARA 743
+N ++V+ + Q L P D + L
Sbjct: 234 Y-----SN-------------QDVVEM---IRNRQVL-------PCPDDCPAWVYALMIE 265
Query: 744 CTQENPQLRPSMRAIVVAL 762
C E P RP + I L
Sbjct: 266 CWNEFPSRRPRFKDIHSRL 284
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 8e-39
Identities = 74/325 (22%), Positives = 122/325 (37%), Gaps = 93/325 (28%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA-------AIKKMDMQAS----KEFLAELKVLTH 538
+ +G +G+G FG V A K A+K + AS ++ L+E VL
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 539 VHHLNLVRLIGYC-VEGSLFLVYEYIENGNLNQHLRGS---------------------- 575
V+H ++++L G C +G L L+ EY + G+L LR S
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 576 GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635
+ LT + A ++G++Y+ E +HRD+ NIL+ + + K++DFGL+
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLS-- 197
Query: 636 TEVGSASVHTRLVGTFGY-------------MPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
R V M E + + DV++FGV+L+E+++
Sbjct: 198 ----------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
Query: 683 AMEAVVKTNETITESTGLVALFEEVLRQP----DPREDLQRLVD-PRLGDDYPIDSVRKM 737
G P P L R+ + P + +M
Sbjct: 248 L---------------G---------GNPYPGIPPERLFNLLKTGHRM--ERPDNCSEEM 281
Query: 738 ARLARACTQENPQLRPSMRAIVVAL 762
RL C ++ P RP I L
Sbjct: 282 YRLMLQCWKQEPDKRPVFADISKDL 306
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 152 bits (384), Expect = 9e-39
Identities = 52/196 (26%), Positives = 98/196 (50%), Gaps = 14/196 (7%)
Query: 497 KIGQGGFGAVFYAELRGEKA----AIKKM----DMQASKEFLAELKVLTHVHHLNLVRLI 548
++G G FG+V R K AIK + + ++E + E +++ + + +VRLI
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 549 GYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYI 608
G C +L LV E G L++ L G ++ + S ++ + G++Y+ E ++
Sbjct: 403 GVCQAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FV 458
Query: 609 HRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGY--MPPEYAQYGEVSP 666
HR++ N+L+ AK++DFGL+K + R G + PE + + S
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 667 KIDVYAFGVVLYELIS 682
+ DV+++GV ++E +S
Sbjct: 519 RSDVWSYGVTMWEALS 534
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-38
Identities = 68/264 (25%), Positives = 109/264 (41%), Gaps = 46/264 (17%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR-GEKAAIK-----KMDMQASKEFLAE---LKVLTHVH 540
+S+ +IG GG VF + AIK + D Q + E L L H
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-H 114
Query: 541 HLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYI 599
++RL Y + + +++V E N +LN L+ + R + + I
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTI 171
Query: 600 HEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR-LVGTFGYMPPE- 657
H+H + +H D+KPAN LI K+ DFG+A + + SV VG YMPPE
Sbjct: 172 HQHGI---VHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 658 ----------YAQYGEVSPKIDVYAFGVVLYEL-------------ISAMEAVVKTNETI 694
++SPK DV++ G +LY + IS + A++ N I
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287
Query: 695 TESTGLVALFEEVLR---QPDPRE 715
++VL+ + DP++
Sbjct: 288 EFPDIPEKDLQDVLKCCLKRDPKQ 311
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-38
Identities = 70/362 (19%), Positives = 134/362 (37%), Gaps = 59/362 (16%)
Query: 427 RRNKVVEASFLPEASEDHYIQHGPAIALVKNSESAALVAAPGVTGITVDKSVEFSYEELA 486
+ + S A+ + +++ + + A ++ + + E E +
Sbjct: 334 KEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERI- 392
Query: 487 KATNDFSMGNKIGQGGFGAVFYAELRGEKA-----AIKKM----DMQASKEFLAELKVLT 537
+G IG+G FG V + AIK ++FL E +
Sbjct: 393 ------ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMR 446
Query: 538 HVHHLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLE 597
H ++V+LIG E ++++ E G L L+ K +L ++ + A + L
Sbjct: 447 QFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALA 505
Query: 598 YIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTF--GYMP 655
Y+ ++HRDI N+L+ N K+ DFGL++ E ++ + G +M
Sbjct: 506 YLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME--DSTYYKASKGKLPIKWMA 560
Query: 656 PEYAQYGEVSPKIDVYAFGVVLYELIS-------AMEAVVKTNETITESTGLVALFEEVL 708
PE + + DV+ FGV ++E++ + N +V+
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-----KN-------------NDVI 602
Query: 709 RQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768
+ E+ +RL P P + + L C +P RP + L T+
Sbjct: 603 GR---IENGERL--PM-----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652
Query: 769 SE 770
+
Sbjct: 653 EK 654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 9e-38
Identities = 80/328 (24%), Positives = 127/328 (38%), Gaps = 81/328 (24%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRG-------EKAAIKKM----DMQASKEFLAELKVLTH 538
N+ IG+G FG VF A G A+K + +F E ++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 539 VHHLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSAR------------ 585
+ N+V+L+G C G + L++EY+ G+LN+ LR T+ +
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 586 ----------MQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635
+ IA A G+ Y+ E ++HRD+ N L+ +N K+ADFGL++
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSR- 222
Query: 636 TEVGSASVHTRLVGTFGY-----MPPEYAQYGEVSPKIDVYAFGVVLYELIS-------A 683
+ SA + MPPE Y + + DV+A+GVVL+E+ S
Sbjct: 223 -NIYSADYYK--ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279
Query: 684 MEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARA 743
M + EEV+ D L P + ++ L R
Sbjct: 280 M-----AH-------------EEVIYY---VRDGNIL-------ACPENCPLELYNLMRL 311
Query: 744 CTQENPQLRPSMRAIVVALMTLSSSSED 771
C + P RPS +I L + +E
Sbjct: 312 CWSKLPADRPSFCSIHRILQRMCERAEG 339
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMD------MQASKEFLAELKVLTHVHH 541
+DF +G +G+G FG V+ A + A+K + + E+++ +H+ H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 542 LNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSAR--MQIALDSARGLEY 598
N++R+ Y ++L+ E+ G L + L+ G+ SA ++A L Y
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELAD----ALHY 129
Query: 599 IHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEY 658
HE V IHRDIKP N+L+ K+ADFG + S T + GT Y+PPE
Sbjct: 130 CHERKV---IHRDIKPENLLMGYKGELKIADFGWSVHAP--SLRRRT-MCGTLDYLPPEM 183
Query: 659 AQYGEVSPKIDVYAFGVVLYELI 681
+ K+D++ GV+ YE +
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFL 206
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 62/194 (31%), Positives = 97/194 (50%), Gaps = 14/194 (7%)
Query: 497 KIGQGGFGAVFYAE--LRGEKAAIKKM--DMQASKEFLA----ELKVLTHVHHLNLVRLI 548
K+G GG V+ AE + K AIK + + +E L E+ + + H N+V +I
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 549 GYCVEGSL-FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVY 607
E +LV EYIE L++++ G L+ + G+++ H+ +
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDMRI--- 132
Query: 608 IHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPK 667
+HRDIKP NILID N K+ DFG+AK S + ++GT Y PE A+
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 668 IDVYAFGVVLYELI 681
D+Y+ G+VLYE++
Sbjct: 193 TDIYSIGIVLYEML 206
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 20/204 (9%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMD------MQASKEFLAELKVLTHVHH 541
DF +GN +G+G F V+ AE G + AIK +D + E+K+ + H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 542 LNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSAR---MQIALDSARGLE 597
+++ L Y ++LV E NG +N++L+ K AR QI G+
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII----TGML 126
Query: 598 YIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE 657
Y+H H + +HRD+ +N+L+ +N K+ADFGLA ++ +T L GT Y+ PE
Sbjct: 127 YLHSHGI---LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPE 182
Query: 658 YAQYGEVSPKIDVYAFGVVLYELI 681
A + DV++ G + Y L+
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLL 206
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-37
Identities = 49/226 (21%), Positives = 95/226 (42%), Gaps = 44/226 (19%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKAAIK---KMDMQASKEFLA--------------- 531
ND+ + + QG F + E + A+K K ++ ++F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 532 --ELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM-- 586
EL+++T + + + G ++++YEY+EN ++ + ++ +
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150
Query: 587 --------QIALDSARGLEYIHEH-TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE 637
+ YIH + HRD+KP+NIL+DKN R K++DFG ++
Sbjct: 151 QVIKCIIKSVLN----SFSYIHNEKNI---CHRDVKPSNILMDKNGRVKLSDFGESEYMV 203
Query: 638 VGSASVHTRLVGTFGYMPPE--YAQYGEVSPKIDVYAFGVVLYELI 681
+ GT+ +MPPE + K+D+++ G+ LY +
Sbjct: 204 --DKKIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF 246
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 55/200 (27%), Positives = 87/200 (43%), Gaps = 26/200 (13%)
Query: 497 KIGQGGFGAVFYAE--LRGEKAAIKKM--DMQASKEFLA----ELKVLTHVHHLNLVRLI 548
+G+GG G V+ AE +R A+K M + + F E + + ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 549 GY-CVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVY 607
+ ++G L++ I +L LR G L + I L+ H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAAGA--- 155
Query: 608 IHRDIKPANILIDKNFRAKVADFGLAK------LTEVGSASVHTRLVGTFGYMPPEYAQY 661
HRD+KP NIL+ + A + DFG+A LT++G+ VGT YM PE
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNT------VGTLYYMAPERFSE 209
Query: 662 GEVSPKIDVYAFGVVLYELI 681
+ + D+YA VLYE +
Sbjct: 210 SHATYRADIYALTCVLYECL 229
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 7e-36
Identities = 55/284 (19%), Positives = 98/284 (34%), Gaps = 59/284 (20%)
Query: 497 KIGQGGFGAVFYAE---LRGEKAAIKKM----DMQASKEFLAELKVLTHVHHLNLVRLI- 548
I GG G ++ A + G +K + D +A +AE + L V H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 549 -----GYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT 603
+ ++V EY+ +L + L + + L+ L Y+H
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG 202
Query: 604 VPVYIHRDIKPANILIDKNFRAKVADFGLAK-LTEVGSASVHTRLVGTFGYMPPEYAQYG 662
+ ++ D+KP NI++ + + K+ D G + G L GT G+ PE +
Sbjct: 203 L---VYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY------LYGTPGFQAPEIVR-T 251
Query: 663 EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD 722
+ D+Y G L L L P + D
Sbjct: 252 GPTVATDIYTVGRTLAALT----------------LDLPT-RNGRYVDGLPED------D 288
Query: 723 PRLGDDYPIDSVRKMARLARACTQENPQLRP-SMRAIVVALMTL 765
P L + L RA +P+ R + + L +
Sbjct: 289 PVLKTYDSYGRL-----LRRA-IDPDPRQRFTTAEEMSAQLTGV 326
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-35
Identities = 62/284 (21%), Positives = 108/284 (38%), Gaps = 43/284 (15%)
Query: 491 DFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQASKEFLAELKVLTHV-HHLNLVRLI 548
F + +G G G + Y + A+K++ + E+++L H N++R
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRY- 83
Query: 549 GYCVE---GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVP 605
+C E ++ E L +++ L + + GL ++H +
Sbjct: 84 -FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLHSLNI- 139
Query: 606 VYIHRDIKPANILI-----DKNFRAKVADFGLAKLTEVGSASVHTR--LVGTFGYMPPEY 658
+HRD+KP NILI +A ++DFGL K VG S R + GT G++ PE
Sbjct: 140 --VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 659 ---AQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715
+ +D+++ G V Y +I + F + R+
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVI----------------SEGSHPFGK----SLQRQ 237
Query: 716 DLQRLVDPRLGDDYPIDSVRKMAR-LARACTQENPQLRPSMRAI 758
L L +P +AR L +PQ RPS + +
Sbjct: 238 ANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 495 GNKIGQGGFGAVFYAE-LR-GEKAAIKKM--DMQASKEFLA----ELKVLTHVHHLNLVR 546
G +G GG V A LR A+K + D+ F E + ++H +V
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 547 LIGYCVEGSL-----FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE 601
+ + ++V EY++ L + G +T +++ D+ + L + H+
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ 134
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLAK-LTEVGSASVHTRLV-GTFGYMPPEYA 659
+ + IHRD+KPANI+I KV DFG+A+ + + G++ T V GT Y+ PE A
Sbjct: 135 NGI---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 660 QYGEVSPKIDVYAFGVVLYELI 681
+ V + DVY+ G VLYE++
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVL 213
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 49/202 (24%), Positives = 85/202 (42%), Gaps = 19/202 (9%)
Query: 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMD------MQASKEFLAELKVLTHVHHL 542
+ G +G+GGF F E A K + ++ E+ + + H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 543 NLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSAR--MQIALDSARGLEYI 599
++V G+ +F+V E +L + + T + QI G +Y+
Sbjct: 76 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV----LGCQYL 131
Query: 600 HEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYA 659
H + V IHRD+K N+ ++++ K+ DFGLA E L GT Y+ PE
Sbjct: 132 HRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVL 187
Query: 660 QYGEVSPKIDVYAFGVVLYELI 681
S ++DV++ G ++Y L+
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLL 209
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-34
Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 23/204 (11%)
Query: 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIK---KMDMQASK---EFLAELKVLTHVHHL 542
+ G +G+GGF F E A K K + + E+ + + H
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 543 NLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLT-WSAR---MQIALDSARGLE 597
++V G+ +F+V E +L + + LT AR QI G +
Sbjct: 102 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIV----LGCQ 155
Query: 598 YIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE 657
Y+H + V IHRD+K N+ ++++ K+ DFGLA E L GT Y+ PE
Sbjct: 156 YLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE 211
Query: 658 YAQYGEVSPKIDVYAFGVVLYELI 681
S ++DV++ G ++Y L+
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLL 235
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 1e-33
Identities = 48/364 (13%), Positives = 94/364 (25%), Gaps = 80/364 (21%)
Query: 444 HYIQHGPAIALVKNSESAALVAAPGVTGITVDKSVEFSYE-ELAKATNDFSMGNKIGQGG 502
P + SE A V+ + F E EL + G +GQ
Sbjct: 31 ELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQED 90
Query: 503 FGAVFYA--ELRGEKAAIKKM-------------------------------DMQASKEF 529
A A + GE + + F
Sbjct: 91 PYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 150
Query: 530 LAELKVLTHVHHLNLVRLIGYCVEG---SLFLVYEYIENGNLNQHL-----RGSGKDTLT 581
+ ++ ++R+ + S F +Y ++ NL S +L
Sbjct: 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLV 209
Query: 582 WSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641
AR+Q+ L R L +H + + +H ++P +I++D+ + F +
Sbjct: 210 HHARLQLTLQVIRLLASLHHYGL---VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAV 266
Query: 642 SVHTRLVGTFGYMPPEYAQY-----GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITE 696
S R + ++ D + G+ +Y +
Sbjct: 267 SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW--------------- 311
Query: 697 STGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPI-DSVRKMARLARACTQENPQLRPSM 755
P+ + + I VR L + + R
Sbjct: 312 -CA---------DLPNTDDAALGGSEWIFRSCKNIPQPVR---ALLEGFLRYPKEDRLLP 358
Query: 756 RAIV 759
+
Sbjct: 359 LQAM 362
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-33
Identities = 59/231 (25%), Positives = 94/231 (40%), Gaps = 49/231 (21%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQASKEFLAELKVLTHV-HHLNLVRL 547
N +G G G V + G A+K+M + L E+K+LT H N++R
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY 74
Query: 548 IG-------------YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSAR 594
C +L + +E+ N++ K+ S QIA
Sbjct: 75 YCSETTDRFLYIALELC-NLNLQ---DLVESKNVSDENLKLQKEYNPISLLRQIA----S 126
Query: 595 GLEYIHEHTVPVYIHRDIKPANILID-------------KNFRAKVADFGLAKLTEVGSA 641
G+ ++H + IHRD+KP NIL+ +N R ++DFGL K + G +
Sbjct: 127 GVAHLHSLKI---IHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 642 SVHTRL---VGTFGYMPPE-------YAQYGEVSPKIDVYAFGVVLYELIS 682
S T L GT G+ PE ++ ID+++ G V Y ++S
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 27/206 (13%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEF---LAELKVLTHVHHLN 543
++ KIGQG G V+ A G++ AI++M++Q + + E+ V+ + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 544 LVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM---QIAL---DSARGL 596
+V + Y V L++V EY+ G+L D +T M QIA + + L
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT--------DVVT-ETCMDEGQIAAVCRECLQAL 129
Query: 597 EYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGL-AKLTEVGSASVHTRLVGTFGYMP 655
E++H + V IHRDIK NIL+ + K+ DFG A++T S + +VGT +M
Sbjct: 130 EFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMA 184
Query: 656 PEYAQYGEVSPKIDVYAFGVVLYELI 681
PE PK+D+++ G++ E+I
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMI 210
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 50/219 (22%), Positives = 97/219 (44%), Gaps = 15/219 (6%)
Query: 471 GITVDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE 528
G+ + + ++ E + + + ++G+G FG V + + G + A+KK+ ++ +
Sbjct: 39 GVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV 98
Query: 529 FLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQ 587
EL + +V L G EG + + E +E G+L Q ++ G L +
Sbjct: 99 --EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALY 154
Query: 588 IALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN-FRAKVADFGLAK-LTEVGSASVHT 645
+ GLEY+H + +H D+K N+L+ + RA + DFG A L G
Sbjct: 155 YLGQALEGLEYLHTRRI---LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211
Query: 646 R---LVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELI 681
+ GT +M PE K+D+++ ++ ++
Sbjct: 212 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 250
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-32
Identities = 30/322 (9%), Positives = 62/322 (19%), Gaps = 72/322 (22%)
Query: 484 ELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKM------DMQASKEFLAELKV 535
L++ + + G VF E A+K +
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115
Query: 536 LTHVHHLNLVRLIGYC---------------------------VEGSLFLVYEYIENGNL 568
+ + + L+ +L
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDL 174
Query: 569 NQ-----HLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF 623
+ A + R + + +H P N+ I +
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGL---VHGHFTPDNLFIMPDG 231
Query: 624 RAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQ--YGEVSPKIDVYAFGVVLYELI 681
R + D + Y P E+ + ++ + G+ +Y +
Sbjct: 232 RLMLGDVSAL----WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287
Query: 682 SAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKM---- 737
F V L P D S +
Sbjct: 288 ----------------CL-FLPFGLVTPGIKGSWKRPSLRVPG-TDSLAFGSCTPLPDFV 329
Query: 738 ARLARACTQENPQLRPSMRAIV 759
L + + R +
Sbjct: 330 KTLIGRFLNFDRRRRLLPLEAM 351
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 53/260 (20%), Positives = 100/260 (38%), Gaps = 43/260 (16%)
Query: 497 KIGQGGFGAVFYAELR--GEKAAIKKM---DMQASKEFLAELKVLTHV-HHLNLVRLIGY 550
+ +GGF V+ A+ G + A+K++ + + ++ + E+ + + H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 551 CVEGS---------LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE 601
G L+ E + + + + L+ ++I + R ++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRL-----------VGT 650
P+ IHRD+K N+L+ K+ DFG A + T
Sbjct: 155 QKPPI-IHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 651 FGYMPPE---YAQYGEVSPKIDVYAFGVVLYELI--------SAMEAVVKTNETI----T 695
Y PE + K D++A G +LY L A +V +I T
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDT 273
Query: 696 ESTGLVALFEEVLRQPDPRE 715
+ T +L +L Q +P E
Sbjct: 274 QYTVFHSLIRAML-QVNPEE 292
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 59/198 (29%), Positives = 107/198 (54%), Gaps = 17/198 (8%)
Query: 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS-KEFLAELKVLTHVHHLNLVRLI 548
F + K+G+G +G+V+ A + G+ AIK++ +++ +E + E+ ++ ++V+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 549 G-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIAL---DSARGLEYIHEHTV 604
G Y L++V EY G+++ +R K TLT +IA + +GLEY+H
Sbjct: 91 GSYFKNTDLWIVMEYCGAGSVSDIIRLRNK-TLT---EDEIATILQSTLKGLEYLHFMRK 146
Query: 605 PVYIHRDIKPANILIDKNFRAKVADFGL-AKLTEVGSASVHTRLVGTFGYMPPEYAQYGE 663
IHRDIK NIL++ AK+ADFG+ +LT+ + + ++GT +M PE Q
Sbjct: 147 ---IHRDIKAGNILLNTEGHAKLADFGVAGQLTD--TMAKRNTVIGTPFWMAPEVIQEIG 201
Query: 664 VSPKIDVYAFGVVLYELI 681
+ D+++ G+ E+
Sbjct: 202 YNCVADIWSLGITAIEMA 219
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 27/203 (13%)
Query: 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEF---LAELKVLTHVHHLNLVR 546
KIG+G G V A + G + A+K MD++ + E+ ++ H N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 547 LIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM---QIAL---DSARGLEYI 599
+ Y V L+++ E+++ G L D ++ R+ QIA + L Y+
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT--------DIVS-QVRLNEEQIATVCEAVLQALAYL 157
Query: 600 HEHTVPVYIHRDIKPANILIDKNFRAKVADFGL-AKLTEVGSASVHTRLVGTFGYMPPEY 658
H V IHRDIK +IL+ + R K++DFG A++++ LVGT +M PE
Sbjct: 158 HAQGV---IHRDIKSDSILLTLDGRVKLSDFGFCAQISK--DVPKRKSLVGTPYWMAPEV 212
Query: 659 AQYGEVSPKIDVYAFGVVLYELI 681
+ ++D+++ G+++ E++
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMV 235
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 490 NDFSMGNKIGQGGFGAVFYAE--LRGEKAAIKKMDMQAS----KEFLAELKVLTHVHHLN 543
+D+ + IG G V A + EK AIK+++++ E L E++ ++ HH N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 544 LVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM---QIAL---DSARGL 596
+V + V+ L+LV + + G++ ++ S + IA + GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 597 EYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGL-AKLTEVGSASVHTR---LVGTFG 652
EY+H++ IHRD+K NIL+ ++ ++ADFG+ A L G + + VGT
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 653 YMPPE-YAQYGEVSPKIDVYAFGVVLYELI 681
+M PE Q K D+++FG+ EL
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELA 221
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 48/256 (18%), Positives = 88/256 (34%), Gaps = 48/256 (18%)
Query: 520 KMDMQASKEFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKD 578
+++ + N V + + L++ + NL +
Sbjct: 99 LSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158
Query: 579 T-----LTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLA 633
+ +QIA +E++H + +HRD+KP+NI + KV DFGL
Sbjct: 159 EDREHGVCLHIFIQIAE----AVEFLHSKGL---MHRDLKPSNIFFTMDDVVKVGDFGLV 211
Query: 634 K-----------LTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
LT + + + HT VGT YM PE S K+D+++ G++L+EL+
Sbjct: 212 TAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY 271
Query: 683 AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLAR 742
+ ++ IT+ +R + + +
Sbjct: 272 SFSTQMERVRIITD-----------VRNLKFPLL-------------FTQKYPQEHMMVQ 307
Query: 743 ACTQENPQLRPSMRAI 758
+P RP I
Sbjct: 308 DMLSPSPTERPEATDI 323
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 21/206 (10%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA--AIK---KMDMQASKEF---LAELKVLTHVHH 541
DF G +G+G F V A AIK K + + E V++ + H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 542 LNLVRLIGYC-VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM---QIALDSARGLE 597
V+L + L+ Y +NG L +++R G T R +I LE
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-CTRFYTAEIVS----ALE 144
Query: 598 YIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR-LVGTFGYMPP 656
Y+H + IHRD+KP NIL++++ ++ DFG AK+ S VGT Y+ P
Sbjct: 145 YLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 657 EYAQYGEVSPKIDVYAFGVVLYELIS 682
E D++A G ++Y+L++
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 50/217 (23%), Positives = 93/217 (42%), Gaps = 31/217 (14%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMD----MQASKEFLAELKVLTHVHHLN 543
+ + + + +GQG VF + G+ AIK + ++ + E +VL ++H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 544 LVRLIGYCVE-----GSLFLVYEYIENGNLNQHLRGSGKDT-LTWSARMQIALDSARGLE 597
+V+L + +E L+ E+ G+L L L S + + D G+
Sbjct: 69 IVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 598 YIHEHTVPVYIHRDIKPANILI----DKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGY 653
++ E+ + +HR+IKP NI+ D K+ DFG A+ E+ L GT Y
Sbjct: 127 HLRENGI---VHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR--ELEDDEQFVSLYGTEEY 181
Query: 654 MPPEYAQYGEV--------SPKIDVYAFGVVLYELIS 682
+ P+ + + +D+++ GV Y +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-32
Identities = 77/280 (27%), Positives = 115/280 (41%), Gaps = 56/280 (20%)
Query: 428 RNKVVEASFLPEASEDHYIQHGPAIALVKN-SESAALVAAPGVTGITVDKSVEFSYEELA 486
R + + + + ++ K+ S+ +VA PG D+ E SY +
Sbjct: 4 RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGP---DRPQEVSYTDT- 59
Query: 487 KATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHVHHLNL 544
IG G FG V+ A+L GE AIKK+ +Q + EL+++ + H N+
Sbjct: 60 ---------KVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNI 109
Query: 545 VRLIGYCV--------EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM------QIAL 590
VRL Y E L LV +Y+ + + R + T Q+
Sbjct: 110 VRLR-YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLF- 166
Query: 591 DSARGLEYIHEHTVPVYIHRDIKPANILIDKN-FRAKVADFGLAKLTEVGSASVH---TR 646
R L YIH + HRDIKP N+L+D + K+ DFG AK G +V +R
Sbjct: 167 ---RSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 220
Query: 647 LVGTFGYMPPE----YAQYGEVSPKIDVYAFGVVLYELIS 682
Y PE Y + IDV++ G VL EL+
Sbjct: 221 Y-----YRAPELIFGATDY---TSSIDVWSAGCVLAELLL 252
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-32
Identities = 62/304 (20%), Positives = 102/304 (33%), Gaps = 70/304 (23%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS-----KEFLAELKVLTHV-H 540
T +F KIG G FG+VF R G AIK+ + + L E+ +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 541 HLNLVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKD--TLTWSARMQIALDSARGLE 597
H ++VR + + + + EY G+L + + + + + L RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 598 YIHEHTVPVYIHRDIKPANILIDKN-------------------FRAKVADFGLAKLTEV 638
YIH ++ +H DIKP+NI I + K+ D G T +
Sbjct: 130 YIHSMSL---VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV--TRI 184
Query: 639 GSASVHTRLVGTFGYMPPEYAQYGEV-SPKIDVYAFGVVLYELISAMEAVVKTNETITES 697
S V G ++ E Q PK D++A + + A
Sbjct: 185 SSPQV---EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL----------- 230
Query: 698 TGLVALFEEVLRQPDPREDLQRLVD---PRLGDDYPIDSVRKMARLARACTQENPQLRPS 754
P + + PR+ + L + +P+ RPS
Sbjct: 231 -------------PRNGDQWHEIRQGRLPRIPQVLSQE----FTELLKVMIHPDPERRPS 273
Query: 755 MRAI 758
A+
Sbjct: 274 AMAL 277
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-31
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 30/217 (13%)
Query: 487 KATNDFSMGNKIGQGGFGAVFYAE--LRGEKAAIKKMDMQASKEFLA----ELKVLTHVH 540
+ + M ++G GGFG V GE+ AIK+ + S + E++++ ++
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 541 HLNLVRLI-------GYCVEGSLFLVYEYIENGNLNQHLRGSGKDT-LT-WSARM---QI 588
H N+V L EY E G+L ++L L R I
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 589 ALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRA---KVADFGLAKLTEVGSASVHT 645
+ L Y+HE+ + IHRD+KP NI++ + K+ D G AK + G
Sbjct: 131 SS----ALRYLHENRI---IHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTE 182
Query: 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
VGT Y+ PE + + + +D ++FG + +E I+
Sbjct: 183 -FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 57/313 (18%), Positives = 101/313 (32%), Gaps = 56/313 (17%)
Query: 489 TNDFSMGNKIGQG--GFGAVFYAE--LRGEKAAIKKMDM-QASKEFL----AELKVLTHV 539
+ + IG+G V A GE ++++++ S E + EL V
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 540 HHLNLVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIAL---DSARG 595
+H N+V + + L++V ++ G+ + D + + IA +
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN---ELAIAYILQGVLKA 140
Query: 596 LEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFG-LAKLTEVGS-----ASVHTRLVG 649
L+YIH +HR +K ++ILI + + ++ + G V
Sbjct: 141 LDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 650 TFGYMPPE-----YAQYGEVSPKIDVYAFGVVLYELIS---------AMEA--------- 686
++ PE Y K D+Y+ G+ EL + A +
Sbjct: 198 VLPWLSPEVLQQNLQGYDA---KSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254
Query: 687 -VVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLAR--- 742
+ TI ++ V P GD R +
Sbjct: 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFV 314
Query: 743 -ACTQENPQLRPS 754
C Q NP RPS
Sbjct: 315 EQCLQRNPDARPS 327
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-31
Identities = 46/292 (15%), Positives = 84/292 (28%), Gaps = 62/292 (21%)
Query: 444 HYIQHGPAIALVKNSESAALVAAPGVTGITVDKSVEFSYE-ELAKATNDFSMGNKIGQGG 502
P + SE A V+ + F E EL + G +GQ
Sbjct: 26 ELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQED 85
Query: 503 FGAVFYAELR--GEKAAIKKMDMQASKE-------------------------------F 529
A A + GE + F
Sbjct: 86 PYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 145
Query: 530 LAELKVLTHVHHLNLVRLIGY---CVEGSLFLVYEYIENGNLNQHL-----RGSGKDTLT 581
+ ++ ++R+ S F +Y ++ NL S +L
Sbjct: 146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLV 204
Query: 582 WSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641
AR+Q+ L R L +H + + +H ++P +I++D+ + F
Sbjct: 205 HHARLQLTLQVIRLLASLHHYGL---VHTYLRPVDIVLDQRGGVFLTGFEHLV-----RD 256
Query: 642 SVHTRLVGTFGYMPPEYAQY-----------GEVSPKIDVYAFGVVLYELIS 682
+ G+ PPE ++ D +A G+V+Y +
Sbjct: 257 GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 3e-31
Identities = 50/217 (23%), Positives = 93/217 (42%), Gaps = 31/217 (14%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMD----MQASKEFLAELKVLTHVHHLN 543
+ + + + +GQG VF + G+ AIK + ++ + E +VL ++H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 544 LVRLIGYCVE-----GSLFLVYEYIENGNLNQHLRGSGKDT-LTWSARMQIALDSARGLE 597
+V+L + +E L+ E+ G+L L L S + + D G+
Sbjct: 69 IVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 598 YIHEHTVPVYIHRDIKPANILI----DKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGY 653
++ E+ + +HR+IKP NI+ D K+ DFG A+ E+ L GT Y
Sbjct: 127 HLRENGI---VHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR--ELEDDEQFVSLYGTEEY 181
Query: 654 MPPEYAQYGEV--------SPKIDVYAFGVVLYELIS 682
+ P+ + + +D+++ GV Y +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-31
Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 30/226 (13%)
Query: 475 DKSVEFSYEELAKAT-NDFSMGNKIGQGGFGAVFYAELRG----------EKAAIKKMDM 523
+ +++ + E + F +G+GGFG VF +++ K +KK
Sbjct: 169 LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKG 228
Query: 524 QASKEFLAELKVLTHVHHLNLVRLIGYC--VEGSLFLVYEYIENGNLNQHLRGSGKDTLT 581
+ E K+L VH +V L Y + L LV + G++ H+ +D
Sbjct: 229 YQGA--MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG 285
Query: 582 WS---ARM---QIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635
+ A QI GLE++H+ + I+RD+KP N+L+D + +++D GLA
Sbjct: 286 FQEPRAIFYTAQIVS----GLEHLHQRNI---IYRDLKPENVLLDDDGNVRISDLGLAVE 338
Query: 636 TEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELI 681
+ G GT G+M PE E +D +A GV LYE+I
Sbjct: 339 LKAGQTKTKGY-AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 22/202 (10%)
Query: 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS----KEFLAELKVLTHVHHLNL 544
F+ KIG+G FG VF + AIK +D++ + ++ E+ VL+ +
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 545 VRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIAL---DSARGLEYIH 600
+ G Y + L+++ EY+ G+ L G QIA + +GL+Y+H
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLD-----ETQIATILREILKGLDYLH 136
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGL-AKLTEVGSASVHTRLVGTFGYMPPEYA 659
IHRDIK AN+L+ ++ K+ADFG+ +LT+ + VGT +M PE
Sbjct: 137 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVI 191
Query: 660 QYGEVSPKIDVYAFGVVLYELI 681
+ K D+++ G+ EL
Sbjct: 192 KQSAYDSKADIWSLGITAIELA 213
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 50/205 (24%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS---KEFLAELKVLTHVHHLNLVR 546
+ + ++G G FG V+ A+ + G AA K ++ ++ ++++ E+++L H +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 547 LIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIAL---DSARGLEYIHEH 602
L+G Y +G L+++ E+ G ++ + + LT QI + L ++H
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR-GLT---EPQIQVVCRQMLEALNFLHSK 136
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGL-AKLTEVGSASVHTRLVGTFGYMPPE---- 657
+ IHRD+K N+L+ ++ADFG+ AK + + +GT +M PE
Sbjct: 137 RI---IHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--TLQKRDSFIGTPYWMAPEVVMC 191
Query: 658 -YAQYGEVSPKIDVYAFGVVLYELI 681
+ K D+++ G+ L E+
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMA 216
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 73/295 (24%), Positives = 117/295 (39%), Gaps = 49/295 (16%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEF-----LAELKVLTHVHHL 542
+ KIG+G +G VF R G+ AIKK L E+++L + H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 543 NLVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE 601
NLV L+ + + L LV+EY ++ + L + + I + + + + H+
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRG-VPEHLVKSITWQTLQAVNFCHK 120
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS-VHTRLVGTFGYMPPE--- 657
H IHRD+KP NILI K+ K+ DFG A+ + S + V T Y PE
Sbjct: 121 HNC---IHRDVKPENILITKHSVIKLCDFGFAR--LLTGPSDYYDDEVATRWYRSPELLV 175
Query: 658 -YAQYGEVSPKIDVYAFGVVLYELISA------------MEAVVKTNETITEST--GLVA 702
QY P +DV+A G V EL+S + + KT +
Sbjct: 176 GDTQY---GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232
Query: 703 L--FEEV-LRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPS 754
F V + P+ E L+ P + + ++ + +P R +
Sbjct: 233 NQYFSGVKIPDPEDMEPLELKF-PNISYP-ALGLLKGCLHM-------DPTERLT 278
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-30
Identities = 53/207 (25%), Positives = 100/207 (48%), Gaps = 23/207 (11%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIK-----KMDMQASKEFLAELKVLTHVHH 541
+ + K+G G +G V + + AIK + ++ + L E+ VL + H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 542 LNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM--QIALDSARGLEY 598
N+++L + + + +LV E + G L + K +A + Q+ G+ Y
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVL----SGVTY 151
Query: 599 IHEHTVPVYIHRDIKPANILI---DKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMP 655
+H+H + +HRD+KP N+L+ +K+ K+ DFGL+ + E +GT Y+
Sbjct: 152 LHKHNI---VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKMKERLGTAYYIA 206
Query: 656 PEYAQYGEVSPKIDVYAFGVVLYELIS 682
PE + + K DV++ GV+L+ L++
Sbjct: 207 PEVLR-KKYDEKCDVWSIGVILFILLA 232
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 4e-30
Identities = 36/225 (16%), Positives = 73/225 (32%), Gaps = 29/225 (12%)
Query: 483 EELAKATNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDMQASKEF---LAE 532
E + + + +G+G F V+ A +K +K EF
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 533 LKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDT---LTWSARMQI 588
++ L ++ + + LV E G L + + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 589 ALDSARGLEYIHEHTVPVYIHRDIKPANILI-----------DKNFRAKVADFGLAK-LT 636
A+ +E +H+ + IH DIKP N ++ D + + D G + +
Sbjct: 178 AMRMLYMIEQVHDCEI---IHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 637 EVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELI 681
++ T T G+ E + +ID + +Y ++
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCML 279
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-30
Identities = 67/227 (29%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 472 ITVDKSVEFSYEELAKAT-NDFSMGNKIGQGGFGAVFYAELRG----------EKAAIKK 520
I ++ +++ + E T N F +G+GGFG V ++R EK IKK
Sbjct: 165 IYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK 224
Query: 521 MDMQASKEFLAELKVLTHVHHLNLVRLIGYC--VEGSLFLVYEYIENGNLNQHLRGSGKD 578
+A L E ++L V+ +V L Y + +L LV + G+L H+ G+
Sbjct: 225 RKGEAMA--LNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQA 281
Query: 579 TLTWS-ARM---QIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK 634
+ A +I GLE +H + ++RD+KP NIL+D + +++D GLA
Sbjct: 282 GFPEARAVFYAAEICC----GLEDLHRERI---VYRDLKPENILLDDHGHIRISDLGLAV 334
Query: 635 LTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELI 681
G ++ R VGT GYM PE + + D +A G +LYE+I
Sbjct: 335 HVPEGQ-TIKGR-VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 379
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-30
Identities = 68/295 (23%), Positives = 118/295 (40%), Gaps = 49/295 (16%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEF-----LAELKVLTHVHHL 542
+ +G+G +G V + G AIKK + + E+K+L + H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 543 NLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE 601
NLV L+ C + +LV+E++++ + L + L + + G+ + H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDH-TILDDLE-LFPNGLDYQVVQKYLFQIINGIGFCHS 142
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS-VHTRLVGTFGYMPPE--- 657
H + IHRDIKP NIL+ ++ K+ DFG A+ + + V+ V T Y PE
Sbjct: 143 HNI---IHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYDDEVATRWYRAPELLV 197
Query: 658 -YAQYGEVSPKIDVYAFGVVLYELISA------------MEAVVKTNETITEST--GLVA 702
+Y +DV+A G ++ E+ + ++ +
Sbjct: 198 GDVKY---GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254
Query: 703 L--FEEV-LRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPS 754
F V L + RE L+R P+L + ID +K + +P RP
Sbjct: 255 NPVFAGVRLPEIKEREPLERRY-PKL-SEVVIDLAKKCLHI-------DPDKRPF 300
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 48/224 (21%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIK-----KMDMQASKE------FLAELKV 535
+++ M +G G G V A R +K AIK K + +++E E+++
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 536 LTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNL------NQHLRGSGKDTLTWSARM--Q 587
L ++H ++++ + ++V E +E G L N+ L Q
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRL--KEATC----KLYFYQ 122
Query: 588 IALDSARGLEYIHEHTVPVYIHRDIKPANILI---DKNFRAKVADFGLAKLTEVGSASVH 644
+ L ++Y+HE+ + IHRD+KP N+L+ +++ K+ DFG +K+ +G S+
Sbjct: 123 MLL----AVQYLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLM 173
Query: 645 TRLVGTFGYMPPE------YAQYGEVSPKIDVYAFGVVLYELIS 682
L GT Y+ PE A Y +D ++ GV+L+ +S
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYN---RAVDCWSLGVILFICLS 214
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-29
Identities = 68/250 (27%), Positives = 104/250 (41%), Gaps = 41/250 (16%)
Query: 455 VKNSESAALVAAPGVTGITVDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELR-G 513
+ N+ + P V K + + + ++ IG G FG VF A+L
Sbjct: 5 MSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVES 64
Query: 514 EKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYCV--------EGSLFLVYEYIEN 565
++ AIKK+ +Q + EL+++ V H N+V L E L LV EY+
Sbjct: 65 DEVAIKKV-LQDKRFKNRELQIMRIVKHPNVVDLK-AFFYSNGDKKDEVFLNLVLEYVPE 122
Query: 566 GNLNQHLRGSGKDTLTWSARM------QIALDSARGLEYIHEHTVPVYIHRDIKPANILI 619
+ + R K T + Q+ R L YIH + HRDIKP N+L+
Sbjct: 123 -TVYRASRHYAKLKQTMPMLLIKLYMYQLL----RSLAYIHSIGI---CHRDIKPQNLLL 174
Query: 620 DKN-FRAKVADFGLAKLTEVGSASVH---TRLVGTFGYMPPE----YAQYGEVSPKIDVY 671
D K+ DFG AK+ G +V +R Y PE Y + ID++
Sbjct: 175 DPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPELIFGATNY---TTNIDIW 226
Query: 672 AFGVVLYELI 681
+ G V+ EL+
Sbjct: 227 STGCVMAELM 236
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-29
Identities = 54/218 (24%), Positives = 104/218 (47%), Gaps = 36/218 (16%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIK-----KMDMQASKE------FLAELKV 535
+++ M +G G G V A R +K AI+ K + +++E E+++
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 536 LTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM--QIALDSA 593
L ++H ++++ + ++V E +E G L + G+ + Q+ L
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL--- 250
Query: 594 RGLEYIHEHTVPVYIHRDIKPANILI---DKNFRAKVADFGLAKLTEVGSASVHTRLVGT 650
++Y+HE+ + IHRD+KP N+L+ +++ K+ DFG +K+ +G S+ L GT
Sbjct: 251 -AVQYLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGT 304
Query: 651 FGYMPPE------YAQYGEVSPKIDVYAFGVVLYELIS 682
Y+ PE A Y +D ++ GV+L+ +S
Sbjct: 305 PTYLAPEVLVSVGTAGYN---RAVDCWSLGVILFICLS 339
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-29
Identities = 56/208 (26%), Positives = 104/208 (50%), Gaps = 24/208 (11%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIK-----KMDMQASKE-FLAELKVLTHVH 540
++ + +G+G FG V + + G++ A+K ++ + KE L E+++L +
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 541 HLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM--QIALDSARGLE 597
H N+++L + +G +LV E G L + + + +AR+ Q+ G+
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL----SGIT 140
Query: 598 YIHEHTVPVYIHRDIKPANILI---DKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYM 654
Y+H++ + +HRD+KP N+L+ K+ ++ DFGL+ E +GT Y+
Sbjct: 141 YMHKNKI---VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--KKMKDKIGTAYYI 195
Query: 655 PPEYAQYGEVSPKIDVYAFGVVLYELIS 682
PE G K DV++ GV+LY L+S
Sbjct: 196 APEVLH-GTYDEKCDVWSTGVILYILLS 222
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-29
Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 23/207 (11%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIK-----KMDMQASKEFLAELKVLTHVHH 541
+++ +G+G FG V + R ++ A+K + + L E+++L + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 542 LNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM--QIALDSARGLEY 598
N+++L S ++V E G L + + + +AR+ Q+ G+ Y
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVF----SGITY 136
Query: 599 IHEHTVPVYIHRDIKPANILI---DKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMP 655
+H+H + +HRD+KP NIL+ +K+ K+ DFGL+ + + +GT Y+
Sbjct: 137 MHKHNI---VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIA 191
Query: 656 PEYAQYGEVSPKIDVYAFGVVLYELIS 682
PE + G K DV++ GV+LY L+S
Sbjct: 192 PEVLR-GTYDEKCDVWSAGVILYILLS 217
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 31/218 (14%)
Query: 487 KATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAE-----------L 533
AT+ + +IG G +G V+ A G A+K + + L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 534 KVLTHVHHLNLVRLIGYCV------EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQ 587
+ L H N+VRL+ C E + LV+E+++ +L +L + L
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124
Query: 588 IALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRL 647
+ RGL+++H + + +HRD+KP NIL+ K+ADFGLA+ T +
Sbjct: 125 LMRQFLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLAR--IYSYQMALTPV 179
Query: 648 VGTFGYMPPEY---AQYGEVSPKIDVYAFGVVLYELIS 682
V T Y PE + Y + +D+++ G + E+
Sbjct: 180 VVTLWYRAPEVLLQSTY---ATPVDMWSVGCIFAEMFR 214
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 38/210 (18%)
Query: 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS------KEFLAELKVLTHVHHLN 543
FS +IG G FGAV++A E AIKKM ++ + E++ L + H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 544 LVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSAR----MQIAL---DSARG 595
++ G Y E + +LV EY GS D L + ++IA + +G
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL---------GSASDLLEVHKKPLQEVEIAAVTHGALQG 166
Query: 596 LEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGL-AKLTEVGSASVHTRLVGTFGYM 654
L Y+H H + IHRD+K NIL+ + K+ DFG + + S VGT +M
Sbjct: 167 LAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWM 217
Query: 655 PPE---YAQYGEVSPKIDVYAFGVVLYELI 681
PE G+ K+DV++ G+ EL
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELA 247
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 85/305 (27%), Positives = 137/305 (44%), Gaps = 56/305 (18%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE-F----LAELKVLTHVHHL 542
+ + KIGQG FG VF A R G+K A+KK+ M+ KE F L E+K+L + H
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76
Query: 543 NLVRLIGYCVE---------GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSA 593
N+V LI C GS++LV+++ E+ +L L + T S ++
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLS-NVLVKFTLSEIKRVMQMLL 134
Query: 594 RGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH---TRLVGT 650
GL YIH + + +HRD+K AN+LI ++ K+ADFGLA+ + S T V T
Sbjct: 135 NGLYYIHRNKI---LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 191
Query: 651 FGYMPPE----YAQYGEVSPKIDVYAFGVVLYELISAMEAVVK-TNE------------T 693
Y PPE YG P ID++ G ++ E+ +++ E +
Sbjct: 192 LWYRPPELLLGERDYG---PPIDLWGAGCIMAEMW-TRSPIMQGNTEQHQLALISQLCGS 247
Query: 694 ITEST--GLVAL--FEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENP 749
IT + +E++ + ++ + + D Y +D + K+ L +P
Sbjct: 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL-------DP 300
Query: 750 QLRPS 754
R
Sbjct: 301 AQRID 305
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 56/235 (23%)
Query: 490 NDFSMGNKIGQGGFGAVFYA--ELRGEKAAIK-----KMDMQASKEFLA----------- 531
N +++ ++IG+G +G V A E A+K K+ QA
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 532 -------------ELKVLTHVHHLNLVRLIGYCV-----EGSLFLVYEYIENGNLNQHLR 573
E+ +L + H N+V+L V E L++V+E + G + +
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPV---ME 127
Query: 574 GSGKDTLT-WSARM---QIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVAD 629
L+ AR + G+EY+H + IHRDIKP+N+L+ ++ K+AD
Sbjct: 128 VPTLKPLSEDQARFYFQDLIK----GIEYLHYQKI---IHRDIKPSNLLVGEDGHIKIAD 180
Query: 630 FGLAKLTEVGSASVHTRLVGTFGYMPPE--YAQYGEVS-PKIDVYAFGVVLYELI 681
FG++ + A + VGT +M PE S +DV+A GV LY +
Sbjct: 181 FGVSNEFKGSDALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-29
Identities = 56/230 (24%), Positives = 98/230 (42%), Gaps = 44/230 (19%)
Query: 481 SYEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKM---DMQASKEFLAELKV 535
+ E K + F + GQG FG V + + G AIKK+ ++E L ++
Sbjct: 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQD 72
Query: 536 LTHVHHLNLVRLIGYCV---------EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM 586
L +HH N+V+L + L +V EY+ + L++ R + + +
Sbjct: 73 LAVLHHPNIVQLQ-SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPIL 130
Query: 587 ------QIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK-NFRAKVADFGLAKLTEVG 639
Q+ R + +H +V V HRDIKP N+L+++ + K+ DFG AK
Sbjct: 131 IKVFLFQLI----RSIGCLHLPSVNV-CHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS 185
Query: 640 SASVH---TRLVGTFGYMPPE----YAQYGEVSPKIDVYAFGVVLYELIS 682
+V +R Y PE Y + +D+++ G + E++
Sbjct: 186 EPNVAYICSRY-----YRAPELIFGNQHY---TTAVDIWSVGCIFAEMML 227
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS--KEFLAELKVL-THVHHLN 543
F + +G G +G V+ G+ AAIK MD+ +E E+ +L + HH N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 544 LVRLIG-------YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIAL---DSA 593
+ G ++ L+LV E+ G++ ++ + +TL IA +
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK---EEWIAYICREIL 139
Query: 594 RGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGL-AKLTEVGSASVHTRLVGTFG 652
RGL ++H+H V IHRDIK N+L+ +N K+ DFG+ A+L + +GT
Sbjct: 140 RGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--TVGRRNTFIGTPY 194
Query: 653 YMPPEYAQYGEVS-----PKIDVYAFGVVLYELI 681
+M PE E K D+++ G+ E+
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 19/220 (8%)
Query: 471 GITVDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYA--ELRGEKAAIKKMDMQASKE 528
G +E+ YE ++ +G+G +G V+ + AIK++ + S+
Sbjct: 8 GDCESDLLEYDYE-----YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY 62
Query: 529 FLA---ELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGS-GKDTLTWS 583
E+ + H+ H N+V+ +G E + + E + G+L+ LR G
Sbjct: 63 SQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQ 122
Query: 584 ARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILID-KNFRAKVADFGLAKLTEVGSAS 642
GL+Y+H++ + +HRDIK N+LI+ + K++DFG +K +
Sbjct: 123 TIGFYTKQILEGLKYLHDNQI---VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179
Query: 643 VHTRLVGTFGYMPPEYAQYGEV--SPKIDVYAFGVVLYEL 680
T GT YM PE G D+++ G + E+
Sbjct: 180 TET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEM 218
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-29
Identities = 51/211 (24%), Positives = 90/211 (42%), Gaps = 33/211 (15%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRG----------EKAAIKKMDMQASKEFLAELKVLTHV 539
+ F + IG+G FG V + K + + + EL+++ +
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNV--FKELQIMQGL 72
Query: 540 HHLNLVRLIGYC--VEGSLFLVYEYIENGNLNQHLRGSGK----DTLTWSARMQIALDSA 593
H LV L Y E +F+V + + G+L HL+ + + ++ +
Sbjct: 73 EHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC--ELVM--- 126
Query: 594 RGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGY 653
L+Y+ + IHRD+KP NIL+D++ + DF +A + + T + GT Y
Sbjct: 127 -ALDYLQNQRI---IHRDMKPDNILLDEHGHVHITDFNIAA--MLPRETQITTMAGTKPY 180
Query: 654 MPPEYAQYGEV---SPKIDVYAFGVVLYELI 681
M PE + S +D ++ GV YEL+
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELL 211
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-29
Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 35/212 (16%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRG----------EKAAIKKMDMQASKEFLAELKVLTHV 539
NDFS+ IG+GGFG V+ +K IK + L E +L+ V
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA--LNERIMLSLV 246
Query: 540 HHLN---LVRLIGYCVE--GSLFLVYEYIENGNLNQHLRGSGK----DTLTWSARMQIAL 590
+ +V + Y L + + + G+L+ HL G D ++A +I L
Sbjct: 247 STGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA--EIIL 303
Query: 591 DSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGT 650
GLE++H V ++RD+KPANIL+D++ +++D GLA + H VGT
Sbjct: 304 ----GLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHAS-VGT 353
Query: 651 FGYMPPEYAQYGEV-SPKIDVYAFGVVLYELI 681
GYM PE Q G D ++ G +L++L+
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-29
Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 34/218 (15%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIK----------------KMDMQASKEFL 530
+ K+G G +G V + + + AIK K + +E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 531 AELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM--Q 587
E+ +L + H N+++L + +LV E+ E G L + + K +A + Q
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154
Query: 588 IALDSARGLEYIHEHTVPVYIHRDIKPANILI---DKNFRAKVADFGLAKLTEVGSASVH 644
I G+ Y+H+H + +HRDIKP NIL+ + K+ DFGL+
Sbjct: 155 IL----SGICYLHKHNI---VHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKL 205
Query: 645 TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
+GT Y+ PE + + + K DV++ GV++Y L+
Sbjct: 206 RDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLC 242
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 9e-29
Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 487 KATNDFSMGNKIGQGGFGAVFYA---ELRGEKAAIKKMDMQASKE-----FLAE---LKV 535
+A + +IG+G +G VF A + G A+K++ +Q +E + E L+
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 536 LTHVHHLNLVRLIGYCV------EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIA 589
L H N+VRL C E L LV+E+++ +L +L + + +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 590 LDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVG 649
RGL+++H H V +HRD+KP NIL+ + + K+ADFGLA+ T +V
Sbjct: 127 FQLLRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMALTSVVV 181
Query: 650 TFGYMPPEY---AQYGEVSPKIDVYAFGVVLYELIS 682
T Y PE + Y + +D+++ G + E+
Sbjct: 182 TLWYRAPEVLLQSSY---ATPVDLWSVGCIFAEMFR 214
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 63/295 (21%), Positives = 124/295 (42%), Gaps = 39/295 (13%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS----KEFLAELKVLTHVHHLN 543
+DF +++G G G VF + G A K + ++ + + EL+VL +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 544 LVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH-E 601
+V G + +G + + E+++ G+L+Q L+ +G+ + +++ +GL Y+ +
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK--VSIAVIKGLTYLREK 150
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLA-KLTEVGSASVHTRLVGTFGYMPPEYAQ 660
H + +HRD+KP+NIL++ K+ DFG++ +L + S+ VGT YM PE Q
Sbjct: 151 HKI---MHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQ 203
Query: 661 YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720
S + D+++ G+ L E+ + + E + + P R
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263
Query: 721 VDPRLGDDYPIDSVRKMARLA---------------------RACTQENPQLRPS 754
++ D P ++ ++ C +NP R
Sbjct: 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 318
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 60/269 (22%), Positives = 97/269 (36%), Gaps = 65/269 (24%)
Query: 473 TVDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFL 530
+ +++ F L + + + IGQG +G V A AIK M+ ++
Sbjct: 9 SGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN 68
Query: 531 A--------ELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLT 581
E++++ +HH N+ RL E + LV E G+L L D+
Sbjct: 69 PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTG 128
Query: 582 WSARMQIALDSAR--------------------------------------GLEYIHEHT 603
A + L Y+H
Sbjct: 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG 188
Query: 604 VPVYIHRDIKPANILI--DKNFRAKVADFGLAKLTEVGSASVHTRL---VGTFGYMPPE- 657
+ HRDIKP N L +K+F K+ DFGL+K + + + GT ++ PE
Sbjct: 189 I---CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV 245
Query: 658 ----YAQYGEVSPKIDVYAFGVVLYELIS 682
YG PK D ++ GV+L+ L+
Sbjct: 246 LNTTNESYG---PKCDAWSAGVLLHLLLM 271
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEF----LAELKVLTHVHHLN 543
+ +K+G+G + V+ + + A+K++ ++ + + E+ +L + H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 544 LVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH 602
+V L E SL LV+EY++ +L Q+L G + RGL Y H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNI-INMHNVKLFLFQLLRGLAYCHRQ 119
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEY---- 658
V +HRD+KP N+LI++ K+ADFGLA+ + + + + V T Y PP+
Sbjct: 120 KV---LHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-YDNEVVTLWYRPPDILLGS 175
Query: 659 AQYGEVSPKIDVYAFGVVLYELIS 682
Y S +ID++ G + YE+ +
Sbjct: 176 TDY---STQIDMWGVGCIFYEMAT 196
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 25/207 (12%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIK---KMDMQASKEFLAELKVLTHVHHLN 543
+++ N IG+G +G V A + + A K K ++ F E++++ + H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 544 LVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM--QIALDSARGLEYIH 600
++RL ++LV E G L + + + +AR+ + + Y H
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDV----LSAVAYCH 123
Query: 601 EHTVPVYIHRDIKPANILI---DKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE 657
+ V HRD+KP N L + K+ DFGLA + G + VGT Y+ P+
Sbjct: 124 KLNV---AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGTPYYVSPQ 178
Query: 658 --YAQYGEVSPKIDVYAFGVVLYELIS 682
YG P+ D ++ GV++Y L+
Sbjct: 179 VLEGLYG---PECDEWSAGVMMYVLLC 202
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 3e-28
Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 22/205 (10%)
Query: 490 NDFSMGNKIGQGGFGAVFYA-ELRGEKAAIKKMDMQASKE-----FLAELKVLTHVHHLN 543
+ K+G+G +G V+ A + +G A+K++ + A E + E+ +L +HH N
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 544 LVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH 602
+V LI E L LV+E++E +L + L K L S RG+ + H+H
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEK-DLKKVLD-ENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS-VHTRLVGTFGYMPPEY--- 658
+ +HRD+KP N+LI+ + K+ADFGLA+ G +T V T Y P+
Sbjct: 139 RI---LHRDLKPQNLLINSDGALKLADFGLAR--AFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 659 -AQYGEVSPKIDVYAFGVVLYELIS 682
+Y S +D+++ G + E+I+
Sbjct: 194 SKKY---STSVDIWSIGCIFAEMIT 215
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 21/209 (10%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE-----FLAELKVLTHVHHL 542
+ KIG+G +G VF A+ R E A+K++ + E L E+ +L + H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 543 NLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE 601
N+VRL + L LV+E+ + +L ++ S L +GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEY--- 658
V +HRD+KP N+LI++N K+A+FGLA+ + ++ V T Y PP+
Sbjct: 120 RNV---LHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVVTLWYRPPDVLFG 175
Query: 659 -AQYGEVSPKIDVYAFGVVLYELISAMEA 686
Y S ID+++ G + EL +A
Sbjct: 176 AKLY---STSIDMWSAGCIFAELANAGRP 201
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 27/209 (12%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIK-----KMDMQASKEFLAELKVLTHVHH 541
+++ +G+G FG V + R ++ A+K + + L E+++L + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 542 LNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM--QIALDSARGLEY 598
N+++L S ++V E G L + + + +AR+ Q+ G+ Y
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVF----SGITY 136
Query: 599 IHEHTVPVYIHRDIKPANILI---DKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMP 655
+H+H + +HRD+KP NIL+ +K+ K+ DFGL+ + +GT Y+
Sbjct: 137 MHKHNI---VHRDLKPENILLESKEKDCDIKIIDFGLST--CFQQNTKMKDRIGTAYYIA 191
Query: 656 PE--YAQYGEVSPKIDVYAFGVVLYELIS 682
PE Y K DV++ GV+LY L+S
Sbjct: 192 PEVLRGTYD---EKCDVWSAGVILYILLS 217
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 36/238 (15%)
Query: 465 AAPGVTGITVDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIK--- 519
A G + + EF K ++++ + ++G+G F V + G + A K
Sbjct: 4 MASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN 63
Query: 520 --KMDMQASKEFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNL------NQ 570
K+ + ++ E ++ + H N+VRL E +LV++ + G L +
Sbjct: 64 TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE 123
Query: 571 HLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI---DKNFRAKV 627
S D S +Q L+ + Y H + + +HR++KP N+L+ K K+
Sbjct: 124 FY--SEADA---SHCIQQILE---SIAYCHSNGI---VHRNLKPENLLLASKAKGAAVKL 172
Query: 628 ADFGLAKLTEVGSASVHTRLVGTFGYMPPE---YAQYGEVSPKIDVYAFGVVLYELIS 682
ADFGLA EV + GT GY+ PE Y +D++A GV+LY L+
Sbjct: 173 ADFGLAI--EVNDSEAWHGFAGTPGYLSPEVLKKDPYS---KPVDIWACGVILYILLV 225
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIK---KMDMQASKE-FLAELKVLTHVHHL 542
+ F K+G G FG V E R G + IK K Q E AE++VL + H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 543 NLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM------QIALDSARG 595
N++++ ++++V E E G L + + + S Q+
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM----NA 136
Query: 596 LEYIHEHTVPVYIHRDIKPANILI---DKNFRAKVADFGLAKLTEVGSASVHTRLVGTFG 652
L Y H V +H+D+KP NIL + K+ DFGLA+L + T GT
Sbjct: 137 LAYFHSQHV---VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTAL 191
Query: 653 YMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
YM PE + +V+ K D+++ GVV+Y L++
Sbjct: 192 YMAPEVFK-RDVTFKCDIWSAGVVMYFLLT 220
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEF----LAELKVLTHVHH 541
+++ F K+G G + V+ + G A+K++ + + + + E+ ++ + H
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 542 LNLVRLIGYCV-EGSLFLVYEYIEN---GNLNQHLRGSGKDTLTWSARMQIALDSARGLE 597
N+VRL E L LV+E+++N ++ G+ L + +GL
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 598 YIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE 657
+ HE+ + +HRD+KP N+LI+K + K+ DFGLA+ + + + V T Y P+
Sbjct: 123 FCHENKI---LHRDLKPQNLLINKRGQLKLGDFGLARAFGI-PVNTFSSEVVTLWYRAPD 178
Query: 658 Y----AQYGEVSPKIDVYAFGVVLYELIS 682
Y S ID+++ G +L E+I+
Sbjct: 179 VLMGSRTY---STSIDIWSCGCILAEMIT 204
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 21/205 (10%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIK---KMDMQASKEFLAELKVLTHVHHLN 543
F +G G F VF + R G+ A+K K E+ VL + H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 544 LVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM--QIALDSARGLEYIH 600
+V L Y +LV + + G L + G T ++ + Q+ ++Y+H
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQV----LSAVKYLH 123
Query: 601 EHTVPVYIHRDIKPANILI---DKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE 657
E+ + +HRD+KP N+L ++N + + DFGL+K+ + G + + GT GY+ PE
Sbjct: 124 ENGI---VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPE 177
Query: 658 YAQYGEVSPKIDVYAFGVVLYELIS 682
S +D ++ GV+ Y L+
Sbjct: 178 VLAQKPYSKAVDCWSIGVITYILLC 202
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 60/225 (26%), Positives = 106/225 (47%), Gaps = 46/225 (20%)
Query: 484 ELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEF--------LAEL 533
++ + + +G+G F V+ A + + AIKK+ + E L E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 534 KVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDS 592
K+L + H N++ L+ + ++ LV++++E +L ++ + L
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIK-----------DNSLVLTP 111
Query: 593 A----------RGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642
+ +GLEY+H+H + +HRD+KP N+L+D+N K+ADFGLAK GS +
Sbjct: 112 SHIKAYMLMTLQGLEYLHQHWI---LHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPN 166
Query: 643 -VHTRLVGTFGYMPPEY----AQYGEVSPKIDVYAFGVVLYELIS 682
+T V T Y PE Y +D++A G +L EL+
Sbjct: 167 RAYTHQVVTRWYRAPELLFGARMY---GVGVDMWAVGCILAELLL 208
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 56/204 (27%), Positives = 100/204 (49%), Gaps = 20/204 (9%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQASKE-----FLAELKVLTHVHHLN 543
+ KIG+G +G V+ A+ GE A+KK+ ++ E + E+ +L + H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 544 LVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH 602
+V+L + L LV+E+++ +L + L + L L G+ Y H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEY---- 658
V +HRD+KP N+LI++ K+ADFGLA+ + +T + T Y P+
Sbjct: 120 RV---LHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIVTLWYRAPDVLMGS 175
Query: 659 AQYGEVSPKIDVYAFGVVLYELIS 682
+Y S ID+++ G + E+++
Sbjct: 176 KKY---STTIDIWSVGCIFAEMVN 196
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 28/210 (13%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIK-----KMDMQASKEFLAELKVLTHVHH 541
++++ + ++G+G F V + G + A K K+ + ++ E ++ + H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 542 LNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM--QIALDSARGLEY 598
N+VRL E +LV++ + G L + + + ++ QI + Y
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----ESIAY 120
Query: 599 IHEHTVPVYIHRDIKPANILI---DKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMP 655
H + + +HR++KP N+L+ K K+ADFGLA EV + GT GY+
Sbjct: 121 CHSNGI---VHRNLKPENLLLASKAKGAAVKLADFGLAI--EVNDSEAWHGFAGTPGYLS 175
Query: 656 PE---YAQYGEVSPKIDVYAFGVVLYELIS 682
PE Y +D++A GV+LY L+
Sbjct: 176 PEVLKKDPYS---KPVDIWACGVILYILLV 202
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 65/271 (23%), Positives = 109/271 (40%), Gaps = 53/271 (19%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA--AIK---KMDMQASKE---FLAELKVLTHVHH 541
D+ + IG+G FG V + + A+K K +M + F E ++ +
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 542 LNLVRLIGYC--VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSAR----- 594
+V+L Y + L++V EY+ G+L + + AR
Sbjct: 129 PWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMS-----------NYDVPEKWARFYTAE 176
Query: 595 ---GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK-LTEVGSASVHTRLVGT 650
L+ IH +IHRD+KP N+L+DK+ K+ADFG + + G T VGT
Sbjct: 177 VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGT 232
Query: 651 FGYMPPE-------YAQYGEVSPKIDVYAFGVVLYELISAM-----EAVVKTNETITEST 698
Y+ PE YG + D ++ GV LYE++ +++V T I
Sbjct: 233 PDYISPEVLKSQGGDGYYG---RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 289
Query: 699 GLVALFEEVLRQPDPREDLQRL-VDP--RLG 726
+ ++ + + + D RLG
Sbjct: 290 NSLTFPDDNDISKEAKNLICAFLTDREVRLG 320
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 38/211 (18%)
Query: 491 DFSMGNKIGQGGFGAVFYAE--LRGEKAAIK-----KMDMQASKEFLAELKVLTHVHHLN 543
++ + IG+G F V A L G + AIK +++ + ++ E++++ ++H N
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 544 LVRLIGYCV---EGSLFLVYEYIENGNLNQHLRGSGKDTLTWS-AR---MQIALDSARGL 596
+V+L + V E +L+L+ EY G + +L G+ + AR QI +
Sbjct: 76 IVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIV----SAV 127
Query: 597 EYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPP 656
+Y H+ + +HRD+K N+L+D + K+ADFG + VG + G Y P
Sbjct: 128 QYCHQKRI---VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-LDA-FCGAPPYAAP 182
Query: 657 E------YAQYGEVSPKIDVYAFGVVLYELI 681
E Y P++DV++ GV+LY L+
Sbjct: 183 ELFQGKKYD-----GPEVDVWSLGVILYTLV 208
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 58/255 (22%), Positives = 112/255 (43%), Gaps = 28/255 (10%)
Query: 444 HYIQHGPAIALVKNSESAALVAAPGVTGITVDKSVEFSYEELAKATNDFS----MGNKIG 499
H+ H + L + +++ + S+ Y + S + +++G
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELG 62
Query: 500 QGGFGAVFYAELR--GEKAAIKKMDMQASKEFL-AELKVLTHVHHLNLVRLIG-YCVEGS 555
+G V+ + + + A+K + K+ + E+ VL + H N+++L +
Sbjct: 63 RGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE 122
Query: 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARM--QIALDSARGLEYIHEHTVPVYIHRDIK 613
+ LV E + G L + G + +A QI + Y+HE+ + +HRD+K
Sbjct: 123 ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL----EAVAYLHENGI---VHRDLK 175
Query: 614 PANILI---DKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE---YAQYGEVSPK 667
P N+L + K+ADFGL+K+ E + + GT GY PE YG P+
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVEHQ--VLMKTVCGTPGYCAPEILRGCAYG---PE 230
Query: 668 IDVYAFGVVLYELIS 682
+D+++ G++ Y L+
Sbjct: 231 VDMWSVGIITYILLC 245
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-27
Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 32/213 (15%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA--AIK---KMDMQASKE---FLAELKVLTHVHH 541
DF + IG+G FG V +L+ A+K K +M E F E VL +
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 542 LNLVRLIGYC--VEGSLFLVYEYIENGNLNQHL-RGSGKDTLTWSARMQIA-LDSARGLE 597
+ L Y + +L+LV +Y G+L L + + AR +A + A ++
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-ARFYLAEMVIA--ID 189
Query: 598 YIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK-LTEVGSASVHTRLVGTFGYMPP 656
+H+ Y+HRDIKP NIL+D N ++ADFG L E G+ VGT Y+ P
Sbjct: 190 SVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISP 245
Query: 657 E--------YAQYGEVSPKIDVYAFGVVLYELI 681
E +YG P+ D ++ GV +YE++
Sbjct: 246 EILQAMEGGKGRYG---PECDWWSLGVCMYEML 275
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 48/210 (22%), Positives = 93/210 (44%), Gaps = 27/210 (12%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE-----FLAELKVLTHVHHL 542
+ + K+G+G +G V+ A E AIK++ ++ +E + E+ +L + H
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 543 NLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE 601
N++ L L L++EY EN +L +++ + ++ G+ + H
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHS 150
Query: 602 HTVPVYIHRDIKPANILIDKNFRA-----KVADFGLAKLTEVGSASVHTRLVGTFGYMPP 656
+HRD+KP N+L+ + + K+ DFGLA+ + T + T Y PP
Sbjct: 151 RRC---LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHEIITLWYRPP 206
Query: 657 EY----AQYGEVSPKIDVYAFGVVLYELIS 682
E Y S +D+++ + E++
Sbjct: 207 EILLGSRHY---STSVDIWSIACIWAEMLM 233
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-27
Identities = 65/214 (30%), Positives = 94/214 (43%), Gaps = 32/214 (14%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA--AIK---KMDMQASKE---FLAELKVLTHVHH 541
+DF + IG+G F V +++ A+K K DM E F E VL +
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 542 LNLVRLIGYC--VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIA-LDSARGLEY 598
+ +L + E L+LV EY G+L L G+ AR +A + A ++
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA--IDS 177
Query: 599 IHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK-LTEVGSASVHTRLVGTFGYMPPE 657
+H Y+HRDIKP NIL+D+ ++ADFG L G+ VGT Y+ PE
Sbjct: 178 VHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-AVGTPDYLSPE 233
Query: 658 ----------YAQYGEVSPKIDVYAFGVVLYELI 681
YG P+ D +A GV YE+
Sbjct: 234 ILQAVGGGPGTGSYG---PECDWWALGVFAYEMF 264
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-27
Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 24/207 (11%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE---FLAELKVLTHVHHLN 543
+ + + ++G G FG V + G K ++ + E+ ++ +HH
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 544 LVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSG-----KDTLTWSARMQIALDSARGLE 597
L+ L + + + L+ E++ G L + + M+ A + GL+
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV---INYMRQACE---GLK 163
Query: 598 YIHEHTVPVYIHRDIKPANILI--DKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMP 655
++HEH++ +H DIKP NI+ K K+ DFGLA ++ + T +
Sbjct: 164 HMHEHSI---VHLDIKPENIMCETKKASSVKIIDFGLAT--KLNPDEIVKVTTATAEFAA 218
Query: 656 PEYAQYGEVSPKIDVYAFGVVLYELIS 682
PE V D++A GV+ Y L+S
Sbjct: 219 PEIVDREPVGFYTDMWAIGVLGYVLLS 245
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 46/214 (21%)
Query: 494 MGNKIGQGGFGAVFYAE--LRGEKAAIKKMDMQASKEFLA----ELKVLTHVHHLNLVRL 547
+ +G+G +G V A + E A+K +DM+ + + E+ + ++H N+V+
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 548 IGYCV---EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSAR--------GL 596
Y +L EY G L + M A+ G+
Sbjct: 71 --YGHRREGNIQYLFLEYCSGGELFDRIEPDI--------GMPE--PDAQRFFHQLMAGV 118
Query: 597 EYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS--VHTRLVGTFGYM 654
Y+H + HRDIKP N+L+D+ K++DFGLA + + ++ GT Y+
Sbjct: 119 VYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYV 174
Query: 655 PPE------YAQYGEVSPKIDVYAFGVVLYELIS 682
PE + + +DV++ G+VL +++
Sbjct: 175 APELLKRREFH-----AEPVDVWSCGIVLTAMLA 203
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 27/212 (12%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASK---------EFLAELKVLT 537
+ + +G ++G G F V + G + A K + + S+ E E+ +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 538 HVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM--QIALDSAR 594
V H N++ L Y + L+ E + G L L + + QI
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL----D 126
Query: 595 GLEYIHEHTVPVYIHRDIKPANILI----DKNFRAKVADFGLAKLTEVGSASVHTRLVGT 650
G+ Y+H + H D+KP NI++ K+ DFGLA E+ + GT
Sbjct: 127 GVNYLHTKKI---AHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKNIFGT 181
Query: 651 FGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
++ PE Y + + D+++ GV+ Y L+S
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 2e-26
Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 30/208 (14%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA--AIK---KMDMQASKEF---LAELKVLTHVHH 541
DF + +G G FG V R A+K K + K+ E +L+ V H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 542 LNLVRLIGYC-VEGSLFLVYEYIENGNLNQHLRGSGK---DTLTWSARM---QIALDSAR 594
++R+ G +F++ +YIE G L LR S + A+ ++ L
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV----AKFYAAEVCL---- 117
Query: 595 GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYM 654
LEY+H + I+RD+KP NIL+DKN K+ DFG AK V + +T L GT Y+
Sbjct: 118 ALEYLHSKDI---IYRDLKPENILLDKNGHIKITDFGFAK--YVPDVT-YT-LCGTPDYI 170
Query: 655 PPEYAQYGEVSPKIDVYAFGVVLYELIS 682
PE + ID ++FG+++YE+++
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLA 198
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 41/208 (19%), Positives = 86/208 (41%), Gaps = 27/208 (12%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE--FLAELKVLTHVHHLNL 544
+ + +G+G FG V + K + ++ + + E+ +L H N+
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI 63
Query: 545 VRLIGYC-VEGSLFLVYEYIENGNL-------NQHLRGSGKDTLTWSARMQIALDSARGL 596
+ L L +++E+I ++ L + ++ + + + L
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFEL--NEREI---VSYVHQVCE---AL 115
Query: 597 EYIHEHTVPVYIHRDIKPANILI--DKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYM 654
+++H H + H DI+P NI+ ++ K+ +FG A+ + G L Y
Sbjct: 116 QFLHSHNI---GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRLLFTAPEYY 170
Query: 655 PPEYAQYGEVSPKIDVYAFGVVLYELIS 682
PE Q+ VS D+++ G ++Y L+S
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLS 198
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 51/225 (22%), Positives = 97/225 (43%), Gaps = 47/225 (20%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASK------------EFLAELK 534
++ +G+G V + ++ A+K +D+ L E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 535 VLTHV-HHLNLVRLIGYCVEGS-LFLVYEYIENGNL------NQHLRGSGKDTLTWSARM 586
+L V H N+++L + FLV++ ++ G L L S K+T M
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL--SEKET---RKIM 130
Query: 587 QIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR 646
+ L+ + +H+ + +HRD+KP NIL+D + K+ DFG + + G
Sbjct: 131 RALLE---VICALHKLNI---VHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLRE 182
Query: 647 LVGTFGYMPPE---------YAQYGEVSPKIDVYAFGVVLYELIS 682
+ GT Y+ PE + YG ++D+++ GV++Y L++
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYG---KEVDMWSTGVIMYTLLA 224
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-26
Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIK-----KMDMQASKEFLAELKVLTHVHH 541
T ++ + ++G+G F V G++ A K+ + ++ E ++ + H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 542 LNLVRLIG-YCVEGSLFLVYEYIENGNL------NQHLRGSGKDTLTWSARMQIALDSAR 594
N+VRL EG +L+++ + G L ++ S D S +Q L+
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYY--SEADA---SHCIQQILE--- 121
Query: 595 GLEYIHEHTVPVYIHRDIKPANILI---DKNFRAKVADFGLAKLTEVGSASVHTRLVGTF 651
+ + H+ V +HR++KP N+L+ K K+ADFGLA E + GT
Sbjct: 122 AVLHCHQMGV---VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF-AGTP 177
Query: 652 GYMPPE---YAQYGEVSPKIDVYAFGVVLYELIS 682
GY+ PE YG +D++A GV+LY L+
Sbjct: 178 GYLSPEVLRKDPYG---KPVDLWACGVILYILLV 208
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 46/214 (21%)
Query: 494 MGNKIGQGGFGAVFYAE--LRGEKAAIKKMDMQASKEFLA----ELKVLTHVHHLNLVRL 547
+ +G+G +G V A + E A+K +DM+ + + E+ + ++H N+V+
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 548 IGYCV---EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSAR--------GL 596
Y +L EY G L + M A+ G+
Sbjct: 71 --YGHRREGNIQYLFLEYCSGGELFDRIEPDI--------GMPE--PDAQRFFHQLMAGV 118
Query: 597 EYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV--HTRLVGTFGYM 654
Y+H + HRDIKP N+L+D+ K++DFGLA + + + GT Y+
Sbjct: 119 VYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYV 174
Query: 655 PPE------YAQYGEVSPKIDVYAFGVVLYELIS 682
PE + + +DV++ G+VL +++
Sbjct: 175 APELLKRREFH-----AEPVDVWSCGIVLTAMLA 203
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 53/230 (23%), Positives = 92/230 (40%), Gaps = 35/230 (15%)
Query: 471 GITVDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASK- 527
G+ K + + + +G ++G G F V + G + A K + + S+
Sbjct: 1 GMETFKQQKV--------EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRA 52
Query: 528 --------EFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKD 578
E E+ +L V H N++ L Y + L+ E + G L L
Sbjct: 53 SRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESL 112
Query: 579 TLTWSARM--QIALDSARGLEYIHEHTVPVYIHRDIKPANILI----DKNFRAKVADFGL 632
+ + QI G+ Y+H + H D+KP NI++ K+ DFGL
Sbjct: 113 SEEEATSFIKQIL----DGVNYLHTKKI---AHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 633 AKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
A E+ + GT ++ PE Y + + D+++ GV+ Y L+S
Sbjct: 166 AH--EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 32/209 (15%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAE--LRGEKAAIKKMDMQASKEFLAELKVLTHV-HHLNLV 545
+D+ + K+G+G + VF A EK +K + K+ E+K+L ++ N++
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNII 94
Query: 546 RL---IGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLT----WSARMQIALDSARGLEY 598
L + V + LV+E++ N + Q TLT +I + L+Y
Sbjct: 95 TLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEIL----KALDY 145
Query: 599 IHEHTVPVYIHRDIKPANILIDKNFRA-KVADFGLAKLTEVGSASVHTRLVGTFGYMPPE 657
H + +HRD+KP N++ID R ++ D+GLA+ G + V + + PE
Sbjct: 146 CHSMGI---MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPE 200
Query: 658 ----YAQYGEVSPKIDVYAFGVVLYELIS 682
Y Y +D+++ G +L +I
Sbjct: 201 LLVDYQMY---DYSLDMWSLGCMLASMIF 226
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 46/224 (20%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMD-----------MQASKEFLAELKV 535
+ + IG+G V R G + A+K M+ + + E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 536 LTHVH-HLNLVRLIGYCVEGS-LFLVYEYIENGNL------NQHLRGSGKDTLTWSARMQ 587
L V H +++ LI S +FLV++ + G L L S K+T + M+
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVAL--SEKET---RSIMR 207
Query: 588 IALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRL 647
L+ + ++H + + +HRD+KP NIL+D N + +++DFG + E G L
Sbjct: 208 SLLE---AVSFLHANNI---VHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLREL 259
Query: 648 VGTFGYMPPE---------YAQYGEVSPKIDVYAFGVVLYELIS 682
GT GY+ PE + YG ++D++A GV+L+ L++
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYG---KEVDLWACGVILFTLLA 300
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 24/205 (11%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA--AIK---KMDMQASKEF---LAELKVLTHVHH 541
+ F +G G FG V + + A+K K + K+ L E ++L V+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 542 LNLVRLIGYC-VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM---QIALDSARGLE 597
LV+L +L++V EY+ G + HLR G+ + AR QI L E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYAAQIVL----TFE 155
Query: 598 YIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE 657
Y+H + I+RD+KP N+LID+ +V DFG AK V + T L GT + PE
Sbjct: 156 YLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRT-WT-LCGTPEALAPE 208
Query: 658 YAQYGEVSPKIDVYAFGVVLYELIS 682
+ +D +A GV++YE+ +
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAA 233
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 25/207 (12%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKAA--------IKKMDMQASKEF--LAELKVLTHV 539
+ F + +GQG FG VF + A +KK ++ E +L V
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 540 HHLNLVRLIGYC--VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM---QIALDSAR 594
+H +V+L Y EG L+L+ +++ G+L L T + ++AL
Sbjct: 84 NHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED-VKFYLAELAL---- 137
Query: 595 GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYM 654
L+++H + I+RD+KP NIL+D+ K+ DFGL+K + ++ GT YM
Sbjct: 138 ALDHLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYM 193
Query: 655 PPEYAQYGEVSPKIDVYAFGVVLYELI 681
PE + D ++FGV+++E++
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEML 220
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 52/216 (24%), Positives = 100/216 (46%), Gaps = 38/216 (17%)
Query: 495 GNKIGQGGFGAVFYAELR----GEKAAIKKMDMQ-ASKEFLAELKVLTHVHHLNLVRLIG 549
G K+G+G +G V+ A+ + + A+K+++ S E+ +L + H N++ L
Sbjct: 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQK 85
Query: 550 YCV---EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSA----------RGL 596
+ + ++L+++Y E+ +L ++ + + + L G+
Sbjct: 86 VFLSHADRKVWLLFDYAEH-DLWHIIKFHRASK---ANKKPVQLPRGMVKSLLYQILDGI 141
Query: 597 EYIHEHTVPVYIHRDIKPANILIDKNFRA----KVADFGLAKL--TEVGSASVHTRLVGT 650
Y+H + V +HRD+KPANIL+ K+AD G A+L + + + +V T
Sbjct: 142 HYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198
Query: 651 FGYMPPEY----AQYGEVSPKIDVYAFGVVLYELIS 682
F Y PE Y + ID++A G + EL++
Sbjct: 199 FWYRAPELLLGARHY---TKAIDIWAIGCIFAELLT 231
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 50/212 (23%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMD---------MQASKEFLAELKVLT 537
+ + MG ++G G F V + G++ A K + + +E E+ +L
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 538 HVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM--QIALDSAR 594
+ H N++ L + + + L+ E + G L L T + + QI
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQIL----D 119
Query: 595 GLEYIHEHTVPVYIHRDIKPANILI----DKNFRAKVADFGLAKLTEVGSASVHTRLVGT 650
G+ Y+H + H D+KP NI++ N R K+ DFG+A ++ + + + GT
Sbjct: 120 GVHYLHSKRI---AHFDLKPENIMLLDKNVPNPRIKLIDFGIAH--KIEAGNEFKNIFGT 174
Query: 651 FGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
++ PE Y + + D+++ GV+ Y L+S
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVITYILLS 206
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 49/212 (23%), Positives = 89/212 (41%), Gaps = 27/212 (12%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMD---------MQASKEFLAELKVLT 537
+ + G ++G G F V + G + A K + + ++ E+ +L
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 538 HVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM--QIALDSAR 594
+ H N++ L Y + + L+ E + G L L T + QI
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL----N 125
Query: 595 GLEYIHEHTVPVYIHRDIKPANILI----DKNFRAKVADFGLAKLTEVGSASVHTRLVGT 650
G+ Y+H + H D+KP NI++ R K+ DFGLA ++ + + GT
Sbjct: 126 GVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIFGT 180
Query: 651 FGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
++ PE Y + + D+++ GV+ Y L+S
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 44/202 (21%), Positives = 88/202 (43%), Gaps = 14/202 (6%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAA---IKKMDMQASKEFLAELKVLTHVHHLN 543
+ + + ++G G FG V R G A + + E++ ++ + H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 544 LVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH 602
LV L + + + ++YE++ G L + + + ++ ++ +GL ++HE+
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 603 TVPVYIHRDIKPANILI--DKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQ 660
+H D+KP NI+ ++ K+ DFGL + GT + PE A+
Sbjct: 275 NY---VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAE 329
Query: 661 YGEVSPKIDVYAFGVVLYELIS 682
V D+++ GV+ Y L+S
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLS 351
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 51/224 (22%), Positives = 95/224 (42%), Gaps = 43/224 (19%)
Query: 486 AKATNDFSMGNKIGQGGFGAVFYAE--LRGEKAAIKKMD---MQASKEFLA----ELKVL 536
AK + MG+ +G+G +G V + A+K + ++ A E+++L
Sbjct: 1 AKLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 537 THVHHLNLVRL---IGYCVEGSLFLVYEYIENGN---LNQHLRGSGKDTLTWSARMQIAL 590
+ H N+++L + + +++V EY G L+ R +
Sbjct: 61 RRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK----------RFPV-- 108
Query: 591 DSAR--------GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642
A GLEY+H + +H+DIKP N+L+ K++ G+A+ +A
Sbjct: 109 CQAHGYFCQLIDGLEYLHSQGI---VHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD 165
Query: 643 --VHTRLVGTFGYMPPEYAQYGEV--SPKIDVYAFGVVLYELIS 682
T G+ + PPE A + K+D+++ GV LY + +
Sbjct: 166 DTCRTS-QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT 208
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 61/205 (29%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA-----AIKKMDMQASKEF---LAELKVLTHVHH 541
NDF +G+G FG V + ++K + A E + E +VL + H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 542 LNLVRLIGYC--VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM---QIALDSARGL 596
L L Y L V EY G L HL T AR +I L
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER-ARFYGAEIVS----AL 118
Query: 597 EYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPP 656
EY+H V ++RDIK N+++DK+ K+ DFGL K A++ T GT Y+ P
Sbjct: 119 EYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAP 174
Query: 657 EYAQYGEVSPKIDVYAFGVVLYELI 681
E + + +D + GVV+YE++
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMM 199
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 54/241 (22%), Positives = 105/241 (43%), Gaps = 36/241 (14%)
Query: 465 AAPGVTGITVDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIK--- 519
+PG++G ++ + ++ + + + IG+G F V R G++ A+K
Sbjct: 1 GSPGISG-GGGGILDMADDD-VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVD 58
Query: 520 -----KMDMQASKEFLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLNQHLR 573
++++ E + + H ++V L+ +G L++V+E+++ +L +
Sbjct: 59 VAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIV 118
Query: 574 GSGKDTLTWSARM------QIALDSARGLEYIHEHTVPVYIHRDIKPANILI---DKNFR 624
+S + QI L Y H++ + IHRD+KP +L+ + +
Sbjct: 119 KRADAGFVYSEAVASHYMRQIL----EALRYCHDNNI---IHRDVKPHCVLLASKENSAP 171
Query: 625 AKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE---YAQYGEVSPKIDVYAFGVVLYELI 681
K+ FG+A R VGT +M PE YG +DV+ GV+L+ L+
Sbjct: 172 VKLGGFGVAIQLGESGLVAGGR-VGTPHFMAPEVVKREPYG---KPVDVWGCGVILFILL 227
Query: 682 S 682
S
Sbjct: 228 S 228
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 27/209 (12%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA-----AIKKMD----MQASKEF---LAELKVLT 537
F + +G+GG+G VF A+K + ++ +K+ AE +L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 538 HVHHLNLVRLIGYC--VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM---QIALDS 592
V H +V LI Y G L+L+ EY+ G L L G A +I++
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT-ACFYLAEISM-- 132
Query: 593 ARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFG 652
L ++H+ + I+RD+KP NI+++ K+ DFGL K + HT GT
Sbjct: 133 --ALGHLHQKGI---IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIE 186
Query: 653 YMPPEYAQYGEVSPKIDVYAFGVVLYELI 681
YM PE + +D ++ G ++Y+++
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDML 215
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-25
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 28/207 (13%)
Query: 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASK---EFLAELKVLTHVHHLNLV 545
S +G G FG V E G K A K + + K E E+ V+ + H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 546 RLIG-YCVEGSLFLVYEYIENGNL-------NQHLRGSGKDTLTWSARMQIALDSARGLE 597
+L + + + LV EY++ G L + +L + DT M+ + G+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNL--TELDT---ILFMKQICE---GIR 201
Query: 598 YIHEHTVPVYIHRDIKPANILI--DKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMP 655
++H+ + +H D+KP NIL + K+ DFGLA+ GT ++
Sbjct: 202 HMHQMYI---LHLDLKPENILCVNRDAKQIKIIDFGLAR--RYKPREKLKVNFGTPEFLA 256
Query: 656 PEYAQYGEVSPKIDVYAFGVVLYELIS 682
PE Y VS D+++ GV+ Y L+S
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIAYMLLS 283
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 54/223 (24%), Positives = 82/223 (36%), Gaps = 55/223 (24%)
Query: 491 DFSMGNKIGQGGFGAVFYAE--LRGEKAAIK-----KMDMQASKEFLA----ELKVLTHV 539
+ +G +G GGFG+V+ AIK ++ E+ +L V
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 540 HHL--NLVRLIGYCV---EGSLFLVYEY-----------IENGNLNQHLRGSGKDTLTWS 583
++RL S L+ E E G L + L
Sbjct: 104 SSGFSGVIRL--LDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL----------- 150
Query: 584 ARM---QIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN-FRAKVADFGLAKLTEVG 639
AR Q+ + + H V +HRDIK NILID N K+ DFG L +
Sbjct: 151 ARSFFWQVL----EAVRHCHNCGV---LHRDIKDENILIDLNRGELKLIDFGSGALLKDT 203
Query: 640 SASVHTRLVGTFGYMPPEYAQYGE-VSPKIDVYAFGVVLYELI 681
GT Y PPE+ +Y V++ G++LY+++
Sbjct: 204 --VYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 243
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 64/303 (21%), Positives = 116/303 (38%), Gaps = 52/303 (17%)
Query: 473 TVDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS---- 526
+ S E ++ A D +IG+G +G+V + G+ A+K++
Sbjct: 8 KLKISPEQHWDFTA---EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ 64
Query: 527 KEFLAELKVLTH-VHHLNLVRLIG-YCVEGSLFLVYEYIENG--NLNQHLRGSGKDTLTW 582
K+ L +L V+ +V+ G EG ++ E + +++ D +
Sbjct: 65 KQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPE 124
Query: 583 SARMQIALDSARGLEYIH-EHTVPVYIHRDIKPANILIDKNFRAKVADFGL-AKLTEVGS 640
+I L + + L ++ + IHRDIKP+NIL+D++ K+ DFG+ +L
Sbjct: 125 EILGKITLATVKALNHLKENLKI---IHRDIKPSNILLDRSGNIKLCDFGISGQLV---- 177
Query: 641 ASV-HTRLVGTFGYMPPEYAQYGEVSP----KIDVYAFGVVLYELISAMEAVVKTNETIT 695
S+ TR G YM PE + DV++ G+ LYEL
Sbjct: 178 DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL--------------- 222
Query: 696 ESTGLVALFEEVLRQPDP-REDLQRLVD---PRLGDDYPIDSVRKMARLARACTQENPQL 751
A + + + L ++V P+L + + C ++
Sbjct: 223 ------ATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESK 276
Query: 752 RPS 754
RP
Sbjct: 277 RPK 279
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 52/228 (22%), Positives = 93/228 (40%), Gaps = 63/228 (27%)
Query: 491 DFSMGNKIGQGGFGAVFYAE--LRGEKAAIK-----------KMDMQASKEFLAELKVLT 537
+S + +G G FG V+ A + ++ +K ++ + E+ +L+
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 538 HVHHLNLVRLIGYCV---EGSLFLV----------YEYI-ENGNLNQHLRGSGKDTLTWS 583
V H N++++ + +G LV + +I + L++ L
Sbjct: 85 RVEHANIIKV--LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL----------- 131
Query: 584 ARM---QIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640
A Q+ + Y+ + IHRDIK NI+I ++F K+ DFG A E G
Sbjct: 132 ASYIFRQLV----SAVGYLRLKDI---IHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK 184
Query: 641 ASVHTRLVGTFGYMPPE------YAQYGEVSPKIDVYAFGVVLYELIS 682
+T GT Y PE Y P++++++ GV LY L+
Sbjct: 185 L-FYT-FCGTIEYCAPEVLMGNPYR-----GPELEMWSLGVTLYTLVF 225
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 31/213 (14%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA-----AIKKMD----MQASKEF---LAELKVLT 537
+F + +G G +G VF A+K + +Q +K E +VL
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 538 HV-HHLNLVRLIGYC--VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM---QIALD 591
H+ LV L Y E L L+ +YI G L HL + T ++ +I L
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-VQIYVGEIVL- 170
Query: 592 SARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTF 651
LE++H+ + I+RDIK NIL+D N + DFGL+K GT
Sbjct: 171 ---ALEHLHKLGI---IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224
Query: 652 GYMPPE---YAQYGEVSPKIDVYAFGVVLYELI 681
YM P+ G +D ++ GV++YEL+
Sbjct: 225 EYMAPDIVRGGDSGH-DKAVDWWSLGVLMYELL 256
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 47/214 (21%)
Query: 494 MGNKIGQGGFGAVFYAE--LRGEKAAIKKMD-MQASKEFLA-----ELKVLTHVHHLNLV 545
+G+ +G G FG V E L G K A+K ++ + + E++ L H +++
Sbjct: 15 LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 546 RLIGYCV---EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSAR-------- 594
+L Y V F+V EY+ G L ++ G R++ AR
Sbjct: 75 KL--YQVISTPTDFFMVMEYVSGGELFDYICKHG--------RVEE--MEARRLFQQILS 122
Query: 595 GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYM 654
++Y H H V +HRD+KP N+L+D + AK+ADFGL+ + G + T G+ Y
Sbjct: 123 AVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS-CGSPNYA 177
Query: 655 PPE------YAQYGEVSPKIDVYAFGVVLYELIS 682
PE YA P++D+++ GV+LY L+
Sbjct: 178 APEVISGRLYA-----GPEVDIWSCGVILYALLC 206
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 47/226 (20%), Positives = 97/226 (42%), Gaps = 23/226 (10%)
Query: 475 DKSVEFSYEE-LAKATNDFS-----MGNKIGQGGFGAVFYAELR--GEKAAIK-----KM 521
V+ E ++ +F+ ++G+G F V + G++ A K +
Sbjct: 8 SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR 67
Query: 522 DMQASKEFLAELKVLTHV-HHLNLVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDT 579
E L E+ VL ++ L Y + L+ EY G + +
Sbjct: 68 GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEM 127
Query: 580 LTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI---DKNFRAKVADFGLAKLT 636
++ + +++ G+ Y+H++ + +H D+KP NIL+ K+ DFG+++
Sbjct: 128 VSENDVIRLIKQILEGVYYLHQNNI---VHLDLKPQNILLSSIYPLGDIKIVDFGMSR-- 182
Query: 637 EVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
++G A ++GT Y+ PE Y ++ D++ G++ Y L++
Sbjct: 183 KIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 56/248 (22%), Positives = 99/248 (39%), Gaps = 72/248 (29%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVR 546
+ +S+G +G G FG V G++ A+KK+ +Q + EL ++ + H+N+++
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV-LQDPRYKNRELDIMKVLDHVNIIK 64
Query: 547 LI---------------------------------------GYCVEGSLFLVYEYIENGN 567
L+ L ++ EY+ +
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-T 123
Query: 568 LNQHLRGSGKDTLTWSARM------QIALDSARGLEYIHEHTVPVYIHRDIKPANILID- 620
L++ L+ + + + Q+ R + +IH + HRDIKP N+L++
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIHSLGI---CHRDIKPQNLLVNS 176
Query: 621 KNFRAKVADFGLAKLTEVGSASVH---TRLVGTFGYMPPE----YAQYGEVSPKIDVYAF 673
K+ K+ DFG AK SV +R Y PE +Y +P ID+++
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEY---TPSIDLWSI 228
Query: 674 GVVLYELI 681
G V ELI
Sbjct: 229 GCVFGELI 236
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 37/267 (13%), Positives = 79/267 (29%), Gaps = 60/267 (22%)
Query: 497 KIGQGGFGAVFYA--ELRGEKAAIKKMDMQAS------KEFLAELKVLTHVHHLNLVRLI 548
G + A + A+ +D Q +E L+ L+ + + R++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 549 GYCVEGSL-FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVY 607
+ +V E+I G+L + S + ++ A + H V
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGV--- 150
Query: 608 IHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPK 667
P+ + + + +A MP +P+
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAY---------------------PATMPD-------ANPQ 182
Query: 668 IDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGD 727
D+ G LY L+ + + +GL + QP D+ R + ++
Sbjct: 183 DDIRGIGASLYALLVNRWPLPEA----GVRSGLAPAERDTAGQPIEPADIDRDIPFQI-- 236
Query: 728 DYPIDSVRKMARLARACTQENPQLRPS 754
+ +A Q + +R +
Sbjct: 237 ----------SAVAARSVQGDGGIRSA 253
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 61/204 (29%), Positives = 89/204 (43%), Gaps = 24/204 (11%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA-----AIKKMDMQASKEF---LAELKVLT-HVH 540
+DF IG+G FG V A + E+ ++K + KE ++E VL +V
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 541 HLNLVRLIGYC--VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM---QIALDSARG 595
H LV L + L+ V +YI G L HL+ AR +IA
Sbjct: 98 HPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR-ARFYAAEIAS----A 151
Query: 596 LEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMP 655
L Y+H + ++RD+KP NIL+D + DFGL K +++ T GT Y+
Sbjct: 152 LGYLHSLNI---VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEYLA 207
Query: 656 PEYAQYGEVSPKIDVYAFGVVLYE 679
PE +D + G VLYE
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYE 231
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-24
Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 22/205 (10%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA-----AIKKMDMQASKEF---LAELKVLTHVHH 541
N+F +G+G FG V + + +KK + A E L E +VL + H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 542 LNLVRLIGYC--VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM---QIALDSARGL 596
L L Y L V EY G L HL + AR +I L
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARFYGAEIVS----AL 261
Query: 597 EYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPP 656
+Y+H VY RD+K N+++DK+ K+ DFGL K A++ T GT Y+ P
Sbjct: 262 DYLHSEKNVVY--RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAP 318
Query: 657 EYAQYGEVSPKIDVYAFGVVLYELI 681
E + + +D + GVV+YE++
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMM 343
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 23/206 (11%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS----KEFLAELKVLTH-VHHL 542
ND ++G G G V+ R G A+K+M + K L +L V+
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 543 NLVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH- 600
+V+ G + +F+ E + R G + + + + L Y+
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK--MTVAIVKALYYLKE 142
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGL-AKLTEVGSASVHTRLVGTFGYMPPEYA 659
+H V IHRD+KP+NIL+D+ + K+ DFG+ +L + + R G YM PE
Sbjct: 143 KHGV---IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPERI 196
Query: 660 QYGEV-----SPKIDVYAFGVVLYEL 680
+ + DV++ G+ L EL
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVEL 222
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 24/206 (11%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA-----AIKKMDMQASKEF---LAELKVLTHV-H 540
DF + +G+G FG VF AE + A+KK + + + E +VL+
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 541 HLNLVRLIGYC--VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM---QIALDSARG 595
H L + + +LF V EY+ G+L H++ K L+ A +I L G
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSR-ATFYAAEIIL----G 130
Query: 596 LEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMP 655
L+++H + ++RD+K NIL+DK+ K+ADFG+ K +G A +T GT Y+
Sbjct: 131 LQFLHSKGI---VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIA 186
Query: 656 PEYAQYGEVSPKIDVYAFGVVLYELI 681
PE + + +D ++FGV+LYE++
Sbjct: 187 PEILLGQKYNHSVDWWSFGVLLYEML 212
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS----KEFLAELKVLTH-VHHL 542
+D ++G+G +G V G+ A+K++ + K L +L + V
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 543 NLVRLIG-YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM--QIALDSARGLEYI 599
V G EG +++ E + + +L++ + T + +IA+ + LE++
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 600 H-EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE- 657
H + +V IHRD+KP+N+LI+ + K+ DFG++ + G YM PE
Sbjct: 126 HSKLSV---IHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDAGCKPYMAPER 180
Query: 658 ---YAQYGEVSPKIDVYAFGVVLYEL 680
S K D+++ G+ + EL
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIEL 206
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 55/257 (21%), Positives = 90/257 (35%), Gaps = 57/257 (22%)
Query: 460 SAALVAAPGVTGITVDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAE--LRGEKAA 517
S G + ++ ++ +G +G+GGFG VF + A
Sbjct: 1 SMLTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVA 60
Query: 518 IKKMDMQASKEFLA---------ELKVLTHVH----HLNLVRLIGYCV---EGSLFLVYE 561
IK + + E+ +L V H ++RL + LV E
Sbjct: 61 IKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL--LDWFETQEGFMLVLE 118
Query: 562 Y-----------IENGNLNQHLRGSGKDTLTWSARM---QIALDSARGLEYIHEHTVPVY 607
E G L + +R Q+ +++ H V
Sbjct: 119 RPLPAQDLFDYITEKGPLGEGP-----------SRCFFGQVV----AAIQHCHSRGV--- 160
Query: 608 IHRDIKPANILID-KNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGE-VS 665
+HRDIK NILID + AK+ DFG L GT Y PPE+ + +
Sbjct: 161 VHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTD-FDGTRVYSPPEWISRHQYHA 217
Query: 666 PKIDVYAFGVVLYELIS 682
V++ G++LY+++
Sbjct: 218 LPATVWSLGILLYDMVC 234
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 57/211 (27%), Positives = 84/211 (39%), Gaps = 45/211 (21%)
Query: 494 MGNKIGQGGFGAVFYAE--LRGEKAAIKKMD-MQASKEFLA-ELKVLTHVHHLNLVRLIG 549
IG G FG L E A+K ++ A E + E+ + H N+VR
Sbjct: 24 FVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRF-- 81
Query: 550 YCV---EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSAR--------GLEY 598
V L ++ EY G L + + +G R D AR G+ Y
Sbjct: 82 KEVILTPTHLAIIMEYASGGELYERICNAG--------RFSE--DEARFFFQQLLSGVSY 131
Query: 599 IHEHTVPVYIHRDIKPANILIDKNF--RAKVADFGLAKLTEVGSASVHTRLVGTFGYMPP 656
H + HRD+K N L+D + R K+ DFG +K + + S + VGT Y+ P
Sbjct: 132 CHSMQI---CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKST-VGTPAYIAP 186
Query: 657 E------YAQYGEVSPKIDVYAFGVVLYELI 681
E Y DV++ GV LY ++
Sbjct: 187 EVLLRQEYD-----GKIADVWSCGVTLYVML 212
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA-----AIKKMDMQASKEF---LAELKVLTHV-H 540
DF+ +G+G FG V +E +G +KK + + + E +VL
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 541 HLNLVRLIGYC--VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM---QIALDSARG 595
L +L C L+ V EY+ G+L H++ G+ A +IA+ G
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH-AVFYAAEIAI----G 133
Query: 596 LEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMP 655
L ++ + I+RD+K N+++D K+ADFG+ K + T GT Y+
Sbjct: 134 LFFLQSKGI---IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIA 189
Query: 656 PEYAQYGEVSPKIDVYAFGVVLYELI 681
PE Y +D +AFGV+LYE++
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEML 215
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 55/217 (25%)
Query: 494 MGNKIGQGGFGAVFYAE--LRGEKAAIKKMDMQASKEFLAELKVLTHV----------HH 541
+G+ +G G FG V + L G K A+K ++ ++ + L V+ + H
Sbjct: 20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILN----RQKIRSLDVVGKIRREIQNLKLFRH 75
Query: 542 LNLVRLIGYCV---EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSAR---- 594
++++L Y V +F+V EY+ G L ++ +G R+ +R
Sbjct: 76 PHIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKNG--------RLDE--KESRRLFQ 123
Query: 595 ----GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGT 650
G++Y H H V +HRD+KP N+L+D + AK+ADFGL+ + G + T G+
Sbjct: 124 QILSGVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS-CGS 178
Query: 651 FGYMPPE------YAQYGEVSPKIDVYAFGVVLYELI 681
Y PE YA P++D+++ GV+LY L+
Sbjct: 179 PNYAAPEVISGRLYA-----GPEVDIWSSGVILYALL 210
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA-----AIKKMDMQASKEF---LAELKVLTHV-H 540
++F +G+G FG V A ++ +KK + + + E ++L+ +
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 541 HLNLVRLIGYC--VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM---QIALDSARG 595
H L +L C LF V E++ G+L H++ S + AR +I
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEAR-ARFYAAEIIS----A 136
Query: 596 LEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMP 655
L ++H+ + I+RD+K N+L+D K+ADFG+ K + T GT Y+
Sbjct: 137 LMFLHDKGI---IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIA 192
Query: 656 PEYAQYGEVSPKIDVYAFGVVLYELI 681
PE Q P +D +A GV+LYE++
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEML 218
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 46/202 (22%), Positives = 86/202 (42%), Gaps = 23/202 (11%)
Query: 493 SMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHV-HHLNLVRLIG 549
+G+G F + + A+K + + E+ L H N+V+L
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHE 73
Query: 550 -YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM--QIALDSARGLEYIHEHTVPV 606
+ + FLV E + G L + ++ + T ++ + ++ + ++H+ V
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLV----SAVSHMHDVGV-- 127
Query: 607 YIHRDIKPANILI---DKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE---YAQ 660
+HRD+KP N+L + N K+ DFG A+L + + T T Y PE
Sbjct: 128 -VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP-CFTLHYAAPELLNQNG 185
Query: 661 YGEVSPKIDVYAFGVVLYELIS 682
Y D+++ GV+LY ++S
Sbjct: 186 YD---ESCDLWSLGVILYTMLS 204
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA-----AIKKMDMQASKEF---LAELKVLTHV-H 540
DF + IG+G + V L+ +KK + ++ E V +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 541 HLNLVRLIGYC--VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM---QIALDSARG 595
H LV L C E LF V EY+ G+L H++ K AR +I+L
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSAEISL----A 122
Query: 596 LEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMP 655
L Y+HE + I+RD+K N+L+D K+ D+G+ K + T GT Y+
Sbjct: 123 LNYLHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIA 178
Query: 656 PEYAQYGEVSPKIDVYAFGVVLYELIS 682
PE + + +D +A GV+++E+++
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMA 205
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 46/207 (22%), Positives = 96/207 (46%), Gaps = 25/207 (12%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTH-VHHLNLV 545
T+ + + IG G + + + A+K +D ++ ++ E+++L H N++
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPTEEIEILLRYGQHPNII 79
Query: 546 RLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARM--QIALDSARGLEYIHEH 602
L +G +++V E ++ G L + + ++ + I + +EY+H
Sbjct: 80 TLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTIT----KTVEYLHAQ 135
Query: 603 TVPVYIHRDIKPANIL-IDKNFRA---KVADFGLAKLTEVGSASVHTRLVGTFGYMPPE- 657
V +HRD+KP+NIL +D++ ++ DFG AK + + T T ++ PE
Sbjct: 136 GV---VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCYTANFVAPEV 191
Query: 658 --YAQYGEVSPKIDVYAFGVVLYELIS 682
Y D+++ GV+LY +++
Sbjct: 192 LERQGYD---AACDIWSLGVLLYTMLT 215
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 37/212 (17%)
Query: 497 KIGQGGFGAVFYA-ELRGEKAAIKKMDMQASKEFLA--------------ELKVLTHVHH 541
I G +GAV + G AIK++ S E+++L H HH
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 542 LNLVRLIGYCVEGS------LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQ-IALDSAR 594
N++ L V L+LV E + +L Q + + ++ +Q
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH-DQRIVIS-PQHIQYFMYHILL 145
Query: 595 GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYM 654
GL +HE V +HRD+ P NIL+ N + DF LA+ + T V Y
Sbjct: 146 GLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLAREDTADANK--THYVTHRWYR 200
Query: 655 PPE----YAQYGEVSPKIDVYAFGVVLYELIS 682
PE + + + +D+++ G V+ E+ +
Sbjct: 201 APELVMQFKGF---TKLVDMWSAGCVMAEMFN 229
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 62/257 (24%), Positives = 106/257 (41%), Gaps = 27/257 (10%)
Query: 443 DHYIQHGPAIALVKNSESAALVAAP--GVTGITVDKSVEFSYEELAKAT-NDFSMGNKIG 499
+Y H + +E+ A G+ + S + + DF + IG
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIG 61
Query: 500 QGGFGAVFYAELRGEKA-----AIKKMDMQASKEF---LAELKVLTHV-HHLNLVRLIGY 550
+G + V L+ +KK + ++ E V +H LV L
Sbjct: 62 RGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-S 120
Query: 551 C--VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM---QIALDSARGLEYIHEHTVP 605
C E LF V EY+ G+L H++ K AR +I+L L Y+HE +
Sbjct: 121 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSAEISL----ALNYLHERGI- 174
Query: 606 VYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVS 665
I+RD+K N+L+D K+ D+G+ K + T GT Y+ PE + +
Sbjct: 175 --IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEILRGEDYG 231
Query: 666 PKIDVYAFGVVLYELIS 682
+D +A GV+++E+++
Sbjct: 232 FSVDWWALGVLMFEMMA 248
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 102 bits (254), Expect = 1e-22
Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 18/203 (8%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA-----AIKKMDMQASKEF---LAELKVLTHV-H 540
DF+ +G+G FG V +E +G +KK + + + E +VL
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 541 HLNLVRLIGYC--VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEY 598
L +L C L+ V EY+ G+L H++ G+ A A + A GL +
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH-AVFYAA-EIAIGLFF 457
Query: 599 IHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEY 658
+ + I+RD+K N+++D K+ADFG+ K + T GT Y+ PE
Sbjct: 458 LQSKGI---IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEI 513
Query: 659 AQYGEVSPKIDVYAFGVVLYELI 681
Y +D +AFGV+LYE++
Sbjct: 514 IAYQPYGKSVDWWAFGVLLYEML 536
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 489 TNDFSMGNK-IGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHV-HHLNL 544
T+D+ + + +G G G V R G+K A+K + S + E+ ++
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY--DSPKARQEVDHHWQASGGPHI 84
Query: 545 VRLIGYC-----VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYI 599
V ++ + L ++ E +E G L ++ G T +I D ++++
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 600 HEHTVPVYIHRDIKPANILI---DKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPP 656
H H + HRD+KP N+L +K+ K+ DFG AK T ++ T T Y+ P
Sbjct: 145 HSHNI---AHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN--ALQTP-CYTPYYVAP 198
Query: 657 E---YAQYGEVSPKIDVYAFGVVLYELIS 682
E +Y D+++ GV++Y L+
Sbjct: 199 EVLGPEKYD---KSCDMWSLGVIMYILLC 224
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-22
Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 33/212 (15%)
Query: 489 TNDFSMGNKIGQGGFGAVFYA--ELRGEKAAIKKMDMQASKEFLA-----ELKVLTHVHH 541
+ +G G +G+V A + GEK AIKK+ E A EL +L H+ H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 542 LNLVRLIGYCVEGS-------LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSAR 594
N++ L+ S +LV +++ +L + + + Q+ +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQML----K 137
Query: 595 GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYM 654
GL+YIH V +HRD+KP N+ ++++ K+ DFGLA+ + + T V T Y
Sbjct: 138 GLKYIHSAGV---VHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVVTRWYR 190
Query: 655 PPE----YAQYGEVSPKIDVYAFGVVLYELIS 682
PE + Y + +D+++ G ++ E+++
Sbjct: 191 APEVILSWMHY---NQTVDIWSVGCIMAEMLT 219
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 9e-22
Identities = 52/209 (24%), Positives = 91/209 (43%), Gaps = 26/209 (12%)
Query: 489 TNDFSMGNKIGQGGFGAVFYA--ELRGEKAAIKKM-----DMQASKEFLAELKVLTHVHH 541
+ IG G G V A + AIKK+ + +K EL ++ V+H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 542 LNLVRLIG-YCVEGS------LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIAL-DSA 593
N++ L+ + + S +++V E ++ NL Q ++ RM L
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDH-----ERMSYLLYQML 137
Query: 594 RGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGY 653
G++++H + IHRD+KP+NI++ + K+ DFGLA+ T V T Y
Sbjct: 138 CGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYY 192
Query: 654 MPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
PE +D+++ G ++ E+I
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIK 221
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 48/214 (22%)
Query: 494 MGNKIGQGGFGAVFYAE--LRGEKAAIKKMD-MQASKEFLA-----ELKVLTHVHHLNLV 545
+ +G+G FG V A +K A+K + K + E+ L + H +++
Sbjct: 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 546 RLIGYCV---EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSAR-------- 594
+L Y V + +V EY G L ++ RM D R
Sbjct: 73 KL--YDVITTPTDIVMVIEYA-GGELFDYIVEKK--------RMTE--DEGRRFFQQIIC 119
Query: 595 GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYM 654
+EY H H + +HRD+KP N+L+D N K+ADFGL+ + G+ + T G+ Y
Sbjct: 120 AIEYCHRHKI---VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-LKT-SCGSPNYA 174
Query: 655 PPE------YAQYGEVSPKIDVYAFGVVLYELIS 682
PE YA P++DV++ G+VLY ++
Sbjct: 175 APEVINGKLYA-----GPEVDVWSCGIVLYVMLV 203
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 34/213 (15%)
Query: 489 TNDFSMGNKIGQGGFGAVFYA--ELRGEKAAIKKM-----DMQASKEFLAELKVLTHVHH 541
+ +G G +GAV A G K AIKK+ +K EL++L H+ H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 542 LNLVRLI-------GYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQ-IALDSA 593
N++ L+ +LV ++ +L + ++ + L R+Q +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMK---HEKLG-EDRIQFLVYQML 138
Query: 594 RGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGY 653
+GL YIH + IHRD+KP N+ ++++ K+ DFGLA+ + S T V T Y
Sbjct: 139 KGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLAR----QADSEMTGYVVTRWY 191
Query: 654 MPPE----YAQYGEVSPKIDVYAFGVVLYELIS 682
PE + +Y + +D+++ G ++ E+I+
Sbjct: 192 RAPEVILNWMRY---TQTVDIWSVGCIMAEMIT 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-21
Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 38/217 (17%)
Query: 489 TNDFSMGNKIGQGGFGAVFYA--ELRGEKAAIKKM----DMQASKEFLAELKVLTHVHHL 542
++ + IG+G +G V A L + AIKK+ + L E+K+L H
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 543 NLVRLIGYCVEGS------LFLVYEYIENGNLNQHLRGSGKDTLTWSARM-----QIALD 591
N++ + + +++V + +E +L + L+ L+ + + QI
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLK---TQHLS-NDHICYFLYQIL-- 138
Query: 592 SARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT--EVGSASVHTRLVG 649
RGL+YIH V +HRD+KP+N+L++ K+ DFGLA++ + T V
Sbjct: 139 --RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 650 TFGYMPPE----YAQYGEVSPKIDVYAFGVVLYELIS 682
T Y PE Y + ID+++ G +L E++S
Sbjct: 194 TRWYRAPEIMLNSKGY---TKSIDIWSVGCILAEMLS 227
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 6e-21
Identities = 49/203 (24%), Positives = 84/203 (41%), Gaps = 24/203 (11%)
Query: 494 MGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHV-HHLNLVRLIG- 549
+G G G V + EK A+K + + E+++ ++VR++
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIVRIVDV 123
Query: 550 ----YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVP 605
Y L +V E ++ G L ++ G T +I ++Y+H +
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI- 182
Query: 606 VYIHRDIKPANILI---DKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE---YA 659
HRD+KP N+L N K+ DFG AK T + S+ T T Y+ PE
Sbjct: 183 --AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTP-CYTPYYVAPEVLGPE 238
Query: 660 QYGEVSPKIDVYAFGVVLYELIS 682
+Y D+++ GV++Y L+
Sbjct: 239 KYD---KSCDMWSLGVIMYILLC 258
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 46/211 (21%), Positives = 85/211 (40%), Gaps = 36/211 (17%)
Query: 498 IGQGGFGAVFYAELR--GEKAAIK---KMDMQASKEFLAELKVLTHV-HHLNLVRLIG-Y 550
+G+G V ++ A+K K E+++L H N++ LI +
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 551 CVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM--QIALDSARGLEYIHEHTVPVYI 608
E +LV+E + G++ H+ ++ + +A L+++H +
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVA----SALDFLHNKGI---A 133
Query: 609 HRDIKPANILI---DKNFRAKVADFGLAKLTEVGSASVHTR------LVGTFGYMPPE-- 657
HRD+KP NIL ++ K+ DF L ++ G+ YM PE
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 658 ------YAQYGEVSPKIDVYAFGVVLYELIS 682
+ Y + D+++ GV+LY L+S
Sbjct: 194 EAFSEEASIYD---KRCDLWSLGVILYILLS 221
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 2e-20
Identities = 50/208 (24%), Positives = 90/208 (43%), Gaps = 24/208 (11%)
Query: 489 TNDFSMGNKIGQGGFGAVFYA--ELRGEKAAIKKMDMQASKEFLA-----ELKVLTHVHH 541
+ IG G G V A + AIKK+ + A EL ++ V+H
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 542 LNLVRLI-------GYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSAR 594
N++ L+ ++LV E ++ NL Q ++ Q+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQML----C 175
Query: 595 GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYM 654
G++++H + IHRD+KP+NI++ + K+ DFGLA+ G++ + T V T Y
Sbjct: 176 GIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 230
Query: 655 PPEYAQYGEVSPKIDVYAFGVVLYELIS 682
PE +D+++ G ++ E++
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVR 258
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 39/222 (17%)
Query: 489 TNDFSMGNKIGQGGFGAVFYA--ELRGEKAAIKKM---DMQASKEFLAELKVLTHVHHLN 543
+ + +G GG G VF A ++ AIKK+ D Q+ K L E+K++ + H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 544 LVRLI---------------GYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQ- 587
+V++ S+++V EY+E +L L + L +
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLE---QGPLL-EEHARL 124
Query: 588 IALDSARGLEYIHEHTVPVYIHRDIKPANILID-KNFRAKVADFGLAKLT--EVGSASVH 644
RGL+YIH V +HRD+KPAN+ I+ ++ K+ DFGLA++
Sbjct: 125 FMYQLLRGLKYIHSANV---LHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181
Query: 645 TRLVGTFGYMPPE----YAQYGEVSPKIDVYAFGVVLYELIS 682
+ + T Y P Y + ID++A G + E+++
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNY---TKAIDMWAAGCIFAEMLT 220
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 56/213 (26%), Positives = 101/213 (47%), Gaps = 34/213 (15%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLA-----ELKVLTHVHH 541
+ + +G G +G+V A G + A+KK+ A EL++L H+ H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 542 LNLVRLI-----GYCVEG--SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQ-IALDSA 593
N++ L+ +E ++LV + +LN ++ LT +Q +
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQ---KLT-DDHVQFLIYQIL 142
Query: 594 RGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGY 653
RGL+YIH + IHRD+KP+N+ ++++ K+ DFGLA+ +A T V T Y
Sbjct: 143 RGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRWY 195
Query: 654 MPPE----YAQYGEVSPKIDVYAFGVVLYELIS 682
PE + Y + +D+++ G ++ EL++
Sbjct: 196 RAPEIMLNWMHY---NQTVDIWSVGCIMAELLT 225
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 7e-20
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 45/216 (20%)
Query: 497 KIGQGGFGAVFYA--ELRGEKAAIKKM----DMQASKEFLAELKVLTHVHHLNLVRLI-- 548
+G+G +G V A + GE AIKK+ + L E+K+L H H N++ +
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 549 ----GYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARM-----QIALDSARGLEYI 599
+ ++++ E ++ +L++ + L+ + Q L R ++ +
Sbjct: 78 QRPDSFENFNEVYIIQELMQT-DLHRVIST---QMLS-DDHIQYFIYQT-L---RAVKVL 128
Query: 600 HEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH---------TRLVGT 650
H V IHRD+KP+N+LI+ N KV DFGLA++ + +A V T
Sbjct: 129 HGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 651 FGYMPPE----YAQYGEVSPKIDVYAFGVVLYELIS 682
Y PE A+Y S +DV++ G +L EL
Sbjct: 186 RWYRAPEVMLTSAKY---SRAMDVWSCGCILAELFL 218
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-19
Identities = 39/157 (24%), Positives = 71/157 (45%), Gaps = 33/157 (21%)
Query: 497 KIGQGGFGAVFYA--ELRGEKAAIKKMDMQASKEFLA-----ELKVLTHVHHLNLVRLIG 549
IG G +G V A +L AIKK+ E+ +L ++H ++V+++
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119
Query: 550 YCVEGS------LFLVYEYIENGNLNQHLRGSGKD-------TLTWSARMQIALDSARGL 596
+ L++V E ++ + + R + TL + + G+
Sbjct: 120 IVIPKDVEKFDELYVVLEIADS-DFKKLFR-TPVYLTELHIKTLLY----NLL----VGV 169
Query: 597 EYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLA 633
+Y+H + +HRD+KPAN L++++ KV DFGLA
Sbjct: 170 KYVHSAGI---LHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 50/236 (21%), Positives = 95/236 (40%), Gaps = 49/236 (20%)
Query: 497 KIGQGGFGAVFYA--ELRGEKAAIKKMDMQASKEFLA-----ELKVLTHVHHLNLVRLIG 549
IG+G +G V+ A + + AIKK++ E+ +L + ++RL
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92
Query: 550 YCVEGS------LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQ-IALDSARGLEYIHEH 602
+ L++V E ++ +L + + + LT ++ I + G +IHE
Sbjct: 93 LIIPDDLLKFDELYIVLEIADS-DLKKLFK-TPIF-LT-EEHIKTILYNLLLGENFIHES 148
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFG---------- 652
+ IHRD+KPAN L++++ KV DFGLA+ + +
Sbjct: 149 GI---IHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK 205
Query: 653 -----------YMPPE----YAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNET 693
Y PE Y + ID+++ G + EL++ +++ +
Sbjct: 206 KQLTSHVVTRWYRAPELILLQENY---TKSIDIWSTGCIFAELLNMLQSHINDPTN 258
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 54/223 (24%), Positives = 98/223 (43%), Gaps = 47/223 (21%)
Query: 496 NKIGQGGFGAVFYA--ELRGEKAAIKKMDMQASKEFLA-----ELKVLTHVH-HLNLVRL 547
K+G+G +G V+ + GE A+KK+ A E+ +LT + H N+V L
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 548 IGYCVEGS---LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQ-IALDSARGLEYIHEHT 603
+ + ++LV++Y+E +L+ +R + L Q + + ++Y+H
Sbjct: 75 LNVLRADNDRDVYLVFDYMET-DLHAVIRA---NILE-PVHKQYVVYQLIKVIKYLHSGG 129
Query: 604 VPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRL---------------- 647
+ +HRD+KP+NIL++ KVADFGL++ +
Sbjct: 130 L---LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 648 ----VGTFGYMPPE----YAQYGEVSPKIDVYAFGVVLYELIS 682
V T Y PE +Y + ID+++ G +L E++
Sbjct: 187 LTDYVATRWYRAPEILLGSTKY---TKGIDMWSLGCILGEILC 226
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 34/173 (19%), Positives = 66/173 (38%), Gaps = 33/173 (19%)
Query: 490 NDFSMGNKIGQGGFGAVFYAE----------LRGEKAAIK-------------KMDMQAS 526
+ + + + G ++ A + +K ++K A
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 527 KEFLAELKVLTHVHHLNLVRLIGYCVEGSL--FLVYEYIENG-NLNQHLRGSGKDTLTWS 583
+ + K L L + +G+ V FLV + G +L L S K L+
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSER 159
Query: 584 ARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKV--ADFGLAK 634
+ +Q+A LE++HE+ Y+H ++ NI +D +++V A +G A
Sbjct: 160 SVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 8e-17
Identities = 43/200 (21%), Positives = 74/200 (37%), Gaps = 39/200 (19%)
Query: 494 MGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHV-HHLNLVRLIG- 549
+G G G V + EK A+K + + E+++ ++VR++
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIVRIVDV 79
Query: 550 ----YCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVP 605
Y L +V E ++ G L ++ G T +I ++Y+H +
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI- 138
Query: 606 VYIHRDIKPANILI---DKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYG 662
HRD+KP N+L N K+ DFG AK E Y
Sbjct: 139 --AHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTGEK------------------YD 176
Query: 663 EVSPKIDVYAFGVVLYELIS 682
D+++ GV++Y L+
Sbjct: 177 ---KSCDMWSLGVIMYILLC 193
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 47/218 (21%), Positives = 81/218 (37%), Gaps = 37/218 (16%)
Query: 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILID 620
+ + + + KD LT + + A+G+E++ IHRD+ NIL+
Sbjct: 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 227
Query: 621 KNFRAKVADFGLAKLTEVGS---ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVL 677
+ K+ DFGLA+ RL +M PE + + DV++FGV+L
Sbjct: 228 EKNVVKICDFGLARDIYKDPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLL 285
Query: 678 YELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDY----PIDS 733
+E+ S G P P + RL + P +
Sbjct: 286 WEIF---------------SLG---------ASPYPGVKIDEEFCRRLKEGTRMRAPDYT 321
Query: 734 VRKMARLARACTQENPQLRPSMRAIVVALMT-LSSSSE 770
+M + C P RP+ +V L L ++++
Sbjct: 322 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 359
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 9e-14
Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 14/98 (14%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRG-------EKAAIKKM----DMQASKEFLAELKVLTH 538
+ +G +G+G FG V A+ G A+K + + ++ELK+L H
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 539 V-HHLNLVRLIGYC--VEGSLFLVYEYIENGNLNQHLR 573
+ HHLN+V L+G C G L ++ E+ + GNL+ +LR
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR 119
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 51/210 (24%), Positives = 80/210 (38%), Gaps = 25/210 (11%)
Query: 490 NDFSMGNKIGQGGFGAVFYAE--LRGEKAAIKKMDMQASKEFLA-ELKVLTHVHHLNLV- 545
+ +G +IG+G FG +F L ++ AIK ++ L E + + +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 69
Query: 546 RLIGYCVEGSL-FLVYEYIENG-NLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT 603
+ + EG LV + + G +L L G+ + A ++ IHE +
Sbjct: 70 NVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKS 126
Query: 604 VPVYIHRDIKPANILIDKNFRAK-----VADFGLAKLTEVGSASVH------TRLVGTFG 652
++RDIKP N LI + V DFG+ K H L GT
Sbjct: 127 ---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 653 YMPPEYAQYG-EVSPKIDVYAFGVVLYELI 681
YM G E S + D+ A G V +
Sbjct: 184 YMSI-NTHLGREQSRRDDLEALGHVFMYFL 212
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 23/208 (11%)
Query: 490 NDFSMGNKIGQGGFGAVFYAE--LRGEKAAIKKMDMQASKEFLA-ELKVLTHVHHLNLV- 545
N F +G KIG G FG ++ E+ AIK +++ L E K+ + +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIP 66
Query: 546 RLIGYCVEGSL-FLVYEYIENG-NLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT 603
+ + VEG LV + + G +L + L+ + +A +E++H
Sbjct: 67 NVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSK- 122
Query: 604 VPVYIHRDIKPANILIDKNFRAK---VADFGLAKLTEVGSASVH------TRLVGTFGYM 654
++HRDIKP N L+ RA + DFGLAK S H L GT Y
Sbjct: 123 --SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 655 PPEYAQYG-EVSPKIDVYAFGVVLYELI 681
G E S + D+ + G VL +
Sbjct: 181 SV-NTHLGIEQSRRDDLESLGYVLMYFL 207
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 48/196 (24%), Positives = 78/196 (39%), Gaps = 40/196 (20%)
Query: 492 FSMGNKIGQGGFGAVFYAE--LRGEKAAIK--KMDMQASKEFLAELKVL----------- 536
+ +G KIG GGFG ++ A + EK A K++ Q + +ELK
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98
Query: 537 ----THVHHLNLVRLIGYCVEGSL-----FLVYEYIENG-NLNQHLRGSGKDTLTWSARM 586
+ +L + G + F+V E + G +L + +G S +
Sbjct: 99 WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGT--FKKSTVL 154
Query: 587 QIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKV--ADFGLAKLTEVGSASVH 644
Q+ + LEYIHE+ Y+H DIK AN+L+ +V AD+GL+
Sbjct: 155 QLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
Query: 645 TR------LVGTFGYM 654
+ GT +
Sbjct: 212 YQENPRKGHNGTIEFT 227
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 73.4 bits (179), Expect = 4e-14
Identities = 46/259 (17%), Positives = 74/259 (28%), Gaps = 74/259 (28%)
Query: 478 VEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKM-----------DMQAS 526
V FS+ T KIG+G FG VF AIK + +
Sbjct: 11 VPFSH---CLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTF 67
Query: 527 KEFLAELKVLTHVHHL---------NLVRLIG-YCVEGS--------------------- 555
+E L E+ + + L + L +CV+GS
Sbjct: 68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127
Query: 556 ---------LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPV 606
LF+V E+ G L + + I L
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEAS--LR 182
Query: 607 YIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRL--------------VGTFG 652
+ HRD+ N+L+ K K+ K + + S + + V
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDV 242
Query: 653 YMPPEYAQYGEVSPKIDVY 671
M + G+ + D+Y
Sbjct: 243 SMDEDLFT-GDGDYQFDIY 260
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 53/208 (25%), Positives = 80/208 (38%), Gaps = 23/208 (11%)
Query: 490 NDFSMGNKIGQGGFGAVFYAE--LRGEKAAIKKMDMQASKEFLA-ELKVLTHVHHLNLV- 545
N + +G KIG G FG ++ GE+ AIK ++ L E K+ + +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 68
Query: 546 RLIGYCVEGSL-FLVYEYIENG-NLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT 603
+ EG +V E + G +L + + + +A +EYIH
Sbjct: 69 TIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKN 125
Query: 604 VPVYIHRDIKPANILIDKNFRAK---VADFGLAKLTEVGSASVH------TRLVGTFGYM 654
+IHRD+KP N L+ + + DFGLAK H L GT Y
Sbjct: 126 ---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 655 PPEYAQYG-EVSPKIDVYAFGVVLYELI 681
G E S + D+ + G VL
Sbjct: 183 SI-NTHLGIEQSRRDDLESLGYVLMYFN 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 41/200 (20%), Positives = 73/200 (36%), Gaps = 41/200 (20%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDMQ--------------ASKE 528
+ +G IGQGGFG ++ A++ +K A E
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 529 FLAELKVLTHVHHLNLVRLIGYCVEGSL-----FLVYEYIENG-NLNQHLRGSGKDTLTW 582
+ + + +L + + G + F++ + G +L + + K +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAK-RFSR 151
Query: 583 SARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKV--ADFGLAKLTEVGS 640
+Q++L LEYIHEH Y+H DIK +N+L++ +V D+GLA
Sbjct: 152 KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 641 ASVH------TRLVGTFGYM 654
GT +
Sbjct: 209 VHKAYAADPKRCHDGTIEFT 228
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 53/210 (25%), Positives = 81/210 (38%), Gaps = 25/210 (11%)
Query: 490 NDFSMGNKIGQGGFGAVFYAE--LRGEKAAIKKMDMQASKEFLA-ELKVLTHVHH-LNLV 545
+F +G KIG G FG + + E AIK M++ L E + + +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 546 RLIGYCVEGSL-FLVYEYIENG-NLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT 603
++ + G +V E + G +L + T + + IA+ +EY+H
Sbjct: 69 QVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDR-TFSLKTVLMIAIQLISRMEYVHSKN 125
Query: 604 VPVYIHRDIKPANILI--DKNFRAKVA---DFGLAKLTEVGSASVH------TRLVGTFG 652
I+RD+KP N LI N +V DF LAK H L GT
Sbjct: 126 ---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTAR 182
Query: 653 YMPPEYAQYG-EVSPKIDVYAFGVVLYELI 681
YM G E S + D+ A G + +
Sbjct: 183 YMSI-NTHLGKEQSRRDDLEALGHMFMYFL 211
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 50/215 (23%), Positives = 88/215 (40%), Gaps = 39/215 (18%)
Query: 489 TNDFSMGNKIGQGGFGAVFYA--ELRGEKAAIK------KMDMQASKEFLAELKVLTHVH 540
+ + + + IG+G FG V A + E AIK QA E+++L ++
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMN 108
Query: 541 HL------NLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSA 593
+V L + + L LV+E + NL LR + ++ + + A
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 594 RGLEYIHEHTVPVYIHRDIKPANILIDKNFRA--KVADFGLAKLTEVGSASVHTRLVGTF 651
L ++ + + IH D+KP NIL+ R+ K+ DFG + ++ + F
Sbjct: 168 TALLFLATPELSI-IHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQRIYQYIQSRF 223
Query: 652 GYMPPE------YAQYGEVSPKIDVYAFGVVLYEL 680
Y PE Y ID+++ G +L E+
Sbjct: 224 -YRSPEVLLGMPY------DLAIDMWSLGCILVEM 251
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 47/200 (23%), Positives = 86/200 (43%), Gaps = 29/200 (14%)
Query: 498 IGQGGFGAVFYA--ELRGEKAAIK------KMDMQASKEFLAELKVLTHVHHL------N 543
IG+G FG V A + A+K + QA E+++L H+ N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTMN 160
Query: 544 LVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH 602
++ ++ + + +E + NL + ++ + + + A + L+ +H++
Sbjct: 161 VIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 603 TVPVYIHRDIKPANILIDKNFRA--KVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQ 660
+ IH D+KP NIL+ + R+ KV DFG + V+T + F Y PE
Sbjct: 220 RI---IHCDLKPENILLKQQGRSGIKVIDFGSSCYE---HQRVYTYIQSRF-YRAPEVIL 272
Query: 661 YGEVSPKIDVYAFGVVLYEL 680
ID+++ G +L EL
Sbjct: 273 GARYGMPIDMWSLGCILAEL 292
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 50/219 (22%), Positives = 96/219 (43%), Gaps = 47/219 (21%)
Query: 497 KIGQGGFGAVFYAE--LRGEKAAIK-----KMDMQASKEFLAELKVLTHVHHL------- 542
K+G G F V+ A+ + A+K K+ +A+++ E+K+L V+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNTKEDS 82
Query: 543 ----NLVRLIGY----CVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSA 593
++++L+ + G + +V+E + NL ++ + QI+
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLL 141
Query: 594 RGLEYIH-EHTVPVYIHRDIKPANILID------KNFRAKVADFGLAKLTEVGSASVHTR 646
GL+Y+H + IH DIKP N+L++ + K+AD G A + +T
Sbjct: 142 LGLDYMHRRCGI---IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD----EHYTN 194
Query: 647 LVGTFGYMPPE---YAQYGEVSPKIDVYAFGVVLYELIS 682
+ T Y PE A +G D+++ +++ELI+
Sbjct: 195 SIQTREYRSPEVLLGAPWG---CGADIWSTACLIFELIT 230
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 8e-08
Identities = 89/622 (14%), Positives = 164/622 (26%), Gaps = 191/622 (30%)
Query: 27 PTYISNIF-GEDIAQILLYNPNIPNQNTIPSDTRISIPFSCDCLNGDFLGHTFTYETQFG 85
+I E+I I+ + + F +
Sbjct: 39 QDMPKSILSKEEIDHII----MSKDA-----VSGTLRLFWTLLSKQ-----EEMVQKFVE 84
Query: 86 DTYEKVASFAFANLTTE--DWVRRVNIYEPTRIPDYAFINVTVNCSCGDRHISRDYGLFT 143
+ F + + TE +Y R Y N ++SR +
Sbjct: 85 EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLY-----NDNQVFAKYNVSRLQ-PYL 138
Query: 144 T-----YPLRPAQNL----------SSVAAEAGVAPQSLQRYNPGTNFSAGTGLVFVPAR 188
LRPA+N+ + VA + +Q +
Sbjct: 139 KLRQALLELRPAKNVLIDGVLGSGKTWVALDV-CLSYKVQCKMDF--------------K 183
Query: 189 VFELKL-------ALLLVLAFFCARRRVEAVAECSKGCDLALASYYLWKGANLTFISKVF 241
+F L L +L +L + + ++ L + + SK +
Sbjct: 184 IFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY 243
Query: 242 DTSIKYIL----------SFNPQ----ITNKDK-----ILAGTRINVP------------ 270
+ + +L +FN +T + K + A T ++
Sbjct: 244 ENCL-LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE 302
Query: 271 ----FSCNCIQNKFLGHSFS---YKVKSGN--TYKRIAELIYANLTTLDWLKSSNAYDEN 321
K+L +V + N IAE I L T D K N
Sbjct: 303 VKSLLL------KYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLT 356
Query: 322 HTPDVSSSVNVIVNCSCGSKSVSKDYGLF-----LTYPL-------RPGENLSSIANEFE 369
+ SS+NV+ + + +F + L ++ + N+
Sbjct: 357 TI--IESSLNVLE--PAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLH 412
Query: 370 LSSELLQSYNPTLDFISGSGLAFVPVKGISSRAIAGISIGGVAGAL---FLAFCVYAGVY 426
S + + + I + + + AL + Y
Sbjct: 413 KYSLVEKQPKESTISI--PSIYLELKVKLENEY-----------ALHRSIVDH------Y 453
Query: 427 RRNKVVEASFLPEASEDHYI-QHGPAIA--LVKNSESAALVAAPGVTGITVDKSVEFSYE 483
K ++ L D Y H I L KN E ++ F
Sbjct: 454 NIPKTFDSDDLIPPYLDQYFYSH---IGHHL-KNIEHP-------------ERMTLFRMV 496
Query: 484 ELAKATNDFS-MGNKI--------GQGGFGAVFYAELRGEKAAIKKMD------MQASKE 528
L DF + KI G +L+ K I D + A +
Sbjct: 497 FL-----DFRFLEQKIRHDSTAWNASGSILNTL-QQLKFYKPYICDNDPKYERLVNAILD 550
Query: 529 FLAELKVLTHVH---HLNLVRL 547
FL K+ ++ + +L+R+
Sbjct: 551 FL--PKIEENLICSKYTDLLRI 570
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.7 bits (128), Expect = 2e-07
Identities = 92/656 (14%), Positives = 181/656 (27%), Gaps = 200/656 (30%)
Query: 207 RRVEAVAECS---KGCDLALASYYL-W----KGANLT--FISKVFDTSIKYILSFNPQIT 256
+ + + E D + L W K + F+ +V + K+++S I
Sbjct: 43 KSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMS---PIK 99
Query: 257 NKDKILAGTRINVPFSCNCIQNKFLGHSFS-YKVKSGNTYKRIAELIYANLTTLDWL--- 312
+ + + + + N F+ Y V Y ++ + + L +
Sbjct: 100 TEQRQPSMMTRMYIEQRDRLYND--NQVFAKYNVSRLQPYLKLRQALL-ELRPAKNVLID 156
Query: 313 ------KSSNAYDENHTPDVSSSVNVIVNCSCGSKSVSK--DYGLF---LTYPLRPGENL 361
K+ + C S V D+ +F L P L
Sbjct: 157 GVLGSGKT-----------------WVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVL 199
Query: 362 SSIANEFELSSELLQSYNPTLDFISGSGLAFVPVKGISSRAIAGISIGGVAGALFL---- 417
+ L ++ ++ D S L ++ R + S L L
Sbjct: 200 EMLQK---LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLK--SKPYENCLLVLLNVQ 254
Query: 418 ------AF---CVYAGVYR-----RNKVVEASFLPEASEDHYIQHGPAIALVKNSESAAL 463
AF C + R K V FL A+ H ++ L E +L
Sbjct: 255 NAKAWNAFNLSC------KILLTTRFKQV-TDFLSAATTTHISLDHHSMTLTP-DEVKSL 306
Query: 464 VAAPGVTGITVDKSVEFSYEEL---AKATNDFSMGNKIGQGGFGAVFYAELRGEKA---- 516
+ K ++ ++L TN + ++ +R A
Sbjct: 307 LL----------KYLDCRPQDLPREVLTTNPRRL----------SIIAESIRDGLATWDN 346
Query: 517 ----AIKKMD--MQASKEFL--AELKVLTHVHHLNLVR---LIGYCVEGSLFLVYEYIEN 565
K+ +++S L AE + L++ I + ++ +
Sbjct: 347 WKHVNCDKLTTIIESSLNVLEPAEYR--KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV 404
Query: 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRA 625
+ L K +L + I I+ ++K
Sbjct: 405 MVVVNKLH---KYSL-------VEKQPKESTISIPS------IYLELK-----------V 437
Query: 626 KVADFGLAKLTEVGSASVHTRLVGTFGYMPPE-YAQYGEVSPKIDVYAFGVVLYELISAM 684
K+ + ++H +V Y P+ + + P +D Y + + + L +
Sbjct: 438 KLEN----------EYALHRSIVDH--YNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNI- 484
Query: 685 EAVVKTNETITESTGLVALFEEV----------LRQPDPREDLQRLVDPRLGD-----DY 729
E + LF V +R + + L Y
Sbjct: 485 -----------EHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPY 533
Query: 730 PIDSVRKMARLARAC------TQENPQLRPSMRAIVVALMTLSSSSEDWDIGSFYE 779
D+ K RL A +EN + +ALM + + +E
Sbjct: 534 ICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMA--------EDEAIFE 581
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 3e-04
Identities = 73/533 (13%), Positives = 149/533 (27%), Gaps = 123/533 (23%)
Query: 294 TYKRIAELIYANLT-------TLDWLK---SSNAYDE-NHTPDVSSSVNVIVNCSC--GS 340
YK I + D K S D + D S +
Sbjct: 17 QYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQE 76
Query: 341 KSVSKDYGLFLTYPLRPGEN--LSSIANEFELSSELLQSYNPTLDFISGSGLAFVPVKGI 398
+ V K F+ LR +S I E S + + Y D + F
Sbjct: 77 EMVQK----FVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYN-- 130
Query: 399 SSRAIAGISIGGVAGALFLAFCVYAGVYRRNKVVEASFLPEASEDHYIQHGPAIALVKNS 458
V R ++ L +A + ++ + +
Sbjct: 131 --------------------------VSRLQPYLK---LRQALLE--LRPAKNVLID--- 156
Query: 459 ESAALVAAPGVTGITVDKSVEFSYEELAKAT-NDFSMGNKIGQGGFGAVFYAELRGEKAA 517
GV G K+ +A + + K+ F +F+ L+ +
Sbjct: 157 ---------GVLGS--GKTW------VALDVCLSYKVQCKM---DFK-IFWLNLKNCNSP 195
Query: 518 IKKMDMQ------------ASKEFLAELKVLTHVHHLNLVRLI---GYCVEGSLFLVYEY 562
++M + + + +K+ H L RL+ Y E L LV
Sbjct: 196 ETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY--ENCL-LVLLN 252
Query: 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH---EHTVPVYIHRDIKPANILI 619
++N S K L + Q+ D H +H ++K ++L
Sbjct: 253 VQNAKAWNAFNLSCK-ILLTTRFKQVT-DFLSAATTTHISLDHHSMTLTPDEVK--SLL- 307
Query: 620 DKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVL-- 677
K D L + + R + + + ++ ++
Sbjct: 308 -----LKYLDCRPQDLPRE-VLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIES 361
Query: 678 -YELISAME--------AVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDD 728
++ E +V + I L ++ +V++ D + +L L +
Sbjct: 362 SLNVLEPAEYRKMFDRLSVFPPSAHIPTIL-LSLIWFDVIKS-DVMVVVNKLHKYSLVEK 419
Query: 729 YPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWDIGSFYENQ 781
P +S + + + ++ +V + + + D+ Y +Q
Sbjct: 420 QPKESTISIPSIYLELKVKLEN-EYALHRSIVDHYNIPKTFDSDDLIPPYLDQ 471
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 43/225 (19%), Positives = 79/225 (35%), Gaps = 55/225 (24%)
Query: 497 KIGQGGFGAVFYA--ELRGEKAAIK------KMDMQASKEFLAELKVLTHV-----HHLN 543
K+G G FG V + A+K K A E +L + ++ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97
Query: 544 LVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH 602
+V+ G + + L++E + +L + + + + ++ + L Y+ +
Sbjct: 98 IVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM 156
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV-----------------GSAS--- 642
++ H D+KP NIL+D + K G A+
Sbjct: 157 SL---THTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS 213
Query: 643 -VHTRLVGTFGYMPPE------YAQYGEVSPKIDVYAFGVVLYEL 680
H ++ T Y PE + D+++FG VL EL
Sbjct: 214 DYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAEL 252
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 8e-07
Identities = 43/221 (19%), Positives = 86/221 (38%), Gaps = 51/221 (23%)
Query: 497 KIGQGGFGAVFYA---ELRGEKAAIK------KMDMQASKEFLAELKVLTHVHHL----- 542
+G+G FG V + G A+K + A +E++VL H++
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNST 76
Query: 543 -NLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH 600
V+++ + G + +V+E + + ++ +G ++A + + ++H
Sbjct: 77 FRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH 135
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV-----------GSAS----VHT 645
+ + H D+KP NIL ++ + + + + GSA+ H+
Sbjct: 136 SNKL---THTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHS 192
Query: 646 RLVGTFGYMPPE------YAQYGEVSPKIDVYAFGVVLYEL 680
LV T Y PE + S DV++ G +L E
Sbjct: 193 TLVSTRHYRAPEVILALGW------SQPCDVWSIGCILIEY 227
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 44/221 (19%), Positives = 78/221 (35%), Gaps = 51/221 (23%)
Query: 497 KIGQGGFGAVFYA---ELRGEKAAIK------KMDMQASKEFLAELKVLTHVHHL----- 542
+G+G FG V + A+K K A E+ VL +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKENK 81
Query: 543 -NLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH 600
V + + G + + +E + N + L+ + +A L ++H
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH 140
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV-----------GSAS----VHT 645
E+ + H D+KP NIL + + + + + GSA+ HT
Sbjct: 141 ENQL---THTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHT 197
Query: 646 RLVGTFGYMPPE------YAQYGEVSPKIDVYAFGVVLYEL 680
+V T Y PPE + + DV++ G +L+E
Sbjct: 198 TIVATRHYRPPEVILELGW------AQPCDVWSIGCILFEY 232
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 53/295 (17%), Positives = 99/295 (33%), Gaps = 85/295 (28%)
Query: 497 KIGQGGFGAVFYAE--LRGEKAAIK--KMDMQASKEFLAELKVLTHVHHLN--------L 544
K+G G F V+ + + A+K K ++ L E+++L V + + +
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 545 VRLIGY-CVEGS----LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSAR----- 594
V+L+ + G + +V+E L + S + L +
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEV---------LGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154
Query: 595 ---GLEYIHEHTVPVYIHRDIKPANILI-------------------------------- 619
GL+Y+H IH DIKP NIL+
Sbjct: 155 VLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 620 ---------DKNFRAKVADFGLAKLTEVGSASV----HTRLVGTFGYMPPEYAQYGEVSP 666
K A+ K+ ++G+A T + T Y E +
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNT 272
Query: 667 KIDVYAFGVVLYELISAMEAV--VKTNETITESTGLVALFEEVLRQPDPREDLQR 719
D+++ + +EL + + + + E T +AL E+L + PR+ +
Sbjct: 273 PADIWSTACMAFELAT-GDYLFEPHSGEEYTRDEDHIALIIELLGKV-PRKLIVA 325
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 790 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4eby_A | 212 | Chitin elicitor receptor kinase 1; pathogen-associ | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4eby_A | 212 | Chitin elicitor receptor kinase 1; pathogen-associ | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.7 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.5 | |
| 2l9y_A | 167 | CVNH-LYSM lectin; carbohydrate, sugar binding prot | 99.38 | |
| 2l9y_A | 167 | CVNH-LYSM lectin; carbohydrate, sugar binding prot | 99.31 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 2gu1_A | 361 | Zinc peptidase; alpha/beta, beta barrel, structura | 99.11 | |
| 2gu1_A | 361 | Zinc peptidase; alpha/beta, beta barrel, structura | 99.0 | |
| 2djp_A | 77 | Hypothetical protein SB145; LYSM, structural genom | 98.95 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.89 | |
| 2djp_A | 77 | Hypothetical protein SB145; LYSM, structural genom | 98.88 | |
| 1e0g_A | 48 | Membrane-bound lytic murein transglycosylase D; ce | 98.86 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.85 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.84 | |
| 1e0g_A | 48 | Membrane-bound lytic murein transglycosylase D; ce | 98.83 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.54 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.29 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.21 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.18 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.16 | |
| 4a1k_A | 165 | Putative L, D-transpeptidase YKUD; transferase, pe | 97.98 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.94 | |
| 4a1k_A | 165 | Putative L, D-transpeptidase YKUD; transferase, pe | 97.87 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.78 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.66 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.63 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.54 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.28 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.08 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.98 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.84 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.82 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.72 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 96.53 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.51 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.51 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.13 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 96.07 | |
| 3slu_A | 371 | M23 peptidase domain protein; outer membrane, hydr | 95.75 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 95.7 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.6 | |
| 3slu_A | 371 | M23 peptidase domain protein; outer membrane, hydr | 95.49 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.3 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.92 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 94.22 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 91.97 | |
| 2l34_A | 33 | TYRO protein tyrosine kinase-binding protein; immu | 88.73 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.58 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.67 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=434.09 Aligned_cols=258 Identities=27% Similarity=0.499 Sum_probs=207.3
Q ss_pred hcCcccceeeeecCceEEEEEEECCceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEEEe
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYI 563 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e~~ 563 (790)
.++|.+.++||+|+||+||+|++++ .+|||.++. +..++|.+|+++|++++|||||+++|+|.++.++||||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy~ 113 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWC 113 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEcC
Confidence 4578889999999999999999875 589999863 3456799999999999999999999999888899999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc-c
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA-S 642 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~-~ 642 (790)
++|+|.++|+... ..++|..+++|+.|++.||+|||++++ |||||||+||||++++.+||+|||+|+....... .
T Consensus 114 ~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~I---iHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 114 EGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNI---IHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp SSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTC---BCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCc---cCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999999997653 369999999999999999999999998 9999999999999999999999999987643322 2
Q ss_pred cccccccCCCccchhcccC---CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 643 VHTRLVGTFGYMPPEYAQY---GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
......||+.|||||++.+ +.++.++|||||||+||||+||+.||...... ......+...
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--------~~~~~~~~~~-------- 253 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--------DQIIFMVGRG-------- 253 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--------HHHHHHHHTT--------
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--------HHHHHHHhcC--------
Confidence 3345689999999999864 46899999999999999999999999653321 1111122111
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
...+.+ ...+.+++..+.+|+.+||+.||++||||.||++.|+.+..+
T Consensus 254 ~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 254 YASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp CCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred CCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 111111 123345667899999999999999999999999999887543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-51 Score=438.76 Aligned_cols=257 Identities=28% Similarity=0.515 Sum_probs=206.8
Q ss_pred cCcccceeeeecCceEEEEEEEC-------CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFL 558 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~l 558 (790)
++|.+.++||+|+||.||+|++. +..||||+++. ...++|.+|+++|++++|||||+++|+|.++ ..||
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56888999999999999999864 56899999974 3456799999999999999999999999864 5899
Q ss_pred EEEEecCCChhhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcE
Q 046083 559 VYEYIENGNLNQHLRGSG-------------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRA 625 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~ 625 (790)
|||||++|+|.++|+... ..+++|.++++++.|+++||+|||++++ |||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~i---iHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCe---ecccccHhhEEECCCCcE
Confidence 999999999999997642 2369999999999999999999999998 999999999999999999
Q ss_pred EEEEeCCCcccccCCc-ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHH
Q 046083 626 KVADFGLAKLTEVGSA-SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVAL 703 (790)
Q Consensus 626 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 703 (790)
||+|||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||..... ...
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--------~~~ 269 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--------TEA 269 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--------HHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--------HHH
Confidence 9999999986643322 22345679999999999999999999999999999999999 8999865322 112
Q ss_pred HHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCcc
Q 046083 704 FEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSED 771 (790)
Q Consensus 704 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~ 771 (790)
...+... .....|..++.++.+|+.+||+.||++||||+||++.|+.+...+..
T Consensus 270 ~~~i~~g--------------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp~ 323 (329)
T 4aoj_A 270 IDCITQG--------------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 323 (329)
T ss_dssp HHHHHHT--------------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC-
T ss_pred HHHHHcC--------------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCcc
Confidence 2222211 11223445567899999999999999999999999999998776554
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=436.57 Aligned_cols=256 Identities=29% Similarity=0.529 Sum_probs=211.3
Q ss_pred cCcccceeeeecCceEEEEEEEC-------CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFL 558 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~l 558 (790)
++|.+.++||+|+||.||+|++. +..||||+++. ...++|.+|+++|++++|||||+++|+|.++ ..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56889999999999999999863 56799999974 3456799999999999999999999999864 5899
Q ss_pred EEEEecCCChhhhhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEE
Q 046083 559 VYEYIENGNLNQHLRGSG-----------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKV 627 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl 627 (790)
|||||++|+|.++|+..+ ...++|.++++++.|+++||+|||++++ +||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~i---iHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHF---VHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc---ccCccCHhhEEECCCCcEEE
Confidence 999999999999997642 3469999999999999999999999998 99999999999999999999
Q ss_pred EEeCCCcccccCCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHH
Q 046083 628 ADFGLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFE 705 (790)
Q Consensus 628 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 705 (790)
+|||+|+........ ......||+.|||||++.+..++.++|||||||+||||+| |+.||..... .....
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--------~~~~~ 241 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEVIE 241 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHH
Confidence 999999866433222 2233568999999999999999999999999999999999 8999965322 12222
Q ss_pred HHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCc
Q 046083 706 EVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770 (790)
Q Consensus 706 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~ 770 (790)
.+.... ....|..++.++.+|+.+||+.||++||||+||++.|+.+...+.
T Consensus 242 ~i~~~~--------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 242 CITQGR--------------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp HHHHTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred HHHcCC--------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 222211 122344566789999999999999999999999999998765443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-51 Score=434.60 Aligned_cols=251 Identities=25% Similarity=0.417 Sum_probs=208.4
Q ss_pred cCcccceeeeecCceEEEEEEEC-------CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLF 557 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~ 557 (790)
.++++.++||+|+||.||+|.+. ++.||||+++. ...++|.+|+.++++++|||||+++|+|.+. ..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34677899999999999999873 46899999964 2357899999999999999999999999854 589
Q ss_pred EEEEEecCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC
Q 046083 558 LVYEYIENGNLNQHLRGSG--------------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF 623 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~ 623 (790)
||||||++|+|.++|.... ...++|..+++++.|+++||+|||++++ |||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~i---iHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHV---VHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCC---CCCCccccceEECCCC
Confidence 9999999999999996532 2358999999999999999999999998 9999999999999999
Q ss_pred cEEEEEeCCCcccccCCc-ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchH
Q 046083 624 RAKVADFGLAKLTEVGSA-SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLV 701 (790)
Q Consensus 624 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~ 701 (790)
.+||+|||+++....... .......||+.|||||++.++.++.++|||||||+||||+| |+.||..... .
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--------~ 254 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--------Q 254 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--------H
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--------H
Confidence 999999999987643322 22344679999999999999999999999999999999999 8999865322 1
Q ss_pred HHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 702 ALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 702 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
.....+.. ......|.+++..+.+|+.+||+.||++||||+||++.|+..
T Consensus 255 ~~~~~i~~--------------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 255 DVVEMIRN--------------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHHT--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHc--------------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 12222221 111233556677899999999999999999999999999854
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=420.72 Aligned_cols=269 Identities=28% Similarity=0.436 Sum_probs=205.9
Q ss_pred cCcccceeeeecCceEEEEEEECCceEEEEEeChhhHHHHHHH--HHHHHhcCCCCCcceEEEEecC-----eEEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAE--LKVLTHVHHLNLVRLIGYCVEG-----SLFLVYEY 562 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~~~~~~~E--~~~l~~l~h~niv~l~g~~~~~-----~~~lv~e~ 562 (790)
++|.+.++||+|+||+||+|+++|+.||||+++....+++..| +..+.+++|||||+++|+|.+. .+||||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 4678899999999999999999999999999987766665544 5555678999999999998743 47999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceeecCCCCCCEEecCCCcEEEEEeCCCcccc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT-----VPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~ 637 (790)
|++|+|.++|+.. .++|..+.+++.|+++||+|||++. .+.|+||||||+||||+.++++||+|||+++...
T Consensus 83 ~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 83 HEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 9999999999864 4899999999999999999999872 2346999999999999999999999999998765
Q ss_pred cCCccc---ccccccCCCccchhcccCC------CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHH
Q 046083 638 VGSASV---HTRLVGTFGYMPPEYAQYG------EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVL 708 (790)
Q Consensus 638 ~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 708 (790)
...... .....||+.|||||++.+. .++.++|||||||+||||+||.+|+...........+. .
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~-------~ 232 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL-------V 232 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT-------S
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc-------c
Confidence 443221 2245799999999999754 46789999999999999999988875433211100000 0
Q ss_pred cCCCChhhh-hhhcCCcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 709 RQPDPREDL-QRLVDPRLGDDYP-----IDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 709 ~~~~~~~~l-~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
......+.+ ..+.+..++...| .+.+..+.+|+.+||+.||++||||.||++.|+++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 000001111 1222233333333 24667899999999999999999999999999988654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=430.42 Aligned_cols=264 Identities=27% Similarity=0.443 Sum_probs=215.3
Q ss_pred cCHHHHHHHhcCcccceeeeecCceEEEEEEECC-------ceEEEEEeCh----hhHHHHHHHHHHHHhcCC-CCCcce
Q 046083 480 FSYEELAKATNDFSMGNKIGQGGFGAVFYAELRG-------EKAAIKKMDM----QASKEFLAELKVLTHVHH-LNLVRL 547 (790)
Q Consensus 480 ~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~g-------~~vavK~~~~----~~~~~~~~E~~~l~~l~h-~niv~l 547 (790)
++..+++...++|++.+.||+|+||.||+|.+.+ +.||||.++. ...++|.+|+++|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4445566667889999999999999999998753 4799999864 334679999999999965 899999
Q ss_pred EEEEec--CeEEEEEEEecCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecC
Q 046083 548 IGYCVE--GSLFLVYEYIENGNLNQHLRGSG--------------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRD 611 (790)
Q Consensus 548 ~g~~~~--~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~d 611 (790)
+|+|.+ +.+++|||||++|+|.++|+... +..++|..++.++.|+++||+|||++++ ||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~i---iHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTC---CCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCe---ecCc
Confidence 999864 34899999999999999997532 2458999999999999999999999998 9999
Q ss_pred CCCCCEEecCCCcEEEEEeCCCcccccCCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccc
Q 046083 612 IKPANILIDKNFRAKVADFGLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVK 689 (790)
Q Consensus 612 lkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~ 689 (790)
|||+|||+++++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876443322 2344678999999999999999999999999999999998 8999965
Q ss_pred cccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 690 TNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
.... ......+.. ..+...|..++.++.+++.+||+.||++|||+.||+++|..+.+
T Consensus 291 ~~~~-------~~~~~~i~~--------------g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 291 VKID-------EEFCRRLKE--------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp CCCS-------HHHHHHHHH--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHH-------HHHHHHHHc--------------CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 3321 011111111 11123344556789999999999999999999999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=425.22 Aligned_cols=246 Identities=25% Similarity=0.428 Sum_probs=202.1
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYE 561 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e 561 (790)
++|++.+.||+|+||.||+|+.. |+.||||+++. ...+.+.+|+++|++++|||||++++++.+ +.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999986 88999999853 334679999999999999999999998875 56899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|+++|+|.++|.......+++..++.++.|++.||+|||++++ +||||||+||||+.++.+||+|||+|+......
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~I---iHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKI---LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTC---EETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCe---eeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 9999999999987665678999999999999999999999998 999999999999999999999999998764221
Q ss_pred ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhc
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 721 (790)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||.... ....+..+.....
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~~~~--------- 242 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS--------MKNLVLKIISGSF--------- 242 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHTCC---------
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHcCCC---------
Confidence 22334679999999999999999999999999999999999999996532 2223333332211
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 722 DPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 722 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
...+...+.++.+|+.+||+.||++|||++|++++
T Consensus 243 -----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 243 -----PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11223445678999999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=416.46 Aligned_cols=263 Identities=24% Similarity=0.406 Sum_probs=217.3
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
++|++.+.||+|+||+||+|+.. ++.||||.++.. ..+.+.+|+++|++++|||||++++++.+ +.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999986 889999999643 34568999999999999999999998875 4589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~I---iHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCC---ccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999998754 59999999999999999999999998 999999999999999999999999999765432
Q ss_pred c-ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 641 A-SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 641 ~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
. ......+||+.|||||++.+..++.++||||+||++|||++|+.||..... ...+..+....
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~~~-------- 250 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--------GLIFAKIIKLE-------- 250 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTC--------
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCC--------
Confidence 2 234457899999999999999999999999999999999999999964321 22333333221
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccCCcCCcccccccccccc
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWDIGSFYENQGLDSLMS 788 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~~~~~~~~~~~~~~~~~ 788 (790)
..+|...+.++.+|+.+||+.||++|||++|++..-+- ..+.||++-+|+.|..
T Consensus 251 -------~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i--------~~Hp~F~~idw~~l~~ 304 (311)
T 4aw0_A 251 -------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPL--------KAHPFFESVTWENLHQ 304 (311)
T ss_dssp -------CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHH--------HTSGGGTTCCCTTGGG
T ss_pred -------CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHH--------HCCCCcCCCCHHHhcC
Confidence 12233445678999999999999999999987543322 2355677777777653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=407.01 Aligned_cols=243 Identities=23% Similarity=0.406 Sum_probs=195.9
Q ss_pred cccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-----CeEEEE
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-----GSLFLV 559 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~lv 559 (790)
|++.++||+|+||+||+|.+. +..||+|++.. ...+.|.+|+++|++++|||||++++++.+ ..+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 356788999999999999986 78999999853 234679999999999999999999998753 237999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC-CCcEEEEEeCCCccccc
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK-NFRAKVADFGLAKLTEV 638 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~-~~~~kl~DfGla~~~~~ 638 (790)
||||++|+|.+++...+ .+++..+..++.|++.||+|||+++ ++|+||||||+||||+. ++.+||+|||+|+....
T Consensus 108 mEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999998653 5999999999999999999999998 22399999999999984 79999999999986432
Q ss_pred CCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 639 GSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
......+||+.|||||++.+ .++.++|||||||+||||+||+.||..... .......+.....+
T Consensus 185 ---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-------~~~~~~~i~~~~~~----- 248 (290)
T 3fpq_A 185 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVTSGVKP----- 248 (290)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHHHTTTCCC-----
T ss_pred ---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-------HHHHHHHHHcCCCC-----
Confidence 23345789999999999874 699999999999999999999999964322 11222222221111
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
...+...+.++.+|+.+||+.||++|||++|++++
T Consensus 249 --------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 249 --------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp --------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01112233568899999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=417.62 Aligned_cols=252 Identities=21% Similarity=0.308 Sum_probs=205.1
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecC
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIEN 565 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~ 565 (790)
.+.|++.++||+|+||.||+|+.. |+.||||+++.+.. +.+|+++|++++|||||++++++.+ +.+|||||||++
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 356888999999999999999986 88999999975432 3469999999999999999998875 468999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC-cEEEEEeCCCcccccCCcc--
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF-RAKVADFGLAKLTEVGSAS-- 642 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~-~~kl~DfGla~~~~~~~~~-- 642 (790)
|+|.++|+..+ .+++..+..++.|++.||+|||++++ |||||||+||||+.++ ++||+|||+|+........
T Consensus 135 g~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~I---iHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 135 GSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRI---LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp CBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTE---ECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---eecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 99999998754 59999999999999999999999997 9999999999999987 6999999999876533211
Q ss_pred --cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 643 --VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 643 --~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
.....+||+.|||||++.+..++.++|||||||++|||++|+.||...... . ....+.....+.
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~---~~~~i~~~~~~~------ 275 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG-----P---LCLKIASEPPPI------ 275 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS-----C---CHHHHHHSCCGG------
T ss_pred eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-----H---HHHHHHcCCCCc------
Confidence 122357999999999999999999999999999999999999999654321 1 111222221110
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
...+...+..+.+++.+||+.||++|||+.|++++|.....
T Consensus 276 ------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 276 ------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp ------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 11233455678999999999999999999999998876543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=413.57 Aligned_cols=247 Identities=23% Similarity=0.391 Sum_probs=206.5
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEe
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
+.|++.++||+|+||.||+|... |+.||||+++. ...+.+.+|+++|++++|||||++++++.+ +.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999986 88999999864 234568899999999999999999998874 5699999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
++|+|.+++... .+++..+..++.|++.||+|||++++ +||||||+||||+.++.+||+|||+++...... ..
T Consensus 154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~I---iHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 226 (346)
T 4fih_A 154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 226 (346)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CC
T ss_pred CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCc---ccccCCHHHEEECCCCCEEEecCcCceecCCCC-Cc
Confidence 999999999863 49999999999999999999999998 999999999999999999999999998764332 23
Q ss_pred ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 644 HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ...+..+.... .+
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~~~----------~~ 288 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIRDNL----------PP 288 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSS----------CC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHcCC----------CC
Confidence 3457899999999999999999999999999999999999999965322 12222222211 11
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.+ ..+...+.++.+|+.+||+.||++|||++|++++-+
T Consensus 289 ~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~ 326 (346)
T 4fih_A 289 RL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF 326 (346)
T ss_dssp CC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred CC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 11 112345567899999999999999999999987644
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=395.59 Aligned_cols=243 Identities=24% Similarity=0.401 Sum_probs=190.9
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh------hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
++|++.+.||+|+||.||+|... ++.||||.++. ...+.+.+|+++|++++|||||++++++.+ +..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999975 88999999853 234568999999999999999999998875 4689999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+ +|+|.+++...+ .+++..+..++.|++.||+|||++++ +||||||+|||++.++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~I---iHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKI---VHRDLKPENLLLDEHLNVKIADFGLSNIMTDG- 165 (275)
T ss_dssp ECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---ccccCChHHeEECCCCCEEEeecCCCeecCCC-
Confidence 999 679999998754 59999999999999999999999998 99999999999999999999999999865432
Q ss_pred cccccccccCCCccchhcccCCCC-CchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEV-SPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
.......||+.|||||++.+..+ +.++||||+||++|||++|+.||.... ....+..+.....
T Consensus 166 -~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~--------~~~~~~~i~~~~~------- 229 (275)
T 3hyh_A 166 -NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES--------IPVLFKNISNGVY------- 229 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCC-------
T ss_pred -CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcCCC-------
Confidence 22345689999999999998876 579999999999999999999996432 2223333322211
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.+|...+.++.+|+.+||+.||++|||++|++++-+
T Consensus 230 --------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw 265 (275)
T 3hyh_A 230 --------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDW 265 (275)
T ss_dssp --------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHH
T ss_pred --------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcc
Confidence 122334567889999999999999999999998644
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=415.23 Aligned_cols=247 Identities=23% Similarity=0.391 Sum_probs=206.3
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEe
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
+.|++.++||+|+||.||+|... |+.||||+++. ...+.+.+|+++|++++|||||++++++.+ +.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999986 88999999853 334568899999999999999999998874 5699999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
++|+|.+++... .+++..+..++.|++.||+|||++++ |||||||+||||+.++.+||+|||+|+.+.... ..
T Consensus 231 ~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~I---iHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 303 (423)
T 4fie_A 231 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 303 (423)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CC
T ss_pred CCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCe---ecccCCHHHEEEcCCCCEEEecCccceECCCCC-cc
Confidence 999999999754 48999999999999999999999998 999999999999999999999999998764332 23
Q ss_pred ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 644 HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ...+..+.... .+
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~~~----------~~ 365 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIRDNL----------PP 365 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSC----------CC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHcCC----------CC
Confidence 3457899999999999999999999999999999999999999965322 12222222211 11
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.+ ........++.+|+.+||+.||++|||++|++++-+
T Consensus 366 ~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~ 403 (423)
T 4fie_A 366 RL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF 403 (423)
T ss_dssp CC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred CC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHH
Confidence 11 112234567899999999999999999999987644
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=405.26 Aligned_cols=242 Identities=25% Similarity=0.357 Sum_probs=194.5
Q ss_pred cCcccceeeeecCceEEEEEEEC-----CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR-----GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFL 558 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~-----g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~l 558 (790)
++|++.+.||+|+||+||+|+.. ++.||||.++.. ....+.+|+++|++++|||||++++++.+ +..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999862 578999998632 23468899999999999999999998874 56999
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
||||+++|+|.+++...+ .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~I---iHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTC---CCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCC---cCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999998754 59999999999999999999999998 9999999999999999999999999986533
Q ss_pred CCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 639 GSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
.. ......+||+.|||||++.+..++.++|||||||++|||++|+.||...+. ......+....
T Consensus 179 ~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~~~------- 242 (304)
T 3ubd_A 179 HE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR--------KETMTMILKAK------- 242 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-------
T ss_pred CC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH--------HHHHHHHHcCC-------
Confidence 22 223457899999999999999999999999999999999999999965322 22233333221
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPS-----MRAIVV 760 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 760 (790)
..+|...+.++.+|+.+||+.||++||| ++|+++
T Consensus 243 --------~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 243 --------LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred --------CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1223345567899999999999999998 456654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=393.50 Aligned_cols=245 Identities=27% Similarity=0.431 Sum_probs=186.5
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC---------
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG--------- 554 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------- 554 (790)
++|++.+.||+|+||.||+|+.. |+.||||+++. ...+.+.+|+++|++++|||||++++++.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999986 88999999853 2346789999999999999999999987532
Q ss_pred ----eEEEEEEEecCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEE
Q 046083 555 ----SLFLVYEYIENGNLNQHLRGSGK-DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVAD 629 (790)
Q Consensus 555 ----~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~D 629 (790)
.+|+||||+++|+|.+++..... ...++..++.++.|++.||+|||++++ +||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~I---iHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGL---MHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcC---ccccCcHHHeEECCCCcEEEcc
Confidence 26899999999999999987543 346778889999999999999999998 9999999999999999999999
Q ss_pred eCCCcccccCCcc-----------cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCcccccccccccccc
Q 046083 630 FGLAKLTEVGSAS-----------VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITEST 698 (790)
Q Consensus 630 fGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~ 698 (790)
||+|+........ ..+..+||+.|||||++.+..++.++|||||||++|||++ ||....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~------- 231 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM------- 231 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-------
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-------
Confidence 9999876533211 1233579999999999999999999999999999999996 553211
Q ss_pred chHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 699 GLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
..............+ .........+.+|+.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~p--------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 232 ERVRTLTDVRNLKFP--------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHHHHHHTTCCC--------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHhcCCCC--------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111111111100 0011233456789999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=384.57 Aligned_cols=265 Identities=28% Similarity=0.404 Sum_probs=202.4
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-------C
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-------G 554 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------~ 554 (790)
.++|++.+.||+|+||+||+|... |+.||||+++. ...+.+.+|+++|++++|||||++++++.. +
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 367999999999999999999986 89999999963 234568899999999999999999998752 3
Q ss_pred eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCc
Q 046083 555 SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK 634 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~ 634 (790)
.+|||||||+ |+|.+++...+ .+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~i---iHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQV---IHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcC---cCCCcCccccccCCCCCEEEeecceee
Confidence 5899999996 68999998654 69999999999999999999999998 999999999999999999999999998
Q ss_pred ccccCC---cccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcC
Q 046083 635 LTEVGS---ASVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQ 710 (790)
Q Consensus 635 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 710 (790)
.+.... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||...+.. +...........
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-----~~l~~I~~~~g~ 281 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-----HQLQLIMMVLGT 281 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-----HHHHHHHHHHCC
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-----HHHHHHHHhcCC
Confidence 654322 2223457899999999998875 5699999999999999999999999654321 111111122221
Q ss_pred CCChh-------hhhhh---cCCcCCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 711 PDPRE-------DLQRL---VDPRLGDD---YPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 711 ~~~~~-------~l~~~---~d~~l~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
+.... ..... +.+..... .......++.+|+.+||+.||++|||++|++++-+-
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 348 (398)
T 4b99_A 282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 348 (398)
T ss_dssp CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhh
Confidence 11100 00000 00000000 001234578899999999999999999999987553
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=378.06 Aligned_cols=200 Identities=26% Similarity=0.411 Sum_probs=169.2
Q ss_pred HHHHHhcCcccceeeeecCceEEEEEEEC-----CceEEEEEeCh-hhHHHHHHHHHHHHhc-CCCCCcceEEEEec-Ce
Q 046083 484 ELAKATNDFSMGNKIGQGGFGAVFYAELR-----GEKAAIKKMDM-QASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GS 555 (790)
Q Consensus 484 ~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~-----g~~vavK~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~ 555 (790)
.+....++|++.++||+|+||+||+|+.+ ++.||+|++.. .....+.+|+++|+.+ +||||+++++++.+ +.
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 33345678999999999999999999763 56899998864 3445688999999998 69999999998874 56
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC-CcEEEEEeCCCc
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN-FRAKVADFGLAK 634 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~-~~~kl~DfGla~ 634 (790)
.|+||||+++|+|.+++. .+++..+..++.|++.||+|||++++ +||||||+|||++.+ +.+||+|||+|+
T Consensus 95 ~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gI---iHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGI---VHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCe---EeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 899999999999999995 38999999999999999999999998 999999999999877 799999999998
Q ss_pred ccccCCc---------------------------ccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCcc
Q 046083 635 LTEVGSA---------------------------SVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEA 686 (790)
Q Consensus 635 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p 686 (790)
....... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 6543211 112235799999999999775 589999999999999999999999
Q ss_pred ccccc
Q 046083 687 VVKTN 691 (790)
Q Consensus 687 ~~~~~ 691 (790)
|....
T Consensus 247 f~~~~ 251 (361)
T 4f9c_A 247 FYKAS 251 (361)
T ss_dssp SSCCS
T ss_pred CCCCC
Confidence 96543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=373.94 Aligned_cols=285 Identities=38% Similarity=0.633 Sum_probs=237.7
Q ss_pred cccccCHHHHHHHhcCcccceeeeecCceEEEEEEEC-CceEEEEEeChhhH----HHHHHHHHHHHhcCCCCCcceEEE
Q 046083 476 KSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQAS----KEFLAELKVLTHVHHLNLVRLIGY 550 (790)
Q Consensus 476 ~~~~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~~~----~~~~~E~~~l~~l~h~niv~l~g~ 550 (790)
....+++.++....++|++.+.||+|+||.||+|... ++.+|||++..... ..+.+|++++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 3457899999999999999999999999999999875 88999999875432 368999999999999999999999
Q ss_pred Eec-CeEEEEEEEecCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCCCCCEEecCCCc
Q 046083 551 CVE-GSLFLVYEYIENGNLNQHLRGSG--KDTLTWSARMQIALDSARGLEYIHEH---TVPVYIHRDIKPANILIDKNFR 624 (790)
Q Consensus 551 ~~~-~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~---~~~~~vH~dlkp~NILl~~~~~ 624 (790)
+.+ ...++||||+++|+|.+++.... ...+++..+..++.+++.||.|||++ ++ +||||||+|||++.++.
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i---vH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI---IHRDVKAANILLDEEFE 172 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCE---ECCCCSGGGEEECTTCC
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe---EeCCCchhhEEECCCCC
Confidence 875 45899999999999999998653 24599999999999999999999999 66 99999999999999999
Q ss_pred EEEEEeCCCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHH
Q 046083 625 AKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALF 704 (790)
Q Consensus 625 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 704 (790)
+||+|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||...............
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-- 250 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD-- 250 (326)
T ss_dssp EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH--
T ss_pred EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH--
Confidence 999999999877554444445567999999999998889999999999999999999999999643322112222222
Q ss_pred HHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 705 EEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 705 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
+.........+..+.+..+...++.+.+..+.+++.+||+.||.+|||++||+++|+....
T Consensus 251 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 251 --WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp --HHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred --HHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 2222223344566677777777888999999999999999999999999999999987433
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=394.00 Aligned_cols=247 Identities=25% Similarity=0.337 Sum_probs=199.7
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhhH------HHHH---HHHHHHHhcCCCCCcceEEEEec-CeE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS------KEFL---AELKVLTHVHHLNLVRLIGYCVE-GSL 556 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~------~~~~---~E~~~l~~l~h~niv~l~g~~~~-~~~ 556 (790)
.++|++.+.||+|+||.||+|+.. |+.||+|+++.... ..+. .++.+++.++|||||++++++.+ +.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 467999999999999999999986 88999999964321 2233 34666777899999999998875 569
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
||||||++||+|.++|...+ .+++..+..++.||+.||+|||++++ |||||||+||||+.+|.+||+|||+|+..
T Consensus 268 ylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~gI---iHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTTE---ECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999998754 59999999999999999999999998 99999999999999999999999999876
Q ss_pred ccCCcccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChh
Q 046083 637 EVGSASVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715 (790)
Q Consensus 637 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (790)
... .....+||+.|||||++.. ..|+.++|||||||+||||++|+.||...... +............
T Consensus 343 ~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~-----~~~~i~~~i~~~~---- 410 (689)
T 3v5w_A 343 SKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEIDRMTLTMA---- 410 (689)
T ss_dssp SSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC-----CHHHHHHHHHHCC----
T ss_pred CCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHhhcCCC----
Confidence 432 2334689999999999974 57999999999999999999999999653321 1122222222211
Q ss_pred hhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 046083 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPS-----MRAIVVALM 763 (790)
Q Consensus 716 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~L~ 763 (790)
..+|...+.++.+|+.+||+.||.+|++ ++||+++-+
T Consensus 411 -----------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf 452 (689)
T 3v5w_A 411 -----------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452 (689)
T ss_dssp -----------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred -----------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence 1233345567899999999999999998 678766443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=368.50 Aligned_cols=285 Identities=38% Similarity=0.650 Sum_probs=233.5
Q ss_pred ccCHHHHHHHhcCcccceeeeecCceEEEEEEEC-CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec-
Q 046083 479 EFSYEELAKATNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE- 553 (790)
Q Consensus 479 ~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~- 553 (790)
.+++.++...+++|++.+.||+|+||.||+|.+. ++.+|||++.. ...+.+.+|++++++++||||+++++++.+
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 4555666778899999999999999999999986 88999999864 345678999999999999999999999875
Q ss_pred CeEEEEEEEecCCChhhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeC
Q 046083 554 GSLFLVYEYIENGNLNQHLRGSGK--DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFG 631 (790)
Q Consensus 554 ~~~~lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfG 631 (790)
+..++||||+++|+|.+++..... ..++|..+++++.|++.||.|||++++ +||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i---vH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI---IHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCe---ecCCCCHHHEEECCCCCEEEeecc
Confidence 458999999999999999976542 359999999999999999999999997 999999999999999999999999
Q ss_pred CCcccccCCc-ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcC
Q 046083 632 LAKLTEVGSA-SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQ 710 (790)
Q Consensus 632 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 710 (790)
+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... +......+.......
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~ 262 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR--EMVNLAEWAVESHNN 262 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS--SCCCHHHHTHHHHTT
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH--HHHHHHHHhhhcccc
Confidence 9986543222 2223456899999999999889999999999999999999999999754432 122222222222221
Q ss_pred CCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccC
Q 046083 711 PDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDW 772 (790)
Q Consensus 711 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~ 772 (790)
..+...+++.+....+.+.+..+.+++.+||+.||++|||++|+++.|+.+...++.|
T Consensus 263 ----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~~~ 320 (321)
T 2qkw_B 263 ----GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQESV 320 (321)
T ss_dssp ----TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSCCC
T ss_pred ----ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcccCc
Confidence 2344556666666778889999999999999999999999999999999887665543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=392.77 Aligned_cols=250 Identities=20% Similarity=0.324 Sum_probs=205.6
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
.++|++.+.||+|+||.||+|..+ |+.||+|.+.. ...+.+.+|+++|+.++|||||++++++.+ ..+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999986 88999998853 344668899999999999999999998875 468999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC--CcEEEEEeCCCcccccCC
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN--FRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~--~~~kl~DfGla~~~~~~~ 640 (790)
|++|+|.++|.... ..+++..+..++.||+.||.|||++++ +||||||+|||++.+ +.+||+|||+++.+....
T Consensus 236 ~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~i---iHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 236 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNY---VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred cCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCe---eeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999997543 359999999999999999999999998 999999999999854 899999999999765332
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
.....+||+.|||||++.+..++.++|||||||++|||++|+.||..... ...+..+......
T Consensus 312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--------~~~~~~i~~~~~~------- 374 (573)
T 3uto_A 312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRNVKSCDWN------- 374 (573)
T ss_dssp --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHTTCCC-------
T ss_pred --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHhCCCC-------
Confidence 23446899999999999999999999999999999999999999965332 2222333222110
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
...........++.+|+.+||+.||.+|||+.|++++-+
T Consensus 375 ----~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw 413 (573)
T 3uto_A 375 ----MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 413 (573)
T ss_dssp ----CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred ----CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence 011111233467889999999999999999999988643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=357.67 Aligned_cols=256 Identities=31% Similarity=0.514 Sum_probs=202.6
Q ss_pred HhcCcccceeeeecCceEEEEEEECCceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEE
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYE 561 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e 561 (790)
..++|++.+.||+|+||.||+|+..+..+|||.+.. ...+++.+|++++++++||||+++++++.+ +..++|||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 356799999999999999999999999999999853 334678999999999999999999999875 45899999
Q ss_pred EecCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--CCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 562 YIENGNLNQHLRGSGK-DTLTWSARMQIALDSARGLEYIHEHT--VPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
|+++|+|.+++..... ..+++..++.++.|++.||+|||+++ + +||||||+|||++.++.+||+|||+++....
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~i---vH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI---VHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCC---CCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCE---ECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 9999999999986542 34899999999999999999999999 7 9999999999999999999999999985433
Q ss_pred CCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 639 GSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .........
T Consensus 192 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--------~~~~~~~~~-------- 254 (309)
T 3p86_A 192 TF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--------QVVAAVGFK-------- 254 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--------HHHHHHHHS--------
T ss_pred cc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhc--------
Confidence 21 1223467899999999999999999999999999999999999999653321 111111100
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
......+...+..+.+++.+||+.||.+|||++|+++.|+.+...
T Consensus 255 -----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 255 -----CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp -----CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred -----CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 111223344556789999999999999999999999999987654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=348.28 Aligned_cols=278 Identities=37% Similarity=0.664 Sum_probs=228.6
Q ss_pred cccCHHHHHHHhcCcccc------eeeeecCceEEEEEEECCceEEEEEeCh-------hhHHHHHHHHHHHHhcCCCCC
Q 046083 478 VEFSYEELAKATNDFSMG------NKIGQGGFGAVFYAELRGEKAAIKKMDM-------QASKEFLAELKVLTHVHHLNL 544 (790)
Q Consensus 478 ~~~~~~~l~~~~~~f~~~------~~lG~G~fg~Vy~a~~~g~~vavK~~~~-------~~~~~~~~E~~~l~~l~h~ni 544 (790)
..|++.++..++++|... +.||+|+||.||+|...++.+|+|++.. ...+.+.+|++++++++||||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 92 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe
Confidence 468999999999999877 8999999999999999999999999853 234678999999999999999
Q ss_pred cceEEEEecC-eEEEEEEEecCCChhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC
Q 046083 545 VRLIGYCVEG-SLFLVYEYIENGNLNQHLRGSG-KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN 622 (790)
Q Consensus 545 v~l~g~~~~~-~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~ 622 (790)
+++++++.+. ..++||||+++++|.+++.... ...+++..++.++.+++.||.|||++++ +||||||+|||++.+
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i---~H~dlkp~Nili~~~ 169 (307)
T 2nru_A 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEA 169 (307)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCGGGEEECTT
T ss_pred EEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCe---ecCCCCHHHEEEcCC
Confidence 9999998754 5899999999999999997532 3469999999999999999999999997 999999999999999
Q ss_pred CcEEEEEeCCCcccccCCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchH
Q 046083 623 FRAKVADFGLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLV 701 (790)
Q Consensus 623 ~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~ 701 (790)
+.+||+|||+++........ ......|++.|+|||.+.+ .++.++||||||+++|||++|..||...... ....
T Consensus 170 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~ 244 (307)
T 2nru_A 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP----QLLL 244 (307)
T ss_dssp CCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS----SBTT
T ss_pred CcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch----HHHH
Confidence 99999999999865433222 2234578999999998874 5899999999999999999999999754332 1122
Q ss_pred HHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 702 ALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 702 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
.+........ ..+...+++.+ ...+...+..+.+++.+||+.||.+|||+++|++.|+.+..
T Consensus 245 ~~~~~~~~~~---~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 245 DIKEEIEDEE---KTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHTTS---CCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHhhhhh---hhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 2222222221 23455555554 34567788899999999999999999999999999998765
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=360.26 Aligned_cols=267 Identities=30% Similarity=0.445 Sum_probs=208.8
Q ss_pred hcCcccceeeeecCceEEEEEEECCceEEEEEeChhhH--HHHHHHHHHHHhcCCCCCcceEEEEecC-----eEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQAS--KEFLAELKVLTHVHHLNLVRLIGYCVEG-----SLFLVYE 561 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~~--~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~lv~e 561 (790)
.++|++.+.||+|+||.||+|++.++.||||++..... ..+..|+.++++++||||+++++++.+. ..++|||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e 102 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA 102 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence 46799999999999999999999999999999975443 3456688889999999999999998743 2699999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCceeecCCCCCCEEecCCCcEEEEEeC
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH----------TVPVYIHRDIKPANILIDKNFRAKVADFG 631 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----------~~~~~vH~dlkp~NILl~~~~~~kl~DfG 631 (790)
|+++|+|.+++... .+++..+++++.|++.||+|||+. ++ +||||||+|||++.++.+||+|||
T Consensus 103 ~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~i---vH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 103 FHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAI---SHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp CCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEE---ECSCCSGGGEEECTTCCEEECCCT
T ss_pred cCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCE---EeCCCChHhEEECCCCeEEEccCC
Confidence 99999999999864 499999999999999999999998 76 999999999999999999999999
Q ss_pred CCcccccCCcc-cccccccCCCccchhcccCC-----CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHH
Q 046083 632 LAKLTEVGSAS-VHTRLVGTFGYMPPEYAQYG-----EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFE 705 (790)
Q Consensus 632 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 705 (790)
+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... .+.
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------~~~ 250 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML------PFE 250 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC------TTH
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc------chh
Confidence 99876543222 22335789999999999863 4567899999999999999999999754332110 011
Q ss_pred HHHcCCCChhhhhhhc-CCcCCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 706 EVLRQPDPREDLQRLV-DPRLGDDY-----PIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 706 ~~~~~~~~~~~l~~~~-d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
...........+.+.+ ........ +...+.++.+|+.+||+.||++|||++||++.|+++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111111112222211 11111111 12456779999999999999999999999999998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=379.10 Aligned_cols=257 Identities=24% Similarity=0.448 Sum_probs=213.5
Q ss_pred HhcCcccceeeeecCceEEEEEEEC-CceEEEEEeChh--hHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEEEec
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ--ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIE 564 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e~~~ 564 (790)
..++|.+.+.||+|+||.||+|.+. +..||||.++.. ..++|.+|+++|++++||||+++++++.+...++||||++
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e~~~ 265 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMA 265 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEECCCT
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEeecC
Confidence 4567899999999999999999987 778999999753 4678999999999999999999999998778999999999
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccc
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH 644 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 644 (790)
+|+|.++++......+++..+++++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++..........
T Consensus 266 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i---vHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 342 (454)
T 1qcf_A 266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 342 (454)
T ss_dssp TCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTC---CCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTT
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCc---cCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceecc
Confidence 9999999986543468999999999999999999999998 9999999999999999999999999987543222222
Q ss_pred cccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 645 TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
....++..|+|||.+....++.++|||||||++|||++ |+.||..... ......+...
T Consensus 343 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i~~~------------- 401 (454)
T 1qcf_A 343 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PEVIRALERG------------- 401 (454)
T ss_dssp CSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHHHHHHT-------------
T ss_pred CCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcC-------------
Confidence 23456788999999998999999999999999999999 9999864321 1111121111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCC
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSS 769 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~ 769 (790)
.....+..++..+.+++.+||+.||++|||+++|++.|+.+....
T Consensus 402 -~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 402 -YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 111223445678999999999999999999999999999876543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=355.52 Aligned_cols=256 Identities=29% Similarity=0.480 Sum_probs=207.4
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
.++|.+.+.||+|+||.||+|.+. ++.+|+|.+.. ...+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 357889999999999999999986 88999998853 445679999999999999999999999875 468999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+++++|.+++.... ..+++..++.++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++........
T Consensus 89 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i---vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 89 IKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNI---IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCc---cCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 99999999998743 369999999999999999999999997 99999999999999999999999999866433221
Q ss_pred c-------------ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHc
Q 046083 643 V-------------HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLR 709 (790)
Q Consensus 643 ~-------------~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 709 (790)
. .....||+.|+|||.+.+..++.++||||||+++|||++|..|+............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~---------- 234 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL---------- 234 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB----------
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh----------
Confidence 1 11457899999999999999999999999999999999999988654332111110
Q ss_pred CCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 710 QPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 710 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
......+... +...+..+.+++.+||+.||++|||++|+++.|+.+...
T Consensus 235 ------~~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 235 ------NVRGFLDRYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp ------CHHHHHHHTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------hhhccccccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0111111111 122334688999999999999999999999999987543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=362.26 Aligned_cols=254 Identities=26% Similarity=0.476 Sum_probs=207.9
Q ss_pred hcCcccceeeeecCceEEEEEEEC---------CceEEEEEeChh----hHHHHHHHHHHHHhc-CCCCCcceEEEEec-
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR---------GEKAAIKKMDMQ----ASKEFLAELKVLTHV-HHLNLVRLIGYCVE- 553 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~---------g~~vavK~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~g~~~~- 553 (790)
.++|++.+.||+|+||.||+|++. +..||||.++.. ..+++.+|+++++++ +||||+++++++.+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467999999999999999999863 346999999642 346789999999999 89999999999875
Q ss_pred CeEEEEEEEecCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe
Q 046083 554 GSLFLVYEYIENGNLNQHLRGSGK--------------DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI 619 (790)
Q Consensus 554 ~~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl 619 (790)
+..|+||||+++|+|.+++..... ..+++..++.++.|++.||+|||++++ +||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i---vHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCe---eccccchhhEEE
Confidence 458999999999999999986432 358999999999999999999999997 999999999999
Q ss_pred cCCCcEEEEEeCCCcccccCCc-ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccc
Q 046083 620 DKNFRAKVADFGLAKLTEVGSA-SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITES 697 (790)
Q Consensus 620 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~ 697 (790)
+.++.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---- 312 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---- 312 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence 9999999999999986543222 12233457889999999999999999999999999999999 99998643211
Q ss_pred cchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 698 TGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
.....+.. ......+..++..+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 313 ----~~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 313 ----ELFKLLKE--------------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp ----GHHHHHHT--------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHHhc--------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111111 11122344556789999999999999999999999999998754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=349.26 Aligned_cols=259 Identities=26% Similarity=0.433 Sum_probs=205.3
Q ss_pred hcCcccceeeeecCceEEEEEEECCceEEEEEeChhhHHHHHHHHHHHHh--cCCCCCcceEEEEec-----CeEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKVLTH--VHHLNLVRLIGYCVE-----GSLFLVYE 561 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~-----~~~~lv~e 561 (790)
.++|++.+.||+|+||.||+|++.++.||||++.....+.+..|.+++.. ++||||+++++++.+ ...++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e 86 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH 86 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence 46799999999999999999999999999999998888888888888877 799999999998653 23799999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceeecCCCCCCEEecCCCcEEEEEeCCC
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH--------EHTVPVYIHRDIKPANILIDKNFRAKVADFGLA 633 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla 633 (790)
|+++|+|.++++. ..+++..+++++.|++.||+||| ++++ +||||||+|||++.++.+||+|||++
T Consensus 87 ~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i---vH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 87 YHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAI---AHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp CCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEE---ECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred hccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCe---ecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 9999999999964 35999999999999999999999 7776 99999999999999999999999999
Q ss_pred cccccCCccc---ccccccCCCccchhcccCC------CCCchhhHHHHHHHHHHHHhC----------Ccccccccccc
Q 046083 634 KLTEVGSASV---HTRLVGTFGYMPPEYAQYG------EVSPKIDVYAFGVVLYELISA----------MEAVVKTNETI 694 (790)
Q Consensus 634 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~~sDvwS~Gvvl~elltG----------~~p~~~~~~~~ 694 (790)
+......... .....||+.|+|||.+.+. .++.++||||||+++|||++| +.||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 8654433221 2234789999999999876 455799999999999999999 66765432211
Q ss_pred ccccchHHHHHHHHcCCCChhhhhhhcCCcCC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 695 TESTGLVALFEEVLRQPDPREDLQRLVDPRLG-DDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
... ........... ..+.+. ...+...+..+.+++.+||+.||++|||++||++.|+++
T Consensus 241 ---~~~-~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 241 ---PSF-EDMRKVVCVDQ--------QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp ---CCH-HHHHHHHTTSC--------CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ---cch-hhhhHHHhccC--------CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 111 11111111100 001110 011235678899999999999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=356.88 Aligned_cols=258 Identities=27% Similarity=0.458 Sum_probs=208.0
Q ss_pred hcCcccceeeeecCceEEEEEEEC-----CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-----GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFL 558 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-----g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~l 558 (790)
.++|++.+.||+|+||.||+|.+. +..||||.++. ...+.+.+|++++++++||||+++++++.++ ..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 357899999999999999999984 34599999974 3346789999999999999999999999854 5899
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
||||+++|+|.++++... ..+++..++.++.+++.||.|||++++ +||||||+|||++.++.+||+|||+++....
T Consensus 128 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~i---vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCe---eCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999997543 369999999999999999999999997 9999999999999999999999999987643
Q ss_pred CCcc--cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChh
Q 046083 639 GSAS--VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715 (790)
Q Consensus 639 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (790)
.... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||..... ......+..
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~~~~~~~~------ 269 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--------RDVISSVEE------ 269 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHHHHHHHT------
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHc------
Confidence 3221 1222346778999999998899999999999999999999 9999855322 111111111
Q ss_pred hhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccC
Q 046083 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDW 772 (790)
Q Consensus 716 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~ 772 (790)
......+...+..+.+++.+||+.||++|||++||++.|+.+....+.-
T Consensus 270 --------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 270 --------GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp --------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred --------CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 1112233445678999999999999999999999999999987765543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=346.97 Aligned_cols=254 Identities=26% Similarity=0.470 Sum_probs=210.0
Q ss_pred hcCcccceeeeecCceEEEEEEEC-CceEEEEEeChh--hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEEec
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ--ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIE 564 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~~~ 564 (790)
.++|++.+.||+|+||.||+|... ++.+|+|++... ..+++.+|++++++++||||+++++++.+. ..++||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 357899999999999999999985 788999999753 456799999999999999999999998754 5899999999
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccc
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH 644 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 644 (790)
+++|.+++.... ..+++..++.++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++..........
T Consensus 89 ~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i---~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 89 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCe---ecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 999999997643 368999999999999999999999998 9999999999999999999999999986543322233
Q ss_pred cccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 645 TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+...
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--------~~~~~~~~~~------------- 223 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTG------------- 223 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTT-------------
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhcC-------------
Confidence 34556788999999998999999999999999999999 8999864322 1112222111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
.....+...+..+.+++.+||+.||++|||++|++++|..+..+
T Consensus 224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 224 -FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 11122233456789999999999999999999999999987643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=358.49 Aligned_cols=253 Identities=22% Similarity=0.393 Sum_probs=205.5
Q ss_pred cCcccceeeeecCceEEEEEEEC--Cc----eEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GE----KAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLV 559 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~----~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv 559 (790)
++|++.+.||+|+||.||+|.+. ++ ++|+|.+.. ...+++.+|+.++++++||||+++++++.++..++|
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v 94 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 56889999999999999999874 33 368888753 344679999999999999999999999998889999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
+||+.+|+|.+++.... ..+++..++.++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++.....
T Consensus 95 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i---vH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCe---eCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 99999999999998754 369999999999999999999999998 99999999999999999999999999876433
Q ss_pred Cccc-ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 640 SASV-HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 640 ~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
.... .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----------------------~~ 228 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----------------------EI 228 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----------------------GH
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH----------------------HH
Confidence 3221 223456889999999999999999999999999999999 99998653321 11
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
...+........+...+..+.+++.+||+.||++|||++|+++.|+.+...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 229 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 111111111223344566799999999999999999999999999987654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=370.99 Aligned_cols=252 Identities=28% Similarity=0.473 Sum_probs=210.7
Q ss_pred hcCcccceeeeecCceEEEEEEECCceEEEEEeChh-hHHHHHHHHHHHHhcCCCCCcceEEEEecC--eEEEEEEEecC
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQ-ASKEFLAELKVLTHVHHLNLVRLIGYCVEG--SLFLVYEYIEN 565 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~lv~e~~~~ 565 (790)
.++|++.+.||+|+||.||+|.+.++.||||.++.. ..+.|.+|+++|++++||||+++++++.+. ..++||||+++
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~ 271 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTT
T ss_pred hHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCC
Confidence 467889999999999999999999999999999753 457799999999999999999999998743 58999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
|+|.++++..+...+++..++.++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++..... ..
T Consensus 272 g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i---vHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~ 344 (450)
T 1k9a_A 272 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF---VHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QD 344 (450)
T ss_dssp CBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe---eCCCCCHhhEEECCCCCEEEeeCCCccccccc----cc
Confidence 999999987665568999999999999999999999997 99999999999999999999999999854321 12
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCc
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 724 (790)
...+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... . ....+. ..
T Consensus 345 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----~---~~~~i~--------------~~ 402 (450)
T 1k9a_A 345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----D---VVPRVE--------------KG 402 (450)
T ss_dssp --CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT-----T---HHHHHH--------------TT
T ss_pred CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----H---HHHHHH--------------cC
Confidence 2356889999999999999999999999999999998 99998653321 1 111111 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCC
Q 046083 725 LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSS 769 (790)
Q Consensus 725 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~ 769 (790)
.....+..++..+.+++.+||+.||.+|||++++++.|+.+....
T Consensus 403 ~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 403 YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 122334456678999999999999999999999999999876543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=377.87 Aligned_cols=255 Identities=30% Similarity=0.514 Sum_probs=213.6
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh--hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEEe
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ--ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYI 563 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~~ 563 (790)
.++|++.+.||+|+||.||+|.+. +..||||.++.. ..++|.+|+++|++++||||+++++++.+. ..++||||+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 467899999999999999999987 789999999743 457899999999999999999999999854 589999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
++|+|.++++......+++..++.++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++.........
T Consensus 299 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i---vHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 375 (495)
T 1opk_A 299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF---IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375 (495)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence 99999999987666679999999999999999999999997 999999999999999999999999998764333222
Q ss_pred ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcC
Q 046083 644 HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD 722 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d 722 (790)
.....++..|+|||.+....++.++|||||||++|||++ |..||...... .... .+.
T Consensus 376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--------~~~~--------------~~~ 433 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYE--------------LLE 433 (495)
T ss_dssp CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--------GHHH--------------HHH
T ss_pred cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--------HHHH--------------HHH
Confidence 333456789999999998899999999999999999999 88888653221 1111 111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 723 PRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 723 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
.......+..++..+.+|+.+||+.||++|||+++|++.|+.+...
T Consensus 434 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 434 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 1222233445567899999999999999999999999999987543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=343.75 Aligned_cols=250 Identities=30% Similarity=0.499 Sum_probs=198.4
Q ss_pred hcCcccceeeeecCceEEEEEEECCceEEEEEeChh-------hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQ-------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVY 560 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~ 560 (790)
.++|++.+.||+|+||.||+|.+.++.+|||.++.. ..+.+.+|+++++.++||||+++++++.++ ..++||
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 357899999999999999999999999999998632 235688999999999999999999998754 589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC--------CCcEEEEEeCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK--------NFRAKVADFGL 632 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~--------~~~~kl~DfGl 632 (790)
||+++++|.+++.. ..+++..++.++.|++.||.|||+++..+++||||||+|||++. ++.+||+|||+
T Consensus 86 e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 86 EFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp ECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 99999999999964 35899999999999999999999999544599999999999986 67899999999
Q ss_pred CcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC
Q 046083 633 AKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD 712 (790)
Q Consensus 633 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (790)
+....... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ......
T Consensus 163 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~----- 226 (271)
T 3dtc_A 163 AREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL--------AVAYGV----- 226 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH--------HHHHHH-----
T ss_pred cccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHhh-----
Confidence 98654322 22456899999999999999999999999999999999999999653221 111111
Q ss_pred ChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 713 PREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 713 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
.........+...+..+.+++.+||+.||.+|||++|+++.|+.+
T Consensus 227 --------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 227 --------AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --------HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --------hcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111122223344557899999999999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=373.49 Aligned_cols=256 Identities=28% Similarity=0.475 Sum_probs=207.4
Q ss_pred hcCcccceeeeecCceEEEEEEEC-CceEEEEEeChh--hHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEEEecC
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ--ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIEN 565 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e~~~~ 565 (790)
.++|++.+.||+|+||.||+|.+. +..||||.++.. ..++|.+|+++|++++||||+++++++.++..++||||+++
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~~~ 262 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 262 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTT
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhhcC
Confidence 467889999999999999999998 467999999753 45789999999999999999999999988889999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
|+|.+++.......+++..++.++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++...........
T Consensus 263 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i---vHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 339 (452)
T 1fmk_A 263 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339 (452)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe---eCCCCChhhEEECCCCCEEECCCccceecCCCceeccc
Confidence 999999986433468999999999999999999999998 99999999999999999999999999876433222223
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCc
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 724 (790)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+.. .
T Consensus 340 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i~~--------------~ 397 (452)
T 1fmk_A 340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVER--------------G 397 (452)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHT--------------T
T ss_pred CCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHc--------------C
Confidence 3456789999999998999999999999999999999 8999854321 111111111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCC
Q 046083 725 LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSS 769 (790)
Q Consensus 725 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~ 769 (790)
.....+..++..+.+++.+||+.||++|||++++++.|+.+....
T Consensus 398 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 398 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 112234455678999999999999999999999999999876543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=346.21 Aligned_cols=260 Identities=27% Similarity=0.432 Sum_probs=205.8
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeC------hhhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMD------MQASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLV 559 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv 559 (790)
.++|++.+.||+|+||.||+|... +..+|+|.+. ....+.+.+|+.++++++||||+++++++.++ ..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 367999999999999999999976 7899999873 23346789999999999999999999998754 58999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+++++|.+++...+ .+++..++.++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRI---VHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999998654 58999999999999999999999998 99999999999999999999999999876543
Q ss_pred CcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
.........||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .......+...... ...
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~~~~~~~~~--~~~ 234 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA--------VSIAIKHIQDSVPN--VTT 234 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH--------HHHHHHHHSSCCCC--HHH
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHhhccCCC--cch
Confidence 33333446799999999999999999999999999999999999999965332 11111222211110 000
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHhhccCCcc
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRP-SMRAIVVALMTLSSSSED 771 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~L~~l~~~~~~ 771 (790)
..+.+.+..+.+++.+||+.||.+|| +++++.+.|..+......
T Consensus 235 --------~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 235 --------DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp --------HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred --------hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 11223456789999999999999998 899999999987655443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=347.80 Aligned_cols=248 Identities=23% Similarity=0.402 Sum_probs=204.6
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
.++|++.+.||+|+||.||+|... ++.||||.+.. ...+.+.+|+.++++++||||+++++++.. +..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 367999999999999999999875 88999999863 334668899999999999999999998874 568999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+++|+|.+++... .+++..+..++.+++.||+|||++++ +||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCc---eeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 9999999999864 48999999999999999999999997 9999999999999999999999999986643322
Q ss_pred cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcC
Q 046083 643 VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD 722 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d 722 (790)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .......... .
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~~~~~~----------~ 233 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------RALYLIATNG----------T 233 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHHC----------S
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC----------C
Confidence 233467999999999999999999999999999999999999999653321 1111111100 0
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 723 PRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 723 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
+ ....+...+..+.+++.+||+.||++|||++|++++-+
T Consensus 234 ~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~ 272 (297)
T 3fxz_A 234 P--ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQF 272 (297)
T ss_dssp C--CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred C--CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 0 11223345567899999999999999999999987544
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=346.55 Aligned_cols=253 Identities=23% Similarity=0.386 Sum_probs=197.8
Q ss_pred hcCcccceeeeecCceEEEEEEEC-----CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-----GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLV 559 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-----g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv 559 (790)
.++|++.+.||+|+||.||+|.+. +..+|+|.++. ...+.+.+|+.++++++||||+++++++.++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv 93 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 93 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEEE
Confidence 467899999999999999999874 34699999864 234678999999999999999999999988889999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+++++|.+++.... ..+++..++.++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEEEETTEEEECC----------
T ss_pred EecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCe---ecccccHHHEEECCCCCEEECccccccccCcc
Confidence 99999999999998653 368999999999999999999999998 99999999999999999999999999876543
Q ss_pred CcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
.........+++.|+|||.+.+..++.++||||||+++|||++ |..||...... . ....+...
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-----~---~~~~i~~~-------- 233 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----D---VIGRIENG-------- 233 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----G---HHHHHHTT--------
T ss_pred cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-----H---HHHHHHcC--------
Confidence 3322334456789999999998899999999999999999996 99998653321 1 11111111
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
.....+...+..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 234 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 234 ------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0112233455678999999999999999999999999998753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=343.18 Aligned_cols=254 Identities=24% Similarity=0.442 Sum_probs=209.0
Q ss_pred hcCcccceeeeecCceEEEEEEEC-CceEEEEEeChh--hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEEec
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ--ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIE 564 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~~~ 564 (790)
.++|++.+.||+|+||.||+|... +..+|+|.++.. ..+++.+|++++.+++||||+++++++.+. ..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 467899999999999999999987 558999999753 456799999999999999999999999754 5899999999
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccc
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH 644 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 644 (790)
+++|.+++...+ ..+++..++.++.|++.||.|||++++ +||||||+|||++.++.+||+|||++...........
T Consensus 87 ~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i---~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 162 (268)
T 3sxs_A 87 NGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQF---IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162 (268)
T ss_dssp TCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTE---EESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred CCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence 999999997653 358999999999999999999999997 9999999999999999999999999987654433333
Q ss_pred cccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 645 TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ..........
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~------------ 222 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--------EVVLKVSQGH------------ 222 (268)
T ss_dssp CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHTTC------------
T ss_pred cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH--------HHHHHHHcCC------------
Confidence 34556778999999998899999999999999999999 99998543221 1111111110
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
....+...+..+.+++.+||+.||++|||++|+++.|+.+...
T Consensus 223 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 223 --RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp --CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred --CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 0111223345789999999999999999999999999987653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=361.88 Aligned_cols=254 Identities=27% Similarity=0.463 Sum_probs=196.5
Q ss_pred hcCcccceeeeecCceEEEEEEEC-----CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-----GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFL 558 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-----g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~l 558 (790)
.++|++.+.||+|+||.||+|++. +..||||.++. ...++|.+|++++++++||||+++++++.++ ..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999874 56799999864 2346799999999999999999999999854 5899
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
||||+++|+|.++++..+ ..+++..++.++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++....
T Consensus 124 v~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCe---eCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999998653 369999999999999999999999998 9999999999999999999999999987643
Q ss_pred CCcccc--cccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChh
Q 046083 639 GSASVH--TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715 (790)
Q Consensus 639 ~~~~~~--~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (790)
...... ....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ......+.
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--------~~~~~~i~------- 264 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--------QDVIKAVD------- 264 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--------HHHHHHHH-------
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHH-------
Confidence 322111 12345778999999999999999999999999999998 9999854321 11111111
Q ss_pred hhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 716 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
.......+..++..+.+++.+||+.||++||+++||++.|..+...
T Consensus 265 -------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 265 -------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp -------TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -------cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 1111222334567899999999999999999999999999987543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=359.65 Aligned_cols=262 Identities=26% Similarity=0.457 Sum_probs=212.6
Q ss_pred hcCcccceeeeecCceEEEEEEEC---------CceEEEEEeChh----hHHHHHHHHHHHHhc-CCCCCcceEEEEecC
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR---------GEKAAIKKMDMQ----ASKEFLAELKVLTHV-HHLNLVRLIGYCVEG 554 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~---------g~~vavK~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 554 (790)
.++|.+.+.||+|+||.||+|... +..+|||+++.. ..+.+.+|+++++++ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 468999999999999999999863 247999998643 346688999999999 999999999999754
Q ss_pred -eEEEEEEEecCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe
Q 046083 555 -SLFLVYEYIENGNLNQHLRGSGK--------------DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI 619 (790)
Q Consensus 555 -~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl 619 (790)
..++||||+++|+|.+++..... ..+++..+++++.|++.||+|||++++ +||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i---vH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCE---ecCCCCcceEEE
Confidence 58999999999999999986532 359999999999999999999999998 999999999999
Q ss_pred cCCCcEEEEEeCCCcccccCCc-ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccc
Q 046083 620 DKNFRAKVADFGLAKLTEVGSA-SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITES 697 (790)
Q Consensus 620 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~ 697 (790)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~----- 299 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 299 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----
Confidence 9999999999999986643322 22233567889999999999999999999999999999999 9999854321
Q ss_pred cchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccCCcC
Q 046083 698 TGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWDIG 775 (790)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~~~~ 775 (790)
......+... .....+...+.++.+++.+||+.||++|||++||++.|+.+.......+..
T Consensus 300 ---~~~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~ 360 (382)
T 3tt0_A 300 ---EELFKLLKEG--------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMG 360 (382)
T ss_dssp ---HHHHHHHHTT--------------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC--
T ss_pred ---HHHHHHHHcC--------------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCC
Confidence 1122222111 112223345567999999999999999999999999999987666655443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=345.31 Aligned_cols=255 Identities=27% Similarity=0.485 Sum_probs=211.7
Q ss_pred hcCcccceeeeecCceEEEEEEEC-CceEEEEEeChh--hHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEEEecC
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ--ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIEN 565 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e~~~~ 565 (790)
.++|++.+.||+|+||.||+|... +..+|+|.++.. ..+.+.+|++++++++||||+++++++.++..++||||+++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 91 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMEN 91 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTT
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEecCCC
Confidence 467899999999999999999987 568999998753 45779999999999999999999999988889999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
++|.+++.......+++..++.++.|++.||+|||++++ +||||||+|||+++++.+||+|||++............
T Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i---~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 168 (279)
T 1qpc_A 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (279)
T ss_dssp CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe---eccCCCHhhEEEcCCCCEEECCCcccccccCccccccc
Confidence 999999976433368999999999999999999999997 99999999999999999999999999876543333333
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCc
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 724 (790)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+...
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~~~-------------- 226 (279)
T 1qpc_A 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQNLERG-------------- 226 (279)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTT--------------
T ss_pred CCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--------HHHHHHHhcc--------------
Confidence 4557889999999998889999999999999999999 8888854321 1111121111
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 725 LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 725 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
.....+...+..+.+++.+||+.||++|||++++++.|+.+...
T Consensus 227 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 11122334456789999999999999999999999999987543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=345.67 Aligned_cols=265 Identities=26% Similarity=0.434 Sum_probs=206.5
Q ss_pred hcCcccceeeeecCceEEEEEEE------CCceEEEEEeChh---hHHHHHHHHHHHHhcCCCCCcceEEEEec---CeE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAEL------RGEKAAIKKMDMQ---ASKEFLAELKVLTHVHHLNLVRLIGYCVE---GSL 556 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~------~g~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~---~~~ 556 (790)
.++|++.+.||+|+||.||+|++ .++.+|||++... ..+.+.+|++++++++||||+++++++.. ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 36789999999999999999985 2788999998643 34678999999999999999999999863 348
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i---vH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCc---ccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 99999999999999998653 358999999999999999999999998 99999999999999999999999999876
Q ss_pred ccCCcc--cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC-
Q 046083 637 EVGSAS--VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP- 713 (790)
Q Consensus 637 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 713 (790)
...... ......++..|+|||.+.+..++.++||||||+++|||++|..|+...... +.........
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----------~~~~~~~~~~~ 234 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----------FMRMIGNDKQG 234 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----------HHHHHCTTCCT
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----------HHhhhcCcccc
Confidence 433221 122345677899999999999999999999999999999999887543211 1111111110
Q ss_pred h---hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 714 R---EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 714 ~---~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
. ..+.+.+........+...+..+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 235 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 0 01112222222233345566789999999999999999999999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=351.45 Aligned_cols=246 Identities=27% Similarity=0.442 Sum_probs=205.1
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
.++|++.+.||+|+||.||+|... |+.||||++.. ...+.+.+|+++++.++||||+++++++.. +..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 467999999999999999999974 88999999853 334568899999999999999999999875 4689999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~i---vHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKRI---VHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp CCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred ECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCE---eccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 9999999999997654 48999999999999999999999998 999999999999999999999999998664332
Q ss_pred cccccccccCCCccchhcccCCCCC-chhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVS-PKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
......||+.|+|||.+.+..++ .++|||||||++|||++|+.||.... .......+.....
T Consensus 169 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~~------- 231 (328)
T 3fe3_A 169 --KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN--------LKELRERVLRGKY------- 231 (328)
T ss_dssp --GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCC-------
T ss_pred --ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCC-------
Confidence 23456799999999999888775 79999999999999999999996432 1222222222111
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
..|...+..+.+++.+||+.||.+|||++|++++-+.
T Consensus 232 --------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~ 268 (328)
T 3fe3_A 232 --------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268 (328)
T ss_dssp --------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTT
T ss_pred --------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhh
Confidence 1223345678899999999999999999999987553
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=346.28 Aligned_cols=253 Identities=26% Similarity=0.455 Sum_probs=206.0
Q ss_pred hcCcccceeeeecCceEEEEEEEC-CceEEEEEeChh--hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEEec
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ--ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIE 564 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~~~ 564 (790)
.++|++.+.||+|+||.||++.+. +..+|+|.++.. ..+++.+|++++.+++||||+++++++.+. ..++||||++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 467899999999999999999987 568999999753 457799999999999999999999999754 5899999999
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccc
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH 644 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 644 (790)
+++|.+++.... ..+++..++.++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++..........
T Consensus 103 ~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i---~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (283)
T 3gen_A 103 NGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178 (283)
T ss_dssp TCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred CCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCc---cCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence 999999997642 359999999999999999999999998 9999999999999999999999999986543322222
Q ss_pred cccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 645 TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+...
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~~~~------------- 237 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------SETAEHIAQG------------- 237 (283)
T ss_dssp TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHHHHHTT-------------
T ss_pred cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh--------hHHHHHHhcc-------------
Confidence 33456788999999998899999999999999999998 9999865332 1111111111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
.....+...+..+.+++.+||+.||.+|||++|++++|..+..
T Consensus 238 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 238 -LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp -CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 1112223334678999999999999999999999999998754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=349.01 Aligned_cols=256 Identities=30% Similarity=0.505 Sum_probs=214.9
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh--hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEE
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ--ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEY 562 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~ 562 (790)
..++|++.+.||+|+||.||+|.+. +..+|+|.+... ..+.+.+|++++++++||||+++++++.+. ..++||||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 4678999999999999999999987 788999998743 456799999999999999999999998754 58999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+++++|.+++.......+++..++.++.+++.||.|||++++ +||||||+||+++.++.+||+|||++.........
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i---~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 167 (288)
T 3kfa_A 91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 167 (288)
T ss_dssp CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTC---CCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE
T ss_pred CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCc---cCCCCCcceEEEcCCCCEEEccCccceeccCCccc
Confidence 999999999988666679999999999999999999999998 99999999999999999999999999876544433
Q ss_pred cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhc
Q 046083 643 VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 721 (790)
......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... . .... +
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-----~---~~~~--------------~ 225 (288)
T 3kfa_A 168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----Q---VYEL--------------L 225 (288)
T ss_dssp EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----G---HHHH--------------H
T ss_pred cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----H---HHHH--------------H
Confidence 4444567889999999999999999999999999999999 88888653321 1 1111 1
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 722 DPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 722 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
........+...+..+.+++.+||+.||.+|||++|+++.|+.+...
T Consensus 226 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 11112223344557899999999999999999999999999987543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=364.80 Aligned_cols=253 Identities=28% Similarity=0.491 Sum_probs=206.2
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYE 561 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e 561 (790)
.++|.+.+.||+|+||.||+|.+. +..||||.++.. ..++|.+|++++++++||||+++++++.+. ..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 467889999999999999999986 789999998743 234688999999999999999999999854 5899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|+++|+|.++++..+ ..+++..++.++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++.......
T Consensus 193 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i---vHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp CCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCc---CCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 999999999998643 358999999999999999999999997 9999999999999999999999999986432211
Q ss_pred ccc-cccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 642 SVH-TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 642 ~~~-~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
... ....+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ... ..+
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--------~~~-~~~----------- 328 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--------QTR-EFV----------- 328 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--------HHH-HHH-----------
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHH-HHH-----------
Confidence 111 11235678999999998899999999999999999998 99998643221 111 111
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
........+..++..+.+++.+||+.||++|||++++++.|+.+..
T Consensus 329 --~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 329 --EKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp --HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 1111122334455688999999999999999999999999998753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=358.93 Aligned_cols=265 Identities=26% Similarity=0.426 Sum_probs=212.9
Q ss_pred ccCHHHHHHHhcCcccceeeeecCceEEEEEEEC-------CceEEEEEeChh----hHHHHHHHHHHHHhc-CCCCCcc
Q 046083 479 EFSYEELAKATNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDMQ----ASKEFLAELKVLTHV-HHLNLVR 546 (790)
Q Consensus 479 ~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~~----~~~~~~~E~~~l~~l-~h~niv~ 546 (790)
.+...++....++|++.+.||+|+||.||+|.+. ++.||||+++.. ..+.+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 3455666667889999999999999999999853 468999999742 345689999999999 7999999
Q ss_pred eEEEEecC--eEEEEEEEecCCChhhhhhcCCC-----------------------------------------------
Q 046083 547 LIGYCVEG--SLFLVYEYIENGNLNQHLRGSGK----------------------------------------------- 577 (790)
Q Consensus 547 l~g~~~~~--~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------- 577 (790)
+++++.+. ..++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 99998753 38999999999999999976432
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 578 -----------------DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 578 -----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
..+++..++.++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~i---vH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 128999999999999999999999998 999999999999999999999999998654322
Q ss_pred c-ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 641 A-SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 641 ~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
. .......||+.|+|||++.+..++.++||||||+++|||++ |..||...... ......+...
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~~~~~~-------- 312 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEFCRRLKEG-------- 312 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-------HHHHHHHHHT--------
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh-------HHHHHHHHcC--------
Confidence 2 22334568899999999999999999999999999999998 99998653321 0111111111
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
.....+......+.+++.+||+.||++|||++|++++|..+..
T Consensus 313 ------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 313 ------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1112233345678999999999999999999999999998754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=341.51 Aligned_cols=250 Identities=20% Similarity=0.353 Sum_probs=205.9
Q ss_pred cCcccceeeeecCceEEEEEEECCceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec---CeEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE---GSLFLVYE 561 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---~~~~lv~e 561 (790)
++|.+.+.||+|+||.||+|++.++.+|||.++. ...+.+.+|++++++++||||+++++++.+ ...++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 5688999999999999999999999999999863 334679999999999999999999999875 34799999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|+++|+|.+++.......+++..++.++.|++.||+|||+++ ++++||||||+|||++.++.++|+|||++.....
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~--- 165 (271)
T 3kmu_A 90 WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS--- 165 (271)
T ss_dssp CCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC---
T ss_pred ccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc---
Confidence 999999999998766557999999999999999999999998 1229999999999999999999999998764321
Q ss_pred ccccccccCCCccchhcccCCCCCc---hhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGEVSP---KIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~---~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
....||+.|+|||.+.+..++. ++||||||+++|||++|+.||..... .........
T Consensus 166 ---~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~--------- 225 (271)
T 3kmu_A 166 ---PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN--------MEIGMKVAL--------- 225 (271)
T ss_dssp ---TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH--------HHHHHHHHH---------
T ss_pred ---cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh--------HHHHHHHHh---------
Confidence 2346799999999998765544 89999999999999999999864322 111111111
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
.......+...+..+.+++.+||+.||++|||++|+++.|..+..
T Consensus 226 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 226 ----EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ----SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ----cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111122334455679999999999999999999999999998754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=343.82 Aligned_cols=254 Identities=21% Similarity=0.353 Sum_probs=205.6
Q ss_pred hcCcccceeeeecCceEEEEEEECC-----ceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELRG-----EKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLV 559 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~g-----~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv 559 (790)
.++|.+.+.||+|+||.||+|.+.+ ..+|+|.+... ..+.+.+|++++++++||||+++++++.++..++|
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v 90 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWII 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEEE
Confidence 4678999999999999999998652 25999998743 45678999999999999999999999988888999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+++++|.+++.... ..+++..++.++.+++.||.|||++++ +||||||+|||++.++.+||+|||++......
T Consensus 91 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 91 MELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINC---VHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp EECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred EecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 99999999999997643 358999999999999999999999998 99999999999999999999999999866543
Q ss_pred CcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
.........+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .. ........
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-----~~---~~~~~~~~------- 231 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-----DV---IGVLEKGD------- 231 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-----GH---HHHHHHTC-------
T ss_pred cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-----HH---HHHHhcCC-------
Confidence 3322334567889999999998899999999999999999998 99998643321 11 11111110
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
....+...+..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 232 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 232 -------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 0111223446789999999999999999999999999987654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=354.18 Aligned_cols=259 Identities=28% Similarity=0.488 Sum_probs=210.0
Q ss_pred HHHHhcCcccceeeeecCceEEEEEEECC-------ceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEec
Q 046083 485 LAKATNDFSMGNKIGQGGFGAVFYAELRG-------EKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVE 553 (790)
Q Consensus 485 l~~~~~~f~~~~~lG~G~fg~Vy~a~~~g-------~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 553 (790)
+....++|++.+.||+|+||.||+|...+ ..+|||.++.. ..+.+.+|++++++++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 34456789999999999999999999863 78999998743 34668999999999999999999999875
Q ss_pred C-eEEEEEEEecCCChhhhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeec
Q 046083 554 G-SLFLVYEYIENGNLNQHLRGSG----------------------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHR 610 (790)
Q Consensus 554 ~-~~~lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~ 610 (790)
+ ..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++++ +||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~i---vH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF---VHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTC---CCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCe---ecC
Confidence 4 5899999999999999997642 1469999999999999999999999998 999
Q ss_pred CCCCCCEEecCCCcEEEEEeCCCcccccCCc-ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCcccc
Q 046083 611 DIKPANILIDKNFRAKVADFGLAKLTEVGSA-SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVV 688 (790)
Q Consensus 611 dlkp~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~ 688 (790)
||||+|||++.++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999986543221 12233567889999999998899999999999999999999 999986
Q ss_pred ccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 689 KTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
.... ......+... .. ...+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 279 ~~~~--------~~~~~~~~~~-------------~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 279 GMAH--------EEVIYYVRDG-------------NI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TSCH--------HHHHHHHHTT-------------CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCCh--------HHHHHHHhCC-------------Cc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 4321 1111222111 10 122334556799999999999999999999999999987654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=354.37 Aligned_cols=254 Identities=22% Similarity=0.391 Sum_probs=204.1
Q ss_pred cCcccceeeeecCceEEEEEEEC--Cce----EEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEK----AAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLV 559 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~----vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv 559 (790)
++|++.+.||+|+||.||+|.+. ++. +++|.+... ..+.+.+|+.++++++||||+++++++.++..++|
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v 92 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLV 92 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEE
Confidence 57899999999999999999975 443 788877532 23457789999999999999999999988889999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+++|+|.+++.... ..+++..++.++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i---vH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTC---CCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCC---CCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 99999999999998642 368999999999999999999999998 99999999999999999999999999876543
Q ss_pred Ccc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 640 SAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 640 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+...
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~------- 233 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--------EVPDLLEKG------- 233 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--------HHHHHHHTT-------
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--------HHHHHHHcC-------
Confidence 322 2234567889999999999999999999999999999999 99998653321 111111111
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCC
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSS 769 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~ 769 (790)
.....+...+..+.+++.+||+.||.+|||++|+++.|..+....
T Consensus 234 -------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 234 -------ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp -------CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred -------CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 011112223445788999999999999999999999999886543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=345.20 Aligned_cols=260 Identities=28% Similarity=0.454 Sum_probs=205.4
Q ss_pred HhcCcccceeeeecCceEEEEEEECCceEEEEEeChhhHHHHHHHHHHHHhc--CCCCCcceEEEEec-----CeEEEEE
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKVLTHV--HHLNLVRLIGYCVE-----GSLFLVY 560 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~~~~~~~E~~~l~~l--~h~niv~l~g~~~~-----~~~~lv~ 560 (790)
..++|++.+.||+|+||.||+|+..++.||||++.......+..|.+++..+ +||||+++++++.+ ...++||
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 114 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLIT 114 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEE
T ss_pred cccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEE
Confidence 4568999999999999999999999999999999877777777777777665 89999999998874 3589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCceeecCCCCCCEEecCCCcEEEEEeCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH--------TVPVYIHRDIKPANILIDKNFRAKVADFGL 632 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~--------~~~~~vH~dlkp~NILl~~~~~~kl~DfGl 632 (790)
||+++|+|.+++... .+++..++.++.+++.||.|||++ ++ +||||||+|||++.++.+||+|||+
T Consensus 115 e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i---vH~Dikp~Nill~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 115 DYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAI---AHRDLKSKNILVKKNGTCCIADLGL 188 (337)
T ss_dssp CCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCE---ECSCCCGGGEEECTTSCEEECCCTT
T ss_pred eccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCE---EecccchHHEEECCCCCEEEEeCCC
Confidence 999999999999754 489999999999999999999998 66 9999999999999999999999999
Q ss_pred CcccccCCccc---ccccccCCCccchhcccCCCCCch------hhHHHHHHHHHHHHhCCc----------cccccccc
Q 046083 633 AKLTEVGSASV---HTRLVGTFGYMPPEYAQYGEVSPK------IDVYAFGVVLYELISAME----------AVVKTNET 693 (790)
Q Consensus 633 a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~------sDvwS~Gvvl~elltG~~----------p~~~~~~~ 693 (790)
++......... .....||+.|+|||.+.+...+.+ +|||||||++|||++|.. ||......
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 268 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC
Confidence 97654332221 124578999999999987766654 999999999999999944 44322211
Q ss_pred cccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 694 ITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYP-----IDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
. .......... ....+....+ ..++.++.+++.+||+.||++|||++||+++|+.+..+
T Consensus 269 ~----~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 269 D----PSYEDMREIV------------CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp S----CCHHHHHHHH------------TTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred C----CchhhhHHHH------------hhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 0 0111111111 1111222222 26778899999999999999999999999999998765
Q ss_pred C
Q 046083 769 S 769 (790)
Q Consensus 769 ~ 769 (790)
.
T Consensus 333 ~ 333 (337)
T 3mdy_A 333 Q 333 (337)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=347.92 Aligned_cols=246 Identities=26% Similarity=0.389 Sum_probs=204.8
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLV 559 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv 559 (790)
.++|++.+.||+|+||.||+++.. ++.+|+|.++.. ..+.+.+|+++++.++||||+++++++.+ +..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367999999999999999999986 889999999643 34568899999999999999999998875 468999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+++|+|.+++...+ .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~i---vHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---ecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999999998643 58999999999999999999999998 99999999999999999999999999854322
Q ss_pred CcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+....
T Consensus 159 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~-------- 221 (337)
T 1o6l_A 159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILMEE-------- 221 (337)
T ss_dssp T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC--------
T ss_pred C-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--------HHHHHHHHcCC--------
Confidence 2 223446799999999999999999999999999999999999999964321 12222222211
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRP-----SMRAIVVALM 763 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~L~ 763 (790)
..++...+.++.+++.+||+.||++|| +++|++++-.
T Consensus 222 -------~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~ 263 (337)
T 1o6l_A 222 -------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred -------CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence 112334456789999999999999999 8999987643
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=377.59 Aligned_cols=256 Identities=28% Similarity=0.475 Sum_probs=211.9
Q ss_pred hcCcccceeeeecCceEEEEEEEC-CceEEEEEeChh--hHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEEEecC
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ--ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIEN 565 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e~~~~ 565 (790)
.++|++.++||+|+||.||+|.+. +..||||.++.. ..++|.+|+++|++++|+||+++++++.++..++||||+++
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~~~ 345 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 345 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTT
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeehhcC
Confidence 467889999999999999999998 467999999753 35789999999999999999999999988889999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
|+|.+++.......+++..++.++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++...........
T Consensus 346 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i---vHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 422 (535)
T 2h8h_A 346 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 422 (535)
T ss_dssp EEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTC
T ss_pred CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe---eCCCCCHhhEEEcCCCcEEEcccccceecCCCceeccc
Confidence 999999986433468999999999999999999999998 99999999999999999999999999865432211222
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCc
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 724 (790)
...++..|+|||.+....++.++|||||||+||||++ |+.||..... ......+.. .
T Consensus 423 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--------~~~~~~i~~--------------~ 480 (535)
T 2h8h_A 423 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVER--------------G 480 (535)
T ss_dssp STTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--------HHHHHHHHT--------------T
T ss_pred CCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHc--------------C
Confidence 3456788999999998999999999999999999999 8999854321 111111111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCC
Q 046083 725 LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSS 769 (790)
Q Consensus 725 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~ 769 (790)
.....+..++..+.+|+.+||+.||++|||+++|++.|+.+....
T Consensus 481 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 481 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 112233445678999999999999999999999999999876543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=358.13 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=207.4
Q ss_pred hcCcccceeeeecCceEEEEEEEC-------CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SL 556 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~ 556 (790)
.++|++.+.||+|+||.||+|.+. +..||||+++. ....++.+|+.++++++||||+++++++.+. ..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367899999999999999999853 45799999853 3445688999999999999999999998754 58
Q ss_pred EEEEEEecCCChhhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC---cEEEE
Q 046083 557 FLVYEYIENGNLNQHLRGSG-----KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF---RAKVA 628 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~---~~kl~ 628 (790)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++++ +||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i---vHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCe---eCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997643 2358999999999999999999999998 9999999999999554 59999
Q ss_pred EeCCCcccccCC-cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHH
Q 046083 629 DFGLAKLTEVGS-ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEE 706 (790)
Q Consensus 629 DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 706 (790)
|||+++...... ........||+.|+|||.+.+..++.++|||||||++|||++ |..||..... ......
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--------~~~~~~ 298 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVLEF 298 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHH
Confidence 999998553222 122234567899999999999999999999999999999998 9999864322 112222
Q ss_pred HHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCc
Q 046083 707 VLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770 (790)
Q Consensus 707 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~ 770 (790)
+... .....+...+..+.+|+.+||+.||++|||++||++.|+.+.....
T Consensus 299 i~~~--------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 299 VTSG--------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp HHTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred HHcC--------------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 2211 1112233445678999999999999999999999999998865543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=342.35 Aligned_cols=257 Identities=31% Similarity=0.556 Sum_probs=198.0
Q ss_pred hcCcccceeeeecCceEEEEEEECCceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEEEe
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYI 563 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e~~ 563 (790)
.++|++.+.||+|+||.||+|.+.+ .+|+|.++. ...+.+.+|++++++++||||+++++++.+...++||||+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~~ 101 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWC 101 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEec
Confidence 4679999999999999999998765 599999863 3346789999999999999999999998888899999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC-cc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS-AS 642 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~-~~ 642 (790)
++++|.+++.... ..+++..++.++.|++.||.|||++++ +||||||+|||++.++.+||+|||++....... ..
T Consensus 102 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i---~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 102 EGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSI---IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp CEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred CCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCc---ccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 9999999997553 469999999999999999999999998 999999999999999999999999998654321 22
Q ss_pred cccccccCCCccchhccc---CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 643 VHTRLVGTFGYMPPEYAQ---YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
......|++.|+|||.+. ...++.++||||||+++|||++|+.||...... ...........
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~-------- 242 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQIIEMVGRGS-------- 242 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-------HHHHHHHHHTS--------
T ss_pred cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-------HHHHHHhcccc--------
Confidence 223457899999999986 567899999999999999999999999653321 11111111111
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
..+.+ ......++..+.+++.+||+.||.+|||++|+++.|+.+..
T Consensus 243 -~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 243 -LSPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -CCCCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -cCcch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 01111 11223445679999999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=343.73 Aligned_cols=260 Identities=23% Similarity=0.386 Sum_probs=212.2
Q ss_pred ccCHHHHHHHhcC----------cccceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCC
Q 046083 479 EFSYEELAKATND----------FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLN 543 (790)
Q Consensus 479 ~~~~~~l~~~~~~----------f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~n 543 (790)
.++++++..+++. |...+.||+|+||.||+|... |+.||||.+.. ...+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 5777888777764 778889999999999999985 88999999863 33567899999999999999
Q ss_pred CcceEEEEec-CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC
Q 046083 544 LVRLIGYCVE-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN 622 (790)
Q Consensus 544 iv~l~g~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~ 622 (790)
|+++++++.. +..++||||+++++|.+++... .+++..+..++.|++.||.|||++++ +||||||+|||++.+
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~i---vH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQGV---IHRDIKSDSILLTLD 177 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHEEECCC
Confidence 9999998875 5689999999999999998753 58999999999999999999999997 999999999999999
Q ss_pred CcEEEEEeCCCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHH
Q 046083 623 FRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVA 702 (790)
Q Consensus 623 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 702 (790)
+.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--------~~ 248 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--------VQ 248 (321)
T ss_dssp CCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HH
T ss_pred CcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HH
Confidence 9999999999986643322 23346799999999999999999999999999999999999999864322 11
Q ss_pred HHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 703 LFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 703 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
....+.... .+.+ ..+...+..+.+++.+||+.||++|||++|++++..-.
T Consensus 249 ~~~~~~~~~----------~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 299 (321)
T 2c30_A 249 AMKRLRDSP----------PPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL 299 (321)
T ss_dssp HHHHHHHSS----------CCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGG
T ss_pred HHHHHhcCC----------CCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 122222111 1111 11223456789999999999999999999999865543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=351.01 Aligned_cols=259 Identities=26% Similarity=0.462 Sum_probs=207.5
Q ss_pred HhcCcccceeeeecCceEEEEEEEC-------CceEEEEEeChh----hHHHHHHHHHHHHhc-CCCCCcceEEEEec-C
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDMQ----ASKEFLAELKVLTHV-HHLNLVRLIGYCVE-G 554 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~ 554 (790)
..++|.+.+.||+|+||.||+|... +..+|+|.+... ..+.+.+|++++.++ +||||+++++++.+ +
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 4578999999999999999999862 457999998642 346789999999999 89999999999875 4
Q ss_pred eEEEEEEEecCCChhhhhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCC
Q 046083 555 SLFLVYEYIENGNLNQHLRGSGK---------------------DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIK 613 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlk 613 (790)
..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++++ +|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i---vH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC---VHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTE---EETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCC
Confidence 58999999999999999986532 248999999999999999999999997 999999
Q ss_pred CCCEEecCCCcEEEEEeCCCcccccCCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccc
Q 046083 614 PANILIDKNFRAKVADFGLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTN 691 (790)
Q Consensus 614 p~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~ 691 (790)
|+|||++.++.+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||+| |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999999866433222 2233567889999999998999999999999999999998 999986543
Q ss_pred cccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCc
Q 046083 692 ETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770 (790)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~ 770 (790)
.. ......+. .......+...+..+.+++.+||+.||.+|||+.|+++.|+.+.....
T Consensus 280 ~~--------~~~~~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 280 VD--------ANFYKLIQ-------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CS--------HHHHHHHH-------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred cH--------HHHHHHHh-------------cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 21 11111111 111122233445679999999999999999999999999998766543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=363.15 Aligned_cols=263 Identities=23% Similarity=0.317 Sum_probs=211.0
Q ss_pred cCHHHHHHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhhH------HHHHHHHHHHHhcCCCCCcceEEEE
Q 046083 480 FSYEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS------KEFLAELKVLTHVHHLNLVRLIGYC 551 (790)
Q Consensus 480 ~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~------~~~~~E~~~l~~l~h~niv~l~g~~ 551 (790)
+.+.++....++|++.+.||+|+||.||+|+.. ++.+|+|+++.... +.+.+|..++..++||||+++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 445666667889999999999999999999986 67899999975322 2388999999999999999999998
Q ss_pred ecC-eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEe
Q 046083 552 VEG-SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADF 630 (790)
Q Consensus 552 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~Df 630 (790)
.+. ..|+||||+++|+|.+++.... ..+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~gi---iHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHY---VHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCe---EecccCHHHeeEcCCCCEEEcch
Confidence 754 5899999999999999998642 359999999999999999999999997 99999999999999999999999
Q ss_pred CCCcccccCCcccccccccCCCccchhccc-----CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHH
Q 046083 631 GLAKLTEVGSASVHTRLVGTFGYMPPEYAQ-----YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFE 705 (790)
Q Consensus 631 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 705 (790)
|+++..............||+.|+|||++. ...++.++|||||||++|||++|+.||..... .....
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~--------~~~~~ 291 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYG 291 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh--------hHHHH
Confidence 999876544443344568999999999987 56789999999999999999999999965322 12222
Q ss_pred HHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHHh
Q 046083 706 EVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQL--RPSMRAIVVALMT 764 (790)
Q Consensus 706 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~L~~ 764 (790)
.++.. .....-+.. .......+.+|+.+||..+|++ ||+++|++++-+-
T Consensus 292 ~i~~~------~~~~~~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff 342 (437)
T 4aw2_A 292 KIMNH------KERFQFPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342 (437)
T ss_dssp HHHTH------HHHCCCCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGG
T ss_pred hhhhc------cccccCCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCcc
Confidence 22210 000001111 1124457889999999888888 9999999886553
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=339.30 Aligned_cols=249 Identities=28% Similarity=0.519 Sum_probs=203.0
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh----------HHHHHHHHHHHHhcCCCCCcceEEEEecCeE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA----------SKEFLAELKVLTHVHHLNLVRLIGYCVEGSL 556 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~----------~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 556 (790)
.++|++.+.||+|+||.||+|.+. ++.+|+|.+.... .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 367899999999999999999985 8899999985311 167899999999999999999999987655
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceeecCCCCCCEEecCCCc-----EEEEE
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT--VPVYIHRDIKPANILIDKNFR-----AKVAD 629 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~~vH~dlkp~NILl~~~~~-----~kl~D 629 (790)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ + +||||||+|||++.++. +||+|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~i---vH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPI---VHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCC---BCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCe---ecCCCCcceEEEeccCCCCceeEEeCC
Confidence 79999999999999887653 46999999999999999999999999 7 99999999999988776 99999
Q ss_pred eCCCcccccCCcccccccccCCCccchhcc--cCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHH
Q 046083 630 FGLAKLTEVGSASVHTRLVGTFGYMPPEYA--QYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEV 707 (790)
Q Consensus 630 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 707 (790)
||+++.... ......|++.|+|||.+ ....++.++||||||+++|||++|+.||...... ........
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~ 242 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG------KIKFINMI 242 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC------HHHHHHHH
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc------HHHHHHHH
Confidence 999975432 23346789999999998 4456789999999999999999999999653321 11111111
Q ss_pred HcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 708 LRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 708 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
.. .......+...+..+.+++.+||+.||++|||++|+++.|+++
T Consensus 243 ~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 RE-------------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HH-------------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred hc-------------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11 1122233445567899999999999999999999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=337.60 Aligned_cols=254 Identities=26% Similarity=0.461 Sum_probs=209.0
Q ss_pred hcCcccceeeeecCceEEEEEEEC-CceEEEEEeChh--hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEEec
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ--ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIE 564 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~~~ 564 (790)
.++|++.+.||+|+||.||++... ++.+|+|.+... ..+++.+|++++++++||||+++++++.+. ..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 357889999999999999999985 778999999753 456799999999999999999999998754 5899999999
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccc
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH 644 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 644 (790)
+++|.+++.... ..+++..++.++.+++.||.|||++++ +||||||+||+++.++.+||+|||++...........
T Consensus 87 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 87 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp TCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 999999998653 368999999999999999999999998 9999999999999999999999999986543222222
Q ss_pred cccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 645 TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+...
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~i~~~------------- 221 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTG------------- 221 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTT-------------
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--------HHHHHHHhcC-------------
Confidence 33456788999999998899999999999999999999 8888864321 1122222211
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
.....+...+..+.+++.+||+.||++|||++|+++.|..+..+
T Consensus 222 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 222 -FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 01112223456789999999999999999999999999987653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=342.92 Aligned_cols=251 Identities=29% Similarity=0.503 Sum_probs=200.4
Q ss_pred cCcccceeeeecCceEEEEEEECCceEEEEEeChh-hHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEEEecCCCh
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQ-ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNL 568 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e~~~~g~L 568 (790)
++|++.+.||+|+||.||+|.+.++.+|+|.+... ..+.+.+|++++++++||||+++++++.+ ..++||||+++|+|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~lv~e~~~~~~L 86 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN-PVCLVMEYAEGGSL 86 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT-TTEEEEECCTTCBH
T ss_pred hHeeeeeEeecCCCceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CcEEEEEcCCCCCH
Confidence 56889999999999999999999999999999754 45679999999999999999999998874 47999999999999
Q ss_pred hhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCCCCCEEecCCCc-EEEEEeCCCcccccCCccc
Q 046083 569 NQHLRGSGK-DTLTWSARMQIALDSARGLEYIHE---HTVPVYIHRDIKPANILIDKNFR-AKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 569 ~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~---~~~~~~vH~dlkp~NILl~~~~~-~kl~DfGla~~~~~~~~~~ 643 (790)
.+++..... ..+++..++.++.|+++||+|||+ +++ +||||||+|||++.++. +||+|||++......
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~i---vH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---- 159 (307)
T 2eva_A 87 YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL---IHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---- 159 (307)
T ss_dssp HHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCC---CCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred HHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCe---ecCCCChhHEEEeCCCCEEEEcccccccccccc----
Confidence 999986543 357899999999999999999999 666 99999999999998886 799999999755322
Q ss_pred ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 644 HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ............
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~------------ 221 (307)
T 2eva_A 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP------AFRIMWAVHNGT------------ 221 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS------HHHHHHHHHTTC------------
T ss_pred cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc------HHHHHHHHhcCC------------
Confidence 22346899999999999999999999999999999999999998643321 111111111110
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
....+...+..+.+++.+||+.||++|||++|+++.|..+...
T Consensus 222 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 222 --RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp --CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred --CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 1112223446788999999999999999999999999987543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=349.70 Aligned_cols=257 Identities=23% Similarity=0.397 Sum_probs=204.2
Q ss_pred hcCcccceeeeecCceEEEEEEEC--Cce----EEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEK----AAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFL 558 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~----vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~l 558 (790)
.++|++.+.||+|+||.||+|.+. ++. +++|.+.. ...+.+.+|+.++++++||||+++++++.++..++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 93 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 93 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceE
Confidence 367999999999999999999975 443 57777742 34578999999999999999999999999888999
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
++||+.+|+|.+++.... ..+++..++.++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++....
T Consensus 94 v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCC---cCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999999998753 369999999999999999999999998 9999999999999999999999999987643
Q ss_pred CCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhh
Q 046083 639 GSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716 (790)
Q Consensus 639 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (790)
.... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... .
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----~----------------- 227 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----E----------------- 227 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----G-----------------
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----H-----------------
Confidence 3222 1223456788999999999999999999999999999999 99998653321 1
Q ss_pred hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCcc
Q 046083 717 LQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSED 771 (790)
Q Consensus 717 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~ 771 (790)
+...+........+...+..+.+++.+||+.||.+|||++|+++.|..+......
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 282 (327)
T 3lzb_A 228 ISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQR 282 (327)
T ss_dssp HHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHH
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCc
Confidence 1111111111222344556789999999999999999999999999998765443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=347.37 Aligned_cols=255 Identities=26% Similarity=0.437 Sum_probs=208.1
Q ss_pred HhcCcccceeeeecCceEEEEEEEC-------CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-e
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-S 555 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~ 555 (790)
..++|.+.+.||+|+||.||+|... +..+|+|.++. ...+.+.+|++++++++||||+++++++.+. .
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 3567999999999999999999862 36899999864 2346788999999999999999999998754 5
Q ss_pred EEEEEEEecCCChhhhhhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCC
Q 046083 556 LFLVYEYIENGNLNQHLRGSGK----------------------DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIK 613 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlk 613 (790)
.++||||+++++|.+++..... ..+++..+++++.|++.||.|||++++ +|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i---vH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL---VHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTE---ECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCC---cccccc
Confidence 8999999999999999986432 348999999999999999999999997 999999
Q ss_pred CCCEEecCCCcEEEEEeCCCcccccCCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccc
Q 046083 614 PANILIDKNFRAKVADFGLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTN 691 (790)
Q Consensus 614 p~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~ 691 (790)
|+|||++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999866433222 2223457889999999998889999999999999999999 999986533
Q ss_pred cccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 692 ETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
.. .....+.. ......+...+..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 258 ~~--------~~~~~~~~--------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 258 PE--------RLFNLLKT--------------GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp GG--------GHHHHHHT--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH--------HHHHHhhc--------------CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 21 11111111 11122233455679999999999999999999999999998754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=344.93 Aligned_cols=258 Identities=26% Similarity=0.434 Sum_probs=209.3
Q ss_pred HhcCcccceeeeecCceEEEEEEEC-------CceEEEEEeChh----hHHHHHHHHHHHHhc-CCCCCcceEEEEec-C
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDMQ----ASKEFLAELKVLTHV-HHLNLVRLIGYCVE-G 554 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~ 554 (790)
..++|++.+.||+|+||.||+|.+. +..+|+|.++.. ..+.+.+|+++++++ +||||+++++++.+ +
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 3467999999999999999999852 568999998743 346789999999999 99999999999875 4
Q ss_pred eEEEEEEEecCCChhhhhhcCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEE
Q 046083 555 SLFLVYEYIENGNLNQHLRGSGK----------------DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANIL 618 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~~----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NIL 618 (790)
..++||||+++|+|.+++..... ..+++..+++++.|++.||.|||++++ +||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCccceEE
Confidence 58999999999999999986542 248999999999999999999999998 99999999999
Q ss_pred ecCCCcEEEEEeCCCcccccCCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCcccccccccccc
Q 046083 619 IDKNFRAKVADFGLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITE 696 (790)
Q Consensus 619 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~ 696 (790)
++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--- 254 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--- 254 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS---
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch---
Confidence 999999999999999876543322 2223457889999999998999999999999999999999 99998653321
Q ss_pred ccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCC
Q 046083 697 STGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSS 769 (790)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~ 769 (790)
........ . ......+...+..+.+++.+||+.||.+|||++|+++.|.++....
T Consensus 255 -----~~~~~~~~---------~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 255 -----SKFYKMIK---------E----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp -----HHHHHHHH---------H----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -----hHHHHHhc---------c----CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 01111111 1 1111122334567899999999999999999999999999876543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=346.13 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=202.7
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYE 561 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e 561 (790)
.++|++.+.||+|+||.||+|... ++.+|||.+... ..+.+.+|+.+++.++||||+++++++.++ ..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999886 889999998532 235688999999999999999999998865 5899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|+++|+|.+++.... .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~gi---vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 86 YCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---cccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999999997643 59999999999999999999999997 9999999999999999999999999986543322
Q ss_pred -ccccccccCCCccchhcccCCCC-CchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 642 -SVHTRLVGTFGYMPPEYAQYGEV-SPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 642 -~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... .....+....
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~~~~~~~-------- 225 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------QEYSDWKEKK-------- 225 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-------HHHHHHHTTC--------
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-------HHHHHHhccc--------
Confidence 22334679999999999987775 779999999999999999999996543211 1111111111
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
............+.+|+.+||+.||++|||++|++++-+-
T Consensus 226 -----~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~ 265 (323)
T 3tki_A 226 -----TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265 (323)
T ss_dssp -----TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred -----ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence 1011112345678899999999999999999999886554
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=347.32 Aligned_cols=270 Identities=23% Similarity=0.404 Sum_probs=205.0
Q ss_pred hcCcccceeeeecCceEEEEEEECCceEEEEEeChhhHHHHHHHHHHHH--hcCCCCCcceEEEEe----cC--eEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKVLT--HVHHLNLVRLIGYCV----EG--SLFLVY 560 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~~~~~~~E~~~l~--~l~h~niv~l~g~~~----~~--~~~lv~ 560 (790)
.++|++.+.||+|+||.||+|+..++.||||+++......+..|.+++. .++||||+++++++. ++ ..++||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 91 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM 91 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence 3679999999999999999999999999999998777777766666654 479999999998653 12 368999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCceeecCCCCCCEEecCCCcEEEEEeC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH---------TVPVYIHRDIKPANILIDKNFRAKVADFG 631 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------~~~~~vH~dlkp~NILl~~~~~~kl~DfG 631 (790)
||+++|+|.+++.... .++..+++++.|++.||+|||+. ++ +||||||+|||++.++.+||+|||
T Consensus 92 e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~i---vH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 92 EYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAI---SHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp CCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCE---ECSSCSGGGEEECTTSCEEECCCT
T ss_pred ecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccce---eecccccceEEEcCCCcEEEeecc
Confidence 9999999999997643 58999999999999999999999 76 999999999999999999999999
Q ss_pred CCcccccCCc-------ccccccccCCCccchhcccC-------CCCCchhhHHHHHHHHHHHHhCCccccccccccccc
Q 046083 632 LAKLTEVGSA-------SVHTRLVGTFGYMPPEYAQY-------GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITES 697 (790)
Q Consensus 632 la~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~ 697 (790)
+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|..|+..........
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 9986643211 11223569999999999986 356779999999999999999988875543321111
Q ss_pred cchHHHHHHHHcCCCChhhhhhhcC-CcCCCCC------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 698 TGLVALFEEVLRQPDPREDLQRLVD-PRLGDDY------PIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~l~~~~d-~~l~~~~------~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
.. +............+...+. ......+ ....+..+.+++.+||+.||++|||++|+++.|+.+...
T Consensus 246 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 246 MA----FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CT----THHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred Hh----hhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 00 0111111111112211111 1111111 234667899999999999999999999999999998743
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=343.96 Aligned_cols=261 Identities=28% Similarity=0.447 Sum_probs=210.7
Q ss_pred HHHhcCcccceeeeecCceEEEEEEECCceEEEEEeChhhHHHHHHHHHHHHh--cCCCCCcceEEEEecC-----eEEE
Q 046083 486 AKATNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKVLTH--VHHLNLVRLIGYCVEG-----SLFL 558 (790)
Q Consensus 486 ~~~~~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~-----~~~l 558 (790)
....++|.+.+.||+|+||.||+|...++.||||.++......+.+|.+++.. ++||||+++++++.+. ..++
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l 117 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 117 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEE
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEE
Confidence 44467899999999999999999999999999999998888889999999988 6899999999998743 5899
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceeecCCCCCCEEecCCCcEEEEEe
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH--------EHTVPVYIHRDIKPANILIDKNFRAKVADF 630 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~~vH~dlkp~NILl~~~~~~kl~Df 630 (790)
||||+++|+|.+++... .+++..++.++.+++.||.||| +.++ +||||||+|||++.++.+||+||
T Consensus 118 v~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i---vH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 118 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI---AHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp EECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEE---ECSCCSGGGEEECTTSCEEECCC
T ss_pred EEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCe---eeCCCCHHHEEECCCCCEEEEEC
Confidence 99999999999999763 4899999999999999999999 7776 99999999999999999999999
Q ss_pred CCCcccccCCcc---cccccccCCCccchhcccCC------CCCchhhHHHHHHHHHHHHhC----------Cccccccc
Q 046083 631 GLAKLTEVGSAS---VHTRLVGTFGYMPPEYAQYG------EVSPKIDVYAFGVVLYELISA----------MEAVVKTN 691 (790)
Q Consensus 631 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~~sDvwS~Gvvl~elltG----------~~p~~~~~ 691 (790)
|++......... ......||+.|+|||.+.+. .++.++||||||+++|||++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 999876543322 12345789999999999765 234789999999999999999 55664432
Q ss_pred cccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 046083 692 ETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYP-----IDSVRKMARLARACTQENPQLRPSMRAIVVALMTLS 766 (790)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~ 766 (790)
... .....+...+ ....+....+ .+....+.+|+.+||+.||++|||++||+++|+.+.
T Consensus 272 ~~~---~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 272 PSD---PSVEEMRKVV-------------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp CSS---CCHHHHHHHH-------------TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCc---ccHHHHHHHH-------------HHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 210 1111111111 1112222222 356778999999999999999999999999999886
Q ss_pred cC
Q 046083 767 SS 768 (790)
Q Consensus 767 ~~ 768 (790)
..
T Consensus 336 ~~ 337 (342)
T 1b6c_B 336 QQ 337 (342)
T ss_dssp HT
T ss_pred HH
Confidence 54
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=351.25 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=201.4
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh------HHHHHHHHHHHHhc-CCCCCcceEEEEec-CeEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA------SKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSLFL 558 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~------~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~~l 558 (790)
.++|++.+.||+|+||.||+|+.. ++.+|+|+++... .+.+..|..++.++ +||||+++++++.+ +..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999986 7789999986432 23478899999887 89999999998875 45899
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
||||+++|+|..++...+ .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~gi---vHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCE---EeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999998653 59999999999999999999999998 9999999999999999999999999985322
Q ss_pred CCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCcccccccccccccc-chHHHHHHHHcCCCChhhh
Q 046083 639 GSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITEST-GLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l 717 (790)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||........... ........+...
T Consensus 206 ~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~------- 277 (396)
T 4dc2_A 206 P-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------- 277 (396)
T ss_dssp T-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-------
T ss_pred C-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-------
Confidence 2 2223456899999999999999999999999999999999999999965432211111 111112222211
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSM------RAIVVA 761 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~------~evl~~ 761 (790)
. ..+|.....++.+|+.+||+.||.+||++ +|++++
T Consensus 278 ------~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 278 ------Q--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp ------C--CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred ------c--cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 1 12334455678999999999999999985 566554
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=339.24 Aligned_cols=267 Identities=19% Similarity=0.282 Sum_probs=211.3
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC---eEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG---SLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~---~~~lv~ 560 (790)
++|.+.+.||+|+||.||+|... ++.||||+++. ...+.+.+|++++++++||||+++++++.+. ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 57899999999999999999987 88999999874 2346788999999999999999999988742 579999
Q ss_pred EEecCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe----cCCCcEEEEEeCCCcc
Q 046083 561 EYIENGNLNQHLRGSGK-DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI----DKNFRAKVADFGLAKL 635 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl----~~~~~~kl~DfGla~~ 635 (790)
||+++++|.+++..... ..+++..++.++.|++.||+|||++++ +||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i---vH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGI---VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCE---ecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999986432 349999999999999999999999997 999999999999 8888899999999987
Q ss_pred cccCCcccccccccCCCccchhccc--------CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHH
Q 046083 636 TEVGSASVHTRLVGTFGYMPPEYAQ--------YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEV 707 (790)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 707 (790)
..... ......||+.|+|||++. +..++.++|||||||++|||++|+.||...... .........+
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~ 239 (319)
T 4euu_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP----RRNKEVMYKI 239 (319)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG----GGCHHHHHHH
T ss_pred cCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc----chhHHHHHHH
Confidence 64332 223456899999999886 578899999999999999999999999654322 1112222333
Q ss_pred HcCCCCh--hhhhhhc--------CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 708 LRQPDPR--EDLQRLV--------DPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 708 ~~~~~~~--~~l~~~~--------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
....... ..+.... +-......+......+.+++.+||+.||++|||++|++++.+..
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 3221110 0000000 00111234567888999999999999999999999999998863
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=345.11 Aligned_cols=251 Identities=18% Similarity=0.287 Sum_probs=205.7
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh--hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEe
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM--QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
.++|++.+.||+|+||.||++... +..+|+|.+.. ...+.+.+|+++++.++||||+++++++.+ +..++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 468999999999999999999986 78899999864 344568899999999999999999998875 5689999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC--CCcEEEEEeCCCcccccCCc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK--NFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~--~~~~kl~DfGla~~~~~~~~ 641 (790)
++|+|.+++.... ..+++..++.++.|++.||.|||++++ +||||||+|||++. ++.+||+|||+++......
T Consensus 84 ~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~gi---vH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~- 158 (321)
T 1tki_A 84 SGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNI---GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCC---CcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence 9999999997643 358999999999999999999999997 99999999999987 7899999999998764332
Q ss_pred ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhc
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 721 (790)
......||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+......... .
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~~~~~~--~-- 225 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMNAEYTFDE--E-- 225 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCCCCCH--H--
T ss_pred -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHHcCCCCCCh--h--
Confidence 23346789999999999988899999999999999999999999965322 1222233322111000 0
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 722 DPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 722 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
.....+.++.+++.+||+.||.+|||+.|++++-+-
T Consensus 226 -------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~ 261 (321)
T 1tki_A 226 -------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp -------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred -------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhh
Confidence 001234578899999999999999999999997664
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=341.19 Aligned_cols=246 Identities=25% Similarity=0.395 Sum_probs=195.9
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh-----------------------------HHHHHHHHHHHH
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA-----------------------------SKEFLAELKVLT 537 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~-----------------------------~~~~~~E~~~l~ 537 (790)
.++|++.+.||+|+||.||+|... ++.||||.+.... .+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 367999999999999999999875 7899999985321 245889999999
Q ss_pred hcCCCCCcceEEEEec---CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCC
Q 046083 538 HVHHLNLVRLIGYCVE---GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKP 614 (790)
Q Consensus 538 ~l~h~niv~l~g~~~~---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp 614 (790)
+++||||+++++++.+ ...++||||+++++|.+++.. ..+++..++.++.|++.||+|||++++ +||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i---vH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKI---IHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCe---eccCCCH
Confidence 9999999999999874 458999999999999987653 369999999999999999999999997 9999999
Q ss_pred CCEEecCCCcEEEEEeCCCcccccCCcccccccccCCCccchhcccCCC---CCchhhHHHHHHHHHHHHhCCccccccc
Q 046083 615 ANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGE---VSPKIDVYAFGVVLYELISAMEAVVKTN 691 (790)
Q Consensus 615 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDvwS~Gvvl~elltG~~p~~~~~ 691 (790)
+|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. .+.++||||||+++|||++|+.||....
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 999999999999999999987643322 233467899999999998665 4789999999999999999999986432
Q ss_pred cccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 692 ETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
. ......+..... ........+..+.+++.+||+.||++|||++|++++-
T Consensus 245 ~--------~~~~~~~~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp 294 (298)
T 2zv2_A 245 I--------MCLHSKIKSQAL-------------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294 (298)
T ss_dssp H--------HHHHHHHHHCCC-------------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred H--------HHHHHHHhcccC-------------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence 1 112222221110 0011123446789999999999999999999998653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.28 Aligned_cols=252 Identities=22% Similarity=0.398 Sum_probs=207.0
Q ss_pred cCcccce-eeeecCceEEEEEEEC----CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEE
Q 046083 490 NDFSMGN-KIGQGGFGAVFYAELR----GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~-~lG~G~fg~Vy~a~~~----g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~ 560 (790)
++|.+.+ .||+|+||.||+|.+. +..+|+|.++. ...+.+.+|++++++++||||+++++++.++..++||
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~ 88 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 88 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEE
Confidence 4566666 9999999999999863 66899999974 3456789999999999999999999999877899999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++++|.+++.... ..+++..++.++.|++.||.|||++++ +||||||+|||++.++.+||+|||++.......
T Consensus 89 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 89 EMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNF---VHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp ECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCCE---eeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 9999999999997543 469999999999999999999999997 999999999999999999999999998764332
Q ss_pred ccc--ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 641 ASV--HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 641 ~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+...
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~~~i~~~------- 229 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQG------- 229 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------HHHHHHHTT-------
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHhcC-------
Confidence 221 123456889999999988889999999999999999998 99998653221 111111111
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
.....+...+..+.+++.+||+.||++||++.++++.|+.+..
T Consensus 230 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 230 -------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1122334556789999999999999999999999999998744
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=339.48 Aligned_cols=251 Identities=29% Similarity=0.498 Sum_probs=202.3
Q ss_pred hcCcccceeeeecCceEEEEEEECCceEEEEEeChh-hHHHHHHHHHHHHhcCCCCCcceEEEEec--CeEEEEEEEecC
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQ-ASKEFLAELKVLTHVHHLNLVRLIGYCVE--GSLFLVYEYIEN 565 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~lv~e~~~~ 565 (790)
.++|++.+.||+|+||.||++...++.+|+|.++.. ..+.+.+|++++++++||||+++++++.+ +..++||||+++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 99 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 99 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCC
Confidence 467899999999999999999999999999999754 45678999999999999999999998754 358999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
++|.+++.......+++..++.++.+++.||+|||++++ +||||||+||+++.++.+||+|||++...... ..
T Consensus 100 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----~~ 172 (278)
T 1byg_A 100 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF---VHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QD 172 (278)
T ss_dssp EEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred CCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCc---cccCCCcceEEEeCCCcEEEeecccccccccc----cc
Confidence 999999986544458999999999999999999999998 99999999999999999999999999854322 12
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCc
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 724 (790)
...+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+ ...
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------~~~~~~--------------~~~ 230 (278)
T 1byg_A 173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DVVPRV--------------EKG 230 (278)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--------GHHHHH--------------TTT
T ss_pred CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHH--------------hcC
Confidence 2357889999999998999999999999999999998 99998643221 111111 111
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 725 LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 725 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
.....+...+..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 231 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 11223334556799999999999999999999999999987653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=348.78 Aligned_cols=249 Identities=20% Similarity=0.351 Sum_probs=203.5
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh---------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ---------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSL 556 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~ 556 (790)
.++|.+.+.||+|+||.||++... |..+|+|.++.. ..+.+.+|+.++++++||||+++++++.+ ...
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999986 889999998632 24678999999999999999999999875 458
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC----cEEEEEeCC
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF----RAKVADFGL 632 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~----~~kl~DfGl 632 (790)
++||||+++|+|.+++...+ .+++..+..++.|++.||.|||++++ +||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~gi---vHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKI---AHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 99999999999999997643 59999999999999999999999997 9999999999998877 799999999
Q ss_pred CcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC
Q 046083 633 AKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD 712 (790)
Q Consensus 633 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (790)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+.....
T Consensus 166 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--------~~~~~~i~~~~~ 235 (361)
T 2yab_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANITAVSY 235 (361)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHTTCC
T ss_pred ceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhcCC
Confidence 98764322 23346799999999999999999999999999999999999999965322 122222222111
Q ss_pred ChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 713 PREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 713 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.. ........+..+.+++.+||+.||.+|||++|++++-+
T Consensus 236 ~~-----------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 275 (361)
T 2yab_A 236 DF-----------DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (361)
T ss_dssp CC-----------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred CC-----------CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence 00 00000123456889999999999999999999987544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=358.62 Aligned_cols=258 Identities=23% Similarity=0.326 Sum_probs=208.9
Q ss_pred HHHHHHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh------HHHHHHHHHHHHhcCCCCCcceEEEEec
Q 046083 482 YEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA------SKEFLAELKVLTHVHHLNLVRLIGYCVE 553 (790)
Q Consensus 482 ~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~------~~~~~~E~~~l~~l~h~niv~l~g~~~~ 553 (790)
+.++....++|++.+.||+|+||.||+|+.. ++.+|+|+++... .+.+.+|++++..++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4455667789999999999999999999986 7889999987532 2347899999999999999999999875
Q ss_pred C-eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCC
Q 046083 554 G-SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGL 632 (790)
Q Consensus 554 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGl 632 (790)
. ..|+||||+++|+|.+++... .+++..+..++.+++.||+|||++++ +||||||+|||++.++.+||+|||+
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~gi---vHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCe---EeccCCHHHeeECCCCCEEEeccce
Confidence 4 589999999999999999754 48999999999999999999999997 9999999999999999999999999
Q ss_pred CcccccCCcccccccccCCCccchhcccCCC----CCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHH
Q 046083 633 AKLTEVGSASVHTRLVGTFGYMPPEYAQYGE----VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVL 708 (790)
Q Consensus 633 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 708 (790)
++..............||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ......++
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~ 286 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIM 286 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHH
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh--------hhHHHHHH
Confidence 9876544333344578999999999997655 78999999999999999999999964322 12222222
Q ss_pred cCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHHh
Q 046083 709 RQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQL--RPSMRAIVVALMT 764 (790)
Q Consensus 709 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~L~~ 764 (790)
... ....-+ .......++.+|+.+||+.+|.+ ||+++||+++-+-
T Consensus 287 ~~~------~~~~~p-----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f 333 (410)
T 3v8s_A 287 NHK------NSLTFP-----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 333 (410)
T ss_dssp THH------HHCCCC-----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred hcc------ccccCC-----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence 110 000000 01123467889999999999988 9999999987664
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=348.06 Aligned_cols=275 Identities=27% Similarity=0.391 Sum_probs=210.8
Q ss_pred cCcccceeeeecCceEEEEEEE------CCceEEEEEeChh---hHHHHHHHHHHHHhcCCCCCcceEEEEec---CeEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAEL------RGEKAAIKKMDMQ---ASKEFLAELKVLTHVHHLNLVRLIGYCVE---GSLF 557 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~------~g~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~---~~~~ 557 (790)
++|++.+.||+|+||.||++++ .+..+|||++... ..+.+.+|++++++++||||+++++++.. ...+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5789999999999999999985 2778999998643 34568999999999999999999998862 3489
Q ss_pred EEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccc
Q 046083 558 LVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~ 637 (790)
+||||+++++|.+++.... ..+++..++.++.+++.||+|||++++ +||||||+|||++.++.+||+|||+++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i---vH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRC---VHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCc---cCCCCChhhEEECCCCCEEEcccccceecc
Confidence 9999999999999997643 258999999999999999999999997 999999999999999999999999998764
Q ss_pred cCCcc--cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChh
Q 046083 638 VGSAS--VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715 (790)
Q Consensus 638 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (790)
..... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........... ..........
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-------~~~~~~~~~~ 251 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-------GCERDVPALS 251 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-------C----CCHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-------ccccccccHH
Confidence 33221 22235678889999999988899999999999999999999999865332100000 0000001111
Q ss_pred hhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccCCcC
Q 046083 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWDIG 775 (790)
Q Consensus 716 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~~~~ 775 (790)
.+.+.+........+...+..+.+++.+||+.||++|||++|+++.|+.+......|+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~ 311 (327)
T 3lxl_A 252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETH 311 (327)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----------
T ss_pred HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcccc
Confidence 222233333333445566778999999999999999999999999999998777776554
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=341.89 Aligned_cols=243 Identities=28% Similarity=0.450 Sum_probs=203.6
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLV 559 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv 559 (790)
.++|++.+.||+|+||.||+++.. ++.+|+|.++.. ..+.+.+|..+++.++||||+++++++.+. ..|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367999999999999999999986 889999999753 345688899999999999999999998754 58999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+++|+|.+++.... .+++..+..++.+++.||+|||++++ +||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~i---vHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDI---IYRDLKPENILLDKNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp ECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTE---ECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred EeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence 99999999999998754 58999999999999999999999997 9999999999999999999999999986532
Q ss_pred CcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+....
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~-------- 219 (318)
T 1fot_A 159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILNAE-------- 219 (318)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHCC--------
T ss_pred ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC--------
Confidence 12346799999999999999999999999999999999999999964321 12222222211
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRP-----SMRAIVVALM 763 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~L~ 763 (790)
+ .++.....++.+++.+||+.||++|| +++|++++-.
T Consensus 220 -----~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~ 261 (318)
T 1fot_A 220 -----L--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261 (318)
T ss_dssp -----C--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred -----C--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcc
Confidence 1 12333456789999999999999999 8899886543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=346.31 Aligned_cols=262 Identities=22% Similarity=0.410 Sum_probs=197.9
Q ss_pred HHHHHhcCcccceeeeecCceEEEEEEEC--Cc---eEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec
Q 046083 484 ELAKATNDFSMGNKIGQGGFGAVFYAELR--GE---KAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE 553 (790)
Q Consensus 484 ~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~---~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 553 (790)
++....++|++.+.||+|+||.||+|.+. ++ .+|||.++. ...+.+.+|++++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 33444578999999999999999999876 22 799999864 345679999999999999999999999875
Q ss_pred Ce-------EEEEEEEecCCChhhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC
Q 046083 554 GS-------LFLVYEYIENGNLNQHLRGSG----KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN 622 (790)
Q Consensus 554 ~~-------~~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~ 622 (790)
.. .++||||+++|+|.+++.... ...+++..+++++.|++.||.|||++++ +||||||+|||++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i---vH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNF---IHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCc---ccCCCCcceEEEcCC
Confidence 32 389999999999999986432 2258999999999999999999999998 999999999999999
Q ss_pred CcEEEEEeCCCcccccCCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccch
Q 046083 623 FRAKVADFGLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGL 700 (790)
Q Consensus 623 ~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~ 700 (790)
+.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------- 246 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA------- 246 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-------
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH-------
Confidence 99999999999865433221 1223456789999999999999999999999999999999 89998653321
Q ss_pred HHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCc
Q 046083 701 VALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770 (790)
Q Consensus 701 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~ 770 (790)
.....+.... ....+...+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 247 -~~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 247 -EIYNYLIGGN--------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp -GHHHHHHTTC--------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred -HHHHHHhcCC--------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 1111111111 112233455679999999999999999999999999998866543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=340.14 Aligned_cols=253 Identities=25% Similarity=0.392 Sum_probs=205.7
Q ss_pred HhcCcccce-eeeecCceEEEEEEEC----CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEecCeEE
Q 046083 488 ATNDFSMGN-KIGQGGFGAVFYAELR----GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLF 557 (790)
Q Consensus 488 ~~~~f~~~~-~lG~G~fg~Vy~a~~~----g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 557 (790)
..++|.+.+ .||+|+||.||+|.+. +..+|||.++.. ..+++.+|+++++.++||||+++++++.++..+
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 93 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWM 93 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcE
Confidence 346788888 9999999999999653 578999998743 246789999999999999999999999777899
Q ss_pred EEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccc
Q 046083 558 LVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~ 637 (790)
+||||+++++|.+++.... .+++..++.++.|++.||.|||++++ +||||||+|||++.++.+||+|||++....
T Consensus 94 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i---~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCCe---EcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 9999999999999998753 58999999999999999999999997 999999999999999999999999998764
Q ss_pred cCCccc--ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 638 VGSASV--HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 638 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
...... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+..
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~----- 235 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEK----- 235 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHT-----
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHc-----
Confidence 433221 122346788999999998889999999999999999999 9999865322 111111111
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
......+...+..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 236 ---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 236 ---------GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp ---------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11122334456789999999999999999999999999998643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=349.57 Aligned_cols=245 Identities=27% Similarity=0.439 Sum_probs=199.1
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhc-CCCCCcceEEEEec-CeEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSLFL 558 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~~l 558 (790)
.++|++.+.||+|+||.||+|+.. ++.+|+|+++.. ..+.+..|.+++..+ +||||+++++++.+ +..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 478999999999999999999986 789999999743 335678899999988 79999999999875 45899
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
||||+++|+|.+++...+ .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++....
T Consensus 102 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gi---vHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGI---IYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCC---cccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999999998653 59999999999999999999999998 9999999999999999999999999985432
Q ss_pred CCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 639 GSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+..+....
T Consensus 177 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~------- 240 (353)
T 3txo_A 177 NG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAILNDE------- 240 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-------
T ss_pred CC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCC-------
Confidence 21 223446799999999999988899999999999999999999999965322 22233332211
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHHH
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSM------RAIVVAL 762 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~------~evl~~L 762 (790)
..++......+.+++.+||+.||.+||++ +|++++-
T Consensus 241 --------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp 282 (353)
T 3txo_A 241 --------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282 (353)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred --------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence 12233345678899999999999999998 7776643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=342.38 Aligned_cols=257 Identities=25% Similarity=0.440 Sum_probs=202.2
Q ss_pred hcCcccceeeeecCceEEEEEEECC------ceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELRG------EKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLF 557 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~g------~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~ 557 (790)
.++|++.+.||+|+||.||+|.... ..+|||.++.. ....+.+|++++++++||||+++++++.+ +..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3568889999999999999998752 25999998742 34568899999999999999999999875 4589
Q ss_pred EEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccc
Q 046083 558 LVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~ 637 (790)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++...
T Consensus 123 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCe---eCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999998653 369999999999999999999999998 999999999999999999999999998764
Q ss_pred cCCccc--ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 638 VGSASV--HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 638 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
...... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+...
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~~~~~~~~---- 266 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HEVMKAINDG---- 266 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTT----
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHCC----
Confidence 332211 122346788999999999999999999999999999999 9999854321 1111111111
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCcc
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSED 771 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~ 771 (790)
.....+...+..+.+++.+||+.||++||++.++++.|+.+......
T Consensus 267 ----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 267 ----------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp ----------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred ----------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 11122334556789999999999999999999999999988665544
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=370.71 Aligned_cols=252 Identities=22% Similarity=0.396 Sum_probs=203.5
Q ss_pred cCcccce-eeeecCceEEEEEEEC----CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEE
Q 046083 490 NDFSMGN-KIGQGGFGAVFYAELR----GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~-~lG~G~fg~Vy~a~~~----g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~ 560 (790)
+++.+.+ .||+|+||.||+|.+. +..||||.++. ...++|.+|+++|++++||||+++++++.++..++||
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~ 414 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 414 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEE
Confidence 4455555 8999999999999874 45799999874 3457899999999999999999999999888899999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++|+|.+++... ...+++..++.++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++......
T Consensus 415 E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~i---iHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNF---VHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp ECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCE---EcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 999999999999764 3469999999999999999999999998 999999999999999999999999998764332
Q ss_pred cccc--cccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 641 ASVH--TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 641 ~~~~--~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
.... ....+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .....+.
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~~~~~i~--------- 553 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIE--------- 553 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--------HHHHHHH---------
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--------HHHHHHH---------
Confidence 2111 12345689999999999999999999999999999998 99998653321 1111111
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
.......+..++..+.+|+.+||+.||++||++++|++.|..+..
T Consensus 554 -----~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 554 -----QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp -----TTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 111223344566789999999999999999999999999988643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=343.95 Aligned_cols=246 Identities=25% Similarity=0.426 Sum_probs=196.3
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC--------
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-------- 554 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-------- 554 (790)
.++|++.+.||+|+||.||+|+.. ++.||||+++. ...+.+.+|++++++++||||+++++++.+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457999999999999999999986 88999999852 3456799999999999999999999987532
Q ss_pred --------------------------------------------------eEEEEEEEecCCChhhhhhcCCC-CCCCHH
Q 046083 555 --------------------------------------------------SLFLVYEYIENGNLNQHLRGSGK-DTLTWS 583 (790)
Q Consensus 555 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~ 583 (790)
..++||||+++++|.+++..... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 27999999999999999987543 456788
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc-----------ccccccccCCC
Q 046083 584 ARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA-----------SVHTRLVGTFG 652 (790)
Q Consensus 584 ~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~gt~~ 652 (790)
.+++++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~i---vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGL---MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCCe---eecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 899999999999999999997 9999999999999999999999999987654321 11233579999
Q ss_pred ccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHH
Q 046083 653 YMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPID 732 (790)
Q Consensus 653 y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 732 (790)
|+|||.+.+..++.++||||||+++|||++|..|+.... ........... ......
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~----------~~~~~~~~~~~--------------~~~~~~ 297 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV----------RIITDVRNLKF--------------PLLFTQ 297 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH----------HHHHHHHTTCC--------------CHHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH----------HHHHHhhccCC--------------Cccccc
Confidence 999999999999999999999999999999877653211 11111111100 001123
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 733 SVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 733 ~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
....+.+++.+||+.||++|||++|++++
T Consensus 298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 298 KYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred CChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 34567899999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=338.36 Aligned_cols=259 Identities=19% Similarity=0.235 Sum_probs=206.6
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-hhHHHHHHHHHHHHhc-CCCCCcceEEEEecC-eEEEEEEEe
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-QASKEFLAELKVLTHV-HHLNLVRLIGYCVEG-SLFLVYEYI 563 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~~~lv~e~~ 563 (790)
.++|++.+.||+|+||.||+|... ++.||||.+.. ...+.+.+|++++..+ +|+|++++++++.++ ..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 357999999999999999999964 88999998864 3345688999999999 799999999998754 589999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCc-----EEEEEeCCCccccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFR-----AKVADFGLAKLTEV 638 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~-----~kl~DfGla~~~~~ 638 (790)
+++|.+++...+ ..+++..+++++.|++.||+|||++++ +||||||+|||++.++. +||+|||+++....
T Consensus 89 -~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i---vH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 89 -GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSL---VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp -CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTE---ECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred -CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCE---ecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 999999998653 359999999999999999999999997 99999999999987776 99999999987654
Q ss_pred CCcc------cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC
Q 046083 639 GSAS------VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD 712 (790)
Q Consensus 639 ~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (790)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .......+.....
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~ 238 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-----NKQKYERIGEKKQ 238 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC-----HHHHHHHHHHHHH
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccc-----cHHHHHHHHhhcc
Confidence 3221 1234679999999999999999999999999999999999999997643211 1111111111000
Q ss_pred ChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 713 PREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 713 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
....... ....+..+.+++.+||+.||++|||+++|++.|..+..
T Consensus 239 -~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 239 -STPLREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp -HSCHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred -CccHHHH---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 0000010 11234578999999999999999999999999998754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=355.12 Aligned_cols=261 Identities=23% Similarity=0.323 Sum_probs=208.1
Q ss_pred cCHHHHHHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh------HHHHHHHHHHHHhcCCCCCcceEEEE
Q 046083 480 FSYEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA------SKEFLAELKVLTHVHHLNLVRLIGYC 551 (790)
Q Consensus 480 ~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~------~~~~~~E~~~l~~l~h~niv~l~g~~ 551 (790)
+.++++....++|++.+.||+|+||.||+++.. ++.+|+|+++... .+.+.+|.+++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 455666667889999999999999999999986 8899999997432 23478999999999999999999988
Q ss_pred ec-CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEe
Q 046083 552 VE-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADF 630 (790)
Q Consensus 552 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~Df 630 (790)
.+ +..|+||||+++|+|.+++...+ ..+++..+..++.+++.||+|||++++ +||||||+|||++.++.+||+||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~gi---iHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGY---VHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCe---eecccCHHHeeecCCCCEEEeec
Confidence 75 45899999999999999998643 358999999999999999999999997 99999999999999999999999
Q ss_pred CCCcccccCCcccccccccCCCccchhccc-------CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHH
Q 046083 631 GLAKLTEVGSASVHTRLVGTFGYMPPEYAQ-------YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVAL 703 (790)
Q Consensus 631 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 703 (790)
|+++..............||+.|+|||++. ...++.++|||||||++|||++|+.||..... ...
T Consensus 207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~ 278 (412)
T 2vd5_A 207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST--------AET 278 (412)
T ss_dssp TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHH
T ss_pred hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH--------HHH
Confidence 999876544333334468999999999987 35789999999999999999999999965332 112
Q ss_pred HHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHHHH
Q 046083 704 FEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLR---PSMRAIVVALM 763 (790)
Q Consensus 704 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R---Pt~~evl~~L~ 763 (790)
+..+.... .....+.. +...+.++.+++.+||. +|.+| |+++|++++-.
T Consensus 279 ~~~i~~~~------~~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpf 330 (412)
T 2vd5_A 279 YGKIVHYK------EHLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330 (412)
T ss_dssp HHHHHTHH------HHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGG
T ss_pred HHHHHhcc------cCcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCC
Confidence 22222100 00001111 12344678999999999 99998 68999987644
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=345.33 Aligned_cols=242 Identities=26% Similarity=0.402 Sum_probs=203.6
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
++|++.+.||+|+||.||+++.. ++.+|+|.++.. ..+.+.+|+++++.++||||+++++++.+ ...|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57999999999999999999986 889999998643 34568899999999999999999998875 4589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~i---vHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---ccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999998654 48999999999999999999999997 99999999999999999999999999865432
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+....
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~--------- 254 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSGK--------- 254 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC---------
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--------HHHHHHHHcCC---------
Confidence 2345789999999999999999999999999999999999999964321 12222222211
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPS-----MRAIVVALM 763 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~L~ 763 (790)
..++...+..+.+++.+||+.||.+||+ ++|++++-.
T Consensus 255 ------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~ 296 (350)
T 1rdq_E 255 ------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp ------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred ------CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence 1123344567899999999999999998 888876544
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=336.16 Aligned_cols=263 Identities=22% Similarity=0.419 Sum_probs=208.4
Q ss_pred cCcccceeeeecCceEEEEEEE------CCceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEec---CeE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAEL------RGEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVE---GSL 556 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~------~g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~---~~~ 556 (790)
++|++.+.||+|+||.||+|++ .++.+|+|.++.. ..+.+.+|++++++++||||+++++++.+ ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588899999999999999984 3789999998743 34678999999999999999999999874 347
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||++++ +||||||+|||++.++.+||+|||++...
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCc---ccCCCchheEEEcCCCCEEECcccccccc
Confidence 99999999999999996543 359999999999999999999999997 99999999999999999999999999876
Q ss_pred ccCCc--ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 637 EVGSA--SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 637 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
..... .......||..|+|||.+.+..++.++||||||+++|||++|..|+..... ............
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------~~~~~~~~~~~~ 246 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----------LFLKMIGPTHGQ 246 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----------HHHHHHCSCCGG
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----------HHhhccCCcccc
Confidence 54332 122345678889999999999999999999999999999999988643211 111111111100
Q ss_pred ---hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 046083 715 ---EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLS 766 (790)
Q Consensus 715 ---~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~ 766 (790)
..+...+........+...+..+.+++.+||+.||.+|||++|+++.|+.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 247 MTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp GHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111222222223344556678999999999999999999999999998763
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=344.02 Aligned_cols=240 Identities=25% Similarity=0.350 Sum_probs=190.0
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhc-CCCCCcceEEEEecC-eEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHV-HHLNLVRLIGYCVEG-SLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~~~lv~ 560 (790)
++|++.++||+|+||+||+|.+. ++.||||++.. .....+..|+..+.++ +||||+++++++.++ ..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999986 88999998753 2334455666666555 899999999998754 589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+ +++|.+++...+ ..++|..++.++.|++.||+|||++++ +||||||+|||++.++.+||+|||++.......
T Consensus 137 e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i---vH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGL---VHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp ECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred ecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCE---ecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 999 669999887653 369999999999999999999999997 999999999999999999999999998654322
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
......||+.|+|||++.+ .++.++|||||||++|||++|..++..... +..+.....
T Consensus 212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----------~~~~~~~~~-------- 269 (311)
T 3p1a_A 212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----------WQQLRQGYL-------- 269 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----------HHHHTTTCC--------
T ss_pred --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------HHHHhccCC--------
Confidence 2334568999999999875 799999999999999999999776543211 111111111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
....+......+.+++.+||+.||++|||++|++++
T Consensus 270 -----~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 270 -----PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp -----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 011112234678999999999999999999999874
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=344.66 Aligned_cols=244 Identities=28% Similarity=0.446 Sum_probs=201.5
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhc-CCCCCcceEEEEec-CeEE
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSLF 557 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~~ 557 (790)
..++|.+.+.||+|+||.||+|+.. ++.+|+|.++.. ..+.+..|.+++..+ +||||+++++++.+ ...|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4578999999999999999999986 789999999753 345678899999887 99999999998875 4689
Q ss_pred EEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccc
Q 046083 558 LVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~ 637 (790)
+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++...
T Consensus 95 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~i---vHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGI---VYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 9999999999999998643 58999999999999999999999998 999999999999999999999999998543
Q ss_pred cCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 638 VGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+..+....
T Consensus 170 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~------ 234 (345)
T 1xjd_A 170 LGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSIRMDN------ 234 (345)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC------
T ss_pred cCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHhCC------
Confidence 222 223456799999999999999999999999999999999999999964322 12222222211
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMR-AIVV 760 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl~ 760 (790)
..++......+.+++.+||+.||++||++. ++++
T Consensus 235 ---------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 ---------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 112333456788999999999999999997 6554
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=345.38 Aligned_cols=249 Identities=21% Similarity=0.345 Sum_probs=202.9
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVY 560 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~ 560 (790)
.++|++.+.||+|+||.||+|... +..+|+|.+.. ...+.+.+|++++++++||||+++++++.+. ..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999986 78999999853 2346688999999999999999999998754 589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC---CcEEEEEeCCCcccc
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN---FRAKVADFGLAKLTE 637 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~---~~~kl~DfGla~~~~ 637 (790)
||+++|+|.+++.... .+++..+..++.|++.||.|||++++ +||||||+|||++.+ +.+||+|||++....
T Consensus 108 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~i---vH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 108 DLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGI---VHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp CCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 9999999999997643 58999999999999999999999998 999999999999865 459999999998664
Q ss_pred cCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 638 VGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
... ......||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+......
T Consensus 183 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--------~~~~~~i~~~~~~---- 248 (362)
T 2bdw_A 183 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYAQIKAGAYD---- 248 (362)
T ss_dssp TCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCC----
T ss_pred CCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhCCCC----
Confidence 322 22346799999999999998999999999999999999999999865321 1222222221110
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.........+..+.+++.+||+.||++|||+.|++++-+
T Consensus 249 -------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 249 -------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 287 (362)
T ss_dssp -------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred -------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 000001234467889999999999999999999987644
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=353.58 Aligned_cols=251 Identities=21% Similarity=0.321 Sum_probs=202.4
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEE
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLV 559 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv 559 (790)
..++|++.+.||+|+||.||++... ++.+|+|.+.. ...+.+.+|++++++++||||+++++++.+ +..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3567999999999999999999875 88999998853 234568899999999999999999999875 458999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEec---CCCcEEEEEeCCCccc
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILID---KNFRAKVADFGLAKLT 636 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~---~~~~~kl~DfGla~~~ 636 (790)
|||+++|+|.+++...+ .+++..+..++.|++.||.|||++++ +||||||+|||++ .++.+||+|||++...
T Consensus 89 ~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~gi---vHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMGV---VHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp ECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999999998754 59999999999999999999999998 9999999999998 5678999999999866
Q ss_pred ccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhh
Q 046083 637 EVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716 (790)
Q Consensus 637 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (790)
.... .......||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+......
T Consensus 164 ~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~~~--- 231 (444)
T 3soa_A 164 EGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--------HRLYQQIKAGAYD--- 231 (444)
T ss_dssp CTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTCCC---
T ss_pred cCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHhCCCC---
Confidence 4332 223346799999999999999999999999999999999999999964322 1222222221110
Q ss_pred hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 717 LQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 717 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.........+..+.+++.+||+.||.+|||+.|++++-+
T Consensus 232 --------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~ 270 (444)
T 3soa_A 232 --------FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPW 270 (444)
T ss_dssp --------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred --------CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 000011133467889999999999999999999988543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.27 Aligned_cols=261 Identities=26% Similarity=0.448 Sum_probs=210.3
Q ss_pred HHHHHHhcCcccceeeeecCceEEEEEEEC-------CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEE
Q 046083 483 EELAKATNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYC 551 (790)
Q Consensus 483 ~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~ 551 (790)
+++....++|++.+.||+|+||.||+|... +..+|+|.+.. .....+.+|++++++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344456678999999999999999999764 56899999864 2345688999999999999999999998
Q ss_pred ecC-eEEEEEEEecCCChhhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC
Q 046083 552 VEG-SLFLVYEYIENGNLNQHLRGSG--------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN 622 (790)
Q Consensus 552 ~~~-~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~ 622 (790)
.++ ..++||||+++|+|.+++.... ...+++..+++++.|++.||.|||++++ +||||||+|||++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i---~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTC---BCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCC---ccCCCccceEEEcCC
Confidence 754 5899999999999999997532 1357999999999999999999999998 999999999999999
Q ss_pred CcEEEEEeCCCcccccCCc-ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccch
Q 046083 623 FRAKVADFGLAKLTEVGSA-SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGL 700 (790)
Q Consensus 623 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~ 700 (790)
+.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------- 246 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------- 246 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--------
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH--------
Confidence 9999999999986543221 12223456889999999998999999999999999999999 8888854321
Q ss_pred HHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 701 VALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 701 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
......+... .. ...+...+..+.+++.+||+.||.+|||+.|+++.|..+...
T Consensus 247 ~~~~~~~~~~-------------~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 247 EQVLRFVMEG-------------GL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp HHHHHHHHTT-------------CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHHHHHHHcC-------------Cc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 1112222211 11 112334456789999999999999999999999999987553
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=342.19 Aligned_cols=248 Identities=22% Similarity=0.388 Sum_probs=202.3
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh---------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ---------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLF 557 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~ 557 (790)
++|.+.+.||+|+||.||+|... +..+|+|.++.. ..+.+.+|++++++++||||+++++++.+ ...+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 56899999999999999999986 889999988532 35679999999999999999999999875 4589
Q ss_pred EEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC----cEEEEEeCCC
Q 046083 558 LVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF----RAKVADFGLA 633 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~----~~kl~DfGla 633 (790)
+||||+++++|.+++... ..+++..++.++.|++.||.|||++++ +||||||+|||++.++ .+||+|||++
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i---vH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCe---EcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999764 359999999999999999999999997 9999999999999887 8999999999
Q ss_pred cccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC
Q 046083 634 KLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+......
T Consensus 166 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~~~~~~~~ 235 (326)
T 2y0a_A 166 HKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANVSAVNYE 235 (326)
T ss_dssp EECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHHTCCC
T ss_pred eECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--------HHHHHHHHhcCCC
Confidence 8764322 22345799999999999999999999999999999999999999964322 1111222111100
Q ss_pred hhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 714 REDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 714 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.........+..+.+++.+||+.||++|||++|++++-+
T Consensus 236 -----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 274 (326)
T 2y0a_A 236 -----------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274 (326)
T ss_dssp -----------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred -----------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 000000123456889999999999999999999998544
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=341.43 Aligned_cols=260 Identities=25% Similarity=0.408 Sum_probs=208.4
Q ss_pred cccceeeeecCceEEEEEEE------CCceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEec---CeEEE
Q 046083 492 FSMGNKIGQGGFGAVFYAEL------RGEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVE---GSLFL 558 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~------~g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~---~~~~l 558 (790)
|++.+.||+|+||.||++.+ .++.+|||+++.. ..+.+.+|++++++++||||+++++++.+ ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48899999999999999875 3678999999753 34668999999999999999999999875 34799
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
||||+++|+|.+++... .+++..++.++.+++.||.|||+.++ +||||||+|||++.++.+||+|||++.....
T Consensus 113 v~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~i---vH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCc---cCCCCchheEEEcCCCCEEECCccccccccc
Confidence 99999999999999864 38999999999999999999999997 9999999999999999999999999987654
Q ss_pred CCcc--cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC---C
Q 046083 639 GSAS--VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD---P 713 (790)
Q Consensus 639 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 713 (790)
.... ......++..|+|||.+.+..++.++||||||+++|||++|+.||....... ........ .
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~----------~~~~~~~~~~~~ 256 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF----------LELIGIAQGQMT 256 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH----------HHHHCSCCHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh----------hhhhcccccchh
Confidence 3321 2233567888999999998899999999999999999999999986532210 00000000 0
Q ss_pred hhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 714 REDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 714 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
...+.+.+........+...+..+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 257 VLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 011223333333334455566789999999999999999999999999998754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=342.76 Aligned_cols=244 Identities=23% Similarity=0.349 Sum_probs=201.8
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh------HHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA------SKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~------~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
++|.+.+.||+|+||.||+|... ++.||+|.+.... .+.+.+|+++++.++||||+++++++.. ...++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999984 8899999986432 3468899999999999999999999875 4689999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+ +|+|.+++...+ .+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~gi---vH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~- 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKI---VHRDLKPENLLLDDNLNVKIADFGLSNIMTDG- 161 (336)
T ss_dssp CCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred ECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence 999 679999887653 59999999999999999999999998 99999999999999999999999999865432
Q ss_pred cccccccccCCCccchhcccCCCC-CchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEV-SPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
.......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||....... ....
T Consensus 162 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---------------------~~~~ 219 (336)
T 3h4j_B 162 -NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN---------------------LFKK 219 (336)
T ss_dssp -BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT---------------------CBCC
T ss_pred -cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH---------------------HHHH
Confidence 22344679999999999988776 789999999999999999999996532210 0000
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
+... ....+...+..+.+++.+||+.||.+|||++|++++-+-
T Consensus 220 i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 262 (336)
T 3h4j_B 220 VNSC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262 (336)
T ss_dssp CCSS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHH
T ss_pred HHcC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhh
Confidence 0000 112233455678999999999999999999999987664
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=343.91 Aligned_cols=245 Identities=26% Similarity=0.426 Sum_probs=202.6
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhc-CCCCCcceEEEEec-CeEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSLFL 558 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~~l 558 (790)
.++|++.+.||+|+||.||+|+.. ++.+|+|.++.. ..+.+..|.+++..+ +||||+++++++.+ +..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 468999999999999999999987 678999999753 335688899999988 89999999998875 56899
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
||||+++|+|.+++...+ .+++..++.++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++....
T Consensus 99 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gi---vHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGI---IYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCE---EeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 999999999999998654 58999999999999999999999998 9999999999999999999999999985432
Q ss_pred CCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 639 GSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+....
T Consensus 174 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~------- 237 (353)
T 2i0e_A 174 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEHN------- 237 (353)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-------
T ss_pred CC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhCC-------
Confidence 22 223456799999999999999999999999999999999999999964321 22223332211
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPS-----MRAIVVAL 762 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~L 762 (790)
..++...+.++.+++.+||+.||.+||+ ++|++++-
T Consensus 238 --------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~ 278 (353)
T 2i0e_A 238 --------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 278 (353)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred --------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence 1223345567899999999999999995 57776543
|
| >4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=315.90 Aligned_cols=182 Identities=49% Similarity=0.922 Sum_probs=166.2
Q ss_pred cchhhhhhheeeecCCCCCHHHHHHHcCCCh--------hhHhhcCCCCCCcccccCCceEEeccccccCCCceeeeeEE
Q 046083 215 CSKGCDLALASYYLWKGANLTFISKVFDTSI--------KYILSFNPQITNKDKILAGTRINVPFSCNCIQNKFLGHSFS 286 (790)
Q Consensus 215 ~~~~~~~~~~~y~v~~gdtl~~Ia~~~~~~~--------~~l~~~N~~~~~~~~l~~gq~l~ip~~~~~~~~~~~~~~~~ 286 (790)
|..+|+.+++.|+|++||||+.||++||+++ ++|+++||++.+++.|++||.|.||.+|.|..+.+.....+
T Consensus 1 ~~~~C~~a~~~Y~V~~GDTL~~IA~~~~vsv~~~~~~~~~~I~~~Np~l~~~~~l~~Gq~L~IP~~~~~~~~~~~~~~~~ 80 (212)
T 4eby_A 1 CRTSCPLALASYYLENGTTLSVINQNLNSSIAPYDQINFDPILRYNSNIKDKDRIQMGSRVLVPFPCECQPGDFLGHNFS 80 (212)
T ss_dssp CCCCCSCEEEEEECCTTCCHHHHHHHTCCSSSCCCSSCCHHHHTTCTTCSCTTSCCTTCEEEEEECCEEETTTEEEEEEE
T ss_pred CCCCCccceEEEEeCCCCCHHHHHHHHCCCchhccccCHHHHHHhccCCCCcCccCCCCEEEEeccccccCCccccCceE
Confidence 7889999999999999999999999999999 99999999997678999999999999999986667777889
Q ss_pred EEeccCchHHHHHHHhhcccccHHHHHhcCCCCCCCCCCCCcEEEEeEeeecCCCcccCCcceEEEeecCCCCccccccc
Q 046083 287 YKVKSGNTYKRIAELIYANLTTLDWLKSSNAYDENHTPDVSSSVNVIVNCSCGSKSVSKDYGLFLTYPLRPGENLSSIAN 366 (790)
Q Consensus 287 y~V~~gDtl~~IA~~~~~~l~~~~~l~~~N~~~~~~~~~~Gq~l~ip~~~~~~~~~~~~~~~~~~~Y~v~~GDtl~~IA~ 366 (790)
|+|++|||||.||++.|.+++++++|+++|+++++.|.+ ||+|.||..|+|+.....++.+..++|+|++|||||+||+
T Consensus 81 Y~V~~GDTL~~IA~~~y~~lvt~~~L~~~N~~~~~~l~~-Gq~L~IP~~~~~~~~~~~~~~~~~~~Y~V~~GDTL~~IA~ 159 (212)
T 4eby_A 81 YSVRQEDTYERVAISNYANLTTMESLQARNPFPATNIPL-SATLNVLVNCSCGDESVSKDFGLFVTYPLRPEDSLSSIAR 159 (212)
T ss_dssp EECCTTCCHHHHHHTTTTTSSCHHHHHHHCCSCTTCCCT-TCEEEEEEECCCCCTTTCSSCCCEEEEECCTTCCHHHHHH
T ss_pred EEecCCCcHHHHHHHhcCCCCCHHHHHHhcCCCcccCCC-CCEEEEcCCCcCCCcccccCCCCeEEEEECCCCcHHHHHH
Confidence 999999999999977888999999999999988877877 9999999999998776666666778999999999999999
Q ss_pred cccCChhhhhhcCCCCccccCCCceeccccC
Q 046083 367 EFELSSELLQSYNPTLDFISGSGLAFVPVKG 397 (790)
Q Consensus 367 ~f~~s~~~l~~~N~~~~~~~~~g~~~iP~~~ 397 (790)
|||+++++|++||+..++....|.++||.+.
T Consensus 160 ~fgvsv~~L~~~N~~~~~~~~~g~l~IP~~~ 190 (212)
T 4eby_A 160 SSGVSADILQRYNPGVNFNSGNGIVYVPGRD 190 (212)
T ss_dssp HHTSCHHHHHHHSTTCCTTSCSSEEEEECCC
T ss_pred HHCcCHHHHHHhcCCCccCCCCCEEEecCCC
Confidence 9999999999999988877777788899764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=346.16 Aligned_cols=250 Identities=22% Similarity=0.350 Sum_probs=201.5
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh--------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ--------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFL 558 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~l 558 (790)
++|++.+.||+|+||.||+|... ++.+|||.++.. ..+.+.+|+++++.++||||+++++++.+ +..|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 56999999999999999999886 889999998642 35678999999999999999999998875 56899
Q ss_pred EEEEecCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCc---EEEEEeCCC
Q 046083 559 VYEYIENGNLNQHLRGS--GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFR---AKVADFGLA 633 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~---~kl~DfGla 633 (790)
||||+++++|.+++... ....+++..+..++.|++.||+|||++++ +||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i---vHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNI---IHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCc---eeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999999887643 23358999999999999999999999997 99999999999987654 999999999
Q ss_pred cccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC
Q 046083 634 KLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+..+......
T Consensus 181 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~i~~~~~~ 250 (351)
T 3c0i_A 181 IQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---------RLFEGIIKGKYK 250 (351)
T ss_dssp EECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---------HHHHHHHHTCCC
T ss_pred eEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---------HHHHHHHcCCCC
Confidence 8764322 223346799999999999999999999999999999999999999965321 122222221110
Q ss_pred hhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 714 REDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 714 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.. ... ....+..+.+++.+||+.||++|||+.|++++-+
T Consensus 251 ~~-~~~----------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 289 (351)
T 3c0i_A 251 MN-PRQ----------WSHISESAKDLVRRMLMLDPAERITVYEALNHPW 289 (351)
T ss_dssp CC-HHH----------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CC-ccc----------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChh
Confidence 00 000 0123457889999999999999999999987544
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=341.29 Aligned_cols=257 Identities=21% Similarity=0.265 Sum_probs=205.1
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-hHHHHHHHHHHHHhc-CCCCCcceEEEEecC-eEEEEEEEe
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-ASKEFLAELKVLTHV-HHLNLVRLIGYCVEG-SLFLVYEYI 563 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~~~lv~e~~ 563 (790)
.++|++.+.||+|+||.||+|... ++.||||.+... ..+.+.+|+++++++ +||||+++++++.++ ..++||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 367999999999999999999964 889999998643 335688999999999 999999999998754 579999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCc-----EEEEEeCCCccccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFR-----AKVADFGLAKLTEV 638 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~-----~kl~DfGla~~~~~ 638 (790)
+++|.+++.... ..+++..++.++.|++.||+|||++++ +||||||+|||++.++. +||+|||+++....
T Consensus 88 -~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i---iHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 88 -GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKNL---IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp -CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred -CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCe---eccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 999999998652 469999999999999999999999997 99999999999999887 99999999986543
Q ss_pred CCcc------cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC
Q 046083 639 GSAS------VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD 712 (790)
Q Consensus 639 ~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (790)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ........+.....
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~-----~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD-----TLKERYQKIGDTKR 237 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS-----SHHHHHHHHHHHHH
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc-----cHHHHHHHHHhhhc
Confidence 3221 123467999999999999999999999999999999999999999764321 12222222111000
Q ss_pred ChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 046083 713 PREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLS 766 (790)
Q Consensus 713 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~ 766 (790)
.... +. +.. ..+ ++.+++..||+.||.+||++++|.+.|..+.
T Consensus 238 -~~~~-~~----~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 238 -ATPI-EV----LCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp -HSCH-HH----HTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred -cCCH-HH----Hhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 0000 00 001 123 7999999999999999999999999998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=341.00 Aligned_cols=264 Identities=26% Similarity=0.430 Sum_probs=211.6
Q ss_pred cCHHHHHHHhcCcccceeeeecCceEEEEEEEC-------CceEEEEEeChh----hHHHHHHHHHHHHhc-CCCCCcce
Q 046083 480 FSYEELAKATNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDMQ----ASKEFLAELKVLTHV-HHLNLVRL 547 (790)
Q Consensus 480 ~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~~----~~~~~~~E~~~l~~l-~h~niv~l 547 (790)
+...++....++|++.+.||+|+||.||+|.+. ++.+|||.++.. ..+.+.+|++++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 344555556788999999999999999999852 478999998742 345688999999999 79999999
Q ss_pred EEEEecC--eEEEEEEEecCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecC
Q 046083 548 IGYCVEG--SLFLVYEYIENGNLNQHLRGSGK--------------DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRD 611 (790)
Q Consensus 548 ~g~~~~~--~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~d 611 (790)
++++.+. ..++||||+++++|.+++..... ..+++..++.++.|++.||.|||++++ +|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i---~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTC---CCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCc---cccc
Confidence 9998743 48999999999999999986542 128999999999999999999999998 9999
Q ss_pred CCCCCEEecCCCcEEEEEeCCCcccccCCc-ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccc
Q 046083 612 IKPANILIDKNFRAKVADFGLAKLTEVGSA-SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVK 689 (790)
Q Consensus 612 lkp~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~ 689 (790)
|||+|||++.++.+||+|||+++....... .......|++.|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999986543322 12234567889999999999999999999999999999998 9999865
Q ss_pred cccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 690 TNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
.... ......+.... ....+...+..+.+++.+||+.||.+|||+.|++++|..+..
T Consensus 254 ~~~~-------~~~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 254 VKID-------EEFCRRLKEGT--------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp CCCS-------HHHHHHHHHTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchh-------HHHHHHhccCc--------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 3321 01111111110 011222344678999999999999999999999999998754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=336.74 Aligned_cols=263 Identities=25% Similarity=0.381 Sum_probs=201.1
Q ss_pred hcCcccceeeeecCceEEEEEEEC-CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYE 561 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e 561 (790)
.++|++.+.||+|+||.||+|... ++.+|+|++... ..+.+.+|++++++++||||+++++++.++ ..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 367999999999999999999985 889999998643 235688999999999999999999998754 5899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|+++ +|.+++.... ..+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++.......
T Consensus 100 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i---vH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 100 FMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRI---LHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp CCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred CCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 9985 8888887643 358999999999999999999999997 9999999999999999999999999987643222
Q ss_pred ccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChh-----
Q 046083 642 SVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE----- 715 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 715 (790)
......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... +...........+....
T Consensus 175 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 175 -SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD-----DQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT-----THHHHHHHHHCCCCTTTSGGGT
T ss_pred -cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHHCCCChHHhhhhh
Confidence 2234578999999999876 56899999999999999999999999654332 12222222222222110
Q ss_pred hhhhhcCCcCC--CCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 716 DLQRLVDPRLG--DDY-----PIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 716 ~l~~~~d~~l~--~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
.+..+.+.... ... ......++.+|+.+||+.||++|||++|++++-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 302 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP 302 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence 00011110000 000 112345788999999999999999999998743
|
| >4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=314.79 Aligned_cols=182 Identities=49% Similarity=0.907 Sum_probs=166.2
Q ss_pred chhhhhhHhhhcccCCCCCHHHHHHHhCCCH--------HHHHhhCCCCCCCCCcCCCCeEEeeeecccCCCCCccccee
Q 046083 8 CNTGCQLALASYYVWEGSNPTYISNIFGEDI--------AQILLYNPNIPNQNTIPSDTRISIPFSCDCLNGDFLGHTFT 79 (790)
Q Consensus 8 c~~~c~~~~~~y~v~~gdtl~~Ia~~~~~~~--------~~l~~~Np~~~~~~~~~~g~~l~ip~~~~~~~~~~~~~~~~ 79 (790)
|+++|+.+++.|+|++||||+.||++||+++ ++|+++||++++++.|.+||.|.||.+|.|..+........
T Consensus 1 ~~~~C~~a~~~Y~V~~GDTL~~IA~~~~vsv~~~~~~~~~~I~~~Np~l~~~~~l~~Gq~L~IP~~~~~~~~~~~~~~~~ 80 (212)
T 4eby_A 1 CRTSCPLALASYYLENGTTLSVINQNLNSSIAPYDQINFDPILRYNSNIKDKDRIQMGSRVLVPFPCECQPGDFLGHNFS 80 (212)
T ss_dssp CCCCCSCEEEEEECCTTCCHHHHHHHTCCSSSCCCSSCCHHHHTTCTTCSCTTSCCTTCEEEEEECCEEETTTEEEEEEE
T ss_pred CCCCCccceEEEEeCCCCCHHHHHHHHCCCchhccccCHHHHHHhccCCCCcCccCCCCEEEEeccccccCCccccCceE
Confidence 8999999999999999999999999999999 99999999998788999999999999999876655666789
Q ss_pred EEeccCCchHHHHhhhcCCCChHHHHHHccCCCCCCCCCCcEEEEEeeccCCCCcccCCceeEEEeecCCCCCHHHHHHH
Q 046083 80 YETQFGDTYEKVASFAFANLTTEDWVRRVNIYEPTRIPDYAFINVTVNCSCGDRHISRDYGLFTTYPLRPAQNLSSVAAE 159 (790)
Q Consensus 80 Y~V~~GDTl~~IA~~~~~~~~t~~~l~~~N~~~~~~l~~Gq~l~iP~~~~~~~~~~~~~~~~~~~y~v~~gd~l~~ia~~ 159 (790)
|+|++|||||.||+++|++++++++|+++|.++++.|++||+|.||..|.|+....+.+.+.+.+|+|++||||+.||++
T Consensus 81 Y~V~~GDTL~~IA~~~y~~lvt~~~L~~~N~~~~~~l~~Gq~L~IP~~~~~~~~~~~~~~~~~~~Y~V~~GDTL~~IA~~ 160 (212)
T 4eby_A 81 YSVRQEDTYERVAISNYANLTTMESLQARNPFPATNIPLSATLNVLVNCSCGDESVSKDFGLFVTYPLRPEDSLSSIARS 160 (212)
T ss_dssp EECCTTCCHHHHHHTTTTTSSCHHHHHHHCCSCTTCCCTTCEEEEEEECCCCCTTTCSSCCCEEEEECCTTCCHHHHHHH
T ss_pred EEecCCCcHHHHHHHhcCCCCCHHHHHHhcCCCcccCCCCCEEEEcCCCcCCCcccccCCCCeEEEEECCCCcHHHHHHH
Confidence 99999999999996689988899999999998999999999999999999877665555666789999999999999999
Q ss_pred hCCChHHHhhhCCCCcccCCcceEEeechh
Q 046083 160 AGVAPQSLQRYNPGTNFSAGTGLVFVPARV 189 (790)
Q Consensus 160 ~~~~~~~l~~~N~~~~~~~~~~~~~~p~~~ 189 (790)
||+++++|+++|+..+...++++++||++.
T Consensus 161 fgvsv~~L~~~N~~~~~~~~~g~l~IP~~~ 190 (212)
T 4eby_A 161 SGVSADILQRYNPGVNFNSGNGIVYVPGRD 190 (212)
T ss_dssp HTSCHHHHHHHSTTCCTTSCSSEEEEECCC
T ss_pred HCcCHHHHHHhcCCCccCCCCCEEEecCCC
Confidence 999999999999987877788888999763
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=341.76 Aligned_cols=268 Identities=33% Similarity=0.559 Sum_probs=210.5
Q ss_pred cCcccceeeeecCceEEEEEEEC--Cce--EEEEEeCh----hhHHHHHHHHHHHHhc-CCCCCcceEEEEec-CeEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEK--AAIKKMDM----QASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSLFLV 559 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~--vavK~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~~lv 559 (790)
++|++.+.||+|+||.||+|... +.. +++|.++. ...+.+.+|+++++++ +||||+++++++.+ +..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57889999999999999999875 444 48898753 2345688999999999 89999999999875 458999
Q ss_pred EEEecCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcE
Q 046083 560 YEYIENGNLNQHLRGSG--------------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRA 625 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~ 625 (790)
|||+++++|.+++.... ...+++..++.++.|++.||.|||++++ +||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCc---cCCCCccceEEEcCCCeE
Confidence 99999999999997643 2469999999999999999999999997 999999999999999999
Q ss_pred EEEEeCCCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHH
Q 046083 626 KVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALF 704 (790)
Q Consensus 626 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 704 (790)
||+|||+++...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ....
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELY 251 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHH
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH--------HHHH
Confidence 999999987432211 1223456889999999998889999999999999999998 9999854321 1111
Q ss_pred HHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccCCcCCcccccccc
Q 046083 705 EEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWDIGSFYENQGLD 784 (790)
Q Consensus 705 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~~~~~~~~~~~~~ 784 (790)
..+.. ......+...+..+.+++.+||+.||.+|||++|+++.|..+......+.....+....+.
T Consensus 252 ~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~~~~~ 317 (327)
T 1fvr_A 252 EKLPQ--------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYA 317 (327)
T ss_dssp HHGGG--------------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBCCBCTTCCCCC
T ss_pred HHhhc--------------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCccccchhccCCcC
Confidence 11111 1112223345567999999999999999999999999999987766655444444444333
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=345.32 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=195.4
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh--hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEe
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ--ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
.++|++.+.||+|+||.||++... ++.||||++... ..+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 467999999999999999999986 889999998642 34678899999999999999999999875 4589999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCc--EEEEEeCCCcccccCCc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFR--AKVADFGLAKLTEVGSA 641 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~--~kl~DfGla~~~~~~~~ 641 (790)
++|+|.+++...+ .+++..+..++.|++.||.|||++++ +||||||+|||++.++. +||+|||+++.....
T Consensus 99 ~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i---vH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-- 171 (361)
T 3uc3_A 99 SGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQI---CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 171 (361)
T ss_dssp CSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTC---CSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEEcCCCCceEEEeecCcccccccc--
Confidence 9999999997643 59999999999999999999999998 99999999999987765 999999999743322
Q ss_pred ccccccccCCCccchhcccCCCCCch-hhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGEVSPK-IDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~-sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
.......||+.|+|||++.+..++.+ +|||||||++|||++|+.||...... .............
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~~~~~~~~~---------- 237 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP----RDYRKTIQRILSV---------- 237 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C----CCHHHHHHHHHTT----------
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH----HHHHHHHHHHhcC----------
Confidence 12234579999999999988887766 89999999999999999999654321 1222222222221
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
.............+.+|+.+||+.||++|||++|++++-+-.
T Consensus 238 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 279 (361)
T 3uc3_A 238 ---KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFL 279 (361)
T ss_dssp ---CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHH
T ss_pred ---CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchh
Confidence 111111112346788999999999999999999999876643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=343.31 Aligned_cols=256 Identities=25% Similarity=0.463 Sum_probs=207.5
Q ss_pred hcCcccceeeeecCceEEEEEEEC---------CceEEEEEeChh----hHHHHHHHHHHHHhc-CCCCCcceEEEEecC
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR---------GEKAAIKKMDMQ----ASKEFLAELKVLTHV-HHLNLVRLIGYCVEG 554 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~---------g~~vavK~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 554 (790)
.++|++.+.||+|+||.||+|.+. +..||+|.++.. ..+.+.+|+++++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467999999999999999999863 467999999743 345688999999999 899999999998754
Q ss_pred -eEEEEEEEecCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe
Q 046083 555 -SLFLVYEYIENGNLNQHLRGSGK--------------DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI 619 (790)
Q Consensus 555 -~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl 619 (790)
..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||++++ +||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCe---eCCCCccceEEE
Confidence 58999999999999999986432 248999999999999999999999997 999999999999
Q ss_pred cCCCcEEEEEeCCCcccccCCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccc
Q 046083 620 DKNFRAKVADFGLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITES 697 (790)
Q Consensus 620 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~ 697 (790)
+.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----- 265 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 265 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-----
Confidence 99999999999999866433221 1223456789999999988889999999999999999999 9999854321
Q ss_pred cchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCC
Q 046083 698 TGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSS 769 (790)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~ 769 (790)
......+.... ....+...+..+.+++.+||+.||.+|||++|+++.|..+....
T Consensus 266 ---~~~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 266 ---EELFKLLKEGH--------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp ---HHHHHHHHHTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---HHHHHHHhcCC--------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 11122211110 11223344567899999999999999999999999999886543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=343.59 Aligned_cols=249 Identities=26% Similarity=0.449 Sum_probs=197.5
Q ss_pred hcCcccceeeeecCceEEEEEEEC-CceEEEEEeCh-----hhHHHHHHHHHHHHhcCC--CCCcceEEEEecC-eEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDM-----QASKEFLAELKVLTHVHH--LNLVRLIGYCVEG-SLFLV 559 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~-~~~lv 559 (790)
.++|++.+.||+|+||.||++... ++.+|||++.. ...+.+.+|++++.+++| +||+++++++.++ ..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 456999999999999999999886 77899998853 234678999999999976 9999999998754 58999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|| +.+++|.+++.... .+++..+..++.|++.||.|||++++ +||||||+|||++ ++.+||+|||+++.....
T Consensus 88 ~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i---iHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGI---VHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EC-CCSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred Ee-CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 99 56789999998753 58999999999999999999999998 9999999999997 578999999999876433
Q ss_pred Ccc-cccccccCCCccchhcccC-----------CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHH
Q 046083 640 SAS-VHTRLVGTFGYMPPEYAQY-----------GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEV 707 (790)
Q Consensus 640 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 707 (790)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~------ 227 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------I------ 227 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------H------
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-------H------
Confidence 222 2234679999999999864 67899999999999999999999999543211 1
Q ss_pred HcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 708 LRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 708 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
..+...+++.....++......+.+++.+||+.||.+|||+.|++++.+.
T Consensus 228 -------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~ 277 (343)
T 3dbq_A 228 -------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277 (343)
T ss_dssp -------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred -------HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence 11223333333334444445678999999999999999999999987664
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=344.16 Aligned_cols=244 Identities=25% Similarity=0.390 Sum_probs=200.7
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
++|++.+.||+|+||.||++... ++.+|+|.+... ..+.+.+|+++++.++||||+++++++.+ +..|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57899999999999999999986 778999998643 33568899999999999999999998875 4689999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+.+|+|.+++.... .+++..+..++.+++.||.|||++++ +||||||+|||++.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~gi---vHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQRI---IHRDMKPDNILLDEHGHVHITDFNIAAMLPRE- 168 (384)
T ss_dssp CCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred ecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---eeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence 9999999999998643 59999999999999999999999997 99999999999999999999999999866432
Q ss_pred cccccccccCCCccchhcccC---CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQY---GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||...... ........+...
T Consensus 169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-----~~~~~~~~~~~~------- 235 (384)
T 4fr4_A 169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST-----SSKEIVHTFETT------- 235 (384)
T ss_dssp -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS-----CHHHHHHHHHHC-------
T ss_pred -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc-----cHHHHHHHHhhc-------
Confidence 22345679999999999964 45899999999999999999999999653321 111112221111
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPS-MRAIVV 760 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~evl~ 760 (790)
...++......+.+|+.+||+.||.+||+ ++++.+
T Consensus 236 --------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 --------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 01223344567899999999999999998 777665
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=336.17 Aligned_cols=262 Identities=24% Similarity=0.370 Sum_probs=199.9
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh--------HHHHHHHHHHHHhc---CCCCCcceEEEEecC-
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA--------SKEFLAELKVLTHV---HHLNLVRLIGYCVEG- 554 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~--------~~~~~~E~~~l~~l---~h~niv~l~g~~~~~- 554 (790)
.++|++.+.||+|+||.||+|... ++.||||.+.... ...+.+|+++++++ +||||+++++++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 578999999999999999999964 8899999986321 34567788777766 499999999998642
Q ss_pred -----eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEE
Q 046083 555 -----SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVAD 629 (790)
Q Consensus 555 -----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~D 629 (790)
..+++|||+. ++|.+++.......+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i---vH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCTTTEEECTTSCEEECS
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEEcCCCCEEEee
Confidence 3789999997 599999987766669999999999999999999999998 9999999999999999999999
Q ss_pred eCCCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHc
Q 046083 630 FGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLR 709 (790)
Q Consensus 630 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 709 (790)
||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 164 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~~ 236 (308)
T 3g33_A 164 FGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-----DQLGKIFDLIG 236 (308)
T ss_dssp CSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH-----HHHHHHHHHHC
T ss_pred CccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhC
Confidence 99998654322 234467899999999999999999999999999999999999999654321 11111112222
Q ss_pred CCCChhhhhh-------hcCCcCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 710 QPDPREDLQR-------LVDPRLGD---DYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 710 ~~~~~~~l~~-------~~d~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
.+.. ..+.. .+.+.... ....+....+.+++.+||+.||++|||+.|++++-
T Consensus 237 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~ 298 (308)
T 3g33_A 237 LPPE-DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 298 (308)
T ss_dssp CCCT-TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred CCCh-hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCc
Confidence 1111 11100 00000000 00113446788999999999999999999998643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=331.91 Aligned_cols=261 Identities=24% Similarity=0.402 Sum_probs=197.5
Q ss_pred cCcccceeeeecCceEEEEEEEC-CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
++|++.+.||+|+||.||+|... ++.+|+|++... ..+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999986 889999998632 23678899999999999999999999875 458999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+++ +|.+++.... ..+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRV---LHRDLKPQNLLINREGELKIADFGLARAFGIPV-R 155 (288)
T ss_dssp CSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHEEEcCCCCEEEeECccccccCccc-c
Confidence 986 9999887643 358999999999999999999999998 999999999999999999999999998654322 1
Q ss_pred cccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh--hhhhh
Q 046083 643 VHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR--EDLQR 719 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~ 719 (790)
......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... ............+... ....+
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-----DQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHHCCCChhhchhhhc
Confidence 22345689999999999764 5899999999999999999999999653321 1111111111111110 00000
Q ss_pred --hcCCcCC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 720 --LVDPRLG-------DDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 720 --~~d~~l~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
..++... ..........+.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0111110 01112345678899999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=344.94 Aligned_cols=262 Identities=18% Similarity=0.260 Sum_probs=201.9
Q ss_pred hcCcccceeeeecCceEEEEEEEC-------CceEEEEEeChhhH--------------HHHHHHHHHHHhcCCCCCcce
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDMQAS--------------KEFLAELKVLTHVHHLNLVRL 547 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~~~~--------------~~~~~E~~~l~~l~h~niv~l 547 (790)
.++|++.+.||+|+||.||+|.+. ++.||||.+..... ..+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 467999999999999999999875 36799999864321 123445566777789999999
Q ss_pred EEEEec-----CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEec--
Q 046083 548 IGYCVE-----GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILID-- 620 (790)
Q Consensus 548 ~g~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~-- 620 (790)
++++.. ...++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++++ +||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i---iHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEY---VHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEEESS
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCe---EEecCCHHHEEEecC
Confidence 998864 2379999999 999999998753 469999999999999999999999997 9999999999999
Q ss_pred CCCcEEEEEeCCCcccccCCcc------cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCcccccccccc
Q 046083 621 KNFRAKVADFGLAKLTEVGSAS------VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETI 694 (790)
Q Consensus 621 ~~~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~ 694 (790)
.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~- 267 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD- 267 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC-
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC-
Confidence 8899999999999866432211 112345999999999999999999999999999999999999999753321
Q ss_pred ccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 695 TESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
............ ..+..++++.+.. ...+.++.+++..||+.+|.+||++++|++.|..+..
T Consensus 268 ---~~~~~~~~~~~~-----~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 268 ---PKYVRDSKIRYR-----ENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp ---HHHHHHHHHHHH-----HCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHHHHHhh-----hhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 111111111111 1223333332211 1234678999999999999999999999999988643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=344.68 Aligned_cols=256 Identities=25% Similarity=0.453 Sum_probs=206.4
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--C-----ceEEEEEeChh----hHHHHHHHHHHHHhc-CCCCCcceEEEEecC-
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--G-----EKAAIKKMDMQ----ASKEFLAELKVLTHV-HHLNLVRLIGYCVEG- 554 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g-----~~vavK~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~- 554 (790)
..++|.+.+.||+|+||.||+|... + ..+|+|.+... ..+.+.+|+++++++ +||||+++++++.++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 4578999999999999999999975 2 37999998743 446789999999999 899999999998754
Q ss_pred eEEEEEEEecCCChhhhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC
Q 046083 555 SLFLVYEYIENGNLNQHLRGSG------------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN 622 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~ 622 (790)
..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++++ +||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i---vH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNC---IHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCc---ccCCcccceEEECCC
Confidence 5899999999999999997532 2358999999999999999999999997 999999999999999
Q ss_pred CcEEEEEeCCCcccccCCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccch
Q 046083 623 FRAKVADFGLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGL 700 (790)
Q Consensus 623 ~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~ 700 (790)
+.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------- 273 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN------- 273 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-------
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh-------
Confidence 99999999999865433222 2233557889999999998899999999999999999998 88888643221
Q ss_pred HHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 701 VALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 701 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
........ .......+...+..+.+++.+||+.||.+|||++||++.|..+..
T Consensus 274 -~~~~~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 274 -SKFYKLVK-------------DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp -HHHHHHHH-------------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHh-------------cCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 01111111 011111222345678999999999999999999999999988654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=348.43 Aligned_cols=254 Identities=25% Similarity=0.416 Sum_probs=194.9
Q ss_pred CcccceeeeecCceEEEEEEEC-----CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEec--CeEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR-----GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVE--GSLFLV 559 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~-----g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~lv 559 (790)
.|.+.+.||+|+||.||+|.+. +..+|+|.++. ...++|.+|+.++++++||||+++++++.+ +..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4778899999999999999874 23589998863 345679999999999999999999998753 458999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i---vHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCE---ecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999998653 358999999999999999999999998 99999999999999999999999999865432
Q ss_pred Ccc---cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChh
Q 046083 640 SAS---VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715 (790)
Q Consensus 640 ~~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (790)
... ......+++.|+|||.+.+..++.++||||||+++|||++ |.+||...... .. ........
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~-----~~---~~~~~~~~---- 313 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DI---TVYLLQGR---- 313 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS-----CH---HHHHHTTC----
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH-----HH---HHHHHcCC----
Confidence 211 1223457789999999999999999999999999999999 66666443221 11 11111110
Q ss_pred hhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCc
Q 046083 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770 (790)
Q Consensus 716 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~ 770 (790)
....+..++..+.+++.+||+.||++|||++|+++.|+.+...-.
T Consensus 314 ----------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 314 ----------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 111223345678999999999999999999999999998865443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=335.46 Aligned_cols=250 Identities=29% Similarity=0.496 Sum_probs=205.1
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhhHHHHHHHHHHHHhcCCCCCcceEEEEec-------------
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVE------------- 553 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------------- 553 (790)
.++|++.+.||+|+||.||+|... ++.+|+|.++... +.+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 88 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS 88 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence 457899999999999999999986 8899999987543 457789999999999999999998742
Q ss_pred ----CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEE
Q 046083 554 ----GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVAD 629 (790)
Q Consensus 554 ----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~D 629 (790)
...++||||+++++|.+++.......+++..++.++.|++.||.|||++++ +||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i---~H~dlkp~Nil~~~~~~~kl~D 165 (284)
T 2a19_B 89 RSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKL---INRDLKPSNIFLVDTKQVKIGD 165 (284)
T ss_dssp CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEEEETTEEEECC
T ss_pred ccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCe---eeccCCHHHEEEcCCCCEEECc
Confidence 237999999999999999986544579999999999999999999999997 9999999999999999999999
Q ss_pred eCCCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHc
Q 046083 630 FGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLR 709 (790)
Q Consensus 630 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 709 (790)
||++....... ......|++.|+|||.+.+..++.++||||||+++|||++|..|+.... ......
T Consensus 166 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----------~~~~~~-- 231 (284)
T 2a19_B 166 FGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----------KFFTDL-- 231 (284)
T ss_dssp CTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----------HHHHHH--
T ss_pred chhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----------HHHHHh--
Confidence 99998764332 2234568999999999999999999999999999999999988874321 111111
Q ss_pred CCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCcc
Q 046083 710 QPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSED 771 (790)
Q Consensus 710 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~ 771 (790)
....+.. ..+..+.+++.+||+.||.+|||+.|+++.|+.+..+.+.
T Consensus 232 -----------~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 232 -----------RDGIISD----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp -----------HTTCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred -----------hcccccc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 1111112 2334688999999999999999999999999998766553
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=343.18 Aligned_cols=251 Identities=22% Similarity=0.356 Sum_probs=190.3
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEEe
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYI 563 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~~ 563 (790)
..++|++.+.||+|+||.||+|... ++.||||.++.. ..+.+.+|++++++++||||+++++++.+. ..++||||+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 4578999999999999999999986 678999998753 345688999999999999999999998754 589999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC---CCcEEEEEeCCCcccccCC
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK---NFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~---~~~~kl~DfGla~~~~~~~ 640 (790)
++++|.+++...+ .+++..++.++.|++.||.|||++++ +||||||+|||++. ++.+||+|||+++.....
T Consensus 131 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i---vH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~- 204 (349)
T 2w4o_A 131 TGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENGI---VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ- 204 (349)
T ss_dssp CSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence 9999999998643 58999999999999999999999998 99999999999975 889999999999865432
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+......
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~i~~~~~~------- 269 (349)
T 2w4o_A 205 -VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-------QFMFRRILNCEYY------- 269 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-------HHHHHHHHTTCCC-------
T ss_pred -cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-------HHHHHHHHhCCCc-------
Confidence 1223457899999999999999999999999999999999999998643221 1122222221110
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.........+..+.+++.+||+.||++|||+.|++++-+
T Consensus 270 ----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 308 (349)
T 2w4o_A 270 ----FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308 (349)
T ss_dssp ----CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred ----cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 001111234567899999999999999999999998644
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.72 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=201.5
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhc-CCCCCcceEEEEec-CeEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSLFLV 559 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~~lv 559 (790)
++|++.+.||+|+||.||+|+.. ++.+|+|.++.. ..+.+.+|..++.++ +||||+++++++.+ ...|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57899999999999999999986 789999998642 335688899999988 89999999998875 568999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+++|+|.+++...+ .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~i---vHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---eecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999998643 58999999999999999999999998 99999999999999999999999999854322
Q ss_pred CcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccc-cchHHHHHHHHcCCCChhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITES-TGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~ 718 (790)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .........+..
T Consensus 164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~--------- 233 (345)
T 3a8x_A 164 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--------- 233 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH---------
T ss_pred C-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc---------
Confidence 1 22345679999999999999999999999999999999999999996533211110 111111111211
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHHH
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSM------RAIVVAL 762 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~------~evl~~L 762 (790)
.. ..+|......+.+++.+||+.||.+||++ +|++++-
T Consensus 234 ----~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp 277 (345)
T 3a8x_A 234 ----KQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 277 (345)
T ss_dssp ----CC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSG
T ss_pred ----CC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCC
Confidence 11 12333455678999999999999999995 6766543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=341.36 Aligned_cols=258 Identities=24% Similarity=0.247 Sum_probs=200.7
Q ss_pred HHHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh--------hHHHHHHHHHHHHhcCCCCCcceEEEEecC
Q 046083 485 LAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ--------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG 554 (790)
Q Consensus 485 l~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 554 (790)
+....++|++.+.||+|+||.||+|... +..+|+|.+... ..+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3445678999999999999999999986 778999998643 346789999999999999999999998854
Q ss_pred -eEEEEEEEecCCChhhhhhcCC--------------------------------------CCCCCHHHHHHHHHHHHHH
Q 046083 555 -SLFLVYEYIENGNLNQHLRGSG--------------------------------------KDTLTWSARMQIALDSARG 595 (790)
Q Consensus 555 -~~~lv~e~~~~g~L~~~l~~~~--------------------------------------~~~l~~~~~~~i~~~ia~~ 595 (790)
..++||||+++|+|.+++.... ...+++..++.++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 5899999999999999985210 1124677788999999999
Q ss_pred HHHHHhCCCCceeecCCCCCCEEecCCC--cEEEEEeCCCcccccCCcc---cccccccCCCccchhcccC--CCCCchh
Q 046083 596 LEYIHEHTVPVYIHRDIKPANILIDKNF--RAKVADFGLAKLTEVGSAS---VHTRLVGTFGYMPPEYAQY--GEVSPKI 668 (790)
Q Consensus 596 L~~LH~~~~~~~vH~dlkp~NILl~~~~--~~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~s~~s 668 (790)
|+|||++++ +||||||+|||++.++ .+||+|||+++........ ......||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~~i---vH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQGI---CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTTE---ECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCCc---cccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 999999997 9999999999998776 8999999999865432211 2234678999999999975 6789999
Q ss_pred hHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccC
Q 046083 669 DVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQEN 748 (790)
Q Consensus 669 DvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~d 748 (790)
||||||+++|||++|+.||..... .............. ...........+.+++.+||+.|
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~li~~~l~~~ 318 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVND--------ADTISQVLNKKLCF-----------ENPNYNVLSPLARDLLSNLLNRN 318 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCT-----------TSGGGGGSCHHHHHHHHHHSCSC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCh--------HHHHHHHHhccccc-----------CCcccccCCHHHHHHHHHHcCCC
Confidence 999999999999999999965332 11222222221100 00001123467899999999999
Q ss_pred CCCCCCHHHHHHHHHh
Q 046083 749 PQLRPSMRAIVVALMT 764 (790)
Q Consensus 749 P~~RPt~~evl~~L~~ 764 (790)
|.+|||+.|++++-+-
T Consensus 319 p~~Rps~~~~l~hp~~ 334 (345)
T 3hko_A 319 VDERFDAMRALQHPWI 334 (345)
T ss_dssp TTTSCCHHHHHHSHHH
T ss_pred hhHCCCHHHHhcChhh
Confidence 9999999999986554
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=370.47 Aligned_cols=244 Identities=26% Similarity=0.412 Sum_probs=199.5
Q ss_pred eeeeecCceEEEEEEEC----CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEEEecCC
Q 046083 496 NKIGQGGFGAVFYAELR----GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENG 566 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~----g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e~~~~g 566 (790)
+.||+|+||.||+|.+. +..||||+++.. ..+++.+|+++|++++||||+++++++.++..++||||+++|
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g 454 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 454 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence 58999999999999663 568999999753 247799999999999999999999999888899999999999
Q ss_pred ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc--cc
Q 046083 567 NLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS--VH 644 (790)
Q Consensus 567 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~--~~ 644 (790)
+|.+++.... .+++..++.++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++........ ..
T Consensus 455 ~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~i---iHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 455 PLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCCE---eCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 9999998643 58999999999999999999999998 99999999999999999999999999876433221 12
Q ss_pred cccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 645 TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
....+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .....+ ..
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~~~~~i--------------~~ 587 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAML--------------EK 587 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHH--------------HT
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHH--------------Hc
Confidence 23456789999999999999999999999999999998 99998653321 111111 11
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLS 766 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~ 766 (790)
......+..++.++.+|+..||+.||++|||+++|++.|..+.
T Consensus 588 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 588 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1122334456678999999999999999999999999998754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=345.38 Aligned_cols=265 Identities=19% Similarity=0.250 Sum_probs=199.7
Q ss_pred hcCcccceeeeecCceEEEEEEEC-----CceEEEEEeChhh--------------HHHHHHHHHHHHhcCCCCCcceEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-----GEKAAIKKMDMQA--------------SKEFLAELKVLTHVHHLNLVRLIG 549 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-----g~~vavK~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~g 549 (790)
.++|.+.+.||+|+||.||+|... +..+|+|...... .+.+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999984 5689999885321 123667888999999999999999
Q ss_pred EEec-----CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC-
Q 046083 550 YCVE-----GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF- 623 (790)
Q Consensus 550 ~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~- 623 (790)
++.. ...++||||+ +++|.+++...+ .+++..++.++.|++.||+|||++++ +||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEY---VHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEEESSST
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---eCCCcCHHHEEEccCCC
Confidence 8865 3489999999 999999998654 69999999999999999999999997 9999999999998887
Q ss_pred -cEEEEEeCCCcccccCCcc------cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCcccccccccccc
Q 046083 624 -RAKVADFGLAKLTEVGSAS------VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITE 696 (790)
Q Consensus 624 -~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~ 696 (790)
.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-- 267 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP-- 267 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH--
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc--
Confidence 9999999999866432211 1134578999999999999999999999999999999999999996432211
Q ss_pred ccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCcc
Q 046083 697 STGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSED 771 (790)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~ 771 (790)
.............. ...+..... +...+..+.+++.+||+.||++|||+++|++.|+.+......
T Consensus 268 -~~~~~~~~~~~~~~--~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 332 (345)
T 2v62_A 268 -VAVQTAKTNLLDEL--PQSVLKWAP-------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGP 332 (345)
T ss_dssp -HHHHHHHHHHHHTT--THHHHHHSC-------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCC
T ss_pred -HHHHHHHHhhcccc--cHHHHhhcc-------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccC
Confidence 11111111111111 111111111 012345789999999999999999999999999987654433
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=333.98 Aligned_cols=253 Identities=26% Similarity=0.417 Sum_probs=200.6
Q ss_pred cCcccceeeeecCceEEEEEEEC-----CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEec--CeEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR-----GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVE--GSLFL 558 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~-----g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~l 558 (790)
.+|++.+.||+|+||.||+|.+. ...+|+|.++. ...+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 45888999999999999999864 22589998864 334678999999999999999999998753 45899
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i---~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCc---cCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999997643 468999999999999999999999998 9999999999999999999999999986543
Q ss_pred CCc---ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCC-ccccccccccccccchHHHHHHHHcCCCCh
Q 046083 639 GSA---SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAM-EAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 639 ~~~---~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
... .......+++.|+|||.+.+..++.++||||||+++|||++|. +||...... . ........
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-----~---~~~~~~~~---- 248 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----D---ITVYLLQG---- 248 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT-----T---HHHHHHTT----
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH-----H---HHHHHhcC----
Confidence 221 1122356788999999999999999999999999999999954 454332211 1 11111111
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
.....+...+..+.+++.+||+.||++|||++|+++.|..+...
T Consensus 249 ----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 249 ----------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp ----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 01111223446789999999999999999999999999987653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.74 Aligned_cols=255 Identities=26% Similarity=0.394 Sum_probs=202.7
Q ss_pred CcccceeeeecCceEEEEEEEC--C---ceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-e-EEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--G---EKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-S-LFLV 559 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g---~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~-~~lv 559 (790)
.|...+.||+|+||.||+|.+. + ..+|+|.++. ...+.+.+|++++++++||||+++++++.+. . .+++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4667799999999999999863 2 2699999864 3346789999999999999999999998743 3 5899
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+.+|+|.+++.... ..+++..++.++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i---~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKF---VHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999999998643 468999999999999999999999998 99999999999999999999999999865332
Q ss_pred C---cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhh
Q 046083 640 S---ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716 (790)
Q Consensus 640 ~---~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (790)
. ........+++.|+|||.+.+..++.++||||||+++|||++|..|+...... .. .......
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~----~~---~~~~~~~------- 243 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP----FD---LTHFLAQ------- 243 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG----GG---HHHHHHT-------
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH----HH---HHHHhhc-------
Confidence 1 11223356788999999999999999999999999999999966665332211 11 1111111
Q ss_pred hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCc
Q 046083 717 LQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770 (790)
Q Consensus 717 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~ 770 (790)
......+...+..+.+++.+||+.||.+|||++++++.|+.+...-.
T Consensus 244 -------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 244 -------GRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp -------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred -------CCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 11112233445678999999999999999999999999998765433
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=347.18 Aligned_cols=270 Identities=20% Similarity=0.279 Sum_probs=201.1
Q ss_pred hcCcccceeeeec--CceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEE
Q 046083 489 TNDFSMGNKIGQG--GFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFL 558 (790)
Q Consensus 489 ~~~f~~~~~lG~G--~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~l 558 (790)
.++|++.+.||+| +||.||+|+.. ++.||||+++.. ..+.+.+|++++++++||||+++++++.+ +..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4679999999999 99999999986 889999998642 34568889999999999999999998875 56899
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
||||+++|+|.+++.......+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||++.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i---vHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 9999999999999987655579999999999999999999999997 9999999999999999999999999875432
Q ss_pred CCc------ccccccccCCCccchhcccC--CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcC
Q 046083 639 GSA------SVHTRLVGTFGYMPPEYAQY--GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQ 710 (790)
Q Consensus 639 ~~~------~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 710 (790)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......................
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 211 11123478999999999987 5799999999999999999999999965432211000000000000000
Q ss_pred CC-Chhh-------------hhhhcCC---------cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 711 PD-PRED-------------LQRLVDP---------RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 711 ~~-~~~~-------------l~~~~d~---------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.. ..+. +...+.. ......+......+.+|+.+||+.||++|||++|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 0000 0000000 00001223345678999999999999999999999876
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=344.12 Aligned_cols=270 Identities=23% Similarity=0.355 Sum_probs=209.4
Q ss_pred cccCHHHHHHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh--hhHHHHHHHHHHHHhcC-----CCCCcceE
Q 046083 478 VEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM--QASKEFLAELKVLTHVH-----HLNLVRLI 548 (790)
Q Consensus 478 ~~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~--~~~~~~~~E~~~l~~l~-----h~niv~l~ 548 (790)
..+++++.....++|.+.++||+|+||.||+|... ++.||||.++. ...+.+..|+++++.++ ||||++++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 34555566666789999999999999999999984 78999999973 44566888999999996 99999999
Q ss_pred EEEec-CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC------
Q 046083 549 GYCVE-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK------ 621 (790)
Q Consensus 549 g~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~------ 621 (790)
+++.. +..++||||+ +++|.+++.......+++..+..++.|++.||+|||++++ +||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i---vHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSL---THTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEESCTTCCEE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCe---eeCCCCcccEEEcccccccc
Confidence 98875 5689999999 8899999987765679999999999999999999999997 99999999999975
Q ss_pred -------------------CCcEEEEEeCCCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh
Q 046083 622 -------------------NFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682 (790)
Q Consensus 622 -------------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt 682 (790)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 789999999999864322 234678999999999999999999999999999999999
Q ss_pred CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcC---------CcCCCCCC--------------------HHH
Q 046083 683 AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD---------PRLGDDYP--------------------IDS 733 (790)
Q Consensus 683 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d---------~~l~~~~~--------------------~~~ 733 (790)
|+.||...... ........... ..+...+..... ..+....+ ...
T Consensus 255 g~~pf~~~~~~-----~~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 328 (360)
T 3llt_A 255 GSLLFRTHEHM-----EHLAMMESIIQ-PIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK 328 (360)
T ss_dssp SSCSCCCSSHH-----HHHHHHHHHTC-CCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCC
T ss_pred CCCCCCCCcHH-----HHHHHHHHhcC-CCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccch
Confidence 99999654321 11111122111 111111111110 00000000 011
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 734 VRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 734 ~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
...+.+|+.+||+.||++|||++|++++
T Consensus 329 ~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 329 HELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 2567899999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=338.48 Aligned_cols=262 Identities=25% Similarity=0.455 Sum_probs=201.4
Q ss_pred HHHHHHHhcCcccceeeeecCceEEEEEEEC-----CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEE
Q 046083 482 YEELAKATNDFSMGNKIGQGGFGAVFYAELR-----GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYC 551 (790)
Q Consensus 482 ~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~-----g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~ 551 (790)
++++....++|.+.+.||+|+||.||+|... +..+|+|.++. ...+.+.+|++++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 3444445678999999999999999999874 23799999863 2346689999999999999999999998
Q ss_pred ecC------eEEEEEEEecCCChhhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC
Q 046083 552 VEG------SLFLVYEYIENGNLNQHLRGS----GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK 621 (790)
Q Consensus 552 ~~~------~~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~ 621 (790)
.+. ..++||||+++++|.+++... ....+++..+++++.+++.||.|||++++ +||||||+|||++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNF---LHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTC---CCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCcceEEEcC
Confidence 743 259999999999999998532 23569999999999999999999999998 99999999999999
Q ss_pred CCcEEEEEeCCCcccccCCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccc
Q 046083 622 NFRAKVADFGLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTG 699 (790)
Q Consensus 622 ~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~ 699 (790)
++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------ 256 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH------ 256 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG------
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH------
Confidence 999999999999865433211 1223457889999999999999999999999999999999 88888543321
Q ss_pred hHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 700 LVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 700 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
......... .....+...+..+.+++.+||+.||.+|||++++++.|..+...
T Consensus 257 --~~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 257 --EMYDYLLHG--------------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp --GHHHHHHTT--------------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHHcC--------------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111111111 11122334556799999999999999999999999999987643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=346.36 Aligned_cols=254 Identities=20% Similarity=0.305 Sum_probs=193.4
Q ss_pred cCcccc-eeeeecCceEEEEEEEC--CceEEEEEeChhhHHHHHHHHHHHHh-cCCCCCcceEEEEec-----CeEEEEE
Q 046083 490 NDFSMG-NKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTH-VHHLNLVRLIGYCVE-----GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~-~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~-----~~~~lv~ 560 (790)
++|.+. +.||+|+||.||++... ++.||||+++. ...+.+|++++.+ .+||||+++++++.. ...|+||
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~ 138 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 138 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEE
Confidence 466665 78999999999999986 78999999864 3456788888754 489999999998753 3489999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC---CCcEEEEEeCCCcccc
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK---NFRAKVADFGLAKLTE 637 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~---~~~~kl~DfGla~~~~ 637 (790)
||+++|+|.+++...+...+++..+..++.|++.||.|||++++ +||||||+|||++. ++.+||+|||+++...
T Consensus 139 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i---vHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 139 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI---AHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp ECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc---cccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 99999999999987655679999999999999999999999997 99999999999998 7899999999998654
Q ss_pred cCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 638 VGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ... ...+.....
T Consensus 216 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~---~~~i~~~~~----- 284 (400)
T 1nxk_A 216 SH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PGM---KTRIRMGQY----- 284 (400)
T ss_dssp -------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-CSH---HHHHHHTCC-----
T ss_pred CC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-HHH---HHHHHcCcc-----
Confidence 22 2233467899999999999999999999999999999999999999654322110 001 111111100
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
............++.+|+.+||+.||++|||++|++++-+..
T Consensus 285 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 326 (400)
T 1nxk_A 285 ------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326 (400)
T ss_dssp ------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred ------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 000001123456789999999999999999999999976643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=336.04 Aligned_cols=250 Identities=24% Similarity=0.422 Sum_probs=198.9
Q ss_pred hcCcccceeeeecCceEEEEEEEC--C-------ceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec-Ce
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--G-------EKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GS 555 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g-------~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~ 555 (790)
.++|.+.+.||+|+||.||+|... + ..+|+|.+.. ...+.+.+|++++++++||||+++++++.+ +.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 357899999999999999999875 3 4699999864 345679999999999999999999999875 45
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCc--------EEE
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFR--------AKV 627 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~--------~kl 627 (790)
.++||||+++++|.+++.... ..+++..++.++.|++.||.|||++++ +||||||+|||++.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~i---vH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTL---IHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCe---ECCCcCcceEEEecCCcccccccceeee
Confidence 899999999999999998653 348999999999999999999999998 99999999999998887 999
Q ss_pred EEeCCCcccccCCcccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHH
Q 046083 628 ADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEE 706 (790)
Q Consensus 628 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 706 (790)
+|||++..... .....|++.|+|||.+.+ ..++.++||||||+++|||++|..|+...... .... .
T Consensus 163 ~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-------~~~~-~ 229 (289)
T 4fvq_A 163 SDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-------QRKL-Q 229 (289)
T ss_dssp CCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHH-H
T ss_pred ccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-------HHHH-H
Confidence 99999875432 123457889999999987 67899999999999999999965554332211 1111 1
Q ss_pred HHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCc
Q 046083 707 VLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770 (790)
Q Consensus 707 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~ 770 (790)
..... . ..+...+..+.+++.+||+.||++|||++|+++.|+.+..+..
T Consensus 230 ~~~~~-----------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 230 FYEDR-----------H----QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp HHHTT-----------C----CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred Hhhcc-----------C----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 11110 0 1111123457899999999999999999999999999876543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=337.80 Aligned_cols=246 Identities=24% Similarity=0.395 Sum_probs=194.5
Q ss_pred hcCcccceeeeecCceEEEEEEE-----CCceEEEEEeChh-------hHHHHHHHHHHHHhcCCCCCcceEEEEec-Ce
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAEL-----RGEKAAIKKMDMQ-------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GS 555 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~-----~g~~vavK~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~ 555 (790)
.++|++.+.||+|+||.||+++. .++.+|+|.++.. ....+.+|++++++++||||+++++++.+ +.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35799999999999999999987 3789999998642 23457889999999999999999998875 46
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
.|+||||+++++|.+++...+ .+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~i---vH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKGI---IYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCE---EcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 899999999999999998643 58999999999999999999999998 9999999999999999999999999975
Q ss_pred cccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChh
Q 046083 636 TEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715 (790)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (790)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+....
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~---- 237 (327)
T 3a62_A 171 SIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--------KKTIDKILKCK---- 237 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTC----
T ss_pred cccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhCC----
Confidence 43222 223346789999999999999999999999999999999999999965322 11222222211
Q ss_pred hhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 046083 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRP-----SMRAIVVALM 763 (790)
Q Consensus 716 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~L~ 763 (790)
...+......+.+++.+||+.||++|| +++|++++-.
T Consensus 238 -----------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 238 -----------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp -----------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred -----------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence 112333456789999999999999999 7888887544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=332.65 Aligned_cols=259 Identities=22% Similarity=0.272 Sum_probs=205.0
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-hhHHHHHHHHHHHHhcCCCCCcceEEEEe--cCeEEEEEEEe
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-QASKEFLAELKVLTHVHHLNLVRLIGYCV--EGSLFLVYEYI 563 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~lv~e~~ 563 (790)
.++|++.+.||+|+||.||+|... ++.+|||.+.. ...+++.+|+++++.++|++++..+.++. +...++||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 468999999999999999999964 88999998864 33456889999999999998888777664 34579999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe---cCCCcEEEEEeCCCcccccCC
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI---DKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl---~~~~~~kl~DfGla~~~~~~~ 640 (790)
+++|.+++.... ..+++..++.++.|++.||+|||++++ +||||||+|||+ +.++.+||+|||+++......
T Consensus 88 -~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i---vH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 88 -GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNF---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp -CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred -CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCe---eeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 899999997543 369999999999999999999999997 999999999999 588899999999998765432
Q ss_pred cc------cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 641 AS------VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 641 ~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ ..............+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~--- 238 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISEKKMSTP--- 238 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS-SSHHHHHHHHHHHSC---
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh-hhhhhhhcccccCCc---
Confidence 21 12346789999999999999999999999999999999999999975432111 111111111111110
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
. . .+ ....+..+.+++.+||+.||++|||+++|++.|..+..
T Consensus 239 --~-~----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 239 --I-E----VL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp --H-H----HH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred --h-H----HH----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 0 0 00 11233578999999999999999999999999998744
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=341.34 Aligned_cols=246 Identities=28% Similarity=0.450 Sum_probs=199.1
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh------hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
+.|+..+.||+|+||.||+|... ++.||||++.. ...+++.+|++++++++||||+++++++.+ +..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45899999999999999999974 88999999852 223568899999999999999999998875 5689999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+. |+|.+++.... ..+++..+..++.+++.||.|||++++ +||||||+|||++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i---vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCe---eeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 9997 58888886432 469999999999999999999999998 99999999999999999999999999865422
Q ss_pred cccccccccCCCccchhccc---CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQ---YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
....||+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+.....
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--------~~~~~~~~~~~~----- 270 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNES----- 270 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSCC-----
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHhcCC-----
Confidence 2357899999999984 56789999999999999999999999865322 111112221111
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLS 766 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~ 766 (790)
+.+ .+...+..+.+++.+||+.||++|||+++++++.+...
T Consensus 271 -----~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 271 -----PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp -----CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred -----CCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 111 11233456889999999999999999999998766543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=333.42 Aligned_cols=260 Identities=22% Similarity=0.278 Sum_probs=202.2
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-hhHHHHHHHHHHHHhcCCCCCcceEEEEe--cCeEEEEEEE
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-QASKEFLAELKVLTHVHHLNLVRLIGYCV--EGSLFLVYEY 562 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~lv~e~ 562 (790)
..++|++.+.||+|+||.||+|... ++.+|||.+.. ...+.+.+|+++++.++|++++..++++. ....++||||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 3578999999999999999999964 88999998653 23346888999999999999888887664 3457999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe---cCCCcEEEEEeCCCcccccC
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI---DKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl---~~~~~~kl~DfGla~~~~~~ 639 (790)
+ +++|.+++.... ..+++..++.++.|++.||.|||++++ +||||||+|||+ +.++.+||+|||+++.....
T Consensus 87 ~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i---vH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 87 L-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNF---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp C-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred c-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 9 999999998543 359999999999999999999999997 999999999999 78899999999999876543
Q ss_pred Ccc------cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC
Q 046083 640 SAS------VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 640 ~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .............+
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~-- 238 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEKKMSTP-- 238 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-SHHHHHHHHHHHSC--
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh-hhhhhhhcccccch--
Confidence 221 123467899999999999999999999999999999999999999764332111 11111111111110
Q ss_pred hhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 714 REDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 714 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
. .. +. ...+..+.+++.+||+.||++|||+++|++.|..+..
T Consensus 239 ---~-~~----~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 239 ---I-EV----LC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp ---H-HH----HT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred ---h-hh----hh----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 0 00 00 1123578999999999999999999999999998754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=346.95 Aligned_cols=242 Identities=27% Similarity=0.422 Sum_probs=191.6
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh------HHHHHHHHHH-HHhcCCCCCcceEEEEec-CeEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA------SKEFLAELKV-LTHVHHLNLVRLIGYCVE-GSLFL 558 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~------~~~~~~E~~~-l~~l~h~niv~l~g~~~~-~~~~l 558 (790)
.++|++.+.||+|+||.||+|+.. +..+|+|.++... .+.+..|..+ ++.++||||+++++++.+ +..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 367999999999999999999986 7789999986432 2345667666 467899999999998875 46899
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
||||+++|+|.+++...+ .+++..+..++.+++.||+|||++++ +||||||+|||++.++.+||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gi---vHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNI---VYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---eecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999999998643 58899999999999999999999998 9999999999999999999999999985432
Q ss_pred CCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 639 GSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
. ........||+.|+|||++.+..++.++|||||||++|||++|..||..... ...+..+....
T Consensus 192 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~------- 255 (373)
T 2r5t_A 192 H-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILNKP------- 255 (373)
T ss_dssp C-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--------HHHHHHHHHSC-------
T ss_pred C-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhcc-------
Confidence 2 1223456799999999999999999999999999999999999999964322 22233333221
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIV 759 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 759 (790)
+ .++......+.+++.+||+.||.+||++.+.+
T Consensus 256 ------~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 256 ------L--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp ------C--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred ------c--CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 1 12233456788999999999999999985433
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=329.41 Aligned_cols=263 Identities=25% Similarity=0.360 Sum_probs=199.8
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYE 561 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e 561 (790)
++|++.+.||+|+||.||+|... ++.+|+|+++. ...+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999986 78999999853 234678899999999999999999999875 45899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|+++ +|.+++.... ..+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i---vH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNV---LHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred cCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence 9986 6666655432 359999999999999999999999997 999999999999999999999999998664322
Q ss_pred ccccccccCCCccchhcccCCC-CCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh--hhhh
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGE-VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR--EDLQ 718 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~ 718 (790)
.......||+.|+|||.+.+.. ++.++|||||||++|||++|..|+...... .............+... ....
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~----~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV----DDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH----HHHHHHHHHHHCCCCTTTCTTGG
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH----HHHHHHHHHHhCCCChhhhhhhc
Confidence 2233457899999999998765 799999999999999999998886543221 11111112222221111 0111
Q ss_pred hhcCCc---------CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 719 RLVDPR---------LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 719 ~~~d~~---------l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
...+.. ............+.+++.+||+.||++|||++|++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 284 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCc
Confidence 111000 00111224556788999999999999999999998743
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.19 Aligned_cols=248 Identities=26% Similarity=0.455 Sum_probs=202.2
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLV 559 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv 559 (790)
.++|++.+.||+|+||.||+|... +..+|+|.+... ....+.+|++++++++||||+++++++.+. ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467999999999999999999986 668999998643 235688999999999999999999998854 58999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+++++|.+++.... .+++..++.++.+++.||.|||++++ +||||||+|||++.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i---~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTC---EECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCE---ecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999999998653 58999999999999999999999998 99999999999999999999999988654322
Q ss_pred CcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
......|++.|+|||.+.+..++.++||||||+++|||++|..||..... ......+...
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~--------- 222 (279)
T 3fdn_A 163 ---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRISRV--------- 222 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHT---------
T ss_pred ---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH--------HHHHHHHHhC---------
Confidence 22345789999999999999999999999999999999999999864321 1111111111
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
....+...+..+.+++.+||+.||++|||++|++++-+--..
T Consensus 223 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 223 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred ------CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence 012233345678899999999999999999999998775433
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=345.53 Aligned_cols=248 Identities=26% Similarity=0.445 Sum_probs=196.8
Q ss_pred cCcccceeeeecCceEEEEEEEC-CceEEEEEeCh-----hhHHHHHHHHHHHHhcC--CCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDM-----QASKEFLAELKVLTHVH--HLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~-----~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~-~~~~lv~ 560 (790)
++|++.+.||+|+||.||++... ++.+|||.+.. ...+.+.+|+++|.+++ ||||+++++++.. ...++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 46999999999999999999876 78899998853 33467899999999996 5999999999875 4589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
| +.+++|.+++.... .+++..+..++.|++.||.|||++++ +||||||+|||++ ++.+||+|||+++......
T Consensus 136 E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~i---vHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGI---VHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTC---CCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 56889999998754 68999999999999999999999998 9999999999996 5789999999998764332
Q ss_pred cc-cccccccCCCccchhcccC-----------CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHH
Q 046083 641 AS-VHTRLVGTFGYMPPEYAQY-----------GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVL 708 (790)
Q Consensus 641 ~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 708 (790)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ...
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------~~~------ 275 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QIS------ 275 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------HHH------
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-------HHH------
Confidence 22 2234679999999999865 4689999999999999999999999954321 111
Q ss_pred cCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 709 RQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 709 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
.+..++++.....++......+.+|+.+||+.||.+|||+.|++++.+.
T Consensus 276 -------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 324 (390)
T 2zmd_A 276 -------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324 (390)
T ss_dssp -------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred -------HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence 1222333332223333335678999999999999999999999987653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=344.42 Aligned_cols=250 Identities=20% Similarity=0.349 Sum_probs=203.8
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh---hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ---ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
.++|++.+.||+|+||.||+|... ++.+|+|.+... ....+.+|++++++++||||+++++++.+ ...++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999986 788999998642 34568899999999999999999999875 468999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC--CCcEEEEEeCCCcccccCC
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK--NFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~--~~~~kl~DfGla~~~~~~~ 640 (790)
+++|+|.+++.... ..+++..++.++.|++.||+|||++++ +||||||+|||++. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~gi---vHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 130 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSI---VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCe---eecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999997643 358999999999999999999999997 99999999999974 5789999999998764332
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
......||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+.....
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~~i~~~~~-------- 267 (387)
T 1kob_A 206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------LETLQNVKRCDW-------- 267 (387)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHHCCC--------
T ss_pred --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCC--------
Confidence 22335789999999999999999999999999999999999999965322 112222222111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
..........+.++.+++.+||+.||.+|||++|++++-+
T Consensus 268 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (387)
T 1kob_A 268 ---EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 307 (387)
T ss_dssp ---CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred ---CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcc
Confidence 0111112234567899999999999999999999998644
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=340.17 Aligned_cols=249 Identities=20% Similarity=0.325 Sum_probs=182.3
Q ss_pred ceeeeecCceEEEEEEEC--CceEEEEEeChhhHHHHHHHHHHHHhcC-CCCCcceEEEEecC-eEEEEEEEecCCChhh
Q 046083 495 GNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHVH-HLNLVRLIGYCVEG-SLFLVYEYIENGNLNQ 570 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~-~~~lv~e~~~~g~L~~ 570 (790)
.+.||+|+||.||+|... ++.+|||.+.......+.+|+.++..+. ||||+++++++.+. ..++||||+++|+|.+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE 95 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHH
Confidence 478999999999999986 7899999998877788999999999997 99999999998854 5899999999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC---cEEEEEeCCCcccccCCccccccc
Q 046083 571 HLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF---RAKVADFGLAKLTEVGSASVHTRL 647 (790)
Q Consensus 571 ~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~---~~kl~DfGla~~~~~~~~~~~~~~ 647 (790)
++.... .+++..+..++.|++.||+|||++++ +||||||+|||++.++ .+||+|||+++....... .....
T Consensus 96 ~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i---vH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~ 169 (325)
T 3kn6_A 96 RIKKKK--HFSETEASYIMRKLVSAVSHMHDVGV---VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLKTP 169 (325)
T ss_dssp HHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred HHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCC---eecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-ccccc
Confidence 998753 59999999999999999999999997 9999999999997765 899999999986543322 22345
Q ss_pred ccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCC
Q 046083 648 VGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGD 727 (790)
Q Consensus 648 ~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 727 (790)
.||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ..........+.. .....
T Consensus 170 ~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~i~~-------------~~~~~ 235 (325)
T 3kn6_A 170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-CTSAVEIMKKIKK-------------GDFSF 235 (325)
T ss_dssp --------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHHHTT-------------TCCCC
T ss_pred CCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-cccHHHHHHHHHc-------------CCCCC
Confidence 689999999999999999999999999999999999999965432111 1111112222211 11100
Q ss_pred C--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 728 D--YPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 728 ~--~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
. .....+.++.+|+.+||+.||.+|||++|++++-+
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w 273 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEW 273 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChh
Confidence 0 01124567899999999999999999999987654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=335.25 Aligned_cols=254 Identities=24% Similarity=0.397 Sum_probs=194.6
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEecC-----e
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-----S 555 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~ 555 (790)
.++|++.+.||+|+||.||+|... ++.+|||.++.. ..+.+.+|++++.+++||||+++++++... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 367999999999999999999975 789999998642 235688999999999999999999987632 2
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
.|+||||+++++|.+++...+ .+++..++.++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---vH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCC---CcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 499999999999999998654 58999999999999999999999998 9999999999999999999999999986
Q ss_pred cccCCcc--cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCC-C
Q 046083 636 TEVGSAS--VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQP-D 712 (790)
Q Consensus 636 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~ 712 (790)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ........... .
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~~~~~~~~ 237 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVAYQHVREDPI 237 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHCCCC
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHhcCCCC
Confidence 5433221 22335689999999999999999999999999999999999999965332 11112222211 1
Q ss_pred ChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH-HHHHhhcc
Q 046083 713 PREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIV-VALMTLSS 767 (790)
Q Consensus 713 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl-~~L~~l~~ 767 (790)
..... ....+..+.+++.+||+.||++||+..+++ +.|.+...
T Consensus 238 ~~~~~------------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 238 PPSAR------------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp CHHHH------------STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred Ccccc------------cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 10000 112345788999999999999999765554 45555443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=356.60 Aligned_cols=252 Identities=27% Similarity=0.386 Sum_probs=207.4
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEE
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFL 558 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~l 558 (790)
..++|++.+.||+|+||.||+|... |+.+|+|++... ..+.+.+|+++|++++||||+++++++.+ +..|+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999985 889999998643 23558899999999999999999998875 46899
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
||||+++|+|.+++...+...+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gI---vHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI---VYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCE---eccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999999987665569999999999999999999999997 9999999999999999999999999987643
Q ss_pred CCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 639 GSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........+...
T Consensus 339 ~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~----~~~~i~~~i~~~-------- 404 (576)
T 2acx_A 339 GQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI----KREEVERLVKEV-------- 404 (576)
T ss_dssp TC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC----CHHHHHHHHHHC--------
T ss_pred Cc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch----hHHHHHHHhhcc--------
Confidence 22 2234579999999999999899999999999999999999999997543211 111111111111
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRP-----SMRAIVVALM 763 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~L~ 763 (790)
...++......+.+|+.+||+.||.+|| +++||+++-.
T Consensus 405 -------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hpf 447 (576)
T 2acx_A 405 -------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447 (576)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGG
T ss_pred -------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChh
Confidence 1122334456789999999999999999 7888887543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=331.49 Aligned_cols=256 Identities=24% Similarity=0.409 Sum_probs=195.5
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh------hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLV 559 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv 559 (790)
.++|++.+.||+|+||.||+|... +..+|+|+++. ...+.+.+|++++++++||||+++++++.+ +..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 357999999999999999999974 88999999863 334678999999999999999999998875 568999
Q ss_pred EEEecCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccc
Q 046083 560 YEYIENGNLNQHLRGS--GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~ 637 (790)
|||+++++|.+++... ....+++..++.++.+++.||.|||++++ +||||||+|||++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i---~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRV---MHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCe---eCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999998742 23468999999999999999999999998 999999999999999999999999998654
Q ss_pred cCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 638 VGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
.... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ........+....
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~------ 254 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEQCD------ 254 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C------CHHHHHHHHHTTC------
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch------hHHHHHHHhhccc------
Confidence 3221 22335689999999999999999999999999999999999999864321 1111111211110
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
.....+...+..+.+++.+||+.||.+|||+++|++.|.++..
T Consensus 255 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 255 -------YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp -------SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 1011112344678999999999999999999999999998754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=334.03 Aligned_cols=257 Identities=23% Similarity=0.309 Sum_probs=196.6
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLV 559 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv 559 (790)
.++|++.+.||+|+||.||+|... ++.+|+|.+... ..+.+.+|++++++++||||+++++++.+ +..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999975 788999998642 23668899999999999999999999874 568999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+++++|.+++.... .+++..++.++.+++.||.|||++++ +||||||+|||++.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i---~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGA---THRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcC---CcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999998643 58999999999999999999999998 99999999999999999999999999866543
Q ss_pred CcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
.........|++.|+|||.+.+..++.++||||||+++|||++|+.||..... . .....+......
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~-~~~~~~~~~~~~----- 253 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL--------S-VMGAHINQAIPR----- 253 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH--------H-HHHHHHHSCCCC-----
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH--------H-HHHHHhccCCCC-----
Confidence 33333345789999999999999999999999999999999999999864321 1 111212111100
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHhhccCCc
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRP-SMRAIVVALMTLSSSSE 770 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~L~~l~~~~~ 770 (790)
....+...+..+.+++.+||+.||++|| +++++++.|..+.....
T Consensus 254 ------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 254 ------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp ------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred ------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 0011223345788999999999999999 99999999998755443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=335.24 Aligned_cols=261 Identities=24% Similarity=0.413 Sum_probs=188.2
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYE 561 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e 561 (790)
.++|++.+.||+|+||.||+|... ++.+|+|.++.. ..+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467999999999999999999876 889999998632 33678899999999999999999999875 46899999
Q ss_pred EecCCChhhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccc
Q 046083 562 YIENGNLNQHLRGSG----KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~ 637 (790)
|++ |+|.+++.... ...+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i---vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKI---LHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCe---eeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999886532 2358999999999999999999999997 999999999999999999999999998654
Q ss_pred cCCcccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh--
Q 046083 638 VGSASVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR-- 714 (790)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 714 (790)
.... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... ............+...
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-----EQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCSCCTTTC
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCChhHh
Confidence 3221 22345789999999999764 6899999999999999999999999654321 1111111222211100
Q ss_pred ------------------hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 715 ------------------EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 715 ------------------~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
..+.+.+.+.. +......+.+++.+||+.||++|||++|++++-+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~ 296 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHT----KEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGC----SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred hhhhhhhhcccccccccchhHHHhhcccc----cccCCHHHHHHHHHHCCCCcccCCCHHHHhCChh
Confidence 00111111111 1123457899999999999999999999987543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=348.33 Aligned_cols=251 Identities=21% Similarity=0.361 Sum_probs=194.2
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh-----------HHHHHHHHHHHHhcCCCCCcceEEEEecC
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA-----------SKEFLAELKVLTHVHHLNLVRLIGYCVEG 554 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 554 (790)
..++|.+.+.||+|+||.||+|... ++.+|||.+.... ...+.+|+++|++++||||+++++++..+
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 212 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 212 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3578999999999999999999986 7899999986432 12478999999999999999999999888
Q ss_pred eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC---CcEEEEEeC
Q 046083 555 SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN---FRAKVADFG 631 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~---~~~kl~DfG 631 (790)
..++||||+++|+|.+++.... .+++..+..++.|++.||+|||++++ +||||||+|||++.+ +.+||+|||
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i---vHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred ceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCChHhEEEecCCCcceEEEeecc
Confidence 8999999999999999987653 59999999999999999999999998 999999999999654 459999999
Q ss_pred CCcccccCCcccccccccCCCccchhcccC---CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHH
Q 046083 632 LAKLTEVGSASVHTRLVGTFGYMPPEYAQY---GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVL 708 (790)
Q Consensus 632 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 708 (790)
+++..... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||...... ... ...+.
T Consensus 288 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~----~~~---~~~i~ 358 (419)
T 3i6u_A 288 HSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----VSL---KDQIT 358 (419)
T ss_dssp TTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS----CCH---HHHHH
T ss_pred cceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch----HHH---HHHHh
Confidence 99876432 22344679999999999853 57889999999999999999999999653321 111 11111
Q ss_pred cCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 709 RQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 709 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
...... .... ....+..+.+++.+||+.||++|||++|++++-+
T Consensus 359 ~~~~~~--~~~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 402 (419)
T 3i6u_A 359 SGKYNF--IPEV---------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 402 (419)
T ss_dssp TTCCCC--CHHH---------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred cCCCCC--Cchh---------hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence 110000 0000 0123457889999999999999999999987543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=335.52 Aligned_cols=259 Identities=22% Similarity=0.342 Sum_probs=202.9
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeC---hhhHHHHHHHHHHHHhcCCCCCcceEEEEec-----CeEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMD---MQASKEFLAELKVLTHVHHLNLVRLIGYCVE-----GSLFL 558 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~l 558 (790)
.++|++.+.||+|+||.||++... ++.+|||++. ....+.+.+|++++++++||||+++++++.. ...++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 467999999999999999999974 8899999884 3445678999999999999999999998862 25799
Q ss_pred EEEEecCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 559 VYEYIENGNLNQHLRGS--GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
||||+++|+|.+++... ....+++..++.++.|++.||.|||++++ +||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i---vH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGY---AHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999998752 23469999999999999999999999997 99999999999999999999999998764
Q ss_pred ccCCcc--------cccccccCCCccchhcccCCC---CCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHH
Q 046083 637 EVGSAS--------VHTRLVGTFGYMPPEYAQYGE---VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFE 705 (790)
Q Consensus 637 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 705 (790)
...... ......|++.|+|||.+.... ++.++||||||+++|||++|+.||....... ....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~---- 257 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---DSVA---- 257 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT---SCHH----
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc---chhh----
Confidence 321111 011245799999999987554 6899999999999999999999985422110 0010
Q ss_pred HHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCc
Q 046083 706 EVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770 (790)
Q Consensus 706 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~ 770 (790)
..... ......+...+..+.+++.+||+.||.+|||++|+++.|+.+.....
T Consensus 258 ~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 258 LAVQN-------------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp HHHHC-------------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred HHhhc-------------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 00000 11111122345679999999999999999999999999998765443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=328.26 Aligned_cols=245 Identities=27% Similarity=0.450 Sum_probs=181.3
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh------HHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA------SKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~------~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~ 560 (790)
++|.+.+.||+|+||.||+|... ++.+|+|.+.... .+.+.+|++++++++||||+++++++.+. ..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 57999999999999999999974 8899999996432 35689999999999999999999998854 589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++++|.+++.... ..+++..++.++.|++.||.|||++++ +||||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGI---LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp ECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred ecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999998643 468999999999999999999999997 999999999999999999999999998654322
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... .+...
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------------------~~~~~ 224 (278)
T 3cok_A 167 E-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN---------------------TLNKV 224 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------------C
T ss_pred C-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH---------------------HHHHH
Confidence 2 1223568999999999998899999999999999999999999986533210 00011
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
.... ...+...+..+.+++.+||+.||++|||+++++++-
T Consensus 225 ~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 264 (278)
T 3cok_A 225 VLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264 (278)
T ss_dssp CSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTST
T ss_pred hhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCc
Confidence 1111 112233456788999999999999999999998643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=325.48 Aligned_cols=250 Identities=21% Similarity=0.347 Sum_probs=203.1
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVY 560 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~ 560 (790)
.++|++.+.||+|+||.||+|... +..+|+|.+... ..+.+.+|++++++++||||+++++++.++ ..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999886 789999998542 346688999999999999999999998754 579999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCc---EEEEEeCCCcccc
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFR---AKVADFGLAKLTE 637 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~---~kl~DfGla~~~~ 637 (790)
||+++++|.+++.... .+++..+..++.+++.||.|||++++ +||||||+|||++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGI---VHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---CcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999999887653 58999999999999999999999997 99999999999976655 9999999998654
Q ss_pred cCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 638 VGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... .............
T Consensus 160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~---- 225 (284)
T 3kk8_A 160 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYAQIKAGAYD---- 225 (284)
T ss_dssp SSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCC----
T ss_pred cCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch--------hHHHHHHHhcccc----
Confidence 322 22346789999999999999999999999999999999999999865322 1122222211100
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
.........+..+.+++.+||+.||++|||++|++++-+-
T Consensus 226 -------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (284)
T 3kk8_A 226 -------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265 (284)
T ss_dssp -------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHH
T ss_pred -------CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccc
Confidence 0001112334678899999999999999999999986654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=344.68 Aligned_cols=261 Identities=15% Similarity=0.211 Sum_probs=205.2
Q ss_pred hcCcccceeeeecCceEEEEEEEC----------CceEEEEEeChhhHHHHHHHHHHHHhcCCCCCcc------------
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR----------GEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVR------------ 546 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~----------g~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 546 (790)
.++|++.+.||+|+||.||+|... ++.+|+|.+... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence 367999999999999999999874 578999998754 46889999999999999887
Q ss_pred ---eEEEEec--CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC
Q 046083 547 ---LIGYCVE--GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK 621 (790)
Q Consensus 547 ---l~g~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~ 621 (790)
+++++.. ...++||||+ +++|.+++.......+++..++.++.|++.||.|||++++ +||||||+|||++.
T Consensus 119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i---vH~Dikp~NIl~~~ 194 (352)
T 2jii_A 119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEY---VHGNVTAENIFVDP 194 (352)
T ss_dssp CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTC---BCSCCCGGGEEEET
T ss_pred ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCc---cCCCCCHHHEEEcC
Confidence 6677663 5689999999 9999999987644579999999999999999999999998 99999999999999
Q ss_pred CC--cEEEEEeCCCcccccCCcc------cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccc
Q 046083 622 NF--RAKVADFGLAKLTEVGSAS------VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNET 693 (790)
Q Consensus 622 ~~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~ 693 (790)
++ .+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 98 8999999999866432211 113357899999999999999999999999999999999999999764321
Q ss_pred cccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 694 ITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
. .........+..... .+.+... .....+..+.+++.+||+.||++|||+++|++.|..+..
T Consensus 275 ~---~~~~~~~~~~~~~~~------~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 275 T---EDIMKQKQKFVDKPG------PFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp H---HHHHHHHHHHHHSCC------CEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred H---HHHHHHHHhccCChh------hhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 1 111111111111111 1111110 001234678999999999999999999999999998753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=343.95 Aligned_cols=246 Identities=25% Similarity=0.352 Sum_probs=194.8
Q ss_pred ccceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecCC
Q 046083 493 SMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENG 566 (790)
Q Consensus 493 ~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~g 566 (790)
...+.||+|+||.||+|... +..+|+|.++. ...+++.+|++++++++||||+++++++.+ +..++||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33678999999999999975 88999999864 345679999999999999999999999875 4589999999999
Q ss_pred ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe--cCCCcEEEEEeCCCcccccCCcccc
Q 046083 567 NLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI--DKNFRAKVADFGLAKLTEVGSASVH 644 (790)
Q Consensus 567 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl--~~~~~~kl~DfGla~~~~~~~~~~~ 644 (790)
+|.+++.... ..+++..++.++.|++.||+|||++++ +||||||+|||+ +.++.+||+|||+++...... ..
T Consensus 172 ~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i---vH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~ 245 (373)
T 2x4f_A 172 ELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYI---LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KL 245 (373)
T ss_dssp EEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BC
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCc---ccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--cc
Confidence 9999887543 358999999999999999999999997 999999999999 667899999999998764332 22
Q ss_pred cccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCc
Q 046083 645 TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724 (790)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 724 (790)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+......
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~~~~----------- 306 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND--------AETLNNILACRWD----------- 306 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCCC-----------
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhccCC-----------
Confidence 345689999999999988999999999999999999999999965332 1222223222110
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 725 LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 725 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
...........++.+|+.+||+.||.+|||++|++++-+
T Consensus 307 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~ 345 (373)
T 2x4f_A 307 LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPW 345 (373)
T ss_dssp SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence 000001123467899999999999999999999998544
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=338.06 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=203.5
Q ss_pred hcCcccceeeeecCceEEEEEEEC-------CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SL 556 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~ 556 (790)
.++|++.+.||+|+||.||+|.+. +..+|||.+.. ....++.+|+.++++++||||+++++++.+. ..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 467899999999999999999842 56899999853 3446788999999999999999999998854 58
Q ss_pred EEEEEEecCCChhhhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC---CCcEEEE
Q 046083 557 FLVYEYIENGNLNQHLRGSGK-----DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK---NFRAKVA 628 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~---~~~~kl~ 628 (790)
++||||+++++|.+++..... ..+++..++.++.+++.||.|||++++ +||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i---~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCe---ecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999986532 358999999999999999999999998 99999999999984 4569999
Q ss_pred EeCCCcccccCCc-ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHH
Q 046083 629 DFGLAKLTEVGSA-SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEE 706 (790)
Q Consensus 629 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 706 (790)
|||+++....... .......|++.|+|||.+.+..++.++||||||+++|||++ |..||..... ......
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~~~ 257 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVLEF 257 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--------HHHHHH
Confidence 9999975533221 12233567889999999998999999999999999999998 8888854321 111122
Q ss_pred HHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCc
Q 046083 707 VLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770 (790)
Q Consensus 707 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~ 770 (790)
+.... ....+...+..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 258 ~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 258 VTSGG--------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp HHTTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred HhcCC--------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 21111 111223445678999999999999999999999999998766544
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=334.06 Aligned_cols=265 Identities=26% Similarity=0.436 Sum_probs=208.9
Q ss_pred hcCcccceeeeecCceEEEEEEE------CCceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEecC---eE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAEL------RGEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVEG---SL 556 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~------~g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~---~~ 556 (790)
.++|++.+.||+|+||.||++.+ .++.||||++.. ...+.+.+|++++++++||||+++++++... ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35689999999999999999985 378899999864 3346789999999999999999999988642 47
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
++||||+++++|.+++.... ..+++..+++++.+++.||+|||++++ +||||||+|||++.++.+||+|||++...
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCE---eccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 99999999999999998753 358999999999999999999999997 99999999999999999999999999876
Q ss_pred ccCCcc--cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 637 EVGSAS--VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 637 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
...... ......++..|+|||.+.+..++.++||||||+++|||++|..|+...... +..........
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~----------~~~~~~~~~~~ 265 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----------FMRMIGNDKQG 265 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH----------HHHHHCTTCCT
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH----------HHHhhccccch
Confidence 543321 122345677899999999888999999999999999999999987542110 11111111100
Q ss_pred ----hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 715 ----EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 715 ----~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
..+.+.+........+...+.++.+++.+||+.||++|||++|+++.|+.+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 266 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 01112222222222344556789999999999999999999999999998753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=350.51 Aligned_cols=244 Identities=26% Similarity=0.455 Sum_probs=203.5
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
++|.+.+.||+|+||.||+|... |+.||||.++.. ..+.+.+|+++++.++||||+++++++.. +..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57899999999999999999986 889999999743 23568899999999999999999999875 4689999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||++......
T Consensus 96 E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~gi---vHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~- 169 (476)
T 2y94_A 96 EYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDG- 169 (476)
T ss_dssp ECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTTE---ECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCC---CcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence 9999999999998643 59999999999999999999999997 99999999999999999999999999876432
Q ss_pred cccccccccCCCccchhcccCCCC-CchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEV-SPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ......+...
T Consensus 170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--------~~~~~~i~~~--------- 231 (476)
T 2y94_A 170 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--------PTLFKKICDG--------- 231 (476)
T ss_dssp -CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--------HHHHHHHHTT---------
T ss_pred -ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHhcC---------
Confidence 22334679999999999988766 6899999999999999999999964321 1222222221
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.. ..+......+.+++.+||+.||.+|||++|++++-+
T Consensus 232 ----~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~ 269 (476)
T 2y94_A 232 ----IF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEW 269 (476)
T ss_dssp ----CC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred ----Cc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHH
Confidence 11 112233457889999999999999999999998654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=333.32 Aligned_cols=254 Identities=24% Similarity=0.410 Sum_probs=198.9
Q ss_pred cCcccceeeeecCceEEEEEEEC---Cc--eEEEEEeCh------hhHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR---GE--KAAIKKMDM------QASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFL 558 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~---g~--~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~l 558 (790)
++|++.+.||+|+||.||+|.+. +. .+|+|.++. ...+.+.+|++++++++||||+++++++.+...++
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 97 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCcee
Confidence 57899999999999999999863 22 589998863 23467899999999999999999999998888999
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
||||+++++|.+++.... ..+++..+.+++.+++.||.|||++++ +|+||||+|||++.++.+||+|||++.....
T Consensus 98 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999999997642 358999999999999999999999997 9999999999999999999999999987643
Q ss_pred CCcc--cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChh
Q 046083 639 GSAS--VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715 (790)
Q Consensus 639 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (790)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+...
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~----- 240 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKIDKE----- 240 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTS-----
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--------HHHHHHHHcc-----
Confidence 3221 1223457788999999998889999999999999999999 9999864322 1122222211
Q ss_pred hhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 716 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
......+...+..+.+++.+||+.||++|||+.++++.|..+...
T Consensus 241 --------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 241 --------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp --------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred --------CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 111122334556799999999999999999999999999987654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=353.79 Aligned_cols=246 Identities=25% Similarity=0.385 Sum_probs=195.9
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLV 559 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv 559 (790)
.++|++.+.||+|+||.||+|... ++.||||.++.. ....+.+|+++++.++||||+++++++.+ +..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999986 789999998743 23457789999999999999999998875 468999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE-HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+ +++ +||||||+|||++.++.+||+|||+++....
T Consensus 227 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~gi---iHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNV---VYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp ECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCC---CCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCE---EECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 99999999999997643 58999999999999999999998 888 9999999999999999999999999985432
Q ss_pred CCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 639 GSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+....
T Consensus 302 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~------- 365 (446)
T 4ejn_A 302 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILMEE------- 365 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-------
T ss_pred CC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHHhCC-------
Confidence 22 223446799999999999999999999999999999999999999965322 12222222211
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRP-----SMRAIVVALM 763 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~L~ 763 (790)
..++......+.+|+.+||+.||.+|| +++|++++-.
T Consensus 366 --------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~ 407 (446)
T 4ejn_A 366 --------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407 (446)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred --------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcc
Confidence 112333456789999999999999999 9999987544
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=332.20 Aligned_cols=250 Identities=24% Similarity=0.411 Sum_probs=201.9
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEe---cCeEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCV---EGSLFL 558 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~---~~~~~l 558 (790)
.++|++.+.||+|+||.||++... ++.+|+|.+.. ...+.+.+|++++++++||||+++++++. +...++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467999999999999999999986 78999999853 34467899999999999999999999875 345899
Q ss_pred EEEEecCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceeecCCCCCCEEecCCCcEEEEEeC
Q 046083 559 VYEYIENGNLNQHLRGSG--KDTLTWSARMQIALDSARGLEYIHEHT-----VPVYIHRDIKPANILIDKNFRAKVADFG 631 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~~vH~dlkp~NILl~~~~~~kl~DfG 631 (790)
||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ + +||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~i---vH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTV---LHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC---------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCee---EEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999997532 345999999999999999999999998 6 999999999999999999999999
Q ss_pred CCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCC
Q 046083 632 LAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQP 711 (790)
Q Consensus 632 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (790)
+++....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+....
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~i~~~~ 232 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGKIREGK 232 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTC
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--------HHHHHHHhhcc
Confidence 9986543221 12335689999999999988999999999999999999999999865321 11111221111
Q ss_pred CChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 712 DPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 712 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
. ...+...+..+.+++.+||+.||++|||++|++++++.
T Consensus 233 ----------~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 233 ----------F----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ----------C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ----------c----ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 0 11223345678999999999999999999999987664
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=343.45 Aligned_cols=270 Identities=19% Similarity=0.278 Sum_probs=212.8
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC---eEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG---SLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~---~~~lv~ 560 (790)
++|.+.+.||+|+||.||+|.+. ++.||||.++. ...+.+.+|++++++++||||+++++++.+. ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 57899999999999999999987 88999999974 2346788999999999999999999998742 479999
Q ss_pred EEecCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe----cCCCcEEEEEeCCCcc
Q 046083 561 EYIENGNLNQHLRGSGK-DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI----DKNFRAKVADFGLAKL 635 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl----~~~~~~kl~DfGla~~ 635 (790)
||+++|+|.+++..... ..+++..++.++.|++.||+|||++++ +||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i---vH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGI---VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCE---EECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999986432 349999999999999999999999997 999999999999 7888899999999986
Q ss_pred cccCCcccccccccCCCccchhcccC--------CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHH
Q 046083 636 TEVGSASVHTRLVGTFGYMPPEYAQY--------GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEV 707 (790)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 707 (790)
..... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...... .........+
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~----~~~~~~~~~~ 239 (396)
T 4eut_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP----RRNKEVMYKI 239 (396)
T ss_dssp CCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT----TTCHHHHHHH
T ss_pred ccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc----cchHHHHHHH
Confidence 54322 2234678999999999864 46788999999999999999999999754322 1112233333
Q ss_pred HcCCCCh--hhhhh-------hc-CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 708 LRQPDPR--EDLQR-------LV-DPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 708 ~~~~~~~--~~l~~-------~~-d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
....... ..+.. +. +.......+......+.+++.+||+.||++||+++|+++.+..+...
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 3322110 00000 00 00111234567888999999999999999999999999999887553
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=345.59 Aligned_cols=274 Identities=24% Similarity=0.367 Sum_probs=197.1
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcC-CCCCcceEEEEec---CeE
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVH-HLNLVRLIGYCVE---GSL 556 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~---~~~ 556 (790)
..++|++.+.||+|+||.||+|... ++.||||++.. ...+.+.+|+.++.++. ||||+++++++.. ...
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 3578999999999999999999876 88999998842 34466889999999997 9999999999863 248
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
|+||||++ ++|.+++... .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++..
T Consensus 87 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i---vHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGL---LHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCE---EeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 99999998 5899999863 58999999999999999999999997 99999999999999999999999999865
Q ss_pred ccC--------------------CcccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccc
Q 046083 637 EVG--------------------SASVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETIT 695 (790)
Q Consensus 637 ~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~ 695 (790)
... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-- 237 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM-- 237 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 321 1112234679999999999976 67899999999999999999999999654321
Q ss_pred cccchHHHHHHHHcCCCChhhhhhhcC------------------CcCCCCC------------CHHHHHHHHHHHHHcc
Q 046083 696 ESTGLVALFEEVLRQPDPREDLQRLVD------------------PRLGDDY------------PIDSVRKMARLARACT 745 (790)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~l~~~~d------------------~~l~~~~------------~~~~~~~l~~li~~Cl 745 (790)
.........+..+. .+.+..+.. ......+ +......+.+|+.+||
T Consensus 238 ---~~~~~i~~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 238 ---NQLERIIGVIDFPS-NEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp ---HHHHHHHHHHCCCC-HHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred ---HHHHHHHHhcCCCC-HHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 11111112222111 111110000 0000000 0123457889999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhccCCccCCc
Q 046083 746 QENPQLRPSMRAIVVALMTLSSSSEDWDI 774 (790)
Q Consensus 746 ~~dP~~RPt~~evl~~L~~l~~~~~~~~~ 774 (790)
+.||++|||++|++++-.--.-...+|++
T Consensus 314 ~~dP~~R~t~~e~l~Hp~~~~~~~~~~~~ 342 (388)
T 3oz6_A 314 QFNPNKRISANDALKHPFVSIFHNPNEEP 342 (388)
T ss_dssp CSSGGGSCCHHHHTTSTTTTTTCCGGGCC
T ss_pred ccCcccCCCHHHHhCCHHHHHhcCCccCC
Confidence 99999999999999875533333344443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=323.93 Aligned_cols=248 Identities=24% Similarity=0.375 Sum_probs=201.2
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYE 561 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e 561 (790)
.++|++.+.||+|+||.||+|... ++.+|+|.++.. ..+.+.+|+.+++.++||||+++++++.++ ..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467999999999999999999986 889999998642 346789999999999999999999998754 5899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|+++++|.+++... ..+++..++.++.|++.||.|||++++ +|+||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCe---eccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999999754 358999999999999999999999997 9999999999999999999999999986543222
Q ss_pred -ccccccccCCCccchhcccCCCC-CchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 642 -SVHTRLVGTFGYMPPEYAQYGEV-SPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 642 -~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
.......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||....... .....+.....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~------- 226 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------QEYSDWKEKKT------- 226 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-------HHHHHHHTTCT-------
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-------HHHHHhhhccc-------
Confidence 12334678999999999987765 779999999999999999999996543211 01111111110
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
........+..+.+++.+||+.||.+|||++|++++
T Consensus 227 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 227 ------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 001112344678899999999999999999999864
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=337.82 Aligned_cols=251 Identities=16% Similarity=0.183 Sum_probs=205.8
Q ss_pred HHhcCcccceeeeecCceEEEEEE-----E--CCceEEEEEeChhhHHHHHHHHHHHHhcC---CCCCcceEEEEec-Ce
Q 046083 487 KATNDFSMGNKIGQGGFGAVFYAE-----L--RGEKAAIKKMDMQASKEFLAELKVLTHVH---HLNLVRLIGYCVE-GS 555 (790)
Q Consensus 487 ~~~~~f~~~~~lG~G~fg~Vy~a~-----~--~g~~vavK~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~-~~ 555 (790)
...++|.+.+.||+|+||.||+|. . .++.+|||+++.....++..|++++.+++ |+|++++++++.. +.
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 345789999999999999999994 2 37899999999888888999999999997 9999999999874 56
Q ss_pred EEEEEEEecCCChhhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC-----------
Q 046083 556 LFLVYEYIENGNLNQHLRGS---GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK----------- 621 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~----------- 621 (790)
.++||||+++|+|.+++... ....+++..++.++.|++.||+|||++++ +||||||+|||++.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i---vHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEI---IHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTE---ECCCCSGGGEEECGGGTCC------
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCe---ecCCCCHHHEEecccccCccccccc
Confidence 89999999999999999742 23469999999999999999999999997 99999999999998
Q ss_pred CCcEEEEEeCCCcccccC-CcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccch
Q 046083 622 NFRAKVADFGLAKLTEVG-SASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGL 700 (790)
Q Consensus 622 ~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~ 700 (790)
++.+||+|||+++.+... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---- 294 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK---- 294 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE----
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee----
Confidence 899999999999765422 222334567999999999999999999999999999999999999998653321100
Q ss_pred HHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHHhhcc
Q 046083 701 VALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLR-PSMRAIVVALMTLSS 767 (790)
Q Consensus 701 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R-Pt~~evl~~L~~l~~ 767 (790)
+...+... + ....+.+++..|++.+|.+| |+++++.+.|.....
T Consensus 295 --------------------~~~~~~~~-~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 295 --------------------PEGLFRRL-P--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp --------------------ECSCCTTC-S--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred --------------------echhcccc-C--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 01111111 1 23457789999999999999 678888888877543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=327.48 Aligned_cols=243 Identities=23% Similarity=0.398 Sum_probs=195.7
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-----CeEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-----GSLF 557 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~ 557 (790)
+.|.+.+.||+|+||.||+|... +..+|+|.+.. ...+.+.+|++++++++||||+++++++.. ...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34788899999999999999986 67899998853 334668999999999999999999998753 2379
Q ss_pred EEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceeecCCCCCCEEec-CCCcEEEEEeCCCc
Q 046083 558 LVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT--VPVYIHRDIKPANILID-KNFRAKVADFGLAK 634 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~~vH~dlkp~NILl~-~~~~~kl~DfGla~ 634 (790)
+||||+++++|.+++.... .+++..++.++.+++.||.|||+++ + +||||||+|||++ .++.+||+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i---~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPI---IHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCC---CCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCE---EECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 9999999999999998643 5899999999999999999999998 6 9999999999997 78999999999997
Q ss_pred ccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 635 LTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
..... ......|++.|+|||.+. +.++.++||||||+++|||++|+.||..... ..............
T Consensus 181 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~- 248 (290)
T 1t4h_A 181 LKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVTSGVKP- 248 (290)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHHHTTTCCC-
T ss_pred ccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc-------HHHHHHHHhccCCc-
Confidence 54322 223457899999999887 4699999999999999999999999864322 11112222111110
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
...+......+.+++.+||+.||.+|||++|++++
T Consensus 249 ------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 249 ------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11112233568999999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=333.13 Aligned_cols=249 Identities=20% Similarity=0.363 Sum_probs=202.6
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh---------hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ---------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SL 556 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~ 556 (790)
.++|++.+.||+|+||.||+|... ++.+|+|.++.. ..+++.+|++++++++||||+++++++.+. ..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356899999999999999999986 789999988532 356799999999999999999999998754 58
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC----cEEEEEeCC
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF----RAKVADFGL 632 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~----~~kl~DfGl 632 (790)
++||||+++++|.+++... ..+++..++.++.|++.||+|||++++ +||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i---vH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKI---AHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 9999999999999999864 358999999999999999999999997 9999999999999888 799999999
Q ss_pred CcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC
Q 046083 633 AKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD 712 (790)
Q Consensus 633 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (790)
+....... ......||+.|+|||.+.+..++.++||||||+++|||++|..||..... ......+.....
T Consensus 166 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~~ 235 (321)
T 2a2a_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANITSVSY 235 (321)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHTTCC
T ss_pred ceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhccc
Confidence 98664322 22345689999999999999999999999999999999999999964322 112222221110
Q ss_pred ChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 713 PREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 713 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
. .........+..+.+++.+||+.||++|||++|++++-+
T Consensus 236 ~-----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~ 275 (321)
T 2a2a_A 236 D-----------FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (321)
T ss_dssp C-----------CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred c-----------cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 0 000000123456889999999999999999999987543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=325.54 Aligned_cols=244 Identities=23% Similarity=0.374 Sum_probs=200.6
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEY 562 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~ 562 (790)
.++|++.+.||+|+||.||+|... +..+|+|++.. ...+.+.+|++++++++||||+++++++.++ ..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 457999999999999999999987 56899999864 3457799999999999999999999998854 58999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe---cCCCcEEEEEeCCCcccccC
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI---DKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl---~~~~~~kl~DfGla~~~~~~ 639 (790)
+++++|.+++.... .+++..++.++.+++.||+|||++++ +||||||+|||+ +.++.+||+|||++......
T Consensus 88 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i---~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 88 CTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNV---AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---cCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 99999999987643 58999999999999999999999997 999999999999 78899999999999865432
Q ss_pred CcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
. ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||..... ......+.....
T Consensus 163 ~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~~------- 224 (277)
T 3f3z_A 163 K--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD--------SEVMLKIREGTF------- 224 (277)
T ss_dssp S--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCC-------
T ss_pred c--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhCCC-------
Confidence 2 2334578999999999875 499999999999999999999999865322 111222222111
Q ss_pred hcCCcCCCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 720 LVDPRLGDDYPI----DSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 720 ~~d~~l~~~~~~----~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
..+. ..+..+.+++.+||+.||++|||+.|++++-+
T Consensus 225 --------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~ 264 (277)
T 3f3z_A 225 --------TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEW 264 (277)
T ss_dssp --------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred --------CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 0111 23467899999999999999999999987543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=350.69 Aligned_cols=250 Identities=27% Similarity=0.405 Sum_probs=204.5
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLV 559 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv 559 (790)
.++|.+.+.||+|+||.||+|+.. |+.+|+|+++.. ..+.+.+|++++++++||||+++++++.+ ...|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999985 889999999643 23568899999999999999999998875 468999
Q ss_pred EEEecCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccc
Q 046083 560 YEYIENGNLNQHLRGSG--KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~ 637 (790)
|||+++|+|.+++.... ...+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gI---vHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI---IYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCC---cccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999997643 3469999999999999999999999997 999999999999999999999999998764
Q ss_pred cCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 638 VGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .........+....
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~----~~~~~~~~~i~~~~------ 409 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK----VENKELKQRVLEQA------ 409 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC----CCHHHHHHHHHHCC------
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc----hhHHHHHHHHhhcc------
Confidence 3322 223458999999999999999999999999999999999999999654321 11122222222211
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSM-----RAIVVA 761 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~~ 761 (790)
..++...+..+.+++.+||+.||++||++ ++++++
T Consensus 410 ---------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 410 ---------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred ---------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 12234455678999999999999999975 666543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=339.92 Aligned_cols=252 Identities=25% Similarity=0.371 Sum_probs=203.4
Q ss_pred hcCcccceeeeecCceEEEEEEE-----CCceEEEEEeChh-------hHHHHHHHHHHHHhc-CCCCCcceEEEEec-C
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAEL-----RGEKAAIKKMDMQ-------ASKEFLAELKVLTHV-HHLNLVRLIGYCVE-G 554 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~-----~g~~vavK~~~~~-------~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~ 554 (790)
.++|++.+.||+|+||.||+++. .++.+|||+++.. ..+.+.+|++++.++ +||||+++++++.+ .
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999987 4789999998642 335677899999999 69999999998875 5
Q ss_pred eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCc
Q 046083 555 SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK 634 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~ 634 (790)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~i---vH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGI---IYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 6899999999999999998643 58999999999999999999999998 999999999999999999999999998
Q ss_pred ccccCCcccccccccCCCccchhcccC--CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC
Q 046083 635 LTEVGSASVHTRLVGTFGYMPPEYAQY--GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD 712 (790)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (790)
..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..............
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~----~~~~~~~~~~~~~~- 282 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK----NSQAEISRRILKSE- 282 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC----CCHHHHHHHHHHCC-
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc----chHHHHHHHHhccC-
Confidence 664433333445679999999999985 34789999999999999999999999654321 11122222222111
Q ss_pred ChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHh
Q 046083 713 PREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRP-----SMRAIVVALMT 764 (790)
Q Consensus 713 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~L~~ 764 (790)
..++......+.+|+.+||+.||.+|| +++|++++...
T Consensus 283 --------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 283 --------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp --------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred --------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 122334456788999999999999999 99999987654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=327.68 Aligned_cols=263 Identities=29% Similarity=0.395 Sum_probs=196.9
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYE 561 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e 561 (790)
++|++.+.||+|+||.||+|... ++.+|+|++... ..+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67999999999999999999986 889999988532 24568899999999999999999999875 46899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|+++++|.+++.... .+++..+..++.+++.||+|||++++ +||||||+|||++.++.+||+|||++........
T Consensus 83 ~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~i---vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 83 YCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHNC---IHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp CCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCCC---cCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 999999999887643 58999999999999999999999997 9999999999999999999999999986543222
Q ss_pred ccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChh-----
Q 046083 642 SVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE----- 715 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 715 (790)
......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... +.............+..
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV-----DQLYLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCSCCHHHHHHHH
T ss_pred -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhcccccccccccc
Confidence 2234578999999999876 57899999999999999999999999654321 11111111111111000
Q ss_pred ---hhhhhcCCcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 716 ---DLQRLVDPRLGDDYP-----IDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 716 ---~l~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.......+......+ ...+..+.+++.+||+.||++|||++|++++-+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 287 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGG
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChH
Confidence 000000000000000 134456889999999999999999999987544
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=338.23 Aligned_cols=239 Identities=24% Similarity=0.401 Sum_probs=199.7
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----------hHHHHHHHHHHHHhcCCCCCcceEEEEecC-
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG- 554 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~- 554 (790)
.++|++.+.||+|+||.||+|... ++.||||.++.. ..+.+.+|++++++++||||+++++++.+.
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 467999999999999999999875 789999998643 223577899999999999999999998754
Q ss_pred eEEEEEEEecCC-ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCC
Q 046083 555 SLFLVYEYIENG-NLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLA 633 (790)
Q Consensus 555 ~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla 633 (790)
..++||||+.+| +|.+++.... .+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~i---vH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKDI---IHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---EEeccCHHHEEEcCCCcEEEeecccc
Confidence 589999999777 9999998654 59999999999999999999999997 99999999999999999999999999
Q ss_pred cccccCCcccccccccCCCccchhcccCCCC-CchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC
Q 046083 634 KLTEVGSASVHTRLVGTFGYMPPEYAQYGEV-SPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD 712 (790)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (790)
+...... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......
T Consensus 178 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------------- 236 (335)
T 3dls_A 178 AYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------------- 236 (335)
T ss_dssp EECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------------------
T ss_pred eECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------------------
Confidence 8764332 2234578999999999988877 88999999999999999999998542211
Q ss_pred ChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 713 PREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 713 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
..... ..+......+.+++.+||+.||++|||++|++++-+
T Consensus 237 --------~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 237 --------VEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp --------TTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred --------Hhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 00000 111123457899999999999999999999998755
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=345.49 Aligned_cols=260 Identities=23% Similarity=0.283 Sum_probs=195.4
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-------C
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-------G 554 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------~ 554 (790)
.++|++.+.||+|+||.||+|... ++.||||++.. ...+.+.+|+++++.++||||+++++++.. .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999876 88999999853 345678899999999999999999999853 2
Q ss_pred eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCc
Q 046083 555 SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK 634 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~ 634 (790)
..|+||||+++ +|.+.+.. .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~i---iHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 47999999987 56666653 38999999999999999999999998 999999999999999999999999998
Q ss_pred ccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC-
Q 046083 635 LTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP- 713 (790)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 713 (790)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +........+..+.+
T Consensus 213 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-----~~~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 213 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-----DQWNKVIEQLGTPCPE 285 (464)
T ss_dssp ----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHHHCSCCHH
T ss_pred ecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhcCCCCHH
Confidence 65432 2234567999999999999999999999999999999999999999654321 111111111111110
Q ss_pred -----hhhhhhhcCC---------------cCCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 714 -----REDLQRLVDP---------------RLGDDY---PIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 714 -----~~~l~~~~d~---------------~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.......+.. .+.... .......+.+|+.+||+.||++|||++|++++-+
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 358 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChh
Confidence 0011111111 000000 0112567899999999999999999999998654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=325.44 Aligned_cols=244 Identities=25% Similarity=0.440 Sum_probs=202.9
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
++|.+.+.||+|+||.||+|... +..+|+|.+... ..+.+.+|++++++++||||+++++++.+ +..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57899999999999999999986 678999998643 23568899999999999999999999875 4589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++++|.+++...+ .+++..++.++.|++.||.|||++++ +||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKV---IHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTE---ECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---eecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 9999999999998653 58999999999999999999999997 99999999999999999999999998755322
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+...
T Consensus 168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~---------- 227 (284)
T 2vgo_A 168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH--------TETHRRIVNV---------- 227 (284)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTT----------
T ss_pred --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH--------hHHHHHHhcc----------
Confidence 12345789999999999999999999999999999999999999864322 1111122111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
. ..++...+..+.+++.+||+.||.+|||++|++++-+-
T Consensus 228 ---~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~ 266 (284)
T 2vgo_A 228 ---D--LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266 (284)
T ss_dssp ---C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHH
T ss_pred ---c--cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHH
Confidence 1 11233345678899999999999999999999986553
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=328.59 Aligned_cols=247 Identities=25% Similarity=0.425 Sum_probs=203.7
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
+.|++.+.||+|+||.||+|... ++.+|+|.+.. ...+.+.+|+.++++++||||+++++++.+ ...++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 56889999999999999999875 78999999863 335779999999999999999999998875 568999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+++++|.+++.. ..+++..+..++.+++.||.|||++++ +|+||||+||+++.++.+||+|||++........
T Consensus 102 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 174 (303)
T 3a7i_A 102 LGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 174 (303)
T ss_dssp CTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCC---ccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence 999999999975 358999999999999999999999997 9999999999999999999999999986543221
Q ss_pred cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcC
Q 046083 643 VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD 722 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d 722 (790)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... .......... ..
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~----------~~ 236 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP--------MKVLFLIPKN----------NP 236 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHS----------CC
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH--------HHHHHHhhcC----------CC
Confidence 22345789999999999999999999999999999999999999854321 1111111111 11
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 723 PRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 723 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
+.+ +...+..+.+++.+||+.||++|||++|++++....
T Consensus 237 ~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 275 (303)
T 3a7i_A 237 PTL----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275 (303)
T ss_dssp CCC----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred CCC----ccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhh
Confidence 111 223345789999999999999999999999876643
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=364.39 Aligned_cols=254 Identities=22% Similarity=0.379 Sum_probs=205.8
Q ss_pred HHhcCcccceeeeecCceEEEEEEEC-----CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecCeEE
Q 046083 487 KATNDFSMGNKIGQGGFGAVFYAELR-----GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLF 557 (790)
Q Consensus 487 ~~~~~f~~~~~lG~G~fg~Vy~a~~~-----g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 557 (790)
...++|++.+.||+|+||.||+|.+. +..+|+|.++. ...+.+.+|+.++++++||||+++++++.++..+
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 466 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW 466 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceE
Confidence 34577999999999999999999874 34699999864 2336789999999999999999999999888899
Q ss_pred EEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccc
Q 046083 558 LVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~ 637 (790)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++...
T Consensus 467 lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~gi---vHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCc---cccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 9999999999999998653 358999999999999999999999998 999999999999999999999999998765
Q ss_pred cCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhh
Q 046083 638 VGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716 (790)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (790)
...........+++.|+|||.+.+..++.++||||||+++|||++ |..||..... ......+....
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--------~~~~~~i~~~~----- 609 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVIGRIENGE----- 609 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHHTC-----
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHcCC-----
Confidence 433333334557789999999998899999999999999999997 9999864322 11111221111
Q ss_pred hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 046083 717 LQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLS 766 (790)
Q Consensus 717 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~ 766 (790)
....+...+..+.+++.+||+.||++|||+.|+++.|..+.
T Consensus 610 ---------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 610 ---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11223345567899999999999999999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=336.09 Aligned_cols=259 Identities=25% Similarity=0.433 Sum_probs=200.4
Q ss_pred cCHHHHHHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh--hhHHHHHHHHHHHHhc-CCCCCcceEEEEec-
Q 046083 480 FSYEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM--QASKEFLAELKVLTHV-HHLNLVRLIGYCVE- 553 (790)
Q Consensus 480 ~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~- 553 (790)
+++.++....++|++.+.||+|+||.||+|... ++.+|||.+.. ...+.+.+|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 344455556788999999999999999999984 88999999853 3457789999999999 89999999998864
Q ss_pred ------CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEE
Q 046083 554 ------GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKV 627 (790)
Q Consensus 554 ------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl 627 (790)
...++||||+++++|.+++.......+++..++.++.|++.||.|||++++ +|+||||+|||++.++.+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i---vH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCSGGGEEECTTCCEEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCcHHHEEEcCCCCEEE
Confidence 358999999999999999987654579999999999999999999999998 99999999999999999999
Q ss_pred EEeCCCcccccCCcccccccccCCCccchhccc-----CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHH
Q 046083 628 ADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQ-----YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVA 702 (790)
Q Consensus 628 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 702 (790)
+|||++........ ......|++.|+|||.+. ...++.++||||||+++|||++|+.||...... .
T Consensus 171 ~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~ 241 (326)
T 2x7f_A 171 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM--------R 241 (326)
T ss_dssp CCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--------H
T ss_pred eeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--------H
Confidence 99999986543221 223456899999999987 567899999999999999999999998543221 1
Q ss_pred HHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 703 LFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 703 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.......... +.+ .+...+..+.+++.+||+.||.+|||+++++++-.
T Consensus 242 ~~~~~~~~~~----------~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~ 289 (326)
T 2x7f_A 242 ALFLIPRNPA----------PRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPF 289 (326)
T ss_dssp HHHHHHHSCC----------CCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHH
T ss_pred HHHHhhcCcc----------ccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhChH
Confidence 1111111111 111 11223457889999999999999999999988544
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=325.23 Aligned_cols=247 Identities=22% Similarity=0.355 Sum_probs=204.1
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh------hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLV 559 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv 559 (790)
.++|.+.+.||+|+||.||++... ++.+|+|.+.. ...+.+.+|+.++++++||||+++++++.+. ..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357889999999999999999986 77899998753 2346788999999999999999999998854 58999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+++++|.+++.... .+++..++.++.|++.||+|||++++ +||||||+|||++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i---~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 99999999999987643 58999999999999999999999997 99999999999999999999999999865432
Q ss_pred CcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+....
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~-------- 231 (294)
T 2rku_A 169 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLRIKKNE-------- 231 (294)
T ss_dssp TC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTTC--------
T ss_pred cc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhhcc--------
Confidence 22 22345789999999999998999999999999999999999999864321 11111111110
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
...+......+.+++.+||+.||++|||++|++++-.-
T Consensus 232 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~ 269 (294)
T 2rku_A 232 -------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 269 (294)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred -------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence 11222344578899999999999999999999987554
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=326.18 Aligned_cols=246 Identities=26% Similarity=0.428 Sum_probs=193.5
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
++|.+.+.||+|+||.||++... +..+|+|.+... ..+.+.+|++++++++||||+++++++.+ ...++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 56889999999999999999986 789999998643 34778999999999999999999999875 458999999
Q ss_pred ecCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe---cCCCcEEEEEeCCCcccc
Q 046083 563 IENGNLNQHLRGS--GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI---DKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 563 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl---~~~~~~kl~DfGla~~~~ 637 (790)
+++|+|.+++... ....+++..++.++.|++.||+|||++++ +||||||+|||+ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i---vH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHV---VHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCE---EECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988643 12469999999999999999999999998 999999999999 456789999999998654
Q ss_pred cCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 638 VGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
... ......|++.|+|||.+. ..++.++||||||+++|||++|+.||..... ...........
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~--------~~~~~~~~~~~------ 241 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL--------EEVQQKATYKE------ 241 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC------
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH--------HHHHhhhccCC------
Confidence 322 223457899999999986 5789999999999999999999999865321 11111111111
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
+..... .......+.+++.+||+.||++|||++|++++
T Consensus 242 -----~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 242 -----PNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp -----CCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred -----cccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 01134568899999999999999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=326.24 Aligned_cols=242 Identities=25% Similarity=0.358 Sum_probs=195.9
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhc-CCCCCcceEEEEec-CeEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSLFLV 559 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~~lv 559 (790)
.++|++.+.||+|+||.||+|... ++.+|+|.++. ....++.+|+..+.++ +||||+++++++.+ +..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467999999999999999999986 88999999863 3446788999999999 99999999999875 568999
Q ss_pred EEEecCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC----------------
Q 046083 560 YEYIENGNLNQHLRGSG--KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK---------------- 621 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~---------------- 621 (790)
|||+++++|.+++.... ...+++..++.++.|++.||.|||++++ +||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i---vH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL---VHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCE---eecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999997642 1468999999999999999999999997 99999999999984
Q ss_pred ---CCcEEEEEeCCCcccccCCcccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccc
Q 046083 622 ---NFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITES 697 (790)
Q Consensus 622 ---~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~ 697 (790)
...+||+|||++....... ...|++.|+|||.+.+. .++.++||||||+++|||++|.+++....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------ 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------ 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------
Confidence 4479999999998654322 23589999999999866 56789999999999999999987753211
Q ss_pred cchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 698 TGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
....+... .. ...+...+..+.+++.+||+.||++|||++|++++-+
T Consensus 236 -----~~~~~~~~----------~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 282 (289)
T 1x8b_A 236 -----QWHEIRQG----------RL----PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 282 (289)
T ss_dssp -----HHHHHHTT----------CC----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTT
T ss_pred -----HHHHHHcC----------CC----CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChH
Confidence 11111111 01 1223334567899999999999999999999987543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=332.03 Aligned_cols=264 Identities=22% Similarity=0.351 Sum_probs=192.5
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh-----HHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEE
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA-----SKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLV 559 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv 559 (790)
..++|++.+.||+|+||.||+|... ++.+|||+++... .+.+.+|++++++++||||+++++++.+ ...++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3467999999999999999999875 8899999986432 3457899999999999999999999875 468999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe-----cCCCcEEEEEeCCCc
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI-----DKNFRAKVADFGLAK 634 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl-----~~~~~~kl~DfGla~ 634 (790)
|||+++ +|.+++.... .+++..+..++.|++.||.|||++++ +||||||+|||+ +.++.+||+|||+++
T Consensus 112 ~e~~~~-~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~i---vH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRRC---LHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EECCSE-EHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EecCCC-CHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCE---ECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 999985 9999998754 48999999999999999999999998 999999999999 455669999999998
Q ss_pred ccccCCcccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC
Q 046083 635 LTEVGSASVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.. .......+..
T Consensus 186 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~-~~~~~~~~~~ 259 (329)
T 3gbz_A 186 AFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI----DQLFK-IFEVLGLPDD 259 (329)
T ss_dssp HHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH-HHHHHCCCCT
T ss_pred ccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH----HHHHH-HHHHhCCCch
Confidence 654322 222345679999999999875 4899999999999999999999999654321 11111 1111111111
Q ss_pred hh--hhh---hhcC--CcCCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 714 RE--DLQ---RLVD--PRLGDD-----YPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 714 ~~--~l~---~~~d--~~l~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.. ... .+.. +..... .+.....++.+|+.+||+.||++|||++|++++-+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 321 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcc
Confidence 00 000 0000 000000 01113467889999999999999999999987443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=333.40 Aligned_cols=251 Identities=22% Similarity=0.325 Sum_probs=185.0
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcC-CCCCcceEEEEe--------c-
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVH-HLNLVRLIGYCV--------E- 553 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~g~~~--------~- 553 (790)
..+|++.+.||+|+||.||+|... ++.+|||++.. ...+.+.+|+.++.++. ||||+++++++. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 457999999999999999999984 88999998843 34567889999999996 999999999884 1
Q ss_pred CeEEEEEEEecCCChhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceeecCCCCCCEEecCCCcEEEEEe
Q 046083 554 GSLFLVYEYIENGNLNQHLRGS-GKDTLTWSARMQIALDSARGLEYIHEHT--VPVYIHRDIKPANILIDKNFRAKVADF 630 (790)
Q Consensus 554 ~~~~lv~e~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~~vH~dlkp~NILl~~~~~~kl~Df 630 (790)
...+++|||+. |+|.+++... ....+++..++.++.|++.||.|||+++ + +||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~i---vH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPI---IHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCC---BCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCE---EEccCCcccEEECCCCCEEEecC
Confidence 23789999996 6999988652 2346999999999999999999999998 7 99999999999999999999999
Q ss_pred CCCcccccCCccc-----------ccccccCCCccchhcc---cCCCCCchhhHHHHHHHHHHHHhCCcccccccccccc
Q 046083 631 GLAKLTEVGSASV-----------HTRLVGTFGYMPPEYA---QYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITE 696 (790)
Q Consensus 631 Gla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~ 696 (790)
|+++......... .....|++.|+|||.+ .+..++.++||||||+++|||++|+.||......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--- 259 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--- 259 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH---
Confidence 9998764322111 1134589999999998 5667899999999999999999999998542211
Q ss_pred ccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 697 STGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
.... .......+......+.+++.+||+.||.+|||++|+++.|+.+...
T Consensus 260 ---------~~~~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 260 ---------RIVN-------------GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp ----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------Hhhc-------------CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0000 0000111112223578999999999999999999999999988653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=329.91 Aligned_cols=264 Identities=20% Similarity=0.305 Sum_probs=203.0
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChhhHHHHHHHHHHHHhcC-CCCCcceEEEEec---CeEEEEEEEe
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHVH-HLNLVRLIGYCVE---GSLFLVYEYI 563 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~---~~~~lv~e~~ 563 (790)
++|++.+.||+|+||.||+|... ++.+|||.++....+.+.+|++++++++ ||||+++++++.+ ...++||||+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~ 115 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 115 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence 67999999999999999999875 8899999999888889999999999997 9999999999875 3489999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC-cEEEEEeCCCcccccCCcc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF-RAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~-~~kl~DfGla~~~~~~~~~ 642 (790)
++++|.+++.. +++..+..++.|++.||+|||++++ +||||||+|||++.++ .+||+|||+++......
T Consensus 116 ~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i---vH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-- 185 (330)
T 3nsz_A 116 NNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGI---MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-- 185 (330)
T ss_dssp CCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC--
T ss_pred CchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCe---eeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC--
Confidence 99999999863 8899999999999999999999997 9999999999999776 89999999998654332
Q ss_pred cccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCcccccccccccccc------chHHHHHHHHcCC-CCh
Q 046083 643 VHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITEST------GLVALFEEVLRQP-DPR 714 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~------~~~~~~~~~~~~~-~~~ 714 (790)
......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||........... ........+.... ...
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence 2234578999999999977 6789999999999999999999999954332110000 0000000000000 000
Q ss_pred hhhhhhcCCc--------CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 715 EDLQRLVDPR--------LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 715 ~~l~~~~d~~--------l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
..+....... .....+......+.+|+.+||+.||++|||++|++++-+
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~ 322 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGG
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCcc
Confidence 1111111110 111112234578999999999999999999999987543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=324.10 Aligned_cols=247 Identities=22% Similarity=0.407 Sum_probs=198.4
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh---------hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ---------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLF 557 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~ 557 (790)
++|++.+.||+|+||.||++... ++.+|+|.++.. ..+.+.+|++++++++||||+++++++.+. ..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56899999999999999999986 789999988532 357799999999999999999999998754 589
Q ss_pred EEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC----cEEEEEeCCC
Q 046083 558 LVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF----RAKVADFGLA 633 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~----~~kl~DfGla 633 (790)
+||||+++++|.+++.... .+++..++.++.+++.||.|||++++ +||||||+||+++.++ .+||+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRI---AHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCc---cCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 9999999999999997643 58999999999999999999999997 9999999999998877 8999999999
Q ss_pred cccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC
Q 046083 634 KLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+......
T Consensus 160 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~ 229 (283)
T 3bhy_A 160 HKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK--------QETLTNISAVNYD 229 (283)
T ss_dssp EECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTTCCC
T ss_pred eeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch--------HHHHHHhHhcccC
Confidence 8654322 22345689999999999999999999999999999999999999865322 1111222111100
Q ss_pred hhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 714 REDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 714 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
.........+..+.+++.+||+.||++|||+.|++++-
T Consensus 230 -----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 267 (283)
T 3bhy_A 230 -----------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHS 267 (283)
T ss_dssp -----------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred -----------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence 00000012345688999999999999999999999853
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=333.67 Aligned_cols=247 Identities=22% Similarity=0.354 Sum_probs=204.1
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh------hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLV 559 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv 559 (790)
.++|.+.+.||+|+||.||++... ++.+|+|.+.. ...+.+.+|+.++++++||||+++++++.+. ..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467999999999999999999986 77899998853 2456788999999999999999999998854 58999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+++++|.+++.... .+++..++.++.|++.||.|||++++ +||||||+|||++.++.+||+|||++......
T Consensus 120 ~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i---vH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCC---EecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999999987643 58999999999999999999999997 99999999999999999999999999876432
Q ss_pred CcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+....
T Consensus 195 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~~-------- 257 (335)
T 2owb_A 195 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLRIKKNE-------- 257 (335)
T ss_dssp TC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTC--------
T ss_pred cc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH--------HHHHHHHhcCC--------
Confidence 22 22345789999999999998999999999999999999999999864321 11111111110
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
. ..+......+.+++.+||+.||++|||++|++++-.-
T Consensus 258 ---~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~ 295 (335)
T 2owb_A 258 ---Y----SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 295 (335)
T ss_dssp ---C----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred ---C----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 0 1122334578899999999999999999999986553
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=361.51 Aligned_cols=245 Identities=26% Similarity=0.430 Sum_probs=203.5
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhc-CCCCCcceEEEEec-CeEE
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSLF 557 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~~ 557 (790)
..++|++.+.||+|+||.||+|+.. ++.+|||+++.. ..+.+..|.+++..+ +||||+++++++.+ +.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999986 678999998743 335678899999988 79999999998875 4689
Q ss_pred EEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccc
Q 046083 558 LVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~ 637 (790)
+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++++ +||||||+||||+.++.+||+|||+++...
T Consensus 419 lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gI---iHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGI---IYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSE---ECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---EeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999998754 59999999999999999999999997 999999999999999999999999998543
Q ss_pred cCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 638 VGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+..+...
T Consensus 494 ~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~------- 557 (674)
T 3pfq_A 494 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEH------- 557 (674)
T ss_dssp CTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHSS-------
T ss_pred cCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhC-------
Confidence 222 223456899999999999999999999999999999999999999965322 2223333321
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSM-----RAIVVA 761 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~~ 761 (790)
. ..+|.....++.+|+.+||+.||++||++ +||+++
T Consensus 558 ------~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 558 ------N--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ------C--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ------C--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 1 12344456788999999999999999997 666543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=335.42 Aligned_cols=253 Identities=19% Similarity=0.324 Sum_probs=201.4
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhhHHHHHHHHHHHHhc-CCCCCcceEEEEecC-eEEEEEEEec
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHV-HHLNLVRLIGYCVEG-SLFLVYEYIE 564 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~~~lv~e~~~ 564 (790)
.++|++.+.||+|+||.||++... ++.+|+|.++... ....+|++++.++ +||||+++++++.++ ..|+||||++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 99 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK 99 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT-CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc-CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence 467999999999999999999986 7899999996543 2345688888888 799999999998864 5899999999
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC----CcEEEEEeCCCcccccCC
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN----FRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~----~~~kl~DfGla~~~~~~~ 640 (790)
+|+|.+++...+ .+++..+..++.+++.||+|||++++ +||||||+|||+..+ +.+||+|||+++......
T Consensus 100 gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~gi---vHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 100 GGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQGV---VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp SCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---EeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 999999998653 59999999999999999999999997 999999999998443 359999999998664332
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
. ......||+.|+|||++.+..++.++|||||||++|||++|..||..... .........+.....
T Consensus 175 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~~~~i~~~~~-------- 240 (342)
T 2qr7_A 175 G-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-----DTPEEILARIGSGKF-------- 240 (342)
T ss_dssp C-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT-----SCHHHHHHHHHHCCC--------
T ss_pred C-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc-----CCHHHHHHHHccCCc--------
Confidence 2 23346789999999999888899999999999999999999999964321 111222222222111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
.+........+..+.+|+.+||+.||++|||+.|++++-+.
T Consensus 241 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 241 ---SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp ---CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred ---ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 11111223345678999999999999999999999987665
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=333.68 Aligned_cols=261 Identities=23% Similarity=0.356 Sum_probs=204.7
Q ss_pred hcCcccceeeeecCceEEEEEEECCceEEEEEeChhhH--------------------HHHHHHHHHHHhcCCCCCcceE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQAS--------------------KEFLAELKVLTHVHHLNLVRLI 548 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~~--------------------~~~~~E~~~l~~l~h~niv~l~ 548 (790)
.++|++.+.||+|+||.||+|...++.||||.+..... +.+.+|++++++++||||++++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 46899999999999999999999999999999874322 7899999999999999999999
Q ss_pred EEEec-CeEEEEEEEecCCChhhh------hhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCEEec
Q 046083 549 GYCVE-GSLFLVYEYIENGNLNQH------LRGSGKDTLTWSARMQIALDSARGLEYIHE-HTVPVYIHRDIKPANILID 620 (790)
Q Consensus 549 g~~~~-~~~~lv~e~~~~g~L~~~------l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~vH~dlkp~NILl~ 620 (790)
+++.+ +..++||||+++++|.++ +.......+++..++.++.|++.||.|||+ +++ +||||||+|||++
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i---~H~dl~p~Nil~~ 186 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNI---CHRDVKPSNILMD 186 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCE---ECCCCCGGGEEEC
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCE---eecCCChHhEEEc
Confidence 99875 458999999999999999 665445679999999999999999999999 887 9999999999999
Q ss_pred CCCcEEEEEeCCCcccccCCcccccccccCCCccchhcccCC-CCCc-hhhHHHHHHHHHHHHhCCcccccccccccccc
Q 046083 621 KNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYG-EVSP-KIDVYAFGVVLYELISAMEAVVKTNETITEST 698 (790)
Q Consensus 621 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~ 698 (790)
.++.+||+|||++...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||......
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----- 258 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL----- 258 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-----
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-----
Confidence 9999999999999865432 23446789999999999877 6666 999999999999999999999654321
Q ss_pred chHHHHHHHHcCCCChh-hhhhhcCCc---CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 699 GLVALFEEVLRQPDPRE-DLQRLVDPR---LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 699 ~~~~~~~~~~~~~~~~~-~l~~~~d~~---l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
......+........ .......+. .........+..+.+++.+||+.||.+|||++|++++-
T Consensus 259 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 259 --VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp --HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred --HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 122222222111000 000000000 00001133456789999999999999999999998743
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=336.09 Aligned_cols=268 Identities=23% Similarity=0.338 Sum_probs=202.7
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYE 561 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e 561 (790)
.++|++.+.||+|+||.||++... +..+|+|.+.. ...+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 357999999999999999999987 88999999853 334678999999999999999999998875 56899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH-TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
|+++++|.+++...+ .+++..+..++.+++.||.|||+. ++ +||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i---~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKI---MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCC---CCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCE---EcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 999999999998654 589999999999999999999995 87 99999999999999999999999999754321
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccc-------h----------HHH
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTG-------L----------VAL 703 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~-------~----------~~~ 703 (790)
......|++.|+|||++.+..++.++||||||+++|||++|+.||...........- . ...
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 223457899999999999999999999999999999999999999654321100000 0 000
Q ss_pred HHHHHcCC---C-ChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 704 FEEVLRQP---D-PREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 704 ~~~~~~~~---~-~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
........ . ..+.+............+......+.+|+.+||+.||++|||++|++++-+-
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 328 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 00000000 0 0011111111111111112345678999999999999999999999987664
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=335.15 Aligned_cols=251 Identities=23% Similarity=0.388 Sum_probs=201.2
Q ss_pred HHHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh-----------HHHHHHHHHHHHhc-CCCCCcceEEE
Q 046083 485 LAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA-----------SKEFLAELKVLTHV-HHLNLVRLIGY 550 (790)
Q Consensus 485 l~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~-----------~~~~~~E~~~l~~l-~h~niv~l~g~ 550 (790)
.....++|.+.+.||+|+||.||+|.+. |+.||||+++... .+.+.+|++++.++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445578999999999999999999986 8899999885322 35678999999999 79999999999
Q ss_pred Eec-CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEE
Q 046083 551 CVE-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVAD 629 (790)
Q Consensus 551 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~D 629 (790)
+.. +..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.++ +|+||||+|||++.++.+||+|
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi---~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNI---VHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTCCEEECC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEECCCCCEEEEe
Confidence 875 4589999999999999999864 358999999999999999999999997 9999999999999999999999
Q ss_pred eCCCcccccCCcccccccccCCCccchhcccC------CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHH
Q 046083 630 FGLAKLTEVGSASVHTRLVGTFGYMPPEYAQY------GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVAL 703 (790)
Q Consensus 630 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 703 (790)
||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ...
T Consensus 244 fG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--------~~~ 313 (365)
T 2y7j_A 244 FGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--------ILM 313 (365)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH
T ss_pred cCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--------HHH
Confidence 99998765322 2334678999999999863 3688999999999999999999999864321 111
Q ss_pred HHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 704 FEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 704 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
...+....... ....+ ...+..+.+++.+||+.||++|||++|++++
T Consensus 314 ~~~i~~~~~~~-~~~~~----------~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 314 LRMIMEGQYQF-SSPEW----------DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHHTCCCC-CHHHH----------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhCCCCC-CCccc----------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 22222111100 00000 1223568899999999999999999999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=330.65 Aligned_cols=256 Identities=18% Similarity=0.337 Sum_probs=202.8
Q ss_pred HHHHHhcCcccc-eeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhc-CCCCCcceEEEEecC
Q 046083 484 ELAKATNDFSMG-NKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHV-HHLNLVRLIGYCVEG 554 (790)
Q Consensus 484 ~l~~~~~~f~~~-~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 554 (790)
......++|.+. +.||+|+||.||+|... ++.+|+|.++. ....++.+|+.++..+ +||||+++++++.+.
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 334445677777 89999999999999986 88999998863 2356789999999999 569999999998754
Q ss_pred -eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC---CCcEEEEEe
Q 046083 555 -SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK---NFRAKVADF 630 (790)
Q Consensus 555 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~---~~~~kl~Df 630 (790)
..++||||+++|+|.+++.......+++..++.++.|++.||+|||++++ +||||||+|||++. ++.+||+||
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~gi---vH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNI---VHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCcCChHHEEEecCCCCCcEEEeeC
Confidence 58999999999999999976655679999999999999999999999997 99999999999988 789999999
Q ss_pred CCCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcC
Q 046083 631 GLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQ 710 (790)
Q Consensus 631 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 710 (790)
|+++...... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+...
T Consensus 179 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~ 248 (327)
T 3lm5_A 179 GMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN--------QETYLNISQV 248 (327)
T ss_dssp GGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHT
T ss_pred ccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--------hHHHHHHHhc
Confidence 9998664322 22345789999999999999999999999999999999999999965332 1111111111
Q ss_pred CCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 711 PDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 711 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
. ..............+.+++.+||+.||++|||++|++++-+
T Consensus 249 ~-----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~ 290 (327)
T 3lm5_A 249 N-----------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW 290 (327)
T ss_dssp C-----------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred c-----------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence 0 01111112234567889999999999999999999987655
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=330.69 Aligned_cols=248 Identities=22% Similarity=0.373 Sum_probs=196.6
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh-----------HHHHHHHHHHHHhcCCCCCcceEEEEecCe
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA-----------SKEFLAELKVLTHVHHLNLVRLIGYCVEGS 555 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 555 (790)
.++|.+.+.||+|+||.||+|... ++.||||.+.... ...+.+|++++++++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 467999999999999999999986 7899999986421 234789999999999999999999998878
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCc---EEEEEeCC
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFR---AKVADFGL 632 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~---~kl~DfGl 632 (790)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||++++ +||||||+|||++.++. +||+|||+
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---vH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 999999999999999997643 58999999999999999999999997 99999999999987654 99999999
Q ss_pred CcccccCCcccccccccCCCccchhccc---CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHc
Q 046083 633 AKLTEVGSASVHTRLVGTFGYMPPEYAQ---YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLR 709 (790)
Q Consensus 633 a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 709 (790)
++..... .......|++.|+|||++. ...++.++||||||+++|||++|..||...... ..+. ..+..
T Consensus 164 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~---~~~~~ 234 (322)
T 2ycf_A 164 SKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----VSLK---DQITS 234 (322)
T ss_dssp CEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS----SCHH---HHHHH
T ss_pred ceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH----HHHH---HHHHh
Confidence 9865422 2223456899999999974 567899999999999999999999999654321 1111 11111
Q ss_pred CCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 710 QPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 710 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
..... .... ....+..+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~--~~~~---------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 235 GKYNF--IPEV---------WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp TCCCC--CHHH---------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred Ccccc--Cchh---------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 10000 0000 01234578899999999999999999999853
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.75 Aligned_cols=249 Identities=24% Similarity=0.405 Sum_probs=202.3
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh---hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ---ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEY 562 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~ 562 (790)
.++|.+.+.||+|+||.||++... ++.+|+|.++.. ..+.+.+|++++++++||||+++++++.+. ..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 357899999999999999999986 889999998643 345688999999999999999999998754 58999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe---cCCCcEEEEEeCCCcccccC
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI---DKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl---~~~~~~kl~DfGla~~~~~~ 639 (790)
+++++|.+++...+ .+++..+..++.|++.||.|||++++ +||||||+|||+ +.++.+||+|||++......
T Consensus 88 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 88 VSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGI---VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTC---CCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred CCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 99999999987643 58999999999999999999999998 999999999999 78899999999999754322
Q ss_pred CcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
......|++.|+|||.+.+..++.++||||||+++|||++|..||..... ......+......
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~~~------ 225 (304)
T 2jam_A 163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--------SKLFEKIKEGYYE------ 225 (304)
T ss_dssp ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHCCCC------
T ss_pred ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCCCC------
Confidence 22335689999999999999999999999999999999999999864322 1222222221110
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
.........+..+.+++.+||+.||++|||++|++++-.-
T Consensus 226 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (304)
T 2jam_A 226 -----FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWI 265 (304)
T ss_dssp -----CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred -----CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 0111222345678999999999999999999999986553
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=320.35 Aligned_cols=249 Identities=22% Similarity=0.371 Sum_probs=201.2
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-------hHHHHHHHHHHHHhcCCCCCcceEEEEec---CeE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-------ASKEFLAELKVLTHVHHLNLVRLIGYCVE---GSL 556 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~---~~~ 556 (790)
.++|.+.+.||+|+||.||++... +..+|+|.++.. ..+.+.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999985 779999999753 24568999999999999999999998842 358
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
++||||++++ |.+++.......+++..++.++.|++.||.|||++++ +||||||+|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i---~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGI---VHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCe---eecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999886 8888876555679999999999999999999999997 99999999999999999999999999866
Q ss_pred ccCC-cccccccccCCCccchhcccCCC--CCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC
Q 046083 637 EVGS-ASVHTRLVGTFGYMPPEYAQYGE--VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 637 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
.... ........|++.|+|||.+.+.. ++.++||||||+++|||++|+.||.... .......+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~i~~~~-- 229 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKLFENIGKGS-- 229 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHCC--
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--------HHHHHHHHhcCC--
Confidence 4322 22223456899999999997644 3789999999999999999999986432 112222222111
Q ss_pred hhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 714 REDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 714 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
...+......+.+++.+||+.||.+|||++|++++-+.
T Consensus 230 -------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 267 (305)
T 2wtk_C 230 -------------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267 (305)
T ss_dssp -------------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred -------------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 01222345678899999999999999999999987554
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=319.43 Aligned_cols=245 Identities=26% Similarity=0.438 Sum_probs=194.1
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh------HHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA------SKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLV 559 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~------~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv 559 (790)
.++|.+.+.||+|+||.||+|... ++.+|||.+.... .+.+.+|+++++.++||||+++++++.+ +..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357999999999999999999986 8899999986432 3568899999999999999999999875 458999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+++++|.+++.... .+++..+..++.|++.||.|||++++ +|+||||+|||++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCS---SCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCC---ccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999997653 48999999999999999999999998 99999999999999999999999999865432
Q ss_pred CcccccccccCCCccchhcccCCCC-CchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGEV-SPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
. ......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||..... ......+....
T Consensus 165 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~------- 227 (276)
T 2h6d_A 165 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--------PTLFKKIRGGV------- 227 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-------
T ss_pred c--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--------HHHHHHhhcCc-------
Confidence 2 2234568999999999987765 6899999999999999999999854321 11222221110
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
...+......+.+++.+||+.||.+|||++|++++-.
T Consensus 228 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~ 264 (276)
T 2h6d_A 228 --------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEW 264 (276)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred --------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChh
Confidence 0112233457889999999999999999999998644
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=323.51 Aligned_cols=249 Identities=20% Similarity=0.316 Sum_probs=184.9
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----h-HHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----A-SKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~-~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
.++|++.+.||+|+||.||+|... ++.+|+|+++.. . .+.+.++...++.++||||+++++++.+ +..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467999999999999999999984 889999998642 1 2234455556788899999999999875 4589999
Q ss_pred EEecCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCEEecCCCcEEEEEeCCCcccc
Q 046083 561 EYIENGNLNQHLRGS--GKDTLTWSARMQIALDSARGLEYIHEH-TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 561 e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~ 637 (790)
||+++ +|.+++... ....+++..++.++.|++.||.|||++ ++ +||||||+|||++.++.+||+|||++....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i---~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV---IHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCC---CCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCe---ecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99975 888877641 234699999999999999999999998 88 999999999999999999999999998654
Q ss_pred cCCcccccccccCCCccchhcc----cCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC
Q 046083 638 VGSASVHTRLVGTFGYMPPEYA----QYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
... ......|++.|+|||.+ .+..++.++||||||+++|||++|+.||...... ...........
T Consensus 162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~-- 230 (290)
T 3fme_A 162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-------FQQLKQVVEEP-- 230 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-------HHHHHHHHHSC--
T ss_pred ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-------HHHHHHHhccC--
Confidence 322 22234689999999996 5567899999999999999999999998643221 11111222111
Q ss_pred hhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 714 REDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 714 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.....+...+..+.+++.+||+.||++|||++|++++-+
T Consensus 231 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~ 269 (290)
T 3fme_A 231 -----------SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPF 269 (290)
T ss_dssp -----------CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred -----------CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcc
Confidence 111111234567899999999999999999999988544
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=331.38 Aligned_cols=263 Identities=24% Similarity=0.379 Sum_probs=196.4
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChhhHH----HHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASK----EFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~~----~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
++|.+.+.||+|+||.||+|... ++.+|+|.++..... .+.+|++++++++||||+++++++.+ +..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999986 789999998754332 35579999999999999999999875 458999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+++ +|.+++...+ ..+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~i---vH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~ 155 (324)
T 3mtl_A 82 LDK-DLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKV---LHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 155 (324)
T ss_dssp CSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTE---EESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred ccc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCc---cCCCcCHHHEEECCCCCEEEccCcccccccCCc-c
Confidence 985 9999988654 368999999999999999999999997 999999999999999999999999998654322 1
Q ss_pred cccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh---
Q 046083 643 VHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ--- 718 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--- 718 (790)
......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ............+.. ..+.
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~~~~~~-~~~~~~~ 229 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE-----EQLHFIFRILGTPTE-ETWPGIL 229 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCCCCT-TTSTTGG
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCCh-Hhchhhh
Confidence 2234568999999999876 56899999999999999999999999654321 112222222222211 1111
Q ss_pred ------hhcCCcCCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 719 ------RLVDPRLGDD----YPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 719 ------~~~d~~l~~~----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
....+..... ........+.+|+.+||+.||++|||++|++++-+-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 285 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhh
Confidence 1111111000 011234678899999999999999999999986554
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=335.71 Aligned_cols=264 Identities=20% Similarity=0.270 Sum_probs=203.0
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh--hHHHHHHHHHHHHhcC--------CCCCcceEEEEe----
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ--ASKEFLAELKVLTHVH--------HLNLVRLIGYCV---- 552 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~--~~~~~~~E~~~l~~l~--------h~niv~l~g~~~---- 552 (790)
.++|++.+.||+|+||.||+|... ++.||||+++.. ..+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 367999999999999999999875 789999999753 3467889999999995 788999999876
Q ss_pred c-CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCEEecCCC-------
Q 046083 553 E-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH-TVPVYIHRDIKPANILIDKNF------- 623 (790)
Q Consensus 553 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~~vH~dlkp~NILl~~~~------- 623 (790)
+ ...++||||+ +++|.+++.......+++..++.++.|++.||.|||++ ++ +||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~gi---vHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRI---IHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCE---ECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCE---ecCCCCHHHeeEeccchhhhhhh
Confidence 2 2489999999 56777777665545799999999999999999999998 87 9999999999999775
Q ss_pred ------------------------------------------cEEEEEeCCCcccccCCcccccccccCCCccchhcccC
Q 046083 624 ------------------------------------------RAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQY 661 (790)
Q Consensus 624 ------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 661 (790)
.+||+|||+++..... .....||+.|+|||++.+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence 7999999999865432 234578999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCcccccccccccc-ccchHHHHHHHHcCCCChhhh------hhhcCCc-----C----
Q 046083 662 GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITE-STGLVALFEEVLRQPDPREDL------QRLVDPR-----L---- 725 (790)
Q Consensus 662 ~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l------~~~~d~~-----l---- 725 (790)
..++.++|||||||++|||++|+.||......... ................ ...+ ..+.... +
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVP-RKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCC-HHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCC-hHHhhcccccccccCCccccccccccC
Confidence 99999999999999999999999999754432111 1111112222222111 0000 0000000 0
Q ss_pred ----------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 726 ----------GDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 726 ----------~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
....+......+.+|+.+||+.||++|||++|++++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 012356777889999999999999999999999874
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=337.28 Aligned_cols=269 Identities=23% Similarity=0.360 Sum_probs=198.5
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec------Ce
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE------GS 555 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~ 555 (790)
.++|++.+.||+|+||.||+|... ++.||||+++. ...+.+.+|+++|++++||||+++++++.. ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999986 78899999863 234678899999999999999999999864 34
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
.|+||||++ ++|.+++... ..+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~gi---vHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGI---IHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCC---CCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 899999987 4999999864 359999999999999999999999997 9999999999999999999999999987
Q ss_pred cccCCc---------------------ccccccccCCCccchhcc-cCCCCCchhhHHHHHHHHHHHHhCCccccccccc
Q 046083 636 TEVGSA---------------------SVHTRLVGTFGYMPPEYA-QYGEVSPKIDVYAFGVVLYELISAMEAVVKTNET 693 (790)
Q Consensus 636 ~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~ 693 (790)
...... .......||+.|+|||++ ....++.++|||||||++|||++|..|+......
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 643221 112456789999999986 5567999999999999999999876655432110
Q ss_pred ---cccc--------------------cchHHHHHHHHcCCCChhhh--------hhhcCCc-CCCCCC-----HHHHHH
Q 046083 694 ---ITES--------------------TGLVALFEEVLRQPDPREDL--------QRLVDPR-LGDDYP-----IDSVRK 736 (790)
Q Consensus 694 ---~~~~--------------------~~~~~~~~~~~~~~~~~~~l--------~~~~d~~-l~~~~~-----~~~~~~ 736 (790)
...+ .+........+..+. .+.+ .+.+... .....+ ......
T Consensus 259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 337 (432)
T 3n9x_A 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPT-EDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD 337 (432)
T ss_dssp CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCC-HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCC-HHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence 0000 011111112222211 1111 1111100 000101 124567
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 737 MARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 737 l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
+.+|+.+||+.||++|||++|++++-.-
T Consensus 338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 365 (432)
T 3n9x_A 338 GINLLESMLKFNPNKRITIDQALDHPYL 365 (432)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTCGGG
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcChhh
Confidence 8899999999999999999999986553
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=324.76 Aligned_cols=251 Identities=25% Similarity=0.397 Sum_probs=199.4
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEe
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
..++|++.+.||+|+||.||+|... ++.+|+|.+... ..+++.+|++++++++||||+++++++.+ +..++||||+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 3467999999999999999999986 889999998743 45778999999999999999999998874 5689999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
++++|.+++.... ..+++..++.++.+++.||.|||++++ +|+||||+||+++.++.+||+|||++........ .
T Consensus 107 ~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i---~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~ 181 (314)
T 3com_A 107 GAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-K 181 (314)
T ss_dssp TTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-C
T ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCC---cCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-c
Confidence 9999999997432 368999999999999999999999997 9999999999999999999999999986543221 2
Q ss_pred ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 644 HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ........... +
T Consensus 182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~----------~ 243 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM--------RAIFMIPTNPP----------P 243 (314)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSCC----------C
T ss_pred cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHhcCCC----------c
Confidence 23457899999999999999999999999999999999999998643221 11111111110 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
. ...+...+..+.+++.+||+.||.+|||+.+++++-.
T Consensus 244 ~--~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~ 281 (314)
T 3com_A 244 T--FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPF 281 (314)
T ss_dssp C--CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred c--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 0 1112234567899999999999999999999987544
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=321.55 Aligned_cols=248 Identities=21% Similarity=0.348 Sum_probs=200.7
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------------hHHHHHHHHHHHHhcC-CCCCcceEEEEec
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------------ASKEFLAELKVLTHVH-HLNLVRLIGYCVE 553 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------------~~~~~~~E~~~l~~l~-h~niv~l~g~~~~ 553 (790)
.++|++.+.||+|+||.||+|... ++.+|||.++.. ..+.+.+|+++++++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 468999999999999999999985 789999998532 2356889999999995 9999999999875
Q ss_pred C-eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCC
Q 046083 554 G-SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGL 632 (790)
Q Consensus 554 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGl 632 (790)
. ..++||||+++++|.+++... ..+++..++.++.+++.||.|||++++ +|+||||+||+++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNI---VHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCcceEEEcCCCcEEEecccc
Confidence 4 589999999999999999864 358999999999999999999999997 9999999999999999999999999
Q ss_pred CcccccCCcccccccccCCCccchhccc------CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHH
Q 046083 633 AKLTEVGSASVHTRLVGTFGYMPPEYAQ------YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEE 706 (790)
Q Consensus 633 a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 706 (790)
+....... ......|++.|+|||.+. ...++.++||||||+++|||++|+.||..... ......
T Consensus 171 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~ 240 (298)
T 1phk_A 171 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------MLMLRM 240 (298)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred hhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--------HHHHHH
Confidence 98654322 223457899999999885 45789999999999999999999999854321 111222
Q ss_pred HHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 707 VLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 707 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
+..... ..........+..+.+++.+||+.||++|||++|++++-
T Consensus 241 ~~~~~~-----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (298)
T 1phk_A 241 IMSGNY-----------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 285 (298)
T ss_dssp HHHTCC-----------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred HhcCCc-----------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhCh
Confidence 222110 000111123456789999999999999999999998743
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=341.11 Aligned_cols=269 Identities=24% Similarity=0.361 Sum_probs=187.9
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec------Ce
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE------GS 555 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~ 555 (790)
.++|++.+.||+|+||.||+|... ++.||||++.. ...+.+.+|+++|++++||||+++++++.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999876 88999999853 334678899999999999999999999842 34
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
.|+||||+. ++|.+++.... .+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++.
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~i---iHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAGI---LHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeccc-cchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCCc---CCCCCChhhEEECCCCCEeecccccchh
Confidence 899999985 69999997643 59999999999999999999999998 9999999999999999999999999987
Q ss_pred cccCCc--------------------------ccccccccCCCccchhcc-cCCCCCchhhHHHHHHHHHHHHhC-----
Q 046083 636 TEVGSA--------------------------SVHTRLVGTFGYMPPEYA-QYGEVSPKIDVYAFGVVLYELISA----- 683 (790)
Q Consensus 636 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDvwS~Gvvl~elltG----- 683 (790)
...... .......||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 642211 122345789999999976 566799999999999999999994
Q ss_pred ------Cccccccccccc---------------cccchHHHHHHHHcCCCChhhhh--------hhcC---CcCCCC---
Q 046083 684 ------MEAVVKTNETIT---------------ESTGLVALFEEVLRQPDPREDLQ--------RLVD---PRLGDD--- 728 (790)
Q Consensus 684 ------~~p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~--------~~~d---~~l~~~--- 728 (790)
+++|........ ...+.......++..+. .+.+. ..+. ......
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPS-EEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCC-HHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCC-HHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 444432211000 00011111122222221 11111 1111 000000
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 729 YPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 729 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
........+.+|+.+||+.||++|||++|++++-.-
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f 400 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFF 400 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhh
Confidence 011235678899999999999999999999997554
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=337.09 Aligned_cols=195 Identities=22% Similarity=0.367 Sum_probs=170.3
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh--hHHHHHHHHHHHHhc------CCCCCcceEEEEe-cCeEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ--ASKEFLAELKVLTHV------HHLNLVRLIGYCV-EGSLF 557 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~--~~~~~~~E~~~l~~l------~h~niv~l~g~~~-~~~~~ 557 (790)
..+|++.+.||+|+||.||+|... ++.||||+++.. ..+.+.+|++++..+ +|+||+++++++. ....+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 457999999999999999999886 789999999753 345678899888887 5779999999887 45689
Q ss_pred EEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCc--EEEEEeCCCcc
Q 046083 558 LVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFR--AKVADFGLAKL 635 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~--~kl~DfGla~~ 635 (790)
+||||+. ++|.+++.......+++..+.+++.|++.||+|||++++ +||||||+|||++.++. +||+|||+++.
T Consensus 176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i---vHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRI---IHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTE---ECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 9999996 599999987765679999999999999999999999997 99999999999999887 99999999975
Q ss_pred cccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccc
Q 046083 636 TEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTN 691 (790)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~ 691 (790)
.... .....||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 252 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 252 EHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 4322 234578999999999999999999999999999999999999986543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=321.77 Aligned_cols=248 Identities=23% Similarity=0.360 Sum_probs=195.4
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEec
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIE 564 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~ 564 (790)
+|.....||+|+||.||+|... +..||||.+.. ...+.+.+|+.+++.++||||+++++++.+ +..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 3455669999999999999985 77899998864 334678999999999999999999999875 46899999999
Q ss_pred CCChhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC-CCcEEEEEeCCCcccccCCcc
Q 046083 565 NGNLNQHLRGSG-KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK-NFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 565 ~g~L~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~-~~~~kl~DfGla~~~~~~~~~ 642 (790)
+++|.+++.... ...+++..+..++.|++.||.|||++++ +|+||||+|||++. ++.+||+|||++....... .
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~ 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI---VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-P 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCE---EccCCChhhEEEECCCCCEEEeecccccccCCCC-C
Confidence 999999998653 3457899999999999999999999997 99999999999987 8999999999998654322 1
Q ss_pred cccccccCCCccchhcccCCC--CCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 643 VHTRLVGTFGYMPPEYAQYGE--VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~--~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
......|++.|+|||.+.+.. ++.++||||||+++|||++|+.||....... ......... .
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~----------~ 242 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ------AAMFKVGMF----------K 242 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH------HHHHHHHHH----------C
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh------HHHHhhccc----------c
Confidence 223457899999999997643 8899999999999999999999986533210 011111000 0
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
. ....+...+..+.+++.+||+.||++|||++|++++-
T Consensus 243 ~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~ 280 (295)
T 2clq_A 243 V----HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDE 280 (295)
T ss_dssp C----CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSG
T ss_pred c----cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 1 1122334456789999999999999999999998743
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=344.55 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=200.9
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVY 560 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~ 560 (790)
.++|++.+.||+|+||.||+|... ++.+|||++.. ...+.+.+|++++++++||||+++++++.+. ..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 357999999999999999999986 88999999853 2356789999999999999999999998854 589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEec---CCCcEEEEEeCCCcccc
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILID---KNFRAKVADFGLAKLTE 637 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~---~~~~~kl~DfGla~~~~ 637 (790)
||+++|+|.+++.... .+++..+..++.|++.||.|||++++ +||||||+|||++ .++.+||+|||+++...
T Consensus 101 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i---vH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNI---VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999999887653 58999999999999999999999998 9999999999995 45679999999998654
Q ss_pred cCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 638 VGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
... ......||+.|+|||++.+ .++.++|||||||++|||++|..||..... ......+.......
T Consensus 176 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~~~~--- 241 (486)
T 3mwu_A 176 QNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDILKRVETGKYAF--- 241 (486)
T ss_dssp CC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCCS---
T ss_pred CCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCC---
Confidence 322 2334579999999999975 599999999999999999999999965322 11222222211100
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
........+..+.+++.+||+.||.+|||+.|++++-+.
T Consensus 242 --------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~ 280 (486)
T 3mwu_A 242 --------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280 (486)
T ss_dssp --------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHH
T ss_pred --------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhh
Confidence 000012344678899999999999999999999997554
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=331.31 Aligned_cols=258 Identities=23% Similarity=0.351 Sum_probs=195.1
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-------
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG------- 554 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------- 554 (790)
.++|++.+.||+|+||.||+|... |+.||||++.. ...+.+.+|++++++++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467999999999999999999985 88999999843 2346688999999999999999999998643
Q ss_pred eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCc
Q 046083 555 SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK 634 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~ 634 (790)
..|+||||+ +++|.+++... .+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~i---vH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCc---cccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 359999999 78999999863 58999999999999999999999997 999999999999999999999999998
Q ss_pred ccccCCcccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC
Q 046083 635 LTEVGSASVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +...........+ .
T Consensus 177 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~l~~i~~~~g~~-~ 246 (367)
T 1cm8_A 177 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-----DQLKEIMKVTGTP-P 246 (367)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHHHCCC-C
T ss_pred ccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhcCCC-C
Confidence 65422 234578999999999877 67999999999999999999999999654321 1111111111111 1
Q ss_pred hhhhhh--------h---cCCcCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 714 REDLQR--------L---VDPRLGD---DYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 714 ~~~l~~--------~---~d~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.+.+.. . +...... .........+.+|+.+||+.||.+|||++|++++-.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~ 310 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChH
Confidence 111110 0 0000000 111234567899999999999999999999998644
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=346.45 Aligned_cols=249 Identities=22% Similarity=0.378 Sum_probs=200.0
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----------------hHHHHHHHHHHHHhcCCCCCcceEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----------------ASKEFLAELKVLTHVHHLNLVRLIGY 550 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----------------~~~~~~~E~~~l~~l~h~niv~l~g~ 550 (790)
.++|.+.++||+|+||.||+|... +..+|+|.+... ..+.+.+|++++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 578999999999999999999986 788999998532 24568899999999999999999999
Q ss_pred EecC-eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC---cEE
Q 046083 551 CVEG-SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF---RAK 626 (790)
Q Consensus 551 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~---~~k 626 (790)
+.+. ..++||||+++|+|.+++.... .+++..+..++.|++.||.|||++++ +||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i---vH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHNI---VHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEESSTTCCSSEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EeCCCcHHHEEEecCCCCccEE
Confidence 8864 5899999999999999987653 59999999999999999999999997 9999999999998775 699
Q ss_pred EEEeCCCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHH
Q 046083 627 VADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEE 706 (790)
Q Consensus 627 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 706 (790)
|+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||..... ......
T Consensus 190 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~ 258 (504)
T 3q5i_A 190 IVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND--------QDIIKK 258 (504)
T ss_dssp ECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred EEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH
Confidence 99999998764322 233467999999999987 5699999999999999999999999965332 122222
Q ss_pred HHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 707 VLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 707 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
+....... ....+ ...+..+.+++.+||+.||.+|||++|++++-+-
T Consensus 259 i~~~~~~~-~~~~~----------~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 305 (504)
T 3q5i_A 259 VEKGKYYF-DFNDW----------KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305 (504)
T ss_dssp HHHCCCCC-CHHHH----------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HHcCCCCC-Ccccc----------CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhh
Confidence 22211100 00000 1234578999999999999999999999987654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=320.88 Aligned_cols=250 Identities=27% Similarity=0.431 Sum_probs=193.2
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh--hhHHHHHHHHHHHHhcCCCCCcceEEEEec-----------
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM--QASKEFLAELKVLTHVHHLNLVRLIGYCVE----------- 553 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----------- 553 (790)
.++|++.+.||+|+||.||+|... ++.+|||.+.. ...+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 467999999999999999999975 88999999864 344678999999999999999999998753
Q ss_pred ---CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEe
Q 046083 554 ---GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADF 630 (790)
Q Consensus 554 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~Df 630 (790)
...++||||+++++|.+++.... ..+++..++.++.|++.||+|||++++ +||||||+|||++.++.+||+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i---~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGI---IHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTSCEEECCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCe---ecccCCHHhEEEcCCCCEEEeeC
Confidence 34799999999999999998643 358889999999999999999999998 99999999999999999999999
Q ss_pred CCCcccccCC-------------cccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCcccccccccccc
Q 046083 631 GLAKLTEVGS-------------ASVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITE 696 (790)
Q Consensus 631 Gla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~ 696 (790)
|++....... ........|++.|+|||.+.+. .++.++||||||+++|||++ ||....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~----- 232 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM----- 232 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-----
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-----
Confidence 9998654221 1122345689999999999764 78999999999999999998 332110
Q ss_pred ccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 697 STGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
........+... .......++...+..+.+++.+||+.||.+|||++|++++-+
T Consensus 233 --~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (303)
T 1zy4_A 233 --ERVNILKKLRSV-----------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW 286 (303)
T ss_dssp --HHHHHHHHHHST-----------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSC
T ss_pred --hHHHHHHhcccc-----------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCC
Confidence 111111111111 111222334455567899999999999999999999987433
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=332.49 Aligned_cols=265 Identities=27% Similarity=0.371 Sum_probs=197.9
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh--------HHHHHHHHHHHHhcCCCCCcceEEEEec-CeE
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA--------SKEFLAELKVLTHVHHLNLVRLIGYCVE-GSL 556 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~ 556 (790)
..++|++.+.||+|+||.||+|... ++.+|||.+.... .+.+.+|++++++++||||+++++++.+ +..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3578999999999999999999986 7899999986421 2357899999999999999999999875 458
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
++||||+++ +|.+++.... ..+++..+..++.+++.||+|||++++ +||||||+|||++.++.+||+|||+++..
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i---vH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWI---LHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred EEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCE---ECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 999999987 8988887643 468899999999999999999999998 99999999999999999999999999865
Q ss_pred ccCCcccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChh
Q 046083 637 EVGSASVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715 (790)
Q Consensus 637 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (790)
.... .......||+.|+|||.+.+. .++.++|||||||++|||++|.+||...... ..+...+ .....+.. +
T Consensus 163 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~----~~~~~i~-~~~~~~~~-~ 235 (346)
T 1ua2_A 163 GSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL----DQLTRIF-ETLGTPTE-E 235 (346)
T ss_dssp TSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH-HHHCCCCT-T
T ss_pred cCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH----HHHHHHH-HHcCCCCh-h
Confidence 4322 223345789999999999764 5899999999999999999999988653321 1111111 11111111 1
Q ss_pred hhh------hhcCCcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 716 DLQ------RLVDPRLGDDYP-----IDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 716 ~l~------~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
.+. +.+........+ ......+.+++.+||+.||++|||++|++++-+-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f 295 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhh
Confidence 110 000000001111 2334679999999999999999999999987664
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=326.70 Aligned_cols=254 Identities=21% Similarity=0.354 Sum_probs=194.3
Q ss_pred cCcccc-eeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhc-CCCCCcceEEEEec-CeEEEEEE
Q 046083 490 NDFSMG-NKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYE 561 (790)
Q Consensus 490 ~~f~~~-~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~~lv~e 561 (790)
+.|.+. +.||+|+||.||+|... ++.+|||.++. ...+.+.+|++++.++ +||||+++++++.+ +..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 567774 78999999999999875 88999999854 3356789999999985 79999999999875 56899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCc---EEEEEeCCCccccc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFR---AKVADFGLAKLTEV 638 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~---~kl~DfGla~~~~~ 638 (790)
|+++++|.+++.... .+++..+..++.|++.||+|||++++ +||||||+|||++.++. +||+|||++.....
T Consensus 92 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i---vH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGI---AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCc---eeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999998643 58999999999999999999999998 99999999999988776 99999999986532
Q ss_pred CCc------ccccccccCCCccchhcccC-----CCCCchhhHHHHHHHHHHHHhCCcccccccccccccc---c----h
Q 046083 639 GSA------SVHTRLVGTFGYMPPEYAQY-----GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITEST---G----L 700 (790)
Q Consensus 639 ~~~------~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~---~----~ 700 (790)
... .......||+.|+|||.+.. ..++.++|||||||++|||++|+.||........... . .
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 211 11123468999999999875 4588999999999999999999999976443210000 0 0
Q ss_pred HHHHHHHHcCCCChhhhhhhcCCcCCCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 701 VALFEEVLRQPDPREDLQRLVDPRLGDDYPI----DSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 701 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~----~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
......+... .. .++. ..+..+.+++.+||+.||++|||++|++++-+
T Consensus 247 ~~~~~~i~~~-------------~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 298 (316)
T 2ac3_A 247 NMLFESIQEG-------------KY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW 298 (316)
T ss_dssp HHHHHHHHHC-------------CC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred HHHHHHHhcc-------------Cc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChh
Confidence 1111111111 11 1111 23457899999999999999999999998644
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=347.61 Aligned_cols=249 Identities=24% Similarity=0.398 Sum_probs=203.3
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh------hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLV 559 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv 559 (790)
.++|++.+.||+|+||.||+|... ++.+|||++.. ...+.+.+|++++++++||||+++++++.+ +..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357999999999999999999986 88999999842 345679999999999999999999999885 458999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe---cCCCcEEEEEeCCCccc
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI---DKNFRAKVADFGLAKLT 636 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl---~~~~~~kl~DfGla~~~ 636 (790)
|||+.+|+|.+++.... .+++..+..++.|++.||.|||++++ +||||||+|||+ +.++.+||+|||+++..
T Consensus 105 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i---vH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNKI---VHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999997653 59999999999999999999999998 999999999999 56789999999999866
Q ss_pred ccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhh
Q 046083 637 EVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716 (790)
Q Consensus 637 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (790)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|..||..... ......+.......
T Consensus 180 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~~~~-- 246 (484)
T 3nyv_A 180 EASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--------YDILKKVEKGKYTF-- 246 (484)
T ss_dssp CCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCC--
T ss_pred cccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCCCCC--
Confidence 4332 2234579999999999875 799999999999999999999999965332 11222222211100
Q ss_pred hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 717 LQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 717 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
........+..+.+++.+||+.||.+|||++|++++-+-
T Consensus 247 ---------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~ 285 (484)
T 3nyv_A 247 ---------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI 285 (484)
T ss_dssp ---------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred ---------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhh
Confidence 000012345678999999999999999999999987664
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=345.58 Aligned_cols=248 Identities=23% Similarity=0.369 Sum_probs=197.0
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVY 560 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~ 560 (790)
.++|++.+.||+|+||.||+|... +..+|+|.+.. .....+.+|+++++.++||||+++++++.+. ..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 356999999999999999999986 78899999863 2346789999999999999999999999854 589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC---CcEEEEEeCCCcccc
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN---FRAKVADFGLAKLTE 637 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~---~~~kl~DfGla~~~~ 637 (790)
||+++|+|.+++.... .+++..+..++.|++.||.|||++++ +||||||+|||++.. +.+||+|||++....
T Consensus 116 e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i---vH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNI---VHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---eeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999999887653 58999999999999999999999997 999999999999764 559999999998764
Q ss_pred cCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 638 VGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
... ......||+.|+|||++. ..++.++|||||||++|||++|..||..... ......+.......
T Consensus 191 ~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~~~~--- 256 (494)
T 3lij_A 191 NQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--------QEILRKVEKGKYTF--- 256 (494)
T ss_dssp TTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCCC---
T ss_pred CCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCC---
Confidence 322 234467999999999986 5799999999999999999999999965332 12222222211100
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
+ .......+..+.+++.+||+.||.+|||+.|++++-+
T Consensus 257 ----~----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 294 (494)
T 3lij_A 257 ----D----SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW 294 (494)
T ss_dssp ----C----SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred ----C----chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcc
Confidence 0 0000123457889999999999999999999987543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=328.35 Aligned_cols=263 Identities=24% Similarity=0.383 Sum_probs=197.3
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYE 561 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e 561 (790)
++|++.+.||+|+||.||+|... ++.||+|++.. ...+.+.+|++++++++||||+++++++.+. ..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 57899999999999999999986 78999998742 2345578999999999999999999998754 5899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|+++++|.+++.... .+++..+..++.+++.||.|||++++ +||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i---vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 178 (331)
T 4aaa_A 105 FVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHNI---IHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 178 (331)
T ss_dssp CCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred cCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCE---EccCcChheEEEcCCCcEEEEeCCCceeecCCc-
Confidence 999999998876543 59999999999999999999999998 999999999999999999999999998654322
Q ss_pred ccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh------
Q 046083 642 SVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR------ 714 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 714 (790)
.......|++.|+|||.+.+. .++.++||||||+++|||++|+.||...... ..............+.
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI-----DQLYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCSCCHHHHHHHH
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH-----HHHHHHHHHhCCCChhhhhHhh
Confidence 222345689999999999875 7899999999999999999999998654321 0011111111110000
Q ss_pred --hhhhhhcCCcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 715 --EDLQRLVDPRLGDDYP-----IDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 715 --~~l~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
........+.+....+ ...+..+.+|+.+||+.||++|||++|++++-+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 309 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 0001111111111111 134567999999999999999999999987543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=337.94 Aligned_cols=262 Identities=24% Similarity=0.378 Sum_probs=196.2
Q ss_pred HHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhhHHHHHHHHHHHHhcCCCCCcceEEEEecC----------
Q 046083 487 KATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVEG---------- 554 (790)
Q Consensus 487 ~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~---------- 554 (790)
...++|++.+.||+|+||.||+|... ++.||||++... .....+|+++++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECC-TTSCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 45678999999999999999999875 889999988543 22334799999999999999999987421
Q ss_pred -----------------------------eEEEEEEEecCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 046083 555 -----------------------------SLFLVYEYIENGNLNQHLRG--SGKDTLTWSARMQIALDSARGLEYIHEHT 603 (790)
Q Consensus 555 -----------------------------~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ 603 (790)
..++||||+++ +|.+.+.. .....+++..+..++.|+++||.|||+++
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g 161 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG 161 (383)
T ss_dssp ---------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence 27899999985 88877764 22346999999999999999999999999
Q ss_pred CCceeecCCCCCCEEec-CCCcEEEEEeCCCcccccCCcccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHH
Q 046083 604 VPVYIHRDIKPANILID-KNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELI 681 (790)
Q Consensus 604 ~~~~vH~dlkp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~ell 681 (790)
+ +||||||+|||++ .++.+||+|||+++...... ......||+.|+|||.+.+. .++.++|||||||++|||+
T Consensus 162 i---~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 162 I---CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp E---ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred C---ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 7 9999999999998 68899999999998664332 22345789999999998765 4899999999999999999
Q ss_pred hCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcC-------CcC-----CCCCCHHHHHHHHHHHHHccccCC
Q 046083 682 SAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD-------PRL-----GDDYPIDSVRKMARLARACTQENP 749 (790)
Q Consensus 682 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d-------~~l-----~~~~~~~~~~~l~~li~~Cl~~dP 749 (790)
+|+.||...... +...........+. .+.+..+-. +.+ ...++...+..+.+|+.+||+.||
T Consensus 237 ~g~~pf~~~~~~-----~~~~~i~~~~g~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 237 LGKPLFSGETSI-----DQLVRIIQIMGTPT-KEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HSSCSSCCSSHH-----HHHHHHHHHHCCCC-HHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred hCCCCCCCCChH-----HHHHHHHHHhCCCC-HHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 999999654321 11111111122111 111111100 000 001223345678999999999999
Q ss_pred CCCCCHHHHHHH
Q 046083 750 QLRPSMRAIVVA 761 (790)
Q Consensus 750 ~~RPt~~evl~~ 761 (790)
.+|||+.|++++
T Consensus 311 ~~R~t~~e~l~h 322 (383)
T 3eb0_A 311 DLRINPYEAMAH 322 (383)
T ss_dssp GGSCCHHHHHTS
T ss_pred hhCCCHHHHhcC
Confidence 999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=332.41 Aligned_cols=262 Identities=24% Similarity=0.385 Sum_probs=199.2
Q ss_pred HHHHHHhcCcccceeeeecCceEEEEEEECCceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eE
Q 046083 483 EELAKATNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SL 556 (790)
Q Consensus 483 ~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~ 556 (790)
+++....++|++.+.||+|+||.||+|...+ .+|+|.++.. ..+.+.+|+.++++++||||+++++++.+. ..
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 3334446789999999999999999999875 5899988642 234578899999999999999999998754 58
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
++||||+++++|.+++.... ..+++..++.++.+++.||+|||++++ +||||||+|||++ ++.+||+|||++...
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i---~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGI---LHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTC---CCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred EEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCc---cccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 99999999999999998653 368999999999999999999999998 9999999999998 679999999998754
Q ss_pred ccCCc----ccccccccCCCccchhcccC---------CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHH
Q 046083 637 EVGSA----SVHTRLVGTFGYMPPEYAQY---------GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVAL 703 (790)
Q Consensus 637 ~~~~~----~~~~~~~gt~~y~aPE~~~~---------~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 703 (790)
..... .......|++.|+|||.+.. ..++.++||||||+++|||++|+.||..... ...
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~ 251 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA--------EAI 251 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH--------HHH
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHH
Confidence 32111 11223468999999999864 4578999999999999999999999864322 111
Q ss_pred HHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCcc
Q 046083 704 FEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSED 771 (790)
Q Consensus 704 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~ 771 (790)
....... ..+.. .+...+..+.+++.+||+.||++|||++++++.|+.+......
T Consensus 252 ~~~~~~~----------~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 252 IWQMGTG----------MKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp HHHHHTT----------CCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred HHHhccC----------CCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 1121111 11111 1112334688999999999999999999999999988665443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=332.19 Aligned_cols=273 Identities=23% Similarity=0.282 Sum_probs=201.8
Q ss_pred ccCHHHHHHHhcCcccceeeeecCceEEEEEEEC-CceEEEEEeChh--------------hHHHHHHHHHHHHhcCCCC
Q 046083 479 EFSYEELAKATNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ--------------ASKEFLAELKVLTHVHHLN 543 (790)
Q Consensus 479 ~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~--------------~~~~~~~E~~~l~~l~h~n 543 (790)
.....++....++|++.+.||+|+||.||+|... +..+|||++... ..+.+.+|++++++++|||
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 3456788888999999999999999999999876 889999988531 1267899999999999999
Q ss_pred CcceEEEEec------CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCE
Q 046083 544 LVRLIGYCVE------GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANI 617 (790)
Q Consensus 544 iv~l~g~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NI 617 (790)
|+++++++.. ...++||||++ |+|.+++.... ..+++..+..++.|++.||.|||++++ +||||||+||
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i---vH~Dlkp~NI 165 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGV---VHRDLHPGNI 165 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGE
T ss_pred ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcC---EecCCChHHE
Confidence 9999998742 24799999998 58888887543 469999999999999999999999998 9999999999
Q ss_pred EecCCCcEEEEEeCCCcccccCCcccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCcccccccccccc
Q 046083 618 LIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITE 696 (790)
Q Consensus 618 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~ 696 (790)
|++.++.+||+|||+++..... .......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||......
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--- 240 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY--- 240 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---
T ss_pred EEcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH---
Confidence 9999999999999999754322 22234578999999999876 67899999999999999999999999654321
Q ss_pred ccchHHHHHHHHcCCCCh-------hhhhhhcCCcCCCC-------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 697 STGLVALFEEVLRQPDPR-------EDLQRLVDPRLGDD-------YPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~-------~~l~~~~d~~l~~~-------~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
............+... ......+...+... ........+.+|+.+||+.||++|||++|++++-
T Consensus 241 --~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 318 (362)
T 3pg1_A 241 --NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318 (362)
T ss_dssp --HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred --HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCc
Confidence 1111111111111110 01111111111110 0122345789999999999999999999999865
Q ss_pred H
Q 046083 763 M 763 (790)
Q Consensus 763 ~ 763 (790)
.
T Consensus 319 ~ 319 (362)
T 3pg1_A 319 Y 319 (362)
T ss_dssp G
T ss_pred h
Confidence 4
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=343.40 Aligned_cols=259 Identities=22% Similarity=0.277 Sum_probs=201.9
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-hHHHHHHHHHHHHhcCCCCCcce-EEEEec-CeEEEEEEEe
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-ASKEFLAELKVLTHVHHLNLVRL-IGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-~~~~~~~E~~~l~~l~h~niv~l-~g~~~~-~~~~lv~e~~ 563 (790)
.++|++.++||+|+||.||+|... ++.||||.++.. ..+++..|+++++.++|++.+.. ..++.+ ...++||||+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 468999999999999999999975 889999987643 33568899999999987555544 444444 4579999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe---cCCCcEEEEEeCCCcccccCC
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI---DKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl---~~~~~~kl~DfGla~~~~~~~ 640 (790)
+++|.+++.... ..+++..++.++.||+.||+|||++++ +||||||+|||+ +.++.+||+|||+++......
T Consensus 86 -g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gI---vHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 86 -GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSF---LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp -CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred -CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCE---eecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 999999998543 359999999999999999999999997 999999999999 688999999999998765433
Q ss_pred cc------cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 641 AS------VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 641 ~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
.. ......||+.|+|||.+.+..++.++|||||||+||||++|+.||...... .....+..+..... .
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-----~~~~~~~~i~~~~~-~ 234 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-----TKKQKYEKISEKKV-A 234 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS-----SHHHHHHHHHHHHH-H
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch-----hHHHHHHHHhhccc-c
Confidence 21 122467999999999999999999999999999999999999999764331 11111111111000 0
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
..+..+. . ..+.++.+++..||+.+|++||++++|++.|..+..
T Consensus 235 ~~~~~l~-----~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 235 TSIEALC-----R----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp SCHHHHH-----T----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred ccHHHHh-----c----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 0011111 1 224578999999999999999999999999998743
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=328.31 Aligned_cols=258 Identities=22% Similarity=0.289 Sum_probs=192.9
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-------
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG------- 554 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------- 554 (790)
.++|++.+.||+|+||.||+|... ++.||||++.. ...+.+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367999999999999999999875 78999999853 3346688999999999999999999998632
Q ss_pred eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCc
Q 046083 555 SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK 634 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~ 634 (790)
..++||||+++ +|.+++.. .+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~i---vH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCe---ecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 57999999975 78888863 48999999999999999999999998 999999999999999999999999998
Q ss_pred ccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC-C
Q 046083 635 LTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD-P 713 (790)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 713 (790)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+..++.... +
T Consensus 176 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~~~~~~ 245 (371)
T 2xrw_A 176 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI--------DQWNKVIEQLGTP 245 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHC-CCCC
T ss_pred ccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHhCCC
Confidence 65422 1223457899999999999999999999999999999999999999654321 11122221100 0
Q ss_pred -----------------------hhhhhhhcCCcCCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 714 -----------------------REDLQRLVDPRLGDD---YPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 714 -----------------------~~~l~~~~d~~l~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
...+...+....... .+......+.+|+.+||+.||++|||++|++++-+-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 322 (371)
T 2xrw_A 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322 (371)
T ss_dssp CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcch
Confidence 000111111100000 012236788999999999999999999999987653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=343.38 Aligned_cols=237 Identities=18% Similarity=0.212 Sum_probs=186.8
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh------hhHHHHHHHH---HHHHhcCCCCCcceE-------EE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAEL---KVLTHVHHLNLVRLI-------GY 550 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~------~~~~~~~~E~---~~l~~l~h~niv~l~-------g~ 550 (790)
.++|.+.+.||+|+||.||+|... ++.||||++.. ...+.+.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467999999999999999999964 88999999852 3446788999 555566899999998 65
Q ss_pred EecC------------------eEEEEEEEecCCChhhhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 046083 551 CVEG------------------SLFLVYEYIENGNLNQHLRGSGK-----DTLTWSARMQIALDSARGLEYIHEHTVPVY 607 (790)
Q Consensus 551 ~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ 607 (790)
+.+. ..|+||||+ +|+|.+++...+. ..+++..+++++.|++.||+|||++++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i--- 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL--- 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE---
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCe---
Confidence 5432 278999999 6799999985321 234568889999999999999999997
Q ss_pred eecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccccccccCCCccchhcccCC-----------CCCchhhHHHHHHH
Q 046083 608 IHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYG-----------EVSPKIDVYAFGVV 676 (790)
Q Consensus 608 vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDvwS~Gvv 676 (790)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985322 2334567 999999999877 89999999999999
Q ss_pred HHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 046083 677 LYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMR 756 (790)
Q Consensus 677 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 756 (790)
+|||++|+.||....... ....+... ....+..+.+++.+||+.||++|||+.
T Consensus 303 l~elltg~~Pf~~~~~~~---------------------~~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~ 355 (377)
T 3byv_A 303 IYWIWCADLPITKDAALG---------------------GSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPL 355 (377)
T ss_dssp HHHHHHSSCCC------C---------------------CSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHH
T ss_pred HHHHHHCCCCCccccccc---------------------chhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHH
Confidence 999999999985433210 01111110 012345788999999999999999999
Q ss_pred HHHHH
Q 046083 757 AIVVA 761 (790)
Q Consensus 757 evl~~ 761 (790)
|++++
T Consensus 356 e~l~h 360 (377)
T 3byv_A 356 QAMET 360 (377)
T ss_dssp HHHTS
T ss_pred HHhhC
Confidence 99874
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=323.23 Aligned_cols=248 Identities=21% Similarity=0.395 Sum_probs=197.2
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
.++|++.+.||+|+||.||+|... +..+|+|.+.. ...+.+.+|++++.+++||||+++++++.+ +..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 467999999999999999999986 78999999864 345678999999999999999999998875 458999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+++++|.+++.... ..+++..+..++.+++.||.|||++++ +||||||+|||++.++.+||+|||++....... .
T Consensus 98 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 172 (302)
T 2j7t_A 98 CPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRI---IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-Q 172 (302)
T ss_dssp CTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-H
T ss_pred CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCc---ccCCCCHHHEEECCCCCEEEEECCCCccccccc-c
Confidence 99999999987543 358999999999999999999999998 999999999999999999999999876432111 1
Q ss_pred cccccccCCCccchhcc-----cCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 643 VHTRLVGTFGYMPPEYA-----QYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~-----~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
......|++.|+|||.+ ....++.++||||||+++|||++|..||..... .............
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~---- 240 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSDPP---- 240 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSCCC----
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH--------HHHHHHHhccCCc----
Confidence 12235689999999998 466789999999999999999999999865322 1111122211110
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
....+...+..+.+++.+||+.||++|||+++++++
T Consensus 241 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 241 --------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp --------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred --------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 011123345678999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=321.98 Aligned_cols=264 Identities=27% Similarity=0.425 Sum_probs=201.5
Q ss_pred HhcCcccceeeeecCceEEEEEEEC---CceEEEEEeChhh-----HHHHHHHHHHHHhc---CCCCCcceEEEEe----
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR---GEKAAIKKMDMQA-----SKEFLAELKVLTHV---HHLNLVRLIGYCV---- 552 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~---g~~vavK~~~~~~-----~~~~~~E~~~l~~l---~h~niv~l~g~~~---- 552 (790)
..++|++.+.||+|+||.||+|... ++.||+|.++... ...+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999973 6789999885321 23566788777766 8999999999886
Q ss_pred --cCeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEe
Q 046083 553 --EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADF 630 (790)
Q Consensus 553 --~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~Df 630 (790)
+...++||||++ |+|.+++.......+++..++.++.|++.||.|||++++ +||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi---~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCc---eeccCCHHHeEEcCCCCEEEecC
Confidence 234799999998 599999987665569999999999999999999999998 99999999999999999999999
Q ss_pred CCCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcC
Q 046083 631 GLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQ 710 (790)
Q Consensus 631 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 710 (790)
|+++..... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ............
T Consensus 165 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~~~ 237 (326)
T 1blx_A 165 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-----DQLGKILDVIGL 237 (326)
T ss_dssp CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCC
T ss_pred cccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHHHcCC
Confidence 999865422 1233467899999999999999999999999999999999999998654321 111111111111
Q ss_pred CCChhhhhh-------hcCCc---CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 711 PDPREDLQR-------LVDPR---LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 711 ~~~~~~l~~-------~~d~~---l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
+.. ..+.. ..... ....+....+..+.+++.+||+.||++|||+.|++++-.
T Consensus 238 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 299 (326)
T 1blx_A 238 PGE-EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299 (326)
T ss_dssp CCG-GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred CCc-ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 110 11100 00000 001112334567889999999999999999999987533
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=337.47 Aligned_cols=261 Identities=28% Similarity=0.375 Sum_probs=195.5
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChhhHHHHHHHHHHHHhcCCCCCcceEEEEec-----C--eEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVE-----G--SLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~--~~~lv~ 560 (790)
.+|++.+.||+|+||.||+|.+. ++.||||++.... +.+.+|+++|++++||||+++++++.. . .+++||
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 46889999999999999999985 8899999985432 234579999999999999999998742 1 267999
Q ss_pred EEecCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC-CcEEEEEeCCCcccc
Q 046083 561 EYIENGNLNQHLRG--SGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN-FRAKVADFGLAKLTE 637 (790)
Q Consensus 561 e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~-~~~kl~DfGla~~~~ 637 (790)
||+++ +|.+.+.. .....+++..+..++.|+++||+|||++++ +||||||+|||++.+ +.+||+|||+++...
T Consensus 133 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~i---vHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 133 DYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp ECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTE---ECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred hcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 99986 66666543 223569999999999999999999999997 999999999999965 578999999998654
Q ss_pred cCCcccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhh
Q 046083 638 VGSASVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716 (790)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (790)
... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.. ....+..+ ..+.
T Consensus 209 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~----~~l~~-i~~~lg~p-~~~~ 280 (420)
T 1j1b_A 209 RGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVE-IIKVLGTP-TREQ 280 (420)
T ss_dssp TTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH-HHHHHCSC-CHHH
T ss_pred cCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHH-HHHHhCCC-CHHH
Confidence 322 22345789999999999765 7999999999999999999999999654321 11111 11111111 1222
Q ss_pred hhhhcC-------CcCCC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 717 LQRLVD-------PRLGD-----DYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 717 l~~~~d-------~~l~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
+.++.. +.+.. .++.....++.+|+.+||+.||.+|||+.|++++-.
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~ 339 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence 222111 11100 012234567899999999999999999999997654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=321.49 Aligned_cols=259 Identities=22% Similarity=0.347 Sum_probs=202.2
Q ss_pred hcCcccceeeeecCceEEEEEEE---CCceEEEEEeCh--hhHHHHHHHHHHHHhcCCC------CCcceEEEEec-CeE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAEL---RGEKAAIKKMDM--QASKEFLAELKVLTHVHHL------NLVRLIGYCVE-GSL 556 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~---~g~~vavK~~~~--~~~~~~~~E~~~l~~l~h~------niv~l~g~~~~-~~~ 556 (790)
.++|++.+.||+|+||.||+|.. .++.||||.++. ...+.+.+|+++++.++|+ +++++++++.+ +..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 35799999999999999999987 278899999974 3346788999999998665 49999998874 568
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC---------------
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK--------------- 621 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~--------------- 621 (790)
++||||+ +++|.+++...+...+++..+..++.|++.||+|||++++ +||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i---vH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKL---THTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCC---cCCCCCHHHEEEeccccccccCCcccccc
Confidence 9999999 8899999987765679999999999999999999999997 99999999999987
Q ss_pred ----CCcEEEEEeCCCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccc
Q 046083 622 ----NFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITES 697 (790)
Q Consensus 622 ----~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~ 697 (790)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|..||......
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---- 240 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK---- 240 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH----
T ss_pred ccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH----
Confidence 668999999999864322 23457899999999999999999999999999999999999999654321
Q ss_pred cchHHHHHHHHcCCCChhhhh--------------------------hhcCCcC-CCCCCHHHHHHHHHHHHHccccCCC
Q 046083 698 TGLVALFEEVLRQPDPREDLQ--------------------------RLVDPRL-GDDYPIDSVRKMARLARACTQENPQ 750 (790)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~l~--------------------------~~~d~~l-~~~~~~~~~~~l~~li~~Cl~~dP~ 750 (790)
............. +...+. +...+.. ....+......+.+++.+||+.||.
T Consensus 241 -~~~~~~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 241 -EHLAMMERILGPL-PKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp -HHHHHHHHHHCSC-CHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred -HHHHHHHHHhCCC-CHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 1111222222111 111000 0000000 0112335678899999999999999
Q ss_pred CCCCHHHHHHH
Q 046083 751 LRPSMRAIVVA 761 (790)
Q Consensus 751 ~RPt~~evl~~ 761 (790)
+|||++|++++
T Consensus 319 ~Rpt~~ell~h 329 (339)
T 1z57_A 319 KRITLREALKH 329 (339)
T ss_dssp TSCCHHHHTTS
T ss_pred cccCHHHHhcC
Confidence 99999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=337.24 Aligned_cols=251 Identities=12% Similarity=0.073 Sum_probs=180.4
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh------hhHHHHHHHHHHHHhc--CCCCCcceE-------EEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHV--HHLNLVRLI-------GYC 551 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~------~~~~~~~~E~~~l~~l--~h~niv~l~-------g~~ 551 (790)
..+|.+.+.||+|+||.||+|.+. ++.+|||++.. ...+.+.+|++++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345889999999999999999975 78999999864 2234577785544444 699988754 333
Q ss_pred e-c-----------------CeEEEEEEEecCCChhhhhhcCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCce
Q 046083 552 V-E-----------------GSLFLVYEYIENGNLNQHLRGSGKDTLTWSAR------MQIALDSARGLEYIHEHTVPVY 607 (790)
Q Consensus 552 ~-~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~~~ 607 (790)
. + ...++||||++ |+|.+++...+. .+.+..+ +.++.|++.||+|||++++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~i--- 215 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKGL--- 215 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTE---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCC---
Confidence 2 1 23799999999 899999986432 3455566 7888999999999999997
Q ss_pred eecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccccccccCCCccchhcccC--CCCCchhhHHHHHHHHHHHHhCCc
Q 046083 608 IHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQY--GEVSPKIDVYAFGVVLYELISAME 685 (790)
Q Consensus 608 vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwS~Gvvl~elltG~~ 685 (790)
+||||||+|||++.++.+||+|||+++..... .....+++.|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999865321 113456799999999987 679999999999999999999999
Q ss_pred cccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 686 AVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 686 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
||........... .....................+..+.+|+.+||+.||++|||+.|++++-
T Consensus 292 Pf~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 354 (371)
T 3q60_A 292 PFGLVTPGIKGSW--------------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354 (371)
T ss_dssp STTBCCTTCTTCC--------------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSH
T ss_pred CCCCcCcccccch--------------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCH
Confidence 9976533211000 00000000111111111224557899999999999999999999997643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=328.21 Aligned_cols=263 Identities=30% Similarity=0.419 Sum_probs=199.5
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEec---------
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVE--------- 553 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------- 553 (790)
++|++.+.||+|+||.||+|... ++.+|+|++... ....+.+|++++++++||||+++++++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57999999999999999999985 889999988532 23568899999999999999999998864
Q ss_pred CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCC
Q 046083 554 GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLA 633 (790)
Q Consensus 554 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla 633 (790)
+..++||||+++ +|.+.+.... ..+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i---vH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKI---LHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCe---eCCCCCHHHEEEcCCCCEEEccchhc
Confidence 247999999986 7877776543 359999999999999999999999997 99999999999999999999999999
Q ss_pred cccccCCc---ccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHc
Q 046083 634 KLTEVGSA---SVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLR 709 (790)
Q Consensus 634 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 709 (790)
+....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ...........
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~~~~ 246 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-----HQLALISQLCG 246 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHC
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhC
Confidence 86643221 12234578999999999876 45899999999999999999999998654321 11122222222
Q ss_pred CCCChhhhhhh-----cCC---cCCCCCCH-H------HHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 710 QPDPREDLQRL-----VDP---RLGDDYPI-D------SVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 710 ~~~~~~~l~~~-----~d~---~l~~~~~~-~------~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.... ..+... .+. ........ + ....+.+|+.+||+.||++|||++|++++-+
T Consensus 247 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 314 (351)
T 3mi9_A 247 SITP-EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314 (351)
T ss_dssp CCCT-TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCCh-hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence 1111 111000 000 00000000 1 1345889999999999999999999998654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=325.55 Aligned_cols=263 Identities=24% Similarity=0.360 Sum_probs=201.9
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC------eE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG------SL 556 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~ 556 (790)
.++|++.+.||+|+||.||+|... +..||||++.. ...+.+.+|++++.+++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999876 77899999863 2336688999999999999999999998632 47
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
++||||+++ +|.+++... .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++..
T Consensus 106 ~iv~e~~~~-~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCSE-EHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccCc-CHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 999999985 999999753 48999999999999999999999997 99999999999999999999999999866
Q ss_pred ccCCcc--cccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC
Q 046083 637 EVGSAS--VHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 637 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +...........+.
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~~~~~~~- 252 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL-----DQLNHILGILGSPS- 252 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG-----GHHHHHHHHHCSCC-
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH-----HHHHHHHHHhCCCC-
Confidence 433221 1234579999999998754 45899999999999999999999999654321 11112222222211
Q ss_pred hhhhhhh--------cCCc-CCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 714 REDLQRL--------VDPR-LGDDYP-----IDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 714 ~~~l~~~--------~d~~-l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
.+.+..+ .... .....+ ......+.+|+.+||+.||++|||++|++++-+-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 317 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 1111110 0000 000111 1234678999999999999999999999986553
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=327.45 Aligned_cols=258 Identities=26% Similarity=0.429 Sum_probs=185.2
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
..++|++.+.||+|+||.||+|... ++.||||.+... ..+++.+|++++++++||||+++++++.. +..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3578999999999999999999874 889999988643 34568899999999999999999998874 4689999
Q ss_pred EEecCCChhhhhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCc
Q 046083 561 EYIENGNLNQHLRG------SGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK 634 (790)
Q Consensus 561 e~~~~g~L~~~l~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~ 634 (790)
||+++++|.+++.. .....+++..++.++.|++.||.|||++++ +||||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i---~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCC---CCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999874 123468999999999999999999999998 999999999999999999999999987
Q ss_pred ccccCCc----ccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHc
Q 046083 635 LTEVGSA----SVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLR 709 (790)
Q Consensus 635 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 709 (790)
....... .......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~ 241 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM--------KVLMLTLQ 241 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG--------GHHHHHHT
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh--------hHHHHHhc
Confidence 6543211 11233568999999999875 56899999999999999999999998654321 01111111
Q ss_pred CCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 710 QPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 710 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
..... ......++.. ....+..+.+++.+||+.||.+|||++|++++
T Consensus 242 ~~~~~-~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 242 NDPPS-LETGVQDKEM----LKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SSCCC-TTC-----CC----CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cCCCc-cccccccchh----hhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11100 0001111111 12234578899999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=320.79 Aligned_cols=254 Identities=26% Similarity=0.440 Sum_probs=197.6
Q ss_pred HHHHHhcCcccceeeeecCceEEEEEEEC-CceEEEEEeCh-----hhHHHHHHHHHHHHhcC--CCCCcceEEEEecC-
Q 046083 484 ELAKATNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDM-----QASKEFLAELKVLTHVH--HLNLVRLIGYCVEG- 554 (790)
Q Consensus 484 ~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~-----~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~- 554 (790)
.+....++|++.+.||+|+||.||++... ++.+|||.+.. ...+.+.+|++++.+++ |+||+++++++.+.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 33344577999999999999999999886 78899999853 34467899999999997 59999999998754
Q ss_pred eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCc
Q 046083 555 SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK 634 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~ 634 (790)
..++||| +.+++|.+++.... .+++..++.++.+++.||.|||++++ +||||||+|||+++ +.+||+|||+++
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~dlkp~NIl~~~-~~~kL~Dfg~~~ 174 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGI---VHSDLKPANFLIVD-GMLKLIDFGIAN 174 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred EEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---eecCCCcccEEEEC-CeEEEeeccccc
Confidence 5899999 66889999998753 58999999999999999999999998 99999999999965 899999999998
Q ss_pred ccccCCcc-cccccccCCCccchhcccC-----------CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHH
Q 046083 635 LTEVGSAS-VHTRLVGTFGYMPPEYAQY-----------GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVA 702 (790)
Q Consensus 635 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 702 (790)
........ ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-------~~ 247 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------IS 247 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HH
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-------HH
Confidence 66433221 1234568999999999875 47889999999999999999999998543221 11
Q ss_pred HHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 703 LFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 703 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
.+...+++.....++......+.+++.+||+.||.+|||++|++++.+-
T Consensus 248 -------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~ 296 (313)
T 3cek_A 248 -------------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296 (313)
T ss_dssp -------------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred -------------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence 1122223322223333345678999999999999999999999987653
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.67 Aligned_cols=267 Identities=20% Similarity=0.277 Sum_probs=202.6
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh--hHHHHHHHHHHHHhcC-----------CCCCcceEEEEec
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ--ASKEFLAELKVLTHVH-----------HLNLVRLIGYCVE 553 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~--~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~~ 553 (790)
.++|++.+.||+|+||.||+|... ++.||||.+... ..+.+.+|++++++++ |+||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 357999999999999999999975 889999999743 3466889999999886 8999999998863
Q ss_pred C-----eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCEEec------C
Q 046083 554 G-----SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH-TVPVYIHRDIKPANILID------K 621 (790)
Q Consensus 554 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~~vH~dlkp~NILl~------~ 621 (790)
. ..+++|||+ +++|.+++.......+++..+..++.|++.||+|||++ ++ +||||||+|||++ .
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~i---vH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGI---IHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCE---ECSCCSGGGEEEEEEETTTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCE---EecCCChHHeEEeccCCCcC
Confidence 2 479999999 88999999876556699999999999999999999998 87 9999999999994 4
Q ss_pred CCcEEEEEeCCCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCcccccccccccc-ccch
Q 046083 622 NFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITE-STGL 700 (790)
Q Consensus 622 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~-~~~~ 700 (790)
.+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....
T Consensus 174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 458999999999865432 23357899999999999999999999999999999999999999754422111 1111
Q ss_pred HHHHHHHHcCCCChhhh------hhhcCC-------------------cCCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 046083 701 VALFEEVLRQPDPREDL------QRLVDP-------------------RLGDDYPIDSVRKMARLARACTQENPQLRPSM 755 (790)
Q Consensus 701 ~~~~~~~~~~~~~~~~l------~~~~d~-------------------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 755 (790)
............ ...+ ..++.. .-...++......+.+|+.+||+.||++|||+
T Consensus 250 ~~~~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 250 IAQIIELLGELP-SYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHCSCC-HHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHhcCCCC-HHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 111111111111 0000 000000 00113456788899999999999999999999
Q ss_pred HHHHHHHHh
Q 046083 756 RAIVVALMT 764 (790)
Q Consensus 756 ~evl~~L~~ 764 (790)
+|++++-+-
T Consensus 329 ~ell~hp~f 337 (373)
T 1q8y_A 329 GGLVNHPWL 337 (373)
T ss_dssp HHHHTCGGG
T ss_pred HHHhhChhh
Confidence 999986553
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=322.30 Aligned_cols=264 Identities=24% Similarity=0.354 Sum_probs=200.2
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEec------CeE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVE------GSL 556 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~ 556 (790)
.++|.+.+.||+|+||.||+|... ++.||||.++. .....+.+|++++++++||||+++++++.. ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999986 88999999863 234568899999999999999999998764 358
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
++||||+. ++|.+++... .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~i---vH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999997 5999998763 58999999999999999999999997 99999999999999999999999999876
Q ss_pred ccCCcc---------cccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHH
Q 046083 637 EVGSAS---------VHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEE 706 (790)
Q Consensus 637 ~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 706 (790)
...... ......||+.|+|||.+.. ..++.++|||||||++|||++|+.||...... ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~ 237 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR-----HQLLLIFG 237 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHH
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH-----HHHHHHHH
Confidence 432211 1123568999999998754 67899999999999999999999999654321 11111112
Q ss_pred HHcCCCChhh--------hhhhcCCcC-CCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 707 VLRQPDPRED--------LQRLVDPRL-GDD-----YPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 707 ~~~~~~~~~~--------l~~~~d~~l-~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
....+..... ..+.+.... ... .....+..+.+++.+||+.||++|||++|++++-+-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 2222111100 111110000 000 011345678899999999999999999999986553
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=325.72 Aligned_cols=259 Identities=23% Similarity=0.363 Sum_probs=183.5
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-------C
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-------G 554 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------~ 554 (790)
.++|++.+.||+|+||.||+|... |+.||||++.. ...+.+.+|+++++.++||||+++++++.. .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 368999999999999999999875 88999999853 234678899999999999999999999863 3
Q ss_pred eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCc
Q 046083 555 SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK 634 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~ 634 (790)
..++++||+ +++|.+++.. ..+++..+..++.|+++||.|||++++ +||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~gi---vH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCe---eeCCCCHhhEEECCCCCEEEeeccccc
Confidence 479999999 6799998875 359999999999999999999999998 999999999999999999999999998
Q ss_pred ccccCCcccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC
Q 046083 635 LTEVGSASVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... +...........+..
T Consensus 181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 181 HTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-----DQLKLILRLVGTPGA 251 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCSCCH
T ss_pred ccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCCH
Confidence 65321 234678999999999876 67899999999999999999999999654321 111111122221110
Q ss_pred -------hhhhhhhcCCcCC-CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 714 -------REDLQRLVDPRLG-DDYP-----IDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 714 -------~~~l~~~~d~~l~-~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
......++..... ...+ ......+.+|+.+||+.||.+|||++|++++-.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~ 314 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence 0011111110000 0001 123456889999999999999999999998654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=314.82 Aligned_cols=248 Identities=25% Similarity=0.395 Sum_probs=198.6
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
.++|++.+.||+|+||.||+|... ++.+|+|.+.. ...+.+.+|++++++++||||+++++++.+ ...++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 367999999999999999999985 88999999853 245678999999999999999999999875 4589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC---CcEEEEEeCCCcccc
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN---FRAKVADFGLAKLTE 637 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~---~~~kl~DfGla~~~~ 637 (790)
||+++++|.+++.... .+++..++.++.+++.||.|||++++ +||||||+||+++.+ +.+||+|||++....
T Consensus 101 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i---~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 101 ELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNI---VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 9999999999887643 58999999999999999999999998 999999999999764 479999999998654
Q ss_pred cCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 638 VGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
... ......|++.|+|||.+.+ .++.++||||||+++|||++|..||..... ......+.......
T Consensus 176 ~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~--- 241 (287)
T 2wei_A 176 QNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDILKRVETGKYAF--- 241 (287)
T ss_dssp CCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCC---
T ss_pred CCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCC---
Confidence 322 1223457899999999875 589999999999999999999999865322 11122222211100
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
+ . ......+..+.+++.+||+.||++|||++|++++-.
T Consensus 242 ----~--~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~ 279 (287)
T 2wei_A 242 ----D--L--PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (287)
T ss_dssp ----C--S--GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred ----C--c--hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHH
Confidence 0 0 000123457899999999999999999999998543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=323.28 Aligned_cols=254 Identities=20% Similarity=0.292 Sum_probs=175.3
Q ss_pred hcCcccce-eeeecCceEEEEEEEC--CceEEEEEeChhhHHHHHHHHHHHHhcCCCCCcceEEEEec-----CeEEEEE
Q 046083 489 TNDFSMGN-KIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVE-----GSLFLVY 560 (790)
Q Consensus 489 ~~~f~~~~-~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~lv~ 560 (790)
.++|.+.+ .||+|+||.||+|... ++.||||++.... .........++.++||||+++++++.. ...++||
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 105 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence 46788855 6999999999999987 8899999986432 222223344567799999999998763 2379999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC---CCcEEEEEeCCCcccc
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK---NFRAKVADFGLAKLTE 637 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~---~~~~kl~DfGla~~~~ 637 (790)
||+++|+|.+++.......+++..++.++.|++.||.|||++++ +||||||+|||++. ++.+||+|||+++...
T Consensus 106 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~i---vH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 106 ECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNI---AHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp ECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 99999999999987765679999999999999999999999997 99999999999976 4559999999998654
Q ss_pred cCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 638 VGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||........... .......
T Consensus 183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~~~-------- 247 (336)
T 3fhr_A 183 QN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG----MKRRIRL-------- 247 (336)
T ss_dssp ------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------------
T ss_pred cc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh----HHHhhhc--------
Confidence 22 22345689999999999888899999999999999999999999965432110000 0000000
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
.............+..+.+++.+||+.||.+|||++|++++-+-
T Consensus 248 ---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 291 (336)
T 3fhr_A 248 ---GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred ---cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 00001111112345678999999999999999999999986654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=319.61 Aligned_cols=261 Identities=22% Similarity=0.338 Sum_probs=201.0
Q ss_pred hcCcccceeeeecCceEEEEEEEC--C-ceEEEEEeCh--hhHHHHHHHHHHHHhcCCCC------CcceEEEEe-cCeE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--G-EKAAIKKMDM--QASKEFLAELKVLTHVHHLN------LVRLIGYCV-EGSL 556 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g-~~vavK~~~~--~~~~~~~~E~~~l~~l~h~n------iv~l~g~~~-~~~~ 556 (790)
.++|++.+.||+|+||.||+|... + ..||+|.++. ...+.+.+|++++++++|++ ++.+++++. ++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 368999999999999999999975 3 6899999975 34567888999999997665 888888876 4568
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe-----------------
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI----------------- 619 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl----------------- 619 (790)
++||||+ +++|.+++.......+++..++.++.|++.||+|||++++ +||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i---vH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQL---THTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTE---ECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEEecccccccccccccccc
Confidence 9999999 6688888876655579999999999999999999999997 999999999999
Q ss_pred --cCCCcEEEEEeCCCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccc
Q 046083 620 --DKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITES 697 (790)
Q Consensus 620 --~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~ 697 (790)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---- 245 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR---- 245 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----
T ss_pred cccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH----
Confidence 56789999999999864322 23457899999999999999999999999999999999999999654321
Q ss_pred cchHHHHHHHHcCCCChhhhhhh--------------------------cCCcC-CCCCCHHHHHHHHHHHHHccccCCC
Q 046083 698 TGLVALFEEVLRQPDPREDLQRL--------------------------VDPRL-GDDYPIDSVRKMARLARACTQENPQ 750 (790)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~l~~~--------------------------~d~~l-~~~~~~~~~~~l~~li~~Cl~~dP~ 750 (790)
............ .+...+... ..+.. .......+...+.+|+.+||+.||+
T Consensus 246 -~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 246 -EHLVMMEKILGP-IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp -HHHHHHHHHHCC-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred -HHHHHHHHHcCC-CcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 111112222211 111111000 00000 0011234566899999999999999
Q ss_pred CCCCHHHHHHHHH
Q 046083 751 LRPSMRAIVVALM 763 (790)
Q Consensus 751 ~RPt~~evl~~L~ 763 (790)
+|||++|++++-+
T Consensus 324 ~Rpt~~e~l~hp~ 336 (355)
T 2eu9_A 324 QRITLAEALLHPF 336 (355)
T ss_dssp TSCCHHHHTTSGG
T ss_pred hCcCHHHHhcChh
Confidence 9999999987544
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=322.57 Aligned_cols=269 Identities=25% Similarity=0.330 Sum_probs=191.5
Q ss_pred HHHHHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh--hhHHHHHHHHHHHHhcCCCCCcceEEEEec-C---
Q 046083 483 EELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM--QASKEFLAELKVLTHVHHLNLVRLIGYCVE-G--- 554 (790)
Q Consensus 483 ~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~--- 554 (790)
++.....++|++.+.||+|+||.||+|... +..+|||++.. .....+.+|++.+..++||||+++++++.. +
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 445566789999999999999999999986 78999998853 233456778888999999999999998853 1
Q ss_pred ----eEEEEEEEecCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCceeecCCCCCCEEecC-CCcE
Q 046083 555 ----SLFLVYEYIENGNLNQHLRG--SGKDTLTWSARMQIALDSARGLEYIH--EHTVPVYIHRDIKPANILIDK-NFRA 625 (790)
Q Consensus 555 ----~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~~~~~vH~dlkp~NILl~~-~~~~ 625 (790)
..++||||+++ +|.+.+.. .....+++..+..++.+++.||.||| ++++ +||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~i---vH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNV---CHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCC---BCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCe---ecCcCCHHHEEEeCCCCcE
Confidence 17899999987 55544432 22346899999999999999999999 8887 99999999999997 8999
Q ss_pred EEEEeCCCcccccCCcccccccccCCCccchhcccCCC-CCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHH
Q 046083 626 KVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGE-VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALF 704 (790)
Q Consensus 626 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 704 (790)
||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... ......
T Consensus 172 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-----~~~~~~ 244 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-----GQLHEI 244 (360)
T ss_dssp EECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHH
T ss_pred EEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-----HHHHHH
Confidence 999999998664332 223456899999999986654 899999999999999999999999654321 111111
Q ss_pred HHHHcCCCChhhhhhhcCCc---------------CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 705 EEVLRQPDPREDLQRLVDPR---------------LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 705 ~~~~~~~~~~~~l~~~~d~~---------------l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
......+ ..+.+..+.... .....+......+.+|+.+||+.||.+|||+.|++++-+
T Consensus 245 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 317 (360)
T 3e3p_A 245 VRVLGCP-SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY 317 (360)
T ss_dssp HHHHCCC-CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGG
T ss_pred HHHcCCC-CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcc
Confidence 1111111 111111111000 001122235678999999999999999999999998654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=317.37 Aligned_cols=261 Identities=26% Similarity=0.374 Sum_probs=192.5
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEe-----------
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCV----------- 552 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~----------- 552 (790)
.++|++.+.||+|+||.||+|... ++.+|+|++.. ...+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 367999999999999999999987 78999998853 34567899999999999999999999873
Q ss_pred ----cCeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEec-CCCcEEE
Q 046083 553 ----EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILID-KNFRAKV 627 (790)
Q Consensus 553 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~-~~~~~kl 627 (790)
....++||||++ |+|.+++.. ..+++..++.++.|++.||+|||++++ +||||||+|||++ +++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANV---LHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCE---ecCCCCHHHEEEcCCCCeEEE
Confidence 235799999998 599999974 358999999999999999999999998 9999999999997 5679999
Q ss_pred EEeCCCcccccCCc--ccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHH
Q 046083 628 ADFGLAKLTEVGSA--SVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALF 704 (790)
Q Consensus 628 ~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 704 (790)
+|||+++....... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||...... ...
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--------~~~ 234 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL--------EQM 234 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHH
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH--------HHH
Confidence 99999986643211 11233467899999998865 67899999999999999999999999654321 111
Q ss_pred HHHHcC-C-CChhhhhhhcC------------CcCC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 705 EEVLRQ-P-DPREDLQRLVD------------PRLG-DDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 705 ~~~~~~-~-~~~~~l~~~~d------------~~l~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
..+... + ...+...++.. +... .......+.++.+++.+||+.||++|||++|++++-.-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHH
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccc
Confidence 111110 0 00111111100 0000 00011245678999999999999999999999986553
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=333.68 Aligned_cols=262 Identities=25% Similarity=0.339 Sum_probs=193.2
Q ss_pred cCcccceeeeecCceEEEEEEEC-CceEEEEEeChhhHHHHHHHHHHHHhcCCCCCcceEEEEec-C------eEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVE-G------SLFLVYE 561 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~------~~~lv~e 561 (790)
.+|++.+.||+|+||.||+|+.. +..+|+|++.... +...+|+++++.++||||+++++++.. + ..++|||
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~-~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e 118 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK-RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT-TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc-chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence 46889999999999999999986 5668888874321 223469999999999999999998852 1 1789999
Q ss_pred EecCCChhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEec-CCCcEEEEEeCCCcccccC
Q 046083 562 YIENGNLNQHLRG-SGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILID-KNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 562 ~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~-~~~~~kl~DfGla~~~~~~ 639 (790)
|++++.+...... .....+++..+..++.|+++||+|||++++ +||||||+|||++ .++.+||+|||+++.....
T Consensus 119 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i---vHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 119 YVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGI---CHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp CCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCc---cCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 9987544433321 123469999999999999999999999997 9999999999999 7999999999999876433
Q ss_pred CcccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
.. .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... +...........+ ..+.+.
T Consensus 196 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-----~~l~~i~~~~g~p-~~~~~~ 267 (394)
T 4e7w_A 196 EP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-----DQLVEIIKVLGTP-SREQIK 267 (394)
T ss_dssp CC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHHHCCC-CHHHHH
T ss_pred CC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCC-CHHHHH
Confidence 22 2345789999999998765 5899999999999999999999999654321 1111111111111 111111
Q ss_pred hhc----CCcCCC--------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 719 RLV----DPRLGD--------DYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 719 ~~~----d~~l~~--------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.+. ...+.. .++...+.++.+|+.+||+.||.+|||+.|++++-.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 324 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChh
Confidence 110 000000 012234567999999999999999999999998644
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=329.59 Aligned_cols=269 Identities=23% Similarity=0.360 Sum_probs=184.9
Q ss_pred ccc-ceeeeecCceEEEEEEEC----CceEEEEEeChh-hHHHHHHHHHHHHhcCCCCCcceEEEEec---CeEEEEEEE
Q 046083 492 FSM-GNKIGQGGFGAVFYAELR----GEKAAIKKMDMQ-ASKEFLAELKVLTHVHHLNLVRLIGYCVE---GSLFLVYEY 562 (790)
Q Consensus 492 f~~-~~~lG~G~fg~Vy~a~~~----g~~vavK~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~---~~~~lv~e~ 562 (790)
|.+ .++||+|+||.||+|... +..+|||++... ..+.+.+|+++|++++||||+++++++.. ...++||||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~ 101 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 101 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEEC
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeC
Confidence 555 568999999999999964 678999999753 34578899999999999999999998853 458999999
Q ss_pred ecCCChhhhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe----cCCCcEEEEEeC
Q 046083 563 IENGNLNQHLRGS-------GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI----DKNFRAKVADFG 631 (790)
Q Consensus 563 ~~~g~L~~~l~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl----~~~~~~kl~DfG 631 (790)
+++ +|.+++... ....+++..++.++.|++.||.|||++++ +||||||+|||+ +.++.+||+|||
T Consensus 102 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~i---vH~Dlkp~NIll~~~~~~~~~~kl~Dfg 177 (405)
T 3rgf_A 102 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMG 177 (405)
T ss_dssp CSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred CCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCE---eCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence 975 888877532 12259999999999999999999999998 999999999999 778899999999
Q ss_pred CCcccccCCc--ccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCcccccccccccc----ccchHHHH
Q 046083 632 LAKLTEVGSA--SVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITE----STGLVALF 704 (790)
Q Consensus 632 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~----~~~~~~~~ 704 (790)
+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ..+.....
T Consensus 178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i 257 (405)
T 3rgf_A 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257 (405)
T ss_dssp CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence 9987643221 122346789999999999874 5899999999999999999999999654432110 00111111
Q ss_pred HHHHcCCCChhhhhhh------------cCCcCCCCCC---------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 705 EEVLRQPDPREDLQRL------------VDPRLGDDYP---------IDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 705 ~~~~~~~~~~~~l~~~------------~d~~l~~~~~---------~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
...+..+.. ..+..+ +......... ......+.+|+.+||+.||.+|||++|++++-+
T Consensus 258 ~~~~g~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~ 336 (405)
T 3rgf_A 258 FNVMGFPAD-KDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 336 (405)
T ss_dssp HHHHCCCCT-TTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHhhCCCCh-hhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 122221111 011000 0000000000 011346789999999999999999999998776
Q ss_pred hh
Q 046083 764 TL 765 (790)
Q Consensus 764 ~l 765 (790)
-.
T Consensus 337 f~ 338 (405)
T 3rgf_A 337 FL 338 (405)
T ss_dssp GT
T ss_pred hc
Confidence 53
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=321.48 Aligned_cols=197 Identities=25% Similarity=0.325 Sum_probs=168.4
Q ss_pred HHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh--hHHHHHHHHHHHHhcC-CC-----CCcceEEEEec-Ce
Q 046083 487 KATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ--ASKEFLAELKVLTHVH-HL-----NLVRLIGYCVE-GS 555 (790)
Q Consensus 487 ~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~--~~~~~~~E~~~l~~l~-h~-----niv~l~g~~~~-~~ 555 (790)
...++|++.+.||+|+||.||+|... ++.||||+++.. ..+++..|++++..++ |+ +++++++++.. +.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 34578999999999999999999886 788999999743 3466788999998885 55 49999998874 56
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCceeecCCCCCCEEec--CCCcEEEEEeC
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE--HTVPVYIHRDIKPANILID--KNFRAKVADFG 631 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~--~~~~~~vH~dlkp~NILl~--~~~~~kl~DfG 631 (790)
.++||||+.+ +|.+++.......+++..+..++.|++.||.|||+ .++ +||||||+|||++ .++.+||+|||
T Consensus 131 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~i---vHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 131 LCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSI---IHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp EEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCE---ECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred eEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCE---EcCCCCcccEEEecCCCCcEEEEecc
Confidence 8999999964 99999987655679999999999999999999995 455 9999999999994 57889999999
Q ss_pred CCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccc
Q 046083 632 LAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTN 691 (790)
Q Consensus 632 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~ 691 (790)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 207 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 207 SSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99865422 234678999999999999999999999999999999999999997543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=321.19 Aligned_cols=257 Identities=22% Similarity=0.345 Sum_probs=195.9
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-------
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG------- 554 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------- 554 (790)
.++|.+.+.||+|+||.||+|... |+.||||.+.. ...+.+.+|+.++++++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 367899999999999999999986 88999999853 2245688999999999999999999998743
Q ss_pred eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCc
Q 046083 555 SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK 634 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~ 634 (790)
..++||||+. ++|.+++.. .+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~i---vH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGV---VHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTC---CCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEeECCCCcEEEeeccccc
Confidence 2499999998 588888753 48999999999999999999999998 999999999999999999999999998
Q ss_pred ccccCCcccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC
Q 046083 635 LTEVGSASVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
..... .....|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... +...........+.
T Consensus 175 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~~i~~~~~~~~- 244 (353)
T 3coi_A 175 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-----DQLTQILKVTGVPG- 244 (353)
T ss_dssp C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-----HHHHHHHHHHCBCC-
T ss_pred CCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCC-
Confidence 65322 234578999999999876 67899999999999999999999999654321 11111111111110
Q ss_pred hhhh--------hhh---cCCcCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 714 REDL--------QRL---VDPRLGD---DYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 714 ~~~l--------~~~---~d~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.+.. ... +...... .........+.+++.+||+.||++|||++|++++-.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 308 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308 (353)
T ss_dssp HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 0000 000 0000001 112345678999999999999999999999998655
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=322.07 Aligned_cols=257 Identities=23% Similarity=0.353 Sum_probs=195.4
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEecCe------
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVEGS------ 555 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 555 (790)
.++|.+.+.||+|+||.||+|... ++.||||++.. ...+.+.+|+.+++.++||||+++++++....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999876 88999999864 22467889999999999999999999987432
Q ss_pred -EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCc
Q 046083 556 -LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK 634 (790)
Q Consensus 556 -~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~ 634 (790)
.++||||+. ++|.+++.. .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGV---VHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCC---cCCCcCHHHeEECCCCCEEEEecCccc
Confidence 399999998 588888753 48999999999999999999999998 999999999999999999999999998
Q ss_pred ccccCCcccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC
Q 046083 635 LTEVGSASVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... +...........+.
T Consensus 193 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~~~~~~- 262 (371)
T 4exu_A 193 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-----DQLTQILKVTGVPG- 262 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCCCC-
T ss_pred ccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCc-
Confidence 65322 234578999999999987 68999999999999999999999999654321 11111111111110
Q ss_pred hhhh--------h---hhcCCcCCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 714 REDL--------Q---RLVDPRLGDD---YPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 714 ~~~l--------~---~~~d~~l~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.+.. . ..+....... ........+.+|+.+||+.||++|||++|++++-+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 326 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 326 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence 0000 0 0000000000 01123567899999999999999999999998755
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=319.25 Aligned_cols=253 Identities=24% Similarity=0.390 Sum_probs=177.1
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHH-HHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELK-VLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
.++|.+.+.||+|+||.||+|... ++.||||.++. ....++..|+. +++.++||||+++++++.+ +..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 367889999999999999999986 88999999853 23345556665 6777899999999998875 4689999
Q ss_pred EEecCCChhhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 561 EYIENGNLNQHLRG---SGKDTLTWSARMQIALDSARGLEYIHEH-TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 561 e~~~~g~L~~~l~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
||+++ +|.+++.. .....+++..+.+++.+++.||.|||+. ++ +||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~i---vH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKI---IHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSC---CCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCE---eECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99986 88877753 2235689999999999999999999998 88 99999999999999999999999999865
Q ss_pred ccCCcccccccccCCCccchhcc----cCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC
Q 046083 637 EVGSASVHTRLVGTFGYMPPEYA----QYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD 712 (790)
Q Consensus 637 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (790)
.... ......|++.|+|||.+ .+..++.++||||||+++|||++|+.||....... ..+...
T Consensus 177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----------~~~~~~- 242 (327)
T 3aln_A 177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----------DQLTQV- 242 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CCC-
T ss_pred cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----------HHHHHH-
Confidence 4322 12234689999999998 45678999999999999999999999986432110 000000
Q ss_pred ChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 713 PREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 713 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
.....+.+...........+.+++.+||+.||++|||++|++++-.-
T Consensus 243 -----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~ 289 (327)
T 3aln_A 243 -----VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289 (327)
T ss_dssp -----CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred -----hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHH
Confidence 00001111111122345678999999999999999999999875443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=330.73 Aligned_cols=250 Identities=23% Similarity=0.351 Sum_probs=186.8
Q ss_pred cCcccceeeeecCceEEEEE-EECCceEEEEEeChhhHHHHHHHHHHHHhc-CCCCCcceEEEEecC-eEEEEEEEecCC
Q 046083 490 NDFSMGNKIGQGGFGAVFYA-ELRGEKAAIKKMDMQASKEFLAELKVLTHV-HHLNLVRLIGYCVEG-SLFLVYEYIENG 566 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a-~~~g~~vavK~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~~~lv~e~~~~g 566 (790)
+.|...+.||+|+||+||.+ ...|+.||||++.....+.+.+|++++.++ +||||+++++++.++ ..++||||+. |
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 34566789999999999754 445999999999877777889999999987 899999999988754 5899999996 5
Q ss_pred ChhhhhhcCCCCC-----CCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC-------------CcEEEE
Q 046083 567 NLNQHLRGSGKDT-----LTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN-------------FRAKVA 628 (790)
Q Consensus 567 ~L~~~l~~~~~~~-----l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~-------------~~~kl~ 628 (790)
+|.+++....... .++..++.++.|++.||+|||++++ +||||||+|||++.+ +.+||+
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i---vHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKI---IHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCc---cccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 9999998654211 1333457899999999999999997 999999999999654 489999
Q ss_pred EeCCCcccccCCcc---cccccccCCCccchhcccC-------CCCCchhhHHHHHHHHHHHHh-CCccccccccccccc
Q 046083 629 DFGLAKLTEVGSAS---VHTRLVGTFGYMPPEYAQY-------GEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITES 697 (790)
Q Consensus 629 DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~ 697 (790)
|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||......
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---- 246 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR---- 246 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH----
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh----
Confidence 99999876543222 1224579999999999975 578999999999999999999 89998543211
Q ss_pred cchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 698 TGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
. ..+...... .+.+....+...+.++.+++.+||+.||.+|||+.||+++
T Consensus 247 --~----~~i~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 247 --E----SNIIRGIFS--------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp --H----HHHHHTCCC--------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --H----HHHhcCCCC--------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 0 111111100 0111112244667889999999999999999999999863
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.07 Aligned_cols=240 Identities=27% Similarity=0.416 Sum_probs=192.1
Q ss_pred HHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh---------HHHHHHHHHHHHhc----CCCCCcceEEEE
Q 046083 487 KATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA---------SKEFLAELKVLTHV----HHLNLVRLIGYC 551 (790)
Q Consensus 487 ~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~---------~~~~~~E~~~l~~l----~h~niv~l~g~~ 551 (790)
...++|++.+.||+|+||.||+|... ++.+|||.++... ...+.+|+.++.++ +|+||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34578999999999999999999874 7899999986432 23356799999999 899999999998
Q ss_pred ec-CeEEEEEEE-ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEec-CCCcEEEE
Q 046083 552 VE-GSLFLVYEY-IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILID-KNFRAKVA 628 (790)
Q Consensus 552 ~~-~~~~lv~e~-~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~-~~~~~kl~ 628 (790)
.+ +..++|||| +.+++|.+++.... .+++..++.++.|++.||.|||++++ +||||||+||+++ .++.+||+
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGV---VHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTE---ECCCCSGGGEEEETTTTEEEEC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eecCCChhhEEEeCCCCeEEEE
Confidence 74 458999999 78999999998743 58999999999999999999999997 9999999999999 88999999
Q ss_pred EeCCCcccccCCcccccccccCCCccchhcccCCCCC-chhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHH
Q 046083 629 DFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVS-PKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEV 707 (790)
Q Consensus 629 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 707 (790)
|||++....... .....|+..|+|||++.+..+. .++||||||+++|||++|+.||..... .
T Consensus 183 dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------------~ 245 (312)
T 2iwi_A 183 DFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--------------I 245 (312)
T ss_dssp CCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------H
T ss_pred EcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--------------H
Confidence 999998764322 2345689999999999877664 489999999999999999999853211 1
Q ss_pred HcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 708 LRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 708 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.... ..++......+.+++.+||+.||++|||++|++++-.
T Consensus 246 ~~~~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~ 286 (312)
T 2iwi_A 246 LEAE---------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286 (312)
T ss_dssp HHTC---------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred hhhc---------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 1100 0122234467889999999999999999999998644
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=330.07 Aligned_cols=248 Identities=22% Similarity=0.309 Sum_probs=186.7
Q ss_pred hcCcccceeeeecCceE-EEEEEECCceEEEEEeChhhHHHHHHHHHHHHhc-CCCCCcceEEEEecC-eEEEEEEEecC
Q 046083 489 TNDFSMGNKIGQGGFGA-VFYAELRGEKAAIKKMDMQASKEFLAELKVLTHV-HHLNLVRLIGYCVEG-SLFLVYEYIEN 565 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~-Vy~a~~~g~~vavK~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~~~lv~e~~~~ 565 (790)
..+|...+.||+|+||+ ||++...++.||||++.......+.+|+++|+++ +||||+++++++.+. ..|+||||+.
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~- 101 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA- 101 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence 35688899999999998 5566667999999999876555677899999999 799999999988754 5899999996
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC-----CCcEEEEEeCCCcccccCC
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK-----NFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~-----~~~~kl~DfGla~~~~~~~ 640 (790)
|+|.+++..... .+.+..++.++.|++.||.|||++++ +||||||+|||++. ...+||+|||+++......
T Consensus 102 g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~i---vHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 102 ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLNI---VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTTC---CCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCcC---EeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 599999986543 34445567899999999999999998 99999999999943 3468899999998764332
Q ss_pred c--ccccccccCCCccchhccc---CCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 641 A--SVHTRLVGTFGYMPPEYAQ---YGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 641 ~--~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
. .......||+.|+|||++. ...++.++|||||||++|||++ |..||...... ...........
T Consensus 178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---------~~~~~~~~~~~- 247 (432)
T 3p23_A 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---------QANILLGACSL- 247 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---------HHHHHTTCCCC-
T ss_pred cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---------HHHHHhccCCc-
Confidence 2 1223467999999999997 4567889999999999999999 88888432211 11111111000
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.. ...+......+.+|+.+||+.||.+|||++||+++
T Consensus 248 --------~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 248 --------DC--LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp --------TT--SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --------cc--cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 00 01122445668899999999999999999999853
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=319.64 Aligned_cols=241 Identities=25% Similarity=0.394 Sum_probs=196.9
Q ss_pred HHHhcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh---------HHHHHHHHHHHHhcC--CCCCcceEEEEe
Q 046083 486 AKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA---------SKEFLAELKVLTHVH--HLNLVRLIGYCV 552 (790)
Q Consensus 486 ~~~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~---------~~~~~~E~~~l~~l~--h~niv~l~g~~~ 552 (790)
....++|++.+.||+|+||.||+|... ++.||||.++... .+.+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 344578999999999999999999875 7899999986432 245678999999996 599999999988
Q ss_pred c-CeEEEEEEEecC-CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEec-CCCcEEEEE
Q 046083 553 E-GSLFLVYEYIEN-GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILID-KNFRAKVAD 629 (790)
Q Consensus 553 ~-~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~-~~~~~kl~D 629 (790)
+ +..++|||++.+ ++|.+++...+ .+++..++.++.|++.||+|||++++ +||||||+|||++ +++.+||+|
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~i---vH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGV---LHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEEETTTTEEEECC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCc---EeCCCCHHHEEEeCCCCCEEEee
Confidence 5 458999999986 89999998643 58999999999999999999999997 9999999999999 789999999
Q ss_pred eCCCcccccCCcccccccccCCCccchhcccCCCC-CchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHH
Q 046083 630 FGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEV-SPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVL 708 (790)
Q Consensus 630 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 708 (790)
||+++..... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||..... ..
T Consensus 194 fg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------------~~ 256 (320)
T 3a99_A 194 FGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------II 256 (320)
T ss_dssp CTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------HH
T ss_pred Cccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--------------hh
Confidence 9999876432 2234568999999999987766 6789999999999999999999854211 11
Q ss_pred cCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 709 RQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 709 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.... ..+...+.++.+++.+||+.||++|||++|++++-+
T Consensus 257 ~~~~---------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~ 296 (320)
T 3a99_A 257 RGQV---------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 296 (320)
T ss_dssp HCCC---------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred cccc---------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence 1100 011223457889999999999999999999987543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.03 Aligned_cols=249 Identities=22% Similarity=0.358 Sum_probs=177.1
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hH-HHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----AS-KEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~-~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
.++|++.+.||+|+||.||+|... ++.+|||.+... .. +.+.++..+++.++||||+++++++.+ +..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467899999999999999999985 889999998642 12 234445567788899999999999875 4589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH-TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
||+ ++.+..+.... ...+++..++.++.+++.||.|||+. ++ +|+||||+|||++.++.+||+|||++......
T Consensus 104 e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i---~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGV---IHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCE---EeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 44555554432 34689999999999999999999995 88 99999999999999999999999999765432
Q ss_pred CcccccccccCCCccchhccc-----CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQ-----YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
. ......|++.|+|||.+. ...++.++||||||+++|||++|+.||..... .............
T Consensus 179 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~-- 247 (318)
T 2dyl_A 179 K--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-------DFEVLTKVLQEEP-- 247 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-------HHHHHHHHHHSCC--
T ss_pred c--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-------cHHHHHHHhccCC--
Confidence 2 223456899999999994 45788999999999999999999999864321 1112222222111
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
+.+. .....+..+.+++.+||+.||.+|||++|++++-.
T Consensus 248 --------~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (318)
T 2dyl_A 248 --------PLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286 (318)
T ss_dssp --------CCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred --------CCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHH
Confidence 0110 01123457889999999999999999999987543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=298.22 Aligned_cols=230 Identities=16% Similarity=0.137 Sum_probs=179.5
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
++|++.+.||+|+||.||+|... ++.||||.+... ..+.+.+|+.++.+++||||+++++++.+ +..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57999999999999999999987 789999999743 23678999999999999999999999875 4689999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++++|.+++... .....+.+++.|++.||+|||++++ +||||||+|||++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~gi---vH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGV---ALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCC---ccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999999642 3555788999999999999999998 999999999999999999997443
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
|++ .++.++|||||||++|||++|+.||............ .. .+...
T Consensus 175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--------~~------~~~~~ 221 (286)
T 3uqc_A 175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--------ER------DTAGQ 221 (286)
T ss_dssp ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC--------CB------CTTSC
T ss_pred ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH--------HH------HhccC
Confidence 333 3688999999999999999999999764432100000 00 00000
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCcc
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSED 771 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~ 771 (790)
..+ ........+..+.+++.+||+.||++| |+.|+++.|..+......
T Consensus 222 ~~~--~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~ 269 (286)
T 3uqc_A 222 PIE--PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADR 269 (286)
T ss_dssp BCC--HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC----
T ss_pred CCC--hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCc
Confidence 000 000112344678999999999999999 999999999998766543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=333.90 Aligned_cols=273 Identities=23% Similarity=0.331 Sum_probs=199.1
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-------CeE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-------GSL 556 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------~~~ 556 (790)
++|++.+.||+|+||.||+|... ++.||||.++. ...+.+.+|++++++++||||+++++++.. +..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 67999999999999999999875 88999998753 345678999999999999999999998643 347
Q ss_pred EEEEEEecCCChhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCc---EEEEEeCC
Q 046083 557 FLVYEYIENGNLNQHLRGSG-KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFR---AKVADFGL 632 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~---~kl~DfGl 632 (790)
++||||+++|+|.+++.... ...+++..++.++.+++.||+|||++++ +||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gI---VHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRI---IHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTB---CCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCC---ccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999998743 2368999999999999999999999998 99999999999997664 99999999
Q ss_pred CcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchH-HHHHHHHcCC
Q 046083 633 AKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLV-ALFEEVLRQP 711 (790)
Q Consensus 633 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~~~~~~ 711 (790)
+....... ......|++.|+|||.+.+..++.++||||||+++|||++|..||........-..... ..........
T Consensus 171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 171 AKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred cccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 98764332 23446789999999999999999999999999999999999999965321100000000 0000000000
Q ss_pred CChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHH-----HHHHHHhhcc
Q 046083 712 DPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRA-----IVVALMTLSS 767 (790)
Q Consensus 712 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e-----vl~~L~~l~~ 767 (790)
.....+.-.-........+...+..+.+++.+||+.||++|||++| ..+.+..+..
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 0000000000000112334567889999999999999999999977 4455555443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-34 Score=337.14 Aligned_cols=234 Identities=23% Similarity=0.377 Sum_probs=188.0
Q ss_pred hcCcccceeeeecCceEEEEEEEC---CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-e-----
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR---GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-S----- 555 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~---g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~----- 555 (790)
.++|++.+.||+|+||.||+|.+. ++.||||.+.. ...+.+.+|++++.+++||||+++++++.+. .
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999874 68899998853 3345688999999999999999999998742 2
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
.|+||||+++++|.+++.. .+++..++.++.|++.||.|||++++ +||||||+|||++.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~gi---iHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGL---VYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCC---eecccChHHeEEeCC-cEEEEecccchh
Confidence 6999999999999988764 58999999999999999999999997 999999999999986 899999999986
Q ss_pred cccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChh
Q 046083 636 TEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715 (790)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (790)
.... ....||+.|+|||++.+. ++.++|||||||++|||++|..|+....... . .
T Consensus 231 ~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----~------------~-- 285 (681)
T 2pzi_A 231 INSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----L------------P-- 285 (681)
T ss_dssp TTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-----C------------C--
T ss_pred cccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc-----c------------c--
Confidence 5432 345789999999998765 4899999999999999999988875421100 0 0
Q ss_pred hhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHHhh
Q 046083 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPS-MRAIVVALMTL 765 (790)
Q Consensus 716 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~evl~~L~~l 765 (790)
...........+.+++.+||+.||++||+ ++++.+.|..+
T Consensus 286 ----------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 ----------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ----------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00001123356889999999999999995 66666665543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=297.78 Aligned_cols=228 Identities=21% Similarity=0.345 Sum_probs=179.6
Q ss_pred cCcccc-eeeeecCceEEEEEEEC--CceEEEEEeChhhHHHHHHHHHHH-HhcCCCCCcceEEEEec-----CeEEEEE
Q 046083 490 NDFSMG-NKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVL-THVHHLNLVRLIGYCVE-----GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~-~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~~~~~~E~~~l-~~l~h~niv~l~g~~~~-----~~~~lv~ 560 (790)
++|.+. +.||+|+||.||++... ++.+|+|.++. ...+.+|++++ +..+||||+++++++.. ...++||
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 94 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 94 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEE
Confidence 456666 78999999999999985 78999999864 34567888888 55699999999998764 3479999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC---CCcEEEEEeCCCcccc
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK---NFRAKVADFGLAKLTE 637 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~---~~~~kl~DfGla~~~~ 637 (790)
||+++|+|.+++.......+++..++.++.|++.||.|||++++ +||||||+|||++. ++.+||+|||++....
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i---~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 95 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI---AHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp CCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 99999999999988665679999999999999999999999997 99999999999998 7899999999987432
Q ss_pred cCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 638 VGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
+..++.++|||||||++|||++|+.||........ .... .
T Consensus 172 -----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~------------~~~~-----~ 211 (299)
T 3m2w_A 172 -----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------------SPGM-----K 211 (299)
T ss_dssp -----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------CCS-----C
T ss_pred -----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh------------hHHH-----H
Confidence 13467899999999999999999999965332100 0000 0
Q ss_pred hhhcCCcCCCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 046083 718 QRLVDPRLGDDYP----IDSVRKMARLARACTQENPQLRPSMRAIVVALMT 764 (790)
Q Consensus 718 ~~~~d~~l~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 764 (790)
....... ...+ ...+..+.+++.+||+.||++|||++|++++-.-
T Consensus 212 ~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~ 260 (299)
T 3m2w_A 212 TRIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260 (299)
T ss_dssp CSSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HHHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhh
Confidence 0000000 0111 1245678999999999999999999999986553
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=315.91 Aligned_cols=237 Identities=18% Similarity=0.216 Sum_probs=178.9
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh------hhHHHHHHHHHHHHhcCC-CC----------Ccce-
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHVHH-LN----------LVRL- 547 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~------~~~~~~~~E~~~l~~l~h-~n----------iv~l- 547 (790)
.+.+|...+.||+|+||.||+|.+. |+.||||++.. ...+.+.+|+.+++.++| +| ++.+
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3456888999999999999999986 89999999872 224678999999999987 21 1111
Q ss_pred ----------EEEEec------CeEEEEEEEecCCChhhhhh-----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 046083 548 ----------IGYCVE------GSLFLVYEYIENGNLNQHLR-----GSGKDTLTWSARMQIALDSARGLEYIHEHTVPV 606 (790)
Q Consensus 548 ----------~g~~~~------~~~~lv~e~~~~g~L~~~l~-----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ 606 (790)
+.+... ...+++|+++ +++|.+++. ......+++..++.++.|+++||+|||++++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i-- 232 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL-- 232 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE--
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCc--
Confidence 111111 1246666655 679999885 2223468899999999999999999999997
Q ss_pred eeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccccccccCCCccchhcc----------cCCCCCchhhHHHHHHH
Q 046083 607 YIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYA----------QYGEVSPKIDVYAFGVV 676 (790)
Q Consensus 607 ~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~sDvwS~Gvv 676 (790)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||+
T Consensus 233 -iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 -VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp -ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred -ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999998865322 334567 999999999 55568899999999999
Q ss_pred HHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 046083 677 LYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMR 756 (790)
Q Consensus 677 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 756 (790)
+|||++|+.||....... .....+... . ..+..+.+|+.+||+.||++|||+.
T Consensus 307 l~elltg~~Pf~~~~~~~---------------------~~~~~~~~~--~----~~~~~~~~li~~~l~~dP~~Rpt~~ 359 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALG---------------------GSEWIFRSC--K----NIPQPVRALLEGFLRYPKEDRLLPL 359 (413)
T ss_dssp HHHHHHSSCCCCTTGGGS---------------------CSGGGGSSC--C----CCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHCCCCCCCcchhh---------------------hHHHHHhhc--c----cCCHHHHHHHHHHccCChhhCcCHH
Confidence 999999999996533210 011111110 1 2235789999999999999999987
Q ss_pred HHHH
Q 046083 757 AIVV 760 (790)
Q Consensus 757 evl~ 760 (790)
++++
T Consensus 360 ~~l~ 363 (413)
T 3dzo_A 360 QAME 363 (413)
T ss_dssp HHTT
T ss_pred HHHh
Confidence 7754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=8.1e-33 Score=300.46 Aligned_cols=240 Identities=19% Similarity=0.216 Sum_probs=186.1
Q ss_pred hcCcccceeeeecCceEEEEEEECCceEEEEEeChhh-----------HHHHHHHHHHHHhcC---------CCCCcceE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQA-----------SKEFLAELKVLTHVH---------HLNLVRLI 548 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~-----------~~~~~~E~~~l~~l~---------h~niv~l~ 548 (790)
.++|++.+.||+|+||.||+|+..++.||||+++... .+.+.+|++++++++ |||++++.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 3568899999999999999999999999999986432 267899999999885 89999888
Q ss_pred EEEe-------------------------------cCeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 046083 549 GYCV-------------------------------EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLE 597 (790)
Q Consensus 549 g~~~-------------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~ 597 (790)
+.+. ++..|+||||+++|++.+.+.. ..+++..+..++.|++.||+
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHH
Confidence 8642 4568999999999987776653 35899999999999999999
Q ss_pred HHH-hCCCCceeecCCCCCCEEecCCC--------------------cEEEEEeCCCcccccCCcccccccccCCCccch
Q 046083 598 YIH-EHTVPVYIHRDIKPANILIDKNF--------------------RAKVADFGLAKLTEVGSASVHTRLVGTFGYMPP 656 (790)
Q Consensus 598 ~LH-~~~~~~~vH~dlkp~NILl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aP 656 (790)
||| ++++ +||||||+|||++.++ .+||+|||+++..... ...||+.|+||
T Consensus 176 ~lH~~~~i---vHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aP 246 (336)
T 2vuw_A 176 VAEASLRF---EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHCC---BCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCS
T ss_pred HHHHhCCE---eECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccCh
Confidence 999 8998 9999999999999887 8999999999876422 34789999999
Q ss_pred hcccCCCCCchhhHHHHHHH-HHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHH
Q 046083 657 EYAQYGEVSPKIDVYAFGVV-LYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVR 735 (790)
Q Consensus 657 E~~~~~~~s~~sDvwS~Gvv-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~ 735 (790)
|++.+.. +.++||||||++ .+++++|..||..... ............. .........+...+.
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~-------~~~~~~~~~~~~~--------~~~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW-------LHYLTDKMLKQMT--------FKTKCNTPAMKQIKR 310 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH-------HHHHHHHHHHTCC--------CSSCCCSHHHHHHHH
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh-------hhHHHHhhhhhhc--------cCcccchhhhhhcCH
Confidence 9998666 899999998777 7788999988843110 0011111111100 000111112335778
Q ss_pred HHHHHHHHccccCCCCCCCHHHHH-HH
Q 046083 736 KMARLARACTQENPQLRPSMRAIV-VA 761 (790)
Q Consensus 736 ~l~~li~~Cl~~dP~~RPt~~evl-~~ 761 (790)
++.+|+.+||+.| |++|++ ++
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHHHHhccC-----CHHHHHhcC
Confidence 8999999999976 999988 53
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.6e-27 Score=270.14 Aligned_cols=181 Identities=21% Similarity=0.145 Sum_probs=128.0
Q ss_pred eeeecCceEEEEEEEC--CceEEEEEeCh-------------hhHHHHHHHHHHHHhc-CCCCCcceEEEEec-CeEEEE
Q 046083 497 KIGQGGFGAVFYAELR--GEKAAIKKMDM-------------QASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSLFLV 559 (790)
Q Consensus 497 ~lG~G~fg~Vy~a~~~--g~~vavK~~~~-------------~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~~lv 559 (790)
..+.|++|.+..++.. |+.+++|.+.. ...++|.+|+++|+++ .|+||+++++++.+ +..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4566777777766543 99999999842 1235699999999999 79999999999985 469999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||++|++|.++|...+ +++.. +|+.||+.||+|||++|+ |||||||+|||+++++++||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~GI---IHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQGF---WHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTTC---EESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCCc---eeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999998754 46553 588999999999999998 99999999999999999999999999866433
Q ss_pred CcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccc
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAV 687 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~ 687 (790)
. ......+||++|||||++.+ .+..++|+||+|+++++|.++..++
T Consensus 393 ~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 393 C-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred C-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 2 22344679999999999975 5677899999999999887765554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-24 Score=250.53 Aligned_cols=180 Identities=17% Similarity=0.191 Sum_probs=141.8
Q ss_pred ccceeeeecCceEEEEEEECCceEEEEEeChh-----------hHHHHHHHHHHHHhcCCCCCcceEEEEe-cCeEEEEE
Q 046083 493 SMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQ-----------ASKEFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVY 560 (790)
Q Consensus 493 ~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~lv~ 560 (790)
...+.||+|+||.||+|...+..+++|+.... ..+.+.+|++++++++||||+++..++. +...++||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 44679999999999999888999999986321 1345899999999999999995554443 44579999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++++|.+++.. +..++.|+++||+|||++++ +||||||+|||++. .+||+|||+++......
T Consensus 419 E~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gI---iHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 419 SYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDV---IHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp ECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTE---ECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred ECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcC---ccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 99999999999985 45899999999999999997 99999999999999 99999999999765322
Q ss_pred cc------cccccccCCCccchhcccC--CCCCchhhHHHHHHHHHHHHhCCccc
Q 046083 641 AS------VHTRLVGTFGYMPPEYAQY--GEVSPKIDVYAFGVVLYELISAMEAV 687 (790)
Q Consensus 641 ~~------~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwS~Gvvl~elltG~~p~ 687 (790)
.. ......||+.|||||++.. ..|+...|+||..+-.++-+.++.++
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 11 1234679999999999986 56888899999999888888766554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=2e-21 Score=204.92 Aligned_cols=150 Identities=15% Similarity=0.129 Sum_probs=123.5
Q ss_pred CHHHHHHHhcCcccceeeeecCceEEEEEEEC-CceEEEEEeChh---------------------hHHHHHHHHHHHHh
Q 046083 481 SYEELAKATNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ---------------------ASKEFLAELKVLTH 538 (790)
Q Consensus 481 ~~~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~---------------------~~~~~~~E~~~l~~ 538 (790)
.+..+......|.+.+.||+|+||.||+|... |+.+|+|.++.. ....+.+|++++++
T Consensus 81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 34455556667888999999999999999985 789999998632 24568899999999
Q ss_pred cCCCCCcceEEEEecCeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEE
Q 046083 539 VHHLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANIL 618 (790)
Q Consensus 539 l~h~niv~l~g~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NIL 618 (790)
++ | +++++++..+..++||||+++++|.+ +.. .....++.|++.||.|||++++ +||||||+|||
T Consensus 161 l~--~-~~v~~~~~~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~gi---iHrDlkp~NIL 225 (282)
T 1zar_A 161 LQ--G-LAVPKVYAWEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGI---VHGDLSQYNVL 225 (282)
T ss_dssp TT--T-SSSCCEEEEETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTE---ECSCCSTTSEE
T ss_pred cc--C-CCcCeEEeccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCC---EeCCCCHHHEE
Confidence 99 4 66666665566799999999999998 532 1234699999999999999997 99999999999
Q ss_pred ecCCCcEEEEEeCCCcccccCCcccccccccCCCccchhccc
Q 046083 619 IDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQ 660 (790)
Q Consensus 619 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 660 (790)
++ ++.+||+|||+++. +..++|||++.
T Consensus 226 l~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp EE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred EE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 99 99999999999873 34578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=3.6e-17 Score=170.11 Aligned_cols=141 Identities=22% Similarity=0.222 Sum_probs=108.4
Q ss_pred HHHHHHhcCcccceeeeecCceEEEEEEE--CCce--EEEEEeChhh---------------------------HHHHHH
Q 046083 483 EELAKATNDFSMGNKIGQGGFGAVFYAEL--RGEK--AAIKKMDMQA---------------------------SKEFLA 531 (790)
Q Consensus 483 ~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~--~g~~--vavK~~~~~~---------------------------~~~~~~ 531 (790)
..+.....-|.+.+.||+|+||.||+|.. .|+. +|||.++... ...+.+
T Consensus 40 ~~~~~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (258)
T 1zth_A 40 YKLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK 119 (258)
T ss_dssp HHHHHTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred HHHHhCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence 33333333467889999999999999998 5888 9999864321 125788
Q ss_pred HHHHHHhcCCCCC--cceEEEEecCeEEEEEEEecC-C----ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCC
Q 046083 532 ELKVLTHVHHLNL--VRLIGYCVEGSLFLVYEYIEN-G----NLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH-EHT 603 (790)
Q Consensus 532 E~~~l~~l~h~ni--v~l~g~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~ 603 (790)
|+++|.+++|+++ ...+.+ ...+|||||+.+ | +|.++... .++..+..++.+++.||.||| +.+
T Consensus 120 E~~~l~~l~~~~i~~p~~~~~---~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g 191 (258)
T 1zth_A 120 EFRNLERAKEAGVSVPQPYTY---MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE 191 (258)
T ss_dssp HHHHHHHHHHTTCCCCCEEEE---ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC
T ss_pred HHHHHHHHHhCCCCCCeEEEc---CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999999988764 344433 346899999953 4 66665432 224456789999999999999 888
Q ss_pred CCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 604 VPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 604 ~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
+ +||||||+|||++. .++|+|||++...
T Consensus 192 i---vHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 L---VHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp E---ECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred E---EeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 7 99999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.50 E-value=7.3e-14 Score=151.30 Aligned_cols=141 Identities=15% Similarity=0.161 Sum_probs=102.2
Q ss_pred HHHHHhcCcccceeeeecCceEEEEEEEC-CceEEEEEeChhh-----------------HHH--------HHHHHHHHH
Q 046083 484 ELAKATNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQA-----------------SKE--------FLAELKVLT 537 (790)
Q Consensus 484 ~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~~-----------------~~~--------~~~E~~~l~ 537 (790)
.|.....-|++.+.||+|+||.||+|... |+.||||.++... ... ...|...|.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 34333344999999999999999999876 8899999864210 011 234667777
Q ss_pred hcCCCCCcceEEEEecCeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCE
Q 046083 538 HVHHLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANI 617 (790)
Q Consensus 538 ~l~h~niv~l~g~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NI 617 (790)
++.+.++....-+... ..+|||||+++++|.++.... ....++.|++.+|.+||++++ |||||||.||
T Consensus 169 rL~~~gv~vp~p~~~~-~~~LVME~i~G~~L~~l~~~~--------~~~~l~~qll~~l~~lH~~gI---VHrDLKp~NI 236 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQS-RHTIVMSLVDALPMRQVSSVP--------DPASLYADLIALILRLAKHGL---IHGDFNEFNI 236 (397)
T ss_dssp HHHHTTCSCCCEEEEE-TTEEEEECCSCEEGGGCCCCS--------CHHHHHHHHHHHHHHHHHTTE---ECSCCSTTSE
T ss_pred HHHhcCCCCCeeeecc-CceEEEEecCCccHhhhcccH--------HHHHHHHHHHHHHHHHHHCCC---cCCCCCHHHE
Confidence 7755444322222122 247999999999987654321 235678999999999999997 9999999999
Q ss_pred EecCCC----------cEEEEEeCCCccc
Q 046083 618 LIDKNF----------RAKVADFGLAKLT 636 (790)
Q Consensus 618 Ll~~~~----------~~kl~DfGla~~~ 636 (790)
|+++++ .+.|+||+-+...
T Consensus 237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 237 LIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred EEeCCCCcccccccccceEEEEeCCcccC
Confidence 998776 3899999987654
|
| >2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.6e-13 Score=130.67 Aligned_cols=94 Identities=10% Similarity=-0.011 Sum_probs=69.9
Q ss_pred eeEEEEeccCchHHHHHHHhhcccccHHHHHhcCCCCC-CCCCCCCcEEEEeEeeecCCCcccCCcceEEEeecCCCCcc
Q 046083 283 HSFSYKVKSGNTYKRIAELIYANLTTLDWLKSSNAYDE-NHTPDVSSSVNVIVNCSCGSKSVSKDYGLFLTYPLRPGENL 361 (790)
Q Consensus 283 ~~~~y~V~~gDtl~~IA~~~~~~l~~~~~l~~~N~~~~-~~~~~~Gq~l~ip~~~~~~~~~~~~~~~~~~~Y~v~~GDtl 361 (790)
...+|+||+|||||.||++ |. +++.+|++||++.. +.|.+ ||+|.||.....+.............|+|++||+|
T Consensus 61 ~~~~y~V~~GDTL~~IA~~-~~--~~~~~l~~~N~~~~~~~i~~-Gq~L~ip~~~~~~~~~~~~~~~~~~~~~v~~GdtL 136 (167)
T 2l9y_A 61 GTATVTVQQGDTLRDIGRR-FD--CDFHEIARRNNIQNEDLIYP-GQVLQVPTKGGSGGGAGNFWDSARDVRLVDGGKVL 136 (167)
T ss_dssp SCEEEEECTTCCHHHHHHH-TT--CCHHHHHHHHTCCGGGCCCT-TEEEEESCCCCCSSSSCCGGGGEEEEEEETTTTEE
T ss_pred CCceEEECCCCcHHHHHHH-cC--CCHHHHHHHcCCCCcccccC-CCEEEEcCCCCccccccccccccceEEEeCCcCCh
Confidence 3457999999999999954 54 78899999999765 55666 99999997533211111111112368999999999
Q ss_pred ccccccccCChhhhhhcCC
Q 046083 362 SSIANEFELSSELLQSYNP 380 (790)
Q Consensus 362 ~~IA~~f~~s~~~l~~~N~ 380 (790)
+.||++||.++......|.
T Consensus 137 ~aIA~r~G~~v~s~i~Ln~ 155 (167)
T 2l9y_A 137 EAELRYSGGWNRSRIYLDE 155 (167)
T ss_dssp EEEEEETTEEEEEEECGGG
T ss_pred HHHHHHcCCceEEEEEccc
Confidence 9999999988877776665
|
| >2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15} | Back alignment and structure |
|---|
Probab=99.31 E-value=1.4e-13 Score=131.11 Aligned_cols=95 Identities=17% Similarity=0.011 Sum_probs=73.2
Q ss_pred cceeEEeccCCchHHHHhhhcCCCChHHHHHHcc-CCCCCCCCCCcEEEEEeeccCCCCcccCCceeEEEeecCCCCCHH
Q 046083 76 HTFTYETQFGDTYEKVASFAFANLTTEDWVRRVN-IYEPTRIPDYAFINVTVNCSCGDRHISRDYGLFTTYPLRPAQNLS 154 (790)
Q Consensus 76 ~~~~Y~V~~GDTl~~IA~~~~~~~~t~~~l~~~N-~~~~~~l~~Gq~l~iP~~~~~~~~~~~~~~~~~~~y~v~~gd~l~ 154 (790)
+...|+||+|||||.|| ++|+. ++.+|+++| +.+|+.|++||+|+||.....+.............|+|++||+|+
T Consensus 61 ~~~~y~V~~GDTL~~IA-~~~~~--~~~~l~~~N~~~~~~~i~~Gq~L~ip~~~~~~~~~~~~~~~~~~~~~v~~GdtL~ 137 (167)
T 2l9y_A 61 GTATVTVQQGDTLRDIG-RRFDC--DFHEIARRNNIQNEDLIYPGQVLQVPTKGGSGGGAGNFWDSARDVRLVDGGKVLE 137 (167)
T ss_dssp SCEEEEECTTCCHHHHH-HHTTC--CHHHHHHHHTCCGGGCCCTTEEEEESCCCCCSSSSCCGGGGEEEEEEETTTTEEE
T ss_pred CCceEEECCCCcHHHHH-HHcCC--CHHHHHHHcCCCCcccccCCCEEEEcCCCCccccccccccccceEEEeCCcCChH
Confidence 45789999999999999 68865 888888888 667899999999999974322110010111224579999999999
Q ss_pred HHHHHhCCChHHHhhhCCC
Q 046083 155 SVAAEAGVAPQSLQRYNPG 173 (790)
Q Consensus 155 ~ia~~~~~~~~~l~~~N~~ 173 (790)
.||+++|.++...+.+|..
T Consensus 138 aIA~r~G~~v~s~i~Ln~~ 156 (167)
T 2l9y_A 138 AELRYSGGWNRSRIYLDEH 156 (167)
T ss_dssp EEEEETTEEEEEEECGGGT
T ss_pred HHHHHcCCceEEEEEcccc
Confidence 9999999888888888864
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=2.2e-10 Score=118.82 Aligned_cols=143 Identities=13% Similarity=0.114 Sum_probs=113.0
Q ss_pred HHHhcCcccceeeeecCceEEEEEEECCceEEEEEeCh---hhHHHHHHHHHHHHhcC-CCCCcceEEEEec-CeEEEEE
Q 046083 486 AKATNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDM---QASKEFLAELKVLTHVH-HLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 486 ~~~~~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~-~~~~lv~ 560 (790)
......|++...++.|+.+.||++...++.+++|.... .....+.+|+++++.+. |..+.++++++.+ +..|+||
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 34456788888899899999999988889999999875 33456889999999984 6778889988764 4689999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT------------------------------------- 603 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------- 603 (790)
||++|.+|.+.+.. ......++.+++++|..||+..
T Consensus 90 e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 90 SEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp ECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 99999999876421 1123467889999999999821
Q ss_pred -------------------CCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 604 -------------------VPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 604 -------------------~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
-+.++|+|++|.|||++++..+.|+||+.+..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 03479999999999998765667999998753
|
| >2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae} | Back alignment and structure |
|---|
Probab=99.11 E-value=6.7e-11 Score=127.98 Aligned_cols=110 Identities=10% Similarity=0.077 Sum_probs=82.5
Q ss_pred hheeeecCCCCCHHHHHHHcCCChhhHhhcCCCCCC----cccccCCceEEeccccccC--------------------C
Q 046083 222 ALASYYLWKGANLTFISKVFDTSIKYILSFNPQITN----KDKILAGTRINVPFSCNCI--------------------Q 277 (790)
Q Consensus 222 ~~~~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~----~~~l~~gq~l~ip~~~~~~--------------------~ 277 (790)
.|..|+|++||||+.||++||+++++|.++| ++.. .+.|++||.|.||....-. .
T Consensus 6 ~~~~~~Vk~GDTL~~Ia~r~gvs~~~l~~~n-~~~~~~~~~~~L~~Gq~L~i~~~~~~~l~~l~~~~~~~~~~~~~~~~~ 84 (361)
T 2gu1_A 6 KRIHYMVKVGDTLSGIFAQLGVPYSILQKIL-SVDLDHLQLDMIQPGEELELMMDDMGQLSRLIYHMSIVEKAIYTREND 84 (361)
T ss_dssp -CEEEECCTTCCHHHHHHHTTCCHHHHHHHH-HHGGGTCCGGGCCTTCEEEEEECTTSCEEEEEEEEETTEEEEEEECTT
T ss_pred CceEEEECCCCcHHHHHHHcCCCHHHHHHHH-hhcccccchhcCCCCCEEEEEECCCCcceEEEEEcCccceEEEEecCC
Confidence 5778999999999999999999999999999 5532 4689999999999753210 0
Q ss_pred Ccee---------eeeEEEEeccCchHHHHHHHhhcccccHHHHHhcCCCCC------CCCCCCCcEEEEeEee
Q 046083 278 NKFL---------GHSFSYKVKSGNTYKRIAELIYANLTTLDWLKSSNAYDE------NHTPDVSSSVNVIVNC 336 (790)
Q Consensus 278 ~~~~---------~~~~~y~V~~gDtl~~IA~~~~~~l~~~~~l~~~N~~~~------~~~~~~Gq~l~ip~~~ 336 (790)
+.+. .....|+|+.|||||.||++ +. ++.++|++||++.. ..|.+ ||+|.|+...
T Consensus 85 g~f~~~~~~~~~~~~~~~~~v~igdSL~~iA~~-~G--vs~~~i~~ln~i~~~~idf~~~Lr~-GD~l~V~~~~ 154 (361)
T 2gu1_A 85 GSFSYDFQEISGEWREILFSGEINGSFSVSARR-VG--LTSSQVANITQVMKDKIDFSRSLRA-GDRFDILVKQ 154 (361)
T ss_dssp SCEEEEEEECCCEEEEEEEEEESSSCHHHHHHH-TT--CCHHHHHHHHHHHTTTCCTTTCCCC--CEEEEEEEE
T ss_pred CcceeeecccCceEEEEEEEEEECCcHHHHHHH-cC--CCHHHHHHHHHhhcccccccccCCC-CCEEEEEEEE
Confidence 1011 11246999999999999954 44 66799999998543 34666 9999999753
|
| >2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae} | Back alignment and structure |
|---|
Probab=99.00 E-value=2.3e-10 Score=123.81 Aligned_cols=110 Identities=11% Similarity=0.088 Sum_probs=82.2
Q ss_pred HhhhcccCCCCCHHHHHHHhCCCHHHHHhhCCCCC---CCCCcCCCCeEEeeeecccC--------------------CC
Q 046083 15 ALASYYVWEGSNPTYISNIFGEDIAQILLYNPNIP---NQNTIPSDTRISIPFSCDCL--------------------NG 71 (790)
Q Consensus 15 ~~~~y~v~~gdtl~~Ia~~~~~~~~~l~~~Np~~~---~~~~~~~g~~l~ip~~~~~~--------------------~~ 71 (790)
.-..|+|++||||+.||++||+++.+|+++|+..+ +.+.|.+||.|.||...... .+
T Consensus 6 ~~~~~~Vk~GDTL~~Ia~r~gvs~~~l~~~n~~~~~~~~~~~L~~Gq~L~i~~~~~~~l~~l~~~~~~~~~~~~~~~~~g 85 (361)
T 2gu1_A 6 KRIHYMVKVGDTLSGIFAQLGVPYSILQKILSVDLDHLQLDMIQPGEELELMMDDMGQLSRLIYHMSIVEKAIYTRENDG 85 (361)
T ss_dssp -CEEEECCTTCCHHHHHHHTTCCHHHHHHHHHHGGGTCCGGGCCTTCEEEEEECTTSCEEEEEEEEETTEEEEEEECTTS
T ss_pred CceEEEECCCCcHHHHHHHcCCCHHHHHHHHhhcccccchhcCCCCCEEEEEECCCCcceEEEEEcCccceEEEEecCCC
Confidence 34579999999999999999999999999994332 24689999999999753210 00
Q ss_pred CCc---------ccceeEEeccCCchHHHHhhhcCCCChHHHHHHcc-CCCC-----CCCCCCcEEEEEee
Q 046083 72 DFL---------GHTFTYETQFGDTYEKVASFAFANLTTEDWVRRVN-IYEP-----TRIPDYAFINVTVN 127 (790)
Q Consensus 72 ~~~---------~~~~~Y~V~~GDTl~~IA~~~~~~~~t~~~l~~~N-~~~~-----~~l~~Gq~l~iP~~ 127 (790)
.+. .....|+|+.|||||.|| ++|+. +...|+++| +... ..|++||+|.|+..
T Consensus 86 ~f~~~~~~~~~~~~~~~~~v~igdSL~~iA-~~~Gv--s~~~i~~ln~i~~~~idf~~~Lr~GD~l~V~~~ 153 (361)
T 2gu1_A 86 SFSYDFQEISGEWREILFSGEINGSFSVSA-RRVGL--TSSQVANITQVMKDKIDFSRSLRAGDRFDILVK 153 (361)
T ss_dssp CEEEEEEECCCEEEEEEEEEESSSCHHHHH-HHTTC--CHHHHHHHHHHHTTTCCTTTCCCC-CEEEEEEE
T ss_pred cceeeecccCceEEEEEEEEEECCcHHHHH-HHcCC--CHHHHHHHHHhhcccccccccCCCCCEEEEEEE
Confidence 000 012368999999999999 78876 888888888 3332 46999999999974
|
| >2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.95 E-value=4.6e-10 Score=92.78 Aligned_cols=61 Identities=16% Similarity=0.162 Sum_probs=51.2
Q ss_pred CCCeEEeeeecccCCCCCcccceeEEeccCCchHHHHhhhcCCCChHHHHHHccCC-CCCCCCCCcEEEEEeec
Q 046083 56 SDTRISIPFSCDCLNGDFLGHTFTYETQFGDTYEKVASFAFANLTTEDWVRRVNIY-EPTRIPDYAFINVTVNC 128 (790)
Q Consensus 56 ~g~~l~ip~~~~~~~~~~~~~~~~Y~V~~GDTl~~IA~~~~~~~~t~~~l~~~N~~-~~~~l~~Gq~l~iP~~~ 128 (790)
.||.+.||... ....|+|++|||||.|| ++|+. +.++|+++|.+ +++.|++||+|.||...
T Consensus 3 ~Gq~l~ip~~~---------~~~~y~V~~GDTL~~IA-~~~~~--~~~~l~~~N~l~~~~~l~~Gq~l~iP~~~ 64 (77)
T 2djp_A 3 SGSSGCSPVRE---------RRLEHQLEPGDTLAGLA-LKYGV--TMEQIKRANRLYTNDSIFLKKTLYIPILT 64 (77)
T ss_dssp CCCCCCCCCCE---------EEEEECCCTTCCHHHHH-HHHTC--CHHHHHHHHTCCCSSCGGGSSCEEEEEEC
T ss_pred CCcEeeccCCC---------CcEEEEECCCCcHHHHH-HHHCc--CHHHHHHHcCCCCccccCCCCEEEECCCC
Confidence 68999999643 23689999999999999 78865 88889999955 57899999999999853
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.89 E-value=2.2e-09 Score=110.65 Aligned_cols=135 Identities=16% Similarity=0.118 Sum_probs=97.8
Q ss_pred CcccceeeeecCceEEEEEEEC-CceEEEEEeChhhHHHHHHHHHHHHhcCCCC--CcceEEEEec-CeEEEEEEEecCC
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQASKEFLAELKVLTHVHHLN--LVRLIGYCVE-GSLFLVYEYIENG 566 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~-~~~~lv~e~~~~g 566 (790)
++.+....+.|..+.||++... |..+++|.........+..|+++++.+.+.+ +.+++++..+ +..++||||++|.
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~ 100 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 100 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCc
Confidence 3443333345556999999875 6789999987654456788999999986544 4557887764 4589999999998
Q ss_pred ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC------------------------------------------
Q 046083 567 NLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTV------------------------------------------ 604 (790)
Q Consensus 567 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~------------------------------------------ 604 (790)
+|. ... .+ ...++.++++.|..||+...
T Consensus 101 ~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 101 DLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp ETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred ccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 884 221 12 23567778888888887530
Q ss_pred -------------CceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 605 -------------PVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 605 -------------~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
+.++|+|++|.|||++++..+.|+||+.+..
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 1279999999999998876677999998764
|
| >2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.88 E-value=1.3e-09 Score=90.06 Aligned_cols=61 Identities=15% Similarity=0.217 Sum_probs=49.5
Q ss_pred CCceEEeccccccCCCceeeeeEEEEeccCchHHHHHHHhhcccccHHHHHhcCCCC-CCCCCCCCcEEEEeEee
Q 046083 263 AGTRINVPFSCNCIQNKFLGHSFSYKVKSGNTYKRIAELIYANLTTLDWLKSSNAYD-ENHTPDVSSSVNVIVNC 336 (790)
Q Consensus 263 ~gq~l~ip~~~~~~~~~~~~~~~~y~V~~gDtl~~IA~~~~~~l~~~~~l~~~N~~~-~~~~~~~Gq~l~ip~~~ 336 (790)
.||.+.||... ...+|+|++|||||.||++ |. +++++|+++|++. ++.|.+ ||+|.||...
T Consensus 3 ~Gq~l~ip~~~---------~~~~y~V~~GDTL~~IA~~-~~--~~~~~l~~~N~l~~~~~l~~-Gq~l~iP~~~ 64 (77)
T 2djp_A 3 SGSSGCSPVRE---------RRLEHQLEPGDTLAGLALK-YG--VTMEQIKRANRLYTNDSIFL-KKTLYIPILT 64 (77)
T ss_dssp CCCCCCCCCCE---------EEEEECCCTTCCHHHHHHH-HT--CCHHHHHHHHTCCCSSCGGG-SSCEEEEEEC
T ss_pred CCcEeeccCCC---------CcEEEEECCCCcHHHHHHH-HC--cCHHHHHHHcCCCCccccCC-CCEEEECCCC
Confidence 68999999542 2347999999999999954 54 6779999999986 456776 9999999863
|
| >1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1 | Back alignment and structure |
|---|
Probab=98.86 E-value=1.8e-09 Score=80.34 Aligned_cols=45 Identities=22% Similarity=0.446 Sum_probs=41.7
Q ss_pred eeeecCCCCCHHHHHHHcCCChhhHhhcCCCCCCcccccCCceEEecc
Q 046083 224 ASYYLWKGANLTFISKVFDTSIKYILSFNPQITNKDKILAGTRINVPF 271 (790)
Q Consensus 224 ~~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~ip~ 271 (790)
..|+|++||||+.||++||+++++|+++|+ +++.|.+||.|.||.
T Consensus 3 ~~y~V~~GDtl~~Ia~~~~~~~~~l~~~N~---~~~~l~~G~~l~ip~ 47 (48)
T 1e0g_A 3 ITYRVRKGDSLSSIAKRHGVNIKDVMRWNS---DTANLQPGDKLTLFV 47 (48)
T ss_dssp CEEEECTTCCHHHHHHHHTCCHHHHHHHCS---CGGGCCTTEEEECCC
T ss_pred EEEEEcCCCcHHHHHHHHCcCHHHHHHhCC---CCCcCCcCCEEEEec
Confidence 479999999999999999999999999994 567899999999996
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.85 E-value=8.1e-09 Score=112.28 Aligned_cols=139 Identities=14% Similarity=0.240 Sum_probs=108.7
Q ss_pred cceeeeecCceEEEEEEECCceEEEEEeC--hhh----HHHHHHHHHHHHhcC--CCCCcceEEEEecC----eEEEEEE
Q 046083 494 MGNKIGQGGFGAVFYAELRGEKAAIKKMD--MQA----SKEFLAELKVLTHVH--HLNLVRLIGYCVEG----SLFLVYE 561 (790)
Q Consensus 494 ~~~~lG~G~fg~Vy~a~~~g~~vavK~~~--~~~----~~~~~~E~~~l~~l~--h~niv~l~g~~~~~----~~~lv~e 561 (790)
..+.|+.|.++.||+....+..+++|+.. ... ...+.+|.++++.+. +..+.+++.++.+. ..|+|||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 46789999999999999888889999876 322 346888999999997 45678889888754 3799999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT-------------------------------------- 603 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------------- 603 (790)
|++|..+.+... ..++...+..++.++++.|..||...
T Consensus 122 ~v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 122 FVSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp CCCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred ecCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 999988754221 24678888899999999999999831
Q ss_pred -----------------CCceeecCCCCCCEEecCCCc--EEEEEeCCCccc
Q 046083 604 -----------------VPVYIHRDIKPANILIDKNFR--AKVADFGLAKLT 636 (790)
Q Consensus 604 -----------------~~~~vH~dlkp~NILl~~~~~--~kl~DfGla~~~ 636 (790)
.+.++|+|+++.|||++.++. +.|.||+.+..-
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 245899999999999987753 689999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.84 E-value=5.2e-09 Score=110.99 Aligned_cols=185 Identities=19% Similarity=0.240 Sum_probs=124.1
Q ss_pred ceeeeecCceEEEEEEECCceEEEEEeChh-hHHHHHHHHHHHHhcC-CCC--CcceEEEEecC----eEEEEEEEecCC
Q 046083 495 GNKIGQGGFGAVFYAELRGEKAAIKKMDMQ-ASKEFLAELKVLTHVH-HLN--LVRLIGYCVEG----SLFLVYEYIENG 566 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~-~~~~~~~E~~~l~~l~-h~n--iv~l~g~~~~~----~~~lv~e~~~~g 566 (790)
.+.++.|.+..||+.. ..+++|..... ....+.+|.++|+.+. +.. +.+.+.+...+ ..|+|||+++|.
T Consensus 25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~ 101 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGV 101 (304)
T ss_dssp CCEEEECSSEEEEEST---TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCE
T ss_pred eEecCCCCcceEEEEC---CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCe
Confidence 4568999999999864 67889987654 4567889999999884 333 34455554332 248899999998
Q ss_pred ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 046083 567 NLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT------------------------------------------- 603 (790)
Q Consensus 567 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------------- 603 (790)
+|.+.... .++..++..++.++++.|+.||+..
T Consensus 102 ~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 177 (304)
T 3sg8_A 102 PLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFY 177 (304)
T ss_dssp ECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHH
T ss_pred ECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHH
Confidence 88754332 3677778888888888888888621
Q ss_pred ------------CCceeecCCCCCCEEecC--CCcEEEEEeCCCcccccCCccccccc--------------ccCCCccc
Q 046083 604 ------------VPVYIHRDIKPANILIDK--NFRAKVADFGLAKLTEVGSASVHTRL--------------VGTFGYMP 655 (790)
Q Consensus 604 ------------~~~~vH~dlkp~NILl~~--~~~~kl~DfGla~~~~~~~~~~~~~~--------------~gt~~y~a 655 (790)
-+.++|+|++|.||++++ +..+.|+||+.+...+... ...... ....+...
T Consensus 178 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~ 256 (304)
T 3sg8_A 178 RDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISLMEDDEEYGMEFVSKILNHYKHKD 256 (304)
T ss_dssp HHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred HHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence 135799999999999998 4567899999987543210 000000 00001111
Q ss_pred -hhcccCCCCCchhhHHHHHHHHHHHHhCCccccc
Q 046083 656 -PEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVK 689 (790)
Q Consensus 656 -PE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~ 689 (790)
|+.... .....+.|+++.++|++.+|..++..
T Consensus 257 ~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 257 IPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp HHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred cHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 222211 12236899999999999999888743
|
| >1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1 | Back alignment and structure |
|---|
Probab=98.83 E-value=1.8e-09 Score=80.37 Aligned_cols=45 Identities=16% Similarity=0.397 Sum_probs=41.8
Q ss_pred hhcccCCCCCHHHHHHHhCCCHHHHHhhCCCCCCCCCcCCCCeEEeee
Q 046083 17 ASYYVWEGSNPTYISNIFGEDIAQILLYNPNIPNQNTIPSDTRISIPF 64 (790)
Q Consensus 17 ~~y~v~~gdtl~~Ia~~~~~~~~~l~~~Np~~~~~~~~~~g~~l~ip~ 64 (790)
..|+|++||||+.||++||+++++|+++|+ ++..|.+||.|.||.
T Consensus 3 ~~y~V~~GDtl~~Ia~~~~~~~~~l~~~N~---~~~~l~~G~~l~ip~ 47 (48)
T 1e0g_A 3 ITYRVRKGDSLSSIAKRHGVNIKDVMRWNS---DTANLQPGDKLTLFV 47 (48)
T ss_dssp CEEEECTTCCHHHHHHHHTCCHHHHHHHCS---CGGGCCTTEEEECCC
T ss_pred EEEEEcCCCcHHHHHHHHCcCHHHHHHhCC---CCCcCCcCCEEEEec
Confidence 469999999999999999999999999996 567899999999996
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=4.5e-06 Score=86.42 Aligned_cols=134 Identities=16% Similarity=0.156 Sum_probs=97.3
Q ss_pred eeeeecCce-EEEEEEEC--CceEEEEEeChhhHHHHHHHHHHHHhcC-CCCCcceEEEEec-CeEEEEEEEecCCChhh
Q 046083 496 NKIGQGGFG-AVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHVH-HLNLVRLIGYCVE-GSLFLVYEYIENGNLNQ 570 (790)
Q Consensus 496 ~~lG~G~fg-~Vy~a~~~--g~~vavK~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~-~~~~lv~e~~~~g~L~~ 570 (790)
+.+..|..| .||+.... +..+++|........++.+|...|+.+. +--+.++++++.+ +..++|||++++.++.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 345556555 69988765 5678999988777778999999999884 3346677888764 56899999999988877
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----------------------------------------------
Q 046083 571 HLRGSGKDTLTWSARMQIALDSARGLEYIHEHTV---------------------------------------------- 604 (790)
Q Consensus 571 ~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~---------------------------------------------- 604 (790)
...... .....+..++++.|.-||....
T Consensus 110 ~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 183 (272)
T 4gkh_A 110 VLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM 183 (272)
T ss_dssp HHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred cccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence 654311 1223455666667777774211
Q ss_pred ---------CceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 605 ---------PVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 605 ---------~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 2379999999999999877777999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=1.2e-05 Score=84.91 Aligned_cols=135 Identities=19% Similarity=0.259 Sum_probs=95.4
Q ss_pred ceeeeecCceEEEEEEECCceEEEEEeChh-hHHHHHHHHHHHHhcCCC---CCcceEEEEe--cCeEEEEEEEecCCCh
Q 046083 495 GNKIGQGGFGAVFYAELRGEKAAIKKMDMQ-ASKEFLAELKVLTHVHHL---NLVRLIGYCV--EGSLFLVYEYIENGNL 568 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~-~~~~~~~E~~~l~~l~h~---niv~l~g~~~--~~~~~lv~e~~~~g~L 568 (790)
.+.++.|....||+. +..+++|..... ....+.+|.++|+.+.+. .+.+.+.++. ++..++||||++|.+|
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l 100 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQIL 100 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEEC
T ss_pred eeecCCCcceeEEEE---CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeEC
Confidence 467888888899988 788899986543 346789999999999753 2456666664 3457899999999888
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------------
Q 046083 569 NQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH---------------------------------------------- 602 (790)
Q Consensus 569 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------------------------------------------- 602 (790)
.+.... .++......++.++++.|..||+.
T Consensus 101 ~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 176 (306)
T 3tdw_A 101 GEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRF 176 (306)
T ss_dssp HHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHH
T ss_pred chhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHH
Confidence 763221 134444555555555555555542
Q ss_pred -----------CCCceeecCCCCCCEEecC---CCc-EEEEEeCCCccc
Q 046083 603 -----------TVPVYIHRDIKPANILIDK---NFR-AKVADFGLAKLT 636 (790)
Q Consensus 603 -----------~~~~~vH~dlkp~NILl~~---~~~-~kl~DfGla~~~ 636 (790)
.-+.++|+|+.+.|||++. ++. ..|+||+.+...
T Consensus 177 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 177 QSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2234699999999999987 455 489999988753
|
| >4a1k_A Putative L, D-transpeptidase YKUD; transferase, peptidoglycan synthesis; HET: CME; 1.75A {Bacillus subtilis} PDB: 4a1j_A 4a1i_A* 1y7m_A 3zqd_A 4a52_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=2.7e-06 Score=80.80 Aligned_cols=47 Identities=26% Similarity=0.362 Sum_probs=42.1
Q ss_pred hhhcccCCCCCHHHHHHHhCCCHHHHHhhCCCCCCCCCcCCCCeEEeee
Q 046083 16 LASYYVWEGSNPTYISNIFGEDIAQILLYNPNIPNQNTIPSDTRISIPF 64 (790)
Q Consensus 16 ~~~y~v~~gdtl~~Ia~~~~~~~~~l~~~Np~~~~~~~~~~g~~l~ip~ 64 (790)
+.+|+|++||||.+||++|+++..+|+++||+.. ..+++|+.+.||.
T Consensus 2 ~~~y~V~~GdtL~~IA~~f~~g~~~l~~aNp~vd--~~l~~g~~i~ip~ 48 (165)
T 4a1k_A 2 MLTYQVKQGDTLNSIAADFRISTAALLQANPSLQ--AGLTAGQSIVIPG 48 (165)
T ss_dssp CEEEECCTTCCHHHHHHHTTCCHHHHHHHCGGGG--GCCCTTCEEEETT
T ss_pred CEEEEECCCCCHHHHHHHhCCCHHHHHHhCccCC--CccCCCccccCcc
Confidence 3579999999999999999999999999999874 3478999999984
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=2.7e-05 Score=84.15 Aligned_cols=76 Identities=13% Similarity=0.159 Sum_probs=56.4
Q ss_pred ceee-eecCceEEEEEEEC--------CceEEEEEeChhh------HHHHHHHHHHHHhcC-C--CCCcceEEEEecC--
Q 046083 495 GNKI-GQGGFGAVFYAELR--------GEKAAIKKMDMQA------SKEFLAELKVLTHVH-H--LNLVRLIGYCVEG-- 554 (790)
Q Consensus 495 ~~~l-G~G~fg~Vy~a~~~--------g~~vavK~~~~~~------~~~~~~E~~~l~~l~-h--~niv~l~g~~~~~-- 554 (790)
.+.| +.|....+|+.... +..+++|...... ...+.+|.++++.+. + ..+.+++.++.++
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 78888999998765 6788898876432 245788999998884 3 3567788887653
Q ss_pred --eEEEEEEEecCCChhh
Q 046083 555 --SLFLVYEYIENGNLNQ 570 (790)
Q Consensus 555 --~~~lv~e~~~~g~L~~ 570 (790)
..++||||++|..|.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 3689999999877653
|
| >4a1k_A Putative L, D-transpeptidase YKUD; transferase, peptidoglycan synthesis; HET: CME; 1.75A {Bacillus subtilis} PDB: 4a1j_A 4a1i_A* 1y7m_A 3zqd_A 4a52_A* | Back alignment and structure |
|---|
Probab=97.87 E-value=9.2e-06 Score=77.14 Aligned_cols=46 Identities=28% Similarity=0.418 Sum_probs=41.4
Q ss_pred eeeecCCCCCHHHHHHHcCCChhhHhhcCCCCCCcccccCCceEEecc
Q 046083 224 ASYYLWKGANLTFISKVFDTSIKYILSFNPQITNKDKILAGTRINVPF 271 (790)
Q Consensus 224 ~~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~ip~ 271 (790)
..|+|++||||..||++|+++..+|+++||++ ++ .+++||.+.||.
T Consensus 3 ~~y~V~~GdtL~~IA~~f~~g~~~l~~aNp~v-d~-~l~~g~~i~ip~ 48 (165)
T 4a1k_A 3 LTYQVKQGDTLNSIAADFRISTAALLQANPSL-QA-GLTAGQSIVIPG 48 (165)
T ss_dssp EEEECCTTCCHHHHHHHTTCCHHHHHHHCGGG-GG-CCCTTCEEEETT
T ss_pred EEEEECCCCCHHHHHHHhCCCHHHHHHhCccC-CC-ccCCCccccCcc
Confidence 37999999999999999999999999999877 33 478999999984
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00019 Score=75.73 Aligned_cols=138 Identities=15% Similarity=0.178 Sum_probs=94.6
Q ss_pred ccceeeeecCceEEEEEEECCceEEEEEeChhhHHHHHHHHHHHHhcC---CCCCcceEEEEe-cCeEEEEEEEecCCCh
Q 046083 493 SMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKVLTHVH---HLNLVRLIGYCV-EGSLFLVYEYIENGNL 568 (790)
Q Consensus 493 ~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~-~~~~~lv~e~~~~g~L 568 (790)
...+.|+.|....+|+....+..+++|.........+..|.+.|+.+. ...+.+.+.++. ++..++||||+++..+
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDEVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp CEEEEECCSSSSEEEEEESSSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred eeeEEeCCccceeeeEEEECCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 345788999999999998888899999887666677899999998883 356778888876 4568999999998765
Q ss_pred hh-----------hhhcCCC--------------------CCCCHHHHH---HHHH----------------HHHHH-HH
Q 046083 569 NQ-----------HLRGSGK--------------------DTLTWSARM---QIAL----------------DSARG-LE 597 (790)
Q Consensus 569 ~~-----------~l~~~~~--------------------~~l~~~~~~---~i~~----------------~ia~~-L~ 597 (790)
.. .|+.... ..-+|.... ++.. .++.- ..
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 31 1222111 012565432 1111 11111 12
Q ss_pred HHHh-CCCCceeecCCCCCCEEecCCCcEEEEEeC
Q 046083 598 YIHE-HTVPVYIHRDIKPANILIDKNFRAKVADFG 631 (790)
Q Consensus 598 ~LH~-~~~~~~vH~dlkp~NILl~~~~~~kl~DfG 631 (790)
.|.. ...|.++|+|+.+.|++++.++ +.|.||.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3432 2346789999999999999887 8888874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.0002 Score=76.35 Aligned_cols=139 Identities=18% Similarity=0.250 Sum_probs=81.1
Q ss_pred ceeeeecCceEEEEEEECCceEEEEEeChhhHHHHHHHHHHHHhcC-----CCCCcceE-E--E-EecCeEEEEEEEecC
Q 046083 495 GNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKVLTHVH-----HLNLVRLI-G--Y-CVEGSLFLVYEYIEN 565 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-g--~-~~~~~~~lv~e~~~~ 565 (790)
.+.|+.|..+.||+....+..+++|..... ..++..|.+++..+. .|.++... | + ..++..+++|||++|
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~~~vlk~~~~~-~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G 115 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSGAVCLKRIHRP-EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEG 115 (346)
T ss_dssp EEECC----CEEEEEEETTEEEEEEEECSC-HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCC
T ss_pred eeeccccccCcEEEEEeCCCCEEEEecCCC-HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecC
Confidence 345666778999999888777999998753 234445566555552 24443310 1 1 134567999999998
Q ss_pred CChh--------------hhhhc--CC---C-------CCCCHHHHH-------------------------------HH
Q 046083 566 GNLN--------------QHLRG--SG---K-------DTLTWSARM-------------------------------QI 588 (790)
Q Consensus 566 g~L~--------------~~l~~--~~---~-------~~l~~~~~~-------------------------------~i 588 (790)
.++. ..+|. .. . ....|.... .+
T Consensus 116 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (346)
T 2q83_A 116 RPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDGF 195 (346)
T ss_dssp BCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHHH
T ss_pred ccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHH
Confidence 6542 11121 00 0 012343211 01
Q ss_pred HHHHHHHHHHHHh--------C--CCCceeecCCCCCCEEecCCCcEEEEEeCCCc
Q 046083 589 ALDSARGLEYIHE--------H--TVPVYIHRDIKPANILIDKNFRAKVADFGLAK 634 (790)
Q Consensus 589 ~~~ia~~L~~LH~--------~--~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~ 634 (790)
...+..++.+|+. . .-+.++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 196 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 196 IEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1123345667763 1 12347999999999999888889999999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00019 Score=78.67 Aligned_cols=71 Identities=17% Similarity=0.065 Sum_probs=48.9
Q ss_pred ceeeeecCceEEEEEEE--CCceEEEEEeChh----------hHHHHHHHHHHHHhcCC--CC-CcceEEEEecCeEEEE
Q 046083 495 GNKIGQGGFGAVFYAEL--RGEKAAIKKMDMQ----------ASKEFLAELKVLTHVHH--LN-LVRLIGYCVEGSLFLV 559 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~--~g~~vavK~~~~~----------~~~~~~~E~~~l~~l~h--~n-iv~l~g~~~~~~~~lv 559 (790)
.+.||.|.++.||++.. .+..++||..... ....+..|.++++.+.+ +. +.+++.+ .....++|
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d~~~~~lv 113 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DTEMAVTV 113 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ETTTTEEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-cCCccEEE
Confidence 56899999999999965 3678999975421 12346778899888742 33 4455554 34446899
Q ss_pred EEEecCC
Q 046083 560 YEYIENG 566 (790)
Q Consensus 560 ~e~~~~g 566 (790)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00015 Score=80.22 Aligned_cols=77 Identities=12% Similarity=0.141 Sum_probs=48.5
Q ss_pred CceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccccc-ccCCCccchhcccCC---CCCchhhHHHHHHHHHHH
Q 046083 605 PVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRL-VGTFGYMPPEYAQYG---EVSPKIDVYAFGVVLYEL 680 (790)
Q Consensus 605 ~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~s~~sDvwS~Gvvl~el 680 (790)
+.++|+|+++.|||++.++ ++|+||+.+....... ...... .-...|++|+..... ......++......+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 4579999999999998876 9999999987543111 000000 001346666655421 112345666888888888
Q ss_pred HhC
Q 046083 681 ISA 683 (790)
Q Consensus 681 ltG 683 (790)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00086 Score=69.85 Aligned_cols=75 Identities=16% Similarity=0.174 Sum_probs=54.8
Q ss_pred CcccceeeeecCceEEEEEEEC-CceEEEEEeChh---hHHHHHHHHHHHHhcCC---CCCcceEEEEecCeEEEEEEEe
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ---ASKEFLAELKVLTHVHH---LNLVRLIGYCVEGSLFLVYEYI 563 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~---~~~~~~~E~~~l~~l~h---~niv~l~g~~~~~~~~lv~e~~ 563 (790)
.....+.+|.|..+.||+.+.. |+.+++|+.... ....|..|.+.|+.+.. -.+.+.+++. ..++||||+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---~~~lv~e~l 92 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---DRTLAMEWV 92 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---TTEEEEECC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---CceEEEEee
Confidence 4555788999999999999986 789999986532 23457889999998842 2344555442 347899999
Q ss_pred cCCCh
Q 046083 564 ENGNL 568 (790)
Q Consensus 564 ~~g~L 568 (790)
+++..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 87654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0038 Score=65.91 Aligned_cols=156 Identities=13% Similarity=0.151 Sum_probs=90.1
Q ss_pred cCHHHHHHHhcCccc-----ceeeeecCceEEEEEEECCceEEEEEeChh-hHHHHHHHHHHHHhcCCCC--CcceEEE-
Q 046083 480 FSYEELAKATNDFSM-----GNKIGQGGFGAVFYAELRGEKAAIKKMDMQ-ASKEFLAELKVLTHVHHLN--LVRLIGY- 550 (790)
Q Consensus 480 ~~~~~l~~~~~~f~~-----~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~-~~~~~~~E~~~l~~l~h~n--iv~l~g~- 550 (790)
++.+++......|.+ .+.|+.|....+|+....+..+++|..... ..+++..|..++..+.... +.+++..
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~ 86 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRK 86 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCC
Confidence 445555555555554 345667888899999887778999988762 3455667888887773212 2233211
Q ss_pred ------EecCeEEEEEEEecCCChhh--------------hhhcC----CCC---C---CCHHHHHHH------------
Q 046083 551 ------CVEGSLFLVYEYIENGNLNQ--------------HLRGS----GKD---T---LTWSARMQI------------ 588 (790)
Q Consensus 551 ------~~~~~~~lv~e~~~~g~L~~--------------~l~~~----~~~---~---l~~~~~~~i------------ 588 (790)
..++..+++|+|++|..+.. .++.. ... . ..|.....-
T Consensus 87 ~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l 166 (322)
T 2ppq_A 87 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL 166 (322)
T ss_dssp TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred CCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhh
Confidence 12456789999999865421 11211 100 0 123321110
Q ss_pred HHHHHHHHHHHHhC---C-CCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 589 ALDSARGLEYIHEH---T-VPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 589 ~~~ia~~L~~LH~~---~-~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
...+.+.+++++.. . -+.++|+|+.+.|||++++..+.|+||+.+..
T Consensus 167 ~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 167 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 01244455666532 1 13479999999999999876568999998763
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0015 Score=69.45 Aligned_cols=140 Identities=14% Similarity=0.107 Sum_probs=75.7
Q ss_pred eeeeecCceE-EEEEEEC-CceEEEEEeChhhHHHHHHHHHHHHhcCC--CCCcceEEEEecCeEEEEEEEecCCChhhh
Q 046083 496 NKIGQGGFGA-VFYAELR-GEKAAIKKMDMQASKEFLAELKVLTHVHH--LNLVRLIGYCVEGSLFLVYEYIENGNLNQH 571 (790)
Q Consensus 496 ~~lG~G~fg~-Vy~a~~~-g~~vavK~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~lv~e~~~~g~L~~~ 571 (790)
+.|+.|.... +|+.... +..+++|.......+++..|+.++..+.. -.+.+++.+..+.. +++||++.+..+.++
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g-~ll~e~l~~~~l~~~ 102 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEEHARG-LLLIEDLGDALFTEV 102 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT-EEEECCCCSCBHHHH
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeecCCCC-EEEEeeCCCcchHHH
Confidence 4455554444 6677764 67777877654322445567777777642 33556777654434 789999977666543
Q ss_pred hhcC---------------------C---CCCCCHHHHH-------H-------------HHHHHHHHHHHHH---hCCC
Q 046083 572 LRGS---------------------G---KDTLTWSARM-------Q-------------IALDSARGLEYIH---EHTV 604 (790)
Q Consensus 572 l~~~---------------------~---~~~l~~~~~~-------~-------------i~~~ia~~L~~LH---~~~~ 604 (790)
+... . ...++..... . ....+...+..|. ...-
T Consensus 103 l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~~ 182 (333)
T 3csv_A 103 INNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEGD 182 (333)
T ss_dssp HHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCSC
T ss_pred hcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccCC
Confidence 3211 0 0112111100 0 0001112222331 1223
Q ss_pred CceeecCCCCCCEEecCC----CcEEEEEeCCCccc
Q 046083 605 PVYIHRDIKPANILIDKN----FRAKVADFGLAKLT 636 (790)
Q Consensus 605 ~~~vH~dlkp~NILl~~~----~~~kl~DfGla~~~ 636 (790)
+.++|+|+.+.||+++.+ ..+.|+||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 458999999999999875 68999999998753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0027 Score=70.23 Aligned_cols=71 Identities=23% Similarity=0.284 Sum_probs=50.4
Q ss_pred ceeeeecCceEEEEEEEC---------CceEEEEEeChhhH-HHHHHHHHHHHhcCCCCC-cceEEEEecCeEEEEEEEe
Q 046083 495 GNKIGQGGFGAVFYAELR---------GEKAAIKKMDMQAS-KEFLAELKVLTHVHHLNL-VRLIGYCVEGSLFLVYEYI 563 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~---------g~~vavK~~~~~~~-~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~lv~e~~ 563 (790)
.+.|+.|....+|+.... +..+.+|+...... +.+..|..++..+...++ .++++.+.++ +||||+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~g---~v~e~l 154 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSGG---RLEEYI 154 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETTE---EEECCC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCCC---EEEEEe
Confidence 467888888999999875 36788998854222 566789999988853334 5667765443 899999
Q ss_pred cCCCh
Q 046083 564 ENGNL 568 (790)
Q Consensus 564 ~~g~L 568 (790)
+|.+|
T Consensus 155 ~G~~l 159 (429)
T 1nw1_A 155 PSRPL 159 (429)
T ss_dssp CEEEC
T ss_pred CCccc
Confidence 86444
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0049 Score=64.48 Aligned_cols=135 Identities=16% Similarity=0.094 Sum_probs=75.9
Q ss_pred ceeeeecCceEEEEEEECCceEEEEEeChhhH--HHHHHHHHHHHhcCCCCC-cceEEEEecCeEEEEEEEe-cCCChhh
Q 046083 495 GNKIGQGGFGAVFYAELRGEKAAIKKMDMQAS--KEFLAELKVLTHVHHLNL-VRLIGYCVEGSLFLVYEYI-ENGNLNQ 570 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~~--~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~lv~e~~-~~g~L~~ 570 (790)
.+.|+.|....+|+. +.+++|....... .+...|..+++.+....+ .++++++.+ .-++++||+ ++.+|..
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~-~~~~v~e~i~~g~~l~~ 97 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVDPA-TGVMVTRYIAGAQTMSP 97 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEECTT-TCCEEEECCTTCEECCH
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEECC-CCEEEEeecCCCccCCH
Confidence 578888999999998 6788888764321 123568888877743333 455655432 347899999 6544431
Q ss_pred ------------------hhhcCCC---CCCC-HHHHHHHHH--------------HHHHHHH----HHHh-CCCCceee
Q 046083 571 ------------------HLRGSGK---DTLT-WSARMQIAL--------------DSARGLE----YIHE-HTVPVYIH 609 (790)
Q Consensus 571 ------------------~l~~~~~---~~l~-~~~~~~i~~--------------~ia~~L~----~LH~-~~~~~~vH 609 (790)
-+|.... .... +....++.. .+.+.+. .|.. ..-+.++|
T Consensus 98 ~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l~H 177 (301)
T 3dxq_A 98 EKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAACH 177 (301)
T ss_dssp HHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEEEC
T ss_pred hhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCceeec
Confidence 0111110 0011 111111100 0111111 1111 12234799
Q ss_pred cCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 610 RDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 610 ~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
+|+.+.||+ ..++.+.|+||..+..
T Consensus 178 gDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 178 CDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp SCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred cCCCcCCEE-ECCCCEEEEecccccC
Confidence 999999999 5667789999998864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0073 Score=59.11 Aligned_cols=98 Identities=13% Similarity=0.172 Sum_probs=65.3
Q ss_pred ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcccccc
Q 046083 567 NLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR 646 (790)
Q Consensus 567 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 646 (790)
+|.+.|...+ .++++.++|.++.|.+.+|.-+-...-+ ..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 34 SL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 34 SLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred cHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc------------
Confidence 7889998765 4799999999999999998776221111 1223456889999999887664 1111
Q ss_pred cccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh
Q 046083 647 LVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682 (790)
Q Consensus 647 ~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt 682 (790)
.....+.+||... ...+.+.-|||+|+++|.-+-
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0122466888764 456789999999999999884
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.53 E-value=0.00083 Score=47.45 Aligned_cols=38 Identities=24% Similarity=0.219 Sum_probs=25.6
Q ss_pred ccccCCCcceEEehhhHHHHHHHHHHHHhhheeeeccc
Q 046083 393 VPVKGISSRAIAGISIGGVAGALFLAFCVYAGVYRRNK 430 (790)
Q Consensus 393 iP~~~~~~~~i~~i~i~~v~~~~~l~~~~~~~~~rr~~ 430 (790)
.|....+..+|++.+++++++++++++++|++++||+.
T Consensus 3 Cp~~~s~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 3 CPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp CCCCCSCSSSSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred CCCCCCCcceEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 34445677889988888888777777665555444443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.51 E-value=0.01 Score=64.13 Aligned_cols=138 Identities=15% Similarity=0.191 Sum_probs=83.1
Q ss_pred ceeeeecCceEEEEEEEC---------CceEEEEEeChh--hHHHHHHHHHHHHhcC-CCCCcceEEEEecCeEEEEEEE
Q 046083 495 GNKIGQGGFGAVFYAELR---------GEKAAIKKMDMQ--ASKEFLAELKVLTHVH-HLNLVRLIGYCVEGSLFLVYEY 562 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~---------g~~vavK~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~lv~e~ 562 (790)
.+.|..|-...+|+.... +..+.+|+.... ....+.+|.++++.+. +.-..++++++.++ +||||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g---~v~e~ 131 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG---RLEQY 131 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE---EEEEC
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc---cEEEE
Confidence 456766777889998864 367888886432 3456678999998884 33335667766553 89999
Q ss_pred ecCCChhhh-----------------hhcCC---CCCCC--HHHHHHHHHHHHH-------------------HHHHH--
Q 046083 563 IENGNLNQH-----------------LRGSG---KDTLT--WSARMQIALDSAR-------------------GLEYI-- 599 (790)
Q Consensus 563 ~~~g~L~~~-----------------l~~~~---~~~l~--~~~~~~i~~~ia~-------------------~L~~L-- 599 (790)
++|.+|..- ||... ..... |.++.++..++.. .+..|
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 998665421 11111 11222 4455544433321 22333
Q ss_pred --HhCCC-CceeecCCCCCCEEecCC----CcEEEEEeCCCcc
Q 046083 600 --HEHTV-PVYIHRDIKPANILIDKN----FRAKVADFGLAKL 635 (790)
Q Consensus 600 --H~~~~-~~~vH~dlkp~NILl~~~----~~~kl~DfGla~~ 635 (790)
..... ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 32222 358999999999999876 6899999998864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0085 Score=66.62 Aligned_cols=71 Identities=13% Similarity=0.049 Sum_probs=47.9
Q ss_pred ceeeeecCceEEEEEEECC--ceEEEEEeChhhH--HHHHHHHHHHHhcCCCCC-cceEEEEecCeEEEEEEEecCCCh
Q 046083 495 GNKIGQGGFGAVFYAELRG--EKAAIKKMDMQAS--KEFLAELKVLTHVHHLNL-VRLIGYCVEGSLFLVYEYIENGNL 568 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~g--~~vavK~~~~~~~--~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~lv~e~~~~g~L 568 (790)
.+.|+.|-...+|+....+ ..+++|+...... -+...|..++..+...++ .++++++.+ .+||||++|.+|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~---G~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFTN---GRIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEETT---EEEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC---eEEEEeeCCccC
Confidence 4678888889999998876 7888988753221 122578999998865555 466776633 249999987554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.13 E-value=0.057 Score=56.85 Aligned_cols=137 Identities=12% Similarity=0.153 Sum_probs=79.9
Q ss_pred eeeeecCceEEEEEEEC-CceEEEEEeChh--hHHHHHHHHHHHHhcCCC--CCcceEEE------EecCeEEEEEEEec
Q 046083 496 NKIGQGGFGAVFYAELR-GEKAAIKKMDMQ--ASKEFLAELKVLTHVHHL--NLVRLIGY------CVEGSLFLVYEYIE 564 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~--~~~~~~~E~~~l~~l~h~--niv~l~g~------~~~~~~~lv~e~~~ 564 (790)
..++ |....||+.... |+.+++|..... ..+.+..|..++..+... .+.+++.. ..++..+++|||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 4566 778899998775 568999998742 356677788888877421 23333332 12455688999998
Q ss_pred CCChhh-----------h---hhc----CC---CCCCCHHHH----HHHH---------------HHHHHHHHHHHhC--
Q 046083 565 NGNLNQ-----------H---LRG----SG---KDTLTWSAR----MQIA---------------LDSARGLEYIHEH-- 602 (790)
Q Consensus 565 ~g~L~~-----------~---l~~----~~---~~~l~~~~~----~~i~---------------~~ia~~L~~LH~~-- 602 (790)
|..+.. . +|. .. ....++... ..+. ..+.+.++.+...
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 854321 1 111 00 112233221 0010 0111123333221
Q ss_pred --CCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 603 --TVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 603 --~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
.-+.++|+|+++.|||++ + .+.|+||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 223479999999999999 4 899999998764
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=96.07 E-value=0.0013 Score=45.05 Aligned_cols=31 Identities=23% Similarity=0.277 Sum_probs=24.0
Q ss_pred CCCcceEEehhhHHHHHHHHHHHHhhheeee
Q 046083 397 GISSRAIAGISIGGVAGALFLAFCVYAGVYR 427 (790)
Q Consensus 397 ~~~~~~i~~i~i~~v~~~~~l~~~~~~~~~r 427 (790)
+++.++|+||++++++++++++.++|++++|
T Consensus 7 ~ls~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 7 GLTGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 5788999999999998887777666554444
|
| >3slu_A M23 peptidase domain protein; outer membrane, hydrolase; 2.41A {Neisseria meningitidis} | Back alignment and structure |
|---|
Probab=95.75 E-value=0.025 Score=60.55 Aligned_cols=112 Identities=7% Similarity=0.033 Sum_probs=70.4
Q ss_pred hhheeeecCCCCCHHHHHHHcCCChhhHhhcCCCC---CCcccccCCceEEeccccccC----------CCce--ee---
Q 046083 221 LALASYYLWKGANLTFISKVFDTSIKYILSFNPQI---TNKDKILAGTRINVPFSCNCI----------QNKF--LG--- 282 (790)
Q Consensus 221 ~~~~~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~---~~~~~l~~gq~l~ip~~~~~~----------~~~~--~~--- 282 (790)
..|..|+|++||||+.|-+++|++..++.+++... .+...|++||.|.+.....-. .+.. ..
T Consensus 12 ~~W~~~~V~~GDTL~~IL~r~Gls~~di~~i~~~~~~~~~l~~LrpGq~l~i~~~~~~~l~~l~~~~~~~~~~~~v~i~~ 91 (371)
T 3slu_A 12 AYWVQEAVQPGDSLADVLARSGMARDEIARITEKYGGEADLRHLRADQSVHVLVGGDGGAREVQFFTDEDGERNLVALEK 91 (371)
T ss_dssp CEEEEEECCTTCCHHHHHHHTTCCHHHHHHHHTTC------CCBCSSSEEEEEECTTSCEEEEEEEECCTTEEEEEEEEE
T ss_pred CceEEEEECCCCcHHHHHHHcCCCHHHHHHHHHhccccCchhhCCCCCEEEEEECCCCCeEEEEEEecCCCceeEEEEEe
Confidence 36889999999999999999999998888876322 144689999999997653210 0000 00
Q ss_pred eeEEEEe----------------ccCchHHHHHHHhhcccccHHHHHhcCC-----CCCCCCCCCCcEEEEeEee
Q 046083 283 HSFSYKV----------------KSGNTYKRIAELIYANLTTLDWLKSSNA-----YDENHTPDVSSSVNVIVNC 336 (790)
Q Consensus 283 ~~~~y~V----------------~~gDtl~~IA~~~~~~l~~~~~l~~~N~-----~~~~~~~~~Gq~l~ip~~~ 336 (790)
..-.|++ .=.++||..|.+. |+.. ..+++.+. ++=.+|.+ |+++.|....
T Consensus 92 ~dg~f~~~~~~~~~~~~~~~~~g~I~~Sl~~a~~~a--gl~~-~~~~~l~~i~~~~idf~~l~~-GD~f~v~~~~ 162 (371)
T 3slu_A 92 KGGIWRRSASEADMKVLPTLRSVVVKTSARGSLARA--EVPV-EIRESLSGIFAGRFSLDGLKE-GDAVRLIYDS 162 (371)
T ss_dssp ETTEEEECCCGGGEEEEEEEEEEECSSCHHHHHHHT--TCCH-HHHHHHHHHHTTTCCTTCCCT-TCEEEEEEEE
T ss_pred cCCeeEEEeeecccceeeeEEEEEEeccHHHHHHHc--CCCH-HHHHHHHHHHccCcCHHHcCC-CCEEEEEEEE
Confidence 0001322 2378999999543 4433 44443332 22235666 9999998753
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.70 E-value=0.0024 Score=44.99 Aligned_cols=34 Identities=21% Similarity=0.176 Sum_probs=23.4
Q ss_pred CCCcceEEehhhHHHHHHHHHHHHhhheeeeccc
Q 046083 397 GISSRAIAGISIGGVAGALFLAFCVYAGVYRRNK 430 (790)
Q Consensus 397 ~~~~~~i~~i~i~~v~~~~~l~~~~~~~~~rr~~ 430 (790)
+.+..+|++.+++++++++++++++|++++||++
T Consensus 6 ~s~~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 6 HARTPLIAAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp SCSSHHHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred CCCcceEEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 4567788888888888777777665555544443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.60 E-value=0.031 Score=60.11 Aligned_cols=71 Identities=14% Similarity=0.199 Sum_probs=44.2
Q ss_pred ceeeeecCceEEEEEEECC----------ceEEEEEeChhhH--HHHHHHHHHHHhcCCCC-CcceEEEEecCeEEEEEE
Q 046083 495 GNKIGQGGFGAVFYAELRG----------EKAAIKKMDMQAS--KEFLAELKVLTHVHHLN-LVRLIGYCVEGSLFLVYE 561 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~g----------~~vavK~~~~~~~--~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~lv~e 561 (790)
...|+.|..-.+|+....+ ..+++|....... .+...|.++++.+...+ ..++++.. ++ ++|||
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-~~--~~v~e 114 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-NG--GRIEE 114 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-TT--EEEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-CC--cEEEE
Confidence 4567778888999998764 6788888754221 12467888888875333 34666544 22 68999
Q ss_pred EecCCCh
Q 046083 562 YIENGNL 568 (790)
Q Consensus 562 ~~~~g~L 568 (790)
|++|.++
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987544
|
| >3slu_A M23 peptidase domain protein; outer membrane, hydrolase; 2.41A {Neisseria meningitidis} | Back alignment and structure |
|---|
Probab=95.49 E-value=0.061 Score=57.47 Aligned_cols=109 Identities=6% Similarity=0.017 Sum_probs=69.8
Q ss_pred hhhcccCCCCCHHHHHHHhCCCHHHHHhhCCCC---CCCCCcCCCCeEEeeeecccC----------CCCC--c---ccc
Q 046083 16 LASYYVWEGSNPTYISNIFGEDIAQILLYNPNI---PNQNTIPSDTRISIPFSCDCL----------NGDF--L---GHT 77 (790)
Q Consensus 16 ~~~y~v~~gdtl~~Ia~~~~~~~~~l~~~Np~~---~~~~~~~~g~~l~ip~~~~~~----------~~~~--~---~~~ 77 (790)
-..|+|++||||..|-+++|++..++.+.+... .+...|.+||.|.+.....-. .... . ...
T Consensus 14 W~~~~V~~GDTL~~IL~r~Gls~~di~~i~~~~~~~~~l~~LrpGq~l~i~~~~~~~l~~l~~~~~~~~~~~~v~i~~~d 93 (371)
T 3slu_A 14 WVQEAVQPGDSLADVLARSGMARDEIARITEKYGGEADLRHLRADQSVHVLVGGDGGAREVQFFTDEDGERNLVALEKKG 93 (371)
T ss_dssp EEEEECCTTCCHHHHHHHTTCCHHHHHHHHTTC------CCBCSSSEEEEEECTTSCEEEEEEEECCTTEEEEEEEEEET
T ss_pred eEEEEECCCCcHHHHHHHcCCCHHHHHHHHHhccccCchhhCCCCCEEEEEECCCCCeEEEEEEecCCCceeEEEEEecC
Confidence 346999999999999999999998887776333 256789999999998753210 0000 0 000
Q ss_pred eeEEec----------------cCCchHHHHhhhcCCCChHHHHHHcc-----CCCCCCCCCCcEEEEEee
Q 046083 78 FTYETQ----------------FGDTYEKVASFAFANLTTEDWVRRVN-----IYEPTRIPDYAFINVTVN 127 (790)
Q Consensus 78 ~~Y~V~----------------~GDTl~~IA~~~~~~~~t~~~l~~~N-----~~~~~~l~~Gq~l~iP~~ 127 (790)
..|+++ =.++||..| .+.+. +...+++.+ .+|-..|++|+++.|...
T Consensus 94 g~f~~~~~~~~~~~~~~~~~g~I~~Sl~~a~-~~agl--~~~~~~~l~~i~~~~idf~~l~~GD~f~v~~~ 161 (371)
T 3slu_A 94 GIWRRSASEADMKVLPTLRSVVVKTSARGSL-ARAEV--PVEIRESLSGIFAGRFSLDGLKEGDAVRLIYD 161 (371)
T ss_dssp TEEEECCCGGGEEEEEEEEEEECSSCHHHHH-HHTTC--CHHHHHHHHHHHTTTCCTTCCCTTCEEEEEEE
T ss_pred CeeEEEeeecccceeeeEEEEEEeccHHHHH-HHcCC--CHHHHHHHHHHHccCcCHHHcCCCCEEEEEEE
Confidence 123222 278999999 56644 444443332 233346999999999863
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.30 E-value=0.058 Score=57.32 Aligned_cols=32 Identities=25% Similarity=0.369 Sum_probs=27.8
Q ss_pred CceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 605 PVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 605 ~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
..++|+|+.+.||++++++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 35799999999999998888999999887643
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=94.22 E-value=0.0094 Score=41.86 Aligned_cols=30 Identities=17% Similarity=0.161 Sum_probs=16.1
Q ss_pred CCcceEEehhhHHHHHHHHHHHHhhheeeec
Q 046083 398 ISSRAIAGISIGGVAGALFLAFCVYAGVYRR 428 (790)
Q Consensus 398 ~~~~~i~~i~i~~v~~~~~l~~~~~~~~~rr 428 (790)
.....|+++++| +++++++++.++++.+||
T Consensus 9 ~~~~~Ia~~vVG-vll~vi~~l~~~~~~RRR 38 (44)
T 2jwa_A 9 SPLTSIISAVVG-ILLVVVLGVVFGILIKRR 38 (44)
T ss_dssp CSHHHHHHHHHH-HHHHHHHHHHHHHHHHHH
T ss_pred CcccchHHHHHH-HHHHHHHHHHHHhheehh
Confidence 444568888888 444444444433333333
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=91.97 E-value=0.56 Score=51.23 Aligned_cols=137 Identities=15% Similarity=0.221 Sum_probs=82.9
Q ss_pred ceeeeecCceEEEEEEEC---------CceEEEEEeChhh--HHHHHHHHHHHHhcCCCC-CcceEEEEecCeEEEEEEE
Q 046083 495 GNKIGQGGFGAVFYAELR---------GEKAAIKKMDMQA--SKEFLAELKVLTHVHHLN-LVRLIGYCVEGSLFLVYEY 562 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~---------g~~vavK~~~~~~--~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~lv~e~ 562 (790)
.+.+..|-...+|+.... +..+++|+..... .-+..+|.++++.+...+ ..++++.+ .+ ++||||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-~~--~~I~ef 151 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF-PE--GRIEEF 151 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-TT--EEEEEC
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc-CC--CEEEEE
Confidence 456766778899999876 5788888865422 122457888888874333 44556533 22 689999
Q ss_pred ecCCChhh--------------h---hhc--------C---CCCCCCHHHHHHHHHHH-------------------HHH
Q 046083 563 IENGNLNQ--------------H---LRG--------S---GKDTLTWSARMQIALDS-------------------ARG 595 (790)
Q Consensus 563 ~~~g~L~~--------------~---l~~--------~---~~~~l~~~~~~~i~~~i-------------------a~~ 595 (790)
++|..|.. . ||. . .+.+.-|.++.++..++ ...
T Consensus 152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e 231 (424)
T 3mes_A 152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE 231 (424)
T ss_dssp CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence 99866431 0 110 0 11112244443333221 222
Q ss_pred HHHHHhC--------------------C-CCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 596 LEYIHEH--------------------T-VPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 596 L~~LH~~--------------------~-~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
+.+|.+. . -..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 3333311 1 124799999999999 7888999999999864
|
| >2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B | Back alignment and structure |
|---|
Probab=88.73 E-value=0.13 Score=33.83 Aligned_cols=28 Identities=29% Similarity=0.506 Sum_probs=22.6
Q ss_pred CCCcceEEehhhHHHHHHHHHHHHhhhe
Q 046083 397 GISSRAIAGISIGGVAGALFLAFCVYAG 424 (790)
Q Consensus 397 ~~~~~~i~~i~i~~v~~~~~l~~~~~~~ 424 (790)
+++.++|+||+++.+++.+++++.+|++
T Consensus 3 ~L~~gaIaGIVvgdi~~t~~i~~~vy~~ 30 (33)
T 2l34_A 3 TVSPGVLAGIVVGDLVLTVLIALAVYFL 30 (33)
T ss_dssp CCCTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccCcceEEeEeHHHHHHHHHHHHHHhhe
Confidence 3578899999999998888888776654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=86.58 E-value=1.8 Score=46.84 Aligned_cols=30 Identities=27% Similarity=0.517 Sum_probs=25.4
Q ss_pred ceeecCCCCCCEEe------cCCCcEEEEEeCCCcc
Q 046083 606 VYIHRDIKPANILI------DKNFRAKVADFGLAKL 635 (790)
Q Consensus 606 ~~vH~dlkp~NILl------~~~~~~kl~DfGla~~ 635 (790)
.++|+|+.+.|||+ +++..+.++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36899999999999 4566799999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.67 E-value=3.2 Score=40.40 Aligned_cols=116 Identities=11% Similarity=0.139 Sum_probs=76.8
Q ss_pred CCCCCcceEEEEe-cCeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEE
Q 046083 540 HHLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANIL 618 (790)
Q Consensus 540 ~h~niv~l~g~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NIL 618 (790)
.||++++. .+.. ++.+.+.|+.-+.+.=+..++ .++...+++++..++....+++.. +|--|.|+|++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-----~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-----SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-----GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-----hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEE
Confidence 68888876 3443 344555555443222122233 378899999999999877555433 78899999999
Q ss_pred ecCCCcEEEEEeCCCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccc
Q 046083 619 IDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVK 689 (790)
Q Consensus 619 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~ 689 (790)
++.++.+++.-.|+...+. |. ..+...=.-.+=+++..+++++..|..
T Consensus 112 f~~~~~p~i~~RGik~~l~------------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNVVD------------------PL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp ECTTSCEEESCCEETTTBS------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EcCCCCEEEEEccCccCCC------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 9999999998777643321 21 122233344788899999999888754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 790 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-72 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-70 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-68 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-66 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-66 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-63 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-59 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-56 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-50 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-48 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-43 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-39 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-20 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (599), Expect = 4e-72
Identities = 75/288 (26%), Positives = 129/288 (44%), Gaps = 31/288 (10%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNL 544
++G +IG G FG V+ + G+ A+K +++ Q + F E+ VL H+N+
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 545 VRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTV 604
+ +GY L +V ++ E +L HL + IA +A+G++Y+H ++
Sbjct: 67 LLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 605 PVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQY-- 661
IHRD+K NI + ++ K+ DFGLA + S S +L G+ +M PE +
Sbjct: 126 ---IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 662 -GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720
S + DVYAFG+VLYEL+ T + + ++ + DL
Sbjct: 183 KNPYSFQSDVYAFGIVLYELM--------TGQLPYSNINNRDQIIFMVGRGYLSPDL--- 231
Query: 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768
+ + M RL C ++ RP I+ ++ L+ S
Sbjct: 232 ------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (584), Expect = 5e-70
Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 27/284 (9%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDM--QASKEFLAELKVLTHVHHLNLVR 546
+ ++G G FG V+ K A+K + + FLAE ++ + H LVR
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 547 LIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPV 606
L + ++++ EY+ENG+L L+ LT + + +A A G+ +I E
Sbjct: 73 LYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY-- 130
Query: 607 YIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSP 666
IHRD++ ANIL+ K+ADFGLA+L E + + PE YG +
Sbjct: 131 -IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 667 KIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLG 726
K DV++FG++L E+++ + + P+ ++L+R
Sbjct: 190 KSDVWSFGILLTEIVTHGR-----------------IPYPGMTNPEVIQNLERGYRMVRP 232
Query: 727 DDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770
D+ P ++ +L R C +E P+ RP+ + L +++E
Sbjct: 233 DNCP----EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 2e-68
Identities = 78/276 (28%), Positives = 127/276 (46%), Gaps = 31/276 (11%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQAS-KEFLAELKVLTHVHHLNLVRLI 548
+ + IG+G FG V + RG K A+K + A+ + FLAE V+T + H NLV+L+
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLL 66
Query: 549 GYCVE--GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPV 606
G VE G L++V EY+ G+L +LR G+ L ++ +LD +EY+ +
Sbjct: 67 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF-- 124
Query: 607 YIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSP 666
+HRD+ N+L+ ++ AKV+DFGL K S + PE + + S
Sbjct: 125 -VHRDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEALREKKFST 179
Query: 667 KIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLG 726
K DV++FG++L+E+ S F V P +D+ V+
Sbjct: 180 KSDVWSFGILLWEIYS---------------------FGRVPYPRIPLKDVVPRVEKGYK 218
Query: 727 DDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762
D P + + + C + +RPS + L
Sbjct: 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 1e-66
Identities = 76/302 (25%), Positives = 134/302 (44%), Gaps = 27/302 (8%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFL--AELKVLTHVHHLNLVRL 547
+ IG+G FG V+ + RGE+ A+K + + + AE+ + H N++
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGF 62
Query: 548 IGYCVEGS-----LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH 602
I + + L+LV +Y E+G+L +L + T+T +++AL +A GL ++H
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHME 119
Query: 603 TV-----PVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH---TRLVGTFGYM 654
V P HRD+K NIL+ KN +AD GLA + + ++ VGT YM
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 655 PPEY------AQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVL 708
PE ++ E + D+YA G+V +E+ + LV +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV--PSDPS 237
Query: 709 RQPDPREDLQRLVDPRLGDDY-PIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767
+ + ++ + P + + + +++R MA++ R C N R + I L LS
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
Query: 768 SS 769
Sbjct: 298 QE 299
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 6e-66
Identities = 78/307 (25%), Positives = 126/307 (41%), Gaps = 35/307 (11%)
Query: 467 PGVTGITVDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKM--DM 523
P G+ D E E + K+GQG FG V+ + AIK +
Sbjct: 2 PQTQGLAKDAW-EIPRE-------SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT 53
Query: 524 QASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWS 583
+ + FL E +V+ + H LV+L E +++V EY+ G+L L+G L
Sbjct: 54 MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLP 113
Query: 584 ARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643
+ +A A G+ Y+ +HRD++ ANIL+ +N KVADFGLA+L E +
Sbjct: 114 QLVDMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170
Query: 644 HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVAL 703
+ PE A YG + K DV++FG++L EL T
Sbjct: 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT----------------TKGRVP 214
Query: 704 FEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763
+ ++ V+ P + + L C ++ P+ RP+ + L
Sbjct: 215 YPG-----MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
Query: 764 TLSSSSE 770
+S+E
Sbjct: 270 DYFTSTE 276
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 216 bits (552), Expect = 3e-65
Identities = 78/295 (26%), Positives = 131/295 (44%), Gaps = 29/295 (9%)
Query: 481 SYEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS--KEFLAELKVL 536
+Y++ D +M +K+G G +G V+ + A+K + +EFL E V+
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 67
Query: 537 THVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARG 595
+ H NLV+L+G C +++ E++ GNL +LR + ++ + +A +
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 127
Query: 596 LEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMP 655
+EY+ + IHRD+ N L+ +N KVADFGL++L + + H +
Sbjct: 128 MEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184
Query: 656 PEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715
PE Y + S K DV+AFGV+L+E+ T ++ +
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIA----------------TYGMSPYPG-----IDLS 223
Query: 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770
+ L++ + P K+ L RAC Q NP RPS I A T+ S
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 2e-63
Identities = 63/299 (21%), Positives = 118/299 (39%), Gaps = 35/299 (11%)
Query: 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS----KEFLAELKVLTHVHH 541
+DF +++G G G VF + G A K + ++ + + EL+VL +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 542 LNLVRLIGYCVE-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH 600
+V G G + + E+++ G+L+Q L+ +G+ + ++++ +GL Y+
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLR 121
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQ 660
E +HRD+KP+NIL++ K+ DFG++ S+ VGT YM PE Q
Sbjct: 122 EK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQ 176
Query: 661 YGEVSPKIDVYAFGVVLYELIS-----------------AMEAVVKTNETITESTGLVAL 703
S + D+++ G+ L E+ + ET
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 704 FEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMAR----LARACTQENPQLRPSMRAI 758
P + L+D + + P + C +NP R ++ +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 3e-63
Identities = 65/278 (23%), Positives = 117/278 (42%), Gaps = 29/278 (10%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKM--DMQASKEFLAELKVLTHVHHLNLVR 546
D + ++G G FG V Y + R AIK + + EF+ E KV+ ++ H LV+
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 547 LIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVP 605
L G C + +F++ EY+ NG L +LR +++ D +EY+
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQF- 121
Query: 606 VYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVS 665
+HRD+ N L++ KV+DFGL++ + + PPE Y + S
Sbjct: 122 --LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 666 PKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725
K D++AFGV+++E+ S + +E + + L
Sbjct: 180 SKSDIWAFGVLMWEIYSLGK----------------MPYER-----FTNSETAEHIAQGL 218
Query: 726 GDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763
P + K+ + +C E RP+ + ++ ++
Sbjct: 219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 5e-63
Identities = 72/283 (25%), Positives = 130/283 (45%), Gaps = 29/283 (10%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKM--DMQASKEFLAELKVLTHVHHLNLVR 546
++ + +IG G FG V +K AIK + + ++F+ E +V+ + H LV+
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 547 LIGYCVE-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVP 605
L G C+E + LV+E++E+G L+ +LR + + + + LD G+ Y+ E V
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEACV- 122
Query: 606 VYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVS 665
IHRD+ N L+ +N KV+DFG+ + + T + PE + S
Sbjct: 123 --IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 666 PKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725
K DV++FGV+++E+ S + E+ + E++ RL PRL
Sbjct: 181 SKSDVWSFGVLMWEVFS-------EGKIPYENRSNSEVVEDISTGF-------RLYKPRL 226
Query: 726 GDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768
+ ++ C +E P+ RP+ ++ L ++ S
Sbjct: 227 AST-------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 210 bits (536), Expect = 1e-62
Identities = 68/309 (22%), Positives = 132/309 (42%), Gaps = 48/309 (15%)
Query: 480 FSYEELAKATNDFS---------MGNKIGQGGFGAVFYAELR-----GEKAAIKKMDMQA 525
F++E+ +A +F+ + IG G FG V L+ AIK +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 526 S----KEFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTL 580
+ ++FL+E ++ H N++ L G + + + ++ E++ENG+L+ LR +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 581 TWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640
T + + A G++Y+ + +HRD+ NIL++ N KV+DFGL++ E +
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 641 ASVHTR----LVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITE 696
+ + PE QY + + DV+++G+V++E++S
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS-------------- 228
Query: 697 STGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMR 756
+ E +D+ ++ P+D + +L C Q++ RP
Sbjct: 229 -------YGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281
Query: 757 AIVVALMTL 765
IV L +
Sbjct: 282 QIVNTLDKM 290
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 2e-61
Identities = 60/303 (19%), Positives = 125/303 (41%), Gaps = 40/303 (13%)
Query: 483 EELAKATNDFSMGN-KIGQGGFGAVFYAELR----GEKAAIKKMDMQAS----KEFLAEL 533
++L ++ + + ++G G FG+V R AIK + +E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 534 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSA 593
+++ + + +VRLIG C +L LV E G L++ L G ++ + S ++ +
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVS 119
Query: 594 RGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR--LVGTF 651
G++Y+ E +HRD+ N+L+ AK++DFGL+K + R
Sbjct: 120 MGMKYLEEKNF---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 652 GYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQP 711
+ PE + + S + DV+++GV ++E +S + +++
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ----------------KPYKK----- 215
Query: 712 DPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL----MTLSS 767
++ ++ + P + ++ L C + RP + + +L+S
Sbjct: 216 MKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275
Query: 768 SSE 770
E
Sbjct: 276 KVE 278
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 3e-60
Identities = 64/278 (23%), Positives = 116/278 (41%), Gaps = 37/278 (13%)
Query: 496 NKIGQGGFGAVFYAELR----GEKAAIKKMDMQAS-----KEFLAELKVLTHVHHLNLVR 546
++G G FG V + + A+K + +A+ E LAE V+ + + +VR
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 547 LIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPV 606
+IG C S LV E E G LN++L+ + + +++ + G++Y+ E
Sbjct: 73 MIGICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNF-- 128
Query: 607 YIHRDIKPANILIDKNFRAKVADFGLAKL--TEVGSASVHTRLVGTFGYMPPEYAQYGEV 664
+HRD+ N+L+ AK++DFGL+K + T + PE Y +
Sbjct: 129 -VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 665 SPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724
S K DV++FGV+++E S + + ++ +++
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQ----------------KPYRG-----MKGSEVTAMLEKG 226
Query: 725 LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762
P R+M L C + + RP A+ + L
Sbjct: 227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 203 bits (517), Expect = 4e-60
Identities = 75/317 (23%), Positives = 125/317 (39%), Gaps = 59/317 (18%)
Query: 481 SYEELAKATNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDMQAS----KEF 529
L N+ IG+G FG VF A A+K + +AS +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 530 LAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDT--------- 579
E ++ + N+V+L+G C G + L++EY+ G+LN+ LR T
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 580 -------------LTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAK 626
L+ + ++ IA A G+ Y+ E +HRD+ N L+ +N K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVK 180
Query: 627 VADFGLAK-LTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAME 685
+ADFGL++ + +MPPE Y + + DV+A+GVVL+E+
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF---- 236
Query: 686 AVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACT 745
+ + + E + + D + P + ++ L R C
Sbjct: 237 ------------SYGLQPYYG----MAHEEVIYYVRDGNI-LACPENCPLELYNLMRLCW 279
Query: 746 QENPQLRPSMRAIVVAL 762
+ P RPS +I L
Sbjct: 280 SKLPADRPSFCSIHRIL 296
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 2e-59
Identities = 66/308 (21%), Positives = 126/308 (40%), Gaps = 58/308 (18%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRG-------EKAAIKKMDMQAS----KEFLAELKVLTH 538
+ G +G G FG V A G + A+K + +A + ++ELK++T
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 539 V-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLNQHLRGSGK------------------- 577
+ H N+V L+G C G ++L++EY G+L +LR +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 578 --DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK- 634
+ LT+ + A A+G+E++ + +HRD+ N+L+ K+ DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSC---VHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 635 LTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETI 694
+ + V +M PE G + K DV+++G++L+E+ S
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV--------- 264
Query: 695 TESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPS 754
+ + + +L+ D P + ++ + ++C + + RPS
Sbjct: 265 -------NPYPGI----PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS 313
Query: 755 MRAIVVAL 762
+ L
Sbjct: 314 FPNLTSFL 321
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 3e-59
Identities = 70/279 (25%), Positives = 115/279 (41%), Gaps = 40/279 (14%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKM------DMQASKEFLAELKVLTHVHH 541
DF +G +G+G FG V+ A + A+K + + E+++ +H+ H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 542 LNLVRLIGYCVE-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH 600
N++RL GY + ++L+ EY G + + L+ K + A L Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 123
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQ 660
V IHRDIKP N+L+ K+ADFG + +S T L GT Y+PPE +
Sbjct: 124 SKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIE 177
Query: 661 YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720
K+D+++ GV+ YE + + E+ ++ + R D
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFL--------VGKPPFEANTYQETYKRISRVEFTFPD---F 226
Query: 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIV 759
V D L + NP RP +R ++
Sbjct: 227 VTEGARD------------LISRLLKHNPSQRPMLREVL 253
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 4e-59
Identities = 93/323 (28%), Positives = 147/323 (45%), Gaps = 53/323 (16%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGE----KAAIKKMDMQAS----KEFLAELKVLTHV-H 540
ND + IG+G FG V A ++ + AAIK+M AS ++F EL+VL + H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 541 HLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRG--------------SGKDTLTWSAR 585
H N++ L+G C G L+L EY +GNL LR S TL+
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 586 MQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645
+ A D ARG++Y+ + IHRD+ NIL+ +N+ AK+ADFGL++ EV T
Sbjct: 130 LHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFE 705
+M E Y + DV+++GV+L+E++S T L+E
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG-------GTPYCGMTCAELYE 237
Query: 706 EVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765
++ + + P++ ++ L R C +E P RPS I+V+L +
Sbjct: 238 KLPQGYRL--------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
Query: 766 SSSSEDWDIGSFYE---NQGLDS 785
+ + + YE G+D
Sbjct: 284 LEERKTYVNTTLYEKFTYAGIDC 306
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 2e-58
Identities = 62/283 (21%), Positives = 110/283 (38%), Gaps = 37/283 (13%)
Query: 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE-----FLAELKVLTHVHHLN 543
D+ + IG G +G + G+ K++D + E ++E+ +L + H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 544 LVRLIGYCVE---GSLFLVYEYIENGNLNQHLRGSGKD--TLTWSARMQIALDSARGLEY 598
+VR ++ +L++V EY E G+L + K+ L +++ L+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 599 IHEHTVPV--YIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPP 656
H + +HRD+KPAN+ +D K+ DFGLA++ + S VGT YM P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKAFVGTPYYMSP 183
Query: 657 EYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716
E + K D+++ G +LYEL + L ++ R
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELC--------ALMPPFTAFSQKELAGKIREGKFRR-- 233
Query: 717 LQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIV 759
P ++ + RPS+ I+
Sbjct: 234 ------------IPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 2e-58
Identities = 67/312 (21%), Positives = 116/312 (37%), Gaps = 53/312 (16%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDMQAS----KEFLAELKVLTH 538
N S G +G G FG V A A+K + A + ++ELKVL++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 539 V-HHLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKD----------------TL 580
+ +H+N+V L+G C G ++ EY G+L LR L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 581 TWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK-LTEVG 639
+ + A+G+ ++ IHRD+ NIL+ K+ DFGLA+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 640 SASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTG 699
+ V +M PE + + DV+++G+ L+EL S +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-------- 251
Query: 700 LVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIV 759
+++ P + +M + + C +P RP+ + IV
Sbjct: 252 ------------PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
Query: 760 VALMTLSSSSED 771
+ S S +
Sbjct: 300 QLIEKQISESTN 311
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 2e-58
Identities = 58/293 (19%), Positives = 117/293 (39%), Gaps = 36/293 (12%)
Query: 491 DFSMGNKIGQGGFGAVFYAELRGE------KAAIKKM----DMQASKEFLAELKVLTHVH 540
+F +G G FG V+ E AIK++ +A+KE L E V+ V
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 541 HLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH 600
+ ++ RL+G C+ ++ L+ + + G L + KD + + + A+G+ Y+
Sbjct: 70 NPHVCRLLGICLTSTVQLITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT-RLVGTFGYMPPEYA 659
+ + +HRD+ N+L+ K+ DFGLAKL H +M E
Sbjct: 129 DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 660 QYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719
+ + + DV+++GV ++EL+ T ++ P ++
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELM----------------TFGSKPYDG-----IPASEISS 224
Query: 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDW 772
+++ P + + C + RP R +++ ++ + +
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 277
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-58
Identities = 62/295 (21%), Positives = 116/295 (39%), Gaps = 38/295 (12%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELRGEKA------AIKKMDMQAS----KEFLAELKVLTHV 539
+ + IG G FG V+ L+ AIK + + +FL E ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 540 HHLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEY 598
H N++RL G + + ++ EY+ENG + + + A G++Y
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENG-ALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 599 IHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTR--LVGTFGYMPP 656
+ HRD+ NIL++ N KV+DFGL+++ E + +T + P
Sbjct: 126 LANMNYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 657 EYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716
E Y + + DV++FG+V++E+++ + E +
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMT---------------------YGERPYWELSNHE 221
Query: 717 LQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSED 771
+ + ++ P+D + +L C Q+ RP IV L L + +
Sbjct: 222 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 4e-58
Identities = 60/291 (20%), Positives = 117/291 (40%), Gaps = 39/291 (13%)
Query: 482 YEELAKATN---DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE---FLAEL 533
YE + + N + + ++G G FG V+ A+ + AA K +D ++ +E ++ E+
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 534 KVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDS 592
+L H N+V+L+ E +L+++ E+ G ++ + + LT S + +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQT 119
Query: 593 ARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFG 652
L Y+H++ + IHRD+K NIL + K+ADFG++ + +GT
Sbjct: 120 LDALNYLHDNKI---IHRDLKAGNILFTLDGDIKLADFGVSAKNT-RTIQRRDSFIGTPY 175
Query: 653 YMPPEYAQY-----GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEV 707
+M PE K DV++ G+ L E+ E + + ++
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA--------EIEPPHHELNPMRVLLKI 227
Query: 708 LRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
+ P D + C ++N R + +
Sbjct: 228 AKSEPPTLAQPSRWSSNFKD------------FLKKCLEKNVDARWTTSQL 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-57
Identities = 59/278 (21%), Positives = 108/278 (38%), Gaps = 34/278 (12%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHVHHLN 543
D+ + +G+G +G V A R E A+K +DM + E+ + ++H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 544 LVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH 602
+V+ G+ +L EY G L + + + G+ Y+H
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI 122
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQY 661
+ HRDIKP N+L+D+ K++DFGLA + + + ++ GT Y+ PE +
Sbjct: 123 GI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 662 GEV-SPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720
E + +DV++ G+VL ++ E + ++ + +
Sbjct: 180 REFHAEPVDVWSCGIVLTAML--------AGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 231
Query: 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
+D L ENP R ++ I
Sbjct: 232 IDSAPLA------------LLHKILVENPSARITIPDI 257
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-57
Identities = 59/278 (21%), Positives = 109/278 (39%), Gaps = 40/278 (14%)
Query: 495 GNKIGQGGFGAVFYAELR--GEKAAIKKM-----DMQASKEFLAELKVLTHVHHLNLVRL 547
+IG+G F V+ + A ++ + F E ++L + H N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 548 IGYCV-----EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH 602
+ + LV E + +G L +L+ + +GL+++H
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTR 131
Query: 603 TVPVYIHRDIKPANILI-DKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQY 661
T P+ IHRD+K NI I K+ D GLA L AS ++GT +M PE +
Sbjct: 132 TPPI-IHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMYE- 186
Query: 662 GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721
+ +DVYAFG+ + E+ T E + + +R+
Sbjct: 187 EKYDESVDVYAFGMCMLEMA----------------TSEYPYSEC----QNAAQIYRRVT 226
Query: 722 DPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIV 759
+ ++ ++ + C ++N R S++ ++
Sbjct: 227 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-56
Identities = 57/287 (19%), Positives = 104/287 (36%), Gaps = 37/287 (12%)
Query: 490 NDFSMGNKIGQGGFGAVFYAEL-----RGEKAAIKKM------DMQASKEFLAELKVLTH 538
D + K+G G FG V E + A+K + +A +F+ E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 539 VHHLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEY 598
+ H NL+RL G + + +V E G+L + + A+ A G+ Y
Sbjct: 68 LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 599 IHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS--VHTRLVGTFGYMPP 656
+ IHRD+ N+L+ K+ DFGL + + F + P
Sbjct: 127 LESKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 657 EYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716
E + S D + FGV L+E+ + + + + + +
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQ----------------EPWIGL----NGSQI 223
Query: 717 LQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763
L ++ P D + + + C P+ RP+ A+ L+
Sbjct: 224 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 193 bits (492), Expect = 2e-56
Identities = 66/280 (23%), Positives = 110/280 (39%), Gaps = 43/280 (15%)
Query: 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHVHHLN 543
FS +IG G FGAV++A E AIKKM + ++ + E++ L + H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 544 LVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH 602
++ G + E + +LV EY + L + + +GL Y+H H
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSH 134
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQ-- 660
+ IHRD+K NIL+ + K+ DFG A + VGT +M PE
Sbjct: 135 NM---IHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWMAPEVILAM 186
Query: 661 -YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719
G+ K+DV++ G+ EL + + ++ + + P
Sbjct: 187 DEGQYDGKVDVWSLGITCIELA--------ERKPPLFNMNAMSALYHIAQNESP-----A 233
Query: 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIV 759
L + +C Q+ PQ RP+ ++
Sbjct: 234 LQSGHWSEY--------FRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 3e-56
Identities = 70/288 (24%), Positives = 125/288 (43%), Gaps = 39/288 (13%)
Query: 495 GNKIGQGGFGAVFYAEL-----RGEKAAIKKM----DMQASKEFLAELKVLTHVHHLNLV 545
IG+G FG V++ L + A+K + D+ +FL E ++ H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 546 RLIGYCV--EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT 603
L+G C+ EGS +V Y+++G+L +R + T + L A+G++++
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKFLASKK 150
Query: 604 VPVYIHRDIKPANILIDKNFRAKVADFGLAKL---TEVGSASVHTRLVGTFGYMPPEYAQ 660
+HRD+ N ++D+ F KVADFGLA+ E S T +M E Q
Sbjct: 151 F---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 661 YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720
+ + K DV++FGV+L+EL++ + +L+ +RL
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTR-------GAPPYPDVNTFDITVYLLQG-------RRL 253
Query: 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768
+ P D + + C ++RPS +V + + S+
Sbjct: 254 LQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 8e-56
Identities = 58/285 (20%), Positives = 102/285 (35%), Gaps = 34/285 (11%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR-----GEKAAIKKMDMQAS----KEFLAELKVLTHVH 540
+G IG+G FG V AIK S ++FL E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 541 HLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH 600
H ++V+LIG E ++++ E G L + K +L ++ + A + L Y+
Sbjct: 67 HPHIVKLIGVITENPVWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQ 660
+HRDI N+L+ N K+ DFGL++ E + ++ +M PE
Sbjct: 126 SKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 661 YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720
+ + DV+ FGV ++E++ + + +
Sbjct: 183 FRRFTSASDVWMFGVCMWEILM-------HGVKPFQGVKNNDVIGRIENGERL------- 228
Query: 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765
P + + L C +P RP + L T+
Sbjct: 229 -------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 4e-53
Identities = 59/276 (21%), Positives = 107/276 (38%), Gaps = 33/276 (11%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKM---DMQASKEFLAELKVLTHVHHLN 543
++ KIGQG G V+ A G++ AI++M + + E+ V+ + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 544 LVRLIGYCVE-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH 602
+V + + L++V EY+ G+L + + D + + + LE++H +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALEFLHSN 135
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYG 662
V IHRDIK NIL+ + K+ DFG S + +VGT +M PE
Sbjct: 136 QV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTRK 191
Query: 663 EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD 722
PK+D+++ G++ E+I E + + + P +
Sbjct: 192 AYGPKVDIWSLGIMAIEMI--------EGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243
Query: 723 PRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
D C + + R S + +
Sbjct: 244 AIFRD------------FLNRCLDMDVEKRGSAKEL 267
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-52
Identities = 69/294 (23%), Positives = 129/294 (43%), Gaps = 45/294 (15%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDMQAS----KEFLAELKVLTH 538
+M ++GQG FG V+ + + AIK ++ AS EFL E V+
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 539 VHHLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKD--------TLTWSARMQIA 589
+ ++VRL+G ++ E + G+L +LR + S +Q+A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 590 LDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK-LTEVGSASVHTRLV 648
+ A G+ Y++ + +HRD+ N ++ ++F K+ DFG+ + + E + +
Sbjct: 140 GEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 649 GTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVL 708
+M PE + G + DV++FGVVL+E+ T ++ +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA----------------TLAEQPYQGL- 239
Query: 709 RQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762
+ L+ +++ L D P + + L R C Q NP++RPS I+ ++
Sbjct: 240 ---SNEQVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 5e-52
Identities = 72/311 (23%), Positives = 132/311 (42%), Gaps = 57/311 (18%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR---------GEKAAIKKMDMQAS----KEFLAELKVL 536
+ +G +G+G FG V AE K A+K + A+ + ++E++++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 537 THV-HHLNLVRLIGYCVEGS-LFLVYEYIENGNLNQHLRGSG--------------KDTL 580
+ H N++ L+G C + L+++ EY GNL ++L+ ++ L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 581 TWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640
+ + A ARG+EY+ IHRD+ N+L+ ++ K+ADFGLA+
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 641 ASVHTRLV-GTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTG 699
T +M PE + + DV++FGV+L+E+ T
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF----------------TL 233
Query: 700 LVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIV 759
+ + P E+L +L+ D P + ++ + R C P RP+ + +V
Sbjct: 234 GGSPYPG-----VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
Query: 760 VAL---MTLSS 767
L + L+S
Sbjct: 289 EDLDRIVALTS 299
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 2e-51
Identities = 73/305 (23%), Positives = 125/305 (40%), Gaps = 52/305 (17%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDMQAS----KEFLAELKVLTH 538
+ +G +G+G FG V A+ A+K + A+ + ++ELK+L H
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 539 -VHHLNLVRLIGYCVE--GSLFLVYEYIENGNLNQHLRGSG--------------KDTLT 581
HHLN+V L+G C + G L ++ E+ + GNL+ +LR KD LT
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 582 WSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK-LTEVGS 640
+ + A+G+E++ IHRD+ NIL+ + K+ DFGLA+ + +
Sbjct: 133 LEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGL 700
+M PE + + DV++FGV+L+E+ +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF----------------SLG 233
Query: 701 VALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVV 760
+ + V E+ R + P + +M + C P RP+ +V
Sbjct: 234 ASPYPGV----KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
Query: 761 ALMTL 765
L L
Sbjct: 290 HLGNL 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 3e-51
Identities = 62/300 (20%), Positives = 109/300 (36%), Gaps = 41/300 (13%)
Query: 487 KATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTH 538
K DF G +G+G F V A + AIK ++ E V++
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 539 VHHLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLE 597
+ H V+L + L+ Y +NG L +++R G + + LE
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALE 122
Query: 598 YIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA-SVHTRLVGTFGYMPP 656
Y+H + IHRD+KP NIL++++ ++ DFG AK+ S + VGT Y+ P
Sbjct: 123 YLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 657 EYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716
E D++A G ++Y+L+ + +F+++++
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLV--------AGLPPFRAGNEYLIFQKIIKLE----- 226
Query: 717 LQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS---SSEDWD 773
D+P K L + R + + S W+
Sbjct: 227 ----------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 276
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (450), Expect = 5e-50
Identities = 50/278 (17%), Positives = 101/278 (36%), Gaps = 35/278 (12%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKM---DMQASKEFLAELKVLTHVHHLNL 544
+ + + ++G G FG V R G A K + + E++ ++ + H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 545 VRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT 603
V L + + ++YE++ G L + + ++ ++ +GL ++HE+
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENN 144
Query: 604 VPVYIHRDIKPANILI--DKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQY 661
+H D+KP NI+ ++ K+ DFGL + + T GT + PE A+
Sbjct: 145 Y---VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEG 199
Query: 662 GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLR-QPDPREDLQRL 720
V D+++ GV+ Y L+ + + V + +
Sbjct: 200 KPVGYYTDMWSVGVLSYILL--------SGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 251
Query: 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
+ D R +P R ++
Sbjct: 252 ISEDGKD------------FIRKLLLADPNTRMTIHQA 277
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (439), Expect = 5e-49
Identities = 62/288 (21%), Positives = 117/288 (40%), Gaps = 38/288 (13%)
Query: 482 YEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS----KEFLAELKV 535
+++ + + + +G G F V AE + + AIK + +A E+ V
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 536 LTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSAR 594
L + H N+V L G L+L+ + + G L + G T ++
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLD 118
Query: 595 GLEYIHEHTVPVYIHRDIKPANILI---DKNFRAKVADFGLAKLTEVGSASVHTRLVGTF 651
++Y+H+ + +HRD+KP N+L D++ + ++DFGL+K+ + GS V + GT
Sbjct: 119 AVKYLHDLGI---VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VLSTACGTP 173
Query: 652 GYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLR-Q 710
GY+ PE S +D ++ GV+ Y L+ LFE++L+ +
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILL--------CGYPPFYDENDAKLFEQILKAE 225
Query: 711 PDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
+ + D R +++P+ R +
Sbjct: 226 YEFDSPYWDDISDSAKD------------FIRHLMEKDPEKRFTCEQA 261
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 174 bits (442), Expect = 6e-49
Identities = 55/278 (19%), Positives = 106/278 (38%), Gaps = 35/278 (12%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMD---MQASKEFLAELKVLTHVHHLNL 544
+ + + ++G G FG V + G K ++ E+ ++ +HH L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 545 VRLIGYCVE-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT 603
+ L + + L+ E++ G L + ++ + + + GL+++HEH+
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMHEHS 147
Query: 604 VPVYIHRDIKPANILID--KNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQY 661
+ +H DIKP NI+ + K K+ DFGLA ++ + T + PE
Sbjct: 148 I---VHLDIKPENIMCETKKASSVKIIDFGLAT--KLNPDEIVKVTTATAEFAAPEIVDR 202
Query: 662 GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLR-QPDPREDLQRL 720
V D++A GV+ Y L+ + + + + V R + ED
Sbjct: 203 EPVGFYTDMWAIGVLGYVLL--------SGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 254
Query: 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
V P D + Q+ P+ R ++
Sbjct: 255 VSPEAKD------------FIKNLLQKEPRKRLTVHDA 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 168 bits (427), Expect = 8e-48
Identities = 66/292 (22%), Positives = 117/292 (40%), Gaps = 42/292 (14%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKM------DMQASKEFLAELKVLTHVH 540
++ + +G +G GG V A A+K + D F E + ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 541 HLNLVRLIGYCVE-----GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARG 595
H +V + ++V EY++ L + G +T +++ D+ +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQA 123
Query: 596 LEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVH--TRLVGTFGY 653
L + H++ + IHRD+KPANI+I KV DFG+A+ SV ++GT Y
Sbjct: 124 LNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 654 MPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQ-PD 712
+ PE A+ V + DVY+ G VLYE++ T E V++ + +R+ P
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVL--------TGEPPFTGDSPVSVAYQHVREDPI 232
Query: 713 PREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRP-SMRAIVVALM 763
P + L + +NP+ R + + L+
Sbjct: 233 PPSARHEGLSADLDA------------VVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 4e-47
Identities = 45/276 (16%), Positives = 100/276 (36%), Gaps = 34/276 (12%)
Query: 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE--FLAELKVLTHVHHLNLVR 546
+ + +G+G FG V + K + ++ + + E+ +L H N++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILH 65
Query: 547 LIGYCVE-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVP 605
L L +++E+I ++ + + S + L + L+++H H +
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHSHNI- 123
Query: 606 VYIHRDIKPANILID--KNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGE 663
H DI+P NI+ ++ K+ +FG A+ + G L Y PE Q+
Sbjct: 124 --GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDV 179
Query: 664 VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLR-QPDPREDLQRLVD 722
VS D+++ G ++Y L+ + + + E ++ + E+ + +
Sbjct: 180 VSTATDMWSLGTLVYVLL--------SGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231
Query: 723 PRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
D + + R +
Sbjct: 232 IEAMD------------FVDRLLVKERKSRMTASEA 255
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 5e-47
Identities = 71/294 (24%), Positives = 119/294 (40%), Gaps = 29/294 (9%)
Query: 487 KATNDFSMGNKIGQGGFGAVFYAELR---GEKAAIKKMDMQASKE--------FLAELKV 535
+A + +IG+G +G VF A G A+K++ +Q +E +A L+
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 536 LTHVHHLNLVRLIGYCV------EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIA 589
L H N+VRL C E L LV+E+++ +L + + +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPEPGVPTETIKDMM 122
Query: 590 LDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVG 649
RGL+++H H V +HRD+KP NIL+ + + K+ADFGLA++ T +V
Sbjct: 123 FQLLRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVV 177
Query: 650 TFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-----AMEAVVKTNETITESTGLVALF 704
T Y PE + +D+++ G + E+ + V I + GL
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 705 EEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
+ PR+ + + + D L C NP R S +
Sbjct: 238 DWPRDVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 165 bits (419), Expect = 1e-46
Identities = 51/290 (17%), Positives = 105/290 (36%), Gaps = 48/290 (16%)
Query: 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS------------KEFLAELKVL 536
++ +G+G V + ++ A+K +D+ + L E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 537 THVH-HLNLVRLIGYCVEG-SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSAR 594
V H N+++L FLV++ ++ G L +L L+ +I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLE 121
Query: 595 GLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYM 654
+ +H+ + +HRD+KP NIL+D + K+ DFG + ++ + GT Y+
Sbjct: 122 VICALHKLNI---VHRDLKPENILLDDDMNIKLTDFGFSC--QLDPGEKLREVCGTPSYL 176
Query: 655 PPEYAQYGEV------SPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVL 708
PE + ++D+++ GV++Y L+ + + ++
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL--------AGSPPFWHRKQMLMLRMIM 228
Query: 709 RQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
+ + G D + L PQ R +
Sbjct: 229 SG-----------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-46
Identities = 68/282 (24%), Positives = 117/282 (41%), Gaps = 43/282 (15%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS------KEFLAELKVLTHV-H 540
DF + +G+G FG VF AE + + AIK + + + E +VL+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 541 HLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYI 599
H L + + +LF V EY+ G+L H++ K S A + GL+++
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFL 119
Query: 600 HEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYA 659
H + ++RD+K NIL+DK+ K+ADFG+ K +G + GT Y+ PE
Sbjct: 120 HSKGI---VYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-AKTNTFCGTPDYIAPEIL 175
Query: 660 QYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719
+ + +D ++FGV+LYE++ G + P +D +
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEML----------------IG---------QSPFHGQDEEE 210
Query: 720 LVDPRLGDDYPIDSV--RKMARLARACTQENPQLRPSMRAIV 759
L D+ ++ L P+ R +R +
Sbjct: 211 LFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDI 252
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 165 bits (419), Expect = 9e-46
Identities = 67/281 (23%), Positives = 106/281 (37%), Gaps = 41/281 (14%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAE---LKVLTH 538
NDFS+ IG+GGFG V+ G+ A+K +D Q L E L +++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 539 VHHLNLVRLIGYCVE-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLE 597
+V + L + + + G+L+ HL G + + A + GLE
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--EADMRFYAAEIILGLE 121
Query: 598 YIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE 657
++H V ++RD+KPANIL+D++ +++D GLA S VGT GYM PE
Sbjct: 122 HMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDF---SKKKPHASVGTHGYMAPE 175
Query: 658 YAQYGE-VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716
Q G D ++ G +L++L+ + E +
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLL--------RGHSPFRQHKTKDKHEIDRMTLTMAVE 227
Query: 717 LQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRA 757
L P L L Q + R
Sbjct: 228 LPDSFSPELRS------------LLEGLLQRDVNRRLGCLG 256
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-45
Identities = 66/288 (22%), Positives = 119/288 (41%), Gaps = 30/288 (10%)
Query: 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE-----FLAELKVLTHVHHLN 543
+F KIG+G +G V+ A + GE A+KK+ + E + E+ +L ++H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 544 LVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH 602
+V+L+ E L+LV+E++ + +L + + S + +GL + H H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYG 662
V +HRD+KP N+LI+ K+ADFGLA+ V + +V + P
Sbjct: 122 RV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 663 EVSPKIDVYAFGVVLYELIS------------AMEAVVKTNETITESTGLVALFEEVLRQ 710
S +D+++ G + E+++ + + +T T E ++ V
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV-----VWPGVTSM 233
Query: 711 PDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
PD + + P L +P R S +A
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLD-EDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (406), Expect = 9e-45
Identities = 62/306 (20%), Positives = 97/306 (31%), Gaps = 41/306 (13%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-ASKEFLAELKVLTHVHHLNLVR 546
N + +G KIG G FG ++ GE+ AIK ++ + E K+ + +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 66
Query: 547 LIGYCVE--GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTV 604
I +C +V E + + S K + + +A +EYIH
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHSKNF 124
Query: 605 PVYIHRDIKPANILI---DKNFRAKVADFGLAKLTEVGSASVH------TRLVGTFGYMP 655
IHRD+KP N L+ K + DFGLAK H L GT Y
Sbjct: 125 ---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 656 PEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715
E S + D+ + G VL + ++ R + +
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFN--------LGSLPWQGLKAATKRQKYERISEKK- 232
Query: 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE----- 770
L YP + A C +P + L
Sbjct: 233 --MSTPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDY 286
Query: 771 --DWDI 774
DW++
Sbjct: 287 VFDWNM 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 9e-44
Identities = 78/326 (23%), Positives = 117/326 (35%), Gaps = 51/326 (15%)
Query: 458 SESAALVAAPGVTGITVDKSVEFSYEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEK 515
S+ +VA PG D+ E SY + IG G FG V+ A+L GE
Sbjct: 1 SKVTTVVATPGQGP---DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGEL 47
Query: 516 AAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVEGS-------LFLVYEYIENGNL 568
AIKK+ Q + EL+++ + H N+VRL + L LV +Y+
Sbjct: 48 VAIKKVL-QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 106
Query: 569 NQHLRGS-GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN-FRAK 626
S K TL R L YIH + HRDIKP N+L+D + K
Sbjct: 107 RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLK 163
Query: 627 VADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS---- 682
+ DFG AK G + + + P + + IDV++ G VL EL+
Sbjct: 164 LCDFGSAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
Query: 683 --------AMEAVVKTNETITEST--GLVALFEEVLRQPDPREDLQRLVDPRLGDDYPID 732
+ ++K T T + + E ++ PR +
Sbjct: 223 FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPE---- 278
Query: 733 SVRKMARLARACTQENPQLRPSMRAI 758
L + P R +
Sbjct: 279 ----AIALCSRLLEYTPTARLTPLEA 300
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-43
Identities = 54/276 (19%), Positives = 100/276 (36%), Gaps = 33/276 (11%)
Query: 494 MGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHV-HHLNLVRLIGY 550
+G G G V + EK A+K + + E+++ ++VR++
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDV 73
Query: 551 C-----VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVP 605
L +V E ++ G L ++ G T +I ++Y+H +
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI- 132
Query: 606 VYIHRDIKPANILIDK---NFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYG 662
HRD+KP N+L N K+ DFG AK E S + T T Y+ PE
Sbjct: 133 --AHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPE 188
Query: 663 EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD 722
+ D+++ GV++Y L+ S +A+ + + R+
Sbjct: 189 KYDKSCDMWSLGVIMYILL--------CGYPPFYSNHGLAISPGMKTRI-------RMGQ 233
Query: 723 PRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
+ + ++ L R + P R ++
Sbjct: 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 156 bits (396), Expect = 2e-43
Identities = 61/282 (21%), Positives = 110/282 (39%), Gaps = 18/282 (6%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQASKE-----FLAELKVLTHVHHLN 543
+ KIG+G +G V+ A+ GE A+KK+ ++ E + E+ +L + H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 544 LVRLIGYCVEG-SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEH 602
+V+L L LV+E+++ G L L G+ Y H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHDR 119
Query: 603 TVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYG 662
V +HRD+KP N+LI++ K+ADFGLA+ + +V + P
Sbjct: 120 RV---LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 663 EVSPKIDVYAFGVVLYELISAM-----EAVVKTNETITESTGLVALFEEVLRQPDPREDL 717
+ S ID+++ G + E+++ + I G P+ D
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 718 QRLVDPRLGDDYPIDSVRKMAR-LARACTQENPQLRPSMRAI 758
V L + + + + L + +P R + +
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 157 bits (398), Expect = 2e-43
Identities = 66/278 (23%), Positives = 107/278 (38%), Gaps = 45/278 (16%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKM------DMQASKEFLAELKVLTHVHH 541
DF + +G G FG V R G A+K + ++ + E +L+ V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 542 LNLVRLIGYCVE-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH 600
++R+ G + +F++ +YIE G L LR S + + A + LEY+H
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF--YAAEVCLALEYLH 121
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQ 660
+ I+RD+KP NIL+DKN K+ DFG AK V L GT Y+ PE
Sbjct: 122 SKDI---IYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVS 174
Query: 661 YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720
+ ID ++FG+++YE++ G P + +
Sbjct: 175 TKPYNKSIDWWSFGILIYEML----------------AG---------YTPFYDSNTMKT 209
Query: 721 VDPRLGDDYPIDSV--RKMARLARACTQENPQLRPSMR 756
+ L + + L + R
Sbjct: 210 YEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNL 247
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 4e-43
Identities = 58/295 (19%), Positives = 115/295 (38%), Gaps = 45/295 (15%)
Query: 480 FSYEELAKATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ---------ASKE 528
F E + + + G ++G G F V + G + A K + + + ++
Sbjct: 3 FRQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59
Query: 529 FLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQ 587
E+ +L + H N++ L + + L+ E + G L L K++LT +
Sbjct: 60 IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATE 117
Query: 588 IALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN----FRAKVADFGLAKLTEVGSASV 643
G+ Y+H + H D+KP NI++ R K+ DFGLA ++ +
Sbjct: 118 FLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNE 172
Query: 644 HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVAL 703
+ GT ++ PE Y + + D+++ GV+ Y L+S + +
Sbjct: 173 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----------- 221
Query: 704 FEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
+E L V+ D+Y ++ R ++P+ R +++
Sbjct: 222 -QETLAN-------VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 9e-43
Identities = 83/298 (27%), Positives = 129/298 (43%), Gaps = 34/298 (11%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE-----FLAELKVLTHVHHL 542
+ + KIGQG FG VF A R G+K A+KK+ M+ KE L E+K+L + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 543 NLVRLIGYCV---------EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSA 593
N+V LI C +GS++LV+++ E+ K TL+ R +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR--VMQMLL 127
Query: 594 RGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS---VHTRLVGT 650
GL YIH + + +HRD+K AN+LI ++ K+ADFGLA+ + S +T V T
Sbjct: 128 NGLYYIHRNKI---LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 651 FGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITE---STGLVALFEE 706
Y PPE + P ID++ G ++ E+ + + E S ++ E
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244
Query: 707 VLRQPDPREDLQRLVDPRLGDDYPIDSVRKMAR------LARACTQENPQLRPSMRAI 758
V D E ++L + D ++ R L +P R
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 9e-43
Identities = 74/289 (25%), Positives = 125/289 (43%), Gaps = 41/289 (14%)
Query: 496 NKIGQGGFGAVFYAELR--GEKAAIKKMDM--------QASKEFLAELKVLTHVHHLNLV 545
+ +G+G F V+ A + + AIKK+ + ++ L E+K+L + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 546 RLIGYCVE-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTV 604
L+ ++ LV++++E S LT S L + +GLEY+H+H +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV--LTPSHIKAYMLMTLQGLEYLHQHWI 121
Query: 605 PVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEV 664
+HRD+KP N+L+D+N K+ADFGLAK +T V T Y PE +
Sbjct: 122 ---LHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 665 -SPKIDVYAFGVVLYELIS------------AMEAVVKTNETITEST--GLVALFEEVLR 709
+D++A G +L EL+ + + +T T TE + +L + V
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 710 QPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
+ P L + GDD + L + NP R +
Sbjct: 238 KSFPGIPLHHIF-SAAGDD--------LLDLIQGLFLFNPCARITATQA 277
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 7e-42
Identities = 57/296 (19%), Positives = 111/296 (37%), Gaps = 36/296 (12%)
Query: 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKM----DMQASKEFLAELKVLTHVHHL 542
++ + IG+G +G V A + AIKK+ + L E+K+L H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 543 NLVRLIGYCVEGS-----LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLE 597
N++ + + + ++ +L + L+ L+ RGL+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK---TQHLSNDHICYFLYQILRGLK 123
Query: 598 YIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS--VHTRLVGTFGYMP 655
YIH V +HRD+KP+N+L++ K+ DFGLA++ + T V T Y
Sbjct: 124 YIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 656 PEYAQYGEV-SPKIDVYAFGVVLYELIS------------AMEAVVKTNETITESTGLVA 702
PE + + ID+++ G +L E++S + ++ + ++
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 703 LFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
+ + ++ RL + ++ L NP R +
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKAL----DLLDKMLTFNPHKRIEVEQA 292
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 151 bits (381), Expect = 3e-41
Identities = 51/306 (16%), Positives = 95/306 (31%), Gaps = 43/306 (14%)
Query: 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA-SKEFLAELKVLTHVHHLNLVRLI 548
+ +G +IG+G FG +F ++ AIK ++ + + E + + + +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 549 GYCVE--GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPV 606
Y + LV + + G + L + A ++ IHE ++
Sbjct: 67 YYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL-- 122
Query: 607 YIHRDIKPANILIDKNFR-----AKVADFGLAKLTEVGSASVH------TRLVGTFGYMP 655
++RDIKP N LI + V DFG+ K H L GT YM
Sbjct: 123 -VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 656 PEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715
E S + D+ A G V + + ++ R + ++
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFL--------RGSLPWQGLKAATNKQKYERIGEKKQ 233
Query: 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE----- 770
L +P + + P + +
Sbjct: 234 STPL---RELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDE 286
Query: 771 --DWDI 774
DW++
Sbjct: 287 NFDWNL 292
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-40
Identities = 67/278 (24%), Positives = 108/278 (38%), Gaps = 42/278 (15%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS------KEFLAELKVLTHVHH 541
NDF +G+G FG V + G A+K + + + E +VL + H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 542 LNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH 600
L L L V EY G L HL + T + LEY+H
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLH 122
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQ 660
V ++RDIK N+++DK+ K+ DFGL K A++ GT Y+ PE +
Sbjct: 123 SRDV---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-TFCGTPEYLAPEVLE 178
Query: 661 YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720
+ +D + GVV+YE++ G R P +D +RL
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMM----------------CG---------RLPFYNQDHERL 213
Query: 721 VDPRLGDDYPI-DSVRKMAR-LARACTQENPQLRPSMR 756
+ L ++ ++ A+ L +++P+ R
Sbjct: 214 FELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGG 251
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 5e-40
Identities = 66/290 (22%), Positives = 112/290 (38%), Gaps = 32/290 (11%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE-----FLAELKVLTHVHHL 542
+ KIG+G +G VF A+ R E A+K++ + E L E+ +L + H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 543 NLVRLIGYCVEG-SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE 601
N+VRL L LV+E+ + +G +GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD--PEIVKSFLFQLLKGLGFCHS 119
Query: 602 HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQY 661
V +HRD+KP N+LI++N K+A+FGLA+ + +V + P
Sbjct: 120 RNV---LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 662 GEVSPKIDVYAFGVVLYELISA-------------MEAVVKTNETITESTGLVALFEEVL 708
S ID+++ G + EL +A ++ + + T TE + +
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ-----WPSMT 231
Query: 709 RQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
+ PD + L + P + L + + NP R S
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLN-ATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 1e-39
Identities = 62/285 (21%), Positives = 99/285 (34%), Gaps = 52/285 (18%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKM---------DMQASKEFLAELKVLTH 538
+ + +G +G GGFG+V+ AIK + ++ E+ +L
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 539 VH--HLNLVRLIGYCVE-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARG 595
V ++RL+ + S L+ E E L
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEA 122
Query: 596 LEYIHEHTVPVYIHRDIKPANILIDKN-FRAKVADFGLAKLTEVGSASVHTRLVGTFGYM 654
+ + H V +HRDIK NILID N K+ DFG L + +V+T GT Y
Sbjct: 123 VRHCHNCGV---LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYS 176
Query: 655 PPEYAQYGEV-SPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713
PPE+ +Y V++ G++LY+++ E I +V +
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR---------GQVFFRQRV 227
Query: 714 REDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758
+ Q L+ R C P RP+ I
Sbjct: 228 SSECQHLI--------------------RWCLALRPSDRPTFEEI 252
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 146 bits (370), Expect = 2e-39
Identities = 60/292 (20%), Positives = 117/292 (40%), Gaps = 33/292 (11%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHV-HHLNLVR 546
+D+ + K+G+G + VF A EK +K + K+ E+K+L ++ N++
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 94
Query: 547 LIGYC---VEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT 603
L V + LV+E++ N + Q + TLT + + L+Y H
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG 149
Query: 604 VPVYIHRDIKPANILID-KNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPE-YAQY 661
+ HRD+KP N++ID ++ + ++ D+GLA+ G + V + + PE Y
Sbjct: 150 IM---HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPELLVDY 204
Query: 662 GEVSPKIDVYAFGVVLYELIS------AMEAVVKTNETITESTGLVALFEEVLR-----Q 710
+D+++ G +L +I I + G L++ + +
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 711 PDPREDLQRLVDPRLGDDYPIDSVRKMARLA----RACTQENPQLRPSMRAI 758
P + L R R ++ ++ A + + Q R + R
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 5e-37
Identities = 62/305 (20%), Positives = 116/305 (38%), Gaps = 36/305 (11%)
Query: 480 FSYEELAKAT----NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKE----- 528
F +E+ K + +G G +GAV A G K AIKK+ E
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 529 FLAELKVLTHVHHLNLVRLIGYCVEGS-------LFLVYEYIENGNLNQHLRGSGKDTLT 581
EL++L H+ H N++ L+ +LV ++ G L K L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK--LG 119
Query: 582 WSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641
+ +GL YIH IHRD+KP N+ ++++ K+ DFGLA+ + +
Sbjct: 120 EDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQAD---S 173
Query: 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-----AMEAVVKTNETITE 696
+ +V + P + + +D+++ G ++ E+I+ + + I +
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233
Query: 697 STGLVALFEEVLRQPDPREDLQRLVDPRLGDDYP--IDSVRKMAR-LARACTQENPQLRP 753
TG Q D ++ + + D+ + + +A L + + R
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293
Query: 754 SMRAI 758
+
Sbjct: 294 TAGEA 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 137 bits (345), Expect = 5e-36
Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQAS------KEFLAELKVLTHVHH 541
+ F +G G FG V + + G A+K +D Q + L E ++L V+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 542 LNLVRLIGYCVE-GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIH 600
LV+L + +L++V EY+ G + HLR G+ + A EY+H
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 158
Query: 601 EHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQ 660
+ I+RD+KP N+LID+ +V DFG AK + L GT + PE
Sbjct: 159 SLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWTLCGTPEALAPEIIL 211
Query: 661 YGEVSPKIDVYAFGVVLYELIS 682
+ +D +A GV++YE+ +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAA 233
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 4e-35
Identities = 66/284 (23%), Positives = 108/284 (38%), Gaps = 40/284 (14%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR-----GEKAAIKKM-------DMQASKEFLAELKVLT 537
+F + +G G +G VF G+ A+K + + ++ E +VL
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 538 HV-HHLNLVRLIGYCV-EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARG 595
H+ LV L E L L+ +YI G L HL ++ T +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLA 141
Query: 596 LEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMP 655
LE++H+ + I+RDIK NIL+D N + DFGL+K GT YM
Sbjct: 142 LEHLHKLGI---IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
Query: 656 PEYAQYGE--VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713
P+ + G+ +D ++ GV++YEL+ T + G E+ R+
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELL--------TGASPFTVDGEKNSQAEISRRILK 250
Query: 714 REDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRA 757
E YP + L + ++P+ R
Sbjct: 251 SE-----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGP 283
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-33
Identities = 57/310 (18%), Positives = 120/310 (38%), Gaps = 44/310 (14%)
Query: 479 EFSYEELAKA----TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKM-----DMQASK 527
F +EL K + + +G G +G+V A G + A+KK+ + +K
Sbjct: 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62
Query: 528 EFLAELKVLTHVHHLNLVRLIGYCV------EGSLFLVYEYIENGNLNQHLRGSGKDTLT 581
EL++L H+ H N++ L+ E + + ++ +LN ++ LT
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLT 119
Query: 582 WSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641
+ RGL+YIH IHRD+KP+N+ ++++ K+ DFGLA+ T+
Sbjct: 120 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD--- 173
Query: 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS------------AMEAVVK 689
+ + + P + + +D+++ G ++ EL++ ++ +++
Sbjct: 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233
Query: 690 TNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMAR-LARACTQEN 748
T L +++ + P++ +A L +
Sbjct: 234 LVGTPGAE-----LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 288
Query: 749 PQLRPSMRAI 758
R +
Sbjct: 289 SDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 2e-33
Identities = 59/303 (19%), Positives = 106/303 (34%), Gaps = 45/303 (14%)
Query: 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKM-----DMQASKEFLAELKVLTHVHHL 542
+ IG G G V A AIKK+ + +K EL ++ V+H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 543 NLVRLIGYCV-------EGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARG 595
N++ L+ ++LV E ++ + G
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCG 131
Query: 596 LEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHTRLVGTFGYMP 655
++++H IHRD+KP+NI++ + K+ DFGLA+ G++ + T V T Y
Sbjct: 132 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRA 186
Query: 656 PEYAQYGEVSPKIDVYAFGVVLYELIS------------AMEAVVKTNETITESTGLVAL 703
PE +D+++ G ++ E++ V++ T + L
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF-MKKL 245
Query: 704 FEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMAR--------LARACTQENPQLRPSM 755
V + R L P+L D + + + L +P R S+
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 756 RAI 758
Sbjct: 306 DDA 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (269), Expect = 6e-26
Identities = 45/216 (20%), Positives = 82/216 (37%), Gaps = 31/216 (14%)
Query: 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKM--DMQASKEFLAELKVLTHVHHLNLVRL 547
+ + K+G G F V+ A+ A+K + D ++ E+K+L V+ + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 548 IGYCVEGSLFLVYEYIENGNLNQHL---------------RGSGKDTLTWSARMQIALDS 592
L L+ + G H+ + + QI+
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 593 ARGLEYIHEHTVPVYIHRDIKPANILIDKN------FRAKVADFGLAKLTEVGSASVHTR 646
GL+Y+H IH DIKP N+L++ + K+AD G A + +T
Sbjct: 135 LLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD----EHYTN 188
Query: 647 LVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS 682
+ T Y PE D+++ +++ELI+
Sbjct: 189 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 224
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.8 bits (214), Expect = 4e-20
Identities = 22/159 (13%), Positives = 45/159 (28%), Gaps = 22/159 (13%)
Query: 493 SMGNKIGQGGFGAVFYAEL-RGEKAAIKKMD-------------MQASKEFLAELKVLTH 538
++G +G+G AVF + + +K F
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 539 VHHLNLVRLIGYCVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEY 598
L +L G V VY + N L + + + ++ +
Sbjct: 63 NEFRALQKLQGLAVPK----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118
Query: 599 IHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE 637
+ + +H D+ N+L+ + DF +
Sbjct: 119 FYHRGI---VHGDLSQYNVLVS-EEGIWIIDFPQSVEVG 153
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 790 | |||
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1e0ga_ | 48 | Membrane-bound lytic murein transclycosylase D, Ml | 99.18 | |
| d1y7ma2 | 48 | Hypothetical protein YkuD, N-terminal domain {Baci | 99.15 | |
| d1e0ga_ | 48 | Membrane-bound lytic murein transclycosylase D, Ml | 99.15 | |
| d1y7ma2 | 48 | Hypothetical protein YkuD, N-terminal domain {Baci | 99.1 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.22 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.74 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.04 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.9 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.44 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.18 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-50 Score=420.47 Aligned_cols=257 Identities=27% Similarity=0.473 Sum_probs=214.1
Q ss_pred hcCcccceeeeecCceEEEEEEEC-CceEEEEEeCh--hhHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEEEecC
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDM--QASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIEN 565 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e~~~~ 565 (790)
.++|++.+.||+|+||.||+|.++ +..||||+++. ...++|.+|++++++++|||||+++|++.++..++||||+++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMEN 91 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCCC
Confidence 467899999999999999999997 56899999974 345679999999999999999999999988889999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
|+|.+++.......++|..+++++.|+++||.|||++++ +||||||+||||++++.+||+|||+++...........
T Consensus 92 g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~i---vHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (272)
T d1qpca_ 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (272)
T ss_dssp CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc---ccCccchhheeeecccceeeccccceEEccCCcccccc
Confidence 999998876544569999999999999999999999997 99999999999999999999999999987654444444
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
...||+.|+|||++.++.++.++|||||||++|||+||..|+..... .......+.. ..
T Consensus 169 ~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-------~~~~~~~i~~--------------~~ 227 (272)
T d1qpca_ 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEVIQNLER--------------GY 227 (272)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHT--------------TC
T ss_pred ccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHh--------------cC
Confidence 56789999999999999999999999999999999997666533221 1111222211 11
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCC
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSS 769 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~ 769 (790)
....|...+.++.+|+.+||+.||++||||+||++.|+.+-+++
T Consensus 228 ~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst 271 (272)
T d1qpca_ 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (272)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence 12233445567899999999999999999999999998765543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=415.30 Aligned_cols=258 Identities=29% Similarity=0.529 Sum_probs=206.6
Q ss_pred hcCcccceeeeecCceEEEEEEECCceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEEEe
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYI 563 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e~~ 563 (790)
.++|++.+.||+|+||+||+|++++ .||||+++. ...+.|.+|+++|++++|||||++++++.++..++||||+
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~ 85 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWC 85 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEecC
Confidence 4678999999999999999998765 599999852 3457899999999999999999999999888899999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc-c
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA-S 642 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~-~ 642 (790)
++|+|.+++.... ..+++..+++++.|+++||+|||++++ |||||||+|||++.++.+||+|||+++....... .
T Consensus 86 ~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~i---vHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 86 EGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSI---IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp CEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred CCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCE---eccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 9999999997653 359999999999999999999999998 9999999999999999999999999987653322 2
Q ss_pred cccccccCCCccchhcccC---CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 643 VHTRLVGTFGYMPPEYAQY---GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
......||+.|||||++.+ ..++.++|||||||++|||+||+.||...... ......+....
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-------~~~~~~~~~~~-------- 226 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQIIFMVGRGY-------- 226 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHHHHHTS--------
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcCC--------
Confidence 3345679999999999864 35899999999999999999999999653321 11111111111
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
..+.+ ...+.+++.++.+|+.+||+.||++|||++||++.|+.+..+
T Consensus 227 -~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 227 -LSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp -CCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -CCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 11111 112334556899999999999999999999999999988654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-49 Score=418.09 Aligned_cols=257 Identities=30% Similarity=0.493 Sum_probs=215.8
Q ss_pred HhcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh--hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEEE
Q 046083 488 ATNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM--QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEY 562 (790)
Q Consensus 488 ~~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e~ 562 (790)
..++|++.+.||+|+||+||+|.+. ++.||||+++. ...++|.+|+++|++++|||||++++++.++ ..++||||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 3567899999999999999999986 77899999874 3457899999999999999999999998854 58999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+++|+|.+++.......+++..+++++.|++.||+|||++++ +||||||+||||++++.+||+|||+++........
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~i---iHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCc---ccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 999999999987666789999999999999999999999998 99999999999999999999999999976554444
Q ss_pred cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcC
Q 046083 643 VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVD 722 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d 722 (790)
......|++.|+|||++.+..++.++|||||||++|||++|..|+..... ..... +.+.
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-------~~~~~--------------~~i~ 230 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVY--------------ELLE 230 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHHHH--------------HHHH
T ss_pred eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-------HHHHH--------------HHHh
Confidence 44455689999999999999999999999999999999998777643221 11111 1111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 723 PRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 723 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
.......+...+.++.+|+.+||+.||++|||++||++.|+.+...
T Consensus 231 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 2222334445567899999999999999999999999999876543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-49 Score=409.96 Aligned_cols=253 Identities=26% Similarity=0.467 Sum_probs=198.9
Q ss_pred cCcccceeeeecCceEEEEEEEC-CceEEEEEeCh--hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecC
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDM--QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIEN 565 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~ 565 (790)
++|++.+.||+|+||.||+|.+. ++.||||+++. ...++|.+|++++++++|||||+++|+|.+ +..++||||+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 57889999999999999999986 67899999974 345789999999999999999999999974 568999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
|+|.+++.... ..++|..+++++.|++.||+|||++++ +||||||+|||+++++.+||+|||+++...........
T Consensus 85 g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~i---iHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 85 GCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp CBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTC---CCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccce---eecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 99999987653 468999999999999999999999998 99999999999999999999999999876544433334
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
...||+.|+|||++.+..++.++|||||||++|||+|+..|+..... .......+... .
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-------~~~~~~~i~~~--------------~ 219 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDISTG--------------F 219 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-------HHHHHHHHHHT--------------C
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-------HHHHHHHHHhc--------------C
Confidence 46789999999999999999999999999999999996544432211 11222222211 1
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
....|..++.++.+|+.+||+.||++||||+||+++|+++..
T Consensus 220 ~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 112233445678999999999999999999999999998753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-48 Score=412.14 Aligned_cols=255 Identities=25% Similarity=0.455 Sum_probs=198.7
Q ss_pred cCcccceeeeecCceEEEEEEEC--Cc---eEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GE---KAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLV 559 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~---~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv 559 (790)
++|++.+.||+|+||+||+|.+. ++ .+|||.+.. ...++|.+|+++|++++|||||+++|++.+ +..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45778899999999999999985 32 588998753 344679999999999999999999999975 458999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+++|+|.+++.... ..++|.++++++.|+++||.|||++++ +||||||+||||+.++.+||+|||+++.....
T Consensus 106 ~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~i---iHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCC---ccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999888653 369999999999999999999999998 99999999999999999999999999876533
Q ss_pred Cccc----ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 640 SASV----HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 640 ~~~~----~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
.... .....||+.|||||.+.+..++.++|||||||++|||+| |+.||..... ......+..
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--------~~~~~~i~~----- 248 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--------QDVINAIEQ----- 248 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHT-----
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--------HHHHHHHHc-----
Confidence 2211 112457899999999999999999999999999999998 8999865322 111112111
Q ss_pred hhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCc
Q 046083 715 EDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSE 770 (790)
Q Consensus 715 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~ 770 (790)
......+.+.+..+.+|+.+||+.||++||||+||++.|+++.+++.
T Consensus 249 ---------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~ 295 (299)
T d1jpaa_ 249 ---------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295 (299)
T ss_dssp ---------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred ---------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChh
Confidence 11223344566789999999999999999999999999998766543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=404.13 Aligned_cols=251 Identities=22% Similarity=0.402 Sum_probs=207.4
Q ss_pred hcCcccce-eeeecCceEEEEEEEC----CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEE
Q 046083 489 TNDFSMGN-KIGQGGFGAVFYAELR----GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLV 559 (790)
Q Consensus 489 ~~~f~~~~-~lG~G~fg~Vy~a~~~----g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv 559 (790)
.++|.+.+ +||+|+||.||+|.++ +..||||.++. ...++|.+|+++|++++|||||+++|++.++..|+|
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lv 86 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLV 86 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEE
Confidence 35677777 4999999999999874 34799999863 345679999999999999999999999988889999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+++|+|.+++.... ..+++..+++++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++.....
T Consensus 87 mE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~i---iHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNF---VHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCcCchhheeeccCCceeeccchhhhccccc
Confidence 99999999999986543 469999999999999999999999997 99999999999999999999999999976543
Q ss_pred Cccc--ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhh
Q 046083 640 SASV--HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716 (790)
Q Consensus 640 ~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (790)
.... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||..... ......+..
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--------~~~~~~i~~------- 227 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMAFIEQ------- 227 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHHHHHHHT-------
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--------HHHHHHHHc-------
Confidence 3222 223568999999999999999999999999999999998 8999865322 111111111
Q ss_pred hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 717 LQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 717 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
......|...+.++.+|+.+||+.||++||||.+|++.|+..
T Consensus 228 -------~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 228 -------GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp -------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111233445667899999999999999999999999988754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=396.24 Aligned_cols=250 Identities=26% Similarity=0.461 Sum_probs=210.2
Q ss_pred cCcccceeeeecCceEEEEEEEC-CceEEEEEeCh--hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEecC
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDM--QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIEN 565 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~~~ 565 (790)
++|++.++||+|+||+||+|+++ +..||||.++. ...++|.+|++++++++||||++++|+|.+ +..++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 68999999999999999999997 56899999864 345789999999999999999999999875 568999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
|+|.+++.... ..+++..+++++.|+++||+|||++++ +||||||+|||+++++.+||+|||+++...........
T Consensus 84 g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~i---iH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 84 GCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp EEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTB---CCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred CcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCc---ccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 99999977543 368999999999999999999999998 99999999999999999999999999876554444444
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCc
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 724 (790)
...||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... ......+.. .
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--------~~~~~~i~~--------------~ 217 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------SETAEHIAQ--------------G 217 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHHHHHHHT--------------T
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH--------HHHHHHHHh--------------C
Confidence 5678999999999999999999999999999999998 7888865432 111111211 1
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 725 LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 725 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
.....|...+.++.+|+.+||+.||++|||++||+++|..+
T Consensus 218 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 218 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 11223344556899999999999999999999999998653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-48 Score=403.98 Aligned_cols=257 Identities=28% Similarity=0.465 Sum_probs=207.3
Q ss_pred hcCcccceeeeecCceEEEEEEEC-CceEEEEEeChh--hHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEEEecC
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ--ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIEN 565 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e~~~~ 565 (790)
.++|++.+.||+|+||.||+|.++ +..||||+++.. ..+.|.+|+.++++++|||||+++|++.+++.++||||+++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~ 95 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 95 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTT
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecCC
Confidence 357999999999999999999987 568999999743 34779999999999999999999999988889999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
|+|..++.......++|..+++++.|++.||+|||++++ +||||||+||||+.++++||+|||+++...........
T Consensus 96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~i---vH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 172 (285)
T d1fmka3 96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172 (285)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhhe---ecccccceEEEECCCCcEEEcccchhhhccCCCceeec
Confidence 999999876544569999999999999999999999998 99999999999999999999999999876544333334
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCcC
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRL 725 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 725 (790)
...||+.|+|||++..+.++.++|||||||++|||++|..|+..... .......+.. ..
T Consensus 173 ~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-------~~~~~~~i~~--------------~~ 231 (285)
T d1fmka3 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVLDQVER--------------GY 231 (285)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHT--------------TC
T ss_pred cccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-------HHHHHHHHHh--------------cC
Confidence 46789999999999999999999999999999999997766644321 1112222211 11
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCC
Q 046083 726 GDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSS 769 (790)
Q Consensus 726 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~ 769 (790)
....+...+.++.+++.+||+.||++||||++|++.|+....+.
T Consensus 232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 22334455678999999999999999999999999998765443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=400.26 Aligned_cols=258 Identities=25% Similarity=0.431 Sum_probs=203.8
Q ss_pred cCcccceeeeecCceEEEEEEECC------ceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELRG------EKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFL 558 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~g------~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~l 558 (790)
+.|+..+.||+|+||.||+|.+++ ..||||+++. ...++|.+|++++++++|||||+++|++.+ +..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 468889999999999999998762 3699999864 234568999999999999999999999975 45899
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
||||+.+++|.+++.... ..++|..+++++.|++.||+|||++++ +||||||+||||+.++.+||+|||+++....
T Consensus 87 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~i---iHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcccccc---ccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999999887653 469999999999999999999999998 9999999999999999999999999987644
Q ss_pred CCcc--cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhh
Q 046083 639 GSAS--VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRED 716 (790)
Q Consensus 639 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (790)
.... ......||+.|+|||++.++.++.++|||||||++|||++|..|+..... .......+
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-------~~~~~~~i--------- 226 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------NHEVMKAI--------- 226 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHH---------
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-------HHHHHHHH---------
Confidence 3222 22335689999999999999999999999999999999997666543221 11111111
Q ss_pred hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccC
Q 046083 717 LQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDW 772 (790)
Q Consensus 717 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~ 772 (790)
........+.+.+..+.+|+.+||+.||++||||.||++.|+.+...++..
T Consensus 227 -----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~l 277 (283)
T d1mqba_ 227 -----NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 277 (283)
T ss_dssp -----HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred -----hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcccc
Confidence 122223345556678999999999999999999999999999887665443
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=400.62 Aligned_cols=243 Identities=26% Similarity=0.409 Sum_probs=200.1
Q ss_pred eeeeecCceEEEEEEEC----CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEEEEEecCC
Q 046083 496 NKIGQGGFGAVFYAELR----GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENG 566 (790)
Q Consensus 496 ~~lG~G~fg~Vy~a~~~----g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv~e~~~~g 566 (790)
++||+|+||.||+|.+. ++.||||+++.. ..++|.+|+++|++++|||||+++|+|.++..++||||+++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 57999999999999864 357999998632 346799999999999999999999999887889999999999
Q ss_pred ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc--c
Q 046083 567 NLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV--H 644 (790)
Q Consensus 567 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~--~ 644 (790)
+|.++++... .++|..+++++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++......... .
T Consensus 93 ~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~i---iHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 93 PLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred cHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCCc---ccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 9999998654 59999999999999999999999997 999999999999999999999999998765433222 2
Q ss_pred cccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 645 TRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 645 ~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
....||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... ......+..
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--------~~~~~~i~~-------------- 225 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEK-------------- 225 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHT--------------
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--------HHHHHHHHc--------------
Confidence 23578999999999999999999999999999999998 8999864321 111111111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
......|..++.++.+|+.+||+.||++|||+++|++.|+..
T Consensus 226 ~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 226 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 112233445567899999999999999999999999888754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=399.32 Aligned_cols=247 Identities=24% Similarity=0.376 Sum_probs=201.0
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYE 561 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e 561 (790)
.++|++.+.||+|+||+||+|+.. |+.||||+++.. ..+.+.+|+++|++++||||+++++++.++ ..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 367999999999999999999986 889999998642 235689999999999999999999998754 5899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|+++|+|.+++.... .+++..+..++.|++.||+|||++++ +||||||+|||+++++.+||+|||+|+.......
T Consensus 84 y~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~I---iHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCC---ccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999999997643 69999999999999999999999997 9999999999999999999999999997654332
Q ss_pred -ccccccccCCCccchhcccCCCC-CchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 642 -SVHTRLVGTFGYMPPEYAQYGEV-SPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 642 -~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
.......||+.|||||++.+..+ +.++|||||||++|||++|+.||....... ...........
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-------~~~~~~~~~~~------- 224 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------QEYSDWKEKKT------- 224 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-------HHHHHHHTTCT-------
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-------HHHHHHhcCCC-------
Confidence 23345789999999999988776 578999999999999999999996543211 11111111111
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVV 760 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 760 (790)
........+.++.+|+.+||+.||++|||++|+++
T Consensus 225 ------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 225 ------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01111234467889999999999999999999865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-47 Score=393.45 Aligned_cols=243 Identities=27% Similarity=0.466 Sum_probs=204.8
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~ 560 (790)
++|++.+.||+|+||.||+|+.. ++.||+|.+... ..+.+.+|++++++++||||+++++++.++ ..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999986 789999998642 245688999999999999999999998854 589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~i---vHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred eecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 9999999999998654 59999999999999999999999998 99999999999999999999999999865432
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+....
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~--------- 220 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRISRVE--------- 220 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTTC---------
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCC---------
Confidence 23346799999999999999999999999999999999999999964321 12222222211
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
..+|...+.++.+|+.+||+.||++|||++|++++-+
T Consensus 221 ------~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~ 257 (263)
T d2j4za1 221 ------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 257 (263)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHH
T ss_pred ------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcC
Confidence 1223344567899999999999999999999987543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=397.82 Aligned_cols=249 Identities=24% Similarity=0.413 Sum_probs=193.8
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec---CeEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE---GSLFLV 559 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---~~~~lv 559 (790)
++|++.+.||+|+||.||+|+.. |+.||||.++. ...+.+.+|++++++++|||||++++++.+ +.+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999986 78999999863 234568899999999999999999998863 348999
Q ss_pred EEEecCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCC--CceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 560 YEYIENGNLNQHLRGS--GKDTLTWSARMQIALDSARGLEYIHEHTV--PVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~--~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
|||+++|+|.+++... ....+++..++.++.|++.||+|||+.+. ..|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998652 23469999999999999999999999761 1249999999999999999999999999987
Q ss_pred cccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChh
Q 046083 636 TEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715 (790)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (790)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+....
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--------~~~~~~i~~~~---- 230 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGKIREGK---- 230 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTC----
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--------HHHHHHHHcCC----
Confidence 65322 223456899999999999999999999999999999999999999964321 12222222211
Q ss_pred hhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 716 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
. ...+...+.++.+|+.+||+.||.+|||++|++++
T Consensus 231 ---------~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 231 ---------F-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ---------C-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---------C-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1 11233445678999999999999999999999863
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=394.69 Aligned_cols=250 Identities=29% Similarity=0.497 Sum_probs=203.3
Q ss_pred hcCcccceeeeecCceEEEEEEECCceEEEEEeChh-hHHHHHHHHHHHHhcCCCCCcceEEEEec--CeEEEEEEEecC
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQ-ASKEFLAELKVLTHVHHLNLVRLIGYCVE--GSLFLVYEYIEN 565 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~lv~e~~~~ 565 (790)
.++|++.+.||+|+||.||+|.++|..||||+++.+ ..++|.+|++++++++||||++++|+|.+ +.+++||||+++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~ 85 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 85 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred HHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence 356888999999999999999999999999999754 45679999999999999999999999864 348999999999
Q ss_pred CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccccc
Q 046083 566 GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASVHT 645 (790)
Q Consensus 566 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 645 (790)
|+|.++|.......++|..+++++.|++.||.|||+.++ +||||||+|||++.++.+||+|||+++..... ..
T Consensus 86 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~i---vH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~~ 158 (262)
T d1byga_ 86 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF---VHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QD 158 (262)
T ss_dssp EEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCce---eccccchHhheecCCCCEeecccccceecCCC----Cc
Confidence 999999976544568999999999999999999999998 99999999999999999999999999865422 22
Q ss_pred ccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCCc
Q 046083 646 RLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPR 724 (790)
Q Consensus 646 ~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 724 (790)
...++..|+|||++.+..++.++|||||||++|||+| |+.|+...... + .. ..+...
T Consensus 159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~-----~---~~--------------~~i~~~ 216 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----D---VV--------------PRVEKG 216 (262)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----G---HH--------------HHHTTT
T ss_pred cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH-----H---HH--------------HHHHcC
Confidence 3467899999999999999999999999999999998 67776443211 1 11 111122
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 725 LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 725 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
...+++...+.++.+|+.+||+.||.+||||.||+++|+.+.+
T Consensus 217 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 217 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 2334455566789999999999999999999999999998764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=394.48 Aligned_cols=245 Identities=24% Similarity=0.408 Sum_probs=204.2
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEe
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
++|++.++||+|+||+||+|... |+.||||+++. ...+.+.+|++++++++|||||++++++.+ +..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999976 88999999864 334678999999999999999999998875 5689999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
++|+|.+++... .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++...... ..
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~i---iHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 172 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CC
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCC---cccCCcHHHeEECCCCcEeeccchhheeecccc-cc
Confidence 999999988753 48999999999999999999999997 999999999999999999999999998764332 22
Q ss_pred ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhcCC
Q 046083 644 HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLVDP 723 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 723 (790)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........... +
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~~~~~~~----------~ 234 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------RALYLIATNGT----------P 234 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHHCS----------C
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--------HHHHHHHhCCC----------C
Confidence 34567999999999999999999999999999999999999999643321 11111111100 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 724 RLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 724 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
....+...+..+.+|+.+||+.||++|||++|++++
T Consensus 235 --~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 235 --ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp --CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred --CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112234455678999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-47 Score=397.69 Aligned_cols=262 Identities=24% Similarity=0.409 Sum_probs=211.5
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
++|++.+.||+|+||+||+|+.. ++.||||+++.. ..+.+.+|+++|++++||||+++++++.+ +..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999986 889999998642 33568999999999999999999999875 4689999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++++ +||||||+|||+++++.+||+|||+++......
T Consensus 88 Ey~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~i---iHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccccE---EcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999988654 59999999999999999999999998 999999999999999999999999998765332
Q ss_pred c-ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 641 A-SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 641 ~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+....
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~~-------- 226 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--------YLIFQKIIKLE-------- 226 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHTTC--------
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH--------HHHHHHHHcCC--------
Confidence 2 223446799999999999999999999999999999999999999964321 12222222211
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccCCcCCccccccccccc
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWDIGSFYENQGLDSLM 787 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~~~~~~~~~~~~~~~~ 787 (790)
..+|...+.++.+|+.+||+.||++|||++|++...+-+ .+.|+.+-+|+.|.
T Consensus 227 -------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~--------~Hpff~~i~w~~l~ 279 (288)
T d1uu3a_ 227 -------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK--------AHPFFESVTWENLH 279 (288)
T ss_dssp -------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHH--------TSGGGTTCCCTTGG
T ss_pred -------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHH--------cCCccCCCCHHHhh
Confidence 122334456789999999999999999999986654322 23556666666654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=403.88 Aligned_cols=251 Identities=27% Similarity=0.480 Sum_probs=205.0
Q ss_pred hcCcccceeeeecCceEEEEEEECC-------ceEEEEEeCh----hhHHHHHHHHHHHHhc-CCCCCcceEEEEec-Ce
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELRG-------EKAAIKKMDM----QASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GS 555 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~g-------~~vavK~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~ 555 (790)
.++|++.+.||+|+||+||+|++.+ ..||+|.+.. .....+.+|+.+|.++ +|||||++++++.+ +.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4679999999999999999998752 2589998853 2335689999999998 89999999999975 45
Q ss_pred EEEEEEEecCCChhhhhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCC
Q 046083 556 LFLVYEYIENGNLNQHLRGSGK---------------------DTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKP 614 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp 614 (790)
.++||||+++|+|.++|+.... ..+++..++.++.|++.||+|||++++ +||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~I---iHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC---VHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTE---EETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCe---eeccCch
Confidence 8999999999999999975421 358999999999999999999999997 9999999
Q ss_pred CCEEecCCCcEEEEEeCCCcccccCCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCcccccccc
Q 046083 615 ANILIDKNFRAKVADFGLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNE 692 (790)
Q Consensus 615 ~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~ 692 (790)
+|||++.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876543322 2334668999999999999999999999999999999998 8999865332
Q ss_pred ccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 693 TITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
. ..+..++ ........|...+.++.+|+.+||+.||++|||++||+++|.
T Consensus 273 ~--------~~~~~~~-------------~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 D--------ANFYKLI-------------QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp S--------HHHHHHH-------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H--------HHHHHHH-------------hcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1 1111122 122222344455678999999999999999999999999985
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=392.03 Aligned_cols=253 Identities=23% Similarity=0.385 Sum_probs=199.0
Q ss_pred hcCcccceeeeecCceEEEEEEEC-----CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-----GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLV 559 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-----g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv 559 (790)
.++|++.+.||+|+||.||+|.+. +..||||.++. ...+.|.+|++++++++||||++++|++.++..++|
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv 85 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 85 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEE
Confidence 467999999999999999999875 24688998863 334669999999999999999999999988889999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+++|+|.+++.... ..+++..++.++.|+++||.|||++++ +||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~i---iHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCe---eccccchhheeecCCCcEEEccchhheeccCC
Confidence 99999999999887643 368999999999999999999999998 99999999999999999999999999876544
Q ss_pred CcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
.........||+.|+|||.+.+..++.++|||||||++|||++ |.+||...... .....+...
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--------~~~~~i~~~-------- 225 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------DVIGRIENG-------- 225 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------GHHHHHHTT--------
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcC--------
Confidence 4444455678999999999999999999999999999999998 88888654321 111122211
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
.....+...+..+.+|+.+||+.||++|||++||++.|+.+..
T Consensus 226 ------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 226 ------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1112344556789999999999999999999999999987643
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=399.37 Aligned_cols=253 Identities=22% Similarity=0.375 Sum_probs=206.8
Q ss_pred cCcccceeeeecCceEEEEEEEC--Cc----eEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GE----KAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLV 559 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~----~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~lv 559 (790)
++|++.+.||+|+||+||+|.+. |+ +||+|+++. ...++|.+|++++++++|||||+++|+|.++..+++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence 46999999999999999999875 33 589998863 345679999999999999999999999999889999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
+||+.+|+|.+++.... ..+++..+++++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~i---iHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCc---ccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 99999999999887653 469999999999999999999999998 99999999999999999999999999876543
Q ss_pred Cccc-ccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 640 SASV-HTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 640 ~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
.... .....||+.|+|||++.++.++.++|||||||++|||+| |..||...... .+ ...+..
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-----~~---~~~i~~-------- 228 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----EI---SSILEK-------- 228 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-----GH---HHHHHH--------
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-----HH---HHHHHc--------
Confidence 3322 233568999999999999999999999999999999998 77887543221 11 111111
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 718 QRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 718 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
......|..++..+.+|+.+||+.||.+|||+.||+++|..+...
T Consensus 229 ------~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 229 ------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ------CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 111233445567899999999999999999999999999887544
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-46 Score=387.08 Aligned_cols=243 Identities=23% Similarity=0.404 Sum_probs=194.9
Q ss_pred cccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-----CeEEEE
Q 046083 492 FSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-----GSLFLV 559 (790)
Q Consensus 492 f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~lv 559 (790)
|++.++||+|+||+||+|.+. +..||+|.+.. ...+.|.+|+++|++++|||||++++++.+ ..+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 356778999999999999986 77899998853 234568999999999999999999998753 237999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEec-CCCcEEEEEeCCCccccc
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILID-KNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~-~~~~~kl~DfGla~~~~~ 638 (790)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+++ ++|+||||||+|||++ +++.+||+|||+++....
T Consensus 91 mE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999998653 5899999999999999999999998 1239999999999996 578999999999986432
Q ss_pred CCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 639 GSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
. ......||+.|||||++.+ .++.++|||||||++|||++|+.||..... .......+.....+
T Consensus 168 ~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-------~~~~~~~i~~~~~~----- 231 (270)
T d1t4ha_ 168 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVTSGVKP----- 231 (270)
T ss_dssp T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHHHTTTCCC-----
T ss_pred C---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-------HHHHHHHHHcCCCC-----
Confidence 2 2345689999999999875 699999999999999999999999964321 11222222221111
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
..++.....++.+|+.+||+.||++|||++|++++
T Consensus 232 --------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 232 --------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp --------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 11112233568899999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-46 Score=391.38 Aligned_cols=247 Identities=22% Similarity=0.379 Sum_probs=202.0
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEe
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
+.|++.+.||+|+||.||+|+.. +..+|||+++. ...+.+.+|+++|++++|||||++++++.+ +..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999986 78999999853 445678999999999999999999998874 5689999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCccc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSASV 643 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 643 (790)
++|+|.+++.... ..+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++...... ..
T Consensus 92 ~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~i---vHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKI---IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp TTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCE---EEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 9999999987543 369999999999999999999999997 999999999999999999999999997653221 12
Q ss_pred ccccccCCCccchhccc-----CCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 644 HTRLVGTFGYMPPEYAQ-----YGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 644 ~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||...... .....+.....+
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~--------~~~~~i~~~~~~----- 233 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--------RVLLKIAKSEPP----- 233 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG--------GHHHHHHHSCCC-----
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH--------HHHHHHHcCCCC-----
Confidence 23467999999999984 456899999999999999999999999654321 112222221110
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
....+...+.++.+|+.+||+.||++|||++|++++
T Consensus 234 -------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 234 -------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 012233456788999999999999999999999764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=399.47 Aligned_cols=264 Identities=24% Similarity=0.380 Sum_probs=202.1
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYE 561 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e 561 (790)
.++|++.++||+|+||+||+|+.. |+.||+|+++. ...+.+.+|+++|++++|||||++++++.+ +..|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 578999999999999999999986 78999999853 334678999999999999999999999875 46899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHE-HTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
|+++|+|.+++...+ .+++..+..++.|++.||.|||+ +++ +||||||+|||++.++.+||+|||+|+.....
T Consensus 85 y~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~I---iHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKI---MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp CCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCC---CCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred cCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCE---EccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 999999999998654 59999999999999999999997 487 99999999999999999999999999865422
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHH----------------
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALF---------------- 704 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~---------------- 704 (790)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.................
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 23346899999999999999999999999999999999999999965432210000000000
Q ss_pred -H-HHHcC--CCC-hhhhhhhcCCcCCCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 705 -E-EVLRQ--PDP-REDLQRLVDPRLGDDYP-IDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 705 -~-~~~~~--~~~-~~~l~~~~d~~l~~~~~-~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
. ..... ... .+.+........ ...+ .....++.+|+.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPP-PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCC-CCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhHHHHHhhhhccCC-ccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0 00000 000 001111111100 1111 1234678899999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.6e-46 Score=393.14 Aligned_cols=258 Identities=28% Similarity=0.456 Sum_probs=208.8
Q ss_pred HHHHHhcCcccceeeeecCceEEEEEEECC-------ceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEe
Q 046083 484 ELAKATNDFSMGNKIGQGGFGAVFYAELRG-------EKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCV 552 (790)
Q Consensus 484 ~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~g-------~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~ 552 (790)
+|+...++|++.+.||+|+||+||+|++.+ ..||||+++.. ..++|.+|+++|++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 344456789999999999999999998753 57999998642 3467999999999999999999999987
Q ss_pred c-CeEEEEEEEecCCChhhhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceee
Q 046083 553 E-GSLFLVYEYIENGNLNQHLRGSG----------------------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIH 609 (790)
Q Consensus 553 ~-~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH 609 (790)
+ +..+++|||+++|+|.+++.... ...+++..+++++.|++.||+|||++++ ||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~i---vH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF---VH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTC---CC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCe---Ee
Confidence 5 45899999999999999996422 2348999999999999999999999998 99
Q ss_pred cCCCCCCEEecCCCcEEEEEeCCCcccccCCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCC-ccc
Q 046083 610 RDIKPANILIDKNFRAKVADFGLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAM-EAV 687 (790)
Q Consensus 610 ~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~-~p~ 687 (790)
|||||+|||+|.++.+||+|||+++........ ......|++.|+|||.+.+..++.++|||||||++|||++|. +||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 999999999999999999999999865433222 223467889999999999999999999999999999999996 455
Q ss_pred cccccccccccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 046083 688 VKTNETITESTGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLS 766 (790)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~ 766 (790)
..... ......+... . ....+..++.++.+|+.+||+.+|++||||.||++.|+++.
T Consensus 244 ~~~~~--------~e~~~~v~~~-------------~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAH--------EEVIYYVRDG-------------N-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCH--------HHHHHHHHTT-------------C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCH--------HHHHHHHHcC-------------C-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 43221 1112222211 1 12234455668999999999999999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-45 Score=391.53 Aligned_cols=240 Identities=28% Similarity=0.434 Sum_probs=197.4
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeCh------hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYE 561 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e 561 (790)
.|+..+.||+|+||.||+|+.. ++.||||+++. ...+.+.+|+++|++++|||||++++++.+ +..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4899999999999999999975 78899999853 223568899999999999999999999875 56899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|+.+|+|..++... ..+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++....
T Consensus 96 ~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~i---iHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167 (309)
T ss_dssp CCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCE---eccCCCcceEEECCCCCEEEeecccccccCC---
Confidence 99999998776654 359999999999999999999999998 9999999999999999999999999986532
Q ss_pred ccccccccCCCccchhcccC---CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 642 SVHTRLVGTFGYMPPEYAQY---GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
.....||+.|||||++.+ ..++.++|||||||++|||++|+.||..... ............
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--------~~~~~~i~~~~~------ 231 (309)
T d1u5ra_ 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNES------ 231 (309)
T ss_dssp --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSCC------
T ss_pred --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhCCC------
Confidence 234579999999999864 4689999999999999999999999864322 111222222111
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
+.+ .+...+..+.+|+.+||+.||.+|||++|++++
T Consensus 232 ----~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 232 ----PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp ----CCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----CCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 111 122334678999999999999999999999874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-46 Score=387.81 Aligned_cols=251 Identities=24% Similarity=0.408 Sum_probs=199.7
Q ss_pred cCcccceeeeecCceEEEEEEEC---C--ceEEEEEeCh------hhHHHHHHHHHHHHhcCCCCCcceEEEEecCeEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR---G--EKAAIKKMDM------QASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFL 558 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~---g--~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~l 558 (790)
++|++.+.||+|+||.||+|++. + ..||||+++. +..++|.+|+++|++++||||++++|++.+...++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence 56999999999999999999874 2 2689998863 23467999999999999999999999998888899
Q ss_pred EEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccccc
Q 046083 559 VYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 559 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~ 638 (790)
||||+++|+|.+++.... ..+++..+++++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++....
T Consensus 88 v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~i---iHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCE---eeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999999999887643 359999999999999999999999997 9999999999999999999999999997654
Q ss_pred CCcc--cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccccchHHHHHHHHcCCCChh
Q 046083 639 GSAS--VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715 (790)
Q Consensus 639 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (790)
.... ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||..... ......+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~--------~~~~~~i~~~----- 230 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKIDKE----- 230 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTS-----
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH--------HHHHHHHHhC-----
Confidence 3322 2233567889999999999999999999999999999998 8999864322 1222222222
Q ss_pred hhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 716 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
......+...+..+.+|+.+||+.||++|||+.||++.|.++
T Consensus 231 --------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 --------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp --------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 122233344556799999999999999999999999998864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=390.58 Aligned_cols=270 Identities=33% Similarity=0.557 Sum_probs=212.6
Q ss_pred cCcccceeeeecCceEEEEEEEC--Cc--eEEEEEeCh----hhHHHHHHHHHHHHhc-CCCCCcceEEEEec-CeEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GE--KAAIKKMDM----QASKEFLAELKVLTHV-HHLNLVRLIGYCVE-GSLFLV 559 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~--~vavK~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~~lv 559 (790)
++|++.+.||+|+||.||+|.+. +. .||||+++. +..++|.+|+++|+++ +|||||+++|++.+ +..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57889999999999999999986 33 578888753 2345799999999999 79999999999875 468999
Q ss_pred EEEecCCChhhhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcE
Q 046083 560 YEYIENGNLNQHLRGS--------------GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRA 625 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~ 625 (790)
|||+++|+|.++|+.. ....++|..+++++.|+++||.|||++++ +||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~i---iHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCc---cccccccceEEEcCCCce
Confidence 9999999999999753 23569999999999999999999999997 999999999999999999
Q ss_pred EEEEeCCCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCc-cccccccccccccchHHHH
Q 046083 626 KVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAME-AVVKTNETITESTGLVALF 704 (790)
Q Consensus 626 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~-p~~~~~~~~~~~~~~~~~~ 704 (790)
||+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||.... .....
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--------~~~~~ 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAELY 236 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHH
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--------HHHHH
Confidence 9999999986542221 223568999999999999999999999999999999999765 453321 11111
Q ss_pred HHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccCCccCCcCCcccccccc
Q 046083 705 EEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSSSEDWDIGSFYENQGLD 784 (790)
Q Consensus 705 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~~~~~~~~~~~~~~~~~ 784 (790)
..+.. ......+...+.++.+|+.+||+.||++||||+||++.|+++.......-.++..++...+
T Consensus 237 ~~i~~--------------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~~~~~~~e~~~~~ 302 (309)
T d1fvra_ 237 EKLPQ--------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYA 302 (309)
T ss_dssp HHGGG--------------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBCCBCTTCCCCC
T ss_pred HHHHh--------------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcCCCCCchhhccccc
Confidence 11111 1122334456678999999999999999999999999999987665555445555555544
Q ss_pred cc
Q 046083 785 SL 786 (790)
Q Consensus 785 ~~ 786 (790)
.+
T Consensus 303 ~~ 304 (309)
T d1fvra_ 303 GI 304 (309)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=389.64 Aligned_cols=256 Identities=28% Similarity=0.444 Sum_probs=197.8
Q ss_pred HHhcCcccceeeeecCceEEEEEEEC-------CceEEEEEeCh----hhHHHHHHHHHHHHhc-CCCCCcceEEEEecC
Q 046083 487 KATNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDM----QASKEFLAELKVLTHV-HHLNLVRLIGYCVEG 554 (790)
Q Consensus 487 ~~~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 554 (790)
...++|++.++||+|+||.||+|.+. ++.||||+++. ...+.+.+|..++.++ +|+||+.+++++.+.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 33468999999999999999999874 35799999864 3345678888888887 689999999988643
Q ss_pred --eEEEEEEEecCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEE
Q 046083 555 --SLFLVYEYIENGNLNQHLRGSG--------------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANIL 618 (790)
Q Consensus 555 --~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NIL 618 (790)
..++||||+++|+|.++++... ...+++..++.++.|+++||.|||++++ +||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~i---vHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCC---cCCcCCcccee
Confidence 4899999999999999997532 2358999999999999999999999998 99999999999
Q ss_pred ecCCCcEEEEEeCCCcccccCCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCC-cccccccccccc
Q 046083 619 IDKNFRAKVADFGLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAM-EAVVKTNETITE 696 (790)
Q Consensus 619 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~-~p~~~~~~~~~~ 696 (790)
|++++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+||. +||......
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--- 243 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--- 243 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS---
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH---
Confidence 999999999999999865433322 233467999999999999999999999999999999999975 456432211
Q ss_pred ccchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 046083 697 STGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLS 766 (790)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~ 766 (790)
..+...+.. ......+...+.++.+++.+||+.||++|||++||+++|+.+.
T Consensus 244 -----~~~~~~~~~-------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 244 -----EEFCRRLKE-------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp -----HHHHHHHHH-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HHHHHHHhc-------------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111111111 1112233345567899999999999999999999999999874
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-45 Score=389.20 Aligned_cols=248 Identities=25% Similarity=0.443 Sum_probs=190.7
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYE 561 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e 561 (790)
.+.|++.+.||+|+||+||+|+.. ++.||||.+... ..+.+.+|+++|++++||||+++++++.+ +..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999986 789999998642 23457899999999999999999999875 45899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEec---CCCcEEEEEeCCCccccc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILID---KNFRAKVADFGLAKLTEV 638 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~---~~~~~kl~DfGla~~~~~ 638 (790)
|+++|+|.+++...+ .+++..+..++.|++.||+|||++++ +||||||+|||+. +++.+||+|||+++....
T Consensus 88 ~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~i---iHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLGI---VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhcee---eeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 999999999998643 59999999999999999999999998 9999999999994 578999999999986543
Q ss_pred CCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 639 GSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 639 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
. .......||+.|||||++.+..++.++|||||||++|||++|+.||..... ......+.....
T Consensus 163 ~--~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~~~------ 226 (307)
T d1a06a_ 163 G--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND--------AKLFEQILKAEY------ 226 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHTTCC------
T ss_pred C--CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHhccCC------
Confidence 2 223446799999999999999999999999999999999999999964322 122233332211
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 719 RLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 719 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
......+.+.+.++.+|+.+||+.||++|||++|++++-
T Consensus 227 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 265 (307)
T d1a06a_ 227 -----EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHP 265 (307)
T ss_dssp -----CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred -----CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence 111122234456789999999999999999999998863
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=384.33 Aligned_cols=268 Identities=28% Similarity=0.417 Sum_probs=205.1
Q ss_pred cCcccceeeeecCceEEEEEEECCceEEEEEeChhhHHHHHHHHHH--HHhcCCCCCcceEEEEecC-----eEEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQASKEFLAELKV--LTHVHHLNLVRLIGYCVEG-----SLFLVYEY 562 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~~~~~~~E~~~--l~~l~h~niv~l~g~~~~~-----~~~lv~e~ 562 (790)
++|.+.+.||+|+||.||+|+++|+.||||+++....+++..|.++ +.+++||||++++++|.+. .+++||||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence 5688899999999999999999999999999987766666555554 4577999999999998742 47999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceeecCCCCCCEEecCCCcEEEEEeCCCcccc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHT-----VPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~ 637 (790)
+++|+|.++|+.. .++|..+++++.+++.||+|||+.. .+.|+||||||+||||+.++.+||+|||+++...
T Consensus 83 ~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 83 HEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred ccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence 9999999999864 4999999999999999999999752 1345999999999999999999999999999775
Q ss_pred cCCcc---cccccccCCCccchhcccCCC------CCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHH
Q 046083 638 VGSAS---VHTRLVGTFGYMPPEYAQYGE------VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVL 708 (790)
Q Consensus 638 ~~~~~---~~~~~~gt~~y~aPE~~~~~~------~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 708 (790)
..... ......||+.|+|||++.... ++.++|||||||+||||+||..|+............. .
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~-------~ 232 (303)
T d1vjya_ 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL-------V 232 (303)
T ss_dssp TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT-------S
T ss_pred CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc-------c
Confidence 43322 223467999999999987543 5779999999999999999988875433221100000 0
Q ss_pred cCCCCh-hhhhhhcCCcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 709 RQPDPR-EDLQRLVDPRLGDDYP-----IDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 709 ~~~~~~-~~l~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
...... .......+..++...+ .+....+.+|+.+||+.||++|||+.||++.|+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 000011 1111222223322222 2456779999999999999999999999999998764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2e-44 Score=389.72 Aligned_cols=248 Identities=21% Similarity=0.335 Sum_probs=204.3
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
.++|++.+.||+|+||.||+|+.. |+.||||++.. ...+.+.+|+++|++++|||||++++++.+ +..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 358999999999999999999986 88999999864 334668899999999999999999998875 569999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEec--CCCcEEEEEeCCCcccccCC
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILID--KNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~--~~~~~kl~DfGla~~~~~~~ 640 (790)
+++|+|.+++.... ..+++..+..++.||+.||.|||++++ +||||||+|||++ .++.+||+|||+++......
T Consensus 105 ~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~i---iHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 105 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNY---VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---eeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999996543 359999999999999999999999998 9999999999995 46789999999998765332
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
......||+.|||||++.+..++.++|||||||++|||++|+.||..... ...+..+......
T Consensus 181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~~~------- 243 (350)
T d1koaa2 181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRNVKSCDWN------- 243 (350)
T ss_dssp --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCC-------
T ss_pred --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCC-------
Confidence 23446799999999999999999999999999999999999999964321 2223333322110
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.........+.++.+|+.+||+.||++|||++|++++
T Consensus 244 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 244 ----MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ----SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ----CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111112345678999999999999999999999886
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=382.32 Aligned_cols=249 Identities=26% Similarity=0.429 Sum_probs=202.0
Q ss_pred ceeeeecCceEEEEEEECC-----ceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEec--CeEEEEEEEe
Q 046083 495 GNKIGQGGFGAVFYAELRG-----EKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVE--GSLFLVYEYI 563 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~g-----~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~lv~e~~ 563 (790)
.++||+|+||+||+|.+.. ..||||+++. ...++|.+|+++|++++||||++++|++.+ +..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 5789999999999999752 2589999853 345679999999999999999999999864 4689999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc-
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS- 642 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~- 642 (790)
++|+|.++++... ..+++..+++++.|++.||.|||+.++ +||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~i---iHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccCc---ccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999999988653 467899999999999999999999998 99999999999999999999999999876543222
Q ss_pred --cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 643 --VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 643 --~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
......||+.|+|||.+....++.++||||||+++|||+||..||...... ......+....
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-------~~~~~~i~~g~--------- 251 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-------FDITVYLLQGR--------- 251 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTTC---------
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-------HHHHHHHHcCC---------
Confidence 222356899999999999999999999999999999999988887542211 11111111111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
....|..++..+.+|+.+||+.||++||||.||+++|+.+...
T Consensus 252 -----~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 252 -----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1122334456789999999999999999999999999998654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.2e-44 Score=382.08 Aligned_cols=240 Identities=28% Similarity=0.440 Sum_probs=202.8
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
++|++.+.||+|+||+||+|+.+ |+.||||+++.. ..+.+.+|+.++++++||||+++++++.+ +..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999986 889999998642 34678999999999999999999999875 4589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+++|+|..++.... .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~i---iHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDI---IYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTE---ECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCcE---EccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 9999999999998754 58889999999999999999999997 99999999999999999999999999876432
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
.....||+.|||||++.+..++.++|||||||++|||++|+.||..... ......+....
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~~--------- 217 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILNAE--------- 217 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHCC---------
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH--------HHHHHHHHcCC---------
Confidence 2346899999999999999999999999999999999999999965322 12222222211
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRP-----SMRAIVVA 761 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 761 (790)
..++...+.++.+++.+||+.||.+|| |++|++++
T Consensus 218 ------~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 ------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ------CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 122334456788999999999999996 89999865
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=379.25 Aligned_cols=246 Identities=22% Similarity=0.386 Sum_probs=202.6
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh---------hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---------QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLF 557 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~ 557 (790)
++|++.+.||+|+||+||+|... |+.||||+++. ...+.+.+|+++|++++|||||++++++.+. ..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 67999999999999999999986 88999999852 1246799999999999999999999998754 589
Q ss_pred EEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC----cEEEEEeCCC
Q 046083 558 LVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF----RAKVADFGLA 633 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~----~~kl~DfGla 633 (790)
+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++++ +||||||+|||++.++ .+||+|||++
T Consensus 90 iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~i---vHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcce---eecccccceEEEecCCCcccceEecchhhh
Confidence 9999999999999998654 59999999999999999999999997 9999999999998776 5999999999
Q ss_pred cccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC
Q 046083 634 KLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+......
T Consensus 165 ~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~~~~ 234 (293)
T d1jksa_ 165 HKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANVSAVNYE 234 (293)
T ss_dssp EECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHTTCCC
T ss_pred hhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH--------HHHHHHHHhcCCC
Confidence 8764332 23446789999999999999999999999999999999999999965322 1222222222110
Q ss_pred hhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 714 REDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 714 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.....+...+..+.+|+.+||+.||++|||++|++++
T Consensus 235 -----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 235 -----------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp -----------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000111234578899999999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.2e-44 Score=387.47 Aligned_cols=247 Identities=21% Similarity=0.362 Sum_probs=204.3
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh---hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEe
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM---QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
++|++.+.||+|+||.||+|... |+.||||+++. ...+.+.+|+++|++++|||||++++++.+ +..|+||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999985 88999999864 334568899999999999999999999875 5689999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEec--CCCcEEEEEeCCCcccccCCc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILID--KNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~--~~~~~kl~DfGla~~~~~~~~ 641 (790)
++|+|.+++...+ ..+++..+..++.||+.||.|||++++ +||||||+||||+ .++.+||+|||+++......
T Consensus 109 ~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~i---iHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 109 SGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSI---VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp CCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCe---eecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 9999999887543 359999999999999999999999998 9999999999998 67899999999998765432
Q ss_pred ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhc
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 721 (790)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.....
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~~--------- 245 (352)
T d1koba_ 184 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------LETLQNVKRCDW--------- 245 (352)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHHCCC---------
T ss_pred -ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCC---------
Confidence 23446789999999999999999999999999999999999999964322 122222222111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 722 DPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 722 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
..........+.++.+|+.+||+.||.+|||++|++++
T Consensus 246 --~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 246 --EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp --CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112223445678999999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=381.36 Aligned_cols=255 Identities=26% Similarity=0.466 Sum_probs=203.5
Q ss_pred hcCcccceeeeecCceEEEEEEECC---------ceEEEEEeCh----hhHHHHHHHHHHHHhc-CCCCCcceEEEEecC
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELRG---------EKAAIKKMDM----QASKEFLAELKVLTHV-HHLNLVRLIGYCVEG 554 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~g---------~~vavK~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 554 (790)
.++|++.+.||+|+||.||+|+..+ ..||||+++. ....++.+|...+.++ +|||||+++++|.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4578899999999999999998642 3699999864 2346788899999888 899999999999854
Q ss_pred -eEEEEEEEecCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe
Q 046083 555 -SLFLVYEYIENGNLNQHLRGSG--------------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI 619 (790)
Q Consensus 555 -~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl 619 (790)
..++||||+++|+|.+++.... ...+++.++++++.|++.||+|||++++ |||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~i---vHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCE---Eeeeecccceee
Confidence 5899999999999999997543 2358999999999999999999999998 999999999999
Q ss_pred cCCCcEEEEEeCCCcccccCCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHh-CCccccccccccccc
Q 046083 620 DKNFRAKVADFGLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELIS-AMEAVVKTNETITES 697 (790)
Q Consensus 620 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~ellt-G~~p~~~~~~~~~~~ 697 (790)
+.++.+||+|||+++........ ......|++.|+|||.+.++.++.++|||||||++|||++ |++||.....
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~----- 243 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 243 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-----
Confidence 99999999999999976543322 2334678999999999999999999999999999999998 6777753221
Q ss_pred cchHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 698 TGLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
...+..+.. ......+...+.++.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus 244 ---~~~~~~i~~--------------~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 244 ---EELFKLLKE--------------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp ---HHHHHHHHT--------------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHHHHHHc--------------CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 112221111 112233444556799999999999999999999999999987543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-44 Score=382.31 Aligned_cols=244 Identities=26% Similarity=0.391 Sum_probs=205.3
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLV 559 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv 559 (790)
.++|++.+.||+|+||.||+|+.. ++.||||+++.. ..+.+.+|+++|++++||||+++++++.+. .+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 367999999999999999999986 889999998743 346688999999999999999999988865 58999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+++|+|.+++...+ .+++..+..++.|++.||+|||++++ +||||||+|||+++++.+||+|||+|+.....
T Consensus 84 ~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~i---iHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCc---cccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999999998754 58999999999999999999999998 99999999999999999999999999865432
Q ss_pred CcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ...........
T Consensus 159 ~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--------~~~~~~i~~~~-------- 221 (337)
T d1o6la_ 159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILMEE-------- 221 (337)
T ss_dssp T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC--------
T ss_pred C-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--------HHHHHHHhcCC--------
Confidence 2 233457899999999999999999999999999999999999999965432 12222222211
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPS-----MRAIVVA 761 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 761 (790)
..+|...+.++.+|+.+||+.||.+||+ ++|++++
T Consensus 222 -------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 222 -------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -------CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1223345567889999999999999995 8888774
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-44 Score=382.24 Aligned_cols=257 Identities=26% Similarity=0.424 Sum_probs=208.0
Q ss_pred hcCcccceeeeecCceEEEEEEEC-------CceEEEEEeCh----hhHHHHHHHHHHHHhc-CCCCCcceEEEEecC-e
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDM----QASKEFLAELKVLTHV-HHLNLVRLIGYCVEG-S 555 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~ 555 (790)
.++|++.+.||+|+||.||+|++. +..||||+++. ....+|.+|+.+++++ +|||||+++++|.+. .
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 467899999999999999999863 35799999974 3345689999999999 699999999999865 4
Q ss_pred EEEEEEEecCCChhhhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEe
Q 046083 556 LFLVYEYIENGNLNQHLRGSG----------------KDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILI 619 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl 619 (790)
.++||||+++|+|.++++... ...+++..+.+++.|+++||+|||++++ +||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~i---vHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCe---eecccccccccc
Confidence 899999999999999997542 2358999999999999999999999998 999999999999
Q ss_pred cCCCcEEEEEeCCCcccccCCc-ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCcccccccccccccc
Q 046083 620 DKNFRAKVADFGLAKLTEVGSA-SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITEST 698 (790)
Q Consensus 620 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~ 698 (790)
+.++.+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||+|+..|+......
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~----- 253 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV----- 253 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS-----
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH-----
Confidence 9999999999999997654332 2233467899999999999999999999999999999999955554332211
Q ss_pred chHHHHHHHHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhccC
Q 046083 699 GLVALFEEVLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSSS 768 (790)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~~ 768 (790)
. +.+.+++........+...+..+.+|+.+||+.||++||||+||++.|++..+.
T Consensus 254 --~-------------~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 254 --D-------------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp --S-------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --H-------------HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 0 111122222222333444557899999999999999999999999999876543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.7e-43 Score=371.35 Aligned_cols=254 Identities=23% Similarity=0.385 Sum_probs=200.4
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh------hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-----e
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM------QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-----S 555 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~ 555 (790)
.++|++.+.||+|+||.||+|+.. ++.||||.++. ...+.|.+|++++++++||||+++++++... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 367999999999999999999975 88999999863 2235689999999999999999999987632 2
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
.|+||||+++++|.+++...+ .+++.+++.++.|++.||+|||++++ +||||||+|||++.++..+|+|||.+..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~i---iHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCc---cCccccCcccccCccccceeehhhhhhh
Confidence 789999999999999987654 59999999999999999999999998 9999999999999999999999999876
Q ss_pred cccCCc--ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC
Q 046083 636 TEVGSA--SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 636 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .......+.....
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVAYQHVREDPI 232 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHCCCC
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH--------HHHHHHHHhcCCC
Confidence 543222 223346799999999999999999999999999999999999999964322 1222222222111
Q ss_pred hhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHhhc
Q 046083 714 REDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRP-SMRAIVVALMTLS 766 (790)
Q Consensus 714 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~L~~l~ 766 (790)
.. .....+.+..+.+++.+||+.||++|| |++++++.|.++.
T Consensus 233 ~~-----------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 PP-----------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CG-----------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CC-----------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 00 011123446789999999999999999 8999999998764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-43 Score=382.95 Aligned_cols=240 Identities=27% Similarity=0.409 Sum_probs=202.6
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~ 560 (790)
++|++.+.||+|+||.||+|+.+ |+.||||+++.. ..+.+.+|+++|+.++||||+++++++.+ ...++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999986 889999998642 23568899999999999999999998875 4589999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCC
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGS 640 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 640 (790)
||+.+|+|.+++...+ .+++..+..++.||+.||.|||++++ |||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~i---iHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCE---ecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 9999999999998654 59999999999999999999999997 99999999999999999999999999876432
Q ss_pred cccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 641 ASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 641 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
.....||+.|||||++.+..++.++|||||||++|||++|+.||..... ......+....
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~~--------- 254 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSGK--------- 254 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC---------
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH--------HHHHHHHhcCC---------
Confidence 2346799999999999999999999999999999999999999964321 22222222221
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 046083 721 VDPRLGDDYPIDSVRKMARLARACTQENPQLRP-----SMRAIVVA 761 (790)
Q Consensus 721 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 761 (790)
...+...+.++.+++.+||+.||.+|+ |++|++++
T Consensus 255 ------~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 255 ------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ------CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 112233456789999999999999994 89999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=378.27 Aligned_cols=254 Identities=25% Similarity=0.417 Sum_probs=207.1
Q ss_pred hcCcccceeeeecCceEEEEEEEC-------CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-CeE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR-------GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSL 556 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~-------g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~ 556 (790)
.++|++.+.||+|+||+||+|.+. +..||||+++. .....|.+|++++++++||||++++|++.. ...
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 467889999999999999999874 46799999974 233458999999999999999999999874 568
Q ss_pred EEEEEEecCCChhhhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEE
Q 046083 557 FLVYEYIENGNLNQHLRGS--------GKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVA 628 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~ 628 (790)
++||||+++|+|.+++... ....+++..+.+++.++++||.|||++++ +||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~i---vHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTC---BCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCe---eeceEcCCceeecCCceEEEe
Confidence 9999999999999988642 12357999999999999999999999998 999999999999999999999
Q ss_pred EeCCCcccccCCcc-cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCC-ccccccccccccccchHHHHHH
Q 046083 629 DFGLAKLTEVGSAS-VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAM-EAVVKTNETITESTGLVALFEE 706 (790)
Q Consensus 629 DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~ 706 (790)
|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||+||. .||.... .......
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~--------~~~~~~~ 247 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--------NEQVLRF 247 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--------HHHHHHH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC--------HHHHHHH
Confidence 99999876443322 233456899999999999999999999999999999999985 5553321 1222222
Q ss_pred HHcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcc
Q 046083 707 VLRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLSS 767 (790)
Q Consensus 707 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~~ 767 (790)
+.. .. ....+...+..+.+++.+||+.+|++||||++|+++|++...
T Consensus 248 i~~-------------~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 248 VME-------------GG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHT-------------TC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHh-------------CC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 222 11 122334455689999999999999999999999999987654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.8e-43 Score=367.51 Aligned_cols=246 Identities=22% Similarity=0.358 Sum_probs=201.9
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------------hHHHHHHHHHHHHhcC-CCCCcceEEEEecC
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------------ASKEFLAELKVLTHVH-HLNLVRLIGYCVEG 554 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------------~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~ 554 (790)
++|++.+.||+|+||+||+|+.. ++.+|||+++.. ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999985 789999998532 1245889999999997 99999999999854
Q ss_pred -eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCC
Q 046083 555 -SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLA 633 (790)
Q Consensus 555 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla 633 (790)
..|+||||+++|+|.+++...+ .+++..++.++.||+.||+|||++++ +||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~i---vHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNI---VHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCC---cccccccceEEEcCCCCeEEccchhe
Confidence 5899999999999999998654 59999999999999999999999997 99999999999999999999999999
Q ss_pred cccccCCcccccccccCCCccchhcccC------CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHH
Q 046083 634 KLTEVGSASVHTRLVGTFGYMPPEYAQY------GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEV 707 (790)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 707 (790)
+...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ......+
T Consensus 158 ~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--------~~~~~~i 227 (277)
T d1phka_ 158 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------MLMLRMI 227 (277)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH
T ss_pred eEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--------HHHHHHH
Confidence 8765432 2345679999999998853 3578899999999999999999999965432 1122222
Q ss_pred HcCCCChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 708 LRQPDPREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 708 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
..... ..........+.++.+|+.+||+.||++|||++||+++
T Consensus 228 ~~~~~-----------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 MSGNY-----------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHTCC-----------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HhCCC-----------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 22211 11111223455789999999999999999999998764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=377.34 Aligned_cols=249 Identities=21% Similarity=0.296 Sum_probs=199.1
Q ss_pred cCcccce-eeeecCceEEEEEEEC--CceEEEEEeChhhHHHHHHHHHHHHhc-CCCCCcceEEEEec-----CeEEEEE
Q 046083 490 NDFSMGN-KIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHV-HHLNLVRLIGYCVE-----GSLFLVY 560 (790)
Q Consensus 490 ~~f~~~~-~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-----~~~~lv~ 560 (790)
++|.+.+ .||+|+||+||+|+.. ++.||||+++. .+.+.+|++++.++ +|||||++++++.+ ..+|+||
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivm 88 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 88 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEE
Confidence 5788765 5999999999999975 78999999864 34577899987655 89999999998753 3489999
Q ss_pred EEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC---CCcEEEEEeCCCcccc
Q 046083 561 EYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK---NFRAKVADFGLAKLTE 637 (790)
Q Consensus 561 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~---~~~~kl~DfGla~~~~ 637 (790)
|||++|+|.+++...+...+++..+..++.|++.||+|||++++ +||||||+|||++. ++.+||+|||+++...
T Consensus 89 Ey~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~i---iHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 89 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI---AHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp ECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred ECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCC---ccccccccccccccccccccccccccceeeecc
Confidence 99999999999987655679999999999999999999999998 99999999999975 5679999999998765
Q ss_pred cCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhh
Q 046083 638 VGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDL 717 (790)
Q Consensus 638 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 717 (790)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||........ ...+..
T Consensus 166 ~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--------~~~~~~-------- 227 (335)
T d2ozaa1 166 SHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--------SPGMKT-------- 227 (335)
T ss_dssp CCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------------
T ss_pred CCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--------HHHHHH--------
Confidence 332 23456799999999999999999999999999999999999999976433210 000000
Q ss_pred hhhcCCcCCCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 718 QRLVDPRLGDDY--PIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 718 ~~~~d~~l~~~~--~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
.+......... ....+.++.+|+.+||+.||++|||+.|++++-
T Consensus 228 -~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 273 (335)
T d2ozaa1 228 -RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 273 (335)
T ss_dssp -CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSH
T ss_pred -HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence 01111111111 124456799999999999999999999998863
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-42 Score=378.02 Aligned_cols=245 Identities=24% Similarity=0.338 Sum_probs=197.1
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh------HHHHHH---HHHHHHhcCCCCCcceEEEEec-CeE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA------SKEFLA---ELKVLTHVHHLNLVRLIGYCVE-GSL 556 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~------~~~~~~---E~~~l~~l~h~niv~l~g~~~~-~~~ 556 (790)
.++|++.+.||+|+||.||+|+.. |+.||||++.... ...+.+ |+++++.++|||||++++++.+ +..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 368999999999999999999986 8899999986422 122334 4667777889999999998875 468
Q ss_pred EEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCccc
Q 046083 557 FLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLT 636 (790)
Q Consensus 557 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~ 636 (790)
|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++..
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~i---iHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCCc---cceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999998654 58899999999999999999999998 99999999999999999999999999866
Q ss_pred ccCCcccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChh
Q 046083 637 EVGSASVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715 (790)
Q Consensus 637 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (790)
... ......||+.|+|||++.. ..++.++|||||||++|||+||+.||...... ........
T Consensus 158 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~~~~~~~--------- 220 (364)
T d1omwa3 158 SKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEIDRM--------- 220 (364)
T ss_dssp SSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS-----CHHHHHHH---------
T ss_pred CCC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh---------
Confidence 432 2334679999999999975 56899999999999999999999999654321 11111111
Q ss_pred hhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 046083 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPS-----MRAIVVA 761 (790)
Q Consensus 716 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 761 (790)
.... ....+...+.++.+|+.+||+.||++||| ++|++++
T Consensus 221 ----~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 221 ----TLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ----SSSC--CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ----cccC--CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 1111 11223345567899999999999999999 6888764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-43 Score=372.85 Aligned_cols=249 Identities=18% Similarity=0.295 Sum_probs=203.2
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh--HHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEEe
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA--SKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYI 563 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~~ 563 (790)
.++|++.+.||+|+||+||+|... ++.+|||.++... ...+.+|+++|++++||||+++++++.+ +..|+||||+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 367999999999999999999986 7899999997543 3458899999999999999999998874 5699999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC--CCcEEEEEeCCCcccccCCc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK--NFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~--~~~~kl~DfGla~~~~~~~~ 641 (790)
++|+|.+++...+ ..+++.++..++.|++.||+|||++++ +||||||+|||++. ...+||+|||+++......
T Consensus 84 ~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~i---iHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~- 158 (321)
T d1tkia_ 84 SGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNI---GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCC---CcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence 9999999997653 358999999999999999999999998 99999999999985 4589999999998764322
Q ss_pred ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhc
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 721 (790)
......+++.|+|||.+.+..++.++|||||||++|||++|..||..... ...+..+........ .
T Consensus 159 -~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~--------~~~~~~i~~~~~~~~---~-- 224 (321)
T d1tkia_ 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMNAEYTFD---E-- 224 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCCCCC---H--
T ss_pred -cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCC---h--
Confidence 23345789999999999999999999999999999999999999965332 222333332211000 0
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046083 722 DPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVAL 762 (790)
Q Consensus 722 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 762 (790)
......+.++.+|+.+||+.||.+|||++|++++-
T Consensus 225 ------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 259 (321)
T d1tkia_ 225 ------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp ------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred ------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 00012345688999999999999999999999853
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-43 Score=373.86 Aligned_cols=242 Identities=28% Similarity=0.448 Sum_probs=200.3
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh------hHHHHHHHHHHHH-hcCCCCCcceEEEEecC-eEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ------ASKEFLAELKVLT-HVHHLNLVRLIGYCVEG-SLFLV 559 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~------~~~~~~~E~~~l~-~l~h~niv~l~g~~~~~-~~~lv 559 (790)
++|++.+.||+|+||+||+|+.. ++.||||+++.. ..+.+..|..++. .++||||+++++++.++ ..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 67999999999999999999985 889999999642 2345777777765 68999999999998854 58999
Q ss_pred EEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccC
Q 046083 560 YEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 560 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~ 639 (790)
|||+++|+|.+++.... .+++..+..++.|++.||+|||++++ +||||||+|||+++++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~i---iHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGI---VYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCe---eeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999998654 48899999999999999999999998 99999999999999999999999999865432
Q ss_pred CcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQR 719 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 719 (790)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+....
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~~~-------- 219 (320)
T d1xjda_ 157 D-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSIRMDN-------- 219 (320)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC--------
T ss_pred c-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCC--------
Confidence 2 233456799999999999999999999999999999999999999965322 12222222111
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 046083 720 LVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMR-AIVV 760 (790)
Q Consensus 720 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl~ 760 (790)
..+|...+.++.+|+.+||+.||++|||+. |+++
T Consensus 220 -------~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 -------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -------CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 122334456789999999999999999995 6754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=360.91 Aligned_cols=261 Identities=26% Similarity=0.427 Sum_probs=198.5
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYE 561 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e 561 (790)
++|++.++||+|+||+||+|+.. ++.||||+++.. ..+.+.+|+++|++++|||||++++++.++ ..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999986 889999998643 245789999999999999999999998754 6899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
|+.+ ++.+++.......+++..+..++.|++.||+|||++++ |||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~I---iHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~- 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 156 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCE---EccccCchheeecccCcceeccCCcceeccCCc-
Confidence 9976 55555544444569999999999999999999999998 999999999999999999999999998664322
Q ss_pred ccccccccCCCccchhcccCCC-CCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhh
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGE-VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRL 720 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 720 (790)
.......||+.|+|||.+.... ++.++|||||||++|||++|+.||...... ..+.... .....+.. ......
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~----~~~~~i~-~~~~~~~~-~~~~~~ 230 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI----DQLFRIF-RTLGTPDE-VVWPGV 230 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHH-HHHCCCCT-TTSTTG
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH----HHHHHHH-HhcCCCch-hhcccc
Confidence 2334467999999999887665 588999999999999999999999654321 1111111 11111110 000000
Q ss_pred c-CCcCCCCC-----------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 721 V-DPRLGDDY-----------PIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 721 ~-d~~l~~~~-----------~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
. .+...... .......+.+|+.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 00000000 01234678899999999999999999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-42 Score=362.17 Aligned_cols=256 Identities=27% Similarity=0.338 Sum_probs=193.4
Q ss_pred cceeeeecCceEEEEEEEC--CceEEEEEeChhh--------HHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 494 MGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA--------SKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 494 ~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
..++||+|+||+||+|+.. |+.||||+++... .+.+.+|+++|++++|||||++++++.+ +..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3579999999999999975 8899999986422 2358899999999999999999999875 468999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+.++++..+.... ..+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~i---iHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 82 METDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHWI---LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp CSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred hcchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhccce---ecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 9998777666543 358889999999999999999999998 9999999999999999999999999986543322
Q ss_pred cccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhhhhc
Q 046083 643 VHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQRLV 721 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 721 (790)
......||+.|+|||++... .++.++|||||||++|||++|+.||...... +...........+.. +.+....
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-----~~l~~i~~~~~~~~~-~~~~~~~ 229 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-----DQLTRIFETLGTPTE-EQWPDMC 229 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHHHCCCCT-TTSSSTT
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH-----HHHHHHHHhcCCCCh-hhccchh
Confidence 22345789999999998654 5799999999999999999999998654321 111111222221111 1000000
Q ss_pred ---CC---cCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 722 ---DP---RLGDDYP-----IDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 722 ---d~---~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.. ......+ ......+.+|+.+||+.||++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00 0000111 1234678999999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=360.89 Aligned_cols=235 Identities=26% Similarity=0.412 Sum_probs=193.2
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChhh---------HHHHHHHHHHHHhcC--CCCCcceEEEEec-Ce
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQA---------SKEFLAELKVLTHVH--HLNLVRLIGYCVE-GS 555 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~---------~~~~~~E~~~l~~l~--h~niv~l~g~~~~-~~ 555 (790)
++|++.+.||+|+||+||+|+.. |+.||||+++... ..++.+|+.+|++++ ||||+++++++.+ +.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999986 8899999986421 233678999999996 8999999999875 46
Q ss_pred EEEEEEEecC-CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCC-CcEEEEEeCCC
Q 046083 556 LFLVYEYIEN-GNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKN-FRAKVADFGLA 633 (790)
Q Consensus 556 ~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~-~~~kl~DfGla 633 (790)
.++||||+.+ +++.+++.... .+++..+..++.|++.||+|||++++ +||||||+|||++.+ +.+||+|||++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~i---iHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGV---LHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCC---ccccCcccceEEecCCCeEEECccccc
Confidence 8999999976 67888887643 59999999999999999999999997 999999999999854 79999999999
Q ss_pred cccccCCcccccccccCCCccchhcccCCCC-CchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC
Q 046083 634 KLTEVGSASVHTRLVGTFGYMPPEYAQYGEV-SPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD 712 (790)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (790)
+..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .+....
T Consensus 159 ~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------------~i~~~~- 220 (273)
T d1xwsa_ 159 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------EIIRGQ- 220 (273)
T ss_dssp EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------HHHHCC-
T ss_pred eecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------------HHhhcc-
Confidence 865432 2345679999999999987766 567899999999999999999985421 111110
Q ss_pred ChhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 713 PREDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 713 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
..++...+.++.+|+.+||+.||++|||++|++++
T Consensus 221 --------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 --------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp --------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01122334678999999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=359.78 Aligned_cols=261 Identities=25% Similarity=0.397 Sum_probs=196.5
Q ss_pred hcCcccceeeeecCceEEEEEEEC---CceEEEEEeChh-----hHHHHHHHHHHHHhc---CCCCCcceEEEEec----
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR---GEKAAIKKMDMQ-----ASKEFLAELKVLTHV---HHLNLVRLIGYCVE---- 553 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~---g~~vavK~~~~~-----~~~~~~~E~~~l~~l---~h~niv~l~g~~~~---- 553 (790)
.++|++.++||+|+||+||+|+.. ++.||||+++.. ....+.+|+++|+.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999974 457899998532 223466777777665 79999999998752
Q ss_pred --CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeC
Q 046083 554 --GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFG 631 (790)
Q Consensus 554 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfG 631 (790)
...+++|||++++.+...... ....+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~~i---vHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCE---EecCCCccEEEEcCCCCeeecchh
Confidence 247999999998776554443 34568999999999999999999999998 999999999999999999999999
Q ss_pred CCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCC
Q 046083 632 LAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQP 711 (790)
Q Consensus 632 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (790)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +...........+
T Consensus 162 ~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-----~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 162 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-----DQLGKILDVIGLP 234 (305)
T ss_dssp SCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCCC
T ss_pred hhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-----HHHHHHHHhhCCC
Confidence 99865422 2334578999999999999999999999999999999999999999654321 1111111222111
Q ss_pred CChhhhh-------hhcCCcC---CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 712 DPREDLQ-------RLVDPRL---GDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 712 ~~~~~l~-------~~~d~~l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.. ..+. ....... ...+.......+.+|+.+||+.||++|||++|++++
T Consensus 235 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 235 GE-EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CG-GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ch-hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 11 1110 0000000 011122345678899999999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.2e-41 Score=352.98 Aligned_cols=261 Identities=24% Similarity=0.391 Sum_probs=196.7
Q ss_pred cCcccceeeeecCceEEEEEEEC-CceEEEEEeChh-----hHHHHHHHHHHHHhcCCCCCcceEEEEec-CeEEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ-----ASKEFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY 562 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~lv~e~ 562 (790)
++|++.++||+|+||+||+|+++ ++.||||+++.. ..+.+.+|+.+|++++||||+++++++.+ +..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 68999999999999999999987 789999998642 24679999999999999999999998875 458999999
Q ss_pred ecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCcc
Q 046083 563 IENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 563 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 642 (790)
+.++.+..+.... ..+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~I---vHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRV---LHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp CSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcE---EecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence 9887777666544 359999999999999999999999998 9999999999999999999999999987543222
Q ss_pred cccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChh--hhhh
Q 046083 643 VHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE--DLQR 719 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~l~~ 719 (790)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... ..+.. .......+.... ....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~----~~~~~-i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA----DQLMR-IFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHH-HHHHHCCCCTTTSTTGGG
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH----HHHHH-HHHhhCCCChhhccchhh
Confidence 22335689999999998754 5689999999999999999999999654321 11111 111111111100 0000
Q ss_pred hc--CCcCC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 720 LV--DPRLG-------DDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 720 ~~--d~~l~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.. +.... ..........+.+|+.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00000 01122345678899999999999999999999853
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-40 Score=351.06 Aligned_cols=256 Identities=23% Similarity=0.294 Sum_probs=194.7
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChh-hHHHHHHHHHHHHhcCCCCCcceEEEE-ec-CeEEEEEEEec
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ-ASKEFLAELKVLTHVHHLNLVRLIGYC-VE-GSLFLVYEYIE 564 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~-~~-~~~~lv~e~~~ 564 (790)
++|++.+.||+|+||.||+|++. |+.||||.+... ..+++..|+++++.++|+|++..+..+ .+ ...++||||+.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~ 86 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence 57999999999999999999986 789999987643 335688999999999888777666554 33 45789999984
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEec---CCCcEEEEEeCCCcccccCCc
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILID---KNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~---~~~~~kl~DfGla~~~~~~~~ 641 (790)
++|.+.+.... ..+++..+..++.|++.||+|||++++ +||||||+|||++ .+..+||+|||+++.......
T Consensus 87 -~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i---iHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 87 -PSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNF---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp -CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred -Cchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCe---eeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 57766665443 369999999999999999999999997 9999999999985 456799999999997654322
Q ss_pred c------cccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChh
Q 046083 642 S------VHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPRE 715 (790)
Q Consensus 642 ~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (790)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .............+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~-~~~~~~~~~~~~~~---- 236 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEKKMSTP---- 236 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHHSC----
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH-HHHHHhhcccCCCC----
Confidence 1 223467999999999999999999999999999999999999999764432110 00101001100000
Q ss_pred hhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 046083 716 DLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTL 765 (790)
Q Consensus 716 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l 765 (790)
... +. ...+.++.+++..||+.+|++||+++++.+.|+.+
T Consensus 237 -~~~-----~~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 237 -IEV-----LC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp -HHH-----HT----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred -hhH-----hc----cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 000 11 12345789999999999999999999998887765
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-39 Score=350.82 Aligned_cols=262 Identities=20% Similarity=0.308 Sum_probs=199.7
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeChhhHHHHHHHHHHHHhcC-CCCCcceEEEEec---CeEEEEEEEe
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHVH-HLNLVRLIGYCVE---GSLFLVYEYI 563 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~---~~~~lv~e~~ 563 (790)
++|++.++||+|+||+||+|+.. ++.||||+++....+++.+|+++|++++ ||||+++++++.. ...++||||+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence 57999999999999999999986 8899999999888888999999999995 9999999998863 3489999999
Q ss_pred cCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC-cEEEEEeCCCcccccCCcc
Q 046083 564 ENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF-RAKVADFGLAKLTEVGSAS 642 (790)
Q Consensus 564 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~-~~kl~DfGla~~~~~~~~~ 642 (790)
.+++|..+.+ .+++..+..++.|++.||.|||++++ +||||||+|||++.++ .+||+|||+++......
T Consensus 115 ~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~gI---vHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~-- 184 (328)
T d3bqca1 115 NNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGI---MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-- 184 (328)
T ss_dssp CSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC--
T ss_pred CCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhccc---ccccccccceEEcCCCCeeeecccccceeccCCC--
Confidence 9999987653 48999999999999999999999998 9999999999998655 68999999998764332
Q ss_pred cccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchH------HHHHHHHcC-CCCh
Q 046083 643 VHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLV------ALFEEVLRQ-PDPR 714 (790)
Q Consensus 643 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~------~~~~~~~~~-~~~~ 714 (790)
......+|+.|+|||.+.+. .++.++||||+||+++||++|+.||.............. ......... ....
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 23446789999999998765 479999999999999999999999965433211000000 000000000 0000
Q ss_pred hhhhhhcCCc--------CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 715 EDLQRLVDPR--------LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 715 ~~l~~~~d~~--------l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.......... ...........++.+|+.+||+.||++|||++|++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111110 0111112345678899999999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-39 Score=346.77 Aligned_cols=265 Identities=29% Similarity=0.386 Sum_probs=195.8
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec--------
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-------- 553 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------- 553 (790)
.++|++.++||+|+||+||+|+.. |+.||||++.. ...+++.+|+++|++++|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 367999999999999999999985 88999999853 234668899999999999999999998743
Q ss_pred -CeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCC
Q 046083 554 -GSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGL 632 (790)
Q Consensus 554 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGl 632 (790)
+..++||||+.++.+..+.... ..++...+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~--~~~~~~~~~~i~~qil~~l~~lH~~~i---vHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNKI---LHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT--CCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhhhcc--cccccHHHHHHHHHHHHHHHHhccCCE---EecCcCchheeecCCCcEEeeecce
Confidence 2479999999887766555433 358899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCcc---cccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHH
Q 046083 633 AKLTEVGSAS---VHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVL 708 (790)
Q Consensus 633 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 708 (790)
++........ ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||..... ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~-----~~~~~~i~~~~ 238 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-----QHQLALISQLC 238 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHH
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH-----HHHHHHHHHhc
Confidence 9865432221 22235799999999998765 689999999999999999999999965332 11122222222
Q ss_pred cCCCChh-------hhhhhcCCcCCCCCCH-------HHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 709 RQPDPRE-------DLQRLVDPRLGDDYPI-------DSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 709 ~~~~~~~-------~l~~~~d~~l~~~~~~-------~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
....... ..............+. .....+.+|+.+||+.||++|||++|++++=.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf 307 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307 (318)
T ss_dssp CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChh
Confidence 2211100 0000010000001111 11345678999999999999999999997543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-39 Score=348.27 Aligned_cols=262 Identities=23% Similarity=0.322 Sum_probs=195.3
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-----eEE
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-----SLF 557 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~ 557 (790)
+++|++.++||+|+||+||+|... |+.||||+++. ...+.+.+|+++|++++|||++++++++... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 457999999999999999999876 88999999863 2345788999999999999999999998642 235
Q ss_pred EEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccc
Q 046083 558 LVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTE 637 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~ 637 (790)
++++|+.+|+|.+++... .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++...
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~i---iHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCC---cCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 666777899999999754 48999999999999999999999998 999999999999999999999999998654
Q ss_pred cCCcc--cccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh
Q 046083 638 VGSAS--VHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR 714 (790)
Q Consensus 638 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (790)
..... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||...... +...........+...
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL-----DQLNHILGILGSPSQE 235 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCSCCHH
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH-----HHHHHHhhhccCCChh
Confidence 33221 2344679999999999854 46789999999999999999999999654321 1111111111111100
Q ss_pred --------hhhhhhcCCcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 715 --------EDLQRLVDPRLGDDYP-----IDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 715 --------~~l~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
...............+ .....++.+|+.+||+.||.+|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000001111 1223468899999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-40 Score=356.42 Aligned_cols=259 Identities=26% Similarity=0.332 Sum_probs=192.6
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChhhHHHHHHHHHHHHhcCCCCCcceEEEEec-------CeEEEEEE
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVE-------GSLFLVYE 561 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------~~~~lv~e 561 (790)
+|+..++||+|+||+||+|++. |+.||||+++... +.+.+|+++|++++||||+++++++.. ..+++|||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 4777899999999999999986 8899999986432 234579999999999999999998752 12689999
Q ss_pred EecCCChhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCC-cEEEEEeCCCcccccC
Q 046083 562 YIENGNLNQHLRG-SGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNF-RAKVADFGLAKLTEVG 639 (790)
Q Consensus 562 ~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~-~~kl~DfGla~~~~~~ 639 (790)
|++++.+..+.+. .....+++..+..++.|++.||+|||++++ +||||||+|||++.++ .+||+|||+++.....
T Consensus 100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~I---iHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTE---ECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCC---cccCCCcceEEEecCCCceeEecccchhhccCC
Confidence 9987644443322 223469999999999999999999999998 9999999999999775 8999999999876433
Q ss_pred CcccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCChhhhh
Q 046083 640 SASVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPREDLQ 718 (790)
Q Consensus 640 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 718 (790)
. ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||...... +...........+ ..+.+.
T Consensus 177 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-----~~l~~i~~~~g~~-~~~~~~ 248 (350)
T d1q5ka_ 177 E--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-----DQLVEIIKVLGTP-TREQIR 248 (350)
T ss_dssp S--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-----HHHHHHHHHHCCC-CHHHHH
T ss_pred c--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-----HHHHHHHHHhCCC-hHHhhh
Confidence 2 2334678999999998765 57899999999999999999999999654321 1111111111111 111111
Q ss_pred hhcCCc----C--------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 719 RLVDPR----L--------GDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 719 ~~~d~~----l--------~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
...... + ...........+.+|+.+||+.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111100 0 001112345678899999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=348.93 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=199.9
Q ss_pred cCcccceeeeecCceEEEEEEEC-----CceEEEEEeChh-------hHHHHHHHHHHHHhcCC-CCCcceEEEEec-Ce
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR-----GEKAAIKKMDMQ-------ASKEFLAELKVLTHVHH-LNLVRLIGYCVE-GS 555 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~-----g~~vavK~~~~~-------~~~~~~~E~~~l~~l~h-~niv~l~g~~~~-~~ 555 (790)
++|++.+.||+|+||+||+|... |+.||||.++.. ..+.+.+|++++++++| |||+++++++.+ ..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999862 678999998632 34568899999999966 899999998874 56
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
.+++|||+.+|+|.+++...+ .+.......++.|++.||+|||++++ +||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~i---vHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGI---IYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCE---EeccCCccceeecCCCCEEEeeccchhh
Confidence 899999999999999998754 46788899999999999999999998 9999999999999999999999999987
Q ss_pred cccCCcccccccccCCCccchhcccCC--CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC
Q 046083 636 TEVGSASVHTRLVGTFGYMPPEYAQYG--EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
+............|++.|++||.+.+. .++.++|||||||+||||++|+.||...... ..............
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~----~~~~~i~~~~~~~~-- 252 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK----NSQAEISRRILKSE-- 252 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC----CCHHHHHHHHHHCC--
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcccCC--
Confidence 654444444557899999999999764 4788999999999999999999999665432 11111112111111
Q ss_pred hhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 046083 714 REDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPS-----MRAIVVA 761 (790)
Q Consensus 714 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 761 (790)
...+...+.++.+|+.+||+.||.+||| ++|++++
T Consensus 253 -------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 253 -------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 1223345678999999999999999994 7888754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.2e-39 Score=342.37 Aligned_cols=257 Identities=19% Similarity=0.225 Sum_probs=201.0
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-hhHHHHHHHHHHHHhcCC-CCCcceEEEEec-CeEEEEEEEec
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-QASKEFLAELKVLTHVHH-LNLVRLIGYCVE-GSLFLVYEYIE 564 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~-~~~~lv~e~~~ 564 (790)
++|++.+.||+|+||+||+|++. |+.||||.++. ...+.+.+|++.+..++| +|++.+++++.+ ...++||||+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~- 83 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 83 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence 67999999999999999999976 78999998854 334567889999999965 899999998875 4589999998
Q ss_pred CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecC-----CCcEEEEEeCCCcccccC
Q 046083 565 NGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDK-----NFRAKVADFGLAKLTEVG 639 (790)
Q Consensus 565 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~-----~~~~kl~DfGla~~~~~~ 639 (790)
+++|.+++...+ ..+++..+..++.|++.||+|||++++ +||||||+|||++. ++.+||+|||+++.....
T Consensus 84 ~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~gi---iHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 84 GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSL---VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTE---ECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCc---eeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 679999987654 368999999999999999999999997 99999999999974 568999999999876432
Q ss_pred Cc------ccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCC
Q 046083 640 SA------SVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDP 713 (790)
Q Consensus 640 ~~------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (790)
.. .......||+.|||||.+.+..++.++|||||||++|||++|+.||....... .......+.....
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~-----~~~~~~~i~~~~~- 233 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-----NKQKYERIGEKKQ- 233 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC-----HHHHHHHHHHHHH-
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchh-----HHHHHHHHHhccC-
Confidence 21 12234679999999999999999999999999999999999999996543321 1111111111000
Q ss_pred hhhhhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 046083 714 REDLQRLVDPRLGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVALMTLS 766 (790)
Q Consensus 714 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~l~ 766 (790)
.....+ +.. ..+.++.+++..|++.+|++||+++.+.+.|..+.
T Consensus 234 ~~~~~~-----l~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 234 STPLRE-----LCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HSCHHH-----HTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CCChHH-----hcC----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 000111 111 23356889999999999999999999888887653
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-39 Score=350.18 Aligned_cols=257 Identities=22% Similarity=0.336 Sum_probs=191.8
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-------
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG------- 554 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------- 554 (790)
.++|++.++||+|+||+||+|... |+.||||+++. ...+.+.+|+++|++++|||||++++++...
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999986 88999999863 2345688999999999999999999998642
Q ss_pred eEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCc
Q 046083 555 SLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAK 634 (790)
Q Consensus 555 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~ 634 (790)
..|+||||+ +.+|..+++.. .+++..+..++.|++.||.|||++++ +||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~I---iHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCCC---cccccCcchhhccccccccccccccee
Confidence 369999999 55788777643 59999999999999999999999998 999999999999999999999999998
Q ss_pred ccccCCcccccccccCCCccchhcccC-CCCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC-
Q 046083 635 LTEVGSASVHTRLVGTFGYMPPEYAQY-GEVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD- 712 (790)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 712 (790)
..... .+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... ............+.
T Consensus 170 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-----~~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 170 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-----DQLKEIMKVTGTPPA 240 (346)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHHHCCCCH
T ss_pred ccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-----HHHHHHHhccCCCcH
Confidence 65432 344678999999999876 45789999999999999999999999654321 11111111111110
Q ss_pred -------Ch--hhhhhhcCCcCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 713 -------PR--EDLQRLVDPRLGD---DYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 713 -------~~--~~l~~~~d~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
.. ......+...... .........+.+|+.+||+.||.+|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 0000001000000 1112334567899999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-39 Score=339.43 Aligned_cols=262 Identities=26% Similarity=0.348 Sum_probs=201.9
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEecC-eEEEEEE
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYE 561 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~lv~e 561 (790)
++|++.++||+|+||+||+|++. ++.||||+++. ...+.+.+|+.+|++++||||+++++++.+. ..++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999986 78899999853 3356789999999999999999999998854 5899999
Q ss_pred EecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcccccCCc
Q 046083 562 YIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKLTEVGSA 641 (790)
Q Consensus 562 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 641 (790)
++.+++|..++...+ .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+||+|||.++.......
T Consensus 82 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~~I---vHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRNV---LHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcCCE---eeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999988887643 58899999999999999999999997 9999999999999999999999999987653322
Q ss_pred ccccccccCCCccchhcccCCC-CCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCCCh--hhhh
Q 046083 642 SVHTRLVGTFGYMPPEYAQYGE-VSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPDPR--EDLQ 718 (790)
Q Consensus 642 ~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~ 718 (790)
......+++.|+|||.+.... ++.++|||||||++|||++|+.||...... .+............... ....
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV----DDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH----HHHHHHHHHHHCCCCTTTCTTGG
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH----HHHHHHHHhhcCCCChhhhhhhh
Confidence 233356788999999987665 689999999999999999999997543221 11112222222221110 0011
Q ss_pred hhcCCc---------CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046083 719 RLVDPR---------LGDDYPIDSVRKMARLARACTQENPQLRPSMRAIVVA 761 (790)
Q Consensus 719 ~~~d~~---------l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 761 (790)
...+.. -...........+.+|+.+||+.||.+|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111100 0011223445678899999999999999999999764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-38 Score=343.36 Aligned_cols=264 Identities=20% Similarity=0.245 Sum_probs=189.1
Q ss_pred cCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec-------Ce
Q 046083 490 NDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE-------GS 555 (790)
Q Consensus 490 ~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------~~ 555 (790)
++|++.++||+|+||+||+|.+. |+.||||+++. .....+.+|+.++++++||||+++++++.. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999986 88999999853 334568899999999999999999998852 35
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
+|+||||+.++.+ +.+. ..+++..+..++.|++.||.|||++++ +||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~l~-~~~~----~~~~~~~i~~~~~qil~gl~~LH~~gi---iHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQ----MELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHH-HHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchHHH-Hhhh----cCCCHHHHHHHHHHHHHHHHHhhhccc---ccccCCccccccccccceeeechhhhhc
Confidence 8999999977544 4443 248999999999999999999999998 9999999999999999999999999886
Q ss_pred cccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccccc--------------cchH
Q 046083 636 TEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETITES--------------TGLV 701 (790)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~--------------~~~~ 701 (790)
.... .......+|+.|+|||++.+..++.++||||+||+++||++|+.||.......... ....
T Consensus 169 ~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 169 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 5432 22344678999999999999999999999999999999999999996543210000 0000
Q ss_pred HHHHHHHcCCC--ChhhhhhhcCCcCCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 702 ALFEEVLRQPD--PREDLQRLVDPRLGDD---YPIDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 702 ~~~~~~~~~~~--~~~~l~~~~d~~l~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
........... ................ ........+.+|+.+||+.||++|||++|++++-+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw 313 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 313 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence 00011111100 0001111111111111 12345678899999999999999999999987643
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-37 Score=337.22 Aligned_cols=260 Identities=22% Similarity=0.330 Sum_probs=194.6
Q ss_pred hcCcccceeeeecCceEEEEEEEC--CceEEEEEeCh-----hhHHHHHHHHHHHHhcCCCCCcceEEEEec------Ce
Q 046083 489 TNDFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDM-----QASKEFLAELKVLTHVHHLNLVRLIGYCVE------GS 555 (790)
Q Consensus 489 ~~~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~ 555 (790)
.++|++.++||+|+||+||+|+.. |+.||||+++. ...+.+.+|+++|++++|||++++++++.. ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 568999999999999999999875 88999999863 234568899999999999999999998752 23
Q ss_pred EEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 556 LFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 556 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
.+++|||+.+|+|.+++... .+++..+..++.|++.||+|||++++ +||||||+|||++.++.+|++|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~gi---iHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCCC---cccccCCccccccccccccccccchhcc
Confidence 56778888999999999643 59999999999999999999999998 9999999999999999999999999975
Q ss_pred cccCCcccccccccCCCccchhcccCC-CCCchhhHHHHHHHHHHHHhCCccccccccccccccchHHHHHHHHcCCC--
Q 046083 636 TEVGSASVHTRLVGTFGYMPPEYAQYG-EVSPKIDVYAFGVVLYELISAMEAVVKTNETITESTGLVALFEEVLRQPD-- 712 (790)
Q Consensus 636 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 712 (790)
... ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...... ..............
T Consensus 171 ~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~-----~~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 171 TDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-----DQLKLILRLVGTPGAE 241 (348)
T ss_dssp CTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCCCCHH
T ss_pred cCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhcCCCChH
Confidence 432 23345789999999987665 4689999999999999999999999654321 11111111111110
Q ss_pred -----ChhhhhhhcCCcCC-CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 046083 713 -----PREDLQRLVDPRLG-DDYP-----IDSVRKMARLARACTQENPQLRPSMRAIVVALM 763 (790)
Q Consensus 713 -----~~~~l~~~~d~~l~-~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 763 (790)
.............. ...+ ......+.+|+.+||+.||.+|||++|++++=+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~ 303 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHh
Confidence 00011111111000 0000 123456889999999999999999999998533
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.6e-34 Score=311.00 Aligned_cols=263 Identities=20% Similarity=0.256 Sum_probs=190.6
Q ss_pred CcccceeeeecCceEEEEEEEC--CceEEEEEeChh--hHHHHHHHHHHHHhcC-----------CCCCcceEEEEec--
Q 046083 491 DFSMGNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ--ASKEFLAELKVLTHVH-----------HLNLVRLIGYCVE-- 553 (790)
Q Consensus 491 ~f~~~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~--~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~~-- 553 (790)
+|++.++||+|+||+||+|+.. |+.||||+++.. ..+.+.+|++++++++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 5999999999999999999985 889999999754 3466788999988875 5789999988753
Q ss_pred -CeEEEEEEEecCCChh-hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCEEecCCC------c
Q 046083 554 -GSLFLVYEYIENGNLN-QHLRGSGKDTLTWSARMQIALDSARGLEYIHE-HTVPVYIHRDIKPANILIDKNF------R 624 (790)
Q Consensus 554 -~~~~lv~e~~~~g~L~-~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~vH~dlkp~NILl~~~~------~ 624 (790)
...+++|+++..+... ..........+++..+..++.|++.||+|||+ .++ +||||||+|||++.++ .
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~I---vHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGI---IHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCE---ECSCCSGGGEEEEEEETTTTEEE
T ss_pred ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCc---ccccCChhHeeeeccCcccccce
Confidence 3466777776655433 33334445678999999999999999999998 776 9999999999998655 3
Q ss_pred EEEEEeCCCcccccCCcccccccccCCCccchhcccCCCCCchhhHHHHHHHHHHHHhCCccccccccccc-cccchHHH
Q 046083 625 AKVADFGLAKLTEVGSASVHTRLVGTFGYMPPEYAQYGEVSPKIDVYAFGVVLYELISAMEAVVKTNETIT-ESTGLVAL 703 (790)
Q Consensus 625 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS~Gvvl~elltG~~p~~~~~~~~~-~~~~~~~~ 703 (790)
++++|||.+..... ......||+.|+|||.+....++.++||||+||+++||++|+.||........ ...+....
T Consensus 171 ~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 89999999985432 22346799999999999999999999999999999999999999865432211 11111111
Q ss_pred HHHHHcCCCChhhh------hhhcCC-----c--------------CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 046083 704 FEEVLRQPDPREDL------QRLVDP-----R--------------LGDDYPIDSVRKMARLARACTQENPQLRPSMRAI 758 (790)
Q Consensus 704 ~~~~~~~~~~~~~l------~~~~d~-----~--------------l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev 758 (790)
....+.... .... ....+. . ............+.+|+.+||+.||.+|||++|+
T Consensus 247 ~~~~lg~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 247 IIELLGELP-SYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHCSCC-HHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHhCCCC-HHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 111221111 1110 000000 0 0112345677889999999999999999999999
Q ss_pred HHH
Q 046083 759 VVA 761 (790)
Q Consensus 759 l~~ 761 (790)
+++
T Consensus 326 L~H 328 (362)
T d1q8ya_ 326 VNH 328 (362)
T ss_dssp HTC
T ss_pred hcC
Confidence 886
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=7.6e-21 Score=186.22 Aligned_cols=160 Identities=14% Similarity=0.150 Sum_probs=119.2
Q ss_pred ccceeeeecCceEEEEEEEC-CceEEEEEeChh---------------------hHHHHHHHHHHHHhcCCCCCcceEEE
Q 046083 493 SMGNKIGQGGFGAVFYAELR-GEKAAIKKMDMQ---------------------ASKEFLAELKVLTHVHHLNLVRLIGY 550 (790)
Q Consensus 493 ~~~~~lG~G~fg~Vy~a~~~-g~~vavK~~~~~---------------------~~~~~~~E~~~l~~l~h~niv~l~g~ 550 (790)
.+.++||+|+||.||+|... |+.||||.++.. .......|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 46899999999999999875 889999986421 11234568889999999999998866
Q ss_pred EecCeEEEEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEecCCCcEEEEEe
Q 046083 551 CVEGSLFLVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTVPVYIHRDIKPANILIDKNFRAKVADF 630 (790)
Q Consensus 551 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~vH~dlkp~NILl~~~~~~kl~Df 630 (790)
.. .+++|||+++..+.+ ++.....+++.|++++|+|||++++ +||||||+|||++++ .++|+||
T Consensus 83 ~~---~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~gi---iHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 83 EG---NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGI---VHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp ET---TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTE---ECSCCSTTSEEEETT-EEEECCC
T ss_pred cC---CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCE---EEccCChhheeeeCC-CEEEEEC
Confidence 42 379999998865543 2333456789999999999999997 999999999999965 5899999
Q ss_pred CCCcccccCCcccccccccCCCccc------hhcccCCCCCchhhHHHHHHHHH
Q 046083 631 GLAKLTEVGSASVHTRLVGTFGYMP------PEYAQYGEVSPKIDVYAFGVVLY 678 (790)
Q Consensus 631 Gla~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~s~~sDvwS~Gvvl~ 678 (790)
|+|......... .|.. .|.+ ...|+.++|+||..--++
T Consensus 147 G~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 147 PQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp TTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred CCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHHh
Confidence 999765432221 0111 1111 356788899999765443
|
| >d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: LysM domain superfamily: LysM domain family: LysM domain domain: Membrane-bound lytic murein transclycosylase D, MltD species: Escherichia coli [TaxId: 562]
Probab=99.18 E-value=8.1e-12 Score=89.96 Aligned_cols=45 Identities=24% Similarity=0.418 Sum_probs=41.4
Q ss_pred eeeecCCCCCHHHHHHHcCCChhhHhhcCCCCCCcccccCCceEEecc
Q 046083 224 ASYYLWKGANLTFISKVFDTSIKYILSFNPQITNKDKILAGTRINVPF 271 (790)
Q Consensus 224 ~~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~ip~ 271 (790)
.+|+|++||||+.||++||+++++|+++| +++ +.|++||.|.||+
T Consensus 3 v~y~V~~GDTl~~IA~~y~vs~~~i~~~N-~l~--~~l~~Gq~L~i~v 47 (48)
T d1e0ga_ 3 ITYRVRKGDSLSSIAKRHGVNIKDVMRWN-SDT--ANLQPGDKLTLFV 47 (48)
T ss_dssp CEEEECTTCCHHHHHHHHTCCHHHHHHHC-SCG--GGCCTTEEEECCC
T ss_pred EEEEECCCCCHHHHHHHHCCCHHHHHHHc-CCc--ccCcCCCEEEEEe
Confidence 36999999999999999999999999999 783 3699999999996
|
| >d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: LysM domain superfamily: LysM domain family: LysM domain domain: Hypothetical protein YkuD, N-terminal domain species: Bacillus subtilis [TaxId: 1423]
Probab=99.15 E-value=1e-11 Score=89.86 Aligned_cols=46 Identities=26% Similarity=0.318 Sum_probs=41.4
Q ss_pred eeeecCCCCCHHHHHHHcCCChhhHhhcCCCCCCcccccCCceEEecc
Q 046083 224 ASYYLWKGANLTFISKVFDTSIKYILSFNPQITNKDKILAGTRINVPF 271 (790)
Q Consensus 224 ~~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~ip~ 271 (790)
..|+|++||||++||++||+++++|+++| ++.+ +.|++||.|.||.
T Consensus 2 i~y~V~~GDTL~~IA~~y~v~~~~i~~~N-~~~~-~~l~~Gq~L~IPg 47 (48)
T d1y7ma2 2 LTYQVKQGDTLNSIAADFRISTAALLQAN-PSLQ-AGLTAGQSIVIPG 47 (48)
T ss_dssp EEEECCTTCCHHHHHHHTTSCCCCCCCTS-CTTC-SSCCTTCEEEETT
T ss_pred EEEEECCCCCHHHHHHHhCCCHHHHHHHc-CCCC-CCCCCCCEEEeCC
Confidence 36999999999999999999999999999 5645 4699999999993
|
| >d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: LysM domain superfamily: LysM domain family: LysM domain domain: Membrane-bound lytic murein transclycosylase D, MltD species: Escherichia coli [TaxId: 562]
Probab=99.15 E-value=8.4e-12 Score=89.86 Aligned_cols=45 Identities=16% Similarity=0.357 Sum_probs=41.5
Q ss_pred hhcccCCCCCHHHHHHHhCCCHHHHHhhCCCCCCCCCcCCCCeEEeee
Q 046083 17 ASYYVWEGSNPTYISNIFGEDIAQILLYNPNIPNQNTIPSDTRISIPF 64 (790)
Q Consensus 17 ~~y~v~~gdtl~~Ia~~~~~~~~~l~~~Np~~~~~~~~~~g~~l~ip~ 64 (790)
.+|+|++||||++||++||+++++|+++| +++ +.|.+||.|.||+
T Consensus 3 v~y~V~~GDTl~~IA~~y~vs~~~i~~~N-~l~--~~l~~Gq~L~i~v 47 (48)
T d1e0ga_ 3 ITYRVRKGDSLSSIAKRHGVNIKDVMRWN-SDT--ANLQPGDKLTLFV 47 (48)
T ss_dssp CEEEECTTCCHHHHHHHHTCCHHHHHHHC-SCG--GGCCTTEEEECCC
T ss_pred EEEEECCCCCHHHHHHHHCCCHHHHHHHc-CCc--ccCcCCCEEEEEe
Confidence 47999999999999999999999999999 675 3699999999997
|
| >d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: LysM domain superfamily: LysM domain family: LysM domain domain: Hypothetical protein YkuD, N-terminal domain species: Bacillus subtilis [TaxId: 1423]
Probab=99.10 E-value=9.1e-12 Score=90.13 Aligned_cols=45 Identities=27% Similarity=0.345 Sum_probs=41.0
Q ss_pred hhcccCCCCCHHHHHHHhCCCHHHHHhhCCCCCCCCCcCCCCeEEee
Q 046083 17 ASYYVWEGSNPTYISNIFGEDIAQILLYNPNIPNQNTIPSDTRISIP 63 (790)
Q Consensus 17 ~~y~v~~gdtl~~Ia~~~~~~~~~l~~~Np~~~~~~~~~~g~~l~ip 63 (790)
..|+|++||||++||++||+++++|+++|| +.+ +.|.+||.|.||
T Consensus 2 i~y~V~~GDTL~~IA~~y~v~~~~i~~~N~-~~~-~~l~~Gq~L~IP 46 (48)
T d1y7ma2 2 LTYQVKQGDTLNSIAADFRISTAALLQANP-SLQ-AGLTAGQSIVIP 46 (48)
T ss_dssp EEEECCTTCCHHHHHHHTTSCCCCCCCTSC-TTC-SSCCTTCEEEET
T ss_pred EEEEECCCCCHHHHHHHhCCCHHHHHHHcC-CCC-CCCCCCCEEEeC
Confidence 479999999999999999999999999996 444 469999999998
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.22 E-value=6.7e-06 Score=82.14 Aligned_cols=146 Identities=14% Similarity=0.151 Sum_probs=101.4
Q ss_pred HHHHHHhcCcccceeeeecCceEEEEEEECCceEEEEEeChhh---HHHHHHHHHHHHhcC-CCCCcceEEEEe-cCeEE
Q 046083 483 EELAKATNDFSMGNKIGQGGFGAVFYAELRGEKAAIKKMDMQA---SKEFLAELKVLTHVH-HLNLVRLIGYCV-EGSLF 557 (790)
Q Consensus 483 ~~l~~~~~~f~~~~~lG~G~fg~Vy~a~~~g~~vavK~~~~~~---~~~~~~E~~~l~~l~-h~niv~l~g~~~-~~~~~ 557 (790)
.++..-...|+..+..+-+..+.||+....+..+++|+..... ...+.+|...+..+. +--+.+++.+.. ++..+
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3556666777766665444457899998888889999886432 345778888888774 444567777765 45689
Q ss_pred EEEEEecCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC---------------------------------
Q 046083 558 LVYEYIENGNLNQHLRGSGKDTLTWSARMQIALDSARGLEYIHEHTV--------------------------------- 604 (790)
Q Consensus 558 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~--------------------------------- 604 (790)
+||+++++.++.+..... .. ...++.++++.++.||+...
T Consensus 87 lv~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 999999998886654321 11 22345556666666664221
Q ss_pred -----------------------CceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 605 -----------------------PVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 605 -----------------------~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
+.++|+|+.|.|||++++...-|.||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1369999999999999876677999998763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.74 E-value=4.3e-05 Score=75.62 Aligned_cols=129 Identities=18% Similarity=0.132 Sum_probs=83.7
Q ss_pred eeeecCc-eEEEEEEEC-CceEEEEEeChhhHHHHHHHHHHHHhcCC--CCCcceEEEEec-CeEEEEEEEecCCChhhh
Q 046083 497 KIGQGGF-GAVFYAELR-GEKAAIKKMDMQASKEFLAELKVLTHVHH--LNLVRLIGYCVE-GSLFLVYEYIENGNLNQH 571 (790)
Q Consensus 497 ~lG~G~f-g~Vy~a~~~-g~~vavK~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~-~~~~lv~e~~~~g~L~~~ 571 (790)
.+..|.. +.||+.... +..+++|........++..|...++.+.. -.+.+++.++.+ +..++||||++|-++.+.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~ 96 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSS 96 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTS
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccccc
Confidence 4445543 679999887 55688898876666667888888887743 335667777664 458999999988665431
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHHHHHHHH---------------------------------------------------
Q 046083 572 LRGSGKDTLTWSARMQIALDSARGLEYIH--------------------------------------------------- 600 (790)
Q Consensus 572 l~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------------------------------------------------- 600 (790)
. +.- ...+.++.+.|+-||
T Consensus 97 ~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 166 (255)
T d1nd4a_ 97 H-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 166 (255)
T ss_dssp C-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred c-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHH
Confidence 1 000 111122222233333
Q ss_pred hCC----CCceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 601 EHT----VPVYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 601 ~~~----~~~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
... -+.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 167 ~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 167 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 211 12379999999999999876678999998763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.04 E-value=0.00089 Score=70.56 Aligned_cols=73 Identities=18% Similarity=0.091 Sum_probs=47.4
Q ss_pred ceeeeecCceEEEEEEEC--CceEEEEEeChh----------hHHHHHHHHHHHHhcC-C--CCCcceEEEEecCeEEEE
Q 046083 495 GNKIGQGGFGAVFYAELR--GEKAAIKKMDMQ----------ASKEFLAELKVLTHVH-H--LNLVRLIGYCVEGSLFLV 559 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~--g~~vavK~~~~~----------~~~~~~~E~~~l~~l~-h--~niv~l~g~~~~~~~~lv 559 (790)
.+.||.|....||+.... ++.++||.-.+. .......|.+.|+.+. + ..+.+++.+.. ...++|
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~-~~~~lv 109 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT-EMAVTV 109 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET-TTTEEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC-CCCEEE
Confidence 567899999999999865 567888864321 1233456788787662 2 34556665543 345789
Q ss_pred EEEecCCCh
Q 046083 560 YEYIENGNL 568 (790)
Q Consensus 560 ~e~~~~g~L 568 (790)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.90 E-value=0.021 Score=57.45 Aligned_cols=157 Identities=14% Similarity=0.131 Sum_probs=87.9
Q ss_pred ccCHHHHHHHhcCcccceeee-----ecCceEEEEEEECCceEEEEEeChh-hHHHHHHHHHHHHhcCCC-----CCcce
Q 046083 479 EFSYEELAKATNDFSMGNKIG-----QGGFGAVFYAELRGEKAAIKKMDMQ-ASKEFLAELKVLTHVHHL-----NLVRL 547 (790)
Q Consensus 479 ~~~~~~l~~~~~~f~~~~~lG-----~G~fg~Vy~a~~~g~~vavK~~~~~-~~~~~~~E~~~l~~l~h~-----niv~l 547 (790)
.++.+|+.....+|.+++... .|---+.|+.+.++..+++|+.... ..+++..|++++..+.+. ..+..
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~ 81 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR 81 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCCCHHHHHHHHHHHHhhhhcccccccccee
Confidence 356678888888887755443 4555678999988888999998653 445566678788777422 22211
Q ss_pred E-E---EEecCeEEEEEEEecCCChhh--------------hhhc----CC-C--CCCCH------------------HH
Q 046083 548 I-G---YCVEGSLFLVYEYIENGNLNQ--------------HLRG----SG-K--DTLTW------------------SA 584 (790)
Q Consensus 548 ~-g---~~~~~~~~lv~e~~~~g~L~~--------------~l~~----~~-~--~~l~~------------------~~ 584 (790)
. | ...++....++.++.+..... .++. .. . ..... ..
T Consensus 82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (316)
T d2ppqa1 82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 161 (316)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence 1 1 122445566777776643321 0000 00 0 00000 01
Q ss_pred HHHHHHHHHHHHHHHHhCCCC-ceeecCCCCCCEEecCCCcEEEEEeCCCcc
Q 046083 585 RMQIALDSARGLEYIHEHTVP-VYIHRDIKPANILIDKNFRAKVADFGLAKL 635 (790)
Q Consensus 585 ~~~i~~~ia~~L~~LH~~~~~-~~vH~dlkp~NILl~~~~~~kl~DfGla~~ 635 (790)
....+......+.-.+....+ .+||+|+.+.||+++.+...-|.||+.+..
T Consensus 162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 112222233333333333322 369999999999999987778999998863
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.44 E-value=0.038 Score=55.85 Aligned_cols=64 Identities=11% Similarity=0.166 Sum_probs=43.4
Q ss_pred eEEEEEEEC-CceEEEEEeChh--hHHHHHHHHHHHHhcCCCCC--cceEE------EEecCeEEEEEEEecCCC
Q 046083 504 GAVFYAELR-GEKAAIKKMDMQ--ASKEFLAELKVLTHVHHLNL--VRLIG------YCVEGSLFLVYEYIENGN 567 (790)
Q Consensus 504 g~Vy~a~~~-g~~vavK~~~~~--~~~~~~~E~~~l~~l~h~ni--v~l~g------~~~~~~~~lv~e~~~~g~ 567 (790)
-.||++... |..+++|..++. ..+++..|...+..+....+ +..+. +..++..+.++++++|..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 489999886 788999998754 45778889998888742221 11111 223455788999998643
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.18 E-value=0.033 Score=57.97 Aligned_cols=72 Identities=21% Similarity=0.235 Sum_probs=48.0
Q ss_pred ceeeeecCceEEEEEEEC---------CceEEEEEeCh-hhHHHHHHHHHHHHhcCCCCC-cceEEEEecCeEEEEEEEe
Q 046083 495 GNKIGQGGFGAVFYAELR---------GEKAAIKKMDM-QASKEFLAELKVLTHVHHLNL-VRLIGYCVEGSLFLVYEYI 563 (790)
Q Consensus 495 ~~~lG~G~fg~Vy~a~~~---------g~~vavK~~~~-~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~lv~e~~ 563 (790)
.+.|+-|-.=.+|++... ...+.++.... ...-...+|..+++.+.-.++ .++++++.+ .+|+||+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~---g~I~efi 123 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG---GRLEEYI 123 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT---EEEECCC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC---ceEEEEe
Confidence 467777777899999864 24566666542 233456678888888853344 467777654 5789999
Q ss_pred cCCChh
Q 046083 564 ENGNLN 569 (790)
Q Consensus 564 ~~g~L~ 569 (790)
++..|.
T Consensus 124 ~g~~l~ 129 (395)
T d1nw1a_ 124 PSRPLS 129 (395)
T ss_dssp CEEECC
T ss_pred ccccCC
Confidence 875443
|